[
    {
        "id": "14967461.T1.T22",
        "sentence": "@CHEMICAL$ inhibitors currently under investigation include the small molecules @GENE$ (Iressa, ZD1839) and erlotinib (Tarceva, OSI-774), as well as monoclonal antibodies such as cetuximab (IMC-225, Erbitux).",
        "relation": "CPR:4"
    },
    {
        "id": "14967461.T2.T22",
        "sentence": "@CHEMICAL$ inhibitors currently under investigation include the small molecules gefitinib (@GENE$, ZD1839) and erlotinib (Tarceva, OSI-774), as well as monoclonal antibodies such as cetuximab (IMC-225, Erbitux).",
        "relation": "CPR:4"
    },
    {
        "id": "14967461.T3.T22",
        "sentence": "@CHEMICAL$ inhibitors currently under investigation include the small molecules gefitinib (Iressa, @GENE$) and erlotinib (Tarceva, OSI-774), as well as monoclonal antibodies such as cetuximab (IMC-225, Erbitux).",
        "relation": "CPR:4"
    },
    {
        "id": "14967461.T4.T22",
        "sentence": "@CHEMICAL$ inhibitors currently under investigation include the small molecules gefitinib (Iressa, ZD1839) and @GENE$ (Tarceva, OSI-774), as well as monoclonal antibodies such as cetuximab (IMC-225, Erbitux).",
        "relation": "CPR:4"
    },
    {
        "id": "14967461.T5.T22",
        "sentence": "@CHEMICAL$ inhibitors currently under investigation include the small molecules gefitinib (Iressa, ZD1839) and erlotinib (@GENE$, OSI-774), as well as monoclonal antibodies such as cetuximab (IMC-225, Erbitux).",
        "relation": "CPR:4"
    },
    {
        "id": "14967461.T6.T22",
        "sentence": "@CHEMICAL$ inhibitors currently under investigation include the small molecules gefitinib (Iressa, ZD1839) and erlotinib (Tarceva, @GENE$), as well as monoclonal antibodies such as cetuximab (IMC-225, Erbitux).",
        "relation": "CPR:4"
    },
    {
        "id": "14967461.T7.T22",
        "sentence": "@CHEMICAL$ inhibitors currently under investigation include the small molecules gefitinib (Iressa, ZD1839) and erlotinib (Tarceva, OSI-774), as well as monoclonal antibodies such as @GENE$ (IMC-225, Erbitux).",
        "relation": "CPR:4"
    },
    {
        "id": "14967461.T8.T22",
        "sentence": "@CHEMICAL$ inhibitors currently under investigation include the small molecules gefitinib (Iressa, ZD1839) and erlotinib (Tarceva, OSI-774), as well as monoclonal antibodies such as cetuximab (@GENE$, Erbitux).",
        "relation": "CPR:4"
    },
    {
        "id": "14967461.T9.T22",
        "sentence": "@CHEMICAL$ inhibitors currently under investigation include the small molecules gefitinib (Iressa, ZD1839) and erlotinib (Tarceva, OSI-774), as well as monoclonal antibodies such as cetuximab (IMC-225, @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "14967461.T10.T24",
        "sentence": "Agents that have only begun to undergo clinical evaluation include @CHEMICAL$, an irreversible pan-erbB @GENE$ inhibitor, and PKI166 and GW572016, both examples of dual kinase inhibitors (inhibiting epidermal growth factor receptor and Her2).",
        "relation": "CPR:4"
    },
    {
        "id": "14967461.T10.T23",
        "sentence": "Agents that have only begun to undergo clinical evaluation include @CHEMICAL$, an irreversible pan-@GENE$ tyrosine kinase inhibitor, and PKI166 and GW572016, both examples of dual kinase inhibitors (inhibiting epidermal growth factor receptor and Her2).",
        "relation": "CPR:4"
    },
    {
        "id": "14967461.T12.T25",
        "sentence": "Agents that have only begun to undergo clinical evaluation include CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, and @CHEMICAL$ and GW572016, both examples of dual @GENE$ inhibitors (inhibiting epidermal growth factor receptor and Her2).",
        "relation": "CPR:4"
    },
    {
        "id": "14967461.T12.T26",
        "sentence": "Agents that have only begun to undergo clinical evaluation include CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, and @CHEMICAL$ and GW572016, both examples of dual kinase inhibitors (inhibiting @GENE$ and Her2).",
        "relation": "CPR:4"
    },
    {
        "id": "14967461.T12.T27",
        "sentence": "Agents that have only begun to undergo clinical evaluation include CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, and @CHEMICAL$ and GW572016, both examples of dual kinase inhibitors (inhibiting epidermal growth factor receptor and @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "14967461.T13.T25",
        "sentence": "Agents that have only begun to undergo clinical evaluation include CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, and PKI166 and @CHEMICAL$, both examples of dual @GENE$ inhibitors (inhibiting epidermal growth factor receptor and Her2).",
        "relation": "CPR:4"
    },
    {
        "id": "14967461.T13.T26",
        "sentence": "Agents that have only begun to undergo clinical evaluation include CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, and PKI166 and @CHEMICAL$, both examples of dual kinase inhibitors (inhibiting @GENE$ and Her2).",
        "relation": "CPR:4"
    },
    {
        "id": "14967461.T13.T27",
        "sentence": "Agents that have only begun to undergo clinical evaluation include CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, and PKI166 and @CHEMICAL$, both examples of dual kinase inhibitors (inhibiting epidermal growth factor receptor and @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "7678677.T14.T19",
        "sentence": "@CHEMICAL$ and bromoacetylalprenololmenthane are competitive slowly reversible antagonists at the @GENE$ of rat left atria.",
        "relation": "CPR:6"
    },
    {
        "id": "7678677.T15.T19",
        "sentence": "Alprenolol and @CHEMICAL$ are competitive slowly reversible antagonists at the @GENE$ of rat left atria.",
        "relation": "CPR:6"
    },
    {
        "id": "7678677.T1.T16",
        "sentence": "Alprenolol and @CHEMICAL$ at 10(-7), 3 x 10(-7), and 10(-6) M inhibited the cardiac stimulation response slightly, which is indicative of membrane-stabilizing activity independent of @GENE$ blockade.",
        "relation": "CPR:4"
    },
    {
        "id": "7678677.T13.T16",
        "sentence": "@CHEMICAL$ and BAAM at 10(-7), 3 x 10(-7), and 10(-6) M inhibited the cardiac stimulation response slightly, which is indicative of membrane-stabilizing activity independent of @GENE$ blockade.",
        "relation": "CPR:4"
    },
    {
        "id": "7678677.T3.T17",
        "sentence": "@CHEMICAL$ and BAAM also caused surmountable antagonism of isoprenaline responses, and this @GENE$ antagonism was slowly reversible.",
        "relation": "CPR:6"
    },
    {
        "id": "7678677.T4.T17",
        "sentence": "Alprenolol and @CHEMICAL$ also caused surmountable antagonism of isoprenaline responses, and this @GENE$ antagonism was slowly reversible.",
        "relation": "CPR:6"
    },
    {
        "id": "7678677.T6.T17",
        "sentence": "Alprenolol and BAAM also caused surmountable antagonism of @CHEMICAL$ responses, and this @GENE$ antagonism was slowly reversible.",
        "relation": "CPR:5"
    },
    {
        "id": "7678677.T10.T18",
        "sentence": "We conclude that @CHEMICAL$ and BAAM are competitive slowly reversible @GENE$ antagonists on rat left atria.",
        "relation": "CPR:6"
    },
    {
        "id": "7678677.T11.T18",
        "sentence": "We conclude that alprenolol and @CHEMICAL$ are competitive slowly reversible @GENE$ antagonists on rat left atria.",
        "relation": "CPR:6"
    },
    {
        "id": "16789740.T4.T13",
        "sentence": "Discovery and optimization of @CHEMICAL$ as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of @GENE$ binding.",
        "relation": "CPR:4"
    },
    {
        "id": "17199504.T2.T12",
        "sentence": "@CHEMICAL$ plays a role in purine salvage by catalyzing the direct conversion of @GENE$ to adenosine monophosphate.",
        "relation": "CPR:9"
    },
    {
        "id": "17199504.T3.T12",
        "sentence": "@CHEMICAL$ plays a role in purine salvage by catalyzing the direct conversion of adenine to @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "16437532.T11.T39",
        "sentence": "BACKGROUND: Since the introduction of the first @CHEMICAL$ inhibitor (ChEI) in 1997, most clinicians and probably most patients would consider the cholinergic drugs, @GENE$, galantamine and rivastigmine, to be the first line pharmacotherapy for mild to moderate Alzheimer's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "16437532.T12.T39",
        "sentence": "BACKGROUND: Since the introduction of the first @CHEMICAL$ inhibitor (ChEI) in 1997, most clinicians and probably most patients would consider the cholinergic drugs, donepezil, @GENE$ and rivastigmine, to be the first line pharmacotherapy for mild to moderate Alzheimer's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "16437532.T15.T39",
        "sentence": "BACKGROUND: Since the introduction of the first @CHEMICAL$ inhibitor (ChEI) in 1997, most clinicians and probably most patients would consider the cholinergic drugs, donepezil, galantamine and @GENE$, to be the first line pharmacotherapy for mild to moderate Alzheimer's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "16437532.T25.T40",
        "sentence": "The drugs have slightly different pharmacological properties, but they all work by inhibiting the breakdown of @CHEMICAL$, an important neurotransmitter associated with memory, by blocking the enzyme @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "11716850.T1.T42",
        "sentence": "@CHEMICAL$ (KAD-1229), a new anti-diabetic drug, is thought to stimulate insulin secretion by closing the @GENE$ in pancreatic beta-cells.",
        "relation": "CPR:4"
    },
    {
        "id": "11716850.T1.T62",
        "sentence": "@CHEMICAL$ (KAD-1229), a new anti-diabetic drug, is thought to stimulate @GENE$ secretion by closing the ATP-sensitive K+ (K(ATP)) channels in pancreatic beta-cells.",
        "relation": "CPR:3"
    },
    {
        "id": "11716850.T15.T42",
        "sentence": "Mitiglinide (@CHEMICAL$), a new anti-diabetic drug, is thought to stimulate insulin secretion by closing the @GENE$ in pancreatic beta-cells.",
        "relation": "CPR:4"
    },
    {
        "id": "11716850.T15.T62",
        "sentence": "Mitiglinide (@CHEMICAL$), a new anti-diabetic drug, is thought to stimulate @GENE$ secretion by closing the ATP-sensitive K+ (K(ATP)) channels in pancreatic beta-cells.",
        "relation": "CPR:3"
    },
    {
        "id": "11716850.T33.T56",
        "sentence": "Patch-clamp analysis using inside-out recording configuration showed that @CHEMICAL$ inhibits the @GENE$/SUR1 channel currents in a dose-dependent manner (IC50 value, 100 nM) but does not significantly inhibit either Kir6.2/SUR2A or Kir6.2/SUR2B channel currents even at high doses (more than 10 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "11716850.T33.T57",
        "sentence": "Patch-clamp analysis using inside-out recording configuration showed that @CHEMICAL$ inhibits the Kir6.2/@GENE$ channel currents in a dose-dependent manner (IC50 value, 100 nM) but does not significantly inhibit either Kir6.2/SUR2A or Kir6.2/SUR2B channel currents even at high doses (more than 10 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "11716850.T34.T63",
        "sentence": "@CHEMICAL$ inhibits @GENE$/SUR1 and Kir6.2/SUR2B channels at 100 nM, and inhibits Kir6.2/SUR2A channels at high concentrations (1 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "11716850.T34.T64",
        "sentence": "@CHEMICAL$ inhibits Kir6.2/@GENE$ and Kir6.2/SUR2B channels at 100 nM, and inhibits Kir6.2/SUR2A channels at high concentrations (1 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "11716850.T34.T65",
        "sentence": "@CHEMICAL$ inhibits Kir6.2/SUR1 and @GENE$/SUR2B channels at 100 nM, and inhibits Kir6.2/SUR2A channels at high concentrations (1 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "11716850.T34.T66",
        "sentence": "@CHEMICAL$ inhibits Kir6.2/SUR1 and Kir6.2/@GENE$ channels at 100 nM, and inhibits Kir6.2/SUR2A channels at high concentrations (1 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "11716850.T34.T67",
        "sentence": "@CHEMICAL$ inhibits Kir6.2/SUR1 and Kir6.2/SUR2B channels at 100 nM, and inhibits @GENE$/SUR2A channels at high concentrations (1 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "11716850.T34.T68",
        "sentence": "@CHEMICAL$ inhibits Kir6.2/SUR1 and Kir6.2/SUR2B channels at 100 nM, and inhibits Kir6.2/@GENE$ channels at high concentrations (1 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "11716850.T25.T47",
        "sentence": "These results indicate that, similar to the sulfonylureas, mitiglinide is highly specific to the Kir6.2/SUR1 complex, i.e., the pancreatic beta-cell @CHEMICAL$, and suggest that @GENE$ may be a clinically useful anti-diabetic drug.",
        "relation": "CPR:5"
    },
    {
        "id": "23487168.T1.T14",
        "sentence": "Although generally highly specific for @CHEMICAL$, some ARBs, particularly @GENE$, are partial agonists at peroxisome proliferator-activated receptor-g.",
        "relation": "CPR:6"
    },
    {
        "id": "23487168.T1.T15",
        "sentence": "Although generally highly specific for angiotensin II type 1 receptors, some ARBs, particularly @CHEMICAL$, are partial agonists at @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "23019138.T17.T29",
        "sentence": "Direct-acting @CHEMICAL$ agonists, including @GENE$, WIN 55,212 [R-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate], AM2389 [9b-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol], and AM4054 [9b-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia.",
        "relation": "CPR:5"
    },
    {
        "id": "23019138.T18.T29",
        "sentence": "Direct-acting @CHEMICAL$ agonists, including D(9)-tetrahydrocannabinol, @GENE$ [R-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate], AM2389 [9b-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol], and AM4054 [9b-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia.",
        "relation": "CPR:5"
    },
    {
        "id": "23019138.T19.T29",
        "sentence": "Direct-acting @CHEMICAL$ agonists, including D(9)-tetrahydrocannabinol, WIN 55,212 [@GENE$], AM2389 [9b-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol], and AM4054 [9b-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia.",
        "relation": "CPR:5"
    },
    {
        "id": "23019138.T20.T29",
        "sentence": "Direct-acting @CHEMICAL$ agonists, including D(9)-tetrahydrocannabinol, WIN 55,212 [R-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate], @GENE$ [9b-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol], and AM4054 [9b-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia.",
        "relation": "CPR:5"
    },
    {
        "id": "23019138.T21.T29",
        "sentence": "Direct-acting @CHEMICAL$ agonists, including D(9)-tetrahydrocannabinol, WIN 55,212 [R-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate], AM2389 [@GENE$], and AM4054 [9b-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia.",
        "relation": "CPR:5"
    },
    {
        "id": "23019138.T22.T29",
        "sentence": "Direct-acting @CHEMICAL$ agonists, including D(9)-tetrahydrocannabinol, WIN 55,212 [R-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate], AM2389 [9b-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol], and @GENE$ [9b-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia.",
        "relation": "CPR:5"
    },
    {
        "id": "23019138.T23.T29",
        "sentence": "Direct-acting @CHEMICAL$ agonists, including D(9)-tetrahydrocannabinol, WIN 55,212 [R-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate], AM2389 [9b-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol], and AM4054 [@GENE$], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia.",
        "relation": "CPR:5"
    },
    {
        "id": "23019138.T5.T24",
        "sentence": "Methanandamide (10.0 mg/kg) had lesser effect than other CB agonists, and the @CHEMICAL$ agonist @GENE$ [1-(methylpiperidin-2-ylmethyl)-3-(2-iodo-5-nitrobenzoyl)indole], the anandamide transport inhibitor AM404, and the CB antagonist rimonabant did not have diuretic effects.",
        "relation": "CPR:5"
    },
    {
        "id": "23019138.T6.T24",
        "sentence": "Methanandamide (10.0 mg/kg) had lesser effect than other CB agonists, and the @CHEMICAL$ agonist AM1241 [@GENE$], the anandamide transport inhibitor AM404, and the CB antagonist rimonabant did not have diuretic effects.",
        "relation": "CPR:5"
    },
    {
        "id": "23019138.T8.T24",
        "sentence": "Methanandamide (10.0 mg/kg) had lesser effect than other CB agonists, and the @CHEMICAL$ agonist AM1241 [1-(methylpiperidin-2-ylmethyl)-3-(2-iodo-5-nitrobenzoyl)indole], the anandamide transport inhibitor @GENE$, and the CB antagonist rimonabant did not have diuretic effects.",
        "relation": "CPR:5"
    },
    {
        "id": "23019138.T10.T25",
        "sentence": "In further studies, the diuretic effects of the @CHEMICAL$ agonist @GENE$ were similar in male and female rats, displayed a relatively rapid onset to action, and were dose-dependently antagonized by 30 minutes pretreatment with rimonabant, but not by the vanilloid receptor type I antagonist capsazepine, nor were the effects of WIN 55,212 antagonized by the CB2 antagonist AM630 [(6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl) methanone)].",
        "relation": "CPR:5"
    },
    {
        "id": "23019138.T11.T25",
        "sentence": "In further studies, the diuretic effects of the @CHEMICAL$ agonist AM4054 were similar in male and female rats, displayed a relatively rapid onset to action, and were dose-dependently antagonized by 30 minutes pretreatment with @GENE$, but not by the vanilloid receptor type I antagonist capsazepine, nor were the effects of WIN 55,212 antagonized by the CB2 antagonist AM630 [(6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl) methanone)].",
        "relation": "CPR:6"
    },
    {
        "id": "23019138.T13.T26",
        "sentence": "In further studies, the diuretic effects of the CB1 agonist AM4054 were similar in male and female rats, displayed a relatively rapid onset to action, and were dose-dependently antagonized by 30 minutes pretreatment with rimonabant, but not by the @CHEMICAL$ antagonist @GENE$, nor were the effects of WIN 55,212 antagonized by the CB2 antagonist AM630 [(6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl) methanone)].",
        "relation": "CPR:6"
    },
    {
        "id": "23019138.T14.T27",
        "sentence": "In further studies, the diuretic effects of the CB1 agonist AM4054 were similar in male and female rats, displayed a relatively rapid onset to action, and were dose-dependently antagonized by 30 minutes pretreatment with rimonabant, but not by the vanilloid receptor type I antagonist capsazepine, nor were the effects of @CHEMICAL$ antagonized by the @GENE$ antagonist AM630 [(6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl) methanone)].",
        "relation": "CPR:5"
    },
    {
        "id": "23019138.T15.T27",
        "sentence": "In further studies, the diuretic effects of the CB1 agonist AM4054 were similar in male and female rats, displayed a relatively rapid onset to action, and were dose-dependently antagonized by 30 minutes pretreatment with rimonabant, but not by the vanilloid receptor type I antagonist capsazepine, nor were the effects of WIN 55,212 antagonized by the @CHEMICAL$ antagonist @GENE$ [(6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl) methanone)].",
        "relation": "CPR:6"
    },
    {
        "id": "23019138.T16.T27",
        "sentence": "In further studies, the diuretic effects of the CB1 agonist AM4054 were similar in male and female rats, displayed a relatively rapid onset to action, and were dose-dependently antagonized by 30 minutes pretreatment with rimonabant, but not by the vanilloid receptor type I antagonist capsazepine, nor were the effects of WIN 55,212 antagonized by the @CHEMICAL$ antagonist AM630 [@GENE$].",
        "relation": "CPR:6"
    },
    {
        "id": "12065695.T12.T24",
        "sentence": "@CHEMICAL$ (NS-398), a selective @GENE$ inhibitor, also inhibited cell proliferation, whereas it did not cause apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "12065695.T13.T24",
        "sentence": "N-[2-(cyclohexyloxyl)-4-nitrophenyl]-methanesulfonamide (@CHEMICAL$), a selective @GENE$ inhibitor, also inhibited cell proliferation, whereas it did not cause apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "15736931.T15.T45",
        "sentence": "Mutation of arginine 228 to lysine enhances the glucosyltransferase activity of bovine beta-1,4-galactosyltransferase I. Beta-1,4-galactosyltransferase I (beta4Gal-T1) normally transfers Gal from UDP-Gal to GlcNAc in the presence of Mn(2+) ion (Gal-T activity) and also transfers Glc from @CHEMICAL$ to GlcNAc (@GENE$ activity), albeit at only 0.3% efficiency.",
        "relation": "CPR:9"
    },
    {
        "id": "15736931.T30.T43",
        "sentence": "Mutation of arginine 228 to lysine enhances the glucosyltransferase activity of bovine beta-1,4-galactosyltransferase I. Beta-1,4-galactosyltransferase I (beta4Gal-T1) normally transfers Gal from @CHEMICAL$ to GlcNAc in the presence of Mn(2+) ion (@GENE$ activity) and also transfers Glc from UDP-Glc to GlcNAc (Glc-T activity), albeit at only 0.3% efficiency.",
        "relation": "CPR:9"
    },
    {
        "id": "15736931.T30.T38",
        "sentence": "Mutation of arginine 228 to lysine enhances the glucosyltransferase activity of bovine beta-1,4-galactosyltransferase I. @CHEMICAL$ (beta4Gal-T1) normally transfers Gal from @GENE$ to GlcNAc in the presence of Mn(2+) ion (Gal-T activity) and also transfers Glc from UDP-Glc to GlcNAc (Glc-T activity), albeit at only 0.3% efficiency.",
        "relation": "CPR:9"
    },
    {
        "id": "15736931.T30.T49",
        "sentence": "Mutation of arginine 228 to lysine enhances the glucosyltransferase activity of bovine beta-1,4-galactosyltransferase I. Beta-1,4-galactosyltransferase I (@CHEMICAL$) normally transfers Gal from @GENE$ to GlcNAc in the presence of Mn(2+) ion (Gal-T activity) and also transfers Glc from UDP-Glc to GlcNAc (Glc-T activity), albeit at only 0.3% efficiency.",
        "relation": "CPR:9"
    },
    {
        "id": "15736931.T37.T56",
        "sentence": "Mutation of arginine 228 to @CHEMICAL$ enhances the @GENE$ activity of bovine beta-1,4-galactosyltransferase I. Beta-1,4-galactosyltransferase I (beta4Gal-T1) normally transfers Gal from UDP-Gal to GlcNAc in the presence of Mn(2+) ion (Gal-T activity) and also transfers Glc from UDP-Glc to GlcNAc (Glc-T activity), albeit at only 0.3% efficiency.",
        "relation": "CPR:3"
    },
    {
        "id": "23414802.T4.T12",
        "sentence": "Discovery of novel @CHEMICAL$ derivatives as @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23414802.T1.T8",
        "sentence": "In this study, a novel series of @CHEMICAL$ derivatives were synthesized and evaluated for inhibiting TMPRSS4 @GENE$ activity and suppressing cancer cell invasion.",
        "relation": "CPR:4"
    },
    {
        "id": "23414802.T1.T7",
        "sentence": "In this study, a novel series of @CHEMICAL$ derivatives were synthesized and evaluated for inhibiting @GENE$ serine protease activity and suppressing cancer cell invasion.",
        "relation": "CPR:4"
    },
    {
        "id": "15908512.T13.T29",
        "sentence": "The selective @CHEMICAL$ agonist @GENE$ caused an enhancement of hippocampal CA3 network activity, as measured by an increase in frequency of spontaneous burst discharges recorded in the CA3 region.",
        "relation": "CPR:5"
    },
    {
        "id": "15908512.T5.T20",
        "sentence": "The selective @CHEMICAL$ antagonists @GENE$ and metoprolol blocked isoproterenol-induced enhancement, with apparent K(b) values of 85 +/- 36 and 3.9 +/- 1.7 nM, respectively.",
        "relation": "CPR:6"
    },
    {
        "id": "15908512.T6.T20",
        "sentence": "The selective @CHEMICAL$ antagonists atenolol and @GENE$ blocked isoproterenol-induced enhancement, with apparent K(b) values of 85 +/- 36 and 3.9 +/- 1.7 nM, respectively.",
        "relation": "CPR:6"
    },
    {
        "id": "15908512.T7.T20",
        "sentence": "The selective @CHEMICAL$ antagonists atenolol and metoprolol blocked @GENE$-induced enhancement, with apparent K(b) values of 85 +/- 36 and 3.9 +/- 1.7 nM, respectively.",
        "relation": "CPR:5"
    },
    {
        "id": "15908512.T9.T21",
        "sentence": "In contrast, the selective @CHEMICAL$ antagonists @GENE$ and butoxamine inhibited isoproterenol-mediated enhancement with apparent low affinities (K(b) of 222 +/- 61 and 9268 +/- 512 nM, respectively).",
        "relation": "CPR:6"
    },
    {
        "id": "15908512.T10.T21",
        "sentence": "In contrast, the selective @CHEMICAL$ antagonists ICI-118,551 and @GENE$ inhibited isoproterenol-mediated enhancement with apparent low affinities (K(b) of 222 +/- 61 and 9268 +/- 512 nM, respectively).",
        "relation": "CPR:6"
    },
    {
        "id": "15908512.T11.T21",
        "sentence": "In contrast, the selective @CHEMICAL$ antagonists ICI-118,551 and butoxamine inhibited @GENE$-mediated enhancement with apparent low affinities (K(b) of 222 +/- 61 and 9268 +/- 512 nM, respectively).",
        "relation": "CPR:5"
    },
    {
        "id": "15908512.T12.T24",
        "sentence": "Together, this pharmacological profile of subtype-selective betaAR antagonists indicates that in this model, @CHEMICAL$ activation is responsible for the enhanced hippocampal CA3 network activity initiated by @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "14507899.T15.T16",
        "sentence": "@CHEMICAL$ agonist @GENE$ enhances functional recovery after detachment caused by subretinal injection in normal and rds mice.",
        "relation": "CPR:5"
    },
    {
        "id": "12904467.T13.T24",
        "sentence": "Selective antagonism of GluR5 @CHEMICAL$-mediated synaptic currents by @GENE$ in rat basolateral amygdala neurons.",
        "relation": "CPR:6"
    },
    {
        "id": "12904467.T13.T23",
        "sentence": "Selective antagonism of @CHEMICAL$ kainate-receptor-mediated synaptic currents by @GENE$ in rat basolateral amygdala neurons.",
        "relation": "CPR:6"
    },
    {
        "id": "12904467.T5.T18",
        "sentence": "In whole-cell voltage-clamp recordings from principal neurons of the rat basolateral amygdala, @CHEMICAL$ at low concentrations (IC50, approximately 0.5 microm) selectively inhibited pharmacologically isolated excitatory synaptic currents mediated by @GENE$ containing the GluR5 subunit.",
        "relation": "CPR:4"
    },
    {
        "id": "12904467.T5.T19",
        "sentence": "In whole-cell voltage-clamp recordings from principal neurons of the rat basolateral amygdala, @CHEMICAL$ at low concentrations (IC50, approximately 0.5 microm) selectively inhibited pharmacologically isolated excitatory synaptic currents mediated by kainate receptors containing the @GENE$ subunit.",
        "relation": "CPR:4"
    },
    {
        "id": "12904467.T7.T20",
        "sentence": "@CHEMICAL$ also partially depressed predominantly @GENE$-mediated EPSCs, but with lower efficacy.",
        "relation": "CPR:4"
    },
    {
        "id": "12904467.T11.T22",
        "sentence": "Inhibition of GluR5 @CHEMICAL$ could represent a key mechanism underlying the anticonvulsant activity of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12904467.T11.T21",
        "sentence": "Inhibition of @CHEMICAL$ kainate receptors could represent a key mechanism underlying the anticonvulsant activity of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "16851960.T1.T17",
        "sentence": "Density functional theory calculations using the hybrid functional B3LYP have been performed to study the @CHEMICAL$ transfer step in @GENE$ (GNMT).",
        "relation": "CPR:9"
    },
    {
        "id": "16851960.T1.T18",
        "sentence": "Density functional theory calculations using the hybrid functional B3LYP have been performed to study the @CHEMICAL$ transfer step in glycine N-methyltransferase (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "16851960.T8.T19",
        "sentence": "The starting point for the calculations is the recent X-ray crystal structure of @CHEMICAL$ complexed with @GENE$ and acetate.",
        "relation": "CPR:9"
    },
    {
        "id": "16434489.T13.T38",
        "sentence": "@CHEMICAL$ (BMS-354825) inhibits KIT@GENE$, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis.",
        "relation": "CPR:4"
    },
    {
        "id": "16434489.T13.T37",
        "sentence": "@CHEMICAL$ (BMS-354825) inhibits @GENE$D816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis.",
        "relation": "CPR:4"
    },
    {
        "id": "16434489.T14.T38",
        "sentence": "Dasatinib (@CHEMICAL$) inhibits KIT@GENE$, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis.",
        "relation": "CPR:4"
    },
    {
        "id": "16434489.T7.T24",
        "sentence": "This mutation is inherently resistant to imatinib and, to date, there remains no effective curative therapy for systemic mastocytosis associated with KITD816V. @CHEMICAL$ (BMS-354825) is a novel orally bioavailable @GENE$/ABL inhibitor that has activity against multiple imatinib-resistant BCR-ABL isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia (CML).",
        "relation": "CPR:4"
    },
    {
        "id": "16434489.T7.T25",
        "sentence": "This mutation is inherently resistant to imatinib and, to date, there remains no effective curative therapy for systemic mastocytosis associated with KITD816V. @CHEMICAL$ (BMS-354825) is a novel orally bioavailable SRC/@GENE$ inhibitor that has activity against multiple imatinib-resistant BCR-ABL isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia (CML).",
        "relation": "CPR:4"
    },
    {
        "id": "16434489.T8.T24",
        "sentence": "This mutation is inherently resistant to imatinib and, to date, there remains no effective curative therapy for systemic mastocytosis associated with KITD816V. Dasatinib (@CHEMICAL$) is a novel orally bioavailable @GENE$/ABL inhibitor that has activity against multiple imatinib-resistant BCR-ABL isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia (CML).",
        "relation": "CPR:4"
    },
    {
        "id": "16434489.T8.T25",
        "sentence": "This mutation is inherently resistant to imatinib and, to date, there remains no effective curative therapy for systemic mastocytosis associated with KITD816V. Dasatinib (@CHEMICAL$) is a novel orally bioavailable SRC/@GENE$ inhibitor that has activity against multiple imatinib-resistant BCR-ABL isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia (CML).",
        "relation": "CPR:4"
    },
    {
        "id": "16434489.T11.T33",
        "sentence": "In this study, we demonstrate significant inhibitory activity of @CHEMICAL$ against both wild-type KIT and the KIT@GENE$ mutation in the nanomolar range in in vitro and cell-based kinase assays.",
        "relation": "CPR:4"
    },
    {
        "id": "16434489.T11.T30",
        "sentence": "In this study, we demonstrate significant inhibitory activity of @CHEMICAL$ against both wild-type @GENE$ and the KITD816V mutation in the nanomolar range in in vitro and cell-based kinase assays.",
        "relation": "CPR:4"
    },
    {
        "id": "16434489.T11.T32",
        "sentence": "In this study, we demonstrate significant inhibitory activity of @CHEMICAL$ against both wild-type KIT and the @GENE$D816V mutation in the nanomolar range in in vitro and cell-based kinase assays.",
        "relation": "CPR:4"
    },
    {
        "id": "16434489.T12.T36",
        "sentence": "Additionally, @CHEMICAL$ leads to growth inhibition of a KIT@GENE$-harboring human masto-cytosis cell line.",
        "relation": "CPR:4"
    },
    {
        "id": "16434489.T12.T35",
        "sentence": "Additionally, @CHEMICAL$ leads to growth inhibition of a @GENE$D816V-harboring human masto-cytosis cell line.",
        "relation": "CPR:4"
    },
    {
        "id": "12110374.T21.T40",
        "sentence": "Dopamine D(2) receptor-induced @CHEMICAL$-mediated production of @GENE$ in D(2)-transfected Chinese hamster ovary cells without simultaneous administration of a Ca(2+)-mobilizing agent.",
        "relation": "CPR:9"
    },
    {
        "id": "12110374.T12.T33",
        "sentence": "In the present report, we show that dopamine, under the same conditions, also induces a concentration-dependent increase in the production of PGE(2), with a maximal effect of 235% at approximately 100 microM, and with an EC(50) of 794 nM. The effect was counteracted by the @CHEMICAL$ antagonist @GENE$, pertussis toxin, the inhibitor of intracellular Ca(2+) release TMB-8, incubation in Ca(2+)-free experimental medium, and PKC desensitization obtained by chronic pretreatment with the phorbol ester TPA.",
        "relation": "CPR:6"
    },
    {
        "id": "12110374.T1.T22",
        "sentence": "It was also antagonized by the non-specific cyclooxygenase (COX) inhibitor, indomethacin, and by the selective COX-2 inhibitor, NS-398, but not by the specific @CHEMICAL$ inhibitor, @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12110374.T16.T36",
        "sentence": "It was also antagonized by the non-specific @CHEMICAL$ (COX) inhibitor, @GENE$, and by the selective COX-2 inhibitor, NS-398, but not by the specific COX-1 inhibitor, valeryl salicylate.",
        "relation": "CPR:4"
    },
    {
        "id": "12110374.T16.T37",
        "sentence": "It was also antagonized by the non-specific cyclooxygenase (@CHEMICAL$) inhibitor, @GENE$, and by the selective COX-2 inhibitor, NS-398, but not by the specific COX-1 inhibitor, valeryl salicylate.",
        "relation": "CPR:4"
    },
    {
        "id": "12110374.T18.T38",
        "sentence": "It was also antagonized by the non-specific cyclooxygenase (COX) inhibitor, indomethacin, and by the selective @CHEMICAL$ inhibitor, @GENE$, but not by the specific COX-1 inhibitor, valeryl salicylate.",
        "relation": "CPR:4"
    },
    {
        "id": "12110374.T2.T23",
        "sentence": "Both the non-specific @CHEMICAL$ inhibitor, @GENE$, and an inhibitor of cPLA(2) and iPLA(2), AACOF3, counteracted the effect; in contrast, a selective iPLA(2) inhibitor, BEL, and a selective sPLA(2) inhibitor, TAPC, were ineffective.",
        "relation": "CPR:4"
    },
    {
        "id": "12110374.T5.T28",
        "sentence": "The results reinforce previous assumptions that @CHEMICAL$ may interact with eicosanoid metabolism by means of @GENE$ activation, and implicate an involvement of cPLA(2) and COX-2 in this effect.",
        "relation": "CPR:3"
    },
    {
        "id": "23551063.T14.T31",
        "sentence": "A high throughput assay for the glucuronidation of @CHEMICAL$ by recombinant @GENE$ and liver microsomes.",
        "relation": "CPR:9"
    },
    {
        "id": "23551063.T7.T18",
        "sentence": "Abstract 1.  UDP-glucuronosyltransferases (UGTs) are versatile and important conjugation enzymes in the metabolism of drugs and other xenobiotics. 2.  We have developed a convenient quantitative multi-well plate assay to measure the glucuronidation rate of @CHEMICAL$ (HFC) for several @GENE$. 3.  We have used this method to screen 11 recombinant human UGTs for HFC glucuronidation activity and studied the reaction kinetics with the most active enzymes.",
        "relation": "CPR:9"
    },
    {
        "id": "23551063.T8.T18",
        "sentence": "Abstract 1.  UDP-glucuronosyltransferases (UGTs) are versatile and important conjugation enzymes in the metabolism of drugs and other xenobiotics. 2.  We have developed a convenient quantitative multi-well plate assay to measure the glucuronidation rate of 7-hydroxy-4-trifluoromethylcoumarin (@CHEMICAL$) for several @GENE$. 3.  We have used this method to screen 11 recombinant human UGTs for HFC glucuronidation activity and studied the reaction kinetics with the most active enzymes.",
        "relation": "CPR:9"
    },
    {
        "id": "23551063.T9.T19",
        "sentence": "Abstract 1.  UDP-glucuronosyltransferases (UGTs) are versatile and important conjugation enzymes in the metabolism of drugs and other xenobiotics. 2.  We have developed a convenient quantitative multi-well plate assay to measure the glucuronidation rate of 7-hydroxy-4-trifluoromethylcoumarin (HFC) for several UGTs. 3.  We have used this method to screen 11 recombinant @CHEMICAL$ for @GENE$ glucuronidation activity and studied the reaction kinetics with the most active enzymes.",
        "relation": "CPR:9"
    },
    {
        "id": "23551063.T11.T26",
        "sentence": "We have also examined the HFC glucuronidation activity of liver microsomes from human, pig, rabbit and rat. 4.  At a substrate concentration of 20 mM, the most active @CHEMICAL$ glucuronidation catalysts were UGT1A10 followed by UGT1A6 >UGT1A7 >UGT2A1, whereas at 300 mM UGT1A6 was about 10 times better catalyst than the other recombinant @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23551063.T11.T21",
        "sentence": "We have also examined the HFC glucuronidation activity of liver microsomes from human, pig, rabbit and rat. 4.  At a substrate concentration of 20 mM, the most active @CHEMICAL$ glucuronidation catalysts were @GENE$ followed by UGT1A6 >UGT1A7 >UGT2A1, whereas at 300 mM UGT1A6 was about 10 times better catalyst than the other recombinant UGTs.",
        "relation": "CPR:9"
    },
    {
        "id": "23551063.T11.T22",
        "sentence": "We have also examined the HFC glucuronidation activity of liver microsomes from human, pig, rabbit and rat. 4.  At a substrate concentration of 20 mM, the most active @CHEMICAL$ glucuronidation catalysts were UGT1A10 followed by @GENE$ >UGT1A7 >UGT2A1, whereas at 300 mM UGT1A6 was about 10 times better catalyst than the other recombinant UGTs.",
        "relation": "CPR:9"
    },
    {
        "id": "23551063.T11.T23",
        "sentence": "We have also examined the HFC glucuronidation activity of liver microsomes from human, pig, rabbit and rat. 4.  At a substrate concentration of 20 mM, the most active @CHEMICAL$ glucuronidation catalysts were UGT1A10 followed by UGT1A6 >@GENE$ >UGT2A1, whereas at 300 mM UGT1A6 was about 10 times better catalyst than the other recombinant UGTs.",
        "relation": "CPR:9"
    },
    {
        "id": "23551063.T11.T24",
        "sentence": "We have also examined the HFC glucuronidation activity of liver microsomes from human, pig, rabbit and rat. 4.  At a substrate concentration of 20 mM, the most active @CHEMICAL$ glucuronidation catalysts were UGT1A10 followed by UGT1A6 >UGT1A7 >@GENE$, whereas at 300 mM UGT1A6 was about 10 times better catalyst than the other recombinant UGTs.",
        "relation": "CPR:9"
    },
    {
        "id": "23551063.T11.T25",
        "sentence": "We have also examined the HFC glucuronidation activity of liver microsomes from human, pig, rabbit and rat. 4.  At a substrate concentration of 20 mM, the most active @CHEMICAL$ glucuronidation catalysts were UGT1A10 followed by UGT1A6 >UGT1A7 >UGT2A1, whereas at 300 mM @GENE$ was about 10 times better catalyst than the other recombinant UGTs.",
        "relation": "CPR:9"
    },
    {
        "id": "23551063.T1.T15",
        "sentence": "UGT1A6 exhibited a significantly higher Vmax and Km values toward both @CHEMICAL$ and UDP-glucuronic acid than the other @GENE$. 5.  Human, pig and rabbit, but not rat liver microsomes, catalyzed HFC glucuronidation at high rates. 6.  This new method is particularly suitable for fast activity screenings of UGTs 1A6, 1A7, 1A10 and 2A1 and HFC glucuronidation activity determination from various samples.",
        "relation": "CPR:9"
    },
    {
        "id": "23551063.T1.T30",
        "sentence": "@CHEMICAL$ exhibited a significantly higher Vmax and Km values toward both @GENE$ and UDP-glucuronic acid than the other UGTs. 5.  Human, pig and rabbit, but not rat liver microsomes, catalyzed HFC glucuronidation at high rates. 6.  This new method is particularly suitable for fast activity screenings of UGTs 1A6, 1A7, 1A10 and 2A1 and HFC glucuronidation activity determination from various samples.",
        "relation": "CPR:9"
    },
    {
        "id": "23551063.T2.T15",
        "sentence": "UGT1A6 exhibited a significantly higher Vmax and Km values toward both HFC and @CHEMICAL$-glucuronic acid than the other @GENE$. 5.  Human, pig and rabbit, but not rat liver microsomes, catalyzed HFC glucuronidation at high rates. 6.  This new method is particularly suitable for fast activity screenings of UGTs 1A6, 1A7, 1A10 and 2A1 and HFC glucuronidation activity determination from various samples.",
        "relation": "CPR:9"
    },
    {
        "id": "23551063.T2.T30",
        "sentence": "@CHEMICAL$ exhibited a significantly higher Vmax and Km values toward both HFC and @GENE$-glucuronic acid than the other UGTs. 5.  Human, pig and rabbit, but not rat liver microsomes, catalyzed HFC glucuronidation at high rates. 6.  This new method is particularly suitable for fast activity screenings of UGTs 1A6, 1A7, 1A10 and 2A1 and HFC glucuronidation activity determination from various samples.",
        "relation": "CPR:9"
    },
    {
        "id": "23551063.T3.T15",
        "sentence": "UGT1A6 exhibited a significantly higher Vmax and Km values toward both HFC and UDP-@CHEMICAL$ than the other @GENE$. 5.  Human, pig and rabbit, but not rat liver microsomes, catalyzed HFC glucuronidation at high rates. 6.  This new method is particularly suitable for fast activity screenings of UGTs 1A6, 1A7, 1A10 and 2A1 and HFC glucuronidation activity determination from various samples.",
        "relation": "CPR:9"
    },
    {
        "id": "23551063.T3.T30",
        "sentence": "@CHEMICAL$ exhibited a significantly higher Vmax and Km values toward both HFC and UDP-@GENE$ than the other UGTs. 5.  Human, pig and rabbit, but not rat liver microsomes, catalyzed HFC glucuronidation at high rates. 6.  This new method is particularly suitable for fast activity screenings of UGTs 1A6, 1A7, 1A10 and 2A1 and HFC glucuronidation activity determination from various samples.",
        "relation": "CPR:9"
    },
    {
        "id": "23474889.T3.T24",
        "sentence": "This inhibition was blocked when mice were pretreated with the selective @CHEMICAL$ agonist @GENE$ (10 mg/kg).",
        "relation": "CPR:5"
    },
    {
        "id": "14501155.T8.T23",
        "sentence": "The 5-HT(1/2/5/7)-receptor antagonist methysergide and the @CHEMICAL$ antagonist @GENE$ enhanced clomipramine-induced hyperglycemia, while the 5-HT(1A/1B)-receptor antagonist (-)-propranolol and the 5-HT(3/4)-receptor antagonist tropisetron did not affect it.",
        "relation": "CPR:6"
    },
    {
        "id": "14501155.T10.T24",
        "sentence": "The 5-HT(1/2/5/7)-receptor antagonist methysergide and the 5-HT(2A/2B/2C)-receptor antagonist LY 53857 enhanced clomipramine-induced hyperglycemia, while the @CHEMICAL$ antagonist @GENE$ and the 5-HT(3/4)-receptor antagonist tropisetron did not affect it.",
        "relation": "CPR:6"
    },
    {
        "id": "14501155.T11.T25",
        "sentence": "The 5-HT(1/2/5/7)-receptor antagonist methysergide and the 5-HT(2A/2B/2C)-receptor antagonist LY 53857 enhanced clomipramine-induced hyperglycemia, while the 5-HT(1A/1B)-receptor antagonist (-)-propranolol and the @CHEMICAL$ antagonist @GENE$ did not affect it.",
        "relation": "CPR:6"
    },
    {
        "id": "14501155.T13.T26",
        "sentence": "The @CHEMICAL$ antagonist @GENE$ facilitated hyperglycemia induced by clomipramine, although the 5-HT(2A)-receptor antagonist ketanserin was without effect.",
        "relation": "CPR:6"
    },
    {
        "id": "14501155.T15.T27",
        "sentence": "The 5-HT(2B/2C)-receptor antagonist SB 206553 facilitated hyperglycemia induced by clomipramine, although the @CHEMICAL$-receptor antagonist @GENE$ was without effect.",
        "relation": "CPR:6"
    },
    {
        "id": "14501155.T17.T28",
        "sentence": "These results suggest that @CHEMICAL$ induces hyperglycemia in mice by blocking the @GENE$and/or 5-HT(2C) receptors, which results in facilitation of adrenaline release.",
        "relation": "CPR:4"
    },
    {
        "id": "14501155.T17.T29",
        "sentence": "These results suggest that @CHEMICAL$ induces hyperglycemia in mice by blocking the 5-HT(2B )and/or @GENE$ receptors, which results in facilitation of adrenaline release.",
        "relation": "CPR:4"
    },
    {
        "id": "14984733.T1.T22",
        "sentence": "@CHEMICAL$ (PtdSer) is made in mammalian cells by two @GENE$, PSS1 and PSS2.",
        "relation": "CPR:9"
    },
    {
        "id": "14984733.T1.T25",
        "sentence": "@CHEMICAL$ (PtdSer) is made in mammalian cells by two PtdSer synthases, @GENE$ and PSS2.",
        "relation": "CPR:9"
    },
    {
        "id": "14984733.T1.T26",
        "sentence": "@CHEMICAL$ (PtdSer) is made in mammalian cells by two PtdSer synthases, PSS1 and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "14984733.T6.T18",
        "sentence": "Moreover, a normal level of expression of @CHEMICAL$ and/or PSS2 is not required for generating the pool of @GENE$ externalized during apoptosis.",
        "relation": "CPR:9"
    },
    {
        "id": "14984733.T6.T19",
        "sentence": "Moreover, a normal level of expression of PSS1 and/or @CHEMICAL$ is not required for generating the pool of @GENE$ externalized during apoptosis.",
        "relation": "CPR:9"
    },
    {
        "id": "15126366.T13.T32",
        "sentence": "@CHEMICAL$ isoforms did show different sensitivity and selectivity for down-regulation by @GENE$ and phorbol 12-myristate 13-acetate (PMA) in WEHI-231, HOP-92, and Colo-205 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "15126366.T14.T32",
        "sentence": "@CHEMICAL$ isoforms did show different sensitivity and selectivity for down-regulation by I3A and @GENE$ (PMA) in WEHI-231, HOP-92, and Colo-205 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "15126366.T15.T32",
        "sentence": "@CHEMICAL$ isoforms did show different sensitivity and selectivity for down-regulation by I3A and phorbol 12-myristate 13-acetate (@GENE$) in WEHI-231, HOP-92, and Colo-205 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "15126366.T2.T36",
        "sentence": "I3A induced a higher level of secretion of the inflammatory @CHEMICAL$ interleukin 6 compared with @GENE$ in the WEHI-231 cells and displayed a marked biphasic dose-response curve for the induction.",
        "relation": "CPR:3"
    },
    {
        "id": "15126366.T2.T24",
        "sentence": "I3A induced a higher level of secretion of the inflammatory cytokine @CHEMICAL$ compared with @GENE$ in the WEHI-231 cells and displayed a marked biphasic dose-response curve for the induction.",
        "relation": "CPR:3"
    },
    {
        "id": "15126366.T22.T36",
        "sentence": "@CHEMICAL$ induced a higher level of secretion of the inflammatory @GENE$ interleukin 6 compared with PMA in the WEHI-231 cells and displayed a marked biphasic dose-response curve for the induction.",
        "relation": "CPR:3"
    },
    {
        "id": "15126366.T22.T24",
        "sentence": "@CHEMICAL$ induced a higher level of secretion of the inflammatory cytokine @GENE$ compared with PMA in the WEHI-231 cells and displayed a marked biphasic dose-response curve for the induction.",
        "relation": "CPR:3"
    },
    {
        "id": "15126366.T6.T27",
        "sentence": "The in vitro kinase activity of @CHEMICAL$ induced by @GENE$ was lower than that induced by PMA.",
        "relation": "CPR:3"
    },
    {
        "id": "15126366.T7.T27",
        "sentence": "The in vitro kinase activity of @CHEMICAL$ induced by I3A was lower than that induced by @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23629516.T2.T21",
        "sentence": "@CHEMICAL$, liver fatty-acid binding protein and cytochrome P450 (CYP) 3A37 mRNA levels were significantly induced by @GENE$, while TDCPP induced CYP3A37 and CYP2H1.",
        "relation": "CPR:3"
    },
    {
        "id": "23629516.T2.T22",
        "sentence": "Type I deiodinase, @CHEMICAL$ and cytochrome P450 (CYP) 3A37 mRNA levels were significantly induced by @GENE$, while TDCPP induced CYP3A37 and CYP2H1.",
        "relation": "CPR:3"
    },
    {
        "id": "23629516.T2.T23",
        "sentence": "Type I deiodinase, liver fatty-acid binding protein and @CHEMICAL$ mRNA levels were significantly induced by @GENE$, while TDCPP induced CYP3A37 and CYP2H1.",
        "relation": "CPR:3"
    },
    {
        "id": "23629516.T3.T19",
        "sentence": "Type I deiodinase, liver fatty-acid binding protein and cytochrome P450 (CYP) 3A37 mRNA levels were significantly induced by TCPP, while @CHEMICAL$ induced @GENE$ and CYP2H1.",
        "relation": "CPR:3"
    },
    {
        "id": "23629516.T3.T20",
        "sentence": "Type I deiodinase, liver fatty-acid binding protein and cytochrome P450 (CYP) 3A37 mRNA levels were significantly induced by TCPP, while @CHEMICAL$ induced CYP3A37 and @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23418674.T2.T10",
        "sentence": "The results suggested that both the @CHEMICAL$ extract and berberine were able to activate @GENE$, and Rhizoma Coptis contains potential natural agonists of PPARs besides berberine.",
        "relation": "CPR:5"
    },
    {
        "id": "23418674.T3.T10",
        "sentence": "The results suggested that both the EtOAc extract and @CHEMICAL$ were able to activate @GENE$, and Rhizoma Coptis contains potential natural agonists of PPARs besides berberine.",
        "relation": "CPR:5"
    },
    {
        "id": "23418674.T4.T10",
        "sentence": "The results suggested that both the EtOAc extract and berberine were able to activate @CHEMICAL$, and Rhizoma Coptis contains potential natural agonists of PPARs besides @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "23418674.T4.T12",
        "sentence": "The results suggested that both the EtOAc extract and berberine were able to activate PPARa/b/g, and Rhizoma Coptis contains potential natural agonists of @CHEMICAL$ besides @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "10583449.T12.T19",
        "sentence": "This hypothesis was tested by investigating whether, in subjects with essential hypertension, the natriuretic response to specific @CHEMICAL$-angiotensin-aldosterone system (RAAS) blockade by renin-inhibitor @GENE$ could be predicted from pretreatment renal vascular tone.",
        "relation": "CPR:4"
    },
    {
        "id": "10583449.T12.T20",
        "sentence": "This hypothesis was tested by investigating whether, in subjects with essential hypertension, the natriuretic response to specific renin-@CHEMICAL$-aldosterone system (RAAS) blockade by renin-inhibitor @GENE$ could be predicted from pretreatment renal vascular tone.",
        "relation": "CPR:4"
    },
    {
        "id": "10583449.T12.T21",
        "sentence": "This hypothesis was tested by investigating whether, in subjects with essential hypertension, the natriuretic response to specific renin-angiotensin-aldosterone system (RAAS) blockade by @CHEMICAL$-inhibitor @GENE$ could be predicted from pretreatment renal vascular tone.",
        "relation": "CPR:4"
    },
    {
        "id": "9003761.T6.T24",
        "sentence": "These channels have a conductance of 14 pS. TREK-1 currents are insensitive to pharmacological agents that block @CHEMICAL$ activity such as @GENE$ and quinidine.",
        "relation": "CPR:4"
    },
    {
        "id": "9003761.T7.T24",
        "sentence": "These channels have a conductance of 14 pS. TREK-1 currents are insensitive to pharmacological agents that block @CHEMICAL$ activity such as quinine and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "14757703.T14.T35",
        "sentence": "@CHEMICAL$ mediates cardiostimulation by activation of the 'putative' @GENE$; however, it has recently been reported that disruption of the beta(1)-adrenoceptor gene abolishes this effect.",
        "relation": "CPR:3"
    },
    {
        "id": "14757703.T14.T27",
        "sentence": "@CHEMICAL$ mediates cardiostimulation by activation of the 'putative' beta(4)-adrenoceptor; however, it has recently been reported that disruption of the @GENE$ gene abolishes this effect.",
        "relation": "CPR:3"
    },
    {
        "id": "14757703.T6.T25",
        "sentence": "@CHEMICAL$ but not isoprenaline initiated arrhythmias at lower concentrations following @GENE$ overexpression. 5. (125)I-Cyanopindolol saturation binding in Adv.beta(1) myocytes demonstrated approximately 18-fold increase in beta(1)-adrenoceptors. (3)H-CGP 12177A saturation binding, in the presence of propranolol, increased approximately 5-fold following overexpression of beta(1)-adrenoceptors. 6.",
        "relation": "CPR:3"
    },
    {
        "id": "14757703.T8.T26",
        "sentence": "CGP 12177A but not isoprenaline initiated arrhythmias at lower concentrations following beta(1)-adrenoceptor overexpression. 5. @CHEMICAL$ saturation binding in Adv.beta(1) myocytes demonstrated approximately 18-fold increase in @GENE$. (3)H-CGP 12177A saturation binding, in the presence of propranolol, increased approximately 5-fold following overexpression of beta(1)-adrenoceptors. 6.",
        "relation": "CPR:3"
    },
    {
        "id": "14757703.T9.T28",
        "sentence": "CGP 12177A but not isoprenaline initiated arrhythmias at lower concentrations following beta(1)-adrenoceptor overexpression. 5. (125)I-Cyanopindolol saturation binding in Adv.beta(1) myocytes demonstrated approximately 18-fold increase in beta(1)-adrenoceptors. @CHEMICAL$ saturation binding, in the presence of propranolol, increased approximately 5-fold following overexpression of @GENE$. 6.",
        "relation": "CPR:3"
    },
    {
        "id": "14757703.T10.T28",
        "sentence": "CGP 12177A but not isoprenaline initiated arrhythmias at lower concentrations following beta(1)-adrenoceptor overexpression. 5. (125)I-Cyanopindolol saturation binding in Adv.beta(1) myocytes demonstrated approximately 18-fold increase in beta(1)-adrenoceptors. (3)H-CGP 12177A saturation binding, in the presence of @CHEMICAL$, increased approximately 5-fold following overexpression of @GENE$. 6.",
        "relation": "CPR:3"
    },
    {
        "id": "11287128.T1.T3",
        "sentence": "In contrast, in the presence of @CHEMICAL$ UFH accelerated the inhibition of @GENE$ by antithrombin 10-fold more efficiently than comparable concentrations of the high affinity fractions of enoxaparin and fragmin.",
        "relation": "CPR:4"
    },
    {
        "id": "11287128.T1.T4",
        "sentence": "In contrast, in the presence of @CHEMICAL$ UFH accelerated the inhibition of factor Xa by @GENE$ 10-fold more efficiently than comparable concentrations of the high affinity fractions of enoxaparin and fragmin.",
        "relation": "CPR:4"
    },
    {
        "id": "15673388.T5.T8",
        "sentence": "\"INTRODUCTION: The principal aim of this study was to assess the efficacy of @CHEMICAL$ in suppressing @GENE$ in vitro and in modulating the rate dependence of the QT interval in the \"\"SQT1\"\" form of the short QT syndrome.\"",
        "relation": "CPR:4"
    },
    {
        "id": "15673388.T2.T9",
        "sentence": "CONCLUSION: Oral @CHEMICAL$ is effective in suppressing the gain of function in @GENE$ responsible for some cases of short QT syndrome with a mutation in HERG and thus restoring normal rate dependence of the QT interval and rendering ventricular tachycardia/ventricular fibrillation noninducible.",
        "relation": "CPR:4"
    },
    {
        "id": "15070163.T6.T13",
        "sentence": "The IC50-values obtained for the inhibition of lipopolysaccharide (LPS)-induced release of prostaglandin E2 (PGE2) reflecting @CHEMICAL$-mediated @GENE$ release were 47 microg/ml and 0.6 microg/ml, for the Salix extract 1520L and rofecoxib-like research compound L745337, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "15070163.T1.T11",
        "sentence": "Our results indicate that Salix extract 1520L inhibits @CHEMICAL$-mediated @GENE$ release through compounds other than salicin or salicylate.",
        "relation": "CPR:9"
    },
    {
        "id": "11299519.T1.T3",
        "sentence": "Mutations in the follicle-stimulating hormone-beta (FSH beta) and FSH receptor genes in mice and humans. @CHEMICAL$ (FSH), a dimeric glycoprotein synthesized in the anterior pituitary gland, is important for the production of sex @GENE$ and gametes.",
        "relation": "CPR:9"
    },
    {
        "id": "11299519.T1.T8",
        "sentence": "Mutations in the follicle-stimulating hormone-beta (FSH beta) and FSH receptor genes in mice and humans. Follicle-stimulating hormone (@CHEMICAL$), a dimeric glycoprotein synthesized in the anterior pituitary gland, is important for the production of sex @GENE$ and gametes.",
        "relation": "CPR:9"
    },
    {
        "id": "11299519.T2.T9",
        "sentence": "Humans with @CHEMICAL$ gene mutations tend to have a more severe phenotype than those with FSHR gene mutations, although infertility and varying degrees of impaired sex @GENE$ production occur in both types of mutations.",
        "relation": "CPR:9"
    },
    {
        "id": "17333137.T7.T19",
        "sentence": "OBJECTIVES: The aim of the current study was to assess the activity of @CHEMICAL$, a nonsubtype-selective @GENE$ inhibitor, in several animal models predictive of antipsychotic-like efficacy and side-effect liability and to use PDE4B wild-type and knockout mice to begin to understand the subtypes involved in the activity of rolipram.",
        "relation": "CPR:4"
    },
    {
        "id": "17333137.T5.T17",
        "sentence": "These results suggest that PDE4B mediates the antipsychotic effects of rolipram in CAR and that the @CHEMICAL$-regulated @GENE$ signaling pathway may play a role in the pathophysiology and pharmacotherapy of psychosis.",
        "relation": "CPR:9"
    },
    {
        "id": "14523001.T3.T18",
        "sentence": "@CHEMICAL$, the transporter for the essential @GENE$, arginine and lysine, is one of the up-regulated genes.",
        "relation": "CPR:9"
    },
    {
        "id": "14523001.T4.T18",
        "sentence": "@CHEMICAL$, the transporter for the essential amino acids, @GENE$ and lysine, is one of the up-regulated genes.",
        "relation": "CPR:9"
    },
    {
        "id": "14523001.T5.T18",
        "sentence": "@CHEMICAL$, the transporter for the essential amino acids, arginine and @GENE$, is one of the up-regulated genes.",
        "relation": "CPR:9"
    },
    {
        "id": "23644411.T1.T17",
        "sentence": "RESULTS: Fractionated bulb extracts and the two isolated @CHEMICAL$ (1) and (2) induced NO production and @GENE$ mRNA expression in fibroblast cell culture.",
        "relation": "CPR:3"
    },
    {
        "id": "10988273.T13.T21",
        "sentence": "On the basis of data obtained in rabbits, the imidazoline receptor ligand @CHEMICAL$ has been suggested to decrease blood pressure in humans by activating central @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "10988273.T10.T25",
        "sentence": "A prerequisite for this hypothesis was the unproved assumption that rabbit and human @CHEMICAL$ are equally activated by @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "10988273.T14.T29",
        "sentence": "Human atrial appendages and rabbit pulmonary arteries were used to determine the potencies of alpha(2)-adrenoceptor agonists in inhibiting the electrically (2 Hz) evoked [(3)H]norepinephrine release and of antagonists in counteracting the @CHEMICAL$-mediated inhibition induced by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "10988273.T1.T30",
        "sentence": "In the rabbit pulmonary artery, rilmenidine and oxymetazoline are potent full agonists, whereas in the human atrial appendages they are antagonists at the @CHEMICAL$, sharing this property with @GENE$, phentolamine, and idazoxan.",
        "relation": "CPR:6"
    },
    {
        "id": "10988273.T2.T30",
        "sentence": "In the rabbit pulmonary artery, rilmenidine and oxymetazoline are potent full agonists, whereas in the human atrial appendages they are antagonists at the @CHEMICAL$, sharing this property with rauwolscine, @GENE$, and idazoxan.",
        "relation": "CPR:6"
    },
    {
        "id": "10988273.T3.T30",
        "sentence": "In the rabbit pulmonary artery, rilmenidine and oxymetazoline are potent full agonists, whereas in the human atrial appendages they are antagonists at the @CHEMICAL$, sharing this property with rauwolscine, phentolamine, and @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "10988273.T15.T30",
        "sentence": "In the rabbit pulmonary artery, @CHEMICAL$ and oxymetazoline are potent full agonists, whereas in the human atrial appendages they are antagonists at the @GENE$, sharing this property with rauwolscine, phentolamine, and idazoxan.",
        "relation": "CPR:6"
    },
    {
        "id": "10988273.T16.T30",
        "sentence": "In the rabbit pulmonary artery, rilmenidine and @CHEMICAL$ are potent full agonists, whereas in the human atrial appendages they are antagonists at the @GENE$, sharing this property with rauwolscine, phentolamine, and idazoxan.",
        "relation": "CPR:6"
    },
    {
        "id": "10988273.T6.T20",
        "sentence": "The sympathetic nerves of both the human atrial appendages and rabbit pulmonary artery are endowed with @CHEMICAL$, at which, however, both @GENE$ and oxymetazoline exhibit different properties (antagonism and agonism, respectively).",
        "relation": "CPR:6"
    },
    {
        "id": "10988273.T7.T20",
        "sentence": "The sympathetic nerves of both the human atrial appendages and rabbit pulmonary artery are endowed with @CHEMICAL$, at which, however, both rilmenidine and @GENE$ exhibit different properties (antagonism and agonism, respectively).",
        "relation": "CPR:5"
    },
    {
        "id": "10988273.T8.T22",
        "sentence": "The antagonistic property of @CHEMICAL$ at @GENE$ indicates that in contrast to the suggestion based on rabbit data, the hypotensive property of the drug in humans is not due to activation of alpha(2A)-adrenoceptors but other, presumably I(1)-imidazoline receptors, are probably involved.",
        "relation": "CPR:6"
    },
    {
        "id": "12606421.T6.T35",
        "sentence": "@CHEMICAL$ completely blocked the rise of levels of the two most abundant species, 5.0 kb and 4.5 kb, of the @GENE$ mRNA, during both the infantile and the juvenile periods.",
        "relation": "CPR:4"
    },
    {
        "id": "12606421.T8.T36",
        "sentence": "@CHEMICAL$ also abolished the developmental rise of the @GENE$ subunit mRNAs during the two periods of the study.",
        "relation": "CPR:4"
    },
    {
        "id": "2568212.T13.T36",
        "sentence": "The chemistry, pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosages of the nonsedating @CHEMICAL$ antagonists @GENE$, astemizole, loratadine, and acrivastine are reviewed.",
        "relation": "CPR:6"
    },
    {
        "id": "2568212.T14.T36",
        "sentence": "The chemistry, pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosages of the nonsedating @CHEMICAL$ antagonists terfenadine, @GENE$, loratadine, and acrivastine are reviewed.",
        "relation": "CPR:6"
    },
    {
        "id": "2568212.T15.T36",
        "sentence": "The chemistry, pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosages of the nonsedating @CHEMICAL$ antagonists terfenadine, astemizole, @GENE$, and acrivastine are reviewed.",
        "relation": "CPR:6"
    },
    {
        "id": "2568212.T16.T36",
        "sentence": "The chemistry, pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosages of the nonsedating @CHEMICAL$ antagonists terfenadine, astemizole, loratadine, and @GENE$ are reviewed.",
        "relation": "CPR:6"
    },
    {
        "id": "2568212.T17.T37",
        "sentence": "@CHEMICAL$ and astemizole are chemically unrelated to @GENE$ antagonists such as diphenhydramine and chlorpheniramine.",
        "relation": "CPR:6"
    },
    {
        "id": "2568212.T18.T37",
        "sentence": "Terfenadine and @CHEMICAL$ are chemically unrelated to @GENE$ antagonists such as diphenhydramine and chlorpheniramine.",
        "relation": "CPR:6"
    },
    {
        "id": "2568212.T20.T37",
        "sentence": "Terfenadine and astemizole are chemically unrelated to @CHEMICAL$ antagonists such as @GENE$ and chlorpheniramine.",
        "relation": "CPR:6"
    },
    {
        "id": "2568212.T21.T37",
        "sentence": "Terfenadine and astemizole are chemically unrelated to @CHEMICAL$ antagonists such as diphenhydramine and @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "23597450.T13.T36",
        "sentence": "Anti-inflammatory effect of @CHEMICAL$ via the suppression of @GENE$ pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23597450.T10.T34",
        "sentence": "Promoter assay revealed that @CHEMICAL$ inhibits LPS-induced nitric oxide and prostaglandin E2 production through the suppression of @GENE$ and COX-2 at the transcriptional level.",
        "relation": "CPR:4"
    },
    {
        "id": "23597450.T10.T35",
        "sentence": "Promoter assay revealed that @CHEMICAL$ inhibits LPS-induced nitric oxide and prostaglandin E2 production through the suppression of iNOS and @GENE$ at the transcriptional level.",
        "relation": "CPR:4"
    },
    {
        "id": "23597450.T2.T14",
        "sentence": "In addition, @CHEMICAL$ inhibits @GENE$-dependent inflammatory responses by modulating IkB kinase (IKK)-inhibitor kBa (IkBa)-NF-kB signaling.",
        "relation": "CPR:4"
    },
    {
        "id": "23597450.T3.T20",
        "sentence": "Consistent with these results, @CHEMICAL$ significantly reduced serum levels of inflammatory @GENE$ and mortality in mice challenged with lipopolysaccharide.",
        "relation": "CPR:4"
    },
    {
        "id": "23274894.T10.T27",
        "sentence": "G6PC2: A Negative Regulator of Basal @CHEMICAL$-Stimulated @GENE$ Secretion. Elevated fasting blood glucose (FBG) is associated with increased risk for the development of type 2 diabetes and cardiovascular-associated mortality.",
        "relation": "CPR:3"
    },
    {
        "id": "23274894.T9.T24",
        "sentence": "G6pc2 deletion resulted in a leftward shift in the dose-response curve for @CHEMICAL$-stimulated @GENE$ secretion (GSIS).",
        "relation": "CPR:3"
    },
    {
        "id": "23274894.T4.T14",
        "sentence": "These data suggest that @CHEMICAL$ represents a novel, negative regulator of basal GSIS that acts by hydrolyzing @GENE$, thereby reducing glycolytic flux.",
        "relation": "CPR:9"
    },
    {
        "id": "23362262.T2.T43",
        "sentence": "Using the @CHEMICAL$ inhibitor @GENE$ we found that TGFb-induced both early and sustained activation of TORC1 and TORC2 was necessary for deptor suppression.",
        "relation": "CPR:4"
    },
    {
        "id": "23362262.T3.T49",
        "sentence": "@CHEMICAL$-induced reversal of @GENE$ suppression by TGFb was associated with a significant inhibition of TGFb-stimulated protein synthesis and hypertrophy.",
        "relation": "CPR:3"
    },
    {
        "id": "22537794.T15.T39",
        "sentence": "METHODS: (+/-)-Modafinil and its R-(-)- and S-(+)-enantiomers were synthesized and tested for inhibition of @CHEMICAL$ (DA) uptake and [(3)H]WIN 35428 binding in @GENE$ (DAT) wild-type and mutants with altered conformational equilibria.",
        "relation": "CPR:9"
    },
    {
        "id": "22537794.T15.T40",
        "sentence": "METHODS: (+/-)-Modafinil and its R-(-)- and S-(+)-enantiomers were synthesized and tested for inhibition of @CHEMICAL$ (DA) uptake and [(3)H]WIN 35428 binding in human dopamine transporter (@GENE$) wild-type and mutants with altered conformational equilibria.",
        "relation": "CPR:9"
    },
    {
        "id": "22537794.T16.T39",
        "sentence": "METHODS: (+/-)-Modafinil and its R-(-)- and S-(+)-enantiomers were synthesized and tested for inhibition of [(3)H] dopamine (@CHEMICAL$) uptake and [(3)H]WIN 35428 binding in @GENE$ (DAT) wild-type and mutants with altered conformational equilibria.",
        "relation": "CPR:9"
    },
    {
        "id": "22537794.T16.T40",
        "sentence": "METHODS: (+/-)-Modafinil and its R-(-)- and S-(+)-enantiomers were synthesized and tested for inhibition of [(3)H] dopamine (@CHEMICAL$) uptake and [(3)H]WIN 35428 binding in human dopamine transporter (@GENE$) wild-type and mutants with altered conformational equilibria.",
        "relation": "CPR:9"
    },
    {
        "id": "22537794.T25.T41",
        "sentence": "RESULTS: (+/-)-, R-, and S-modafinil bind to the @CHEMICAL$ and inhibit @GENE$ uptake less potently than cocaine, with R-modafinil having approximately threefold higher affinity than its S-enantiomer.",
        "relation": "CPR:9"
    },
    {
        "id": "23411172.T6.T24",
        "sentence": "Apple @CHEMICAL$ suppress antigen presentation of @GENE$ by THP-1-derived dendritic cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23411172.T2.T10",
        "sentence": "A significant decrease in @CHEMICAL$ expression was observed in the AP and fractionated @GENE$-treated cells in the presence of ovalbumin (OVA), but no effect on CD86 expression was observed.",
        "relation": "CPR:4"
    },
    {
        "id": "23411172.T4.T21",
        "sentence": "Furthermore, the up-regulation of @CHEMICAL$ and TNF-a was found in the @GENE$ trimers-treated cells in the presence of OVA.",
        "relation": "CPR:3"
    },
    {
        "id": "23411172.T4.T22",
        "sentence": "Furthermore, the up-regulation of IL-12 and @CHEMICAL$ was found in the @GENE$ trimers-treated cells in the presence of OVA.",
        "relation": "CPR:3"
    },
    {
        "id": "10403635.T16.T40",
        "sentence": "The acute toxicity of organophosphorus (OP) compounds in mammals is due to their irreversible inhibition of @CHEMICAL$ (AChE) in the nervous system, which leads to increased synaptic @GENE$ levels.",
        "relation": "CPR:9"
    },
    {
        "id": "10403635.T16.T42",
        "sentence": "The acute toxicity of organophosphorus (OP) compounds in mammals is due to their irreversible inhibition of acetylcholinesterase (@CHEMICAL$) in the nervous system, which leads to increased synaptic @GENE$ levels.",
        "relation": "CPR:9"
    },
    {
        "id": "10403635.T20.T40",
        "sentence": "The acute toxicity of @CHEMICAL$ (OP) compounds in mammals is due to their irreversible inhibition of @GENE$ (AChE) in the nervous system, which leads to increased synaptic acetylcholine levels.",
        "relation": "CPR:4"
    },
    {
        "id": "10403635.T20.T42",
        "sentence": "The acute toxicity of @CHEMICAL$ (OP) compounds in mammals is due to their irreversible inhibition of acetylcholinesterase (@GENE$) in the nervous system, which leads to increased synaptic acetylcholine levels.",
        "relation": "CPR:4"
    },
    {
        "id": "10403635.T11.T45",
        "sentence": "In phosphotriesterase and physostigmine-treated mice, a 4- and 2-fold higher @CHEMICAL$ dose, respectively, was needed to cause a 50% inhibition of brain @GENE$ activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23238784.T8.T15",
        "sentence": "The @CHEMICAL$ activity could be induced 2-fold by @GENE$, whereas CYP2C9 activity remained equally high.",
        "relation": "CPR:3"
    },
    {
        "id": "23238784.T8.T16",
        "sentence": "The CYP3A4 activity could be induced 2-fold by @CHEMICAL$, whereas @GENE$ activity remained equally high.",
        "relation": "CPR:3"
    },
    {
        "id": "23466229.T5.T10",
        "sentence": "@CHEMICAL$ as a template for structure-based drug design: identification of new pyrazole series of irreversible @GENE$ inhibitors with improved lipophilic efficiency.",
        "relation": "CPR:4"
    },
    {
        "id": "23466229.T6.T10",
        "sentence": "PF-04859989 as a template for structure-based drug design: identification of new @CHEMICAL$ series of irreversible @GENE$ inhibitors with improved lipophilic efficiency.",
        "relation": "CPR:4"
    },
    {
        "id": "23466229.T4.T7",
        "sentence": "The structure-based design, synthesis, and biological evaluation of a new @CHEMICAL$ series of irreversible @GENE$ inhibitors are described herein.",
        "relation": "CPR:4"
    },
    {
        "id": "23466229.T1.T8",
        "sentence": "The modification of the inhibitor scaffold of 1 and 2 from a @CHEMICAL$ core to a tetrahydropyrazolopyridinone core led to discovery of a new series of potent @GENE$ inhibitors with excellent physicochemical properties.",
        "relation": "CPR:4"
    },
    {
        "id": "23466229.T2.T8",
        "sentence": "The modification of the inhibitor scaffold of 1 and 2 from a dihydroquinolinone core to a @CHEMICAL$ core led to discovery of a new series of potent @GENE$ inhibitors with excellent physicochemical properties.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T2.T43",
        "sentence": "The capacity of @CHEMICAL$ inhibitors, with the exception of @GENE$ and ambenonium, to displace bound [3H]-oxotremorine-M in preference to [3H]quinuclinidyl benzilate predicts that the former compounds could act as potential agonists at muscarinic receptors.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T3.T43",
        "sentence": "The capacity of @CHEMICAL$ inhibitors, with the exception of tacrine and @GENE$, to displace bound [3H]-oxotremorine-M in preference to [3H]quinuclinidyl benzilate predicts that the former compounds could act as potential agonists at muscarinic receptors.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T6.T45",
        "sentence": "Moreover, the rank order for potency in inhibiting @CHEMICAL$ (@GENE$>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T6.T46",
        "sentence": "Moreover, the rank order for potency in inhibiting acetylcholinesterase (@CHEMICAL$>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of @GENE$ also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T7.T45",
        "sentence": "Moreover, the rank order for potency in inhibiting @CHEMICAL$ (ambenonium>@GENE$=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T7.T46",
        "sentence": "Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>@CHEMICAL$=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of @GENE$ also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T8.T45",
        "sentence": "Moreover, the rank order for potency in inhibiting @CHEMICAL$ (ambenonium>neostigmine=@GENE$ =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T8.T46",
        "sentence": "Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=@CHEMICAL$ =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of @GENE$ also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T9.T45",
        "sentence": "Moreover, the rank order for potency in inhibiting @CHEMICAL$ (ambenonium>neostigmine=physostigmine =@GENE$>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T9.T46",
        "sentence": "Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =@CHEMICAL$>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of @GENE$ also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T10.T45",
        "sentence": "Moreover, the rank order for potency in inhibiting @CHEMICAL$ (ambenonium>neostigmine=physostigmine =tacrine>@GENE$=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T10.T46",
        "sentence": "Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =tacrine>@CHEMICAL$=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of @GENE$ also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T11.T45",
        "sentence": "Moreover, the rank order for potency in inhibiting @CHEMICAL$ (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=@GENE$=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T11.T46",
        "sentence": "Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=@CHEMICAL$=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of @GENE$ also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T12.T45",
        "sentence": "Moreover, the rank order for potency in inhibiting @CHEMICAL$ (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=@GENE$ >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T12.T46",
        "sentence": "Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=@CHEMICAL$ >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of @GENE$ also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T13.T45",
        "sentence": "Moreover, the rank order for potency in inhibiting @CHEMICAL$ (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >@GENE$>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T13.T46",
        "sentence": "Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >@CHEMICAL$>parathion>gramine) indicated that the most effective inhibitors of @GENE$ also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T14.T45",
        "sentence": "Moreover, the rank order for potency in inhibiting @CHEMICAL$ (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>@GENE$>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T14.T46",
        "sentence": "Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>@CHEMICAL$>gramine) indicated that the most effective inhibitors of @GENE$ also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T15.T45",
        "sentence": "Moreover, the rank order for potency in inhibiting @CHEMICAL$ (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>@GENE$) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11330337.T15.T46",
        "sentence": "Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>@CHEMICAL$) indicated that the most effective inhibitors of @GENE$ also displaced [3H]-oxotremorine-M to the greatest extent.",
        "relation": "CPR:4"
    },
    {
        "id": "16494569.T10.T21",
        "sentence": "CONCLUSIONS: Total vitamin B6 is abnormally high in autism, consistent with previous reports of an impaired @CHEMICAL$ for the conversion of @GENE$ and pyridoxal to PLP.",
        "relation": "CPR:9"
    },
    {
        "id": "16494569.T11.T21",
        "sentence": "CONCLUSIONS: Total vitamin B6 is abnormally high in autism, consistent with previous reports of an impaired @CHEMICAL$ for the conversion of pyridoxine and @GENE$ to PLP.",
        "relation": "CPR:9"
    },
    {
        "id": "16494569.T12.T21",
        "sentence": "CONCLUSIONS: Total vitamin B6 is abnormally high in autism, consistent with previous reports of an impaired @CHEMICAL$ for the conversion of pyridoxine and pyridoxal to @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23273219.T3.T12",
        "sentence": "Synthesis, molecular modeling and evaluation of novel @CHEMICAL$ derivatives as dual inhibitors for @GENE$ and Ab aggregation.",
        "relation": "CPR:4"
    },
    {
        "id": "23273219.T3.T13",
        "sentence": "Synthesis, molecular modeling and evaluation of novel @CHEMICAL$ derivatives as dual inhibitors for cholinesterases and @GENE$ aggregation.",
        "relation": "CPR:4"
    },
    {
        "id": "23273219.T2.T4",
        "sentence": "To develop new drugs for treatment of Alzheimer's disease, a group of @CHEMICAL$ was designed, synthesized and tested for their ability to inhibit @GENE$, butyrylcholinesterase and aggregation of amyloid beta peptides (1-40, 1-42 and 1-40_1-42).",
        "relation": "CPR:4"
    },
    {
        "id": "23273219.T2.T5",
        "sentence": "To develop new drugs for treatment of Alzheimer's disease, a group of @CHEMICAL$ was designed, synthesized and tested for their ability to inhibit acetylcholinesterase, @GENE$ and aggregation of amyloid beta peptides (1-40, 1-42 and 1-40_1-42).",
        "relation": "CPR:4"
    },
    {
        "id": "23273219.T1.T10",
        "sentence": "The enzyme inhibition assay results indicated that compounds moderately inhibit both acetylcholinesterase and butyrylcholinesterase. b-Amyloid aggregation results showed that all compounds exhibited remarkable @CHEMICAL$ fibril aggregation inhibition activity with a nearly similar potential as the reference compound @GENE$, which makes them promising anti-Alzheimer drug candidates.",
        "relation": "CPR:4"
    },
    {
        "id": "20230007.T19.T33",
        "sentence": "Here, translocation studies using the human androgen receptor (hAR) and the human glucocorticoid receptor (hGR) were performed to aid in identifying the mechanism by which anabolic-androgenic @CHEMICAL$ (AAS) were activating @GENE$ and potentially interacting with hGR and how glucocorticoid ligands were interacting with the hGR and hAR.",
        "relation": "CPR:3"
    },
    {
        "id": "17015640.T17.T33",
        "sentence": "@CHEMICAL$, a balanced inhibitor of @GENE$ and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis.",
        "relation": "CPR:4"
    },
    {
        "id": "17015640.T17.T34",
        "sentence": "@CHEMICAL$, a balanced inhibitor of cyclooxygenase and @GENE$, reduces inflammation in a rabbit model of atherosclerosis.",
        "relation": "CPR:4"
    },
    {
        "id": "17015640.T1.T30",
        "sentence": "@CHEMICAL$, a dual anti-inflammatory drug that inhibits 5-lipoxygenase (@GENE$) and cyclooxygenase (COX) enzymes, may have a better cardiovascular profile that cycloxygenase-2 inhibitors due to cycloxygenase-1 blockade-mediated antithrombotic effect and a better gastrointestinal tolerability.",
        "relation": "CPR:4"
    },
    {
        "id": "17015640.T1.T31",
        "sentence": "@CHEMICAL$, a dual anti-inflammatory drug that inhibits 5-lipoxygenase (LOX) and @GENE$ (COX) enzymes, may have a better cardiovascular profile that cycloxygenase-2 inhibitors due to cycloxygenase-1 blockade-mediated antithrombotic effect and a better gastrointestinal tolerability.",
        "relation": "CPR:4"
    },
    {
        "id": "17015640.T1.T32",
        "sentence": "@CHEMICAL$, a dual anti-inflammatory drug that inhibits 5-lipoxygenase (LOX) and cyclooxygenase (@GENE$) enzymes, may have a better cardiovascular profile that cycloxygenase-2 inhibitors due to cycloxygenase-1 blockade-mediated antithrombotic effect and a better gastrointestinal tolerability.",
        "relation": "CPR:4"
    },
    {
        "id": "17015640.T1.T27",
        "sentence": "@CHEMICAL$, a dual anti-inflammatory drug that inhibits 5-lipoxygenase (LOX) and cyclooxygenase (COX) enzymes, may have a better cardiovascular profile that cycloxygenase-2 inhibitors due to @GENE$ blockade-mediated antithrombotic effect and a better gastrointestinal tolerability.",
        "relation": "CPR:4"
    },
    {
        "id": "17015640.T1.T29",
        "sentence": "@CHEMICAL$, a dual anti-inflammatory drug that inhibits @GENE$ (LOX) and cyclooxygenase (COX) enzymes, may have a better cardiovascular profile that cycloxygenase-2 inhibitors due to cycloxygenase-1 blockade-mediated antithrombotic effect and a better gastrointestinal tolerability.",
        "relation": "CPR:4"
    },
    {
        "id": "17015640.T12.T28",
        "sentence": "We examined the anti-inflammatory effect of licofelone on atherosclerotic lesions as well as in isolated neutrophils from whole blood of rabbits compared with a selective inhibitor of @CHEMICAL$, @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17015640.T16.T20",
        "sentence": "@CHEMICAL$ reduced intima/media ratio in injured arteries, the macrophages infiltration in the neointimal area, monocyte chemoattractant protein-1 (MCP-1) gene expression, and the activation of @GENE$ in rabbit atheroma.",
        "relation": "CPR:4"
    },
    {
        "id": "17015640.T16.T18",
        "sentence": "@CHEMICAL$ reduced intima/media ratio in injured arteries, the macrophages infiltration in the neointimal area, @GENE$ (MCP-1) gene expression, and the activation of nuclear factor-kappaB in rabbit atheroma.",
        "relation": "CPR:4"
    },
    {
        "id": "17015640.T16.T19",
        "sentence": "@CHEMICAL$ reduced intima/media ratio in injured arteries, the macrophages infiltration in the neointimal area, monocyte chemoattractant protein-1 (@GENE$) gene expression, and the activation of nuclear factor-kappaB in rabbit atheroma.",
        "relation": "CPR:4"
    },
    {
        "id": "17015640.T2.T21",
        "sentence": "Moreover, @CHEMICAL$ inhibited @GENE$ and 5-LOX protein expression in vascular lesions.",
        "relation": "CPR:4"
    },
    {
        "id": "17015640.T2.T22",
        "sentence": "Moreover, @CHEMICAL$ inhibited COX-2 and @GENE$ protein expression in vascular lesions.",
        "relation": "CPR:4"
    },
    {
        "id": "17015640.T3.T23",
        "sentence": "@CHEMICAL$ only diminished @GENE$ protein expression and MCP-1 gene expression in vascular atheroma.",
        "relation": "CPR:4"
    },
    {
        "id": "17015640.T3.T24",
        "sentence": "@CHEMICAL$ only diminished COX-2 protein expression and @GENE$ gene expression in vascular atheroma.",
        "relation": "CPR:4"
    },
    {
        "id": "17015640.T5.T25",
        "sentence": "@CHEMICAL$ almost abolished @GENE$ activity by inhibiting leukotriene B4 generation in rabbit neutrophils and prevented platelet thromboxane B2 production from whole blood.",
        "relation": "CPR:4"
    },
    {
        "id": "17015640.T6.T25",
        "sentence": "Licofelone almost abolished @CHEMICAL$ activity by inhibiting @GENE$ generation in rabbit neutrophils and prevented platelet thromboxane B2 production from whole blood.",
        "relation": "CPR:9"
    },
    {
        "id": "17015640.T7.T25",
        "sentence": "Licofelone almost abolished @CHEMICAL$ activity by inhibiting leukotriene B4 generation in rabbit neutrophils and prevented platelet @GENE$ production from whole blood.",
        "relation": "CPR:9"
    },
    {
        "id": "15177307.T11.T14",
        "sentence": "No influence of moderate hepatic impairment on the pharmacokinetics of @CHEMICAL$, an oral @GENE$ selective inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "15177307.T6.T12",
        "sentence": "The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics (PK) of the novel @CHEMICAL$ (COX-2) selective inhibitor @GENE$ (Prexige), so that dose recommendations for clinical use can be provided.",
        "relation": "CPR:4"
    },
    {
        "id": "15177307.T6.T13",
        "sentence": "The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics (PK) of the novel cyclooxygenase-2 (@CHEMICAL$) selective inhibitor @GENE$ (Prexige), so that dose recommendations for clinical use can be provided.",
        "relation": "CPR:4"
    },
    {
        "id": "15177307.T7.T12",
        "sentence": "The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics (PK) of the novel @CHEMICAL$ (COX-2) selective inhibitor lumiracoxib (@GENE$), so that dose recommendations for clinical use can be provided.",
        "relation": "CPR:4"
    },
    {
        "id": "15177307.T7.T13",
        "sentence": "The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics (PK) of the novel cyclooxygenase-2 (@CHEMICAL$) selective inhibitor lumiracoxib (@GENE$), so that dose recommendations for clinical use can be provided.",
        "relation": "CPR:4"
    },
    {
        "id": "23395981.T6.T15",
        "sentence": "In addition, @CHEMICAL$ induced degradation of @GENE$ (DNMT-1, DNMT-3a, and DNMT-3b), as well as the methyl CpG-binding proteins (MeCP-2, MBD-2 and MBD-3), in MEF cells by the proteasomal pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23395981.T6.T19",
        "sentence": "In addition, @CHEMICAL$ induced degradation of DNA methyltransferases (DNMT-1, DNMT-3a, and DNMT-3b), as well as the @GENE$ (MeCP-2, MBD-2 and MBD-3), in MEF cells by the proteasomal pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23395981.T6.T16",
        "sentence": "In addition, @CHEMICAL$ induced degradation of DNA methyltransferases (@GENE$1, DNMT-3a, and DNMT-3b), as well as the methyl CpG-binding proteins (MeCP-2, MBD-2 and MBD-3), in MEF cells by the proteasomal pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23395981.T6.T17",
        "sentence": "In addition, @CHEMICAL$ induced degradation of DNA methyltransferases (DNMT-1, @GENE$, and DNMT-3b), as well as the methyl CpG-binding proteins (MeCP-2, MBD-2 and MBD-3), in MEF cells by the proteasomal pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23395981.T6.T18",
        "sentence": "In addition, @CHEMICAL$ induced degradation of DNA methyltransferases (DNMT-1, DNMT-3a, and @GENE$), as well as the methyl CpG-binding proteins (MeCP-2, MBD-2 and MBD-3), in MEF cells by the proteasomal pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23395981.T6.T20",
        "sentence": "In addition, @CHEMICAL$ induced degradation of DNA methyltransferases (DNMT-1, DNMT-3a, and DNMT-3b), as well as the methyl CpG-binding proteins (@GENE$, MBD-2 and MBD-3), in MEF cells by the proteasomal pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23395981.T6.T21",
        "sentence": "In addition, @CHEMICAL$ induced degradation of DNA methyltransferases (DNMT-1, DNMT-3a, and DNMT-3b), as well as the methyl CpG-binding proteins (MeCP-2, @GENE$ and MBD-3), in MEF cells by the proteasomal pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23395981.T6.T22",
        "sentence": "In addition, @CHEMICAL$ induced degradation of DNA methyltransferases (DNMT-1, DNMT-3a, and DNMT-3b), as well as the methyl CpG-binding proteins (MeCP-2, MBD-2 and @GENE$), in MEF cells by the proteasomal pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "1705137.T43.T51",
        "sentence": "Comparison of the @CHEMICAL$ inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors @GENE$ and toloxatone, and assessment of their effect on psychometric performance in healthy subjects. 1.",
        "relation": "CPR:4"
    },
    {
        "id": "1705137.T43.T52",
        "sentence": "Comparison of the monoamine oxidase inhibiting properties of two reversible and selective @CHEMICAL$ inhibitors @GENE$ and toloxatone, and assessment of their effect on psychometric performance in healthy subjects. 1.",
        "relation": "CPR:4"
    },
    {
        "id": "1705137.T44.T51",
        "sentence": "Comparison of the @CHEMICAL$ inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and @GENE$, and assessment of their effect on psychometric performance in healthy subjects. 1.",
        "relation": "CPR:4"
    },
    {
        "id": "1705137.T44.T52",
        "sentence": "Comparison of the monoamine oxidase inhibiting properties of two reversible and selective @CHEMICAL$ inhibitors moclobemide and @GENE$, and assessment of their effect on psychometric performance in healthy subjects. 1.",
        "relation": "CPR:4"
    },
    {
        "id": "1705137.T9.T48",
        "sentence": "The effects of two reversible, predominantly @CHEMICAL$ (MAO-A) inhibitors, moclobemide (150 mg three times daily) and @GENE$ (400-200-400 mg day-1) on monoamine metabolites and psychometric performance were compared in a double-blind placebo controlled crossover study in 12 healthy subjects. 2.",
        "relation": "CPR:4"
    },
    {
        "id": "1705137.T41.T48",
        "sentence": "The effects of two reversible, predominantly @CHEMICAL$ (MAO-A) inhibitors, @GENE$ (150 mg three times daily) and toloxatone (400-200-400 mg day-1) on monoamine metabolites and psychometric performance were compared in a double-blind placebo controlled crossover study in 12 healthy subjects. 2.",
        "relation": "CPR:4"
    },
    {
        "id": "1705137.T11.T47",
        "sentence": "Before the next drug intake, @CHEMICAL$ inhibition, as judged by the decrease of plasma DHPG concentration, was significantly different from placebo with @GENE$ but not with toloxatone. 5.",
        "relation": "CPR:4"
    },
    {
        "id": "1705137.T12.T47",
        "sentence": "Before the next drug intake, @CHEMICAL$ inhibition, as judged by the decrease of plasma DHPG concentration, was significantly different from placebo with moclobemide but not with @GENE$. 5.",
        "relation": "CPR:4"
    },
    {
        "id": "23453071.T2.T10",
        "sentence": "Previously, we have found that @CHEMICAL$, a nicotinamide derivative, inhibits vascular endothelial growth factor (@GENE$)-mediated angiogenesis signaling in human endothelial cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23453071.T2.T13",
        "sentence": "Previously, we have found that @CHEMICAL$, a nicotinamide derivative, inhibits @GENE$ (VEGF)-mediated angiogenesis signaling in human endothelial cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23453071.T4.T10",
        "sentence": "Previously, we have found that BRN-103, a @CHEMICAL$ derivative, inhibits vascular endothelial growth factor (@GENE$)-mediated angiogenesis signaling in human endothelial cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23453071.T4.T13",
        "sentence": "Previously, we have found that BRN-103, a @CHEMICAL$ derivative, inhibits @GENE$ (VEGF)-mediated angiogenesis signaling in human endothelial cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23453071.T6.T12",
        "sentence": "Furthermore, @CHEMICAL$ inhibited the VEGF-induced phosphorylation and intracellular @GENE$ activity of VEGF receptor 2 (VEGFR2) and the activation of its downstream AKT pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23453071.T6.T16",
        "sentence": "Furthermore, @CHEMICAL$ inhibited the VEGF-induced phosphorylation and intracellular tyrosine kinase activity of VEGF receptor 2 (VEGFR2) and the activation of its downstream @GENE$ pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23453071.T6.T11",
        "sentence": "Furthermore, @CHEMICAL$ inhibited the @GENE$-induced phosphorylation and intracellular tyrosine kinase activity of VEGF receptor 2 (VEGFR2) and the activation of its downstream AKT pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23453071.T6.T14",
        "sentence": "Furthermore, @CHEMICAL$ inhibited the VEGF-induced phosphorylation and intracellular tyrosine kinase activity of @GENE$ (VEGFR2) and the activation of its downstream AKT pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23453071.T6.T15",
        "sentence": "Furthermore, @CHEMICAL$ inhibited the VEGF-induced phosphorylation and intracellular tyrosine kinase activity of VEGF receptor 2 (@GENE$) and the activation of its downstream AKT pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "10328230.T15.T24",
        "sentence": "Inhibition of @CHEMICAL$ (MMP-2) by @GENE$ and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma.",
        "relation": "CPR:4"
    },
    {
        "id": "10328230.T15.T25",
        "sentence": "Inhibition of gelatinase A (@CHEMICAL$) by @GENE$ and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma.",
        "relation": "CPR:4"
    },
    {
        "id": "10328230.T16.T24",
        "sentence": "Inhibition of @CHEMICAL$ (MMP-2) by batimastat and @GENE$ reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma.",
        "relation": "CPR:4"
    },
    {
        "id": "10328230.T16.T25",
        "sentence": "Inhibition of gelatinase A (@CHEMICAL$) by batimastat and @GENE$ reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma.",
        "relation": "CPR:4"
    },
    {
        "id": "10328230.T4.T17",
        "sentence": "We have examined the effects of the synthetic matrix metalloproteinase inhibitor, batimastat (BB-94) and the @CHEMICAL$ inhibitor, @GENE$, on metalloproteinase activity of murine Lewis-lung-carcinoma cells (3LL) in vitro, and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice.",
        "relation": "CPR:4"
    },
    {
        "id": "10328230.T13.T21",
        "sentence": "We have examined the effects of the synthetic @CHEMICAL$ inhibitor, @GENE$ (BB-94) and the angiotensin-converting enzyme inhibitor, captopril, on metalloproteinase activity of murine Lewis-lung-carcinoma cells (3LL) in vitro, and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice.",
        "relation": "CPR:4"
    },
    {
        "id": "10328230.T14.T21",
        "sentence": "We have examined the effects of the synthetic @CHEMICAL$ inhibitor, batimastat (@GENE$) and the angiotensin-converting enzyme inhibitor, captopril, on metalloproteinase activity of murine Lewis-lung-carcinoma cells (3LL) in vitro, and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice.",
        "relation": "CPR:4"
    },
    {
        "id": "10328230.T9.T22",
        "sentence": "Here we report that @CHEMICAL$ treatment resulted in decreased transcription and protein levels of @GENE$ by 3LL cells.",
        "relation": "CPR:4"
    },
    {
        "id": "10328230.T10.T23",
        "sentence": "Both @CHEMICAL$ and captopril also prevented substrate degradation by @GENE$ released in conditioned medium by cultured cells.",
        "relation": "CPR:4"
    },
    {
        "id": "17079868.T4.T7",
        "sentence": "@CHEMICAL$ (MTRR) is an enzyme involved in the conversion of @GENE$ to methionine.",
        "relation": "CPR:9"
    },
    {
        "id": "17079868.T4.T10",
        "sentence": "Methionine synthase reductase (@CHEMICAL$) is an enzyme involved in the conversion of @GENE$ to methionine.",
        "relation": "CPR:9"
    },
    {
        "id": "17079868.T5.T7",
        "sentence": "@CHEMICAL$ (MTRR) is an enzyme involved in the conversion of Hcy to @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17079868.T5.T10",
        "sentence": "Methionine synthase reductase (@CHEMICAL$) is an enzyme involved in the conversion of Hcy to @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17081103.T1.T27",
        "sentence": "@CHEMICAL$ reduce hydroperoxides to the corresponding @GENE$ by means of glutathione (GSH).",
        "relation": "CPR:9"
    },
    {
        "id": "23152189.T20.T34",
        "sentence": "@CHEMICAL$ decreased the expression of the @GENE$, SLC2A1, and most of the glycolytic transcripts, followed by decreases in glycolytic intermediates, including pyruvate.",
        "relation": "CPR:4"
    },
    {
        "id": "23152189.T20.T35",
        "sentence": "@CHEMICAL$ decreased the expression of the glucose transporter, @GENE$, and most of the glycolytic transcripts, followed by decreases in glycolytic intermediates, including pyruvate.",
        "relation": "CPR:4"
    },
    {
        "id": "23152189.T3.T36",
        "sentence": "Mitochondrial @CHEMICAL$ activity and the GSH/glutathione disulfide ratio were decreased by @GENE$, ultimately leading to mitochondrial dysfunction, characterized by decreased inner mitochondrial membrane potential and ATP production, and increased production of the reactive oxygen species (ROS), hydrogen peroxide.",
        "relation": "CPR:4"
    },
    {
        "id": "19427182.T21.T33",
        "sentence": "@CHEMICAL$ is involved in hepatic @GENE$ secretion.",
        "relation": "CPR:9"
    },
    {
        "id": "19427182.T10.T24",
        "sentence": "Vitamin E (alpha-tocopherol) is an essential fat-soluble nutrient with antioxidant properties. alpha-Tocopherol transfer protein (@CHEMICAL$), the product of the gene responsible for familial isolated vitamin E deficiency, plays an important role in maintaining the plasma @GENE$ level by mediating the secretion of alpha-tocopherol by the liver.",
        "relation": "CPR:9"
    },
    {
        "id": "19427182.T10.T32",
        "sentence": "Vitamin E (alpha-tocopherol) is an essential fat-soluble nutrient with antioxidant properties. @CHEMICAL$ (alpha-TTP), the product of the gene responsible for familial isolated vitamin E deficiency, plays an important role in maintaining the plasma @GENE$ level by mediating the secretion of alpha-tocopherol by the liver.",
        "relation": "CPR:9"
    },
    {
        "id": "19427182.T11.T24",
        "sentence": "Vitamin E (alpha-tocopherol) is an essential fat-soluble nutrient with antioxidant properties. alpha-Tocopherol transfer protein (@CHEMICAL$), the product of the gene responsible for familial isolated vitamin E deficiency, plays an important role in maintaining the plasma alpha-tocopherol level by mediating the secretion of @GENE$ by the liver.",
        "relation": "CPR:9"
    },
    {
        "id": "19427182.T11.T32",
        "sentence": "Vitamin E (alpha-tocopherol) is an essential fat-soluble nutrient with antioxidant properties. @CHEMICAL$ (alpha-TTP), the product of the gene responsible for familial isolated vitamin E deficiency, plays an important role in maintaining the plasma alpha-tocopherol level by mediating the secretion of @GENE$ by the liver.",
        "relation": "CPR:9"
    },
    {
        "id": "19427182.T19.T28",
        "sentence": "First, addition of @CHEMICAL$ (apoA-I), a direct acceptor of the ATP-binding cassette transporter A1 (ABCA1)-secreted lipids, increased @GENE$ secretion in a dose-dependent manner.",
        "relation": "CPR:9"
    },
    {
        "id": "19427182.T19.T29",
        "sentence": "First, addition of apolipoprotein A-I (@CHEMICAL$), a direct acceptor of the ATP-binding cassette transporter A1 (ABCA1)-secreted lipids, increased @GENE$ secretion in a dose-dependent manner.",
        "relation": "CPR:9"
    },
    {
        "id": "19427182.T19.T30",
        "sentence": "First, addition of apolipoprotein A-I (apoA-I), a direct acceptor of the @CHEMICAL$ (ABCA1)-secreted lipids, increased @GENE$ secretion in a dose-dependent manner.",
        "relation": "CPR:9"
    },
    {
        "id": "19427182.T19.T31",
        "sentence": "First, addition of apolipoprotein A-I (apoA-I), a direct acceptor of the ATP-binding cassette transporter A1 (@CHEMICAL$)-secreted lipids, increased @GENE$ secretion in a dose-dependent manner.",
        "relation": "CPR:9"
    },
    {
        "id": "19427182.T2.T22",
        "sentence": "Second, @CHEMICAL$, an antiatherogenic compound reported to be an inactivator of @GENE$ reduced hepatic alpha-tocopherol secretion.",
        "relation": "CPR:4"
    },
    {
        "id": "19427182.T5.T23",
        "sentence": "Third, @CHEMICAL$-RNAi suppressed hepatic @GENE$ secretion.",
        "relation": "CPR:9"
    },
    {
        "id": "19427182.T8.T25",
        "sentence": "These results strongly suggest that @CHEMICAL$ is substantially involved in hepatic @GENE$ secretion.",
        "relation": "CPR:9"
    },
    {
        "id": "13129570.T1.T31",
        "sentence": "Synthesis and in vitro pharmacology at AMPA and kainate preferring glutamate receptors of 4-heteroarylmethylidene glutamate analogues. @CHEMICAL$ (1) is a potent @GENE$ agonist with moderate affinity for native kainic acid (KA) receptors, whereas (S)-E-4-(2,2-dimethylpropylidene)glutamic acid (3) show high affinity for the GluR5 subtype of KA receptors and much lower affinity for the GluR2 subtype of AMPA receptors.",
        "relation": "CPR:5"
    },
    {
        "id": "15650315.T12.T30",
        "sentence": "@CHEMICAL$, a leukotriene receptor antagonist, inhibits interleukin-5 production via a mechanism distinct from @GENE$ antagonism.",
        "relation": "CPR:6"
    },
    {
        "id": "15650315.T12.T31",
        "sentence": "@CHEMICAL$, a @GENE$ antagonist, inhibits interleukin-5 production via a mechanism distinct from leukotriene receptor antagonism.",
        "relation": "CPR:6"
    },
    {
        "id": "15650315.T12.T32",
        "sentence": "@CHEMICAL$, a leukotriene receptor antagonist, inhibits @GENE$ production via a mechanism distinct from leukotriene receptor antagonism.",
        "relation": "CPR:4"
    },
    {
        "id": "15650315.T1.T23",
        "sentence": "BACKGROUND: @CHEMICAL$, a @GENE$ (CysLTR1) antagonist, inhibits not only airway smooth muscle contraction, but also allergic inflammation.",
        "relation": "CPR:6"
    },
    {
        "id": "15650315.T1.T25",
        "sentence": "BACKGROUND: @CHEMICAL$, a cysteinyl leukotriene receptor 1 (@GENE$) antagonist, inhibits not only airway smooth muscle contraction, but also allergic inflammation.",
        "relation": "CPR:6"
    },
    {
        "id": "15650315.T5.T21",
        "sentence": "The aim of this study was to determine the mechanism of @CHEMICAL$-induced @GENE$ (IL-5) inhibition in allergic inflammation.",
        "relation": "CPR:4"
    },
    {
        "id": "15650315.T5.T22",
        "sentence": "The aim of this study was to determine the mechanism of @CHEMICAL$-induced interleukin-5 (@GENE$) inhibition in allergic inflammation.",
        "relation": "CPR:4"
    },
    {
        "id": "15650315.T9.T28",
        "sentence": "RESULTS: Pretreatment of lung tissues with @CHEMICAL$ alone significantly decreased the amount of @GENE$ protein in the culture medium by 40%.",
        "relation": "CPR:4"
    },
    {
        "id": "15650315.T2.T16",
        "sentence": "@CHEMICAL$-induced inhibition of @GENE$ mRNA expression was noted in various cells, irrespective of their CysLTR1 mRNA expression status.",
        "relation": "CPR:4"
    },
    {
        "id": "15650315.T4.T19",
        "sentence": "CONCLUSION: Our results indicate that @CHEMICAL$ inhibits @GENE$ synthesis via a mechanism distinct from CysLTR1 antagonism.",
        "relation": "CPR:4"
    },
    {
        "id": "15650315.T4.T20",
        "sentence": "CONCLUSION: Our results indicate that @CHEMICAL$ inhibits IL-5 synthesis via a mechanism distinct from @GENE$ antagonism.",
        "relation": "CPR:6"
    },
    {
        "id": "15963471.T1.T40",
        "sentence": "@CHEMICAL$ are a new class of anti-diabetic agents which increase insulin sensitivity by binding to the peroxisome proliferator-activated receptor gamma (PPAR(gamma)) and stimulating the expression of @GENE$-responsive genes involved in glucose and lipid metabolism.",
        "relation": "CPR:3"
    },
    {
        "id": "15963471.T1.T44",
        "sentence": "@CHEMICAL$ are a new class of anti-diabetic agents which increase @GENE$ sensitivity by binding to the peroxisome proliferator-activated receptor gamma (PPAR(gamma)) and stimulating the expression of insulin-responsive genes involved in glucose and lipid metabolism.",
        "relation": "CPR:3"
    },
    {
        "id": "15963471.T2.T29",
        "sentence": "The effect of troglitazone on ENT1 was PPAR(gamma)-independent and kinetic studies revealed that @CHEMICAL$ was a competitive inhibitor of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15963471.T10.T31",
        "sentence": "The difference in structure of @CHEMICAL$ did not account for its inhibitory effect on @GENE$ because Vitamin E did not inhibit [3H]adenosine uptake by HASMCs.",
        "relation": "CPR:4"
    },
    {
        "id": "15963471.T13.T35",
        "sentence": "Using the nucleoside transporter deficient PK15NTD cells stably expressing ENT1 and ENT2, it was found that @CHEMICAL$ inhibited @GENE$ but had no effect on ENT2.",
        "relation": "CPR:4"
    },
    {
        "id": "15963471.T14.T38",
        "sentence": "From these results, it is suggested that @CHEMICAL$ may enhance the vasodilatory effect of adenosine by inhibiting @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15963471.T16.T39",
        "sentence": "Pharmacologically, @CHEMICAL$ is a novel inhibitor of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15805193.T6.T17",
        "sentence": "@CHEMICAL$ is principally metabolized by CYP2C9, and both are probable substrates of the @GENE$ P-glycoprotein.",
        "relation": "CPR:9"
    },
    {
        "id": "15805193.T6.T18",
        "sentence": "@CHEMICAL$ is principally metabolized by CYP2C9, and both are probable substrates of the drug transporter @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "15805193.T6.T16",
        "sentence": "@CHEMICAL$ is principally metabolized by @GENE$, and both are probable substrates of the drug transporter P-glycoprotein.",
        "relation": "CPR:9"
    },
    {
        "id": "23517912.T15.T36",
        "sentence": "@CHEMICAL$ treatment of preadipocytes reduced the phosphorylation of S6K1 and @GENE$ in a time- and concentration-dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "23517912.T15.T35",
        "sentence": "@CHEMICAL$ treatment of preadipocytes reduced the phosphorylation of @GENE$ and mTORC1 in a time- and concentration-dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "23517912.T16.T37",
        "sentence": "To further our understanding of how @CHEMICAL$ negatively regulates @GENE$ signaling, we analyzed the phosphorylation of S6K1, mTOR and Akt in fisetin-treated TSC2-knockdown cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23517912.T18.T42",
        "sentence": "The results suggested that @CHEMICAL$ treatment inhibits @GENE$ activity in an Akt-dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "23517912.T18.T43",
        "sentence": "The results suggested that @CHEMICAL$ treatment inhibits mTORC1 activity in an @GENE$-dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "23517912.T4.T21",
        "sentence": "Fisetin treatment inhibited adipocyte differentiation, consistent with the negative effect of @CHEMICAL$ on @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23517912.T10.T24",
        "sentence": "We also observed that @CHEMICAL$ efficiently suppressed the phosphorylation of @GENE$, S6K1 and mTORC1 in adipose tissue.",
        "relation": "CPR:4"
    },
    {
        "id": "23517912.T10.T26",
        "sentence": "We also observed that @CHEMICAL$ efficiently suppressed the phosphorylation of Akt, S6K1 and @GENE$ in adipose tissue.",
        "relation": "CPR:4"
    },
    {
        "id": "23517912.T10.T25",
        "sentence": "We also observed that @CHEMICAL$ efficiently suppressed the phosphorylation of Akt, @GENE$ and mTORC1 in adipose tissue.",
        "relation": "CPR:4"
    },
    {
        "id": "23517912.T11.T27",
        "sentence": "Collectively, these results suggest that inhibition of @CHEMICAL$ signaling by @GENE$ prevents adipocyte differentiation of 3T3-L1 preadipocytes and obesity in HFD-fed mice.",
        "relation": "CPR:4"
    },
    {
        "id": "10047461.T16.T62",
        "sentence": "Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the @CHEMICAL$ inhibitor @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "10047461.T1.T50",
        "sentence": "@CHEMICAL$ (ZD1694) is a specific antifolate-based @GENE$ inhibitor active in a variety of solid tumor malignancies.",
        "relation": "CPR:4"
    },
    {
        "id": "10047461.T10.T46",
        "sentence": "Studies were carried out in vitro to evaluate downstream molecular alterations induced as a consequence of the potent and sustained inhibition of @CHEMICAL$ by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "10047461.T13.T57",
        "sentence": "@CHEMICAL$ treatment resulted in the decrease in p27(kip1) expression, with an increase in cyclin E and cdk2 protein expression and @GENE$ activities 24 h after a 2-h exposure.",
        "relation": "CPR:3"
    },
    {
        "id": "10047461.T13.T54",
        "sentence": "@CHEMICAL$ treatment resulted in the decrease in @GENE$ expression, with an increase in cyclin E and cdk2 protein expression and kinase activities 24 h after a 2-h exposure.",
        "relation": "CPR:4"
    },
    {
        "id": "10047461.T13.T55",
        "sentence": "@CHEMICAL$ treatment resulted in the decrease in p27(kip1) expression, with an increase in @GENE$ and cdk2 protein expression and kinase activities 24 h after a 2-h exposure.",
        "relation": "CPR:3"
    },
    {
        "id": "10047461.T13.T56",
        "sentence": "@CHEMICAL$ treatment resulted in the decrease in p27(kip1) expression, with an increase in cyclin E and @GENE$ protein expression and kinase activities 24 h after a 2-h exposure.",
        "relation": "CPR:3"
    },
    {
        "id": "10047461.T2.T30",
        "sentence": "The studies with dThyd rescue from @CHEMICAL$-cdk2 protein overexpression and growth inhibition by @GENE$ indicate that increased cyclin E-cdk2 protein expression is associated with effective inhibition of thymidylate synthase and resultant dNTP pool imbalance.",
        "relation": "CPR:4"
    },
    {
        "id": "10047461.T2.T30",
        "sentence": "The studies with dThyd rescue from @CHEMICAL$-cdk2 protein overexpression and growth inhibition by @GENE$ indicate that increased cyclin E-cdk2 protein expression is associated with effective inhibition of thymidylate synthase and resultant dNTP pool imbalance.",
        "relation": "CPR:3"
    },
    {
        "id": "10047461.T2.T31",
        "sentence": "The studies with dThyd rescue from cyclin E-@CHEMICAL$ protein overexpression and growth inhibition by @GENE$ indicate that increased cyclin E-cdk2 protein expression is associated with effective inhibition of thymidylate synthase and resultant dNTP pool imbalance.",
        "relation": "CPR:4"
    },
    {
        "id": "10047461.T2.T31",
        "sentence": "The studies with dThyd rescue from cyclin E-@CHEMICAL$ protein overexpression and growth inhibition by @GENE$ indicate that increased cyclin E-cdk2 protein expression is associated with effective inhibition of thymidylate synthase and resultant dNTP pool imbalance.",
        "relation": "CPR:3"
    },
    {
        "id": "10047461.T2.T32",
        "sentence": "The studies with dThyd rescue from cyclin E-cdk2 protein overexpression and growth inhibition by @CHEMICAL$ indicate that increased @GENE$-cdk2 protein expression is associated with effective inhibition of thymidylate synthase and resultant dNTP pool imbalance.",
        "relation": "CPR:3"
    },
    {
        "id": "10047461.T2.T33",
        "sentence": "The studies with dThyd rescue from cyclin E-cdk2 protein overexpression and growth inhibition by @CHEMICAL$ indicate that increased cyclin E-@GENE$ protein expression is associated with effective inhibition of thymidylate synthase and resultant dNTP pool imbalance.",
        "relation": "CPR:3"
    },
    {
        "id": "10047461.T2.T34",
        "sentence": "The studies with dThyd rescue from cyclin E-cdk2 protein overexpression and growth inhibition by @CHEMICAL$ indicate that increased cyclin E-cdk2 protein expression is associated with effective inhibition of @GENE$ and resultant dNTP pool imbalance.",
        "relation": "CPR:4"
    },
    {
        "id": "10047461.T7.T41",
        "sentence": "These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of thymidylate synthase by @CHEMICAL$ and kilobase DNA fragmentation may correlate with the reduction of p27(kip1) expression and the increase in cyclin E and cdk2 @GENE$ activities.",
        "relation": "CPR:3"
    },
    {
        "id": "10047461.T7.T37",
        "sentence": "These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of @CHEMICAL$ by @GENE$ and kilobase DNA fragmentation may correlate with the reduction of p27(kip1) expression and the increase in cyclin E and cdk2 kinase activities.",
        "relation": "CPR:4"
    },
    {
        "id": "10047461.T7.T38",
        "sentence": "These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of thymidylate synthase by @CHEMICAL$ and kilobase DNA fragmentation may correlate with the reduction of @GENE$ expression and the increase in cyclin E and cdk2 kinase activities.",
        "relation": "CPR:4"
    },
    {
        "id": "10047461.T7.T39",
        "sentence": "These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of thymidylate synthase by @CHEMICAL$ and kilobase DNA fragmentation may correlate with the reduction of p27(kip1) expression and the increase in @GENE$ and cdk2 kinase activities.",
        "relation": "CPR:3"
    },
    {
        "id": "10047461.T7.T40",
        "sentence": "These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of thymidylate synthase by @CHEMICAL$ and kilobase DNA fragmentation may correlate with the reduction of p27(kip1) expression and the increase in cyclin E and @GENE$ kinase activities.",
        "relation": "CPR:3"
    },
    {
        "id": "23481236.T17.T46",
        "sentence": "Cells were also evaluated in the presence of @CHEMICAL$, an inhibitor of @GENE$ and thus AKt (0-100 nM).",
        "relation": "CPR:4"
    },
    {
        "id": "23481236.T17.T47",
        "sentence": "Cells were also evaluated in the presence of @CHEMICAL$, an inhibitor of phosphatidylinositol 3-kinases and thus @GENE$ (0-100 nM).",
        "relation": "CPR:4"
    },
    {
        "id": "23481236.T2.T26",
        "sentence": "Saturated @CHEMICAL$ increased ceramides, up-regulated PTP1B, and had @GENE$ and PTP1B phosphorylation at Ser 50 impaired.",
        "relation": "CPR:3"
    },
    {
        "id": "23481236.T2.T25",
        "sentence": "Saturated @CHEMICAL$ increased ceramides, up-regulated @GENE$, and had AKt and PTP1B phosphorylation at Ser 50 impaired.",
        "relation": "CPR:3"
    },
    {
        "id": "23481236.T2.T27",
        "sentence": "Saturated @CHEMICAL$ increased ceramides, up-regulated PTP1B, and had AKt and @GENE$ phosphorylation at Ser 50 impaired.",
        "relation": "CPR:3"
    },
    {
        "id": "23481236.T6.T30",
        "sentence": "Only FFAs that increased @CHEMICAL$ caused impairment of @GENE$ and PTP1B phosphorylation at Ser 50.",
        "relation": "CPR:4"
    },
    {
        "id": "23481236.T6.T31",
        "sentence": "Only FFAs that increased @CHEMICAL$ caused impairment of AKt and @GENE$ phosphorylation at Ser 50.",
        "relation": "CPR:4"
    },
    {
        "id": "17661345.T6.T9",
        "sentence": "@CHEMICAL$ (IDO), a @GENE$ catabolizing enzyme, has been implicated in the pathogenesis of various neurological disorders.",
        "relation": "CPR:9"
    },
    {
        "id": "17661345.T6.T16",
        "sentence": "Indoleamine 2,3-dioxygenase (@CHEMICAL$), a @GENE$ catabolizing enzyme, has been implicated in the pathogenesis of various neurological disorders.",
        "relation": "CPR:9"
    },
    {
        "id": "23422569.T12.T45",
        "sentence": "To determine whether dysregulation of SIRT1 promotes @CHEMICAL$-dependent production of reactive @GENE$ species (ROS) and impairs endothelial function we assessed the effects of three structurally different inhibitors of SIRT1 (nicotinamide, sirtinol, EX527) in aorta segments isolated from young Wistar rats.",
        "relation": "CPR:9"
    },
    {
        "id": "23422569.T14.T47",
        "sentence": "To determine whether dysregulation of SIRT1 promotes NADPH oxidase-dependent production of reactive oxygen species (ROS) and impairs endothelial function we assessed the effects of three structurally different inhibitors of @CHEMICAL$ (@GENE$, sirtinol, EX527) in aorta segments isolated from young Wistar rats.",
        "relation": "CPR:4"
    },
    {
        "id": "23422569.T15.T47",
        "sentence": "To determine whether dysregulation of SIRT1 promotes NADPH oxidase-dependent production of reactive oxygen species (ROS) and impairs endothelial function we assessed the effects of three structurally different inhibitors of @CHEMICAL$ (nicotinamide, @GENE$, EX527) in aorta segments isolated from young Wistar rats.",
        "relation": "CPR:4"
    },
    {
        "id": "23422569.T16.T47",
        "sentence": "To determine whether dysregulation of SIRT1 promotes NADPH oxidase-dependent production of reactive oxygen species (ROS) and impairs endothelial function we assessed the effects of three structurally different inhibitors of @CHEMICAL$ (nicotinamide, sirtinol, @GENE$) in aorta segments isolated from young Wistar rats.",
        "relation": "CPR:4"
    },
    {
        "id": "23422569.T21.T50",
        "sentence": "Endothelial dysfunction induced by SIRT1 inhibition was prevented by treatment of the vessels with the @CHEMICAL$ inhibitor @GENE$ or superoxide dismutase.",
        "relation": "CPR:4"
    },
    {
        "id": "23422569.T1.T24",
        "sentence": "Inhibition of @CHEMICAL$ significantly increased vascular @GENE$ production, enhanced NADPH oxidase activity, and mRNA expression of its subunits p22(phox) and NOX4, which were prevented by resveratrol.",
        "relation": "CPR:9"
    },
    {
        "id": "23422569.T3.T25",
        "sentence": "Inhibition of SIRT1 significantly increased vascular superoxide production, enhanced @CHEMICAL$ activity, and mRNA expression of its subunits p22(phox) and NOX4, which were prevented by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23422569.T3.T26",
        "sentence": "Inhibition of SIRT1 significantly increased vascular superoxide production, enhanced NADPH oxidase activity, and mRNA expression of its subunits @CHEMICAL$ and NOX4, which were prevented by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23422569.T3.T27",
        "sentence": "Inhibition of SIRT1 significantly increased vascular superoxide production, enhanced NADPH oxidase activity, and mRNA expression of its subunits p22(phox) and @CHEMICAL$, which were prevented by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23422569.T4.T31",
        "sentence": "Peroxisome proliferator-activated receptor-a (PPARa) activation mimicked the effects of @CHEMICAL$ while PPARa inhibition prevented the effects of this @GENE$ activator.",
        "relation": "CPR:3"
    },
    {
        "id": "23422569.T5.T35",
        "sentence": "SIRT1 co-precipitated with PPARa and @CHEMICAL$ increased the acetylation of the PPARa coactivator @GENE$, which was suppressed by resveratrol.",
        "relation": "CPR:3"
    },
    {
        "id": "23422569.T6.T35",
        "sentence": "SIRT1 co-precipitated with PPARa and nicotinamide increased the acetylation of the PPARa coactivator @CHEMICAL$, which was suppressed by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23500776.T12.T22",
        "sentence": "@CHEMICAL$ activity induction in peripheral blood lymphocytes, liver and brain tissues of rats orally exposed to @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23500776.T3.T19",
        "sentence": "Little is known in terms of multi-matrix @CHEMICAL$ activity induction under repeated oral exposure to planar @GENE$ (PHH, PAH).",
        "relation": "CPR:3"
    },
    {
        "id": "23500776.T5.T19",
        "sentence": "Little is known in terms of multi-matrix @CHEMICAL$ activity induction under repeated oral exposure to planar halogenated and polycyclic aromatic hydrocarbons (PHH, @GENE$).",
        "relation": "CPR:3"
    },
    {
        "id": "23322769.T2.T12",
        "sentence": "Repression of @CHEMICAL$ (FNTA) by siRNA and the enzyme inhibitor @GENE$ caused elevation of ApoA-I secretion from hepatocytes and from transgenic mice expressing hApoA-I and cholesterol ester transfer protein transgenes.",
        "relation": "CPR:4"
    },
    {
        "id": "23322769.T2.T13",
        "sentence": "Repression of farnesyltransferase (@CHEMICAL$) by siRNA and the enzyme inhibitor @GENE$ caused elevation of ApoA-I secretion from hepatocytes and from transgenic mice expressing hApoA-I and cholesterol ester transfer protein transgenes.",
        "relation": "CPR:4"
    },
    {
        "id": "23322769.T2.T14",
        "sentence": "Repression of farnesyltransferase (FNTA) by siRNA and the enzyme inhibitor @CHEMICAL$ caused elevation of @GENE$ secretion from hepatocytes and from transgenic mice expressing hApoA-I and cholesterol ester transfer protein transgenes.",
        "relation": "CPR:3"
    },
    {
        "id": "23322769.T2.T15",
        "sentence": "Repression of farnesyltransferase (FNTA) by siRNA and the enzyme inhibitor @CHEMICAL$ caused elevation of ApoA-I secretion from hepatocytes and from transgenic mice expressing @GENE$ and cholesterol ester transfer protein transgenes.",
        "relation": "CPR:3"
    },
    {
        "id": "17020418.T1.T22",
        "sentence": "@CHEMICAL$ are biosynthesised from androgens by the @GENE$ enzyme complex called aromatase.",
        "relation": "CPR:9"
    },
    {
        "id": "17020418.T1.T24",
        "sentence": "@CHEMICAL$ are biosynthesised from androgens by the CYP450 enzyme complex called @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17020418.T6.T24",
        "sentence": "Estrogens are biosynthesised from @CHEMICAL$ by the CYP450 enzyme complex called @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17020418.T5.T19",
        "sentence": "In breast cancer, intratumoural @CHEMICAL$ is the source for local @GENE$ production in the tissue.",
        "relation": "CPR:9"
    },
    {
        "id": "17020418.T9.T21",
        "sentence": "The potent and selective third-generation @CHEMICAL$ inhibitors @GENE$, letrozole and exemestane were introduced to the market as endocrine therapy in postmenopausal patients failing anti-estrogen therapy alone, or multiple hormonal therapies.",
        "relation": "CPR:4"
    },
    {
        "id": "17020418.T10.T21",
        "sentence": "The potent and selective third-generation @CHEMICAL$ inhibitors anastrozole, @GENE$ and exemestane were introduced to the market as endocrine therapy in postmenopausal patients failing anti-estrogen therapy alone, or multiple hormonal therapies.",
        "relation": "CPR:4"
    },
    {
        "id": "17020418.T12.T23",
        "sentence": "@CHEMICAL$ and letrozole are both non-steroidal @GENE$ inhibitors that compete with the substrate for binding to the enzyme active site.",
        "relation": "CPR:4"
    },
    {
        "id": "17020418.T13.T23",
        "sentence": "Anastrozole and @CHEMICAL$ are both non-steroidal @GENE$ inhibitors that compete with the substrate for binding to the enzyme active site.",
        "relation": "CPR:4"
    },
    {
        "id": "23489628.T2.T12",
        "sentence": "Identification and synthesis of @CHEMICAL$ derivatives as BRAF(@GENE$) inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23489628.T2.T11",
        "sentence": "Identification and synthesis of @CHEMICAL$ derivatives as @GENE$(V600E) inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23489628.T1.T6",
        "sentence": "In this study, we employed virtual screening and chemical synthesis to identify a series of @CHEMICAL$ derivatives as potent BRAF(@GENE$) inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23489628.T1.T5",
        "sentence": "In this study, we employed virtual screening and chemical synthesis to identify a series of @CHEMICAL$ derivatives as potent @GENE$(V600E) inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23578390.T6.T12",
        "sentence": "Exposure of cells to 4mM @CHEMICAL$ for 24h induced @GENE$ activation, ultrastructural alterations, and resulted in the translocation of Bax to the mitochondria and the release of cytochrome c from the mitochondrial inter-membrane space into the cytosol, indicating that fluoride-mediated apoptosis is mitochondria-dependent.",
        "relation": "CPR:3"
    },
    {
        "id": "23578390.T8.T15",
        "sentence": "@CHEMICAL$ treatment also increased phosphorylation of @GENE$ and ERK, but not p38, and apoptosis induced by fluoride was notably or partly suppressed by treatment with JNK or ERK inhibitors, respectively.",
        "relation": "CPR:3"
    },
    {
        "id": "23578390.T8.T16",
        "sentence": "@CHEMICAL$ treatment also increased phosphorylation of JNK and @GENE$, but not p38, and apoptosis induced by fluoride was notably or partly suppressed by treatment with JNK or ERK inhibitors, respectively.",
        "relation": "CPR:3"
    },
    {
        "id": "19780818.T1.T26",
        "sentence": "Furthermore, the @CHEMICAL$ channel blockers @GENE$ and Probenecid were less effective in inhibiting Panx1 currents when Kvbeta3 was co-expressed.",
        "relation": "CPR:4"
    },
    {
        "id": "19780818.T2.T26",
        "sentence": "Furthermore, the @CHEMICAL$ channel blockers carbenoxolone and @GENE$ were less effective in inhibiting Panx1 currents when Kvbeta3 was co-expressed.",
        "relation": "CPR:4"
    },
    {
        "id": "23200255.T1.T11",
        "sentence": "Part 5: hybrid PDE3/4 inhibitors as dual bronchorelaxant/anti-inflammatory agents for inhaled administration. @CHEMICAL$ (KCA-1490) exhibits moderate dual @GENE$-inhibitory activity and promises as a combined bronchodilatory/anti-inflammatory agent.",
        "relation": "CPR:4"
    },
    {
        "id": "23200255.T2.T11",
        "sentence": "Part 5: hybrid PDE3/4 inhibitors as dual bronchorelaxant/anti-inflammatory agents for inhaled administration. (-)-6-(7-Methoxy-2-(trifluoromethyl)pyrazolo[1,5-a]pyridin-4-yl)-5-methyl-4,5-dihydropyridazin-3(2H)-one (@CHEMICAL$) exhibits moderate dual @GENE$-inhibitory activity and promises as a combined bronchodilatory/anti-inflammatory agent.",
        "relation": "CPR:4"
    },
    {
        "id": "23200255.T3.T12",
        "sentence": "@CHEMICAL$-alkylation of the pyridazinone ring markedly enhances potency against @GENE$ but suppresses PDE3 inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "23200255.T3.T13",
        "sentence": "@CHEMICAL$-alkylation of the pyridazinone ring markedly enhances potency against PDE4 but suppresses @GENE$ inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "23200255.T4.T12",
        "sentence": "N-alkylation of the @CHEMICAL$ ring markedly enhances potency against @GENE$ but suppresses PDE3 inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "23200255.T4.T13",
        "sentence": "N-alkylation of the @CHEMICAL$ ring markedly enhances potency against PDE4 but suppresses @GENE$ inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "23200255.T5.T14",
        "sentence": "Addition of a @CHEMICAL$ extension to the N-alkyl group facilitates both enhancement of @GENE$-inhibitory activity and restoration of potent PDE3 inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "23200255.T5.T15",
        "sentence": "Addition of a @CHEMICAL$ extension to the N-alkyl group facilitates both enhancement of PDE4-inhibitory activity and restoration of potent @GENE$ inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "23200255.T6.T14",
        "sentence": "Addition of a 6-aryl-4,5-dihydropyridazin-3(2H)-one extension to the @CHEMICAL$-alkyl group facilitates both enhancement of @GENE$-inhibitory activity and restoration of potent PDE3 inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "23200255.T6.T15",
        "sentence": "Addition of a 6-aryl-4,5-dihydropyridazin-3(2H)-one extension to the @CHEMICAL$-alkyl group facilitates both enhancement of PDE4-inhibitory activity and restoration of potent @GENE$ inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "11031122.T5.T9",
        "sentence": "@CHEMICAL$ (FRD) is the key enzyme in @GENE$ respiration induced by anaerobic growth of bacteria.",
        "relation": "CPR:9"
    },
    {
        "id": "11031122.T5.T15",
        "sentence": "Fumarate reductase (@CHEMICAL$) is the key enzyme in @GENE$ respiration induced by anaerobic growth of bacteria.",
        "relation": "CPR:9"
    },
    {
        "id": "11031122.T6.T19",
        "sentence": "The frdA gene coding for subunit A of FRD, and two control genes, @CHEMICAL$ and copP associated with the export of @GENE$ out of H. pylori, were inactivated by insertion of the chloramphenicol acetyltransferase cassette into these individual genes.",
        "relation": "CPR:9"
    },
    {
        "id": "11031122.T6.T20",
        "sentence": "The frdA gene coding for subunit A of FRD, and two control genes, copA and @CHEMICAL$ associated with the export of @GENE$ out of H. pylori, were inactivated by insertion of the chloramphenicol acetyltransferase cassette into these individual genes.",
        "relation": "CPR:9"
    },
    {
        "id": "11031122.T2.T14",
        "sentence": "Given that @CHEMICAL$, present in all H. pylori strains, is immunogenic in H. pylori -infected patients and H. pylori growth in vitro can be inhibited by three anthelmintics (@GENE$, oxantel and thiabendazole), this enzyme could potentially be used both as a novel drug target as well as in the development of vaccines for H. pylori prevention and eradication.",
        "relation": "CPR:4"
    },
    {
        "id": "11031122.T3.T14",
        "sentence": "Given that @CHEMICAL$, present in all H. pylori strains, is immunogenic in H. pylori -infected patients and H. pylori growth in vitro can be inhibited by three anthelmintics (morantel, @GENE$ and thiabendazole), this enzyme could potentially be used both as a novel drug target as well as in the development of vaccines for H. pylori prevention and eradication.",
        "relation": "CPR:4"
    },
    {
        "id": "11031122.T4.T14",
        "sentence": "Given that @CHEMICAL$, present in all H. pylori strains, is immunogenic in H. pylori -infected patients and H. pylori growth in vitro can be inhibited by three anthelmintics (morantel, oxantel and @GENE$), this enzyme could potentially be used both as a novel drug target as well as in the development of vaccines for H. pylori prevention and eradication.",
        "relation": "CPR:4"
    },
    {
        "id": "10381000.T4.T8",
        "sentence": "To begin to examine whether these changes are mediated by alterations in gene expression for @CHEMICAL$ (TPH), the rate-limiting enzyme in @GENE$ biosynthesis, we quantitated its mRNA levels by competitive reverse transcription-polymerase chain reaction (RT-PCR). Repeated immobilization stress (2 h, 7 days) elicited a six- or ten-fold rise in TPH mRNA in median raphe nucleus (MRN) and dorsal raphe nucleus (DRN), respectively, without significantly altering TPH mRNA levels in the pineal gland.",
        "relation": "CPR:9"
    },
    {
        "id": "10381000.T4.T9",
        "sentence": "To begin to examine whether these changes are mediated by alterations in gene expression for tryptophan hydroxylase (@CHEMICAL$), the rate-limiting enzyme in @GENE$ biosynthesis, we quantitated its mRNA levels by competitive reverse transcription-polymerase chain reaction (RT-PCR). Repeated immobilization stress (2 h, 7 days) elicited a six- or ten-fold rise in TPH mRNA in median raphe nucleus (MRN) and dorsal raphe nucleus (DRN), respectively, without significantly altering TPH mRNA levels in the pineal gland.",
        "relation": "CPR:9"
    },
    {
        "id": "10381000.T5.T12",
        "sentence": "In contrast, there was little change in mRNA levels for @CHEMICAL$ (GTPCH), the rate limiting enzyme in synthesis of the @GENE$ (BH4), the obligate cofactor for TPH.",
        "relation": "CPR:9"
    },
    {
        "id": "10381000.T5.T13",
        "sentence": "In contrast, there was little change in mRNA levels for GTP cyclohydrolase I (@CHEMICAL$), the rate limiting enzyme in synthesis of the @GENE$ (BH4), the obligate cofactor for TPH.",
        "relation": "CPR:9"
    },
    {
        "id": "10381000.T6.T12",
        "sentence": "In contrast, there was little change in mRNA levels for @CHEMICAL$ (GTPCH), the rate limiting enzyme in synthesis of the tetrahydrobiopterin (@GENE$), the obligate cofactor for TPH.",
        "relation": "CPR:9"
    },
    {
        "id": "10381000.T6.T13",
        "sentence": "In contrast, there was little change in mRNA levels for GTP cyclohydrolase I (@CHEMICAL$), the rate limiting enzyme in synthesis of the tetrahydrobiopterin (@GENE$), the obligate cofactor for TPH.",
        "relation": "CPR:9"
    },
    {
        "id": "23411246.T6.T23",
        "sentence": "In relation to zinc bioavailability, @CHEMICAL$, b-CPPs, a(s1)-CN(64-74)4P and b-CN(1-25)4P increased @GENE$ uptake.",
        "relation": "CPR:9"
    },
    {
        "id": "23411246.T6.T24",
        "sentence": "In relation to zinc bioavailability, a-CPPs, @CHEMICAL$, a(s1)-CN(64-74)4P and b-CN(1-25)4P increased @GENE$ uptake.",
        "relation": "CPR:9"
    },
    {
        "id": "23411246.T6.T25",
        "sentence": "In relation to zinc bioavailability, a-CPPs, b-CPPs, @CHEMICAL$(64-74)4P and b-CN(1-25)4P increased @GENE$ uptake.",
        "relation": "CPR:9"
    },
    {
        "id": "23411246.T6.T26",
        "sentence": "In relation to zinc bioavailability, a-CPPs, b-CPPs, a(s1)-CN(64-74)4P and @CHEMICAL$(1-25)4P increased @GENE$ uptake.",
        "relation": "CPR:9"
    },
    {
        "id": "23178380.T1.T7",
        "sentence": "In contrast to parenteral delivery of rBChE, which currently requires posttranslational modification for good plasma stability, an unmodified aer-rBChE pretreatment given 1-40h prior to >1 LD50 of aer-@CHEMICAL$ (Px) was able to prevent inhibition of circulating @GENE$ in a dose-dependent manner.",
        "relation": "CPR:3"
    },
    {
        "id": "23290487.T3.T8",
        "sentence": "Next to @CHEMICAL$, the predominant protein influencing @GENE$ metabolism is PPARa and g whose expressions were also positively modulated.",
        "relation": "CPR:9"
    },
    {
        "id": "9732824.T2.T12",
        "sentence": "Both the @CHEMICAL$ inhibitor @GENE$ and alpha 1-adrenoceptor antagonists (e.g. alfuzosin, doxazosin, prazosin, tamsulosin and terazosin) have been recommended as appropriate treatment options for patients with lower urinary tract symptoms (LUTS) associated with benign prostatic obstruction (BPO), and their efficacy has been proven in several placebo-controlled trials.",
        "relation": "CPR:4"
    },
    {
        "id": "9732824.T3.T13",
        "sentence": "Both the 5 alpha-reductase inhibitor finasteride and @CHEMICAL$ antagonists (e.g. @GENE$, doxazosin, prazosin, tamsulosin and terazosin) have been recommended as appropriate treatment options for patients with lower urinary tract symptoms (LUTS) associated with benign prostatic obstruction (BPO), and their efficacy has been proven in several placebo-controlled trials.",
        "relation": "CPR:6"
    },
    {
        "id": "9732824.T4.T13",
        "sentence": "Both the 5 alpha-reductase inhibitor finasteride and @CHEMICAL$ antagonists (e.g. alfuzosin, @GENE$, prazosin, tamsulosin and terazosin) have been recommended as appropriate treatment options for patients with lower urinary tract symptoms (LUTS) associated with benign prostatic obstruction (BPO), and their efficacy has been proven in several placebo-controlled trials.",
        "relation": "CPR:6"
    },
    {
        "id": "9732824.T5.T13",
        "sentence": "Both the 5 alpha-reductase inhibitor finasteride and @CHEMICAL$ antagonists (e.g. alfuzosin, doxazosin, @GENE$, tamsulosin and terazosin) have been recommended as appropriate treatment options for patients with lower urinary tract symptoms (LUTS) associated with benign prostatic obstruction (BPO), and their efficacy has been proven in several placebo-controlled trials.",
        "relation": "CPR:6"
    },
    {
        "id": "9732824.T6.T13",
        "sentence": "Both the 5 alpha-reductase inhibitor finasteride and @CHEMICAL$ antagonists (e.g. alfuzosin, doxazosin, prazosin, @GENE$ and terazosin) have been recommended as appropriate treatment options for patients with lower urinary tract symptoms (LUTS) associated with benign prostatic obstruction (BPO), and their efficacy has been proven in several placebo-controlled trials.",
        "relation": "CPR:6"
    },
    {
        "id": "9732824.T7.T13",
        "sentence": "Both the 5 alpha-reductase inhibitor finasteride and @CHEMICAL$ antagonists (e.g. alfuzosin, doxazosin, prazosin, tamsulosin and @GENE$) have been recommended as appropriate treatment options for patients with lower urinary tract symptoms (LUTS) associated with benign prostatic obstruction (BPO), and their efficacy has been proven in several placebo-controlled trials.",
        "relation": "CPR:6"
    },
    {
        "id": "11972287.T8.T15",
        "sentence": "Central @CHEMICAL$ receptor stimulation by @GENE$ increases blood glucose in rats.",
        "relation": "CPR:3"
    },
    {
        "id": "11972287.T2.T11",
        "sentence": "Injections of @CHEMICAL$, a selective @GENE$ receptor agonist, induced a significant increase in blood glucose in non-stressed rats in both fasted and in fed states.",
        "relation": "CPR:5"
    },
    {
        "id": "11972287.T4.T12",
        "sentence": "The hyperglycemic effect of @CHEMICAL$ central administration was blocked by pretreatment with ondansetron, a specific @GENE$ receptor antagonist, indicating that the effects here obtained with m-CPBG were a result of its interaction with 5-HT3 receptors.",
        "relation": "CPR:5"
    },
    {
        "id": "23375813.T6.T10",
        "sentence": "@CHEMICAL$, a potent @GENE$ inhibitor from Tabernaemontana divaricata.",
        "relation": "CPR:4"
    },
    {
        "id": "23375813.T3.T7",
        "sentence": "Guided by the @CHEMICAL$ inhibiting activity, the @GENE$ 3'-R/S-hydroxyvoacamine was isolated from a stem extract of Tabernaemontana divaricata, a plant used in Thailand in traditional rejuvenation remedies for improving the memory.",
        "relation": "CPR:4"
    },
    {
        "id": "23375813.T5.T7",
        "sentence": "Guided by the @CHEMICAL$ inhibiting activity, the bisindole alkaloid @GENE$ was isolated from a stem extract of Tabernaemontana divaricata, a plant used in Thailand in traditional rejuvenation remedies for improving the memory.",
        "relation": "CPR:4"
    },
    {
        "id": "22931530.T5.T9",
        "sentence": "@CHEMICAL$: Synthetic Methodologies and Pharmaceutical Applications as @GENE$ Inhibitors. a-Amino-a'-halomethylketones are interesting scaffolds bearing (at least) two sequential electrophilic carbons that by interacting with the nucleophilic moieties of several enzymes, represent the ideal candidates for in vivo and in vitro inhibition studies.",
        "relation": "CPR:4"
    },
    {
        "id": "23600432.T1.T8",
        "sentence": "Introduction: @CHEMICAL$ (5-LO) is a crucial enzyme of the @GENE$ (AA) cascade and catalyzes the formation of bioactive leukotrienes (LTs) with the help of FLAP, the 5-LO-activating protein.",
        "relation": "CPR:9"
    },
    {
        "id": "23600432.T1.T11",
        "sentence": "Introduction: 5-Lipoxygenase (@CHEMICAL$) is a crucial enzyme of the @GENE$ (AA) cascade and catalyzes the formation of bioactive leukotrienes (LTs) with the help of FLAP, the 5-LO-activating protein.",
        "relation": "CPR:9"
    },
    {
        "id": "23531488.T1.T7",
        "sentence": "Using a transient heterologous cell expression system, we find that the transport activities of the @CHEMICAL$ variant towards substrates @GENE$ and rosuvastatin are similar to the well-characterized full length variant.",
        "relation": "CPR:9"
    },
    {
        "id": "23531488.T2.T7",
        "sentence": "Using a transient heterologous cell expression system, we find that the transport activities of the @CHEMICAL$ variant towards substrates estrone sulfate and @GENE$ are similar to the well-characterized full length variant.",
        "relation": "CPR:9"
    },
    {
        "id": "14530799.T17.T33",
        "sentence": "@CHEMICAL$ is an uncompetitive (channel blocking) @GENE$ antagonist.",
        "relation": "CPR:6"
    },
    {
        "id": "14530799.T20.T34",
        "sentence": "Like other @CHEMICAL$ antagonists, @GENE$ at high concentrations can inhibit mechanisms of synaptic plasticity that are believed to underlie learning and memory.",
        "relation": "CPR:6"
    },
    {
        "id": "14530799.T3.T24",
        "sentence": "\"Blockade of @CHEMICAL$ by @GENE$ could theoretically confer disease-modifying activity in AD by inhibiting the \"\"weak\"\" NMDA receptor-dependent excitotoxicity that has been hypothesized to play a role in the progressive neuronal loss that underlies the evolving dementia.\"",
        "relation": "CPR:4"
    },
    {
        "id": "14530799.T3.T25",
        "sentence": "\"Blockade of NMDA receptors by @CHEMICAL$ could theoretically confer disease-modifying activity in AD by inhibiting the \"\"weak\"\" @GENE$-dependent excitotoxicity that has been hypothesized to play a role in the progressive neuronal loss that underlies the evolving dementia.\"",
        "relation": "CPR:4"
    },
    {
        "id": "14530799.T5.T26",
        "sentence": "Moreover, recent in vitro studies suggest that @CHEMICAL$ abrogates @GENE$ (Abeta) toxicity and possibly inhibits Abeta production.",
        "relation": "CPR:4"
    },
    {
        "id": "14530799.T5.T27",
        "sentence": "Moreover, recent in vitro studies suggest that @CHEMICAL$ abrogates beta-amyloid (@GENE$) toxicity and possibly inhibits Abeta production.",
        "relation": "CPR:4"
    },
    {
        "id": "14530799.T5.T28",
        "sentence": "Moreover, recent in vitro studies suggest that @CHEMICAL$ abrogates beta-amyloid (Abeta) toxicity and possibly inhibits @GENE$ production.",
        "relation": "CPR:4"
    },
    {
        "id": "14530799.T6.T29",
        "sentence": "Considerable attention has focused on the investigation of theories to explain the better tolerability of @CHEMICAL$ over other @GENE$ antagonists, particularly those that act by a similar channel blocking mechanism such as dissociative anesthetic-like agents (phencyclidine, ketamine, MK-801).",
        "relation": "CPR:6"
    },
    {
        "id": "16480505.T2.T9",
        "sentence": "The concomitantly administered effects of @CHEMICAL$ on other drugs can result in their altered metabolism or transportation that are metabolised by @GENE$ or transported by p-glycoprotein in the gastrointestinal tract and liver.",
        "relation": "CPR:9"
    },
    {
        "id": "16480505.T2.T10",
        "sentence": "The concomitantly administered effects of @CHEMICAL$ on other drugs can result in their altered metabolism or transportation that are metabolised by cytochromes P450 or transported by @GENE$ in the gastrointestinal tract and liver.",
        "relation": "CPR:9"
    },
    {
        "id": "16480505.T3.T11",
        "sentence": "In general, @CHEMICAL$ can act on a pattern: rifampicin activates the @GENE$ that in turn affects cytochromes P450, glucuronosyltransferases and p-glycoprotein activities.",
        "relation": "CPR:5"
    },
    {
        "id": "16480505.T4.T11",
        "sentence": "In general, rifampicin can act on a pattern: @CHEMICAL$ activates the @GENE$ that in turn affects cytochromes P450, glucuronosyltransferases and p-glycoprotein activities.",
        "relation": "CPR:3"
    },
    {
        "id": "23354070.T2.T10",
        "sentence": "We describe here the isolation and biochemical characterization of the marine natural @CHEMICAL$ palinurin as a @GENE$ inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "23354070.T3.T10",
        "sentence": "We describe here the isolation and biochemical characterization of the marine natural sesquiterpene @CHEMICAL$ as a @GENE$ inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "23354070.T4.T11",
        "sentence": "Experimental studies performed for characterizing the inhibitory mechanism indicate that @CHEMICAL$ inhibition by @GENE$ cannot be competed out by ATP nor peptide substrate.",
        "relation": "CPR:4"
    },
    {
        "id": "23354070.T6.T13",
        "sentence": "Moreover, molecular dynamics simulations have identified an allosteric mechanism by which binding of @CHEMICAL$ leads to @GENE$ inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "23580446.T3.T7",
        "sentence": "@CHEMICAL$-derived @GENE$ can influence several processes that are linked to carcinogenesis.",
        "relation": "CPR:9"
    },
    {
        "id": "23580446.T4.T27",
        "sentence": "Platelet-induced @CHEMICAL$-dependent @GENE$ synthesis in HT29 cells was involved in downregulation of p21(WAF1/CIP1) and upregulation of cyclinB1, since these effects were prevented by rofecoxib(a selective COX-2 inhibitor) and rescued by exogenous PGE2.",
        "relation": "CPR:9"
    },
    {
        "id": "23580446.T5.T28",
        "sentence": "Platelet-induced COX-2-dependent PGE2 synthesis in HT29 cells was involved in downregulation of @CHEMICAL$(WAF1/CIP1) and upregulation of cyclinB1, since these effects were prevented by @GENE$(a selective COX-2 inhibitor) and rescued by exogenous PGE2.",
        "relation": "CPR:3"
    },
    {
        "id": "23580446.T5.T29",
        "sentence": "Platelet-induced COX-2-dependent PGE2 synthesis in HT29 cells was involved in downregulation of p21(@CHEMICAL$/CIP1) and upregulation of cyclinB1, since these effects were prevented by @GENE$(a selective COX-2 inhibitor) and rescued by exogenous PGE2.",
        "relation": "CPR:3"
    },
    {
        "id": "23580446.T5.T30",
        "sentence": "Platelet-induced COX-2-dependent PGE2 synthesis in HT29 cells was involved in downregulation of p21(WAF1/@CHEMICAL$) and upregulation of cyclinB1, since these effects were prevented by @GENE$(a selective COX-2 inhibitor) and rescued by exogenous PGE2.",
        "relation": "CPR:3"
    },
    {
        "id": "23580446.T5.T31",
        "sentence": "Platelet-induced COX-2-dependent PGE2 synthesis in HT29 cells was involved in downregulation of p21(WAF1/CIP1) and upregulation of @CHEMICAL$, since these effects were prevented by @GENE$(a selective COX-2 inhibitor) and rescued by exogenous PGE2.",
        "relation": "CPR:4"
    },
    {
        "id": "23580446.T5.T32",
        "sentence": "Platelet-induced COX-2-dependent PGE2 synthesis in HT29 cells was involved in downregulation of p21(WAF1/CIP1) and upregulation of cyclinB1, since these effects were prevented by @CHEMICAL$(a selective @GENE$ inhibitor) and rescued by exogenous PGE2.",
        "relation": "CPR:4"
    },
    {
        "id": "22634361.T14.T18",
        "sentence": "Previous studies demonstrated that the @CHEMICAL$-selective orthosteric agonist, @GENE$ produced anxiolytic- but not antidepressant-like effects upon peripheral administration.",
        "relation": "CPR:5"
    },
    {
        "id": "22634361.T7.T19",
        "sentence": "The anti-hyperthermic effect of Lu AF21934 (5 mg/kg) in the SIH test was inhibited by the @CHEMICAL$ antagonist @GENE$ (10 mg/kg) and was not serotonin-dependent, as it persisted in serotonin-deficient mice and upon blockade of either 5-HT(1A) receptors by WAY100635, or 5-HT(2A/2C) receptors by ritanserin.",
        "relation": "CPR:6"
    },
    {
        "id": "22634361.T11.T20",
        "sentence": "The anti-hyperthermic effect of Lu AF21934 (5 mg/kg) in the SIH test was inhibited by the benzodiazepine receptor antagonist flumazenil (10 mg/kg) and was not serotonin-dependent, as it persisted in serotonin-deficient mice and upon blockade of either @CHEMICAL$ receptors by @GENE$, or 5-HT(2A/2C) receptors by ritanserin.",
        "relation": "CPR:4"
    },
    {
        "id": "22634361.T13.T21",
        "sentence": "The anti-hyperthermic effect of Lu AF21934 (5 mg/kg) in the SIH test was inhibited by the benzodiazepine receptor antagonist flumazenil (10 mg/kg) and was not serotonin-dependent, as it persisted in serotonin-deficient mice and upon blockade of either 5-HT(1A) receptors by WAY100635, or @CHEMICAL$ receptors by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17979301.T36.T58",
        "sentence": "Present results of point mutations of full-length PDE5 showed that maximum catalysis was decreased 2650-fold in H613A and 55-fold in F820A. Catalytic-site affinities for cGMP, vardenafil, sildenafil, @CHEMICAL$, or 3-isobutyl-1-methylxanthine (IBMX) were respectively weakened 14-, 123-, 30-, 51-, and 43-fold for Y612A; 63-, 511-, 43-, 95- and 61-fold for @GENE$; and 59-, 448-, 71-, 137-, and 93-fold for F820A.",
        "relation": "CPR:9"
    },
    {
        "id": "23583806.T6.T17",
        "sentence": "@CHEMICAL$ treatment showed reduced production of pro-inflammatory @GENE$ and NO and increased HO-1 activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23583806.T6.T18",
        "sentence": "@CHEMICAL$ treatment showed reduced production of pro-inflammatory cytokines and NO and increased @GENE$ activity.",
        "relation": "CPR:3"
    },
    {
        "id": "17567713.T10.T16",
        "sentence": "Recently, it has been shown that the activation of particular @CHEMICAL$ bitter taste receptors is partially involved with the bitter aftertaste sensation of @GENE$ and acesulfame-K. To more fully understand the biology behind these phenomena we have addressed the question of whether AS could stimulate transient receptor potential vanilloid-1 (TRPV1) receptors, as these receptors are activated by a large range of structurally different chemicals.",
        "relation": "CPR:3"
    },
    {
        "id": "17567713.T11.T16",
        "sentence": "Recently, it has been shown that the activation of particular @CHEMICAL$ bitter taste receptors is partially involved with the bitter aftertaste sensation of saccharin and @GENE$. To more fully understand the biology behind these phenomena we have addressed the question of whether AS could stimulate transient receptor potential vanilloid-1 (TRPV1) receptors, as these receptors are activated by a large range of structurally different chemicals.",
        "relation": "CPR:3"
    },
    {
        "id": "17567713.T2.T14",
        "sentence": "We also found that @CHEMICAL$ receptors are activated by @GENE$, ZnSO(4), and FeSO(4), three salts known to produce a metallic taste sensation.",
        "relation": "CPR:3"
    },
    {
        "id": "17567713.T3.T14",
        "sentence": "We also found that @CHEMICAL$ receptors are activated by CuSO(4), @GENE$, and FeSO(4), three salts known to produce a metallic taste sensation.",
        "relation": "CPR:3"
    },
    {
        "id": "17567713.T4.T14",
        "sentence": "We also found that @CHEMICAL$ receptors are activated by CuSO(4), ZnSO(4), and @GENE$, three salts known to produce a metallic taste sensation.",
        "relation": "CPR:3"
    },
    {
        "id": "15974585.T4.T19",
        "sentence": "@CHEMICAL$ CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "15974585.T1.T13",
        "sentence": "CXCL8 activates PMNs by binding the seven-transmembrane (7-TM) G-protein-coupled receptors CXC chemokine receptor 1 (CXCR1) and CXC chemokine receptor 2 (CXCR2). @CHEMICAL$ (1) was previously reported to be a potent and specific noncompetitive inhibitor of @GENE$-induced human PMNs chemotaxis.",
        "relation": "CPR:4"
    },
    {
        "id": "23221006.T17.T29",
        "sentence": "Role of organic cation/carnitine transporter 1 in uptake of @CHEMICAL$ and inhibitory effect on @GENE$ respiration in mitochondria.",
        "relation": "CPR:4"
    },
    {
        "id": "23221006.T17.T28",
        "sentence": "Role of @CHEMICAL$ in uptake of @GENE$ and inhibitory effect on complex I respiration in mitochondria.",
        "relation": "CPR:9"
    },
    {
        "id": "23221006.T1.T27",
        "sentence": "@CHEMICAL$ causes lactic acidosis in clinical situations due to inhibition of @GENE$. It is reportedly taken up by hepatocytes and exhibits mitochondrial toxicity in the liver.",
        "relation": "CPR:4"
    },
    {
        "id": "23221006.T9.T24",
        "sentence": "In this study, uptake of phenformin and [(14)C]tetraethylammonium (TEA) and @CHEMICAL$ inhibition by @GENE$ were examined in isolated liver and heart mitochondria.",
        "relation": "CPR:4"
    },
    {
        "id": "23221006.T3.T19",
        "sentence": "Inhibition by phenformin of oxygen consumption via complex I respiration in isolated rat liver mitochondria was greater than that in heart mitochondria, whereas inhibitory effect of @CHEMICAL$ on @GENE$ respiration was similar in inside-out structured submitochondrial particles prepared from rat livers and hearts.",
        "relation": "CPR:4"
    },
    {
        "id": "23221006.T15.T18",
        "sentence": "Inhibition by @CHEMICAL$ of oxygen consumption via @GENE$ respiration in isolated rat liver mitochondria was greater than that in heart mitochondria, whereas inhibitory effect of phenformin on complex I respiration was similar in inside-out structured submitochondrial particles prepared from rat livers and hearts.",
        "relation": "CPR:4"
    },
    {
        "id": "23221006.T5.T22",
        "sentence": "These observations suggest that uptake of @CHEMICAL$ into liver mitochondria is at least partly mediated by OCTN1 and functionally relevant to its inhibition potential of @GENE$ respiration.",
        "relation": "CPR:4"
    },
    {
        "id": "23221006.T5.T21",
        "sentence": "These observations suggest that uptake of @CHEMICAL$ into liver mitochondria is at least partly mediated by @GENE$ and functionally relevant to its inhibition potential of complex I respiration.",
        "relation": "CPR:9"
    },
    {
        "id": "23358258.T1.T7",
        "sentence": "A series of @CHEMICAL$ derivatives in which a methylene was inserted at position 8 of xanthine scaffold was synthesized and evaluated as inhibitors of @GENE$ (DPP-4) for the treatment of type 2 diabetes.",
        "relation": "CPR:4"
    },
    {
        "id": "23358258.T1.T8",
        "sentence": "A series of @CHEMICAL$ derivatives in which a methylene was inserted at position 8 of xanthine scaffold was synthesized and evaluated as inhibitors of dipeptidyl peptidase 4 (@GENE$) for the treatment of type 2 diabetes.",
        "relation": "CPR:4"
    },
    {
        "id": "23358258.T5.T7",
        "sentence": "A series of xanthine derivatives in which a methylene was inserted at position 8 of @CHEMICAL$ scaffold was synthesized and evaluated as inhibitors of @GENE$ (DPP-4) for the treatment of type 2 diabetes.",
        "relation": "CPR:4"
    },
    {
        "id": "23358258.T5.T8",
        "sentence": "A series of xanthine derivatives in which a methylene was inserted at position 8 of @CHEMICAL$ scaffold was synthesized and evaluated as inhibitors of dipeptidyl peptidase 4 (@GENE$) for the treatment of type 2 diabetes.",
        "relation": "CPR:4"
    },
    {
        "id": "15224175.T38.T61",
        "sentence": "The animals were divided into thirteen groups (n=4 each) receiving an i.v. bolus injection of, either physiological saline (0.3 ml/kg; control), or the antagonists @CHEMICAL$ (300 microg/kg; @GENE$), BRL15572 (300 microg/kg; 5-HT1D), rauwolscine (300 microg/kg; alpha2), SB224289 + BRL15572 (300 microg/kg each), SB224289 + rauwolscine (300 microg/kg each), BRL15572 + rauwolscine (300 microg/kg each), rauwolscine (300 microg/kg) + prazosin (100 microg/kg; alpha1), SB224289 (300 microg/kg) + prazosin (100 microg/kg), SB224289 (300 microg/kg) + rauwolscine (300 microg/kg) + prazosin (100 microg/kg), SB224289 (300 microg/kg) + prazosin (100 microg/kg) + BRL44408 (1,000 microg/kg; alpha2A), SB224289 (300 microg/kg) + prazosin (100 microg/kg)+ imiloxan (1,000 microg/kg; alpha2B), or SB224289 (300 microg/kg) + prazosin (100 microg/kg) + MK912 (300 microg/kg; alpha2C).",
        "relation": "CPR:6"
    },
    {
        "id": "15224175.T39.T62",
        "sentence": "The animals were divided into thirteen groups (n=4 each) receiving an i.v. bolus injection of, either physiological saline (0.3 ml/kg; control), or the antagonists SB224289 (300 microg/kg; 5-HT1B), @CHEMICAL$ (300 microg/kg; @GENE$), rauwolscine (300 microg/kg; alpha2), SB224289 + BRL15572 (300 microg/kg each), SB224289 + rauwolscine (300 microg/kg each), BRL15572 + rauwolscine (300 microg/kg each), rauwolscine (300 microg/kg) + prazosin (100 microg/kg; alpha1), SB224289 (300 microg/kg) + prazosin (100 microg/kg), SB224289 (300 microg/kg) + rauwolscine (300 microg/kg) + prazosin (100 microg/kg), SB224289 (300 microg/kg) + prazosin (100 microg/kg) + BRL44408 (1,000 microg/kg; alpha2A), SB224289 (300 microg/kg) + prazosin (100 microg/kg)+ imiloxan (1,000 microg/kg; alpha2B), or SB224289 (300 microg/kg) + prazosin (100 microg/kg) + MK912 (300 microg/kg; alpha2C).",
        "relation": "CPR:6"
    },
    {
        "id": "11692072.T6.T15",
        "sentence": "In an earlier report, DRD2 E8 A/A genotype was associated with reduced responsiveness to the @CHEMICAL$ agonist @GENE$; however, it is not clear whether both findings share the same biological basis.",
        "relation": "CPR:5"
    },
    {
        "id": "23318471.T1.T44",
        "sentence": "As predicted, TES enhanced the production of both peroxynitrite precursors (i.e., superoxide and nitic oxide), and @CHEMICAL$ was identified as the likely source of @GENE$-stimulated superoxide production.",
        "relation": "CPR:9"
    },
    {
        "id": "23318471.T2.T44",
        "sentence": "As predicted, TES enhanced the production of both peroxynitrite precursors (i.e., superoxide and nitic oxide), and @CHEMICAL$ was identified as the likely source of TES-stimulated @GENE$ production.",
        "relation": "CPR:9"
    },
    {
        "id": "23318471.T3.T39",
        "sentence": "Functional and biochemical studies indicated that @CHEMICAL$ signaling involved activity of the phosphoinositide 3 (PI3) kinase-protein kinase B (Akt) cascade initiated by activation of the @GENE$ and culminated in enhanced production of cGMP and microvascular vasodilation.",
        "relation": "CPR:3"
    },
    {
        "id": "23318471.T10.T40",
        "sentence": "These findings, derived from a variety of analytical and functional approaches, provide evidence for a novel nongenomic signaling mechanism for androgen action in the microvasculature: TES-stimulated vasodilation mediated primarily by @CHEMICAL$ formed from @GENE$-generated superoxide and NO.",
        "relation": "CPR:9"
    },
    {
        "id": "23318471.T12.T40",
        "sentence": "These findings, derived from a variety of analytical and functional approaches, provide evidence for a novel nongenomic signaling mechanism for androgen action in the microvasculature: TES-stimulated vasodilation mediated primarily by peroxynitrite formed from @CHEMICAL$-generated @GENE$ and NO.",
        "relation": "CPR:9"
    },
    {
        "id": "23318471.T13.T40",
        "sentence": "These findings, derived from a variety of analytical and functional approaches, provide evidence for a novel nongenomic signaling mechanism for androgen action in the microvasculature: TES-stimulated vasodilation mediated primarily by peroxynitrite formed from @CHEMICAL$-generated superoxide and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "12560076.T21.T28",
        "sentence": "@CHEMICAL$ catalyzes specific elimination of @GENE$ to pyruvate.",
        "relation": "CPR:9"
    },
    {
        "id": "12560076.T22.T28",
        "sentence": "@CHEMICAL$ catalyzes specific elimination of L-serine to @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "12560076.T1.T23",
        "sentence": "@CHEMICAL$ was previously identified in mammalian brain and was shown to be a co-agonist at the 'glycine' site of the @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "12560076.T4.T24",
        "sentence": "Racemization of @CHEMICAL$ is catalyzed by @GENE$, a pyridoxal 5'-phosphate-dependent enzyme expressed mainly in brain and liver.",
        "relation": "CPR:9"
    },
    {
        "id": "17161452.T4.T16",
        "sentence": "Pharmacogenetic analysis of two genes, the @CHEMICAL$ metabolic enzyme @GENE$ and warfarin target enzyme, vitamin K epoxide reductase complex 1 VKORC1, confirmed their influence on warfarin maintenance dose.",
        "relation": "CPR:9"
    },
    {
        "id": "17161452.T8.T19",
        "sentence": "Possession of @CHEMICAL$*2 or CYP2C9*3 variant alleles, which result in decreased enzyme activity, is associated with a significant decrease in the mean @GENE$ dose.",
        "relation": "CPR:9"
    },
    {
        "id": "17161452.T8.T20",
        "sentence": "Possession of CYP2C9*2 or @CHEMICAL$*3 variant alleles, which result in decreased enzyme activity, is associated with a significant decrease in the mean @GENE$ dose.",
        "relation": "CPR:9"
    },
    {
        "id": "21631396.T13.T35",
        "sentence": "@CHEMICAL$ inhibits T-cell activation by targeting @GENE$, NFAT and AP-1 signaling pathways.",
        "relation": "CPR:4"
    },
    {
        "id": "21631396.T13.T36",
        "sentence": "@CHEMICAL$ inhibits T-cell activation by targeting NF-kappaB, @GENE$ and AP-1 signaling pathways.",
        "relation": "CPR:4"
    },
    {
        "id": "21631396.T13.T37",
        "sentence": "@CHEMICAL$ inhibits T-cell activation by targeting NF-kappaB, NFAT and @GENE$ signaling pathways.",
        "relation": "CPR:4"
    },
    {
        "id": "21631396.T9.T23",
        "sentence": "We found that @CHEMICAL$ inhibits @GENE$ (IL-2) and tumor necrosis factor (TNF) alpha-gene transcription in stimulated Jurkat cells, a human T-cell leukemia cell line.",
        "relation": "CPR:4"
    },
    {
        "id": "21631396.T9.T24",
        "sentence": "We found that @CHEMICAL$ inhibits interleukin-2 (@GENE$) and tumor necrosis factor (TNF) alpha-gene transcription in stimulated Jurkat cells, a human T-cell leukemia cell line.",
        "relation": "CPR:4"
    },
    {
        "id": "21631396.T9.T25",
        "sentence": "We found that @CHEMICAL$ inhibits interleukin-2 (IL-2) and @GENE$-gene transcription in stimulated Jurkat cells, a human T-cell leukemia cell line.",
        "relation": "CPR:3"
    },
    {
        "id": "21631396.T12.T32",
        "sentence": "To further characterize the inhibitory mechanisms of PSE at the transcriptional level, we examined the transcriptional activities of nuclear factor kappa B (NF-kappaB), nuclear factor of activated T cells (NFAT), and activator protein-1 (AP-1) transcription factors and found that @CHEMICAL$ inhibited @GENE$-dependent transcriptional activity without affecting either the phosphorylation, the degradation of the cytoplasmic NF-kappaB inhibitory protein, IkappaBalpha or the DNA-binding activity.",
        "relation": "CPR:4"
    },
    {
        "id": "21631396.T2.T14",
        "sentence": "However, phosphorylation of the @CHEMICAL$/RelA subunit was clearly inhibited by @GENE$ in stimulated cells.",
        "relation": "CPR:4"
    },
    {
        "id": "21631396.T2.T15",
        "sentence": "However, phosphorylation of the p65/@CHEMICAL$ subunit was clearly inhibited by @GENE$ in stimulated cells.",
        "relation": "CPR:4"
    },
    {
        "id": "21631396.T3.T16",
        "sentence": "In addition, @CHEMICAL$ inhibited the transcriptional activity of @GENE$ without interfering with the calcium-induced NFAT dephosphorylation event, which represents the major signaling pathway for its activation.",
        "relation": "CPR:4"
    },
    {
        "id": "21631396.T4.T17",
        "sentence": "In addition, PSE inhibited the transcriptional activity of NFAT without interfering with the @CHEMICAL$-induced @GENE$ dephosphorylation event, which represents the major signaling pathway for its activation.",
        "relation": "CPR:3"
    },
    {
        "id": "21631396.T5.T21",
        "sentence": "NFAT cooperates with c-Jun, a compound of the AP-1 complex, to activate target genes, and we also found that @CHEMICAL$ inhibited both @GENE$ activation and AP-1 transcriptional activity.",
        "relation": "CPR:4"
    },
    {
        "id": "21631396.T5.T22",
        "sentence": "NFAT cooperates with c-Jun, a compound of the AP-1 complex, to activate target genes, and we also found that @CHEMICAL$ inhibited both JNK activation and @GENE$ transcriptional activity.",
        "relation": "CPR:4"
    },
    {
        "id": "15932636.T5.T26",
        "sentence": "Furthermore, experiments showed that treatment with @CHEMICAL$ results in a reduction in the amount of @GENE$ protein in peritoneal exudate cells.",
        "relation": "CPR:4"
    },
    {
        "id": "12213829.T15.T45",
        "sentence": "Micromolar Ntp dose-dependently increased the mean open channel probability in ligand-free solution (P(O(max))) and attenuated the @CHEMICAL$ inhibition of @GENE$/SUR1, but had no effect on homomeric K(IR)6.2 channels.",
        "relation": "CPR:4"
    },
    {
        "id": "12213829.T15.T46",
        "sentence": "Micromolar Ntp dose-dependently increased the mean open channel probability in ligand-free solution (P(O(max))) and attenuated the @CHEMICAL$ inhibition of K(IR)6.2/@GENE$, but had no effect on homomeric K(IR)6.2 channels.",
        "relation": "CPR:4"
    },
    {
        "id": "12213829.T2.T26",
        "sentence": "These effects resemble those seen with N-terminal deletions (DeltaN) of K(IR)6.0, and application of Ntp to @CHEMICAL$ decreased their P(O(max)) and apparent IC(50) for @GENE$ in the absence of Mg(2+).",
        "relation": "CPR:4"
    },
    {
        "id": "15953344.T2.T11",
        "sentence": "@CHEMICAL$ (MCTs) are proton-linked membrane carriers involved in the transport of @GENE$ such as lactate, pyruvate, as well as ketone bodies.",
        "relation": "CPR:9"
    },
    {
        "id": "15953344.T2.T14",
        "sentence": "Monocarboxylate transporters (@CHEMICAL$) are proton-linked membrane carriers involved in the transport of @GENE$ such as lactate, pyruvate, as well as ketone bodies.",
        "relation": "CPR:9"
    },
    {
        "id": "15953344.T4.T11",
        "sentence": "@CHEMICAL$ (MCTs) are proton-linked membrane carriers involved in the transport of monocarboxylates such as @GENE$, pyruvate, as well as ketone bodies.",
        "relation": "CPR:9"
    },
    {
        "id": "15953344.T4.T14",
        "sentence": "Monocarboxylate transporters (@CHEMICAL$) are proton-linked membrane carriers involved in the transport of monocarboxylates such as @GENE$, pyruvate, as well as ketone bodies.",
        "relation": "CPR:9"
    },
    {
        "id": "15953344.T6.T11",
        "sentence": "@CHEMICAL$ (MCTs) are proton-linked membrane carriers involved in the transport of monocarboxylates such as lactate, @GENE$, as well as ketone bodies.",
        "relation": "CPR:9"
    },
    {
        "id": "15953344.T6.T14",
        "sentence": "Monocarboxylate transporters (@CHEMICAL$) are proton-linked membrane carriers involved in the transport of monocarboxylates such as lactate, @GENE$, as well as ketone bodies.",
        "relation": "CPR:9"
    },
    {
        "id": "15953344.T7.T11",
        "sentence": "@CHEMICAL$ (MCTs) are proton-linked membrane carriers involved in the transport of monocarboxylates such as lactate, pyruvate, as well as @GENE$ bodies.",
        "relation": "CPR:9"
    },
    {
        "id": "15953344.T7.T14",
        "sentence": "Monocarboxylate transporters (@CHEMICAL$) are proton-linked membrane carriers involved in the transport of monocarboxylates such as lactate, pyruvate, as well as @GENE$ bodies.",
        "relation": "CPR:9"
    },
    {
        "id": "15953344.T9.T22",
        "sentence": "Interestingly, part of @CHEMICAL$ immunoreactivity is located at postsynaptic sites, suggesting a particular role of @GENE$ and their transporters in synaptic transmission.",
        "relation": "CPR:9"
    },
    {
        "id": "22445601.T12.T29",
        "sentence": "Differentiating the roles of mGlu2 and mGlu3 receptors using @CHEMICAL$, an @GENE$ agonist/mGlu3 antagonist.",
        "relation": "CPR:5"
    },
    {
        "id": "22445601.T12.T30",
        "sentence": "Differentiating the roles of mGlu2 and mGlu3 receptors using @CHEMICAL$, an mGlu2 agonist/@GENE$ antagonist.",
        "relation": "CPR:6"
    },
    {
        "id": "22445601.T6.T20",
        "sentence": "@CHEMICAL$ was claimed from human mGlu receptors expressed in non-neuronal cells to be a selective orthosteric @GENE$ agonist and mGlu3 antagonist.",
        "relation": "CPR:5"
    },
    {
        "id": "22445601.T6.T21",
        "sentence": "@CHEMICAL$ was claimed from human mGlu receptors expressed in non-neuronal cells to be a selective orthosteric mGlu2 agonist and @GENE$ antagonist.",
        "relation": "CPR:6"
    },
    {
        "id": "22445601.T1.T13",
        "sentence": "These results confirm the selective @CHEMICAL$ agonist and mGlu3 antagonist actions of @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "22445601.T1.T14",
        "sentence": "These results confirm the selective mGlu2 agonist and @CHEMICAL$ antagonist actions of @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "6227474.T17.T32",
        "sentence": "Selective precipitation of cytosol receptors with 36% @CHEMICAL$ reduced @GENE$ concentrations to negligible levels.",
        "relation": "CPR:4"
    },
    {
        "id": "23360412.T19.T27",
        "sentence": "The activity of the human nasal mucosa microsomes was inhibited by @CHEMICAL$, a known @GENE$ inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "3345199.T6.T26",
        "sentence": "Effects of some mono- and bisquaternary ammonium compounds on the reactivatability of soman-inhibited human acetylcholinesterase in vitro. @CHEMICAL$ (AChE) inhibited by the organophosphate soman (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by @GENE$ due to dealkylation of the soman-enzyme complex.",
        "relation": "CPR:3"
    },
    {
        "id": "3345199.T6.T32",
        "sentence": "Effects of some mono- and bisquaternary ammonium compounds on the reactivatability of soman-inhibited human acetylcholinesterase in vitro. Acetylcholinesterase (@CHEMICAL$) inhibited by the organophosphate soman (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by @GENE$ due to dealkylation of the soman-enzyme complex.",
        "relation": "CPR:3"
    },
    {
        "id": "3345199.T16.T26",
        "sentence": "Effects of some mono- and bisquaternary ammonium compounds on the reactivatability of soman-inhibited human acetylcholinesterase in vitro. @CHEMICAL$ (AChE) inhibited by the @GENE$ soman (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex.",
        "relation": "CPR:4"
    },
    {
        "id": "3345199.T16.T32",
        "sentence": "Effects of some mono- and bisquaternary ammonium compounds on the reactivatability of soman-inhibited human acetylcholinesterase in vitro. Acetylcholinesterase (@CHEMICAL$) inhibited by the @GENE$ soman (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex.",
        "relation": "CPR:4"
    },
    {
        "id": "3345199.T17.T26",
        "sentence": "Effects of some mono- and bisquaternary ammonium compounds on the reactivatability of soman-inhibited human acetylcholinesterase in vitro. @CHEMICAL$ (AChE) inhibited by the organophosphate @GENE$ (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex.",
        "relation": "CPR:4"
    },
    {
        "id": "3345199.T17.T32",
        "sentence": "Effects of some mono- and bisquaternary ammonium compounds on the reactivatability of soman-inhibited human acetylcholinesterase in vitro. Acetylcholinesterase (@CHEMICAL$) inhibited by the organophosphate @GENE$ (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex.",
        "relation": "CPR:4"
    },
    {
        "id": "3345199.T18.T26",
        "sentence": "Effects of some mono- and bisquaternary ammonium compounds on the reactivatability of soman-inhibited human acetylcholinesterase in vitro. @CHEMICAL$ (AChE) inhibited by the organophosphate soman (@GENE$) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex.",
        "relation": "CPR:4"
    },
    {
        "id": "3345199.T18.T32",
        "sentence": "Effects of some mono- and bisquaternary ammonium compounds on the reactivatability of soman-inhibited human acetylcholinesterase in vitro. Acetylcholinesterase (@CHEMICAL$) inhibited by the organophosphate soman (@GENE$) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex.",
        "relation": "CPR:4"
    },
    {
        "id": "3345199.T25.T35",
        "sentence": "Effects of some mono- and bisquaternary ammonium compounds on the reactivatability of @CHEMICAL$-inhibited @GENE$ in vitro. Acetylcholinesterase (AChE) inhibited by the organophosphate soman (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex.",
        "relation": "CPR:4"
    },
    {
        "id": "3345199.T15.T33",
        "sentence": "The effect of the four mono- and bisquaternary ammonium compounds tetramethylammonium (TMA), hexamethonium, decamethonium and suxamethonium on the reactivatability of @CHEMICAL$-inhibited, solubilized @GENE$ from human erythrocytes was investigated in vitro.",
        "relation": "CPR:4"
    },
    {
        "id": "3345199.T7.T30",
        "sentence": "If the effectors were added after 5 min of aging they increased the activity of @CHEMICAL$-inhibited @GENE$, but to a considerably smaller extent than HI 6.",
        "relation": "CPR:4"
    },
    {
        "id": "11278845.T15.T36",
        "sentence": "First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, @CHEMICAL$-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. @GENE$, etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected.",
        "relation": "CPR:4"
    },
    {
        "id": "11278845.T15.T37",
        "sentence": "First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive @CHEMICAL$ poisons (e.g. @GENE$, etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected.",
        "relation": "CPR:4"
    },
    {
        "id": "11278845.T16.T36",
        "sentence": "First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, @CHEMICAL$-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, @GENE$, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected.",
        "relation": "CPR:4"
    },
    {
        "id": "11278845.T16.T37",
        "sentence": "First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive @CHEMICAL$ poisons (e.g. doxorubicin, @GENE$, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected.",
        "relation": "CPR:4"
    },
    {
        "id": "11278845.T17.T36",
        "sentence": "First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, @CHEMICAL$-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, @GENE$, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected.",
        "relation": "CPR:4"
    },
    {
        "id": "11278845.T17.T37",
        "sentence": "First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive @CHEMICAL$ poisons (e.g. doxorubicin, etoposide, @GENE$, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected.",
        "relation": "CPR:4"
    },
    {
        "id": "11278845.T18.T36",
        "sentence": "First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, @CHEMICAL$-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, mitoxantrone, and @GENE$) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected.",
        "relation": "CPR:4"
    },
    {
        "id": "11278845.T18.T37",
        "sentence": "First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive @CHEMICAL$ poisons (e.g. doxorubicin, etoposide, mitoxantrone, and @GENE$) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected.",
        "relation": "CPR:4"
    },
    {
        "id": "11278845.T20.T38",
        "sentence": "First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive @CHEMICAL$ poisons (e.g. @GENE$, batracylin, and menadione) was only slightly (less than 3-fold) affected.",
        "relation": "CPR:4"
    },
    {
        "id": "11278845.T21.T38",
        "sentence": "First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive @CHEMICAL$ poisons (e.g. amonafide, @GENE$, and menadione) was only slightly (less than 3-fold) affected.",
        "relation": "CPR:4"
    },
    {
        "id": "11278845.T22.T38",
        "sentence": "First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive @CHEMICAL$ poisons (e.g. amonafide, batracylin, and @GENE$) was only slightly (less than 3-fold) affected.",
        "relation": "CPR:4"
    },
    {
        "id": "11278845.T24.T40",
        "sentence": "In addition, ADP was shown to strongly antagonize @CHEMICAL$-mediated DNA cleavage induced by @GENE$-sensitive but not ATP-insensitive TOP2 poisons.",
        "relation": "CPR:3"
    },
    {
        "id": "11278845.T2.T44",
        "sentence": "Second, C427A mutant human TOP2alpha, which exhibits reduced @CHEMICAL$ activity, was shown to exhibit cross-resistance to all ATP-sensitive but not @GENE$-insensitive TOP2 poisons.",
        "relation": "CPR:4"
    },
    {
        "id": "23500772.T11.T25",
        "sentence": "Activation of @CHEMICAL$ with @GENE$ attenuates diabetes induced myocardial injury in rats.",
        "relation": "CPR:3"
    },
    {
        "id": "23500772.T1.T15",
        "sentence": "This study assessed changes in myocardial ALDH2 expression in the diabetic rat, in particular the diabetic rat pretreated with @CHEMICAL$ activator @GENE$ (EtOH).",
        "relation": "CPR:3"
    },
    {
        "id": "23500772.T2.T15",
        "sentence": "This study assessed changes in myocardial ALDH2 expression in the diabetic rat, in particular the diabetic rat pretreated with @CHEMICAL$ activator ethanol (@GENE$).",
        "relation": "CPR:3"
    },
    {
        "id": "23500772.T6.T20",
        "sentence": "HbA1c level in DM12W group was higher than in DM4W group, @CHEMICAL$ level in @GENE$+DM8W group was lower than in DM8W group.",
        "relation": "CPR:4"
    },
    {
        "id": "23500772.T9.T23",
        "sentence": "Compared with DM8W group, @CHEMICAL$ and ALDH2 in @GENE$+DM8W group was increased, MDA was decreased.",
        "relation": "CPR:3"
    },
    {
        "id": "23500772.T9.T24",
        "sentence": "Compared with DM8W group, SOD and @CHEMICAL$ in @GENE$+DM8W group was increased, MDA was decreased.",
        "relation": "CPR:3"
    },
    {
        "id": "15078100.T15.T24",
        "sentence": "Kinetic mechanism of @CHEMICAL$ and its inhibition by the antimalarial @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15078100.T8.T19",
        "sentence": "@CHEMICAL$ catalyzes the two-electron reduction of @GENE$ via the oxidation of N-alkylated or N-ribosylated nicotinamides.",
        "relation": "CPR:9"
    },
    {
        "id": "15078100.T9.T19",
        "sentence": "@CHEMICAL$ catalyzes the two-electron reduction of menadione via the oxidation of @GENE$ or N-ribosylated nicotinamides.",
        "relation": "CPR:9"
    },
    {
        "id": "15078100.T10.T19",
        "sentence": "@CHEMICAL$ catalyzes the two-electron reduction of menadione via the oxidation of N-alkylated or @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "15078100.T11.T21",
        "sentence": "To investigate the mechanism and consequences of inhibition of @CHEMICAL$ by the @GENE$ further, we have used steady-state and transient-state kinetics to define the mechanism of QR2.",
        "relation": "CPR:4"
    },
    {
        "id": "15078100.T11.T22",
        "sentence": "To investigate the mechanism and consequences of inhibition of QR2 by the @CHEMICAL$ further, we have used steady-state and transient-state kinetics to define the mechanism of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15078100.T7.T17",
        "sentence": "Our studies shed light on the possible in vivo potency of the @CHEMICAL$ and provide a foundation for future studies aimed at creating more potent @GENE$ inhibitors and at understanding the physiological significance of QR2.",
        "relation": "CPR:4"
    },
    {
        "id": "23531031.T1.T14",
        "sentence": "Methods: Stabilized anaplastic thyroid cancer cell lines (BHT-101 and CAL-62) and primary cultures from patients who underwent thyroidectomy for anaplastic thyroid cancer were treated with the @CHEMICAL$ inhibitor @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23531031.T4.T17",
        "sentence": "Results: Our results demonstrate that treatment with @CHEMICAL$ leads to @GENE$ RNA expression as shown by RT-PCR and luciferase assay, and to protein expression as determined by immunofluorescence in vitro and by immunohistochemistry in xenograft tumors.",
        "relation": "CPR:3"
    },
    {
        "id": "23393220.T34.T50",
        "sentence": "\"Pharmacokinetic Interactions between @CHEMICAL$ Inhibitor @GENE$ and 5-Methoxy-N,N-Dimethyltryptamine, and the Impact of CYP2D6 Status. 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT or street name \"\"5-MEO\"\") is a newer designer drug belonging to a group of naturally occurring indolealkylamines.\"",
        "relation": "CPR:4"
    },
    {
        "id": "23393220.T18.T43",
        "sentence": "Our recent study has demonstrated that coadministration of @CHEMICAL$ (MAO-A) inhibitor @GENE$ (5 mg/kg) increases systemic exposure to 5-MeO-DMT (2 mg/kg) and active metabolite bufotenine.",
        "relation": "CPR:4"
    },
    {
        "id": "23393220.T18.T44",
        "sentence": "Our recent study has demonstrated that coadministration of monoamine oxidase A (@CHEMICAL$) inhibitor @GENE$ (5 mg/kg) increases systemic exposure to 5-MeO-DMT (2 mg/kg) and active metabolite bufotenine.",
        "relation": "CPR:4"
    },
    {
        "id": "23393220.T28.T46",
        "sentence": "Our data revealed that inhibition of @CHEMICAL$-mediated metabolic elimination by @GENE$ (2, 5, and 15 mg/kg) led to a sharp increase in systemic and cerebral exposure to 5-MeO-DMT (2 and 10 mg/kg) at all dose combinations.",
        "relation": "CPR:4"
    },
    {
        "id": "23393220.T5.T37",
        "sentence": "The in vivo inhibitory effect of @CHEMICAL$ on @GENE$-catalyzed bufotenine formation was confirmed by in vitro study using purified CYP2D6.",
        "relation": "CPR:4"
    },
    {
        "id": "23393220.T5.T38",
        "sentence": "The in vivo inhibitory effect of @CHEMICAL$ on CYP2D6-catalyzed bufotenine formation was confirmed by in vitro study using purified @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23393220.T6.T37",
        "sentence": "The in vivo inhibitory effect of harmaline on @CHEMICAL$-catalyzed @GENE$ formation was confirmed by in vitro study using purified CYP2D6.",
        "relation": "CPR:9"
    },
    {
        "id": "23393220.T6.T38",
        "sentence": "The in vivo inhibitory effect of harmaline on CYP2D6-catalyzed @CHEMICAL$ formation was confirmed by in vitro study using purified @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23393220.T8.T39",
        "sentence": "Given these findings, a unified PK model including the inhibition of @CHEMICAL$- and CYP2D6-catalyzed @GENE$ metabolism by harmaline was developed to describe blood harmaline, 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models.",
        "relation": "CPR:9"
    },
    {
        "id": "23393220.T8.T40",
        "sentence": "Given these findings, a unified PK model including the inhibition of MAO-A- and @CHEMICAL$-catalyzed @GENE$ metabolism by harmaline was developed to describe blood harmaline, 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models.",
        "relation": "CPR:9"
    },
    {
        "id": "23393220.T8.T41",
        "sentence": "Given these findings, a unified PK model including the inhibition of MAO-A- and CYP2D6-catalyzed @CHEMICAL$ metabolism by harmaline was developed to describe blood harmaline, 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-@GENE$ mouse models.",
        "relation": "CPR:9"
    },
    {
        "id": "23393220.T9.T39",
        "sentence": "Given these findings, a unified PK model including the inhibition of @CHEMICAL$- and CYP2D6-catalyzed 5-MeO-DMT metabolism by @GENE$ was developed to describe blood harmaline, 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models.",
        "relation": "CPR:4"
    },
    {
        "id": "23393220.T9.T40",
        "sentence": "Given these findings, a unified PK model including the inhibition of MAO-A- and @CHEMICAL$-catalyzed 5-MeO-DMT metabolism by @GENE$ was developed to describe blood harmaline, 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models.",
        "relation": "CPR:4"
    },
    {
        "id": "23393220.T9.T41",
        "sentence": "Given these findings, a unified PK model including the inhibition of MAO-A- and CYP2D6-catalyzed 5-MeO-DMT metabolism by @CHEMICAL$ was developed to describe blood harmaline, 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-@GENE$ mouse models.",
        "relation": "CPR:4"
    },
    {
        "id": "23393220.T10.T39",
        "sentence": "Given these findings, a unified PK model including the inhibition of @CHEMICAL$- and CYP2D6-catalyzed 5-MeO-DMT metabolism by harmaline was developed to describe blood @GENE$, 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models.",
        "relation": "CPR:4"
    },
    {
        "id": "23393220.T10.T40",
        "sentence": "Given these findings, a unified PK model including the inhibition of MAO-A- and @CHEMICAL$-catalyzed 5-MeO-DMT metabolism by harmaline was developed to describe blood @GENE$, 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models.",
        "relation": "CPR:4"
    },
    {
        "id": "23393220.T10.T41",
        "sentence": "Given these findings, a unified PK model including the inhibition of MAO-A- and CYP2D6-catalyzed 5-MeO-DMT metabolism by harmaline was developed to describe blood @CHEMICAL$, 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-@GENE$ mouse models.",
        "relation": "CPR:4"
    },
    {
        "id": "23393220.T11.T39",
        "sentence": "Given these findings, a unified PK model including the inhibition of @CHEMICAL$- and CYP2D6-catalyzed 5-MeO-DMT metabolism by harmaline was developed to describe blood harmaline, @GENE$, and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models.",
        "relation": "CPR:9"
    },
    {
        "id": "23393220.T11.T40",
        "sentence": "Given these findings, a unified PK model including the inhibition of MAO-A- and @CHEMICAL$-catalyzed 5-MeO-DMT metabolism by harmaline was developed to describe blood harmaline, @GENE$, and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models.",
        "relation": "CPR:9"
    },
    {
        "id": "23393220.T11.T41",
        "sentence": "Given these findings, a unified PK model including the inhibition of MAO-A- and CYP2D6-catalyzed 5-MeO-DMT metabolism by harmaline was developed to describe blood harmaline, @CHEMICAL$, and bufotenine PK profiles in both wild-type and Tg-@GENE$ mouse models.",
        "relation": "CPR:9"
    },
    {
        "id": "14505791.T17.T21",
        "sentence": "Compared pharmacological characteristics in humans of racemic @CHEMICAL$ and levocetirizine, two @GENE$ antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "14505791.T18.T21",
        "sentence": "Compared pharmacological characteristics in humans of racemic cetirizine and @CHEMICAL$, two @GENE$ antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "14505791.T6.T20",
        "sentence": "The potent @CHEMICAL$ antagonist cetirizine (Zyrtec) is a racemic mixture of levocetirizine (now available under the trademark @GENE$ and dextrocetirizine.",
        "relation": "CPR:6"
    },
    {
        "id": "14505791.T7.T20",
        "sentence": "The potent @CHEMICAL$ antagonist cetirizine (Zyrtec) is a racemic mixture of levocetirizine (now available under the trademark Xyzal and @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "14505791.T10.T20",
        "sentence": "The potent @CHEMICAL$ antagonist @GENE$ (Zyrtec) is a racemic mixture of levocetirizine (now available under the trademark Xyzal and dextrocetirizine.",
        "relation": "CPR:6"
    },
    {
        "id": "14505791.T11.T20",
        "sentence": "The potent @CHEMICAL$ antagonist cetirizine (@GENE$) is a racemic mixture of levocetirizine (now available under the trademark Xyzal and dextrocetirizine.",
        "relation": "CPR:6"
    },
    {
        "id": "14505791.T15.T20",
        "sentence": "The potent @CHEMICAL$ antagonist cetirizine (Zyrtec) is a racemic mixture of @GENE$ (now available under the trademark Xyzal and dextrocetirizine.",
        "relation": "CPR:6"
    },
    {
        "id": "23414235.T3.T16",
        "sentence": "@CHEMICAL$, an Inhibitor of @GENE$ Isolated from the Culture Broth of Streptomyces sp.",
        "relation": "CPR:4"
    },
    {
        "id": "23414235.T2.T5",
        "sentence": "A new inhibitor of @CHEMICAL$, @GENE$ (1), was isolated from the culture broth of Streptomyces sp.",
        "relation": "CPR:4"
    },
    {
        "id": "15561973.T7.T34",
        "sentence": "As opposed to the rat and flounder orthologs, @CHEMICAL$ was hardly inhibited by @GENE$ concentrations up to 5 mM. In the absence of sodium, however, lithium can mediate succinate-dependent currents.",
        "relation": "CPR:4"
    },
    {
        "id": "15866288.T7.T17",
        "sentence": "Effects of inhibition of @CHEMICAL$ (u-PA) by @GENE$ in the cornea and tear fluid of eyes irradiated with UVB.",
        "relation": "CPR:4"
    },
    {
        "id": "15866288.T7.T18",
        "sentence": "Effects of inhibition of urokinase-type plasminogen activator (@CHEMICAL$) by @GENE$ in the cornea and tear fluid of eyes irradiated with UVB.",
        "relation": "CPR:4"
    },
    {
        "id": "15866288.T6.T9",
        "sentence": "The purpose of the present study was to test our hypothesis that @CHEMICAL$, a specific u-PA inhibitor, effectively decreases @GENE$ activity in cornea as well as in tear fluid and favourably affects corneal healing.",
        "relation": "CPR:4"
    },
    {
        "id": "15866288.T6.T15",
        "sentence": "The purpose of the present study was to test our hypothesis that @CHEMICAL$, a specific @GENE$ inhibitor, effectively decreases u-PA activity in cornea as well as in tear fluid and favourably affects corneal healing.",
        "relation": "CPR:4"
    },
    {
        "id": "15866288.T4.T12",
        "sentence": "Therefore, comparative histochemical and biochemical studies of @CHEMICAL$ and the effects of amiloride were performed on rabbit corneas and tear fluid using the sensitive fluorogenic substrate @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "15866288.T1.T10",
        "sentence": "When @CHEMICAL$ was dropped on the eye surface on the first day of irradiation and subsequently daily until the end of the experiment, @GENE$ activity in both cornea and tear fluid was strongly inhibited.",
        "relation": "CPR:4"
    },
    {
        "id": "15866288.T2.T11",
        "sentence": "In conclusion, early application of @CHEMICAL$ inhibited @GENE$ activity in UVB-irradiated corneas as well as in tear fluid and diminished the development of corneal pathology.",
        "relation": "CPR:4"
    },
    {
        "id": "20427668.T7.T17",
        "sentence": "@CHEMICAL$ also inhibited ACTH and cortisol secretion in response to exogenous @GENE$ stimulation, inferring rapid feedback inhibition at the anterior pituitary.",
        "relation": "CPR:4"
    },
    {
        "id": "20427668.T8.T17",
        "sentence": "Prednisolone also inhibited ACTH and @CHEMICAL$ secretion in response to exogenous @GENE$ stimulation, inferring rapid feedback inhibition at the anterior pituitary.",
        "relation": "CPR:9"
    },
    {
        "id": "23177256.T10.T19",
        "sentence": "Pharmacophore identification of @CHEMICAL$ inhibitor @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23177256.T8.T12",
        "sentence": "A structure-activity relationship (SAR) study of the @CHEMICAL$ (Myc) inhibitor @GENE$ (N-([1,1'-biphenyl]-2-yl)-7-nitrobenzo[c][1,2,5]oxadiazol-4-amine, 1) - which targets a hydrophobic domain of the Myc oncoprotein that is flanked by arginine residues - was executed in order to determine its pharmacophore. Whilst the 7-nitrobenzofurazan was found to be critical for inhibitory activity, the ortho-biphenyl could be replaced with a para-carboxyphenyl group to furnish the new inhibitor JY-3-094 (3q).",
        "relation": "CPR:4"
    },
    {
        "id": "23177256.T8.T15",
        "sentence": "A structure-activity relationship (SAR) study of the c-Myc (@CHEMICAL$) inhibitor @GENE$ (N-([1,1'-biphenyl]-2-yl)-7-nitrobenzo[c][1,2,5]oxadiazol-4-amine, 1) - which targets a hydrophobic domain of the Myc oncoprotein that is flanked by arginine residues - was executed in order to determine its pharmacophore. Whilst the 7-nitrobenzofurazan was found to be critical for inhibitory activity, the ortho-biphenyl could be replaced with a para-carboxyphenyl group to furnish the new inhibitor JY-3-094 (3q).",
        "relation": "CPR:4"
    },
    {
        "id": "23177256.T9.T12",
        "sentence": "A structure-activity relationship (SAR) study of the @CHEMICAL$ (Myc) inhibitor 10074-G5 (@GENE$, 1) - which targets a hydrophobic domain of the Myc oncoprotein that is flanked by arginine residues - was executed in order to determine its pharmacophore. Whilst the 7-nitrobenzofurazan was found to be critical for inhibitory activity, the ortho-biphenyl could be replaced with a para-carboxyphenyl group to furnish the new inhibitor JY-3-094 (3q).",
        "relation": "CPR:4"
    },
    {
        "id": "23177256.T9.T15",
        "sentence": "A structure-activity relationship (SAR) study of the c-Myc (@CHEMICAL$) inhibitor 10074-G5 (@GENE$, 1) - which targets a hydrophobic domain of the Myc oncoprotein that is flanked by arginine residues - was executed in order to determine its pharmacophore. Whilst the 7-nitrobenzofurazan was found to be critical for inhibitory activity, the ortho-biphenyl could be replaced with a para-carboxyphenyl group to furnish the new inhibitor JY-3-094 (3q).",
        "relation": "CPR:4"
    },
    {
        "id": "23177256.T7.T18",
        "sentence": "Importantly, the carboxylic acid of @CHEMICAL$ improves the physicochemical properties of the lead compound, which will facilitate the incorporation of additional hydrophobicity that might enhance @GENE$ inhibitory activity further still.",
        "relation": "CPR:4"
    },
    {
        "id": "17603755.T3.T8",
        "sentence": "@CHEMICAL$, a small iminosugar molecule approved for the treatment of Gaucher disease, reversibly inhibits @GENE$, which catalyses the first committed step in glycosphingolipid synthesis.",
        "relation": "CPR:4"
    },
    {
        "id": "23270965.T2.T15",
        "sentence": "Furthermore, compared with control groups, the plaque endothelium level of @CHEMICAL$ was 3-fold increased and the liver level of p75(NTR) was 17.4-fold increased by @GENE$-HD.",
        "relation": "CPR:3"
    },
    {
        "id": "23270965.T2.T16",
        "sentence": "Furthermore, compared with control groups, the plaque endothelium level of p75(NTR) was 3-fold increased and the liver level of @CHEMICAL$ was 17.4-fold increased by @GENE$-HD.",
        "relation": "CPR:3"
    },
    {
        "id": "23270965.T3.T17",
        "sentence": "Meanwhile, the serum level of KC (a functional homolog of @CHEMICAL$ and the main proinflammatory alpha chemokine in mice) in apoE(-/-) mice was up to 357pg/ml in @GENE$-HD treated group.",
        "relation": "CPR:3"
    },
    {
        "id": "23270965.T3.T18",
        "sentence": "Meanwhile, the serum level of KC (a functional homolog of IL-8 and the main proinflammatory @CHEMICAL$ in mice) in apoE(-/-) mice was up to 357pg/ml in @GENE$-HD treated group.",
        "relation": "CPR:3"
    },
    {
        "id": "23270965.T4.T22",
        "sentence": "Thus, @CHEMICAL$ contributes to the instability of atherosclerotic plaque in apoE(-/-) mice through activating p75(NTR) and @GENE$ and cell apoptosis in plaque.",
        "relation": "CPR:3"
    },
    {
        "id": "23270965.T4.T21",
        "sentence": "Thus, @CHEMICAL$ contributes to the instability of atherosclerotic plaque in apoE(-/-) mice through activating @GENE$ and IL-8 and cell apoptosis in plaque.",
        "relation": "CPR:3"
    },
    {
        "id": "9633680.T4.T17",
        "sentence": "@CHEMICAL$ is absorbed in the small bowel and is rapidly catabolized by @GENE$ (AADC) and catechol-O-methyltransferase (COMT).",
        "relation": "CPR:9"
    },
    {
        "id": "9633680.T4.T18",
        "sentence": "@CHEMICAL$ is absorbed in the small bowel and is rapidly catabolized by aromatic-L-amino-acid decarboxylase (@GENE$) and catechol-O-methyltransferase (COMT).",
        "relation": "CPR:9"
    },
    {
        "id": "9633680.T4.T19",
        "sentence": "@CHEMICAL$ is absorbed in the small bowel and is rapidly catabolized by aromatic-L-amino-acid decarboxylase (AADC) and @GENE$ (COMT).",
        "relation": "CPR:9"
    },
    {
        "id": "9633680.T4.T20",
        "sentence": "@CHEMICAL$ is absorbed in the small bowel and is rapidly catabolized by aromatic-L-amino-acid decarboxylase (AADC) and catechol-O-methyltransferase (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "9633680.T8.T21",
        "sentence": "Because gastric @CHEMICAL$ and COMT degrade @GENE$, the drug is given with inhibitors of AADC (carbidopa or benserazide), and inhibitors of COMT will also enter clinical use.",
        "relation": "CPR:9"
    },
    {
        "id": "9633680.T8.T22",
        "sentence": "Because gastric AADC and @CHEMICAL$ degrade @GENE$, the drug is given with inhibitors of AADC (carbidopa or benserazide), and inhibitors of COMT will also enter clinical use.",
        "relation": "CPR:9"
    },
    {
        "id": "9633680.T9.T23",
        "sentence": "Because gastric AADC and COMT degrade levodopa, the drug is given with inhibitors of @CHEMICAL$ (@GENE$ or benserazide), and inhibitors of COMT will also enter clinical use.",
        "relation": "CPR:4"
    },
    {
        "id": "9633680.T10.T23",
        "sentence": "Because gastric AADC and COMT degrade levodopa, the drug is given with inhibitors of @CHEMICAL$ (carbidopa or @GENE$), and inhibitors of COMT will also enter clinical use.",
        "relation": "CPR:4"
    },
    {
        "id": "16636450.T2.T10",
        "sentence": "Rats were fed experimental diets containing SPI or @CHEMICAL$ as a @GENE$ source.",
        "relation": "CPR:9"
    },
    {
        "id": "11732752.T2.T21",
        "sentence": "Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: @CHEMICAL$ of L-alanine for @GENE$, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B. The vaginal aminopeptidase enzymatic activity of different species was determined spectrofluorometrically.",
        "relation": "CPR:9"
    },
    {
        "id": "11732752.T3.T21",
        "sentence": "Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of @CHEMICAL$ for @GENE$, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B. The vaginal aminopeptidase enzymatic activity of different species was determined spectrofluorometrically.",
        "relation": "CPR:9"
    },
    {
        "id": "11732752.T4.T22",
        "sentence": "Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, @CHEMICAL$ of L-leucine for @GENE$, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B. The vaginal aminopeptidase enzymatic activity of different species was determined spectrofluorometrically.",
        "relation": "CPR:9"
    },
    {
        "id": "11732752.T5.T22",
        "sentence": "Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of @CHEMICAL$ for @GENE$, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B. The vaginal aminopeptidase enzymatic activity of different species was determined spectrofluorometrically.",
        "relation": "CPR:9"
    },
    {
        "id": "11732752.T7.T23",
        "sentence": "Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, @CHEMICAL$ of L-glutamic acid for @GENE$ and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B. The vaginal aminopeptidase enzymatic activity of different species was determined spectrofluorometrically.",
        "relation": "CPR:9"
    },
    {
        "id": "11732752.T8.T23",
        "sentence": "Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of @CHEMICAL$ for @GENE$ and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B. The vaginal aminopeptidase enzymatic activity of different species was determined spectrofluorometrically.",
        "relation": "CPR:9"
    },
    {
        "id": "11732752.T9.T25",
        "sentence": "Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and @CHEMICAL$ of L-arginine for @GENE$. The vaginal aminopeptidase enzymatic activity of different species was determined spectrofluorometrically.",
        "relation": "CPR:9"
    },
    {
        "id": "11732752.T10.T25",
        "sentence": "Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of @CHEMICAL$ for @GENE$. The vaginal aminopeptidase enzymatic activity of different species was determined spectrofluorometrically.",
        "relation": "CPR:9"
    },
    {
        "id": "11732752.T12.T28",
        "sentence": "The inhibition of @CHEMICAL$ activity in the presence of @GENE$ and puromycin inhibitors was also investigated.",
        "relation": "CPR:4"
    },
    {
        "id": "11732752.T13.T28",
        "sentence": "The inhibition of @CHEMICAL$ activity in the presence of bestatin and @GENE$ inhibitors was also investigated.",
        "relation": "CPR:4"
    },
    {
        "id": "23231502.T13.T28",
        "sentence": "Here, we demonstrate that @CHEMICAL$ (Pin1), an enzyme that catalyzes the conversion of the peptide bond of @GENE$/pThr-Pro moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification.",
        "relation": "CPR:9"
    },
    {
        "id": "23231502.T13.T29",
        "sentence": "Here, we demonstrate that peptidyl-prolyl cis/trans-isomerase A1 (@CHEMICAL$), an enzyme that catalyzes the conversion of the peptide bond of @GENE$/pThr-Pro moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification.",
        "relation": "CPR:9"
    },
    {
        "id": "23231502.T14.T28",
        "sentence": "Here, we demonstrate that @CHEMICAL$ (Pin1), an enzyme that catalyzes the conversion of the peptide bond of pSer/@GENE$-Pro moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification.",
        "relation": "CPR:9"
    },
    {
        "id": "23231502.T14.T29",
        "sentence": "Here, we demonstrate that peptidyl-prolyl cis/trans-isomerase A1 (@CHEMICAL$), an enzyme that catalyzes the conversion of the peptide bond of pSer/@GENE$-Pro moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification.",
        "relation": "CPR:9"
    },
    {
        "id": "23231502.T15.T28",
        "sentence": "Here, we demonstrate that @CHEMICAL$ (Pin1), an enzyme that catalyzes the conversion of the peptide bond of pSer/pThr-@GENE$ moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification.",
        "relation": "CPR:9"
    },
    {
        "id": "23231502.T15.T29",
        "sentence": "Here, we demonstrate that peptidyl-prolyl cis/trans-isomerase A1 (@CHEMICAL$), an enzyme that catalyzes the conversion of the peptide bond of pSer/pThr-@GENE$ moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification.",
        "relation": "CPR:9"
    },
    {
        "id": "16484281.T18.T32",
        "sentence": "Withdrawal from free-choice @CHEMICAL$ consumption results in increased packing density of @GENE$-immunoreactive astrocytes in the prelimbic cortex of alcohol-preferring rats.",
        "relation": "CPR:3"
    },
    {
        "id": "16484281.T7.T26",
        "sentence": "Astrocytes may play a role in these manifestations because astrocytes are essential in the regulation of released @CHEMICAL$ and its conversion to glutamine through the enzyme @GENE$ (GS).",
        "relation": "CPR:9"
    },
    {
        "id": "16484281.T7.T27",
        "sentence": "Astrocytes may play a role in these manifestations because astrocytes are essential in the regulation of released @CHEMICAL$ and its conversion to glutamine through the enzyme glutamine synthetase (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "16484281.T8.T26",
        "sentence": "Astrocytes may play a role in these manifestations because astrocytes are essential in the regulation of released glutamate and its conversion to @CHEMICAL$ through the enzyme @GENE$ (GS).",
        "relation": "CPR:9"
    },
    {
        "id": "16484281.T8.T27",
        "sentence": "Astrocytes may play a role in these manifestations because astrocytes are essential in the regulation of released glutamate and its conversion to @CHEMICAL$ through the enzyme glutamine synthetase (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "23298258.T10.T27",
        "sentence": "@CHEMICAL$ protects hepatocellular carcinoma cells against serum-starvation-induced cell death by upregulating @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "12699699.T3.T16",
        "sentence": "The protein exhibited modest @CHEMICAL$-dependent @GENE$ activities with guaiacol, potassium iodide, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS).",
        "relation": "CPR:3"
    },
    {
        "id": "12699699.T4.T16",
        "sentence": "The protein exhibited modest H(2)O(2)-dependent @CHEMICAL$ activities with @GENE$, potassium iodide, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS).",
        "relation": "CPR:9"
    },
    {
        "id": "12699699.T5.T16",
        "sentence": "The protein exhibited modest H(2)O(2)-dependent @CHEMICAL$ activities with guaiacol, @GENE$, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS).",
        "relation": "CPR:9"
    },
    {
        "id": "12699699.T6.T16",
        "sentence": "The protein exhibited modest H(2)O(2)-dependent @CHEMICAL$ activities with guaiacol, potassium iodide, and @GENE$ (ABTS).",
        "relation": "CPR:9"
    },
    {
        "id": "12699699.T7.T16",
        "sentence": "The protein exhibited modest H(2)O(2)-dependent @CHEMICAL$ activities with guaiacol, potassium iodide, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "23435367.T1.T9",
        "sentence": "@CHEMICAL$ (FDX1; adrenodoxin) is an iron-sulfur protein that is involved in various metabolic processes, including @GENE$ hormone synthesis in mammalian tissues.",
        "relation": "CPR:9"
    },
    {
        "id": "23435367.T1.T10",
        "sentence": "Ferredoxin 1 (@CHEMICAL$; adrenodoxin) is an iron-sulfur protein that is involved in various metabolic processes, including @GENE$ hormone synthesis in mammalian tissues.",
        "relation": "CPR:9"
    },
    {
        "id": "23435367.T1.T11",
        "sentence": "Ferredoxin 1 (FDX1; @CHEMICAL$) is an iron-sulfur protein that is involved in various metabolic processes, including @GENE$ hormone synthesis in mammalian tissues.",
        "relation": "CPR:9"
    },
    {
        "id": "23435367.T2.T9",
        "sentence": "@CHEMICAL$ (FDX1; adrenodoxin) is an iron-sulfur protein that is involved in various metabolic processes, including @GENE$ synthesis in mammalian tissues.",
        "relation": "CPR:9"
    },
    {
        "id": "23435367.T2.T10",
        "sentence": "Ferredoxin 1 (@CHEMICAL$; adrenodoxin) is an iron-sulfur protein that is involved in various metabolic processes, including @GENE$ synthesis in mammalian tissues.",
        "relation": "CPR:9"
    },
    {
        "id": "23435367.T2.T11",
        "sentence": "Ferredoxin 1 (FDX1; @CHEMICAL$) is an iron-sulfur protein that is involved in various metabolic processes, including @GENE$ synthesis in mammalian tissues.",
        "relation": "CPR:9"
    },
    {
        "id": "23435367.T5.T19",
        "sentence": "Luciferase reporter assays showed that transcription of @CHEMICAL$ was synergistically activated by the NR5A family and @GENE$ treatment through two SF-1 binding sites and a CRE-like sequence in a human ovarian granulosa cell line, KGN.",
        "relation": "CPR:3"
    },
    {
        "id": "23435367.T7.T24",
        "sentence": "These results indicate transcription of @CHEMICAL$ is regulated by the NR5A family and @GENE$ signaling, and participates in steroid hormone production in ovarian granulosa cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23435367.T8.T24",
        "sentence": "These results indicate transcription of @CHEMICAL$ is regulated by the NR5A family and cAMP signaling, and participates in @GENE$ hormone production in ovarian granulosa cells.",
        "relation": "CPR:9"
    },
    {
        "id": "10752671.T1.T8",
        "sentence": "@CHEMICAL$, an effective competitive inhibitor of the @GENE$ used orally for palliative treatment of prostatic carcinoma and regulation of prostatic hyperplasia was evaluated for its genotoxic effects in the intact rat and in primary cultures of human hepatocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "10752671.T5.T9",
        "sentence": "In the liver of rats given @CHEMICAL$ as initiating agent at the dose of 500 mg/kg/week for 6 successive weeks, @GENE$-positive foci were detected only in 3 of 10 rats.",
        "relation": "CPR:3"
    },
    {
        "id": "23439561.T3.T18",
        "sentence": "@CHEMICAL$ (COX-2)-derived @GENE$ (PGE2) has been shown to be important in esophageal tumorigenesis.",
        "relation": "CPR:9"
    },
    {
        "id": "23439561.T3.T25",
        "sentence": "Cycloxygenase-2 (@CHEMICAL$)-derived @GENE$ (PGE2) has been shown to be important in esophageal tumorigenesis.",
        "relation": "CPR:9"
    },
    {
        "id": "23439561.T5.T18",
        "sentence": "@CHEMICAL$ (COX-2)-derived prostaglandin E2 (@GENE$) has been shown to be important in esophageal tumorigenesis.",
        "relation": "CPR:9"
    },
    {
        "id": "23439561.T5.T25",
        "sentence": "Cycloxygenase-2 (@CHEMICAL$)-derived prostaglandin E2 (@GENE$) has been shown to be important in esophageal tumorigenesis.",
        "relation": "CPR:9"
    },
    {
        "id": "23439561.T6.T36",
        "sentence": "We have shown that @CHEMICAL$ mediates acid-induced @GENE$ production.",
        "relation": "CPR:9"
    },
    {
        "id": "23439561.T4.T30",
        "sentence": "We conclude that @CHEMICAL$ mediates acid-induced increase in @GENE$ production and cell proliferation.",
        "relation": "CPR:9"
    },
    {
        "id": "23318726.T14.T27",
        "sentence": "@CHEMICAL$ also increased @GENE$ (HO-1) protein expression and HO activity.",
        "relation": "CPR:3"
    },
    {
        "id": "23318726.T14.T28",
        "sentence": "@CHEMICAL$ also increased heme oxygenase-1 (@GENE$) protein expression and HO activity.",
        "relation": "CPR:3"
    },
    {
        "id": "23318726.T14.T29",
        "sentence": "@CHEMICAL$ also increased heme oxygenase-1 (HO-1) protein expression and @GENE$ activity.",
        "relation": "CPR:3"
    },
    {
        "id": "23318726.T18.T21",
        "sentence": "Furthermore, @CHEMICAL$ treatment caused nuclear accumulation of nuclear factor-E2-related factor 2 (Nrf2) and increased the promoter activity of @GENE$ (AREs).",
        "relation": "CPR:3"
    },
    {
        "id": "23318726.T18.T22",
        "sentence": "Furthermore, @CHEMICAL$ treatment caused nuclear accumulation of nuclear factor-E2-related factor 2 (Nrf2) and increased the promoter activity of antioxidant response elements (@GENE$).",
        "relation": "CPR:3"
    },
    {
        "id": "23318726.T18.T31",
        "sentence": "Furthermore, @CHEMICAL$ treatment caused nuclear accumulation of @GENE$ (Nrf2) and increased the promoter activity of antioxidant response elements (AREs).",
        "relation": "CPR:3"
    },
    {
        "id": "23318726.T18.T32",
        "sentence": "Furthermore, @CHEMICAL$ treatment caused nuclear accumulation of nuclear factor-E2-related factor 2 (@GENE$) and increased the promoter activity of antioxidant response elements (AREs).",
        "relation": "CPR:3"
    },
    {
        "id": "23318726.T3.T25",
        "sentence": "Treatment of HDP cells with a c-Jun NH2-terminal kinase (JNK) inhibitor also reduced @CHEMICAL$-induced @GENE$ expression, and butein treatment led to increased JNK phosphorylation.",
        "relation": "CPR:3"
    },
    {
        "id": "23318726.T4.T26",
        "sentence": "Treatment of HDP cells with a c-Jun NH2-terminal kinase (JNK) inhibitor also reduced butein-induced HO-1 expression, and @CHEMICAL$ treatment led to increased @GENE$ phosphorylation.",
        "relation": "CPR:3"
    },
    {
        "id": "7986344.T4.T15",
        "sentence": "Folding pathway of guanidine-denatured disulfide-intact wild-type and mutant bovine pancreatic ribonuclease A. The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its @CHEMICAL$ mutant (Pro42Ala) have been studied by monitoring tyrosine burial and @GENE$ (2'CMP) inhibitor binding.",
        "relation": "CPR:4"
    },
    {
        "id": "7986344.T4.T16",
        "sentence": "Folding pathway of guanidine-denatured disulfide-intact wild-type and mutant bovine pancreatic ribonuclease A. The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its proline-42-to-alanine mutant (@CHEMICAL$) have been studied by monitoring tyrosine burial and @GENE$ (2'CMP) inhibitor binding.",
        "relation": "CPR:4"
    },
    {
        "id": "7986344.T4.T20",
        "sentence": "Folding pathway of guanidine-denatured disulfide-intact wild-type and mutant bovine pancreatic ribonuclease A. The refolding kinetics of guanidine-denatured disulfide-intact @CHEMICAL$ (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and @GENE$ (2'CMP) inhibitor binding.",
        "relation": "CPR:4"
    },
    {
        "id": "7986344.T4.T22",
        "sentence": "Folding pathway of guanidine-denatured disulfide-intact wild-type and mutant bovine pancreatic ribonuclease A. The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (@CHEMICAL$) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and @GENE$ (2'CMP) inhibitor binding.",
        "relation": "CPR:4"
    },
    {
        "id": "7986344.T5.T15",
        "sentence": "Folding pathway of guanidine-denatured disulfide-intact wild-type and mutant bovine pancreatic ribonuclease A. The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its @CHEMICAL$ mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (@GENE$) inhibitor binding.",
        "relation": "CPR:4"
    },
    {
        "id": "7986344.T5.T16",
        "sentence": "Folding pathway of guanidine-denatured disulfide-intact wild-type and mutant bovine pancreatic ribonuclease A. The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its proline-42-to-alanine mutant (@CHEMICAL$) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (@GENE$) inhibitor binding.",
        "relation": "CPR:4"
    },
    {
        "id": "7986344.T5.T20",
        "sentence": "Folding pathway of guanidine-denatured disulfide-intact wild-type and mutant bovine pancreatic ribonuclease A. The refolding kinetics of guanidine-denatured disulfide-intact @CHEMICAL$ (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (@GENE$) inhibitor binding.",
        "relation": "CPR:4"
    },
    {
        "id": "7986344.T5.T22",
        "sentence": "Folding pathway of guanidine-denatured disulfide-intact wild-type and mutant bovine pancreatic ribonuclease A. The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (@CHEMICAL$) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (@GENE$) inhibitor binding.",
        "relation": "CPR:4"
    },
    {
        "id": "7986344.T7.T17",
        "sentence": "The folding rate for wild-type @CHEMICAL$ is faster in the presence of the inhibitor @GENE$ than in its absence, indicating that the transition-state structure in the rate-determining step is stabilized by 2'CMP.",
        "relation": "CPR:4"
    },
    {
        "id": "23264615.T3.T29",
        "sentence": "During early pregnancy in sheep, the elongating conceptus secretes interferon-t (IFNT) and the conceptus as well as endometrial epithelia produce @CHEMICAL$ (PG) via @GENE$ (PTGS2) and cortisol via hydroxysteroid (11-b) dehydrogenase 1 (HSD11B1).",
        "relation": "CPR:9"
    },
    {
        "id": "23264615.T3.T30",
        "sentence": "During early pregnancy in sheep, the elongating conceptus secretes interferon-t (IFNT) and the conceptus as well as endometrial epithelia produce @CHEMICAL$ (PG) via PG synthase 2 (@GENE$) and cortisol via hydroxysteroid (11-b) dehydrogenase 1 (HSD11B1).",
        "relation": "CPR:9"
    },
    {
        "id": "23264615.T7.T31",
        "sentence": "During early pregnancy in sheep, the elongating conceptus secretes interferon-t (IFNT) and the conceptus as well as endometrial epithelia produce prostaglandins (PG) via PG synthase 2 (PTGS2) and @CHEMICAL$ via @GENE$ (HSD11B1).",
        "relation": "CPR:9"
    },
    {
        "id": "23264615.T7.T32",
        "sentence": "During early pregnancy in sheep, the elongating conceptus secretes interferon-t (IFNT) and the conceptus as well as endometrial epithelia produce prostaglandins (PG) via PG synthase 2 (PTGS2) and @CHEMICAL$ via hydroxysteroid (11-b) dehydrogenase 1 (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "23264615.T11.T36",
        "sentence": "The primary aim of these studies was to test the hypothesis that @CHEMICAL$-derived @GENE$ has a biological role in endometrial function and conceptus development during early pregnancy in sheep.",
        "relation": "CPR:9"
    },
    {
        "id": "23264615.T13.T38",
        "sentence": "In study 1, cyclic ewes received vehicle, cortisol, @CHEMICAL$ (PF; a selective inhibitor of @GENE$), cortisol and PF, meloxicam (a selective inhibitor of PTGS2), cortisol and meloxicam, recombinant ovine IFNT, or IFNT and PF into the uterus from day 10 to day14 after estrus.",
        "relation": "CPR:4"
    },
    {
        "id": "23264615.T15.T40",
        "sentence": "In study 1, cyclic ewes received vehicle, cortisol, PF 915275 (PF; a selective inhibitor of HSD11B1), cortisol and PF, @CHEMICAL$ (a selective inhibitor of @GENE$), cortisol and meloxicam, recombinant ovine IFNT, or IFNT and PF into the uterus from day 10 to day14 after estrus.",
        "relation": "CPR:4"
    },
    {
        "id": "23264615.T18.T20",
        "sentence": "@CHEMICAL$ and IFNT stimulated endometrial @GENE$ expression and activity, increased endometrial PTGS2 activity and the amount of PG in the uterine lumen, and up-regulated many conceptus elongation-related genes in the endometrium.",
        "relation": "CPR:3"
    },
    {
        "id": "23264615.T18.T21",
        "sentence": "@CHEMICAL$ and IFNT stimulated endometrial HSD11B1 expression and activity, increased endometrial @GENE$ activity and the amount of PG in the uterine lumen, and up-regulated many conceptus elongation-related genes in the endometrium.",
        "relation": "CPR:3"
    },
    {
        "id": "23264615.T4.T27",
        "sentence": "These results suggest that @CHEMICAL$-derived @GENE$ mediates, in part, actions of ovarian progesterone and the conceptus on endometrial function and support the hypothesis that IFNT, PG, and cortisol coordinately regulate endometrial functions important for conceptus elongation and implantation during early pregnancy in sheep.",
        "relation": "CPR:9"
    },
    {
        "id": "7944828.T29.T47",
        "sentence": "@CHEMICAL$ (D-1997): a novel agonist at @GENE$ in the canine basilar artery.",
        "relation": "CPR:5"
    },
    {
        "id": "7944828.T30.T47",
        "sentence": "2-(2-Aminoethyl)-quinoline (@CHEMICAL$): a novel agonist at @GENE$ in the canine basilar artery.",
        "relation": "CPR:5"
    },
    {
        "id": "7944828.T2.T32",
        "sentence": "The effects of D-1997 in the basilar artery were not modified by incubation with either the @CHEMICAL$ antagonist @GENE$ (0.01-1 microM), the 5-HT3 and 5-HT4 receptor antagonist ICS205930 (tropisetron; 0.1-10 microM), the 5-HT1A receptor antagonist spiroxatrine (0.01-1 microM), the beta-adrenoceptor blocker with high affinity for 5-HT1A and 5-HT1B binding sites (+/-)-pindolol (0.01-1 microM), or the alpha 1-adrenoceptor antagonist prazosin (0.01-1 microM).",
        "relation": "CPR:6"
    },
    {
        "id": "7944828.T3.T33",
        "sentence": "The effects of D-1997 in the basilar artery were not modified by incubation with either the 5-HT2 receptor antagonist ketanserin (0.01-1 microM), the @CHEMICAL$ and 5-HT4 receptor antagonist ICS205930 (@GENE$; 0.1-10 microM), the 5-HT1A receptor antagonist spiroxatrine (0.01-1 microM), the beta-adrenoceptor blocker with high affinity for 5-HT1A and 5-HT1B binding sites (+/-)-pindolol (0.01-1 microM), or the alpha 1-adrenoceptor antagonist prazosin (0.01-1 microM).",
        "relation": "CPR:6"
    },
    {
        "id": "7944828.T3.T34",
        "sentence": "The effects of D-1997 in the basilar artery were not modified by incubation with either the 5-HT2 receptor antagonist ketanserin (0.01-1 microM), the 5-HT3 and @CHEMICAL$ receptor antagonist ICS205930 (@GENE$; 0.1-10 microM), the 5-HT1A receptor antagonist spiroxatrine (0.01-1 microM), the beta-adrenoceptor blocker with high affinity for 5-HT1A and 5-HT1B binding sites (+/-)-pindolol (0.01-1 microM), or the alpha 1-adrenoceptor antagonist prazosin (0.01-1 microM).",
        "relation": "CPR:6"
    },
    {
        "id": "7944828.T4.T35",
        "sentence": "The effects of D-1997 in the basilar artery were not modified by incubation with either the 5-HT2 receptor antagonist ketanserin (0.01-1 microM), the 5-HT3 and 5-HT4 receptor antagonist ICS205930 (tropisetron; 0.1-10 microM), the @CHEMICAL$ receptor antagonist @GENE$ (0.01-1 microM), the beta-adrenoceptor blocker with high affinity for 5-HT1A and 5-HT1B binding sites (+/-)-pindolol (0.01-1 microM), or the alpha 1-adrenoceptor antagonist prazosin (0.01-1 microM).",
        "relation": "CPR:6"
    },
    {
        "id": "7944828.T6.T36",
        "sentence": "The effects of D-1997 in the basilar artery were not modified by incubation with either the 5-HT2 receptor antagonist ketanserin (0.01-1 microM), the 5-HT3 and 5-HT4 receptor antagonist ICS205930 (tropisetron; 0.1-10 microM), the 5-HT1A receptor antagonist spiroxatrine (0.01-1 microM), the @CHEMICAL$ blocker with high affinity for 5-HT1A and 5-HT1B binding sites @GENE$ (0.01-1 microM), or the alpha 1-adrenoceptor antagonist prazosin (0.01-1 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "7944828.T7.T39",
        "sentence": "The effects of D-1997 in the basilar artery were not modified by incubation with either the 5-HT2 receptor antagonist ketanserin (0.01-1 microM), the 5-HT3 and 5-HT4 receptor antagonist ICS205930 (tropisetron; 0.1-10 microM), the 5-HT1A receptor antagonist spiroxatrine (0.01-1 microM), the beta-adrenoceptor blocker with high affinity for 5-HT1A and 5-HT1B binding sites (+/-)-pindolol (0.01-1 microM), or the @CHEMICAL$ antagonist @GENE$ (0.01-1 microM).",
        "relation": "CPR:6"
    },
    {
        "id": "7944828.T8.T40",
        "sentence": "In contrast, the @CHEMICAL$-induced responses were potently and concentration-dependently antagonized by the mixed @GENE$ and 5-HT2 receptor antagonist methiothepin (0.01-1 microM).",
        "relation": "CPR:5"
    },
    {
        "id": "7944828.T8.T41",
        "sentence": "In contrast, the @CHEMICAL$-induced responses were potently and concentration-dependently antagonized by the mixed 5-HT1-like and @GENE$ antagonist methiothepin (0.01-1 microM).",
        "relation": "CPR:5"
    },
    {
        "id": "7944828.T10.T40",
        "sentence": "In contrast, the D-1997-induced responses were potently and concentration-dependently antagonized by the mixed @CHEMICAL$ and 5-HT2 receptor antagonist @GENE$ (0.01-1 microM).",
        "relation": "CPR:6"
    },
    {
        "id": "7944828.T10.T41",
        "sentence": "In contrast, the D-1997-induced responses were potently and concentration-dependently antagonized by the mixed 5-HT1-like and @CHEMICAL$ antagonist @GENE$ (0.01-1 microM).",
        "relation": "CPR:6"
    },
    {
        "id": "7944828.T11.T42",
        "sentence": "It is concluded that @CHEMICAL$ contracts the canine basilar artery by stimulating @GENE$ unrelated to either the 5-HT1A or 5-HT1B receptor subtypes.",
        "relation": "CPR:3"
    },
    {
        "id": "7944828.T11.T43",
        "sentence": "It is concluded that @CHEMICAL$ contracts the canine basilar artery by stimulating 5-HT1-like receptors unrelated to either the @GENE$ or 5-HT1B receptor subtypes.",
        "relation": "CPR:3"
    },
    {
        "id": "7944828.T11.T44",
        "sentence": "It is concluded that @CHEMICAL$ contracts the canine basilar artery by stimulating 5-HT1-like receptors unrelated to either the 5-HT1A or @GENE$ receptor subtypes.",
        "relation": "CPR:3"
    },
    {
        "id": "23229512.T7.T22",
        "sentence": "Although Bak and Bcl-2-associated X protein (Bax), another member of the Bcl-2 family, are generally thought to be functionally redundant, only Bak is necessary and sufficient for @CHEMICAL$-induced @GENE$ (cyt c) release and cell death.",
        "relation": "CPR:3"
    },
    {
        "id": "23229512.T7.T23",
        "sentence": "Although Bak and Bcl-2-associated X protein (Bax), another member of the Bcl-2 family, are generally thought to be functionally redundant, only Bak is necessary and sufficient for @CHEMICAL$-induced cytochrome c (@GENE$) release and cell death.",
        "relation": "CPR:3"
    },
    {
        "id": "23142538.T5.T15",
        "sentence": "In muscle and liver, @CHEMICAL$ (10 ng/kg/day) induced increases in methylation and decreases in mRNA expression of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "20624440.T1.T16",
        "sentence": "@CHEMICAL$ is a propargylamine and irreversible @GENE$ inhibitor used for the treatment of Parkinson's disease (PD).",
        "relation": "CPR:4"
    },
    {
        "id": "20624440.T6.T16",
        "sentence": "Rasagiline is a @CHEMICAL$ and irreversible @GENE$ inhibitor used for the treatment of Parkinson's disease (PD).",
        "relation": "CPR:4"
    },
    {
        "id": "19337422.T1.T15",
        "sentence": "@CHEMICAL$ is a selective @GENE$ blocker used to induce free water diuresis in the treatment of euvolemic or hypervolemic hyponatremia.",
        "relation": "CPR:4"
    },
    {
        "id": "19337422.T8.T16",
        "sentence": "Prolonged use of @CHEMICAL$ leads to increased endogenous levels of @GENE$ and perhaps over-stimulation of V(1A) receptors.",
        "relation": "CPR:3"
    },
    {
        "id": "19337422.T8.T17",
        "sentence": "Prolonged use of @CHEMICAL$ leads to increased endogenous levels of AVP and perhaps over-stimulation of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "19337422.T11.T18",
        "sentence": "In addition, @CHEMICAL$ is metabolized by the @GENE$ system; thus physicians should be aware of the potential for increased interactions with other medications.",
        "relation": "CPR:9"
    },
    {
        "id": "23277230.T1.T19",
        "sentence": "@CHEMICAL$ treatment showed a significant decline in the levels of blood glucose, @GENE$ (HbA1c), NF-kB p65 unit (in pancreas) and IL-1b (plasma), serum nitric oxide (NO) with an elevation in plasma insulin.",
        "relation": "CPR:4"
    },
    {
        "id": "23277230.T1.T20",
        "sentence": "@CHEMICAL$ treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (@GENE$), NF-kB p65 unit (in pancreas) and IL-1b (plasma), serum nitric oxide (NO) with an elevation in plasma insulin.",
        "relation": "CPR:4"
    },
    {
        "id": "23277230.T1.T21",
        "sentence": "@CHEMICAL$ treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), @GENE$ p65 unit (in pancreas) and IL-1b (plasma), serum nitric oxide (NO) with an elevation in plasma insulin.",
        "relation": "CPR:4"
    },
    {
        "id": "23277230.T1.T24",
        "sentence": "@CHEMICAL$ treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), NF-kB p65 unit (in pancreas) and IL-1b (plasma), serum nitric oxide (NO) with an elevation in plasma @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23277230.T1.T22",
        "sentence": "@CHEMICAL$ treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), NF-kB @GENE$ unit (in pancreas) and IL-1b (plasma), serum nitric oxide (NO) with an elevation in plasma insulin.",
        "relation": "CPR:4"
    },
    {
        "id": "23277230.T1.T23",
        "sentence": "@CHEMICAL$ treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), NF-kB p65 unit (in pancreas) and @GENE$ (plasma), serum nitric oxide (NO) with an elevation in plasma insulin.",
        "relation": "CPR:4"
    },
    {
        "id": "23423570.T5.T18",
        "sentence": "High-@CHEMICAL$ environment enhanced oxidative stress and increased @GENE$ secretion from keratinocytes: New insights on impaired diabetic wound healing.",
        "relation": "CPR:3"
    },
    {
        "id": "23423570.T3.T7",
        "sentence": "Using cultured human keratinocytes and diabetic rat model, the current study showed that high-@CHEMICAL$ environment enhanced @GENE$ production via epidermal growth factor receptor (EGFR) -extracelluar signal-regulated kinase (ERK) pathway in a reactive oxygen species (ROS)-dependent manner in keratinocytes.",
        "relation": "CPR:3"
    },
    {
        "id": "23423570.T2.T6",
        "sentence": "In conclusion, @CHEMICAL$ production and neutrophil infiltration are increased in high-@GENE$ environment due to elevated ROS level and contributed to impaired wound healing in diabetic skin.",
        "relation": "CPR:3"
    },
    {
        "id": "23313794.T8.T26",
        "sentence": "The results showed that (1) 15mg/kg body weight PhIP induced obvious histopathological changes in gastric mucosa; (2) @CHEMICAL$ (10 and/or 15mg/kg) significantly decreased @GENE$ (SOD) and glutathioneperoxidase (GPx) activities, while increased catalase (CAT) activity compared with the control.",
        "relation": "CPR:4"
    },
    {
        "id": "23313794.T8.T27",
        "sentence": "The results showed that (1) 15mg/kg body weight PhIP induced obvious histopathological changes in gastric mucosa; (2) @CHEMICAL$ (10 and/or 15mg/kg) significantly decreased superoxide dismutase (@GENE$) and glutathioneperoxidase (GPx) activities, while increased catalase (CAT) activity compared with the control.",
        "relation": "CPR:4"
    },
    {
        "id": "23313794.T8.T28",
        "sentence": "The results showed that (1) 15mg/kg body weight PhIP induced obvious histopathological changes in gastric mucosa; (2) @CHEMICAL$ (10 and/or 15mg/kg) significantly decreased superoxide dismutase (SOD) and @GENE$ (GPx) activities, while increased catalase (CAT) activity compared with the control.",
        "relation": "CPR:4"
    },
    {
        "id": "23313794.T8.T29",
        "sentence": "The results showed that (1) 15mg/kg body weight PhIP induced obvious histopathological changes in gastric mucosa; (2) @CHEMICAL$ (10 and/or 15mg/kg) significantly decreased superoxide dismutase (SOD) and glutathioneperoxidase (@GENE$) activities, while increased catalase (CAT) activity compared with the control.",
        "relation": "CPR:4"
    },
    {
        "id": "23313794.T8.T30",
        "sentence": "The results showed that (1) 15mg/kg body weight PhIP induced obvious histopathological changes in gastric mucosa; (2) @CHEMICAL$ (10 and/or 15mg/kg) significantly decreased superoxide dismutase (SOD) and glutathioneperoxidase (GPx) activities, while increased @GENE$ (CAT) activity compared with the control.",
        "relation": "CPR:3"
    },
    {
        "id": "23313794.T8.T31",
        "sentence": "The results showed that (1) 15mg/kg body weight PhIP induced obvious histopathological changes in gastric mucosa; (2) @CHEMICAL$ (10 and/or 15mg/kg) significantly decreased superoxide dismutase (SOD) and glutathioneperoxidase (GPx) activities, while increased catalase (@GENE$) activity compared with the control.",
        "relation": "CPR:3"
    },
    {
        "id": "23313794.T16.T19",
        "sentence": "With the elevated doses of PhIP, malondialdehyde (MDA) contents, protein carbonyl (PCO) contents and DNA-protein crosslinks (DPC) coefficients were significantly raised in a dose-dependent manner; (3) @CHEMICAL$ at the doses of 10mg/kg and/or 15mg/kg significantly inhibited p16 mRNA and protein expression, whereas enhanced c-fos and @GENE$ expression relative to control.",
        "relation": "CPR:3"
    },
    {
        "id": "23313794.T16.T32",
        "sentence": "With the elevated doses of PhIP, malondialdehyde (MDA) contents, protein carbonyl (PCO) contents and DNA-protein crosslinks (DPC) coefficients were significantly raised in a dose-dependent manner; (3) @CHEMICAL$ at the doses of 10mg/kg and/or 15mg/kg significantly inhibited @GENE$ mRNA and protein expression, whereas enhanced c-fos and c-jun expression relative to control.",
        "relation": "CPR:4"
    },
    {
        "id": "23313794.T16.T33",
        "sentence": "With the elevated doses of PhIP, malondialdehyde (MDA) contents, protein carbonyl (PCO) contents and DNA-protein crosslinks (DPC) coefficients were significantly raised in a dose-dependent manner; (3) @CHEMICAL$ at the doses of 10mg/kg and/or 15mg/kg significantly inhibited p16 mRNA and protein expression, whereas enhanced @GENE$ and c-jun expression relative to control.",
        "relation": "CPR:3"
    },
    {
        "id": "23313794.T2.T20",
        "sentence": "The data indicated that @CHEMICAL$ could cause stomach injury, oxidative stress in rat stomachs as well as the activation of @GENE$ and c-jun and inactivation of p16, which may play a role in the pathogenesis of PhIP-associated stomach cancer.",
        "relation": "CPR:3"
    },
    {
        "id": "23313794.T2.T21",
        "sentence": "The data indicated that @CHEMICAL$ could cause stomach injury, oxidative stress in rat stomachs as well as the activation of c-fos and @GENE$ and inactivation of p16, which may play a role in the pathogenesis of PhIP-associated stomach cancer.",
        "relation": "CPR:3"
    },
    {
        "id": "23313794.T2.T22",
        "sentence": "The data indicated that @CHEMICAL$ could cause stomach injury, oxidative stress in rat stomachs as well as the activation of c-fos and c-jun and inactivation of @GENE$, which may play a role in the pathogenesis of PhIP-associated stomach cancer.",
        "relation": "CPR:4"
    },
    {
        "id": "12003347.T16.T29",
        "sentence": "We also shortly discuss the ongoing debate on whether @CHEMICAL$ is the actual reaction product of @GENE$ catalysis, as well as the phenomenon of NO-mediated autoinhibition.",
        "relation": "CPR:9"
    },
    {
        "id": "1375507.T20.T34",
        "sentence": "@CHEMICAL$ analogues inhibit @GENE$ expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism.",
        "relation": "CPR:4"
    },
    {
        "id": "1375507.T12.T28",
        "sentence": "The present studies were undertaken to determine whether stable analogues of @CHEMICAL$, a potent endothelium-derived platelet inhibitor and vasodilator, could inhibit @GENE$ expression by human monocytic cells.",
        "relation": "CPR:4"
    },
    {
        "id": "1375507.T13.T32",
        "sentence": "Preincubation for 30 minutes with @CHEMICAL$, ciprostene, and carbacyclin led to a dose-dependent inhibition of @GENE$ expression induced by all three challenging agents.",
        "relation": "CPR:4"
    },
    {
        "id": "1375507.T14.T32",
        "sentence": "Preincubation for 30 minutes with iloprost, @CHEMICAL$, and carbacyclin led to a dose-dependent inhibition of @GENE$ expression induced by all three challenging agents.",
        "relation": "CPR:4"
    },
    {
        "id": "1375507.T15.T32",
        "sentence": "Preincubation for 30 minutes with iloprost, ciprostene, and @CHEMICAL$ led to a dose-dependent inhibition of @GENE$ expression induced by all three challenging agents.",
        "relation": "CPR:4"
    },
    {
        "id": "1375507.T5.T24",
        "sentence": "This effect was potentiated by @CHEMICAL$, an inhibitor of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "1375507.T6.T25",
        "sentence": "The inhibitory effects of iloprost on @CHEMICAL$ expression were also potentiated by @GENE$ and mimicked by forskolin and dibutyryl cyclic AMP but not dibutyryl cyclic GMP.",
        "relation": "CPR:4"
    },
    {
        "id": "1375507.T7.T25",
        "sentence": "The inhibitory effects of iloprost on @CHEMICAL$ expression were also potentiated by isobutylmethylxanthine and mimicked by @GENE$ and dibutyryl cyclic AMP but not dibutyryl cyclic GMP.",
        "relation": "CPR:4"
    },
    {
        "id": "1375507.T8.T25",
        "sentence": "The inhibitory effects of iloprost on @CHEMICAL$ expression were also potentiated by isobutylmethylxanthine and mimicked by forskolin and d@GENE$ but not dibutyryl cyclic GMP.",
        "relation": "CPR:4"
    },
    {
        "id": "1375507.T10.T26",
        "sentence": "These results suggest that @CHEMICAL$ may play a role in downregulating @GENE$ expression in monocytes, at least in part via elevation of intracellular levels of cyclic AMP.",
        "relation": "CPR:4"
    },
    {
        "id": "1375507.T11.T26",
        "sentence": "These results suggest that prostacyclin may play a role in downregulating @CHEMICAL$ expression in monocytes, at least in part via elevation of intracellular levels of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15132128.T2.T20",
        "sentence": "PURPOSE: The @CHEMICAL$ (capecitabine) is converted to 5-fluorouracil (5-FU) by thymidine phosphorylase (@GENE$) inside target tissues. 5-FU interferes with DNA synthesis by blocking thymidylate synthase (TS) but is inactivated by dihydropyrimidine dehydrogenase (DPD).",
        "relation": "CPR:9"
    },
    {
        "id": "15132128.T2.T43",
        "sentence": "PURPOSE: The @CHEMICAL$ (capecitabine) is converted to 5-fluorouracil (5-FU) by @GENE$ (TP) inside target tissues. 5-FU interferes with DNA synthesis by blocking thymidylate synthase (TS) but is inactivated by dihydropyrimidine dehydrogenase (DPD).",
        "relation": "CPR:9"
    },
    {
        "id": "15132128.T3.T26",
        "sentence": "PURPOSE: The fluoropyrimidine carbamate (capecitabine) is converted to 5-fluorouracil (5-FU) by thymidine phosphorylase (TP) inside target tissues. @CHEMICAL$ interferes with DNA synthesis by blocking @GENE$ (TS) but is inactivated by dihydropyrimidine dehydrogenase (DPD).",
        "relation": "CPR:4"
    },
    {
        "id": "15132128.T3.T27",
        "sentence": "PURPOSE: The fluoropyrimidine carbamate (capecitabine) is converted to 5-fluorouracil (5-FU) by thymidine phosphorylase (TP) inside target tissues. @CHEMICAL$ interferes with DNA synthesis by blocking thymidylate synthase (@GENE$) but is inactivated by dihydropyrimidine dehydrogenase (DPD).",
        "relation": "CPR:4"
    },
    {
        "id": "15132128.T8.T20",
        "sentence": "PURPOSE: The fluoropyrimidine carbamate (@CHEMICAL$) is converted to 5-fluorouracil (5-FU) by thymidine phosphorylase (@GENE$) inside target tissues. 5-FU interferes with DNA synthesis by blocking thymidylate synthase (TS) but is inactivated by dihydropyrimidine dehydrogenase (DPD).",
        "relation": "CPR:9"
    },
    {
        "id": "15132128.T8.T43",
        "sentence": "PURPOSE: The fluoropyrimidine carbamate (@CHEMICAL$) is converted to 5-fluorouracil (5-FU) by @GENE$ (TP) inside target tissues. 5-FU interferes with DNA synthesis by blocking thymidylate synthase (TS) but is inactivated by dihydropyrimidine dehydrogenase (DPD).",
        "relation": "CPR:9"
    },
    {
        "id": "15132128.T10.T20",
        "sentence": "PURPOSE: The fluoropyrimidine carbamate (capecitabine) is converted to @CHEMICAL$ (5-FU) by thymidine phosphorylase (@GENE$) inside target tissues. 5-FU interferes with DNA synthesis by blocking thymidylate synthase (TS) but is inactivated by dihydropyrimidine dehydrogenase (DPD).",
        "relation": "CPR:9"
    },
    {
        "id": "15132128.T10.T43",
        "sentence": "PURPOSE: The fluoropyrimidine carbamate (capecitabine) is converted to @CHEMICAL$ (5-FU) by @GENE$ (TP) inside target tissues. 5-FU interferes with DNA synthesis by blocking thymidylate synthase (TS) but is inactivated by dihydropyrimidine dehydrogenase (DPD).",
        "relation": "CPR:9"
    },
    {
        "id": "15132128.T11.T20",
        "sentence": "PURPOSE: The fluoropyrimidine carbamate (capecitabine) is converted to 5-fluorouracil (@CHEMICAL$) by thymidine phosphorylase (@GENE$) inside target tissues. 5-FU interferes with DNA synthesis by blocking thymidylate synthase (TS) but is inactivated by dihydropyrimidine dehydrogenase (DPD).",
        "relation": "CPR:9"
    },
    {
        "id": "15132128.T11.T43",
        "sentence": "PURPOSE: The fluoropyrimidine carbamate (capecitabine) is converted to 5-fluorouracil (@CHEMICAL$) by @GENE$ (TP) inside target tissues. 5-FU interferes with DNA synthesis by blocking thymidylate synthase (TS) but is inactivated by dihydropyrimidine dehydrogenase (DPD).",
        "relation": "CPR:9"
    },
    {
        "id": "15132128.T7.T30",
        "sentence": "Favorable enzyme profiles (high @CHEMICAL$ and low DPD) generate high intratumor levels of @GENE$ that are effective against many tumors, especially those with low TS.",
        "relation": "CPR:9"
    },
    {
        "id": "15132128.T7.T31",
        "sentence": "Favorable enzyme profiles (high TP and low @CHEMICAL$) generate high intratumor levels of @GENE$ that are effective against many tumors, especially those with low TS.",
        "relation": "CPR:9"
    },
    {
        "id": "8667211.T6.T15",
        "sentence": "Previous studies by this research team proved that vasodilating @CHEMICAL$ (PGs) E1, E2 and I2 inhibit @GENE$ (CA) in vitro and in vivo, which suggested involvement of CA in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of PGs.",
        "relation": "CPR:4"
    },
    {
        "id": "8667211.T6.T20",
        "sentence": "Previous studies by this research team proved that vasodilating @CHEMICAL$ (PGs) E1, E2 and I2 inhibit carbonic anhydrase (@GENE$) in vitro and in vivo, which suggested involvement of CA in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of PGs.",
        "relation": "CPR:4"
    },
    {
        "id": "8667211.T9.T15",
        "sentence": "Previous studies by this research team proved that vasodilating prostaglandins (@CHEMICAL$) E1, E2 and I2 inhibit @GENE$ (CA) in vitro and in vivo, which suggested involvement of CA in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of PGs.",
        "relation": "CPR:4"
    },
    {
        "id": "8667211.T9.T20",
        "sentence": "Previous studies by this research team proved that vasodilating prostaglandins (@CHEMICAL$) E1, E2 and I2 inhibit carbonic anhydrase (@GENE$) in vitro and in vivo, which suggested involvement of CA in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of PGs.",
        "relation": "CPR:4"
    },
    {
        "id": "8667211.T10.T30",
        "sentence": "Histamine and @CHEMICAL$ added to NSAIDs amplified the activating effect of the latter on @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "8667211.T11.T31",
        "sentence": "Association of PGE2 or @CHEMICAL$ to NSAIDs reduced NSAID-induced activation of @GENE$ and CA II.",
        "relation": "CPR:4"
    },
    {
        "id": "8667211.T11.T32",
        "sentence": "Association of PGE2 or @CHEMICAL$ to NSAIDs reduced NSAID-induced activation of CA I and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "8667211.T1.T13",
        "sentence": "Indomethacin abolished the inhibitory effect of @CHEMICAL$ on @GENE$ and CA II.",
        "relation": "CPR:4"
    },
    {
        "id": "8667211.T1.T14",
        "sentence": "Indomethacin abolished the inhibitory effect of @CHEMICAL$ on CA I and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "8667211.T12.T13",
        "sentence": "@CHEMICAL$ abolished the inhibitory effect of acetazolamide on @GENE$ and CA II.",
        "relation": "CPR:3"
    },
    {
        "id": "8667211.T12.T14",
        "sentence": "@CHEMICAL$ abolished the inhibitory effect of acetazolamide on CA I and @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "12047490.T15.T24",
        "sentence": "@CHEMICAL$ inhibition was measured as percentage inhibition of serum @GENE$ generation in clotting whole blood, and as closure time with use of the platelet function analyser PFA-100.",
        "relation": "CPR:9"
    },
    {
        "id": "12047490.T5.T22",
        "sentence": "CONCLUSIONS: In the maximum registered dosage, @CHEMICAL$ inhibits thromboxane production much more than meloxicam, signifying less @GENE$ selectivity of the former.",
        "relation": "CPR:4"
    },
    {
        "id": "12826271.T7.T11",
        "sentence": "Treatment with @CHEMICAL$ resulted in nuclear condensation (a morphological change due to apoptosis of NSCs) 24hr after the treatment and activated @GENE$ after 6 hr, indicating that diclofenac may cause apoptosis of neuronal cells via activation of the caspase cascade.",
        "relation": "CPR:3"
    },
    {
        "id": "12826271.T8.T12",
        "sentence": "Treatment with diclofenac resulted in nuclear condensation (a morphological change due to apoptosis of NSCs) 24hr after the treatment and activated caspase-3 after 6 hr, indicating that @CHEMICAL$ may cause apoptosis of neuronal cells via activation of the @GENE$ cascade.",
        "relation": "CPR:3"
    },
    {
        "id": "23563205.T1.T10",
        "sentence": "Correlation between activation of @CHEMICAL$ and resistin downregulation in a mouse adipocyte cell line by a series of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23563205.T1.T11",
        "sentence": "Correlation between activation of PPARg and @CHEMICAL$ downregulation in a mouse adipocyte cell line by a series of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23305850.T1.T7",
        "sentence": "Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported @CHEMICAL$ target genes in response to NRF2 inducers (@GENE$, tert-butylhydroquinone, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.",
        "relation": "CPR:3"
    },
    {
        "id": "23305850.T1.T8",
        "sentence": "Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to @CHEMICAL$ inducers (@GENE$, tert-butylhydroquinone, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.",
        "relation": "CPR:3"
    },
    {
        "id": "23305850.T1.T9",
        "sentence": "Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (@CHEMICAL$, tert-butylhydroquinone, cinnamic aldehyde, and hydrogen peroxide) showed that the @GENE$ is highly inducible by all treatments.",
        "relation": "CPR:3"
    },
    {
        "id": "23305850.T2.T7",
        "sentence": "Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported @CHEMICAL$ target genes in response to NRF2 inducers (sulforaphane, @GENE$, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.",
        "relation": "CPR:3"
    },
    {
        "id": "23305850.T2.T8",
        "sentence": "Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to @CHEMICAL$ inducers (sulforaphane, @GENE$, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.",
        "relation": "CPR:3"
    },
    {
        "id": "23305850.T2.T9",
        "sentence": "Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (sulforaphane, @CHEMICAL$, cinnamic aldehyde, and hydrogen peroxide) showed that the @GENE$ is highly inducible by all treatments.",
        "relation": "CPR:3"
    },
    {
        "id": "23305850.T3.T7",
        "sentence": "Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported @CHEMICAL$ target genes in response to NRF2 inducers (sulforaphane, tert-butylhydroquinone, @GENE$, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.",
        "relation": "CPR:3"
    },
    {
        "id": "23305850.T3.T8",
        "sentence": "Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to @CHEMICAL$ inducers (sulforaphane, tert-butylhydroquinone, @GENE$, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.",
        "relation": "CPR:3"
    },
    {
        "id": "23305850.T3.T9",
        "sentence": "Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (sulforaphane, tert-butylhydroquinone, @CHEMICAL$, and hydrogen peroxide) showed that the @GENE$ is highly inducible by all treatments.",
        "relation": "CPR:3"
    },
    {
        "id": "23305850.T4.T7",
        "sentence": "Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported @CHEMICAL$ target genes in response to NRF2 inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and @GENE$) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.",
        "relation": "CPR:3"
    },
    {
        "id": "23305850.T4.T8",
        "sentence": "Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to @CHEMICAL$ inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and @GENE$) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments.",
        "relation": "CPR:3"
    },
    {
        "id": "23305850.T4.T9",
        "sentence": "Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and @CHEMICAL$) showed that the @GENE$ is highly inducible by all treatments.",
        "relation": "CPR:3"
    },
    {
        "id": "23305850.T5.T18",
        "sentence": "The treatment of U937 cells with NRF2 inducers including @CHEMICAL$ effectively elevated the expression of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23305850.T5.T17",
        "sentence": "The treatment of U937 cells with @CHEMICAL$ inducers including @GENE$ effectively elevated the expression of AKR1B1, 1B10, 1C1, 1C2, and 1C3.",
        "relation": "CPR:3"
    },
    {
        "id": "23305850.T6.T19",
        "sentence": "Whereas, the levels of both the basal and @CHEMICAL$-inducible expression of @GENE$ were significantly reduced in NRF2-silenced stable U937 cells compared to the control cells.",
        "relation": "CPR:3"
    },
    {
        "id": "10446934.T8.T30",
        "sentence": "@CHEMICAL$ and angiotensinogen genes were downregulated in dTGR and were increased by @GENE$ and cilazapril treatments, whereas no changes in the expression of rat ACE and AT1A receptor genes were observed.",
        "relation": "CPR:3"
    },
    {
        "id": "10446934.T8.T31",
        "sentence": "Human and rat renin and @CHEMICAL$ genes were downregulated in dTGR and were increased by @GENE$ and cilazapril treatments, whereas no changes in the expression of rat ACE and AT1A receptor genes were observed.",
        "relation": "CPR:3"
    },
    {
        "id": "10446934.T9.T30",
        "sentence": "@CHEMICAL$ and angiotensinogen genes were downregulated in dTGR and were increased by losartan and @GENE$ treatments, whereas no changes in the expression of rat ACE and AT1A receptor genes were observed.",
        "relation": "CPR:3"
    },
    {
        "id": "10446934.T9.T31",
        "sentence": "Human and rat renin and @CHEMICAL$ genes were downregulated in dTGR and were increased by losartan and @GENE$ treatments, whereas no changes in the expression of rat ACE and AT1A receptor genes were observed.",
        "relation": "CPR:3"
    },
    {
        "id": "10446934.T11.T34",
        "sentence": "@CHEMICAL$ expression was increased by @GENE$ but not by losartan.",
        "relation": "CPR:3"
    },
    {
        "id": "12123767.T3.T11",
        "sentence": "In addition to this pronounced loss of function, @CHEMICAL$ also showed a 10-fold increase in the persistent late @GENE$ current.",
        "relation": "CPR:3"
    },
    {
        "id": "23219339.T14.T21",
        "sentence": "Western blot analysis revealed that @CHEMICAL$ decreased the expression of @GENE$ and repaired the balance of pro- and anti-apoptotic proteins.",
        "relation": "CPR:4"
    },
    {
        "id": "23219339.T15.T22",
        "sentence": "Furthermore, @CHEMICAL$ significantly reversed the up-regulation of @GENE$ and inhibited the calcium overload in the cultured neurons after challenging the NMDA.",
        "relation": "CPR:4"
    },
    {
        "id": "23219339.T4.T19",
        "sentence": "@CHEMICAL$ showed partial protection in the cortical neurons via down-regulation of NR2B containing @GENE$ and up-regulation of Bcl-2 family.",
        "relation": "CPR:4"
    },
    {
        "id": "23219339.T4.T18",
        "sentence": "@CHEMICAL$ showed partial protection in the cortical neurons via down-regulation of @GENE$ containing NMDA receptors and up-regulation of Bcl-2 family.",
        "relation": "CPR:4"
    },
    {
        "id": "23219339.T4.T20",
        "sentence": "@CHEMICAL$ showed partial protection in the cortical neurons via down-regulation of NR2B containing NMDA receptors and up-regulation of @GENE$ family.",
        "relation": "CPR:3"
    },
    {
        "id": "23146691.T2.T15",
        "sentence": "@CHEMICAL$ inhibits @GENE$-induced inflammatory responses in vitro and in vivo.",
        "relation": "CPR:4"
    },
    {
        "id": "19228178.T9.T16",
        "sentence": "Pharmacology of @CHEMICAL$, a selective @GENE$/MT2 receptor agonist: a novel therapeutic drug for sleep disorders.",
        "relation": "CPR:5"
    },
    {
        "id": "19228178.T9.T17",
        "sentence": "Pharmacology of @CHEMICAL$, a selective MT1/@GENE$ receptor agonist: a novel therapeutic drug for sleep disorders.",
        "relation": "CPR:5"
    },
    {
        "id": "19228178.T2.T11",
        "sentence": "@CHEMICAL$ (Rozerem; Takeda Pharmaceutical Company Limited, Osaka, Japan) is an orally active, highly selective melatonin @GENE$/MT(2) receptor agonist.",
        "relation": "CPR:5"
    },
    {
        "id": "19228178.T2.T12",
        "sentence": "@CHEMICAL$ (Rozerem; Takeda Pharmaceutical Company Limited, Osaka, Japan) is an orally active, highly selective melatonin MT(1)/@GENE$ receptor agonist.",
        "relation": "CPR:5"
    },
    {
        "id": "19228178.T5.T14",
        "sentence": "\"Unlike the sedative hypnotics that target GABA(A) receptor complexes, @CHEMICAL$ is a chronohypnotic that acts on the melatonin @GENE$ and MT(2) receptors, which are primarily located in the suprachiasmatic nucleus, the body's \"\"master clock.\"\" As such, ramelteon possesses the first new therapeutic mechanism of action for a prescription insomnia medication in over three decades.\"",
        "relation": "CPR:5"
    },
    {
        "id": "19228178.T5.T15",
        "sentence": "\"Unlike the sedative hypnotics that target GABA(A) receptor complexes, @CHEMICAL$ is a chronohypnotic that acts on the melatonin MT(1) and @GENE$ receptors, which are primarily located in the suprachiasmatic nucleus, the body's \"\"master clock.\"\" As such, ramelteon possesses the first new therapeutic mechanism of action for a prescription insomnia medication in over three decades.\"",
        "relation": "CPR:5"
    },
    {
        "id": "15843826.T9.T19",
        "sentence": "@CHEMICAL$ slightly inhibited the growth of both myeloma cells and HUVECs, and remarkably inhibited the growth of HUVECs stimulated by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15843826.T11.T15",
        "sentence": "@CHEMICAL$ inhibited VEGF-induced phosphorylation of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15843826.T11.T20",
        "sentence": "@CHEMICAL$ inhibited @GENE$-induced phosphorylation of VEGF receptor.",
        "relation": "CPR:4"
    },
    {
        "id": "15843826.T1.T16",
        "sentence": "In addition, @CHEMICAL$-induced formation of tube-like structures in vitro and neovascularization in mouse corneas were significantly inhibited by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "9231746.T8.T22",
        "sentence": "We have examined the effect of @CHEMICAL$ @GENE$ blockers felodipine and nicardipine on CaMPDE.",
        "relation": "CPR:4"
    },
    {
        "id": "9231746.T10.T22",
        "sentence": "We have examined the effect of dihydropyridine @CHEMICAL$ blockers @GENE$ and nicardipine on CaMPDE.",
        "relation": "CPR:4"
    },
    {
        "id": "9231746.T11.T22",
        "sentence": "We have examined the effect of dihydropyridine @CHEMICAL$ blockers felodipine and @GENE$ on CaMPDE.",
        "relation": "CPR:4"
    },
    {
        "id": "9231746.T12.T27",
        "sentence": "The results suggest that the 63-kDa (PDE 1B1) and 60-kDa (PDE 1A2) @CHEMICAL$ isozymes are inhibited by @GENE$ and nicardipine by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other.",
        "relation": "CPR:4"
    },
    {
        "id": "9231746.T12.T25",
        "sentence": "The results suggest that the 63-kDa (@CHEMICAL$) and 60-kDa (PDE 1A2) CaMPDE isozymes are inhibited by @GENE$ and nicardipine by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other.",
        "relation": "CPR:4"
    },
    {
        "id": "9231746.T12.T26",
        "sentence": "The results suggest that the 63-kDa (PDE 1B1) and 60-kDa (@CHEMICAL$) CaMPDE isozymes are inhibited by @GENE$ and nicardipine by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other.",
        "relation": "CPR:4"
    },
    {
        "id": "9231746.T13.T27",
        "sentence": "The results suggest that the 63-kDa (PDE 1B1) and 60-kDa (PDE 1A2) @CHEMICAL$ isozymes are inhibited by felodipine and @GENE$ by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other.",
        "relation": "CPR:4"
    },
    {
        "id": "9231746.T13.T25",
        "sentence": "The results suggest that the 63-kDa (@CHEMICAL$) and 60-kDa (PDE 1A2) CaMPDE isozymes are inhibited by felodipine and @GENE$ by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other.",
        "relation": "CPR:4"
    },
    {
        "id": "9231746.T13.T26",
        "sentence": "The results suggest that the 63-kDa (PDE 1B1) and 60-kDa (@CHEMICAL$) CaMPDE isozymes are inhibited by felodipine and @GENE$ by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other.",
        "relation": "CPR:4"
    },
    {
        "id": "9231746.T2.T18",
        "sentence": "Felodipine and nicardipine have similar affinities for 60-kDa @CHEMICAL$ isozymes but bring about different levels of enzyme inhibition, suggesting the possibility of designing specific drugs that can protect the enzyme from inhibition by @GENE$ Ca2+-channel blockers.",
        "relation": "CPR:4"
    },
    {
        "id": "9231746.T2.T19",
        "sentence": "Felodipine and nicardipine have similar affinities for 60-kDa CaMPDE isozymes but bring about different levels of enzyme inhibition, suggesting the possibility of designing specific drugs that can protect the enzyme from inhibition by @CHEMICAL$ @GENE$ blockers.",
        "relation": "CPR:4"
    },
    {
        "id": "23260346.T1.T10",
        "sentence": "Several inhibitors of @CHEMICAL$ have been described, including @GENE$, which is currently in phase 3 clinical development for the treatment of atherosclerosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23260346.T4.T17",
        "sentence": "We show that both @CHEMICAL$ and a novel class of structurally distinct carbamate inhibitors inactivate @GENE$ in mouse tissues and human cell lines with high selectivity.",
        "relation": "CPR:4"
    },
    {
        "id": "23260346.T5.T17",
        "sentence": "We show that both darapladib and a novel class of structurally distinct @CHEMICAL$ inhibitors inactivate @GENE$ in mouse tissues and human cell lines with high selectivity.",
        "relation": "CPR:4"
    },
    {
        "id": "14725487.T2.T22",
        "sentence": "Sepracor in the US is developing arformoterol [R,R-formoterol], a single isomer form of the @CHEMICAL$ agonist @GENE$ [eformoterol].",
        "relation": "CPR:5"
    },
    {
        "id": "14725487.T4.T22",
        "sentence": "Sepracor in the US is developing arformoterol [R,R-formoterol], a single isomer form of the @CHEMICAL$ agonist formoterol [@GENE$].",
        "relation": "CPR:5"
    },
    {
        "id": "23402364.T2.T37",
        "sentence": "Nitric oxide products of @CHEMICAL$ displayed significantly diminished @GENE$-dependent cleavage of DNA and cytotoxicity to human HL-60 leukemia cells.",
        "relation": "CPR:4"
    },
    {
        "id": "11319232.T7.T32",
        "sentence": "Consistent with these locations, @CHEMICAL$, an inhibitor of ACS4, inhibited @GENE$ activity 47% in MAM and 28% in endoplasmic reticulum.",
        "relation": "CPR:4"
    },
    {
        "id": "11319232.T7.T31",
        "sentence": "Consistent with these locations, @CHEMICAL$, an inhibitor of @GENE$, inhibited ACS activity 47% in MAM and 28% in endoplasmic reticulum.",
        "relation": "CPR:4"
    },
    {
        "id": "11319232.T8.T34",
        "sentence": "@CHEMICAL$, a second ACS4 inhibitor, inhibited @GENE$ activity <10% in microsomes and mitochondria and 45% in MAM.",
        "relation": "CPR:4"
    },
    {
        "id": "11319232.T8.T33",
        "sentence": "@CHEMICAL$, a second @GENE$ inhibitor, inhibited ACS activity <10% in microsomes and mitochondria and 45% in MAM.",
        "relation": "CPR:4"
    },
    {
        "id": "11319232.T9.T37",
        "sentence": "@CHEMICAL$, a competitive inhibitor of both ACS1 and ACS4, inhibited @GENE$ activity similarly in endoplasmic reticulum, MAM, and mitochondria, suggesting that a hitherto unidentified triacsin-sensitive ACS is present in mitochondria.",
        "relation": "CPR:4"
    },
    {
        "id": "11319232.T9.T35",
        "sentence": "@CHEMICAL$, a competitive inhibitor of both @GENE$ and ACS4, inhibited ACS activity similarly in endoplasmic reticulum, MAM, and mitochondria, suggesting that a hitherto unidentified triacsin-sensitive ACS is present in mitochondria.",
        "relation": "CPR:4"
    },
    {
        "id": "11319232.T9.T36",
        "sentence": "@CHEMICAL$, a competitive inhibitor of both ACS1 and @GENE$, inhibited ACS activity similarly in endoplasmic reticulum, MAM, and mitochondria, suggesting that a hitherto unidentified triacsin-sensitive ACS is present in mitochondria.",
        "relation": "CPR:4"
    },
    {
        "id": "11319232.T3.T17",
        "sentence": "Re-feeding normal chow or a high @CHEMICAL$ diet for 24 h after a 48-h fast increased both @GENE$ and ACS4 protein expression 1.5-2.0-fold, consistent with inhibition studies.",
        "relation": "CPR:3"
    },
    {
        "id": "11319232.T3.T18",
        "sentence": "Re-feeding normal chow or a high @CHEMICAL$ diet for 24 h after a 48-h fast increased both ACS1 and @GENE$ protein expression 1.5-2.0-fold, consistent with inhibition studies.",
        "relation": "CPR:3"
    },
    {
        "id": "11319232.T4.T19",
        "sentence": "These results suggest that @CHEMICAL$ and ACS4 may be linked to @GENE$ synthesis.",
        "relation": "CPR:9"
    },
    {
        "id": "11319232.T4.T20",
        "sentence": "These results suggest that ACS1 and @CHEMICAL$ may be linked to @GENE$ synthesis.",
        "relation": "CPR:9"
    },
    {
        "id": "11585753.T8.T25",
        "sentence": "\"The @CHEMICAL$ inhibitor @GENE$ (\"\"Iressa\"\") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells.\"",
        "relation": "CPR:4"
    },
    {
        "id": "11585753.T8.T26",
        "sentence": "\"The tyrosine kinase inhibitor @CHEMICAL$ (\"\"Iressa\"\") inhibits @GENE$-driven signaling and suppresses the growth of HER2-overexpressing tumor cells.\"",
        "relation": "CPR:4"
    },
    {
        "id": "11585753.T9.T25",
        "sentence": "\"The @CHEMICAL$ inhibitor ZD1839 (\"\"@GENE$\"\") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells.\"",
        "relation": "CPR:4"
    },
    {
        "id": "11585753.T9.T24",
        "sentence": "\"The tyrosine kinase inhibitor ZD1839 (\"\"@CHEMICAL$\"\") inhibits HER2-driven signaling and suppresses the growth of @GENE$-overexpressing tumor cells.\"",
        "relation": "CPR:4"
    },
    {
        "id": "11585753.T9.T26",
        "sentence": "\"The tyrosine kinase inhibitor ZD1839 (\"\"@CHEMICAL$\"\") inhibits @GENE$-driven signaling and suppresses the growth of HER2-overexpressing tumor cells.\"",
        "relation": "CPR:4"
    },
    {
        "id": "11585753.T10.T25",
        "sentence": "\"The @CHEM-GENE$ inhibitor ZD1839 (\"\"Iressa\"\") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells.\"",
        "relation": "CPR:9"
    },
    {
        "id": "11585753.T2.T13",
        "sentence": "\"@CHEMICAL$ (\"\"Iressa\"\"), a quinazoline @GENE$ inhibitor selective for the EGFR, has shown good activity in preclinical studies and in the early phase of clinical trials.\"",
        "relation": "CPR:4"
    },
    {
        "id": "11585753.T2.T14",
        "sentence": "\"@CHEMICAL$ (\"\"Iressa\"\"), a quinazoline tyrosine kinase inhibitor selective for the @GENE$, has shown good activity in preclinical studies and in the early phase of clinical trials.\"",
        "relation": "CPR:4"
    },
    {
        "id": "11585753.T3.T13",
        "sentence": "\"ZD1839 (\"\"@CHEMICAL$\"\"), a quinazoline @GENE$ inhibitor selective for the EGFR, has shown good activity in preclinical studies and in the early phase of clinical trials.\"",
        "relation": "CPR:4"
    },
    {
        "id": "11585753.T3.T14",
        "sentence": "\"ZD1839 (\"\"@CHEMICAL$\"\"), a quinazoline tyrosine kinase inhibitor selective for the @GENE$, has shown good activity in preclinical studies and in the early phase of clinical trials.\"",
        "relation": "CPR:4"
    },
    {
        "id": "11585753.T4.T13",
        "sentence": "\"ZD1839 (\"\"Iressa\"\"), a @CHEM-GENE$ inhibitor selective for the EGFR, has shown good activity in preclinical studies and in the early phase of clinical trials.\"",
        "relation": "CPR:9"
    },
    {
        "id": "11585753.T7.T21",
        "sentence": "Growth inhibition of these tumor cell lines was associated with the dephosphorylation of EGFR, HER2, and HER3, accompanied by the loss of association of HER3 with @CHEM-GENE$, and down-regulation of Akt activity.",
        "relation": "CPR:9"
    },
    {
        "id": "11585753.T1.T12",
        "sentence": "These studies suggest that HER2-overexpressing tumors are particularly susceptible to the inhibition of HER family @CHEM-GENE$ signaling and suggest novel strategies to treat these particularly aggressive tumors.",
        "relation": "CPR:9"
    },
    {
        "id": "19068776.T17.T21",
        "sentence": "[Pharmacological effects of a @CHEMICAL$ antagonist @GENE$ on alcohol dependence].",
        "relation": "CPR:6"
    },
    {
        "id": "19068776.T6.T19",
        "sentence": "In many countries, a @CHEMICAL$ antagonist @GENE$ has been used in the treatment of alcohol dependence.",
        "relation": "CPR:6"
    },
    {
        "id": "12373423.T2.T28",
        "sentence": "RESULTS: In drug discrimination studies, @CHEMICAL$ fully mimicked the @GENE$ agonist LY 293284, only partially substituted for LSD and DOI, and failed to substitute for (+)-amphetamine. Lisuride produced a significant dose-related increase in flat body posture, forepaw treading, and lower-lip retraction which reflect a modulation of behavior by action at central 5-HT(1A) receptors.",
        "relation": "CPR:5"
    },
    {
        "id": "12373423.T3.T28",
        "sentence": "RESULTS: In drug discrimination studies, lisuride fully mimicked the @CHEMICAL$ agonist @GENE$, only partially substituted for LSD and DOI, and failed to substitute for (+)-amphetamine. Lisuride produced a significant dose-related increase in flat body posture, forepaw treading, and lower-lip retraction which reflect a modulation of behavior by action at central 5-HT(1A) receptors.",
        "relation": "CPR:5"
    },
    {
        "id": "12373423.T8.T30",
        "sentence": "Only pMPPI [@CHEMICAL$], a selective @GENE$ antagonist, was effective in inhibiting all 5-HT syndrome behaviors produced by lisuride, whereas pMPPI was without effect on any behavior induced by LSD.",
        "relation": "CPR:6"
    },
    {
        "id": "12373423.T12.T31",
        "sentence": "Lisuride dose dependently decreased body temperature in rats with a potency similar to that of the selective @CHEMICAL$ agonist @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "12183670.T1.T40",
        "sentence": "@CHEMICAL$, an efficacious antidepressant and smoking cessation agent, inhibits dopamine and norepinephrine transporters (@GENE$ and NET, respectively).",
        "relation": "CPR:4"
    },
    {
        "id": "12183670.T1.T41",
        "sentence": "@CHEMICAL$, an efficacious antidepressant and smoking cessation agent, inhibits dopamine and norepinephrine transporters (DAT and @GENE$, respectively).",
        "relation": "CPR:4"
    },
    {
        "id": "12183670.T30.T49",
        "sentence": "To eliminate the interaction of @CHEMICAL$ with @GENE$ or NET, nomifensine or desipramine, respectively, was included in the superfusion buffer.",
        "relation": "CPR:4"
    },
    {
        "id": "12183670.T30.T50",
        "sentence": "To eliminate the interaction of @CHEMICAL$ with DAT or @GENE$, nomifensine or desipramine, respectively, was included in the superfusion buffer.",
        "relation": "CPR:4"
    },
    {
        "id": "12183670.T17.T43",
        "sentence": "Thus, @CHEMICAL$ acts as an antagonist at alpha3beta2* and alpha3beta4* nAChRs in rat striatum and hippocampus, respectively, across the same concentration range that inhibits @GENE$ and NET function.",
        "relation": "CPR:4"
    },
    {
        "id": "12183670.T17.T44",
        "sentence": "Thus, @CHEMICAL$ acts as an antagonist at alpha3beta2* and alpha3beta4* nAChRs in rat striatum and hippocampus, respectively, across the same concentration range that inhibits DAT and @GENE$ function.",
        "relation": "CPR:4"
    },
    {
        "id": "12183670.T18.T45",
        "sentence": "The combination of @CHEMICAL$ and transporter inhibition produced by @GENE$ may contribute to its clinical efficacy as a smoking cessation agent.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T16.T33",
        "sentence": "@CHEMICAL$-containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of @GENE$ signaling pathways and Bim-mediated activation of the intrinsic apoptotic pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T16.T34",
        "sentence": "@CHEMICAL$-containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and @GENE$-mediated activation of the intrinsic apoptotic pathway.",
        "relation": "CPR:3"
    },
    {
        "id": "23085435.T17.T33",
        "sentence": "Nitrogen-containing @CHEMICAL$ induce apoptosis of hematopoietic tumor cells via inhibition of @GENE$ signaling pathways and Bim-mediated activation of the intrinsic apoptotic pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T17.T34",
        "sentence": "Nitrogen-containing @CHEMICAL$ induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and @GENE$-mediated activation of the intrinsic apoptotic pathway.",
        "relation": "CPR:3"
    },
    {
        "id": "23085435.T1.T19",
        "sentence": "@CHEMICAL$-containing bisphosphonates (N-BPs) induce apoptosis in tumor cells by inhibiting the prenylation of small @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T3.T19",
        "sentence": "Nitrogen-containing @CHEMICAL$ (N-BPs) induce apoptosis in tumor cells by inhibiting the prenylation of small @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T6.T19",
        "sentence": "Nitrogen-containing bisphosphonates (@CHEMICAL$-BPs) induce apoptosis in tumor cells by inhibiting the prenylation of small @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T7.T19",
        "sentence": "Nitrogen-containing bisphosphonates (N-@CHEMICAL$) induce apoptosis in tumor cells by inhibiting the prenylation of small @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T10.T20",
        "sentence": "Furthermore, @CHEMICAL$-BPs decreased the levels of @GENE$ (ERK) and mTOR via suppression of Ras prenylation and enhanced Bim expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T10.T21",
        "sentence": "Furthermore, @CHEMICAL$-BPs decreased the levels of phosphorylated extracellular signal-regulated kinase (@GENE$) and mTOR via suppression of Ras prenylation and enhanced Bim expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T10.T23",
        "sentence": "Furthermore, @CHEMICAL$-BPs decreased the levels of phosphorylated extracellular signal-regulated kinase (ERK) and mTOR via suppression of @GENE$ prenylation and enhanced Bim expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T10.T22",
        "sentence": "Furthermore, @CHEMICAL$-BPs decreased the levels of phosphorylated extracellular signal-regulated kinase (ERK) and @GENE$ via suppression of Ras prenylation and enhanced Bim expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T10.T24",
        "sentence": "Furthermore, @CHEMICAL$-BPs decreased the levels of phosphorylated extracellular signal-regulated kinase (ERK) and mTOR via suppression of Ras prenylation and enhanced @GENE$ expression.",
        "relation": "CPR:3"
    },
    {
        "id": "23085435.T11.T20",
        "sentence": "Furthermore, N-@CHEMICAL$ decreased the levels of @GENE$ (ERK) and mTOR via suppression of Ras prenylation and enhanced Bim expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T11.T21",
        "sentence": "Furthermore, N-@CHEMICAL$ decreased the levels of phosphorylated extracellular signal-regulated kinase (@GENE$) and mTOR via suppression of Ras prenylation and enhanced Bim expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T11.T23",
        "sentence": "Furthermore, N-@CHEMICAL$ decreased the levels of phosphorylated extracellular signal-regulated kinase (ERK) and mTOR via suppression of @GENE$ prenylation and enhanced Bim expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T11.T22",
        "sentence": "Furthermore, N-@CHEMICAL$ decreased the levels of phosphorylated extracellular signal-regulated kinase (ERK) and @GENE$ via suppression of Ras prenylation and enhanced Bim expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T11.T24",
        "sentence": "Furthermore, N-@CHEMICAL$ decreased the levels of phosphorylated extracellular signal-regulated kinase (ERK) and mTOR via suppression of Ras prenylation and enhanced @GENE$ expression.",
        "relation": "CPR:3"
    },
    {
        "id": "23085435.T12.T28",
        "sentence": "The present results indicated that @CHEMICAL$-BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the @GENE$/MEK/ERK and Ras/mTOR pathways.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T12.T29",
        "sentence": "The present results indicated that @CHEMICAL$-BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/@GENE$/ERK and Ras/mTOR pathways.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T12.T30",
        "sentence": "The present results indicated that @CHEMICAL$-BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/@GENE$ and Ras/mTOR pathways.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T12.T31",
        "sentence": "The present results indicated that @CHEMICAL$-BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/ERK and @GENE$/mTOR pathways.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T12.T25",
        "sentence": "The present results indicated that @CHEMICAL$-BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of @GENE$ and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways.",
        "relation": "CPR:3"
    },
    {
        "id": "23085435.T12.T26",
        "sentence": "The present results indicated that @CHEMICAL$-BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and @GENE$, and enhancing Bim expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways.",
        "relation": "CPR:3"
    },
    {
        "id": "23085435.T12.T27",
        "sentence": "The present results indicated that @CHEMICAL$-BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing @GENE$ expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways.",
        "relation": "CPR:3"
    },
    {
        "id": "23085435.T12.T32",
        "sentence": "The present results indicated that @CHEMICAL$-BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/ERK and Ras/@GENE$ pathways.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T13.T28",
        "sentence": "The present results indicated that N-@CHEMICAL$ induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the @GENE$/MEK/ERK and Ras/mTOR pathways.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T13.T29",
        "sentence": "The present results indicated that N-@CHEMICAL$ induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/@GENE$/ERK and Ras/mTOR pathways.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T13.T30",
        "sentence": "The present results indicated that N-@CHEMICAL$ induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/@GENE$ and Ras/mTOR pathways.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T13.T31",
        "sentence": "The present results indicated that N-@CHEMICAL$ induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/ERK and @GENE$/mTOR pathways.",
        "relation": "CPR:4"
    },
    {
        "id": "23085435.T13.T25",
        "sentence": "The present results indicated that N-@CHEMICAL$ induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of @GENE$ and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways.",
        "relation": "CPR:3"
    },
    {
        "id": "23085435.T13.T26",
        "sentence": "The present results indicated that N-@CHEMICAL$ induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and @GENE$, and enhancing Bim expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways.",
        "relation": "CPR:3"
    },
    {
        "id": "23085435.T13.T27",
        "sentence": "The present results indicated that N-@CHEMICAL$ induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing @GENE$ expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways.",
        "relation": "CPR:3"
    },
    {
        "id": "23085435.T13.T32",
        "sentence": "The present results indicated that N-@CHEMICAL$ induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/ERK and Ras/@GENE$ pathways.",
        "relation": "CPR:4"
    },
    {
        "id": "23600800.T2.T33",
        "sentence": "The reduction of @CHEMICAL$ expression levels was reversed by the proteasomal inhibitor @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "20104269.T3.T22",
        "sentence": "We investigated the involvement of the farnesoid X receptor (FXR), a nuclear receptor for bile acids, in the @CHEMICAL$ (CDCA)-induced expression of @GENE$ and MUC2 in normal rat gastric epithelial cells (RGM-1 cells).",
        "relation": "CPR:3"
    },
    {
        "id": "20104269.T3.T23",
        "sentence": "We investigated the involvement of the farnesoid X receptor (FXR), a nuclear receptor for bile acids, in the @CHEMICAL$ (CDCA)-induced expression of Cdx2 and @GENE$ in normal rat gastric epithelial cells (RGM-1 cells).",
        "relation": "CPR:3"
    },
    {
        "id": "20104269.T4.T22",
        "sentence": "We investigated the involvement of the farnesoid X receptor (FXR), a nuclear receptor for bile acids, in the chenodeoxycholic acid (@CHEMICAL$)-induced expression of @GENE$ and MUC2 in normal rat gastric epithelial cells (RGM-1 cells).",
        "relation": "CPR:3"
    },
    {
        "id": "20104269.T4.T23",
        "sentence": "We investigated the involvement of the farnesoid X receptor (FXR), a nuclear receptor for bile acids, in the chenodeoxycholic acid (@CHEMICAL$)-induced expression of Cdx2 and @GENE$ in normal rat gastric epithelial cells (RGM-1 cells).",
        "relation": "CPR:3"
    },
    {
        "id": "20104269.T5.T24",
        "sentence": "RGM-1 cells were treated with @CHEMICAL$ or GW4064, an @GENE$ agonist, in the presence or absence of guggulsterone, an FXR antagonist.",
        "relation": "CPR:5"
    },
    {
        "id": "20104269.T6.T24",
        "sentence": "RGM-1 cells were treated with CDCA or @CHEMICAL$, an @GENE$ agonist, in the presence or absence of guggulsterone, an FXR antagonist.",
        "relation": "CPR:5"
    },
    {
        "id": "20104269.T7.T25",
        "sentence": "RGM-1 cells were treated with CDCA or GW4064, an FXR agonist, in the presence or absence of @CHEMICAL$, an @GENE$ antagonist.",
        "relation": "CPR:6"
    },
    {
        "id": "20104269.T8.T26",
        "sentence": "@CHEMICAL$ induced dose-dependent expression of @GENE$ and MUC2 at both the mRNA and protein levels.",
        "relation": "CPR:3"
    },
    {
        "id": "20104269.T8.T27",
        "sentence": "@CHEMICAL$ induced dose-dependent expression of Cdx2 and @GENE$ at both the mRNA and protein levels.",
        "relation": "CPR:3"
    },
    {
        "id": "20104269.T9.T28",
        "sentence": "The maximum stimulation of @CHEMICAL$ and MUC2 mRNA induced by @GENE$ was observed at 3 h and by 6 h, respectively.",
        "relation": "CPR:3"
    },
    {
        "id": "20104269.T9.T29",
        "sentence": "The maximum stimulation of Cdx2 and @CHEMICAL$ mRNA induced by @GENE$ was observed at 3 h and by 6 h, respectively.",
        "relation": "CPR:3"
    },
    {
        "id": "20104269.T2.T12",
        "sentence": "The effects of CDCA and GW4064 on expression of @CHEMICAL$ and MUC2 were abolished by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "20104269.T2.T13",
        "sentence": "The effects of CDCA and GW4064 on expression of Cdx2 and @CHEMICAL$ were abolished by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12213053.T19.T35",
        "sentence": "@CHEMICAL$ analogues as potential inhibitors of the @GENE$ at the dopamine transporter.",
        "relation": "CPR:4"
    },
    {
        "id": "12213053.T19.T36",
        "sentence": "@CHEMICAL$ analogues as potential inhibitors of the cocaine binding site at the @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12213053.T21.T36",
        "sentence": "Mazindol analogues as potential inhibitors of the cocaine binding site at the @CHEM-GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "12213053.T9.T24",
        "sentence": "Several active analogues were also evaluated for their ability to block uptake of @CHEMICAL$, 5-HT, and NE and inhibit binding of [(125)I] RTI-55 at HEK-@GENE$, HEK-hSERT, and HEK-hNET cells.",
        "relation": "CPR:9"
    },
    {
        "id": "12213053.T10.T25",
        "sentence": "Several active analogues were also evaluated for their ability to block uptake of DA, @CHEMICAL$, and NE and inhibit binding of [(125)I] RTI-55 at HEK-hDAT, HEK-@GENE$, and HEK-hNET cells.",
        "relation": "CPR:9"
    },
    {
        "id": "12213053.T11.T26",
        "sentence": "Several active analogues were also evaluated for their ability to block uptake of DA, 5-HT, and @CHEMICAL$ and inhibit binding of [(125)I] RTI-55 at HEK-hDAT, HEK-hSERT, and HEK-@GENE$ cells.",
        "relation": "CPR:9"
    },
    {
        "id": "16547651.T6.T22",
        "sentence": "@CHEMICAL$ affects aromatic amino acid biosynthesis by inhibiting @GENE$ (EPSPS).",
        "relation": "CPR:4"
    },
    {
        "id": "16547651.T6.T23",
        "sentence": "@CHEMICAL$ affects aromatic amino acid biosynthesis by inhibiting 5-enolpyruvylshikimate-3-phosphate synthase (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "16547651.T9.T24",
        "sentence": "@CHEMICAL$ inhibits @GENE$ and blocks biosynthesis of glutamine.",
        "relation": "CPR:4"
    },
    {
        "id": "16547651.T11.T24",
        "sentence": "Glufosinate inhibits @CHEMICAL$ and blocks biosynthesis of @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23579178.T15.T29",
        "sentence": "Mechanisms of Glucose Lowering of @CHEMICAL$ Inhibitor @GENE$ When Used Alone or With Metformin in Type 2 Diabetes: A double-tracer study. OBJECTIVETo assess glucose-lowering mechanisms of sitagliptin (S), metformin (M), and the two combined (M+S).RESEARCH DESIGN AND METHODSWe randomized 16 patients with type 2 diabetes mellitus (T2DM) to four 6-week treatments with placebo (P), M, S, and M+S. After each period, subjects received a 6-h meal tolerance test (MTT) with [(14)C]glucose to calculate glucose kinetics.",
        "relation": "CPR:4"
    },
    {
        "id": "23423713.T13.T34",
        "sentence": "Upon co-exposure to @CHEMICAL$ and TCDD, V(5+) significantly potentiated the TCDD-mediated induction of the @GENE$, Cyp1a2, and Cyp1b1 mRNA, protein, and catalytic activity levels at 24 h. In vitro, V(5+) decreased the TCDD-mediated induction of Cyp1a1 mRNA, protein, and catalytic activity levels.",
        "relation": "CPR:3"
    },
    {
        "id": "23423713.T13.T35",
        "sentence": "Upon co-exposure to @CHEMICAL$ and TCDD, V(5+) significantly potentiated the TCDD-mediated induction of the Cyp1a1, @GENE$, and Cyp1b1 mRNA, protein, and catalytic activity levels at 24 h. In vitro, V(5+) decreased the TCDD-mediated induction of Cyp1a1 mRNA, protein, and catalytic activity levels.",
        "relation": "CPR:3"
    },
    {
        "id": "23423713.T13.T36",
        "sentence": "Upon co-exposure to @CHEMICAL$ and TCDD, V(5+) significantly potentiated the TCDD-mediated induction of the Cyp1a1, Cyp1a2, and @GENE$ mRNA, protein, and catalytic activity levels at 24 h. In vitro, V(5+) decreased the TCDD-mediated induction of Cyp1a1 mRNA, protein, and catalytic activity levels.",
        "relation": "CPR:3"
    },
    {
        "id": "23423713.T14.T34",
        "sentence": "Upon co-exposure to V(5+) and @CHEMICAL$, V(5+) significantly potentiated the TCDD-mediated induction of the @GENE$, Cyp1a2, and Cyp1b1 mRNA, protein, and catalytic activity levels at 24 h. In vitro, V(5+) decreased the TCDD-mediated induction of Cyp1a1 mRNA, protein, and catalytic activity levels.",
        "relation": "CPR:3"
    },
    {
        "id": "23423713.T14.T35",
        "sentence": "Upon co-exposure to V(5+) and @CHEMICAL$, V(5+) significantly potentiated the TCDD-mediated induction of the Cyp1a1, @GENE$, and Cyp1b1 mRNA, protein, and catalytic activity levels at 24 h. In vitro, V(5+) decreased the TCDD-mediated induction of Cyp1a1 mRNA, protein, and catalytic activity levels.",
        "relation": "CPR:3"
    },
    {
        "id": "23423713.T14.T36",
        "sentence": "Upon co-exposure to V(5+) and @CHEMICAL$, V(5+) significantly potentiated the TCDD-mediated induction of the Cyp1a1, Cyp1a2, and @GENE$ mRNA, protein, and catalytic activity levels at 24 h. In vitro, V(5+) decreased the TCDD-mediated induction of Cyp1a1 mRNA, protein, and catalytic activity levels.",
        "relation": "CPR:3"
    },
    {
        "id": "23423713.T15.T34",
        "sentence": "Upon co-exposure to V(5+) and TCDD, @CHEMICAL$ significantly potentiated the TCDD-mediated induction of the @GENE$, Cyp1a2, and Cyp1b1 mRNA, protein, and catalytic activity levels at 24 h. In vitro, V(5+) decreased the TCDD-mediated induction of Cyp1a1 mRNA, protein, and catalytic activity levels.",
        "relation": "CPR:3"
    },
    {
        "id": "23423713.T15.T35",
        "sentence": "Upon co-exposure to V(5+) and TCDD, @CHEMICAL$ significantly potentiated the TCDD-mediated induction of the Cyp1a1, @GENE$, and Cyp1b1 mRNA, protein, and catalytic activity levels at 24 h. In vitro, V(5+) decreased the TCDD-mediated induction of Cyp1a1 mRNA, protein, and catalytic activity levels.",
        "relation": "CPR:3"
    },
    {
        "id": "23423713.T15.T36",
        "sentence": "Upon co-exposure to V(5+) and TCDD, @CHEMICAL$ significantly potentiated the TCDD-mediated induction of the Cyp1a1, Cyp1a2, and @GENE$ mRNA, protein, and catalytic activity levels at 24 h. In vitro, V(5+) decreased the TCDD-mediated induction of Cyp1a1 mRNA, protein, and catalytic activity levels.",
        "relation": "CPR:3"
    },
    {
        "id": "23423713.T17.T34",
        "sentence": "Upon co-exposure to V(5+) and TCDD, V(5+) significantly potentiated the @CHEMICAL$-mediated induction of the @GENE$, Cyp1a2, and Cyp1b1 mRNA, protein, and catalytic activity levels at 24 h. In vitro, V(5+) decreased the TCDD-mediated induction of Cyp1a1 mRNA, protein, and catalytic activity levels.",
        "relation": "CPR:3"
    },
    {
        "id": "23423713.T17.T35",
        "sentence": "Upon co-exposure to V(5+) and TCDD, V(5+) significantly potentiated the @CHEMICAL$-mediated induction of the Cyp1a1, @GENE$, and Cyp1b1 mRNA, protein, and catalytic activity levels at 24 h. In vitro, V(5+) decreased the TCDD-mediated induction of Cyp1a1 mRNA, protein, and catalytic activity levels.",
        "relation": "CPR:3"
    },
    {
        "id": "23423713.T17.T36",
        "sentence": "Upon co-exposure to V(5+) and TCDD, V(5+) significantly potentiated the @CHEMICAL$-mediated induction of the Cyp1a1, Cyp1a2, and @GENE$ mRNA, protein, and catalytic activity levels at 24 h. In vitro, V(5+) decreased the TCDD-mediated induction of Cyp1a1 mRNA, protein, and catalytic activity levels.",
        "relation": "CPR:3"
    },
    {
        "id": "23423713.T19.T37",
        "sentence": "Upon co-exposure to V(5+) and TCDD, V(5+) significantly potentiated the TCDD-mediated induction of the Cyp1a1, Cyp1a2, and Cyp1b1 mRNA, protein, and catalytic activity levels at 24 h. In vitro, @CHEMICAL$ decreased the TCDD-mediated induction of @GENE$ mRNA, protein, and catalytic activity levels.",
        "relation": "CPR:4"
    },
    {
        "id": "23423713.T20.T37",
        "sentence": "Upon co-exposure to V(5+) and TCDD, V(5+) significantly potentiated the TCDD-mediated induction of the Cyp1a1, Cyp1a2, and Cyp1b1 mRNA, protein, and catalytic activity levels at 24 h. In vitro, V(5+) decreased the @CHEMICAL$-mediated induction of @GENE$ mRNA, protein, and catalytic activity levels.",
        "relation": "CPR:3"
    },
    {
        "id": "23423713.T21.T39",
        "sentence": "Furthermore, @CHEMICAL$ significantly inhibited the TCDD-induced @GENE$-dependent luciferase activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23423713.T22.T39",
        "sentence": "Furthermore, V(5+) significantly inhibited the @CHEMICAL$-induced @GENE$-dependent luciferase activity.",
        "relation": "CPR:3"
    },
    {
        "id": "23423713.T1.T24",
        "sentence": "@CHEMICAL$ also increased @GENE$ (Hb) levels in animals treated for 24 h.",
        "relation": "CPR:3"
    },
    {
        "id": "23423713.T1.T25",
        "sentence": "@CHEMICAL$ also increased serum hemoglobin (@GENE$) levels in animals treated for 24 h.",
        "relation": "CPR:3"
    },
    {
        "id": "23423713.T2.T27",
        "sentence": "Upon treatment of isolated hepatocytes with Hb alone or in the presence of @CHEMICAL$, there was an increase in the @GENE$-dependent luciferase activity.",
        "relation": "CPR:3"
    },
    {
        "id": "8600944.T11.T18",
        "sentence": "@CHEMICAL$ therapy results in reduced mRNA expression of @GENE$ (IL-4) and IL-5 in cells from bronchoalveolar lavage (BAL) but not of IFN-gamma.",
        "relation": "CPR:4"
    },
    {
        "id": "8600944.T11.T22",
        "sentence": "@CHEMICAL$ therapy results in reduced mRNA expression of interleukin-4 (@GENE$) and IL-5 in cells from bronchoalveolar lavage (BAL) but not of IFN-gamma.",
        "relation": "CPR:4"
    },
    {
        "id": "8600944.T11.T25",
        "sentence": "@CHEMICAL$ therapy results in reduced mRNA expression of interleukin-4 (IL-4) and @GENE$ in cells from bronchoalveolar lavage (BAL) but not of IFN-gamma.",
        "relation": "CPR:4"
    },
    {
        "id": "8600944.T7.T29",
        "sentence": "In vitro studies with blood-derived T cells, however, show inhibition of all three @CHEMICAL$ by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "8600944.T9.T30",
        "sentence": "@CHEMICAL$ (DEX) inhibited the anti-@GENE$-induced production of IL-4, IL-5 and IFN-gamma in all 20 clones tested.",
        "relation": "CPR:4"
    },
    {
        "id": "8600944.T9.T31",
        "sentence": "@CHEMICAL$ (DEX) inhibited the anti-CD3-induced production of @GENE$, IL-5 and IFN-gamma in all 20 clones tested.",
        "relation": "CPR:4"
    },
    {
        "id": "8600944.T9.T32",
        "sentence": "@CHEMICAL$ (DEX) inhibited the anti-CD3-induced production of IL-4, @GENE$ and IFN-gamma in all 20 clones tested.",
        "relation": "CPR:4"
    },
    {
        "id": "8600944.T9.T33",
        "sentence": "@CHEMICAL$ (DEX) inhibited the anti-CD3-induced production of IL-4, IL-5 and @GENE$ in all 20 clones tested.",
        "relation": "CPR:4"
    },
    {
        "id": "8600944.T10.T30",
        "sentence": "Dexamethasone (@CHEMICAL$) inhibited the anti-@GENE$-induced production of IL-4, IL-5 and IFN-gamma in all 20 clones tested.",
        "relation": "CPR:4"
    },
    {
        "id": "8600944.T10.T31",
        "sentence": "Dexamethasone (@CHEMICAL$) inhibited the anti-CD3-induced production of @GENE$, IL-5 and IFN-gamma in all 20 clones tested.",
        "relation": "CPR:4"
    },
    {
        "id": "8600944.T10.T32",
        "sentence": "Dexamethasone (@CHEMICAL$) inhibited the anti-CD3-induced production of IL-4, @GENE$ and IFN-gamma in all 20 clones tested.",
        "relation": "CPR:4"
    },
    {
        "id": "8600944.T10.T33",
        "sentence": "Dexamethasone (@CHEMICAL$) inhibited the anti-CD3-induced production of IL-4, IL-5 and @GENE$ in all 20 clones tested.",
        "relation": "CPR:4"
    },
    {
        "id": "8600944.T12.T37",
        "sentence": "@CHEMICAL$ enhanced the ratio @GENE$/IL-4 (mean +/- SEM: control, 28.7 +/- 17.6; with 10-7 M DEX, 55.0 +/- 27.5, P<0.005).",
        "relation": "CPR:3"
    },
    {
        "id": "8600944.T12.T38",
        "sentence": "@CHEMICAL$ enhanced the ratio IFN-gamma/@GENE$ (mean +/- SEM: control, 28.7 +/- 17.6; with 10-7 M DEX, 55.0 +/- 27.5, P<0.005).",
        "relation": "CPR:3"
    },
    {
        "id": "8600944.T1.T16",
        "sentence": "Interestingly, two categories of clones were distinguished based on the effects of GCS on IL-2 production and IL-2R alpha expression and proliferation; 1) In low IL-2 producers DEX blocked IL-2 production and decreased IL-2R alpha expression and proliferation; 2) In high IL-2 producers @CHEMICAL$ inhibited @GENE$ production partially and enhanced IL-2R alpha expression and proliferation.",
        "relation": "CPR:4"
    },
    {
        "id": "8600944.T1.T17",
        "sentence": "Interestingly, two categories of clones were distinguished based on the effects of GCS on IL-2 production and IL-2R alpha expression and proliferation; 1) In low IL-2 producers DEX blocked IL-2 production and decreased IL-2R alpha expression and proliferation; 2) In high IL-2 producers @CHEMICAL$ inhibited IL-2 production partially and enhanced @GENE$ expression and proliferation.",
        "relation": "CPR:3"
    },
    {
        "id": "8600944.T14.T42",
        "sentence": "Interestingly, two categories of clones were distinguished based on the effects of GCS on IL-2 production and IL-2R alpha expression and proliferation; 1) In low IL-2 producers @CHEMICAL$ blocked @GENE$ production and decreased IL-2R alpha expression and proliferation; 2) In high IL-2 producers DEX inhibited IL-2 production partially and enhanced IL-2R alpha expression and proliferation.",
        "relation": "CPR:4"
    },
    {
        "id": "8600944.T14.T43",
        "sentence": "Interestingly, two categories of clones were distinguished based on the effects of GCS on IL-2 production and IL-2R alpha expression and proliferation; 1) In low IL-2 producers @CHEMICAL$ blocked IL-2 production and decreased @GENE$ expression and proliferation; 2) In high IL-2 producers DEX inhibited IL-2 production partially and enhanced IL-2R alpha expression and proliferation.",
        "relation": "CPR:4"
    },
    {
        "id": "8600944.T3.T23",
        "sentence": "In conclusion, the production of @CHEMICAL$ and IL-5 by T-cell clones (derived either from BAL or blood) was more sensitive to inhibition by @GENE$ than that of IFN-gamma, which may account for the therapeutic effects of glucocorticosteroids in patients with asthma.",
        "relation": "CPR:4"
    },
    {
        "id": "8600944.T3.T24",
        "sentence": "In conclusion, the production of IL-4 and @CHEMICAL$ by T-cell clones (derived either from BAL or blood) was more sensitive to inhibition by @GENE$ than that of IFN-gamma, which may account for the therapeutic effects of glucocorticosteroids in patients with asthma.",
        "relation": "CPR:4"
    },
    {
        "id": "8600944.T3.T26",
        "sentence": "In conclusion, the production of IL-4 and IL-5 by T-cell clones (derived either from BAL or blood) was more sensitive to inhibition by @CHEMICAL$ than that of @GENE$, which may account for the therapeutic effects of glucocorticosteroids in patients with asthma.",
        "relation": "CPR:4"
    },
    {
        "id": "23519392.T10.T23",
        "sentence": "Pregnane X Receptor Mediates Dyslipidemia Induced by the @CHEMICAL$ Inhibitor @GENE$ in Mice.",
        "relation": "CPR:4"
    },
    {
        "id": "23519392.T5.T18",
        "sentence": "In the present study, we identified @CHEMICAL$, a widely used HIV PI, as a potent @GENE$-selective agonist.",
        "relation": "CPR:5"
    },
    {
        "id": "23519392.T7.T20",
        "sentence": "@CHEMICAL$ efficiently activated @GENE$ and induced PXR target gene expression in vitro and in vivo.",
        "relation": "CPR:3"
    },
    {
        "id": "23519392.T7.T21",
        "sentence": "@CHEMICAL$ efficiently activated PXR and induced @GENE$ target gene expression in vitro and in vivo.",
        "relation": "CPR:3"
    },
    {
        "id": "23519392.T3.T13",
        "sentence": "@CHEMICAL$-mediated @GENE$ activation stimulated the expression of several key intestinal genes involved in lipid homeostasis.",
        "relation": "CPR:3"
    },
    {
        "id": "22718571.T13.T20",
        "sentence": "Anti-diabetic Activity of Swertiamarin is due to an Active Metabolite, @CHEMICAL$, that Upregulates @GENE$ Gene Expression in 3T3-L1 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "22718571.T6.T16",
        "sentence": "@CHEMICAL$ treatment had no significant effect on adipogenesis, or the mRNA expression of PPAR-g and GLUT-4; however, there was a significant increase in the mRNA expression of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "22718571.T8.T17",
        "sentence": "On the other hand, treatment with @CHEMICAL$ significantly increased adipogenesis, which was associated with a significant increase in the mRNA expression of @GENE$, GLUT-4 and adiponectin.",
        "relation": "CPR:3"
    },
    {
        "id": "22718571.T8.T18",
        "sentence": "On the other hand, treatment with @CHEMICAL$ significantly increased adipogenesis, which was associated with a significant increase in the mRNA expression of PPAR-g, @GENE$ and adiponectin.",
        "relation": "CPR:3"
    },
    {
        "id": "22718571.T8.T19",
        "sentence": "On the other hand, treatment with @CHEMICAL$ significantly increased adipogenesis, which was associated with a significant increase in the mRNA expression of PPAR-g, GLUT-4 and @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23261645.T10.T14",
        "sentence": "@CHEMICAL$ also inhibited other channels including @GENE$, Cav3.2, and HCN2; however, the Kv11.1 (hERG) channel was minimally affected.",
        "relation": "CPR:4"
    },
    {
        "id": "23261645.T10.T15",
        "sentence": "@CHEMICAL$ also inhibited other channels including Cav1.2, @GENE$, and HCN2; however, the Kv11.1 (hERG) channel was minimally affected.",
        "relation": "CPR:4"
    },
    {
        "id": "23261645.T10.T16",
        "sentence": "@CHEMICAL$ also inhibited other channels including Cav1.2, Cav3.2, and @GENE$; however, the Kv11.1 (hERG) channel was minimally affected.",
        "relation": "CPR:4"
    },
    {
        "id": "15732037.T1.T20",
        "sentence": "Treatment with @CHEMICAL$ reversed both protein and mRNA of @GENE$, VEGF, BNP, and NGF-beta to the baseline values.",
        "relation": "CPR:4"
    },
    {
        "id": "15732037.T1.T21",
        "sentence": "Treatment with @CHEMICAL$ reversed both protein and mRNA of HIF-1alpha, @GENE$, BNP, and NGF-beta to the baseline values.",
        "relation": "CPR:4"
    },
    {
        "id": "15732037.T1.T22",
        "sentence": "Treatment with @CHEMICAL$ reversed both protein and mRNA of HIF-1alpha, VEGF, @GENE$, and NGF-beta to the baseline values.",
        "relation": "CPR:4"
    },
    {
        "id": "15732037.T1.T23",
        "sentence": "Treatment with @CHEMICAL$ reversed both protein and mRNA of HIF-1alpha, VEGF, BNP, and @GENE$ to the baseline values.",
        "relation": "CPR:3"
    },
    {
        "id": "15732037.T2.T24",
        "sentence": "Increased immunohistochemical labeling of @CHEMICAL$, VEGF, and BNP in the ventricular myocardium was observed in the shunt group and @GENE$ again normalized the labeling.",
        "relation": "CPR:4"
    },
    {
        "id": "15732037.T2.T25",
        "sentence": "Increased immunohistochemical labeling of HIF-1alpha, @CHEMICAL$, and BNP in the ventricular myocardium was observed in the shunt group and @GENE$ again normalized the labeling.",
        "relation": "CPR:4"
    },
    {
        "id": "15732037.T2.T26",
        "sentence": "Increased immunohistochemical labeling of HIF-1alpha, VEGF, and @CHEMICAL$ in the ventricular myocardium was observed in the shunt group and @GENE$ again normalized the labeling.",
        "relation": "CPR:4"
    },
    {
        "id": "15732037.T3.T29",
        "sentence": "Treatment with @CHEMICAL$ is associated with a reversal of abnormal regulation of @GENE$ and VEGF in the failing ventricular myocardium.",
        "relation": "CPR:4"
    },
    {
        "id": "15732037.T3.T30",
        "sentence": "Treatment with @CHEMICAL$ is associated with a reversal of abnormal regulation of HIF-1alpha and @GENE$ in the failing ventricular myocardium.",
        "relation": "CPR:4"
    },
    {
        "id": "17588737.T1.T16",
        "sentence": "These effects were fully counteracted by dietary @CHEMICAL$ which inhibited ROS overproduction and GSH consumption, rendered the reactive transcription of glutathione-associated enzymes unnecessary and blocked the intracellular signals leading to the overexpression and rearrangement of @GENE$ signalling molecule.",
        "relation": "CPR:4"
    },
    {
        "id": "17499824.T21.T32",
        "sentence": "The enzyme requires PLP and divalent cations such as Ca(2+), Mg(2+), or Mn(2+), but not ATP, whereas mammalian @CHEMICAL$ activity is increased by @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "17308037.T7.T39",
        "sentence": "In kidneys, stimulation of adenylyl cyclase causes egress of cAMP, conversion of cAMP to AMP by ecto-phosphodiesterase, and metabolism of @CHEMICAL$ to adenosine by @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17308037.T8.T39",
        "sentence": "In kidneys, stimulation of adenylyl cyclase causes egress of cAMP, conversion of cAMP to AMP by ecto-phosphodiesterase, and metabolism of AMP to @CHEMICAL$ by @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17308037.T19.T25",
        "sentence": "In kidneys, stimulation of adenylyl cyclase causes egress of cAMP, conversion of @CHEMICAL$ to AMP by ecto-@GENE$, and metabolism of AMP to adenosine by ecto-5'-nucleotidase.",
        "relation": "CPR:9"
    },
    {
        "id": "17308037.T22.T25",
        "sentence": "In kidneys, stimulation of adenylyl cyclase causes egress of cAMP, conversion of cAMP to @CHEMICAL$ by ecto-@GENE$, and metabolism of AMP to adenosine by ecto-5'-nucleotidase.",
        "relation": "CPR:9"
    },
    {
        "id": "17308037.T17.T55",
        "sentence": "A broad-spectrum @CHEMICAL$ (PDE) inhibitor (@GENE$, 300 microM, n=6) and an ecto-phosphodiesterase inhibitor (1,3-dipropyl-8-p-sulfophenylxanthine, 1 mM, n=6) significantly attenuated cAMP-induced AMP secretion by 60 and 74%, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "17308037.T17.T56",
        "sentence": "A broad-spectrum phosphodiesterase (@CHEMICAL$) inhibitor (@GENE$, 300 microM, n=6) and an ecto-phosphodiesterase inhibitor (1,3-dipropyl-8-p-sulfophenylxanthine, 1 mM, n=6) significantly attenuated cAMP-induced AMP secretion by 60 and 74%, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "17308037.T1.T26",
        "sentence": "Blockade of PDE1 (8-methoxymethyl-3-isobutyl-1-methylxanthine, 100 microM), PDE2 [erythro-9-(2-hydroxy-3-nonyl)adenine, 30 microM], @CHEMICAL$ (@GENE$, 10 microM; cGMP, 10 microM), PDE4 (Ro 20-1724 [4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one], 100 microM), PDE5 and PDE6 (zaprinast, 30 microM), and PDE7 [BRL-50481 (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity.",
        "relation": "CPR:4"
    },
    {
        "id": "17308037.T2.T27",
        "sentence": "Blockade of PDE1 (8-methoxymethyl-3-isobutyl-1-methylxanthine, 100 microM), PDE2 [erythro-9-(2-hydroxy-3-nonyl)adenine, 30 microM], PDE3 (milrinone, 10 microM; cGMP, 10 microM), @CHEMICAL$ (Ro 20-1724 [@GENE$], 100 microM), PDE5 and PDE6 (zaprinast, 30 microM), and PDE7 [BRL-50481 (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity.",
        "relation": "CPR:4"
    },
    {
        "id": "17308037.T3.T29",
        "sentence": "Blockade of PDE1 (8-methoxymethyl-3-isobutyl-1-methylxanthine, 100 microM), PDE2 [erythro-9-(2-hydroxy-3-nonyl)adenine, 30 microM], PDE3 (milrinone, 10 microM; cGMP, 10 microM), PDE4 (Ro 20-1724 [4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one], 100 microM), PDE5 and @CHEMICAL$ (@GENE$, 30 microM), and PDE7 [BRL-50481 (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity.",
        "relation": "CPR:4"
    },
    {
        "id": "17308037.T3.T28",
        "sentence": "Blockade of PDE1 (8-methoxymethyl-3-isobutyl-1-methylxanthine, 100 microM), PDE2 [erythro-9-(2-hydroxy-3-nonyl)adenine, 30 microM], PDE3 (milrinone, 10 microM; cGMP, 10 microM), PDE4 (Ro 20-1724 [4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one], 100 microM), @CHEMICAL$ and PDE6 (@GENE$, 30 microM), and PDE7 [BRL-50481 (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity.",
        "relation": "CPR:4"
    },
    {
        "id": "17308037.T4.T30",
        "sentence": "Blockade of PDE1 (8-methoxymethyl-3-isobutyl-1-methylxanthine, 100 microM), PDE2 [erythro-9-(2-hydroxy-3-nonyl)adenine, 30 microM], PDE3 (milrinone, 10 microM; cGMP, 10 microM), PDE4 (Ro 20-1724 [4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one], 100 microM), PDE5 and PDE6 (zaprinast, 30 microM), and @CHEMICAL$ [@GENE$ (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity.",
        "relation": "CPR:4"
    },
    {
        "id": "17308037.T5.T30",
        "sentence": "Blockade of PDE1 (8-methoxymethyl-3-isobutyl-1-methylxanthine, 100 microM), PDE2 [erythro-9-(2-hydroxy-3-nonyl)adenine, 30 microM], PDE3 (milrinone, 10 microM; cGMP, 10 microM), PDE4 (Ro 20-1724 [4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one], 100 microM), PDE5 and PDE6 (zaprinast, 30 microM), and @CHEMICAL$ [BRL-50481 (@GENE$), 10 microM] did not alter renal ecto-phosphodiesterase activity.",
        "relation": "CPR:4"
    },
    {
        "id": "17308037.T23.T57",
        "sentence": "Blockade of @CHEMICAL$ (@GENE$, 100 microM), PDE2 [erythro-9-(2-hydroxy-3-nonyl)adenine, 30 microM], PDE3 (milrinone, 10 microM; cGMP, 10 microM), PDE4 (Ro 20-1724 [4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one], 100 microM), PDE5 and PDE6 (zaprinast, 30 microM), and PDE7 [BRL-50481 (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity.",
        "relation": "CPR:4"
    },
    {
        "id": "17308037.T24.T58",
        "sentence": "Blockade of PDE1 (8-methoxymethyl-3-isobutyl-1-methylxanthine, 100 microM), @CHEMICAL$ [@GENE$, 30 microM], PDE3 (milrinone, 10 microM; cGMP, 10 microM), PDE4 (Ro 20-1724 [4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one], 100 microM), PDE5 and PDE6 (zaprinast, 30 microM), and PDE7 [BRL-50481 (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity.",
        "relation": "CPR:4"
    },
    {
        "id": "17308037.T6.T32",
        "sentence": "Administration of a concentration (100 microM) of @CHEMICAL$ that blocks @GENE$ inhibited ecto-phosphodiesterase activity (by 44%).",
        "relation": "CPR:4"
    },
    {
        "id": "17308037.T6.T33",
        "sentence": "Administration of a concentration (100 microM) of @CHEMICAL$ that blocks PDE8 inhibited ecto-@GENE$ activity (by 44%).",
        "relation": "CPR:4"
    },
    {
        "id": "17308037.T9.T34",
        "sentence": "However, a lower concentration of @CHEMICAL$ (3 microM) that blocks @GENE$, PDE10, and PDE11, but not PDE8, did not inhibit ecto-phosphodiesterase activity.",
        "relation": "CPR:4"
    },
    {
        "id": "17308037.T9.T35",
        "sentence": "However, a lower concentration of @CHEMICAL$ (3 microM) that blocks PDE9, @GENE$, and PDE11, but not PDE8, did not inhibit ecto-phosphodiesterase activity.",
        "relation": "CPR:4"
    },
    {
        "id": "17308037.T9.T36",
        "sentence": "However, a lower concentration of @CHEMICAL$ (3 microM) that blocks PDE9, PDE10, and @GENE$, but not PDE8, did not inhibit ecto-phosphodiesterase activity.",
        "relation": "CPR:4"
    },
    {
        "id": "17308037.T10.T40",
        "sentence": "These data support the conclusion that renal ecto-@CHEMICAL$ activity is not mediated by PDE1, PDE2, PDE3, PDE4, PDE5, PDE6, PDE7, PDE9, PDE10, or PDE11 and is inhibited by high concentrations of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "19389876.T1.T18",
        "sentence": "@CHEMICAL$ is an endothelin type A (ET(A))-selective receptor antagonist that is metabolized primarily by glucuronidation but also undergoes oxidative metabolism by @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "19389876.T1.T19",
        "sentence": "@CHEMICAL$ is an @GENE$ antagonist that is metabolized primarily by glucuronidation but also undergoes oxidative metabolism by CYP3A4.",
        "relation": "CPR:6"
    },
    {
        "id": "19389876.T4.T20",
        "sentence": "The potential for @CHEMICAL$, the archetypal strong inhibitor of @GENE$, to alter the pharmacokinetic profile of ambrisentan and its oxidative metabolite, 4-hydroxymethyl ambrisentan, was assessed in an open-label, nonrandomized, 2-period, single-sequence study in 16 healthy men.",
        "relation": "CPR:4"
    },
    {
        "id": "19389876.T14.T17",
        "sentence": "In summary, @CHEMICAL$ had no clinically significant effect on the pharmacokinetics or safety profile of ambrisentan; therefore, no changes in ambrisentan dose should be necessary when the drug is administered concomitantly with known @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23414340.T31.T52",
        "sentence": "Although @CHEMICAL$ (GSTO1) and arsenic methyltransferase have been shown or thought to catalyze @GENE$ reduction, their role in DMAs(V) reduction in vivo, or in cell extracts is uncertain.",
        "relation": "CPR:9"
    },
    {
        "id": "23414340.T31.T54",
        "sentence": "Although glutathione S-transferase omega 1 (GSTO1) and @CHEMICAL$ have been shown or thought to catalyze @GENE$ reduction, their role in DMAs(V) reduction in vivo, or in cell extracts is uncertain.",
        "relation": "CPR:9"
    },
    {
        "id": "23414340.T9.T47",
        "sentence": "Pretreatment of rats with glutathione (GSH) depletors (phorone or BSO) delayed the elimination of DMAs(V) and the accumulation of RBC-bound DMAs, whereas the indirect @CHEMICAL$ inhibitor periodate-oxidized @GENE$ was without effect.",
        "relation": "CPR:4"
    },
    {
        "id": "23414340.T17.T48",
        "sentence": "Although @CHEMICAL$ (TRR) inhibitors (@GENE$ and Sb(III)) inhibited cytosolic DMAs(V) reduction, recombinant rat TRR plus NADPH, alone or when added to the cytosol, failed to support DMAs(V) reduction.",
        "relation": "CPR:4"
    },
    {
        "id": "23414340.T17.T49",
        "sentence": "Although thioredoxin reductase (@CHEMICAL$) inhibitors (@GENE$ and Sb(III)) inhibited cytosolic DMAs(V) reduction, recombinant rat TRR plus NADPH, alone or when added to the cytosol, failed to support DMAs(V) reduction.",
        "relation": "CPR:4"
    },
    {
        "id": "23414340.T18.T48",
        "sentence": "Although @CHEMICAL$ (TRR) inhibitors (aurothioglucose and @GENE$) inhibited cytosolic DMAs(V) reduction, recombinant rat TRR plus NADPH, alone or when added to the cytosol, failed to support DMAs(V) reduction.",
        "relation": "CPR:4"
    },
    {
        "id": "23414340.T18.T49",
        "sentence": "Although thioredoxin reductase (@CHEMICAL$) inhibitors (aurothioglucose and @GENE$) inhibited cytosolic DMAs(V) reduction, recombinant rat TRR plus NADPH, alone or when added to the cytosol, failed to support DMAs(V) reduction.",
        "relation": "CPR:4"
    },
    {
        "id": "10480573.T2.T13",
        "sentence": "The @CHEMICAL$ activity of EGFR was little inhibited by @GENE$ in a cell-free system.",
        "relation": "CPR:4"
    },
    {
        "id": "10480573.T2.T9",
        "sentence": "The kinase activity of @CHEMICAL$ was little inhibited by @GENE$ in a cell-free system.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T10.T38",
        "sentence": "@CHEMICAL$ (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and @GENE$ VEGFR/PDGFR in tumor vasculature. Activating mutations in Ras and B-RAF were identified in several human cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T10.T39",
        "sentence": "@CHEMICAL$ (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases @GENE$/PDGFR in tumor vasculature. Activating mutations in Ras and B-RAF were identified in several human cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T10.T40",
        "sentence": "@CHEMICAL$ (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/@GENE$ in tumor vasculature. Activating mutations in Ras and B-RAF were identified in several human cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T10.T41",
        "sentence": "@CHEMICAL$ (BAY 43-9006, Nexavar), a dual-action inhibitor that targets @GENE$/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature. Activating mutations in Ras and B-RAF were identified in several human cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T10.T42",
        "sentence": "@CHEMICAL$ (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/@GENE$/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature. Activating mutations in Ras and B-RAF were identified in several human cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T10.T43",
        "sentence": "@CHEMICAL$ (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/@GENE$ pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature. Activating mutations in Ras and B-RAF were identified in several human cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T12.T38",
        "sentence": "Sorafenib (@CHEMICAL$, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and @GENE$ VEGFR/PDGFR in tumor vasculature. Activating mutations in Ras and B-RAF were identified in several human cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T12.T39",
        "sentence": "Sorafenib (@CHEMICAL$, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases @GENE$/PDGFR in tumor vasculature. Activating mutations in Ras and B-RAF were identified in several human cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T12.T40",
        "sentence": "Sorafenib (@CHEMICAL$, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/@GENE$ in tumor vasculature. Activating mutations in Ras and B-RAF were identified in several human cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T12.T41",
        "sentence": "Sorafenib (@CHEMICAL$, Nexavar), a dual-action inhibitor that targets @GENE$/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature. Activating mutations in Ras and B-RAF were identified in several human cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T12.T42",
        "sentence": "Sorafenib (@CHEMICAL$, Nexavar), a dual-action inhibitor that targets RAF/@GENE$/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature. Activating mutations in Ras and B-RAF were identified in several human cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T12.T43",
        "sentence": "Sorafenib (@CHEMICAL$, Nexavar), a dual-action inhibitor that targets RAF/MEK/@GENE$ pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature. Activating mutations in Ras and B-RAF were identified in several human cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T13.T38",
        "sentence": "Sorafenib (BAY 43-9006, @CHEMICAL$), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and @GENE$ VEGFR/PDGFR in tumor vasculature. Activating mutations in Ras and B-RAF were identified in several human cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T13.T39",
        "sentence": "Sorafenib (BAY 43-9006, @CHEMICAL$), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases @GENE$/PDGFR in tumor vasculature. Activating mutations in Ras and B-RAF were identified in several human cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T13.T40",
        "sentence": "Sorafenib (BAY 43-9006, @CHEMICAL$), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/@GENE$ in tumor vasculature. Activating mutations in Ras and B-RAF were identified in several human cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T13.T41",
        "sentence": "Sorafenib (BAY 43-9006, @CHEMICAL$), a dual-action inhibitor that targets @GENE$/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature. Activating mutations in Ras and B-RAF were identified in several human cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T13.T42",
        "sentence": "Sorafenib (BAY 43-9006, @CHEMICAL$), a dual-action inhibitor that targets RAF/@GENE$/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature. Activating mutations in Ras and B-RAF were identified in several human cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T13.T43",
        "sentence": "Sorafenib (BAY 43-9006, @CHEMICAL$), a dual-action inhibitor that targets RAF/MEK/@GENE$ pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature. Activating mutations in Ras and B-RAF were identified in several human cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T5.T31",
        "sentence": "A novel class of @CHEMICAL$ that inhibits C-RAF @GENE$ was discovered using a combination of medicinal and combinatorial chemistry approaches.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T5.T30",
        "sentence": "A novel class of @CHEMICAL$ that inhibits @GENE$ kinase was discovered using a combination of medicinal and combinatorial chemistry approaches.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T9.T32",
        "sentence": "@CHEMICAL$ inhibited the @GENE$ activity of both C-RAF and B-RAF (wild type and V600E mutant).",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T9.T35",
        "sentence": "@CHEMICAL$ inhibited the kinase activity of both C-RAF and B-RAF (wild type and @GENE$ mutant).",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T9.T33",
        "sentence": "@CHEMICAL$ inhibited the kinase activity of both @GENE$ and B-RAF (wild type and V600E mutant).",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T9.T34",
        "sentence": "@CHEMICAL$ inhibited the kinase activity of both C-RAF and @GENE$ (wild type and V600E mutant).",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T2.T15",
        "sentence": "Further characterization of @CHEMICAL$ revealed that this molecule was a multikinase inhibitor that targeted the @GENE$ family (VEGFR-2 and VEGFR-3) and platelet-derived growth factor receptor family (PDGFR-beta and Kit), which play key roles in tumor progression and angiogenesis.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T2.T18",
        "sentence": "Further characterization of @CHEMICAL$ revealed that this molecule was a multikinase inhibitor that targeted the vascular endothelial growth factor receptor family (VEGFR-2 and VEGFR-3) and @GENE$ family (PDGFR-beta and Kit), which play key roles in tumor progression and angiogenesis.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T2.T16",
        "sentence": "Further characterization of @CHEMICAL$ revealed that this molecule was a multikinase inhibitor that targeted the vascular endothelial growth factor receptor family (@GENE$ and VEGFR-3) and platelet-derived growth factor receptor family (PDGFR-beta and Kit), which play key roles in tumor progression and angiogenesis.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T2.T17",
        "sentence": "Further characterization of @CHEMICAL$ revealed that this molecule was a multikinase inhibitor that targeted the vascular endothelial growth factor receptor family (VEGFR-2 and @GENE$) and platelet-derived growth factor receptor family (PDGFR-beta and Kit), which play key roles in tumor progression and angiogenesis.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T2.T19",
        "sentence": "Further characterization of @CHEMICAL$ revealed that this molecule was a multikinase inhibitor that targeted the vascular endothelial growth factor receptor family (VEGFR-2 and VEGFR-3) and platelet-derived growth factor receptor family (@GENE$ and Kit), which play key roles in tumor progression and angiogenesis.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T2.T20",
        "sentence": "Further characterization of @CHEMICAL$ revealed that this molecule was a multikinase inhibitor that targeted the vascular endothelial growth factor receptor family (VEGFR-2 and VEGFR-3) and platelet-derived growth factor receptor family (PDGFR-beta and @GENE$), which play key roles in tumor progression and angiogenesis.",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T3.T22",
        "sentence": "Thus, @CHEMICAL$ may inhibit tumor growth by a dual mechanism, acting either directly on the tumor (through inhibition of @GENE$ and Kit signaling) and/or on tumor angiogenesis (through inhibition of VEGFR and PDGFR signaling).",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T3.T24",
        "sentence": "Thus, @CHEMICAL$ may inhibit tumor growth by a dual mechanism, acting either directly on the tumor (through inhibition of Raf and Kit signaling) and/or on tumor angiogenesis (through inhibition of @GENE$ and PDGFR signaling).",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T3.T25",
        "sentence": "Thus, @CHEMICAL$ may inhibit tumor growth by a dual mechanism, acting either directly on the tumor (through inhibition of Raf and Kit signaling) and/or on tumor angiogenesis (through inhibition of VEGFR and @GENE$ signaling).",
        "relation": "CPR:4"
    },
    {
        "id": "16757355.T3.T23",
        "sentence": "Thus, @CHEMICAL$ may inhibit tumor growth by a dual mechanism, acting either directly on the tumor (through inhibition of Raf and @GENE$ signaling) and/or on tumor angiogenesis (through inhibition of VEGFR and PDGFR signaling).",
        "relation": "CPR:4"
    },
    {
        "id": "23619386.T7.T17",
        "sentence": "@CHEMICAL$ inhibits @GENE$ and selected peptidase activities of the catalytic core proteasome at low micromolar concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "23619386.T7.T18",
        "sentence": "@CHEMICAL$ inhibits proteinase and selected @GENE$ activities of the catalytic core proteasome at low micromolar concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "23619386.T7.T19",
        "sentence": "@CHEMICAL$ inhibits proteinase and selected peptidase activities of the catalytic core @GENE$ at low micromolar concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "14507109.T8.T52",
        "sentence": "Ten IU/mL urokinase was also incubated with pooled plasma of stroke patients, that was previously oxidized with the @CHEMICAL$ (1O2) donor chloramine T (CT), to destroy @GENE$ and alpha2-antiplasmin.",
        "relation": "CPR:4"
    },
    {
        "id": "14507109.T9.T52",
        "sentence": "Ten IU/mL urokinase was also incubated with pooled plasma of stroke patients, that was previously oxidized with the singlet oxygen (@CHEMICAL$) donor chloramine T (CT), to destroy @GENE$ and alpha2-antiplasmin.",
        "relation": "CPR:4"
    },
    {
        "id": "14507109.T10.T52",
        "sentence": "Ten IU/mL urokinase was also incubated with pooled plasma of stroke patients, that was previously oxidized with the singlet oxygen (1O2) donor @CHEMICAL$ (CT), to destroy @GENE$ and alpha2-antiplasmin.",
        "relation": "CPR:4"
    },
    {
        "id": "14507109.T10.T53",
        "sentence": "Ten IU/mL urokinase was also incubated with pooled plasma of stroke patients, that was previously oxidized with the singlet oxygen (1O2) donor @CHEMICAL$ (CT), to destroy plasmatic PAI-1 and alpha2-anti@GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "14507109.T11.T52",
        "sentence": "Ten IU/mL urokinase was also incubated with pooled plasma of stroke patients, that was previously oxidized with the singlet oxygen (1O2) donor chloramine T (@CHEMICAL$), to destroy @GENE$ and alpha2-antiplasmin.",
        "relation": "CPR:4"
    },
    {
        "id": "14507109.T11.T53",
        "sentence": "Ten IU/mL urokinase was also incubated with pooled plasma of stroke patients, that was previously oxidized with the singlet oxygen (1O2) donor chloramine T (@CHEMICAL$), to destroy plasmatic PAI-1 and alpha2-anti@GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "14507109.T2.T13",
        "sentence": "For determination of @CHEMICAL$ activity, 10 microL thereof was incubated with 150 microL 1.5 M @GENE$, pH 8.7, and 100 microL 20 mM CT preoxidized (15 minutes 37 degrees C) pooled normal citrate buffered EDTA-plasma for 30 minutes (37 degrees C).",
        "relation": "CPR:9"
    },
    {
        "id": "14507109.T6.T14",
        "sentence": "For determination of [@CHEMICAL$+Pli]-activity, @GENE$ was added after this incubation. 25-microL 6 mM Val-Leu-Lys-pNA were added and deltaA/h at room temperature (RT) was monitored, using a microtiterplate reader. [PA+Pli]-Pli = PA.",
        "relation": "CPR:9"
    },
    {
        "id": "14507109.T6.T15",
        "sentence": "For determination of [PA+@CHEMICAL$]-activity, @GENE$ was added after this incubation. 25-microL 6 mM Val-Leu-Lys-pNA were added and deltaA/h at room temperature (RT) was monitored, using a microtiterplate reader. [PA+Pli]-Pli = PA.",
        "relation": "CPR:9"
    },
    {
        "id": "23291559.T1.T16",
        "sentence": "KCNK1, a member of the family of two-pore @CHEMICAL$, is specifically induced in the livers of male mice after @GENE$ treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "23291559.T1.T10",
        "sentence": "@CHEMICAL$, a member of the family of two-pore K(+) ion channels, is specifically induced in the livers of male mice after @GENE$ treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "23291559.T2.T12",
        "sentence": "Here, we have determined the molecular mechanism of this male-specific activation of the @CHEMICAL$ gene and characterized KCNK1 as a @GENE$-inducible antihyperplasia factor.",
        "relation": "CPR:3"
    },
    {
        "id": "23291559.T2.T13",
        "sentence": "Here, we have determined the molecular mechanism of this male-specific activation of the Kcnk1 gene and characterized @CHEMICAL$ as a @GENE$-inducible antihyperplasia factor.",
        "relation": "CPR:3"
    },
    {
        "id": "23291559.T3.T14",
        "sentence": "Upon activation by @CHEMICAL$, @GENE$ CAR binds the 97-bp response element (-2441/-2345) within the Kcnk1 promoter.",
        "relation": "CPR:3"
    },
    {
        "id": "23291559.T3.T15",
        "sentence": "Upon activation by @CHEMICAL$, nuclear receptor @GENE$ binds the 97-bp response element (-2441/-2345) within the Kcnk1 promoter.",
        "relation": "CPR:3"
    },
    {
        "id": "23291559.T7.T21",
        "sentence": "These results indicate that @CHEMICAL$ treatment induces @GENE$ to elicit a male-specific and growth-suppressing signal.",
        "relation": "CPR:3"
    },
    {
        "id": "23623751.T1.T21",
        "sentence": "@CHEMICAL$, an inhibitor of @GENE$ (DAT and NET, respectively), is a standard treatment for ADHD.",
        "relation": "CPR:4"
    },
    {
        "id": "23623751.T1.T24",
        "sentence": "@CHEMICAL$, an inhibitor of dopamine and norepinephrine transporters (@GENE$ and NET, respectively), is a standard treatment for ADHD.",
        "relation": "CPR:4"
    },
    {
        "id": "23623751.T1.T25",
        "sentence": "@CHEMICAL$, an inhibitor of dopamine and norepinephrine transporters (DAT and @GENE$, respectively), is a standard treatment for ADHD.",
        "relation": "CPR:4"
    },
    {
        "id": "23623751.T3.T17",
        "sentence": "@CHEMICAL$ increased @GENE$ Vmax in SHR mPFC and decreased DAT Vmax in WKY OFC.",
        "relation": "CPR:3"
    },
    {
        "id": "23623751.T3.T18",
        "sentence": "@CHEMICAL$ increased DAT Vmax in SHR mPFC and decreased @GENE$ Vmax in WKY OFC.",
        "relation": "CPR:4"
    },
    {
        "id": "23623751.T4.T19",
        "sentence": "Also, @CHEMICAL$ decreased @GENE$ Km in WIS OFC.",
        "relation": "CPR:4"
    },
    {
        "id": "23623751.T9.T23",
        "sentence": "Thus, the increase in mPFC @CHEMICAL$ function was an SHR-specific long term consequence of @GENE$ treatment during adolescence, which may be responsible for the treatment-induced alterations in behavior including the observed increases in cocaine self-administration.",
        "relation": "CPR:3"
    },
    {
        "id": "10340919.T24.T31",
        "sentence": "OBJECTIVE: To evaluate the extent of human cyclooxygenase-1 (COX-1) inhibition by @CHEMICAL$, which has been reported to preferentially inhibit @GENE$ (COX-2).",
        "relation": "CPR:4"
    },
    {
        "id": "10340919.T24.T32",
        "sentence": "OBJECTIVE: To evaluate the extent of human cyclooxygenase-1 (COX-1) inhibition by @CHEMICAL$, which has been reported to preferentially inhibit cyclooxygenase-2 (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "10340919.T24.T37",
        "sentence": "OBJECTIVE: To evaluate the extent of @CHEMICAL$ (COX-1) inhibition by @GENE$, which has been reported to preferentially inhibit cyclooxygenase-2 (COX-2).",
        "relation": "CPR:4"
    },
    {
        "id": "10340919.T24.T38",
        "sentence": "OBJECTIVE: To evaluate the extent of human cyclooxygenase-1 (@CHEMICAL$) inhibition by @GENE$, which has been reported to preferentially inhibit cyclooxygenase-2 (COX-2).",
        "relation": "CPR:4"
    },
    {
        "id": "10340919.T12.T35",
        "sentence": "The effects of @CHEMICAL$ were compared with those of diclofenac, a nonselective @GENE$ inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "10340919.T13.T35",
        "sentence": "The effects of meloxicam were compared with those of @CHEMICAL$, a nonselective @GENE$ inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "10340919.T16.T36",
        "sentence": "METHODS: @CHEMICAL$ inhibition was determined by measuring thromboxane B2 (TXB2)-generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg @GENE$ and 75 mg diclofenac and at steady state (15 mg meloxicam daily and 150 mg diclofenac daily).",
        "relation": "CPR:4"
    },
    {
        "id": "10340919.T17.T36",
        "sentence": "METHODS: @CHEMICAL$ inhibition was determined by measuring thromboxane B2 (TXB2)-generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg meloxicam and 75 mg @GENE$ and at steady state (15 mg meloxicam daily and 150 mg diclofenac daily).",
        "relation": "CPR:4"
    },
    {
        "id": "10340919.T18.T36",
        "sentence": "METHODS: @CHEMICAL$ inhibition was determined by measuring thromboxane B2 (TXB2)-generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg meloxicam and 75 mg diclofenac and at steady state (15 mg @GENE$ daily and 150 mg diclofenac daily).",
        "relation": "CPR:4"
    },
    {
        "id": "10340919.T19.T36",
        "sentence": "METHODS: @CHEMICAL$ inhibition was determined by measuring thromboxane B2 (TXB2)-generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg meloxicam and 75 mg diclofenac and at steady state (15 mg meloxicam daily and 150 mg @GENE$ daily).",
        "relation": "CPR:4"
    },
    {
        "id": "10340919.T11.T33",
        "sentence": "Thus our data suggest that the @CHEMICAL$ preference of @GENE$ observed in vitro may not result in clinical advantages when the higher dose of 15 mg is needed.",
        "relation": "CPR:4"
    },
    {
        "id": "23454149.T13.T22",
        "sentence": "Inhibition of angiogenesis and invasion by @CHEMICAL$ is mediated by downregulation of VEGF and MMP-9 through @GENE$ pathway in MDA-MB-231 breast cancer cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23454149.T13.T23",
        "sentence": "Inhibition of angiogenesis and invasion by @CHEMICAL$ is mediated by downregulation of @GENE$ and MMP-9 through Akt pathway in MDA-MB-231 breast cancer cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23454149.T13.T24",
        "sentence": "Inhibition of angiogenesis and invasion by @CHEMICAL$ is mediated by downregulation of VEGF and @GENE$ through Akt pathway in MDA-MB-231 breast cancer cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23454149.T11.T17",
        "sentence": "Gelatin zymography showed that @CHEMICAL$ inhibited secretion and activity of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23454149.T12.T18",
        "sentence": "Western blotting demonstrated that @CHEMICAL$ effectively suppressed the expression of @GENE$, p-VEGFR-2, p-EGFR, and p-Akt.",
        "relation": "CPR:4"
    },
    {
        "id": "23454149.T12.T21",
        "sentence": "Western blotting demonstrated that @CHEMICAL$ effectively suppressed the expression of VEGF, p-VEGFR-2, p-EGFR, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23454149.T12.T19",
        "sentence": "Western blotting demonstrated that @CHEMICAL$ effectively suppressed the expression of VEGF, @GENE$, p-EGFR, and p-Akt.",
        "relation": "CPR:4"
    },
    {
        "id": "23454149.T12.T20",
        "sentence": "Western blotting demonstrated that @CHEMICAL$ effectively suppressed the expression of VEGF, p-VEGFR-2, @GENE$, and p-Akt.",
        "relation": "CPR:4"
    },
    {
        "id": "23454149.T1.T14",
        "sentence": "These results suggested that @CHEMICAL$ could inhibit invasion and angiogenesis by downregulation of @GENE$and MMP-9, resulting from the inhibition of Akt pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23454149.T1.T16",
        "sentence": "These results suggested that @CHEMICAL$ could inhibit invasion and angiogenesis by downregulation of VEGFand MMP-9, resulting from the inhibition of @GENE$ pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23454149.T1.T15",
        "sentence": "These results suggested that @CHEMICAL$ could inhibit invasion and angiogenesis by downregulation of VEGFand @GENE$, resulting from the inhibition of Akt pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "16365052.T4.T9",
        "sentence": "Expression of @CHEMICAL$ (L-PK) is upregulated in the liver by dietary @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "16365052.T4.T12",
        "sentence": "Expression of L-type pyruvate kinase (@CHEMICAL$) is upregulated in the liver by dietary @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "10690753.T18.T37",
        "sentence": "@CHEMICAL$ block of recombinant @GENE$: selectivity for the NR2B subunit.",
        "relation": "CPR:4"
    },
    {
        "id": "10690753.T18.T38",
        "sentence": "@CHEMICAL$ block of recombinant N-methyl-D-aspartate receptors: selectivity for the @GENE$ subunit.",
        "relation": "CPR:4"
    },
    {
        "id": "10690753.T8.T26",
        "sentence": "The anticonvulsant @CHEMICAL$ blocks N-methyl-D-asparate (NMDA) receptors but fails to exhibit the neurobehavioral toxicity characteristic of other @GENE$ antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "10690753.T8.T29",
        "sentence": "The anticonvulsant @CHEMICAL$ blocks @GENE$ but fails to exhibit the neurobehavioral toxicity characteristic of other NMDA receptor antagonists.",
        "relation": "CPR:4"
    },
    {
        "id": "10690753.T10.T28",
        "sentence": "To investigate the possibility that felbamate's favorable toxicity profile could be related to NMDA receptor subtype selectivity, we examined the specificity of @CHEMICAL$ block of recombinant @GENE$ composed of the NR1a subunit and various NR2 subunits.",
        "relation": "CPR:4"
    },
    {
        "id": "10690753.T10.T31",
        "sentence": "To investigate the possibility that felbamate's favorable toxicity profile could be related to NMDA receptor subtype selectivity, we examined the specificity of @CHEMICAL$ block of recombinant NMDA receptors composed of the NR1a subunit and various @GENE$ subunits.",
        "relation": "CPR:4"
    },
    {
        "id": "10690753.T10.T30",
        "sentence": "To investigate the possibility that felbamate's favorable toxicity profile could be related to NMDA receptor subtype selectivity, we examined the specificity of @CHEMICAL$ block of recombinant NMDA receptors composed of the @GENE$ subunit and various NR2 subunits.",
        "relation": "CPR:4"
    },
    {
        "id": "10690753.T13.T32",
        "sentence": "@CHEMICAL$ produced a rapid, concentration-dependent block of currents evoked by 50 microM NMDA and 10 microM glycine in human embryonic kidney 293 cells expressing the @GENE$ subunit, and either the NR2A, NR2B or NR2C subunits; the IC50 values for block were 2.6, 0.52 and 2.4 mM, respectively (holding potential, - 60 mV).",
        "relation": "CPR:4"
    },
    {
        "id": "10690753.T13.T33",
        "sentence": "@CHEMICAL$ produced a rapid, concentration-dependent block of currents evoked by 50 microM NMDA and 10 microM glycine in human embryonic kidney 293 cells expressing the rat NR1a subunit, and either the @GENE$, NR2B or NR2C subunits; the IC50 values for block were 2.6, 0.52 and 2.4 mM, respectively (holding potential, - 60 mV).",
        "relation": "CPR:4"
    },
    {
        "id": "10690753.T13.T34",
        "sentence": "@CHEMICAL$ produced a rapid, concentration-dependent block of currents evoked by 50 microM NMDA and 10 microM glycine in human embryonic kidney 293 cells expressing the rat NR1a subunit, and either the NR2A, @GENE$ or NR2C subunits; the IC50 values for block were 2.6, 0.52 and 2.4 mM, respectively (holding potential, - 60 mV).",
        "relation": "CPR:4"
    },
    {
        "id": "10690753.T13.T35",
        "sentence": "@CHEMICAL$ produced a rapid, concentration-dependent block of currents evoked by 50 microM NMDA and 10 microM glycine in human embryonic kidney 293 cells expressing the rat NR1a subunit, and either the NR2A, NR2B or @GENE$ subunits; the IC50 values for block were 2.6, 0.52 and 2.4 mM, respectively (holding potential, - 60 mV).",
        "relation": "CPR:4"
    },
    {
        "id": "10690753.T1.T20",
        "sentence": "The higher affinity of @CHEMICAL$ block of @GENE$ containing the NR2B subunit could be accounted for by more rapid association and slower dissociation from these sites.",
        "relation": "CPR:4"
    },
    {
        "id": "10690753.T1.T21",
        "sentence": "The higher affinity of @CHEMICAL$ block of NMDA receptors containing the @GENE$ subunit could be accounted for by more rapid association and slower dissociation from these sites.",
        "relation": "CPR:4"
    },
    {
        "id": "10690753.T3.T22",
        "sentence": "We conclude that @CHEMICAL$ exhibits modest selectivity for @GENE$ composed of NR1a/NR2B subunits.",
        "relation": "CPR:4"
    },
    {
        "id": "10690753.T3.T23",
        "sentence": "We conclude that @CHEMICAL$ exhibits modest selectivity for NMDA receptors composed of @GENE$/NR2B subunits.",
        "relation": "CPR:4"
    },
    {
        "id": "10690753.T3.T24",
        "sentence": "We conclude that @CHEMICAL$ exhibits modest selectivity for NMDA receptors composed of NR1a/@GENE$ subunits.",
        "relation": "CPR:4"
    },
    {
        "id": "10690753.T5.T25",
        "sentence": "This selectivity could, in part, account for the more favorable clinical profile of @CHEMICAL$ in comparison with @GENE$ antagonists that do not show subunit selectivity.",
        "relation": "CPR:6"
    },
    {
        "id": "23532634.T1.T28",
        "sentence": "In four (10 %) patients the peak @CHEMICAL$-stimulated @GENE$ values were lower than 18 mg/dL. When the test repeated after attainment of euthyroidism, all of the patients had normal cortisol response.",
        "relation": "CPR:9"
    },
    {
        "id": "23532634.T6.T30",
        "sentence": "@CHEMICAL$-stimulated peak @GENE$, delta cortisol, and delta DHEA-S levels are decreased during hyperthyroidism, probably due to increased turnover.",
        "relation": "CPR:9"
    },
    {
        "id": "23532634.T7.T30",
        "sentence": "@CHEMICAL$-stimulated peak cortisol, @GENE$, and delta DHEA-S levels are decreased during hyperthyroidism, probably due to increased turnover.",
        "relation": "CPR:9"
    },
    {
        "id": "23532634.T8.T30",
        "sentence": "@CHEMICAL$-stimulated peak cortisol, delta cortisol, and @GENE$-S levels are decreased during hyperthyroidism, probably due to increased turnover.",
        "relation": "CPR:9"
    },
    {
        "id": "10999950.T9.T34",
        "sentence": "Previously, we showed that the @CHEMICAL$ (hkor) stably expressed in Chinese hamster ovary (CHO) cells underwent down-regulation after prolonged @GENE$ treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "10999950.T9.T38",
        "sentence": "Previously, we showed that the human kappa-opioid receptor (@CHEMICAL$) stably expressed in Chinese hamster ovary (CHO) cells underwent down-regulation after prolonged @GENE$ treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "10999950.T10.T33",
        "sentence": "@CHEMICAL$ caused a significant down-regulation of the @GENE$, although etorphine did not.",
        "relation": "CPR:4"
    },
    {
        "id": "10999950.T14.T41",
        "sentence": "Expression of the dominant negative mutants arrestin-2(319-418) or dynamin I-K44A significantly reduced @CHEMICAL$-induced down-regulation of the @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "10999950.T15.T45",
        "sentence": "Coexpression of GRK2 or GRK2 and arrestin-2 permitted @CHEMICAL$ to induce down-regulation of the @GENE$, although expression of arrestin-2 or dynamin I alone did not.",
        "relation": "CPR:4"
    },
    {
        "id": "10999950.T16.T49",
        "sentence": "Expression of the dominant negative mutants rab5A-@CHEMICAL$ or rab7-N125I blunted @GENE$-induced down-regulation.",
        "relation": "CPR:4"
    },
    {
        "id": "10999950.T16.T50",
        "sentence": "Expression of the dominant negative mutants rab5A-N133I or @CHEMICAL$-N125I blunted @GENE$-induced down-regulation.",
        "relation": "CPR:4"
    },
    {
        "id": "10999950.T16.T51",
        "sentence": "Expression of the dominant negative mutants rab5A-N133I or rab7-@CHEMICAL$ blunted @GENE$-induced down-regulation.",
        "relation": "CPR:4"
    },
    {
        "id": "10999950.T16.T48",
        "sentence": "Expression of the dominant negative mutants @CHEMICAL$-N133I or rab7-N125I blunted @GENE$-induced down-regulation.",
        "relation": "CPR:4"
    },
    {
        "id": "10999950.T2.T18",
        "sentence": "Pretreatment with lysosomal enzyme inhibitors [(2S, 3S)trans-epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester or chloroquine] or proteasome inhibitors (@CHEMICAL$ inhibitor I, @GENE$, or lactacystin) decreased the extent of U50,488H-induced down-regulation.",
        "relation": "CPR:4"
    },
    {
        "id": "10999950.T3.T18",
        "sentence": "Pretreatment with lysosomal enzyme inhibitors [(2S, 3S)trans-epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester or chloroquine] or proteasome inhibitors (@CHEMICAL$ inhibitor I, MG-132, or @GENE$) decreased the extent of U50,488H-induced down-regulation.",
        "relation": "CPR:4"
    },
    {
        "id": "10999950.T7.T20",
        "sentence": "These results indicate that @CHEMICAL$-induced down-regulation of the @GENE$ involves GRK-, arrestin-2-, dynamin-, rab5-, and rab7-dependent mechanisms and receptors seem to be trafficked to lysosomes and proteasomes for degradation.",
        "relation": "CPR:4"
    },
    {
        "id": "10999950.T8.T27",
        "sentence": "Thus, @CHEMICAL$-induced internalization and down-regulation of the @GENE$ share initial common mechanisms.",
        "relation": "CPR:4"
    },
    {
        "id": "23313557.T1.T14",
        "sentence": "In Alexander cells, only when they were transfected with FXR+RXR, @CHEMICAL$ caused up-regulation of @GENE$ and OSTb, and a down-regulation of CYP27A1.",
        "relation": "CPR:3"
    },
    {
        "id": "23313557.T1.T15",
        "sentence": "In Alexander cells, only when they were transfected with FXR+RXR, @CHEMICAL$ caused up-regulation of SHP and @GENE$, and a down-regulation of CYP27A1.",
        "relation": "CPR:3"
    },
    {
        "id": "23313557.T1.T16",
        "sentence": "In Alexander cells, only when they were transfected with FXR+RXR, @CHEMICAL$ caused up-regulation of SHP and OSTb, and a down-regulation of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23313557.T5.T21",
        "sentence": "Moreover, GCs have a synergistic effect on @CHEMICAL$-induced @GENE$ activation, whereas chenodeoxycholate and GW4064 have an additive effect.",
        "relation": "CPR:3"
    },
    {
        "id": "10947967.T8.T21",
        "sentence": "Kinetic parameters for @CHEMICAL$ inactivation by @GENE$ were obtained by using both the conventional dilution assay method and the more complex progress curve method.",
        "relation": "CPR:4"
    },
    {
        "id": "10947967.T3.T11",
        "sentence": "Stereochemical studies established that @CHEMICAL$ inactivation by @GENE$ is stereospecific with respect to the moiety at the P(2) position, which is consistent with previous results with substrates and reversible inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "10947967.T4.T13",
        "sentence": "In contrast, @CHEMICAL$, which is a competitive inhibitor with respect to ascorbate, exhibits a low degree of stereospecificity in binding to the ascorbate sites of both @GENE$ and dopamine-beta-hydroxylase.",
        "relation": "CPR:4"
    },
    {
        "id": "10947967.T4.T14",
        "sentence": "In contrast, @CHEMICAL$, which is a competitive inhibitor with respect to ascorbate, exhibits a low degree of stereospecificity in binding to the ascorbate sites of both PAM and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23530018.T11.T30",
        "sentence": "Five classes of chalcogenopyrylium dyes (CGPs) were examined for their ability to modulate transport of @CHEMICAL$ (E217bG) (a prototypical @GENE$ substrate) into MRP-enriched inside-out membrane vesicles.",
        "relation": "CPR:9"
    },
    {
        "id": "23530018.T12.T30",
        "sentence": "Five classes of chalcogenopyrylium dyes (CGPs) were examined for their ability to modulate transport of [(3)H]estradiol glucuronide (@CHEMICAL$) (a prototypical @GENE$ substrate) into MRP-enriched inside-out membrane vesicles.",
        "relation": "CPR:9"
    },
    {
        "id": "23530018.T15.T32",
        "sentence": "Sixteen of 34 @CHEMICAL$ inhibited @GENE$-mediated E217bG uptake by >50% (IC50's 0.7-7.6 mM).",
        "relation": "CPR:4"
    },
    {
        "id": "23530018.T17.T32",
        "sentence": "Sixteen of 34 CGPs inhibited @CHEMICAL$-mediated @GENE$ uptake by >50% (IC50's 0.7-7.6 mM).",
        "relation": "CPR:9"
    },
    {
        "id": "23530018.T19.T33",
        "sentence": "Of 9 CGPs with IC50's <2 mM, two belonged to Class I, two to Class III and five to Class V. When tested in the intact cells, only 4 of 16 @CHEMICAL$ (at 10 mM) inhibited @GENE$-mediated calcein efflux by >50% (III-1, V-3, -4, -6) while a fifth (I-5) inhibited efflux by just 23%.",
        "relation": "CPR:4"
    },
    {
        "id": "23530018.T20.T33",
        "sentence": "Of 9 CGPs with IC50's <2 mM, two belonged to Class I, two to Class III and five to Class V. When tested in the intact cells, only 4 of 16 CGPs (at 10 mM) inhibited @CHEMICAL$-mediated @GENE$ efflux by >50% (III-1, V-3, -4, -6) while a fifth (I-5) inhibited efflux by just 23%.",
        "relation": "CPR:9"
    },
    {
        "id": "23530018.T21.T34",
        "sentence": "These five @CHEMICAL$ also inhibited [(3)H]E217bG uptake by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23530018.T22.T34",
        "sentence": "These five CGPs also inhibited @CHEMICAL$ uptake by @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "12244038.T17.T68",
        "sentence": "@CHEMICAL$, a lipid-lowering drug, inhibits the induction of @GENE$ in human astrocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "12244038.T18.T68",
        "sentence": "Gemfibrozil, a lipid-lowering drug, inhibits the induction of @CHEM-GENE$ in human astrocytes.",
        "relation": "CPR:9"
    },
    {
        "id": "12244038.T1.T56",
        "sentence": "@CHEMICAL$, a lipid-lowering drug, inhibited @GENE$-induced production of NO and the expression of inducible nitric-oxide synthase (iNOS) in human U373MG astroglial cells and primary astrocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "12244038.T1.T20",
        "sentence": "@CHEMICAL$, a lipid-lowering drug, inhibited cytokine-induced production of NO and the expression of @GENE$ (iNOS) in human U373MG astroglial cells and primary astrocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "12244038.T1.T29",
        "sentence": "@CHEMICAL$, a lipid-lowering drug, inhibited cytokine-induced production of NO and the expression of inducible nitric-oxide synthase (@GENE$) in human U373MG astroglial cells and primary astrocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "12244038.T2.T20",
        "sentence": "Gemfibrozil, a lipid-lowering drug, inhibited cytokine-induced production of NO and the expression of @CHEM-GENE$ (iNOS) in human U373MG astroglial cells and primary astrocytes.",
        "relation": "CPR:9"
    },
    {
        "id": "12244038.T2.T29",
        "sentence": "Gemfibrozil, a lipid-lowering drug, inhibited cytokine-induced production of NO and the expression of inducible @CHEMICAL$ synthase (@GENE$) in human U373MG astroglial cells and primary astrocytes.",
        "relation": "CPR:9"
    },
    {
        "id": "12244038.T14.T20",
        "sentence": "Gemfibrozil, a lipid-lowering drug, inhibited cytokine-induced production of @CHEMICAL$ and the expression of @GENE$ (iNOS) in human U373MG astroglial cells and primary astrocytes.",
        "relation": "CPR:9"
    },
    {
        "id": "12244038.T14.T29",
        "sentence": "Gemfibrozil, a lipid-lowering drug, inhibited cytokine-induced production of @CHEMICAL$ and the expression of inducible nitric-oxide synthase (@GENE$) in human U373MG astroglial cells and primary astrocytes.",
        "relation": "CPR:9"
    },
    {
        "id": "12244038.T6.T53",
        "sentence": "Similar to @CHEMICAL$, clofibrate, another fibrate drug, also inhibited the expression of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12244038.T8.T53",
        "sentence": "Similar to gemfibrozil, @CHEMICAL$, another fibrate drug, also inhibited the expression of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12244038.T9.T53",
        "sentence": "Similar to gemfibrozil, clofibrate, another @CHEMICAL$ drug, also inhibited the expression of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12244038.T10.T54",
        "sentence": "Inhibition of @CHEMICAL$-driven luciferase activity by @GENE$ in cytokine-stimulated U373MG astroglial cells suggests that this compound inhibits the transcription of iNOS.",
        "relation": "CPR:4"
    },
    {
        "id": "12244038.T10.T57",
        "sentence": "Inhibition of human iNOS promoter-driven luciferase activity by @CHEMICAL$ in cytokine-stimulated U373MG astroglial cells suggests that this compound inhibits the transcription of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12244038.T11.T58",
        "sentence": "Since @CHEMICAL$ is known to activate @GENE$ (PPAR-alpha), we investigated the role of PPAR-alpha in gemfibrozil-mediated inhibition of iNOS.",
        "relation": "CPR:3"
    },
    {
        "id": "12244038.T11.T59",
        "sentence": "Since @CHEMICAL$ is known to activate peroxisome proliferator-activated receptor-alpha (@GENE$), we investigated the role of PPAR-alpha in gemfibrozil-mediated inhibition of iNOS.",
        "relation": "CPR:3"
    },
    {
        "id": "12244038.T12.T60",
        "sentence": "Since gemfibrozil is known to activate peroxisome proliferator-activated receptor-alpha (PPAR-alpha), we investigated the role of @CHEMICAL$ in @GENE$-mediated inhibition of iNOS.",
        "relation": "CPR:3"
    },
    {
        "id": "12244038.T12.T61",
        "sentence": "Since gemfibrozil is known to activate peroxisome proliferator-activated receptor-alpha (PPAR-alpha), we investigated the role of PPAR-alpha in @CHEMICAL$-mediated inhibition of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12244038.T13.T62",
        "sentence": "@CHEMICAL$ induced @GENE$ (PPRE)-dependent luciferase activity, which was inhibited by the expression of DeltahPPAR-alpha, the dominant-negative mutant of human PPAR-alpha.",
        "relation": "CPR:3"
    },
    {
        "id": "12244038.T13.T63",
        "sentence": "@CHEMICAL$ induced peroxisome proliferator-responsive element (@GENE$)-dependent luciferase activity, which was inhibited by the expression of DeltahPPAR-alpha, the dominant-negative mutant of human PPAR-alpha.",
        "relation": "CPR:3"
    },
    {
        "id": "12244038.T15.T67",
        "sentence": "However, DeltahPPAR-alpha was unable to abrogate @CHEMICAL$-mediated inhibition of @GENE$ suggesting that gemfibrozil inhibits iNOS independent of PPAR-alpha.",
        "relation": "CPR:4"
    },
    {
        "id": "12244038.T16.T19",
        "sentence": "However, DeltahPPAR-alpha was unable to abrogate gemfibrozil-mediated inhibition of iNOS suggesting that @CHEMICAL$ inhibits @GENE$ independent of PPAR-alpha.",
        "relation": "CPR:4"
    },
    {
        "id": "12244038.T4.T45",
        "sentence": "Interestingly, @CHEMICAL$ strongly inhibited the activation of @GENE$, AP-1, and C/EBPbeta but not that of GAS in cytokine-stimulated astroglial cells.",
        "relation": "CPR:4"
    },
    {
        "id": "12244038.T4.T46",
        "sentence": "Interestingly, @CHEMICAL$ strongly inhibited the activation of NF-kappaB, @GENE$, and C/EBPbeta but not that of GAS in cytokine-stimulated astroglial cells.",
        "relation": "CPR:4"
    },
    {
        "id": "12244038.T4.T47",
        "sentence": "Interestingly, @CHEMICAL$ strongly inhibited the activation of NF-kappaB, AP-1, and @GENE$ but not that of GAS in cytokine-stimulated astroglial cells.",
        "relation": "CPR:4"
    },
    {
        "id": "12244038.T5.T50",
        "sentence": "These results suggest that @CHEMICAL$ inhibits the induction of iNOS probably by inhibiting the activation of @GENE$, AP-1, and C/EBPbeta and that gemfibrozil, a prescribed drug for humans, may further find its therapeutic use in neuroinflammatory diseases.",
        "relation": "CPR:4"
    },
    {
        "id": "12244038.T5.T49",
        "sentence": "These results suggest that @CHEMICAL$ inhibits the induction of @GENE$ probably by inhibiting the activation of NF-kappaB, AP-1, and C/EBPbeta and that gemfibrozil, a prescribed drug for humans, may further find its therapeutic use in neuroinflammatory diseases.",
        "relation": "CPR:4"
    },
    {
        "id": "12244038.T5.T51",
        "sentence": "These results suggest that @CHEMICAL$ inhibits the induction of iNOS probably by inhibiting the activation of NF-kappaB, @GENE$, and C/EBPbeta and that gemfibrozil, a prescribed drug for humans, may further find its therapeutic use in neuroinflammatory diseases.",
        "relation": "CPR:4"
    },
    {
        "id": "12244038.T5.T52",
        "sentence": "These results suggest that @CHEMICAL$ inhibits the induction of iNOS probably by inhibiting the activation of NF-kappaB, AP-1, and @GENE$ and that gemfibrozil, a prescribed drug for humans, may further find its therapeutic use in neuroinflammatory diseases.",
        "relation": "CPR:4"
    },
    {
        "id": "17692748.T6.T15",
        "sentence": "OBJECTIVES: The aim of this study was to determine whether cocaine's sympathomimetic actions can be reversed by a potent centrally acting @CHEMICAL$ (AR) agonist (@GENE$).",
        "relation": "CPR:5"
    },
    {
        "id": "17692748.T6.T17",
        "sentence": "OBJECTIVES: The aim of this study was to determine whether cocaine's sympathomimetic actions can be reversed by a potent centrally acting alpha2 adrenergic receptor (@CHEMICAL$) agonist (@GENE$).",
        "relation": "CPR:5"
    },
    {
        "id": "15465035.T18.T29",
        "sentence": "The inhibitory effect of @CHEMICAL$ on @GENE$ activation is not dependent on nitric oxide-soluble guanylyl cyclase pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "15465035.T11.T23",
        "sentence": "We demonstrate that among the three nitrates, only @CHEMICAL$ inhibits @GENE$ activation in response to hypoxia.",
        "relation": "CPR:4"
    },
    {
        "id": "15465035.T14.T26",
        "sentence": "@CHEMICAL$ inhibits the accumulation of HIF-1alpha, the regulatory subunit of @GENE$, and the transcriptional activation of HIF-1alpha via a mechanism that is not dependent on either NO or soluble guanylate cyclase.",
        "relation": "CPR:4"
    },
    {
        "id": "15465035.T14.T25",
        "sentence": "@CHEMICAL$ inhibits the accumulation of @GENE$, the regulatory subunit of HIF-1, and the transcriptional activation of HIF-1alpha via a mechanism that is not dependent on either NO or soluble guanylate cyclase.",
        "relation": "CPR:4"
    },
    {
        "id": "15465035.T14.T27",
        "sentence": "@CHEMICAL$ inhibits the accumulation of HIF-1alpha, the regulatory subunit of HIF-1, and the transcriptional activation of @GENE$ via a mechanism that is not dependent on either NO or soluble guanylate cyclase.",
        "relation": "CPR:4"
    },
    {
        "id": "11430635.T14.T39",
        "sentence": "@CHEMICAL$ activates @GENE$ and antagonizes the effect of the specific carbonic anhydrase inhibitor acetazolamide, by a direct mechanism of action.",
        "relation": "CPR:3"
    },
    {
        "id": "11430635.T14.T40",
        "sentence": "@CHEMICAL$ activates carbonic anhydrase and antagonizes the effect of the specific @GENE$ inhibitor acetazolamide, by a direct mechanism of action.",
        "relation": "CPR:3"
    },
    {
        "id": "11430635.T15.T39",
        "sentence": "Indomethacin activates @CHEMICAL$ and antagonizes the effect of the specific carbonic anhydrase inhibitor @GENE$, by a direct mechanism of action.",
        "relation": "CPR:4"
    },
    {
        "id": "11430635.T15.T40",
        "sentence": "Indomethacin activates carbonic anhydrase and antagonizes the effect of the specific @CHEMICAL$ inhibitor @GENE$, by a direct mechanism of action.",
        "relation": "CPR:4"
    },
    {
        "id": "11430635.T9.T31",
        "sentence": "RESULTS: @CHEMICAL$, in vitro and in vivo. induces an increase in erythorcyte @GENE$ and CA II activity.",
        "relation": "CPR:3"
    },
    {
        "id": "11430635.T9.T32",
        "sentence": "RESULTS: @CHEMICAL$, in vitro and in vivo. induces an increase in erythorcyte CA I and @GENE$ activity.",
        "relation": "CPR:3"
    },
    {
        "id": "11430635.T10.T33",
        "sentence": "@CHEMICAL$, a specific inhibitor of @GENE$, reduces the activity of CA I and CA II from red cells.",
        "relation": "CPR:4"
    },
    {
        "id": "11430635.T10.T34",
        "sentence": "@CHEMICAL$, a specific inhibitor of CA, reduces the activity of @GENE$ and CA II from red cells.",
        "relation": "CPR:4"
    },
    {
        "id": "11430635.T10.T35",
        "sentence": "@CHEMICAL$, a specific inhibitor of CA, reduces the activity of CA I and @GENE$ from red cells.",
        "relation": "CPR:4"
    },
    {
        "id": "11430635.T12.T36",
        "sentence": "@CHEMICAL$ completely antagonizes @GENE$ activity, i.e. abolishes the inhibitory effect of acetazolamide on CA.",
        "relation": "CPR:3"
    },
    {
        "id": "11430635.T12.T37",
        "sentence": "@CHEMICAL$ completely antagonizes CA activity, i.e. abolishes the inhibitory effect of acetazolamide on @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "11430635.T13.T36",
        "sentence": "Indomethacin completely antagonizes @CHEMICAL$ activity, i.e. abolishes the inhibitory effect of @GENE$ on CA.",
        "relation": "CPR:4"
    },
    {
        "id": "11430635.T13.T37",
        "sentence": "Indomethacin completely antagonizes CA activity, i.e. abolishes the inhibitory effect of @CHEMICAL$ on @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "11430635.T1.T18",
        "sentence": "CONCLUSIONS: Our results show that @CHEMICAL$, a known @GENE$ (COX) inhibitor, is also an activator of CA.",
        "relation": "CPR:4"
    },
    {
        "id": "11430635.T1.T19",
        "sentence": "CONCLUSIONS: Our results show that @CHEMICAL$, a known cyclooxygenase (@GENE$) inhibitor, is also an activator of CA.",
        "relation": "CPR:4"
    },
    {
        "id": "11430635.T1.T20",
        "sentence": "CONCLUSIONS: Our results show that @CHEMICAL$, a known cyclooxygenase (COX) inhibitor, is also an activator of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "11430635.T2.T21",
        "sentence": "Our data also prove that @CHEMICAL$ is not only an activator of @GENE$ but also antagonizes the effect of acetazolamide, a specific inhibitor of this enzyme.",
        "relation": "CPR:3"
    },
    {
        "id": "11430635.T3.T21",
        "sentence": "Our data also prove that indomethacin is not only an activator of @CHEMICAL$ but also antagonizes the effect of @GENE$, a specific inhibitor of this enzyme.",
        "relation": "CPR:4"
    },
    {
        "id": "11430635.T5.T25",
        "sentence": "In view of the role of CA in acid-base balance as well as the fact that an increase or decrease in its activity is accompanied by an increase or decrease in intra- and extracellular pH, our results suggest that: firstly, @CHEMICAL$ activation induced by @GENE$ might cause changes in COX activity; secondly, PGs are synthetized as a consequence of the changes in COX activity, a hypothesis that requires further study.",
        "relation": "CPR:3"
    },
    {
        "id": "12871155.T1.T17",
        "sentence": "The acetylcholinesterase (@CHEMICAL$) and butyrylcholinesterase (BuChE) inhibitory activities of a series of @GENE$ (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T1.T18",
        "sentence": "The acetylcholinesterase (AChE) and @CHEMICAL$ (BuChE) inhibitory activities of a series of @GENE$ (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T1.T19",
        "sentence": "The @CHEMICAL$ (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of @GENE$ (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T1.T20",
        "sentence": "The acetylcholinesterase (AChE) and butyrylcholinesterase (@CHEMICAL$) inhibitory activities of a series of @GENE$ (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T3.T17",
        "sentence": "The acetylcholinesterase (@CHEMICAL$) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), @GENE$ (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T3.T18",
        "sentence": "The acetylcholinesterase (AChE) and @CHEMICAL$ (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), @GENE$ (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T3.T19",
        "sentence": "The @CHEMICAL$ (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), @GENE$ (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T3.T20",
        "sentence": "The acetylcholinesterase (AChE) and butyrylcholinesterase (@CHEMICAL$) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), @GENE$ (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T4.T17",
        "sentence": "The acetylcholinesterase (@CHEMICAL$) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), @GENE$ (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T4.T18",
        "sentence": "The acetylcholinesterase (AChE) and @CHEMICAL$ (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), @GENE$ (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T4.T19",
        "sentence": "The @CHEMICAL$ (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), @GENE$ (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T4.T20",
        "sentence": "The acetylcholinesterase (AChE) and butyrylcholinesterase (@CHEMICAL$) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), @GENE$ (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T5.T17",
        "sentence": "The acetylcholinesterase (@CHEMICAL$) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ @GENE$ (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T5.T18",
        "sentence": "The acetylcholinesterase (AChE) and @CHEMICAL$ (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ @GENE$ (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T5.T19",
        "sentence": "The @CHEMICAL$ (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ @GENE$ (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T5.T20",
        "sentence": "The acetylcholinesterase (AChE) and butyrylcholinesterase (@CHEMICAL$) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ @GENE$ (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T6.T17",
        "sentence": "The acetylcholinesterase (@CHEMICAL$) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), @GENE$ (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T6.T18",
        "sentence": "The acetylcholinesterase (AChE) and @CHEMICAL$ (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), @GENE$ (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T6.T19",
        "sentence": "The @CHEMICAL$ (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), @GENE$ (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T6.T20",
        "sentence": "The acetylcholinesterase (AChE) and butyrylcholinesterase (@CHEMICAL$) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), @GENE$ (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T7.T17",
        "sentence": "The acetylcholinesterase (@CHEMICAL$) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ @GENE$ (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T7.T18",
        "sentence": "The acetylcholinesterase (AChE) and @CHEMICAL$ (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ @GENE$ (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T7.T19",
        "sentence": "The @CHEMICAL$ (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ @GENE$ (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T7.T20",
        "sentence": "The acetylcholinesterase (AChE) and butyrylcholinesterase (@CHEMICAL$) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ @GENE$ (16) are described.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T14.T21",
        "sentence": "These compounds are competitive and, in a few cases, non-competitive inhibitors for @CHEMICAL$, the most potent being compound (14), though three-fold less active than @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12871155.T2.T15",
        "sentence": "The @CHEMICAL$ inhibitory activity is only significant in compounds 11 and 14, ten-fold less active than @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23643730.T19.T28",
        "sentence": "@CHEMICAL$, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of @GENE$ expression in human prostate cancer LNCaP cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23643730.T2.T20",
        "sentence": "Moreover, we found that @CHEMICAL$ significantly inhibited the expression levels of @GENE$ (AR) and prostate-specific antigen (PSA) in a dose-dependent manner, as well as abrogated up-regulation of AR and PSA genes with and/or without dihydrotestosterone (DHT).",
        "relation": "CPR:4"
    },
    {
        "id": "23643730.T2.T21",
        "sentence": "Moreover, we found that @CHEMICAL$ significantly inhibited the expression levels of androgen receptor (@GENE$) and prostate-specific antigen (PSA) in a dose-dependent manner, as well as abrogated up-regulation of AR and PSA genes with and/or without dihydrotestosterone (DHT).",
        "relation": "CPR:4"
    },
    {
        "id": "23643730.T2.T22",
        "sentence": "Moreover, we found that @CHEMICAL$ significantly inhibited the expression levels of androgen receptor (AR) and @GENE$ (PSA) in a dose-dependent manner, as well as abrogated up-regulation of AR and PSA genes with and/or without dihydrotestosterone (DHT).",
        "relation": "CPR:4"
    },
    {
        "id": "23643730.T2.T23",
        "sentence": "Moreover, we found that @CHEMICAL$ significantly inhibited the expression levels of androgen receptor (AR) and prostate-specific antigen (@GENE$) in a dose-dependent manner, as well as abrogated up-regulation of AR and PSA genes with and/or without dihydrotestosterone (DHT).",
        "relation": "CPR:4"
    },
    {
        "id": "23643730.T2.T24",
        "sentence": "Moreover, we found that @CHEMICAL$ significantly inhibited the expression levels of androgen receptor (AR) and prostate-specific antigen (PSA) in a dose-dependent manner, as well as abrogated up-regulation of @GENE$ and PSA genes with and/or without dihydrotestosterone (DHT).",
        "relation": "CPR:4"
    },
    {
        "id": "23643730.T2.T25",
        "sentence": "Moreover, we found that @CHEMICAL$ significantly inhibited the expression levels of androgen receptor (AR) and prostate-specific antigen (PSA) in a dose-dependent manner, as well as abrogated up-regulation of AR and @GENE$ genes with and/or without dihydrotestosterone (DHT).",
        "relation": "CPR:4"
    },
    {
        "id": "23643730.T7.T26",
        "sentence": "Take together, our results demonstrated that @CHEMICAL$ might induce the apoptosis in LNCaP cell via down-regulation of @GENE$ expression.",
        "relation": "CPR:4"
    },
    {
        "id": "6146346.T9.T13",
        "sentence": "@CHEMICAL$, a potent @GENE$ antagonist: effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels.",
        "relation": "CPR:6"
    },
    {
        "id": "6146346.T5.T12",
        "sentence": "The efficacy of @CHEMICAL$, a new, long acting, oral @GENE$ antagonist was compared to placebo for the treatment of allergic rhinitis and conjunctivitis during the grass pollen season of 1982.",
        "relation": "CPR:6"
    },
    {
        "id": "19370562.T13.T19",
        "sentence": "@CHEMICAL$, the first of the @GENE$ inhibitors to undergo extensive trials for this purpose, was associated with significant adverse effects including hepatotoxicity.",
        "relation": "CPR:4"
    },
    {
        "id": "19370562.T14.T20",
        "sentence": "Other @CHEMICAL$ inhibitors, including @GENE$, with superior properties in terms of specificity of action and low risk of adverse effects, have now been introduced.",
        "relation": "CPR:4"
    },
    {
        "id": "12881227.T8.T31",
        "sentence": "DBS was measured by using the pH-stat method and by using CO2-sensitive electrodes. @CHEMICAL$ (50 microM; DMA), a concentration that selectively inhibits the @GENE$ isoforms NHE1 and NHE2, but not NHE3, did not affect DBS.",
        "relation": "CPR:4"
    },
    {
        "id": "12881227.T8.T32",
        "sentence": "DBS was measured by using the pH-stat method and by using CO2-sensitive electrodes. @CHEMICAL$ (50 microM; DMA), a concentration that selectively inhibits the NHE isoforms @GENE$ and NHE2, but not NHE3, did not affect DBS.",
        "relation": "CPR:4"
    },
    {
        "id": "12881227.T8.T33",
        "sentence": "DBS was measured by using the pH-stat method and by using CO2-sensitive electrodes. @CHEMICAL$ (50 microM; DMA), a concentration that selectively inhibits the NHE isoforms NHE1 and @GENE$, but not NHE3, did not affect DBS.",
        "relation": "CPR:4"
    },
    {
        "id": "12881227.T8.T34",
        "sentence": "DBS was measured by using the pH-stat method and by using CO2-sensitive electrodes. @CHEMICAL$ (50 microM; DMA), a concentration that selectively inhibits the NHE isoforms NHE1 and NHE2, but not @GENE$, did not affect DBS.",
        "relation": "CPR:4"
    },
    {
        "id": "12881227.T9.T31",
        "sentence": "DBS was measured by using the pH-stat method and by using CO2-sensitive electrodes. 5-(N,N-dimethyl)-amiloride (50 microM; @CHEMICAL$), a concentration that selectively inhibits the @GENE$ isoforms NHE1 and NHE2, but not NHE3, did not affect DBS.",
        "relation": "CPR:4"
    },
    {
        "id": "12881227.T9.T32",
        "sentence": "DBS was measured by using the pH-stat method and by using CO2-sensitive electrodes. 5-(N,N-dimethyl)-amiloride (50 microM; @CHEMICAL$), a concentration that selectively inhibits the NHE isoforms @GENE$ and NHE2, but not NHE3, did not affect DBS.",
        "relation": "CPR:4"
    },
    {
        "id": "12881227.T9.T33",
        "sentence": "DBS was measured by using the pH-stat method and by using CO2-sensitive electrodes. 5-(N,N-dimethyl)-amiloride (50 microM; @CHEMICAL$), a concentration that selectively inhibits the NHE isoforms NHE1 and @GENE$, but not NHE3, did not affect DBS.",
        "relation": "CPR:4"
    },
    {
        "id": "12881227.T9.T34",
        "sentence": "DBS was measured by using the pH-stat method and by using CO2-sensitive electrodes. 5-(N,N-dimethyl)-amiloride (50 microM; @CHEMICAL$), a concentration that selectively inhibits the NHE isoforms NHE1 and NHE2, but not @GENE$, did not affect DBS.",
        "relation": "CPR:4"
    },
    {
        "id": "12881227.T11.T36",
        "sentence": "Nevertheless, 3 mM @CHEMICAL$, a higher concentration that inhibits @GENE$, NHE2, and NHE3, significantly increased DBS.",
        "relation": "CPR:4"
    },
    {
        "id": "12881227.T11.T37",
        "sentence": "Nevertheless, 3 mM @CHEMICAL$, a higher concentration that inhibits NHE1, @GENE$, and NHE3, significantly increased DBS.",
        "relation": "CPR:4"
    },
    {
        "id": "12881227.T11.T38",
        "sentence": "Nevertheless, 3 mM @CHEMICAL$, a higher concentration that inhibits NHE1, NHE2, and @GENE$, significantly increased DBS.",
        "relation": "CPR:4"
    },
    {
        "id": "12881227.T13.T39",
        "sentence": "Moreover, @CHEMICAL$ and S3226, both specific inhibitors of @GENE$ only, or perfusion with Na+-free solutions, dose dependently increased DBS, as measured by pH-stat and CO2-sensitive electrode, without affecting intracellular pH. Coperfusion with 0.1 microM indomethacin, 0.5 mM DIDS, or 1 mM methazolamide did not affect S3226-induced DBS.",
        "relation": "CPR:4"
    },
    {
        "id": "12881227.T14.T39",
        "sentence": "Moreover, S1611 and @CHEMICAL$, both specific inhibitors of @GENE$ only, or perfusion with Na+-free solutions, dose dependently increased DBS, as measured by pH-stat and CO2-sensitive electrode, without affecting intracellular pH. Coperfusion with 0.1 microM indomethacin, 0.5 mM DIDS, or 1 mM methazolamide did not affect S3226-induced DBS.",
        "relation": "CPR:4"
    },
    {
        "id": "12881227.T20.T41",
        "sentence": "Nevertheless, coperfusion with 0.1 and 0.3 mM @CHEMICAL$, which inhibits the @GENE$ (CFTR), dose dependently inhibited S3226-induced DBS.",
        "relation": "CPR:4"
    },
    {
        "id": "12881227.T20.T42",
        "sentence": "Nevertheless, coperfusion with 0.1 and 0.3 mM @CHEMICAL$, which inhibits the cystic fibrosis transmembrane conductor regulator (@GENE$), dose dependently inhibited S3226-induced DBS.",
        "relation": "CPR:4"
    },
    {
        "id": "12881227.T5.T23",
        "sentence": "In conclusion, only specific apical NHE3 inhibition increased DBS, whereas prostaglandin synthesis, Na+-HCO3- cotransporter activation, or intracellular @CHEMICAL$- formation by @GENE$ was not involved.",
        "relation": "CPR:9"
    },
    {
        "id": "23249624.T15.T36",
        "sentence": "Mechanisms limiting distribution of the threonine-protein kinase B-RaF(@CHEMICAL$) inhibitor @GENE$ to the brain: implications for the treatment of melanoma brain metastases.",
        "relation": "CPR:4"
    },
    {
        "id": "23249624.T15.T35",
        "sentence": "Mechanisms limiting distribution of the @CHEMICAL$(V600E) inhibitor @GENE$ to the brain: implications for the treatment of melanoma brain metastases.",
        "relation": "CPR:4"
    },
    {
        "id": "23249624.T13.T32",
        "sentence": "In vitro accumulation studies conducted in Madin-Darby canine kidney II cells indicate that @CHEMICAL$ is an avid substrate for both @GENE$ and BCRP.",
        "relation": "CPR:9"
    },
    {
        "id": "23249624.T13.T33",
        "sentence": "In vitro accumulation studies conducted in Madin-Darby canine kidney II cells indicate that @CHEMICAL$ is an avid substrate for both P-gp and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23249624.T5.T24",
        "sentence": "Further, compared with @CHEMICAL$, another BRAF(@GENE$) inhibitor, dabrafenib showed greater brain penetration with a similar dose.",
        "relation": "CPR:4"
    },
    {
        "id": "23249624.T5.T23",
        "sentence": "Further, compared with @CHEMICAL$, another @GENE$(V600E) inhibitor, dabrafenib showed greater brain penetration with a similar dose.",
        "relation": "CPR:4"
    },
    {
        "id": "23330542.T1.T6",
        "sentence": "Since the original discovery of @CHEMICAL$ analogs as @GENE$ antagonists, we have preliminarily defined an important PXR antagonist pharmacophore and developed less-toxic PXR antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "23330542.T1.T7",
        "sentence": "Since the original discovery of @CHEMICAL$ analogs as PXR antagonists, we have preliminarily defined an important @GENE$ antagonist pharmacophore and developed less-toxic PXR antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "23330542.T1.T8",
        "sentence": "Since the original discovery of @CHEMICAL$ analogs as PXR antagonists, we have preliminarily defined an important PXR antagonist pharmacophore and developed less-toxic @GENE$ antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "11160515.T11.T27",
        "sentence": "Activation of endogenous @CHEMICAL$ (sst2) by @GENE$ or activation of transiently transfected rat D2 dopamine receptors (rD2(long)) by quinpirole had no effect.",
        "relation": "CPR:3"
    },
    {
        "id": "11160515.T11.T28",
        "sentence": "Activation of endogenous somatostatin receptor subtype 2 (@CHEMICAL$) by @GENE$ or activation of transiently transfected rat D2 dopamine receptors (rD2(long)) by quinpirole had no effect.",
        "relation": "CPR:3"
    },
    {
        "id": "11160515.T13.T29",
        "sentence": "Activation of endogenous somatostatin receptor subtype 2 (sst2) by somatostatin-14 or activation of transiently transfected @CHEMICAL$ (rD2(long)) by @GENE$ had no effect.",
        "relation": "CPR:3"
    },
    {
        "id": "11160515.T13.T30",
        "sentence": "Activation of endogenous somatostatin receptor subtype 2 (sst2) by somatostatin-14 or activation of transiently transfected rat D2 dopamine receptors (@CHEMICAL$(long)) by @GENE$ had no effect.",
        "relation": "CPR:3"
    },
    {
        "id": "11160515.T17.T31",
        "sentence": "In contrast, in the same system, @CHEMICAL$-type currents, formed from transiently transfected alpha(1B)/alpha(2)delta-1/beta(3), showed strong @GENE$-mediated inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "23403203.T12.T24",
        "sentence": "Levels of @CHEMICAL$ protein were also decreased in a dose- and time-dependent manner following @GENE$ treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "23403203.T3.T19",
        "sentence": "Co-treatment of astrocytes with @CHEMICAL$ and the intracellular Ca(2+) chelator BAPTA-AM prevented downregulation of @GENE$ and inhibition of GJIC.",
        "relation": "CPR:4"
    },
    {
        "id": "23403203.T6.T19",
        "sentence": "Co-treatment of astrocytes with antofine and the intracellular Ca(2+) chelator @CHEMICAL$ prevented downregulation of @GENE$ and inhibition of GJIC.",
        "relation": "CPR:3"
    },
    {
        "id": "23403203.T7.T21",
        "sentence": "Moreover, co-treatment with @CHEMICAL$ and a specific PKCb inhibitor prevented endocytosis of gap junctions, downregulation of @GENE$, and inhibition of GJIC.",
        "relation": "CPR:4"
    },
    {
        "id": "23403203.T8.T23",
        "sentence": "Taken together, these findings indicate that @CHEMICAL$ induces Cx43 gap junction disassembly by the @GENE$ signaling pathway.",
        "relation": "CPR:3"
    },
    {
        "id": "10406837.T13.T24",
        "sentence": "@CHEMICAL$ inhibits @GENE$-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats.",
        "relation": "CPR:4"
    },
    {
        "id": "10406837.T2.T23",
        "sentence": "Isometric contraction induced by a submaximal concentration of @CHEMICAL$ (10(-7) mol/L) was reduced in a dose-dependent way by @GENE$ (IC(50)=0.5+/-0.04 micromol/L).",
        "relation": "CPR:4"
    },
    {
        "id": "10406837.T5.T16",
        "sentence": "The stimulatory effect of [Ca(2+)](i) induced by a submaximal concentration of @CHEMICAL$ (10(-7) mol/L) was blocked by @GENE$ (IC(50)=0.5+/-0.3 nmol/L).",
        "relation": "CPR:4"
    },
    {
        "id": "10406837.T6.T17",
        "sentence": "Our findings suggest that @CHEMICAL$ blocks the vasoconstrictor action of @GENE$ in vitro.",
        "relation": "CPR:4"
    },
    {
        "id": "10406837.T7.T18",
        "sentence": "This action can be related to the ability of @CHEMICAL$ to block the increase of [Ca(2+)](i) induced by @GENE$ in VSMCs.",
        "relation": "CPR:4"
    },
    {
        "id": "23262271.T3.T6",
        "sentence": "Among the isolated compounds, @CHEMICAL$ (8), oxyresveratrol (9), and steppogenin (12) were found to exhibit significant @GENE$ inhibition activities.",
        "relation": "CPR:4"
    },
    {
        "id": "23262271.T4.T6",
        "sentence": "Among the isolated compounds, trans-dihydromorin (8), @CHEMICAL$ (9), and steppogenin (12) were found to exhibit significant @GENE$ inhibition activities.",
        "relation": "CPR:4"
    },
    {
        "id": "23262271.T5.T6",
        "sentence": "Among the isolated compounds, trans-dihydromorin (8), oxyresveratrol (9), and @CHEMICAL$ (12) were found to exhibit significant @GENE$ inhibition activities.",
        "relation": "CPR:4"
    },
    {
        "id": "10670413.T12.T50",
        "sentence": "Prostaglandin E1, E2, @CHEMICAL$ (a stable analogue of thromboxane A2), 17-phenyl-trinor-PGE2 (an EP1-selective agonist) and sulprostone (an EP3-selective agonist) inhibited the HVA Ca2+ current (HVA ICa) dose-dependently, and the rank order of potency to inhibit @GENE$ was sulprostone>PGE2, PGE1>STA2>>17-phenyl-trinor-PGE2.",
        "relation": "CPR:4"
    },
    {
        "id": "10670413.T13.T50",
        "sentence": "Prostaglandin E1, E2, STA2 (a stable analogue of @CHEMICAL$), 17-phenyl-trinor-PGE2 (an EP1-selective agonist) and sulprostone (an EP3-selective agonist) inhibited the HVA Ca2+ current (HVA ICa) dose-dependently, and the rank order of potency to inhibit @GENE$ was sulprostone>PGE2, PGE1>STA2>>17-phenyl-trinor-PGE2.",
        "relation": "CPR:4"
    },
    {
        "id": "10670413.T14.T50",
        "sentence": "Prostaglandin E1, E2, STA2 (a stable analogue of thromboxane A2), @CHEMICAL$ (an EP1-selective agonist) and sulprostone (an EP3-selective agonist) inhibited the HVA Ca2+ current (HVA ICa) dose-dependently, and the rank order of potency to inhibit @GENE$ was sulprostone>PGE2, PGE1>STA2>>17-phenyl-trinor-PGE2.",
        "relation": "CPR:4"
    },
    {
        "id": "10670413.T14.T48",
        "sentence": "Prostaglandin E1, E2, STA2 (a stable analogue of thromboxane A2), @CHEMICAL$ (an @GENE$-selective agonist) and sulprostone (an EP3-selective agonist) inhibited the HVA Ca2+ current (HVA ICa) dose-dependently, and the rank order of potency to inhibit HVA Ca2+ channels was sulprostone>PGE2, PGE1>STA2>>17-phenyl-trinor-PGE2.",
        "relation": "CPR:5"
    },
    {
        "id": "10670413.T15.T50",
        "sentence": "Prostaglandin E1, E2, STA2 (a stable analogue of thromboxane A2), 17-phenyl-trinor-PGE2 (an EP1-selective agonist) and @CHEMICAL$ (an EP3-selective agonist) inhibited the HVA Ca2+ current (HVA ICa) dose-dependently, and the rank order of potency to inhibit @GENE$ was sulprostone>PGE2, PGE1>STA2>>17-phenyl-trinor-PGE2.",
        "relation": "CPR:4"
    },
    {
        "id": "10670413.T15.T49",
        "sentence": "Prostaglandin E1, E2, STA2 (a stable analogue of thromboxane A2), 17-phenyl-trinor-PGE2 (an EP1-selective agonist) and @CHEMICAL$ (an @GENE$-selective agonist) inhibited the HVA Ca2+ current (HVA ICa) dose-dependently, and the rank order of potency to inhibit HVA Ca2+ channels was sulprostone>PGE2, PGE1>STA2>>17-phenyl-trinor-PGE2.",
        "relation": "CPR:5"
    },
    {
        "id": "10670413.T18.T50",
        "sentence": "Prostaglandin E1, E2, STA2 (a stable analogue of thromboxane A2), 17-phenyl-trinor-PGE2 (an EP1-selective agonist) and sulprostone (an EP3-selective agonist) inhibited the HVA Ca2+ current (HVA ICa) dose-dependently, and the rank order of potency to inhibit @CHEMICAL$ was @GENE$>PGE2, PGE1>STA2>>17-phenyl-trinor-PGE2.",
        "relation": "CPR:4"
    },
    {
        "id": "10670413.T19.T50",
        "sentence": "Prostaglandin E1, E2, STA2 (a stable analogue of thromboxane A2), 17-phenyl-trinor-PGE2 (an EP1-selective agonist) and sulprostone (an EP3-selective agonist) inhibited the HVA Ca2+ current (HVA ICa) dose-dependently, and the rank order of potency to inhibit @CHEMICAL$ was sulprostone>@GENE$, PGE1>STA2>>17-phenyl-trinor-PGE2.",
        "relation": "CPR:4"
    },
    {
        "id": "10670413.T20.T50",
        "sentence": "Prostaglandin E1, E2, STA2 (a stable analogue of thromboxane A2), 17-phenyl-trinor-PGE2 (an EP1-selective agonist) and sulprostone (an EP3-selective agonist) inhibited the HVA Ca2+ current (HVA ICa) dose-dependently, and the rank order of potency to inhibit @CHEMICAL$ was sulprostone>PGE2, @GENE$>STA2>>17-phenyl-trinor-PGE2.",
        "relation": "CPR:4"
    },
    {
        "id": "10670413.T21.T50",
        "sentence": "Prostaglandin E1, E2, STA2 (a stable analogue of thromboxane A2), 17-phenyl-trinor-PGE2 (an EP1-selective agonist) and sulprostone (an EP3-selective agonist) inhibited the HVA Ca2+ current (HVA ICa) dose-dependently, and the rank order of potency to inhibit @CHEMICAL$ was sulprostone>PGE2, PGE1>@GENE$>>17-phenyl-trinor-PGE2.",
        "relation": "CPR:4"
    },
    {
        "id": "10670413.T22.T50",
        "sentence": "Prostaglandin E1, E2, STA2 (a stable analogue of thromboxane A2), 17-phenyl-trinor-PGE2 (an EP1-selective agonist) and sulprostone (an EP3-selective agonist) inhibited the HVA Ca2+ current (HVA ICa) dose-dependently, and the rank order of potency to inhibit @CHEMICAL$ was sulprostone>PGE2, PGE1>STA2>>@GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "10670413.T24.T51",
        "sentence": "@CHEMICAL$ (10(-5) M), a selective @GENE$ antagonist, showed no effect on the PGE1- or PGE2-induced inhibition of the HVA ICa, thereby indicating that PGE1- and PGE2-induced inhibition of the HVA Ca2+ channels is possibly mediated by the EP3 receptor.",
        "relation": "CPR:6"
    },
    {
        "id": "10670413.T27.T52",
        "sentence": "SC-51089 (10(-5) M), a selective EP1-receptor antagonist, showed no effect on the PGE1- or PGE2-induced inhibition of the HVA ICa, thereby indicating that @CHEMICAL$- and PGE2-induced inhibition of the @GENE$ is possibly mediated by the EP3 receptor.",
        "relation": "CPR:4"
    },
    {
        "id": "10670413.T28.T52",
        "sentence": "SC-51089 (10(-5) M), a selective EP1-receptor antagonist, showed no effect on the PGE1- or PGE2-induced inhibition of the HVA ICa, thereby indicating that PGE1- and @CHEMICAL$-induced inhibition of the @GENE$ is possibly mediated by the EP3 receptor.",
        "relation": "CPR:4"
    },
    {
        "id": "10670413.T7.T43",
        "sentence": "The inhibitory effect of PGE1 or sulprostone was prevented by pretreatment with pertussis toxin [islet activating protein (IAP)] or phorbol-12-myristate-13-acetate (PMA), and the @CHEMICAL$ (PKC) inhibitor @GENE$ blocked the action of PMA.",
        "relation": "CPR:4"
    },
    {
        "id": "10670413.T7.T44",
        "sentence": "The inhibitory effect of PGE1 or sulprostone was prevented by pretreatment with pertussis toxin [islet activating protein (IAP)] or phorbol-12-myristate-13-acetate (PMA), and the protein kinase C (@CHEMICAL$) inhibitor @GENE$ blocked the action of PMA.",
        "relation": "CPR:4"
    },
    {
        "id": "10670413.T9.T45",
        "sentence": "It was concluded that @CHEMICAL$ selectively reduces both N- and R-type Ca2+ currents by activating a @GENE$ probably through the EP3 receptor in paratracheal ganglion cells.",
        "relation": "CPR:3"
    },
    {
        "id": "11936838.T9.T20",
        "sentence": "Inhibition of @CHEMICAL$ and MIP-2 transcription and translation by @GENE$ in muscle tissue infected with the parasite Trichinella spiralis.",
        "relation": "CPR:4"
    },
    {
        "id": "11936838.T9.T21",
        "sentence": "Inhibition of MCP-1 and @CHEMICAL$ transcription and translation by @GENE$ in muscle tissue infected with the parasite Trichinella spiralis.",
        "relation": "CPR:4"
    },
    {
        "id": "11936838.T2.T10",
        "sentence": "In addition, we found that @CHEMICAL$ transcription and translation was completely inhibited by @GENE$, while MIP-2 transcription and translation was partially inhibited at 30 and 40 days; yet it was totally inhibited after 10 and 20 days in encysted diaphragm tissue infected by T. spiralis.",
        "relation": "CPR:4"
    },
    {
        "id": "11936838.T2.T11",
        "sentence": "In addition, we found that MCP-1 transcription and translation was completely inhibited by @CHEMICAL$, while @GENE$ transcription and translation was partially inhibited at 30 and 40 days; yet it was totally inhibited after 10 and 20 days in encysted diaphragm tissue infected by T. spiralis.",
        "relation": "CPR:4"
    },
    {
        "id": "23422872.T1.T3",
        "sentence": "This is described in a case study of the expedited review and approval of @CHEMICAL$, a novel @GENE$ inhibitor, in Japan in the context of the emergence of new strain of influenza in 2009.",
        "relation": "CPR:4"
    },
    {
        "id": "23238783.T9.T25",
        "sentence": "The influence of sex, ethnicity, and @CHEMICAL$ genotype on @GENE$ metabolism as an index of hepatic CYP2B6 activity in humans.",
        "relation": "CPR:9"
    },
    {
        "id": "23238783.T4.T19",
        "sentence": "To identify important covariates associated with interindividual variation in CYP2B6 activity in vivo, we evaluated these effects in healthy volunteers using @CHEMICAL$ (Wellbutrin SR GlaxoSmithKline, Research Triangle Park, NC) as a @GENE$ probe substrate.",
        "relation": "CPR:9"
    },
    {
        "id": "23238783.T5.T19",
        "sentence": "To identify important covariates associated with interindividual variation in CYP2B6 activity in vivo, we evaluated these effects in healthy volunteers using bupropion (@CHEMICAL$ GlaxoSmithKline, Research Triangle Park, NC) as a @GENE$ probe substrate.",
        "relation": "CPR:9"
    },
    {
        "id": "23238783.T1.T14",
        "sentence": "These results suggest that @CHEMICAL$ genotype is the most important patient variable for predicting the level of CYP2B6 activity in women, when measured by the metabolism of @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23238783.T1.T15",
        "sentence": "These results suggest that CYP2B6 genotype is the most important patient variable for predicting the level of @CHEMICAL$ activity in women, when measured by the metabolism of @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23238783.T2.T16",
        "sentence": "The @CHEMICAL$ metabolic ratio appears to detect known differences in @GENE$ activity associated with genetic polymorphism, across different ethnic groups.",
        "relation": "CPR:9"
    },
    {
        "id": "17192395.T2.T8",
        "sentence": "The identification of the @CHEMICAL$ SUCNR1 in platelets is of particular interest, because physiologically relevant concentrations of @GENE$ were shown to potentiate the effect of low doses of a variety of platelet agonists.",
        "relation": "CPR:5"
    },
    {
        "id": "17192395.T2.T9",
        "sentence": "The identification of the succinate receptor @CHEMICAL$ in platelets is of particular interest, because physiologically relevant concentrations of @GENE$ were shown to potentiate the effect of low doses of a variety of platelet agonists.",
        "relation": "CPR:5"
    },
    {
        "id": "23100158.T7.T14",
        "sentence": "The results demonstrated that b-ionone-induced apoptosis in a dose-dependent manner in SGC-7901 cells treated with b-ionone (25, 50, 100 and 200 mmol/L) for 24 h. @CHEMICAL$ was also shown to induce the expression of cleaved-@GENE$ and inhibit bcl-2 expression in SGC-7901 cells in a dose-dependent manner.",
        "relation": "CPR:3"
    },
    {
        "id": "23100158.T7.T15",
        "sentence": "The results demonstrated that b-ionone-induced apoptosis in a dose-dependent manner in SGC-7901 cells treated with b-ionone (25, 50, 100 and 200 mmol/L) for 24 h. @CHEMICAL$ was also shown to induce the expression of cleaved-caspase-3 and inhibit @GENE$ expression in SGC-7901 cells in a dose-dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "23100158.T8.T16",
        "sentence": "The significantly decreased levels of @CHEMICAL$ and p-AKT expression were observed in SGC-7901 cells after @GENE$ treatments in a time- and dose-dependent manner (P < 0.01).",
        "relation": "CPR:4"
    },
    {
        "id": "23100158.T8.T17",
        "sentence": "The significantly decreased levels of p-PI3K and @CHEMICAL$ expression were observed in SGC-7901 cells after @GENE$ treatments in a time- and dose-dependent manner (P < 0.01).",
        "relation": "CPR:4"
    },
    {
        "id": "12517247.T16.T33",
        "sentence": "Within the class of @CHEMICAL$ blockers, @GENE$ differs from other currently available agents in terms of chemical structure, as it is a non-biphenyl, non-tetrazole, non-peptide antagonist with a dual pharmacological mode of action.",
        "relation": "CPR:4"
    },
    {
        "id": "12517247.T4.T23",
        "sentence": "In clinical trials, eprosartan has been demonstrated to be at least as effective in reducing blood pressure as the @CHEMICAL$ inhibitor @GENE$, and has significantly lower side effects.",
        "relation": "CPR:4"
    },
    {
        "id": "17040106.T25.T41",
        "sentence": "Reductive detoxification of @CHEMICAL$ carcinogens by human NADH cytochrome b5 reductase and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T25.T42",
        "sentence": "Reductive detoxification of @CHEMICAL$ carcinogens by @GENE$ and cytochrome b5.",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T17.T37",
        "sentence": "On the basis of our findings with structurally similar arylhydroxylamine metabolites of therapeutic drugs, we hypothesized that the reductive detoxification of @CHEMICAL$ carcinogens was catalyzed by @GENE$ (b5R) and cytochrome b5 (cyt b5).",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T17.T38",
        "sentence": "On the basis of our findings with structurally similar arylhydroxylamine metabolites of therapeutic drugs, we hypothesized that the reductive detoxification of @CHEMICAL$ carcinogens was catalyzed by NADH cytochrome b5 reductase (@GENE$) and cytochrome b5 (cyt b5).",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T17.T39",
        "sentence": "On the basis of our findings with structurally similar arylhydroxylamine metabolites of therapeutic drugs, we hypothesized that the reductive detoxification of @CHEMICAL$ carcinogens was catalyzed by NADH cytochrome b5 reductase (b5R) and @GENE$ (cyt b5).",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T17.T40",
        "sentence": "On the basis of our findings with structurally similar arylhydroxylamine metabolites of therapeutic drugs, we hypothesized that the reductive detoxification of @CHEMICAL$ carcinogens was catalyzed by NADH cytochrome b5 reductase (b5R) and cytochrome b5 (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T2.T27",
        "sentence": "We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (@CHEMICAL$; found in grilled meats) was indeed catalyzed by a purified system containing only @GENE$ and cyt b5.",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T2.T28",
        "sentence": "We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (@CHEMICAL$; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T19.T27",
        "sentence": "We found that reduction of the carcinogenic @CHEMICAL$ of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only @GENE$ and cyt b5.",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T19.T28",
        "sentence": "We found that reduction of the carcinogenic @CHEMICAL$ of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T20.T27",
        "sentence": "We found that reduction of the carcinogenic hydroxylamines of the @CHEMICAL$ 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only @GENE$ and cyt b5.",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T20.T28",
        "sentence": "We found that reduction of the carcinogenic hydroxylamines of the @CHEMICAL$ 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T21.T27",
        "sentence": "We found that reduction of the carcinogenic hydroxylamines of the aromatic amine @CHEMICAL$ (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only @GENE$ and cyt b5.",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T21.T28",
        "sentence": "We found that reduction of the carcinogenic hydroxylamines of the aromatic amine @CHEMICAL$ (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T22.T27",
        "sentence": "We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (@CHEMICAL$; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only @GENE$ and cyt b5.",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T22.T28",
        "sentence": "We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (@CHEMICAL$; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T23.T27",
        "sentence": "We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the @CHEMICAL$ 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only @GENE$ and cyt b5.",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T23.T28",
        "sentence": "We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the @CHEMICAL$ 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T24.T27",
        "sentence": "We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine @CHEMICAL$ (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only @GENE$ and cyt b5.",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T24.T28",
        "sentence": "We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine @CHEMICAL$ (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T4.T31",
        "sentence": "Polyclonal antisera to either @CHEMICAL$ or cyt b5 significantly inhibited @GENE$ (NHOH-4-ABP) reduction by 95 and 89%, respectively, and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both NHOH-4-ABP and N-hydroxy-PhIP (NHOH-PhIP).",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T4.T32",
        "sentence": "Polyclonal antisera to either b5R or @CHEMICAL$ significantly inhibited @GENE$ (NHOH-4-ABP) reduction by 95 and 89%, respectively, and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both NHOH-4-ABP and N-hydroxy-PhIP (NHOH-PhIP).",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T5.T31",
        "sentence": "Polyclonal antisera to either @CHEMICAL$ or cyt b5 significantly inhibited N-hydroxy-4-aminobiphenyl (@GENE$) reduction by 95 and 89%, respectively, and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both NHOH-4-ABP and N-hydroxy-PhIP (NHOH-PhIP).",
        "relation": "CPR:9"
    },
    {
        "id": "17040106.T5.T32",
        "sentence": "Polyclonal antisera to either b5R or @CHEMICAL$ significantly inhibited N-hydroxy-4-aminobiphenyl (@GENE$) reduction by 95 and 89%, respectively, and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both NHOH-4-ABP and N-hydroxy-PhIP (NHOH-PhIP).",
        "relation": "CPR:9"
    },
    {
        "id": "11264758.T12.T16",
        "sentence": "Clinical effects of @CHEMICAL$, an oral @GENE$ antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial.",
        "relation": "CPR:6"
    },
    {
        "id": "11264758.T10.T15",
        "sentence": "@CHEMICAL$ is a new, orally active, selective inhibitor of CysLt1 @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "11264758.T10.T14",
        "sentence": "@CHEMICAL$ is a new, orally active, selective inhibitor of @GENE$ leukotriene receptor.",
        "relation": "CPR:4"
    },
    {
        "id": "16291873.T12.T20",
        "sentence": "We used mutagenesis of these residues, combined with an investigation of @CHEMICAL$ block by close analogs of @GENE$ and ibutilide, to assess how specific alterations in drug structure affected potency and binding interactions.",
        "relation": "CPR:4"
    },
    {
        "id": "16291873.T13.T20",
        "sentence": "We used mutagenesis of these residues, combined with an investigation of @CHEMICAL$ block by close analogs of clofilium and @GENE$, to assess how specific alterations in drug structure affected potency and binding interactions.",
        "relation": "CPR:4"
    },
    {
        "id": "17390078.T6.T30",
        "sentence": "@CHEMICAL$ is a @GENE$ inhibitor that induces the hydrolysis of body choline esters, including acetylcholine at cholinergic synapses.",
        "relation": "CPR:4"
    },
    {
        "id": "17390078.T1.T13",
        "sentence": "There was also an increase in @CHEMICAL$, Trio, Rho-A, Rac-3, EGFR, Notch-4, Dvl-2, Ezrin, beta catenin and mutant p53 protein expression in the @GENE$-treated cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17390078.T1.T14",
        "sentence": "There was also an increase in c-kit, @CHEMICAL$, Rho-A, Rac-3, EGFR, Notch-4, Dvl-2, Ezrin, beta catenin and mutant p53 protein expression in the @GENE$-treated cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17390078.T1.T15",
        "sentence": "There was also an increase in c-kit, Trio, @CHEMICAL$, Rac-3, EGFR, Notch-4, Dvl-2, Ezrin, beta catenin and mutant p53 protein expression in the @GENE$-treated cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17390078.T1.T16",
        "sentence": "There was also an increase in c-kit, Trio, Rho-A, @CHEMICAL$, EGFR, Notch-4, Dvl-2, Ezrin, beta catenin and mutant p53 protein expression in the @GENE$-treated cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17390078.T1.T18",
        "sentence": "There was also an increase in c-kit, Trio, Rho-A, Rac-3, EGFR, @CHEMICAL$, Dvl-2, Ezrin, beta catenin and mutant p53 protein expression in the @GENE$-treated cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17390078.T1.T19",
        "sentence": "There was also an increase in c-kit, Trio, Rho-A, Rac-3, EGFR, Notch-4, @CHEMICAL$, Ezrin, beta catenin and mutant p53 protein expression in the @GENE$-treated cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17390078.T1.T20",
        "sentence": "There was also an increase in c-kit, Trio, Rho-A, Rac-3, EGFR, Notch-4, Dvl-2, @CHEMICAL$, beta catenin and mutant p53 protein expression in the @GENE$-treated cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17390078.T1.T21",
        "sentence": "There was also an increase in c-kit, Trio, Rho-A, Rac-3, EGFR, Notch-4, Dvl-2, Ezrin, @CHEMICAL$ and mutant p53 protein expression in the @GENE$-treated cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17390078.T1.T22",
        "sentence": "There was also an increase in c-kit, Trio, Rho-A, Rac-3, EGFR, Notch-4, Dvl-2, Ezrin, beta catenin and mutant @CHEMICAL$ protein expression in the @GENE$-treated cells.",
        "relation": "CPR:3"
    },
    {
        "id": "9722550.T8.T14",
        "sentence": "@CHEMICAL$ (EC 3.1.4.45; phosphodiester alpha-GlcNAcase) catalyzes the second step in the synthesis of the @GENE$ determinant required for efficient intracellular targeting of newly synthesized lysosomal hydrolases to the lysosome.",
        "relation": "CPR:9"
    },
    {
        "id": "9722550.T8.T20",
        "sentence": "N-Acetylglucosamine-1-phosphodiester alpha-N-Acetylglucosaminidase (@CHEMICAL$; phosphodiester alpha-GlcNAcase) catalyzes the second step in the synthesis of the @GENE$ determinant required for efficient intracellular targeting of newly synthesized lysosomal hydrolases to the lysosome.",
        "relation": "CPR:9"
    },
    {
        "id": "9722550.T8.T22",
        "sentence": "N-Acetylglucosamine-1-phosphodiester alpha-N-Acetylglucosaminidase (EC 3.1.4.45; @CHEMICAL$) catalyzes the second step in the synthesis of the @GENE$ determinant required for efficient intracellular targeting of newly synthesized lysosomal hydrolases to the lysosome.",
        "relation": "CPR:9"
    },
    {
        "id": "9722550.T10.T21",
        "sentence": "The purified @CHEMICAL$ has a specific activity of 498 micromol of @GENE$ cleaved per h per mg of protein using 0.5 mM [3H]GlcNAc-alpha-phosphomannose-alpha-methyl as substrate.",
        "relation": "CPR:9"
    },
    {
        "id": "9722550.T11.T21",
        "sentence": "The purified @CHEMICAL$ has a specific activity of 498 micromol of [3H]GlcNAc-alpha-phosphomannose-alpha-methyl cleaved per h per mg of protein using 0.5 mM @GENE$ as substrate.",
        "relation": "CPR:9"
    },
    {
        "id": "23500382.T13.T24",
        "sentence": "In the in vitro assay, @CHEMICAL$ (20 and 50mg/mL) markedly inhibited changes in various biochemical substances (nitric oxide (NO), @GENE$ (LDH), superoxide dismutase (SOD), and catalase (CAT)) in human umbilical vein endothelial cells (HUVECs) damaged by high glucose (35mM) and restored vascular endothelial structure by balancing the matrix metalloproteinases-the tissue inhibitors of matrix metalloproteinases (MMP-TIMP) system.",
        "relation": "CPR:4"
    },
    {
        "id": "23500382.T13.T25",
        "sentence": "In the in vitro assay, @CHEMICAL$ (20 and 50mg/mL) markedly inhibited changes in various biochemical substances (nitric oxide (NO), lactic dehydrogenase (@GENE$), superoxide dismutase (SOD), and catalase (CAT)) in human umbilical vein endothelial cells (HUVECs) damaged by high glucose (35mM) and restored vascular endothelial structure by balancing the matrix metalloproteinases-the tissue inhibitors of matrix metalloproteinases (MMP-TIMP) system.",
        "relation": "CPR:4"
    },
    {
        "id": "23500382.T13.T26",
        "sentence": "In the in vitro assay, @CHEMICAL$ (20 and 50mg/mL) markedly inhibited changes in various biochemical substances (nitric oxide (NO), lactic dehydrogenase (LDH), @GENE$ (SOD), and catalase (CAT)) in human umbilical vein endothelial cells (HUVECs) damaged by high glucose (35mM) and restored vascular endothelial structure by balancing the matrix metalloproteinases-the tissue inhibitors of matrix metalloproteinases (MMP-TIMP) system.",
        "relation": "CPR:4"
    },
    {
        "id": "23500382.T13.T27",
        "sentence": "In the in vitro assay, @CHEMICAL$ (20 and 50mg/mL) markedly inhibited changes in various biochemical substances (nitric oxide (NO), lactic dehydrogenase (LDH), superoxide dismutase (@GENE$), and catalase (CAT)) in human umbilical vein endothelial cells (HUVECs) damaged by high glucose (35mM) and restored vascular endothelial structure by balancing the matrix metalloproteinases-the tissue inhibitors of matrix metalloproteinases (MMP-TIMP) system.",
        "relation": "CPR:4"
    },
    {
        "id": "23500382.T13.T28",
        "sentence": "In the in vitro assay, @CHEMICAL$ (20 and 50mg/mL) markedly inhibited changes in various biochemical substances (nitric oxide (NO), lactic dehydrogenase (LDH), superoxide dismutase (SOD), and @GENE$ (CAT)) in human umbilical vein endothelial cells (HUVECs) damaged by high glucose (35mM) and restored vascular endothelial structure by balancing the matrix metalloproteinases-the tissue inhibitors of matrix metalloproteinases (MMP-TIMP) system.",
        "relation": "CPR:4"
    },
    {
        "id": "23500382.T13.T29",
        "sentence": "In the in vitro assay, @CHEMICAL$ (20 and 50mg/mL) markedly inhibited changes in various biochemical substances (nitric oxide (NO), lactic dehydrogenase (LDH), superoxide dismutase (SOD), and catalase (@GENE$)) in human umbilical vein endothelial cells (HUVECs) damaged by high glucose (35mM) and restored vascular endothelial structure by balancing the matrix metalloproteinases-the tissue inhibitors of matrix metalloproteinases (MMP-TIMP) system.",
        "relation": "CPR:4"
    },
    {
        "id": "23500382.T19.T22",
        "sentence": "The vascular protective effects of @CHEMICAL$ were speculated to be attributed to oxidative stress inhibition and the reduction of @GENE$ (NF-kB) mRNA expression levels in high glucose conditions.",
        "relation": "CPR:4"
    },
    {
        "id": "23500382.T19.T23",
        "sentence": "The vascular protective effects of @CHEMICAL$ were speculated to be attributed to oxidative stress inhibition and the reduction of nuclear factor kappa B (@GENE$) mRNA expression levels in high glucose conditions.",
        "relation": "CPR:4"
    },
    {
        "id": "23071106.T1.T49",
        "sentence": "@CHEMICAL$ and gliclazide block the @GENE$ K(ir)6.2/Sur1, causing membrane depolarization and stimulating insulin secretion in pancreatic beta cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23071106.T1.T42",
        "sentence": "@CHEMICAL$ and gliclazide block the K(ATP) channel K(ir)6.2/Sur1, causing membrane depolarization and stimulating @GENE$ secretion in pancreatic beta cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23071106.T1.T51",
        "sentence": "@CHEMICAL$ and gliclazide block the K(ATP) channel @GENE$/Sur1, causing membrane depolarization and stimulating insulin secretion in pancreatic beta cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23071106.T1.T52",
        "sentence": "@CHEMICAL$ and gliclazide block the K(ATP) channel K(ir)6.2/@GENE$, causing membrane depolarization and stimulating insulin secretion in pancreatic beta cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23071106.T20.T48",
        "sentence": "@CHEMICAL$ secretion stimulated by both 200 mM @GENE$ and 20 mM gliclazide, concentrations that had equivalent effects on membrane potential, was inhibited by thapsigargin (1 mM) or the L-type Ca(2+) channel blocker nicardipine (2 mM) and was potentiated by 8-pCPT-2'-O-Me-cAMP-AM at concentrations >2 mM in INS-1 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23071106.T21.T48",
        "sentence": "@CHEMICAL$ secretion stimulated by both 200 mM tolbutamide and 20 mM @GENE$, concentrations that had equivalent effects on membrane potential, was inhibited by thapsigargin (1 mM) or the L-type Ca(2+) channel blocker nicardipine (2 mM) and was potentiated by 8-pCPT-2'-O-Me-cAMP-AM at concentrations >2 mM in INS-1 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23071106.T22.T48",
        "sentence": "@CHEMICAL$ secretion stimulated by both 200 mM tolbutamide and 20 mM gliclazide, concentrations that had equivalent effects on membrane potential, was inhibited by @GENE$ (1 mM) or the L-type Ca(2+) channel blocker nicardipine (2 mM) and was potentiated by 8-pCPT-2'-O-Me-cAMP-AM at concentrations >2 mM in INS-1 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23071106.T24.T48",
        "sentence": "@CHEMICAL$ secretion stimulated by both 200 mM tolbutamide and 20 mM gliclazide, concentrations that had equivalent effects on membrane potential, was inhibited by thapsigargin (1 mM) or the L-type Ca(2+) channel blocker @GENE$ (2 mM) and was potentiated by 8-pCPT-2'-O-Me-cAMP-AM at concentrations >2 mM in INS-1 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23071106.T24.T50",
        "sentence": "Insulin secretion stimulated by both 200 mM tolbutamide and 20 mM gliclazide, concentrations that had equivalent effects on membrane potential, was inhibited by thapsigargin (1 mM) or the @CHEMICAL$ blocker @GENE$ (2 mM) and was potentiated by 8-pCPT-2'-O-Me-cAMP-AM at concentrations >2 mM in INS-1 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23071106.T25.T48",
        "sentence": "@CHEMICAL$ secretion stimulated by both 200 mM tolbutamide and 20 mM gliclazide, concentrations that had equivalent effects on membrane potential, was inhibited by thapsigargin (1 mM) or the L-type Ca(2+) channel blocker nicardipine (2 mM) and was potentiated by @GENE$ at concentrations >2 mM in INS-1 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23071106.T7.T43",
        "sentence": "Ca(2+) transients stimulated by either tolbutamide or gliclazide were inhibited by thapsigargin or nicardipine and were significantly potentiated by 8-pCPT-2'-O-Me-cAMP-AM at 5 mM but not 1 mM. Both tolbutamide and gliclazide stimulated phospholipase C activity; however, only gliclazide did so independently of its activity at K(ATP) channels, and this activity was partially inhibited by pertussis toxin. 8-pCPT-2'-O-Me-cAMP-AM alone (5 mM) did not stimulate insulin secretion, but did increase intracellular Ca(2+) concentration significantly, and this activity was inhibited by 25 mM 2-aminoethoxydiphenylborate (2-APB) or the removal of extracellular Ca(2+). @CHEMICAL$ potentiation of @GENE$ secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 mM) and enhanced by the PKC inhibitor bisindolylmaleimide I (1 mM).",
        "relation": "CPR:3"
    },
    {
        "id": "23071106.T8.T43",
        "sentence": "Ca(2+) transients stimulated by either tolbutamide or gliclazide were inhibited by thapsigargin or nicardipine and were significantly potentiated by 8-pCPT-2'-O-Me-cAMP-AM at 5 mM but not 1 mM. Both tolbutamide and gliclazide stimulated phospholipase C activity; however, only gliclazide did so independently of its activity at K(ATP) channels, and this activity was partially inhibited by pertussis toxin. 8-pCPT-2'-O-Me-cAMP-AM alone (5 mM) did not stimulate insulin secretion, but did increase intracellular Ca(2+) concentration significantly, and this activity was inhibited by 25 mM 2-aminoethoxydiphenylborate (2-APB) or the removal of extracellular Ca(2+). 8-pCPT-2'-O-Me-cAMP-AM potentiation of @CHEMICAL$ secretion stimulated by @GENE$ was markedly inhibited by 2-APB (25 mM) and enhanced by the PKC inhibitor bisindolylmaleimide I (1 mM).",
        "relation": "CPR:3"
    },
    {
        "id": "23071106.T9.T43",
        "sentence": "Ca(2+) transients stimulated by either tolbutamide or gliclazide were inhibited by thapsigargin or nicardipine and were significantly potentiated by 8-pCPT-2'-O-Me-cAMP-AM at 5 mM but not 1 mM. Both tolbutamide and gliclazide stimulated phospholipase C activity; however, only gliclazide did so independently of its activity at K(ATP) channels, and this activity was partially inhibited by pertussis toxin. 8-pCPT-2'-O-Me-cAMP-AM alone (5 mM) did not stimulate insulin secretion, but did increase intracellular Ca(2+) concentration significantly, and this activity was inhibited by 25 mM 2-aminoethoxydiphenylborate (2-APB) or the removal of extracellular Ca(2+). 8-pCPT-2'-O-Me-cAMP-AM potentiation of @CHEMICAL$ secretion stimulated by tolbutamide was markedly inhibited by @GENE$ (25 mM) and enhanced by the PKC inhibitor bisindolylmaleimide I (1 mM).",
        "relation": "CPR:4"
    },
    {
        "id": "23071106.T10.T43",
        "sentence": "Ca(2+) transients stimulated by either tolbutamide or gliclazide were inhibited by thapsigargin or nicardipine and were significantly potentiated by 8-pCPT-2'-O-Me-cAMP-AM at 5 mM but not 1 mM. Both tolbutamide and gliclazide stimulated phospholipase C activity; however, only gliclazide did so independently of its activity at K(ATP) channels, and this activity was partially inhibited by pertussis toxin. 8-pCPT-2'-O-Me-cAMP-AM alone (5 mM) did not stimulate insulin secretion, but did increase intracellular Ca(2+) concentration significantly, and this activity was inhibited by 25 mM 2-aminoethoxydiphenylborate (2-APB) or the removal of extracellular Ca(2+). 8-pCPT-2'-O-Me-cAMP-AM potentiation of @CHEMICAL$ secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 mM) and enhanced by the PKC inhibitor @GENE$ (1 mM).",
        "relation": "CPR:3"
    },
    {
        "id": "23071106.T10.T44",
        "sentence": "Ca(2+) transients stimulated by either tolbutamide or gliclazide were inhibited by thapsigargin or nicardipine and were significantly potentiated by 8-pCPT-2'-O-Me-cAMP-AM at 5 mM but not 1 mM. Both tolbutamide and gliclazide stimulated phospholipase C activity; however, only gliclazide did so independently of its activity at K(ATP) channels, and this activity was partially inhibited by pertussis toxin. 8-pCPT-2'-O-Me-cAMP-AM alone (5 mM) did not stimulate insulin secretion, but did increase intracellular Ca(2+) concentration significantly, and this activity was inhibited by 25 mM 2-aminoethoxydiphenylborate (2-APB) or the removal of extracellular Ca(2+). 8-pCPT-2'-O-Me-cAMP-AM potentiation of insulin secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 mM) and enhanced by the @CHEMICAL$ inhibitor @GENE$ (1 mM).",
        "relation": "CPR:4"
    },
    {
        "id": "23071106.T31.T53",
        "sentence": "Ca(2+) transients stimulated by either tolbutamide or gliclazide were inhibited by thapsigargin or nicardipine and were significantly potentiated by 8-pCPT-2'-O-Me-cAMP-AM at 5 mM but not 1 mM. Both @CHEMICAL$ and gliclazide stimulated @GENE$ activity; however, only gliclazide did so independently of its activity at K(ATP) channels, and this activity was partially inhibited by pertussis toxin. 8-pCPT-2'-O-Me-cAMP-AM alone (5 mM) did not stimulate insulin secretion, but did increase intracellular Ca(2+) concentration significantly, and this activity was inhibited by 25 mM 2-aminoethoxydiphenylborate (2-APB) or the removal of extracellular Ca(2+). 8-pCPT-2'-O-Me-cAMP-AM potentiation of insulin secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 mM) and enhanced by the PKC inhibitor bisindolylmaleimide I (1 mM).",
        "relation": "CPR:3"
    },
    {
        "id": "23071106.T32.T53",
        "sentence": "Ca(2+) transients stimulated by either tolbutamide or gliclazide were inhibited by thapsigargin or nicardipine and were significantly potentiated by 8-pCPT-2'-O-Me-cAMP-AM at 5 mM but not 1 mM. Both tolbutamide and @CHEMICAL$ stimulated @GENE$ activity; however, only gliclazide did so independently of its activity at K(ATP) channels, and this activity was partially inhibited by pertussis toxin. 8-pCPT-2'-O-Me-cAMP-AM alone (5 mM) did not stimulate insulin secretion, but did increase intracellular Ca(2+) concentration significantly, and this activity was inhibited by 25 mM 2-aminoethoxydiphenylborate (2-APB) or the removal of extracellular Ca(2+). 8-pCPT-2'-O-Me-cAMP-AM potentiation of insulin secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 mM) and enhanced by the PKC inhibitor bisindolylmaleimide I (1 mM).",
        "relation": "CPR:3"
    },
    {
        "id": "23071106.T33.T54",
        "sentence": "Ca(2+) transients stimulated by either tolbutamide or gliclazide were inhibited by thapsigargin or nicardipine and were significantly potentiated by 8-pCPT-2'-O-Me-cAMP-AM at 5 mM but not 1 mM. Both tolbutamide and gliclazide stimulated phospholipase C activity; however, only @CHEMICAL$ did so independently of its activity at @GENE$, and this activity was partially inhibited by pertussis toxin. 8-pCPT-2'-O-Me-cAMP-AM alone (5 mM) did not stimulate insulin secretion, but did increase intracellular Ca(2+) concentration significantly, and this activity was inhibited by 25 mM 2-aminoethoxydiphenylborate (2-APB) or the removal of extracellular Ca(2+). 8-pCPT-2'-O-Me-cAMP-AM potentiation of insulin secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 mM) and enhanced by the PKC inhibitor bisindolylmaleimide I (1 mM).",
        "relation": "CPR:3"
    },
    {
        "id": "23071106.T14.T45",
        "sentence": "Our data demonstrate that the actions of both tolbutamide and gliclazide are strongly potentiated by 8-pCPT-2'-O-Me-cAMP-AM, that @CHEMICAL$ can stimulate @GENE$ activity via a partially pertussis toxin-sensitive mechanism, and that 8-pCPT-2'-O-Me-cAMP-AM potentiation of tolbutamide action may involve activation of a 2-APB-sensitive Ca(2+) influx.",
        "relation": "CPR:3"
    },
    {
        "id": "22972179.T5.T22",
        "sentence": "Phosphorylation of @CHEMICAL$ at Thr172 increased by 1.4-fold within 5 min, and remained elevated throughout a 30-min time course, in response to @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "22972179.T6.T27",
        "sentence": "Phosphorylation of ER-stress marker @CHEMICAL$ was also increased but only at 30 min of @GENE$ exposure. 2-Deoxyglucose increased phosphorylation of tuberous sclerosis complex 2 (TSC2) on AMPK consensus sites but did not change the amount of TSC1 bound to TSC2.",
        "relation": "CPR:3"
    },
    {
        "id": "22972179.T7.T9",
        "sentence": "Phosphorylation of ER-stress marker eIF2a was also increased but only at 30 min of 2-deoxyglucose exposure. @CHEMICAL$ increased phosphorylation of tuberous sclerosis complex 2 (TSC2) on @GENE$ consensus sites but did not change the amount of TSC1 bound to TSC2.",
        "relation": "CPR:3"
    },
    {
        "id": "22972179.T7.T8",
        "sentence": "Phosphorylation of ER-stress marker eIF2a was also increased but only at 30 min of 2-deoxyglucose exposure. @CHEMICAL$ increased phosphorylation of tuberous sclerosis complex 2 (@GENE$) on AMPK consensus sites but did not change the amount of TSC1 bound to TSC2.",
        "relation": "CPR:3"
    },
    {
        "id": "22972179.T7.T11",
        "sentence": "Phosphorylation of ER-stress marker eIF2a was also increased but only at 30 min of 2-deoxyglucose exposure. @CHEMICAL$ increased phosphorylation of tuberous sclerosis complex 2 (TSC2) on AMPK consensus sites but did not change the amount of TSC1 bound to @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "22972179.T7.T28",
        "sentence": "Phosphorylation of ER-stress marker eIF2a was also increased but only at 30 min of 2-deoxyglucose exposure. @CHEMICAL$ increased phosphorylation of @GENE$ (TSC2) on AMPK consensus sites but did not change the amount of TSC1 bound to TSC2.",
        "relation": "CPR:3"
    },
    {
        "id": "17919259.T8.T22",
        "sentence": "@CHEMICAL$: a dual @GENE$ antagonist [corrected].",
        "relation": "CPR:6"
    },
    {
        "id": "17919259.T6.T19",
        "sentence": "@CHEMICAL$ is a nonpeptide dual @GENE$ antagonist.",
        "relation": "CPR:6"
    },
    {
        "id": "1977506.T2.T20",
        "sentence": "@CHEMICAL$ antagonists have been utilized, following their initial chemical synthesis in 1933, both in the treatment of conditions in which @GENE$ is considered to be of pathogenic importance and conversely to help elucidate the role of histamine in disease, through an evaluation of their influence on disease expression.",
        "relation": "CPR:5"
    },
    {
        "id": "1977506.T16.T20",
        "sentence": "@CHEMICAL$ antagonists have been utilized, following their initial chemical synthesis in 1933, both in the treatment of conditions in which histamine is considered to be of pathogenic importance and conversely to help elucidate the role of @GENE$ in disease, through an evaluation of their influence on disease expression.",
        "relation": "CPR:5"
    },
    {
        "id": "1977506.T18.T27",
        "sentence": "While there is considerable indirect evidence to implicate @CHEMICAL$ in the pathogenesis of asthma, a critical evaluation of @GENE$ antagonism in this condition has, until recently, proved difficult, as many of the early H1-receptor antagonists possessed additional actions, such as anti-cholinergic, local anaesthetic, alpha-adrenoceptor antagonistic and anti-serotonin activity.",
        "relation": "CPR:5"
    },
    {
        "id": "1977506.T18.T28",
        "sentence": "While there is considerable indirect evidence to implicate @CHEMICAL$ in the pathogenesis of asthma, a critical evaluation of H1-receptor antagonism in this condition has, until recently, proved difficult, as many of the early @GENE$ antagonists possessed additional actions, such as anti-cholinergic, local anaesthetic, alpha-adrenoceptor antagonistic and anti-serotonin activity.",
        "relation": "CPR:5"
    },
    {
        "id": "1977506.T3.T23",
        "sentence": "The recent development of @CHEMICAL$ antagonists devoid of clinical sedative effects has enabled the administration of doses of H1-antihistamines which achieve a greater degree of H1-receptor blockade within the airways, thus permitting a better appraisal of the role of @GENE$ in this condition.",
        "relation": "CPR:5"
    },
    {
        "id": "1977506.T3.T25",
        "sentence": "The recent development of H1-receptor antagonists devoid of clinical sedative effects has enabled the administration of doses of H1-antihistamines which achieve a greater degree of @CHEMICAL$ blockade within the airways, thus permitting a better appraisal of the role of @GENE$ in this condition.",
        "relation": "CPR:5"
    },
    {
        "id": "23639738.T9.T17",
        "sentence": "@CHEMICAL$ (CE) induced surface erosion of @GENE$ (PEC) and drug release from PEC under mild physiological environment was investigated.",
        "relation": "CPR:9"
    },
    {
        "id": "23639738.T9.T18",
        "sentence": "Cholesterol esterase (@CHEMICAL$) induced surface erosion of @GENE$ (PEC) and drug release from PEC under mild physiological environment was investigated.",
        "relation": "CPR:9"
    },
    {
        "id": "23639738.T13.T17",
        "sentence": "@CHEMICAL$ (CE) induced surface erosion of poly(ethylene carbonate) (@GENE$) and drug release from PEC under mild physiological environment was investigated.",
        "relation": "CPR:9"
    },
    {
        "id": "23639738.T13.T18",
        "sentence": "Cholesterol esterase (@CHEMICAL$) induced surface erosion of poly(ethylene carbonate) (@GENE$) and drug release from PEC under mild physiological environment was investigated.",
        "relation": "CPR:9"
    },
    {
        "id": "17479245.T3.T18",
        "sentence": "Intravenous @CHEMICAL$ significantly increased the acute @GENE$ response (129 +/- 12 vs 36 +/- 6 ng/l in controls; p < 0.01), notably without affecting plasma glucose.",
        "relation": "CPR:3"
    },
    {
        "id": "17479245.T5.T19",
        "sentence": "Isolated islets displayed improved @CHEMICAL$-stimulated @GENE$ secretion after GRA treatment (0.061 +/- 0.007 vs 0.030 +/- 0.004 pmol islet(-1) h(-1) at 16.7 mmol/l glucose; p < 0.001), without affecting islet glucose oxidation.",
        "relation": "CPR:3"
    },
    {
        "id": "23552101.T1.T20",
        "sentence": "@CHEMICAL$ encodes phosphatidylinositol 4-phosphate 5-kinase b type I (pip5k1b), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate @GENE$ [PI(4,5)P2].",
        "relation": "CPR:9"
    },
    {
        "id": "23552101.T1.T21",
        "sentence": "PIP5K1B encodes @CHEMICAL$ (pip5k1b), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate @GENE$ [PI(4,5)P2].",
        "relation": "CPR:9"
    },
    {
        "id": "23552101.T1.T22",
        "sentence": "PIP5K1B encodes phosphatidylinositol 4-phosphate 5-kinase b type I (@CHEMICAL$), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate @GENE$ [PI(4,5)P2].",
        "relation": "CPR:9"
    },
    {
        "id": "23552101.T2.T20",
        "sentence": "@CHEMICAL$ encodes phosphatidylinositol 4-phosphate 5-kinase b type I (pip5k1b), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [@GENE$].",
        "relation": "CPR:9"
    },
    {
        "id": "23552101.T2.T21",
        "sentence": "PIP5K1B encodes @CHEMICAL$ (pip5k1b), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [@GENE$].",
        "relation": "CPR:9"
    },
    {
        "id": "23552101.T2.T22",
        "sentence": "PIP5K1B encodes phosphatidylinositol 4-phosphate 5-kinase b type I (@CHEMICAL$), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [@GENE$].",
        "relation": "CPR:9"
    },
    {
        "id": "23552101.T6.T20",
        "sentence": "@CHEMICAL$ encodes phosphatidylinositol 4-phosphate 5-kinase b type I (pip5k1b), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates @GENE$ [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2].",
        "relation": "CPR:9"
    },
    {
        "id": "23552101.T6.T21",
        "sentence": "PIP5K1B encodes @CHEMICAL$ (pip5k1b), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates @GENE$ [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2].",
        "relation": "CPR:9"
    },
    {
        "id": "23552101.T6.T22",
        "sentence": "PIP5K1B encodes phosphatidylinositol 4-phosphate 5-kinase b type I (@CHEMICAL$), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates @GENE$ [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2].",
        "relation": "CPR:9"
    },
    {
        "id": "23552101.T7.T20",
        "sentence": "@CHEMICAL$ encodes phosphatidylinositol 4-phosphate 5-kinase b type I (pip5k1b), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [@GENE$] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2].",
        "relation": "CPR:9"
    },
    {
        "id": "23552101.T7.T21",
        "sentence": "PIP5K1B encodes @CHEMICAL$ (pip5k1b), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [@GENE$] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2].",
        "relation": "CPR:9"
    },
    {
        "id": "23552101.T7.T22",
        "sentence": "PIP5K1B encodes phosphatidylinositol 4-phosphate 5-kinase b type I (@CHEMICAL$), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [@GENE$] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2].",
        "relation": "CPR:9"
    },
    {
        "id": "23552101.T3.T8",
        "sentence": "Accordingly, loss of @CHEMICAL$ function in FRDA cells was accompanied by decreased @GENE$ levels and was shown instrumental for destabilization of the actin network and delayed cell spreading.",
        "relation": "CPR:9"
    },
    {
        "id": "23453039.T8.T28",
        "sentence": "The expression of @CHEMICAL$ is stimulated through the action of insulin in liver cells in vitro and in vivo and it is decreased in the liver of rats with type I diabetes induced by @GENE$ administration in vivo.",
        "relation": "CPR:4"
    },
    {
        "id": "19428322.T4.T15",
        "sentence": "@CHEMICAL$ activators @GENE$ and AICAR partly prevented the cell cycle block, oxidative stress and apoptosis induced by compound C.",
        "relation": "CPR:3"
    },
    {
        "id": "19428322.T5.T15",
        "sentence": "@CHEMICAL$ activators metformin and @GENE$ partly prevented the cell cycle block, oxidative stress and apoptosis induced by compound C.",
        "relation": "CPR:3"
    },
    {
        "id": "17391279.T11.T25",
        "sentence": "@CHEMICAL$ treatment led to an increase in lipid peroxidation, @GENE$ and glucose-6-phosphate dehydrogenase activities and to a decrease in catalase activity and glutathione levels in gastric mucosa.",
        "relation": "CPR:3"
    },
    {
        "id": "17391279.T11.T26",
        "sentence": "@CHEMICAL$ treatment led to an increase in lipid peroxidation, glutathione peroxidase and @GENE$ activities and to a decrease in catalase activity and glutathione levels in gastric mucosa.",
        "relation": "CPR:3"
    },
    {
        "id": "17391279.T11.T27",
        "sentence": "@CHEMICAL$ treatment led to an increase in lipid peroxidation, glutathione peroxidase and glucose-6-phosphate dehydrogenase activities and to a decrease in @GENE$ activity and glutathione levels in gastric mucosa.",
        "relation": "CPR:4"
    },
    {
        "id": "23386702.T36.T53",
        "sentence": "Reversible inhibition of @CHEMICAL$ by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23386702.T1.T37",
        "sentence": "@CHEMICAL$ hydrolyze esters, amides, and thioesters to produce carboxylic acids and resulting @GENE$, amines, and thiols, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "23386702.T5.T37",
        "sentence": "@CHEMICAL$ hydrolyze esters, amides, and thioesters to produce carboxylic acids and resulting alcohols, @GENE$, and thiols, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "23386702.T8.T37",
        "sentence": "@CHEMICAL$ hydrolyze esters, amides, and thioesters to produce carboxylic acids and resulting alcohols, amines, and @GENE$, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "23386702.T21.T37",
        "sentence": "@CHEMICAL$ hydrolyze @GENE$, amides, and thioesters to produce carboxylic acids and resulting alcohols, amines, and thiols, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "23386702.T24.T37",
        "sentence": "@CHEMICAL$ hydrolyze esters, @GENE$, and thioesters to produce carboxylic acids and resulting alcohols, amines, and thiols, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "23386702.T27.T37",
        "sentence": "@CHEMICAL$ hydrolyze esters, amides, and @GENE$ to produce carboxylic acids and resulting alcohols, amines, and thiols, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "23386702.T30.T37",
        "sentence": "@CHEMICAL$ hydrolyze esters, amides, and thioesters to produce @GENE$ and resulting alcohols, amines, and thiols, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "23386702.T20.T39",
        "sentence": "@CHEMICAL$ are colocalized with carboxylesterases and have the potential to further metabolize @GENE$ to acyl glucuronides, but it is currently unknown if acyl glucuronides, being esters, also interact with carboxylesterases.",
        "relation": "CPR:9"
    },
    {
        "id": "23386702.T20.T46",
        "sentence": "Uridine 5'-diphosphate- glucuronosyltransferases are colocalized with @CHEMICAL$ and have the potential to further metabolize @GENE$ to acyl glucuronides, but it is currently unknown if acyl glucuronides, being esters, also interact with carboxylesterases.",
        "relation": "CPR:9"
    },
    {
        "id": "23386702.T22.T39",
        "sentence": "@CHEMICAL$ are colocalized with carboxylesterases and have the potential to further metabolize carboxylic acids to @GENE$, but it is currently unknown if acyl glucuronides, being esters, also interact with carboxylesterases.",
        "relation": "CPR:9"
    },
    {
        "id": "23386702.T22.T46",
        "sentence": "Uridine 5'-diphosphate- glucuronosyltransferases are colocalized with @CHEMICAL$ and have the potential to further metabolize carboxylic acids to @GENE$, but it is currently unknown if acyl glucuronides, being esters, also interact with carboxylesterases.",
        "relation": "CPR:9"
    },
    {
        "id": "23386702.T23.T39",
        "sentence": "@CHEMICAL$ are colocalized with carboxylesterases and have the potential to further metabolize carboxylic acids to acyl glucuronides, but it is currently unknown if @GENE$, being esters, also interact with carboxylesterases.",
        "relation": "CPR:9"
    },
    {
        "id": "23386702.T26.T48",
        "sentence": "Objective: This study explores the ability of @CHEMICAL$ to act as substrates or inhibitors of @GENE$ (hCES1) and 2 (hCES2). Methods: The stability of six acyl glucuronides in the presence of hCES1, hCES2, and buffer alone (100 mM potassium phosphate, pH 7.4, 37*C) were investigated.",
        "relation": "CPR:9"
    },
    {
        "id": "23386702.T26.T48",
        "sentence": "Objective: This study explores the ability of @CHEMICAL$ to act as substrates or inhibitors of @GENE$ (hCES1) and 2 (hCES2). Methods: The stability of six acyl glucuronides in the presence of hCES1, hCES2, and buffer alone (100 mM potassium phosphate, pH 7.4, 37*C) were investigated.",
        "relation": "CPR:4"
    },
    {
        "id": "23386702.T26.T49",
        "sentence": "Objective: This study explores the ability of @CHEMICAL$ to act as substrates or inhibitors of human carboxylesterases 1 (@GENE$) and 2 (hCES2). Methods: The stability of six acyl glucuronides in the presence of hCES1, hCES2, and buffer alone (100 mM potassium phosphate, pH 7.4, 37*C) were investigated.",
        "relation": "CPR:9"
    },
    {
        "id": "23386702.T26.T49",
        "sentence": "Objective: This study explores the ability of @CHEMICAL$ to act as substrates or inhibitors of human carboxylesterases 1 (@GENE$) and 2 (hCES2). Methods: The stability of six acyl glucuronides in the presence of hCES1, hCES2, and buffer alone (100 mM potassium phosphate, pH 7.4, 37*C) were investigated.",
        "relation": "CPR:4"
    },
    {
        "id": "23386702.T26.T50",
        "sentence": "Objective: This study explores the ability of @CHEMICAL$ to act as substrates or inhibitors of human carboxylesterases 1 (hCES1) and 2 (@GENE$). Methods: The stability of six acyl glucuronides in the presence of hCES1, hCES2, and buffer alone (100 mM potassium phosphate, pH 7.4, 37*C) were investigated.",
        "relation": "CPR:9"
    },
    {
        "id": "23386702.T26.T50",
        "sentence": "Objective: This study explores the ability of @CHEMICAL$ to act as substrates or inhibitors of human carboxylesterases 1 (hCES1) and 2 (@GENE$). Methods: The stability of six acyl glucuronides in the presence of hCES1, hCES2, and buffer alone (100 mM potassium phosphate, pH 7.4, 37*C) were investigated.",
        "relation": "CPR:4"
    },
    {
        "id": "23386702.T28.T51",
        "sentence": "Objective: This study explores the ability of acyl glucuronides to act as substrates or inhibitors of human carboxylesterases 1 (hCES1) and 2 (hCES2). Methods: The stability of six @CHEMICAL$ in the presence of @GENE$, hCES2, and buffer alone (100 mM potassium phosphate, pH 7.4, 37*C) were investigated.",
        "relation": "CPR:9"
    },
    {
        "id": "23386702.T28.T52",
        "sentence": "Objective: This study explores the ability of acyl glucuronides to act as substrates or inhibitors of human carboxylesterases 1 (hCES1) and 2 (hCES2). Methods: The stability of six @CHEMICAL$ in the presence of hCES1, @GENE$, and buffer alone (100 mM potassium phosphate, pH 7.4, 37*C) were investigated.",
        "relation": "CPR:9"
    },
    {
        "id": "23386702.T9.T38",
        "sentence": "@CHEMICAL$, clopidogrel-b-d-glucuronide, ibuprofen-b-d-glucuronide, (R)-naproxen-b-d-glucuronide, and (S)-naproxen-b-d-glucuronide selectively inhibited @GENE$, with Ki values of 4.32 + 0.47, 24.8 + 4.2, 355 + 38, 468 + 21, 707 + 64 mM, respectively, but did not significantly inhibit hCES2.",
        "relation": "CPR:4"
    },
    {
        "id": "23386702.T10.T38",
        "sentence": "Diclofenac-b-d-glucuronide, @CHEMICAL$, ibuprofen-b-d-glucuronide, (R)-naproxen-b-d-glucuronide, and (S)-naproxen-b-d-glucuronide selectively inhibited @GENE$, with Ki values of 4.32 + 0.47, 24.8 + 4.2, 355 + 38, 468 + 21, 707 + 64 mM, respectively, but did not significantly inhibit hCES2.",
        "relation": "CPR:4"
    },
    {
        "id": "23386702.T11.T38",
        "sentence": "Diclofenac-b-d-glucuronide, clopidogrel-b-d-glucuronide, @CHEMICAL$, (R)-naproxen-b-d-glucuronide, and (S)-naproxen-b-d-glucuronide selectively inhibited @GENE$, with Ki values of 4.32 + 0.47, 24.8 + 4.2, 355 + 38, 468 + 21, 707 + 64 mM, respectively, but did not significantly inhibit hCES2.",
        "relation": "CPR:4"
    },
    {
        "id": "23386702.T12.T38",
        "sentence": "Diclofenac-b-d-glucuronide, clopidogrel-b-d-glucuronide, ibuprofen-b-d-glucuronide, @CHEMICAL$, and (S)-naproxen-b-d-glucuronide selectively inhibited @GENE$, with Ki values of 4.32 + 0.47, 24.8 + 4.2, 355 + 38, 468 + 21, 707 + 64 mM, respectively, but did not significantly inhibit hCES2.",
        "relation": "CPR:4"
    },
    {
        "id": "23386702.T13.T38",
        "sentence": "Diclofenac-b-d-glucuronide, clopidogrel-b-d-glucuronide, ibuprofen-b-d-glucuronide, (R)-naproxen-b-d-glucuronide, and @CHEMICAL$ selectively inhibited @GENE$, with Ki values of 4.32 + 0.47, 24.8 + 4.2, 355 + 38, 468 + 21, 707 + 64 mM, respectively, but did not significantly inhibit hCES2.",
        "relation": "CPR:4"
    },
    {
        "id": "23386702.T19.T45",
        "sentence": "Conclusion: Drug-drug interaction studies may be warranted for drugs that metabolize to @CHEMICAL$ due to the potential inhibition of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23274771.T6.T18",
        "sentence": "Furthermore, @CHEMICAL$-treated WT and p65(-/-) MEFs differed in their expression of various apoptosis-associated molecules, when the former demonstrated a decrease in the percentage of @GENE$-positive and a more prominent decrease in the percentage of p53-positive cells, while a decreased percentage of IkBa-positive and a more prominent decrease in the percentage of bcl-2-positive cells was detected among the latter.",
        "relation": "CPR:4"
    },
    {
        "id": "23523949.T22.T44",
        "sentence": "RESULTS: @CHEMICAL$ induced histophatological damages and elevated the level of cardiac marker @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23523949.T1.T31",
        "sentence": "@CHEMICAL$ (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and @GENE$, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN.",
        "relation": "CPR:4"
    },
    {
        "id": "23523949.T1.T32",
        "sentence": "@CHEMICAL$ (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of @GENE$/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN.",
        "relation": "CPR:4"
    },
    {
        "id": "23523949.T1.T33",
        "sentence": "@CHEMICAL$ (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/@GENE$ ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN.",
        "relation": "CPR:4"
    },
    {
        "id": "23523949.T1.T34",
        "sentence": "@CHEMICAL$ (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of @GENE$ and release of cytochrome c to the cytosol induced by DZN.",
        "relation": "CPR:3"
    },
    {
        "id": "23523949.T1.T35",
        "sentence": "@CHEMICAL$ (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of @GENE$ to the cytosol induced by DZN.",
        "relation": "CPR:4"
    },
    {
        "id": "23523949.T2.T31",
        "sentence": "Crocin (25 and 50mg/kg) or @CHEMICAL$ improved histopathological damages, decreased MDA and @GENE$, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN.",
        "relation": "CPR:4"
    },
    {
        "id": "23523949.T2.T32",
        "sentence": "Crocin (25 and 50mg/kg) or @CHEMICAL$ improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of @GENE$/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN.",
        "relation": "CPR:4"
    },
    {
        "id": "23523949.T2.T33",
        "sentence": "Crocin (25 and 50mg/kg) or @CHEMICAL$ improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/@GENE$ ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN.",
        "relation": "CPR:4"
    },
    {
        "id": "23523949.T2.T34",
        "sentence": "Crocin (25 and 50mg/kg) or @CHEMICAL$ improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of @GENE$ and release of cytochrome c to the cytosol induced by DZN.",
        "relation": "CPR:3"
    },
    {
        "id": "23523949.T6.T32",
        "sentence": "Crocin (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of @CHEMICAL$/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23523949.T6.T33",
        "sentence": "Crocin (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/@CHEMICAL$ ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23523949.T6.T34",
        "sentence": "Crocin (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of @CHEMICAL$ and release of cytochrome c to the cytosol induced by @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23523949.T6.T35",
        "sentence": "Crocin (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of @CHEMICAL$ to the cytosol induced by @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "11730729.T20.T29",
        "sentence": "Effect of @CHEMICAL$-induced constitutive @GENE$ activity on contractile receptor function in airway smooth muscle.",
        "relation": "CPR:3"
    },
    {
        "id": "11730729.T10.T28",
        "sentence": "In the present study, we investigated the effect of @CHEMICAL$-induced constitutive @GENE$ activity on muscarinic receptor agonist- and histamine-induced bovine tracheal smooth muscle contractions.",
        "relation": "CPR:3"
    },
    {
        "id": "11730729.T9.T26",
        "sentence": "Bovine tracheal smooth muscle strips were incubated with 10 microM fenoterol or vehicle for various periods of time (5, 30 min, 18 h) at 37 degrees C. After extensive washout (3 h, 37 degrees C), isometric contractions were measured to the full @CHEMICAL$ agonist @GENE$, the partial muscarinic receptor agonist 4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium (McN-A-343) and histamine.",
        "relation": "CPR:5"
    },
    {
        "id": "11730729.T11.T27",
        "sentence": "Bovine tracheal smooth muscle strips were incubated with 10 microM fenoterol or vehicle for various periods of time (5, 30 min, 18 h) at 37 degrees C. After extensive washout (3 h, 37 degrees C), isometric contractions were measured to the full muscarinic receptor agonist methacholine, the partial @CHEMICAL$ agonist @GENE$ (McN-A-343) and histamine.",
        "relation": "CPR:5"
    },
    {
        "id": "11730729.T13.T27",
        "sentence": "Bovine tracheal smooth muscle strips were incubated with 10 microM fenoterol or vehicle for various periods of time (5, 30 min, 18 h) at 37 degrees C. After extensive washout (3 h, 37 degrees C), isometric contractions were measured to the full muscarinic receptor agonist methacholine, the partial @CHEMICAL$ agonist 4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium (McN-A-343) and @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "11730729.T4.T22",
        "sentence": "In conclusion, @CHEMICAL$-induced constitutive @GENE$ activity reduces muscarinic receptor agonist- and histamine-induced contractions of bovine tracheal smooth muscle, which can be reversed by the inverse agonist timolol.",
        "relation": "CPR:3"
    },
    {
        "id": "11730729.T7.T22",
        "sentence": "In conclusion, fenoterol-induced constitutive @CHEMICAL$ activity reduces muscarinic receptor agonist- and histamine-induced contractions of bovine tracheal smooth muscle, which can be reversed by the inverse agonist @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "23247009.T11.T20",
        "sentence": "@CHEMICAL$ reduces the expression of lipopolysaccharide-induced inflammatory markers by inhibition of @GENE$ in murine macrophages and ocular tissues.",
        "relation": "CPR:4"
    },
    {
        "id": "23247009.T7.T13",
        "sentence": "@CHEMICAL$ (AR) catalyzes the reduction of toxic lipid @GENE$ to their alcohol products and mediates inflammatory signals triggered by lipopolysaccharide (LPS).",
        "relation": "CPR:9"
    },
    {
        "id": "23247009.T7.T14",
        "sentence": "Aldose reductase (@CHEMICAL$) catalyzes the reduction of toxic lipid @GENE$ to their alcohol products and mediates inflammatory signals triggered by lipopolysaccharide (LPS).",
        "relation": "CPR:9"
    },
    {
        "id": "23247009.T9.T13",
        "sentence": "@CHEMICAL$ (AR) catalyzes the reduction of toxic lipid aldehydes to their @GENE$ products and mediates inflammatory signals triggered by lipopolysaccharide (LPS).",
        "relation": "CPR:9"
    },
    {
        "id": "23247009.T9.T14",
        "sentence": "Aldose reductase (@CHEMICAL$) catalyzes the reduction of toxic lipid aldehydes to their @GENE$ products and mediates inflammatory signals triggered by lipopolysaccharide (LPS).",
        "relation": "CPR:9"
    },
    {
        "id": "23247009.T2.T15",
        "sentence": "@CHEMICAL$ (BGG), a recently described @GENE$ inhibitor, was purified from extracts of the Indian gooseberry (Emblica officinalis).",
        "relation": "CPR:4"
    },
    {
        "id": "23247009.T3.T15",
        "sentence": "Beta-glucogallin (@CHEMICAL$), a recently described @GENE$ inhibitor, was purified from extracts of the Indian gooseberry (Emblica officinalis).",
        "relation": "CPR:4"
    },
    {
        "id": "23247009.T4.T16",
        "sentence": "In this study, we found that @CHEMICAL$ showed low cytotoxicity in Raw264.7 murine macrophages and effectively inhibited @GENE$ activity as measured by a decrease in sorbitol accumulation.",
        "relation": "CPR:4"
    },
    {
        "id": "23247009.T6.T18",
        "sentence": "In addition, @CHEMICAL$-mediated inhibition of AR prevented LPS-induced activation of @GENE$ and p38 and lowered ROS levels, which could inhibit LPS-induced apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23247009.T6.T19",
        "sentence": "In addition, @CHEMICAL$-mediated inhibition of AR prevented LPS-induced activation of JNK and @GENE$ and lowered ROS levels, which could inhibit LPS-induced apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23247009.T6.T17",
        "sentence": "In addition, @CHEMICAL$-mediated inhibition of @GENE$ prevented LPS-induced activation of JNK and p38 and lowered ROS levels, which could inhibit LPS-induced apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "9480923.T16.T40",
        "sentence": "Exogenous @CHEMICAL$ activates @GENE$ via Rac-dependent signalling pathway.",
        "relation": "CPR:3"
    },
    {
        "id": "9480923.T12.T30",
        "sentence": "Treatment of Rat-2 fibroblast cells with @CHEMICAL$ caused the stimulation of @GENE$-dependent reporter gene activity in a dose- and time-dependent manner by transient transfection analysis.",
        "relation": "CPR:3"
    },
    {
        "id": "9480923.T13.T33",
        "sentence": "Next, we examined the role of Rho family GTPases in the @CHEMICAL$-induced signalling to @GENE$ activation.",
        "relation": "CPR:3"
    },
    {
        "id": "9480923.T14.T37",
        "sentence": "By reporter gene analysis following transient transfections with various plasmids expressing a dominant negative mutant form of Cdc42, Rac1 or RhoA, @CHEMICAL$-induced @GENE$ activation was shown to be selectively repressed by pEXV-RacN17 encoding a dominant negative mutant of Rac1, suggesting that Rac activity is essential for the signalling cascade of ceramide to the nucleus.",
        "relation": "CPR:3"
    },
    {
        "id": "9480923.T4.T21",
        "sentence": "In a further study to analyse the downstream mediator of Rac in the ceramide-signalling pathway, we observed that either pretreatment with mepacrine, a potent and specific inhibitor of phospholipase A2, or co-transfection with antisense cytosolic phospholipase A2 (cPLA2) oligonucleotide repressed the @CHEMICAL$-induced @GENE$ activation selectively, implying a critical role of cPLA2 in C2-ceramide-induced signalling to nucleus.",
        "relation": "CPR:3"
    },
    {
        "id": "9480923.T6.T24",
        "sentence": "Consistent with these results, the translocation of cPLA2 protein as well as the release of @CHEMICAL$, a principal product of @GENE$, was rapidly induced by the addition of C2-ceramide in a Rac-dependent manner.",
        "relation": "CPR:9"
    },
    {
        "id": "9480923.T8.T27",
        "sentence": "Together, our findings suggest the critical role of 'Rac and subsequent activation of @CHEMICAL$' in @GENE$-signalling to nucleus.",
        "relation": "CPR:3"
    },
    {
        "id": "16730121.T14.T18",
        "sentence": "Effect of @CHEMICAL$ (TAK-375), a selective @GENE$ agonist, on motor performance in mice.",
        "relation": "CPR:5"
    },
    {
        "id": "16730121.T15.T18",
        "sentence": "Effect of ramelteon (@CHEMICAL$), a selective @GENE$ agonist, on motor performance in mice.",
        "relation": "CPR:5"
    },
    {
        "id": "16730121.T1.T16",
        "sentence": "Effect of @CHEMICAL$ (ramelteon, TAK-375), a selective @GENE$ agonist, on motor coordination was studied using rota-rod performance in mice.",
        "relation": "CPR:5"
    },
    {
        "id": "16730121.T12.T16",
        "sentence": "Effect of (S)-N-[2-(1,6,7,8-tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide (@CHEMICAL$, TAK-375), a selective @GENE$ agonist, on motor coordination was studied using rota-rod performance in mice.",
        "relation": "CPR:5"
    },
    {
        "id": "16730121.T13.T16",
        "sentence": "Effect of (S)-N-[2-(1,6,7,8-tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide (ramelteon, @CHEMICAL$), a selective @GENE$ agonist, on motor coordination was studied using rota-rod performance in mice.",
        "relation": "CPR:5"
    },
    {
        "id": "23410005.T4.T14",
        "sentence": "Synthesis and cancer stem cell-based activity of substituted @CHEMICAL$ designed as next generation @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23410005.T1.T7",
        "sentence": "Our previous work, built on the early pioneering multikinase inhibitor @CHEMICAL$, resulted in the only @GENE$ vascular-targeted PI3K inhibitor prodrug, SF1126, which has now completed Phase I clinical trials.",
        "relation": "CPR:4"
    },
    {
        "id": "23410005.T1.T8",
        "sentence": "Our previous work, built on the early pioneering multikinase inhibitor @CHEMICAL$, resulted in the only PI3K vascular-targeted @GENE$ inhibitor prodrug, SF1126, which has now completed Phase I clinical trials.",
        "relation": "CPR:4"
    },
    {
        "id": "23410005.T2.T7",
        "sentence": "Our previous work, built on the early pioneering multikinase inhibitor LY294002, resulted in the only @CHEMICAL$ vascular-targeted PI3K inhibitor prodrug, @GENE$, which has now completed Phase I clinical trials.",
        "relation": "CPR:4"
    },
    {
        "id": "23410005.T2.T8",
        "sentence": "Our previous work, built on the early pioneering multikinase inhibitor LY294002, resulted in the only PI3K vascular-targeted @CHEMICAL$ inhibitor prodrug, @GENE$, which has now completed Phase I clinical trials.",
        "relation": "CPR:4"
    },
    {
        "id": "23410005.T3.T12",
        "sentence": "We embarked on the exploration of scaffolds that retained such properties while simultaneously exhibiting an increased potency toward PI3K. This work resulted in the discovery of the @CHEMICAL$ system as the foundation of a new compound class of potential @GENE$ inhibitors having improved potency toward PI3K. The synthesis and cancer stem cell-based activity of these compounds are reported herein.",
        "relation": "CPR:4"
    },
    {
        "id": "23410005.T3.T13",
        "sentence": "We embarked on the exploration of scaffolds that retained such properties while simultaneously exhibiting an increased potency toward PI3K. This work resulted in the discovery of the @CHEMICAL$ system as the foundation of a new compound class of potential PI3K inhibitors having improved potency toward @GENE$. The synthesis and cancer stem cell-based activity of these compounds are reported herein.",
        "relation": "CPR:4"
    },
    {
        "id": "16978033.T6.T25",
        "sentence": "@CHEMICAL$, a @GENE$ inhibitor is currently in phase II clinical trials.",
        "relation": "CPR:4"
    },
    {
        "id": "15686475.T7.T41",
        "sentence": "Firstly, the V(max) of @CHEMICAL$ was increased when ApoCaM was present whereas the affinity for the substrate, @GENE$, was not affected.",
        "relation": "CPR:9"
    },
    {
        "id": "17488480.T1.T32",
        "sentence": "@CHEMICAL$ (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (@GENE$) and cystathionine-beta-synthase (CBS).",
        "relation": "CPR:9"
    },
    {
        "id": "17488480.T1.T34",
        "sentence": "@CHEMICAL$ (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and @GENE$ (CBS).",
        "relation": "CPR:9"
    },
    {
        "id": "17488480.T1.T38",
        "sentence": "@CHEMICAL$ (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "17488480.T1.T49",
        "sentence": "@CHEMICAL$ (H(2)S) is synthesized from L-cysteine via the action of @GENE$ (CSE) and cystathionine-beta-synthase (CBS).",
        "relation": "CPR:9"
    },
    {
        "id": "17488480.T15.T32",
        "sentence": "Hydrogen sulphide (@CHEMICAL$) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (@GENE$) and cystathionine-beta-synthase (CBS).",
        "relation": "CPR:9"
    },
    {
        "id": "17488480.T15.T34",
        "sentence": "Hydrogen sulphide (@CHEMICAL$) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and @GENE$ (CBS).",
        "relation": "CPR:9"
    },
    {
        "id": "17488480.T15.T38",
        "sentence": "Hydrogen sulphide (@CHEMICAL$) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "17488480.T15.T49",
        "sentence": "Hydrogen sulphide (@CHEMICAL$) is synthesized from L-cysteine via the action of @GENE$ (CSE) and cystathionine-beta-synthase (CBS).",
        "relation": "CPR:9"
    },
    {
        "id": "17488480.T18.T32",
        "sentence": "Hydrogen sulphide (H(2)S) is synthesized from @CHEMICAL$ via the action of cystathionine-gamma-lyase (@GENE$) and cystathionine-beta-synthase (CBS).",
        "relation": "CPR:9"
    },
    {
        "id": "17488480.T18.T34",
        "sentence": "Hydrogen sulphide (H(2)S) is synthesized from @CHEMICAL$ via the action of cystathionine-gamma-lyase (CSE) and @GENE$ (CBS).",
        "relation": "CPR:9"
    },
    {
        "id": "17488480.T18.T38",
        "sentence": "Hydrogen sulphide (H(2)S) is synthesized from @CHEMICAL$ via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "17488480.T18.T49",
        "sentence": "Hydrogen sulphide (H(2)S) is synthesized from @CHEMICAL$ via the action of @GENE$ (CSE) and cystathionine-beta-synthase (CBS).",
        "relation": "CPR:9"
    },
    {
        "id": "17488480.T17.T44",
        "sentence": "In this study, we investigated the presence of H(2)S and the expression of @CHEMICAL$ synthesizing enzymes, @GENE$ and CBS, in isolated mouse pancreatic acini.",
        "relation": "CPR:9"
    },
    {
        "id": "17488480.T17.T45",
        "sentence": "In this study, we investigated the presence of H(2)S and the expression of @CHEMICAL$ synthesizing enzymes, CSE and @GENE$, in isolated mouse pancreatic acini.",
        "relation": "CPR:9"
    },
    {
        "id": "17488480.T20.T46",
        "sentence": "@CHEMICAL$ increased the levels of H(2)S and @GENE$ mRNA expression while CBS mRNA expression was decreased.",
        "relation": "CPR:3"
    },
    {
        "id": "17488480.T20.T47",
        "sentence": "@CHEMICAL$ increased the levels of H(2)S and CSE mRNA expression while @GENE$ mRNA expression was decreased.",
        "relation": "CPR:4"
    },
    {
        "id": "17488480.T22.T48",
        "sentence": "In addition, cells pre-treated with @CHEMICAL$ (PAG, 3 mM), a @GENE$ inhibitor, reduced the formation of H(2)S in caerulein treated cells, suggesting that CSE may be the main enzyme involved in H(2)S formation in mouse acinar cells.",
        "relation": "CPR:4"
    },
    {
        "id": "17488480.T23.T48",
        "sentence": "In addition, cells pre-treated with DL-propargylglycine (@CHEMICAL$, 3 mM), a @GENE$ inhibitor, reduced the formation of H(2)S in caerulein treated cells, suggesting that CSE may be the main enzyme involved in H(2)S formation in mouse acinar cells.",
        "relation": "CPR:4"
    },
    {
        "id": "17488480.T27.T50",
        "sentence": "In addition, cells pre-treated with DL-propargylglycine (PAG, 3 mM), a CSE inhibitor, reduced the formation of H(2)S in caerulein treated cells, suggesting that @CHEMICAL$ may be the main enzyme involved in @GENE$ formation in mouse acinar cells.",
        "relation": "CPR:9"
    },
    {
        "id": "17488480.T3.T51",
        "sentence": "Furthermore, @CHEMICAL$ (SP) concentration in the acini and expression of SP gene (preprotachykinin-A, PPT-A) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue @GENE$-treated acinar cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17488480.T3.T52",
        "sentence": "Furthermore, substance P (@CHEMICAL$) concentration in the acini and expression of SP gene (preprotachykinin-A, PPT-A) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue @GENE$-treated acinar cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17488480.T3.T53",
        "sentence": "Furthermore, substance P (SP) concentration in the acini and expression of @CHEMICAL$ gene (preprotachykinin-A, PPT-A) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue @GENE$-treated acinar cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17488480.T3.T54",
        "sentence": "Furthermore, substance P (SP) concentration in the acini and expression of SP gene (@CHEMICAL$, PPT-A) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue @GENE$-treated acinar cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17488480.T3.T55",
        "sentence": "Furthermore, substance P (SP) concentration in the acini and expression of SP gene (preprotachykinin-A, @CHEMICAL$) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue @GENE$-treated acinar cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17488480.T3.T56",
        "sentence": "Furthermore, substance P (SP) concentration in the acini and expression of SP gene (preprotachykinin-A, PPT-A) and @CHEMICAL$ (NK-1R), the primary receptor for SP, are increased in secretagogue @GENE$-treated acinar cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17488480.T3.T57",
        "sentence": "Furthermore, substance P (SP) concentration in the acini and expression of SP gene (preprotachykinin-A, PPT-A) and neurokinin-1 receptor (@CHEMICAL$), the primary receptor for SP, are increased in secretagogue @GENE$-treated acinar cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17488480.T5.T35",
        "sentence": "Inhibition of endogenous production of @CHEMICAL$ by PAG significantly suppressed @GENE$ concentration, PPT-A expression and NK1-R expression in the acini.",
        "relation": "CPR:4"
    },
    {
        "id": "17488480.T5.T36",
        "sentence": "Inhibition of endogenous production of @CHEMICAL$ by PAG significantly suppressed SP concentration, @GENE$ expression and NK1-R expression in the acini.",
        "relation": "CPR:4"
    },
    {
        "id": "17488480.T5.T37",
        "sentence": "Inhibition of endogenous production of @CHEMICAL$ by PAG significantly suppressed SP concentration, PPT-A expression and @GENE$ expression in the acini.",
        "relation": "CPR:4"
    },
    {
        "id": "17488480.T10.T39",
        "sentence": "To determine whether H(2)S itself provoked inflammation in acinar cells, the cells were treated with H(2)S donor drug, @CHEMICAL$ (NaHS), (10, 50 and 100 muM), that resulted in a significant increase in @GENE$ concentration and expression of PPT-A and NK1-R in acinar cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17488480.T10.T40",
        "sentence": "To determine whether H(2)S itself provoked inflammation in acinar cells, the cells were treated with H(2)S donor drug, @CHEMICAL$ (NaHS), (10, 50 and 100 muM), that resulted in a significant increase in SP concentration and expression of @GENE$ and NK1-R in acinar cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17488480.T10.T41",
        "sentence": "To determine whether H(2)S itself provoked inflammation in acinar cells, the cells were treated with H(2)S donor drug, @CHEMICAL$ (NaHS), (10, 50 and 100 muM), that resulted in a significant increase in SP concentration and expression of PPT-A and @GENE$ in acinar cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17488480.T11.T39",
        "sentence": "To determine whether H(2)S itself provoked inflammation in acinar cells, the cells were treated with H(2)S donor drug, sodium hydrosulphide (@CHEMICAL$), (10, 50 and 100 muM), that resulted in a significant increase in @GENE$ concentration and expression of PPT-A and NK1-R in acinar cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17488480.T11.T40",
        "sentence": "To determine whether H(2)S itself provoked inflammation in acinar cells, the cells were treated with H(2)S donor drug, sodium hydrosulphide (@CHEMICAL$), (10, 50 and 100 muM), that resulted in a significant increase in SP concentration and expression of @GENE$ and NK1-R in acinar cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17488480.T11.T41",
        "sentence": "To determine whether H(2)S itself provoked inflammation in acinar cells, the cells were treated with H(2)S donor drug, sodium hydrosulphide (@CHEMICAL$), (10, 50 and 100 muM), that resulted in a significant increase in SP concentration and expression of PPT-A and @GENE$ in acinar cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17488480.T13.T42",
        "sentence": "These results suggest that the pro-inflammatory effect of @CHEMICAL$ may be mediated by @GENE$-NK-1R related pathway in mouse pancreatic acinar cells.",
        "relation": "CPR:9"
    },
    {
        "id": "17488480.T13.T43",
        "sentence": "These results suggest that the pro-inflammatory effect of @CHEMICAL$ may be mediated by SP-@GENE$ related pathway in mouse pancreatic acinar cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23631499.T2.T14",
        "sentence": "The results showed that administration of @CHEMICAL$ resulted in a significant elevation in the levels of AchE activity, CRP, @GENE$, and MCP-1 accompanied with a significant depletion in the Ach level.",
        "relation": "CPR:3"
    },
    {
        "id": "23631499.T2.T12",
        "sentence": "The results showed that administration of @CHEMICAL$ resulted in a significant elevation in the levels of @GENE$ activity, CRP, NF-kB, and MCP-1 accompanied with a significant depletion in the Ach level.",
        "relation": "CPR:3"
    },
    {
        "id": "23631499.T2.T13",
        "sentence": "The results showed that administration of @CHEMICAL$ resulted in a significant elevation in the levels of AchE activity, @GENE$, NF-kB, and MCP-1 accompanied with a significant depletion in the Ach level.",
        "relation": "CPR:3"
    },
    {
        "id": "23631499.T2.T15",
        "sentence": "The results showed that administration of @CHEMICAL$ resulted in a significant elevation in the levels of AchE activity, CRP, NF-kB, and @GENE$ accompanied with a significant depletion in the Ach level.",
        "relation": "CPR:3"
    },
    {
        "id": "23578607.T20.T31",
        "sentence": "The biological activities of 6-DHSG were attenuated by sulfhydryl antioxidants such as glutathione (GSH) or N-acetyl cysteine (NAC), but not ascorbic acid (ASC). @CHEMICAL$ was metabolised by GSH to form a GSH conjugate (GS-6-DHSG) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of @GENE$ (GST).",
        "relation": "CPR:9"
    },
    {
        "id": "23578607.T20.T32",
        "sentence": "The biological activities of 6-DHSG were attenuated by sulfhydryl antioxidants such as glutathione (GSH) or N-acetyl cysteine (NAC), but not ascorbic acid (ASC). @CHEMICAL$ was metabolised by GSH to form a GSH conjugate (GS-6-DHSG) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of glutathione-S-transferase (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "23578607.T23.T31",
        "sentence": "The biological activities of 6-DHSG were attenuated by sulfhydryl antioxidants such as glutathione (GSH) or N-acetyl cysteine (NAC), but not ascorbic acid (ASC). 6-DHSG was metabolised by GSH to form a GSH conjugate (@CHEMICAL$) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of @GENE$ (GST).",
        "relation": "CPR:9"
    },
    {
        "id": "23578607.T23.T32",
        "sentence": "The biological activities of 6-DHSG were attenuated by sulfhydryl antioxidants such as glutathione (GSH) or N-acetyl cysteine (NAC), but not ascorbic acid (ASC). 6-DHSG was metabolised by GSH to form a GSH conjugate (@CHEMICAL$) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of glutathione-S-transferase (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "23115325.T22.T39",
        "sentence": "The concentration response to @CHEMICAL$ (LEVC), a @GENE$ opener, was significantly shifted to the left in the inflamed smooth-muscle cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23115325.T23.T39",
        "sentence": "The concentration response to levcromakalim (@CHEMICAL$), a @GENE$ opener, was significantly shifted to the left in the inflamed smooth-muscle cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23115325.T9.T32",
        "sentence": "In control cells, pretreatment with 100 mM NaHS shifted the EC(50) for LEV-induced currents from 2838 (n = 6) to 154 (n = 8) nM. Sulfhydration of @CHEMICAL$ (SUR2B) was induced by @GENE$ and colonic inflammation.",
        "relation": "CPR:3"
    },
    {
        "id": "23115325.T9.T33",
        "sentence": "In control cells, pretreatment with 100 mM NaHS shifted the EC(50) for LEV-induced currents from 2838 (n = 6) to 154 (n = 8) nM. Sulfhydration of sulfonylurea receptor 2B (@CHEMICAL$) was induced by @GENE$ and colonic inflammation.",
        "relation": "CPR:3"
    },
    {
        "id": "17497253.T1.T4",
        "sentence": "Pharmacological treatment has been studied and it could be demonstrated, that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as, e.g., @CHEMICAL$ or ibutilide in patients with a mutation in the @GENE$-coding gene KCNH2 (HERG).",
        "relation": "CPR:4"
    },
    {
        "id": "17497253.T1.T5",
        "sentence": "Pharmacological treatment has been studied and it could be demonstrated, that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as, e.g., @CHEMICAL$ or ibutilide in patients with a mutation in the IKr-coding gene @GENE$ (HERG).",
        "relation": "CPR:4"
    },
    {
        "id": "17497253.T1.T6",
        "sentence": "Pharmacological treatment has been studied and it could be demonstrated, that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as, e.g., @CHEMICAL$ or ibutilide in patients with a mutation in the IKr-coding gene KCNH2 (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "17497253.T2.T4",
        "sentence": "Pharmacological treatment has been studied and it could be demonstrated, that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as, e.g., sotalol or @CHEMICAL$ in patients with a mutation in the @GENE$-coding gene KCNH2 (HERG).",
        "relation": "CPR:4"
    },
    {
        "id": "17497253.T2.T5",
        "sentence": "Pharmacological treatment has been studied and it could be demonstrated, that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as, e.g., sotalol or @CHEMICAL$ in patients with a mutation in the IKr-coding gene @GENE$ (HERG).",
        "relation": "CPR:4"
    },
    {
        "id": "17497253.T2.T6",
        "sentence": "Pharmacological treatment has been studied and it could be demonstrated, that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as, e.g., sotalol or @CHEMICAL$ in patients with a mutation in the IKr-coding gene KCNH2 (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "6374639.T4.T18",
        "sentence": "Although inhibition of @CHEMICAL$ release can be achieved by @GENE$ and progestins, an optimal inhibitory effect on the prostate is obtained by the combined administration of the antiandrogen with an LHRH agonist that causes a specific blockage of testicular androgen biosynthesis as well as an inhibition of the LH responsiveness to LHRH.",
        "relation": "CPR:4"
    },
    {
        "id": "6374639.T5.T18",
        "sentence": "Although inhibition of @CHEMICAL$ release can be achieved by estrogen and @GENE$, an optimal inhibitory effect on the prostate is obtained by the combined administration of the antiandrogen with an LHRH agonist that causes a specific blockage of testicular androgen biosynthesis as well as an inhibition of the LH responsiveness to LHRH.",
        "relation": "CPR:4"
    },
    {
        "id": "14600253.T15.T28",
        "sentence": "Mechanisms of @CHEMICAL$ uptake in the choroid plexus: studies in wild-type and @GENE$ knockout mice.",
        "relation": "CPR:9"
    },
    {
        "id": "14600253.T7.T22",
        "sentence": "The choroid plexus uptake of @CHEMICAL$ was studied in @GENE$ (PEPT2) wild-type and null mice as a function of temperature, transport inhibitors, pH, and saturability.",
        "relation": "CPR:9"
    },
    {
        "id": "14600253.T7.T27",
        "sentence": "The choroid plexus uptake of @CHEMICAL$ was studied in peptide transporter 2 (@GENE$) wild-type and null mice as a function of temperature, transport inhibitors, pH, and saturability.",
        "relation": "CPR:9"
    },
    {
        "id": "14600253.T6.T20",
        "sentence": "At normal pH (7.4) and temperature (37 degrees C), the uptake of 1 microM @CHEMICAL$ was reduced by 83% in @GENE$(-/-) mice as compared with PEPT2(+/+) mice (p < 0.001).",
        "relation": "CPR:9"
    },
    {
        "id": "14600253.T6.T21",
        "sentence": "At normal pH (7.4) and temperature (37 degrees C), the uptake of 1 microM @CHEMICAL$ was reduced by 83% in PEPT2(-/-) mice as compared with @GENE$(+/+) mice (p < 0.001).",
        "relation": "CPR:9"
    },
    {
        "id": "14600253.T11.T23",
        "sentence": "Glycylsarcosine coadministration could inhibit the uptake of @CHEMICAL$ in @GENE$(+/+) mice (p < 0.01) but not PEPT2(-/-) mice.",
        "relation": "CPR:9"
    },
    {
        "id": "14600253.T11.T24",
        "sentence": "Glycylsarcosine coadministration could inhibit the uptake of @CHEMICAL$ in PEPT2(+/+) mice (p < 0.01) but not @GENE$(-/-) mice.",
        "relation": "CPR:9"
    },
    {
        "id": "14600253.T12.T25",
        "sentence": "Although a proton-stimulated uptake of @CHEMICAL$ was demonstrated in @GENE$(+/+) mice (pH 6.5 versus pH 7.4; p < 0.01), no pH dependence was observed in PEPT2(-/-) mice.",
        "relation": "CPR:9"
    },
    {
        "id": "14600253.T12.T26",
        "sentence": "Although a proton-stimulated uptake of @CHEMICAL$ was demonstrated in PEPT2(+/+) mice (pH 6.5 versus pH 7.4; p < 0.01), no pH dependence was observed in @GENE$(-/-) mice.",
        "relation": "CPR:9"
    },
    {
        "id": "14600253.T5.T18",
        "sentence": "These findings demonstrate that @CHEMICAL$ is the primary transporter responsible for @GENE$ uptake in the choroid plexus.",
        "relation": "CPR:9"
    },
    {
        "id": "23625750.T15.T27",
        "sentence": "The effects of the @CHEMICAL$ agonist @GENE$ on sodium taurocholate-induced experimental acute pancreatitis.",
        "relation": "CPR:5"
    },
    {
        "id": "23625750.T11.T24",
        "sentence": "The experiments were performed on 80 male Wistar rats, 58 of which survived, subdivided into 3 groups: C-control rats, I-EAP group, and II-EAP group treated with the @CHEMICAL$ agonist @GENE$ (1-deoxy-1-6[[(3-iodophenyl) methyl]amino]-9H-purin-9-yl)-N-methyl-B-D-ribofuronamide at a dose of 0.75 mg/kg b.w. i.p. at 48, 24, 12 and 1 h before and 1 h after the injection of 5 % sodium taurocholate solution into the biliary-pancreatic duct.",
        "relation": "CPR:5"
    },
    {
        "id": "23625750.T12.T24",
        "sentence": "The experiments were performed on 80 male Wistar rats, 58 of which survived, subdivided into 3 groups: C-control rats, I-EAP group, and II-EAP group treated with the @CHEMICAL$ agonist IB-MECA @GENE$ at a dose of 0.75 mg/kg b.w. i.p. at 48, 24, 12 and 1 h before and 1 h after the injection of 5 % sodium taurocholate solution into the biliary-pancreatic duct.",
        "relation": "CPR:5"
    },
    {
        "id": "23625750.T1.T17",
        "sentence": "In the @CHEMICAL$ group, @GENE$ activity was decreased with statistically high significance compared to group I. The activity of lipase was not significantly different among the experimental groups but higher than in the control group.",
        "relation": "CPR:4"
    },
    {
        "id": "23625750.T4.T20",
        "sentence": "The use of @CHEMICAL$ agonist @GENE$ attenuates EAP.",
        "relation": "CPR:5"
    },
    {
        "id": "23350847.T2.T5",
        "sentence": "@CHEMICAL$ as Selective @GENE$ Inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23350847.T1.T4",
        "sentence": "We describe the discovery of several @CHEMICAL$ as potent and selective @GENE$ inhibitors and the efforts that eventually led to the desired improvements in physicochemical properties and human whole blood potencies.",
        "relation": "CPR:4"
    },
    {
        "id": "23182954.T4.T17",
        "sentence": "@CHEMICAL$ plus PM(2.5) exposure, however, induced CRP, IL-6, @GENE$, LDH and MDA increase, SOD and HRV decrease significantly in a dose-response way.",
        "relation": "CPR:3"
    },
    {
        "id": "23182954.T4.T18",
        "sentence": "@CHEMICAL$ plus PM(2.5) exposure, however, induced CRP, IL-6, CK, @GENE$ and MDA increase, SOD and HRV decrease significantly in a dose-response way.",
        "relation": "CPR:3"
    },
    {
        "id": "23182954.T4.T19",
        "sentence": "@CHEMICAL$ plus PM(2.5) exposure, however, induced CRP, IL-6, CK, LDH and MDA increase, @GENE$ and HRV decrease significantly in a dose-response way.",
        "relation": "CPR:4"
    },
    {
        "id": "23182954.T4.T15",
        "sentence": "@CHEMICAL$ plus PM(2.5) exposure, however, induced @GENE$, IL-6, CK, LDH and MDA increase, SOD and HRV decrease significantly in a dose-response way.",
        "relation": "CPR:3"
    },
    {
        "id": "23182954.T4.T16",
        "sentence": "@CHEMICAL$ plus PM(2.5) exposure, however, induced CRP, @GENE$, CK, LDH and MDA increase, SOD and HRV decrease significantly in a dose-response way.",
        "relation": "CPR:3"
    },
    {
        "id": "18465538.T2.T11",
        "sentence": "@CHEMICAL$, a @GENE$ inhibitor, arrests cell division and causes apoptosis in non-small lung cancer cells [283660].",
        "relation": "CPR:4"
    },
    {
        "id": "18465538.T5.T12",
        "sentence": "In ex vivo experiments with tumor cells from refractory chronic lymphoblastic leukemia, dose-dependent @CHEMICAL$ inhibition associated with apoptotic changes was seen at concentrations greater than 100 nM of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "18465538.T9.T13",
        "sentence": "@CHEMICAL$ inhibits @GENE$ with an IC50 value of 0.4 mM [285707].",
        "relation": "CPR:4"
    },
    {
        "id": "15110853.T12.T19",
        "sentence": "@CHEMICAL$ inhibitors: @GENE$ incorporating adamantyl moieties with strong anticonvulsant activity.",
        "relation": "CPR:4"
    },
    {
        "id": "15110853.T13.T19",
        "sentence": "@CHEMICAL$ inhibitors: aromatic and heterocyclic sulfonamides incorporating @GENE$ moieties with strong anticonvulsant activity.",
        "relation": "CPR:4"
    },
    {
        "id": "15110853.T9.T14",
        "sentence": "Some of these derivatives showed good inhibitory potency against two @CHEMICAL$ isozymes involved in important physiological processes, CA I, and CA II, of the same order of magnitude as the clinically used drugs @GENE$ and methazolamide.",
        "relation": "CPR:4"
    },
    {
        "id": "15110853.T9.T15",
        "sentence": "Some of these derivatives showed good inhibitory potency against two human CA isozymes involved in important physiological processes, @CHEMICAL$, and CA II, of the same order of magnitude as the clinically used drugs @GENE$ and methazolamide.",
        "relation": "CPR:4"
    },
    {
        "id": "15110853.T9.T16",
        "sentence": "Some of these derivatives showed good inhibitory potency against two human CA isozymes involved in important physiological processes, CA I, and @CHEMICAL$, of the same order of magnitude as the clinically used drugs @GENE$ and methazolamide.",
        "relation": "CPR:4"
    },
    {
        "id": "15110853.T11.T14",
        "sentence": "Some of these derivatives showed good inhibitory potency against two @CHEMICAL$ isozymes involved in important physiological processes, CA I, and CA II, of the same order of magnitude as the clinically used drugs acetazolamide and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15110853.T11.T15",
        "sentence": "Some of these derivatives showed good inhibitory potency against two human CA isozymes involved in important physiological processes, @CHEMICAL$, and CA II, of the same order of magnitude as the clinically used drugs acetazolamide and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15110853.T11.T16",
        "sentence": "Some of these derivatives showed good inhibitory potency against two human CA isozymes involved in important physiological processes, CA I, and @CHEMICAL$, of the same order of magnitude as the clinically used drugs acetazolamide and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12067524.T1.T17",
        "sentence": "BACKGROUND AND AIMS: @CHEMICAL$ (GAD, EC 4.1.1.15) catalyses the conversion of glutamate to @GENE$ (GABA).",
        "relation": "CPR:9"
    },
    {
        "id": "12067524.T1.T22",
        "sentence": "BACKGROUND AND AIMS: Glutamic acid decarboxylase (@CHEMICAL$, EC 4.1.1.15) catalyses the conversion of glutamate to @GENE$ (GABA).",
        "relation": "CPR:9"
    },
    {
        "id": "12067524.T1.T23",
        "sentence": "BACKGROUND AND AIMS: Glutamic acid decarboxylase (GAD, @CHEMICAL$) catalyses the conversion of glutamate to @GENE$ (GABA).",
        "relation": "CPR:9"
    },
    {
        "id": "12067524.T3.T17",
        "sentence": "BACKGROUND AND AIMS: @CHEMICAL$ (GAD, EC 4.1.1.15) catalyses the conversion of glutamate to gamma-aminobutyric acid (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "12067524.T3.T22",
        "sentence": "BACKGROUND AND AIMS: Glutamic acid decarboxylase (@CHEMICAL$, EC 4.1.1.15) catalyses the conversion of glutamate to gamma-aminobutyric acid (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "12067524.T3.T23",
        "sentence": "BACKGROUND AND AIMS: Glutamic acid decarboxylase (GAD, @CHEMICAL$) catalyses the conversion of glutamate to gamma-aminobutyric acid (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "12067524.T11.T17",
        "sentence": "BACKGROUND AND AIMS: @CHEMICAL$ (GAD, EC 4.1.1.15) catalyses the conversion of @GENE$ to gamma-aminobutyric acid (GABA).",
        "relation": "CPR:9"
    },
    {
        "id": "12067524.T11.T22",
        "sentence": "BACKGROUND AND AIMS: Glutamic acid decarboxylase (@CHEMICAL$, EC 4.1.1.15) catalyses the conversion of @GENE$ to gamma-aminobutyric acid (GABA).",
        "relation": "CPR:9"
    },
    {
        "id": "12067524.T11.T23",
        "sentence": "BACKGROUND AND AIMS: Glutamic acid decarboxylase (GAD, @CHEMICAL$) catalyses the conversion of @GENE$ to gamma-aminobutyric acid (GABA).",
        "relation": "CPR:9"
    },
    {
        "id": "23541436.T3.T11",
        "sentence": "FCEO significantly inhibited @CHEMICAL$ (NO) and prostaglandin E2 (PGE2) by suppressing the protein expression of @GENE$ (iNOS) and cyclooxygenase (COX)-2, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "23541436.T3.T12",
        "sentence": "FCEO significantly inhibited @CHEMICAL$ (NO) and prostaglandin E2 (PGE2) by suppressing the protein expression of inducible nitric oxide synthase (@GENE$) and cyclooxygenase (COX)-2, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "23541436.T4.T11",
        "sentence": "FCEO significantly inhibited nitric oxide (@CHEMICAL$) and prostaglandin E2 (PGE2) by suppressing the protein expression of @GENE$ (iNOS) and cyclooxygenase (COX)-2, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "23541436.T4.T12",
        "sentence": "FCEO significantly inhibited nitric oxide (@CHEMICAL$) and prostaglandin E2 (PGE2) by suppressing the protein expression of inducible nitric oxide synthase (@GENE$) and cyclooxygenase (COX)-2, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "23541436.T5.T13",
        "sentence": "FCEO significantly inhibited nitric oxide (NO) and @CHEMICAL$ (PGE2) by suppressing the protein expression of inducible nitric oxide synthase (iNOS) and @GENE$, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "23541436.T6.T13",
        "sentence": "FCEO significantly inhibited nitric oxide (NO) and prostaglandin E2 (@CHEMICAL$) by suppressing the protein expression of inducible nitric oxide synthase (iNOS) and @GENE$, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T11.T39",
        "sentence": "@CHEMICAL$ and milrinone, selective @GENE$ inhibitors, suppressed TNF secretion to a lesser extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T11.T40",
        "sentence": "@CHEMICAL$ and milrinone, selective PDE3 inhibitors, suppressed @GENE$ secretion to a lesser extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T12.T39",
        "sentence": "Amrinone and @CHEMICAL$, selective @GENE$ inhibitors, suppressed TNF secretion to a lesser extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T12.T40",
        "sentence": "Amrinone and @CHEMICAL$, selective PDE3 inhibitors, suppressed @GENE$ secretion to a lesser extent.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T1.T13",
        "sentence": "The effects of @CHEMICAL$ (unspecific @GENE$ inhibitor), vinpocetine (PDE1 inhibitor), EHNA (PDE2 inhibitor) and the PDE5 inhibitors zaprinast and E 4021 were weak.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T2.T14",
        "sentence": "The effects of theophylline (unspecific PDE inhibitor), @CHEMICAL$ (@GENE$ inhibitor), EHNA (PDE2 inhibitor) and the PDE5 inhibitors zaprinast and E 4021 were weak.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T3.T16",
        "sentence": "The effects of theophylline (unspecific PDE inhibitor), vinpocetine (PDE1 inhibitor), EHNA (PDE2 inhibitor) and the @CHEMICAL$ inhibitors @GENE$ and E 4021 were weak.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T4.T16",
        "sentence": "The effects of theophylline (unspecific PDE inhibitor), vinpocetine (PDE1 inhibitor), EHNA (PDE2 inhibitor) and the @CHEMICAL$ inhibitors zaprinast and @GENE$ were weak.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T5.T17",
        "sentence": "In human blood, the tested glucocorticoids @CHEMICAL$, dexamethasone and fluticasone inhibited the LPS induced @GENE$ release potently in a concentration dependent manner, whereas in dispersed human nasal polyp cells, the effect of the glucocorticoids on allergically induced TNF release, with the exception of dexamethasone, was much less pronounced.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T5.T18",
        "sentence": "In human blood, the tested glucocorticoids @CHEMICAL$, dexamethasone and fluticasone inhibited the LPS induced TNF release potently in a concentration dependent manner, whereas in dispersed human nasal polyp cells, the effect of the glucocorticoids on allergically induced @GENE$ release, with the exception of dexamethasone, was much less pronounced.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T6.T17",
        "sentence": "In human blood, the tested glucocorticoids beclomethasone, @CHEMICAL$ and fluticasone inhibited the LPS induced @GENE$ release potently in a concentration dependent manner, whereas in dispersed human nasal polyp cells, the effect of the glucocorticoids on allergically induced TNF release, with the exception of dexamethasone, was much less pronounced.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T6.T18",
        "sentence": "In human blood, the tested glucocorticoids beclomethasone, @CHEMICAL$ and fluticasone inhibited the LPS induced TNF release potently in a concentration dependent manner, whereas in dispersed human nasal polyp cells, the effect of the glucocorticoids on allergically induced @GENE$ release, with the exception of dexamethasone, was much less pronounced.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T7.T17",
        "sentence": "In human blood, the tested glucocorticoids beclomethasone, dexamethasone and @CHEMICAL$ inhibited the LPS induced @GENE$ release potently in a concentration dependent manner, whereas in dispersed human nasal polyp cells, the effect of the glucocorticoids on allergically induced TNF release, with the exception of dexamethasone, was much less pronounced.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T7.T18",
        "sentence": "In human blood, the tested glucocorticoids beclomethasone, dexamethasone and @CHEMICAL$ inhibited the LPS induced TNF release potently in a concentration dependent manner, whereas in dispersed human nasal polyp cells, the effect of the glucocorticoids on allergically induced @GENE$ release, with the exception of dexamethasone, was much less pronounced.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T9.T23",
        "sentence": "The selective @CHEMICAL$ inhibitors, and to a certain extent the PDE3 inhibitors @GENE$ and milrinone, reduced the GM-CSF release in a concentration dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T9.T24",
        "sentence": "The selective PDE 4 inhibitors, and to a certain extent the @CHEMICAL$ inhibitors @GENE$ and milrinone, reduced the GM-CSF release in a concentration dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T9.T25",
        "sentence": "The selective PDE 4 inhibitors, and to a certain extent the PDE3 inhibitors @CHEMICAL$ and milrinone, reduced the @GENE$ release in a concentration dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T10.T23",
        "sentence": "The selective @CHEMICAL$ inhibitors, and to a certain extent the PDE3 inhibitors amrinone and @GENE$, reduced the GM-CSF release in a concentration dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T10.T24",
        "sentence": "The selective PDE 4 inhibitors, and to a certain extent the @CHEMICAL$ inhibitors amrinone and @GENE$, reduced the GM-CSF release in a concentration dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "11969359.T10.T25",
        "sentence": "The selective PDE 4 inhibitors, and to a certain extent the PDE3 inhibitors amrinone and @CHEMICAL$, reduced the @GENE$ release in a concentration dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "23538162.T12.T31",
        "sentence": "Activating glucocorticoid receptor-@CHEMICAL$ signaling pathway contributes to @GENE$ protection against b-amyloid peptide-induced human endothelial cells apoptosis.",
        "relation": "CPR:3"
    },
    {
        "id": "23538162.T12.T29",
        "sentence": "Activating glucocorticoid receptor-ERK signaling pathway contributes to @CHEMICAL$ protection against @GENE$-induced human endothelial cells apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23538162.T12.T30",
        "sentence": "Activating @CHEMICAL$-ERK signaling pathway contributes to @GENE$ protection against b-amyloid peptide-induced human endothelial cells apoptosis.",
        "relation": "CPR:3"
    },
    {
        "id": "23538162.T5.T19",
        "sentence": "@CHEMICAL$ attenuated the @GENE$-associated mitochondrial apoptotic events, accompanied by inhibiting HIF-1a expression followed by intracellular reactive nitrogen species generation, and protein nitrotyrosination.",
        "relation": "CPR:4"
    },
    {
        "id": "23538162.T5.T20",
        "sentence": "@CHEMICAL$ attenuated the Ab25-35-associated mitochondrial apoptotic events, accompanied by inhibiting @GENE$ expression followed by intracellular reactive nitrogen species generation, and protein nitrotyrosination.",
        "relation": "CPR:4"
    },
    {
        "id": "23538162.T7.T21",
        "sentence": "These protective effects were abolished by @CHEMICAL$ (GR) antagonist @GENE$ or p-ERK inhibitor U0126 rather than estrogen receptor a antagonist ICI 82,780.",
        "relation": "CPR:6"
    },
    {
        "id": "23538162.T7.T22",
        "sentence": "These protective effects were abolished by glucocorticoid receptor (@CHEMICAL$) antagonist @GENE$ or p-ERK inhibitor U0126 rather than estrogen receptor a antagonist ICI 82,780.",
        "relation": "CPR:6"
    },
    {
        "id": "23538162.T8.T23",
        "sentence": "These protective effects were abolished by glucocorticoid receptor (GR) antagonist RU486 or @CHEMICAL$ inhibitor @GENE$ rather than estrogen receptor a antagonist ICI 82,780.",
        "relation": "CPR:4"
    },
    {
        "id": "23538162.T10.T24",
        "sentence": "These protective effects were abolished by glucocorticoid receptor (GR) antagonist RU486 or p-ERK inhibitor U0126 rather than @CHEMICAL$ antagonist @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "23538162.T11.T27",
        "sentence": "Taken together, our results suggested that @CHEMICAL$ protected against Ab25-35-induced apoptosis at least in part by two complementary GR-dependent @GENE$ phosphorylation pathways: (1) down-regulating HIF-1a initiated protein nitrotyrosination, and (2) inhibiting mitochondrial apoptotic cascades.",
        "relation": "CPR:3"
    },
    {
        "id": "23538162.T11.T25",
        "sentence": "Taken together, our results suggested that @CHEMICAL$ protected against @GENE$-induced apoptosis at least in part by two complementary GR-dependent ERK phosphorylation pathways: (1) down-regulating HIF-1a initiated protein nitrotyrosination, and (2) inhibiting mitochondrial apoptotic cascades.",
        "relation": "CPR:4"
    },
    {
        "id": "23538162.T11.T28",
        "sentence": "Taken together, our results suggested that @CHEMICAL$ protected against Ab25-35-induced apoptosis at least in part by two complementary GR-dependent ERK phosphorylation pathways: (1) down-regulating @GENE$ initiated protein nitrotyrosination, and (2) inhibiting mitochondrial apoptotic cascades.",
        "relation": "CPR:4"
    },
    {
        "id": "23538162.T1.T13",
        "sentence": "These data provided a novel insight to the mechanisms of @CHEMICAL$protective effects on @GENE$-induced endothelial cells apoptosis, suggesting that GR-ERK signaling pathway might play an important role in it.",
        "relation": "CPR:4"
    },
    {
        "id": "1386491.T9.T17",
        "sentence": "Effectiveness of @CHEMICAL$ inhibition (@GENE$) in congestive heart failure.",
        "relation": "CPR:4"
    },
    {
        "id": "1386491.T1.T13",
        "sentence": "@CHEMICAL$ is a novel, orally active inhibitor of @GENE$ EC 3.4.24.11, the enzyme that degrades atrial natriuretic peptide (ANP).",
        "relation": "CPR:4"
    },
    {
        "id": "1386491.T1.T15",
        "sentence": "@CHEMICAL$ is a novel, orally active inhibitor of neutral endopeptidase @GENE$, the enzyme that degrades atrial natriuretic peptide (ANP).",
        "relation": "CPR:4"
    },
    {
        "id": "1386491.T4.T12",
        "sentence": "On study day 1, @CHEMICAL$ acutely increased plasma @GENE$ levels, suppressed aldosterone and decreased right atrial and pulmonary capillary wedge pressures.",
        "relation": "CPR:3"
    },
    {
        "id": "1386491.T7.T16",
        "sentence": "On study day 10, the acute effects of @CHEMICAL$ were similar to those on day 1 (i.e., @GENE$ was further increased, aldosterone was suppressed, and right and left ventricular filling pressures were decreased).",
        "relation": "CPR:3"
    },
    {
        "id": "23357976.T7.T11",
        "sentence": "@CHEMICAL$ encoded by the HSD11B2 gene converts @GENE$ to inactive cortisone, and alteration in this enzymatic activity might affect glucose homeostasis by affecting circulating levels or tissue availability of glucocorticoids.",
        "relation": "CPR:9"
    },
    {
        "id": "23357976.T7.T17",
        "sentence": "Type 2 11b-hydroxysteroid dehydrogenase encoded by the @CHEMICAL$ gene converts @GENE$ to inactive cortisone, and alteration in this enzymatic activity might affect glucose homeostasis by affecting circulating levels or tissue availability of glucocorticoids.",
        "relation": "CPR:9"
    },
    {
        "id": "23357976.T9.T11",
        "sentence": "@CHEMICAL$ encoded by the HSD11B2 gene converts cortisol to inactive @GENE$, and alteration in this enzymatic activity might affect glucose homeostasis by affecting circulating levels or tissue availability of glucocorticoids.",
        "relation": "CPR:9"
    },
    {
        "id": "23357976.T9.T17",
        "sentence": "Type 2 11b-hydroxysteroid dehydrogenase encoded by the @CHEMICAL$ gene converts cortisol to inactive @GENE$, and alteration in this enzymatic activity might affect glucose homeostasis by affecting circulating levels or tissue availability of glucocorticoids.",
        "relation": "CPR:9"
    },
    {
        "id": "14680444.T2.T6",
        "sentence": "The @CHEMICAL$ antagonist, @GENE$, is selective for alpha(1A)- and alpha(1D)- over alpha(1B)-adrenoceptors.",
        "relation": "CPR:6"
    },
    {
        "id": "14680444.T2.T7",
        "sentence": "The alpha(1)-adrenoceptor antagonist, @CHEMICAL$, is selective for @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "22989705.T19.T31",
        "sentence": "The obtained results showed that @CHEMICAL$ improved the renal function, structural changes, renal malondialdehyde (MDA), tumor necrosis factor alpha (TNF-a), @GENE$ (NF-kB) genes expression in cisplatin injected rats.",
        "relation": "CPR:3"
    },
    {
        "id": "22989705.T19.T32",
        "sentence": "The obtained results showed that @CHEMICAL$ improved the renal function, structural changes, renal malondialdehyde (MDA), tumor necrosis factor alpha (TNF-a), nuclear factor kappa B (@GENE$) genes expression in cisplatin injected rats.",
        "relation": "CPR:3"
    },
    {
        "id": "22989705.T19.T29",
        "sentence": "The obtained results showed that @CHEMICAL$ improved the renal function, structural changes, renal malondialdehyde (MDA), @GENE$ (TNF-a), nuclear factor kappa B (NF-kB) genes expression in cisplatin injected rats.",
        "relation": "CPR:3"
    },
    {
        "id": "22989705.T19.T30",
        "sentence": "The obtained results showed that @CHEMICAL$ improved the renal function, structural changes, renal malondialdehyde (MDA), tumor necrosis factor alpha (@GENE$), nuclear factor kappa B (NF-kB) genes expression in cisplatin injected rats.",
        "relation": "CPR:3"
    },
    {
        "id": "22989705.T22.T31",
        "sentence": "The obtained results showed that pioglitazone improved the renal function, structural changes, renal malondialdehyde (MDA), tumor necrosis factor alpha (TNF-a), @CHEMICAL$ (NF-kB) genes expression in @GENE$ injected rats.",
        "relation": "CPR:4"
    },
    {
        "id": "22989705.T22.T32",
        "sentence": "The obtained results showed that pioglitazone improved the renal function, structural changes, renal malondialdehyde (MDA), tumor necrosis factor alpha (TNF-a), nuclear factor kappa B (@CHEMICAL$) genes expression in @GENE$ injected rats.",
        "relation": "CPR:4"
    },
    {
        "id": "22989705.T22.T29",
        "sentence": "The obtained results showed that pioglitazone improved the renal function, structural changes, renal malondialdehyde (MDA), @CHEMICAL$ (TNF-a), nuclear factor kappa B (NF-kB) genes expression in @GENE$ injected rats.",
        "relation": "CPR:4"
    },
    {
        "id": "22989705.T22.T30",
        "sentence": "The obtained results showed that pioglitazone improved the renal function, structural changes, renal malondialdehyde (MDA), tumor necrosis factor alpha (@CHEMICAL$), nuclear factor kappa B (NF-kB) genes expression in @GENE$ injected rats.",
        "relation": "CPR:4"
    },
    {
        "id": "17327465.T1.T11",
        "sentence": "Combining in vivo and in vitro findings, we identified nine @CHEMICAL$ agonists, six of which are marketed therapeutics and have been approved by the U.S. Food and Drug Administration, including @GENE$, flutamide, and nimodipine.",
        "relation": "CPR:5"
    },
    {
        "id": "17327465.T2.T11",
        "sentence": "Combining in vivo and in vitro findings, we identified nine @CHEMICAL$ agonists, six of which are marketed therapeutics and have been approved by the U.S. Food and Drug Administration, including leflunomide, @GENE$, and nimodipine.",
        "relation": "CPR:5"
    },
    {
        "id": "17327465.T3.T11",
        "sentence": "Combining in vivo and in vitro findings, we identified nine @CHEMICAL$ agonists, six of which are marketed therapeutics and have been approved by the U.S. Food and Drug Administration, including leflunomide, flutamide, and @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "16546990.T9.T27",
        "sentence": "@CHEMICAL$ metabolites simultaneously (a) increase cellular cyclic GMP and subsequently activate @GENE$ (PKG); (b) activate c-jun NH2-terminal kinase (JNK); (c) inhibit extracellular signal-regulated kinase 1/2 (ERK1/2); and (d) decrease beta-catenin protein expression at times and doses consistent with apoptosis.",
        "relation": "CPR:3"
    },
    {
        "id": "16546990.T9.T28",
        "sentence": "@CHEMICAL$ metabolites simultaneously (a) increase cellular cyclic GMP and subsequently activate cyclic GMP-dependent protein kinase (@GENE$); (b) activate c-jun NH2-terminal kinase (JNK); (c) inhibit extracellular signal-regulated kinase 1/2 (ERK1/2); and (d) decrease beta-catenin protein expression at times and doses consistent with apoptosis.",
        "relation": "CPR:3"
    },
    {
        "id": "16546990.T9.T29",
        "sentence": "@CHEMICAL$ metabolites simultaneously (a) increase cellular cyclic GMP and subsequently activate cyclic GMP-dependent protein kinase (PKG); (b) activate @GENE$ (JNK); (c) inhibit extracellular signal-regulated kinase 1/2 (ERK1/2); and (d) decrease beta-catenin protein expression at times and doses consistent with apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "16546990.T9.T30",
        "sentence": "@CHEMICAL$ metabolites simultaneously (a) increase cellular cyclic GMP and subsequently activate cyclic GMP-dependent protein kinase (PKG); (b) activate c-jun NH2-terminal kinase (@GENE$); (c) inhibit extracellular signal-regulated kinase 1/2 (ERK1/2); and (d) decrease beta-catenin protein expression at times and doses consistent with apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "16546990.T9.T33",
        "sentence": "@CHEMICAL$ metabolites simultaneously (a) increase cellular cyclic GMP and subsequently activate cyclic GMP-dependent protein kinase (PKG); (b) activate c-jun NH2-terminal kinase (JNK); (c) inhibit extracellular signal-regulated kinase 1/2 (ERK1/2); and (d) decrease @GENE$ protein expression at times and doses consistent with apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "16546990.T2.T23",
        "sentence": "Cotreatment with @CHEMICAL$ and YC-1 synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of sulindac treatment on ERK1/2, @GENE$, and beta-catenin.",
        "relation": "CPR:3"
    },
    {
        "id": "16546990.T2.T24",
        "sentence": "Cotreatment with @CHEMICAL$ and YC-1 synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of sulindac treatment on ERK1/2, JNK, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "16546990.T3.T23",
        "sentence": "Cotreatment with U0126 and @CHEMICAL$ synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of sulindac treatment on ERK1/2, @GENE$, and beta-catenin.",
        "relation": "CPR:3"
    },
    {
        "id": "16546990.T3.T24",
        "sentence": "Cotreatment with U0126 and @CHEMICAL$ synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of sulindac treatment on ERK1/2, JNK, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "16546990.T4.T23",
        "sentence": "Cotreatment with U0126 and YC-1 synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of @CHEMICAL$ treatment on ERK1/2, @GENE$, and beta-catenin.",
        "relation": "CPR:3"
    },
    {
        "id": "16546990.T4.T24",
        "sentence": "Cotreatment with U0126 and YC-1 synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of @CHEMICAL$ treatment on ERK1/2, JNK, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "10530931.T4.T11",
        "sentence": "Synthesis and antagonistic activity at @CHEMICAL$ subtypes of some 2-carbonyl derivatives of @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "10530931.T5.T11",
        "sentence": "Synthesis and antagonistic activity at @CHEMICAL$ subtypes of some @GENE$ derivatives of diphenidol.",
        "relation": "CPR:6"
    },
    {
        "id": "10530931.T3.T6",
        "sentence": "A series of 2-carbonyl analogues of the muscarinic antagonist @CHEMICAL$ bearing 1-substituents of different lipophilic, electronic, and steric properties was synthesized and their affinity for the @GENE$ subtypes was evaluated by functional tests.",
        "relation": "CPR:6"
    },
    {
        "id": "10530931.T2.T10",
        "sentence": "This work showed that appropriate structural modification of @CHEMICAL$ can lead to @GENE$-selective muscarinic antagonists of possible interest in the field of Alzheimer's disease.",
        "relation": "CPR:6"
    },
    {
        "id": "23266505.T19.T37",
        "sentence": "Activation of an apoptotic signal transduction pathway involved in the upregulation of @CHEMICAL$ and apoptosis-inducing factor in @GENE$-induced primary cultured cardiomyocytes.",
        "relation": "CPR:3"
    },
    {
        "id": "23266505.T19.T38",
        "sentence": "Activation of an apoptotic signal transduction pathway involved in the upregulation of calpain and @CHEMICAL$ in @GENE$-induced primary cultured cardiomyocytes.",
        "relation": "CPR:3"
    },
    {
        "id": "23266505.T7.T21",
        "sentence": "In this study, @CHEMICAL$ (ALD)-induced apoptosis of cardiomyocyte was evaluated based on the previous studies, and the roles of @GENE$ signaling were clarified.",
        "relation": "CPR:3"
    },
    {
        "id": "23266505.T10.T21",
        "sentence": "In this study, aldosterone (@CHEMICAL$)-induced apoptosis of cardiomyocyte was evaluated based on the previous studies, and the roles of @GENE$ signaling were clarified.",
        "relation": "CPR:3"
    },
    {
        "id": "23266505.T17.T31",
        "sentence": "@CHEMICAL$ increased @GENE$ expression and caspase-3 activity and promoted Bid cleavage.",
        "relation": "CPR:3"
    },
    {
        "id": "23266505.T17.T32",
        "sentence": "@CHEMICAL$ increased calpain expression and @GENE$ activity and promoted Bid cleavage.",
        "relation": "CPR:3"
    },
    {
        "id": "23266505.T1.T34",
        "sentence": "The upregulation of @CHEMICAL$, tBid and caspase-3 activity were further inhibited by treatment with EGTA in the presence of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23266505.T1.T35",
        "sentence": "The upregulation of calpain, @CHEMICAL$ and caspase-3 activity were further inhibited by treatment with EGTA in the presence of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23266505.T1.T36",
        "sentence": "The upregulation of calpain, tBid and @CHEMICAL$ activity were further inhibited by treatment with EGTA in the presence of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23266505.T18.T34",
        "sentence": "The upregulation of @CHEMICAL$, tBid and caspase-3 activity were further inhibited by treatment with @GENE$ in the presence of ALD.",
        "relation": "CPR:4"
    },
    {
        "id": "23266505.T18.T35",
        "sentence": "The upregulation of calpain, @CHEMICAL$ and caspase-3 activity were further inhibited by treatment with @GENE$ in the presence of ALD.",
        "relation": "CPR:4"
    },
    {
        "id": "23266505.T18.T36",
        "sentence": "The upregulation of calpain, tBid and @CHEMICAL$ activity were further inhibited by treatment with @GENE$ in the presence of ALD.",
        "relation": "CPR:4"
    },
    {
        "id": "23266505.T2.T20",
        "sentence": "Additionally, @CHEMICAL$ levels in the cytosol decreased due to @GENE$ but not due to calpeptin.",
        "relation": "CPR:4"
    },
    {
        "id": "23266505.T4.T22",
        "sentence": "Furthermore, treatment with @CHEMICAL$ not only attenuated the pro-apoptotic effect of ALD but reversed the ALD-induced increase of @GENE$ and AIF levels.",
        "relation": "CPR:4"
    },
    {
        "id": "23266505.T4.T23",
        "sentence": "Furthermore, treatment with @CHEMICAL$ not only attenuated the pro-apoptotic effect of ALD but reversed the ALD-induced increase of calpain and @GENE$ levels.",
        "relation": "CPR:4"
    },
    {
        "id": "23266505.T6.T22",
        "sentence": "Furthermore, treatment with spironoclactone not only attenuated the pro-apoptotic effect of ALD but reversed the @CHEMICAL$-induced increase of @GENE$ and AIF levels.",
        "relation": "CPR:3"
    },
    {
        "id": "23266505.T6.T23",
        "sentence": "Furthermore, treatment with spironoclactone not only attenuated the pro-apoptotic effect of ALD but reversed the @CHEMICAL$-induced increase of calpain and @GENE$ levels.",
        "relation": "CPR:3"
    },
    {
        "id": "2855105.T1.T37",
        "sentence": "@CHEMICAL$ is a peripheral opiate agonist able to inhibit @GENE$ secretion.",
        "relation": "CPR:4"
    },
    {
        "id": "2855105.T14.T34",
        "sentence": "In all patients @CHEMICAL$ induced a significant fall in plasma @GENE$ levels.",
        "relation": "CPR:4"
    },
    {
        "id": "2855105.T2.T40",
        "sentence": "CRH caused a rise in plasma ACTH after both loperamide (from 30 +/- 16.6 to a peak of 108 +/- 31 pmol/l) and placebo (from 98.5 +/- 47 to 211 +/- 61.7 pmol/l): the interaction between treatments and time was significant, and the first phase of @CHEMICAL$-induced ACTH secretion was significantly lower after @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "2855105.T2.T41",
        "sentence": "CRH caused a rise in plasma ACTH after both loperamide (from 30 +/- 16.6 to a peak of 108 +/- 31 pmol/l) and placebo (from 98.5 +/- 47 to 211 +/- 61.7 pmol/l): the interaction between treatments and time was significant, and the first phase of CRH-induced @CHEMICAL$ secretion was significantly lower after @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23116643.T3.T22",
        "sentence": "@CHEMICAL$ intoxication caused hepatic necrosis and increased serum @GENE$ activity.",
        "relation": "CPR:3"
    },
    {
        "id": "23116643.T10.T25",
        "sentence": "@CHEMICAL$ administration triggered inflammatory response in mice livers by activating @GENE$ (NF-kB), which coincided with the induction of tumor necrosis factor-alpha (TNF-a) and cyclooxygenase-2 (COX-2).",
        "relation": "CPR:3"
    },
    {
        "id": "23116643.T10.T26",
        "sentence": "@CHEMICAL$ administration triggered inflammatory response in mice livers by activating nuclear factor-kappaB (@GENE$), which coincided with the induction of tumor necrosis factor-alpha (TNF-a) and cyclooxygenase-2 (COX-2).",
        "relation": "CPR:3"
    },
    {
        "id": "23116643.T10.T27",
        "sentence": "@CHEMICAL$ administration triggered inflammatory response in mice livers by activating nuclear factor-kappaB (NF-kB), which coincided with the induction of @GENE$ (TNF-a) and cyclooxygenase-2 (COX-2).",
        "relation": "CPR:3"
    },
    {
        "id": "23116643.T10.T28",
        "sentence": "@CHEMICAL$ administration triggered inflammatory response in mice livers by activating nuclear factor-kappaB (NF-kB), which coincided with the induction of tumor necrosis factor-alpha (@GENE$) and cyclooxygenase-2 (COX-2).",
        "relation": "CPR:3"
    },
    {
        "id": "23116643.T10.T29",
        "sentence": "@CHEMICAL$ administration triggered inflammatory response in mice livers by activating nuclear factor-kappaB (NF-kB), which coincided with the induction of tumor necrosis factor-alpha (TNF-a) and @GENE$ (COX-2).",
        "relation": "CPR:3"
    },
    {
        "id": "23116643.T10.T30",
        "sentence": "@CHEMICAL$ administration triggered inflammatory response in mice livers by activating nuclear factor-kappaB (NF-kB), which coincided with the induction of tumor necrosis factor-alpha (TNF-a) and cyclooxygenase-2 (@GENE$).",
        "relation": "CPR:3"
    },
    {
        "id": "23116643.T1.T17",
        "sentence": "Furthermore, RA significantly inhibited the @CHEMICAL$-induced apoptosis, which was evident from decreased cleavage of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "9399012.T19.T27",
        "sentence": "Pre-clinical pharmacology of @CHEMICAL$ (Zomig; formerly 311C90), a centrally and peripherally acting @GENE$ agonist for migraine.",
        "relation": "CPR:5"
    },
    {
        "id": "9399012.T20.T27",
        "sentence": "Pre-clinical pharmacology of zolmitriptan (@CHEMICAL$; formerly 311C90), a centrally and peripherally acting @GENE$ agonist for migraine.",
        "relation": "CPR:5"
    },
    {
        "id": "9399012.T22.T27",
        "sentence": "Pre-clinical pharmacology of zolmitriptan (Zomig; formerly @CHEMICAL$), a centrally and peripherally acting @GENE$ agonist for migraine.",
        "relation": "CPR:5"
    },
    {
        "id": "9399012.T1.T25",
        "sentence": "@CHEMICAL$ (Zomig; formerly 311C90) is a novel @GENE$ receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura.",
        "relation": "CPR:5"
    },
    {
        "id": "9399012.T3.T25",
        "sentence": "Zolmitriptan (@CHEMICAL$; formerly 311C90) is a novel @GENE$ receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura.",
        "relation": "CPR:5"
    },
    {
        "id": "9399012.T14.T25",
        "sentence": "Zolmitriptan (Zomig; formerly @CHEMICAL$) is a novel @GENE$ receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura.",
        "relation": "CPR:5"
    },
    {
        "id": "9399012.T2.T23",
        "sentence": "These actions are consistent with a pre-junctional inhibition of neuropeptide release from perivascular afferents of the trigeminal nerve, as confirmed by independent studies showing that @CHEMICAL$ blocks elevations of @GENE$ in jugular venous blood during electrical stimulation of the trigeminal ganglion.",
        "relation": "CPR:4"
    },
    {
        "id": "23411272.T2.T10",
        "sentence": "It has been reported that oligomeric @CHEMICAL$ of lotus seedpod (LSOPC) is effective in the alleviation of Alzheimer's disease and diabetes through its antioxidant and @GENE$-potentiating activities.",
        "relation": "CPR:3"
    },
    {
        "id": "17210712.T12.T53",
        "sentence": "They all expressed ASS, but not @CHEMICAL$ (OTC), the enzyme that converts @GENE$, the product of degradation of arginine with rhArg, to citrulline, which is converted back to arginine via ASS.",
        "relation": "CPR:9"
    },
    {
        "id": "17210712.T12.T54",
        "sentence": "They all expressed ASS, but not ornithine transcarbamylase (@CHEMICAL$), the enzyme that converts @GENE$, the product of degradation of arginine with rhArg, to citrulline, which is converted back to arginine via ASS.",
        "relation": "CPR:9"
    },
    {
        "id": "17210712.T13.T55",
        "sentence": "They all expressed ASS, but not ornithine transcarbamylase (OTC), the enzyme that converts ornithine, the product of degradation of @CHEMICAL$ with @GENE$, to citrulline, which is converted back to arginine via ASS.",
        "relation": "CPR:9"
    },
    {
        "id": "17210712.T14.T55",
        "sentence": "They all expressed ASS, but not ornithine transcarbamylase (OTC), the enzyme that converts ornithine, the product of degradation of arginine with @CHEMICAL$, to @GENE$, which is converted back to arginine via ASS.",
        "relation": "CPR:9"
    },
    {
        "id": "17210712.T15.T56",
        "sentence": "They all expressed ASS, but not ornithine transcarbamylase (OTC), the enzyme that converts ornithine, the product of degradation of arginine with rhArg, to citrulline, which is converted back to @CHEMICAL$ via @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17210712.T2.T26",
        "sentence": "This surprising correlation between the lack of OTC expression and sensitivity of ASS-positive HCC cells shows that OTC-deficient HCCs are sensitive to @CHEMICAL$-mediated @GENE$ depletion.",
        "relation": "CPR:9"
    },
    {
        "id": "17210712.T3.T30",
        "sentence": "Therefore, pretreatment tumor gene expression profiling of ASS and OTC could aid in predicting tumor response to @CHEMICAL$ depletion with @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "10225363.T2.T18",
        "sentence": "To establish the relative importance of these subtypes, we compared the effects of sumatriptan with those of a selective @CHEMICAL$ receptor agonist (@GENE$) on c-fos protein expression in the trigeminal nucleus caudalis. c-fos expression was induced in urethane-anaesthetized rats by intracisternal capsaicin administration.",
        "relation": "CPR:5"
    },
    {
        "id": "10225363.T4.T20",
        "sentence": "To establish the relative importance of these subtypes, we compared the effects of sumatriptan with those of a selective 5-HT1F receptor agonist (LY 344864) on c-fos protein expression in the trigeminal nucleus caudalis. @CHEMICAL$ expression was induced in urethane-anaesthetized rats by intracisternal @GENE$ administration.",
        "relation": "CPR:3"
    },
    {
        "id": "10225363.T5.T21",
        "sentence": "@CHEMICAL$ and LY 344864 decreased the number of capsaicin-induced @GENE$-like immunoreactive cells within trigeminal nucleus caudalis (ID50 = 0.04 and 0.6 mg kg(-1)).",
        "relation": "CPR:4"
    },
    {
        "id": "10225363.T6.T21",
        "sentence": "Sumatriptan and @CHEMICAL$ decreased the number of capsaicin-induced @GENE$-like immunoreactive cells within trigeminal nucleus caudalis (ID50 = 0.04 and 0.6 mg kg(-1)).",
        "relation": "CPR:4"
    },
    {
        "id": "10225363.T7.T21",
        "sentence": "Sumatriptan and LY 344864 decreased the number of @CHEMICAL$-induced @GENE$-like immunoreactive cells within trigeminal nucleus caudalis (ID50 = 0.04 and 0.6 mg kg(-1)).",
        "relation": "CPR:3"
    },
    {
        "id": "10225363.T11.T22",
        "sentence": "The effect of sumatriptan, but not of LY 344864, was prevented by pretreatment with the antagonist @CHEMICAL$, which displays high affinity for @GENE$ receptors.",
        "relation": "CPR:6"
    },
    {
        "id": "16516814.T14.T32",
        "sentence": "The involvement of @CHEMICAL$ and EP2 receptors is indicated by studies with the EP1 selective agonist @GENE$, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific).",
        "relation": "CPR:5"
    },
    {
        "id": "16516814.T14.T34",
        "sentence": "The involvement of EP1 and EP2 receptors is indicated by studies with the @CHEMICAL$ selective agonist @GENE$, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific).",
        "relation": "CPR:5"
    },
    {
        "id": "16516814.T15.T33",
        "sentence": "The involvement of EP1 and @CHEMICAL$ is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist @GENE$ (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific).",
        "relation": "CPR:5"
    },
    {
        "id": "16516814.T15.T35",
        "sentence": "The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the @CHEMICAL$ selective agonist @GENE$ (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific).",
        "relation": "CPR:5"
    },
    {
        "id": "16516814.T16.T32",
        "sentence": "The involvement of @CHEMICAL$ and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists @GENE$ (EP1 specific) and AH 6809 (EP1 and EP2 specific).",
        "relation": "CPR:5"
    },
    {
        "id": "16516814.T16.T34",
        "sentence": "The involvement of EP1 and EP2 receptors is indicated by studies with the @CHEMICAL$ selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists @GENE$ (EP1 specific) and AH 6809 (EP1 and EP2 specific).",
        "relation": "CPR:5"
    },
    {
        "id": "16516814.T16.T36",
        "sentence": "The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists @CHEMICAL$ (EP1 specific) and AH 6809 (@GENE$ and EP2 specific).",
        "relation": "CPR:5"
    },
    {
        "id": "16516814.T17.T32",
        "sentence": "The involvement of @CHEMICAL$ and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and @GENE$ (EP1 and EP2 specific).",
        "relation": "CPR:5"
    },
    {
        "id": "16516814.T17.T33",
        "sentence": "The involvement of EP1 and @CHEMICAL$ is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and @GENE$ (EP1 and EP2 specific).",
        "relation": "CPR:5"
    },
    {
        "id": "16516814.T17.T34",
        "sentence": "The involvement of EP1 and EP2 receptors is indicated by studies with the @CHEMICAL$ selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and @GENE$ (EP1 and EP2 specific).",
        "relation": "CPR:5"
    },
    {
        "id": "16516814.T17.T35",
        "sentence": "The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the @CHEMICAL$ selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and @GENE$ (EP1 and EP2 specific).",
        "relation": "CPR:5"
    },
    {
        "id": "16516814.T17.T36",
        "sentence": "The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and @CHEMICAL$ (@GENE$ and EP2 specific).",
        "relation": "CPR:6"
    },
    {
        "id": "16516814.T17.T37",
        "sentence": "The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and @CHEMICAL$ (EP1 and @GENE$ specific).",
        "relation": "CPR:6"
    },
    {
        "id": "16516814.T2.T23",
        "sentence": "In addition to this evidence (for the involvement of EP2 receptors), evidence for the involvement of EP1 receptors in the @CHEMICAL$ mediated stimulation of @GENE$ subunit gene transcription includes the stimulatory effect of 17-phenyl trinor PGE2, as well as the inhibitory effects of SC-51089.",
        "relation": "CPR:3"
    },
    {
        "id": "16516814.T5.T23",
        "sentence": "In addition to this evidence (for the involvement of EP2 receptors), evidence for the involvement of EP1 receptors in the PGE1 mediated stimulation of @CHEMICAL$ subunit gene transcription includes the stimulatory effect of @GENE$, as well as the inhibitory effects of SC-51089.",
        "relation": "CPR:3"
    },
    {
        "id": "16516814.T6.T23",
        "sentence": "In addition to this evidence (for the involvement of EP2 receptors), evidence for the involvement of EP1 receptors in the PGE1 mediated stimulation of @CHEMICAL$ subunit gene transcription includes the stimulatory effect of 17-phenyl trinor PGE2, as well as the inhibitory effects of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "16516814.T8.T28",
        "sentence": "Also consistent with the involvement of Gq coupled EP1 receptors, the PGE1 stimulation is inhibited by the PKCI vector (encoding the PKC inhibitory domain), the @CHEMICAL$ inhibitor @GENE$, thapsigargin, as well as the calmodulin antagonists W7 and W13.",
        "relation": "CPR:4"
    },
    {
        "id": "16516814.T10.T28",
        "sentence": "Also consistent with the involvement of Gq coupled EP1 receptors, the PGE1 stimulation is inhibited by the PKCI vector (encoding the PKC inhibitory domain), the @CHEMICAL$ inhibitor Go 6976, @GENE$, as well as the calmodulin antagonists W7 and W13.",
        "relation": "CPR:4"
    },
    {
        "id": "16516814.T12.T30",
        "sentence": "Also consistent with the involvement of Gq coupled EP1 receptors, the PGE1 stimulation is inhibited by the PKCI vector (encoding the PKC inhibitory domain), the PKC inhibitor Go 6976, thapsigargin, as well as the @CHEMICAL$ antagonists @GENE$ and W13.",
        "relation": "CPR:6"
    },
    {
        "id": "16516814.T13.T30",
        "sentence": "Also consistent with the involvement of Gq coupled EP1 receptors, the PGE1 stimulation is inhibited by the PKCI vector (encoding the PKC inhibitory domain), the PKC inhibitor Go 6976, thapsigargin, as well as the @CHEMICAL$ antagonists W7 and @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "23410798.T14.T19",
        "sentence": "Spiro heterocycles as potential inhibitors of @CHEMICAL$: Pd/C-mediated synthesis of novel @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23410798.T7.T15",
        "sentence": "Novel @CHEMICAL$ were designed as potential inhibitiors of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "10200320.T17.T36",
        "sentence": "@CHEMICAL$ suppress activation of microglia: down-regulation of @GENE$ by 15-deoxy-Delta12,14-prostaglandin J2.",
        "relation": "CPR:4"
    },
    {
        "id": "10200320.T18.T36",
        "sentence": "Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of @CHEMICAL$ by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "10200320.T10.T33",
        "sentence": "@CHEMICAL$ were potent inhibitors of @GENE$ induction and were more effective than their precursors, prostaglandins E2 and D2. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) was the most potent prostaglandin among those tested.",
        "relation": "CPR:4"
    },
    {
        "id": "10200320.T11.T33",
        "sentence": "Cyclopentenone prostaglandins were potent inhibitors of @CHEMICAL$ induction and were more effective than their precursors, @GENE$. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) was the most potent prostaglandin among those tested.",
        "relation": "CPR:4"
    },
    {
        "id": "10200320.T15.T34",
        "sentence": "In activated microglia, @CHEMICAL$ suppressed @GENE$ activity, iNOS mRNA, and protein levels.",
        "relation": "CPR:4"
    },
    {
        "id": "10200320.T15.T35",
        "sentence": "In activated microglia, @CHEMICAL$ suppressed iNOS promoter activity, @GENE$ mRNA, and protein levels.",
        "relation": "CPR:4"
    },
    {
        "id": "10200320.T4.T27",
        "sentence": "The action of 15d-PGJ2 does not appear to involve its nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) because troglitazone, a specific ligand of PPARgamma, was unable to inhibit iNOS induction, and neither troglitazone nor 15d-PGJ2 could stimulate the activity of a PPAR-dependent promoter in the absence of cotransfected PPARgamma. @CHEMICAL$ did not block nuclear translocation or DNA-binding activity of the transcription factor NFkappaB, but it did inhibit the activity of an @GENE$ reporter construct, suggesting that the mechanism of suppression of microglial iNOS by 15d-PGJ2 may involve interference with NFkappaB transcriptional activity in the nucleus.",
        "relation": "CPR:4"
    },
    {
        "id": "10200320.T5.T28",
        "sentence": "The action of 15d-PGJ2 does not appear to involve its nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) because troglitazone, a specific ligand of PPARgamma, was unable to inhibit iNOS induction, and neither troglitazone nor 15d-PGJ2 could stimulate the activity of a PPAR-dependent promoter in the absence of cotransfected PPARgamma. 15d-PGJ2 did not block nuclear translocation or DNA-binding activity of the transcription factor NFkappaB, but it did inhibit the activity of an NFkappaB reporter construct, suggesting that the mechanism of suppression of microglial @CHEMICAL$ by @GENE$ may involve interference with NFkappaB transcriptional activity in the nucleus.",
        "relation": "CPR:4"
    },
    {
        "id": "3828735.T9.T23",
        "sentence": "In vitro studies, however, revealed that @CHEMICAL$ inhibits @GENE$ clot formation because of the Ca2+-chelating ability of its constituent ethanolamine, although oleate or benzyl alcohol exhibited procoagulant activity in FPA formation in vitro.",
        "relation": "CPR:4"
    },
    {
        "id": "3828735.T5.T16",
        "sentence": "The activation may be accelerated by an acute inflammatory process provoked by @CHEMICAL$, which is supported by such clinical manifestations as mild fever, retrosternal pain leukocytosis and an increase in plasma @GENE$ level which was observed in all during the period.",
        "relation": "CPR:3"
    },
    {
        "id": "12093311.T3.T19",
        "sentence": "OBJECTIVE: @CHEMICAL$ and rofecoxib are two relatively new nonsteroidal anti-inflammatory drugs (NSAIDs) that selectively inhibit the @GENE$ (COX-2) isoenzyme at therapeutic concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "12093311.T3.T20",
        "sentence": "OBJECTIVE: @CHEMICAL$ and rofecoxib are two relatively new nonsteroidal anti-inflammatory drugs (NSAIDs) that selectively inhibit the cyclo-oxygenase-2 (@GENE$) isoenzyme at therapeutic concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "12093311.T10.T19",
        "sentence": "OBJECTIVE: Celecoxib and @CHEMICAL$ are two relatively new nonsteroidal anti-inflammatory drugs (NSAIDs) that selectively inhibit the @GENE$ (COX-2) isoenzyme at therapeutic concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "12093311.T10.T20",
        "sentence": "OBJECTIVE: Celecoxib and @CHEMICAL$ are two relatively new nonsteroidal anti-inflammatory drugs (NSAIDs) that selectively inhibit the cyclo-oxygenase-2 (@GENE$) isoenzyme at therapeutic concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "12093311.T11.T23",
        "sentence": "This study was conducted in order to understand the association between acute renal failure and the two @CHEMICAL$ inhibitors @GENE$ and rofecoxib.",
        "relation": "CPR:4"
    },
    {
        "id": "12093311.T12.T23",
        "sentence": "This study was conducted in order to understand the association between acute renal failure and the two @CHEMICAL$ inhibitors celecoxib and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "8799556.T1.T42",
        "sentence": "RS 17053 showed high affinity and selectivity for alpha 1A adrenoceptors (pKi 8.6) relative to alpha 1B (pKi = 7.3) and alpha 1D (pKi = 7.1) subtypes. 3. @CHEMICAL$, (-)-tamsulosin, SL 89,0591, Rec 15/2739, SNAP 1069 and RS 17053 appeared to act as competitive antagonists of noradrenaline-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "8799556.T2.T42",
        "sentence": "RS 17053 showed high affinity and selectivity for alpha 1A adrenoceptors (pKi 8.6) relative to alpha 1B (pKi = 7.3) and alpha 1D (pKi = 7.1) subtypes. 3. (+)-Tamsulosin, @CHEMICAL$, SL 89,0591, Rec 15/2739, SNAP 1069 and RS 17053 appeared to act as competitive antagonists of noradrenaline-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "8799556.T3.T42",
        "sentence": "RS 17053 showed high affinity and selectivity for alpha 1A adrenoceptors (pKi 8.6) relative to alpha 1B (pKi = 7.3) and alpha 1D (pKi = 7.1) subtypes. 3. (+)-Tamsulosin, (-)-tamsulosin, @CHEMICAL$, Rec 15/2739, SNAP 1069 and RS 17053 appeared to act as competitive antagonists of noradrenaline-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "8799556.T4.T42",
        "sentence": "RS 17053 showed high affinity and selectivity for alpha 1A adrenoceptors (pKi 8.6) relative to alpha 1B (pKi = 7.3) and alpha 1D (pKi = 7.1) subtypes. 3. (+)-Tamsulosin, (-)-tamsulosin, SL 89,0591, @CHEMICAL$, SNAP 1069 and RS 17053 appeared to act as competitive antagonists of noradrenaline-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "8799556.T5.T42",
        "sentence": "RS 17053 showed high affinity and selectivity for alpha 1A adrenoceptors (pKi 8.6) relative to alpha 1B (pKi = 7.3) and alpha 1D (pKi = 7.1) subtypes. 3. (+)-Tamsulosin, (-)-tamsulosin, SL 89,0591, Rec 15/2739, @CHEMICAL$ and RS 17053 appeared to act as competitive antagonists of noradrenaline-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "8799556.T6.T42",
        "sentence": "RS 17053 showed high affinity and selectivity for alpha 1A adrenoceptors (pKi 8.6) relative to alpha 1B (pKi = 7.3) and alpha 1D (pKi = 7.1) subtypes. 3. (+)-Tamsulosin, (-)-tamsulosin, SL 89,0591, Rec 15/2739, SNAP 1069 and @CHEMICAL$ appeared to act as competitive antagonists of noradrenaline-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "8925876.T3.T16",
        "sentence": "The potency of the antipsychotic drug, @CHEMICAL$, to antagonize alpha 1A-adrenoceptor-mediated contraction in rat vas deferens and vasoconstriction in rat perfused kidney, and alpha 1B-adrenoceptor-mediated contractions in spleen from guinea-pig and mouse was evaluated and compared to that of @GENE$ subtype-discriminating antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "8925876.T3.T15",
        "sentence": "The potency of the antipsychotic drug, @CHEMICAL$, to antagonize alpha 1A-adrenoceptor-mediated contraction in rat vas deferens and vasoconstriction in rat perfused kidney, and @GENE$-mediated contractions in spleen from guinea-pig and mouse was evaluated and compared to that of alpha 1-adrenoceptor subtype-discriminating antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "8925876.T3.T19",
        "sentence": "The potency of the antipsychotic drug, @CHEMICAL$, to antagonize @GENE$-mediated contraction in rat vas deferens and vasoconstriction in rat perfused kidney, and alpha 1B-adrenoceptor-mediated contractions in spleen from guinea-pig and mouse was evaluated and compared to that of alpha 1-adrenoceptor subtype-discriminating antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "16497876.T2.T8",
        "sentence": "In this article, the action of @CHEMICAL$ (BMS-354825) is contrasted with that of imatinib, a @GENE$ inhibitor that is currently being used to treat chronic myelogenous leukemia and other disorders.",
        "relation": "CPR:4"
    },
    {
        "id": "16497876.T3.T8",
        "sentence": "In this article, the action of dasatinib (@CHEMICAL$) is contrasted with that of imatinib, a @GENE$ inhibitor that is currently being used to treat chronic myelogenous leukemia and other disorders.",
        "relation": "CPR:4"
    },
    {
        "id": "16497876.T4.T8",
        "sentence": "In this article, the action of dasatinib (BMS-354825) is contrasted with that of @CHEMICAL$, a @GENE$ inhibitor that is currently being used to treat chronic myelogenous leukemia and other disorders.",
        "relation": "CPR:4"
    },
    {
        "id": "16497876.T6.T15",
        "sentence": "The work of Chen and colleagues shows that @CHEMICAL$ is a particularly potent inhibitor of @GENE$ and that the compound also targets Src kinase.",
        "relation": "CPR:4"
    },
    {
        "id": "16497876.T6.T16",
        "sentence": "The work of Chen and colleagues shows that @CHEMICAL$ is a particularly potent inhibitor of PDGFR and that the compound also targets @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "9928259.T14.T22",
        "sentence": "From these data, it is inferred that both the @CHEMICAL$ and NET contribute to the active clearance of exogenously applied @GENE$ in the dentate gyrus.",
        "relation": "CPR:9"
    },
    {
        "id": "9928259.T14.T23",
        "sentence": "From these data, it is inferred that both the SERT and @CHEMICAL$ contribute to the active clearance of exogenously applied @GENE$ in the dentate gyrus.",
        "relation": "CPR:9"
    },
    {
        "id": "9928259.T15.T24",
        "sentence": "In another experiment, @CHEMICAL$, an antagonist of the @GENE$, also prolonged the clearance of 5-HT from the CA3 region.",
        "relation": "CPR:6"
    },
    {
        "id": "9928259.T1.T25",
        "sentence": "These and other data have generated a working hypothesis that activation of the terminal @CHEMICAL$ enhances the kinetics of @GENE$ uptake through an effect on the serotonin transporter.",
        "relation": "CPR:9"
    },
    {
        "id": "9928259.T1.T21",
        "sentence": "These and other data have generated a working hypothesis that activation of the terminal serotonin autoreceptor enhances the kinetics of @CHEMICAL$ uptake through an effect on the @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "2530096.T14.T22",
        "sentence": "The anti-amnesic effect of minaprine on the cycloheximide-induced memory impairment was also antagonized by a serotonin (5-HT) releaser, p-chloroamphetamine, and by a 5-HT precursor, 5-hydroxytryptophan, whereas a @CHEMICAL$-selective agonist, @GENE$, was inactive.",
        "relation": "CPR:5"
    },
    {
        "id": "2530096.T17.T23",
        "sentence": "The memory-improving effect of minaprine on cycloheximide-induced amnesia was potentiated by a selective @CHEMICAL$ antagonist, @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "12742526.T1.T24",
        "sentence": "Even though the activities of @CHEMICAL$ and GNMT were elevated, the concentration of liver @GENE$ was decreased (24%, p<0.001) and S-adenosylhomocysteine increased (113%, p<0.001) in the dwarf mice.",
        "relation": "CPR:9"
    },
    {
        "id": "12742526.T1.T25",
        "sentence": "Even though the activities of MAT and @CHEMICAL$ were elevated, the concentration of liver @GENE$ was decreased (24%, p<0.001) and S-adenosylhomocysteine increased (113%, p<0.001) in the dwarf mice.",
        "relation": "CPR:9"
    },
    {
        "id": "12742526.T2.T24",
        "sentence": "Even though the activities of @CHEMICAL$ and GNMT were elevated, the concentration of liver S-adenosylmethionine was decreased (24%, p<0.001) and @GENE$ increased (113%, p<0.001) in the dwarf mice.",
        "relation": "CPR:9"
    },
    {
        "id": "12742526.T2.T25",
        "sentence": "Even though the activities of MAT and @CHEMICAL$ were elevated, the concentration of liver S-adenosylmethionine was decreased (24%, p<0.001) and @GENE$ increased (113%, p<0.001) in the dwarf mice.",
        "relation": "CPR:9"
    },
    {
        "id": "14508322.T18.T35",
        "sentence": "Activation of @CHEMICAL$ mediates the cardiovascular effects of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "14508322.T4.T34",
        "sentence": "BACKGROUND: The intravenous anesthetic etomidate exhibits structural similarities to specific @CHEMICAL$ agonists of the type such as @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "14508322.T12.T29",
        "sentence": "METHODS: Sedative and cardiovascular responses to etomidate and the alpha2-agonist, @CHEMICAL$, were determined in mice deficient in @GENE$ subtypes.",
        "relation": "CPR:5"
    },
    {
        "id": "14508322.T13.T30",
        "sentence": "Inhibition of binding of the @CHEMICAL$ antagonist @GENE$ to recombinant alpha2-receptors by etomidate was tested in human embryonic kidney (HEK293) cells in vitro.",
        "relation": "CPR:6"
    },
    {
        "id": "14508322.T13.T31",
        "sentence": "Inhibition of binding of the alpha2-receptor antagonist @CHEMICAL$ to recombinant @GENE$ by etomidate was tested in human embryonic kidney (HEK293) cells in vitro.",
        "relation": "CPR:6"
    },
    {
        "id": "14508322.T3.T19",
        "sentence": "In membranes from HEK293 cells transfected with @CHEMICAL$, etomidate inhibited binding of the alpha2-antagonist, @GENE$, with higher potency from alpha2B- and alpha2C-receptors than from alpha2A-receptors (Ki alpha2A 208 microm, alpha2B 26 microm, alpha2C 56 microm).",
        "relation": "CPR:6"
    },
    {
        "id": "14508322.T3.T21",
        "sentence": "In membranes from HEK293 cells transfected with alpha2-receptors, etomidate inhibited binding of the alpha2-antagonist, @CHEMICAL$, with higher potency from alpha2B- and alpha2C-receptors than from @GENE$ (Ki alpha2A 208 microm, alpha2B 26 microm, alpha2C 56 microm).",
        "relation": "CPR:6"
    },
    {
        "id": "14508322.T5.T23",
        "sentence": "In alpha2B-receptor-expressing HEK293 cells, @CHEMICAL$ rapidly increased phosphorylation of the @GENE$ ERK1/2.",
        "relation": "CPR:3"
    },
    {
        "id": "14508322.T5.T24",
        "sentence": "In alpha2B-receptor-expressing HEK293 cells, @CHEMICAL$ rapidly increased phosphorylation of the extracellular signal-related kinases @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "14508322.T6.T25",
        "sentence": "CONCLUSIONS: These results indicate that @CHEMICAL$ acts as an agonist at @GENE$, which appears in vivo primarily as an alpha2B-receptor-mediated increase in blood pressure.",
        "relation": "CPR:5"
    },
    {
        "id": "23315277.T13.T15",
        "sentence": "Quantitative real-time polymerase chain reaction analysis showed that following the exposure of cells to @CHEMICAL$ NPs, the messenger RNA level of apoptotic genes (@GENE$ and caspase-9) were upregulated in a dose-dependent manner.",
        "relation": "CPR:3"
    },
    {
        "id": "23315277.T13.T16",
        "sentence": "Quantitative real-time polymerase chain reaction analysis showed that following the exposure of cells to @CHEMICAL$ NPs, the messenger RNA level of apoptotic genes (caspase-3 and @GENE$) were upregulated in a dose-dependent manner.",
        "relation": "CPR:3"
    },
    {
        "id": "23315277.T1.T17",
        "sentence": "Moreover, activities of @CHEMICAL$ and caspase-9 enzymes were also significantly higher in both kinds of cells exposed to @GENE$ NPs.",
        "relation": "CPR:3"
    },
    {
        "id": "23315277.T1.T18",
        "sentence": "Moreover, activities of caspase-3 and @CHEMICAL$ enzymes were also significantly higher in both kinds of cells exposed to @GENE$ NPs.",
        "relation": "CPR:3"
    },
    {
        "id": "23550066.T12.T36",
        "sentence": "The @CHEMICAL$ Allele Significantly Alters the N-demethylation of @GENE$ Enantiomers In Vitro.",
        "relation": "CPR:9"
    },
    {
        "id": "23550066.T1.T31",
        "sentence": "@CHEMICAL$ is primarily metabolized to norketamine by hepatic @GENE$ and CYP3A4-mediated N-demethylation.",
        "relation": "CPR:9"
    },
    {
        "id": "23550066.T1.T35",
        "sentence": "@CHEMICAL$ is primarily metabolized to norketamine by hepatic cytochrome P450 (CYP) 2B6 and @GENE$-mediated N-demethylation.",
        "relation": "CPR:9"
    },
    {
        "id": "23550066.T7.T25",
        "sentence": "The @CHEMICAL$ allele is associated with reduced enzyme expression and activity that may lead to interindividual variability in @GENE$ metabolism.",
        "relation": "CPR:9"
    },
    {
        "id": "23550066.T9.T26",
        "sentence": "We examined the N-demethylation of individual @CHEMICAL$ enantiomers using human liver microsomes (HLMs) genotyped for the @GENE$ allele, insect cell expressed recombinant CYP2B6 and CYP3A4 enzymes and COS-1 cell expressed recombinant CYP2B6.1 and CYP2B6.6 protein variant.",
        "relation": "CPR:9"
    },
    {
        "id": "23550066.T11.T13",
        "sentence": "The intrinsic clearance for both @CHEMICAL$ enantiomers by the high affinity enzyme in HLMs with @GENE$/*1 genotype were at least 2-fold and 6-fold higher, respectively, than those for CYP2B6*1/*6 genotype and CYP2B6*6/*6 genotype.",
        "relation": "CPR:9"
    },
    {
        "id": "23550066.T2.T18",
        "sentence": "@CHEMICAL$ (@GENE$ inhibitor, 25 mM) and the monoclonal antibody against CYP2B6 but not troleandomycin (CYP3A4 inhibitor, 25 mM) or the monoclonal antibody against CYP3A4 inhibited ketamine N-demethylation at clinically relevant concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "23550066.T3.T20",
        "sentence": "ThioTEPA (CYP2B6 inhibitor, 25 mM) and the monoclonal antibody against CYP2B6 but not @CHEMICAL$ (@GENE$ inhibitor, 25 mM) or the monoclonal antibody against CYP3A4 inhibited ketamine N-demethylation at clinically relevant concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "23550066.T5.T23",
        "sentence": "These results indicate a major role of @CHEMICAL$ in @GENE$ N-demethylation in vitro and a significant impact of the CYP2B6*6 allele on enzyme-ketamine binding and catalytic activity.",
        "relation": "CPR:9"
    },
    {
        "id": "23550066.T6.T24",
        "sentence": "These results indicate a major role of CYP2B6 in ketamine N-demethylation in vitro and a significant impact of the @CHEMICAL$ allele on enzyme-@GENE$ binding and catalytic activity.",
        "relation": "CPR:9"
    },
    {
        "id": "11792932.T1.T44",
        "sentence": "PURPOSE: Testosterone-to-estradiol ratio levels in infertile men improve during treatment with the @CHEMICAL$ inhibitor, @GENE$, and resulting changes in semen parameters.",
        "relation": "CPR:4"
    },
    {
        "id": "11792932.T7.T42",
        "sentence": "We evaluated the effect of @CHEMICAL$, a more selective @GENE$ inhibitor, on the hormonal and semen profiles of infertile men with abnormal baseline testosterone-to-estradiol ratios.",
        "relation": "CPR:4"
    },
    {
        "id": "23043184.T2.T29",
        "sentence": "The results show that CYP2E1 inhibits @CHEMICAL$-mediated metabolism of @GENE$ (BNZ) with a K(i) of 0.04 mM.",
        "relation": "CPR:9"
    },
    {
        "id": "23043184.T3.T29",
        "sentence": "The results show that CYP2E1 inhibits @CHEMICAL$-mediated metabolism of benzphetamine (@GENE$) with a K(i) of 0.04 mM.",
        "relation": "CPR:9"
    },
    {
        "id": "23043184.T4.T31",
        "sentence": "However, CYP2B4 is not an inhibitor of @CHEMICAL$-mediated @GENE$ hydroxylation.",
        "relation": "CPR:9"
    },
    {
        "id": "15336276.T1.T12",
        "sentence": "To explore for the existence of an auxiliary hydrophobic binding register remote from the active site of PSMA a series of @CHEMICAL$ derivatives of glutamic acid were synthesized and evaluated for their inhibitory potencies against @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15336276.T2.T12",
        "sentence": "To explore for the existence of an auxiliary hydrophobic binding register remote from the active site of PSMA a series of phenylalkylphosphonamidate derivatives of @CHEMICAL$ were synthesized and evaluated for their inhibitory potencies against @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23551329.T11.T26",
        "sentence": "In PFC, @CHEMICAL$ caused activation of @GENE$, augmentation of pro-survival Bcl-2 protein and enhanced Bcl-2/Bax protein ratio, as well Bcl-2 translocation to mitochondria.",
        "relation": "CPR:3"
    },
    {
        "id": "23551329.T11.T27",
        "sentence": "In PFC, @CHEMICAL$ caused activation of AKT, augmentation of pro-survival @GENE$ protein and enhanced Bcl-2/Bax protein ratio, as well Bcl-2 translocation to mitochondria.",
        "relation": "CPR:3"
    },
    {
        "id": "23551329.T11.T28",
        "sentence": "In PFC, @CHEMICAL$ caused activation of AKT, augmentation of pro-survival Bcl-2 protein and enhanced @GENE$/Bax protein ratio, as well Bcl-2 translocation to mitochondria.",
        "relation": "CPR:3"
    },
    {
        "id": "23551329.T11.T29",
        "sentence": "In PFC, @CHEMICAL$ caused activation of AKT, augmentation of pro-survival Bcl-2 protein and enhanced Bcl-2/@GENE$ protein ratio, as well Bcl-2 translocation to mitochondria.",
        "relation": "CPR:3"
    },
    {
        "id": "23551329.T1.T15",
        "sentence": "Results of RT-PCR analysis showed decrease of @CHEMICAL$ mRNA level and no significant difference in Bcl-2 and Bax mRNA expressions in @GENE$-treated rats.",
        "relation": "CPR:4"
    },
    {
        "id": "17205056.T12.T26",
        "sentence": "Antitumor activity of @CHEMICAL$ in @GENE$-driven leukemic cells. Activating internal tandem duplication (ITD) insertions in the juxtamembrane domain of the FLT3 tyrosine kinase are found in about one fourth of patients with acute myeloid leukemia and have been shown to be an independent negative prognostic factor for survival.",
        "relation": "CPR:4"
    },
    {
        "id": "17205056.T2.T15",
        "sentence": "We show that @CHEMICAL$ (BAY 43-9006, Nexavar) potently inhibits @GENE$ enzymatic and signaling activities.",
        "relation": "CPR:4"
    },
    {
        "id": "17205056.T3.T15",
        "sentence": "We show that sorafenib (@CHEMICAL$, Nexavar) potently inhibits @GENE$ enzymatic and signaling activities.",
        "relation": "CPR:4"
    },
    {
        "id": "17205056.T4.T15",
        "sentence": "We show that sorafenib (BAY 43-9006, @CHEMICAL$) potently inhibits @GENE$ enzymatic and signaling activities.",
        "relation": "CPR:4"
    },
    {
        "id": "17205056.T5.T19",
        "sentence": "In HEK293 cells stably transfected with FLT3-WT or FLT3-ITD, @CHEMICAL$ blocked basal and ligand dependent FLT3-mediated tyrosine autophosphorylation as well as @GENE$ and Stat5 phosphorylation.",
        "relation": "CPR:4"
    },
    {
        "id": "17205056.T5.T18",
        "sentence": "In HEK293 cells stably transfected with FLT3-WT or FLT3-ITD, @CHEMICAL$ blocked basal and ligand dependent @GENE$-mediated tyrosine autophosphorylation as well as extracellular signal-regulated kinase1/2 and Stat5 phosphorylation.",
        "relation": "CPR:4"
    },
    {
        "id": "17205056.T5.T20",
        "sentence": "In HEK293 cells stably transfected with FLT3-WT or FLT3-ITD, @CHEMICAL$ blocked basal and ligand dependent FLT3-mediated tyrosine autophosphorylation as well as extracellular signal-regulated kinase1/2 and @GENE$ phosphorylation.",
        "relation": "CPR:4"
    },
    {
        "id": "17205056.T7.T22",
        "sentence": "In leukemia cell lines MV4-11 and EOL-1, @CHEMICAL$ treatment resulted in decreased cell proliferation and inhibition of @GENE$ signaling.",
        "relation": "CPR:4"
    },
    {
        "id": "17205056.T8.T23",
        "sentence": "The growth of the @CHEMICAL$-independent RS4-11 cell line was only weakly inhibited by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17205056.T1.T13",
        "sentence": "The demonstration that @CHEMICAL$ exhibits potent target inhibition and efficacy in @GENE$-driven models suggests that this compound may have a therapeutic benefit for patients with FLT3-driven leukemias.",
        "relation": "CPR:4"
    },
    {
        "id": "17205056.T1.T14",
        "sentence": "The demonstration that @CHEMICAL$ exhibits potent target inhibition and efficacy in FLT3-driven models suggests that this compound may have a therapeutic benefit for patients with @GENE$-driven leukemias.",
        "relation": "CPR:4"
    },
    {
        "id": "23041257.T13.T15",
        "sentence": "@CHEMICAL$ up-regulated the expression of Bax, down-regulated the expression of Bcl-2, and significantly increased the ratio of @GENE$/Bcl-2.",
        "relation": "CPR:3"
    },
    {
        "id": "23041257.T13.T16",
        "sentence": "@CHEMICAL$ up-regulated the expression of Bax, down-regulated the expression of Bcl-2, and significantly increased the ratio of Bax/@GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23041257.T13.T25",
        "sentence": "@CHEMICAL$ up-regulated the expression of @GENE$, down-regulated the expression of Bcl-2, and significantly increased the ratio of Bax/Bcl-2.",
        "relation": "CPR:3"
    },
    {
        "id": "23041257.T13.T26",
        "sentence": "@CHEMICAL$ up-regulated the expression of Bax, down-regulated the expression of @GENE$, and significantly increased the ratio of Bax/Bcl-2.",
        "relation": "CPR:4"
    },
    {
        "id": "23041257.T1.T17",
        "sentence": "@CHEMICAL$ also caused the phosphorylation of @GENE$ and p38(MAPK).",
        "relation": "CPR:3"
    },
    {
        "id": "23041257.T1.T18",
        "sentence": "@CHEMICAL$ also caused the phosphorylation of JNK and @GENE$(MAPK).",
        "relation": "CPR:3"
    },
    {
        "id": "23041257.T1.T19",
        "sentence": "@CHEMICAL$ also caused the phosphorylation of JNK and p38(@GENE$).",
        "relation": "CPR:3"
    },
    {
        "id": "12927775.T6.T15",
        "sentence": "Structure-based design of @CHEMICAL$, a novel orally effective @GENE$ inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "12927775.T3.T13",
        "sentence": "This led to the discovery of @CHEMICAL$, a highly potent and selective inhibitor of @GENE$ in vitro, and in vivo; once-daily oral doses of aliskiren inhibit renin and lower blood pressure in sodium-depleted marmosets and hypertensive human patients.",
        "relation": "CPR:4"
    },
    {
        "id": "12927775.T4.T14",
        "sentence": "This led to the discovery of aliskiren, a highly potent and selective inhibitor of human renin in vitro, and in vivo; once-daily oral doses of @CHEMICAL$ inhibit @GENE$ and lower blood pressure in sodium-depleted marmosets and hypertensive human patients.",
        "relation": "CPR:4"
    },
    {
        "id": "12927775.T1.T7",
        "sentence": "@CHEMICAL$ represents the first in a novel class of @GENE$ inhibitors with the potential for treatment of hypertension and related cardiovascular diseases.",
        "relation": "CPR:4"
    },
    {
        "id": "20531964.T1.T18",
        "sentence": "@CHEMICAL$ (RAD001, Afinitor((R)) Novartis) is the first oral inhibitor of @GENE$ (mammalian target of rapamycin) to reach the oncology clinic.",
        "relation": "CPR:4"
    },
    {
        "id": "20531964.T1.T19",
        "sentence": "@CHEMICAL$ (RAD001, Afinitor((R)) Novartis) is the first oral inhibitor of mTOR (@GENE$) to reach the oncology clinic.",
        "relation": "CPR:4"
    },
    {
        "id": "20531964.T3.T18",
        "sentence": "Everolimus (@CHEMICAL$, Afinitor((R)) Novartis) is the first oral inhibitor of @GENE$ (mammalian target of rapamycin) to reach the oncology clinic.",
        "relation": "CPR:4"
    },
    {
        "id": "20531964.T3.T19",
        "sentence": "Everolimus (@CHEMICAL$, Afinitor((R)) Novartis) is the first oral inhibitor of mTOR (@GENE$) to reach the oncology clinic.",
        "relation": "CPR:4"
    },
    {
        "id": "20531964.T6.T18",
        "sentence": "Everolimus (RAD001, @CHEMICAL$) is the first oral inhibitor of @GENE$ (mammalian target of rapamycin) to reach the oncology clinic.",
        "relation": "CPR:4"
    },
    {
        "id": "20531964.T6.T19",
        "sentence": "Everolimus (RAD001, @CHEMICAL$) is the first oral inhibitor of mTOR (@GENE$) to reach the oncology clinic.",
        "relation": "CPR:4"
    },
    {
        "id": "20531964.T9.T16",
        "sentence": "A phase III randomized placebo-controlled trial has examined the impact of everolimus in patients with clear cell renal cancers and progressive disease on or within 6 months of the @CHEMICAL$ tyrosine kinase inhibitors @GENE$ and/or sorafenib.",
        "relation": "CPR:4"
    },
    {
        "id": "20531964.T9.T17",
        "sentence": "A phase III randomized placebo-controlled trial has examined the impact of everolimus in patients with clear cell renal cancers and progressive disease on or within 6 months of the VEGFR @CHEMICAL$ inhibitors @GENE$ and/or sorafenib.",
        "relation": "CPR:4"
    },
    {
        "id": "20531964.T10.T16",
        "sentence": "A phase III randomized placebo-controlled trial has examined the impact of everolimus in patients with clear cell renal cancers and progressive disease on or within 6 months of the @CHEMICAL$ tyrosine kinase inhibitors sunitinib and/or @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "20531964.T10.T17",
        "sentence": "A phase III randomized placebo-controlled trial has examined the impact of everolimus in patients with clear cell renal cancers and progressive disease on or within 6 months of the VEGFR @CHEMICAL$ inhibitors sunitinib and/or @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23535327.T5.T6",
        "sentence": "Synthesis and structure-activity relationship of @CHEMICAL$ derivatives as potent and selective @GENE$ (ACAT2) inhibitors: Part 2.",
        "relation": "CPR:4"
    },
    {
        "id": "23535327.T5.T7",
        "sentence": "Synthesis and structure-activity relationship of @CHEMICAL$ derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (@GENE$) inhibitors: Part 2.",
        "relation": "CPR:4"
    },
    {
        "id": "1680855.T1.T45",
        "sentence": "@CHEMICAL$ inhibits @GENE$ secretion via pertussis toxin-sensitive mechanisms.",
        "relation": "CPR:4"
    },
    {
        "id": "1680855.T16.T48",
        "sentence": "@CHEMICAL$ which also inhibits @GENE$ secretion was less efficient (inhibition by 20%).",
        "relation": "CPR:4"
    },
    {
        "id": "1680855.T21.T52",
        "sentence": "In contrast to @CHEMICAL$ and somatostatin, galanin, another inhibitor of @GENE$ secretion, reduced Ca2+ currents by about 40% in a pertussis toxin-insensitive manner.",
        "relation": "CPR:4"
    },
    {
        "id": "1680855.T22.T52",
        "sentence": "In contrast to adrenaline and @CHEMICAL$, galanin, another inhibitor of @GENE$ secretion, reduced Ca2+ currents by about 40% in a pertussis toxin-insensitive manner.",
        "relation": "CPR:4"
    },
    {
        "id": "1680855.T10.T44",
        "sentence": "These G-proteins are likely to be involved in the adrenaline-induced inhibition of dihydropyridine-sensitive Ca2+ currents and in other signal transduction pathways contributing to the @CHEMICAL$-induced inhibition of @GENE$ secretion.",
        "relation": "CPR:4"
    },
    {
        "id": "23532918.T16.T28",
        "sentence": "Synthesis and in Vitro Characterisation of @CHEMICAL$-Based Fluorescein Conjugates as GluN1/GluN2B @GENE$ Antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "23532918.T16.T26",
        "sentence": "Synthesis and in Vitro Characterisation of @CHEMICAL$-Based Fluorescein Conjugates as @GENE$/GluN2B N-Methyl-D-aspartate Receptor Antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "23532918.T16.T27",
        "sentence": "Synthesis and in Vitro Characterisation of @CHEMICAL$-Based Fluorescein Conjugates as GluN1/@GENE$ N-Methyl-D-aspartate Receptor Antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "23532918.T17.T28",
        "sentence": "Synthesis and in Vitro Characterisation of Ifenprodil-Based @CHEMICAL$ Conjugates as GluN1/GluN2B @GENE$ Antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "23532918.T17.T26",
        "sentence": "Synthesis and in Vitro Characterisation of Ifenprodil-Based @CHEMICAL$ Conjugates as @GENE$/GluN2B N-Methyl-D-aspartate Receptor Antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "23532918.T17.T27",
        "sentence": "Synthesis and in Vitro Characterisation of Ifenprodil-Based @CHEMICAL$ Conjugates as GluN1/@GENE$ N-Methyl-D-aspartate Receptor Antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "23532918.T9.T24",
        "sentence": "@CHEMICAL$, known as the @GENE$ antagonist of reference, was chosen as the template for the elaboration of probes.",
        "relation": "CPR:6"
    },
    {
        "id": "17434872.T25.T43",
        "sentence": "Molecular determinants for the selective inhibition of @CHEMICAL$ by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17434872.T1.T40",
        "sentence": "@CHEMICAL$ is the first example of a marketed @GENE$ inhibitor of the arylacetic acid class, and it is reported to be the most selective COXIB in vivo.",
        "relation": "CPR:4"
    },
    {
        "id": "17434872.T18.T40",
        "sentence": "Lumiracoxib is the first example of a marketed @CHEMICAL$ inhibitor of the @GENE$ class, and it is reported to be the most selective COXIB in vivo.",
        "relation": "CPR:4"
    },
    {
        "id": "17434872.T16.T37",
        "sentence": "Using standard assays, @CHEMICAL$ was found to be a poor inhibitor of purified @GENE$ and a relatively weak inhibitor of purified human COX-2.",
        "relation": "CPR:4"
    },
    {
        "id": "17434872.T16.T38",
        "sentence": "Using standard assays, @CHEMICAL$ was found to be a poor inhibitor of purified ovine COX-1 and a relatively weak inhibitor of purified @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17434872.T17.T41",
        "sentence": "Kinetic studies with @CHEMICAL$ demonstrated that it was a time-dependent and slowly reversible inhibitor of @GENE$ that exhibited at least two binding steps during inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "17434872.T23.T42",
        "sentence": "Inhibition studies demonstrated that the @CHEMICAL$ group on the phenylacetic acid ring is required for @GENE$ selectivity.",
        "relation": "CPR:4"
    },
    {
        "id": "17434872.T24.T42",
        "sentence": "Inhibition studies demonstrated that the methyl group on the @CHEMICAL$ ring is required for @GENE$ selectivity.",
        "relation": "CPR:4"
    },
    {
        "id": "17434872.T2.T26",
        "sentence": "The chemical identity and position of the substituents on the lower @CHEMICAL$ ring were important in determining the potency and extent of @GENE$ inhibition as well as COX-2 selectivity.",
        "relation": "CPR:4"
    },
    {
        "id": "17434872.T8.T30",
        "sentence": "Mutation of Ser-530 to Ala or Val-349 to Ala or Leu abolished the potent inhibition observed with wild-type @CHEMICAL$ and key @GENE$ analogs.",
        "relation": "CPR:4"
    },
    {
        "id": "17434872.T10.T31",
        "sentence": "Interestingly, a @CHEMICAL$ mutant was inhibited with equal potency to human COX-2 with @GENE$-, 2,6-dimethyl-, or 2-chloro-6-methyl-substituted inhibitors and, in the case of lumiracoxib, actually showed an increase in potency.",
        "relation": "CPR:4"
    },
    {
        "id": "17434872.T10.T32",
        "sentence": "Interestingly, a Val-349 to Ile mutant was inhibited with equal potency to @CHEMICAL$ with @GENE$-, 2,6-dimethyl-, or 2-chloro-6-methyl-substituted inhibitors and, in the case of lumiracoxib, actually showed an increase in potency.",
        "relation": "CPR:4"
    },
    {
        "id": "17434872.T11.T31",
        "sentence": "Interestingly, a @CHEMICAL$ mutant was inhibited with equal potency to human COX-2 with 2,6-dichloro-, @GENE$-, or 2-chloro-6-methyl-substituted inhibitors and, in the case of lumiracoxib, actually showed an increase in potency.",
        "relation": "CPR:4"
    },
    {
        "id": "17434872.T11.T32",
        "sentence": "Interestingly, a Val-349 to Ile mutant was inhibited with equal potency to @CHEMICAL$ with 2,6-dichloro-, @GENE$-, or 2-chloro-6-methyl-substituted inhibitors and, in the case of lumiracoxib, actually showed an increase in potency.",
        "relation": "CPR:4"
    },
    {
        "id": "17434872.T12.T31",
        "sentence": "Interestingly, a @CHEMICAL$ mutant was inhibited with equal potency to human COX-2 with 2,6-dichloro-, 2,6-dimethyl-, or @GENE$-substituted inhibitors and, in the case of lumiracoxib, actually showed an increase in potency.",
        "relation": "CPR:4"
    },
    {
        "id": "17434872.T12.T32",
        "sentence": "Interestingly, a Val-349 to Ile mutant was inhibited with equal potency to @CHEMICAL$ with 2,6-dichloro-, 2,6-dimethyl-, or @GENE$-substituted inhibitors and, in the case of lumiracoxib, actually showed an increase in potency.",
        "relation": "CPR:4"
    },
    {
        "id": "17434872.T13.T31",
        "sentence": "Interestingly, a @CHEMICAL$ mutant was inhibited with equal potency to human COX-2 with 2,6-dichloro-, 2,6-dimethyl-, or 2-chloro-6-methyl-substituted inhibitors and, in the case of @GENE$, actually showed an increase in potency.",
        "relation": "CPR:4"
    },
    {
        "id": "17434872.T13.T32",
        "sentence": "Interestingly, a Val-349 to Ile mutant was inhibited with equal potency to @CHEMICAL$ with 2,6-dichloro-, 2,6-dimethyl-, or 2-chloro-6-methyl-substituted inhibitors and, in the case of @GENE$, actually showed an increase in potency.",
        "relation": "CPR:4"
    },
    {
        "id": "17434872.T15.T34",
        "sentence": "Taken together with a recent crystal structure of a lumiracoxib-COX-2 complex, the kinetic analyses presented herein of the inhibition of mutant @CHEMICAL$ by @GENE$ allows the definition of the molecular basis of COX-2 inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "19429089.T8.T27",
        "sentence": "The present study examined the effect of antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), on @CHEMICAL$ activity by measuring adenosine triphosphate-dependent @GENE$ uptake into synaptic vesicles prepared from rat striatum.",
        "relation": "CPR:9"
    },
    {
        "id": "19429089.T19.T30",
        "sentence": "Moreover, kinetic analysis revealed that inhibition by @CHEMICAL$, a typical @GENE$ inhibitor, was uncompetitive, decreasing maximum velocity and affinity for dopamine.",
        "relation": "CPR:4"
    },
    {
        "id": "19429089.T20.T30",
        "sentence": "Moreover, kinetic analysis revealed that inhibition by reserpine, a typical @CHEMICAL$ inhibitor, was uncompetitive, decreasing maximum velocity and affinity for @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "19429089.T1.T31",
        "sentence": "These results suggest that fluoxetine inhibited the activity of @CHEMICAL$ by a mechanism different from that of @GENE$ and did not directly interact with the active site of VMAT2.",
        "relation": "CPR:4"
    },
    {
        "id": "19429089.T23.T26",
        "sentence": "These results suggest that @CHEMICAL$ inhibited the activity of VMAT2 by a mechanism different from that of reserpine and did not directly interact with the active site of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "19429089.T23.T31",
        "sentence": "These results suggest that @CHEMICAL$ inhibited the activity of @GENE$ by a mechanism different from that of reserpine and did not directly interact with the active site of VMAT2.",
        "relation": "CPR:4"
    },
    {
        "id": "10864881.T35.T48",
        "sentence": "@CHEMICAL$, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other @GENE$ antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "10864881.T35.T47",
        "sentence": "@CHEMICAL$, a @GENE$ antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "10864881.T1.T38",
        "sentence": "@CHEMICAL$, a @GENE$ antagonist used for the treatment of glaucoma, is known to be neuroprotective in paradigms of ischaemia/excitotoxicity.",
        "relation": "CPR:6"
    },
    {
        "id": "10864881.T19.T40",
        "sentence": "In this study, we examined whether @CHEMICAL$ and other @GENE$ antagonists interact directly with neurotoxin binding to sites 1 and 2 of the voltage-sensitive sodium channel (Na(+) channel) in rat cerebrocortical synaptosomes.",
        "relation": "CPR:6"
    },
    {
        "id": "10864881.T25.T44",
        "sentence": "Betaxolol inhibited specific [(3)H]-batrachotoxinin-A 20-alpha-benzoate ([(3)H]-BTX-B) binding to neurotoxin site 2 in a concentration-dependent manner with an IC(50) value of 9.8 microM. Comparison of all the @CHEMICAL$ antagonists tested revealed a potency order of @GENE$>betaxolol approximately levobetaxolol>levobunolol approximately carteolol>/=timolol>atenolol.",
        "relation": "CPR:6"
    },
    {
        "id": "10864881.T26.T44",
        "sentence": "Betaxolol inhibited specific [(3)H]-batrachotoxinin-A 20-alpha-benzoate ([(3)H]-BTX-B) binding to neurotoxin site 2 in a concentration-dependent manner with an IC(50) value of 9.8 microM. Comparison of all the @CHEMICAL$ antagonists tested revealed a potency order of propranolol>@GENE$ approximately levobetaxolol>levobunolol approximately carteolol>/=timolol>atenolol.",
        "relation": "CPR:6"
    },
    {
        "id": "10864881.T27.T44",
        "sentence": "Betaxolol inhibited specific [(3)H]-batrachotoxinin-A 20-alpha-benzoate ([(3)H]-BTX-B) binding to neurotoxin site 2 in a concentration-dependent manner with an IC(50) value of 9.8 microM. Comparison of all the @CHEMICAL$ antagonists tested revealed a potency order of propranolol>betaxolol approximately @GENE$>levobunolol approximately carteolol>/=timolol>atenolol.",
        "relation": "CPR:6"
    },
    {
        "id": "10864881.T28.T44",
        "sentence": "Betaxolol inhibited specific [(3)H]-batrachotoxinin-A 20-alpha-benzoate ([(3)H]-BTX-B) binding to neurotoxin site 2 in a concentration-dependent manner with an IC(50) value of 9.8 microM. Comparison of all the @CHEMICAL$ antagonists tested revealed a potency order of propranolol>betaxolol approximately levobetaxolol>@GENE$ approximately carteolol>/=timolol>atenolol.",
        "relation": "CPR:6"
    },
    {
        "id": "10864881.T29.T44",
        "sentence": "Betaxolol inhibited specific [(3)H]-batrachotoxinin-A 20-alpha-benzoate ([(3)H]-BTX-B) binding to neurotoxin site 2 in a concentration-dependent manner with an IC(50) value of 9.8 microM. Comparison of all the @CHEMICAL$ antagonists tested revealed a potency order of propranolol>betaxolol approximately levobetaxolol>levobunolol approximately @GENE$>/=timolol>atenolol.",
        "relation": "CPR:6"
    },
    {
        "id": "10864881.T30.T44",
        "sentence": "Betaxolol inhibited specific [(3)H]-batrachotoxinin-A 20-alpha-benzoate ([(3)H]-BTX-B) binding to neurotoxin site 2 in a concentration-dependent manner with an IC(50) value of 9.8 microM. Comparison of all the @CHEMICAL$ antagonists tested revealed a potency order of propranolol>betaxolol approximately levobetaxolol>levobunolol approximately carteolol>/=@GENE$>atenolol.",
        "relation": "CPR:6"
    },
    {
        "id": "10864881.T31.T44",
        "sentence": "Betaxolol inhibited specific [(3)H]-batrachotoxinin-A 20-alpha-benzoate ([(3)H]-BTX-B) binding to neurotoxin site 2 in a concentration-dependent manner with an IC(50) value of 9.8 microM. Comparison of all the @CHEMICAL$ antagonists tested revealed a potency order of propranolol>betaxolol approximately levobetaxolol>levobunolol approximately carteolol>/=timolol>@GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "22982445.T13.T35",
        "sentence": "@CHEMICAL$ induces cognitive impairment through enhancement of @GENE$-mediated amyloid-b generation in mice.",
        "relation": "CPR:3"
    },
    {
        "id": "22982445.T13.T36",
        "sentence": "@CHEMICAL$ induces cognitive impairment through enhancement of CysLT1 R-mediated @GENE$ generation in mice.",
        "relation": "CPR:3"
    },
    {
        "id": "22982445.T6.T24",
        "sentence": "The results demonstrated that intracerebral infusions of @CHEMICAL$ (1 ng/mouse) produced memory impairment as determined by Morris water maze test and Y-maze test in mice, and caused the accumulation of @GENE$ and Ab1-42 in the hippocampus and cortex through increased activity of b- and g-secretases accompanied with increased expression of amyloid precursor protein (APP).",
        "relation": "CPR:3"
    },
    {
        "id": "22982445.T6.T25",
        "sentence": "The results demonstrated that intracerebral infusions of @CHEMICAL$ (1 ng/mouse) produced memory impairment as determined by Morris water maze test and Y-maze test in mice, and caused the accumulation of Ab1-40 and @GENE$ in the hippocampus and cortex through increased activity of b- and g-secretases accompanied with increased expression of amyloid precursor protein (APP).",
        "relation": "CPR:3"
    },
    {
        "id": "22982445.T6.T26",
        "sentence": "The results demonstrated that intracerebral infusions of @CHEMICAL$ (1 ng/mouse) produced memory impairment as determined by Morris water maze test and Y-maze test in mice, and caused the accumulation of Ab1-40 and Ab1-42 in the hippocampus and cortex through increased activity of b- and g-secretases accompanied with increased expression of @GENE$ (APP).",
        "relation": "CPR:3"
    },
    {
        "id": "22982445.T6.T28",
        "sentence": "The results demonstrated that intracerebral infusions of @CHEMICAL$ (1 ng/mouse) produced memory impairment as determined by Morris water maze test and Y-maze test in mice, and caused the accumulation of Ab1-40 and Ab1-42 in the hippocampus and cortex through increased activity of b- and g-secretases accompanied with increased expression of amyloid precursor protein (@GENE$).",
        "relation": "CPR:3"
    },
    {
        "id": "22982445.T7.T31",
        "sentence": "@CHEMICAL$ also induced expression of cysteinyl leukotriene receptor 1 (CysLT(1)R) and @GENE$ p65 in the hippocampus and cortex.",
        "relation": "CPR:3"
    },
    {
        "id": "22982445.T7.T29",
        "sentence": "@CHEMICAL$ also induced expression of @GENE$ (CysLT(1)R) and NF-kB p65 in the hippocampus and cortex.",
        "relation": "CPR:3"
    },
    {
        "id": "22982445.T7.T30",
        "sentence": "@CHEMICAL$ also induced expression of cysteinyl leukotriene receptor 1 (@GENE$) and NF-kB p65 in the hippocampus and cortex.",
        "relation": "CPR:3"
    },
    {
        "id": "22982445.T7.T32",
        "sentence": "@CHEMICAL$ also induced expression of cysteinyl leukotriene receptor 1 (CysLT(1)R) and NF-kB @GENE$ in the hippocampus and cortex.",
        "relation": "CPR:3"
    },
    {
        "id": "22982445.T9.T34",
        "sentence": "Pretreatment with @CHEMICAL$ (1.5 ng/mouse, intracerebroventricularly), a @GENE$ antagonist, blocked LTD4-induced amyloidogenesis, memory deficits.",
        "relation": "CPR:6"
    },
    {
        "id": "22982445.T1.T16",
        "sentence": "Moreover, @CHEMICAL$-induced increases in CysLT(1)R and @GENE$ p65 in the brain were also attenuated by pranlukast.",
        "relation": "CPR:3"
    },
    {
        "id": "22982445.T1.T15",
        "sentence": "Moreover, @CHEMICAL$-induced increases in @GENE$ and NF-kB p65 in the brain were also attenuated by pranlukast.",
        "relation": "CPR:3"
    },
    {
        "id": "22982445.T1.T17",
        "sentence": "Moreover, @CHEMICAL$-induced increases in CysLT(1)R and NF-kB @GENE$ in the brain were also attenuated by pranlukast.",
        "relation": "CPR:3"
    },
    {
        "id": "22982445.T2.T16",
        "sentence": "Moreover, LTD4-induced increases in CysLT(1)R and @CHEMICAL$ p65 in the brain were also attenuated by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "22982445.T2.T15",
        "sentence": "Moreover, LTD4-induced increases in @CHEMICAL$ and NF-kB p65 in the brain were also attenuated by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "22982445.T2.T17",
        "sentence": "Moreover, LTD4-induced increases in CysLT(1)R and NF-kB @CHEMICAL$ in the brain were also attenuated by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "22982445.T3.T18",
        "sentence": "These results suggest that @CHEMICAL$ increases @GENE$ burden via activation of CysLT(1)R, which further affects APP levels and activity of b- and g-secretases via the NF-kB pathway.",
        "relation": "CPR:3"
    },
    {
        "id": "22982445.T3.T19",
        "sentence": "These results suggest that @CHEMICAL$ increases Ab peptide burden via activation of @GENE$, which further affects APP levels and activity of b- and g-secretases via the NF-kB pathway.",
        "relation": "CPR:3"
    },
    {
        "id": "18381445.T5.T28",
        "sentence": "@CHEMICAL$ increase p21 through inhibition of histone deacetylase activity and release of promoter-associated @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "18381445.T5.T30",
        "sentence": "@CHEMICAL$ increase p21 through inhibition of @GENE$ activity and release of promoter-associated HDAC1/2.",
        "relation": "CPR:4"
    },
    {
        "id": "18381445.T5.T29",
        "sentence": "@CHEMICAL$ increase @GENE$ through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.",
        "relation": "CPR:3"
    },
    {
        "id": "18381445.T1.T9",
        "sentence": "@CHEMICAL$ are @GENE$ inhibitors broadly used for the control of hypercholesterolemia.",
        "relation": "CPR:4"
    },
    {
        "id": "18381445.T4.T18",
        "sentence": "In the subsequent enzymatic assay, it was shown that @CHEMICAL$ inhibited @GENE$ activity competitively with a K(i) value of 31.6 micromol/L. Sp1 but not p53 sites were found to be the statins-responsive element shown by p21 luciferase-promoter assays.",
        "relation": "CPR:4"
    },
    {
        "id": "17049513.T4.T12",
        "sentence": "Recent studies have reported that @CHEMICAL$, a kinase inhibitor that targets the intracellular @GENE$ BCR-ABL and the platelet derived growth factor (PDGF) receptor, is an effective inhibitor of the macrophage colony stimulating factor (M-CSF) receptor, c-FMS.",
        "relation": "CPR:4"
    },
    {
        "id": "17049513.T4.T20",
        "sentence": "Recent studies have reported that @CHEMICAL$, a kinase inhibitor that targets the intracellular tyrosine kinase BCR-ABL and the @GENE$, is an effective inhibitor of the macrophage colony stimulating factor (M-CSF) receptor, c-FMS.",
        "relation": "CPR:4"
    },
    {
        "id": "17049513.T4.T26",
        "sentence": "Recent studies have reported that @CHEMICAL$, a @GENE$ inhibitor that targets the intracellular tyrosine kinase BCR-ABL and the platelet derived growth factor (PDGF) receptor, is an effective inhibitor of the macrophage colony stimulating factor (M-CSF) receptor, c-FMS.",
        "relation": "CPR:4"
    },
    {
        "id": "17049513.T4.T17",
        "sentence": "Recent studies have reported that @CHEMICAL$, a kinase inhibitor that targets the intracellular tyrosine kinase @GENE$-ABL and the platelet derived growth factor (PDGF) receptor, is an effective inhibitor of the macrophage colony stimulating factor (M-CSF) receptor, c-FMS.",
        "relation": "CPR:4"
    },
    {
        "id": "17049513.T4.T18",
        "sentence": "Recent studies have reported that @CHEMICAL$, a kinase inhibitor that targets the intracellular tyrosine kinase BCR-@GENE$ and the platelet derived growth factor (PDGF) receptor, is an effective inhibitor of the macrophage colony stimulating factor (M-CSF) receptor, c-FMS.",
        "relation": "CPR:4"
    },
    {
        "id": "17049513.T4.T22",
        "sentence": "Recent studies have reported that @CHEMICAL$, a kinase inhibitor that targets the intracellular tyrosine kinase BCR-ABL and the platelet derived growth factor (PDGF) receptor, is an effective inhibitor of the @GENE$, c-FMS.",
        "relation": "CPR:4"
    },
    {
        "id": "17049513.T4.T23",
        "sentence": "Recent studies have reported that @CHEMICAL$, a kinase inhibitor that targets the intracellular tyrosine kinase BCR-ABL and the platelet derived growth factor (PDGF) receptor, is an effective inhibitor of the macrophage colony stimulating factor (M-CSF) receptor, @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17049513.T5.T24",
        "sentence": "Given that @CHEMICAL$ signalling through c-FMS plays an important role in osteoclast biology, we speculated that blocking such a pathway with @GENE$ may modulate osteoclast activity.",
        "relation": "CPR:4"
    },
    {
        "id": "17049513.T5.T25",
        "sentence": "Given that M-CSF signalling through @CHEMICAL$ plays an important role in osteoclast biology, we speculated that blocking such a pathway with @GENE$ may modulate osteoclast activity.",
        "relation": "CPR:4"
    },
    {
        "id": "17049513.T2.T19",
        "sentence": "Imatinib was also found to inhibit M-CSF-induced osteoclast survival as well as M-CSF-induced osteoclast bone resorbing activity, but was without effect on interleukin 1alpha (IL-1alpha) and receptor activator of nuclear factor kappa B ligand (RANKL)-induced inhibition of osteoclasts apoptosis, further supporting the hypothesis that @CHEMICAL$ may affect mature osteoclasts through the inhibition of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17049513.T9.T28",
        "sentence": "@CHEMICAL$ was also found to inhibit @GENE$-induced osteoclast survival as well as M-CSF-induced osteoclast bone resorbing activity, but was without effect on interleukin 1alpha (IL-1alpha) and receptor activator of nuclear factor kappa B ligand (RANKL)-induced inhibition of osteoclasts apoptosis, further supporting the hypothesis that imatinib may affect mature osteoclasts through the inhibition of c-FMS.",
        "relation": "CPR:4"
    },
    {
        "id": "17049513.T9.T29",
        "sentence": "@CHEMICAL$ was also found to inhibit M-CSF-induced osteoclast survival as well as @GENE$-induced osteoclast bone resorbing activity, but was without effect on interleukin 1alpha (IL-1alpha) and receptor activator of nuclear factor kappa B ligand (RANKL)-induced inhibition of osteoclasts apoptosis, further supporting the hypothesis that imatinib may affect mature osteoclasts through the inhibition of c-FMS.",
        "relation": "CPR:4"
    },
    {
        "id": "10493852.T3.T14",
        "sentence": "Structural basis for @CHEMICAL$ inhibition upon @GENE$ binding to the CD11a I-domain.",
        "relation": "CPR:4"
    },
    {
        "id": "10493852.T1.T4",
        "sentence": "We report here that @CHEMICAL$, a drug clinically used for lowering cholesterol levels, inhibits the interaction of @GENE$ with its counter-receptor intercellular adhesion molecule-1.",
        "relation": "CPR:4"
    },
    {
        "id": "10493852.T1.T5",
        "sentence": "We report here that @CHEMICAL$, a drug clinically used for lowering cholesterol levels, inhibits the interaction of human LFA-1 with its counter-receptor @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23316965.T1.T7",
        "sentence": "Particularly, the effects of @CHEMICAL$ used as a non selective @GENE$ inhibitor in experimental and clinical studies will be discussed.",
        "relation": "CPR:4"
    },
    {
        "id": "23339625.T12.T23",
        "sentence": "Time-dependent changes in hepatic and intestinal induction of @CHEMICAL$ after administration of @GENE$ to rats.",
        "relation": "CPR:3"
    },
    {
        "id": "23339625.T1.T15",
        "sentence": "We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal @CHEMICAL$ (CYP3A) in rats using @GENE$ (DEX-P) and midazolam (MDZ) as an inducer and a substrate to CYP3A, respectively. 2.",
        "relation": "CPR:3"
    },
    {
        "id": "23339625.T1.T16",
        "sentence": "We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (@CHEMICAL$) in rats using @GENE$ (DEX-P) and midazolam (MDZ) as an inducer and a substrate to CYP3A, respectively. 2.",
        "relation": "CPR:3"
    },
    {
        "id": "23339625.T1.T17",
        "sentence": "We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (CYP3A) in rats using @CHEMICAL$ (DEX-P) and midazolam (MDZ) as an inducer and a substrate to @GENE$, respectively. 2.",
        "relation": "CPR:9"
    },
    {
        "id": "23339625.T1.T17",
        "sentence": "We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (CYP3A) in rats using @CHEMICAL$ (DEX-P) and midazolam (MDZ) as an inducer and a substrate to @GENE$, respectively. 2.",
        "relation": "CPR:3"
    },
    {
        "id": "23339625.T2.T15",
        "sentence": "We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal @CHEMICAL$ (CYP3A) in rats using dexamethasone 21-phosphate (@GENE$) and midazolam (MDZ) as an inducer and a substrate to CYP3A, respectively. 2.",
        "relation": "CPR:3"
    },
    {
        "id": "23339625.T2.T16",
        "sentence": "We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (@CHEMICAL$) in rats using dexamethasone 21-phosphate (@GENE$) and midazolam (MDZ) as an inducer and a substrate to CYP3A, respectively. 2.",
        "relation": "CPR:3"
    },
    {
        "id": "23339625.T2.T17",
        "sentence": "We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (CYP3A) in rats using dexamethasone 21-phosphate (@CHEMICAL$) and midazolam (MDZ) as an inducer and a substrate to @GENE$, respectively. 2.",
        "relation": "CPR:9"
    },
    {
        "id": "23339625.T2.T17",
        "sentence": "We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (CYP3A) in rats using dexamethasone 21-phosphate (@CHEMICAL$) and midazolam (MDZ) as an inducer and a substrate to @GENE$, respectively. 2.",
        "relation": "CPR:3"
    },
    {
        "id": "23339625.T3.T15",
        "sentence": "We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal @CHEMICAL$ (CYP3A) in rats using dexamethasone 21-phosphate (DEX-P) and @GENE$ (MDZ) as an inducer and a substrate to CYP3A, respectively. 2.",
        "relation": "CPR:9"
    },
    {
        "id": "23339625.T3.T16",
        "sentence": "We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (@CHEMICAL$) in rats using dexamethasone 21-phosphate (DEX-P) and @GENE$ (MDZ) as an inducer and a substrate to CYP3A, respectively. 2.",
        "relation": "CPR:9"
    },
    {
        "id": "23339625.T3.T17",
        "sentence": "We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (CYP3A) in rats using dexamethasone 21-phosphate (DEX-P) and @CHEMICAL$ (MDZ) as an inducer and a substrate to @GENE$, respectively. 2.",
        "relation": "CPR:9"
    },
    {
        "id": "23339625.T3.T17",
        "sentence": "We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (CYP3A) in rats using dexamethasone 21-phosphate (DEX-P) and @CHEMICAL$ (MDZ) as an inducer and a substrate to @GENE$, respectively. 2.",
        "relation": "CPR:3"
    },
    {
        "id": "23339625.T4.T16",
        "sentence": "We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (@CHEMICAL$) in rats using dexamethasone 21-phosphate (DEX-P) and midazolam (@GENE$) as an inducer and a substrate to CYP3A, respectively. 2.",
        "relation": "CPR:9"
    },
    {
        "id": "23339625.T4.T17",
        "sentence": "We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (CYP3A) in rats using dexamethasone 21-phosphate (DEX-P) and midazolam (@CHEMICAL$) as an inducer and a substrate to @GENE$, respectively. 2.",
        "relation": "CPR:9"
    },
    {
        "id": "23339625.T4.T17",
        "sentence": "We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (CYP3A) in rats using dexamethasone 21-phosphate (DEX-P) and midazolam (@CHEMICAL$) as an inducer and a substrate to @GENE$, respectively. 2.",
        "relation": "CPR:3"
    },
    {
        "id": "23339625.T8.T20",
        "sentence": "@CHEMICAL$ induction in the liver increased depending on the dose of @GENE$, whereas that in intestine showed a mild increase, but the induction level was almost constant regardless of the dose of DEX-P. 4.",
        "relation": "CPR:3"
    },
    {
        "id": "23339625.T9.T20",
        "sentence": "@CHEMICAL$ induction in the liver increased depending on the dose of DEX-P, whereas that in intestine showed a mild increase, but the induction level was almost constant regardless of the dose of @GENE$. 4.",
        "relation": "CPR:3"
    },
    {
        "id": "23339625.T10.T21",
        "sentence": "Administration of a single dose of @CHEMICAL$ showed a temporal increase in @GENE$ activity in both tissues and the induction ratios reached maximum values at 12 h after DEX-P administration.",
        "relation": "CPR:3"
    },
    {
        "id": "23339625.T11.T21",
        "sentence": "Administration of a single dose of DEX-P showed a temporal increase in @CHEMICAL$ activity in both tissues and the induction ratios reached maximum values at 12 h after @GENE$ administration.",
        "relation": "CPR:3"
    },
    {
        "id": "17275903.T11.T34",
        "sentence": "@CHEMICAL$ is responsible for @GENE$ conversion to lactate through glycolysis.",
        "relation": "CPR:9"
    },
    {
        "id": "17275903.T12.T34",
        "sentence": "@CHEMICAL$ is responsible for pyruvate conversion to @GENE$ through glycolysis.",
        "relation": "CPR:9"
    },
    {
        "id": "17429625.T18.T30",
        "sentence": "Preclinical pharmacokinetics and in vitro metabolism of @CHEMICAL$ (BMS-354825): a potent oral multi-targeted @GENE$ inhibitor against SRC and BCR-ABL.",
        "relation": "CPR:4"
    },
    {
        "id": "17429625.T18.T31",
        "sentence": "Preclinical pharmacokinetics and in vitro metabolism of @CHEMICAL$ (BMS-354825): a potent oral multi-targeted kinase inhibitor against @GENE$ and BCR-ABL.",
        "relation": "CPR:4"
    },
    {
        "id": "17429625.T18.T32",
        "sentence": "Preclinical pharmacokinetics and in vitro metabolism of @CHEMICAL$ (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and @GENE$-ABL.",
        "relation": "CPR:4"
    },
    {
        "id": "17429625.T18.T33",
        "sentence": "Preclinical pharmacokinetics and in vitro metabolism of @CHEMICAL$ (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-@GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17429625.T19.T30",
        "sentence": "Preclinical pharmacokinetics and in vitro metabolism of dasatinib (@CHEMICAL$): a potent oral multi-targeted @GENE$ inhibitor against SRC and BCR-ABL.",
        "relation": "CPR:4"
    },
    {
        "id": "17429625.T19.T31",
        "sentence": "Preclinical pharmacokinetics and in vitro metabolism of dasatinib (@CHEMICAL$): a potent oral multi-targeted kinase inhibitor against @GENE$ and BCR-ABL.",
        "relation": "CPR:4"
    },
    {
        "id": "17429625.T19.T32",
        "sentence": "Preclinical pharmacokinetics and in vitro metabolism of dasatinib (@CHEMICAL$): a potent oral multi-targeted kinase inhibitor against SRC and @GENE$-ABL.",
        "relation": "CPR:4"
    },
    {
        "id": "17429625.T19.T33",
        "sentence": "Preclinical pharmacokinetics and in vitro metabolism of dasatinib (@CHEMICAL$): a potent oral multi-targeted kinase inhibitor against SRC and BCR-@GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17429625.T6.T26",
        "sentence": "PURPOSE: Dasatinib (@CHEMICAL$), a potent oral multi-targeted @GENE$ inhibitor against SRC and BCR-ABL, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance.",
        "relation": "CPR:4"
    },
    {
        "id": "17429625.T6.T27",
        "sentence": "PURPOSE: Dasatinib (@CHEMICAL$), a potent oral multi-targeted kinase inhibitor against @GENE$ and BCR-ABL, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance.",
        "relation": "CPR:4"
    },
    {
        "id": "17429625.T6.T28",
        "sentence": "PURPOSE: Dasatinib (@CHEMICAL$), a potent oral multi-targeted kinase inhibitor against SRC and @GENE$-ABL, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance.",
        "relation": "CPR:4"
    },
    {
        "id": "17429625.T6.T29",
        "sentence": "PURPOSE: Dasatinib (@CHEMICAL$), a potent oral multi-targeted kinase inhibitor against SRC and BCR-@GENE$, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance.",
        "relation": "CPR:4"
    },
    {
        "id": "17429625.T17.T26",
        "sentence": "PURPOSE: @CHEMICAL$ (BMS-354825), a potent oral multi-targeted @GENE$ inhibitor against SRC and BCR-ABL, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance.",
        "relation": "CPR:4"
    },
    {
        "id": "17429625.T17.T27",
        "sentence": "PURPOSE: @CHEMICAL$ (BMS-354825), a potent oral multi-targeted kinase inhibitor against @GENE$ and BCR-ABL, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance.",
        "relation": "CPR:4"
    },
    {
        "id": "17429625.T17.T28",
        "sentence": "PURPOSE: @CHEMICAL$ (BMS-354825), a potent oral multi-targeted kinase inhibitor against SRC and @GENE$-ABL, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance.",
        "relation": "CPR:4"
    },
    {
        "id": "17429625.T17.T29",
        "sentence": "PURPOSE: @CHEMICAL$ (BMS-354825), a potent oral multi-targeted kinase inhibitor against SRC and BCR-@GENE$, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance.",
        "relation": "CPR:4"
    },
    {
        "id": "7582530.T14.T24",
        "sentence": "The results of this study suggest that @CHEMICAL$ predominantly, but not exclusively, mediates contraction of rat aorta through the activation of an @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23123646.T3.T20",
        "sentence": "An increase in the @CHEMICAL$/ATP ratio opens @GENE$, leading to membrane hyperpolarization.",
        "relation": "CPR:3"
    },
    {
        "id": "23123646.T4.T20",
        "sentence": "An increase in the ADP/@CHEMICAL$ ratio opens @GENE$, leading to membrane hyperpolarization.",
        "relation": "CPR:3"
    },
    {
        "id": "10693877.T10.T13",
        "sentence": "Comparison of the effect of @CHEMICAL$ (a @GENE$ inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial.",
        "relation": "CPR:4"
    },
    {
        "id": "10693877.T6.T12",
        "sentence": "OBJECTIVE: This randomized, double-blind study tested the hypothesis that @CHEMICAL$, a drug that specifically inhibits @GENE$, would cause fewer gastroduodenal ulcers than ibuprofen (in a multicenter trial), and its side effects would be equivalent to those of placebo (in a prespecified analysis combining the results with another trial of identical design).",
        "relation": "CPR:4"
    },
    {
        "id": "23123250.T15.T24",
        "sentence": "Effective treatment requires drugs that can simultaneously protect by reversible binding to the acetylcholinesterase (AChE) and blocking cascades of seizure related brain damage, inflammation, neuronal degeneration as well as promoting induction of neuroregeneration. @CHEMICAL$ ([-]-Hup A), is a naturally occurring potent reversible @GENE$ inhibitor that penetrates the blood-brain barrier.",
        "relation": "CPR:4"
    },
    {
        "id": "23123250.T16.T24",
        "sentence": "Effective treatment requires drugs that can simultaneously protect by reversible binding to the acetylcholinesterase (AChE) and blocking cascades of seizure related brain damage, inflammation, neuronal degeneration as well as promoting induction of neuroregeneration. [-]-Huperzine A (@CHEMICAL$), is a naturally occurring potent reversible @GENE$ inhibitor that penetrates the blood-brain barrier.",
        "relation": "CPR:4"
    },
    {
        "id": "23123250.T18.T27",
        "sentence": "The synthetic stereoisomer, @CHEMICAL$, is less toxic due to poor @GENE$ inhibition and is suitable for both pre-/post-exposure treatments of nerve agent toxicity. [+]-Hup A block the N-methyl-d-aspartate (NMDA)-induced seizure in rats, reduce excitatory amino acid induced neurotoxicity and also prevent soman induced toxicity with minimum performance decrement.",
        "relation": "CPR:4"
    },
    {
        "id": "23564313.T7.T27",
        "sentence": "Also, @CHEMICAL$ enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, @GENE$, p38, inhibitor of kappaBa (IkBa) kinase, and inositol requiring enzyme 1a.",
        "relation": "CPR:3"
    },
    {
        "id": "23564313.T7.T28",
        "sentence": "Also, @CHEMICAL$ enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, @GENE$, inhibitor of kappaBa (IkBa) kinase, and inositol requiring enzyme 1a.",
        "relation": "CPR:3"
    },
    {
        "id": "23564313.T7.T31",
        "sentence": "Also, @CHEMICAL$ enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaBa (IkBa) @GENE$, and inositol requiring enzyme 1a.",
        "relation": "CPR:3"
    },
    {
        "id": "23564313.T7.T25",
        "sentence": "Also, @CHEMICAL$ enhances the phosphorylation of @GENE$, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaBa (IkBa) kinase, and inositol requiring enzyme 1a.",
        "relation": "CPR:3"
    },
    {
        "id": "23564313.T7.T26",
        "sentence": "Also, @CHEMICAL$ enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of @GENE$, c-jun-N-terminal kinase, p38, inhibitor of kappaBa (IkBa) kinase, and inositol requiring enzyme 1a.",
        "relation": "CPR:3"
    },
    {
        "id": "23564313.T7.T29",
        "sentence": "Also, @CHEMICAL$ enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, @GENE$ (IkBa) kinase, and inositol requiring enzyme 1a.",
        "relation": "CPR:3"
    },
    {
        "id": "23564313.T7.T30",
        "sentence": "Also, @CHEMICAL$ enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaBa (@GENE$) kinase, and inositol requiring enzyme 1a.",
        "relation": "CPR:3"
    },
    {
        "id": "23564313.T7.T32",
        "sentence": "Also, @CHEMICAL$ enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaBa (IkBa) kinase, and @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23564313.T1.T13",
        "sentence": "In addition, @CHEMICAL$ induces the DNA-binding activities of the transcription factor @GENE$, HSF1, AP-1, and ATF-2, together with the expression of HSP70 and Bax proteins.",
        "relation": "CPR:3"
    },
    {
        "id": "23564313.T1.T17",
        "sentence": "In addition, @CHEMICAL$ induces the DNA-binding activities of the transcription factor NF-kB, HSF1, AP-1, and ATF-2, together with the expression of @GENE$ and Bax proteins.",
        "relation": "CPR:3"
    },
    {
        "id": "23564313.T1.T14",
        "sentence": "In addition, @CHEMICAL$ induces the DNA-binding activities of the transcription factor NF-kB, @GENE$, AP-1, and ATF-2, together with the expression of HSP70 and Bax proteins.",
        "relation": "CPR:3"
    },
    {
        "id": "23564313.T1.T15",
        "sentence": "In addition, @CHEMICAL$ induces the DNA-binding activities of the transcription factor NF-kB, HSF1, @GENE$, and ATF-2, together with the expression of HSP70 and Bax proteins.",
        "relation": "CPR:3"
    },
    {
        "id": "23564313.T1.T16",
        "sentence": "In addition, @CHEMICAL$ induces the DNA-binding activities of the transcription factor NF-kB, HSF1, AP-1, and @GENE$, together with the expression of HSP70 and Bax proteins.",
        "relation": "CPR:3"
    },
    {
        "id": "23564313.T1.T18",
        "sentence": "In addition, @CHEMICAL$ induces the DNA-binding activities of the transcription factor NF-kB, HSF1, AP-1, and ATF-2, together with the expression of HSP70 and @GENE$ proteins.",
        "relation": "CPR:3"
    },
    {
        "id": "10373451.T20.T37",
        "sentence": "Cloning and characterization of a novel @CHEMICAL$ that hydrolyzes both @GENE$ and cGMP (PDE10A). cDNA encoding a novel phosphodiesterase (PDE) was isolated from a human fetal lung cDNA library and designated PDE10A. The deduced amino acid sequence contains 779 amino acids, including a putative cGMP binding sequence in the amino-terminal portion of the molecule and a catalytic domain that is 16-47% identical in amino acid sequence to those of other PDE families.",
        "relation": "CPR:9"
    },
    {
        "id": "10373451.T20.T36",
        "sentence": "Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both @CHEMICAL$ and cGMP (@GENE$). cDNA encoding a novel phosphodiesterase (PDE) was isolated from a human fetal lung cDNA library and designated PDE10A. The deduced amino acid sequence contains 779 amino acids, including a putative cGMP binding sequence in the amino-terminal portion of the molecule and a catalytic domain that is 16-47% identical in amino acid sequence to those of other PDE families.",
        "relation": "CPR:9"
    },
    {
        "id": "10373451.T21.T37",
        "sentence": "Cloning and characterization of a novel @CHEMICAL$ that hydrolyzes both cAMP and @GENE$ (PDE10A). cDNA encoding a novel phosphodiesterase (PDE) was isolated from a human fetal lung cDNA library and designated PDE10A. The deduced amino acid sequence contains 779 amino acids, including a putative cGMP binding sequence in the amino-terminal portion of the molecule and a catalytic domain that is 16-47% identical in amino acid sequence to those of other PDE families.",
        "relation": "CPR:9"
    },
    {
        "id": "10373451.T21.T36",
        "sentence": "Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and @CHEMICAL$ (@GENE$). cDNA encoding a novel phosphodiesterase (PDE) was isolated from a human fetal lung cDNA library and designated PDE10A. The deduced amino acid sequence contains 779 amino acids, including a putative cGMP binding sequence in the amino-terminal portion of the molecule and a catalytic domain that is 16-47% identical in amino acid sequence to those of other PDE families.",
        "relation": "CPR:9"
    },
    {
        "id": "10373451.T6.T29",
        "sentence": "Recombinant @CHEMICAL$ transfected and expressed in COS-7 cells hydrolyzed @GENE$ and cGMP with Km values of 0.26 and 7.2 microM, respectively, and Vmax with cGMP was almost twice that with cAMP.",
        "relation": "CPR:9"
    },
    {
        "id": "10373451.T7.T29",
        "sentence": "Recombinant @CHEMICAL$ transfected and expressed in COS-7 cells hydrolyzed cAMP and @GENE$ with Km values of 0.26 and 7.2 microM, respectively, and Vmax with cGMP was almost twice that with cAMP.",
        "relation": "CPR:9"
    },
    {
        "id": "10373451.T8.T29",
        "sentence": "Recombinant @CHEMICAL$ transfected and expressed in COS-7 cells hydrolyzed cAMP and cGMP with Km values of 0.26 and 7.2 microM, respectively, and Vmax with @GENE$ was almost twice that with cAMP.",
        "relation": "CPR:9"
    },
    {
        "id": "10373451.T9.T29",
        "sentence": "Recombinant @CHEMICAL$ transfected and expressed in COS-7 cells hydrolyzed cAMP and cGMP with Km values of 0.26 and 7.2 microM, respectively, and Vmax with cGMP was almost twice that with @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "10373451.T10.T31",
        "sentence": "Of the @CHEMICAL$ inhibitors tested, @GENE$ was most effective, with IC50 values of 1.2 and 0.45 microM for inhibition of cAMP and cGMP hydrolysis, respectively. cGMP inhibited hydrolysis of cAMP, and cAMP inhibited cGMP hydrolysis with IC50 values of 14 and 0.39 microM, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "10373451.T11.T31",
        "sentence": "Of the @CHEMICAL$ inhibitors tested, dipyridamole was most effective, with IC50 values of 1.2 and 0.45 microM for inhibition of @GENE$ and cGMP hydrolysis, respectively. cGMP inhibited hydrolysis of cAMP, and cAMP inhibited cGMP hydrolysis with IC50 values of 14 and 0.39 microM, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "10373451.T12.T31",
        "sentence": "Of the @CHEMICAL$ inhibitors tested, dipyridamole was most effective, with IC50 values of 1.2 and 0.45 microM for inhibition of cAMP and @GENE$ hydrolysis, respectively. cGMP inhibited hydrolysis of cAMP, and cAMP inhibited cGMP hydrolysis with IC50 values of 14 and 0.39 microM, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "12907443.T2.T19",
        "sentence": "The @CHEMICAL$ analog 5-aza-2'-deoxycytidine (decitabine) hypomethylates DNA by inhibiting @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12907443.T3.T19",
        "sentence": "The cytosine analog @CHEMICAL$ (decitabine) hypomethylates DNA by inhibiting @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12907443.T4.T19",
        "sentence": "The cytosine analog 5-aza-2'-deoxycytidine (@CHEMICAL$) hypomethylates DNA by inhibiting @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12907443.T5.T20",
        "sentence": "We examined if subcutaneous @CHEMICAL$ could increase @GENE$ levels and improve SSD pathophysiology without cytotoxicity.",
        "relation": "CPR:3"
    },
    {
        "id": "12907443.T1.T11",
        "sentence": "Weekly subcutaneous @CHEMICAL$ produces cumulative increases in @GENE$ and total hemoglobin through a noncytotoxic mechanism of action.",
        "relation": "CPR:3"
    },
    {
        "id": "12907443.T1.T12",
        "sentence": "Weekly subcutaneous @CHEMICAL$ produces cumulative increases in HbF and total @GENE$ through a noncytotoxic mechanism of action.",
        "relation": "CPR:3"
    },
    {
        "id": "23583257.T4.T21",
        "sentence": "Nox4 @CHEMICAL$ activity is thought to be constitutive and regulated at the transcriptional level; however, we challenge this point of view and suggest that specific @GENE$ derivatives could modulate this activity.",
        "relation": "CPR:3"
    },
    {
        "id": "23583257.T4.T20",
        "sentence": "@CHEMICAL$ oxidase activity is thought to be constitutive and regulated at the transcriptional level; however, we challenge this point of view and suggest that specific @GENE$ derivatives could modulate this activity.",
        "relation": "CPR:3"
    },
    {
        "id": "23583257.T5.T22",
        "sentence": "In fact, we demonstrated a significant stimulation of @CHEMICAL$ activity by 4 @GENE$ derivatives (AA-861, tBuBHQ, tBuBQ, and duroquinone) observed in 3 different cellular models, HEK293E, T-RExT, and chondrocyte cell lines.",
        "relation": "CPR:3"
    },
    {
        "id": "23583257.T6.T22",
        "sentence": "In fact, we demonstrated a significant stimulation of @CHEMICAL$ activity by 4 quinone derivatives (@GENE$, tBuBHQ, tBuBQ, and duroquinone) observed in 3 different cellular models, HEK293E, T-RExT, and chondrocyte cell lines.",
        "relation": "CPR:3"
    },
    {
        "id": "23583257.T7.T22",
        "sentence": "In fact, we demonstrated a significant stimulation of @CHEMICAL$ activity by 4 quinone derivatives (AA-861, @GENE$, tBuBQ, and duroquinone) observed in 3 different cellular models, HEK293E, T-RExT, and chondrocyte cell lines.",
        "relation": "CPR:3"
    },
    {
        "id": "23583257.T8.T22",
        "sentence": "In fact, we demonstrated a significant stimulation of @CHEMICAL$ activity by 4 quinone derivatives (AA-861, tBuBHQ, @GENE$, and duroquinone) observed in 3 different cellular models, HEK293E, T-RExT, and chondrocyte cell lines.",
        "relation": "CPR:3"
    },
    {
        "id": "23583257.T9.T22",
        "sentence": "In fact, we demonstrated a significant stimulation of @CHEMICAL$ activity by 4 quinone derivatives (AA-861, tBuBHQ, tBuBQ, and @GENE$) observed in 3 different cellular models, HEK293E, T-RExT, and chondrocyte cell lines.",
        "relation": "CPR:3"
    },
    {
        "id": "23583257.T3.T30",
        "sentence": "Such model of @CHEMICAL$ activity regulation could provide new insight into the understanding of the molecular mechanism of the electron transfer through the enzyme, i.e., its potential redox regulation, and could also define new therapeutic targets in diseases in which @GENE$ and Nox4 are implicated.",
        "relation": "CPR:3"
    },
    {
        "id": "21475861.T9.T18",
        "sentence": "Although the inhibition of @CHEMICAL$ by @GENE$, which leads to its anti-inflammatory/analgesic properties, has been well studied, the mechanisms involved in its chemopreventive effects as well as some of its adverse effects are as yet ill-defined.",
        "relation": "CPR:4"
    },
    {
        "id": "21475861.T2.T17",
        "sentence": "In a recent study using protein-specific anti-acetyl lysine antibodies and immunological methods, we demonstrated the ability of @CHEMICAL$ to acetylate the @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23344961.T7.T24",
        "sentence": "Second, @CHEMICAL$, a @GENE$ catalytic inhibitor known to deplete Top2b, specifically sensitized MEFs to CPT.",
        "relation": "CPR:4"
    },
    {
        "id": "23344961.T7.T25",
        "sentence": "Second, @CHEMICAL$, a Top2 catalytic inhibitor known to deplete @GENE$, specifically sensitized MEFs to CPT.",
        "relation": "CPR:4"
    },
    {
        "id": "23344961.T10.T28",
        "sentence": "To explore the molecular basis for CPT hypersensitivity in Top2b-deficient cells, we found that upon @CHEMICAL$ exposure, the @GENE$ (RNAP LS) became progressively depleted, followed by recovery to nearly the original level in wild-type MEFs, whereas RNAP LS remained depleted without recovery in Top2b-deficient cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23344961.T10.T29",
        "sentence": "To explore the molecular basis for CPT hypersensitivity in Top2b-deficient cells, we found that upon @CHEMICAL$ exposure, the RNA polymerase II large subunit (@GENE$) became progressively depleted, followed by recovery to nearly the original level in wild-type MEFs, whereas RNAP LS remained depleted without recovery in Top2b-deficient cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23344961.T10.T30",
        "sentence": "To explore the molecular basis for CPT hypersensitivity in Top2b-deficient cells, we found that upon @CHEMICAL$ exposure, the RNA polymerase II large subunit (RNAP LS) became progressively depleted, followed by recovery to nearly the original level in wild-type MEFs, whereas @GENE$ remained depleted without recovery in Top2b-deficient cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23344961.T2.T18",
        "sentence": "Altogether, our findings support a model in which Top2b deficiency promotes @CHEMICAL$-induced apoptosis in quiescent non-S-phase cells, possibly due to @GENE$ depletion and p53 accumulation.",
        "relation": "CPR:4"
    },
    {
        "id": "23344961.T2.T19",
        "sentence": "Altogether, our findings support a model in which Top2b deficiency promotes @CHEMICAL$-induced apoptosis in quiescent non-S-phase cells, possibly due to RNAP LS depletion and @GENE$ accumulation.",
        "relation": "CPR:3"
    },
    {
        "id": "2833901.T40.T77",
        "sentence": "Effects of @CHEMICAL$ (a dihydropyridine @GENE$ blocker) and analogues on calmodulin-dependent enzymes.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T41.T77",
        "sentence": "Effects of felodipine (a @CHEMICAL$ @GENE$ blocker) and analogues on calmodulin-dependent enzymes.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T16.T56",
        "sentence": "We have examined the effects on the activities of three calmodulin-dependent enzymes (cAMP phosphodiesterase, caldesmon kinase and myosin light chain kinase) of the dihydropyridine @CHEMICAL$ blocker @GENE$ and three analogues (p-chloro, oxidized and t-butyl) exhibiting different pharmacological potencies.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T25.T67",
        "sentence": "The @CHEMICAL$ was inhibited completely by @GENE$ and the p-chloro analogue with IC50 values of 3.7 and 1.5 microM respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T26.T67",
        "sentence": "The @CHEMICAL$ was inhibited completely by felodipine and the @GENE$ analogue with IC50 values of 3.7 and 1.5 microM respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T29.T70",
        "sentence": "@CHEMICAL$ and the p-chloro analogue inhibited the basal (Ca2+/calmodulin-independent) activity of @GENE$ as well as the calmodulin-stimulated activity.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T29.T71",
        "sentence": "@CHEMICAL$ and the p-chloro analogue inhibited the basal (Ca2+/calmodulin-independent) activity of cAMP phosphodiesterase as well as the @GENE$-stimulated activity.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T30.T70",
        "sentence": "Felodipine and the @CHEMICAL$ analogue inhibited the basal (Ca2+/calmodulin-independent) activity of @GENE$ as well as the calmodulin-stimulated activity.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T30.T71",
        "sentence": "Felodipine and the @CHEMICAL$ analogue inhibited the basal (Ca2+/calmodulin-independent) activity of cAMP phosphodiesterase as well as the @GENE$-stimulated activity.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T34.T73",
        "sentence": "Calmodulin was relatively ineffective in preventing inhibition of @CHEMICAL$ by @GENE$ and the p-chloro analogue.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T35.T73",
        "sentence": "Calmodulin was relatively ineffective in preventing inhibition of @CHEMICAL$ by felodipine and the @GENE$ analogue.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T38.T44",
        "sentence": "@CHEMICAL$ and the p-chloro analogue inhibited Ca2+/calmodulin-dependent @GENE$ with similar potencies (IC50 = 17.4 microM), whereas the oxidized and t-butyl analogues caused no inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T39.T44",
        "sentence": "Felodipine and the @CHEMICAL$ analogue inhibited Ca2+/calmodulin-dependent @GENE$ with similar potencies (IC50 = 17.4 microM), whereas the oxidized and t-butyl analogues caused no inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T3.T46",
        "sentence": "Similarly, @CHEMICAL$ and the p-chloro analogue inhibited @GENE$ activity whether the isolated 20 kD light chain (IC50 = 12.6 microM) or intact myosin (IC50 = 11.0 microM) was used as substrate.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T4.T46",
        "sentence": "Similarly, felodipine and the @CHEMICAL$ analogue inhibited @GENE$ activity whether the isolated 20 kD light chain (IC50 = 12.6 microM) or intact myosin (IC50 = 11.0 microM) was used as substrate.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T9.T57",
        "sentence": "@CHEMICAL$ and the p-chloro analogue inhibited the actin-activated @GENE$ activity of smooth muscle myosin (IC50 = 25.1 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T9.T58",
        "sentence": "@CHEMICAL$ and the p-chloro analogue inhibited the actin-activated Mg2+-ATPase activity of smooth muscle @GENE$ (IC50 = 25.1 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T10.T57",
        "sentence": "Felodipine and the @CHEMICAL$ analogue inhibited the actin-activated @GENE$ activity of smooth muscle myosin (IC50 = 25.1 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T10.T58",
        "sentence": "Felodipine and the @CHEMICAL$ analogue inhibited the actin-activated Mg2+-ATPase activity of smooth muscle @GENE$ (IC50 = 25.1 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T14.T59",
        "sentence": "Similarly, @CHEMICAL$ and the p-chloro analogue blocked @GENE$ filament assembly induced by low concentrations of calmodulin, whereas the oxidized and t-butyl analogues did not.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T15.T59",
        "sentence": "Similarly, felodipine and the @CHEMICAL$ analogue blocked @GENE$ filament assembly induced by low concentrations of calmodulin, whereas the oxidized and t-butyl analogues did not.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T19.T62",
        "sentence": "Again, inhibition of the actin-activated @CHEMICAL$ Mg2+-ATPase and myosin filament assembly by @GENE$ and the p-chloro analogue could be reversed by raising the calmodulin concentration.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T19.T63",
        "sentence": "Again, inhibition of the actin-activated myosin @CHEMICAL$ and myosin filament assembly by @GENE$ and the p-chloro analogue could be reversed by raising the calmodulin concentration.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T19.T64",
        "sentence": "Again, inhibition of the actin-activated myosin Mg2+-ATPase and @CHEMICAL$ filament assembly by @GENE$ and the p-chloro analogue could be reversed by raising the calmodulin concentration.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T20.T62",
        "sentence": "Again, inhibition of the actin-activated @CHEMICAL$ Mg2+-ATPase and myosin filament assembly by felodipine and the @GENE$ analogue could be reversed by raising the calmodulin concentration.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T20.T63",
        "sentence": "Again, inhibition of the actin-activated myosin @CHEMICAL$ and myosin filament assembly by felodipine and the @GENE$ analogue could be reversed by raising the calmodulin concentration.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T20.T64",
        "sentence": "Again, inhibition of the actin-activated myosin Mg2+-ATPase and @CHEMICAL$ filament assembly by felodipine and the @GENE$ analogue could be reversed by raising the calmodulin concentration.",
        "relation": "CPR:4"
    },
    {
        "id": "2833901.T22.T66",
        "sentence": "These observations suggest that some of the pharmacological actions of @CHEMICAL$ on smooth muscle may involve inhibition of @GENE$ which are functionally involved in the regulation of smooth muscle contraction.",
        "relation": "CPR:4"
    },
    {
        "id": "23541637.T14.T38",
        "sentence": "@CHEMICAL$-induced @GENE$ and basal Na(+)/K(+)-ATPase trafficking via protein kinase D1-phosphatidylinositol 4-kinaseIIIb trans Golgi signalling in M1 cortical collecting duct cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23541637.T14.T39",
        "sentence": "@CHEMICAL$-induced ENaC and basal @GENE$ trafficking via protein kinase D1-phosphatidylinositol 4-kinaseIIIb trans Golgi signalling in M1 cortical collecting duct cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23541637.T6.T25",
        "sentence": "@CHEMICAL$ also induces the rapid phosphorylation of @GENE$ (PKD1).",
        "relation": "CPR:3"
    },
    {
        "id": "23541637.T6.T26",
        "sentence": "@CHEMICAL$ also induces the rapid phosphorylation of Protein Kinase D1 (@GENE$).",
        "relation": "CPR:3"
    },
    {
        "id": "10727715.T16.T36",
        "sentence": "This effect has been attributed to the antagonist effects of @CHEMICAL$ at the @GENE$ receptor.",
        "relation": "CPR:6"
    },
    {
        "id": "10727715.T17.T37",
        "sentence": "In the present study, we compared the pharmacology of @CHEMICAL$, WAY-100635 (a @GENE$ antagonist), GR127935 (a 5-HT(1B/1D) antagonist), and isamoltane (a 5-HT(1B) antagonist), when given acutely in combination with fluoxetine, using in vivo microdialysis in the frontal cortex of the freely moving rat.",
        "relation": "CPR:6"
    },
    {
        "id": "10727715.T18.T37",
        "sentence": "In the present study, we compared the pharmacology of (+/-)pindolol, @CHEMICAL$ (a @GENE$ antagonist), GR127935 (a 5-HT(1B/1D) antagonist), and isamoltane (a 5-HT(1B) antagonist), when given acutely in combination with fluoxetine, using in vivo microdialysis in the frontal cortex of the freely moving rat.",
        "relation": "CPR:6"
    },
    {
        "id": "10727715.T21.T39",
        "sentence": "In the present study, we compared the pharmacology of (+/-)pindolol, WAY-100635 (a 5-HT(1A) antagonist), GR127935 (a 5-HT(1B/1D) antagonist), and @CHEMICAL$ (a @GENE$ antagonist), when given acutely in combination with fluoxetine, using in vivo microdialysis in the frontal cortex of the freely moving rat.",
        "relation": "CPR:6"
    },
    {
        "id": "10727715.T12.T35",
        "sentence": "In addition, by comparing the combined administration of (+/-)pindolol with either WAY100635, GR127935 or isamoltane, we have determined that @CHEMICAL$ produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the 5-HT(1B/D) receptor in addition to any activity it has at the presynaptic @GENE$ receptor.",
        "relation": "CPR:6"
    },
    {
        "id": "23636303.T13.T25",
        "sentence": "In the local presence into the LC of the @CHEMICAL$ antagonist @GENE$ (1 mM), systemic citalopram increased NA in the LC (Emax = 157 + 25 %) and PFC (Emax = 175 + 24 %).",
        "relation": "CPR:6"
    },
    {
        "id": "23636303.T1.T19",
        "sentence": "Local LC citalopram effect was abolished by LC presence of the @CHEMICAL$ receptor antagonist @GENE$ (1 mM) but not the 5-HT1/2 receptor antagonist methiothepin (1 mM).",
        "relation": "CPR:6"
    },
    {
        "id": "23636303.T2.T20",
        "sentence": "Local LC citalopram effect was abolished by LC presence of the 5-HT3 receptor antagonist MDL72222 (1 mM) but not the @CHEMICAL$ receptor antagonist @GENE$ (1 mM).",
        "relation": "CPR:6"
    },
    {
        "id": "17658513.T8.T21",
        "sentence": "Real-time quantitative reverse-transcription polymerase chain reaction and immunohistochemical analysis were performed to determine mRNA levels and receptor protein expressions respectively, for alpha(1A)-, alpha(1B)- and alpha(1D)-adrenoceptors in hamster ureteral smooth muscle. alpha(1)-Adrenoceptor antagonists were tested against the @CHEMICAL$ (@GENE$ agonist)-induced contraction in isolated hamster ureteral preparations using a functional experimental approach.",
        "relation": "CPR:5"
    },
    {
        "id": "17658513.T9.T24",
        "sentence": "@CHEMICAL$ and phenylephrine (@GENE$ agonist) each produced a concentration-dependent tonic contraction, their pD(2) values being 6.87+/-0.08 and 6.10+/-0.05, respectively.",
        "relation": "CPR:5"
    },
    {
        "id": "17658513.T10.T24",
        "sentence": "Noradrenaline and @CHEMICAL$ (@GENE$ agonist) each produced a concentration-dependent tonic contraction, their pD(2) values being 6.87+/-0.08 and 6.10+/-0.05, respectively.",
        "relation": "CPR:5"
    },
    {
        "id": "17658513.T1.T11",
        "sentence": "@CHEMICAL$ (nonselective @GENE$ antagonist), silodosin (selective alpha(1A)-adrenoceptor antagonist) and BMY-7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride) (selective alpha(1D)-adrenoceptor antagonist) competitively antagonized the phenylephrine-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively).",
        "relation": "CPR:6"
    },
    {
        "id": "17658513.T2.T12",
        "sentence": "Prazosin (nonselective alpha(1)-adrenoceptor antagonist), @CHEMICAL$ (selective @GENE$ antagonist) and BMY-7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride) (selective alpha(1D)-adrenoceptor antagonist) competitively antagonized the phenylephrine-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively).",
        "relation": "CPR:6"
    },
    {
        "id": "17658513.T3.T13",
        "sentence": "Prazosin (nonselective alpha(1)-adrenoceptor antagonist), silodosin (selective alpha(1A)-adrenoceptor antagonist) and @CHEMICAL$ (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride) (selective @GENE$ antagonist) competitively antagonized the phenylephrine-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively).",
        "relation": "CPR:6"
    },
    {
        "id": "17658513.T4.T13",
        "sentence": "Prazosin (nonselective alpha(1)-adrenoceptor antagonist), silodosin (selective alpha(1A)-adrenoceptor antagonist) and BMY-7378 (@CHEMICAL$) (selective @GENE$ antagonist) competitively antagonized the phenylephrine-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively).",
        "relation": "CPR:6"
    },
    {
        "id": "17658513.T5.T11",
        "sentence": "Prazosin (nonselective @CHEMICAL$ antagonist), silodosin (selective alpha(1A)-adrenoceptor antagonist) and BMY-7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride) (selective alpha(1D)-adrenoceptor antagonist) competitively antagonized the @GENE$-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively).",
        "relation": "CPR:5"
    },
    {
        "id": "17658513.T5.T12",
        "sentence": "Prazosin (nonselective alpha(1)-adrenoceptor antagonist), silodosin (selective @CHEMICAL$ antagonist) and BMY-7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride) (selective alpha(1D)-adrenoceptor antagonist) competitively antagonized the @GENE$-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively).",
        "relation": "CPR:5"
    },
    {
        "id": "17658513.T5.T13",
        "sentence": "Prazosin (nonselective alpha(1)-adrenoceptor antagonist), silodosin (selective alpha(1A)-adrenoceptor antagonist) and BMY-7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride) (selective @CHEMICAL$ antagonist) competitively antagonized the @GENE$-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively).",
        "relation": "CPR:5"
    },
    {
        "id": "21262851.T7.T52",
        "sentence": "@CHEMICAL$ and other positive GABA(A)R modulators, including barbiturates, ethanol, and neurosteroids, can also inhibit @GENE$ (L-VGCCs), which could contribute to reduced neuronal excitability.",
        "relation": "CPR:4"
    },
    {
        "id": "21262851.T7.T53",
        "sentence": "@CHEMICAL$ and other positive GABA(A)R modulators, including barbiturates, ethanol, and neurosteroids, can also inhibit L-type voltage-gated calcium channels (@GENE$), which could contribute to reduced neuronal excitability.",
        "relation": "CPR:4"
    },
    {
        "id": "21262851.T18.T52",
        "sentence": "BDZs and other positive GABA(A)R modulators, including @CHEMICAL$, ethanol, and neurosteroids, can also inhibit @GENE$ (L-VGCCs), which could contribute to reduced neuronal excitability.",
        "relation": "CPR:4"
    },
    {
        "id": "21262851.T18.T53",
        "sentence": "BDZs and other positive GABA(A)R modulators, including @CHEMICAL$, ethanol, and neurosteroids, can also inhibit L-type voltage-gated calcium channels (@GENE$), which could contribute to reduced neuronal excitability.",
        "relation": "CPR:4"
    },
    {
        "id": "21262851.T19.T52",
        "sentence": "BDZs and other positive GABA(A)R modulators, including barbiturates, @CHEMICAL$, and neurosteroids, can also inhibit @GENE$ (L-VGCCs), which could contribute to reduced neuronal excitability.",
        "relation": "CPR:4"
    },
    {
        "id": "21262851.T19.T53",
        "sentence": "BDZs and other positive GABA(A)R modulators, including barbiturates, @CHEMICAL$, and neurosteroids, can also inhibit L-type voltage-gated calcium channels (@GENE$), which could contribute to reduced neuronal excitability.",
        "relation": "CPR:4"
    },
    {
        "id": "21262851.T20.T52",
        "sentence": "BDZs and other positive GABA(A)R modulators, including barbiturates, ethanol, and @CHEMICAL$, can also inhibit @GENE$ (L-VGCCs), which could contribute to reduced neuronal excitability.",
        "relation": "CPR:4"
    },
    {
        "id": "21262851.T20.T53",
        "sentence": "BDZs and other positive GABA(A)R modulators, including barbiturates, ethanol, and @CHEMICAL$, can also inhibit L-type voltage-gated calcium channels (@GENE$), which could contribute to reduced neuronal excitability.",
        "relation": "CPR:4"
    },
    {
        "id": "21262851.T2.T35",
        "sentence": "@CHEMICAL$ channels were less sensitive to @GENE$ inhibition than Ca(v)1.2 channels, similar to dihydropyridine (DHP) L-VGCC antagonists.",
        "relation": "CPR:4"
    },
    {
        "id": "21262851.T2.T37",
        "sentence": "Ca(v)1.3 channels were less sensitive to @CHEMICAL$ inhibition than @GENE$ channels, similar to dihydropyridine (DHP) L-VGCC antagonists.",
        "relation": "CPR:4"
    },
    {
        "id": "21262851.T3.T38",
        "sentence": "Ca(v)1.3 channels were less sensitive to pentobarbital inhibition than Ca(v)1.2 channels, similar to @CHEMICAL$ (DHP) @GENE$ antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "21262851.T3.T35",
        "sentence": "@CHEMICAL$ channels were less sensitive to pentobarbital inhibition than Ca(v)1.2 channels, similar to @GENE$ (DHP) L-VGCC antagonists.",
        "relation": "CPR:4"
    },
    {
        "id": "21262851.T3.T37",
        "sentence": "Ca(v)1.3 channels were less sensitive to pentobarbital inhibition than @CHEMICAL$ channels, similar to @GENE$ (DHP) L-VGCC antagonists.",
        "relation": "CPR:4"
    },
    {
        "id": "21262851.T4.T38",
        "sentence": "Ca(v)1.3 channels were less sensitive to pentobarbital inhibition than Ca(v)1.2 channels, similar to dihydropyridine (@CHEMICAL$) @GENE$ antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "21262851.T4.T35",
        "sentence": "@CHEMICAL$ channels were less sensitive to pentobarbital inhibition than Ca(v)1.2 channels, similar to dihydropyridine (@GENE$) L-VGCC antagonists.",
        "relation": "CPR:4"
    },
    {
        "id": "21262851.T4.T37",
        "sentence": "Ca(v)1.3 channels were less sensitive to pentobarbital inhibition than @CHEMICAL$ channels, similar to dihydropyridine (@GENE$) L-VGCC antagonists.",
        "relation": "CPR:4"
    },
    {
        "id": "21262851.T5.T42",
        "sentence": "All GABA(A)R modulators induced a negative shift in the steady-state inactivation curve of Ca(v)1.3 channels, but only @CHEMICAL$ and pentobarbital induced a negative shift in @GENE$ channel inactivation.",
        "relation": "CPR:4"
    },
    {
        "id": "21262851.T6.T42",
        "sentence": "All GABA(A)R modulators induced a negative shift in the steady-state inactivation curve of Ca(v)1.3 channels, but only BDZs and @CHEMICAL$ induced a negative shift in @GENE$ channel inactivation.",
        "relation": "CPR:4"
    },
    {
        "id": "21262851.T14.T48",
        "sentence": "Despite the structural similarity between benzothiazepines and BDZs, mutation of an amino acid important for diltiazem potency (@CHEMICAL$) did not affect @GENE$ potency.",
        "relation": "CPR:4"
    },
    {
        "id": "21262851.T15.T49",
        "sentence": "Although @CHEMICAL$ inhibition by @GENE$ occurred at concentrations that are possibly too high to be clinically relevant and is not likely to play a role in the up-regulation of L-VGCCs during long-term treatment, pentobarbital and ethanol inhibited L-VGCCs at clinically relevant concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "21262851.T17.T51",
        "sentence": "Although L-VGCC inhibition by BDZs occurred at concentrations that are possibly too high to be clinically relevant and is not likely to play a role in the up-regulation of L-VGCCs during long-term treatment, @CHEMICAL$ and ethanol inhibited @GENE$ at clinically relevant concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T22.T50",
        "sentence": "@CHEMICAL$ inhibits nitric oxide production in lipopolysaccharide-stimulated BV2 microglia via @GENE$ suppression and Nrf-2-dependent heme oxygenase-1 induction.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T22.T51",
        "sentence": "@CHEMICAL$ inhibits nitric oxide production in lipopolysaccharide-stimulated BV2 microglia via NF-kB suppression and @GENE$-dependent heme oxygenase-1 induction.",
        "relation": "CPR:3"
    },
    {
        "id": "23542513.T22.T52",
        "sentence": "@CHEMICAL$ inhibits nitric oxide production in lipopolysaccharide-stimulated BV2 microglia via NF-kB suppression and Nrf-2-dependent @GENE$ induction.",
        "relation": "CPR:3"
    },
    {
        "id": "23542513.T14.T32",
        "sentence": "In this study, we found that @CHEMICAL$ (5HHMF) from Hizikia fusiforme considerably inhibits lipopolysaccharide (LPS)-stimulated NO production by suppressing the expression of @GENE$ (iNOS) in BV2 microglia.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T14.T33",
        "sentence": "In this study, we found that @CHEMICAL$ (5HHMF) from Hizikia fusiforme considerably inhibits lipopolysaccharide (LPS)-stimulated NO production by suppressing the expression of inducible NO synthase (@GENE$) in BV2 microglia.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T18.T32",
        "sentence": "In this study, we found that 5-hydroxy-3,6,7,8,3'4'-hexamethoxyflavone (@CHEMICAL$) from Hizikia fusiforme considerably inhibits lipopolysaccharide (LPS)-stimulated NO production by suppressing the expression of @GENE$ (iNOS) in BV2 microglia.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T18.T33",
        "sentence": "In this study, we found that 5-hydroxy-3,6,7,8,3'4'-hexamethoxyflavone (@CHEMICAL$) from Hizikia fusiforme considerably inhibits lipopolysaccharide (LPS)-stimulated NO production by suppressing the expression of inducible NO synthase (@GENE$) in BV2 microglia.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T13.T34",
        "sentence": "In addition, @CHEMICAL$ blocked LPS-induced phosphorylation of @GENE$, resulting in suppression of the nuclear translocation of nuclear factor-kB (NF-kB) subunits, namely p65 and p50, which are important molecules involved in the regulation of iNOS expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T13.T35",
        "sentence": "In addition, @CHEMICAL$ blocked LPS-induced phosphorylation of IkB, resulting in suppression of the nuclear translocation of @GENE$ (NF-kB) subunits, namely p65 and p50, which are important molecules involved in the regulation of iNOS expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T13.T36",
        "sentence": "In addition, @CHEMICAL$ blocked LPS-induced phosphorylation of IkB, resulting in suppression of the nuclear translocation of nuclear factor-kB (@GENE$) subunits, namely p65 and p50, which are important molecules involved in the regulation of iNOS expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T13.T37",
        "sentence": "In addition, @CHEMICAL$ blocked LPS-induced phosphorylation of IkB, resulting in suppression of the nuclear translocation of nuclear factor-kB (NF-kB) subunits, namely @GENE$ and p50, which are important molecules involved in the regulation of iNOS expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T13.T38",
        "sentence": "In addition, @CHEMICAL$ blocked LPS-induced phosphorylation of IkB, resulting in suppression of the nuclear translocation of nuclear factor-kB (NF-kB) subunits, namely p65 and @GENE$, which are important molecules involved in the regulation of iNOS expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T15.T40",
        "sentence": "@CHEMICAL$ (PDTC), a specific @GENE$ inhibitor, along with 20S proteasome inhibitor (PSI) significantly inhibited LPS-induced iNOS expression, which indirectly suggested that 5HHMF downregulated iNOS expression by suppressing NF-kB activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T15.T42",
        "sentence": "@CHEMICAL$ (PDTC), a specific NF-kB inhibitor, along with 20S proteasome inhibitor (PSI) significantly inhibited LPS-induced @GENE$ expression, which indirectly suggested that 5HHMF downregulated iNOS expression by suppressing NF-kB activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T16.T40",
        "sentence": "Pyrrolidine dithiocarbamate (@CHEMICAL$), a specific @GENE$ inhibitor, along with 20S proteasome inhibitor (PSI) significantly inhibited LPS-induced iNOS expression, which indirectly suggested that 5HHMF downregulated iNOS expression by suppressing NF-kB activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T16.T42",
        "sentence": "Pyrrolidine dithiocarbamate (@CHEMICAL$), a specific NF-kB inhibitor, along with 20S proteasome inhibitor (PSI) significantly inhibited LPS-induced @GENE$ expression, which indirectly suggested that 5HHMF downregulated iNOS expression by suppressing NF-kB activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T17.T44",
        "sentence": "Pyrrolidine dithiocarbamate (PDTC), a specific NF-kB inhibitor, along with 20S proteasome inhibitor (PSI) significantly inhibited LPS-induced iNOS expression, which indirectly suggested that @CHEMICAL$ downregulated iNOS expression by suppressing @GENE$ activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T17.T43",
        "sentence": "Pyrrolidine dithiocarbamate (PDTC), a specific NF-kB inhibitor, along with 20S proteasome inhibitor (PSI) significantly inhibited LPS-induced iNOS expression, which indirectly suggested that @CHEMICAL$ downregulated @GENE$ expression by suppressing NF-kB activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T19.T45",
        "sentence": "Thus, we found that @CHEMICAL$ enhances @GENE$ (HO-1) expression via nuclear factor-erythroid 2-related factor 2 (Nrf2) activation.",
        "relation": "CPR:3"
    },
    {
        "id": "23542513.T19.T46",
        "sentence": "Thus, we found that @CHEMICAL$ enhances heme oxygenase-1 (@GENE$) expression via nuclear factor-erythroid 2-related factor 2 (Nrf2) activation.",
        "relation": "CPR:3"
    },
    {
        "id": "23542513.T19.T47",
        "sentence": "Thus, we found that @CHEMICAL$ enhances heme oxygenase-1 (HO-1) expression via @GENE$ (Nrf2) activation.",
        "relation": "CPR:3"
    },
    {
        "id": "23542513.T19.T48",
        "sentence": "Thus, we found that @CHEMICAL$ enhances heme oxygenase-1 (HO-1) expression via nuclear factor-erythroid 2-related factor 2 (@GENE$) activation.",
        "relation": "CPR:3"
    },
    {
        "id": "23542513.T20.T49",
        "sentence": "In addition, @CHEMICAL$ (CoPP), a specific @GENE$ inducer, predominantly suppressed LPS-induced NO production.",
        "relation": "CPR:3"
    },
    {
        "id": "23542513.T21.T49",
        "sentence": "In addition, cobalt protoporphyrin (@CHEMICAL$), a specific @GENE$ inducer, predominantly suppressed LPS-induced NO production.",
        "relation": "CPR:3"
    },
    {
        "id": "23542513.T2.T24",
        "sentence": "In contrast, @CHEMICAL$ (ZnPP), a specific @GENE$ inhibitor, showed a partial suppressive effect of 5HHMF on LPS-induced NO production.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T3.T24",
        "sentence": "In contrast, zinc protoporphyrin (@CHEMICAL$), a specific @GENE$ inhibitor, showed a partial suppressive effect of 5HHMF on LPS-induced NO production.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T6.T25",
        "sentence": "Further, @CHEMICAL$ increased specific DNA-binding activity of @GENE$, and transient knockdown with Nrf2 siRNA subsequently reversed 5HHMF-induced NO inhibition, which was followed by suppression of HO-1 activity.",
        "relation": "CPR:3"
    },
    {
        "id": "23542513.T6.T26",
        "sentence": "Further, @CHEMICAL$ increased specific DNA-binding activity of Nrf2, and transient knockdown with @GENE$ siRNA subsequently reversed 5HHMF-induced NO inhibition, which was followed by suppression of HO-1 activity.",
        "relation": "CPR:3"
    },
    {
        "id": "23542513.T6.T27",
        "sentence": "Further, @CHEMICAL$ increased specific DNA-binding activity of Nrf2, and transient knockdown with Nrf2 siRNA subsequently reversed 5HHMF-induced NO inhibition, which was followed by suppression of @GENE$ activity.",
        "relation": "CPR:3"
    },
    {
        "id": "23542513.T7.T25",
        "sentence": "Further, 5HHMF increased specific DNA-binding activity of @CHEMICAL$, and transient knockdown with Nrf2 siRNA subsequently reversed @GENE$-induced NO inhibition, which was followed by suppression of HO-1 activity.",
        "relation": "CPR:3"
    },
    {
        "id": "23542513.T7.T26",
        "sentence": "Further, 5HHMF increased specific DNA-binding activity of Nrf2, and transient knockdown with @CHEMICAL$ siRNA subsequently reversed @GENE$-induced NO inhibition, which was followed by suppression of HO-1 activity.",
        "relation": "CPR:3"
    },
    {
        "id": "23542513.T7.T27",
        "sentence": "Further, 5HHMF increased specific DNA-binding activity of Nrf2, and transient knockdown with Nrf2 siRNA subsequently reversed @CHEMICAL$-induced NO inhibition, which was followed by suppression of @GENE$ activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T8.T27",
        "sentence": "Further, 5HHMF increased specific DNA-binding activity of Nrf2, and transient knockdown with Nrf2 siRNA subsequently reversed 5HHMF-induced @CHEMICAL$ inhibition, which was followed by suppression of @GENE$ activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T9.T29",
        "sentence": "Taken together, our findings indicate that @CHEMICAL$ suppresses NO production through modulation of iNOS, consequently suppressing @GENE$ activity and induction of Nrf2-dependent HO-1 activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T9.T30",
        "sentence": "Taken together, our findings indicate that @CHEMICAL$ suppresses NO production through modulation of iNOS, consequently suppressing NF-kB activity and induction of @GENE$-dependent HO-1 activity.",
        "relation": "CPR:3"
    },
    {
        "id": "23542513.T9.T31",
        "sentence": "Taken together, our findings indicate that @CHEMICAL$ suppresses NO production through modulation of iNOS, consequently suppressing NF-kB activity and induction of Nrf2-dependent @GENE$ activity.",
        "relation": "CPR:3"
    },
    {
        "id": "23542513.T10.T29",
        "sentence": "Taken together, our findings indicate that 5HHMF suppresses @CHEMICAL$ production through modulation of iNOS, consequently suppressing @GENE$ activity and induction of Nrf2-dependent HO-1 activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T10.T30",
        "sentence": "Taken together, our findings indicate that 5HHMF suppresses @CHEMICAL$ production through modulation of iNOS, consequently suppressing NF-kB activity and induction of @GENE$-dependent HO-1 activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23542513.T10.T31",
        "sentence": "Taken together, our findings indicate that 5HHMF suppresses @CHEMICAL$ production through modulation of iNOS, consequently suppressing NF-kB activity and induction of Nrf2-dependent @GENE$ activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23582273.T6.T10",
        "sentence": "Synthesis and antitumor activity of @CHEMICAL$ possessing 1,4-benzodioxan moiety as a novel class of potent @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23582273.T7.T10",
        "sentence": "Synthesis and antitumor activity of 1,3,4-oxadiazole possessing @CHEMICAL$ moiety as a novel class of potent @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23131798.T4.T10",
        "sentence": "Discovery of novel cannabinoid receptor ligands by a virtual screening approach: further development of @CHEMICAL$ as @GENE$ agonists. 3D ligand-based virtual screening was employed to identify novel scaffolds for cannabinoid receptor ligand development.",
        "relation": "CPR:5"
    },
    {
        "id": "23131798.T1.T7",
        "sentence": "One of the @CHEMICAL$ agonists, @GENE$ (19, -logEC(50)=7.5, E(max)=255%) was selected for further development.",
        "relation": "CPR:5"
    },
    {
        "id": "23131798.T2.T8",
        "sentence": "As far as we are aware, the compound's @CHEMICAL$ scaffold represents a new core structure for @GENE$ agonists.",
        "relation": "CPR:5"
    },
    {
        "id": "12727196.T9.T14",
        "sentence": "The discovery of an inducible @CHEMICAL$ whose apparent substrate preference is @GENE$ indicates that polyamine catabolism is more complex than that originally proposed.",
        "relation": "CPR:9"
    },
    {
        "id": "12727196.T3.T15",
        "sentence": "Purified @CHEMICAL$/SMO oxidizes both @GENE$ (K(m)=1.6 microM) and N(1)-acetylspermine (K(m)=51 microM), but does not oxidize spermidine.",
        "relation": "CPR:9"
    },
    {
        "id": "12727196.T3.T16",
        "sentence": "Purified PAOh1/@CHEMICAL$ oxidizes both @GENE$ (K(m)=1.6 microM) and N(1)-acetylspermine (K(m)=51 microM), but does not oxidize spermidine.",
        "relation": "CPR:9"
    },
    {
        "id": "12727196.T4.T15",
        "sentence": "Purified @CHEMICAL$/SMO oxidizes both spermine (K(m)=1.6 microM) and @GENE$ (K(m)=51 microM), but does not oxidize spermidine.",
        "relation": "CPR:9"
    },
    {
        "id": "12727196.T4.T16",
        "sentence": "Purified PAOh1/@CHEMICAL$ oxidizes both spermine (K(m)=1.6 microM) and @GENE$ (K(m)=51 microM), but does not oxidize spermidine.",
        "relation": "CPR:9"
    },
    {
        "id": "12727196.T7.T17",
        "sentence": "The purified human enzyme also does not oxidize eight representative antitumor polyamine analogues; however, specific oligamine analogues were found to be potent inhibitors of the oxidation of @CHEMICAL$ by @GENE$/SMO.",
        "relation": "CPR:9"
    },
    {
        "id": "12727196.T7.T18",
        "sentence": "The purified human enzyme also does not oxidize eight representative antitumor polyamine analogues; however, specific oligamine analogues were found to be potent inhibitors of the oxidation of @CHEMICAL$ by PAOh1/@GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "12650833.T10.T30",
        "sentence": "The i.c.v. administration of very low doses of @CHEMICAL$ (0.001-1 pg/mouse) and cantharidin (0.001-1 ng/mouse), which inhibit @GENE$, produced a dose-dependent antagonism of the antinociception induced by morphine (s.c.).",
        "relation": "CPR:4"
    },
    {
        "id": "12650833.T11.T30",
        "sentence": "The i.c.v. administration of very low doses of okadaic acid (0.001-1 pg/mouse) and @CHEMICAL$ (0.001-1 ng/mouse), which inhibit @GENE$, produced a dose-dependent antagonism of the antinociception induced by morphine (s.c.).",
        "relation": "CPR:4"
    },
    {
        "id": "12650833.T18.T33",
        "sentence": "On the other hand, high doses of @CHEMICAL$ (10 ng/mouse, i.c.v.) and cantharidin (1 microg/mouse, i.c.v.), which also block @GENE$, and calyculin-A (0.1 fg/mouse-1 ng/mouse, i.c.v.), which inhibits equally both PP1 and PP2A, did not modify the morphine-induced antinociception.",
        "relation": "CPR:4"
    },
    {
        "id": "12650833.T19.T33",
        "sentence": "On the other hand, high doses of okadaic acid (10 ng/mouse, i.c.v.) and @CHEMICAL$ (1 microg/mouse, i.c.v.), which also block @GENE$, and calyculin-A (0.1 fg/mouse-1 ng/mouse, i.c.v.), which inhibits equally both PP1 and PP2A, did not modify the morphine-induced antinociception.",
        "relation": "CPR:4"
    },
    {
        "id": "12650833.T20.T24",
        "sentence": "On the other hand, high doses of okadaic acid (10 ng/mouse, i.c.v.) and cantharidin (1 microg/mouse, i.c.v.), which also block PP1, and @CHEMICAL$ (0.1 fg/mouse-1 ng/mouse, i.c.v.), which inhibits equally both @GENE$ and PP2A, did not modify the morphine-induced antinociception.",
        "relation": "CPR:4"
    },
    {
        "id": "12650833.T20.T25",
        "sentence": "On the other hand, high doses of okadaic acid (10 ng/mouse, i.c.v.) and cantharidin (1 microg/mouse, i.c.v.), which also block PP1, and @CHEMICAL$ (0.1 fg/mouse-1 ng/mouse, i.c.v.), which inhibits equally both PP1 and @GENE$, did not modify the morphine-induced antinociception.",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T21.T35",
        "sentence": "Carbonic anhydrase inhibitors. Inhibition of @CHEMICAL$ with a series of natural product @GENE$ and phenolic acids.",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T22.T35",
        "sentence": "Carbonic anhydrase inhibitors. Inhibition of @CHEMICAL$ with a series of natural product polyphenols and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T1.T25",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, @CHEMICAL$, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the @GENE$ carbonic anhydrase (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T1.T26",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, @CHEMICAL$, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme @GENE$ (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T1.T27",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, @CHEMICAL$, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (@GENE$, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T1.T28",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, @CHEMICAL$, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T3.T25",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, @CHEMICAL$, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the @GENE$ carbonic anhydrase (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T3.T26",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, @CHEMICAL$, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme @GENE$ (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T3.T27",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, @CHEMICAL$, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (@GENE$, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T3.T28",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, @CHEMICAL$, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T4.T25",
        "sentence": "A series of @CHEMICAL$ and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the @GENE$ carbonic anhydrase (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T4.T26",
        "sentence": "A series of @CHEMICAL$ and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme @GENE$ (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T4.T27",
        "sentence": "A series of @CHEMICAL$ and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (@GENE$, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T4.T28",
        "sentence": "A series of @CHEMICAL$ and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T5.T25",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, @CHEMICAL$, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the @GENE$ carbonic anhydrase (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T5.T26",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, @CHEMICAL$, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme @GENE$ (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T5.T27",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, @CHEMICAL$, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (@GENE$, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T5.T28",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, @CHEMICAL$, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T6.T25",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, @CHEMICAL$, quercetin, and ellagic acid, were investigated for their inhibitory effects against the @GENE$ carbonic anhydrase (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T6.T26",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, @CHEMICAL$, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme @GENE$ (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T6.T27",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, @CHEMICAL$, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (@GENE$, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T6.T28",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, @CHEMICAL$, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T7.T25",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, @CHEMICAL$, and ellagic acid, were investigated for their inhibitory effects against the @GENE$ carbonic anhydrase (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T7.T26",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, @CHEMICAL$, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme @GENE$ (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T7.T27",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, @CHEMICAL$, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (@GENE$, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T7.T28",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, @CHEMICAL$, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T8.T25",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and @CHEMICAL$, were investigated for their inhibitory effects against the @GENE$ carbonic anhydrase (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T8.T26",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and @CHEMICAL$, were investigated for their inhibitory effects against the metalloenzyme @GENE$ (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T8.T27",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and @CHEMICAL$, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (@GENE$, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T8.T28",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and @CHEMICAL$, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T9.T25",
        "sentence": "A series of phenolic acids and @CHEMICAL$ natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the @GENE$ carbonic anhydrase (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T9.T26",
        "sentence": "A series of phenolic acids and @CHEMICAL$ natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme @GENE$ (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T9.T27",
        "sentence": "A series of phenolic acids and @CHEMICAL$ natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (@GENE$, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T9.T28",
        "sentence": "A series of phenolic acids and @CHEMICAL$ natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T11.T25",
        "sentence": "A series of phenolic acids and phenol natural products, such as @CHEMICAL$, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the @GENE$ carbonic anhydrase (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T11.T26",
        "sentence": "A series of phenolic acids and phenol natural products, such as @CHEMICAL$, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme @GENE$ (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T11.T27",
        "sentence": "A series of phenolic acids and phenol natural products, such as @CHEMICAL$, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (@GENE$, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T11.T28",
        "sentence": "A series of phenolic acids and phenol natural products, such as @CHEMICAL$, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T17.T25",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, @CHEMICAL$, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the @GENE$ carbonic anhydrase (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T17.T26",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, @CHEMICAL$, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme @GENE$ (CA, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T17.T27",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, @CHEMICAL$, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (@GENE$, EC 4.2.1.1).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T17.T28",
        "sentence": "A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, @CHEMICAL$, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T12.T33",
        "sentence": "@CHEMICAL$ like the ones investigated here possess a @GENE$ inhibition mechanism distinct of that of the sulfonamides/sulfamates used clinically or the coumarins.",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T13.T33",
        "sentence": "Phenols like the ones investigated here possess a @CHEMICAL$ inhibition mechanism distinct of that of the @GENE$/sulfamates used clinically or the coumarins.",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T14.T33",
        "sentence": "Phenols like the ones investigated here possess a @CHEMICAL$ inhibition mechanism distinct of that of the sulfonamides/@GENE$ used clinically or the coumarins.",
        "relation": "CPR:4"
    },
    {
        "id": "20185318.T15.T33",
        "sentence": "Phenols like the ones investigated here possess a @CHEMICAL$ inhibition mechanism distinct of that of the sulfonamides/sulfamates used clinically or the @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15689518.T2.T11",
        "sentence": "@CHEMICAL$ (SDH), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of @GENE$ and L-threonine to yield pyruvate or 2-oxobutyrate.",
        "relation": "CPR:9"
    },
    {
        "id": "15689518.T2.T13",
        "sentence": "L-serine dehydratase (@CHEMICAL$), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of @GENE$ and L-threonine to yield pyruvate or 2-oxobutyrate.",
        "relation": "CPR:9"
    },
    {
        "id": "15689518.T3.T11",
        "sentence": "@CHEMICAL$ (SDH), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and @GENE$ to yield pyruvate or 2-oxobutyrate.",
        "relation": "CPR:9"
    },
    {
        "id": "15689518.T3.T13",
        "sentence": "L-serine dehydratase (@CHEMICAL$), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and @GENE$ to yield pyruvate or 2-oxobutyrate.",
        "relation": "CPR:9"
    },
    {
        "id": "15689518.T4.T11",
        "sentence": "@CHEMICAL$ (SDH), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and L-threonine to yield @GENE$ or 2-oxobutyrate.",
        "relation": "CPR:9"
    },
    {
        "id": "15689518.T4.T13",
        "sentence": "L-serine dehydratase (@CHEMICAL$), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and L-threonine to yield @GENE$ or 2-oxobutyrate.",
        "relation": "CPR:9"
    },
    {
        "id": "15689518.T5.T11",
        "sentence": "@CHEMICAL$ (SDH), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and L-threonine to yield pyruvate or @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "15689518.T5.T13",
        "sentence": "L-serine dehydratase (@CHEMICAL$), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and L-threonine to yield pyruvate or @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23578688.T8.T11",
        "sentence": "Synthesis and evaluation of @CHEMICAL$ linked prodrugs of BMS-582949, a clinical @GENE$ inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "23578688.T9.T11",
        "sentence": "Synthesis and evaluation of carbamoylmethylene linked prodrugs of @CHEMICAL$, a clinical @GENE$ inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "23578688.T1.T10",
        "sentence": "A series of @CHEMICAL$ linked prodrugs of 1 (BMS-582949), a clinical @GENE$ inhibitor, were synthesized and evaluated.",
        "relation": "CPR:4"
    },
    {
        "id": "23578688.T6.T10",
        "sentence": "A series of carbamoylmethylene linked prodrugs of 1 (@CHEMICAL$), a clinical @GENE$ inhibitor, were synthesized and evaluated.",
        "relation": "CPR:4"
    },
    {
        "id": "12956944.T8.T26",
        "sentence": "RESULTS: @CHEMICAL$ given to rats in drinking water decreased the level of @GENE$ protein in the nucleus accumbens (-75 %) at the time of exposure to ethanol.",
        "relation": "CPR:4"
    },
    {
        "id": "12956944.T11.T27",
        "sentence": "The decrement of @CHEMICAL$ protein in the nucleus accumbens remained at 24 h (-35 %) and 72 h (-28 %) of @GENE$ withdrawal, which recovered toward control level after 7 d of ethanol withdrawal.",
        "relation": "CPR:4"
    },
    {
        "id": "12956944.T12.T27",
        "sentence": "The decrement of @CHEMICAL$ protein in the nucleus accumbens remained at 24 h (-35 %) and 72 h (-28 %) of ethanol withdrawal, which recovered toward control level after 7 d of @GENE$ withdrawal.",
        "relation": "CPR:4"
    },
    {
        "id": "12956944.T1.T21",
        "sentence": "However, when naloxone was administered concurrently with @CHEMICAL$ treatment, it antagonized the down-regulation of @GENE$ protein in the nucleus accumbens (142 %) of rats exposed to ethanol.",
        "relation": "CPR:4"
    },
    {
        "id": "12956944.T2.T21",
        "sentence": "However, when naloxone was administered concurrently with ethanol treatment, it antagonized the down-regulation of @CHEMICAL$ protein in the nucleus accumbens (142 %) of rats exposed to @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12956944.T3.T22",
        "sentence": "CONCLUSION: A long-term intake of @CHEMICAL$ solution down-regulates the phosphorylation of @GENE$ in the nucleus accumbens, and those changes can be reversed by naloxone, which may be one kind of the molecular mechanisms associated with ethanol dependence.",
        "relation": "CPR:4"
    },
    {
        "id": "12956944.T4.T22",
        "sentence": "CONCLUSION: A long-term intake of ethanol solution down-regulates the phosphorylation of @CHEMICAL$ in the nucleus accumbens, and those changes can be reversed by @GENE$, which may be one kind of the molecular mechanisms associated with ethanol dependence.",
        "relation": "CPR:3"
    },
    {
        "id": "23397055.T1.T27",
        "sentence": "Adenosine and N(6)-cyclopentyl-adenosine (@CHEMICAL$, @GENE$ agonist) constricted MVs but not MAs.",
        "relation": "CPR:5"
    },
    {
        "id": "23397055.T23.T27",
        "sentence": "@CHEMICAL$ and N(6)-cyclopentyl-adenosine (CPA, @GENE$ agonist) constricted MVs but not MAs.",
        "relation": "CPR:5"
    },
    {
        "id": "23397055.T24.T27",
        "sentence": "Adenosine and @CHEMICAL$ (CPA, @GENE$ agonist) constricted MVs but not MAs.",
        "relation": "CPR:5"
    },
    {
        "id": "23397055.T9.T28",
        "sentence": "The @CHEMICAL$ agonist @GENE$ (C23H29N7O6.HCl.xH2O) (0.001-0.1 mM) did not alter NE oxidation currents.",
        "relation": "CPR:5"
    },
    {
        "id": "23397055.T11.T28",
        "sentence": "The @CHEMICAL$ agonist CGS21680 (@GENE$) (0.001-0.1 mM) did not alter NE oxidation currents.",
        "relation": "CPR:5"
    },
    {
        "id": "23605695.T1.T20",
        "sentence": "@CHEMICAL$ (Signifor(r)) is a new subcutaneous somatostatin analogue that acts via somatostatin receptors to inhibit the secretion of @GENE$ from the pituitary adenoma in patients with Cushing's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "23605695.T5.T20",
        "sentence": "Pasireotide (@CHEMICAL$(r)) is a new subcutaneous somatostatin analogue that acts via somatostatin receptors to inhibit the secretion of @GENE$ from the pituitary adenoma in patients with Cushing's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "23017388.T4.T12",
        "sentence": "Also, @CHEMICAL$ showed anti-angiogenic activity by decreasing the expression of @GENE$ and VEGF.",
        "relation": "CPR:4"
    },
    {
        "id": "23017388.T4.T13",
        "sentence": "Also, @CHEMICAL$ showed anti-angiogenic activity by decreasing the expression of HIF-1a and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23017388.T7.T14",
        "sentence": "When further examined for its anticancer mechanism, @CHEMICAL$ effectively suppressed the @GENE$/mTOR pathway both in vitro and in vivo.",
        "relation": "CPR:4"
    },
    {
        "id": "23017388.T7.T15",
        "sentence": "When further examined for its anticancer mechanism, @CHEMICAL$ effectively suppressed the AKT/@GENE$ pathway both in vitro and in vivo.",
        "relation": "CPR:4"
    },
    {
        "id": "23017388.T8.T16",
        "sentence": "Taken together, our study demonstrated that @CHEMICAL$ inhibits the @GENE$/mTOR pathway, leading to the suppression of tumor growth and angiogenesis together with induction of apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23017388.T8.T17",
        "sentence": "Taken together, our study demonstrated that @CHEMICAL$ inhibits the AKT/@GENE$ pathway, leading to the suppression of tumor growth and angiogenesis together with induction of apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "15777622.T6.T28",
        "sentence": "Apolipoprotein E3 (apoE3) safeguards pig proximal tubular LLC-PK1 cells against reduction in SGLT1 activity induced by gentamicin C. Megalin, a family of @CHEMICAL$ related to the low-density lipoprotein (LDL) receptor, is a major pathway for proximal tubular @GENE$ accumulation.",
        "relation": "CPR:9"
    },
    {
        "id": "15777622.T6.T32",
        "sentence": "Apolipoprotein E3 (apoE3) safeguards pig proximal tubular LLC-PK1 cells against reduction in SGLT1 activity induced by gentamicin C. Megalin, a family of endocytic receptors related to the @CHEMICAL$, is a major pathway for proximal tubular @GENE$ accumulation.",
        "relation": "CPR:9"
    },
    {
        "id": "15777622.T18.T44",
        "sentence": "Apolipoprotein E3 (apoE3) safeguards pig proximal tubular LLC-PK1 cells against reduction in @CHEMICAL$ activity induced by @GENE$. Megalin, a family of endocytic receptors related to the low-density lipoprotein (LDL) receptor, is a major pathway for proximal tubular aminoglycoside accumulation.",
        "relation": "CPR:4"
    },
    {
        "id": "15777622.T9.T29",
        "sentence": "We previously reported that @CHEMICAL$ antibiotics reduce @GENE$-dependent glucose transport in pig proximal tubular epithelial LLC-PK1 cells in parallel with the order of their nephrotoxicity.",
        "relation": "CPR:4"
    },
    {
        "id": "15777622.T11.T30",
        "sentence": "In this study, using a model of @CHEMICAL$ (GMC)-induced reduction in @GENE$ activity, we examined whether ligands for megalin protect LLC-PK1 cells from the GMC-induced reduction in SGLT1 activity.",
        "relation": "CPR:4"
    },
    {
        "id": "15777622.T12.T30",
        "sentence": "In this study, using a model of gentamicin C (@CHEMICAL$)-induced reduction in @GENE$ activity, we examined whether ligands for megalin protect LLC-PK1 cells from the GMC-induced reduction in SGLT1 activity.",
        "relation": "CPR:4"
    },
    {
        "id": "15777622.T13.T31",
        "sentence": "In this study, using a model of gentamicin C (GMC)-induced reduction in SGLT1 activity, we examined whether ligands for megalin protect LLC-PK1 cells from the @CHEMICAL$-induced reduction in @GENE$ activity.",
        "relation": "CPR:4"
    },
    {
        "id": "15777622.T15.T39",
        "sentence": "Then the cells were treated with various concentrations of apoE3, lactoferrin and bovine serum albumin with or without 100 microg/ml of GMC, and the @CHEMICAL$-dependent @GENE$ (AMG) uptake and levels of SGLT1 expression were determined.",
        "relation": "CPR:9"
    },
    {
        "id": "15777622.T16.T39",
        "sentence": "Then the cells were treated with various concentrations of apoE3, lactoferrin and bovine serum albumin with or without 100 microg/ml of GMC, and the @CHEMICAL$-dependent methyl alpha-D-glucopyranoside (@GENE$) uptake and levels of SGLT1 expression were determined.",
        "relation": "CPR:9"
    },
    {
        "id": "2877081.T17.T21",
        "sentence": "Actions of @CHEMICAL$, a selective @GENE$ antagonist, on gastric acid secretion in dogs, rats and frogs.",
        "relation": "CPR:6"
    },
    {
        "id": "2877081.T1.T19",
        "sentence": "@CHEMICAL$ (LY139037), a selective @GENE$ antagonist, is a potent inhibitor of gastric acid secretion.",
        "relation": "CPR:6"
    },
    {
        "id": "2877081.T2.T19",
        "sentence": "Nizatidine (@CHEMICAL$), a selective @GENE$ antagonist, is a potent inhibitor of gastric acid secretion.",
        "relation": "CPR:6"
    },
    {
        "id": "23172777.T5.T11",
        "sentence": "3D-QSAR-assisted drug design: identification of a potent @CHEMICAL$-based @GENE$ inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "23172777.T3.T8",
        "sentence": "Three different 3D-QSAR models were built and validated by using a set of 66 @CHEMICAL$ (Model I) and furanopyrimidine (Model II) compounds with IC(50) values toward @GENE$ ranging from 33 nM to 10.5 mM. The best 3D-QSAR model, Model III, constructed with 24 training set compounds from both series, showed robustness (r(2) (CV) =0.54 and 0.52 for CoMFA and CoMSIA, respectively) and superior predictive capacity for 42 test set compounds (R(2) (pred) =0.52 and 0.67, CoMFA and CoMSIA).",
        "relation": "CPR:4"
    },
    {
        "id": "23172777.T4.T8",
        "sentence": "Three different 3D-QSAR models were built and validated by using a set of 66 pyrazole (Model I) and @CHEMICAL$ (Model II) compounds with IC(50) values toward @GENE$ ranging from 33 nM to 10.5 mM. The best 3D-QSAR model, Model III, constructed with 24 training set compounds from both series, showed robustness (r(2) (CV) =0.54 and 0.52 for CoMFA and CoMSIA, respectively) and superior predictive capacity for 42 test set compounds (R(2) (pred) =0.52 and 0.67, CoMFA and CoMSIA).",
        "relation": "CPR:4"
    },
    {
        "id": "23172777.T1.T6",
        "sentence": "Based on these suggestions, the rational redesign of @CHEMICAL$ 24 (clog P=7.41; @GENE$ IC(50) =43 nM; HCT-116 IC(50) =400 nM) led to the identification of quinazoline 67 (clog P=5.28; Aurora A IC(50) =25 nM; HCT-116 IC(50) =23 nM).",
        "relation": "CPR:4"
    },
    {
        "id": "23172777.T2.T7",
        "sentence": "Based on these suggestions, the rational redesign of furanopyrimidine 24 (clog P=7.41; Aurora A IC(50) =43 nM; HCT-116 IC(50) =400 nM) led to the identification of @CHEMICAL$ 67 (clog P=5.28; @GENE$ IC(50) =25 nM; HCT-116 IC(50) =23 nM).",
        "relation": "CPR:4"
    },
    {
        "id": "23585058.T5.T15",
        "sentence": "Chelation of calcium ions by BAPTA-AM or blockade of @CHEMICAL$ activation by @GENE$ also prevented the NMDA effects.",
        "relation": "CPR:4"
    },
    {
        "id": "23585058.T8.T18",
        "sentence": "Thus prolonged activation of NMDA receptors in hippocampal neurons reduced @CHEMICAL$ expression through @GENE$ entry and at least in part by ERK1/2 activation.",
        "relation": "CPR:4"
    },
    {
        "id": "19549602.T11.T27",
        "sentence": "@CHEMICAL$ is a @GENE$ and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity.",
        "relation": "CPR:5"
    },
    {
        "id": "19549602.T11.T28",
        "sentence": "@CHEMICAL$ is a TrkA and @GENE$ receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity.",
        "relation": "CPR:5"
    },
    {
        "id": "19549602.T2.T16",
        "sentence": "@CHEMICAL$, but not any other tricyclic or selective serotonin reuptake inhibitor antidepressants, promotes @GENE$ autophosphorylation in primary neurons and induces neurite outgrowth in PC12 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "19549602.T10.T13",
        "sentence": "Thus, @CHEMICAL$ acts as a TrkA and @GENE$ agonist and possesses marked neurotrophic activity.",
        "relation": "CPR:5"
    },
    {
        "id": "19549602.T10.T26",
        "sentence": "Thus, @CHEMICAL$ acts as a @GENE$ and TrkB agonist and possesses marked neurotrophic activity.",
        "relation": "CPR:5"
    },
    {
        "id": "14737100.T7.T48",
        "sentence": "Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/@CHEMICAL$ kinase inhibitor @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "14737100.T4.T34",
        "sentence": "@CHEMICAL$, a reversible small molecule inhibitor of EGFR and ErbB2 @GENE$, inhibits baseline p95ErbB2 phosphorylation in BT474 cells and tumor xenografts.",
        "relation": "CPR:4"
    },
    {
        "id": "14737100.T4.T32",
        "sentence": "@CHEMICAL$, a reversible small molecule inhibitor of @GENE$ and ErbB2 tyrosine kinases, inhibits baseline p95ErbB2 phosphorylation in BT474 cells and tumor xenografts.",
        "relation": "CPR:4"
    },
    {
        "id": "14737100.T4.T33",
        "sentence": "@CHEMICAL$, a reversible small molecule inhibitor of EGFR and @GENE$ tyrosine kinases, inhibits baseline p95ErbB2 phosphorylation in BT474 cells and tumor xenografts.",
        "relation": "CPR:4"
    },
    {
        "id": "14737100.T4.T36",
        "sentence": "@CHEMICAL$, a reversible small molecule inhibitor of EGFR and ErbB2 tyrosine kinases, inhibits baseline @GENE$ phosphorylation in BT474 cells and tumor xenografts.",
        "relation": "CPR:4"
    },
    {
        "id": "14737100.T6.T40",
        "sentence": "Inhibition of p95ErbB2, p185ErbB2, and EGFR phosphorylation by @CHEMICAL$ resulted in the inhibition of downstream phospho-@GENE$, phospho-AKT, and cyclin D steady-state protein levels.",
        "relation": "CPR:4"
    },
    {
        "id": "14737100.T6.T41",
        "sentence": "Inhibition of p95ErbB2, p185ErbB2, and EGFR phosphorylation by @CHEMICAL$ resulted in the inhibition of downstream phospho-Erk1/2, phospho-@GENE$, and cyclin D steady-state protein levels.",
        "relation": "CPR:4"
    },
    {
        "id": "14737100.T6.T42",
        "sentence": "Inhibition of p95ErbB2, p185ErbB2, and EGFR phosphorylation by @CHEMICAL$ resulted in the inhibition of downstream phospho-Erk1/2, phospho-AKT, and @GENE$ steady-state protein levels.",
        "relation": "CPR:4"
    },
    {
        "id": "14737100.T6.T37",
        "sentence": "Inhibition of @CHEMICAL$, p185ErbB2, and EGFR phosphorylation by @GENE$ resulted in the inhibition of downstream phospho-Erk1/2, phospho-AKT, and cyclin D steady-state protein levels.",
        "relation": "CPR:4"
    },
    {
        "id": "14737100.T6.T38",
        "sentence": "Inhibition of p95ErbB2, @CHEMICAL$, and EGFR phosphorylation by @GENE$ resulted in the inhibition of downstream phospho-Erk1/2, phospho-AKT, and cyclin D steady-state protein levels.",
        "relation": "CPR:4"
    },
    {
        "id": "14737100.T6.T39",
        "sentence": "Inhibition of p95ErbB2, p185ErbB2, and @CHEMICAL$ phosphorylation by @GENE$ resulted in the inhibition of downstream phospho-Erk1/2, phospho-AKT, and cyclin D steady-state protein levels.",
        "relation": "CPR:4"
    },
    {
        "id": "14737100.T1.T44",
        "sentence": "Increased phosphorylation of p95ErbB2 and @CHEMICAL$ in response to HRG was abrogated to varying degrees by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "14737100.T1.T43",
        "sentence": "Increased phosphorylation of @CHEMICAL$ and AKT in response to HRG was abrogated to varying degrees by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17409426.T4.T20",
        "sentence": "@CHEMICAL$ inhibited @GENE$ in HT-29 and DLD-1 cells in a time- and concentration-dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "17409426.T6.T22",
        "sentence": "@CHEMICAL$ and SC-236, a selective @GENE$ (COX-2) inhibitor, exerted a similar effect as sulindac.",
        "relation": "CPR:4"
    },
    {
        "id": "17409426.T6.T23",
        "sentence": "@CHEMICAL$ and SC-236, a selective cyclooxygenase-2 (@GENE$) inhibitor, exerted a similar effect as sulindac.",
        "relation": "CPR:4"
    },
    {
        "id": "17409426.T7.T22",
        "sentence": "Indomethacin and @CHEMICAL$, a selective @GENE$ (COX-2) inhibitor, exerted a similar effect as sulindac.",
        "relation": "CPR:4"
    },
    {
        "id": "17409426.T7.T23",
        "sentence": "Indomethacin and @CHEMICAL$, a selective cyclooxygenase-2 (@GENE$) inhibitor, exerted a similar effect as sulindac.",
        "relation": "CPR:4"
    },
    {
        "id": "17409426.T10.T29",
        "sentence": "@CHEMICAL$ inhibited @GENE$ protein expression and PPARdelta transcriptional activity.",
        "relation": "CPR:4"
    },
    {
        "id": "17409426.T10.T30",
        "sentence": "@CHEMICAL$ inhibited PPARdelta protein expression and @GENE$ transcriptional activity.",
        "relation": "CPR:4"
    },
    {
        "id": "15795320.T2.T21",
        "sentence": "Synergistic cytotoxicity was demonstrated, and @CHEMICAL$ significantly decreased the amount of @GENE$, enhanced apoptosis, and increased the expression of dCK in A549 and Calu-6 cells, as well as the expression of the human nucleoside equilibrative transporter 1 (hENT1) in all cell lines.",
        "relation": "CPR:4"
    },
    {
        "id": "15795320.T2.T22",
        "sentence": "Synergistic cytotoxicity was demonstrated, and @CHEMICAL$ significantly decreased the amount of phosphorylated Akt, enhanced apoptosis, and increased the expression of @GENE$ in A549 and Calu-6 cells, as well as the expression of the human nucleoside equilibrative transporter 1 (hENT1) in all cell lines.",
        "relation": "CPR:3"
    },
    {
        "id": "15795320.T2.T23",
        "sentence": "Synergistic cytotoxicity was demonstrated, and @CHEMICAL$ significantly decreased the amount of phosphorylated Akt, enhanced apoptosis, and increased the expression of dCK in A549 and Calu-6 cells, as well as the expression of the @GENE$ (hENT1) in all cell lines.",
        "relation": "CPR:3"
    },
    {
        "id": "15795320.T2.T24",
        "sentence": "Synergistic cytotoxicity was demonstrated, and @CHEMICAL$ significantly decreased the amount of phosphorylated Akt, enhanced apoptosis, and increased the expression of dCK in A549 and Calu-6 cells, as well as the expression of the human nucleoside equilibrative transporter 1 (@GENE$) in all cell lines.",
        "relation": "CPR:3"
    },
    {
        "id": "15795320.T6.T29",
        "sentence": "These data demonstrated that 1) @CHEMICAL$ and pemetrexed synergistically interact against NSCLC cells through the suppression of @GENE$ phosphorylation and induction of apoptosis; 2) the gene expression profile of critical genes may predict for drug chemosensitivity; and 3) pemetrexed enhances dCK and hENT1 expression, thus suggesting the role of gene-expression modulation for rational development of chemotherapy combinations.",
        "relation": "CPR:4"
    },
    {
        "id": "15795320.T7.T29",
        "sentence": "These data demonstrated that 1) gemcitabine and @CHEMICAL$ synergistically interact against NSCLC cells through the suppression of @GENE$ phosphorylation and induction of apoptosis; 2) the gene expression profile of critical genes may predict for drug chemosensitivity; and 3) pemetrexed enhances dCK and hENT1 expression, thus suggesting the role of gene-expression modulation for rational development of chemotherapy combinations.",
        "relation": "CPR:4"
    },
    {
        "id": "15795320.T9.T30",
        "sentence": "These data demonstrated that 1) gemcitabine and pemetrexed synergistically interact against NSCLC cells through the suppression of Akt phosphorylation and induction of apoptosis; 2) the gene expression profile of critical genes may predict for drug chemosensitivity; and 3) @CHEMICAL$ enhances @GENE$ and hENT1 expression, thus suggesting the role of gene-expression modulation for rational development of chemotherapy combinations.",
        "relation": "CPR:3"
    },
    {
        "id": "15795320.T9.T31",
        "sentence": "These data demonstrated that 1) gemcitabine and pemetrexed synergistically interact against NSCLC cells through the suppression of Akt phosphorylation and induction of apoptosis; 2) the gene expression profile of critical genes may predict for drug chemosensitivity; and 3) @CHEMICAL$ enhances dCK and @GENE$ expression, thus suggesting the role of gene-expression modulation for rational development of chemotherapy combinations.",
        "relation": "CPR:3"
    },
    {
        "id": "12850267.T1.T24",
        "sentence": "@CHEMICAL$ (KA) is an endogenous @GENE$ antagonist at the level of the different ionotropic glutamate receptors.",
        "relation": "CPR:6"
    },
    {
        "id": "12850267.T1.T33",
        "sentence": "@CHEMICAL$ (KA) is an endogenous glutamate receptor antagonist at the level of the different @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "12850267.T3.T24",
        "sentence": "Kynurenic acid (@CHEMICAL$) is an endogenous @GENE$ antagonist at the level of the different ionotropic glutamate receptors.",
        "relation": "CPR:6"
    },
    {
        "id": "12850267.T3.T33",
        "sentence": "Kynurenic acid (@CHEMICAL$) is an endogenous glutamate receptor antagonist at the level of the different @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "12850267.T6.T20",
        "sentence": "One of the enzymes responsible for the production of @CHEMICAL$, @GENE$ (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15).",
        "relation": "CPR:9"
    },
    {
        "id": "12850267.T6.T21",
        "sentence": "One of the enzymes responsible for the production of @CHEMICAL$, kynurenine aminotransferase I (@GENE$), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15).",
        "relation": "CPR:9"
    },
    {
        "id": "12850267.T8.T20",
        "sentence": "One of the enzymes responsible for the production of KA, @CHEMICAL$ (KATI), also catalyses the reversible transamination of @GENE$ to oxoglutaramic acid (GTK, EC 2.6.1.15).",
        "relation": "CPR:9"
    },
    {
        "id": "12850267.T8.T21",
        "sentence": "One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (@CHEMICAL$), also catalyses the reversible transamination of @GENE$ to oxoglutaramic acid (GTK, EC 2.6.1.15).",
        "relation": "CPR:9"
    },
    {
        "id": "12850267.T8.T22",
        "sentence": "One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of @CHEMICAL$ to oxoglutaramic acid (@GENE$, EC 2.6.1.15).",
        "relation": "CPR:9"
    },
    {
        "id": "12850267.T9.T20",
        "sentence": "One of the enzymes responsible for the production of KA, @CHEMICAL$ (KATI), also catalyses the reversible transamination of glutamine to @GENE$ (GTK, EC 2.6.1.15).",
        "relation": "CPR:9"
    },
    {
        "id": "12850267.T9.T21",
        "sentence": "One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (@CHEMICAL$), also catalyses the reversible transamination of glutamine to @GENE$ (GTK, EC 2.6.1.15).",
        "relation": "CPR:9"
    },
    {
        "id": "12850267.T9.T22",
        "sentence": "One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to @CHEMICAL$ (@GENE$, EC 2.6.1.15).",
        "relation": "CPR:9"
    },
    {
        "id": "12850267.T9.T23",
        "sentence": "One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to @CHEMICAL$ (GTK, @GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "23628791.T9.T24",
        "sentence": "Combined treatment of @CHEMICAL$ and DA further augments cell toxicity, ROS production and @GENE$ phosphorylation in LRRK2 deficient cells compared to controls.",
        "relation": "CPR:3"
    },
    {
        "id": "22983867.T6.T26",
        "sentence": "The results showed that IR tyrosine phosphorylation (@CHEMICAL$) was reduced by 42 % in @GENE$-obese mice (MSG, 6.7 + 0.2 arbitrary units (a.u.); control, 11.5 + 0.4 a.u.); on the other hand, exercise training increased pIR by 76 % in MSG mice without affecting control mice (MSG, 11.8 + 0.3; control, 12.8 + 0.2 a.u.).",
        "relation": "CPR:4"
    },
    {
        "id": "22983867.T6.T27",
        "sentence": "The results showed that IR tyrosine phosphorylation (pIR) was reduced by 42 % in @CHEMICAL$-obese mice (MSG, 6.7 + 0.2 arbitrary units (a.u.); control, 11.5 + 0.4 a.u.); on the other hand, exercise training increased @GENE$ by 76 % in MSG mice without affecting control mice (MSG, 11.8 + 0.3; control, 12.8 + 0.2 a.u.).",
        "relation": "CPR:4"
    },
    {
        "id": "22983867.T7.T26",
        "sentence": "The results showed that IR tyrosine phosphorylation (@CHEMICAL$) was reduced by 42 % in MSG-obese mice (@GENE$, 6.7 + 0.2 arbitrary units (a.u.); control, 11.5 + 0.4 a.u.); on the other hand, exercise training increased pIR by 76 % in MSG mice without affecting control mice (MSG, 11.8 + 0.3; control, 12.8 + 0.2 a.u.).",
        "relation": "CPR:4"
    },
    {
        "id": "22983867.T7.T27",
        "sentence": "The results showed that IR tyrosine phosphorylation (pIR) was reduced by 42 % in MSG-obese mice (@CHEMICAL$, 6.7 + 0.2 arbitrary units (a.u.); control, 11.5 + 0.4 a.u.); on the other hand, exercise training increased @GENE$ by 76 % in MSG mice without affecting control mice (MSG, 11.8 + 0.3; control, 12.8 + 0.2 a.u.).",
        "relation": "CPR:4"
    },
    {
        "id": "22983867.T9.T26",
        "sentence": "The results showed that IR tyrosine phosphorylation (@CHEMICAL$) was reduced by 42 % in MSG-obese mice (MSG, 6.7 + 0.2 arbitrary units (a.u.); control, 11.5 + 0.4 a.u.); on the other hand, exercise training increased pIR by 76 % in @GENE$ mice without affecting control mice (MSG, 11.8 + 0.3; control, 12.8 + 0.2 a.u.).",
        "relation": "CPR:4"
    },
    {
        "id": "22983867.T9.T27",
        "sentence": "The results showed that IR tyrosine phosphorylation (pIR) was reduced by 42 % in MSG-obese mice (MSG, 6.7 + 0.2 arbitrary units (a.u.); control, 11.5 + 0.4 a.u.); on the other hand, exercise training increased @CHEMICAL$ by 76 % in @GENE$ mice without affecting control mice (MSG, 11.8 + 0.3; control, 12.8 + 0.2 a.u.).",
        "relation": "CPR:4"
    },
    {
        "id": "22983867.T10.T26",
        "sentence": "The results showed that IR tyrosine phosphorylation (@CHEMICAL$) was reduced by 42 % in MSG-obese mice (MSG, 6.7 + 0.2 arbitrary units (a.u.); control, 11.5 + 0.4 a.u.); on the other hand, exercise training increased pIR by 76 % in MSG mice without affecting control mice (@GENE$, 11.8 + 0.3; control, 12.8 + 0.2 a.u.).",
        "relation": "CPR:4"
    },
    {
        "id": "22983867.T10.T27",
        "sentence": "The results showed that IR tyrosine phosphorylation (pIR) was reduced by 42 % in MSG-obese mice (MSG, 6.7 + 0.2 arbitrary units (a.u.); control, 11.5 + 0.4 a.u.); on the other hand, exercise training increased @CHEMICAL$ by 76 % in MSG mice without affecting control mice (@GENE$, 11.8 + 0.3; control, 12.8 + 0.2 a.u.).",
        "relation": "CPR:4"
    },
    {
        "id": "22983867.T11.T29",
        "sentence": "Although the treatment with @CHEMICAL$ increased IRS-1 tyrosine phosphorylation (@GENE$) by 96 % (MSG, 17.02 + 0.6; control, 8.7 + 0.2 a.u.), exercise training also increased it in both groups (control, 13.6 + 0.1; MSG, 22.2 + 1.1 a.u.).",
        "relation": "CPR:3"
    },
    {
        "id": "22983867.T13.T29",
        "sentence": "Although the treatment with MSG increased IRS-1 tyrosine phosphorylation (@CHEMICAL$) by 96 % (@GENE$, 17.02 + 0.6; control, 8.7 + 0.2 a.u.), exercise training also increased it in both groups (control, 13.6 + 0.1; MSG, 22.2 + 1.1 a.u.).",
        "relation": "CPR:3"
    },
    {
        "id": "22983867.T14.T29",
        "sentence": "Although the treatment with MSG increased IRS-1 tyrosine phosphorylation (@CHEMICAL$) by 96 % (MSG, 17.02 + 0.6; control, 8.7 + 0.2 a.u.), exercise training also increased it in both groups (control, 13.6 + 0.1; @GENE$, 22.2 + 1.1 a.u.).",
        "relation": "CPR:3"
    },
    {
        "id": "12614192.T2.T10",
        "sentence": "The scientific basis of this treatment of ED includes relaxation of the corpus cavernosum smooth muscle tissue by inhibition of @CHEMICAL$ that breaks down @GENE$, the key pathway for the production of erectile function in humans.",
        "relation": "CPR:9"
    },
    {
        "id": "12614192.T3.T11",
        "sentence": "Many clinical studies, both pre- and post-marketing, have demonstrated the clinical efficacy and safety of @CHEMICAL$ (Viagra, Pfizer) - the first approved selective @GENE$ inhibitor for the treatment of ED.",
        "relation": "CPR:4"
    },
    {
        "id": "12614192.T4.T11",
        "sentence": "Many clinical studies, both pre- and post-marketing, have demonstrated the clinical efficacy and safety of sildenafil (@CHEMICAL$, Pfizer) - the first approved selective @GENE$ inhibitor for the treatment of ED.",
        "relation": "CPR:4"
    },
    {
        "id": "12614192.T5.T13",
        "sentence": "@CHEMICAL$ is inhibitory of PDE5 at a rate tenfold higher than for the next @GENE$ (PDE6), which produces visual changes through the retinal rods.",
        "relation": "CPR:4"
    },
    {
        "id": "12614192.T5.T14",
        "sentence": "@CHEMICAL$ is inhibitory of PDE5 at a rate tenfold higher than for the next PDE (@GENE$), which produces visual changes through the retinal rods.",
        "relation": "CPR:4"
    },
    {
        "id": "12614192.T5.T12",
        "sentence": "@CHEMICAL$ is inhibitory of @GENE$ at a rate tenfold higher than for the next PDE (PDE6), which produces visual changes through the retinal rods.",
        "relation": "CPR:4"
    },
    {
        "id": "12614192.T1.T9",
        "sentence": "With the use of @CHEMICAL$, it has been clearly, clinically demonstrated that the selective inhibition of @GENE$ is an appropriate, effective, safe method for the treatment of ED of all aetiologies and severities.",
        "relation": "CPR:4"
    },
    {
        "id": "17545671.T12.T30",
        "sentence": "We show that cytosolic aspartate aminotransferase (cAspAT) is involved in adipocyte glyceroneogenesis, a regulated pathway that controls fatty acid homeostasis by promoting glycerol 3-phosphate formation for fatty acid re-esterification during fasting. @CHEMICAL$ activity, as well as the incorporation of [(14)C]aspartate into the neutral lipid fraction of 3T3-F442A adipocytes was stimulated by the @GENE$ (TZD) rosiglitazone.",
        "relation": "CPR:3"
    },
    {
        "id": "17545671.T13.T30",
        "sentence": "We show that cytosolic aspartate aminotransferase (cAspAT) is involved in adipocyte glyceroneogenesis, a regulated pathway that controls fatty acid homeostasis by promoting glycerol 3-phosphate formation for fatty acid re-esterification during fasting. @CHEMICAL$ activity, as well as the incorporation of [(14)C]aspartate into the neutral lipid fraction of 3T3-F442A adipocytes was stimulated by the thiazolidinedione (@GENE$) rosiglitazone.",
        "relation": "CPR:3"
    },
    {
        "id": "17545671.T14.T30",
        "sentence": "We show that cytosolic aspartate aminotransferase (cAspAT) is involved in adipocyte glyceroneogenesis, a regulated pathway that controls fatty acid homeostasis by promoting glycerol 3-phosphate formation for fatty acid re-esterification during fasting. @CHEMICAL$ activity, as well as the incorporation of [(14)C]aspartate into the neutral lipid fraction of 3T3-F442A adipocytes was stimulated by the thiazolidinedione (TZD) @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "17545671.T4.T22",
        "sentence": "@CHEMICAL$ ectopic expression activated the cAspAT gene transcription in absence of rosiglitazone, and its protein amount in nuclear extracts is 1.8-fold increased by @GENE$ treatment of adipocytes.",
        "relation": "CPR:3"
    },
    {
        "id": "17545671.T4.T23",
        "sentence": "RORalpha ectopic expression activated the @CHEMICAL$ gene transcription in absence of rosiglitazone, and its protein amount in nuclear extracts is 1.8-fold increased by @GENE$ treatment of adipocytes.",
        "relation": "CPR:3"
    },
    {
        "id": "17545671.T6.T24",
        "sentence": "Finally, the amounts of @CHEMICAL$ and cAspAT mRNAs were similarly increased by @GENE$ treatment of human adipose tissue explants, confirming coordinated regulation.",
        "relation": "CPR:3"
    },
    {
        "id": "17545671.T6.T26",
        "sentence": "Finally, the amounts of RORalpha and @CHEMICAL$ mRNAs were similarly increased by @GENE$ treatment of human adipose tissue explants, confirming coordinated regulation.",
        "relation": "CPR:3"
    },
    {
        "id": "17545671.T7.T27",
        "sentence": "Our data identify @CHEMICAL$ as a new member of glyceroneogenesis, transcriptionally regulated by @GENE$ via the control of RORalpha expression by PPARgamma in adipocytes.",
        "relation": "CPR:3"
    },
    {
        "id": "23291630.T5.T17",
        "sentence": "@CHEMICAL$, a potent and selective @GENE$ inhibitor, achieves antitumor activity while sparing platelets.",
        "relation": "CPR:4"
    },
    {
        "id": "23291630.T1.T10",
        "sentence": "The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of @CHEMICAL$, a selective inhibitor of both @GENE$ and BCL-2-like 1 (BCL-X(L)), which has shown clinical efficacy in some BCL-2-dependent hematological cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "23291630.T1.T11",
        "sentence": "The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of @CHEMICAL$, a selective inhibitor of both BCL-2 and @GENE$ (BCL-X(L)), which has shown clinical efficacy in some BCL-2-dependent hematological cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "23291630.T1.T12",
        "sentence": "The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of @CHEMICAL$, a selective inhibitor of both BCL-2 and BCL-2-like 1 (@GENE$), which has shown clinical efficacy in some BCL-2-dependent hematological cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "23291630.T2.T15",
        "sentence": "Here we report the re-engineering of @CHEMICAL$ to create a highly potent, orally bioavailable and @GENE$-selective inhibitor, ABT-199.",
        "relation": "CPR:4"
    },
    {
        "id": "23291630.T3.T15",
        "sentence": "Here we report the re-engineering of navitoclax to create a highly potent, orally bioavailable and @CHEMICAL$-selective inhibitor, @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23618901.T1.T12",
        "sentence": "Suppression of @CHEMICAL$ by the pharmacological inhibitor (@GENE$) markedly reduced VEGF release by HFL-1 in response to CSE and this effect was confirmed by TbR1 siRNA.",
        "relation": "CPR:4"
    },
    {
        "id": "23618901.T1.T13",
        "sentence": "Suppression of TbR1 by the pharmacological inhibitor (@CHEMICAL$) markedly reduced @GENE$ release by HFL-1 in response to CSE and this effect was confirmed by TbR1 siRNA.",
        "relation": "CPR:4"
    },
    {
        "id": "23348500.T1.T18",
        "sentence": "@CHEMICAL$ binds to the CPPHA site on mGlu5 and potentiates @GENE$-mediated responses in both recombinant and native systems.",
        "relation": "CPR:3"
    },
    {
        "id": "10462128.T23.T36",
        "sentence": "Combination treatment with the selective @CHEMICAL$ antagonist @GENE$ produced a dose-dependent augmentation of venlafaxine-induced (3-30 mg/kg s.c) extracellular 5-HT concentrations, but had no further effect on NA above that produced by venlafaxine alone.",
        "relation": "CPR:6"
    },
    {
        "id": "10462128.T3.T31",
        "sentence": "The beta-adrenergic/@CHEMICAL$ receptor antagonist @GENE$ and the selective 5-HT1B/D antagonist GR127935 produced no significant augmentation of venlafaxine-induced changes in either 5-HT or NA.",
        "relation": "CPR:6"
    },
    {
        "id": "12724156.T1.T41",
        "sentence": "The selective GluR5 kainate receptor agonist ATPA induces spontaneous epileptiform bursting that is sensitive to the GluR5 @CHEMICAL$ antagonist @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "12724156.T1.T40",
        "sentence": "The selective GluR5 kainate receptor agonist ATPA induces spontaneous epileptiform bursting that is sensitive to the @CHEMICAL$ kainate receptor antagonist @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "12724156.T5.T24",
        "sentence": "However, @CHEMICAL$ at low concentrations causes slow inhibition of GluR5 @GENE$-mediated synaptic currents in the basolateral amygdala, indicating that it may protect against seizures, at least in part, through suppression of GluR5 kainate receptor responses.",
        "relation": "CPR:4"
    },
    {
        "id": "12724156.T5.T28",
        "sentence": "However, @CHEMICAL$ at low concentrations causes slow inhibition of GluR5 kainate receptor-mediated synaptic currents in the basolateral amygdala, indicating that it may protect against seizures, at least in part, through suppression of GluR5 @GENE$ responses.",
        "relation": "CPR:4"
    },
    {
        "id": "12724156.T5.T23",
        "sentence": "However, @CHEMICAL$ at low concentrations causes slow inhibition of @GENE$ kainate receptor-mediated synaptic currents in the basolateral amygdala, indicating that it may protect against seizures, at least in part, through suppression of GluR5 kainate receptor responses.",
        "relation": "CPR:4"
    },
    {
        "id": "12724156.T5.T27",
        "sentence": "However, @CHEMICAL$ at low concentrations causes slow inhibition of GluR5 kainate receptor-mediated synaptic currents in the basolateral amygdala, indicating that it may protect against seizures, at least in part, through suppression of @GENE$ kainate receptor responses.",
        "relation": "CPR:4"
    },
    {
        "id": "22899102.T19.T32",
        "sentence": "@CHEMICAL$ are involved in the transport of the @GENE$ conjugates of the ultimate carcinogen of benzo[a]pyrene in human Caco-2 cells.",
        "relation": "CPR:9"
    },
    {
        "id": "22899102.T11.T29",
        "sentence": "The ultimate carcinogenic Phase I BP metabolite anti-BP-7,8-dihydrodiol-9,10-epoxide (BPDE) can be detoxified by @CHEMICAL$ conjugate formation catalyzed by @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "22899102.T3.T20",
        "sentence": "Inhibition studies revealed that the @CHEMICAL$ (ABCCs) are involved in the transport of @GENE$ conjugates.",
        "relation": "CPR:9"
    },
    {
        "id": "22899102.T3.T21",
        "sentence": "Inhibition studies revealed that the multidrug resistance-associated proteins (@CHEMICAL$) are involved in the transport of @GENE$ conjugates.",
        "relation": "CPR:9"
    },
    {
        "id": "22899102.T4.T22",
        "sentence": "Stable @CHEMICAL$, ABCC2 and ABCC3 knockdown cell lines were generated, thus making it possible to demonstrate that ABCC1 mediates the basolateral and ABCC2 the apical excretion of @GENE$ conjugates.",
        "relation": "CPR:9"
    },
    {
        "id": "22899102.T4.T23",
        "sentence": "Stable ABCC1, @CHEMICAL$ and ABCC3 knockdown cell lines were generated, thus making it possible to demonstrate that ABCC1 mediates the basolateral and ABCC2 the apical excretion of @GENE$ conjugates.",
        "relation": "CPR:9"
    },
    {
        "id": "22899102.T4.T25",
        "sentence": "Stable ABCC1, ABCC2 and ABCC3 knockdown cell lines were generated, thus making it possible to demonstrate that @CHEMICAL$ mediates the basolateral and ABCC2 the apical excretion of @GENE$ conjugates.",
        "relation": "CPR:9"
    },
    {
        "id": "22899102.T4.T26",
        "sentence": "Stable ABCC1, ABCC2 and ABCC3 knockdown cell lines were generated, thus making it possible to demonstrate that ABCC1 mediates the basolateral and @CHEMICAL$ the apical excretion of @GENE$ conjugates.",
        "relation": "CPR:9"
    },
    {
        "id": "23265491.T5.T12",
        "sentence": "Pretreatment of human breast carcinoma MCF-7 cells for 24 h with the groundnut extract and soybean @CHEMICAL$ increased gene expression of @GENE$ (HO-1), a major antioxidative stress enzyme.",
        "relation": "CPR:3"
    },
    {
        "id": "23265491.T5.T13",
        "sentence": "Pretreatment of human breast carcinoma MCF-7 cells for 24 h with the groundnut extract and soybean @CHEMICAL$ increased gene expression of heme oxygenase-1 (@GENE$), a major antioxidative stress enzyme.",
        "relation": "CPR:3"
    },
    {
        "id": "16846546.T28.T42",
        "sentence": "Comparison of @CHEMICAL$ inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "16846546.T29.T42",
        "sentence": "Comparison of @CHEMICAL$ inhibitory activity and ocular anti-inflammatory effects of @GENE$ and bromfenac sodium.",
        "relation": "CPR:4"
    },
    {
        "id": "16846546.T19.T37",
        "sentence": "OBJECTIVE: To compare the cyclooxygenase (COX) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs (NSAIDs) ketorolac tromethamine (ketorolac) and bromfenac sodium (bromfenac). METHODS: @CHEMICAL$ activity and selectivity was determined in vitro by measuring @GENE$ (PGE(2)) production following incubation of varying concentrations of NSAID with human recombinant COX-1 or COX-2 and arachidonic acid.",
        "relation": "CPR:9"
    },
    {
        "id": "16846546.T20.T37",
        "sentence": "OBJECTIVE: To compare the cyclooxygenase (COX) activity and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs (NSAIDs) ketorolac tromethamine (ketorolac) and bromfenac sodium (bromfenac). METHODS: @CHEMICAL$ activity and selectivity was determined in vitro by measuring prostaglandin E(2) (@GENE$) production following incubation of varying concentrations of NSAID with human recombinant COX-1 or COX-2 and arachidonic acid.",
        "relation": "CPR:9"
    },
    {
        "id": "16846546.T3.T32",
        "sentence": "RESULTS: @CHEMICAL$ was six times more active against COX-1 (IC(50) = 0.02 microM) than COX-2 (IC(50) = 0.12 microM) while bromfenac was approximately 32 times more active against @GENE$ (IC(50) = 0.0066 microM) than COX-1 (IC(50) = 0.210 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "16846546.T3.T33",
        "sentence": "RESULTS: @CHEMICAL$ was six times more active against COX-1 (IC(50) = 0.02 microM) than COX-2 (IC(50) = 0.12 microM) while bromfenac was approximately 32 times more active against COX-2 (IC(50) = 0.0066 microM) than @GENE$ (IC(50) = 0.210 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "16846546.T4.T30",
        "sentence": "RESULTS: Ketorolac was six times more active against @CHEMICAL$ (IC(50) = 0.02 microM) than COX-2 (IC(50) = 0.12 microM) while @GENE$ was approximately 32 times more active against COX-2 (IC(50) = 0.0066 microM) than COX-1 (IC(50) = 0.210 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "16846546.T4.T31",
        "sentence": "RESULTS: Ketorolac was six times more active against COX-1 (IC(50) = 0.02 microM) than @CHEMICAL$ (IC(50) = 0.12 microM) while @GENE$ was approximately 32 times more active against COX-2 (IC(50) = 0.0066 microM) than COX-1 (IC(50) = 0.210 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "18715952.T15.T38",
        "sentence": "Tumor-growth-promoting @CHEMICAL$ @GENE$ pathway provides medulloblastoma therapeutic targets.",
        "relation": "CPR:9"
    },
    {
        "id": "18715952.T2.T21",
        "sentence": "@CHEMICAL$ is synthesized from arachidonic acid by @GENE$ (COX) and prostaglandin E synthases (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4).",
        "relation": "CPR:9"
    },
    {
        "id": "18715952.T2.T22",
        "sentence": "@CHEMICAL$ is synthesized from arachidonic acid by cyclooxygenases (@GENE$) and prostaglandin E synthases (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4).",
        "relation": "CPR:9"
    },
    {
        "id": "18715952.T2.T23",
        "sentence": "@CHEMICAL$ is synthesized from arachidonic acid by cyclooxygenases (COX) and @GENE$ (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4).",
        "relation": "CPR:9"
    },
    {
        "id": "18715952.T2.T24",
        "sentence": "@CHEMICAL$ is synthesized from arachidonic acid by cyclooxygenases (COX) and prostaglandin E synthases (@GENE$) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4).",
        "relation": "CPR:9"
    },
    {
        "id": "18715952.T4.T21",
        "sentence": "PGE(2) is synthesized from @CHEMICAL$ by @GENE$ (COX) and prostaglandin E synthases (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4).",
        "relation": "CPR:9"
    },
    {
        "id": "18715952.T4.T22",
        "sentence": "PGE(2) is synthesized from @CHEMICAL$ by cyclooxygenases (@GENE$) and prostaglandin E synthases (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4).",
        "relation": "CPR:9"
    },
    {
        "id": "18715952.T4.T23",
        "sentence": "PGE(2) is synthesized from @CHEMICAL$ by cyclooxygenases (COX) and @GENE$ (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4).",
        "relation": "CPR:9"
    },
    {
        "id": "18715952.T4.T24",
        "sentence": "PGE(2) is synthesized from @CHEMICAL$ by cyclooxygenases (COX) and prostaglandin E synthases (@GENE$) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4).",
        "relation": "CPR:9"
    },
    {
        "id": "18715952.T11.T35",
        "sentence": "@CHEMICAL$ and EP(3) receptor antagonists @GENE$ and ONO-AE3-240, but not the EP(4) antagonists ONO-AE3-208 and AH 23848, inhibited tumor cell proliferation, indicating the significance of EP(1) and EP(3) but not EP(4) for MB growth.",
        "relation": "CPR:6"
    },
    {
        "id": "18715952.T11.T36",
        "sentence": "EP(1) and @CHEMICAL$ antagonists @GENE$ and ONO-AE3-240, but not the EP(4) antagonists ONO-AE3-208 and AH 23848, inhibited tumor cell proliferation, indicating the significance of EP(1) and EP(3) but not EP(4) for MB growth.",
        "relation": "CPR:6"
    },
    {
        "id": "18715952.T12.T35",
        "sentence": "@CHEMICAL$ and EP(3) receptor antagonists ONO-8713 and @GENE$, but not the EP(4) antagonists ONO-AE3-208 and AH 23848, inhibited tumor cell proliferation, indicating the significance of EP(1) and EP(3) but not EP(4) for MB growth.",
        "relation": "CPR:6"
    },
    {
        "id": "18715952.T12.T36",
        "sentence": "EP(1) and @CHEMICAL$ antagonists ONO-8713 and @GENE$, but not the EP(4) antagonists ONO-AE3-208 and AH 23848, inhibited tumor cell proliferation, indicating the significance of EP(1) and EP(3) but not EP(4) for MB growth.",
        "relation": "CPR:6"
    },
    {
        "id": "18715952.T13.T37",
        "sentence": "EP(1) and EP(3) receptor antagonists ONO-8713 and ONO-AE3-240, but not the @CHEMICAL$ antagonists @GENE$ and AH 23848, inhibited tumor cell proliferation, indicating the significance of EP(1) and EP(3) but not EP(4) for MB growth.",
        "relation": "CPR:6"
    },
    {
        "id": "18715952.T14.T37",
        "sentence": "EP(1) and EP(3) receptor antagonists ONO-8713 and ONO-AE3-240, but not the @CHEMICAL$ antagonists ONO-AE3-208 and @GENE$, inhibited tumor cell proliferation, indicating the significance of EP(1) and EP(3) but not EP(4) for MB growth.",
        "relation": "CPR:6"
    },
    {
        "id": "18282775.T10.T31",
        "sentence": "Inhibitors of @CHEMICAL$ (@GENE$; 0.1-10 microM) and PDE3 (cilostazol; 0.1-10 microM) delayed spontaneous eosinophil apoptosis maximally by 25% and 15%, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "18282775.T11.T32",
        "sentence": "Inhibitors of PDE4 (rolipram; 0.1-10 microM) and @CHEMICAL$ (@GENE$; 0.1-10 microM) delayed spontaneous eosinophil apoptosis maximally by 25% and 15%, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "18282775.T6.T15",
        "sentence": "Inhibitor of @CHEMICAL$ (@GENE$; 0.1-10 microM) did not affect eosinophil apoptosis and only slightly increased spontaneous neutrophil apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "16702329.T3.T17",
        "sentence": "@CHEMICAL$, a @GENE$ antagonist, prevented (P < 0.01) the lutein-induced iNOS mRNA downregulation in HD11 cells.",
        "relation": "CPR:6"
    },
    {
        "id": "16702329.T3.T18",
        "sentence": "@CHEMICAL$, a PPARgamma antagonist, prevented (P < 0.01) the lutein-induced @GENE$ mRNA downregulation in HD11 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "12373557.T15.T21",
        "sentence": "Stereospecific inhibition of @CHEMICAL$ by @GENE$ isomers.",
        "relation": "CPR:4"
    },
    {
        "id": "12373557.T8.T16",
        "sentence": "To extend structure-activity analyses of binding sites within @CHEMICAL$ and to determine which stereoisomer displayed the best selectivity for PET imaging applications, we tested the @GENE$ compounds for their abilities to inhibit [(3)H]neurotransmitter uptake into platelets, transfected cells, and chromaffin vesicles.",
        "relation": "CPR:4"
    },
    {
        "id": "12373557.T10.T17",
        "sentence": "We hypothesized that the @CHEMICAL$ compounds would be most potent at the @GENE$ (NET) compared to the serotonin or dopamine transporters and that the 1R diastereomers would be more effective than 1S diastereomers.",
        "relation": "CPR:4"
    },
    {
        "id": "12373557.T10.T18",
        "sentence": "We hypothesized that the @CHEMICAL$ compounds would be most potent at the norepinephrine transporter (@GENE$) compared to the serotonin or dopamine transporters and that the 1R diastereomers would be more effective than 1S diastereomers.",
        "relation": "CPR:4"
    },
    {
        "id": "23429912.T12.T40",
        "sentence": "@CHEMICAL$ inhibition of canonical @GENE$ signaling disrupts prostatic bud formation in mouse urogenital sinus.",
        "relation": "CPR:4"
    },
    {
        "id": "23429912.T8.T30",
        "sentence": "In support of the hypothesis that @CHEMICAL$ decreases canonical @GENE$ signaling, we identify inhibitory effects of TCDD on multiple components of the canonical Wnt signaling pathway in the UGS that temporally coincide with the inhibitory effect of TCDD on prostatic bud formation: (1) expression of R-spondins (Rspo2 and Rspo3) that promote canonical Wnt signaling is reduced; (2) expression of Lef1, Tcf1, and Wif1, established canonical Wnt target genes, is decreased; (3) expression of Lgr5, a RSPO receptor that activates canonical Wnt signaling, is reduced; and (4) expression of Dickkopfs (Dkks), inhibitors of canonical Wnt signaling, is not increased by TCDD.",
        "relation": "CPR:4"
    },
    {
        "id": "23429912.T11.T32",
        "sentence": "In support of the hypothesis that TCDD decreases canonical Wnt signaling, we identify inhibitory effects of TCDD on multiple components of the canonical Wnt signaling pathway in the UGS that temporally coincide with the inhibitory effect of @CHEMICAL$ on prostatic bud formation: (1) expression of @GENE$ (Rspo2 and Rspo3) that promote canonical Wnt signaling is reduced; (2) expression of Lef1, Tcf1, and Wif1, established canonical Wnt target genes, is decreased; (3) expression of Lgr5, a RSPO receptor that activates canonical Wnt signaling, is reduced; and (4) expression of Dickkopfs (Dkks), inhibitors of canonical Wnt signaling, is not increased by TCDD.",
        "relation": "CPR:4"
    },
    {
        "id": "23429912.T11.T13",
        "sentence": "In support of the hypothesis that TCDD decreases canonical Wnt signaling, we identify inhibitory effects of TCDD on multiple components of the canonical Wnt signaling pathway in the UGS that temporally coincide with the inhibitory effect of @CHEMICAL$ on prostatic bud formation: (1) expression of R-spondins (Rspo2 and Rspo3) that promote canonical Wnt signaling is reduced; (2) expression of Lef1, Tcf1, and Wif1, established canonical Wnt target genes, is decreased; (3) expression of @GENE$, a RSPO receptor that activates canonical Wnt signaling, is reduced; and (4) expression of Dickkopfs (Dkks), inhibitors of canonical Wnt signaling, is not increased by TCDD.",
        "relation": "CPR:4"
    },
    {
        "id": "23429912.T11.T14",
        "sentence": "In support of the hypothesis that TCDD decreases canonical Wnt signaling, we identify inhibitory effects of TCDD on multiple components of the canonical Wnt signaling pathway in the UGS that temporally coincide with the inhibitory effect of @CHEMICAL$ on prostatic bud formation: (1) expression of R-spondins (Rspo2 and Rspo3) that promote canonical Wnt signaling is reduced; (2) expression of Lef1, Tcf1, and Wif1, established canonical Wnt target genes, is decreased; (3) expression of Lgr5, a @GENE$ that activates canonical Wnt signaling, is reduced; and (4) expression of Dickkopfs (Dkks), inhibitors of canonical Wnt signaling, is not increased by TCDD.",
        "relation": "CPR:4"
    },
    {
        "id": "23429912.T11.T33",
        "sentence": "In support of the hypothesis that TCDD decreases canonical Wnt signaling, we identify inhibitory effects of TCDD on multiple components of the canonical Wnt signaling pathway in the UGS that temporally coincide with the inhibitory effect of @CHEMICAL$ on prostatic bud formation: (1) expression of R-spondins (@GENE$ and Rspo3) that promote canonical Wnt signaling is reduced; (2) expression of Lef1, Tcf1, and Wif1, established canonical Wnt target genes, is decreased; (3) expression of Lgr5, a RSPO receptor that activates canonical Wnt signaling, is reduced; and (4) expression of Dickkopfs (Dkks), inhibitors of canonical Wnt signaling, is not increased by TCDD.",
        "relation": "CPR:4"
    },
    {
        "id": "23429912.T11.T34",
        "sentence": "In support of the hypothesis that TCDD decreases canonical Wnt signaling, we identify inhibitory effects of TCDD on multiple components of the canonical Wnt signaling pathway in the UGS that temporally coincide with the inhibitory effect of @CHEMICAL$ on prostatic bud formation: (1) expression of R-spondins (Rspo2 and @GENE$) that promote canonical Wnt signaling is reduced; (2) expression of Lef1, Tcf1, and Wif1, established canonical Wnt target genes, is decreased; (3) expression of Lgr5, a RSPO receptor that activates canonical Wnt signaling, is reduced; and (4) expression of Dickkopfs (Dkks), inhibitors of canonical Wnt signaling, is not increased by TCDD.",
        "relation": "CPR:4"
    },
    {
        "id": "23429912.T11.T36",
        "sentence": "In support of the hypothesis that TCDD decreases canonical Wnt signaling, we identify inhibitory effects of TCDD on multiple components of the canonical Wnt signaling pathway in the UGS that temporally coincide with the inhibitory effect of @CHEMICAL$ on prostatic bud formation: (1) expression of R-spondins (Rspo2 and Rspo3) that promote canonical Wnt signaling is reduced; (2) expression of @GENE$, Tcf1, and Wif1, established canonical Wnt target genes, is decreased; (3) expression of Lgr5, a RSPO receptor that activates canonical Wnt signaling, is reduced; and (4) expression of Dickkopfs (Dkks), inhibitors of canonical Wnt signaling, is not increased by TCDD.",
        "relation": "CPR:4"
    },
    {
        "id": "23429912.T11.T37",
        "sentence": "In support of the hypothesis that TCDD decreases canonical Wnt signaling, we identify inhibitory effects of TCDD on multiple components of the canonical Wnt signaling pathway in the UGS that temporally coincide with the inhibitory effect of @CHEMICAL$ on prostatic bud formation: (1) expression of R-spondins (Rspo2 and Rspo3) that promote canonical Wnt signaling is reduced; (2) expression of Lef1, @GENE$, and Wif1, established canonical Wnt target genes, is decreased; (3) expression of Lgr5, a RSPO receptor that activates canonical Wnt signaling, is reduced; and (4) expression of Dickkopfs (Dkks), inhibitors of canonical Wnt signaling, is not increased by TCDD.",
        "relation": "CPR:4"
    },
    {
        "id": "23429912.T11.T38",
        "sentence": "In support of the hypothesis that TCDD decreases canonical Wnt signaling, we identify inhibitory effects of TCDD on multiple components of the canonical Wnt signaling pathway in the UGS that temporally coincide with the inhibitory effect of @CHEMICAL$ on prostatic bud formation: (1) expression of R-spondins (Rspo2 and Rspo3) that promote canonical Wnt signaling is reduced; (2) expression of Lef1, Tcf1, and @GENE$, established canonical Wnt target genes, is decreased; (3) expression of Lgr5, a RSPO receptor that activates canonical Wnt signaling, is reduced; and (4) expression of Dickkopfs (Dkks), inhibitors of canonical Wnt signaling, is not increased by TCDD.",
        "relation": "CPR:4"
    },
    {
        "id": "23429912.T2.T19",
        "sentence": "Thus, the @CHEMICAL$-induced reduction in canonical @GENE$ signaling is associated with a decrease in activators (Rspo2 and Rspo3) rather than an increase in inhibitors (Dkk1 and Dkk2) of the pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23429912.T2.T20",
        "sentence": "Thus, the @CHEMICAL$-induced reduction in canonical Wnt signaling is associated with a decrease in activators (@GENE$ and Rspo3) rather than an increase in inhibitors (Dkk1 and Dkk2) of the pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23429912.T2.T21",
        "sentence": "Thus, the @CHEMICAL$-induced reduction in canonical Wnt signaling is associated with a decrease in activators (Rspo2 and @GENE$) rather than an increase in inhibitors (Dkk1 and Dkk2) of the pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23429912.T2.T22",
        "sentence": "Thus, the @CHEMICAL$-induced reduction in canonical Wnt signaling is associated with a decrease in activators (Rspo2 and Rspo3) rather than an increase in inhibitors (@GENE$ and Dkk2) of the pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23429912.T2.T23",
        "sentence": "Thus, the @CHEMICAL$-induced reduction in canonical Wnt signaling is associated with a decrease in activators (Rspo2 and Rspo3) rather than an increase in inhibitors (Dkk1 and @GENE$) of the pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23429912.T4.T26",
        "sentence": "This study focuses on determining whether treatment of TCDD-exposed UGS organ cultures with RSPO2 and/or RSPO3 is capable of rescuing the inhibitory effects of @CHEMICAL$ on canonical @GENE$ signaling and prostatic bud formation.",
        "relation": "CPR:4"
    },
    {
        "id": "23429912.T5.T28",
        "sentence": "We discovered that each RSPO alone or in combination partially rescues @CHEMICAL$ inhibition of both canonical @GENE$ signaling and prostatic bud formation.",
        "relation": "CPR:4"
    },
    {
        "id": "23446230.T2.T10",
        "sentence": "@CHEMICAL$ (CYP2J2) metabolizes arachidonic acids to form epoxyeicosatrienoic acids (@GENE$), which possess various beneficial effects on the cardiovascular system.",
        "relation": "CPR:9"
    },
    {
        "id": "23446230.T2.T17",
        "sentence": "Cytochrome P450 epoxygenase 2J2 (@CHEMICAL$) metabolizes arachidonic acids to form epoxyeicosatrienoic acids (@GENE$), which possess various beneficial effects on the cardiovascular system.",
        "relation": "CPR:9"
    },
    {
        "id": "23446230.T5.T10",
        "sentence": "@CHEMICAL$ (CYP2J2) metabolizes @GENE$ to form epoxyeicosatrienoic acids (EETs), which possess various beneficial effects on the cardiovascular system.",
        "relation": "CPR:9"
    },
    {
        "id": "23446230.T5.T17",
        "sentence": "Cytochrome P450 epoxygenase 2J2 (@CHEMICAL$) metabolizes @GENE$ to form epoxyeicosatrienoic acids (EETs), which possess various beneficial effects on the cardiovascular system.",
        "relation": "CPR:9"
    },
    {
        "id": "23446230.T7.T10",
        "sentence": "@CHEMICAL$ (CYP2J2) metabolizes arachidonic acids to form @GENE$ (EETs), which possess various beneficial effects on the cardiovascular system.",
        "relation": "CPR:9"
    },
    {
        "id": "23446230.T7.T17",
        "sentence": "Cytochrome P450 epoxygenase 2J2 (@CHEMICAL$) metabolizes arachidonic acids to form @GENE$ (EETs), which possess various beneficial effects on the cardiovascular system.",
        "relation": "CPR:9"
    },
    {
        "id": "23446230.T4.T16",
        "sentence": "However, whether increasing @CHEMICAL$ production by @GENE$ overexpression in vivo could prevent abdominal aortic aneurysm (AAA) remains unknown.",
        "relation": "CPR:9"
    },
    {
        "id": "23446230.T8.T27",
        "sentence": "In cultured vascular smooth muscle cells (VSMCs), rAAV-mediated CYP2J2 overexpression and @CHEMICAL$ markedly suppressed Ang II-induced inflammatory @GENE$ expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23446230.T8.T26",
        "sentence": "In cultured vascular smooth muscle cells (VSMCs), rAAV-mediated CYP2J2 overexpression and @CHEMICAL$ markedly suppressed @GENE$-induced inflammatory cytokine expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23446230.T1.T12",
        "sentence": "Moreover, overexpressed CYP2J2 and @CHEMICAL$ inhibited @GENE$-induced macrophage migration in a VSMC-macrophage coculture system.",
        "relation": "CPR:4"
    },
    {
        "id": "23536521.T13.T22",
        "sentence": "A decrease in @CHEMICAL$ activity was observed when the slices were exposed to @GENE$ at the concentrations of 1, 10 and 30 mM. The same compound showed higher scavenger capacity of NO than the inorganic compound.",
        "relation": "CPR:4"
    },
    {
        "id": "23293129.T6.T12",
        "sentence": "Cotreatments of 5, 10 and 20 mg/mL concentrations of MEP with @CHEMICAL$ decreased the frequencies of SCE and the malondialdehyde level and increased amount of @GENE$, glutathione and glutathione peroxidase which were decreased by aflatoxin.",
        "relation": "CPR:3"
    },
    {
        "id": "23293129.T11.T13",
        "sentence": "Cotreatments of 5, 10 and 20 mg/mL concentrations of MEP with aflatoxin B(1) decreased the frequencies of SCE and the malondialdehyde level and increased amount of superoxide dismutase, glutathione and @CHEMICAL$ which were decreased by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23528251.T4.T20",
        "sentence": "@CHEMICAL$ (PB), a typical @GENE$ activator, increased the gene expression of HIF-target genes in the livers of mice, including erythropoietin, heme oxygenase-1 and vascular endothelial growth factor-a.",
        "relation": "CPR:3"
    },
    {
        "id": "23528251.T4.T22",
        "sentence": "@CHEMICAL$ (PB), a typical CAR activator, increased the gene expression of HIF-target genes in the livers of mice, including @GENE$, heme oxygenase-1 and vascular endothelial growth factor-a.",
        "relation": "CPR:3"
    },
    {
        "id": "23528251.T4.T23",
        "sentence": "@CHEMICAL$ (PB), a typical CAR activator, increased the gene expression of HIF-target genes in the livers of mice, including erythropoietin, @GENE$ and vascular endothelial growth factor-a.",
        "relation": "CPR:3"
    },
    {
        "id": "23528251.T4.T24",
        "sentence": "@CHEMICAL$ (PB), a typical CAR activator, increased the gene expression of HIF-target genes in the livers of mice, including erythropoietin, heme oxygenase-1 and @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23528251.T5.T27",
        "sentence": "@CHEMICAL$, a typical @GENE$ activator, induced the gene expression of CAR-target genes, including cyp2b9 and cyp2b10, an accumulation of nuclear CAR and an increase in the PB-responsive enhancer module-mediated transactivation in the mouse liver.",
        "relation": "CPR:3"
    },
    {
        "id": "23528251.T5.T29",
        "sentence": "@CHEMICAL$, a typical HIF activator, induced the gene expression of CAR-target genes, including @GENE$ and cyp2b10, an accumulation of nuclear CAR and an increase in the PB-responsive enhancer module-mediated transactivation in the mouse liver.",
        "relation": "CPR:3"
    },
    {
        "id": "23528251.T5.T30",
        "sentence": "@CHEMICAL$, a typical HIF activator, induced the gene expression of CAR-target genes, including cyp2b9 and @GENE$, an accumulation of nuclear CAR and an increase in the PB-responsive enhancer module-mediated transactivation in the mouse liver.",
        "relation": "CPR:3"
    },
    {
        "id": "12671891.T1.T21",
        "sentence": "BACKGROUND & AIMS: Of the 2 genes (MAT1A, MAT2A) encoding @CHEMICAL$, the enzyme that synthesizes @GENE$, MAT1A, is expressed in liver, whereas MAT2A is expressed in extrahepatic tissues.",
        "relation": "CPR:9"
    },
    {
        "id": "12671891.T1.T12",
        "sentence": "BACKGROUND & AIMS: Of the 2 genes (MAT1A, MAT2A) encoding methionine adenosyltransferase, the enzyme that synthesizes @CHEMICAL$, @GENE$, is expressed in liver, whereas MAT2A is expressed in extrahepatic tissues.",
        "relation": "CPR:9"
    },
    {
        "id": "12671891.T1.T17",
        "sentence": "BACKGROUND & AIMS: Of the 2 genes (@CHEMICAL$, MAT2A) encoding methionine adenosyltransferase, the enzyme that synthesizes @GENE$, MAT1A, is expressed in liver, whereas MAT2A is expressed in extrahepatic tissues.",
        "relation": "CPR:9"
    },
    {
        "id": "12671891.T1.T18",
        "sentence": "BACKGROUND & AIMS: Of the 2 genes (MAT1A, @CHEMICAL$) encoding methionine adenosyltransferase, the enzyme that synthesizes @GENE$, MAT1A, is expressed in liver, whereas MAT2A is expressed in extrahepatic tissues.",
        "relation": "CPR:9"
    },
    {
        "id": "12671891.T7.T19",
        "sentence": "The beta subunit has been cloned and shown to lower the K(m) of @CHEMICAL$ (the MAT2A product) for @GENE$ and to render the enzyme more susceptible to S-adenosylmethionine inhibition.",
        "relation": "CPR:9"
    },
    {
        "id": "12671891.T7.T20",
        "sentence": "The beta subunit has been cloned and shown to lower the K(m) of methionine adenosyltransferase II alpha2 (the @CHEMICAL$ product) for @GENE$ and to render the enzyme more susceptible to S-adenosylmethionine inhibition.",
        "relation": "CPR:9"
    },
    {
        "id": "12671891.T9.T19",
        "sentence": "The beta subunit has been cloned and shown to lower the K(m) of @CHEMICAL$ (the MAT2A product) for methionine and to render the enzyme more susceptible to @GENE$ inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "12671891.T9.T20",
        "sentence": "The beta subunit has been cloned and shown to lower the K(m) of methionine adenosyltransferase II alpha2 (the @CHEMICAL$ product) for methionine and to render the enzyme more susceptible to @GENE$ inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "8636122.T14.T30",
        "sentence": "Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific @CHEMICAL$ antagonist @GENE$. The antagonist SR 141716A has a high specificity for the central CB1 cannabinoid receptor and negligeable affinity for the peripheral CB2 receptor, making it an excellent tool for probing receptor structure-activity relationships.",
        "relation": "CPR:6"
    },
    {
        "id": "7885191.T12.T52",
        "sentence": "The channel activators @CHEMICAL$ and moxidectin usually retain their inhibitory potency in the @GENE$ subunit mutants.",
        "relation": "CPR:4"
    },
    {
        "id": "7885191.T13.T52",
        "sentence": "The channel activators avermectin and @CHEMICAL$ usually retain their inhibitory potency in the @GENE$ subunit mutants.",
        "relation": "CPR:4"
    },
    {
        "id": "15120421.T14.T45",
        "sentence": "At 10(-6)M in transcription assays, none of these compounds showed progestin agonist activity, whereas @CHEMICAL$ and its monodemethylated metabolite manifested slight @GENE$ agonist activity.",
        "relation": "CPR:5"
    },
    {
        "id": "10891536.T1.T51",
        "sentence": "Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. @CHEMICAL$ (5-FU), 5-fluoro-2'-deoxyuridine (FdUrd) and 5-trifluorothymidine (F3(d)Thd) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of @GENE$ (TS).",
        "relation": "CPR:4"
    },
    {
        "id": "10891536.T1.T52",
        "sentence": "Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. @CHEMICAL$ (5-FU), 5-fluoro-2'-deoxyuridine (FdUrd) and 5-trifluorothymidine (F3(d)Thd) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of thymidylate synthase (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "10891536.T16.T51",
        "sentence": "Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. 5-Fluorouracil (@CHEMICAL$), 5-fluoro-2'-deoxyuridine (FdUrd) and 5-trifluorothymidine (F3(d)Thd) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of @GENE$ (TS).",
        "relation": "CPR:4"
    },
    {
        "id": "10891536.T16.T52",
        "sentence": "Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. 5-Fluorouracil (@CHEMICAL$), 5-fluoro-2'-deoxyuridine (FdUrd) and 5-trifluorothymidine (F3(d)Thd) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of thymidylate synthase (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "10891536.T27.T51",
        "sentence": "Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. 5-Fluorouracil (5-FU), @CHEMICAL$ (FdUrd) and 5-trifluorothymidine (F3(d)Thd) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of @GENE$ (TS).",
        "relation": "CPR:4"
    },
    {
        "id": "10891536.T27.T52",
        "sentence": "Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. 5-Fluorouracil (5-FU), @CHEMICAL$ (FdUrd) and 5-trifluorothymidine (F3(d)Thd) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of thymidylate synthase (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "10891536.T29.T51",
        "sentence": "Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. 5-Fluorouracil (5-FU), 5-fluoro-2'-deoxyuridine (@CHEMICAL$) and 5-trifluorothymidine (F3(d)Thd) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of @GENE$ (TS).",
        "relation": "CPR:4"
    },
    {
        "id": "10891536.T29.T52",
        "sentence": "Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. 5-Fluorouracil (5-FU), 5-fluoro-2'-deoxyuridine (@CHEMICAL$) and 5-trifluorothymidine (F3(d)Thd) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of thymidylate synthase (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "10891536.T30.T51",
        "sentence": "Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. 5-Fluorouracil (5-FU), 5-fluoro-2'-deoxyuridine (FdUrd) and @CHEMICAL$ (F3(d)Thd) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of @GENE$ (TS).",
        "relation": "CPR:4"
    },
    {
        "id": "10891536.T30.T52",
        "sentence": "Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. 5-Fluorouracil (5-FU), 5-fluoro-2'-deoxyuridine (FdUrd) and @CHEMICAL$ (F3(d)Thd) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of thymidylate synthase (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "10891536.T37.T51",
        "sentence": "Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. 5-Fluorouracil (5-FU), 5-fluoro-2'-deoxyuridine (FdUrd) and 5-trifluorothymidine (@CHEMICAL$) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of @GENE$ (TS).",
        "relation": "CPR:4"
    },
    {
        "id": "10891536.T37.T52",
        "sentence": "Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. 5-Fluorouracil (5-FU), 5-fluoro-2'-deoxyuridine (FdUrd) and 5-trifluorothymidine (@CHEMICAL$) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of thymidylate synthase (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "10891536.T20.T47",
        "sentence": "When DLD-1/FdUrd cells expressing increased TS mRNA were treated with FdUrd and F3(d)Thd for only 4 h, the resistance ratios of DLD-1/FdUrd cells to parental DLD-1 cells were markedly different for FdUrd and F3(d)Thd, suggesting that the cytotoxicity with short-time exposure to @CHEMICAL$ is due to a mechanism other than @GENE$ inhibition, although the cytotoxicity of F3(d)Thd in the short-time is low compared to that of long-time exposure.",
        "relation": "CPR:4"
    },
    {
        "id": "10891536.T22.T48",
        "sentence": "In conclusion, @CHEMICAL$, an antimetabolite that inhibits @GENE$ activity, may be effective against 5-FU and/or FdUrd-resistance in colorectal cancer cells caused by amplification of TS and/or deletion of orotate phosphoribosyltransferase.",
        "relation": "CPR:4"
    },
    {
        "id": "1332478.T7.T13",
        "sentence": "The failure of the myometrium to respond to @CHEMICAL$ (desensitization) was associated with significant reductions in agonist-induced cyclic adenosine monophosphate production and @GENE$ concentration in myometrial tissue collected from these animals compared with the saline solution-treated controls.",
        "relation": "CPR:4"
    },
    {
        "id": "23116965.T21.T25",
        "sentence": "Antiarrhythmic effects of @CHEMICAL$, a novel @GENE$ agonist in cultured neonatal rat ventricular myocytes. (-)-Epicatechin-3-gallate (ECG), a polyphenol extracted from green tea, has been proposed as an effective compound for improving cardiac contractility.",
        "relation": "CPR:5"
    },
    {
        "id": "16920841.T2.T31",
        "sentence": "Choline dehydrogenase (CHDH) and @CHEMICAL$ (BHMT) are 2 enzymes involved in @GENE$ oxidation.",
        "relation": "CPR:9"
    },
    {
        "id": "16920841.T2.T34",
        "sentence": "Choline dehydrogenase (CHDH) and betaine-homocysteine methyltransferase (@CHEMICAL$) are 2 enzymes involved in @GENE$ oxidation.",
        "relation": "CPR:9"
    },
    {
        "id": "16920841.T2.T24",
        "sentence": "@CHEMICAL$ (CHDH) and betaine-homocysteine methyltransferase (BHMT) are 2 enzymes involved in @GENE$ oxidation.",
        "relation": "CPR:9"
    },
    {
        "id": "16920841.T2.T30",
        "sentence": "Choline dehydrogenase (@CHEMICAL$) and betaine-homocysteine methyltransferase (BHMT) are 2 enzymes involved in @GENE$ oxidation.",
        "relation": "CPR:9"
    },
    {
        "id": "16920841.T18.T37",
        "sentence": "Liver @CHEMICAL$ activity was 1.3-fold higher in rats fed the Met deficient diet containing @GENE$, which was reflected in corresponding increases in mRNA content and immunodetectable protein.",
        "relation": "CPR:3"
    },
    {
        "id": "16920841.T3.T25",
        "sentence": "Independent of dietary @CHEMICAL$, supplemental Met increased hepatic @GENE$ activity approximately 30%.",
        "relation": "CPR:3"
    },
    {
        "id": "16920841.T4.T25",
        "sentence": "Independent of dietary choline, supplemental @CHEMICAL$ increased hepatic @GENE$ activity approximately 30%.",
        "relation": "CPR:3"
    },
    {
        "id": "23418087.T21.T25",
        "sentence": "The @CHEMICAL$ homeostasis proteins sarcoendoplasmic reticulum ATPase 2a (SERCA2a), sodium calcium exchanger-1, phospholamban (@GENE$), phospho-PLB, and calsequestrin 2 are important for contraction and relaxation.",
        "relation": "CPR:9"
    },
    {
        "id": "23418087.T21.T26",
        "sentence": "The @CHEMICAL$ homeostasis proteins sarcoendoplasmic reticulum ATPase 2a (SERCA2a), sodium calcium exchanger-1, phospholamban (PLB), @GENE$, and calsequestrin 2 are important for contraction and relaxation.",
        "relation": "CPR:9"
    },
    {
        "id": "23418087.T21.T27",
        "sentence": "The @CHEMICAL$ homeostasis proteins sarcoendoplasmic reticulum ATPase 2a (SERCA2a), sodium calcium exchanger-1, phospholamban (PLB), phospho-PLB, and @GENE$ are important for contraction and relaxation.",
        "relation": "CPR:9"
    },
    {
        "id": "23418087.T21.T30",
        "sentence": "The @CHEMICAL$ homeostasis proteins @GENE$ (SERCA2a), sodium calcium exchanger-1, phospholamban (PLB), phospho-PLB, and calsequestrin 2 are important for contraction and relaxation.",
        "relation": "CPR:9"
    },
    {
        "id": "23418087.T21.T31",
        "sentence": "The @CHEMICAL$ homeostasis proteins sarcoendoplasmic reticulum ATPase 2a (@GENE$), sodium calcium exchanger-1, phospholamban (PLB), phospho-PLB, and calsequestrin 2 are important for contraction and relaxation.",
        "relation": "CPR:9"
    },
    {
        "id": "23418087.T21.T32",
        "sentence": "The @CHEMICAL$ homeostasis proteins sarcoendoplasmic reticulum ATPase 2a (SERCA2a), @GENE$, phospholamban (PLB), phospho-PLB, and calsequestrin 2 are important for contraction and relaxation.",
        "relation": "CPR:9"
    },
    {
        "id": "23418087.T21.T33",
        "sentence": "The @CHEMICAL$ homeostasis proteins sarcoendoplasmic reticulum ATPase 2a (SERCA2a), sodium calcium exchanger-1, @GENE$ (PLB), phospho-PLB, and calsequestrin 2 are important for contraction and relaxation.",
        "relation": "CPR:9"
    },
    {
        "id": "23418087.T6.T28",
        "sentence": "@CHEMICAL$ expression was increased in all @GENE$ males and BPA 0.5 females and reduced in BPA 200 females.",
        "relation": "CPR:3"
    },
    {
        "id": "23418087.T8.T28",
        "sentence": "@CHEMICAL$ expression was increased in all BPA males and @GENE$ 0.5 females and reduced in BPA 200 females.",
        "relation": "CPR:3"
    },
    {
        "id": "23418087.T9.T28",
        "sentence": "@CHEMICAL$ expression was increased in all BPA males and BPA 0.5 females and reduced in @GENE$ 200 females.",
        "relation": "CPR:4"
    },
    {
        "id": "23000445.T7.T24",
        "sentence": "The results showed that @CHEMICAL$ promotes the expression of @GENE$ and Beclin-1.",
        "relation": "CPR:3"
    },
    {
        "id": "23000445.T7.T25",
        "sentence": "The results showed that @CHEMICAL$ promotes the expression of LC3-II and @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23000445.T10.T13",
        "sentence": "@CHEMICAL$ also suppressed the activation of mammalian target of rapamycin (mTOR) and @GENE$ (p70S6K) by regulating the expression of the extracellular signal-regulated kinase (ERK1/2) and p38 involved mitogen-activated protein kinase (MAPK) signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23000445.T10.T14",
        "sentence": "@CHEMICAL$ also suppressed the activation of mammalian target of rapamycin (mTOR) and p70-S6 kinase (@GENE$ by regulating the expression of the extracellular signal-regulated kinase (ERK1/2) and p38 involved mitogen-activated protein kinase (MAPK) signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23000445.T10.T26",
        "sentence": "@CHEMICAL$ also suppressed the activation of @GENE$ (mTOR) and p70-S6 kinase (p70S6K) by regulating the expression of the extracellular signal-regulated kinase (ERK1/2) and p38 involved mitogen-activated protein kinase (MAPK) signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23000445.T10.T27",
        "sentence": "@CHEMICAL$ also suppressed the activation of mammalian target of rapamycin (@GENE$) and p70-S6 kinase (p70S6K) by regulating the expression of the extracellular signal-regulated kinase (ERK1/2) and p38 involved mitogen-activated protein kinase (MAPK) signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23125284.T1.T17",
        "sentence": "The @CHEMICAL$ (cytochrome c oxidase) is a multi-subunit enzyme that transfers electrons from cytochrome c to molecular @GENE$, yielding water.",
        "relation": "CPR:9"
    },
    {
        "id": "23125284.T1.T19",
        "sentence": "The mitochondrial respiratory chain complex IV (@CHEMICAL$) is a multi-subunit enzyme that transfers electrons from cytochrome c to molecular @GENE$, yielding water.",
        "relation": "CPR:9"
    },
    {
        "id": "23419638.T22.T40",
        "sentence": "@CHEMICAL$ activates the @GENE$ and induces CYP1A1 in primary human hepatocytes and human cancer cell lines HepG2 and LS174T. We examined the effects of anthocyanidins (cyanidin, delphinidin, malvidin, peonidin, petunidin, pelargonidin) on the aryl hydrocarbon receptor (AhR)-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23419638.T9.T32",
        "sentence": "@CHEMICAL$-dependent reporter gene expression in transfected HepG2 cells was increased by @GENE$ in a concentration-dependent manner at 24h.",
        "relation": "CPR:3"
    },
    {
        "id": "23419638.T10.T33",
        "sentence": "Similarly, @CHEMICAL$ induced the expression of @GENE$ mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR. CYP1A1 and CYP1A2 mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures (approximately 5% of TCDD potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme.",
        "relation": "CPR:3"
    },
    {
        "id": "23419638.T12.T33",
        "sentence": "Similarly, pelargonidin induced the expression of @CHEMICAL$ mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM @GENE$ (TCDD), the most potent activator of AhR. CYP1A1 and CYP1A2 mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures (approximately 5% of TCDD potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme.",
        "relation": "CPR:3"
    },
    {
        "id": "23419638.T12.T34",
        "sentence": "Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM @CHEMICAL$ (TCDD), the most potent activator of @GENE$. CYP1A1 and CYP1A2 mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures (approximately 5% of TCDD potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme.",
        "relation": "CPR:3"
    },
    {
        "id": "23419638.T14.T33",
        "sentence": "Similarly, pelargonidin induced the expression of @CHEMICAL$ mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (@GENE$), the most potent activator of AhR. CYP1A1 and CYP1A2 mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures (approximately 5% of TCDD potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme.",
        "relation": "CPR:3"
    },
    {
        "id": "23419638.T14.T34",
        "sentence": "Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (@CHEMICAL$), the most potent activator of @GENE$. CYP1A1 and CYP1A2 mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures (approximately 5% of TCDD potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme.",
        "relation": "CPR:3"
    },
    {
        "id": "23419638.T15.T35",
        "sentence": "Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR. @CHEMICAL$ and CYP1A2 mRNAs were also increased by @GENE$ in three primary human hepatocytes cultures (approximately 5% of TCDD potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme.",
        "relation": "CPR:3"
    },
    {
        "id": "23419638.T15.T36",
        "sentence": "Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR. CYP1A1 and @CHEMICAL$ mRNAs were also increased by @GENE$ in three primary human hepatocytes cultures (approximately 5% of TCDD potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme.",
        "relation": "CPR:3"
    },
    {
        "id": "23419638.T15.T37",
        "sentence": "Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR. CYP1A1 and CYP1A2 mRNAs were also increased by @CHEMICAL$ in three primary human hepatocytes cultures (approximately 5% of TCDD potency) and the increase in @GENE$ protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme.",
        "relation": "CPR:3"
    },
    {
        "id": "23419638.T15.T38",
        "sentence": "Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR. CYP1A1 and CYP1A2 mRNAs were also increased by @CHEMICAL$ in three primary human hepatocytes cultures (approximately 5% of TCDD potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of @GENE$ enzyme.",
        "relation": "CPR:3"
    },
    {
        "id": "23419638.T17.T35",
        "sentence": "Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR. @CHEMICAL$ and CYP1A2 mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures (approximately 5% of @GENE$ potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme.",
        "relation": "CPR:3"
    },
    {
        "id": "23419638.T17.T36",
        "sentence": "Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR. CYP1A1 and @CHEMICAL$ mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures (approximately 5% of @GENE$ potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme.",
        "relation": "CPR:3"
    },
    {
        "id": "23419638.T17.T37",
        "sentence": "Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR. CYP1A1 and CYP1A2 mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures (approximately 5% of @CHEMICAL$ potency) and the increase in @GENE$ protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme.",
        "relation": "CPR:3"
    },
    {
        "id": "23419638.T17.T38",
        "sentence": "Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR. CYP1A1 and CYP1A2 mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures (approximately 5% of @CHEMICAL$ potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of @GENE$ enzyme.",
        "relation": "CPR:3"
    },
    {
        "id": "23419638.T1.T23",
        "sentence": "Ligand binding analysis demonstrated that pelargonidin was a weak ligand of AhR. Enzyme kinetic analyses using human liver microsomes revealed inhibition of @CHEMICAL$ activity by @GENE$ (IC50 78 mM) and pelargonidin (IC50 33 mM).",
        "relation": "CPR:4"
    },
    {
        "id": "23419638.T2.T23",
        "sentence": "Ligand binding analysis demonstrated that pelargonidin was a weak ligand of AhR. Enzyme kinetic analyses using human liver microsomes revealed inhibition of @CHEMICAL$ activity by delphinidin (IC50 78 mM) and @GENE$ (IC50 33 mM).",
        "relation": "CPR:4"
    },
    {
        "id": "23419638.T4.T27",
        "sentence": "Overall, although most anthocyanidins had no effects on AhR-CYP1A1 signaling, @CHEMICAL$ can bind to and activate the @GENE$ and AhR-dependent gene expression, and pelargonidin and delphinidin inhibit the CYP1A1 catalytic activity.",
        "relation": "CPR:3"
    },
    {
        "id": "23419638.T6.T29",
        "sentence": "Overall, although most anthocyanidins had no effects on AhR-CYP1A1 signaling, pelargonidin can bind to and activate the AhR and AhR-dependent gene expression, and @CHEMICAL$ and delphinidin inhibit the @GENE$ catalytic activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23419638.T7.T29",
        "sentence": "Overall, although most anthocyanidins had no effects on AhR-CYP1A1 signaling, pelargonidin can bind to and activate the AhR and AhR-dependent gene expression, and pelargonidin and @CHEMICAL$ inhibit the @GENE$ catalytic activity.",
        "relation": "CPR:4"
    },
    {
        "id": "7680751.T9.T23",
        "sentence": "In HEK-293 cells stably transfected with this receptor, @CHEMICAL$ elicits a potent stimulation of @GENE$ activity, which is blocked by antipsychotic and antidepressant drugs.",
        "relation": "CPR:3"
    },
    {
        "id": "23489521.T1.T2",
        "sentence": "A head-to-head comparison between insulin detemir and NPH insulin in women with type 1 diabetes showed that while foetal outcomes did not differ, fasting plasma @CHEMICAL$ improved with @GENE$ detemir without an increased incidence of hypoglycaemia.",
        "relation": "CPR:3"
    },
    {
        "id": "17284757.T9.T21",
        "sentence": "BACKGROUND: Delta(6)-Desaturase (FADS2) is the rate-limiting step in the polyunsaturated fatty acid (PUFA) biosynthetic pathway. OBJECTIVE: The aim was to test whether the common deletion [T/-] in the promoter of @CHEMICAL$ affects the @GENE$ biosynthetic pathway and consequently modifies the effect of alpha-linolenic acid (ALA) on myocardial infarction (MI).",
        "relation": "CPR:9"
    },
    {
        "id": "17284757.T10.T21",
        "sentence": "BACKGROUND: Delta(6)-Desaturase (FADS2) is the rate-limiting step in the polyunsaturated fatty acid (PUFA) biosynthetic pathway. OBJECTIVE: The aim was to test whether the common deletion [T/-] in the promoter of @CHEMICAL$ affects the PUFA biosynthetic pathway and consequently modifies the effect of @GENE$ (ALA) on myocardial infarction (MI).",
        "relation": "CPR:9"
    },
    {
        "id": "17284757.T11.T21",
        "sentence": "BACKGROUND: Delta(6)-Desaturase (FADS2) is the rate-limiting step in the polyunsaturated fatty acid (PUFA) biosynthetic pathway. OBJECTIVE: The aim was to test whether the common deletion [T/-] in the promoter of @CHEMICAL$ affects the PUFA biosynthetic pathway and consequently modifies the effect of alpha-linolenic acid (@GENE$) on myocardial infarction (MI).",
        "relation": "CPR:9"
    },
    {
        "id": "10398211.T12.T21",
        "sentence": "We evaluated the effects of @CHEMICAL$ and an angiotensin-converting enzyme inhibitor (@GENE$) on nerve blood flow (NBF) and electrophysiology in control and diabetic rats.",
        "relation": "CPR:4"
    },
    {
        "id": "10398211.T12.T23",
        "sentence": "We evaluated the effects of angiotensin II and an @CHEMICAL$ inhibitor (@GENE$) on nerve blood flow (NBF) and electrophysiology in control and diabetic rats.",
        "relation": "CPR:4"
    },
    {
        "id": "10398211.T1.T16",
        "sentence": "We topically applied the nitric oxide synthase (@CHEMICAL$) inhibitor, @GENE$, on sciatic nerve and observed reduced inhibition of NBF in EDN, which was correctable with a cilazapril diet.",
        "relation": "CPR:4"
    },
    {
        "id": "10398211.T1.T24",
        "sentence": "We topically applied the @CHEMICAL$ (NOS) inhibitor, @GENE$, on sciatic nerve and observed reduced inhibition of NBF in EDN, which was correctable with a cilazapril diet.",
        "relation": "CPR:4"
    },
    {
        "id": "23376140.T3.T17",
        "sentence": "@CHEMICAL$ activates @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23376140.T9.T26",
        "sentence": "However, after 12h @CHEMICAL$ treatment, cell viability diminished in 50%, accompanied by a drastic decrease of @GENE$ production, and an increase in p53 activation and the pro-apoptotic protein Bax.",
        "relation": "CPR:4"
    },
    {
        "id": "23376140.T9.T27",
        "sentence": "However, after 12h @CHEMICAL$ treatment, cell viability diminished in 50%, accompanied by a drastic decrease of metallothionein-II production, and an increase in @GENE$ activation and the pro-apoptotic protein Bax.",
        "relation": "CPR:3"
    },
    {
        "id": "23376140.T9.T28",
        "sentence": "However, after 12h @CHEMICAL$ treatment, cell viability diminished in 50%, accompanied by a drastic decrease of metallothionein-II production, and an increase in p53 activation and the pro-apoptotic protein @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "14642426.T12.T20",
        "sentence": "The inhibitory effect of @CHEMICAL$ on the stress-induced plasma @GENE$ level in mice.",
        "relation": "CPR:4"
    },
    {
        "id": "14642426.T2.T13",
        "sentence": "Ginseng total @CHEMICAL$, ginsenosides Rb2, Rg1 and Rd administered intraperitoneally attenuated the immobilization stress-induced increase in plasma @GENE$ level.",
        "relation": "CPR:4"
    },
    {
        "id": "14642426.T3.T13",
        "sentence": "Ginseng total saponins, @CHEMICAL$ administered intraperitoneally attenuated the immobilization stress-induced increase in plasma @GENE$ level.",
        "relation": "CPR:4"
    },
    {
        "id": "14642426.T5.T16",
        "sentence": "@CHEMICAL$ significantly decreased norepinephrine and/or epinephrine-induced increase of @GENE$ level in macrophage cell line (RAW 264.7).",
        "relation": "CPR:4"
    },
    {
        "id": "14642426.T6.T16",
        "sentence": "Ginsenosides Rb2, Rd and Rg1 significantly decreased @CHEMICAL$ and/or epinephrine-induced increase of @GENE$ level in macrophage cell line (RAW 264.7).",
        "relation": "CPR:3"
    },
    {
        "id": "14642426.T7.T16",
        "sentence": "Ginsenosides Rb2, Rd and Rg1 significantly decreased norepinephrine and/or @CHEMICAL$-induced increase of @GENE$ level in macrophage cell line (RAW 264.7).",
        "relation": "CPR:3"
    },
    {
        "id": "14642426.T8.T18",
        "sentence": "Thus, it can be suggested that the inhibitory action of @CHEMICAL$ against the immobilization stress-induced increase of plasma @GENE$ level would be in periphery; at least in part, mediated by blocking norepinephrine- and/or epinephrine-induced increase of IL-6 level in macrophage rather than in the brain.",
        "relation": "CPR:4"
    },
    {
        "id": "14642426.T8.T19",
        "sentence": "Thus, it can be suggested that the inhibitory action of @CHEMICAL$ against the immobilization stress-induced increase of plasma IL-6 level would be in periphery; at least in part, mediated by blocking norepinephrine- and/or epinephrine-induced increase of @GENE$ level in macrophage rather than in the brain.",
        "relation": "CPR:4"
    },
    {
        "id": "14642426.T9.T19",
        "sentence": "Thus, it can be suggested that the inhibitory action of ginseng saponins against the immobilization stress-induced increase of plasma IL-6 level would be in periphery; at least in part, mediated by blocking @CHEMICAL$- and/or epinephrine-induced increase of @GENE$ level in macrophage rather than in the brain.",
        "relation": "CPR:3"
    },
    {
        "id": "14642426.T10.T19",
        "sentence": "Thus, it can be suggested that the inhibitory action of ginseng saponins against the immobilization stress-induced increase of plasma IL-6 level would be in periphery; at least in part, mediated by blocking norepinephrine- and/or @CHEMICAL$-induced increase of @GENE$ level in macrophage rather than in the brain.",
        "relation": "CPR:3"
    },
    {
        "id": "17352516.T1.T19",
        "sentence": "@CHEMICAL$, an oral dipeptidyl peptidase-4 (DPP-4) inhibitor, improves glycaemic control by inhibiting DPP-4 inactivation of the @GENE$ glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.",
        "relation": "CPR:3"
    },
    {
        "id": "17352516.T1.T18",
        "sentence": "@CHEMICAL$, an oral dipeptidyl peptidase-4 (DPP-4) inhibitor, improves glycaemic control by inhibiting @GENE$ inactivation of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.",
        "relation": "CPR:4"
    },
    {
        "id": "17352516.T1.T20",
        "sentence": "@CHEMICAL$, an oral dipeptidyl peptidase-4 (DPP-4) inhibitor, improves glycaemic control by inhibiting DPP-4 inactivation of the incretin hormones @GENE$ and glucose-dependent insulinotropic polypeptide.",
        "relation": "CPR:3"
    },
    {
        "id": "17352516.T1.T21",
        "sentence": "@CHEMICAL$, an oral dipeptidyl peptidase-4 (DPP-4) inhibitor, improves glycaemic control by inhibiting DPP-4 inactivation of the incretin hormones glucagon-like peptide-1 and @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "17352516.T1.T22",
        "sentence": "@CHEMICAL$, an oral @GENE$ (DPP-4) inhibitor, improves glycaemic control by inhibiting DPP-4 inactivation of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.",
        "relation": "CPR:4"
    },
    {
        "id": "17352516.T1.T26",
        "sentence": "@CHEMICAL$, an oral dipeptidyl peptidase-4 (@GENE$) inhibitor, improves glycaemic control by inhibiting DPP-4 inactivation of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.",
        "relation": "CPR:4"
    },
    {
        "id": "17352516.T15.T28",
        "sentence": "Improvements from baseline in mean @CHEMICAL$ (HbA(1c)) were significantly greater with @GENE$ monotherapy than with placebo in patients with type 2 diabetes.",
        "relation": "CPR:3"
    },
    {
        "id": "17352516.T15.T29",
        "sentence": "Improvements from baseline in mean glycosylated haemoglobin (@CHEMICAL$) were significantly greater with @GENE$ monotherapy than with placebo in patients with type 2 diabetes.",
        "relation": "CPR:3"
    },
    {
        "id": "17352516.T2.T30",
        "sentence": "As add-on therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment, sitagliptin improved @CHEMICAL$ to a significantly greater extent than placebo when added to @GENE$ or pioglitazone and was noninferior to glipizide when added to metformin.",
        "relation": "CPR:3"
    },
    {
        "id": "17352516.T3.T30",
        "sentence": "As add-on therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment, sitagliptin improved @CHEMICAL$ to a significantly greater extent than placebo when added to metformin or @GENE$ and was noninferior to glipizide when added to metformin.",
        "relation": "CPR:3"
    },
    {
        "id": "17352516.T5.T30",
        "sentence": "As add-on therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment, sitagliptin improved @CHEMICAL$ to a significantly greater extent than placebo when added to metformin or pioglitazone and was noninferior to glipizide when added to @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17352516.T16.T30",
        "sentence": "As add-on therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment, @CHEMICAL$ improved @GENE$ to a significantly greater extent than placebo when added to metformin or pioglitazone and was noninferior to glipizide when added to metformin.",
        "relation": "CPR:3"
    },
    {
        "id": "23643883.T2.T27",
        "sentence": "In addition, pretreatment with @CHEMICAL$ (Z-VAD-fmk), a broad spectrum of @GENE$ inhibitor, could not rescue apoptotic cells from ClpP toxicity.",
        "relation": "CPR:4"
    },
    {
        "id": "23643883.T3.T27",
        "sentence": "In addition, pretreatment with Z-Val-Ala-Asp-fluoromethylketone (@CHEMICAL$), a broad spectrum of @GENE$ inhibitor, could not rescue apoptotic cells from ClpP toxicity.",
        "relation": "CPR:4"
    },
    {
        "id": "10095983.T7.T10",
        "sentence": "@CHEMICAL$ is a new inhibitor of @GENE$ enzyme.",
        "relation": "CPR:4"
    },
    {
        "id": "10095983.T1.T8",
        "sentence": "In the long term, @CHEMICAL$ has been shown to be more effective than placebo in reducing body weight and serum total and @GENE$ cholesterol levels.",
        "relation": "CPR:4"
    },
    {
        "id": "23435915.T4.T27",
        "sentence": "@CHEMICAL$ decreased myosin light chain kinase (MLCK) protein contents and MLCK mRNA expression in IJS, and inhibited both phosphorylation and Mg(2+)-@GENE$ activity of purified myosin, implicating that the decrease of MLCK contents and inhibition of MLCK activity are involved in the genistin-induced inhibitory effects.",
        "relation": "CPR:4"
    },
    {
        "id": "23435915.T4.T24",
        "sentence": "@CHEMICAL$ decreased @GENE$ (MLCK) protein contents and MLCK mRNA expression in IJS, and inhibited both phosphorylation and Mg(2+)-ATPase activity of purified myosin, implicating that the decrease of MLCK contents and inhibition of MLCK activity are involved in the genistin-induced inhibitory effects.",
        "relation": "CPR:4"
    },
    {
        "id": "23435915.T4.T25",
        "sentence": "@CHEMICAL$ decreased myosin light chain kinase (@GENE$) protein contents and MLCK mRNA expression in IJS, and inhibited both phosphorylation and Mg(2+)-ATPase activity of purified myosin, implicating that the decrease of MLCK contents and inhibition of MLCK activity are involved in the genistin-induced inhibitory effects.",
        "relation": "CPR:4"
    },
    {
        "id": "23435915.T4.T26",
        "sentence": "@CHEMICAL$ decreased myosin light chain kinase (MLCK) protein contents and @GENE$ mRNA expression in IJS, and inhibited both phosphorylation and Mg(2+)-ATPase activity of purified myosin, implicating that the decrease of MLCK contents and inhibition of MLCK activity are involved in the genistin-induced inhibitory effects.",
        "relation": "CPR:4"
    },
    {
        "id": "23435915.T6.T28",
        "sentence": "Genistin decreased myosin light chain kinase (MLCK) protein contents and MLCK mRNA expression in IJS, and inhibited both phosphorylation and Mg(2+)-ATPase activity of purified myosin, implicating that the decrease of @CHEMICAL$ contents and inhibition of MLCK activity are involved in the @GENE$-induced inhibitory effects.",
        "relation": "CPR:4"
    },
    {
        "id": "23435915.T6.T29",
        "sentence": "Genistin decreased myosin light chain kinase (MLCK) protein contents and MLCK mRNA expression in IJS, and inhibited both phosphorylation and Mg(2+)-ATPase activity of purified myosin, implicating that the decrease of MLCK contents and inhibition of @CHEMICAL$ activity are involved in the @GENE$-induced inhibitory effects.",
        "relation": "CPR:4"
    },
    {
        "id": "23333261.T3.T16",
        "sentence": "It was found that expression of @CHEMICAL$ protein in cortical neurons was increased in @GENE$-induced diabetes mellitus rat model.",
        "relation": "CPR:3"
    },
    {
        "id": "23333261.T1.T6",
        "sentence": "Moreover, @CHEMICAL$ alleviated @GENE$ expression, and reversely raised Drebrin expression in neurons treated with hyperglycaemia.",
        "relation": "CPR:3"
    },
    {
        "id": "23333261.T1.T7",
        "sentence": "Moreover, @CHEMICAL$ alleviated Sim2 expression, and reversely raised @GENE$ expression in neurons treated with hyperglycaemia.",
        "relation": "CPR:3"
    },
    {
        "id": "20091113.T6.T9",
        "sentence": "Polymorphisms in @CHEMICAL$ (SLC6A3) are associated with stimulant effects of @GENE$: an exploratory pharmacogenetic study using healthy volunteers.",
        "relation": "CPR:3"
    },
    {
        "id": "20091113.T6.T10",
        "sentence": "Polymorphisms in dopamine transporter (@CHEMICAL$) are associated with stimulant effects of @GENE$: an exploratory pharmacogenetic study using healthy volunteers.",
        "relation": "CPR:3"
    },
    {
        "id": "23384446.T19.T38",
        "sentence": "Endothelium-dependent relaxations, nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF)-type, were studied in rabbit iliac artery and aortic rings using the @CHEMICAL$ agonist @GENE$ (ACh) and by cyclopiazonic acid (CPA), which promotes store-operated Ca(2+) entry by inhibiting the endothelial SERCA pump.",
        "relation": "CPR:5"
    },
    {
        "id": "23384446.T20.T38",
        "sentence": "Endothelium-dependent relaxations, nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF)-type, were studied in rabbit iliac artery and aortic rings using the @CHEMICAL$ agonist acetylcholine (@GENE$) and by cyclopiazonic acid (CPA), which promotes store-operated Ca(2+) entry by inhibiting the endothelial SERCA pump.",
        "relation": "CPR:5"
    },
    {
        "id": "23384446.T21.T39",
        "sentence": "Endothelium-dependent relaxations, nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF)-type, were studied in rabbit iliac artery and aortic rings using the G protein-coupled receptor agonist acetylcholine (ACh) and by @CHEMICAL$ (CPA), which promotes store-operated Ca(2+) entry by inhibiting the endothelial @GENE$ pump.",
        "relation": "CPR:4"
    },
    {
        "id": "23384446.T22.T39",
        "sentence": "Endothelium-dependent relaxations, nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF)-type, were studied in rabbit iliac artery and aortic rings using the G protein-coupled receptor agonist acetylcholine (ACh) and by cyclopiazonic acid (@CHEMICAL$), which promotes store-operated Ca(2+) entry by inhibiting the endothelial @GENE$ pump.",
        "relation": "CPR:4"
    },
    {
        "id": "23384446.T2.T35",
        "sentence": "Potentiation was prevented by catalase, the catalase/superoxide dismutase mimetic manganese porphyrin and the @CHEMICAL$ inhibitor @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23384446.T11.T36",
        "sentence": "Our results suggest that arsenite can potentiate EDHF-type relaxations via a mechanism that is dependent on hydrogen peroxide, thus demonstrating that dismutation of the @CHEMICAL$ anion generated by @GENE$ can potentially offset loss of NO bioavailability under conditions of reduced eNOS activity.",
        "relation": "CPR:9"
    },
    {
        "id": "17570561.T7.T19",
        "sentence": "We isolated partial cDNAs that codified for enzymes implicated in the @CHEMICAL$ biosynthesis such as @GENE$ (PAL) and chalcone synthase (CHS), and an antioxidant enzyme such as ascorbate peroxidase (APX).",
        "relation": "CPR:9"
    },
    {
        "id": "17570561.T7.T20",
        "sentence": "We isolated partial cDNAs that codified for enzymes implicated in the @CHEMICAL$ biosynthesis such as l-phenylalanine ammonia-lyase (@GENE$) and chalcone synthase (CHS), and an antioxidant enzyme such as ascorbate peroxidase (APX).",
        "relation": "CPR:9"
    },
    {
        "id": "17570561.T7.T21",
        "sentence": "We isolated partial cDNAs that codified for enzymes implicated in the @CHEMICAL$ biosynthesis such as l-phenylalanine ammonia-lyase (PAL) and @GENE$ (CHS), and an antioxidant enzyme such as ascorbate peroxidase (APX).",
        "relation": "CPR:9"
    },
    {
        "id": "17570561.T7.T22",
        "sentence": "We isolated partial cDNAs that codified for enzymes implicated in the @CHEMICAL$ biosynthesis such as l-phenylalanine ammonia-lyase (PAL) and chalcone synthase (@GENE$), and an antioxidant enzyme such as ascorbate peroxidase (APX).",
        "relation": "CPR:9"
    },
    {
        "id": "17570561.T7.T23",
        "sentence": "We isolated partial cDNAs that codified for enzymes implicated in the @CHEMICAL$ biosynthesis such as l-phenylalanine ammonia-lyase (PAL) and chalcone synthase (CHS), and an antioxidant enzyme such as @GENE$ (APX).",
        "relation": "CPR:9"
    },
    {
        "id": "17570561.T7.T24",
        "sentence": "We isolated partial cDNAs that codified for enzymes implicated in the @CHEMICAL$ biosynthesis such as l-phenylalanine ammonia-lyase (PAL) and chalcone synthase (CHS), and an antioxidant enzyme such as ascorbate peroxidase (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "17884974.T14.T35",
        "sentence": "@CHEMICAL$ (paracetamol) is a selective @GENE$ inhibitor in man.",
        "relation": "CPR:4"
    },
    {
        "id": "17884974.T15.T35",
        "sentence": "Acetaminophen (@CHEMICAL$) is a selective @GENE$ inhibitor in man.",
        "relation": "CPR:4"
    },
    {
        "id": "17884974.T5.T25",
        "sentence": "The fact that @CHEMICAL$ acts functionally as a selective @GENE$ inhibitor led us to investigate the hypothesis of whether it works via preferential COX-2 blockade.",
        "relation": "CPR:4"
    },
    {
        "id": "17884974.T8.T27",
        "sentence": "Ex vivo @CHEMICAL$ inhibition and pharmacokinetics of @GENE$ were assessed in 5 volunteers receiving single 1000 mg doses orally.",
        "relation": "CPR:4"
    },
    {
        "id": "17884974.T10.T28",
        "sentence": "Coagulation-induced @CHEMICAL$ and lipopolysaccharide-induced prostaglandin E(2) were measured ex vivo and in vitro in human whole blood as indices of @GENE$ and COX-2 activity.",
        "relation": "CPR:9"
    },
    {
        "id": "17884974.T11.T29",
        "sentence": "Coagulation-induced thromboxane B(2) and lipopolysaccharide-induced @CHEMICAL$ were measured ex vivo and in vitro in human whole blood as indices of COX-1 and @GENE$ activity.",
        "relation": "CPR:9"
    },
    {
        "id": "17884974.T12.T30",
        "sentence": "In vitro, @CHEMICAL$ elicited a 4.4-fold selectivity toward @GENE$ inhibition (IC(50)=113.7 micromol/L for COX-1; IC(50)=25.8 micromol/L for COX-2).",
        "relation": "CPR:4"
    },
    {
        "id": "17884974.T12.T31",
        "sentence": "In vitro, @CHEMICAL$ elicited a 4.4-fold selectivity toward COX-2 inhibition (IC(50)=113.7 micromol/L for @GENE$; IC(50)=25.8 micromol/L for COX-2).",
        "relation": "CPR:4"
    },
    {
        "id": "17884974.T12.T32",
        "sentence": "In vitro, @CHEMICAL$ elicited a 4.4-fold selectivity toward COX-2 inhibition (IC(50)=113.7 micromol/L for COX-1; IC(50)=25.8 micromol/L for @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "17884974.T13.T16",
        "sentence": "@CHEMICAL$ plasma concentrations remained above the in vitro IC(50) for @GENE$ for at least 5 h postadministration.",
        "relation": "CPR:4"
    },
    {
        "id": "17884974.T1.T17",
        "sentence": "Ex vivo IC(50) values (@CHEMICAL$: 105.2 micromol/L; COX-2: 26.3 micromol/L) of @GENE$ compared favorably with its in vitro IC(50) values.",
        "relation": "CPR:4"
    },
    {
        "id": "17884974.T1.T18",
        "sentence": "Ex vivo IC(50) values (COX-1: 105.2 micromol/L; @CHEMICAL$: 26.3 micromol/L) of @GENE$ compared favorably with its in vitro IC(50) values.",
        "relation": "CPR:4"
    },
    {
        "id": "17884974.T2.T19",
        "sentence": "In contrast to previous concepts, @CHEMICAL$ inhibited @GENE$ by more than 80%, i.e., to a degree comparable to nonsteroidal antiinflammatory drugs (NSAIDs) and selective COX-2 inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "17884974.T4.T22",
        "sentence": "In view of its substantial @CHEMICAL$ inhibition, recently defined cardiovascular warnings for use of COX-2 inhibitors should also be considered for @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17159811.T4.T19",
        "sentence": "OBJECTIVES: The alkaloid @CHEMICAL$ (GAL), which exhibits a combined @GENE$ and direct parasympathomimetic mechanism of action, is employed in conjunction with therapeutic interventions in the stimulation of central cholinergic transfer in cognitive diseases.",
        "relation": "CPR:4"
    },
    {
        "id": "17159811.T6.T19",
        "sentence": "OBJECTIVES: The alkaloid galantamine (@CHEMICAL$), which exhibits a combined @GENE$ and direct parasympathomimetic mechanism of action, is employed in conjunction with therapeutic interventions in the stimulation of central cholinergic transfer in cognitive diseases.",
        "relation": "CPR:4"
    },
    {
        "id": "17159811.T9.T20",
        "sentence": "RESULTS: Following administration of the highest of the @CHEMICAL$ doses used (2.5; 5; 10 mg/kg i.m.), @GENE$ activity decreased mainly in the frontal cortex, hippocampus and hypophysis.",
        "relation": "CPR:4"
    },
    {
        "id": "17159811.T10.T22",
        "sentence": "In the interaction of @CHEMICAL$ and CAR, @GENE$ inhibition was stronger but without any statistical significance.",
        "relation": "CPR:4"
    },
    {
        "id": "23022324.T5.T13",
        "sentence": "@CHEMICAL$ increased the mRNA levels of the @GENE$ and decreased the mRNA levels of tau and tubulin in a dose-dependent manner; no significant effect was found in the mRNA levels of the heavy subunit of neurofilament, microtubule-associated protein 2, or actin.",
        "relation": "CPR:3"
    },
    {
        "id": "23022324.T5.T15",
        "sentence": "@CHEMICAL$ increased the mRNA levels of the light and medium subunits of neurofilament and decreased the mRNA levels of tau and @GENE$ in a dose-dependent manner; no significant effect was found in the mRNA levels of the heavy subunit of neurofilament, microtubule-associated protein 2, or actin.",
        "relation": "CPR:4"
    },
    {
        "id": "23022324.T5.T14",
        "sentence": "@CHEMICAL$ increased the mRNA levels of the light and medium subunits of neurofilament and decreased the mRNA levels of @GENE$ and tubulin in a dose-dependent manner; no significant effect was found in the mRNA levels of the heavy subunit of neurofilament, microtubule-associated protein 2, or actin.",
        "relation": "CPR:4"
    },
    {
        "id": "2855368.T16.T18",
        "sentence": "A @CHEMICAL$ with selective and long-acting opioid antagonism at @GENE$ in vitro.",
        "relation": "CPR:6"
    },
    {
        "id": "18068977.T3.T13",
        "sentence": "Inhibition of @CHEMICAL$ (DPP-IV) by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "18068977.T3.T14",
        "sentence": "Inhibition of dipeptidyl peptidase-IV (@CHEMICAL$) by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "18068977.T1.T11",
        "sentence": "In this report, we show that the hypolipidemic agent @CHEMICAL$ is a competitive inhibitor of @GENE$ in vitro, with K(i)=57.8+/-2.3 microM. These results may have implications in the development of novel DPP-IV inhibitors based on the use of atorvastatin as a lead compound for the treatment of type 2 diabetes.",
        "relation": "CPR:4"
    },
    {
        "id": "18068977.T2.T12",
        "sentence": "In this report, we show that the hypolipidemic agent atorvastatin is a competitive inhibitor of porcine DPP-IV in vitro, with K(i)=57.8+/-2.3 microM. These results may have implications in the development of novel @CHEMICAL$ inhibitors based on the use of @GENE$ as a lead compound for the treatment of type 2 diabetes.",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T14.T41",
        "sentence": "@CHEMICAL$ suppresses @GENE$ oligomer-induced microglia activation and thereby protects PC-12 cells from inflammation-mediated toxicity.",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T5.T30",
        "sentence": "In this study, focus was given to evaluate the ability of @CHEMICAL$, an indole alkaloid isolated from marine-derived Microsporum sp., to attenuate microglial activation by oligomeric @GENE$ (Ab42).",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T5.T31",
        "sentence": "In this study, focus was given to evaluate the ability of @CHEMICAL$, an indole alkaloid isolated from marine-derived Microsporum sp., to attenuate microglial activation by oligomeric amyloid-b 1-42 (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T6.T30",
        "sentence": "In this study, focus was given to evaluate the ability of neoechinulin A, an @CHEMICAL$ alkaloid isolated from marine-derived Microsporum sp., to attenuate microglial activation by oligomeric @GENE$ (Ab42).",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T6.T31",
        "sentence": "In this study, focus was given to evaluate the ability of neoechinulin A, an @CHEMICAL$ alkaloid isolated from marine-derived Microsporum sp., to attenuate microglial activation by oligomeric amyloid-b 1-42 (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T7.T32",
        "sentence": "@CHEMICAL$ treatment significantly inhibited the generation of reactive oxygen and nitrogen species in @GENE$-activated BV-2 microglia cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T10.T33",
        "sentence": "In addition, we found that @CHEMICAL$ significantly suppressed the production of neurotoxic inflammatory mediator @GENE$ (TNF-a), interleukin-1b (IL-1b), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) in activated BV-2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T10.T34",
        "sentence": "In addition, we found that @CHEMICAL$ significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor-a (@GENE$), interleukin-1b (IL-1b), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) in activated BV-2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T10.T35",
        "sentence": "In addition, we found that @CHEMICAL$ significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor-a (TNF-a), @GENE$ (IL-1b), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) in activated BV-2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T10.T36",
        "sentence": "In addition, we found that @CHEMICAL$ significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor-a (TNF-a), interleukin-1b (@GENE$), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) in activated BV-2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T10.T38",
        "sentence": "In addition, we found that @CHEMICAL$ significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor-a (TNF-a), interleukin-1b (IL-1b), @GENE$ (IL-6), and prostaglandin E2 (PGE2) in activated BV-2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T10.T39",
        "sentence": "In addition, we found that @CHEMICAL$ significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor-a (TNF-a), interleukin-1b (IL-1b), interleukin-6 (@GENE$), and prostaglandin E2 (PGE2) in activated BV-2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T2.T21",
        "sentence": "Further, activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by neoechinulin A. The molecular mechanism studies suggested that @CHEMICAL$ may block the phosphorylation of @GENE$ (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-kB (NF-kB) p65 and p50 subunits.",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T2.T22",
        "sentence": "Further, activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by neoechinulin A. The molecular mechanism studies suggested that @CHEMICAL$ may block the phosphorylation of mitogen-activated protein kinase (@GENE$) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-kB (NF-kB) p65 and p50 subunits.",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T2.T23",
        "sentence": "Further, activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by neoechinulin A. The molecular mechanism studies suggested that @CHEMICAL$ may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule @GENE$, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-kB (NF-kB) p65 and p50 subunits.",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T2.T26",
        "sentence": "Further, activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by neoechinulin A. The molecular mechanism studies suggested that @CHEMICAL$ may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of @GENE$ (NF-kB) p65 and p50 subunits.",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T2.T27",
        "sentence": "Further, activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by neoechinulin A. The molecular mechanism studies suggested that @CHEMICAL$ may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-kB (@GENE$) p65 and p50 subunits.",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T2.T24",
        "sentence": "Further, activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by neoechinulin A. The molecular mechanism studies suggested that @CHEMICAL$ may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, @GENE$ (ASK-1) and nuclear translocation of nuclear factor-kB (NF-kB) p65 and p50 subunits.",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T2.T25",
        "sentence": "Further, activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by neoechinulin A. The molecular mechanism studies suggested that @CHEMICAL$ may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (@GENE$) and nuclear translocation of nuclear factor-kB (NF-kB) p65 and p50 subunits.",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T2.T28",
        "sentence": "Further, activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by neoechinulin A. The molecular mechanism studies suggested that @CHEMICAL$ may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-kB (NF-kB) @GENE$ and p50 subunits.",
        "relation": "CPR:4"
    },
    {
        "id": "23261590.T2.T29",
        "sentence": "Further, activated microglia-mediated apoptosis of PC-12 pheochromocytoma cells was significantly repressed by neoechinulin A. The molecular mechanism studies suggested that @CHEMICAL$ may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-kB (NF-kB) p65 and @GENE$ subunits.",
        "relation": "CPR:4"
    },
    {
        "id": "22370641.T10.T26",
        "sentence": "@CHEMICAL$ increased the activity of the @GENE$ through Cav1-dependent binding of b-catenin to the proximal WNT6 promoter.",
        "relation": "CPR:3"
    },
    {
        "id": "22370641.T10.T29",
        "sentence": "@CHEMICAL$ increased the activity of the human WNT6 promoter through Cav1-dependent binding of b-catenin to the proximal @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "22370641.T11.T30",
        "sentence": "@CHEMICAL$ increased both @GENE$/Wnt6 and Cav1 expression in human GC cells and within the tumor area of a murine model of GC (CEA424-SV40 TAg).",
        "relation": "CPR:3"
    },
    {
        "id": "22370641.T11.T31",
        "sentence": "@CHEMICAL$ increased both WNT6/@GENE$ and Cav1 expression in human GC cells and within the tumor area of a murine model of GC (CEA424-SV40 TAg).",
        "relation": "CPR:3"
    },
    {
        "id": "22370641.T11.T32",
        "sentence": "@CHEMICAL$ increased both WNT6/Wnt6 and @GENE$ expression in human GC cells and within the tumor area of a murine model of GC (CEA424-SV40 TAg).",
        "relation": "CPR:3"
    },
    {
        "id": "22370641.T4.T14",
        "sentence": "These results showed that @CHEMICAL$ and Cav1 are upregulated by chemotherapeutics and enhance the resistance of GC cells to @GENE$ drugs.",
        "relation": "CPR:3"
    },
    {
        "id": "22370641.T4.T15",
        "sentence": "These results showed that WNT6 and @CHEMICAL$ are upregulated by chemotherapeutics and enhance the resistance of GC cells to @GENE$ drugs.",
        "relation": "CPR:3"
    },
    {
        "id": "23583884.T11.T27",
        "sentence": "In this study, using reverse transcriptase PCR (RT-PCR) and ELISA, we showed that @CHEMICAL$ up-regulated the expression and secretion of @GENE$ (TNF-a) in a time-dependent manner in cultured HAPI microglial cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23583884.T11.T28",
        "sentence": "In this study, using reverse transcriptase PCR (RT-PCR) and ELISA, we showed that @CHEMICAL$ up-regulated the expression and secretion of tumor necrosis factor-alpha (@GENE$) in a time-dependent manner in cultured HAPI microglial cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23583884.T13.T29",
        "sentence": "@CHEMICAL$ also caused a fast (within 30min as judged by the increase in its mRNA level) activation of @GENE$ (cPLA2).",
        "relation": "CPR:3"
    },
    {
        "id": "23583884.T13.T30",
        "sentence": "@CHEMICAL$ also caused a fast (within 30min as judged by the increase in its mRNA level) activation of cytosolic phospholipase A2 (@GENE$).",
        "relation": "CPR:3"
    },
    {
        "id": "23583884.T14.T31",
        "sentence": "This initial action was accompanied by up-regulation of @CHEMICAL$ (COX-2), an important inflammation marker within 1h after @GENE$ treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "23583884.T14.T32",
        "sentence": "This initial action was accompanied by up-regulation of cyclooxygenase-2 (@CHEMICAL$), an important inflammation marker within 1h after @GENE$ treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "23583884.T4.T21",
        "sentence": "Further, @CHEMICAL$ exposure could induce phosphorylation- and ubiquitination-dependent degradation of @GENE$, and the translocation of NF-kB p65 from the cytosol to the nucleus in this microglial cell line.",
        "relation": "CPR:3"
    },
    {
        "id": "23583884.T5.T23",
        "sentence": "Thus, the @CHEMICAL$ signaling pathway can be activated after @GENE$ treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "23583884.T7.T24",
        "sentence": "However, Ca(2+) blockers also obviously attenuated @CHEMICAL$ activation and transnuclear transport induced by @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23583884.T8.T25",
        "sentence": "In concert with these results, we highlighted that the secretion of pro-inflammatory @CHEMICAL$ and NF-kB activation induced by @GENE$ can be mediated by elevation of [Ca(2+)]i in HAPI microglial cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23583884.T8.T26",
        "sentence": "In concert with these results, we highlighted that the secretion of pro-inflammatory cytokine and @CHEMICAL$ activation induced by @GENE$ can be mediated by elevation of [Ca(2+)]i in HAPI microglial cells.",
        "relation": "CPR:3"
    },
    {
        "id": "18093407.T8.T17",
        "sentence": "The ARB @CHEMICAL$ is a nonbiphenyl nontetrazole @GENE$ (AT1) antagonist, which acts to decrease total peripheral resistance.",
        "relation": "CPR:6"
    },
    {
        "id": "18093407.T8.T18",
        "sentence": "The ARB @CHEMICAL$ is a nonbiphenyl nontetrazole angiotensin II type 1 receptor (@GENE$) antagonist, which acts to decrease total peripheral resistance.",
        "relation": "CPR:6"
    },
    {
        "id": "10401556.T17.T40",
        "sentence": "The putative @CHEMICAL$ antagonist @GENE$, but not the alpha 1B-adrenoceptor antagonist chloroethylclonidine (10 microM) antagonized noradrenaline-induced contractions of SMA.",
        "relation": "CPR:6"
    },
    {
        "id": "10401556.T18.T41",
        "sentence": "The putative alpha 1L-adrenoceptor antagonist JTH-601, but not the @CHEMICAL$ antagonist @GENE$ (10 microM) antagonized noradrenaline-induced contractions of SMA.",
        "relation": "CPR:6"
    },
    {
        "id": "10401556.T1.T44",
        "sentence": "The potency of the selective alpha 1D-adrenoceptor antagonist BMY 7378 against noradrenaline (pA2 = 6.16 +/- 0.13) and of the selective alpha 1A-adrenoceptor antagonist RS-17053 against noradrenaline (pKB = 8.35 +/- 0.10) and against the selective @CHEMICAL$ agonist @GENE$ (pKB = 8.40 +/- 0.09) were too low to account for alpha 1D- and alpha 1A-adrenoceptor involvement. 4.",
        "relation": "CPR:5"
    },
    {
        "id": "10401556.T20.T42",
        "sentence": "The potency of the selective @CHEMICAL$ antagonist @GENE$ against noradrenaline (pA2 = 6.16 +/- 0.13) and of the selective alpha 1A-adrenoceptor antagonist RS-17053 against noradrenaline (pKB = 8.35 +/- 0.10) and against the selective alpha 1A-adrenoceptor agonist A-61603 (pKB = 8.40 +/- 0.09) were too low to account for alpha 1D- and alpha 1A-adrenoceptor involvement. 4.",
        "relation": "CPR:6"
    },
    {
        "id": "10401556.T23.T43",
        "sentence": "The potency of the selective alpha 1D-adrenoceptor antagonist BMY 7378 against noradrenaline (pA2 = 6.16 +/- 0.13) and of the selective @CHEMICAL$ antagonist @GENE$ against noradrenaline (pKB = 8.35 +/- 0.10) and against the selective alpha 1A-adrenoceptor agonist A-61603 (pKB = 8.40 +/- 0.09) were too low to account for alpha 1D- and alpha 1A-adrenoceptor involvement. 4.",
        "relation": "CPR:6"
    },
    {
        "id": "7768269.T23.T28",
        "sentence": "Doses of dimethocaine (1.7 mg/kg) and cocaine (0.3 mg/kg) which produced full (> 80%) substitution for cocaine were administered in combination with the @CHEMICAL$ antagonist @GENE$ ((-)-trans-6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H -benzo [d]naphtho-(2,1-b)azepine) and the dopamine D2 receptor antagonist raclopride (both at 0.003-0.03 mg/kg).",
        "relation": "CPR:6"
    },
    {
        "id": "7768269.T24.T28",
        "sentence": "Doses of dimethocaine (1.7 mg/kg) and cocaine (0.3 mg/kg) which produced full (> 80%) substitution for cocaine were administered in combination with the @CHEMICAL$ antagonist SCH 39166 (@GENE$) and the dopamine D2 receptor antagonist raclopride (both at 0.003-0.03 mg/kg).",
        "relation": "CPR:6"
    },
    {
        "id": "7768269.T26.T29",
        "sentence": "Doses of dimethocaine (1.7 mg/kg) and cocaine (0.3 mg/kg) which produced full (> 80%) substitution for cocaine were administered in combination with the dopamine D1 receptor antagonist SCH 39166 ((-)-trans-6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H -benzo [d]naphtho-(2,1-b)azepine) and the @CHEMICAL$ antagonist @GENE$ (both at 0.003-0.03 mg/kg).",
        "relation": "CPR:6"
    },
    {
        "id": "11401111.T2.T18",
        "sentence": "@CHEMICAL$ reduced the risk of death or heart failure in patients with above-median levels of @GENE$ or adrenomedullin, or both, to rates not significantly different from those observed in patients with levels below the median value.",
        "relation": "CPR:4"
    },
    {
        "id": "11401111.T2.T19",
        "sentence": "@CHEMICAL$ reduced the risk of death or heart failure in patients with above-median levels of N-BNP or @GENE$, or both, to rates not significantly different from those observed in patients with levels below the median value.",
        "relation": "CPR:4"
    },
    {
        "id": "11401111.T5.T22",
        "sentence": "@CHEMICAL$ reduced mortality and heart failure in patients with higher pre-treatment plasma @GENE$ and adrenomedullin.",
        "relation": "CPR:4"
    },
    {
        "id": "11401111.T5.T23",
        "sentence": "@CHEMICAL$ reduced mortality and heart failure in patients with higher pre-treatment plasma N-BNP and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23146690.T6.T22",
        "sentence": "In combination with @CHEMICAL$, the ability of resveratrol to reduce the contents of @GENE$ and its target gene products was also evident in a time- and dose-dependent experiment.",
        "relation": "CPR:4"
    },
    {
        "id": "23146690.T7.T22",
        "sentence": "In combination with clofarabine, the ability of @CHEMICAL$ to reduce the contents of @GENE$ and its target gene products was also evident in a time- and dose-dependent experiment.",
        "relation": "CPR:4"
    },
    {
        "id": "23146690.T9.T23",
        "sentence": "The inhibition of @CHEMICAL$ using @GENE$ augmented a decrease in the p21 level induced by their combination, but it showed no significant effects on expression of Sp1 and cyclin D1.",
        "relation": "CPR:4"
    },
    {
        "id": "23146690.T9.T24",
        "sentence": "The inhibition of phosphoinositide 3-kinase using @CHEMICAL$ augmented a decrease in the @GENE$ level induced by their combination, but it showed no significant effects on expression of Sp1 and cyclin D1.",
        "relation": "CPR:4"
    },
    {
        "id": "23146690.T1.T14",
        "sentence": "Taken together, the data provide evidence that the synergistic antiproliferative effect of @CHEMICAL$ and clofarabine is linked to the inhibition of @GENE$ and Sp1 activities, and suggest that this combination may have therapeutic value in treatment of malignant mesothelioma.",
        "relation": "CPR:4"
    },
    {
        "id": "23146690.T1.T15",
        "sentence": "Taken together, the data provide evidence that the synergistic antiproliferative effect of @CHEMICAL$ and clofarabine is linked to the inhibition of Akt and @GENE$ activities, and suggest that this combination may have therapeutic value in treatment of malignant mesothelioma.",
        "relation": "CPR:4"
    },
    {
        "id": "23146690.T2.T14",
        "sentence": "Taken together, the data provide evidence that the synergistic antiproliferative effect of resveratrol and @CHEMICAL$ is linked to the inhibition of @GENE$ and Sp1 activities, and suggest that this combination may have therapeutic value in treatment of malignant mesothelioma.",
        "relation": "CPR:4"
    },
    {
        "id": "23146690.T2.T15",
        "sentence": "Taken together, the data provide evidence that the synergistic antiproliferative effect of resveratrol and @CHEMICAL$ is linked to the inhibition of Akt and @GENE$ activities, and suggest that this combination may have therapeutic value in treatment of malignant mesothelioma.",
        "relation": "CPR:4"
    },
    {
        "id": "23122079.T16.T36",
        "sentence": "@CHEMICAL$ attenuates high glucose-induced lipid accumulation in human HepG2 hepatocytes through the activation of LKB1/@GENE$-dependent signalling.",
        "relation": "CPR:3"
    },
    {
        "id": "23122079.T16.T35",
        "sentence": "@CHEMICAL$ attenuates high glucose-induced lipid accumulation in human HepG2 hepatocytes through the activation of @GENE$/AMP-activated protein kinase-dependent signalling.",
        "relation": "CPR:3"
    },
    {
        "id": "23122079.T7.T24",
        "sentence": "@CHEMICAL$ strongly inhibited high glucose-induced @GENE$ (FAS) expression by modulating sterol regulatory element-binding protein-1c (SREBP-1c) activation.",
        "relation": "CPR:4"
    },
    {
        "id": "23122079.T7.T25",
        "sentence": "@CHEMICAL$ strongly inhibited high glucose-induced fatty acid synthase (@GENE$) expression by modulating sterol regulatory element-binding protein-1c (SREBP-1c) activation.",
        "relation": "CPR:4"
    },
    {
        "id": "23122079.T8.T24",
        "sentence": "Phillyrin strongly inhibited high @CHEMICAL$-induced @GENE$ (FAS) expression by modulating sterol regulatory element-binding protein-1c (SREBP-1c) activation.",
        "relation": "CPR:3"
    },
    {
        "id": "23122079.T8.T25",
        "sentence": "Phillyrin strongly inhibited high @CHEMICAL$-induced fatty acid synthase (@GENE$) expression by modulating sterol regulatory element-binding protein-1c (SREBP-1c) activation.",
        "relation": "CPR:3"
    },
    {
        "id": "23122079.T12.T28",
        "sentence": "Moreover, use of the pharmacological @CHEMICAL$ (AMPK) inhibitor @GENE$ revealed that AMPK is essential for suppressing SREBP-1c expression in phillyrin-treated cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23122079.T12.T29",
        "sentence": "Moreover, use of the pharmacological AMP-activated protein kinase (@CHEMICAL$) inhibitor @GENE$ revealed that AMPK is essential for suppressing SREBP-1c expression in phillyrin-treated cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23122079.T12.T30",
        "sentence": "Moreover, use of the pharmacological AMP-activated protein kinase (AMPK) inhibitor @CHEMICAL$ revealed that @GENE$ is essential for suppressing SREBP-1c expression in phillyrin-treated cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23122079.T14.T34",
        "sentence": "Finally, we found that liver kinase B1 (LKB1) phosphorylation is required for the @CHEMICAL$-enhanced activation of @GENE$ in HepG2 hepatocytes.",
        "relation": "CPR:3"
    },
    {
        "id": "23122079.T2.T23",
        "sentence": "These results indicate that phillyrin prevents lipid accumulation in HepG2 cells by blocking the expression of SREBP-1c and FAS through LKB1/AMPK activation, suggesting that @CHEMICAL$ is a novel @GENE$ activator with a role in the prevention and treatment of obesity.",
        "relation": "CPR:3"
    },
    {
        "id": "23122079.T15.T22",
        "sentence": "These results indicate that @CHEMICAL$ prevents lipid accumulation in HepG2 cells by blocking the expression of SREBP-1c and FAS through LKB1/@GENE$ activation, suggesting that phillyrin is a novel AMPK activator with a role in the prevention and treatment of obesity.",
        "relation": "CPR:3"
    },
    {
        "id": "23122079.T15.T19",
        "sentence": "These results indicate that @CHEMICAL$ prevents lipid accumulation in HepG2 cells by blocking the expression of @GENE$ and FAS through LKB1/AMPK activation, suggesting that phillyrin is a novel AMPK activator with a role in the prevention and treatment of obesity.",
        "relation": "CPR:4"
    },
    {
        "id": "23122079.T15.T20",
        "sentence": "These results indicate that @CHEMICAL$ prevents lipid accumulation in HepG2 cells by blocking the expression of SREBP-1c and @GENE$ through LKB1/AMPK activation, suggesting that phillyrin is a novel AMPK activator with a role in the prevention and treatment of obesity.",
        "relation": "CPR:4"
    },
    {
        "id": "23122079.T15.T21",
        "sentence": "These results indicate that @CHEMICAL$ prevents lipid accumulation in HepG2 cells by blocking the expression of SREBP-1c and FAS through @GENE$/AMPK activation, suggesting that phillyrin is a novel AMPK activator with a role in the prevention and treatment of obesity.",
        "relation": "CPR:3"
    },
    {
        "id": "23642478.T6.T17",
        "sentence": "@CHEMICAL$ incorporating cyanoacrylamide moieties strongly inhibit @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23642478.T7.T17",
        "sentence": "Benzenesulfonamides incorporating @CHEMICAL$ moieties strongly inhibit @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23642478.T1.T9",
        "sentence": "A series of @CHEMICAL$ incorporating cyanoacrylamide moieties (tyrphostine analogs) were assayed as inhibitors of the b-carbonic anhydrase (@GENE$, EC 4.2.1.1) from Saccharomyces cerevisiae, ScCA.",
        "relation": "CPR:4"
    },
    {
        "id": "23642478.T1.T8",
        "sentence": "A series of @CHEMICAL$ incorporating cyanoacrylamide moieties (tyrphostine analogs) were assayed as inhibitors of the @GENE$ (CA, EC 4.2.1.1) from Saccharomyces cerevisiae, ScCA.",
        "relation": "CPR:4"
    },
    {
        "id": "23642478.T1.T10",
        "sentence": "A series of @CHEMICAL$ incorporating cyanoacrylamide moieties (tyrphostine analogs) were assayed as inhibitors of the b-carbonic anhydrase (CA, @GENE$) from Saccharomyces cerevisiae, ScCA.",
        "relation": "CPR:4"
    },
    {
        "id": "23642478.T1.T11",
        "sentence": "A series of @CHEMICAL$ incorporating cyanoacrylamide moieties (tyrphostine analogs) were assayed as inhibitors of the b-carbonic anhydrase (CA, EC 4.2.1.1) from Saccharomyces cerevisiae, @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23642478.T2.T9",
        "sentence": "A series of benzenesulfonamides incorporating @CHEMICAL$ moieties (tyrphostine analogs) were assayed as inhibitors of the b-carbonic anhydrase (@GENE$, EC 4.2.1.1) from Saccharomyces cerevisiae, ScCA.",
        "relation": "CPR:4"
    },
    {
        "id": "23642478.T2.T8",
        "sentence": "A series of benzenesulfonamides incorporating @CHEMICAL$ moieties (tyrphostine analogs) were assayed as inhibitors of the @GENE$ (CA, EC 4.2.1.1) from Saccharomyces cerevisiae, ScCA.",
        "relation": "CPR:4"
    },
    {
        "id": "23642478.T2.T10",
        "sentence": "A series of benzenesulfonamides incorporating @CHEMICAL$ moieties (tyrphostine analogs) were assayed as inhibitors of the b-carbonic anhydrase (CA, @GENE$) from Saccharomyces cerevisiae, ScCA.",
        "relation": "CPR:4"
    },
    {
        "id": "23642478.T2.T11",
        "sentence": "A series of benzenesulfonamides incorporating @CHEMICAL$ moieties (tyrphostine analogs) were assayed as inhibitors of the b-carbonic anhydrase (CA, EC 4.2.1.1) from Saccharomyces cerevisiae, @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23642478.T5.T9",
        "sentence": "A series of benzenesulfonamides incorporating cyanoacrylamide moieties (@CHEMICAL$ analogs) were assayed as inhibitors of the b-carbonic anhydrase (@GENE$, EC 4.2.1.1) from Saccharomyces cerevisiae, ScCA.",
        "relation": "CPR:4"
    },
    {
        "id": "23642478.T5.T8",
        "sentence": "A series of benzenesulfonamides incorporating cyanoacrylamide moieties (@CHEMICAL$ analogs) were assayed as inhibitors of the @GENE$ (CA, EC 4.2.1.1) from Saccharomyces cerevisiae, ScCA.",
        "relation": "CPR:4"
    },
    {
        "id": "23642478.T5.T10",
        "sentence": "A series of benzenesulfonamides incorporating cyanoacrylamide moieties (@CHEMICAL$ analogs) were assayed as inhibitors of the b-carbonic anhydrase (CA, @GENE$) from Saccharomyces cerevisiae, ScCA.",
        "relation": "CPR:4"
    },
    {
        "id": "23642478.T5.T11",
        "sentence": "A series of benzenesulfonamides incorporating cyanoacrylamide moieties (@CHEMICAL$ analogs) were assayed as inhibitors of the b-carbonic anhydrase (CA, EC 4.2.1.1) from Saccharomyces cerevisiae, @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23063590.T16.T34",
        "sentence": "@CHEMICAL$ inhibits melanogenesis through downregulation of @GENE$-dependent expression of HMG-CoA reductase gene.",
        "relation": "CPR:4"
    },
    {
        "id": "23063590.T16.T35",
        "sentence": "@CHEMICAL$ inhibits melanogenesis through downregulation of C/EBP a-dependent expression of @GENE$ gene.",
        "relation": "CPR:4"
    },
    {
        "id": "23063590.T10.T22",
        "sentence": "The mRNA levels of @CHEMICAL$ (MITF) and its downstream genes tyrosinase, tyrosinase-related protein (TRP)-1, and TRP-2 were reduced by @GENE$ treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "23063590.T10.T23",
        "sentence": "The mRNA levels of microphthalmia-associated transcription factor (@CHEMICAL$) and its downstream genes tyrosinase, tyrosinase-related protein (TRP)-1, and TRP-2 were reduced by @GENE$ treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "23063590.T10.T24",
        "sentence": "The mRNA levels of microphthalmia-associated transcription factor (MITF) and its downstream genes @CHEMICAL$, tyrosinase-related protein (TRP)-1, and TRP-2 were reduced by @GENE$ treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "23063590.T10.T25",
        "sentence": "The mRNA levels of microphthalmia-associated transcription factor (MITF) and its downstream genes tyrosinase, @CHEMICAL$, and TRP-2 were reduced by @GENE$ treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "23063590.T10.T26",
        "sentence": "The mRNA levels of microphthalmia-associated transcription factor (MITF) and its downstream genes tyrosinase, tyrosinase-related protein (TRP)-1, and @CHEMICAL$ were reduced by @GENE$ treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "23063590.T11.T27",
        "sentence": "Additionally, the mRNA levels of melanogenesis-related genes (@CHEMICAL$, stem cell factor (SCF), and macrophage migration inhibitory factor (MIF)) were down-regulated by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23063590.T11.T28",
        "sentence": "Additionally, the mRNA levels of melanogenesis-related genes (c-KIT, @CHEMICAL$ (SCF), and macrophage migration inhibitory factor (MIF)) were down-regulated by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23063590.T11.T29",
        "sentence": "Additionally, the mRNA levels of melanogenesis-related genes (c-KIT, stem cell factor (@CHEMICAL$), and macrophage migration inhibitory factor (MIF)) were down-regulated by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23063590.T11.T30",
        "sentence": "Additionally, the mRNA levels of melanogenesis-related genes (c-KIT, stem cell factor (SCF), and @CHEMICAL$ (MIF)) were down-regulated by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23063590.T11.T31",
        "sentence": "Additionally, the mRNA levels of melanogenesis-related genes (c-KIT, stem cell factor (SCF), and macrophage migration inhibitory factor (@CHEMICAL$)) were down-regulated by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23063590.T13.T32",
        "sentence": "Furthermore, cAMP production and @CHEMICAL$ (PKA) activity were suppressed by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23063590.T13.T33",
        "sentence": "Furthermore, cAMP production and protein kinase A (@CHEMICAL$) activity were suppressed by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23063590.T15.T18",
        "sentence": "Moreover, attempts to elucidate a possible mechanism underlying the artemisinic acid-mediated effects revealed that @CHEMICAL$ regulated melanogenesis by inhibiting cholesterol synthesis through downregulation of the @GENE$ gene, which was mediated through reduced expression of the CCAAT/enhancer-binding protein (C/EBP) a gene.",
        "relation": "CPR:4"
    },
    {
        "id": "23063590.T15.T19",
        "sentence": "Moreover, attempts to elucidate a possible mechanism underlying the artemisinic acid-mediated effects revealed that @CHEMICAL$ regulated melanogenesis by inhibiting cholesterol synthesis through downregulation of the hydroxymethylglutaryl CoA (HMG CoA) reductase gene, which was mediated through reduced expression of the @GENE$ gene.",
        "relation": "CPR:4"
    },
    {
        "id": "23063590.T5.T20",
        "sentence": "Taken together, these findings indicate that the inhibition of melanogenesis by @CHEMICAL$ occurs through reduced expression of the @GENE$ gene, which is mediated by C/EBP a inhibition and suggest that artemisinic acid may be useful as a hyperpigmentation inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "23063590.T5.T21",
        "sentence": "Taken together, these findings indicate that the inhibition of melanogenesis by @CHEMICAL$ occurs through reduced expression of the HMG CoA reductase gene, which is mediated by @GENE$ inhibition and suggest that artemisinic acid may be useful as a hyperpigmentation inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "7711211.T11.T23",
        "sentence": "As determined by Western and Northern blot analyses, @CHEMICAL$ inhibited the P4-induced @GENE$ gene expression in a dose-dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "7711211.T13.T24",
        "sentence": "The estrogenic agent @CHEMICAL$ and estradiol at a dose of 1.0 mg also inhibited the @GENE$ gene expression induced by P4.",
        "relation": "CPR:4"
    },
    {
        "id": "7711211.T14.T24",
        "sentence": "The estrogenic agent 3 beta,5 alpha-NET and @CHEMICAL$ at a dose of 1.0 mg also inhibited the @GENE$ gene expression induced by P4.",
        "relation": "CPR:4"
    },
    {
        "id": "7711211.T15.T25",
        "sentence": "Both @CHEMICAL$ and 3 beta,5 alpha-NET blocked the @GENE$ down-regulation induced by P4 as assessed by Western and Northern blot methods.",
        "relation": "CPR:3"
    },
    {
        "id": "7711211.T16.T25",
        "sentence": "Both 5 alpha-NET and @CHEMICAL$ blocked the @GENE$ down-regulation induced by P4 as assessed by Western and Northern blot methods.",
        "relation": "CPR:3"
    },
    {
        "id": "7711211.T2.T26",
        "sentence": "The inhibition of @CHEMICAL$ synthesis and PR down-regulation by @GENE$ and 3 beta,5 alpha-NET indicates that these NET metabolites possess antiprogestational properties.",
        "relation": "CPR:4"
    },
    {
        "id": "7711211.T2.T27",
        "sentence": "The inhibition of UG synthesis and @CHEMICAL$ down-regulation by @GENE$ and 3 beta,5 alpha-NET indicates that these NET metabolites possess antiprogestational properties.",
        "relation": "CPR:3"
    },
    {
        "id": "7711211.T3.T26",
        "sentence": "The inhibition of @CHEMICAL$ synthesis and PR down-regulation by 5 alpha-NET and @GENE$ indicates that these NET metabolites possess antiprogestational properties.",
        "relation": "CPR:4"
    },
    {
        "id": "7711211.T3.T27",
        "sentence": "The inhibition of UG synthesis and @CHEMICAL$ down-regulation by 5 alpha-NET and @GENE$ indicates that these NET metabolites possess antiprogestational properties.",
        "relation": "CPR:4"
    },
    {
        "id": "7711211.T4.T26",
        "sentence": "The inhibition of @CHEMICAL$ synthesis and PR down-regulation by 5 alpha-NET and 3 beta,5 alpha-NET indicates that these @GENE$ metabolites possess antiprogestational properties.",
        "relation": "CPR:4"
    },
    {
        "id": "7711211.T4.T27",
        "sentence": "The inhibition of UG synthesis and @CHEMICAL$ down-regulation by 5 alpha-NET and 3 beta,5 alpha-NET indicates that these @GENE$ metabolites possess antiprogestational properties.",
        "relation": "CPR:4"
    },
    {
        "id": "23552851.T8.T21",
        "sentence": "Meanwhile, autophagy was detected as early as 12 h after an exposure to low-dose @CHEMICAL$, as indicated by an up-regulated expression of @GENE$ and beclin-1 proteins.",
        "relation": "CPR:3"
    },
    {
        "id": "23552851.T8.T22",
        "sentence": "Meanwhile, autophagy was detected as early as 12 h after an exposure to low-dose @CHEMICAL$, as indicated by an up-regulated expression of LC3-II and @GENE$ proteins.",
        "relation": "CPR:3"
    },
    {
        "id": "23552851.T11.T13",
        "sentence": "Treatment of A549 and H1299 cells with @CHEMICAL$ caused a dose-dependent increase in ERK1/2 and @GENE$ activity, accompanied with a decreased PI3K expression and decreased phosphorylation of Akt and mTOR.",
        "relation": "CPR:3"
    },
    {
        "id": "23552851.T11.T14",
        "sentence": "Treatment of A549 and H1299 cells with @CHEMICAL$ caused a dose-dependent increase in ERK1/2 and JNK1/2 activity, accompanied with a decreased @GENE$ expression and decreased phosphorylation of Akt and mTOR.",
        "relation": "CPR:4"
    },
    {
        "id": "23552851.T11.T15",
        "sentence": "Treatment of A549 and H1299 cells with @CHEMICAL$ caused a dose-dependent increase in ERK1/2 and JNK1/2 activity, accompanied with a decreased PI3K expression and decreased phosphorylation of @GENE$ and mTOR.",
        "relation": "CPR:4"
    },
    {
        "id": "23552851.T11.T16",
        "sentence": "Treatment of A549 and H1299 cells with @CHEMICAL$ caused a dose-dependent increase in ERK1/2 and JNK1/2 activity, accompanied with a decreased PI3K expression and decreased phosphorylation of Akt and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23552851.T11.T23",
        "sentence": "Treatment of A549 and H1299 cells with @CHEMICAL$ caused a dose-dependent increase in @GENE$ and JNK1/2 activity, accompanied with a decreased PI3K expression and decreased phosphorylation of Akt and mTOR.",
        "relation": "CPR:3"
    },
    {
        "id": "23550028.T5.T19",
        "sentence": "Our results showed that @CHEMICAL$ decreased phosphorylation-ERK1/2 (p-ERK1/2), and increased @GENE$, but did not affect expressions of p-JNK1/2 in U937 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23550028.T6.T21",
        "sentence": "Moreover, treatment of U937 cells with @CHEMICAL$ resulted in activation of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23550028.T1.T11",
        "sentence": "Furthermore, PD98059 (ERK1/2 inhibitor) significantly enhanced 2-hydroxy-3-methylanthraquinone-induced apoptosis in U937 cells, whereas caspase-3 inhibitor or @CHEMICAL$ (@GENE$ inhibitor), decreased apoptosis in U937 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23550028.T2.T12",
        "sentence": "Taken together, our study for the first time suggests that @CHEMICAL$ is able to enhance apoptosis of U937 cells, at least in part, through activation of @GENE$ and downregulation of p-ERK1/2.",
        "relation": "CPR:3"
    },
    {
        "id": "10444166.T11.T18",
        "sentence": "@CHEMICAL$ activity was found to be strongly increased in the @GENE$-selected line and purine nucleoside phosphorylase was increased in the 2-chlorodeoxyadenosine-selected line.",
        "relation": "CPR:3"
    },
    {
        "id": "10444166.T12.T19",
        "sentence": "Ribonucleotide reductase activity was found to be strongly increased in the gemcitabine-selected line and @CHEMICAL$ was increased in the @GENE$-selected line.",
        "relation": "CPR:3"
    },
    {
        "id": "23466232.T4.T14",
        "sentence": "A new series of @CHEMICAL$ analogues as @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23466232.T3.T9",
        "sentence": "Several members of a new family of non-sugar-type @CHEMICAL$ inhibitors, bearing a @GENE$ moiety and various substituent at the N2 position, were synthesized and their activities were investigated.",
        "relation": "CPR:4"
    },
    {
        "id": "23466232.T2.T13",
        "sentence": "Structure-activity relationship studies indicated that @CHEMICAL$ moiety is a favorable scaffold to exert the @GENE$ inhibitory activity and substituents at the N2 position have considerable influence on the efficacy of the inhibition activities.",
        "relation": "CPR:4"
    },
    {
        "id": "22865292.T1.T12",
        "sentence": "The lysosomal inhibitor @CHEMICAL$ significantly increased @GENE$ accumulation in +/+ cells, consistent with the hypothesis that higher lysosomal pH impairs RCAN1 degradation, leading to a higher RCAN1/NFATc1 ratio and consequently NFATc1 inhibition.",
        "relation": "CPR:3"
    },
    {
        "id": "23539296.T2.T20",
        "sentence": "Here, we have now found that activation of @CHEMICAL$ MAPK by @GENE$ potentiated induction of CYP2B6 mRNA by CAR ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes. siRNA knockdown of p38 MAPK abrogated the ability of anisomycin to synergistically induce CYP2B6 mRNA.",
        "relation": "CPR:3"
    },
    {
        "id": "23539296.T2.T21",
        "sentence": "Here, we have now found that activation of p38 @CHEMICAL$ by @GENE$ potentiated induction of CYP2B6 mRNA by CAR ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes. siRNA knockdown of p38 MAPK abrogated the ability of anisomycin to synergistically induce CYP2B6 mRNA.",
        "relation": "CPR:3"
    },
    {
        "id": "23539296.T2.T22",
        "sentence": "Here, we have now found that activation of p38 MAPK by @CHEMICAL$ potentiated induction of @GENE$ mRNA by CAR ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes. siRNA knockdown of p38 MAPK abrogated the ability of anisomycin to synergistically induce CYP2B6 mRNA.",
        "relation": "CPR:3"
    },
    {
        "id": "23539296.T3.T26",
        "sentence": "Here, we have now found that activation of p38 MAPK by anisomycin potentiated induction of CYP2B6 mRNA by CAR ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes. siRNA knockdown of p38 MAPK abrogated the ability of @CHEMICAL$ to synergistically induce @GENE$ mRNA.",
        "relation": "CPR:3"
    },
    {
        "id": "23539296.T4.T27",
        "sentence": "In addition to @CHEMICAL$, @GENE$ co-treatment potentiated an increase in CYP2A7 and CYP2C9 mRNAs but not CYP3A4 or UDP-glucuronosyltransferase 1A1 mRNAs.",
        "relation": "CPR:3"
    },
    {
        "id": "23539296.T4.T28",
        "sentence": "In addition to CYP2B6, @CHEMICAL$ co-treatment potentiated an increase in @GENE$ and CYP2C9 mRNAs but not CYP3A4 or UDP-glucuronosyltransferase 1A1 mRNAs.",
        "relation": "CPR:3"
    },
    {
        "id": "23539296.T4.T29",
        "sentence": "In addition to CYP2B6, @CHEMICAL$ co-treatment potentiated an increase in CYP2A7 and @GENE$ mRNAs but not CYP3A4 or UDP-glucuronosyltransferase 1A1 mRNAs.",
        "relation": "CPR:3"
    },
    {
        "id": "23609606.T3.T14",
        "sentence": "No effects were observed when @CHEMICAL$ was assessed for P450-dependent and P450-independent cytotoxicity to THLE cell lines, time-dependent inhibition of five major @GENE$ enzymes, inhibition of the biliary efflux transporters BSEP and MRP2 or mitochondrial toxicity to THLE or HepG2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23609606.T3.T15",
        "sentence": "No effects were observed when @CHEMICAL$ was assessed for P450-dependent and P450-independent cytotoxicity to THLE cell lines, time-dependent inhibition of five major human cytochrome P450 enzymes, inhibition of the biliary @GENE$ BSEP and MRP2 or mitochondrial toxicity to THLE or HepG2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23609606.T3.T16",
        "sentence": "No effects were observed when @CHEMICAL$ was assessed for P450-dependent and P450-independent cytotoxicity to THLE cell lines, time-dependent inhibition of five major human cytochrome P450 enzymes, inhibition of the biliary efflux transporters @GENE$ and MRP2 or mitochondrial toxicity to THLE or HepG2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23609606.T3.T17",
        "sentence": "No effects were observed when @CHEMICAL$ was assessed for P450-dependent and P450-independent cytotoxicity to THLE cell lines, time-dependent inhibition of five major human cytochrome P450 enzymes, inhibition of the biliary efflux transporters BSEP and @GENE$ or mitochondrial toxicity to THLE or HepG2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "17034761.T11.T32",
        "sentence": "@CHEMICAL$, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17034761.T8.T18",
        "sentence": "Our results demonstrated that @CHEMICAL$ suppressed TLR4-mediated activation of transcription factors, @GENE$ and IRF3, and expression of COX-2, a pro-inflammatory enzyme.",
        "relation": "CPR:4"
    },
    {
        "id": "17034761.T8.T17",
        "sentence": "Our results demonstrated that @CHEMICAL$ suppressed @GENE$-mediated activation of transcription factors, NF-kappaB and IRF3, and expression of COX-2, a pro-inflammatory enzyme.",
        "relation": "CPR:4"
    },
    {
        "id": "17034761.T8.T19",
        "sentence": "Our results demonstrated that @CHEMICAL$ suppressed TLR4-mediated activation of transcription factors, NF-kappaB and @GENE$, and expression of COX-2, a pro-inflammatory enzyme.",
        "relation": "CPR:4"
    },
    {
        "id": "17034761.T8.T20",
        "sentence": "Our results demonstrated that @CHEMICAL$ suppressed TLR4-mediated activation of transcription factors, NF-kappaB and IRF3, and expression of @GENE$, a pro-inflammatory enzyme.",
        "relation": "CPR:4"
    },
    {
        "id": "17034761.T9.T21",
        "sentence": "This suppression was well correlated with the inhibitory effect of @CHEMICAL$ on the homodimerization of @GENE$ induced by an agonist.",
        "relation": "CPR:4"
    },
    {
        "id": "17034761.T10.T22",
        "sentence": "Furthermore, @CHEMICAL$ inhibited @GENE$ activation induced by MyD88-dependent downstream signaling components of TLR4, MyD88, IKKbeta, and p65.",
        "relation": "CPR:4"
    },
    {
        "id": "17034761.T1.T28",
        "sentence": "@CHEMICAL$ activation induced by MyD88-independent signaling components, TRIF and TBK1, was also downregulated by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17034761.T1.T30",
        "sentence": "IRF3 activation induced by MyD88-independent signaling components, @CHEMICAL$ and TBK1, was also downregulated by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17034761.T1.T31",
        "sentence": "IRF3 activation induced by MyD88-independent signaling components, TRIF and @CHEMICAL$, was also downregulated by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17034761.T2.T13",
        "sentence": "Our results first demonstrate that @CHEMICAL$ suppresses the multiple steps in @GENE$ signaling, especially the homodimerization of TLR4.",
        "relation": "CPR:4"
    },
    {
        "id": "17034761.T2.T14",
        "sentence": "Our results first demonstrate that @CHEMICAL$ suppresses the multiple steps in TLR4 signaling, especially the homodimerization of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17034761.T3.T15",
        "sentence": "The results suggest that the suppression of @CHEMICAL$ activity by @GENE$ may be the molecular mechanism through which auranofin exerts anti-rheumatic activity.",
        "relation": "CPR:4"
    },
    {
        "id": "17034761.T4.T15",
        "sentence": "The results suggest that the suppression of @CHEMICAL$ activity by auranofin may be the molecular mechanism through which @GENE$ exerts anti-rheumatic activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23584948.T2.T7",
        "sentence": "@CHEMICAL$ (Caprelsa(r), AstraZeneca) is a once-daily oral @GENE$ inhibitor that selectively inhibits signalling mediated by growth-factor receptor tyrosine kinase RET (constitutively activated in roughly 60 % of all MTCs), vascular endothelial growth-factor receptors 2 and 3, and epidermal growth-factor receptors.",
        "relation": "CPR:4"
    },
    {
        "id": "23584948.T2.T8",
        "sentence": "@CHEMICAL$ (Caprelsa(r), AstraZeneca) is a once-daily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by @GENE$ RET (constitutively activated in roughly 60 % of all MTCs), vascular endothelial growth-factor receptors 2 and 3, and epidermal growth-factor receptors.",
        "relation": "CPR:4"
    },
    {
        "id": "23584948.T2.T9",
        "sentence": "@CHEMICAL$ (Caprelsa(r), AstraZeneca) is a once-daily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor tyrosine kinase @GENE$ (constitutively activated in roughly 60 % of all MTCs), vascular endothelial growth-factor receptors 2 and 3, and epidermal growth-factor receptors.",
        "relation": "CPR:4"
    },
    {
        "id": "23584948.T2.T11",
        "sentence": "@CHEMICAL$ (Caprelsa(r), AstraZeneca) is a once-daily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor tyrosine kinase RET (constitutively activated in roughly 60 % of all MTCs), vascular endothelial growth-factor receptors 2 and 3, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23584948.T3.T7",
        "sentence": "Vandetanib (@CHEMICAL$(r), AstraZeneca) is a once-daily oral @GENE$ inhibitor that selectively inhibits signalling mediated by growth-factor receptor tyrosine kinase RET (constitutively activated in roughly 60 % of all MTCs), vascular endothelial growth-factor receptors 2 and 3, and epidermal growth-factor receptors.",
        "relation": "CPR:4"
    },
    {
        "id": "23584948.T3.T11",
        "sentence": "Vandetanib (@CHEMICAL$(r), AstraZeneca) is a once-daily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor tyrosine kinase RET (constitutively activated in roughly 60 % of all MTCs), vascular endothelial growth-factor receptors 2 and 3, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23521080.T1.T12",
        "sentence": "One exception is @CHEMICAL$ (TXA), which, as a lysine mimetic, inhibits binding of plasminogen to @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23521080.T1.T11",
        "sentence": "One exception is @CHEMICAL$ (TXA), which, as a lysine mimetic, inhibits binding of @GENE$ to fibrin.",
        "relation": "CPR:4"
    },
    {
        "id": "23521080.T2.T12",
        "sentence": "One exception is tranexamic acid (@CHEMICAL$), which, as a lysine mimetic, inhibits binding of plasminogen to @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23521080.T2.T11",
        "sentence": "One exception is tranexamic acid (@CHEMICAL$), which, as a lysine mimetic, inhibits binding of @GENE$ to fibrin.",
        "relation": "CPR:4"
    },
    {
        "id": "23521080.T3.T12",
        "sentence": "One exception is tranexamic acid (TXA), which, as a @CHEMICAL$ mimetic, inhibits binding of plasminogen to @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23521080.T3.T11",
        "sentence": "One exception is tranexamic acid (TXA), which, as a @CHEMICAL$ mimetic, inhibits binding of @GENE$ to fibrin.",
        "relation": "CPR:4"
    },
    {
        "id": "23521080.T6.T13",
        "sentence": "In this study, we report a computational approach, where the focus was on finding electrostatic potential similarities to TXA. Coupling this computational technique with a high-quality low-throughput screen identified @CHEMICAL$ (4-PIOL) as a potent @GENE$ binding inhibitor with the potential for the treatment of various bleeding disorders.",
        "relation": "CPR:4"
    },
    {
        "id": "23521080.T7.T13",
        "sentence": "In this study, we report a computational approach, where the focus was on finding electrostatic potential similarities to TXA. Coupling this computational technique with a high-quality low-throughput screen identified 5-(4-piperidyl)-3-isoxazolol (@CHEMICAL$) as a potent @GENE$ binding inhibitor with the potential for the treatment of various bleeding disorders.",
        "relation": "CPR:4"
    },
    {
        "id": "16835395.T4.T24",
        "sentence": "Epididymal tissue from wild-type mice responded in vitro to @CHEMICAL$ and isoprenaline with increased glycerol release, reduced @GENE$ release, and increased cAMP accumulation.",
        "relation": "CPR:4"
    },
    {
        "id": "16835395.T5.T24",
        "sentence": "Epididymal tissue from wild-type mice responded in vitro to noradrenaline and @CHEMICAL$ with increased glycerol release, reduced @GENE$ release, and increased cAMP accumulation.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T14.T29",
        "sentence": "@CHEMICAL$ inhibitors @GENE$ and arachidonyl trifluoromethyl ketone suppressed interleukin-2 (IL-2) expression in murine primary splenocytes.",
        "relation": "CPR:3"
    },
    {
        "id": "10207608.T14.T30",
        "sentence": "Phospholipase A2 inhibitors @CHEMICAL$ and arachidonyl trifluoromethyl ketone suppressed @GENE$ (IL-2) expression in murine primary splenocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T14.T31",
        "sentence": "Phospholipase A2 inhibitors @CHEMICAL$ and arachidonyl trifluoromethyl ketone suppressed interleukin-2 (@GENE$) expression in murine primary splenocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T15.T29",
        "sentence": "@CHEMICAL$ inhibitors p-bromophenacyl bromide and @GENE$ suppressed interleukin-2 (IL-2) expression in murine primary splenocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T15.T30",
        "sentence": "Phospholipase A2 inhibitors p-bromophenacyl bromide and @CHEMICAL$ suppressed @GENE$ (IL-2) expression in murine primary splenocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T15.T31",
        "sentence": "Phospholipase A2 inhibitors p-bromophenacyl bromide and @CHEMICAL$ suppressed interleukin-2 (@GENE$) expression in murine primary splenocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T1.T18",
        "sentence": "Therefore, the objective of the present study was to investigate the effects of @CHEMICAL$ inhibitors @GENE$ (BPB) and arachidonyl trifluoromethyl ketone (AACOCF3) on interleukin-2 (IL-2) expression in murine primary splenocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T2.T18",
        "sentence": "Therefore, the objective of the present study was to investigate the effects of @CHEMICAL$ inhibitors p-bromophenacyl bromide (@GENE$) and arachidonyl trifluoromethyl ketone (AACOCF3) on interleukin-2 (IL-2) expression in murine primary splenocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T3.T18",
        "sentence": "Therefore, the objective of the present study was to investigate the effects of @CHEMICAL$ inhibitors p-bromophenacyl bromide (BPB) and @GENE$ (AACOCF3) on interleukin-2 (IL-2) expression in murine primary splenocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T4.T18",
        "sentence": "Therefore, the objective of the present study was to investigate the effects of @CHEMICAL$ inhibitors p-bromophenacyl bromide (BPB) and arachidonyl trifluoromethyl ketone (@GENE$) on interleukin-2 (IL-2) expression in murine primary splenocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T5.T22",
        "sentence": "Pretreatment of the splenocytes with both @CHEMICAL$ and AACOCF3 suppressed phorbol 12-myristate 13-acetate plus ionomycin-induced @GENE$ secretion in a concentration-dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T6.T22",
        "sentence": "Pretreatment of the splenocytes with both BPB and @CHEMICAL$ suppressed phorbol 12-myristate 13-acetate plus ionomycin-induced @GENE$ secretion in a concentration-dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T7.T22",
        "sentence": "Pretreatment of the splenocytes with both BPB and AACOCF3 suppressed @CHEMICAL$ plus ionomycin-induced @GENE$ secretion in a concentration-dependent manner.",
        "relation": "CPR:3"
    },
    {
        "id": "10207608.T8.T23",
        "sentence": "Inhibition > 90% of @CHEMICAL$ secretion was observed at 1 microM @GENE$ and 10 microM AACOCF3 compared to the respective vehicle control.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T9.T23",
        "sentence": "Inhibition > 90% of @CHEMICAL$ secretion was observed at 1 microM BPB and 10 microM @GENE$ compared to the respective vehicle control.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T10.T24",
        "sentence": "Likewise, @CHEMICAL$ steady-state mRNA expression was inhibited by both PLA2 inhibitors in a concentration-dependent fashion with > 90% inhibition at 1 microM @GENE$ and 20 microM AACOCF3.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T10.T25",
        "sentence": "Likewise, IL-2 steady-state mRNA expression was inhibited by both @CHEMICAL$ inhibitors in a concentration-dependent fashion with > 90% inhibition at 1 microM @GENE$ and 20 microM AACOCF3.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T11.T24",
        "sentence": "Likewise, @CHEMICAL$ steady-state mRNA expression was inhibited by both PLA2 inhibitors in a concentration-dependent fashion with > 90% inhibition at 1 microM BPB and 20 microM @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T11.T25",
        "sentence": "Likewise, IL-2 steady-state mRNA expression was inhibited by both @CHEMICAL$ inhibitors in a concentration-dependent fashion with > 90% inhibition at 1 microM BPB and 20 microM @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T12.T27",
        "sentence": "Taken together, these data demonstrated that @CHEMICAL$ inhibitors @GENE$ and AACOCF3 are robust inhibitors of IL-2 expression at both the mRNA and protein levels in murine splenocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T12.T28",
        "sentence": "Taken together, these data demonstrated that PLA2 inhibitors @CHEMICAL$ and AACOCF3 are robust inhibitors of @GENE$ expression at both the mRNA and protein levels in murine splenocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T13.T27",
        "sentence": "Taken together, these data demonstrated that @CHEMICAL$ inhibitors BPB and @GENE$ are robust inhibitors of IL-2 expression at both the mRNA and protein levels in murine splenocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "10207608.T13.T28",
        "sentence": "Taken together, these data demonstrated that PLA2 inhibitors BPB and @CHEMICAL$ are robust inhibitors of @GENE$ expression at both the mRNA and protein levels in murine splenocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "23127916.T6.T13",
        "sentence": "The two basic mainstays of gastrointestinal stromal tumours (GIST) treatment are surgery and @CHEMICAL$, a selective @GENE$ inhibitor that allows achieving a stable or responding disease in about 80% of patients with unresectable/metastatic GIST.",
        "relation": "CPR:4"
    },
    {
        "id": "22878908.T3.T22",
        "sentence": "We have previously reported that @CHEMICAL$ reduce estrogen synthesis by inhibiting @GENE$ activity in human granulosa cells (HGC).",
        "relation": "CPR:4"
    },
    {
        "id": "22878908.T4.T22",
        "sentence": "We have previously reported that TZDs reduce @CHEMICAL$ synthesis by inhibiting @GENE$ activity in human granulosa cells (HGC).",
        "relation": "CPR:9"
    },
    {
        "id": "22878908.T7.T24",
        "sentence": "We studied mouse osteoblasts alone or in a co-culture with HGC to determine whether @CHEMICAL$ inhibition of @GENE$ plays a role in their effects on bone metabolism.",
        "relation": "CPR:4"
    },
    {
        "id": "22878908.T15.T27",
        "sentence": "@CHEMICAL$ also inhibited @GENE$ activity (58-75%, p<0.046) and osteocalcin production (52-75%, p<0.031).",
        "relation": "CPR:4"
    },
    {
        "id": "22878908.T15.T28",
        "sentence": "@CHEMICAL$ also inhibited alkaline phosphatase activity (58-75%, p<0.046) and @GENE$ production (52-75%, p<0.031).",
        "relation": "CPR:4"
    },
    {
        "id": "22878908.T2.T21",
        "sentence": "@CHEMICAL$ effects on osteoblast viability, oleic acid uptake, alkaline phosphatase and osteocalcin production are independent of their effects on @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15155769.T5.T19",
        "sentence": "@CHEMICAL$ (CrAT) catalyze the reversible conversion of @GENE$ and carnitine to acetylcarnitine and free CoA. To redesign the specificity of rat CrAT toward its substrates, we mutated Met564.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T5.T25",
        "sentence": "Carnitine acetyltransferases (@CHEMICAL$) catalyze the reversible conversion of @GENE$ and carnitine to acetylcarnitine and free CoA. To redesign the specificity of rat CrAT toward its substrates, we mutated Met564.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T6.T19",
        "sentence": "@CHEMICAL$ (CrAT) catalyze the reversible conversion of acetyl-CoA and @GENE$ to acetylcarnitine and free CoA. To redesign the specificity of rat CrAT toward its substrates, we mutated Met564.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T6.T25",
        "sentence": "Carnitine acetyltransferases (@CHEMICAL$) catalyze the reversible conversion of acetyl-CoA and @GENE$ to acetylcarnitine and free CoA. To redesign the specificity of rat CrAT toward its substrates, we mutated Met564.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T7.T19",
        "sentence": "@CHEMICAL$ (CrAT) catalyze the reversible conversion of acetyl-CoA and carnitine to @GENE$ and free CoA. To redesign the specificity of rat CrAT toward its substrates, we mutated Met564.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T7.T25",
        "sentence": "Carnitine acetyltransferases (@CHEMICAL$) catalyze the reversible conversion of acetyl-CoA and carnitine to @GENE$ and free CoA. To redesign the specificity of rat CrAT toward its substrates, we mutated Met564.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T8.T27",
        "sentence": "The @CHEMICAL$ mutated CrAT showed higher activity toward longer chain @GENE$: activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, acetyl-CoA. Kinetic constants of the mutant CrAT showed modification in favor of longer acyl-CoAs as substrates.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T8.T28",
        "sentence": "The M564G mutated @CHEMICAL$ showed higher activity toward longer chain @GENE$: activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, acetyl-CoA. Kinetic constants of the mutant CrAT showed modification in favor of longer acyl-CoAs as substrates.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T8.T29",
        "sentence": "The M564G mutated CrAT showed higher activity toward longer chain @CHEMICAL$: activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type @GENE$, and lower activity toward its natural substrate, acetyl-CoA. Kinetic constants of the mutant CrAT showed modification in favor of longer acyl-CoAs as substrates.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T9.T27",
        "sentence": "The @CHEMICAL$ mutated CrAT showed higher activity toward longer chain acyl-CoAs: activity toward @GENE$ was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, acetyl-CoA. Kinetic constants of the mutant CrAT showed modification in favor of longer acyl-CoAs as substrates.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T9.T28",
        "sentence": "The M564G mutated @CHEMICAL$ showed higher activity toward longer chain acyl-CoAs: activity toward @GENE$ was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, acetyl-CoA. Kinetic constants of the mutant CrAT showed modification in favor of longer acyl-CoAs as substrates.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T9.T29",
        "sentence": "The M564G mutated CrAT showed higher activity toward longer chain acyl-CoAs: activity toward @CHEMICAL$ was 1250-fold higher than that of the wild-type @GENE$, and lower activity toward its natural substrate, acetyl-CoA. Kinetic constants of the mutant CrAT showed modification in favor of longer acyl-CoAs as substrates.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T10.T27",
        "sentence": "The @CHEMICAL$ mutated CrAT showed higher activity toward longer chain acyl-CoAs: activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, @GENE$. Kinetic constants of the mutant CrAT showed modification in favor of longer acyl-CoAs as substrates.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T10.T28",
        "sentence": "The M564G mutated @CHEMICAL$ showed higher activity toward longer chain acyl-CoAs: activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, @GENE$. Kinetic constants of the mutant CrAT showed modification in favor of longer acyl-CoAs as substrates.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T10.T29",
        "sentence": "The M564G mutated CrAT showed higher activity toward longer chain acyl-CoAs: activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type @CHEMICAL$, and lower activity toward its natural substrate, @GENE$. Kinetic constants of the mutant CrAT showed modification in favor of longer acyl-CoAs as substrates.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T11.T30",
        "sentence": "The M564G mutated CrAT showed higher activity toward longer chain acyl-CoAs: activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, acetyl-CoA. Kinetic constants of the mutant @CHEMICAL$ showed modification in favor of longer @GENE$ as substrates.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T15.T32",
        "sentence": "In the reverse case, mutation of the orthologous glycine (Gly553) to methionine in @CHEMICAL$ (COT) decreased activity toward its natural substrates, medium- and long-chain @GENE$, and increased activity toward short-chain acyl-CoAs.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T15.T33",
        "sentence": "In the reverse case, mutation of the orthologous glycine (Gly553) to methionine in carnitine octanoyltransferase (@CHEMICAL$) decreased activity toward its natural substrates, medium- and long-chain @GENE$, and increased activity toward short-chain acyl-CoAs.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T16.T32",
        "sentence": "In the reverse case, mutation of the orthologous glycine (Gly553) to methionine in @CHEMICAL$ (COT) decreased activity toward its natural substrates, medium- and long-chain acyl-CoAs, and increased activity toward short-chain @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T16.T33",
        "sentence": "In the reverse case, mutation of the orthologous glycine (Gly553) to methionine in carnitine octanoyltransferase (@CHEMICAL$) decreased activity toward its natural substrates, medium- and long-chain acyl-CoAs, and increased activity toward short-chain @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "15155769.T1.T20",
        "sentence": "We conclude that Met564 blocks the entry of medium- and long-chain @CHEMICAL$ to the catalytic site of @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "2226440.T1.T25",
        "sentence": "@CHEMICAL$ (adrenaline, noradrenaline and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (@GENE$, EC 1.14.16.1).",
        "relation": "CPR:4"
    },
    {
        "id": "2226440.T1.T26",
        "sentence": "@CHEMICAL$ (adrenaline, noradrenaline and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (phenylalanine hydroxylase, @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "2226440.T1.T30",
        "sentence": "@CHEMICAL$ (adrenaline, noradrenaline and dopamine) are potent inhibitors of @GENE$ (phenylalanine hydroxylase, EC 1.14.16.1).",
        "relation": "CPR:4"
    },
    {
        "id": "2226440.T11.T25",
        "sentence": "Catecholamines (@CHEMICAL$, noradrenaline and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (@GENE$, EC 1.14.16.1).",
        "relation": "CPR:4"
    },
    {
        "id": "2226440.T11.T26",
        "sentence": "Catecholamines (@CHEMICAL$, noradrenaline and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (phenylalanine hydroxylase, @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "2226440.T11.T30",
        "sentence": "Catecholamines (@CHEMICAL$, noradrenaline and dopamine) are potent inhibitors of @GENE$ (phenylalanine hydroxylase, EC 1.14.16.1).",
        "relation": "CPR:4"
    },
    {
        "id": "2226440.T15.T25",
        "sentence": "Catecholamines (adrenaline, @CHEMICAL$ and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (@GENE$, EC 1.14.16.1).",
        "relation": "CPR:4"
    },
    {
        "id": "2226440.T15.T26",
        "sentence": "Catecholamines (adrenaline, @CHEMICAL$ and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (phenylalanine hydroxylase, @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "2226440.T15.T30",
        "sentence": "Catecholamines (adrenaline, @CHEMICAL$ and dopamine) are potent inhibitors of @GENE$ (phenylalanine hydroxylase, EC 1.14.16.1).",
        "relation": "CPR:4"
    },
    {
        "id": "2226440.T16.T25",
        "sentence": "Catecholamines (adrenaline, noradrenaline and @CHEMICAL$) are potent inhibitors of phenylalanine 4-monooxygenase (@GENE$, EC 1.14.16.1).",
        "relation": "CPR:4"
    },
    {
        "id": "2226440.T16.T26",
        "sentence": "Catecholamines (adrenaline, noradrenaline and @CHEMICAL$) are potent inhibitors of phenylalanine 4-monooxygenase (phenylalanine hydroxylase, @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "2226440.T16.T30",
        "sentence": "Catecholamines (adrenaline, noradrenaline and @CHEMICAL$) are potent inhibitors of @GENE$ (phenylalanine hydroxylase, EC 1.14.16.1).",
        "relation": "CPR:4"
    },
    {
        "id": "23256725.T2.T13",
        "sentence": "Central and peripheral administration of @CHEMICAL$ stimulates the hypothalamic-pituitary-gonadal (HPG) axis whilst pre-administration of a @GENE$ (GnRH) antagonist abolishes this effect.",
        "relation": "CPR:4"
    },
    {
        "id": "23256725.T3.T13",
        "sentence": "Central and peripheral administration of @CHEMICAL$ stimulates the hypothalamic-pituitary-gonadal (HPG) axis whilst pre-administration of a gonadotrophin releasing hormone (@GENE$) antagonist abolishes this effect.",
        "relation": "CPR:4"
    },
    {
        "id": "12188035.T5.T20",
        "sentence": "@CHEMICAL$ (DEX), betamethasone (BM), and their esterified-derivatives had full transrepression agonistic activity in a reporter assay using CV-1 cells transfected with either @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "12188035.T6.T20",
        "sentence": "Dexamethasone (@CHEMICAL$), betamethasone (BM), and their esterified-derivatives had full transrepression agonistic activity in a reporter assay using CV-1 cells transfected with either @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "12188035.T7.T20",
        "sentence": "Dexamethasone (DEX), @CHEMICAL$ (BM), and their esterified-derivatives had full transrepression agonistic activity in a reporter assay using CV-1 cells transfected with either @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "12188035.T8.T20",
        "sentence": "Dexamethasone (DEX), betamethasone (@CHEMICAL$), and their esterified-derivatives had full transrepression agonistic activity in a reporter assay using CV-1 cells transfected with either @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "12188035.T9.T22",
        "sentence": "The esterified-@CHEMICAL$, however, had only partial transactivation agonistic activity in cells transfected with @GENE$, whereas BM and esterified-DEX had full transactivation agonistic activity.",
        "relation": "CPR:5"
    },
    {
        "id": "12188035.T10.T22",
        "sentence": "The esterified-BM, however, had only partial transactivation agonistic activity in cells transfected with @CHEMICAL$, whereas @GENE$ and esterified-DEX had full transactivation agonistic activity.",
        "relation": "CPR:5"
    },
    {
        "id": "12188035.T11.T22",
        "sentence": "The esterified-BM, however, had only partial transactivation agonistic activity in cells transfected with @CHEMICAL$, whereas BM and esterified-@GENE$ had full transactivation agonistic activity.",
        "relation": "CPR:5"
    },
    {
        "id": "12188035.T1.T14",
        "sentence": "Moreover, in rat hepatoma H4-II-E cells, the esterified-@CHEMICAL$ failed to induce tyrosine aminotransferase, which is regulated by @GENE$-mediated transactivation activity.",
        "relation": "CPR:5"
    },
    {
        "id": "12188035.T3.T16",
        "sentence": "Consistent with the weak transactivation activity of esterified-@CHEMICAL$ mediated by @GENE$, there were few side effects, evaluated by thymus involution and body weight loss, in an antigen-induced asthmatic model in rats.",
        "relation": "CPR:5"
    },
    {
        "id": "11089538.T2.T9",
        "sentence": "Moreover, @CHEMICAL$ noticeably increased in response to TGF-beta1 and @GENE$ (atRA) in HPEC and PC-3 cells, and it decreased in response to IGF-I in HPEC.",
        "relation": "CPR:3"
    },
    {
        "id": "11089538.T3.T9",
        "sentence": "Moreover, @CHEMICAL$ noticeably increased in response to TGF-beta1 and all-trans retinoic acid (@GENE$) in HPEC and PC-3 cells, and it decreased in response to IGF-I in HPEC.",
        "relation": "CPR:3"
    },
    {
        "id": "11089538.T5.T20",
        "sentence": "Although the data collected on @CHEMICAL$ in prostate are modest, its role as a growth stimulator and/or protooncogene is supported by its preferential expression in cancerous cells and its down-regulation by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15921304.T4.T10",
        "sentence": "On the basis of FIP1L1-PDGFRa fusion gene hypereosinophilic syndrome would be classified as a clonal disease and in the FIP1L1-PDGFRa positive cases the @CHEMICAL$ inhibitor @GENE$ (Glivec) would be effective.",
        "relation": "CPR:4"
    },
    {
        "id": "23327877.T16.T31",
        "sentence": "Transport by @CHEMICAL$ and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several @GENE$ derivatives.",
        "relation": "CPR:9"
    },
    {
        "id": "23327877.T16.T32",
        "sentence": "Transport by OATP1B1 and @CHEMICAL$ enhances the cytotoxicity of epigallocatechin 3-O-gallate and several @GENE$ derivatives.",
        "relation": "CPR:9"
    },
    {
        "id": "23327877.T17.T31",
        "sentence": "Transport by @CHEMICAL$ and OATP1B3 enhances the cytotoxicity of @GENE$ and several quercetin derivatives.",
        "relation": "CPR:9"
    },
    {
        "id": "23327877.T17.T32",
        "sentence": "Transport by OATP1B1 and @CHEMICAL$ enhances the cytotoxicity of @GENE$ and several quercetin derivatives.",
        "relation": "CPR:9"
    },
    {
        "id": "23327877.T11.T27",
        "sentence": "Uptake of the radiolabeled model substrates @CHEMICAL$, estrone 3-sulfate, and dehydroepiandrosterone sulfate (DHEAS) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary (CHO) cells stably expressing either @GENE$ or OATP1B3.",
        "relation": "CPR:9"
    },
    {
        "id": "23327877.T11.T28",
        "sentence": "Uptake of the radiolabeled model substrates @CHEMICAL$, estrone 3-sulfate, and dehydroepiandrosterone sulfate (DHEAS) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary (CHO) cells stably expressing either OATP1B1 or @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23327877.T12.T27",
        "sentence": "Uptake of the radiolabeled model substrates estradiol 17b-glucuronide, @CHEMICAL$, and dehydroepiandrosterone sulfate (DHEAS) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary (CHO) cells stably expressing either @GENE$ or OATP1B3.",
        "relation": "CPR:9"
    },
    {
        "id": "23327877.T12.T28",
        "sentence": "Uptake of the radiolabeled model substrates estradiol 17b-glucuronide, @CHEMICAL$, and dehydroepiandrosterone sulfate (DHEAS) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary (CHO) cells stably expressing either OATP1B1 or @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23327877.T13.T27",
        "sentence": "Uptake of the radiolabeled model substrates estradiol 17b-glucuronide, estrone 3-sulfate, and @CHEMICAL$ (DHEAS) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary (CHO) cells stably expressing either @GENE$ or OATP1B3.",
        "relation": "CPR:9"
    },
    {
        "id": "23327877.T13.T28",
        "sentence": "Uptake of the radiolabeled model substrates estradiol 17b-glucuronide, estrone 3-sulfate, and @CHEMICAL$ (DHEAS) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary (CHO) cells stably expressing either OATP1B1 or @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23327877.T14.T27",
        "sentence": "Uptake of the radiolabeled model substrates estradiol 17b-glucuronide, estrone 3-sulfate, and dehydroepiandrosterone sulfate (@CHEMICAL$) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary (CHO) cells stably expressing either @GENE$ or OATP1B3.",
        "relation": "CPR:9"
    },
    {
        "id": "23327877.T14.T28",
        "sentence": "Uptake of the radiolabeled model substrates estradiol 17b-glucuronide, estrone 3-sulfate, and dehydroepiandrosterone sulfate (@CHEMICAL$) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary (CHO) cells stably expressing either OATP1B1 or @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23327877.T15.T19",
        "sentence": "Compound 6 stimulated OATP1B3-mediated @CHEMICAL$ uptake by increasing the apparent affinity of @GENE$ for its substrate.",
        "relation": "CPR:9"
    },
    {
        "id": "23327877.T15.T30",
        "sentence": "Compound 6 stimulated @CHEMICAL$-mediated @GENE$ uptake by increasing the apparent affinity of OATP1B3 for its substrate.",
        "relation": "CPR:9"
    },
    {
        "id": "23327877.T1.T20",
        "sentence": "Cytotoxicity assays demonstrated that @CHEMICAL$ (EGCG) and most of compounds 1-6 killed preferentially @GENE$-expressing CHO cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23327877.T2.T20",
        "sentence": "Cytotoxicity assays demonstrated that epigallocatechin 3-O-gallate (@CHEMICAL$) and most of compounds 1-6 killed preferentially @GENE$-expressing CHO cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23327877.T4.T21",
        "sentence": "EGCG, 1, and 3 were the most potent cytotoxic compounds, with @CHEMICAL$ and 3 selectively killing @GENE$-expressing cells.",
        "relation": "CPR:9"
    },
    {
        "id": "16633143.T10.T19",
        "sentence": "@CHEMICAL$, a selective norepinephrine reuptake inhibitor, exhibits high affinity and selectivity for the @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23473681.T2.T13",
        "sentence": "We previously employed a chemical genomic strategy to identify a novel small molecule, @CHEMICAL$, as a likely inhibitor of the @GENE$ targeting chaperone, LolA. Here, we report on the degradation of MAC13243 into the active species, S-(4-chlorobenzyl)isothiourea.",
        "relation": "CPR:4"
    },
    {
        "id": "23473681.T2.T14",
        "sentence": "We previously employed a chemical genomic strategy to identify a novel small molecule, @CHEMICAL$, as a likely inhibitor of the bacterial lipoprotein targeting @GENE$, LolA. Here, we report on the degradation of MAC13243 into the active species, S-(4-chlorobenzyl)isothiourea.",
        "relation": "CPR:4"
    },
    {
        "id": "23473681.T2.T15",
        "sentence": "We previously employed a chemical genomic strategy to identify a novel small molecule, @CHEMICAL$, as a likely inhibitor of the bacterial lipoprotein targeting chaperone, @GENE$. Here, we report on the degradation of MAC13243 into the active species, S-(4-chlorobenzyl)isothiourea.",
        "relation": "CPR:4"
    },
    {
        "id": "23391485.T1.T14",
        "sentence": "Our results showed that low dose BPA and E2 could influence the mammosphere area of iDMECs and upregulate the expression level of Oct4 and Nanog proteins, while only @CHEMICAL$ could downregulate the expression of @GENE$ protein.",
        "relation": "CPR:4"
    },
    {
        "id": "23391485.T10.T12",
        "sentence": "Our results showed that low dose @CHEMICAL$ and E2 could influence the mammosphere area of iDMECs and upregulate the expression level of @GENE$ and Nanog proteins, while only BPA could downregulate the expression of E-cadherin protein.",
        "relation": "CPR:3"
    },
    {
        "id": "23391485.T10.T13",
        "sentence": "Our results showed that low dose @CHEMICAL$ and E2 could influence the mammosphere area of iDMECs and upregulate the expression level of Oct4 and @GENE$ proteins, while only BPA could downregulate the expression of E-cadherin protein.",
        "relation": "CPR:3"
    },
    {
        "id": "23473804.T15.T32",
        "sentence": "To this end, 158N murine oligodendrocytes were treated with @CHEMICAL$ or 7bOHC inducing an apoptotic mode of cell death characterized by condensation/fragmentation of the nuclei, dephosphorylation of Akt and GSK3, mitochondrial depolarization involving @GENE$, and caspase-3 activation.",
        "relation": "CPR:3"
    },
    {
        "id": "23473804.T15.T33",
        "sentence": "To this end, 158N murine oligodendrocytes were treated with @CHEMICAL$ or 7bOHC inducing an apoptotic mode of cell death characterized by condensation/fragmentation of the nuclei, dephosphorylation of Akt and GSK3, mitochondrial depolarization involving Mcl-1, and @GENE$ activation.",
        "relation": "CPR:3"
    },
    {
        "id": "23473804.T16.T32",
        "sentence": "To this end, 158N murine oligodendrocytes were treated with 7KC or @CHEMICAL$ inducing an apoptotic mode of cell death characterized by condensation/fragmentation of the nuclei, dephosphorylation of Akt and GSK3, mitochondrial depolarization involving @GENE$, and caspase-3 activation.",
        "relation": "CPR:3"
    },
    {
        "id": "23473804.T16.T33",
        "sentence": "To this end, 158N murine oligodendrocytes were treated with 7KC or @CHEMICAL$ inducing an apoptotic mode of cell death characterized by condensation/fragmentation of the nuclei, dephosphorylation of Akt and GSK3, mitochondrial depolarization involving Mcl-1, and @GENE$ activation.",
        "relation": "CPR:3"
    },
    {
        "id": "23473804.T12.T28",
        "sentence": "Thus, in 158N cells, the ability of @CHEMICAL$ to trigger a mode of cell death by apoptosis involving @GENE$ and caspase-3 activation is independent of the increase in the Ca(2+) level and of their accumulation in lipid raft microdomains.",
        "relation": "CPR:3"
    },
    {
        "id": "23473804.T12.T29",
        "sentence": "Thus, in 158N cells, the ability of @CHEMICAL$ to trigger a mode of cell death by apoptosis involving GSK-3 and @GENE$ activation is independent of the increase in the Ca(2+) level and of their accumulation in lipid raft microdomains.",
        "relation": "CPR:3"
    },
    {
        "id": "12566304.T9.T32",
        "sentence": "@CHEMICAL$ inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and @GENE$ in human colon cancer cells.",
        "relation": "CPR:4"
    },
    {
        "id": "12566304.T9.T33",
        "sentence": "@CHEMICAL$ inhibits @GENE$-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.",
        "relation": "CPR:4"
    },
    {
        "id": "12566304.T5.T18",
        "sentence": "@CHEMICAL$ and selective @GENE$ inhibitors cause regression of colonic polyps in familial polyposis patients.",
        "relation": "CPR:4"
    },
    {
        "id": "12566304.T8.T24",
        "sentence": "@CHEMICAL$ metabolites and other nonsteroidal anti-inflammatory drugs selectively inhibit @GENE$ phosphorylation in human colon cancer cells.",
        "relation": "CPR:4"
    },
    {
        "id": "12566304.T1.T10",
        "sentence": "EGF-stimulated phosphorylation of ERK and Bad is blocked by pretreatment with @CHEMICAL$, a selective @GENE$ inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "12566304.T1.T30",
        "sentence": "EGF-stimulated phosphorylation of @CHEMICAL$ and Bad is blocked by pretreatment with @GENE$, a selective MAP kinase kinase (MKK)1/2 inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "12566304.T1.T29",
        "sentence": "@CHEMICAL$-stimulated phosphorylation of ERK and Bad is blocked by pretreatment with @GENE$, a selective MAP kinase kinase (MKK)1/2 inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "12566304.T1.T31",
        "sentence": "EGF-stimulated phosphorylation of ERK and @CHEMICAL$ is blocked by pretreatment with @GENE$, a selective MAP kinase kinase (MKK)1/2 inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "12566304.T2.T11",
        "sentence": "Similarly, pretreatment with @CHEMICAL$ blocks the ability of @GENE$ to induce ERK1/2 and Bad phosphorylation, but also down-regulates total Bad but not ERK1/2 protein levels.",
        "relation": "CPR:4"
    },
    {
        "id": "12566304.T2.T13",
        "sentence": "Similarly, pretreatment with @CHEMICAL$ blocks the ability of EGF to induce ERK1/2 and @GENE$ phosphorylation, but also down-regulates total Bad but not ERK1/2 protein levels.",
        "relation": "CPR:4"
    },
    {
        "id": "12566304.T2.T14",
        "sentence": "Similarly, pretreatment with @CHEMICAL$ blocks the ability of EGF to induce ERK1/2 and Bad phosphorylation, but also down-regulates total @GENE$ but not ERK1/2 protein levels.",
        "relation": "CPR:4"
    },
    {
        "id": "12566304.T3.T16",
        "sentence": "The ability of @CHEMICAL$ to block @GENE$ signaling by the EGF receptor may account for at least part of its potent growth-inhibitory effects against cancer cells.",
        "relation": "CPR:4"
    },
    {
        "id": "12566304.T3.T17",
        "sentence": "The ability of @CHEMICAL$ to block ERK1/2 signaling by the @GENE$ may account for at least part of its potent growth-inhibitory effects against cancer cells.",
        "relation": "CPR:4"
    },
    {
        "id": "20573261.T2.T22",
        "sentence": "After inflammation was established mice were dosed with the @CHEMICAL$ antagonist, @GENE$, or anti-IL-13 antibody for comparison.",
        "relation": "CPR:6"
    },
    {
        "id": "17197042.T8.T25",
        "sentence": "Development and validation of a non-radioactive @CHEMICAL$ assay for studying cytomegalovirus resistance to @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17197042.T1.T9",
        "sentence": "The activity of polymerases containing mutations known to confer resistance to foscarnet (V715M, T700A and N495K) was inhibited by concentrations of @CHEMICAL$ eight to 14 times higher than those required to inhibit wild-type @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17197042.T1.T21",
        "sentence": "The activity of @CHEMICAL$ containing mutations known to confer resistance to foscarnet (V715M, T700A and N495K) was inhibited by concentrations of @GENE$ eight to 14 times higher than those required to inhibit wild-type polymerases.",
        "relation": "CPR:4"
    },
    {
        "id": "17197042.T1.T22",
        "sentence": "The activity of polymerases containing mutations known to confer resistance to foscarnet (@CHEMICAL$, T700A and N495K) was inhibited by concentrations of @GENE$ eight to 14 times higher than those required to inhibit wild-type polymerases.",
        "relation": "CPR:4"
    },
    {
        "id": "17197042.T1.T23",
        "sentence": "The activity of polymerases containing mutations known to confer resistance to foscarnet (V715M, @CHEMICAL$ and N495K) was inhibited by concentrations of @GENE$ eight to 14 times higher than those required to inhibit wild-type polymerases.",
        "relation": "CPR:4"
    },
    {
        "id": "17197042.T1.T24",
        "sentence": "The activity of polymerases containing mutations known to confer resistance to foscarnet (V715M, T700A and @CHEMICAL$) was inhibited by concentrations of @GENE$ eight to 14 times higher than those required to inhibit wild-type polymerases.",
        "relation": "CPR:4"
    },
    {
        "id": "23291323.T10.T14",
        "sentence": "Absorption and secretion of @CHEMICAL$ increase at acid pH levels, possibly because of its non-ionized state at these pHs and/or because of participation of a F(-)/H(+) cotransporter or a @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23291323.T10.T15",
        "sentence": "Absorption and secretion of @CHEMICAL$ increase at acid pH levels, possibly because of its non-ionized state at these pHs and/or because of participation of a @GENE$ or a F(-)/OH(-) antiporter.",
        "relation": "CPR:9"
    },
    {
        "id": "23265892.T7.T10",
        "sentence": "Structure activity relationship studies of @CHEMICAL$ @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23265892.T1.T9",
        "sentence": "An investigation is detailed of the structure activity relationships (SAR) of two sulfone side chains of compound (-)-1a (@CHEMICAL$), a potent, PS1-selective @GENE$ inhibitor and clinical candidate for the treatment of Alzheimer's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "23265892.T1.T8",
        "sentence": "An investigation is detailed of the structure activity relationships (SAR) of two sulfone side chains of compound (-)-1a (@CHEMICAL$), a potent, @GENE$-selective g-secretase inhibitor and clinical candidate for the treatment of Alzheimer's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "12388748.T5.T14",
        "sentence": "Culture of HepG2 cells with @CHEMICAL$ has now been shown to induce both the formation of intracellular aggregates containing @GENE$ as well as an increase in the abundance of K18 mRNA.",
        "relation": "CPR:3"
    },
    {
        "id": "12388748.T5.T15",
        "sentence": "Culture of HepG2 cells with @CHEMICAL$ has now been shown to induce both the formation of intracellular aggregates containing K18 as well as an increase in the abundance of @GENE$ mRNA.",
        "relation": "CPR:3"
    },
    {
        "id": "12398910.T1.T20",
        "sentence": "\"Low levels of @CHEMICAL$ may reduce the density of the @GENE$ (SERT) by either increasing trafficking or reducing synthesis; a \"\"neuroadaptive response\"\".\"",
        "relation": "CPR:4"
    },
    {
        "id": "12398910.T1.T22",
        "sentence": "\"Low levels of @CHEMICAL$ may reduce the density of the serotonin transporter (@GENE$) by either increasing trafficking or reducing synthesis; a \"\"neuroadaptive response\"\".\"",
        "relation": "CPR:4"
    },
    {
        "id": "12398910.T2.T17",
        "sentence": "To determine whether @CHEMICAL$ (MDMA)-induced reductions in @GENE$ density could be related to such a mechanism, p-chlorophenylalanine or MDMA was administered to rats, and brain serotonin and SERT density were measured.",
        "relation": "CPR:4"
    },
    {
        "id": "12398910.T3.T17",
        "sentence": "To determine whether 3,4-methylenedioxymethamphetamine (@CHEMICAL$)-induced reductions in @GENE$ density could be related to such a mechanism, p-chlorophenylalanine or MDMA was administered to rats, and brain serotonin and SERT density were measured.",
        "relation": "CPR:4"
    },
    {
        "id": "12398910.T8.T19",
        "sentence": "However, only @CHEMICAL$ reduced @GENE$ density.",
        "relation": "CPR:4"
    },
    {
        "id": "12398910.T10.T21",
        "sentence": "This observation suggests that @CHEMICAL$-induced reductions in @GENE$ density do not represent neuroadaptive responses to decreased levels of brain serotonin, but may occur in response to some other stimulus or to the neurotoxic effects of MDMA.",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T15.T40",
        "sentence": "@CHEMICAL$ improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/@GENE$ signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T15.T38",
        "sentence": "@CHEMICAL$ improves TNBS-induced colitis in rats by inhibiting @GENE$ expression via the TLR4/NF-kB signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T15.T39",
        "sentence": "@CHEMICAL$ improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the @GENE$/NF-kB signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T10.T31",
        "sentence": "This study explored whether @CHEMICAL$ improves colonic inflammation in a rat colitis model through inhibition of the TLR4/@GENE$ signaling pathway and IL-27 expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T10.T30",
        "sentence": "This study explored whether @CHEMICAL$ improves colonic inflammation in a rat colitis model through inhibition of the @GENE$/NF-kB signaling pathway and IL-27 expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T10.T32",
        "sentence": "This study explored whether @CHEMICAL$ improves colonic inflammation in a rat colitis model through inhibition of the TLR4/NF-kB signaling pathway and @GENE$ expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T14.T16",
        "sentence": "Compared with the untreated colitis group, the @CHEMICAL$-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of @GENE$ mRNA, IL-27 mRNA, TLR4 protein, NF-kB p65 protein, and IL-27 p28 protein (p < 0.05).",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T14.T19",
        "sentence": "Compared with the untreated colitis group, the @CHEMICAL$-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-kB mRNA, IL-27 mRNA, TLR4 protein, @GENE$ p65 protein, and IL-27 p28 protein (p < 0.05).",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T14.T17",
        "sentence": "Compared with the untreated colitis group, the @CHEMICAL$-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-kB mRNA, @GENE$ mRNA, TLR4 protein, NF-kB p65 protein, and IL-27 p28 protein (p < 0.05).",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T14.T18",
        "sentence": "Compared with the untreated colitis group, the @CHEMICAL$-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-kB mRNA, IL-27 mRNA, @GENE$ protein, NF-kB p65 protein, and IL-27 p28 protein (p < 0.05).",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T14.T20",
        "sentence": "Compared with the untreated colitis group, the @CHEMICAL$-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-kB mRNA, IL-27 mRNA, TLR4 protein, NF-kB @GENE$ protein, and IL-27 p28 protein (p < 0.05).",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T14.T21",
        "sentence": "Compared with the untreated colitis group, the @CHEMICAL$-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-kB mRNA, IL-27 mRNA, TLR4 protein, NF-kB p65 protein, and @GENE$ p28 protein (p < 0.05).",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T14.T22",
        "sentence": "Compared with the untreated colitis group, the @CHEMICAL$-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-kB mRNA, IL-27 mRNA, TLR4 protein, NF-kB p65 protein, and IL-27 @GENE$ protein (p < 0.05).",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T14.T37",
        "sentence": "Compared with the untreated colitis group, the @CHEMICAL$-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, @GENE$ activity, and expressions of NF-kB mRNA, IL-27 mRNA, TLR4 protein, NF-kB p65 protein, and IL-27 p28 protein (p < 0.05).",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T4.T25",
        "sentence": "There was no significant difference in TLR4, @CHEMICAL$, and IL-27 mRNA and proteins between @GENE$-treated and sulfasalazine-treated groups.",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T4.T24",
        "sentence": "There was no significant difference in @CHEMICAL$, NF-kB, and IL-27 mRNA and proteins between @GENE$-treated and sulfasalazine-treated groups.",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T4.T26",
        "sentence": "There was no significant difference in TLR4, NF-kB, and @CHEMICAL$ mRNA and proteins between @GENE$-treated and sulfasalazine-treated groups.",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T5.T25",
        "sentence": "There was no significant difference in TLR4, @CHEMICAL$, and IL-27 mRNA and proteins between curcumin-treated and @GENE$-treated groups.",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T5.T24",
        "sentence": "There was no significant difference in @CHEMICAL$, NF-kB, and IL-27 mRNA and proteins between curcumin-treated and @GENE$-treated groups.",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T5.T26",
        "sentence": "There was no significant difference in TLR4, NF-kB, and @CHEMICAL$ mRNA and proteins between curcumin-treated and @GENE$-treated groups.",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T9.T28",
        "sentence": "The anti-inflammatory actions of @CHEMICAL$ on colitis may involve inhibition of the TLR4/@GENE$ signaling pathway and of IL-27 expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T9.T27",
        "sentence": "The anti-inflammatory actions of @CHEMICAL$ on colitis may involve inhibition of the @GENE$/NF-kB signaling pathway and of IL-27 expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23250811.T9.T29",
        "sentence": "The anti-inflammatory actions of @CHEMICAL$ on colitis may involve inhibition of the TLR4/NF-kB signaling pathway and of @GENE$ expression.",
        "relation": "CPR:4"
    },
    {
        "id": "17418819.T1.T17",
        "sentence": "A @CHEMICAL$ inhibitor-@GENE$ (DIOA)-blocked RVD more in HCEC than RCEC.",
        "relation": "CPR:4"
    },
    {
        "id": "17418819.T2.T17",
        "sentence": "A @CHEMICAL$ inhibitor-[(dihydroindenyl)oxy] alkanoic acid (@GENE$)-blocked RVD more in HCEC than RCEC.",
        "relation": "CPR:4"
    },
    {
        "id": "17418819.T3.T18",
        "sentence": "Under isotonic conditions, @CHEMICAL$ (NEM) produced @GENE$ activation and transient cell shrinkage.",
        "relation": "CPR:3"
    },
    {
        "id": "17418819.T4.T18",
        "sentence": "Under isotonic conditions, N-ethylmaleimide (@CHEMICAL$) produced @GENE$ activation and transient cell shrinkage.",
        "relation": "CPR:3"
    },
    {
        "id": "3440035.T2.T13",
        "sentence": "Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists. Derivatives of @CHEMICAL$ are a new class of non-peptide cholecystokinin (@GENE$) antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "3440035.T2.T21",
        "sentence": "Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists. Derivatives of @CHEMICAL$ are a new class of non-peptide @GENE$ (CCK) antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "3440035.T12.T23",
        "sentence": "Pharmacological properties of @CHEMICAL$ as a member of a new class of @GENE$ antagonists. Derivatives of 5-(dipentylamino)-5-oxo-pentanoic acid are a new class of non-peptide cholecystokinin (CCK) antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "3440035.T1.T16",
        "sentence": "The most potent compound, @CHEMICAL$ (lorglumide, CR 1409), has a great affinity for the pancreatic CCK receptors and is a competitive, specific and potent @GENE$ antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the CCK-induced amylase secretion of isolated pancreatic acini.",
        "relation": "CPR:6"
    },
    {
        "id": "3440035.T3.T16",
        "sentence": "The most potent compound, D,L-4-(3,4-dichlorobenzoylamino)-5-(dipentylamino)-5-oxo-pen tanoic acid (@CHEMICAL$, CR 1409), has a great affinity for the pancreatic CCK receptors and is a competitive, specific and potent @GENE$ antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the CCK-induced amylase secretion of isolated pancreatic acini.",
        "relation": "CPR:6"
    },
    {
        "id": "3440035.T4.T16",
        "sentence": "The most potent compound, D,L-4-(3,4-dichlorobenzoylamino)-5-(dipentylamino)-5-oxo-pen tanoic acid (lorglumide, @CHEMICAL$), has a great affinity for the pancreatic CCK receptors and is a competitive, specific and potent @GENE$ antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the CCK-induced amylase secretion of isolated pancreatic acini.",
        "relation": "CPR:6"
    },
    {
        "id": "3440035.T5.T19",
        "sentence": "In vivo @CHEMICAL$ antagonizes the contraction of the gall bladder of the guinea pig and of the dog provoked by i.v. @GENE$ or ceruletide (caerulein).",
        "relation": "CPR:6"
    },
    {
        "id": "23495205.T1.T17",
        "sentence": "Synthesis and Structure-Activity Relationship Studies of Derivatives of the Dual Aromatase-Sulfatase Inhibitor 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate. @CHEMICAL$ and its ortho-halogenated (F, Cl, Br) derivatives are first-generation dual @GENE$ and sulfatase inhibitors (DASIs).",
        "relation": "CPR:4"
    },
    {
        "id": "23495205.T1.T18",
        "sentence": "Synthesis and Structure-Activity Relationship Studies of Derivatives of the Dual Aromatase-Sulfatase Inhibitor 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate. @CHEMICAL$ and its ortho-halogenated (F, Cl, Br) derivatives are first-generation dual aromatase and @GENE$ inhibitors (DASIs).",
        "relation": "CPR:4"
    },
    {
        "id": "23495205.T2.T17",
        "sentence": "Synthesis and Structure-Activity Relationship Studies of Derivatives of the Dual Aromatase-Sulfatase Inhibitor 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate. 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate and its ortho-halogenated (F, @CHEMICAL$, Br) derivatives are first-generation dual @GENE$ and sulfatase inhibitors (DASIs).",
        "relation": "CPR:4"
    },
    {
        "id": "23495205.T2.T18",
        "sentence": "Synthesis and Structure-Activity Relationship Studies of Derivatives of the Dual Aromatase-Sulfatase Inhibitor 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate. 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate and its ortho-halogenated (F, @CHEMICAL$, Br) derivatives are first-generation dual aromatase and @GENE$ inhibitors (DASIs).",
        "relation": "CPR:4"
    },
    {
        "id": "23495205.T3.T17",
        "sentence": "Synthesis and Structure-Activity Relationship Studies of Derivatives of the Dual Aromatase-Sulfatase Inhibitor 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate. 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate and its ortho-halogenated (F, Cl, @CHEMICAL$) derivatives are first-generation dual @GENE$ and sulfatase inhibitors (DASIs).",
        "relation": "CPR:4"
    },
    {
        "id": "23495205.T3.T18",
        "sentence": "Synthesis and Structure-Activity Relationship Studies of Derivatives of the Dual Aromatase-Sulfatase Inhibitor 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate. 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate and its ortho-halogenated (F, Cl, @CHEMICAL$) derivatives are first-generation dual aromatase and @GENE$ inhibitors (DASIs).",
        "relation": "CPR:4"
    },
    {
        "id": "23495205.T15.T17",
        "sentence": "Synthesis and Structure-Activity Relationship Studies of Derivatives of the Dual Aromatase-Sulfatase Inhibitor 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate. 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate and its ortho-halogenated (@CHEMICAL$, Cl, Br) derivatives are first-generation dual @GENE$ and sulfatase inhibitors (DASIs).",
        "relation": "CPR:4"
    },
    {
        "id": "23495205.T15.T18",
        "sentence": "Synthesis and Structure-Activity Relationship Studies of Derivatives of the Dual Aromatase-Sulfatase Inhibitor 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate. 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate and its ortho-halogenated (@CHEMICAL$, Cl, Br) derivatives are first-generation dual aromatase and @GENE$ inhibitors (DASIs).",
        "relation": "CPR:4"
    },
    {
        "id": "23495205.T16.T22",
        "sentence": "Synthesis and Structure-Activity Relationship Studies of Derivatives of the Dual @CHEMICAL$-Sulfatase Inhibitor @GENE$. 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate and its ortho-halogenated (F, Cl, Br) derivatives are first-generation dual aromatase and sulfatase inhibitors (DASIs).",
        "relation": "CPR:4"
    },
    {
        "id": "23495205.T16.T23",
        "sentence": "Synthesis and Structure-Activity Relationship Studies of Derivatives of the Dual Aromatase-@CHEMICAL$ Inhibitor @GENE$. 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate and its ortho-halogenated (F, Cl, Br) derivatives are first-generation dual aromatase and sulfatase inhibitors (DASIs).",
        "relation": "CPR:4"
    },
    {
        "id": "23495205.T12.T19",
        "sentence": "The most potent in vitro DASI discovered is an @CHEMICAL$ derivative with IC50 values against @GENE$ and steroid sulfatase in a JEG-3 cell preparation of 0.2 and 2.5 nM, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "23495205.T12.T20",
        "sentence": "The most potent in vitro DASI discovered is an @CHEMICAL$ derivative with IC50 values against aromatase and @GENE$ in a JEG-3 cell preparation of 0.2 and 2.5 nM, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "23495205.T14.T21",
        "sentence": "The parent @CHEMICAL$ of this compound inhibits @GENE$ with an IC50 value of 0.028 nM in the same assay.",
        "relation": "CPR:4"
    },
    {
        "id": "23127600.T7.T14",
        "sentence": "As revealed by glucose oxidase (GOD) and radioimmunoassay (RIA), both @CHEMICAL$ (DC, 0.6gkg(-1)d(-1)) and CPS (0.3, 0.6, 1.2gkg(-1)d(-1)) treatments significantly resulted in down-regulation of blood glucose and @GENE$ levels in serum, while the levels of oxidative stress markers were markedly lowered through ELISA assay.",
        "relation": "CPR:4"
    },
    {
        "id": "23127600.T1.T12",
        "sentence": "These findings demonstrate that cinnamon @CHEMICAL$ can exert the hypoglycemic and hypolipidemic effects through the mechanisms that may be associated with repairing pancreatic beta cells in diabetic mice and improving its anti-oxidative capacity, as well as attenuating cytotoxicity via inhibition of iNOS, @GENE$ activation.",
        "relation": "CPR:4"
    },
    {
        "id": "23127600.T1.T11",
        "sentence": "These findings demonstrate that cinnamon @CHEMICAL$ can exert the hypoglycemic and hypolipidemic effects through the mechanisms that may be associated with repairing pancreatic beta cells in diabetic mice and improving its anti-oxidative capacity, as well as attenuating cytotoxicity via inhibition of @GENE$, NF-kB activation.",
        "relation": "CPR:4"
    },
    {
        "id": "8263811.T21.T43",
        "sentence": "These nonadrenoceptor binding sites may explain certain novel platelet aggregatory properties previously ascribed to @CHEMICAL$ and endogenous clonidine-displacing substance(s), and may serve as markers of @GENE$ in humans.",
        "relation": "CPR:3"
    },
    {
        "id": "2886642.T24.T29",
        "sentence": "Effects of @CHEMICAL$, other @GENE$ antagonists and omeprazole on gastric acid secretory states in rats and dogs.",
        "relation": "CPR:6"
    },
    {
        "id": "2886642.T1.T27",
        "sentence": "@CHEMICAL$, a @GENE$ antagonist, inhibited gastric acid secretion in pylorus-ligated rats (ED50 = 4.9 mg/kg intraduodenal; 3.4 mg/kg p.o.; and 0.21 mg/kg i.p.) and in total gastric fistula or Heidenhain pouch dogs stimulated by betazole (ED50 = 0.12 mg/kg p.o. and 0.08 mg/kg i.v.), histamine, tetragastrin, bethanechol, 2-deoxy-D-glucose or a meal (ED50 values ranged from 0.11-0.26 mg/kg p.o.).",
        "relation": "CPR:6"
    },
    {
        "id": "17475673.T9.T28",
        "sentence": "This study examined the inward transport of @CHEMICAL$, an @GENE$ preferential substrate, in monolayers of immortalized renal proximal tubular epithelial (PTE) cells from Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats.",
        "relation": "CPR:9"
    },
    {
        "id": "17475673.T11.T29",
        "sentence": "In the presence of the system L inhibitor BCH, Na(+)-dependent @CHEMICAL$ uptake in WKY and SHR PTE cells was inhibited by alanine, serine, and cysteine, which is consistent with amino acid transport through @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17475673.T12.T29",
        "sentence": "In the presence of the system L inhibitor BCH, Na(+)-dependent l-alanine uptake in WKY and SHR PTE cells was inhibited by @CHEMICAL$, serine, and cysteine, which is consistent with amino acid transport through @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17475673.T13.T29",
        "sentence": "In the presence of the system L inhibitor BCH, Na(+)-dependent l-alanine uptake in WKY and SHR PTE cells was inhibited by alanine, @CHEMICAL$, and cysteine, which is consistent with amino acid transport through @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17475673.T14.T29",
        "sentence": "In the presence of the system L inhibitor BCH, Na(+)-dependent l-alanine uptake in WKY and SHR PTE cells was inhibited by alanine, serine, and @CHEMICAL$, which is consistent with amino acid transport through @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17475673.T15.T29",
        "sentence": "In the presence of the system L inhibitor BCH, Na(+)-dependent l-alanine uptake in WKY and SHR PTE cells was inhibited by alanine, serine, and cysteine, which is consistent with @CHEMICAL$ transport through @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17475673.T18.T22",
        "sentence": "Differences in magnitude of @CHEMICAL$-dependent l-alanine uptake through ASCT2 between WKY and SHR PTE cells correlated positively with differences in @GENE$ protein expression, this being more abundant in WKY PTE cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17475673.T19.T22",
        "sentence": "Differences in magnitude of Na(+)-dependent @CHEMICAL$ uptake through ASCT2 between WKY and SHR PTE cells correlated positively with differences in @GENE$ protein expression, this being more abundant in WKY PTE cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17475673.T19.T30",
        "sentence": "Differences in magnitude of Na(+)-dependent @CHEMICAL$ uptake through @GENE$ between WKY and SHR PTE cells correlated positively with differences in ASCT2 protein expression, this being more abundant in WKY PTE cells.",
        "relation": "CPR:9"
    },
    {
        "id": "17475673.T1.T24",
        "sentence": "In conclusion, immortalized SHR and WKY PTE cells take up @CHEMICAL$ mainly through a high-affinity @GENE$, with functional features of ASCT2 transport.",
        "relation": "CPR:9"
    },
    {
        "id": "17475673.T1.T25",
        "sentence": "In conclusion, immortalized SHR and WKY PTE cells take up @CHEMICAL$ mainly through a high-affinity Na(+)-dependent amino acid transporter, with functional features of @GENE$ transport.",
        "relation": "CPR:9"
    },
    {
        "id": "17475673.T2.T25",
        "sentence": "In conclusion, immortalized SHR and WKY PTE cells take up l-alanine mainly through a high-affinity @CHEMICAL$-dependent amino acid transporter, with functional features of @GENE$ transport.",
        "relation": "CPR:3"
    },
    {
        "id": "17475673.T3.T25",
        "sentence": "In conclusion, immortalized SHR and WKY PTE cells take up l-alanine mainly through a high-affinity Na(+)-dependent @CHEMICAL$ transporter, with functional features of @GENE$ transport.",
        "relation": "CPR:3"
    },
    {
        "id": "11511086.T12.T30",
        "sentence": "The antipsychotic drugs @CHEMICAL$ and pimozide block erg3, a @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "11511086.T12.T29",
        "sentence": "The antipsychotic drugs @CHEMICAL$ and pimozide block @GENE$, a human brain K(+) channel.",
        "relation": "CPR:4"
    },
    {
        "id": "11511086.T13.T30",
        "sentence": "The antipsychotic drugs sertindole and @CHEMICAL$ block erg3, a @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "11511086.T13.T29",
        "sentence": "The antipsychotic drugs sertindole and @CHEMICAL$ block @GENE$, a human brain K(+) channel.",
        "relation": "CPR:4"
    },
    {
        "id": "11511086.T7.T19",
        "sentence": "The antipsychotic drugs @CHEMICAL$ and pimozide are known to prolong the QT interval on the electrocardiogram via a high affinity block of the @GENE$ known as HERG (human ether-a-go-go-related gene; erg1).",
        "relation": "CPR:4"
    },
    {
        "id": "11511086.T7.T21",
        "sentence": "The antipsychotic drugs @CHEMICAL$ and pimozide are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as @GENE$ (human ether-a-go-go-related gene; erg1).",
        "relation": "CPR:4"
    },
    {
        "id": "11511086.T7.T22",
        "sentence": "The antipsychotic drugs @CHEMICAL$ and pimozide are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as HERG (@GENE$; erg1).",
        "relation": "CPR:4"
    },
    {
        "id": "11511086.T7.T23",
        "sentence": "The antipsychotic drugs @CHEMICAL$ and pimozide are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as HERG (human ether-a-go-go-related gene; @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "11511086.T9.T19",
        "sentence": "The antipsychotic drugs sertindole and @CHEMICAL$ are known to prolong the QT interval on the electrocardiogram via a high affinity block of the @GENE$ known as HERG (human ether-a-go-go-related gene; erg1).",
        "relation": "CPR:4"
    },
    {
        "id": "11511086.T9.T21",
        "sentence": "The antipsychotic drugs sertindole and @CHEMICAL$ are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as @GENE$ (human ether-a-go-go-related gene; erg1).",
        "relation": "CPR:4"
    },
    {
        "id": "11511086.T9.T22",
        "sentence": "The antipsychotic drugs sertindole and @CHEMICAL$ are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as HERG (@GENE$; erg1).",
        "relation": "CPR:4"
    },
    {
        "id": "11511086.T9.T23",
        "sentence": "The antipsychotic drugs sertindole and @CHEMICAL$ are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as HERG (human ether-a-go-go-related gene; @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "11511086.T1.T15",
        "sentence": "Inward tail currents measured at -100 mV were blocked in a dose-dependent fashion by sertindole resulting in an IC(50) value of 43 nM. Significant inhibition was observed at concentrations as low as 3 nM. Block of @CHEMICAL$ by @GENE$ also displayed a positive voltage-dependence.",
        "relation": "CPR:4"
    },
    {
        "id": "11511086.T2.T16",
        "sentence": "@CHEMICAL$ blocked @GENE$ channel currents with an IC(50) of 103 nM and significant inhibition was noted at concentrations of 10 nM and higher.",
        "relation": "CPR:4"
    },
    {
        "id": "11511086.T3.T17",
        "sentence": "We conclude that @CHEMICAL$ can be blocked by certain antipsychotic drugs like @GENE$ and pimozide.",
        "relation": "CPR:4"
    },
    {
        "id": "11511086.T4.T17",
        "sentence": "We conclude that @CHEMICAL$ can be blocked by certain antipsychotic drugs like sertindole and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23301860.T2.T6",
        "sentence": "An amphiphile with branched @CHEMICAL$ architecture also activated the @GENE$ pathway but only through L-ficolin recognition.",
        "relation": "CPR:3"
    },
    {
        "id": "17959709.T9.T18",
        "sentence": "Conformational variations of both @CHEMICAL$ and inhibitors provide the structural basis for the physiological effects of vardenafil and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23478800.T13.T58",
        "sentence": "@CHEMICAL$ inhibits @GENE$ activation in breast cancer cells by a reactive oxygen species-mediated mechanism and independently of janus tyrosine kinase 2 and p-rex1.",
        "relation": "CPR:4"
    },
    {
        "id": "23478800.T9.T46",
        "sentence": "Here we found that the anticancer agent @CHEMICAL$, a @GENE$ inhibitor, reduced the activation of Rac1 and motility in response to the ErbB3 ligand heregulin in breast cancer cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23478800.T9.T47",
        "sentence": "Here we found that the anticancer agent @CHEMICAL$, a Jak2 inhibitor, reduced the activation of @GENE$ and motility in response to the ErbB3 ligand heregulin in breast cancer cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23478800.T12.T17",
        "sentence": "Subsequent analysis revealed that @CHEMICAL$ strongly activates @GENE$ and the Rho effector Rho kinase (ROCK) in breast cancer cells and induces the formation of stress fibers.",
        "relation": "CPR:3"
    },
    {
        "id": "23478800.T12.T18",
        "sentence": "Subsequent analysis revealed that @CHEMICAL$ strongly activates RhoA and the @GENE$ effector Rho kinase (ROCK) in breast cancer cells and induces the formation of stress fibers.",
        "relation": "CPR:3"
    },
    {
        "id": "23478800.T12.T19",
        "sentence": "Subsequent analysis revealed that @CHEMICAL$ strongly activates RhoA and the Rho effector @GENE$ (ROCK) in breast cancer cells and induces the formation of stress fibers.",
        "relation": "CPR:3"
    },
    {
        "id": "23478800.T12.T20",
        "sentence": "Subsequent analysis revealed that @CHEMICAL$ strongly activates RhoA and the Rho effector Rho kinase (@GENE$) in breast cancer cells and induces the formation of stress fibers.",
        "relation": "CPR:3"
    },
    {
        "id": "23478800.T1.T23",
        "sentence": "Interestingly, disruption of the RhoA-ROCK pathway prevented the inhibitory effect of @CHEMICAL$ on @GENE$ activation by heregulin.",
        "relation": "CPR:4"
    },
    {
        "id": "23478800.T2.T25",
        "sentence": "Lastly, we found that @CHEMICAL$ activation by @GENE$ is mediated by reactive oxygen species (ROS).",
        "relation": "CPR:3"
    },
    {
        "id": "23478800.T4.T27",
        "sentence": "The ROS scavenger @CHEMICAL$ and the mitochondrial antioxidant Mito-TEMPO rescued the inhibitory effect of cucurbitacin I on @GENE$ activation.",
        "relation": "CPR:3"
    },
    {
        "id": "23478800.T5.T27",
        "sentence": "The ROS scavenger N-acetyl l-cysteine and the mitochondrial antioxidant Mito-TEMPO rescued the inhibitory effect of @CHEMICAL$ on @GENE$ activation.",
        "relation": "CPR:4"
    },
    {
        "id": "23478800.T6.T32",
        "sentence": "Moreover, they established that the inhibitory effect of @CHEMICAL$ on @GENE$ activity involves the alteration of the balance between Rho and Rac.",
        "relation": "CPR:4"
    },
    {
        "id": "15452358.T12.T21",
        "sentence": "Brain but not spinal @CHEMICAL$ receptor is responsible for the anti-allodynic effect of an NR2B subunit-selective antagonist @GENE$ in a rat chronic constriction injury model.",
        "relation": "CPR:6"
    },
    {
        "id": "15452358.T12.T22",
        "sentence": "Brain but not spinal NR2B receptor is responsible for the anti-allodynic effect of an @CHEMICAL$ subunit-selective antagonist @GENE$ in a rat chronic constriction injury model.",
        "relation": "CPR:6"
    },
    {
        "id": "15452358.T10.T19",
        "sentence": "In order to examine the site of action of an NR2B subtype-selective @CHEMICAL$ antagonist @GENE$, we investigated its analgesic effect in a rat model of neuropathic pain at various routes of administration.",
        "relation": "CPR:6"
    },
    {
        "id": "15452358.T10.T18",
        "sentence": "In order to examine the site of action of an @CHEMICAL$ subtype-selective NMDA antagonist @GENE$, we investigated its analgesic effect in a rat model of neuropathic pain at various routes of administration.",
        "relation": "CPR:6"
    },
    {
        "id": "15452358.T1.T13",
        "sentence": "These findings suggest that the anti-allodynia effect of @CHEMICAL$ is ascribable to blockade of @GENE$ receptors at the brain, but not at the spinal cord.",
        "relation": "CPR:4"
    },
    {
        "id": "15452358.T3.T14",
        "sentence": "In contrast, intrathecal injection of a non-selective @CHEMICAL$ antagonist, @GENE$, significantly inhibited CCI-induced mechanical allodynia at a dose of 300 nmol, indicating the difference in the site of action between the non-selective NMDA antagonist and the NR2B-specific NMDA antagonist.",
        "relation": "CPR:6"
    },
    {
        "id": "12504917.T1.T42",
        "sentence": "@CHEMICAL$ [N-propargyl-1R(+)-aminoindan; TVP1012] is a potent irreversible @GENE$ (MAO) inhibitor with selectivity for type B of the enzyme, which is being developed for treatment of Parkinson's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "12504917.T1.T45",
        "sentence": "@CHEMICAL$ [N-propargyl-1R(+)-aminoindan; TVP1012] is a potent irreversible monoamine oxidase (@GENE$) inhibitor with selectivity for type B of the enzyme, which is being developed for treatment of Parkinson's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "12504917.T8.T42",
        "sentence": "Rasagiline [@CHEMICAL$; TVP1012] is a potent irreversible @GENE$ (MAO) inhibitor with selectivity for type B of the enzyme, which is being developed for treatment of Parkinson's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "12504917.T8.T45",
        "sentence": "Rasagiline [@CHEMICAL$; TVP1012] is a potent irreversible monoamine oxidase (@GENE$) inhibitor with selectivity for type B of the enzyme, which is being developed for treatment of Parkinson's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "12504917.T20.T42",
        "sentence": "Rasagiline [N-propargyl-1R(+)-aminoindan; @CHEMICAL$] is a potent irreversible @GENE$ (MAO) inhibitor with selectivity for type B of the enzyme, which is being developed for treatment of Parkinson's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "12504917.T20.T45",
        "sentence": "Rasagiline [N-propargyl-1R(+)-aminoindan; @CHEMICAL$] is a potent irreversible monoamine oxidase (@GENE$) inhibitor with selectivity for type B of the enzyme, which is being developed for treatment of Parkinson's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "12504917.T21.T39",
        "sentence": "Reserpine-induced ptosis was reversed by @CHEMICAL$ at doses above 2 mg x kg(-1) i.p., which inhibit @GENE$ as well as MAO-B, but not at MAO-B-selective doses.",
        "relation": "CPR:4"
    },
    {
        "id": "12504917.T21.T40",
        "sentence": "Reserpine-induced ptosis was reversed by @CHEMICAL$ at doses above 2 mg x kg(-1) i.p., which inhibit MAO-A as well as @GENE$, but not at MAO-B-selective doses.",
        "relation": "CPR:4"
    },
    {
        "id": "12504917.T28.T43",
        "sentence": "However, combination of rasagiline (10 mg x kg(-1) i.p.) with L-DOPA or L-tryptophan (50 mg x kg(-1) i.p.), or rasagiline (10 mg x kg(-1) p.o.) with fluoxetine (10 mg x kg(-1) p.o.), did not induce the behavioural hyperactivity syndrome which is seen following inhibition of both @CHEMICAL$ and MAO-B by @GENE$ together with the monoamine precursors.",
        "relation": "CPR:4"
    },
    {
        "id": "12504917.T28.T44",
        "sentence": "However, combination of rasagiline (10 mg x kg(-1) i.p.) with L-DOPA or L-tryptophan (50 mg x kg(-1) i.p.), or rasagiline (10 mg x kg(-1) p.o.) with fluoxetine (10 mg x kg(-1) p.o.), did not induce the behavioural hyperactivity syndrome which is seen following inhibition of both MAO-A and @CHEMICAL$ by @GENE$ together with the monoamine precursors.",
        "relation": "CPR:4"
    },
    {
        "id": "12504917.T29.T43",
        "sentence": "However, combination of rasagiline (10 mg x kg(-1) i.p.) with L-DOPA or L-tryptophan (50 mg x kg(-1) i.p.), or rasagiline (10 mg x kg(-1) p.o.) with fluoxetine (10 mg x kg(-1) p.o.), did not induce the behavioural hyperactivity syndrome which is seen following inhibition of both @CHEMICAL$ and MAO-B by tranylcypromine together with the @GENE$ precursors.",
        "relation": "CPR:4"
    },
    {
        "id": "12504917.T29.T44",
        "sentence": "However, combination of rasagiline (10 mg x kg(-1) i.p.) with L-DOPA or L-tryptophan (50 mg x kg(-1) i.p.), or rasagiline (10 mg x kg(-1) p.o.) with fluoxetine (10 mg x kg(-1) p.o.), did not induce the behavioural hyperactivity syndrome which is seen following inhibition of both MAO-A and @CHEMICAL$ by tranylcypromine together with the @GENE$ precursors.",
        "relation": "CPR:4"
    },
    {
        "id": "12504917.T10.T37",
        "sentence": "@CHEMICAL$ does not modify CNS monoamine tissue levels or monoamine-induced behavioural syndromes at doses which selectively inhibit @GENE$ but not MAO-A.",
        "relation": "CPR:4"
    },
    {
        "id": "12504917.T10.T38",
        "sentence": "@CHEMICAL$ does not modify CNS monoamine tissue levels or monoamine-induced behavioural syndromes at doses which selectively inhibit MAO-B but not @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "16399380.T2.T11",
        "sentence": "@CHEMICAL$ have dehydroascorbate reductase and thioltransferase activities and also catalyze the reduction of @GENE$, an intermediate in the pathway of arsenic biotransformation.",
        "relation": "CPR:9"
    },
    {
        "id": "17254025.T4.T8",
        "sentence": "The latter reaction, catalyzed by @CHEMICAL$ (ASPA), produces @GENE$ groups plus aspartate and has been proposed to occur in both soluble and membranous subfractions of white matter.",
        "relation": "CPR:9"
    },
    {
        "id": "17254025.T4.T9",
        "sentence": "The latter reaction, catalyzed by aspartoacylase (@CHEMICAL$), produces @GENE$ groups plus aspartate and has been proposed to occur in both soluble and membranous subfractions of white matter.",
        "relation": "CPR:9"
    },
    {
        "id": "17254025.T5.T8",
        "sentence": "The latter reaction, catalyzed by @CHEMICAL$ (ASPA), produces acetyl groups plus @GENE$ and has been proposed to occur in both soluble and membranous subfractions of white matter.",
        "relation": "CPR:9"
    },
    {
        "id": "17254025.T5.T9",
        "sentence": "The latter reaction, catalyzed by aspartoacylase (@CHEMICAL$), produces acetyl groups plus @GENE$ and has been proposed to occur in both soluble and membranous subfractions of white matter.",
        "relation": "CPR:9"
    },
    {
        "id": "11906441.T1.T17",
        "sentence": "It is not yet clear whether @CHEMICAL$ can reduce breast cancer incidence in women with BRCA1 and @GENE$ mutations, although preliminary evidence favors benefit for at least those with a BRCA2 mutation.",
        "relation": "CPR:4"
    },
    {
        "id": "11906441.T1.T18",
        "sentence": "It is not yet clear whether @CHEMICAL$ can reduce breast cancer incidence in women with BRCA1 and BRCA2 mutations, although preliminary evidence favors benefit for at least those with a @GENE$ mutation.",
        "relation": "CPR:4"
    },
    {
        "id": "10694244.T18.T36",
        "sentence": "Troglitazone inhibited the antigen-induced production of LTB(4), C(4) and E(4) and the potency of the inhibition was comparable to that of @CHEMICAL$, a specific inhibitor of @GENE$ (5-LOX) and a clinically used anti-asthmatic drug.",
        "relation": "CPR:4"
    },
    {
        "id": "10694244.T18.T37",
        "sentence": "Troglitazone inhibited the antigen-induced production of LTB(4), C(4) and E(4) and the potency of the inhibition was comparable to that of @CHEMICAL$, a specific inhibitor of 5-lipoxygenase (@GENE$) and a clinically used anti-asthmatic drug.",
        "relation": "CPR:4"
    },
    {
        "id": "10694244.T25.T29",
        "sentence": "Troglitazone inhibited LTB(4) production by the supernatant fraction of RBL-2H3 cell lysate with similar potency to @CHEMICAL$, suggesting that troglitazone inhibits LT production by direct inhibition of @GENE$ activity. 4.",
        "relation": "CPR:4"
    },
    {
        "id": "10694244.T26.T29",
        "sentence": "Troglitazone inhibited LTB(4) production by the supernatant fraction of RBL-2H3 cell lysate with similar potency to zileuton, suggesting that @CHEMICAL$ inhibits LT production by direct inhibition of @GENE$ activity. 4.",
        "relation": "CPR:4"
    },
    {
        "id": "10694244.T6.T31",
        "sentence": "These findings suggest that @CHEMICAL$ inhibits antigen-induced LT production in the IgE-sensitized RBL-2H3 cells and A23187-stimulated rat peritoneal neutrophils by direct inhibition of @GENE$ activity.",
        "relation": "CPR:4"
    },
    {
        "id": "15951260.T1.T18",
        "sentence": "The positive correlation between @CHEMICAL$ and @GENE$ concentrations might be the result of the vitamin A inductive effect during immunoglobulins A synthesis.",
        "relation": "CPR:3"
    },
    {
        "id": "15951260.T1.T19",
        "sentence": "The positive correlation between @CHEMICAL$ and immunoglobulin A concentrations might be the result of the vitamin A inductive effect during @GENE$ synthesis.",
        "relation": "CPR:3"
    },
    {
        "id": "15951260.T2.T18",
        "sentence": "The positive correlation between vitamin A and @CHEMICAL$ concentrations might be the result of the @GENE$ inductive effect during immunoglobulins A synthesis.",
        "relation": "CPR:3"
    },
    {
        "id": "15951260.T2.T19",
        "sentence": "The positive correlation between vitamin A and immunoglobulin A concentrations might be the result of the @CHEMICAL$ inductive effect during @GENE$ synthesis.",
        "relation": "CPR:3"
    },
    {
        "id": "15944809.T8.T12",
        "sentence": "Experimental as well as clinical reports support the hypothesis that @CHEMICAL$ blockers such as @GENE$ may be an appropriate therapeutic approach in LQTS.",
        "relation": "CPR:4"
    },
    {
        "id": "15944809.T9.T13",
        "sentence": "METHODS AND RESULTS: In 8 Langendorff-perfused rabbit hearts, @CHEMICAL$ (0.1 microM), an inhibitor of @GENE$ inactivation, led to a marked increase in QT-interval and simultaneously recorded monophasic ventricular action potentials (MAPs) (p < 0.05) thereby mimicking LQT3.",
        "relation": "CPR:4"
    },
    {
        "id": "17253779.T27.T48",
        "sentence": "Specificity of @CHEMICAL$: formation of @GENE$ and all-trans-7,8- dihydroretinol.",
        "relation": "CPR:9"
    },
    {
        "id": "17253779.T28.T48",
        "sentence": "Specificity of @CHEMICAL$: formation of all-trans-13,14-dihydroretinol and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17253779.T22.T38",
        "sentence": "Specifically, @CHEMICAL$ is transiently oxidized to all-trans-13,14-dihydroretinoic acid before being oxidized further by @GENE$ enzymes.",
        "relation": "CPR:9"
    },
    {
        "id": "17253779.T1.T47",
        "sentence": "Unlike mouse RetSat (mRetSat), @CHEMICAL$ had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of @GENE$ to produce either all-trans-13,14-dihydroretinol or all-trans-7,8-dihydroretinol, respectively. zRetSat A also saturated the 13-14 or 7-8 double bonds of all-trans-3,4-didehydroretinol (vitamin A2), a second endogenous form of vitamin A in zebrafish.",
        "relation": "CPR:9"
    },
    {
        "id": "17253779.T2.T47",
        "sentence": "Unlike mouse RetSat (mRetSat), @CHEMICAL$ had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of all-trans-retinol to produce either @GENE$ or all-trans-7,8-dihydroretinol, respectively. zRetSat A also saturated the 13-14 or 7-8 double bonds of all-trans-3,4-didehydroretinol (vitamin A2), a second endogenous form of vitamin A in zebrafish.",
        "relation": "CPR:9"
    },
    {
        "id": "17253779.T3.T47",
        "sentence": "Unlike mouse RetSat (mRetSat), @CHEMICAL$ had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of all-trans-retinol to produce either all-trans-13,14-dihydroretinol or @GENE$, respectively. zRetSat A also saturated the 13-14 or 7-8 double bonds of all-trans-3,4-didehydroretinol (vitamin A2), a second endogenous form of vitamin A in zebrafish.",
        "relation": "CPR:9"
    },
    {
        "id": "17253779.T5.T29",
        "sentence": "Unlike mouse RetSat (mRetSat), zRetSat A had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of all-trans-retinol to produce either all-trans-13,14-dihydroretinol or all-trans-7,8-dihydroretinol, respectively. @CHEMICAL$ also saturated the 13-14 or 7-8 double bonds of @GENE$ (vitamin A2), a second endogenous form of vitamin A in zebrafish.",
        "relation": "CPR:9"
    },
    {
        "id": "17253779.T6.T29",
        "sentence": "Unlike mouse RetSat (mRetSat), zRetSat A had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of all-trans-retinol to produce either all-trans-13,14-dihydroretinol or all-trans-7,8-dihydroretinol, respectively. @CHEMICAL$ also saturated the 13-14 or 7-8 double bonds of all-trans-3,4-didehydroretinol (@GENE$), a second endogenous form of vitamin A in zebrafish.",
        "relation": "CPR:9"
    },
    {
        "id": "20517484.T1.T8",
        "sentence": "@CHEMICAL$ is a novel, potent, and irreversible @GENE$ (MAO-B) inhibitor which has been approved for treatment of PD.",
        "relation": "CPR:4"
    },
    {
        "id": "20517484.T1.T9",
        "sentence": "@CHEMICAL$ is a novel, potent, and irreversible monoamine oxidase type B (@GENE$) inhibitor which has been approved for treatment of PD.",
        "relation": "CPR:4"
    },
    {
        "id": "20517484.T3.T10",
        "sentence": "@CHEMICAL$ inhibits @GENE$ more potently than selegiline and has the advantage of once-daily dosing.",
        "relation": "CPR:4"
    },
    {
        "id": "10626836.T3.T23",
        "sentence": "Analysis of splice variants and site-directed mutants of the AMPA receptor GluR3 expressed in Xenopus oocytes has shown that @CHEMICAL$ produces a large potentiation of the @GENE$ splice variant and suggested that lithium might inhibit rapid desensitization, which is characteristic of this receptor (Karkanias, N. and Papke, R., Subtype-specific effects of lithium on glutamate receptor function.",
        "relation": "CPR:3"
    },
    {
        "id": "10626836.T8.T23",
        "sentence": "Analysis of splice variants and site-directed mutants of the AMPA receptor GluR3 expressed in Xenopus oocytes has shown that lithium produces a large potentiation of the @CHEMICAL$ splice variant and suggested that @GENE$ might inhibit rapid desensitization, which is characteristic of this receptor (Karkanias, N. and Papke, R., Subtype-specific effects of lithium on glutamate receptor function.",
        "relation": "CPR:3"
    },
    {
        "id": "10626836.T13.T28",
        "sentence": "Science, 9(266) (1994) 1709-1713) greatly attenuates the @CHEMICAL$-induced potentiation of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "10626836.T2.T18",
        "sentence": "Additionally, experiments with the non-desensitizing site-directed mutant GluR3(L507Y) (Stern-Bach, Y., Russo, S., Neuman, M. and Rosenmund, C., A point mutation in the glutamate binding site blocks desensitization of AMPA receptors. Neuron, 21 (1998) 907-918) further confirms that @CHEMICAL$ enhances @GENE$ responses by reducing desensitization, since lithium's effects are reversed in this mutant.",
        "relation": "CPR:3"
    },
    {
        "id": "10626836.T5.T20",
        "sentence": "Specifically, @CHEMICAL$, which potentiates wild-type @GENE$, is ineffective on the non-desensitizing GluR3(L507Y) mutant, but has synergistic effects with lithium on wild-type receptors.",
        "relation": "CPR:3"
    },
    {
        "id": "10626836.T7.T22",
        "sentence": "Specifically, aniracetam, which potentiates wild-type AMPA receptors, is ineffective on the non-desensitizing GluR3(@CHEMICAL$) mutant, but has synergistic effects with @GENE$ on wild-type receptors.",
        "relation": "CPR:3"
    },
    {
        "id": "10626836.T7.T21",
        "sentence": "Specifically, aniracetam, which potentiates wild-type AMPA receptors, is ineffective on the non-desensitizing @CHEMICAL$(L507Y) mutant, but has synergistic effects with @GENE$ on wild-type receptors.",
        "relation": "CPR:3"
    },
    {
        "id": "11009561.T21.T35",
        "sentence": "The @CHEMICAL$ treatment was associated with a 2-fold increase in @GENE$ activity as well as a 70% reduction in endothelial O(2)(-) production compared with those in fructose-fed rats.",
        "relation": "CPR:3"
    },
    {
        "id": "11009561.T24.T26",
        "sentence": "The @CHEMICAL$ treatment also partially improved the @GENE$ sensitivity and blood pressure, as well as the serum triglyceride concentration, in the fructose-fed rats.",
        "relation": "CPR:3"
    },
    {
        "id": "11009561.T4.T28",
        "sentence": "Moreover, @CHEMICAL$ treatment of the fructose-fed rats markedly reduced the lipid peroxide content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors, @GENE$ and activating protein-1, which were increased in fructose-fed rats.",
        "relation": "CPR:4"
    },
    {
        "id": "11009561.T4.T29",
        "sentence": "Moreover, @CHEMICAL$ treatment of the fructose-fed rats markedly reduced the lipid peroxide content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors, nuclear factor-kappaB and @GENE$, which were increased in fructose-fed rats.",
        "relation": "CPR:4"
    },
    {
        "id": "11009561.T5.T28",
        "sentence": "Moreover, BH(4) treatment of the @CHEMICAL$-fed rats markedly reduced the lipid peroxide content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors, @GENE$ and activating protein-1, which were increased in fructose-fed rats.",
        "relation": "CPR:3"
    },
    {
        "id": "11009561.T5.T29",
        "sentence": "Moreover, BH(4) treatment of the @CHEMICAL$-fed rats markedly reduced the lipid peroxide content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors, nuclear factor-kappaB and @GENE$, which were increased in fructose-fed rats.",
        "relation": "CPR:3"
    },
    {
        "id": "11009561.T7.T28",
        "sentence": "Moreover, BH(4) treatment of the fructose-fed rats markedly reduced the lipid peroxide content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors, @CHEMICAL$ and activating protein-1, which were increased in @GENE$-fed rats.",
        "relation": "CPR:3"
    },
    {
        "id": "11009561.T7.T29",
        "sentence": "Moreover, BH(4) treatment of the fructose-fed rats markedly reduced the lipid peroxide content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors, nuclear factor-kappaB and @CHEMICAL$, which were increased in @GENE$-fed rats.",
        "relation": "CPR:3"
    },
    {
        "id": "23543413.T8.T19",
        "sentence": "It has been claimed that hCTR1, the @CHEMICAL$, is the major entry pathway for @GENE$ and related drugs via a mechanism that mimics copper.",
        "relation": "CPR:9"
    },
    {
        "id": "23543413.T8.T18",
        "sentence": "It has been claimed that @CHEMICAL$, the human high affinity copper transporter, is the major entry pathway for @GENE$ and related drugs via a mechanism that mimics copper.",
        "relation": "CPR:9"
    },
    {
        "id": "23543413.T12.T25",
        "sentence": "We confirm the correlation between higher @CHEMICAL$ levels and higher @GENE$-drug uptake in tumor cells sensitive to the drug.",
        "relation": "CPR:9"
    },
    {
        "id": "25225185.T19.T46",
        "sentence": "In the DRN, @CHEMICAL$ completely inhibited the firing of 5-HT neurons via @GENE$ agonism and was more potent than aripiprazole (ED50 = 230 and 700 mug/kg, respectively).",
        "relation": "CPR:5"
    },
    {
        "id": "25225185.T21.T46",
        "sentence": "In the DRN, brexpiprazole completely inhibited the firing of 5-HT neurons via @CHEMICAL$ agonism and was more potent than @GENE$ (ED50 = 230 and 700 mug/kg, respectively).",
        "relation": "CPR:5"
    },
    {
        "id": "25225185.T24.T47",
        "sentence": "In the locus coeruleus, brexpiprazole reversed the inhibitory effect of the preferential @CHEMICAL$ receptor agonist @GENE$ (2,5-dimethoxy-4-iodoamphetamine) on norepinephrine neuronal firing (ED50 = 110 mug/kg), demonstrating 5-HT2A antagonistic action.",
        "relation": "CPR:5"
    },
    {
        "id": "25225185.T25.T47",
        "sentence": "In the locus coeruleus, brexpiprazole reversed the inhibitory effect of the preferential @CHEMICAL$ receptor agonist DOI (@GENE$) on norepinephrine neuronal firing (ED50 = 110 mug/kg), demonstrating 5-HT2A antagonistic action.",
        "relation": "CPR:5"
    },
    {
        "id": "25225185.T4.T32",
        "sentence": "Brexpiprazole reversed the inhibitory effect of the DA agonist @CHEMICAL$ on VTA DA neurons (ED50 = 61 mug/kg), whereas it was ineffective when administered alone, indicating partial agonistic action on @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "25225185.T7.T33",
        "sentence": "Compared with aripiprazole, which significantly inhibited the firing activity of VTA DA neurons, @CHEMICAL$ displayed less efficacy at @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "25225185.T8.T34",
        "sentence": "In the hippocampus, @CHEMICAL$ acted as a full agonist at @GENE$ receptors on pyramidal neurons.",
        "relation": "CPR:5"
    },
    {
        "id": "25225185.T10.T37",
        "sentence": "In the lateral geniculate nucleus, @CHEMICAL$ displayed @GENE$ antagonistic action.",
        "relation": "CPR:6"
    },
    {
        "id": "22859660.T20.T35",
        "sentence": "For @CHEMICAL$ and ET1, MAP was also increased for the @GENE$ group but not in a dose-dependent fashion.",
        "relation": "CPR:3"
    },
    {
        "id": "22859660.T20.T36",
        "sentence": "For AII and @CHEMICAL$, MAP was also increased for the @GENE$ group but not in a dose-dependent fashion.",
        "relation": "CPR:3"
    },
    {
        "id": "23159529.T13.T26",
        "sentence": "Nanobody-albumin nanoparticles (NANAPs) for the delivery of a @CHEMICAL$ inhibitor @GENE$ to EGFR overexpressing tumor cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23159529.T2.T17",
        "sentence": "Glutaraldehyde crosslinked albumin nanoparticles with a size of approximately 100nm were loaded with the @CHEMICAL$ inhibitor @GENE$-L(x)-a platinum-bound sunitinib analogue-which couples the drug to methionine residues of albumin and is released in a reductive environment.",
        "relation": "CPR:4"
    },
    {
        "id": "10950934.T5.T10",
        "sentence": "Endogenously produced asymmetrically methylated @CHEMICAL$ residues are competitive inhibitors of all three isoforms of @GENE$ (NOS).",
        "relation": "CPR:4"
    },
    {
        "id": "10950934.T5.T12",
        "sentence": "Endogenously produced asymmetrically methylated @CHEMICAL$ residues are competitive inhibitors of all three isoforms of nitric oxide synthase (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "10950934.T3.T15",
        "sentence": "The enzyme @CHEMICAL$ (DDAH) specifically hydrolyzes these asymmetrically methylated @GENE$ residues to citrulline and methylamines.",
        "relation": "CPR:9"
    },
    {
        "id": "10950934.T3.T17",
        "sentence": "The enzyme dimethylarginine dimethylaminohydrolase (@CHEMICAL$) specifically hydrolyzes these asymmetrically methylated @GENE$ residues to citrulline and methylamines.",
        "relation": "CPR:9"
    },
    {
        "id": "10950934.T4.T18",
        "sentence": "Previously we have proposed that regulation of asymmetric @CHEMICAL$ concentration by @GENE$ may provide a novel mechanism for the regulation of NOS activity in vivo.",
        "relation": "CPR:9"
    },
    {
        "id": "23465612.T5.T9",
        "sentence": "Structure-based design of novel @CHEMICAL$ @GENE$ inhibitors that do not engage the catalytic aspartates.",
        "relation": "CPR:4"
    },
    {
        "id": "23465612.T3.T8",
        "sentence": "The structure-activity relationship of a series of @CHEMICAL$ @GENE$ inhibitors is described.",
        "relation": "CPR:4"
    },
    {
        "id": "16303771.T2.T14",
        "sentence": "Tissue-type plasminogen activator (tPA), a @CHEMICAL$ protease well known for generating plasmin, has been demonstrated to induce @GENE$ (MMP-9) gene expression and protein secretion in renal interstitial fibroblasts.",
        "relation": "CPR:3"
    },
    {
        "id": "16303771.T2.T35",
        "sentence": "Tissue-type plasminogen activator (tPA), a @CHEMICAL$ protease well known for generating @GENE$, has been demonstrated to induce matrix metalloproteinase-9 (MMP-9) gene expression and protein secretion in renal interstitial fibroblasts.",
        "relation": "CPR:3"
    },
    {
        "id": "16303771.T3.T7",
        "sentence": "Furthermore, tPA induced rapid @CHEMICAL$ phosphorylation on the beta subunit of LRP-1, which was followed by the activation of Mek1 and its downstream @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "16303771.T3.T6",
        "sentence": "Furthermore, tPA induced rapid @CHEMICAL$ phosphorylation on the beta subunit of LRP-1, which was followed by the activation of @GENE$ and its downstream Erk-1 and -2.",
        "relation": "CPR:3"
    },
    {
        "id": "23628509.T1.T24",
        "sentence": "The data show that @CHEMICAL$ is less potent at inducing @GENE$ gene expression in rainbow trout than benzo[a]pyrene (B[a]P), a well-known Ah-receptor agonist.",
        "relation": "CPR:3"
    },
    {
        "id": "23628509.T2.T24",
        "sentence": "The data show that CP[c]Ph is less potent at inducing @CHEMICAL$ gene expression in rainbow trout than @GENE$ (B[a]P), a well-known Ah-receptor agonist.",
        "relation": "CPR:3"
    },
    {
        "id": "23628509.T3.T24",
        "sentence": "The data show that CP[c]Ph is less potent at inducing @CHEMICAL$ gene expression in rainbow trout than benzo[a]pyrene (@GENE$), a well-known Ah-receptor agonist.",
        "relation": "CPR:3"
    },
    {
        "id": "23628509.T4.T25",
        "sentence": "Interestingly, the @CHEMICAL$ dependent up-regulation of @GENE$ mRNA is positively correlated with the incidences of clastogenic changes in rainbow trout erythrocytes.",
        "relation": "CPR:3"
    },
    {
        "id": "23628509.T5.T26",
        "sentence": "@CHEMICAL$ has, comparably to B[a]P, a potential to repress expression of @GENE$, in the head kidney of rainbow trout.",
        "relation": "CPR:4"
    },
    {
        "id": "23628509.T6.T26",
        "sentence": "CP[c]Ph has, comparably to @CHEMICAL$, a potential to repress expression of @GENE$, in the head kidney of rainbow trout.",
        "relation": "CPR:4"
    },
    {
        "id": "23260350.T10.T16",
        "sentence": "Identification of @CHEMICAL$ central cores for the inhibition of @GENE$. Leukotrienes (LT's) are known to play a physiological role in inflammatory immune response.",
        "relation": "CPR:4"
    },
    {
        "id": "23260350.T2.T12",
        "sentence": "Leukotriene A(4) hydrolase (@CHEMICAL$) is a cystolic enzyme that stereospecifically catalyzes the transformation of @GENE$ to LTB(4).",
        "relation": "CPR:9"
    },
    {
        "id": "23260350.T2.T15",
        "sentence": "@CHEMICAL$ (LTA(4)H) is a cystolic enzyme that stereospecifically catalyzes the transformation of @GENE$ to LTB(4).",
        "relation": "CPR:9"
    },
    {
        "id": "23260350.T3.T12",
        "sentence": "Leukotriene A(4) hydrolase (@CHEMICAL$) is a cystolic enzyme that stereospecifically catalyzes the transformation of LTA(4) to @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23260350.T3.T15",
        "sentence": "@CHEMICAL$ (LTA(4)H) is a cystolic enzyme that stereospecifically catalyzes the transformation of LTA(4) to @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23260350.T5.T13",
        "sentence": "This paper describes the identification and synthesis of substituted @CHEMICAL$ as @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23260350.T8.T14",
        "sentence": "@CHEMICAL$ 28 showed dose responsive target engagement and provides a useful tool to explore a @GENE$ inhibitor for the treatment of inflammatory diseases, such as asthma and inflammatory bowel disease (IBD).",
        "relation": "CPR:4"
    },
    {
        "id": "12112047.T6.T8",
        "sentence": "@CHEMICAL$ treatment prevents the formation of activated @GENE$, a known effector of apoptosis, as well as the appearance of a calpain cleaved substrate, a marker of excitotoxic/necrotic cell death.",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T57.T81",
        "sentence": "Neurochemical effects of the @CHEMICAL$ inhibitor @GENE$ on brain GABA and alanine: A comparison with vigabatrin.",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T26.T61",
        "sentence": "PURPOSE: To compare @CHEMICAL$ (PLZ), an antidepressant drug with anxiolytic properties which inhibits @GENE$ (MAO) but also elevates rat brain levels of the amino acids ?-aminobutyric acid (GABA) and alanine (ALA), with vigabatrin (VIG), an anticonvulsant which elevates brain GABA by inhibition of GABA transaminase (GABA-T), with regard to their actions on brain levels of GABA and ALA and on activities of MAO, GABA-T and ALA transaminase (ALA-T).",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T26.T63",
        "sentence": "PURPOSE: To compare @CHEMICAL$ (PLZ), an antidepressant drug with anxiolytic properties which inhibits monoamine oxidase (@GENE$) but also elevates rat brain levels of the amino acids ?-aminobutyric acid (GABA) and alanine (ALA), with vigabatrin (VIG), an anticonvulsant which elevates brain GABA by inhibition of GABA transaminase (GABA-T), with regard to their actions on brain levels of GABA and ALA and on activities of MAO, GABA-T and ALA transaminase (ALA-T).",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T29.T68",
        "sentence": "PURPOSE: To compare phenelzine (PLZ), an antidepressant drug with anxiolytic properties which inhibits monoamine oxidase (MAO) but also elevates rat brain levels of the amino acids ?-aminobutyric acid (GABA) and alanine (ALA), with @CHEMICAL$ (VIG), an anticonvulsant which elevates brain GABA by inhibition of @GENE$ (GABA-T), with regard to their actions on brain levels of GABA and ALA and on activities of MAO, GABA-T and ALA transaminase (ALA-T).",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T29.T69",
        "sentence": "PURPOSE: To compare phenelzine (PLZ), an antidepressant drug with anxiolytic properties which inhibits monoamine oxidase (MAO) but also elevates rat brain levels of the amino acids ?-aminobutyric acid (GABA) and alanine (ALA), with @CHEMICAL$ (VIG), an anticonvulsant which elevates brain GABA by inhibition of GABA transaminase (@GENE$), with regard to their actions on brain levels of GABA and ALA and on activities of MAO, GABA-T and ALA transaminase (ALA-T).",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T30.T68",
        "sentence": "PURPOSE: To compare phenelzine (PLZ), an antidepressant drug with anxiolytic properties which inhibits monoamine oxidase (MAO) but also elevates rat brain levels of the amino acids ?-aminobutyric acid (GABA) and alanine (ALA), with vigabatrin (@CHEMICAL$), an anticonvulsant which elevates brain GABA by inhibition of @GENE$ (GABA-T), with regard to their actions on brain levels of GABA and ALA and on activities of MAO, GABA-T and ALA transaminase (ALA-T).",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T30.T69",
        "sentence": "PURPOSE: To compare phenelzine (PLZ), an antidepressant drug with anxiolytic properties which inhibits monoamine oxidase (MAO) but also elevates rat brain levels of the amino acids ?-aminobutyric acid (GABA) and alanine (ALA), with vigabatrin (@CHEMICAL$), an anticonvulsant which elevates brain GABA by inhibition of GABA transaminase (@GENE$), with regard to their actions on brain levels of GABA and ALA and on activities of MAO, GABA-T and ALA transaminase (ALA-T).",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T33.T61",
        "sentence": "PURPOSE: To compare phenelzine (@CHEMICAL$), an antidepressant drug with anxiolytic properties which inhibits @GENE$ (MAO) but also elevates rat brain levels of the amino acids ?-aminobutyric acid (GABA) and alanine (ALA), with vigabatrin (VIG), an anticonvulsant which elevates brain GABA by inhibition of GABA transaminase (GABA-T), with regard to their actions on brain levels of GABA and ALA and on activities of MAO, GABA-T and ALA transaminase (ALA-T).",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T33.T63",
        "sentence": "PURPOSE: To compare phenelzine (@CHEMICAL$), an antidepressant drug with anxiolytic properties which inhibits monoamine oxidase (@GENE$) but also elevates rat brain levels of the amino acids ?-aminobutyric acid (GABA) and alanine (ALA), with vigabatrin (VIG), an anticonvulsant which elevates brain GABA by inhibition of GABA transaminase (GABA-T), with regard to their actions on brain levels of GABA and ALA and on activities of MAO, GABA-T and ALA transaminase (ALA-T).",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T46.T77",
        "sentence": "RESULTS: Both @CHEMICAL$ and VIG inhibited @GENE$ and elevated GABA levels.",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T47.T77",
        "sentence": "RESULTS: Both PLZ and @CHEMICAL$ inhibited @GENE$ and elevated GABA levels.",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T50.T78",
        "sentence": "Only @CHEMICAL$ inhibited @GENE$ and ALA-T and elevated ALA levels.",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T50.T79",
        "sentence": "Only @CHEMICAL$ inhibited MAO and @GENE$ and elevated ALA levels.",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T1.T60",
        "sentence": "The effects of PLZ on both amino acids and their transaminases were blocked by pre-treatment with the @CHEMICAL$ inhibitor @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T1.T80",
        "sentence": "The effects of PLZ on both amino acids and their @CHEMICAL$ were blocked by pre-treatment with the MAO inhibitor @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T5.T62",
        "sentence": "This pretreament had no effect on the inhibition of @CHEMICAL$ or the elevation of brain GABA levels produced by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T9.T64",
        "sentence": "CONCLUSIONS: At the doses studied, PLZ was as effective as VIG at elevating brain GABA levels, but, unlike @CHEMICAL$, also inhibited @GENE$ and ALA-T (and increased brain ALA levels).",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T9.T65",
        "sentence": "CONCLUSIONS: At the doses studied, PLZ was as effective as VIG at elevating brain GABA levels, but, unlike @CHEMICAL$, also inhibited MAO and @GENE$ (and increased brain ALA levels).",
        "relation": "CPR:4"
    },
    {
        "id": "19203467.T12.T66",
        "sentence": "Pretreatment of rats with the @CHEMICAL$ inhibitor @GENE$ prevented the increase in brain GABA and ALA levels with PLZ, but did not block the effect of VIG on GABA.",
        "relation": "CPR:4"
    },
    {
        "id": "1705633.T11.T19",
        "sentence": "Clinical pharmacology of @CHEMICAL$, a novel, dipeptide @GENE$ inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "1705633.T12.T19",
        "sentence": "Clinical pharmacology of enalkiren, a novel, @CHEMICAL$ @GENE$ inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "1705633.T1.T17",
        "sentence": "@CHEMICAL$ (A-64662), a potent, dipeptide @GENE$ inhibitor, mimics the transition state of the human renin substrate, angiotensinogen.",
        "relation": "CPR:4"
    },
    {
        "id": "1705633.T1.T18",
        "sentence": "@CHEMICAL$ (A-64662), a potent, dipeptide renin inhibitor, mimics the transition state of the @GENE$ substrate, angiotensinogen.",
        "relation": "CPR:4"
    },
    {
        "id": "1705633.T2.T17",
        "sentence": "Enalkiren (@CHEMICAL$), a potent, dipeptide @GENE$ inhibitor, mimics the transition state of the human renin substrate, angiotensinogen.",
        "relation": "CPR:4"
    },
    {
        "id": "1705633.T2.T18",
        "sentence": "Enalkiren (@CHEMICAL$), a potent, dipeptide renin inhibitor, mimics the transition state of the @GENE$ substrate, angiotensinogen.",
        "relation": "CPR:4"
    },
    {
        "id": "1705633.T7.T17",
        "sentence": "Enalkiren (A-64662), a potent, @CHEMICAL$ @GENE$ inhibitor, mimics the transition state of the human renin substrate, angiotensinogen.",
        "relation": "CPR:4"
    },
    {
        "id": "1705633.T7.T18",
        "sentence": "Enalkiren (A-64662), a potent, @CHEMICAL$ renin inhibitor, mimics the transition state of the @GENE$ substrate, angiotensinogen.",
        "relation": "CPR:4"
    },
    {
        "id": "1705633.T4.T15",
        "sentence": "@CHEMICAL$ has been shown to produce dose-related suppression of plasma @GENE$ activity (PRA) and angiotensin II when administered intravenously.",
        "relation": "CPR:4"
    },
    {
        "id": "1705633.T4.T16",
        "sentence": "@CHEMICAL$ has been shown to produce dose-related suppression of plasma renin activity (PRA) and @GENE$ when administered intravenously.",
        "relation": "CPR:4"
    },
    {
        "id": "1705633.T3.T14",
        "sentence": "The results of clinical trials with @CHEMICAL$ are encouraging, and suggest that @GENE$ inhibitors may be safe, useful therapeutic agents in the management of hypertension.",
        "relation": "CPR:4"
    },
    {
        "id": "11861820.T1.T36",
        "sentence": "Also in contrast to effects of multiple METH injections, 1) MDMA caused little or no decrease in binding of the @CHEMICAL$ ligand WIN35428, and 2) neither prevention of hyperthermia nor prior depletion of DA prevented the MDMA-induced reduction in plasmalemmal @GENE$ transport.",
        "relation": "CPR:9"
    },
    {
        "id": "11861820.T21.T36",
        "sentence": "Also in contrast to effects of multiple @CHEMICAL$ injections, 1) MDMA caused little or no decrease in binding of the @GENE$ ligand WIN35428, and 2) neither prevention of hyperthermia nor prior depletion of DA prevented the MDMA-induced reduction in plasmalemmal DA transport.",
        "relation": "CPR:4"
    },
    {
        "id": "11861820.T24.T36",
        "sentence": "Also in contrast to effects of multiple METH injections, 1) MDMA caused little or no decrease in binding of the @CHEMICAL$ ligand WIN35428, and 2) neither prevention of hyperthermia nor prior depletion of @GENE$ prevented the MDMA-induced reduction in plasmalemmal DA transport.",
        "relation": "CPR:9"
    },
    {
        "id": "11861820.T25.T36",
        "sentence": "Also in contrast to effects of multiple METH injections, 1) MDMA caused little or no decrease in binding of the @CHEMICAL$ ligand WIN35428, and 2) neither prevention of hyperthermia nor prior depletion of DA prevented the @GENE$-induced reduction in plasmalemmal DA transport.",
        "relation": "CPR:4"
    },
    {
        "id": "11861820.T5.T29",
        "sentence": "In addition to affecting @CHEMICAL$ function, MDMA rapidly decreased vesicular @GENE$ transport as assessed in striatal vesicles prepared from treated rats.",
        "relation": "CPR:9"
    },
    {
        "id": "23458730.T17.T27",
        "sentence": "Concentration-dependent inhibitory effects of @CHEMICAL$ on the metabolism of dextromethorphan, a dual probe of @GENE$ and CYP3A, in rats.",
        "relation": "CPR:4"
    },
    {
        "id": "23458730.T17.T28",
        "sentence": "Concentration-dependent inhibitory effects of @CHEMICAL$ on the metabolism of dextromethorphan, a dual probe of CYP2D and @GENE$, in rats.",
        "relation": "CPR:4"
    },
    {
        "id": "23458730.T18.T27",
        "sentence": "Concentration-dependent inhibitory effects of baicalin on the metabolism of @CHEMICAL$, a dual probe of @GENE$ and CYP3A, in rats.",
        "relation": "CPR:9"
    },
    {
        "id": "23458730.T18.T28",
        "sentence": "Concentration-dependent inhibitory effects of baicalin on the metabolism of @CHEMICAL$, a dual probe of CYP2D and @GENE$, in rats.",
        "relation": "CPR:9"
    },
    {
        "id": "23458730.T6.T23",
        "sentence": "In the current study, we reveal the inhibitory effects of @CHEMICAL$ on the metabolism of dextromethorphan (DXM), a dual probe substrate of @GENE$ and CYP3A, in rats.",
        "relation": "CPR:4"
    },
    {
        "id": "23458730.T6.T24",
        "sentence": "In the current study, we reveal the inhibitory effects of @CHEMICAL$ on the metabolism of dextromethorphan (DXM), a dual probe substrate of CYP2D and @GENE$, in rats.",
        "relation": "CPR:4"
    },
    {
        "id": "23458730.T7.T23",
        "sentence": "In the current study, we reveal the inhibitory effects of baicalin on the metabolism of @CHEMICAL$ (DXM), a dual probe substrate of @GENE$ and CYP3A, in rats.",
        "relation": "CPR:9"
    },
    {
        "id": "23458730.T7.T24",
        "sentence": "In the current study, we reveal the inhibitory effects of baicalin on the metabolism of @CHEMICAL$ (DXM), a dual probe substrate of CYP2D and @GENE$, in rats.",
        "relation": "CPR:9"
    },
    {
        "id": "23458730.T8.T23",
        "sentence": "In the current study, we reveal the inhibitory effects of baicalin on the metabolism of dextromethorphan (@CHEMICAL$), a dual probe substrate of @GENE$ and CYP3A, in rats.",
        "relation": "CPR:9"
    },
    {
        "id": "23458730.T8.T24",
        "sentence": "In the current study, we reveal the inhibitory effects of baicalin on the metabolism of dextromethorphan (@CHEMICAL$), a dual probe substrate of CYP2D and @GENE$, in rats.",
        "relation": "CPR:9"
    },
    {
        "id": "23458730.T9.T25",
        "sentence": "Lineweaver-Burk plots demonstrated that @CHEMICAL$ inhibited the activities of @GENE$ and CYP3A in a non-competitive manner in rat liver microsomes (RLMs).",
        "relation": "CPR:4"
    },
    {
        "id": "23458730.T9.T26",
        "sentence": "Lineweaver-Burk plots demonstrated that @CHEMICAL$ inhibited the activities of CYP2D and @GENE$ in a non-competitive manner in rat liver microsomes (RLMs).",
        "relation": "CPR:4"
    },
    {
        "id": "23458730.T2.T19",
        "sentence": "The activity of @CHEMICAL$ in excised liver samples from rats following multiple @GENE$ treatment was significantly decreased compared to that of the control group (P<0.05), whereas multiple doses of baicalin had no obvious effect on the activity of CYP2D. Taken together, these data demonstrate that baicalin inhibits the metabolism of DXM in a concentration-dependent manner in rats, possibly through inhibiting hepatic CYP2D and CYP3A activities.",
        "relation": "CPR:4"
    },
    {
        "id": "23458730.T4.T21",
        "sentence": "The activity of CYP3A in excised liver samples from rats following multiple baicalin treatment was significantly decreased compared to that of the control group (P<0.05), whereas multiple doses of baicalin had no obvious effect on the activity of CYP2D. Taken together, these data demonstrate that @CHEMICAL$ inhibits the metabolism of DXM in a concentration-dependent manner in rats, possibly through inhibiting hepatic @GENE$ and CYP3A activities.",
        "relation": "CPR:4"
    },
    {
        "id": "23458730.T4.T22",
        "sentence": "The activity of CYP3A in excised liver samples from rats following multiple baicalin treatment was significantly decreased compared to that of the control group (P<0.05), whereas multiple doses of baicalin had no obvious effect on the activity of CYP2D. Taken together, these data demonstrate that @CHEMICAL$ inhibits the metabolism of DXM in a concentration-dependent manner in rats, possibly through inhibiting hepatic CYP2D and @GENE$ activities.",
        "relation": "CPR:4"
    },
    {
        "id": "23458730.T5.T21",
        "sentence": "The activity of CYP3A in excised liver samples from rats following multiple baicalin treatment was significantly decreased compared to that of the control group (P<0.05), whereas multiple doses of baicalin had no obvious effect on the activity of CYP2D. Taken together, these data demonstrate that baicalin inhibits the metabolism of @CHEMICAL$ in a concentration-dependent manner in rats, possibly through inhibiting hepatic @GENE$ and CYP3A activities.",
        "relation": "CPR:9"
    },
    {
        "id": "23458730.T5.T22",
        "sentence": "The activity of CYP3A in excised liver samples from rats following multiple baicalin treatment was significantly decreased compared to that of the control group (P<0.05), whereas multiple doses of baicalin had no obvious effect on the activity of CYP2D. Taken together, these data demonstrate that baicalin inhibits the metabolism of @CHEMICAL$ in a concentration-dependent manner in rats, possibly through inhibiting hepatic CYP2D and @GENE$ activities.",
        "relation": "CPR:9"
    },
    {
        "id": "23206862.T2.T6",
        "sentence": "Identification of a novel @CHEMICAL$ derivative as a highly potent @GENE$ antagonist with an anti-obesity profile.",
        "relation": "CPR:6"
    },
    {
        "id": "1975995.T4.T9",
        "sentence": "We evaluated the clinical effectiveness of @CHEMICAL$, an ultra-short-acting @GENE$ blocking drug, to control the sinus tachycardia and increase in arterial blood pressures induced by electroconvulsive therapy (ECT).",
        "relation": "CPR:4"
    },
    {
        "id": "16973691.T16.T25",
        "sentence": "The beta(2)-adrenoceptor (@CHEMICAL$) agonists @GENE$ and fenoterol have similar beneficial effects in animal models of heart failure.",
        "relation": "CPR:5"
    },
    {
        "id": "16973691.T16.T26",
        "sentence": "The @CHEMICAL$ (beta(2)-AR) agonists @GENE$ and fenoterol have similar beneficial effects in animal models of heart failure.",
        "relation": "CPR:5"
    },
    {
        "id": "16973691.T17.T25",
        "sentence": "The beta(2)-adrenoceptor (@CHEMICAL$) agonists clenbuterol and @GENE$ have similar beneficial effects in animal models of heart failure.",
        "relation": "CPR:5"
    },
    {
        "id": "16973691.T17.T26",
        "sentence": "The @CHEMICAL$ (beta(2)-AR) agonists clenbuterol and @GENE$ have similar beneficial effects in animal models of heart failure.",
        "relation": "CPR:5"
    },
    {
        "id": "16973691.T4.T23",
        "sentence": "At 3 mmol kg(-1), all agonists induced apoptosis (fenoterol, 1.1 +/- 0.1%; isoprenaline, 0.9 +/- 0.8%; and clenbuterol, 0.4 +/- 0.07%; P < 0.05). @CHEMICAL$ antagonism (10 mg kg(-1) @GENE$) prevented 92% (P < 0.05) of apoptosis induced by all three agonists, but clenbuterol-induced apoptosis could also be prevented by 96% (P < 0.05) by beta(2)-AR antagonism (10 mg kg(-1) ICI 118 551).",
        "relation": "CPR:6"
    },
    {
        "id": "23315644.T1.T7",
        "sentence": "The mouse @CHEMICAL$ subfamily includes members that have wide tissue distribution and are active in the metabolism of @GENE$ (AA), linoleic acid (LA), and other lipids and xenobiotics.",
        "relation": "CPR:9"
    },
    {
        "id": "23315644.T2.T7",
        "sentence": "The mouse @CHEMICAL$ subfamily includes members that have wide tissue distribution and are active in the metabolism of arachidonic acid (AA), @GENE$ (LA), and other lipids and xenobiotics.",
        "relation": "CPR:9"
    },
    {
        "id": "14711372.T9.T16",
        "sentence": "@CHEMICAL$ (carnitine palmitoyltransferase I) catalyses the conversion of @GENE$ into palmitoylcarnitine in the presence of L-carnitine, facilitating the entry of fatty acids into mitochondria.",
        "relation": "CPR:9"
    },
    {
        "id": "14711372.T9.T28",
        "sentence": "CPT I (@CHEMICAL$) catalyses the conversion of @GENE$ into palmitoylcarnitine in the presence of L-carnitine, facilitating the entry of fatty acids into mitochondria.",
        "relation": "CPR:9"
    },
    {
        "id": "14711372.T12.T16",
        "sentence": "@CHEMICAL$ (carnitine palmitoyltransferase I) catalyses the conversion of palmitoyl-CoA into @GENE$ in the presence of L-carnitine, facilitating the entry of fatty acids into mitochondria.",
        "relation": "CPR:9"
    },
    {
        "id": "14711372.T12.T28",
        "sentence": "CPT I (@CHEMICAL$) catalyses the conversion of palmitoyl-CoA into @GENE$ in the presence of L-carnitine, facilitating the entry of fatty acids into mitochondria.",
        "relation": "CPR:9"
    },
    {
        "id": "23500545.T11.T20",
        "sentence": "@CHEMICAL$ uptake from @GENE$, intracellular vesicle transport and lipid transfer are also modified by oxysterols.",
        "relation": "CPR:9"
    },
    {
        "id": "23301897.T2.T16",
        "sentence": "The new compounds 2-4 were also active against this cell line, with ED50 values ranging from 0.46 to 4.7 mM. The cytotoxic compounds were evaluated against a normal colon cell line, CCD-112CoN. In addition, the new compound @CHEMICAL$ (2), three known rocaglate derivatives (9, 11, 12), and a known sesquiterpene, 2-oxaisodauc-5-en-12-al (17), showed significant @GENE$ (p65) inhibitory activity in an ELISA assay.",
        "relation": "CPR:4"
    },
    {
        "id": "23301897.T2.T17",
        "sentence": "The new compounds 2-4 were also active against this cell line, with ED50 values ranging from 0.46 to 4.7 mM. The cytotoxic compounds were evaluated against a normal colon cell line, CCD-112CoN. In addition, the new compound @CHEMICAL$ (2), three known rocaglate derivatives (9, 11, 12), and a known sesquiterpene, 2-oxaisodauc-5-en-12-al (17), showed significant NF-kB (@GENE$) inhibitory activity in an ELISA assay.",
        "relation": "CPR:4"
    },
    {
        "id": "23301897.T3.T16",
        "sentence": "The new compounds 2-4 were also active against this cell line, with ED50 values ranging from 0.46 to 4.7 mM. The cytotoxic compounds were evaluated against a normal colon cell line, CCD-112CoN. In addition, the new compound perviridicin B (2), three known @CHEMICAL$ derivatives (9, 11, 12), and a known sesquiterpene, 2-oxaisodauc-5-en-12-al (17), showed significant @GENE$ (p65) inhibitory activity in an ELISA assay.",
        "relation": "CPR:4"
    },
    {
        "id": "23301897.T3.T17",
        "sentence": "The new compounds 2-4 were also active against this cell line, with ED50 values ranging from 0.46 to 4.7 mM. The cytotoxic compounds were evaluated against a normal colon cell line, CCD-112CoN. In addition, the new compound perviridicin B (2), three known @CHEMICAL$ derivatives (9, 11, 12), and a known sesquiterpene, 2-oxaisodauc-5-en-12-al (17), showed significant NF-kB (@GENE$) inhibitory activity in an ELISA assay.",
        "relation": "CPR:4"
    },
    {
        "id": "23301897.T5.T16",
        "sentence": "The new compounds 2-4 were also active against this cell line, with ED50 values ranging from 0.46 to 4.7 mM. The cytotoxic compounds were evaluated against a normal colon cell line, CCD-112CoN. In addition, the new compound perviridicin B (2), three known rocaglate derivatives (9, 11, 12), and a known @CHEMICAL$, 2-oxaisodauc-5-en-12-al (17), showed significant @GENE$ (p65) inhibitory activity in an ELISA assay.",
        "relation": "CPR:4"
    },
    {
        "id": "23301897.T5.T17",
        "sentence": "The new compounds 2-4 were also active against this cell line, with ED50 values ranging from 0.46 to 4.7 mM. The cytotoxic compounds were evaluated against a normal colon cell line, CCD-112CoN. In addition, the new compound perviridicin B (2), three known rocaglate derivatives (9, 11, 12), and a known @CHEMICAL$, 2-oxaisodauc-5-en-12-al (17), showed significant NF-kB (@GENE$) inhibitory activity in an ELISA assay.",
        "relation": "CPR:4"
    },
    {
        "id": "23301897.T6.T16",
        "sentence": "The new compounds 2-4 were also active against this cell line, with ED50 values ranging from 0.46 to 4.7 mM. The cytotoxic compounds were evaluated against a normal colon cell line, CCD-112CoN. In addition, the new compound perviridicin B (2), three known rocaglate derivatives (9, 11, 12), and a known sesquiterpene, @CHEMICAL$ (17), showed significant @GENE$ (p65) inhibitory activity in an ELISA assay.",
        "relation": "CPR:4"
    },
    {
        "id": "23301897.T6.T17",
        "sentence": "The new compounds 2-4 were also active against this cell line, with ED50 values ranging from 0.46 to 4.7 mM. The cytotoxic compounds were evaluated against a normal colon cell line, CCD-112CoN. In addition, the new compound perviridicin B (2), three known rocaglate derivatives (9, 11, 12), and a known sesquiterpene, @CHEMICAL$ (17), showed significant NF-kB (@GENE$) inhibitory activity in an ELISA assay.",
        "relation": "CPR:4"
    },
    {
        "id": "23567950.T3.T6",
        "sentence": "In further evaluation, the representative compound @CHEMICAL$ (3b) exhibited potent pro-apoptotic activity, through @GENE$ activation, in HeLa cells.",
        "relation": "CPR:3"
    },
    {
        "id": "8836655.T18.T33",
        "sentence": "Epinastine (0.1-100 microM) produced a concentration-dependent inhibition of the noncholinergic contraction, with a maximum inhibition of 91 +/- 7% at 100 microM. Pretreatment of the tissues with combined @CHEMICAL$/5-HT2 antagonists, @GENE$ (1 microM) or methiothepin (0.1 microM), significantly attenuated the inhibitory effect of epinastine on the noncholinergic contraction.",
        "relation": "CPR:6"
    },
    {
        "id": "8836655.T18.T34",
        "sentence": "Epinastine (0.1-100 microM) produced a concentration-dependent inhibition of the noncholinergic contraction, with a maximum inhibition of 91 +/- 7% at 100 microM. Pretreatment of the tissues with combined 5-HT1/@CHEMICAL$ antagonists, @GENE$ (1 microM) or methiothepin (0.1 microM), significantly attenuated the inhibitory effect of epinastine on the noncholinergic contraction.",
        "relation": "CPR:6"
    },
    {
        "id": "8836655.T19.T33",
        "sentence": "Epinastine (0.1-100 microM) produced a concentration-dependent inhibition of the noncholinergic contraction, with a maximum inhibition of 91 +/- 7% at 100 microM. Pretreatment of the tissues with combined @CHEMICAL$/5-HT2 antagonists, methysergide (1 microM) or @GENE$ (0.1 microM), significantly attenuated the inhibitory effect of epinastine on the noncholinergic contraction.",
        "relation": "CPR:6"
    },
    {
        "id": "8836655.T19.T34",
        "sentence": "Epinastine (0.1-100 microM) produced a concentration-dependent inhibition of the noncholinergic contraction, with a maximum inhibition of 91 +/- 7% at 100 microM. Pretreatment of the tissues with combined 5-HT1/@CHEMICAL$ antagonists, methysergide (1 microM) or @GENE$ (0.1 microM), significantly attenuated the inhibitory effect of epinastine on the noncholinergic contraction.",
        "relation": "CPR:6"
    },
    {
        "id": "8836655.T20.T33",
        "sentence": "Epinastine (0.1-100 microM) produced a concentration-dependent inhibition of the noncholinergic contraction, with a maximum inhibition of 91 +/- 7% at 100 microM. Pretreatment of the tissues with combined @CHEMICAL$/5-HT2 antagonists, methysergide (1 microM) or methiothepin (0.1 microM), significantly attenuated the inhibitory effect of @GENE$ on the noncholinergic contraction.",
        "relation": "CPR:5"
    },
    {
        "id": "8836655.T20.T34",
        "sentence": "Epinastine (0.1-100 microM) produced a concentration-dependent inhibition of the noncholinergic contraction, with a maximum inhibition of 91 +/- 7% at 100 microM. Pretreatment of the tissues with combined 5-HT1/@CHEMICAL$ antagonists, methysergide (1 microM) or methiothepin (0.1 microM), significantly attenuated the inhibitory effect of @GENE$ on the noncholinergic contraction.",
        "relation": "CPR:5"
    },
    {
        "id": "8836655.T1.T23",
        "sentence": "Pretreatment with @CHEMICAL$ (1 microM), a @GENE$ antagonist, ketanserin (10 microM), a 5-HT2 antagonist, thioperamide (10 microM), a histamine H3 antagonist, or phentolamine (10 microM), an alpha-adrenergic antagonist, however, had no effect.",
        "relation": "CPR:6"
    },
    {
        "id": "8836655.T2.T24",
        "sentence": "Pretreatment with tropisetron (1 microM), a 5-HT3 antagonist, @CHEMICAL$ (10 microM), a @GENE$ antagonist, thioperamide (10 microM), a histamine H3 antagonist, or phentolamine (10 microM), an alpha-adrenergic antagonist, however, had no effect.",
        "relation": "CPR:6"
    },
    {
        "id": "8836655.T3.T25",
        "sentence": "Pretreatment with tropisetron (1 microM), a 5-HT3 antagonist, ketanserin (10 microM), a 5-HT2 antagonist, @CHEMICAL$ (10 microM), a @GENE$ antagonist, or phentolamine (10 microM), an alpha-adrenergic antagonist, however, had no effect.",
        "relation": "CPR:6"
    },
    {
        "id": "8836655.T6.T26",
        "sentence": "@CHEMICAL$ (10 microM), another @GENE$ antagonist without significant 5-HT receptor binding affinity, did not produce any inhibition of the eNANC contraction.",
        "relation": "CPR:6"
    },
    {
        "id": "8836655.T10.T29",
        "sentence": "These results suggest that @CHEMICAL$, although identified as a 5-HT antagonist, acts as a @GENE$ agonist and that it inhibits the noncholinergic contraction in guinea-pig airways through stimulation of a prejunctional 5-HT1-like receptor, located to sensory nerves.",
        "relation": "CPR:5"
    },
    {
        "id": "8836655.T10.T30",
        "sentence": "These results suggest that @CHEMICAL$, although identified as a 5-HT antagonist, acts as a 5-HT1 agonist and that it inhibits the noncholinergic contraction in guinea-pig airways through stimulation of a prejunctional @GENE$, located to sensory nerves.",
        "relation": "CPR:3"
    },
    {
        "id": "23615073.T8.T24",
        "sentence": "@CHEMICAL$ forestalls cigarette smoke induced @GENE$ activation in alveolar epithelial cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23615073.T4.T13",
        "sentence": "It is possible that @CHEMICAL$, an antioxidant, may prevent cigarette smoke (CS)-induced @GENE$ activation that involves degradation of I-kBe and nuclear translocation of c-Rel/p50 in alveolar epithelial cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23615073.T4.T14",
        "sentence": "It is possible that @CHEMICAL$, an antioxidant, may prevent cigarette smoke (CS)-induced NF-kB activation that involves degradation of @GENE$ and nuclear translocation of c-Rel/p50 in alveolar epithelial cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23615073.T2.T10",
        "sentence": "We observed a significant reduction in CSE induced luciferase expression, NF-kB DNA binding, I-kBe degradation and c-Rel nuclear translocation in cells pretreated with vitamin C. To further validate the result, we examined sub-cellular distribution of c-Rel in lungs of CS-exposed guinea pigs treated or untreated with vitamin C. Result showed that @CHEMICAL$ treatment resulted in markedly reduced @GENE$ nuclear translocation.",
        "relation": "CPR:4"
    },
    {
        "id": "23615073.T7.T22",
        "sentence": "We observed a significant reduction in CSE induced luciferase expression, NF-kB DNA binding, @CHEMICAL$ degradation and c-Rel nuclear translocation in cells pretreated with @GENE$. To further validate the result, we examined sub-cellular distribution of c-Rel in lungs of CS-exposed guinea pigs treated or untreated with vitamin C. Result showed that vitamin C treatment resulted in markedly reduced c-Rel nuclear translocation.",
        "relation": "CPR:4"
    },
    {
        "id": "23615073.T3.T12",
        "sentence": "All these results demonstrate that @CHEMICAL$ prevents CS(E)-induced @GENE$ activation and thus it could be used for the prevention of CS-induced inflammatory diseases.",
        "relation": "CPR:4"
    },
    {
        "id": "23376161.T7.T16",
        "sentence": "@CHEMICAL$ reduced the expression of pro-inflammatory mediates, such as @GENE$ (MCP-1), tumor necrosis factor-a (TNF-a), inducible NO synthase (iNOS), and receptor for AGE (RAGE).",
        "relation": "CPR:4"
    },
    {
        "id": "23376161.T7.T17",
        "sentence": "@CHEMICAL$ reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (@GENE$), tumor necrosis factor-a (TNF-a), inducible NO synthase (iNOS), and receptor for AGE (RAGE).",
        "relation": "CPR:4"
    },
    {
        "id": "23376161.T7.T18",
        "sentence": "@CHEMICAL$ reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (MCP-1), @GENE$ (TNF-a), inducible NO synthase (iNOS), and receptor for AGE (RAGE).",
        "relation": "CPR:4"
    },
    {
        "id": "23376161.T7.T19",
        "sentence": "@CHEMICAL$ reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-a (@GENE$), inducible NO synthase (iNOS), and receptor for AGE (RAGE).",
        "relation": "CPR:4"
    },
    {
        "id": "23376161.T7.T20",
        "sentence": "@CHEMICAL$ reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-a (TNF-a), @GENE$ (iNOS), and receptor for AGE (RAGE).",
        "relation": "CPR:4"
    },
    {
        "id": "23376161.T7.T21",
        "sentence": "@CHEMICAL$ reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-a (TNF-a), inducible NO synthase (@GENE$), and receptor for AGE (RAGE).",
        "relation": "CPR:4"
    },
    {
        "id": "23376161.T7.T22",
        "sentence": "@CHEMICAL$ reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-a (TNF-a), inducible NO synthase (iNOS), and @GENE$ (RAGE).",
        "relation": "CPR:4"
    },
    {
        "id": "23376161.T7.T23",
        "sentence": "@CHEMICAL$ reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-a (TNF-a), inducible NO synthase (iNOS), and receptor for AGE (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "23376161.T9.T24",
        "sentence": "Promoter and electromobility shift assays showed that transcriptional activation of @CHEMICAL$ was significantly reduced by @GENE$ treatment, while AP-1 was not.",
        "relation": "CPR:4"
    },
    {
        "id": "23376161.T10.T13",
        "sentence": "@CHEMICAL$ also suppressed AGE-induced phosphorylation of mitogen activated protein (MAP) kinases, degradation of IkBa and the nuclear localization of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23376161.T10.T26",
        "sentence": "@CHEMICAL$ also suppressed AGE-induced phosphorylation of @GENE$, degradation of IkBa and the nuclear localization of NF-kB.",
        "relation": "CPR:4"
    },
    {
        "id": "23376161.T10.T27",
        "sentence": "@CHEMICAL$ also suppressed AGE-induced phosphorylation of mitogen activated protein (MAP) kinases, degradation of @GENE$ and the nuclear localization of NF-kB.",
        "relation": "CPR:4"
    },
    {
        "id": "23376161.T2.T14",
        "sentence": "Moreover, the production of intracellular reactive oxygen species (ROS) elicited by AGE was also suppressed by @CHEMICAL$ treatment, through dual action of reducing ROS itself and inhibiting @GENE$ activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23376161.T4.T15",
        "sentence": "Our findings indicate that @CHEMICAL$ suppresses AGE-mediated inflammation by inhibiting ROS production and @GENE$ activity.",
        "relation": "CPR:4"
    },
    {
        "id": "20596674.T1.T32",
        "sentence": "@CHEMICAL$ (VP-16) is a @GENE$ (topo II) inhibitor chemotherapeutic agent.",
        "relation": "CPR:4"
    },
    {
        "id": "20596674.T1.T34",
        "sentence": "@CHEMICAL$ (VP-16) is a topoisomerase-II (@GENE$) inhibitor chemotherapeutic agent.",
        "relation": "CPR:4"
    },
    {
        "id": "20596674.T4.T32",
        "sentence": "Etoposide (@CHEMICAL$) is a @GENE$ (topo II) inhibitor chemotherapeutic agent.",
        "relation": "CPR:4"
    },
    {
        "id": "20596674.T4.T34",
        "sentence": "Etoposide (@CHEMICAL$) is a topoisomerase-II (@GENE$) inhibitor chemotherapeutic agent.",
        "relation": "CPR:4"
    },
    {
        "id": "20596674.T23.T39",
        "sentence": "@CHEMICAL$ or VP-16 slightly affected cellular topo II activity in nuclear extracts derived from drug-treated cells while the combination enhanced inhibitory activity and the reduction in band depletion of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "20596674.T24.T39",
        "sentence": "MXF or @CHEMICAL$ slightly affected cellular topo II activity in nuclear extracts derived from drug-treated cells while the combination enhanced inhibitory activity and the reduction in band depletion of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "20596674.T5.T28",
        "sentence": "Apoptosis studies (DAPI staining and @CHEMICAL$ activity) showed a marked increase in the presence of @GENE$ and VP-16 compared to VP-16 alone.",
        "relation": "CPR:3"
    },
    {
        "id": "20596674.T6.T28",
        "sentence": "Apoptosis studies (DAPI staining and @CHEMICAL$ activity) showed a marked increase in the presence of MXF and @GENE$ compared to VP-16 alone.",
        "relation": "CPR:3"
    },
    {
        "id": "20596674.T7.T28",
        "sentence": "Apoptosis studies (DAPI staining and @CHEMICAL$ activity) showed a marked increase in the presence of MXF and VP-16 compared to @GENE$ alone.",
        "relation": "CPR:3"
    },
    {
        "id": "20596674.T11.T31",
        "sentence": "In conclusion, the results suggest that the enhancement in the reduction of @CHEMICAL$ activity by the combined @GENE$/VP-16 treatments was probably due to the increase in the level of the DNA-enzyme cleavable complexes formed by both drugs.",
        "relation": "CPR:4"
    },
    {
        "id": "20596674.T12.T31",
        "sentence": "In conclusion, the results suggest that the enhancement in the reduction of @CHEMICAL$ activity by the combined MXF/@GENE$ treatments was probably due to the increase in the level of the DNA-enzyme cleavable complexes formed by both drugs.",
        "relation": "CPR:4"
    },
    {
        "id": "14719072.T22.T39",
        "sentence": "@CHEMICAL$ currently undergoing clinical trials, has been demonstrated to have at least two mechanisms, inhibition of @GENE$ and incorporation into DNA.",
        "relation": "CPR:4"
    },
    {
        "id": "14719072.T28.T44",
        "sentence": "In the present study, we measured the enzyme activity of thymidine kinase (TK), thymidine phosphorylase (TP) and @CHEMICAL$ (TS) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "14719072.T28.T45",
        "sentence": "In the present study, we measured the enzyme activity of thymidine kinase (TK), thymidine phosphorylase (TP) and thymidilate synthase (@CHEMICAL$) in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "21838705.T2.T14",
        "sentence": "Because clinical studies investigating interactions between garlic and @CHEMICAL$ inhibitors @GENE$ and ritonavir have already been performed, we used these in vivo data to evaluate the in vitro results and the reliability of the models employed as screening tools for forecasting the potential of first-pass intestinal metabolism changes.",
        "relation": "CPR:4"
    },
    {
        "id": "21838705.T3.T14",
        "sentence": "Because clinical studies investigating interactions between garlic and @CHEMICAL$ inhibitors saquinavir and @GENE$ have already been performed, we used these in vivo data to evaluate the in vitro results and the reliability of the models employed as screening tools for forecasting the potential of first-pass intestinal metabolism changes.",
        "relation": "CPR:4"
    },
    {
        "id": "1361547.T15.T26",
        "sentence": "@CHEMICAL$ (> or = 3 x 10(-8) M) and dilevalol (> or = 10(-8) M) caused surmountable antagonism of the isoprenaline responses of the atria and the pA2 values were 8.60 and 8.98 at the @GENE$ of the rat left atria and 7.90 and 8.31, respectively, on the guinea-pig left atria which has functional beta 1- and beta 2-adrenoceptors.",
        "relation": "CPR:6"
    },
    {
        "id": "1361547.T16.T26",
        "sentence": "Labetalol (> or = 3 x 10(-8) M) and @CHEMICAL$ (> or = 10(-8) M) caused surmountable antagonism of the isoprenaline responses of the atria and the pA2 values were 8.60 and 8.98 at the @GENE$ of the rat left atria and 7.90 and 8.31, respectively, on the guinea-pig left atria which has functional beta 1- and beta 2-adrenoceptors.",
        "relation": "CPR:6"
    },
    {
        "id": "1361547.T17.T26",
        "sentence": "Labetalol (> or = 3 x 10(-8) M) and dilevalol (> or = 10(-8) M) caused surmountable antagonism of the @CHEMICAL$ responses of the atria and the pA2 values were 8.60 and 8.98 at the @GENE$ of the rat left atria and 7.90 and 8.31, respectively, on the guinea-pig left atria which has functional beta 1- and beta 2-adrenoceptors.",
        "relation": "CPR:5"
    },
    {
        "id": "1361547.T7.T24",
        "sentence": "The isoprenaline attenuation responses of the portal vein were inhibited by labetalol and dilevalol (both at > or = 10(-7) M) and the pA2 value for the @CHEMICAL$ at @GENE$ was 7.59.",
        "relation": "CPR:6"
    },
    {
        "id": "1361547.T8.T25",
        "sentence": "It is concluded that @CHEMICAL$ and dilevalol are @GENE$ selective antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "1361547.T9.T25",
        "sentence": "It is concluded that labetalol and @CHEMICAL$ are @GENE$ selective antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "10682471.T1.T24",
        "sentence": "@CHEMICAL$ abundance in both myometruim and leiomyomata (center and marginal area) was significantly decreased in 4 patients continuing @GENE$ treatment before the operation but not in the other 2 patients stopping RU486 1 month before operation.",
        "relation": "CPR:4"
    },
    {
        "id": "10682471.T3.T14",
        "sentence": "One of the mechanism of @CHEMICAL$ action on decreasing leiomyomata volume may be related to suppression on expression of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "10954021.T1.T19",
        "sentence": "Experimental cystathioninuria was induced in rats by administration of the @CHEMICAL$ inhibitor, @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17085856.T9.T25",
        "sentence": "The concomitant application of subconvulsive dose of pentetrazole (55.0 mg/kg) with low dose of @CHEMICAL$ (5.0 mg/kg) - a @GENE$ antagonist, immediately induced BDZ withdrawal signs in these animals.",
        "relation": "CPR:6"
    },
    {
        "id": "17085856.T13.T26",
        "sentence": "The non-selective @CHEMICAL$ antagonist (@GENE$), and the selective adenosine A1 receptor antagonist (DPCPX), injected 15 min before the application of pentetrazole and flumazenil, were able to intensify BDZ withdrawal signs in mice.",
        "relation": "CPR:6"
    },
    {
        "id": "17085856.T15.T27",
        "sentence": "The non-selective adenosine receptor antagonist (caffeine), and the selective @CHEMICAL$ antagonist (@GENE$), injected 15 min before the application of pentetrazole and flumazenil, were able to intensify BDZ withdrawal signs in mice.",
        "relation": "CPR:6"
    },
    {
        "id": "15102890.T13.T38",
        "sentence": "Cross-inhibition of @CHEMICAL$- and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15102890.T13.T39",
        "sentence": "Cross-inhibition of SR-BI- and @CHEMICAL$-mediated cholesterol transport by the small molecules BLT-4 and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15102890.T14.T38",
        "sentence": "Cross-inhibition of @CHEMICAL$- and ABCA1-mediated @GENE$ transport by the small molecules BLT-4 and glyburide.",
        "relation": "CPR:9"
    },
    {
        "id": "15102890.T14.T39",
        "sentence": "Cross-inhibition of SR-BI- and @CHEMICAL$-mediated @GENE$ transport by the small molecules BLT-4 and glyburide.",
        "relation": "CPR:9"
    },
    {
        "id": "15102890.T3.T22",
        "sentence": "@CHEMICAL$ is a receptor that binds HDL with high affinity and mediates both the selective lipid uptake of @GENE$ from lipid-rich HDL to cells and the efflux of unesterified cholesterol from cells to HDL.",
        "relation": "CPR:9"
    },
    {
        "id": "15102890.T4.T22",
        "sentence": "@CHEMICAL$ is a receptor that binds HDL with high affinity and mediates both the selective lipid uptake of cholesteryl esters from lipid-rich HDL to cells and the efflux of unesterified @GENE$ from cells to HDL.",
        "relation": "CPR:9"
    },
    {
        "id": "15102890.T5.T26",
        "sentence": "@CHEMICAL$ mediates the efflux of unesterified @GENE$ and phospholipids from cells to lipid-poor apolipoprotein A-I (apoA-I).",
        "relation": "CPR:9"
    },
    {
        "id": "15102890.T7.T32",
        "sentence": "The activities of ABCA1 and other @CHEMICAL$ members are inhibited by the drug @GENE$, and SR-BI-mediated lipid transport is blocked by small molecule inhibitors called BLTs.",
        "relation": "CPR:4"
    },
    {
        "id": "15102890.T7.T31",
        "sentence": "The activities of @CHEMICAL$ and other ATP binding cassette superfamily members are inhibited by the drug @GENE$, and SR-BI-mediated lipid transport is blocked by small molecule inhibitors called BLTs.",
        "relation": "CPR:4"
    },
    {
        "id": "15102890.T8.T34",
        "sentence": "Here, we show that one @CHEMICAL$, [1-(2-methoxy-phenyl)-3-naphthalen-2-yl-urea] (BLT-4), blocked @GENE$-mediated cholesterol efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of SR-BI (IC(50) approximately 55-60 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "15102890.T8.T36",
        "sentence": "Here, we show that one @CHEMICAL$, [1-(2-methoxy-phenyl)-3-naphthalen-2-yl-urea] (BLT-4), blocked ABCA1-mediated cholesterol efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of @GENE$ (IC(50) approximately 55-60 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "15102890.T9.T34",
        "sentence": "Here, we show that one BLT, [@CHEMICAL$] (BLT-4), blocked @GENE$-mediated cholesterol efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of SR-BI (IC(50) approximately 55-60 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "15102890.T9.T36",
        "sentence": "Here, we show that one BLT, [@CHEMICAL$] (BLT-4), blocked ABCA1-mediated cholesterol efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of @GENE$ (IC(50) approximately 55-60 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "15102890.T10.T34",
        "sentence": "Here, we show that one BLT, [1-(2-methoxy-phenyl)-3-naphthalen-2-yl-urea] (@CHEMICAL$), blocked @GENE$-mediated cholesterol efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of SR-BI (IC(50) approximately 55-60 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "15102890.T10.T36",
        "sentence": "Here, we show that one BLT, [1-(2-methoxy-phenyl)-3-naphthalen-2-yl-urea] (@CHEMICAL$), blocked ABCA1-mediated cholesterol efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of @GENE$ (IC(50) approximately 55-60 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "15102890.T11.T34",
        "sentence": "Here, we show that one BLT, [1-(2-methoxy-phenyl)-3-naphthalen-2-yl-urea] (BLT-4), blocked @CHEMICAL$-mediated @GENE$ efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of SR-BI (IC(50) approximately 55-60 microM).",
        "relation": "CPR:9"
    },
    {
        "id": "15102890.T12.T16",
        "sentence": "Reciprocally, @CHEMICAL$ blocked SR-BI-mediated selective lipid uptake and efflux at a potency similar to that for its inhibition of @GENE$ (IC(50) approximately 275-300 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "15102890.T12.T37",
        "sentence": "Reciprocally, @CHEMICAL$ blocked @GENE$-mediated selective lipid uptake and efflux at a potency similar to that for its inhibition of ABCA1 (IC(50) approximately 275-300 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "15102890.T2.T19",
        "sentence": "The reciprocal inhibition of @CHEMICAL$ and ABCA1 by BLT-4 and @GENE$ raises the possibility that these proteins may share similar or common steps in their mechanisms of lipid transport.",
        "relation": "CPR:4"
    },
    {
        "id": "15102890.T2.T20",
        "sentence": "The reciprocal inhibition of SR-BI and @CHEMICAL$ by BLT-4 and @GENE$ raises the possibility that these proteins may share similar or common steps in their mechanisms of lipid transport.",
        "relation": "CPR:4"
    },
    {
        "id": "23444334.T4.T14",
        "sentence": "The treatment of mice with @CHEMICAL$ alone enhances @GENE$ activity to 4.6 folds, protein carbonyl formation increased up to 2.9 folds and DNA synthesis expressed in terms of [(3)H] thymidine incorporation increased to 3.2 folds, and antioxidants and antioxidant enzymes decreased to 1.8-2.5 folds, compared with the corresponding saline-treated controls.",
        "relation": "CPR:3"
    },
    {
        "id": "22872607.T3.T12",
        "sentence": "@CHEMICAL$ (AKRs) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (@GENE$), generating metabolites (o-quinones) and reactive oxygen species (ROS), which are capable of initiating and promoting carcinogenesis.",
        "relation": "CPR:9"
    },
    {
        "id": "22872607.T3.T19",
        "sentence": "Aldo-keto reductases (@CHEMICAL$) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (@GENE$), generating metabolites (o-quinones) and reactive oxygen species (ROS), which are capable of initiating and promoting carcinogenesis.",
        "relation": "CPR:9"
    },
    {
        "id": "22872607.T6.T12",
        "sentence": "@CHEMICAL$ (AKRs) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (PAHs), generating metabolites (@GENE$) and reactive oxygen species (ROS), which are capable of initiating and promoting carcinogenesis.",
        "relation": "CPR:9"
    },
    {
        "id": "22872607.T6.T19",
        "sentence": "Aldo-keto reductases (@CHEMICAL$) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (PAHs), generating metabolites (@GENE$) and reactive oxygen species (ROS), which are capable of initiating and promoting carcinogenesis.",
        "relation": "CPR:9"
    },
    {
        "id": "22872607.T7.T12",
        "sentence": "@CHEMICAL$ (AKRs) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (PAHs), generating metabolites (o-quinones) and reactive @GENE$ species (ROS), which are capable of initiating and promoting carcinogenesis.",
        "relation": "CPR:9"
    },
    {
        "id": "22872607.T7.T19",
        "sentence": "Aldo-keto reductases (@CHEMICAL$) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (PAHs), generating metabolites (o-quinones) and reactive @GENE$ species (ROS), which are capable of initiating and promoting carcinogenesis.",
        "relation": "CPR:9"
    },
    {
        "id": "22872607.T11.T12",
        "sentence": "@CHEMICAL$ (AKRs) metabolize a wide range of substrates, including @GENE$ (PAHs), generating metabolites (o-quinones) and reactive oxygen species (ROS), which are capable of initiating and promoting carcinogenesis.",
        "relation": "CPR:9"
    },
    {
        "id": "22872607.T11.T19",
        "sentence": "Aldo-keto reductases (@CHEMICAL$) metabolize a wide range of substrates, including @GENE$ (PAHs), generating metabolites (o-quinones) and reactive oxygen species (ROS), which are capable of initiating and promoting carcinogenesis.",
        "relation": "CPR:9"
    },
    {
        "id": "22872607.T8.T20",
        "sentence": "Exposure to @CHEMICAL$, their metabolites, and ROS further increase @GENE$ isoform expression that may amplify oxidative damage.",
        "relation": "CPR:3"
    },
    {
        "id": "22872607.T9.T23",
        "sentence": "Despite the importance of @CHEMICAL$ in @GENE$ metabolism, there are no studies that evaluate, in general human populations, the effect of PAHs on AKRs expression in peripheral blood lymphocytes (PBLs).",
        "relation": "CPR:9"
    },
    {
        "id": "23090712.T1.T21",
        "sentence": "The pretreatment with 20 mg L(-1) @CHEMICAL$ could alleviate the effects of UV-B radiation on the activities of @GENE$, glutamine synthetase, glutamate synthase, and glutamate dehydrogenase, promoting amino acid conversion and protein synthesis in soybean seedlings.",
        "relation": "CPR:4"
    },
    {
        "id": "23090712.T1.T22",
        "sentence": "The pretreatment with 20 mg L(-1) @CHEMICAL$ could alleviate the effects of UV-B radiation on the activities of nitrate reductase, @GENE$, glutamate synthase, and glutamate dehydrogenase, promoting amino acid conversion and protein synthesis in soybean seedlings.",
        "relation": "CPR:4"
    },
    {
        "id": "23090712.T1.T23",
        "sentence": "The pretreatment with 20 mg L(-1) @CHEMICAL$ could alleviate the effects of UV-B radiation on the activities of nitrate reductase, glutamine synthetase, @GENE$, and glutamate dehydrogenase, promoting amino acid conversion and protein synthesis in soybean seedlings.",
        "relation": "CPR:4"
    },
    {
        "id": "23090712.T1.T24",
        "sentence": "The pretreatment with 20 mg L(-1) @CHEMICAL$ could alleviate the effects of UV-B radiation on the activities of nitrate reductase, glutamine synthetase, glutamate synthase, and @GENE$, promoting amino acid conversion and protein synthesis in soybean seedlings.",
        "relation": "CPR:4"
    },
    {
        "id": "23374869.T24.T32",
        "sentence": "Inhibition of @CHEMICAL$ by @GENE$ analogues.",
        "relation": "CPR:4"
    },
    {
        "id": "23374869.T4.T28",
        "sentence": "Based on recent reports that the small molecules, isatin and phthalimide, are suitable scaffolds for the design of high potency monoamine oxidase (MAO) inhibitors, the present study examines the @CHEMICAL$ inhibitory properties of a series of @GENE$ [2-benzofuran-1(3H)-one] analogues.",
        "relation": "CPR:4"
    },
    {
        "id": "23374869.T5.T28",
        "sentence": "Based on recent reports that the small molecules, isatin and phthalimide, are suitable scaffolds for the design of high potency monoamine oxidase (MAO) inhibitors, the present study examines the @CHEMICAL$ inhibitory properties of a series of phthalide [@GENE$] analogues.",
        "relation": "CPR:4"
    },
    {
        "id": "23374869.T10.T26",
        "sentence": "Based on recent reports that the small molecules, @CHEMICAL$ and phthalimide, are suitable scaffolds for the design of high potency @GENE$ (MAO) inhibitors, the present study examines the MAO inhibitory properties of a series of phthalide [2-benzofuran-1(3H)-one] analogues.",
        "relation": "CPR:4"
    },
    {
        "id": "23374869.T10.T27",
        "sentence": "Based on recent reports that the small molecules, @CHEMICAL$ and phthalimide, are suitable scaffolds for the design of high potency monoamine oxidase (@GENE$) inhibitors, the present study examines the MAO inhibitory properties of a series of phthalide [2-benzofuran-1(3H)-one] analogues.",
        "relation": "CPR:4"
    },
    {
        "id": "23374869.T11.T26",
        "sentence": "Based on recent reports that the small molecules, isatin and @CHEMICAL$, are suitable scaffolds for the design of high potency @GENE$ (MAO) inhibitors, the present study examines the MAO inhibitory properties of a series of phthalide [2-benzofuran-1(3H)-one] analogues.",
        "relation": "CPR:4"
    },
    {
        "id": "23374869.T11.T27",
        "sentence": "Based on recent reports that the small molecules, isatin and @CHEMICAL$, are suitable scaffolds for the design of high potency monoamine oxidase (@GENE$) inhibitors, the present study examines the MAO inhibitory properties of a series of phthalide [2-benzofuran-1(3H)-one] analogues.",
        "relation": "CPR:4"
    },
    {
        "id": "23374869.T12.T31",
        "sentence": "In most instances, C6-substituted @CHEMICAL$ exhibit @GENE$ specific inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "23374869.T22.T25",
        "sentence": "Among a series of 6-benzyloxyphthalides bearing substituents on the para position of the phenyl ring the general order of potency was CF(3) > I > Br > Cl > F > CH(3) > H. The results also show that the binding modes of representative @CHEMICAL$ are reversible and competitive at both @GENE$ isoforms.",
        "relation": "CPR:4"
    },
    {
        "id": "23139413.T5.T25",
        "sentence": "\"Binding of the agonist angiotensin II (AngII) and inverse agonist @CHEMICAL$ in wild-type @GENE$ changed the accessibility of reporter cysteines, and the pattern was consistent with ligand-specific \"\"lid\"\" conformations of ECL2.\"",
        "relation": "CPR:5"
    },
    {
        "id": "20372850.T17.T37",
        "sentence": "Immunohistochemical characterization of @CHEMICAL$ synthetic enzymes, @GENE$ and thymidylate synthase, in various types of cancer.",
        "relation": "CPR:9"
    },
    {
        "id": "20372850.T17.T38",
        "sentence": "Immunohistochemical characterization of @CHEMICAL$ synthetic enzymes, thymidine kinase-1 and @GENE$, in various types of cancer.",
        "relation": "CPR:9"
    },
    {
        "id": "20372850.T16.T19",
        "sentence": "@CHEMICAL$ (TK-1) and thymidylate synthase (TS) are key enzymes for salvage and de novo @GENE$ synthesis, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "20372850.T16.T27",
        "sentence": "Thymidine kinase-1 (@CHEMICAL$ and thymidylate synthase (TS) are key enzymes for salvage and de novo @GENE$ synthesis, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "20372850.T16.T28",
        "sentence": "Thymidine kinase-1 (TK-1) and @CHEMICAL$ (TS) are key enzymes for salvage and de novo @GENE$ synthesis, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "20372850.T16.T31",
        "sentence": "Thymidine kinase-1 (TK-1) and thymidylate synthase (@CHEMICAL$) are key enzymes for salvage and de novo @GENE$ synthesis, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "20372850.T10.T29",
        "sentence": "@CHEMICAL$ is a novel drug containing trifluorothymidine, which is phosphorylated by @GENE$ to its active monophosphated form, that in turn can inhibit TS.",
        "relation": "CPR:9"
    },
    {
        "id": "20372850.T10.T30",
        "sentence": "@CHEMICAL$ is a novel drug containing trifluorothymidine, which is phosphorylated by TK-1 to its active monophosphated form, that in turn can inhibit @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "20372850.T11.T29",
        "sentence": "TAS-102 is a novel drug containing @CHEMICAL$, which is phosphorylated by @GENE$ to its active monophosphated form, that in turn can inhibit TS.",
        "relation": "CPR:9"
    },
    {
        "id": "20372850.T2.T20",
        "sentence": "Gastrointestinal adenocarcinomas and squamous cell uterine carcinomas were often accompanied by high @CHEMICAL$ expression, indicating activation of @GENE$ synthesis through both the salvage and de novo pathways.",
        "relation": "CPR:9"
    },
    {
        "id": "20347047.T11.T13",
        "sentence": "The contractions to 5-HT were inhibited by @CHEMICAL$ and alosetron indicating involvement of @GENE$ and 5-HT(3) receptors, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "20347047.T12.T14",
        "sentence": "The contractions to 5-HT were inhibited by ketanserin and @CHEMICAL$ indicating involvement of 5-HT(2A) and @GENE$ receptors, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "23552263.T4.T18",
        "sentence": "Regarding @CHEMICAL$ inhibition, @GENE$ was the most potent fraction (IC50: 97 mg/mL).",
        "relation": "CPR:4"
    },
    {
        "id": "23314320.T5.T15",
        "sentence": "The current U.S. military and civilian oxime countermeasure, 2-[(hydroxyimino)methyl]-1-methylpyridin-1-ium chloride (2-PAM), is under consideration for replacement with a more effective @CHEMICAL$ reactivator, @GENE$ (MMB-4).",
        "relation": "CPR:3"
    },
    {
        "id": "23314320.T6.T15",
        "sentence": "The current U.S. military and civilian oxime countermeasure, 2-[(hydroxyimino)methyl]-1-methylpyridin-1-ium chloride (2-PAM), is under consideration for replacement with a more effective @CHEMICAL$ reactivator, 1,1'-methylenebis{4-hydroxyiminomethyl}pyridinium dimethanesulfonate (@GENE$).",
        "relation": "CPR:3"
    },
    {
        "id": "23493374.T12.T43",
        "sentence": "Methylation-specific PCR and bisulfite sequencing identified methylation of this @CHEMICAL$ ((m)CpG) island of the glut3 gene, frequency of methylation increasing 2.5-fold with a 1.6-fold increase in @GENE$ concentrations noted with advancing postnatal age (PN14 vs PN3). 5'-flanking region of glut3-luciferase reporter transient transfection in HT22 hippocampal neurons demonstrated that (m)CpGs inhibit glut3 transcription.",
        "relation": "CPR:3"
    },
    {
        "id": "23493374.T13.T43",
        "sentence": "Methylation-specific PCR and bisulfite sequencing identified methylation of this CpG (@CHEMICAL$) island of the glut3 gene, frequency of methylation increasing 2.5-fold with a 1.6-fold increase in @GENE$ concentrations noted with advancing postnatal age (PN14 vs PN3). 5'-flanking region of glut3-luciferase reporter transient transfection in HT22 hippocampal neurons demonstrated that (m)CpGs inhibit glut3 transcription.",
        "relation": "CPR:3"
    },
    {
        "id": "23493374.T14.T46",
        "sentence": "Methylation-specific PCR and bisulfite sequencing identified methylation of this CpG ((m)CpG) island of the glut3 gene, frequency of methylation increasing 2.5-fold with a 1.6-fold increase in DNA methyl transferase 3a concentrations noted with advancing postnatal age (PN14 vs PN3). 5'-flanking region of glut3-luciferase reporter transient transfection in HT22 hippocampal neurons demonstrated that @CHEMICAL$ inhibit @GENE$ transcription.",
        "relation": "CPR:4"
    },
    {
        "id": "23493374.T3.T28",
        "sentence": "Separate @CHEMICAL$ pretreatment or in combination with trichostatin A reduced (m)CpG and specific small interference RNAs targeting @GENE$ and Creb1 separately or together depleting Mecp2 and/or Creb1 binding of glut3-(m)CpGs reduced glut3 expression in HT22 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23493374.T3.T29",
        "sentence": "Separate @CHEMICAL$ pretreatment or in combination with trichostatin A reduced (m)CpG and specific small interference RNAs targeting Mecp2 and @GENE$ separately or together depleting Mecp2 and/or Creb1 binding of glut3-(m)CpGs reduced glut3 expression in HT22 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23493374.T4.T28",
        "sentence": "Separate 5-aza-2'-deoxycytidine pretreatment or in combination with @CHEMICAL$ reduced (m)CpG and specific small interference RNAs targeting @GENE$ and Creb1 separately or together depleting Mecp2 and/or Creb1 binding of glut3-(m)CpGs reduced glut3 expression in HT22 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23493374.T4.T29",
        "sentence": "Separate 5-aza-2'-deoxycytidine pretreatment or in combination with @CHEMICAL$ reduced (m)CpG and specific small interference RNAs targeting Mecp2 and @GENE$ separately or together depleting Mecp2 and/or Creb1 binding of glut3-(m)CpGs reduced glut3 expression in HT22 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "16554743.T2.T22",
        "sentence": "A pronounced NET knockout-induced shortening of the immobility time in the TST (by ca 50%) compared to WT mice was not reduced any further by @CHEMICAL$-inhibiting ADs such as @GENE$, desipramine, and imipramine.",
        "relation": "CPR:4"
    },
    {
        "id": "16554743.T3.T22",
        "sentence": "A pronounced NET knockout-induced shortening of the immobility time in the TST (by ca 50%) compared to WT mice was not reduced any further by @CHEMICAL$-inhibiting ADs such as reboxetine, @GENE$, and imipramine.",
        "relation": "CPR:4"
    },
    {
        "id": "16554743.T4.T22",
        "sentence": "A pronounced NET knockout-induced shortening of the immobility time in the TST (by ca 50%) compared to WT mice was not reduced any further by @CHEMICAL$-inhibiting ADs such as reboxetine, desipramine, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "16278927.T26.T32",
        "sentence": "In vitro inhibitory effects of non-steroidal anti-inflammatory drugs on 4-methylumbelliferone glucuronidation in recombinant @CHEMICAL$--potent inhibition by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "16278927.T1.T29",
        "sentence": "In conclusion, of the seven NSAIDs investigated, @CHEMICAL$ was the most potent inhibitor of recombinant @GENE$ via 4-MUG in a competitive manner.",
        "relation": "CPR:4"
    },
    {
        "id": "23194825.T3.T44",
        "sentence": "Neither the superoxide radical scavenger, tiron, nor the inhibitor of the @CHEMICAL$, @GENE$, prevented the metabolites' toxicity.",
        "relation": "CPR:4"
    },
    {
        "id": "23194825.T9.T47",
        "sentence": "Importantly, pre-treatment with @CHEMICAL$ (BSO), an inhibitor of @GENE$, prevented a-MeDA induced increase in GSH levels, but did not augment this metabolite cytotoxicity.",
        "relation": "CPR:4"
    },
    {
        "id": "23194825.T10.T47",
        "sentence": "Importantly, pre-treatment with buthionine sulfoximine (@CHEMICAL$), an inhibitor of @GENE$, prevented a-MeDA induced increase in GSH levels, but did not augment this metabolite cytotoxicity.",
        "relation": "CPR:4"
    },
    {
        "id": "23620436.T3.T11",
        "sentence": "@CHEMICAL$-induced lesions presented markers indicative of an aggressive phenotype: lack of basal cells, rupture of the smooth muscle cell layer, loss of E-cadherin, and high @GENE$ staining.",
        "relation": "CPR:3"
    },
    {
        "id": "23620436.T3.T10",
        "sentence": "@CHEMICAL$-induced lesions presented markers indicative of an aggressive phenotype: lack of basal cells, rupture of the smooth muscle cell layer, loss of @GENE$, and high MGMT staining.",
        "relation": "CPR:4"
    },
    {
        "id": "22301814.T4.T15",
        "sentence": "The treatment with @CHEMICAL$ exhibited a significant increase in some serum hepatic and renal biochemical parameters (@GENE$, aspartate aminotransferase, alkaline phosphatase, total protein, albumin, bilirubin, cholesterol, urea and creatinine).",
        "relation": "CPR:3"
    },
    {
        "id": "22301814.T4.T16",
        "sentence": "The treatment with @CHEMICAL$ exhibited a significant increase in some serum hepatic and renal biochemical parameters (alanine aminotransferase, @GENE$, alkaline phosphatase, total protein, albumin, bilirubin, cholesterol, urea and creatinine).",
        "relation": "CPR:3"
    },
    {
        "id": "22301814.T4.T17",
        "sentence": "The treatment with @CHEMICAL$ exhibited a significant increase in some serum hepatic and renal biochemical parameters (alanine aminotransferase, aspartate aminotransferase, @GENE$, total protein, albumin, bilirubin, cholesterol, urea and creatinine).",
        "relation": "CPR:3"
    },
    {
        "id": "22301814.T4.T18",
        "sentence": "The treatment with @CHEMICAL$ exhibited a significant increase in some serum hepatic and renal biochemical parameters (alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, total protein, @GENE$, bilirubin, cholesterol, urea and creatinine).",
        "relation": "CPR:3"
    },
    {
        "id": "23337256.T8.T20",
        "sentence": "However, recent clinical studies have shown that a single low-dose injection of @CHEMICAL$, an @GENE$ (NMDAR) antagonist, has rapid antidepressant effects that are observed within hours and are long lasting.",
        "relation": "CPR:6"
    },
    {
        "id": "23337256.T8.T21",
        "sentence": "However, recent clinical studies have shown that a single low-dose injection of @CHEMICAL$, an N-methyl d-aspartate receptor (@GENE$) antagonist, has rapid antidepressant effects that are observed within hours and are long lasting.",
        "relation": "CPR:6"
    },
    {
        "id": "23574017.T7.T17",
        "sentence": "@CHEMICAL$ is mainly excreted into the bile via @GENE$ (P-gp) and multidrug resistance-associated protein 2 (Mrp2) in hepatobiliary route and metabolized via cytochrome P450 (CYP) 3A subfamily.",
        "relation": "CPR:9"
    },
    {
        "id": "23574017.T7.T18",
        "sentence": "@CHEMICAL$ is mainly excreted into the bile via P-glycoprotein (@GENE$) and multidrug resistance-associated protein 2 (Mrp2) in hepatobiliary route and metabolized via cytochrome P450 (CYP) 3A subfamily.",
        "relation": "CPR:9"
    },
    {
        "id": "23574017.T7.T21",
        "sentence": "@CHEMICAL$ is mainly excreted into the bile via P-glycoprotein (P-gp) and multidrug resistance-associated protein 2 (Mrp2) in hepatobiliary route and metabolized via @GENE$ subfamily.",
        "relation": "CPR:9"
    },
    {
        "id": "23574017.T7.T19",
        "sentence": "@CHEMICAL$ is mainly excreted into the bile via P-glycoprotein (P-gp) and @GENE$ (Mrp2) in hepatobiliary route and metabolized via cytochrome P450 (CYP) 3A subfamily.",
        "relation": "CPR:9"
    },
    {
        "id": "23574017.T7.T20",
        "sentence": "@CHEMICAL$ is mainly excreted into the bile via P-glycoprotein (P-gp) and multidrug resistance-associated protein 2 (@GENE$) in hepatobiliary route and metabolized via cytochrome P450 (CYP) 3A subfamily.",
        "relation": "CPR:9"
    },
    {
        "id": "23574017.T2.T16",
        "sentence": "The slower CL was due to the reduction of hepatic biliary excretion (67.0% decrease) and hepatic @CHEMICAL$ subfamily-mediated metabolism (21.9% decrease) of @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23325562.T16.T43",
        "sentence": "Activation of @CHEMICAL$ and Phosphorylation of Glycogen Synthase Kinase3 b Mediate @GENE$ Induced Apoptosis in HepG2 Liver Cancer Cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23325562.T16.T44",
        "sentence": "Activation of AMP-activated Protein Kinase and Phosphorylation of @CHEMICAL$ Mediate @GENE$ Induced Apoptosis in HepG2 Liver Cancer Cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23325562.T13.T37",
        "sentence": "Interestingly, @CHEMICAL$ increased the phosphorylation of @GENE$ and coenzyme A carboxylase and also enhanced phosphorylation of GSK3b at inactive form serine 9, whereas ursolic acid attenuated the phosphorylation of AKT and mTOR in HepG2 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23325562.T13.T38",
        "sentence": "Interestingly, @CHEMICAL$ increased the phosphorylation of AMPK and @GENE$ and also enhanced phosphorylation of GSK3b at inactive form serine 9, whereas ursolic acid attenuated the phosphorylation of AKT and mTOR in HepG2 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23325562.T13.T39",
        "sentence": "Interestingly, @CHEMICAL$ increased the phosphorylation of AMPK and coenzyme A carboxylase and also enhanced phosphorylation of @GENE$ at inactive form serine 9, whereas ursolic acid attenuated the phosphorylation of AKT and mTOR in HepG2 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23325562.T15.T40",
        "sentence": "Interestingly, ursolic acid increased the phosphorylation of AMPK and coenzyme A carboxylase and also enhanced phosphorylation of GSK3b at inactive form serine 9, whereas @CHEMICAL$ attenuated the phosphorylation of @GENE$ and mTOR in HepG2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23325562.T15.T41",
        "sentence": "Interestingly, ursolic acid increased the phosphorylation of AMPK and coenzyme A carboxylase and also enhanced phosphorylation of GSK3b at inactive form serine 9, whereas @CHEMICAL$ attenuated the phosphorylation of AKT and @GENE$ in HepG2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23325562.T1.T42",
        "sentence": "Conversely, @CHEMICAL$ inhibitor @GENE$ or GSK3b inhibitor SB216763 blocked the cleavages of PARP and caspase 3 induced by ursolic acid in HepG2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23325562.T1.T20",
        "sentence": "Conversely, AMPK inhibitor @CHEMICAL$ or GSK3b inhibitor SB216763 blocked the cleavages of PARP and @GENE$ induced by ursolic acid in HepG2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23325562.T2.T18",
        "sentence": "Conversely, AMPK inhibitor compound C or @CHEMICAL$ inhibitor @GENE$ blocked the cleavages of PARP and caspase 3 induced by ursolic acid in HepG2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23325562.T2.T20",
        "sentence": "Conversely, AMPK inhibitor compound C or GSK3b inhibitor @CHEMICAL$ blocked the cleavages of PARP and @GENE$ induced by ursolic acid in HepG2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23325562.T3.T19",
        "sentence": "Conversely, AMPK inhibitor compound C or GSK3b inhibitor SB216763 blocked the cleavages of @CHEMICAL$ and caspase 3 induced by @GENE$ in HepG2 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23325562.T3.T20",
        "sentence": "Conversely, AMPK inhibitor compound C or GSK3b inhibitor SB216763 blocked the cleavages of PARP and @CHEMICAL$ induced by @GENE$ in HepG2 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23325562.T4.T21",
        "sentence": "Furthermore, proteosomal inhibitor @CHEMICAL$ suppressed @GENE$ activation, GSK3b phosphorylation, cleaved PARP and deceased AEG-1 induced by ursolic acid in HepG2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23325562.T4.T22",
        "sentence": "Furthermore, proteosomal inhibitor @CHEMICAL$ suppressed AMPK activation, @GENE$ phosphorylation, cleaved PARP and deceased AEG-1 induced by ursolic acid in HepG2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23325562.T4.T24",
        "sentence": "Furthermore, proteosomal inhibitor @CHEMICAL$ suppressed AMPK activation, GSK3b phosphorylation, cleaved PARP and deceased @GENE$ induced by ursolic acid in HepG2 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23325562.T5.T21",
        "sentence": "Furthermore, proteosomal inhibitor MG132 suppressed @CHEMICAL$ activation, GSK3b phosphorylation, cleaved PARP and deceased AEG-1 induced by @GENE$ in HepG2 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23325562.T5.T22",
        "sentence": "Furthermore, proteosomal inhibitor MG132 suppressed AMPK activation, @CHEMICAL$ phosphorylation, cleaved PARP and deceased AEG-1 induced by @GENE$ in HepG2 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23325562.T5.T24",
        "sentence": "Furthermore, proteosomal inhibitor MG132 suppressed AMPK activation, GSK3b phosphorylation, cleaved PARP and deceased @CHEMICAL$ induced by @GENE$ in HepG2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23325562.T5.T24",
        "sentence": "Furthermore, proteosomal inhibitor MG132 suppressed AMPK activation, GSK3b phosphorylation, cleaved PARP and deceased @CHEMICAL$ induced by @GENE$ in HepG2 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23325562.T6.T25",
        "sentence": "Overall, our findings suggest that @CHEMICAL$ induced apoptosis in HepG2 cells via @GENE$ activation and GSK3b phosphorylation as a potent chemopreventive agent.",
        "relation": "CPR:3"
    },
    {
        "id": "23325562.T6.T26",
        "sentence": "Overall, our findings suggest that @CHEMICAL$ induced apoptosis in HepG2 cells via AMPK activation and @GENE$ phosphorylation as a potent chemopreventive agent.",
        "relation": "CPR:3"
    },
    {
        "id": "23046524.T4.T11",
        "sentence": "Using @CHEMICAL$ as a reference @GENE$ (AChE) inhibitor, the objective of this study was to develop an adverse outcome pathway (AOP) that provided quantitative linkages across levels of biological organization during zebrafish embryogenesis.",
        "relation": "CPR:4"
    },
    {
        "id": "23046524.T4.T14",
        "sentence": "Using @CHEMICAL$ as a reference acetylcholinesterase (@GENE$) inhibitor, the objective of this study was to develop an adverse outcome pathway (AOP) that provided quantitative linkages across levels of biological organization during zebrafish embryogenesis.",
        "relation": "CPR:4"
    },
    {
        "id": "23046524.T3.T15",
        "sentence": "We then showed that static exposure of embryos to @CHEMICAL$ (31.2-500 nM) from 5 to 96 hpf resulted in significant stage- and concentration-dependent @GENE$ inhibition, albeit these effects were fully reversible within 48 h following transfer to clean water.",
        "relation": "CPR:4"
    },
    {
        "id": "23046524.T1.T8",
        "sentence": "Based on these studies, the frequency of spontaneous tail contractions at 26 hpf - a developmental stage with minimal @CHEMICAL$ expression and activity - was significantly higher following exposure to @GENE$ concentrations as low as 31.2 nM. Overall, our data suggest that (1) normal AChE activity is not required for secondary motoneuron development and (2) spontaneous tail contractions at 26 hpf are sensitive to paraoxon exposure, an effect that may be independent of AChE inhibition.",
        "relation": "CPR:3"
    },
    {
        "id": "9040115.T7.T24",
        "sentence": "There is, however, much information on the direct (acute and chronic) effects of @CHEMICAL$ on the binding properties of opioid receptors, as well as modulation of opioid peptide synthesis and secretion (e.g. a suggested increase in @GENE$ release).",
        "relation": "CPR:3"
    },
    {
        "id": "9040115.T11.T25",
        "sentence": "Conversely, opioid antagonists such as @CHEMICAL$ and naltrexone (which bind to non-selectively @GENE$) have been shown to decrease alcohol consumption under various experimental conditions.",
        "relation": "CPR:6"
    },
    {
        "id": "9040115.T12.T25",
        "sentence": "Conversely, opioid antagonists such as naloxone and @CHEMICAL$ (which bind to non-selectively @GENE$) have been shown to decrease alcohol consumption under various experimental conditions.",
        "relation": "CPR:3"
    },
    {
        "id": "2568748.T1.T4",
        "sentence": "@CHEMICAL$, a unique cardioselective @GENE$ blocker with a half-life of 9 minutes, can enable some patients with relative contraindications to beta blockers to nevertheless benefit from early beta-blocking therapy.",
        "relation": "CPR:4"
    },
    {
        "id": "7929150.T1.T16",
        "sentence": "In catalytic properties, mouse CA V is closest to CA I; however, in inhibition by @CHEMICAL$, ethoxzolamide, and cyanate, @GENE$ is very similar to CA II.",
        "relation": "CPR:4"
    },
    {
        "id": "7929150.T1.T17",
        "sentence": "In catalytic properties, mouse CA V is closest to CA I; however, in inhibition by @CHEMICAL$, ethoxzolamide, and cyanate, CA V is very similar to @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "7929150.T2.T16",
        "sentence": "In catalytic properties, mouse CA V is closest to CA I; however, in inhibition by acetazolamide, @CHEMICAL$, and cyanate, @GENE$ is very similar to CA II.",
        "relation": "CPR:4"
    },
    {
        "id": "7929150.T2.T17",
        "sentence": "In catalytic properties, mouse CA V is closest to CA I; however, in inhibition by acetazolamide, @CHEMICAL$, and cyanate, CA V is very similar to @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "7929150.T3.T16",
        "sentence": "In catalytic properties, mouse CA V is closest to CA I; however, in inhibition by acetazolamide, ethoxzolamide, and @CHEMICAL$, @GENE$ is very similar to CA II.",
        "relation": "CPR:4"
    },
    {
        "id": "7929150.T3.T17",
        "sentence": "In catalytic properties, mouse CA V is closest to CA I; however, in inhibition by acetazolamide, ethoxzolamide, and @CHEMICAL$, CA V is very similar to @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17929831.T5.T19",
        "sentence": "@CHEMICAL$ (AdSS) catalyzes the Mg2+ dependent condensation of a molecule of IMP with aspartate to form @GENE$, in a reaction driven by the hydrolysis of GTP to GDP.",
        "relation": "CPR:9"
    },
    {
        "id": "17929831.T5.T25",
        "sentence": "Adenylosuccinate synthetase (@CHEMICAL$) catalyzes the Mg2+ dependent condensation of a molecule of IMP with aspartate to form @GENE$, in a reaction driven by the hydrolysis of GTP to GDP.",
        "relation": "CPR:9"
    },
    {
        "id": "17929831.T17.T25",
        "sentence": "Adenylosuccinate synthetase (@CHEMICAL$) catalyzes the @GENE$ dependent condensation of a molecule of IMP with aspartate to form adenylosuccinate, in a reaction driven by the hydrolysis of GTP to GDP.",
        "relation": "CPR:9"
    },
    {
        "id": "17929831.T4.T20",
        "sentence": "@CHEMICAL$, a product of the reaction, was found to be a potent inhibitor of @GENE$ showing biphasic inhibition of enzyme activity.",
        "relation": "CPR:4"
    },
    {
        "id": "8052854.T1.T9",
        "sentence": "The anti-inflammatory drugs @CHEMICAL$ and aspirin inhibited the activation of @GENE$, which further explains the mechanism of action of these drugs.",
        "relation": "CPR:4"
    },
    {
        "id": "8052854.T2.T9",
        "sentence": "The anti-inflammatory drugs sodium salicylate and @CHEMICAL$ inhibited the activation of @GENE$, which further explains the mechanism of action of these drugs.",
        "relation": "CPR:4"
    },
    {
        "id": "8052854.T3.T14",
        "sentence": "@CHEMICAL$ and aspirin also inhibited @GENE$-dependent transcription from the Ig kappa enhancer and the human immunodeficiency virus (HIV) long terminal repeat (LTR) in transfected T cells.",
        "relation": "CPR:4"
    },
    {
        "id": "8052854.T3.T15",
        "sentence": "@CHEMICAL$ and aspirin also inhibited NF-kappa B-dependent transcription from the @GENE$ enhancer and the human immunodeficiency virus (HIV) long terminal repeat (LTR) in transfected T cells.",
        "relation": "CPR:4"
    },
    {
        "id": "8052854.T4.T14",
        "sentence": "Sodium salicylate and @CHEMICAL$ also inhibited @GENE$-dependent transcription from the Ig kappa enhancer and the human immunodeficiency virus (HIV) long terminal repeat (LTR) in transfected T cells.",
        "relation": "CPR:4"
    },
    {
        "id": "8052854.T4.T15",
        "sentence": "Sodium salicylate and @CHEMICAL$ also inhibited NF-kappa B-dependent transcription from the @GENE$ enhancer and the human immunodeficiency virus (HIV) long terminal repeat (LTR) in transfected T cells.",
        "relation": "CPR:4"
    },
    {
        "id": "16417577.T6.T19",
        "sentence": "Galanin attenuates @CHEMICAL$ (CREB) phosphorylation induced by chronic @GENE$ and naloxone challenge in Cath.a cells and primary striatal cultures.",
        "relation": "CPR:3"
    },
    {
        "id": "16417577.T6.T20",
        "sentence": "Galanin attenuates cyclic AMP regulatory element-binding protein (@CHEMICAL$) phosphorylation induced by chronic @GENE$ and naloxone challenge in Cath.a cells and primary striatal cultures.",
        "relation": "CPR:3"
    },
    {
        "id": "16417577.T7.T19",
        "sentence": "Galanin attenuates @CHEMICAL$ (CREB) phosphorylation induced by chronic morphine and @GENE$ challenge in Cath.a cells and primary striatal cultures.",
        "relation": "CPR:3"
    },
    {
        "id": "16417577.T7.T20",
        "sentence": "Galanin attenuates cyclic AMP regulatory element-binding protein (@CHEMICAL$) phosphorylation induced by chronic morphine and @GENE$ challenge in Cath.a cells and primary striatal cultures.",
        "relation": "CPR:3"
    },
    {
        "id": "17896959.T11.T34",
        "sentence": "The @CHEMICAL$ (NCX) is a bidirectional transporter that normally extrudes Ca(2+) from the cell (forward mode), but also brings @GENE$ into the cell (reverse mode) under special conditions such as intracellular Na(+) (Na(+)(i)) accumulation or membrane depolarization.",
        "relation": "CPR:9"
    },
    {
        "id": "17896959.T23.T34",
        "sentence": "The @CHEMICAL$ (NCX) is a bidirectional transporter that normally extrudes @GENE$ from the cell (forward mode), but also brings Ca(2+) into the cell (reverse mode) under special conditions such as intracellular Na(+) (Na(+)(i)) accumulation or membrane depolarization.",
        "relation": "CPR:9"
    },
    {
        "id": "17896959.T16.T38",
        "sentence": "The pharmacology of NCX inhibitors has been studied extensively since the development of @CHEMICAL$, a prototype benzyloxyphenyl @GENE$ inhibitor, in 1996.",
        "relation": "CPR:4"
    },
    {
        "id": "17896959.T17.T38",
        "sentence": "The pharmacology of NCX inhibitors has been studied extensively since the development of KB-R7943, a prototype @CHEMICAL$ @GENE$ inhibitor, in 1996.",
        "relation": "CPR:4"
    },
    {
        "id": "17896959.T21.T39",
        "sentence": "Intriguingly, the inhibitory potency of @CHEMICAL$ @GENE$ inhibitors is directly coupled to the rate of Na(+)(i)-dependent inactivation.",
        "relation": "CPR:4"
    },
    {
        "id": "17896959.T6.T28",
        "sentence": "Existing @CHEMICAL$ blockers, such as @GENE$, dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an NCX inhibitory action.",
        "relation": "CPR:4"
    },
    {
        "id": "17896959.T6.T29",
        "sentence": "Existing ion channel blockers, such as @CHEMICAL$, dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an @GENE$ inhibitory action.",
        "relation": "CPR:4"
    },
    {
        "id": "17896959.T7.T28",
        "sentence": "Existing @CHEMICAL$ blockers, such as amiodarone, @GENE$, bepridil, aprindine, and cibenzoline, have been found to have an NCX inhibitory action.",
        "relation": "CPR:4"
    },
    {
        "id": "17896959.T7.T29",
        "sentence": "Existing ion channel blockers, such as amiodarone, @CHEMICAL$, bepridil, aprindine, and cibenzoline, have been found to have an @GENE$ inhibitory action.",
        "relation": "CPR:4"
    },
    {
        "id": "17896959.T8.T28",
        "sentence": "Existing @CHEMICAL$ blockers, such as amiodarone, dronedarone, @GENE$, aprindine, and cibenzoline, have been found to have an NCX inhibitory action.",
        "relation": "CPR:4"
    },
    {
        "id": "17896959.T8.T29",
        "sentence": "Existing ion channel blockers, such as amiodarone, dronedarone, @CHEMICAL$, aprindine, and cibenzoline, have been found to have an @GENE$ inhibitory action.",
        "relation": "CPR:4"
    },
    {
        "id": "17896959.T9.T28",
        "sentence": "Existing @CHEMICAL$ blockers, such as amiodarone, dronedarone, bepridil, @GENE$, and cibenzoline, have been found to have an NCX inhibitory action.",
        "relation": "CPR:4"
    },
    {
        "id": "17896959.T9.T29",
        "sentence": "Existing ion channel blockers, such as amiodarone, dronedarone, bepridil, @CHEMICAL$, and cibenzoline, have been found to have an @GENE$ inhibitory action.",
        "relation": "CPR:4"
    },
    {
        "id": "17896959.T10.T28",
        "sentence": "Existing @CHEMICAL$ blockers, such as amiodarone, dronedarone, bepridil, aprindine, and @GENE$, have been found to have an NCX inhibitory action.",
        "relation": "CPR:4"
    },
    {
        "id": "17896959.T10.T29",
        "sentence": "Existing ion channel blockers, such as amiodarone, dronedarone, bepridil, aprindine, and @CHEMICAL$, have been found to have an @GENE$ inhibitory action.",
        "relation": "CPR:4"
    },
    {
        "id": "17593236.T5.T10",
        "sentence": "Efficacy and safety of the @CHEMICAL$ inhibitor, @GENE$, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.",
        "relation": "CPR:4"
    },
    {
        "id": "17593236.T1.T6",
        "sentence": "AIM: To assess the efficacy and safety of a 24-week treatment with @CHEMICAL$, a highly selective once-daily oral @GENE$ (DPP-4) inhibitor, in patients with type 2 diabetes who had inadequate glycaemic control [glycosylated haemoglobin (HbA(1c)) >or=7.5% and <or=10.5%] while on glimepiride alone or in combination with metformin.",
        "relation": "CPR:4"
    },
    {
        "id": "17593236.T1.T7",
        "sentence": "AIM: To assess the efficacy and safety of a 24-week treatment with @CHEMICAL$, a highly selective once-daily oral dipeptidyl peptidase-4 (@GENE$) inhibitor, in patients with type 2 diabetes who had inadequate glycaemic control [glycosylated haemoglobin (HbA(1c)) >or=7.5% and <or=10.5%] while on glimepiride alone or in combination with metformin.",
        "relation": "CPR:4"
    },
    {
        "id": "23160090.T5.T9",
        "sentence": "@CHEMICAL$ suppressed the expression of @GENE$, Myd88, ICAM-1, TNFa, IL-1b and IL-6 at the mRNA and protein level, and inhibited the adhesion of leukocytes to A549 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23160090.T5.T10",
        "sentence": "@CHEMICAL$ suppressed the expression of TLR-4, @GENE$, ICAM-1, TNFa, IL-1b and IL-6 at the mRNA and protein level, and inhibited the adhesion of leukocytes to A549 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23160090.T5.T11",
        "sentence": "@CHEMICAL$ suppressed the expression of TLR-4, Myd88, @GENE$, TNFa, IL-1b and IL-6 at the mRNA and protein level, and inhibited the adhesion of leukocytes to A549 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23160090.T5.T12",
        "sentence": "@CHEMICAL$ suppressed the expression of TLR-4, Myd88, ICAM-1, @GENE$, IL-1b and IL-6 at the mRNA and protein level, and inhibited the adhesion of leukocytes to A549 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23160090.T5.T13",
        "sentence": "@CHEMICAL$ suppressed the expression of TLR-4, Myd88, ICAM-1, TNFa, @GENE$ and IL-6 at the mRNA and protein level, and inhibited the adhesion of leukocytes to A549 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23160090.T5.T14",
        "sentence": "@CHEMICAL$ suppressed the expression of TLR-4, Myd88, ICAM-1, TNFa, IL-1b and @GENE$ at the mRNA and protein level, and inhibited the adhesion of leukocytes to A549 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23160090.T6.T15",
        "sentence": "@CHEMICAL$ treatment also decreased @GENE$ p65 nuclear translocation and inhibited the phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK).",
        "relation": "CPR:4"
    },
    {
        "id": "23160090.T6.T17",
        "sentence": "@CHEMICAL$ treatment also decreased NF-kB p65 nuclear translocation and inhibited the phosphorylation of @GENE$ mitogen-activated protein kinase (p38 MAPK).",
        "relation": "CPR:4"
    },
    {
        "id": "23160090.T6.T18",
        "sentence": "@CHEMICAL$ treatment also decreased NF-kB p65 nuclear translocation and inhibited the phosphorylation of p38 @GENE$ (p38 MAPK).",
        "relation": "CPR:4"
    },
    {
        "id": "23160090.T6.T19",
        "sentence": "@CHEMICAL$ treatment also decreased NF-kB p65 nuclear translocation and inhibited the phosphorylation of p38 mitogen-activated protein kinase (@GENE$ MAPK).",
        "relation": "CPR:4"
    },
    {
        "id": "23160090.T6.T20",
        "sentence": "@CHEMICAL$ treatment also decreased NF-kB p65 nuclear translocation and inhibited the phosphorylation of p38 mitogen-activated protein kinase (p38 @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "23160090.T6.T16",
        "sentence": "@CHEMICAL$ treatment also decreased NF-kB @GENE$ nuclear translocation and inhibited the phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK).",
        "relation": "CPR:4"
    },
    {
        "id": "23601990.T9.T23",
        "sentence": "Synthesis and biological evaluation of @CHEMICAL$ as potent and selective inhibitors of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23601990.T2.T10",
        "sentence": "A series of @CHEMICAL$ were synthesized and investigated in vitro as inhibitors of pancreatic @GENE$ (CEase) and acetylcholinesterase (AChE).",
        "relation": "CPR:4"
    },
    {
        "id": "23601990.T2.T11",
        "sentence": "A series of @CHEMICAL$ were synthesized and investigated in vitro as inhibitors of pancreatic cholesterol esterase (@GENE$) and acetylcholinesterase (AChE).",
        "relation": "CPR:4"
    },
    {
        "id": "23601990.T2.T12",
        "sentence": "A series of @CHEMICAL$ were synthesized and investigated in vitro as inhibitors of pancreatic cholesterol esterase (CEase) and @GENE$ (AChE).",
        "relation": "CPR:4"
    },
    {
        "id": "23601990.T2.T13",
        "sentence": "A series of @CHEMICAL$ were synthesized and investigated in vitro as inhibitors of pancreatic cholesterol esterase (CEase) and acetylcholinesterase (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "23601990.T3.T14",
        "sentence": "The results showed that most of the synthesized compounds exhibited nanomolar potency against @CHEMICAL$, much better than the parent @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23601990.T4.T15",
        "sentence": "Furthermore, these @CHEMICAL$ demonstrated good to high selectivity for @GENE$ over AChE, which only showed micromolar potency inhibition of AChE. The most selective and potent inhibitor of CEase (3e) had IC50 value of 0.72 nM and 11800-fold selectivity for CEase over AChE. The structure-activity relationships revealed that the free hydroxyl group at position 5 and phosphate group at position 7 of the phosphorylated flavonoids are favorable to the inhibition of CEase.",
        "relation": "CPR:4"
    },
    {
        "id": "23601990.T4.T16",
        "sentence": "Furthermore, these @CHEMICAL$ demonstrated good to high selectivity for CEase over @GENE$, which only showed micromolar potency inhibition of AChE. The most selective and potent inhibitor of CEase (3e) had IC50 value of 0.72 nM and 11800-fold selectivity for CEase over AChE. The structure-activity relationships revealed that the free hydroxyl group at position 5 and phosphate group at position 7 of the phosphorylated flavonoids are favorable to the inhibition of CEase.",
        "relation": "CPR:4"
    },
    {
        "id": "23601990.T4.T17",
        "sentence": "Furthermore, these @CHEMICAL$ demonstrated good to high selectivity for CEase over AChE, which only showed micromolar potency inhibition of @GENE$. The most selective and potent inhibitor of CEase (3e) had IC50 value of 0.72 nM and 11800-fold selectivity for CEase over AChE. The structure-activity relationships revealed that the free hydroxyl group at position 5 and phosphate group at position 7 of the phosphorylated flavonoids are favorable to the inhibition of CEase.",
        "relation": "CPR:4"
    },
    {
        "id": "23601990.T5.T21",
        "sentence": "Furthermore, these phosphorylated flavonoids demonstrated good to high selectivity for CEase over AChE, which only showed micromolar potency inhibition of AChE. The most selective and potent inhibitor of CEase (3e) had IC50 value of 0.72 nM and 11800-fold selectivity for CEase over AChE. The structure-activity relationships revealed that the free @CHEMICAL$ group at position 5 and phosphate group at position 7 of the phosphorylated flavonoids are favorable to the inhibition of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23601990.T6.T21",
        "sentence": "Furthermore, these phosphorylated flavonoids demonstrated good to high selectivity for CEase over AChE, which only showed micromolar potency inhibition of AChE. The most selective and potent inhibitor of CEase (3e) had IC50 value of 0.72 nM and 11800-fold selectivity for CEase over AChE. The structure-activity relationships revealed that the free hydroxyl group at position 5 and @CHEMICAL$ group at position 7 of the phosphorylated flavonoids are favorable to the inhibition of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23601990.T7.T21",
        "sentence": "Furthermore, these phosphorylated flavonoids demonstrated good to high selectivity for CEase over AChE, which only showed micromolar potency inhibition of AChE. The most selective and potent inhibitor of CEase (3e) had IC50 value of 0.72 nM and 11800-fold selectivity for CEase over AChE. The structure-activity relationships revealed that the free hydroxyl group at position 5 and phosphate group at position 7 of the @CHEMICAL$ are favorable to the inhibition of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "16855178.T20.T35",
        "sentence": "In healthy rats, @CHEMICAL$ dose dependently (25, 50, or 100 mg/kg) attenuated CRD-induced hypersensitivity and significantly inhibited CRD-induced overexpression of spinal @GENE$ mRNA, whereas mesalamine had no effect.",
        "relation": "CPR:4"
    },
    {
        "id": "16855178.T23.T36",
        "sentence": "ATB-429-induced antinociception was reversed by @CHEMICAL$, a @GENE$ inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "16855178.T7.T30",
        "sentence": "Colonic @CHEMICAL$ and interkeukin-1beta mRNA and spinal c-FOS mRNA expression were significantly down-regulated by @GENE$, but not by mesalamine.",
        "relation": "CPR:4"
    },
    {
        "id": "16855178.T7.T31",
        "sentence": "Colonic cyclooxygenase-2 and @CHEMICAL$ mRNA and spinal c-FOS mRNA expression were significantly down-regulated by @GENE$, but not by mesalamine.",
        "relation": "CPR:4"
    },
    {
        "id": "16855178.T7.T32",
        "sentence": "Colonic cyclooxygenase-2 and interkeukin-1beta mRNA and spinal @CHEMICAL$ mRNA expression were significantly down-regulated by @GENE$, but not by mesalamine.",
        "relation": "CPR:4"
    },
    {
        "id": "15066664.T26.T35",
        "sentence": "Block of human NaV1.5 @CHEM-GENE$ by novel alpha-hydroxyphenylamide analogues of phenytoin.",
        "relation": "CPR:9"
    },
    {
        "id": "15066664.T26.T36",
        "sentence": "Block of @CHEMICAL$ @GENE$ channels by novel alpha-hydroxyphenylamide analogues of phenytoin.",
        "relation": "CPR:9"
    },
    {
        "id": "15066664.T27.T35",
        "sentence": "Block of human NaV1.5 @CHEMICAL$ by novel @GENE$ analogues of phenytoin.",
        "relation": "CPR:4"
    },
    {
        "id": "15066664.T27.T36",
        "sentence": "Block of @CHEMICAL$ sodium channels by novel @GENE$ analogues of phenytoin.",
        "relation": "CPR:4"
    },
    {
        "id": "15066664.T28.T35",
        "sentence": "Block of human NaV1.5 @CHEMICAL$ by novel alpha-hydroxyphenylamide analogues of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15066664.T28.T36",
        "sentence": "Block of @CHEMICAL$ sodium channels by novel alpha-hydroxyphenylamide analogues of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15066664.T7.T29",
        "sentence": "@CHEM-GENE$ are a critical component of electrically excitable cells.",
        "relation": "CPR:9"
    },
    {
        "id": "15066664.T11.T29",
        "sentence": "@CHEM-GENE$ are a critical component of electrically excitable cells.",
        "relation": "CPR:9"
    },
    {
        "id": "15066664.T2.T30",
        "sentence": "Phenytoin (@CHEMICAL$, DPH) is an established @GENE$ blocker and is a useful anticonvulsant and class 1b antiarrhythmic, and has been effectively used in the treatment of neuropathic pain.",
        "relation": "CPR:4"
    },
    {
        "id": "15066664.T4.T30",
        "sentence": "Phenytoin (diphenylhydantoin, @CHEMICAL$) is an established @GENE$ blocker and is a useful anticonvulsant and class 1b antiarrhythmic, and has been effectively used in the treatment of neuropathic pain.",
        "relation": "CPR:4"
    },
    {
        "id": "15066664.T8.T30",
        "sentence": "Phenytoin (diphenylhydantoin, DPH) is an established @CHEM-GENE$ blocker and is a useful anticonvulsant and class 1b antiarrhythmic, and has been effectively used in the treatment of neuropathic pain.",
        "relation": "CPR:9"
    },
    {
        "id": "15066664.T25.T30",
        "sentence": "@CHEMICAL$ (diphenylhydantoin, DPH) is an established @GENE$ blocker and is a useful anticonvulsant and class 1b antiarrhythmic, and has been effectively used in the treatment of neuropathic pain.",
        "relation": "CPR:4"
    },
    {
        "id": "15066664.T12.T33",
        "sentence": "In this study, we have synthesized novel @CHEMICAL$ analogues of diphenylhydantoin and examined their ability to inhibit human Na(V)1.5 @GENE$ expressed in Chinese Hamster Ovary (CHO-K1) cells.",
        "relation": "CPR:4"
    },
    {
        "id": "15066664.T12.T32",
        "sentence": "In this study, we have synthesized novel @CHEMICAL$ analogues of diphenylhydantoin and examined their ability to inhibit @GENE$ sodium channels expressed in Chinese Hamster Ovary (CHO-K1) cells.",
        "relation": "CPR:4"
    },
    {
        "id": "15066664.T13.T33",
        "sentence": "In this study, we have synthesized novel alpha-hydroxyphenylamide analogues of @CHEMICAL$ and examined their ability to inhibit human Na(V)1.5 @GENE$ expressed in Chinese Hamster Ovary (CHO-K1) cells.",
        "relation": "CPR:4"
    },
    {
        "id": "15066664.T13.T32",
        "sentence": "In this study, we have synthesized novel alpha-hydroxyphenylamide analogues of @CHEMICAL$ and examined their ability to inhibit @GENE$ sodium channels expressed in Chinese Hamster Ovary (CHO-K1) cells.",
        "relation": "CPR:4"
    },
    {
        "id": "15066664.T14.T33",
        "sentence": "In this study, we have synthesized novel alpha-hydroxyphenylamide analogues of diphenylhydantoin and examined their ability to inhibit human Na(V)1.5 @CHEM-GENE$ expressed in Chinese Hamster Ovary (CHO-K1) cells.",
        "relation": "CPR:9"
    },
    {
        "id": "15066664.T14.T32",
        "sentence": "In this study, we have synthesized novel alpha-hydroxyphenylamide analogues of diphenylhydantoin and examined their ability to inhibit @CHEMICAL$ @GENE$ channels expressed in Chinese Hamster Ovary (CHO-K1) cells.",
        "relation": "CPR:9"
    },
    {
        "id": "15066664.T22.T34",
        "sentence": "In comparison to @CHEMICAL$, the novel chloro-substituted alpha-hydroxyphenylamide compounds produced as much as a 20-fold greater tonic and frequency-dependent blockade of @GENE$ channels with an IC(50) value of 14.5 microM.",
        "relation": "CPR:4"
    },
    {
        "id": "15066664.T23.T34",
        "sentence": "In comparison to diphenylhydantoin, the novel @CHEMICAL$-substituted alpha-hydroxyphenylamide compounds produced as much as a 20-fold greater tonic and frequency-dependent blockade of @GENE$ channels with an IC(50) value of 14.5 microM.",
        "relation": "CPR:4"
    },
    {
        "id": "15066664.T24.T34",
        "sentence": "In comparison to diphenylhydantoin, the novel chloro-substituted @CHEMICAL$ compounds produced as much as a 20-fold greater tonic and frequency-dependent blockade of @GENE$ channels with an IC(50) value of 14.5 microM.",
        "relation": "CPR:4"
    },
    {
        "id": "15066664.T10.T31",
        "sentence": "This information may be useful in the development of more potent @CHEM-GENE$ blockers.",
        "relation": "CPR:9"
    },
    {
        "id": "11034583.T12.T22",
        "sentence": "Effects of a @CHEMICAL$ antagonist @GENE$ on gastrointestinal motor and sensory function in humans.",
        "relation": "CPR:6"
    },
    {
        "id": "11034583.T7.T20",
        "sentence": "METHODS: Part A compared the effects of placebo to four doses of a @CHEMICAL$ receptor antagonist (@GENE$) on the cisapride mediated increase in plasma aldosterone (a 5-HT(4) mediated response) and orocaecal transit in 18 subjects.",
        "relation": "CPR:6"
    },
    {
        "id": "11034583.T7.T21",
        "sentence": "METHODS: Part A compared the effects of placebo to four doses of a 5-HT(4) receptor antagonist (@CHEMICAL$) on the cisapride mediated increase in plasma aldosterone (a @GENE$ mediated response) and orocaecal transit in 18 subjects.",
        "relation": "CPR:6"
    },
    {
        "id": "11034583.T8.T20",
        "sentence": "METHODS: Part A compared the effects of placebo to four doses of a @CHEMICAL$ receptor antagonist (SB-207266) on the @GENE$ mediated increase in plasma aldosterone (a 5-HT(4) mediated response) and orocaecal transit in 18 subjects.",
        "relation": "CPR:5"
    },
    {
        "id": "16455797.T8.T21",
        "sentence": "@CHEMICAL$ (SSAT) is a key enzyme in the control of polyamine levels in human cells, as acetylation of @GENE$ and spermine triggers export or degradation.",
        "relation": "CPR:9"
    },
    {
        "id": "16455797.T9.T21",
        "sentence": "@CHEMICAL$ (SSAT) is a key enzyme in the control of polyamine levels in human cells, as acetylation of spermidine and @GENE$ triggers export or degradation.",
        "relation": "CPR:9"
    },
    {
        "id": "16455797.T18.T21",
        "sentence": "@CHEMICAL$ (SSAT) is a key enzyme in the control of @GENE$ levels in human cells, as acetylation of spermidine and spermine triggers export or degradation.",
        "relation": "CPR:9"
    },
    {
        "id": "16455797.T10.T23",
        "sentence": "These unexpected and intriguing complexities seem likely to have some as yet undefined role in regulating @CHEMICAL$ activity or stability as a part of @GENE$ homeostasis.",
        "relation": "CPR:9"
    },
    {
        "id": "23570914.T3.T17",
        "sentence": "Treatment of C57 BL/6 mice with @CHEMICAL$ increased fibroblast viability and collagen production and significantly downregulated @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23570914.T7.T21",
        "sentence": "In a cell-based model, @CHEMICAL$ suppressed Nrf2 activation via @GENE$ phosphorylation, enhancing intracellular reactive oxygen species in lung fibroblasts and stimulating abnormal cell proliferation and collagen secretion.",
        "relation": "CPR:3"
    },
    {
        "id": "23570914.T7.T20",
        "sentence": "In a cell-based model, @CHEMICAL$ suppressed @GENE$ activation via extracellular signal-related kinase phosphorylation, enhancing intracellular reactive oxygen species in lung fibroblasts and stimulating abnormal cell proliferation and collagen secretion.",
        "relation": "CPR:4"
    },
    {
        "id": "23570914.T1.T12",
        "sentence": "To confirm this novel mechanism of bleomycin-induced fibrogenesis, we attempted to upregulate Nrf2 and related antioxidant proteins in bleomycin-treated fibroblasts using a putative @CHEMICAL$ activator, @GENE$, and the results showed that bleomycin-induced fibroblast proliferation and collagen content were attenuated through improved redox balance.",
        "relation": "CPR:3"
    },
    {
        "id": "23570914.T9.T11",
        "sentence": "To confirm this novel mechanism of @CHEMICAL$-induced fibrogenesis, we attempted to upregulate @GENE$ and related antioxidant proteins in bleomycin-treated fibroblasts using a putative Nrf2 activator, caffeic acid phenethyl ester, and the results showed that bleomycin-induced fibroblast proliferation and collagen content were attenuated through improved redox balance.",
        "relation": "CPR:3"
    },
    {
        "id": "23298863.T3.T13",
        "sentence": "Pharmacokinetic and pharmacodynamic modeling of hedgehog inhibitor TAK-441 for the inhibition of Gli1 messenger RNA expression and antitumor efficacy in xenografted tumor model mice. 6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide (@CHEMICAL$) is a potent, selective @GENE$ signaling pathway inhibitor that binds to Smo and is being developed for the treatment of cancer.",
        "relation": "CPR:4"
    },
    {
        "id": "23298863.T6.T19",
        "sentence": "Pharmacokinetic and pharmacodynamic modeling of @CHEMICAL$ inhibitor @GENE$ for the inhibition of Gli1 messenger RNA expression and antitumor efficacy in xenografted tumor model mice. 6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide (TAK-441) is a potent, selective hedgehog signaling pathway inhibitor that binds to Smo and is being developed for the treatment of cancer.",
        "relation": "CPR:4"
    },
    {
        "id": "23298863.T6.T20",
        "sentence": "Pharmacokinetic and pharmacodynamic modeling of hedgehog inhibitor @CHEMICAL$ for the inhibition of @GENE$ messenger RNA expression and antitumor efficacy in xenografted tumor model mice. 6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide (TAK-441) is a potent, selective hedgehog signaling pathway inhibitor that binds to Smo and is being developed for the treatment of cancer.",
        "relation": "CPR:4"
    },
    {
        "id": "23298863.T2.T7",
        "sentence": "The IC50 values for @CHEMICAL$ mRNA inhibition in the tumor and skin by @GENE$ were estimated to be 0.0457 and 0.113 mg/ml, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "10626810.T23.T37",
        "sentence": "In this report, we evaluated the growth-inhibitory effects of @CHEMICAL$, a @GENE$ and COX-2 inhibitor; exisulind (sulindac sulfone), a novel proapoptotic agent that does not inhibit COX enzymes; and nordihydroguaiaretic acid (NDGA), a lipoxygenase inhibitor on human lung cancer cell lines.",
        "relation": "CPR:4"
    },
    {
        "id": "10626810.T23.T38",
        "sentence": "In this report, we evaluated the growth-inhibitory effects of @CHEMICAL$, a COX-1 and @GENE$ inhibitor; exisulind (sulindac sulfone), a novel proapoptotic agent that does not inhibit COX enzymes; and nordihydroguaiaretic acid (NDGA), a lipoxygenase inhibitor on human lung cancer cell lines.",
        "relation": "CPR:4"
    },
    {
        "id": "10626810.T26.T40",
        "sentence": "In this report, we evaluated the growth-inhibitory effects of sulindac sulfide, a COX-1 and COX-2 inhibitor; exisulind (sulindac sulfone), a novel proapoptotic agent that does not inhibit COX enzymes; and @CHEMICAL$ (NDGA), a @GENE$ inhibitor on human lung cancer cell lines.",
        "relation": "CPR:4"
    },
    {
        "id": "10626810.T27.T40",
        "sentence": "In this report, we evaluated the growth-inhibitory effects of sulindac sulfide, a COX-1 and COX-2 inhibitor; exisulind (sulindac sulfone), a novel proapoptotic agent that does not inhibit COX enzymes; and nordihydroguaiaretic acid (@CHEMICAL$), a @GENE$ inhibitor on human lung cancer cell lines.",
        "relation": "CPR:4"
    },
    {
        "id": "20421509.T20.T43",
        "sentence": "@CHEMICAL$ inhibit @GENE$ function by inducing protein oligomerization.",
        "relation": "CPR:4"
    },
    {
        "id": "20421509.T11.T37",
        "sentence": "Using a unique biosensor-based assay, @CHEMICAL$ (TFP) was identified as an inhibitor that disrupts the @GENE$/myosin-IIA interaction.",
        "relation": "CPR:4"
    },
    {
        "id": "20421509.T11.T38",
        "sentence": "Using a unique biosensor-based assay, @CHEMICAL$ (TFP) was identified as an inhibitor that disrupts the S100A4/@GENE$ interaction.",
        "relation": "CPR:4"
    },
    {
        "id": "20421509.T12.T37",
        "sentence": "Using a unique biosensor-based assay, trifluoperazine (@CHEMICAL$) was identified as an inhibitor that disrupts the @GENE$/myosin-IIA interaction.",
        "relation": "CPR:4"
    },
    {
        "id": "20421509.T12.T38",
        "sentence": "Using a unique biosensor-based assay, trifluoperazine (@CHEMICAL$) was identified as an inhibitor that disrupts the S100A4/@GENE$ interaction.",
        "relation": "CPR:4"
    },
    {
        "id": "20421509.T7.T27",
        "sentence": "Assays examining the ability of @CHEMICAL$ to block @GENE$-mediated disassembly of myosin-IIA filaments demonstrate that significant inhibition of S100A4 function occurs only at TFP concentrations that promote S100A4 oligomerization.",
        "relation": "CPR:4"
    },
    {
        "id": "20421509.T7.T28",
        "sentence": "Assays examining the ability of @CHEMICAL$ to block S100A4-mediated disassembly of @GENE$ filaments demonstrate that significant inhibition of S100A4 function occurs only at TFP concentrations that promote S100A4 oligomerization.",
        "relation": "CPR:4"
    },
    {
        "id": "20421509.T8.T29",
        "sentence": "Assays examining the ability of TFP to block S100A4-mediated disassembly of myosin-IIA filaments demonstrate that significant inhibition of @CHEMICAL$ function occurs only at @GENE$ concentrations that promote S100A4 oligomerization.",
        "relation": "CPR:4"
    },
    {
        "id": "20421509.T8.T30",
        "sentence": "Assays examining the ability of TFP to block S100A4-mediated disassembly of myosin-IIA filaments demonstrate that significant inhibition of S100A4 function occurs only at @CHEMICAL$ concentrations that promote @GENE$ oligomerization.",
        "relation": "CPR:3"
    },
    {
        "id": "20421509.T9.T32",
        "sentence": "Together these studies support a unique mode of inhibition in which @CHEMICAL$ disrupt the @GENE$/myosin-IIA interaction by sequestering S100A4 via small molecule-induced oligomerization.",
        "relation": "CPR:4"
    },
    {
        "id": "20421509.T9.T33",
        "sentence": "Together these studies support a unique mode of inhibition in which @CHEMICAL$ disrupt the S100A4/@GENE$ interaction by sequestering S100A4 via small molecule-induced oligomerization.",
        "relation": "CPR:4"
    },
    {
        "id": "7912539.T17.T27",
        "sentence": "Cardiac effects of the @CHEMICAL$ agonist @GENE$ in man.",
        "relation": "CPR:5"
    },
    {
        "id": "7912539.T1.T25",
        "sentence": "The aim of the present study was to evaluate the cardiac effects of the @CHEMICAL$ agonist @GENE$, and determine whether beta 3-receptors are involved in mediating chronotropic or inotropic responses in man.",
        "relation": "CPR:5"
    },
    {
        "id": "7912539.T7.T21",
        "sentence": "Eight normal males received single oral doses of BRL35135 8 mg (BRL) or the selective @CHEMICAL$ agonist @GENE$ 8 mg (SAL), after pretreatment with either placebo (PL), bisoprolol 5 mg (B5) as a selective beta 1-adrenoceptor antagonist, or nadolol 20 mg (N20) to block beta 1- and beta 2- but not beta 3-receptors.",
        "relation": "CPR:5"
    },
    {
        "id": "7912539.T8.T21",
        "sentence": "Eight normal males received single oral doses of BRL35135 8 mg (BRL) or the selective @CHEMICAL$ agonist salbutamol 8 mg (@GENE$), after pretreatment with either placebo (PL), bisoprolol 5 mg (B5) as a selective beta 1-adrenoceptor antagonist, or nadolol 20 mg (N20) to block beta 1- and beta 2- but not beta 3-receptors.",
        "relation": "CPR:5"
    },
    {
        "id": "7912539.T9.T22",
        "sentence": "Eight normal males received single oral doses of BRL35135 8 mg (BRL) or the selective beta 2-adrenoceptor agonist salbutamol 8 mg (SAL), after pretreatment with either placebo (PL), @CHEMICAL$ 5 mg (B5) as a selective @GENE$ antagonist, or nadolol 20 mg (N20) to block beta 1- and beta 2- but not beta 3-receptors.",
        "relation": "CPR:6"
    },
    {
        "id": "7912539.T11.T24",
        "sentence": "Both @CHEMICAL$ and SAL produced a significant increase in postural finger tremor in keeping with @GENE$ stimulation, and this response was totally abolished by pretreatment with N20.",
        "relation": "CPR:3"
    },
    {
        "id": "7912539.T12.T24",
        "sentence": "Both BRL and @CHEMICAL$ produced a significant increase in postural finger tremor in keeping with @GENE$ stimulation, and this response was totally abolished by pretreatment with N20.",
        "relation": "CPR:3"
    },
    {
        "id": "23085979.T3.T18",
        "sentence": "Disruption of contact inhibition, which was induced by toxic AhR ligands @CHEMICAL$ (TCDD) or polycyclic aromatic hydrocarbons in epithelial WB-F344 cells, reduced @GENE$ protein levels, possibly via enhanced proteasomal degradation, significantly decreased the amount of gap junction plaques and downregulated GJIC, in an AhR-dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "23085979.T4.T18",
        "sentence": "Disruption of contact inhibition, which was induced by toxic AhR ligands 2,3,7,8-tetrachlorodibenzo-p-dioxin (@CHEMICAL$) or polycyclic aromatic hydrocarbons in epithelial WB-F344 cells, reduced @GENE$ protein levels, possibly via enhanced proteasomal degradation, significantly decreased the amount of gap junction plaques and downregulated GJIC, in an AhR-dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "23085979.T5.T18",
        "sentence": "Disruption of contact inhibition, which was induced by toxic AhR ligands 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or @CHEMICAL$ in epithelial WB-F344 cells, reduced @GENE$ protein levels, possibly via enhanced proteasomal degradation, significantly decreased the amount of gap junction plaques and downregulated GJIC, in an AhR-dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "23085979.T1.T7",
        "sentence": "Although both intracellular and membrane @CHEMICAL$ pools were markedly reduced in cells released from contact inhibition by @GENE$, siRNA-mediated Cx43 knock-down was not sufficient to stimulate proliferation in contact-inhibited cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23085979.T1.T8",
        "sentence": "Although both intracellular and membrane Cx43 pools were markedly reduced in cells released from contact inhibition by @CHEMICAL$, siRNA-mediated @GENE$ knock-down was not sufficient to stimulate proliferation in contact-inhibited cells.",
        "relation": "CPR:4"
    },
    {
        "id": "17075268.T20.T37",
        "sentence": "@CHEMICAL$ suppresses histamine synthesis by repressing both transcription and activity of @GENE$ in allergic rats.",
        "relation": "CPR:4"
    },
    {
        "id": "17075268.T3.T32",
        "sentence": "BACKGROUND: @CHEMICAL$ synthesized by @GENE$ (HDC) from L-histidine is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity.",
        "relation": "CPR:9"
    },
    {
        "id": "17075268.T3.T34",
        "sentence": "BACKGROUND: @CHEMICAL$ synthesized by histidine decarboxylase (@GENE$) from L-histidine is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity.",
        "relation": "CPR:9"
    },
    {
        "id": "17075268.T18.T32",
        "sentence": "BACKGROUND: Histamine synthesized by @CHEMICAL$ (HDC) from @GENE$ is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity.",
        "relation": "CPR:9"
    },
    {
        "id": "17075268.T18.T34",
        "sentence": "BACKGROUND: Histamine synthesized by histidine decarboxylase (@CHEMICAL$) from @GENE$ is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity.",
        "relation": "CPR:9"
    },
    {
        "id": "17075268.T11.T30",
        "sentence": "However the regulatory mechanism of @CHEMICAL$ synthesis by @GENE$ remains to be elucidated.",
        "relation": "CPR:9"
    },
    {
        "id": "17075268.T4.T22",
        "sentence": "Histamine content, @CHEMICAL$ activity and HDC mRNA expression in nasal mucosa were also significantly increased after @GENE$ provocation.",
        "relation": "CPR:3"
    },
    {
        "id": "17075268.T4.T23",
        "sentence": "Histamine content, HDC activity and @CHEMICAL$ mRNA expression in nasal mucosa were also significantly increased after @GENE$ provocation.",
        "relation": "CPR:3"
    },
    {
        "id": "17075268.T5.T24",
        "sentence": "Pretreatment with @CHEMICAL$ significantly suppressed nasal allergy-like behaviors, up-regulation of histamine content, @GENE$ activity and HDC mRNA induced by TDI in TDI-sensitized rats.",
        "relation": "CPR:4"
    },
    {
        "id": "17075268.T5.T25",
        "sentence": "Pretreatment with @CHEMICAL$ significantly suppressed nasal allergy-like behaviors, up-regulation of histamine content, HDC activity and @GENE$ mRNA induced by TDI in TDI-sensitized rats.",
        "relation": "CPR:4"
    },
    {
        "id": "17075268.T7.T24",
        "sentence": "Pretreatment with dexamethasone significantly suppressed nasal allergy-like behaviors, up-regulation of histamine content, @CHEMICAL$ activity and HDC mRNA induced by @GENE$ in TDI-sensitized rats.",
        "relation": "CPR:3"
    },
    {
        "id": "17075268.T7.T25",
        "sentence": "Pretreatment with dexamethasone significantly suppressed nasal allergy-like behaviors, up-regulation of histamine content, HDC activity and @CHEMICAL$ mRNA induced by @GENE$ in TDI-sensitized rats.",
        "relation": "CPR:3"
    },
    {
        "id": "17075268.T8.T25",
        "sentence": "Pretreatment with dexamethasone significantly suppressed nasal allergy-like behaviors, up-regulation of histamine content, HDC activity and @CHEMICAL$ mRNA induced by TDI in @GENE$-sensitized rats.",
        "relation": "CPR:3"
    },
    {
        "id": "17075268.T9.T26",
        "sentence": "CONCLUSIONS: These findings indicate that increased synthesis of @CHEMICAL$ through up-regulation of @GENE$ gene expression and HDC activity in nasal mucosa plays an important role in the development of nasal hypersensitivity.",
        "relation": "CPR:9"
    },
    {
        "id": "17075268.T9.T27",
        "sentence": "CONCLUSIONS: These findings indicate that increased synthesis of @CHEMICAL$ through up-regulation of HDC gene expression and @GENE$ activity in nasal mucosa plays an important role in the development of nasal hypersensitivity.",
        "relation": "CPR:9"
    },
    {
        "id": "17075268.T10.T28",
        "sentence": "Repression of @CHEMICAL$ gene expression and HDC activity by @GENE$ may underlie its therapeutic effect in the treatment of allergy.",
        "relation": "CPR:4"
    },
    {
        "id": "17075268.T10.T29",
        "sentence": "Repression of HDC gene expression and @CHEMICAL$ activity by @GENE$ may underlie its therapeutic effect in the treatment of allergy.",
        "relation": "CPR:4"
    },
    {
        "id": "23223345.T4.T11",
        "sentence": "CONCLUSIONS A diet that partially replaces @CHEMICAL$ with unsaturated fat may improve @GENE$ sensitivity in a population at risk for cardiovascular disease.",
        "relation": "CPR:3"
    },
    {
        "id": "23381968.T7.T20",
        "sentence": "In this study, we assessed the effects of @CHEMICAL$ and clarithromycin, known CYP2B6 and @GENE$ inhibitors, respectively, on the enantioselective disposition of racemic sibutramine in conjunction with CYP2B6 polymorphisms in humans.",
        "relation": "CPR:4"
    },
    {
        "id": "23381968.T7.T17",
        "sentence": "In this study, we assessed the effects of @CHEMICAL$ and clarithromycin, known CYP2B6 and CYP3A inhibitors, respectively, on the enantioselective disposition of racemic sibutramine in conjunction with @GENE$ polymorphisms in humans.",
        "relation": "CPR:4"
    },
    {
        "id": "23381968.T7.T18",
        "sentence": "In this study, we assessed the effects of @CHEMICAL$ and clarithromycin, known @GENE$ and CYP3A inhibitors, respectively, on the enantioselective disposition of racemic sibutramine in conjunction with CYP2B6 polymorphisms in humans.",
        "relation": "CPR:4"
    },
    {
        "id": "23381968.T8.T20",
        "sentence": "In this study, we assessed the effects of clopidogrel and @CHEMICAL$, known CYP2B6 and @GENE$ inhibitors, respectively, on the enantioselective disposition of racemic sibutramine in conjunction with CYP2B6 polymorphisms in humans.",
        "relation": "CPR:4"
    },
    {
        "id": "23381968.T8.T18",
        "sentence": "In this study, we assessed the effects of clopidogrel and @CHEMICAL$, known @GENE$ and CYP3A inhibitors, respectively, on the enantioselective disposition of racemic sibutramine in conjunction with CYP2B6 polymorphisms in humans.",
        "relation": "CPR:4"
    },
    {
        "id": "11972613.T4.T19",
        "sentence": "Increased @CHEMICAL$ activity in the serum was inhibited by both @GENE$ and MCI-826 by over 90%.",
        "relation": "CPR:4"
    },
    {
        "id": "11972613.T5.T19",
        "sentence": "Increased @CHEMICAL$ activity in the serum was inhibited by both pranlukast and @GENE$ by over 90%.",
        "relation": "CPR:4"
    },
    {
        "id": "11972613.T6.T21",
        "sentence": "CONCLUSIONS: @CHEMICAL$ produced after antigen provocation sequentially induced IL-5 production from some immune component cells via @GENE$ receptor activation.",
        "relation": "CPR:3"
    },
    {
        "id": "15598972.T9.T23",
        "sentence": "Here, we show that meclofenamic acid (meclofenamate) and diclofenac, two related molecules previously used as anti-inflammatory drugs, act as novel KCNQ2/Q3 channel openers. Extracellular application of @CHEMICAL$ (EC(50) = 25 microM) and diclofenac (EC(50) = 2.6 microM) resulted in the activation of @GENE$ K(+) currents, heterologously expressed in Chinese hamster ovary cells.",
        "relation": "CPR:3"
    },
    {
        "id": "15598972.T10.T23",
        "sentence": "Here, we show that meclofenamic acid (meclofenamate) and diclofenac, two related molecules previously used as anti-inflammatory drugs, act as novel KCNQ2/Q3 channel openers. Extracellular application of meclofenamate (EC(50) = 25 microM) and @CHEMICAL$ (EC(50) = 2.6 microM) resulted in the activation of @GENE$ K(+) currents, heterologously expressed in Chinese hamster ovary cells.",
        "relation": "CPR:3"
    },
    {
        "id": "12431845.T19.T32",
        "sentence": "The selective @CHEMICAL$ inhibitor @GENE$ (formerly called tomoxetine or LY139603) has been shown to alleviate symptoms in Attention Deficit/Hyperactivity Disorder (ADHD).",
        "relation": "CPR:4"
    },
    {
        "id": "12431845.T25.T32",
        "sentence": "The selective @CHEMICAL$ inhibitor atomoxetine (formerly called @GENE$ or LY139603) has been shown to alleviate symptoms in Attention Deficit/Hyperactivity Disorder (ADHD).",
        "relation": "CPR:4"
    },
    {
        "id": "12431845.T27.T32",
        "sentence": "The selective @CHEMICAL$ inhibitor atomoxetine (formerly called tomoxetine or @GENE$) has been shown to alleviate symptoms in Attention Deficit/Hyperactivity Disorder (ADHD).",
        "relation": "CPR:4"
    },
    {
        "id": "23298698.T7.T16",
        "sentence": "Lung inflammation, @CHEMICAL$ production, and airway mast cell activity were also prevented under this early short-term treatment with @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23298698.T2.T12",
        "sentence": "Local @CHEMICAL$ administration prevented the increase of airway @GENE$ and osteopontin and kept lung plasmacytoid dendritic cell counts close to baseline.",
        "relation": "CPR:4"
    },
    {
        "id": "23298698.T2.T13",
        "sentence": "Local @CHEMICAL$ administration prevented the increase of airway IL-13 and @GENE$ and kept lung plasmacytoid dendritic cell counts close to baseline.",
        "relation": "CPR:4"
    },
    {
        "id": "23220589.T2.T28",
        "sentence": "Reactivators showed different activity in the reactivation of @CHEMICAL$ after @GENE$, paraoxon and tabun inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "23220589.T3.T28",
        "sentence": "Reactivators showed different activity in the reactivation of @CHEMICAL$ after dichlorvos, @GENE$ and tabun inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "23220589.T4.T28",
        "sentence": "Reactivators showed different activity in the reactivation of @CHEMICAL$ after dichlorvos, paraoxon and @GENE$ inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "23220589.T5.T29",
        "sentence": "@CHEMICAL$ was easier reactivated after @GENE$ treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "23220589.T14.T30",
        "sentence": "The reactivation of brain @CHEMICAL$ inhibited with tabun demonstrated better activity of new compound @GENE$, TMB-4 and obidoxime from symmetric oximes, and BT-05 and BT-03 possessing asymmetric structure.",
        "relation": "CPR:3"
    },
    {
        "id": "23220589.T15.T30",
        "sentence": "The reactivation of brain @CHEMICAL$ inhibited with tabun demonstrated better activity of new compound BT-07-4M, @GENE$ and obidoxime from symmetric oximes, and BT-05 and BT-03 possessing asymmetric structure.",
        "relation": "CPR:3"
    },
    {
        "id": "23220589.T16.T30",
        "sentence": "The reactivation of brain @CHEMICAL$ inhibited with tabun demonstrated better activity of new compound BT-07-4M, TMB-4 and @GENE$ from symmetric oximes, and BT-05 and BT-03 possessing asymmetric structure.",
        "relation": "CPR:3"
    },
    {
        "id": "23220589.T17.T30",
        "sentence": "The reactivation of brain @CHEMICAL$ inhibited with tabun demonstrated better activity of new compound BT-07-4M, TMB-4 and obidoxime from symmetric @GENE$, and BT-05 and BT-03 possessing asymmetric structure.",
        "relation": "CPR:3"
    },
    {
        "id": "23220589.T18.T30",
        "sentence": "The reactivation of brain @CHEMICAL$ inhibited with tabun demonstrated better activity of new compound BT-07-4M, TMB-4 and obidoxime from symmetric oximes, and @GENE$ and BT-03 possessing asymmetric structure.",
        "relation": "CPR:3"
    },
    {
        "id": "23220589.T19.T30",
        "sentence": "The reactivation of brain @CHEMICAL$ inhibited with tabun demonstrated better activity of new compound BT-07-4M, TMB-4 and obidoxime from symmetric oximes, and BT-05 and @GENE$ possessing asymmetric structure.",
        "relation": "CPR:3"
    },
    {
        "id": "23220589.T20.T31",
        "sentence": "All compounds showed low activity toward inhibition of @CHEMICAL$ caused by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15562257.T17.T34",
        "sentence": "State-dependent @CHEMICAL$ block of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15562257.T1.T24",
        "sentence": "@CHEMICAL$ is a @GENE$ antagonist with reported cross-reactivity with other classes of ion channels, including K+, Cl-, and Na+ channels.",
        "relation": "CPR:6"
    },
    {
        "id": "15562257.T10.T25",
        "sentence": "Using whole-cell voltage clamp, we examined @CHEMICAL$ block of four @GENE$ isoforms expressed in human embryonic kidney cells: Nav1.5 (cardiac), Nav1.4 (skeletal muscle), Nav1.2 (brain), and Nav1.7 (peripheral nerve).",
        "relation": "CPR:4"
    },
    {
        "id": "15562257.T10.T26",
        "sentence": "Using whole-cell voltage clamp, we examined @CHEMICAL$ block of four Na+ channel isoforms expressed in human embryonic kidney cells: @GENE$ (cardiac), Nav1.4 (skeletal muscle), Nav1.2 (brain), and Nav1.7 (peripheral nerve).",
        "relation": "CPR:4"
    },
    {
        "id": "15562257.T10.T27",
        "sentence": "Using whole-cell voltage clamp, we examined @CHEMICAL$ block of four Na+ channel isoforms expressed in human embryonic kidney cells: Nav1.5 (cardiac), @GENE$ (skeletal muscle), Nav1.2 (brain), and Nav1.7 (peripheral nerve).",
        "relation": "CPR:4"
    },
    {
        "id": "15562257.T10.T28",
        "sentence": "Using whole-cell voltage clamp, we examined @CHEMICAL$ block of four Na+ channel isoforms expressed in human embryonic kidney cells: Nav1.5 (cardiac), Nav1.4 (skeletal muscle), @GENE$ (brain), and Nav1.7 (peripheral nerve).",
        "relation": "CPR:4"
    },
    {
        "id": "15562257.T10.T29",
        "sentence": "Using whole-cell voltage clamp, we examined @CHEMICAL$ block of four Na+ channel isoforms expressed in human embryonic kidney cells: Nav1.5 (cardiac), Nav1.4 (skeletal muscle), Nav1.2 (brain), and @GENE$ (peripheral nerve).",
        "relation": "CPR:4"
    },
    {
        "id": "15562257.T13.T30",
        "sentence": "@CHEMICAL$ blocked @GENE$ in a use/frequency-dependent manner, indicating preferential binding to states visited during depolarization.",
        "relation": "CPR:4"
    },
    {
        "id": "15562257.T14.T31",
        "sentence": "@CHEMICAL$ blocked currents of all @GENE$ isoforms with similar affinity and a dependence on holding potential, and drug off-rate was slowed at depolarized potentials (k(off) was 0.024/s at -130 mV and 0.007/s at -100 mV for Nav1.5).",
        "relation": "CPR:4"
    },
    {
        "id": "15562257.T14.T32",
        "sentence": "@CHEMICAL$ blocked currents of all Na+ channel isoforms with similar affinity and a dependence on holding potential, and drug off-rate was slowed at depolarized potentials (k(off) was 0.024/s at -130 mV and 0.007/s at -100 mV for @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "15562257.T2.T19",
        "sentence": "In addition, inhibiting the binding of the fast inactivation lid (@CHEMICAL$ ICM + MTSET) did not alter @GENE$ block, confirming that the drug does not preferentially interact with the fast-inactivated state.",
        "relation": "CPR:4"
    },
    {
        "id": "15562257.T7.T21",
        "sentence": "When selectively applied to channels after inducing slow inactivation with a 60-s pulse to -10 mV, @CHEMICAL$ (1 microM) produced 45% fractional block in @GENE$ and greater block (88%) in an isoform (Nav1.4) that slow-inactivates more completely.",
        "relation": "CPR:4"
    },
    {
        "id": "15562257.T7.T22",
        "sentence": "When selectively applied to channels after inducing slow inactivation with a 60-s pulse to -10 mV, @CHEMICAL$ (1 microM) produced 45% fractional block in Nav1.5 and greater block (88%) in an isoform (@GENE$) that slow-inactivates more completely.",
        "relation": "CPR:4"
    },
    {
        "id": "15562257.T8.T23",
        "sentence": "Our results suggest that @CHEMICAL$ blocks @GENE$ in a state-dependent manner that does not depend on fast inactivation but probably involves interaction with one or more slow-inactivated state(s).",
        "relation": "CPR:4"
    },
    {
        "id": "15714982.T1.T11",
        "sentence": "@CHEMICAL$ is a semisynthetic taxane that inhibit tumor growth by induction of microtubule stabilization and promotion of @GENE$ inactivation, which induce apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "15714982.T2.T11",
        "sentence": "Docetaxel is a semisynthetic @CHEMICAL$ that inhibit tumor growth by induction of microtubule stabilization and promotion of @GENE$ inactivation, which induce apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "18708991.T1.T38",
        "sentence": "@CHEMICAL$ is metabolized to its active metabolite, 9-hydroxyrisperidone, mainly by the @GENE$ enzymes CYP2D6 and 3A4.",
        "relation": "CPR:9"
    },
    {
        "id": "18708991.T13.T38",
        "sentence": "Risperidone is metabolized to its active metabolite, @CHEMICAL$, mainly by the @GENE$ enzymes CYP2D6 and 3A4.",
        "relation": "CPR:9"
    },
    {
        "id": "18708991.T11.T32",
        "sentence": "Both @CHEMICAL$ and 9-hydroxyrisperidone are substrates of @GENE$ (P-gp), a transport protein involved in drug absorption, distribution, and elimination.",
        "relation": "CPR:9"
    },
    {
        "id": "18708991.T11.T33",
        "sentence": "Both @CHEMICAL$ and 9-hydroxyrisperidone are substrates of P-glycoprotein (@GENE$), a transport protein involved in drug absorption, distribution, and elimination.",
        "relation": "CPR:9"
    },
    {
        "id": "18708991.T12.T32",
        "sentence": "Both risperidone and @CHEMICAL$ are substrates of @GENE$ (P-gp), a transport protein involved in drug absorption, distribution, and elimination.",
        "relation": "CPR:9"
    },
    {
        "id": "18708991.T12.T33",
        "sentence": "Both risperidone and @CHEMICAL$ are substrates of P-glycoprotein (@GENE$), a transport protein involved in drug absorption, distribution, and elimination.",
        "relation": "CPR:9"
    },
    {
        "id": "15133083.T2.T24",
        "sentence": "Most of the spermidine and the unknown product were found in the cell incubation medium, indicating they were released from the cell. bis(Ethyl) oligoamine analogues of polyamines, such as SL-11144 and SL-11158, as well as arylamine analogues [BW-1, a bis(phenylbenzyl) 3-7-3 analogue] blocked uptake and interconversion of spermine at micromolar levels and, in the case of @CHEMICAL$, acted as substrate for @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "15133083.T3.T27",
        "sentence": "@CHEMICAL$ inhibited @GENE$ activity with a mixed type of inhibition in which the analogue had a 70-fold higher affinity for the enzyme than the natural substrate, spermine.",
        "relation": "CPR:4"
    },
    {
        "id": "23497227.T5.T12",
        "sentence": "Synthesis and in vitro evaluation of @CHEMICAL$ derivatives as potent @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23497227.T2.T6",
        "sentence": "A series of @CHEMICAL$ have been synthesised, characterised and tested for their in vitro EGFR @GENE$ inhibitory activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23497227.T2.T11",
        "sentence": "A series of @CHEMICAL$ have been synthesised, characterised and tested for their in vitro @GENE$ tyrosine kinase inhibitory activity.",
        "relation": "CPR:4"
    },
    {
        "id": "22981796.T4.T8",
        "sentence": "Exposure to @CHEMICAL$ NPs decreased cell viability to 73% (p<0.01) and significantly (p<0.05) elevated levels of @GENE$, intracellular reactive oxygen species and interleukin-8 that mirrored our findings from subacute in vivo inhalation studies in mice.",
        "relation": "CPR:3"
    },
    {
        "id": "22981796.T4.T7",
        "sentence": "Exposure to @CHEMICAL$ NPs decreased cell viability to 73% (p<0.01) and significantly (p<0.05) elevated levels of lactate dehydrogenase, intracellular reactive oxygen species and @GENE$ that mirrored our findings from subacute in vivo inhalation studies in mice.",
        "relation": "CPR:3"
    },
    {
        "id": "23327993.T5.T31",
        "sentence": "The Trx mimetics peptides (TXM) protected insulinoma INS 832/13 cells from oxidative stress induced by selectively inhibiting @CHEMICAL$ with @GENE$ (AuF).",
        "relation": "CPR:4"
    },
    {
        "id": "23327993.T6.T31",
        "sentence": "The Trx mimetics peptides (TXM) protected insulinoma INS 832/13 cells from oxidative stress induced by selectively inhibiting @CHEMICAL$ with auranofin (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "23327993.T8.T32",
        "sentence": "The TXM peptides were effective in inhibiting @CHEMICAL$-induced @GENE$, JNK and p38(MAPK) phosphorylation, in correlation with preventing caspase-3 cleavage and thereby PARP-1 dissociation.",
        "relation": "CPR:3"
    },
    {
        "id": "23327993.T8.T33",
        "sentence": "The TXM peptides were effective in inhibiting @CHEMICAL$-induced MAPK, @GENE$ and p38(MAPK) phosphorylation, in correlation with preventing caspase-3 cleavage and thereby PARP-1 dissociation.",
        "relation": "CPR:3"
    },
    {
        "id": "23327993.T8.T34",
        "sentence": "The TXM peptides were effective in inhibiting @CHEMICAL$-induced MAPK, JNK and @GENE$(MAPK) phosphorylation, in correlation with preventing caspase-3 cleavage and thereby PARP-1 dissociation.",
        "relation": "CPR:3"
    },
    {
        "id": "23327993.T8.T35",
        "sentence": "The TXM peptides were effective in inhibiting @CHEMICAL$-induced MAPK, JNK and p38(@GENE$) phosphorylation, in correlation with preventing caspase-3 cleavage and thereby PARP-1 dissociation.",
        "relation": "CPR:3"
    },
    {
        "id": "10617684.T20.T31",
        "sentence": "Preferential block of late sodium current in the @CHEMICAL$ by the class I(C) antiarrhythmic @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "10617684.T1.T24",
        "sentence": "@CHEMICAL$ block of Na(+) current (I(Na)) was investigated in wild-type (WT) or the long QT syndrome 3 (LQT3) sodium channel alpha subunit mutation with three amino acids deleted (@GENE$) stably transfected into human embryonic kidney 293 cells using whole-cell, patch-clamp recordings.",
        "relation": "CPR:4"
    },
    {
        "id": "10617684.T1.T27",
        "sentence": "@CHEMICAL$ block of Na(+) current (I(Na)) was investigated in wild-type (WT) or the @GENE$ subunit mutation with three amino acids deleted (DeltaKPQ) stably transfected into human embryonic kidney 293 cells using whole-cell, patch-clamp recordings.",
        "relation": "CPR:4"
    },
    {
        "id": "10617684.T4.T27",
        "sentence": "Flecainide block of Na(+) current (I(Na)) was investigated in wild-type (WT) or the @CHEM-GENE$ subunit mutation with three amino acids deleted (DeltaKPQ) stably transfected into human embryonic kidney 293 cells using whole-cell, patch-clamp recordings.",
        "relation": "CPR:9"
    },
    {
        "id": "10617684.T14.T25",
        "sentence": "Compared with WT, @CHEMICAL$ I(Na) was more sensitive to @GENE$, and flecainide preferentially inhibited late I(Na) (mean current between 20 and 23.5 ms after depolarization) compared with peak I(Na).",
        "relation": "CPR:4"
    },
    {
        "id": "10617684.T15.T25",
        "sentence": "Compared with WT, @CHEMICAL$ I(Na) was more sensitive to flecainide, and @GENE$ preferentially inhibited late I(Na) (mean current between 20 and 23.5 ms after depolarization) compared with peak I(Na).",
        "relation": "CPR:4"
    },
    {
        "id": "10617684.T5.T23",
        "sentence": "We conclude that @CHEMICAL$ interacts differently with @GENE$ than with WT, leading to increased block and slowed recovery, especially for late I(Na).",
        "relation": "CPR:4"
    },
    {
        "id": "23118019.T16.T19",
        "sentence": "Both @CHEMICAL$ and 5'-MABN had high affinity for k-receptors (K (i) 1.36 + 0.98 and 0.27 + 0.08, respectively) and were revealed as potent k-antagonists (pA(2) 7.43 and 8.18, respectively) and @GENE$ antagonists (pA(2) 7.62 and 7.85, respectively) in the ileum.",
        "relation": "CPR:6"
    },
    {
        "id": "23118019.T17.T19",
        "sentence": "Both 5'-AMN and @CHEMICAL$ had high affinity for k-receptors (K (i) 1.36 + 0.98 and 0.27 + 0.08, respectively) and were revealed as potent k-antagonists (pA(2) 7.43 and 8.18, respectively) and @GENE$ antagonists (pA(2) 7.62 and 7.85, respectively) in the ileum.",
        "relation": "CPR:6"
    },
    {
        "id": "23522834.T1.T3",
        "sentence": "Polo-like kinase-2 (Plk-2) is a potential therapeutic target for Parkinson's disease and this Letter describes the SAR of a series of @CHEMICAL$ based @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23612487.T12.T41",
        "sentence": "@CHEMICAL$ promotes the nuclear translocation of b-catenin and thereby induces @GENE$ gene expression in osteoblast-like cell lines.",
        "relation": "CPR:3"
    },
    {
        "id": "23612487.T8.T23",
        "sentence": "@CHEMICAL$ activated @GENE$ (PI3K)/Akt signaling, leading to the inhibition of glycogen synthase kinase-3b and the nuclear translocation of b-catenin, followed by the increase of the transcriptional activity by b-catenin/T-cell factor complex formation in both SaOS-2 cells and MC3T3-E1 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23612487.T8.T24",
        "sentence": "@CHEMICAL$ activated phosphatidylinositol 3-kinase (@GENE$)/Akt signaling, leading to the inhibition of glycogen synthase kinase-3b and the nuclear translocation of b-catenin, followed by the increase of the transcriptional activity by b-catenin/T-cell factor complex formation in both SaOS-2 cells and MC3T3-E1 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23612487.T8.T25",
        "sentence": "@CHEMICAL$ activated phosphatidylinositol 3-kinase (PI3K)/@GENE$ signaling, leading to the inhibition of glycogen synthase kinase-3b and the nuclear translocation of b-catenin, followed by the increase of the transcriptional activity by b-catenin/T-cell factor complex formation in both SaOS-2 cells and MC3T3-E1 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23612487.T8.T26",
        "sentence": "@CHEMICAL$ activated phosphatidylinositol 3-kinase (PI3K)/Akt signaling, leading to the inhibition of @GENE$ and the nuclear translocation of b-catenin, followed by the increase of the transcriptional activity by b-catenin/T-cell factor complex formation in both SaOS-2 cells and MC3T3-E1 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23612487.T2.T16",
        "sentence": "Both inhibitors for PI3K and Akt suppressed the nuclear localization of b-catenin and T-cell factor transcriptional activity induced by Wnt-3a. @CHEMICAL$ increased the amount of @GENE$ at both mRNA and protein levels, and increased the activity of alkaline phosphatase, leading to the mineralization.",
        "relation": "CPR:3"
    },
    {
        "id": "23612487.T3.T18",
        "sentence": "These findings suggest that @CHEMICAL$ activates the @GENE$/Akt signaling pathway leading to the promotion of nuclear translocation of b-catenin in osteoblast-like cells, resulting in the upregulation of osteoptotegerin and osteoblast differentiation markers including alkaline phosphatase, probably relating to the inhibition of osteoclast formation and the mineralization, respectively.",
        "relation": "CPR:3"
    },
    {
        "id": "23612487.T3.T19",
        "sentence": "These findings suggest that @CHEMICAL$ activates the PI3K/@GENE$ signaling pathway leading to the promotion of nuclear translocation of b-catenin in osteoblast-like cells, resulting in the upregulation of osteoptotegerin and osteoblast differentiation markers including alkaline phosphatase, probably relating to the inhibition of osteoclast formation and the mineralization, respectively.",
        "relation": "CPR:3"
    },
    {
        "id": "23612487.T3.T20",
        "sentence": "These findings suggest that @CHEMICAL$ activates the PI3K/Akt signaling pathway leading to the promotion of nuclear translocation of @GENE$ in osteoblast-like cells, resulting in the upregulation of osteoptotegerin and osteoblast differentiation markers including alkaline phosphatase, probably relating to the inhibition of osteoclast formation and the mineralization, respectively.",
        "relation": "CPR:3"
    },
    {
        "id": "23612487.T3.T21",
        "sentence": "These findings suggest that @CHEMICAL$ activates the PI3K/Akt signaling pathway leading to the promotion of nuclear translocation of b-catenin in osteoblast-like cells, resulting in the upregulation of @GENE$ and osteoblast differentiation markers including alkaline phosphatase, probably relating to the inhibition of osteoclast formation and the mineralization, respectively.",
        "relation": "CPR:3"
    },
    {
        "id": "23612487.T3.T22",
        "sentence": "These findings suggest that @CHEMICAL$ activates the PI3K/Akt signaling pathway leading to the promotion of nuclear translocation of b-catenin in osteoblast-like cells, resulting in the upregulation of osteoptotegerin and osteoblast differentiation markers including @GENE$, probably relating to the inhibition of osteoclast formation and the mineralization, respectively.",
        "relation": "CPR:3"
    },
    {
        "id": "18847313.T6.T16",
        "sentence": "@CHEMICAL$, a @GENE$ antagonist for the mobilization of hematopoietic stem cells. Stem cells harvested from peripheral blood are the most commonly used graft source in hematopoietic stem cell transplantation.",
        "relation": "CPR:6"
    },
    {
        "id": "18847313.T1.T9",
        "sentence": "@CHEMICAL$ (AMD3100, Genzyme Corporation) is a bicyclam molecule that antagonizes the binding of the @GENE$ stromal cell-derived factor-1 (SDF-1) to its cognate receptor CXCR4.",
        "relation": "CPR:4"
    },
    {
        "id": "18847313.T1.T10",
        "sentence": "@CHEMICAL$ (AMD3100, Genzyme Corporation) is a bicyclam molecule that antagonizes the binding of the chemokine @GENE$ (SDF-1) to its cognate receptor CXCR4.",
        "relation": "CPR:4"
    },
    {
        "id": "18847313.T1.T11",
        "sentence": "@CHEMICAL$ (AMD3100, Genzyme Corporation) is a bicyclam molecule that antagonizes the binding of the chemokine stromal cell-derived factor-1 (@GENE$) to its cognate receptor CXCR4.",
        "relation": "CPR:4"
    },
    {
        "id": "18847313.T1.T12",
        "sentence": "@CHEMICAL$ (AMD3100, Genzyme Corporation) is a bicyclam molecule that antagonizes the binding of the chemokine stromal cell-derived factor-1 (SDF-1) to its cognate receptor @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "18847313.T2.T9",
        "sentence": "Plerixafor (@CHEMICAL$, Genzyme Corporation) is a bicyclam molecule that antagonizes the binding of the @GENE$ stromal cell-derived factor-1 (SDF-1) to its cognate receptor CXCR4.",
        "relation": "CPR:4"
    },
    {
        "id": "18847313.T2.T10",
        "sentence": "Plerixafor (@CHEMICAL$, Genzyme Corporation) is a bicyclam molecule that antagonizes the binding of the chemokine @GENE$ (SDF-1) to its cognate receptor CXCR4.",
        "relation": "CPR:4"
    },
    {
        "id": "18847313.T2.T11",
        "sentence": "Plerixafor (@CHEMICAL$, Genzyme Corporation) is a bicyclam molecule that antagonizes the binding of the chemokine stromal cell-derived factor-1 (@GENE$) to its cognate receptor CXCR4.",
        "relation": "CPR:4"
    },
    {
        "id": "18847313.T2.T12",
        "sentence": "Plerixafor (@CHEMICAL$, Genzyme Corporation) is a bicyclam molecule that antagonizes the binding of the chemokine stromal cell-derived factor-1 (SDF-1) to its cognate receptor @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "18847313.T3.T9",
        "sentence": "Plerixafor (AMD3100, Genzyme Corporation) is a @CHEMICAL$ molecule that antagonizes the binding of the @GENE$ stromal cell-derived factor-1 (SDF-1) to its cognate receptor CXCR4.",
        "relation": "CPR:4"
    },
    {
        "id": "18847313.T3.T10",
        "sentence": "Plerixafor (AMD3100, Genzyme Corporation) is a @CHEMICAL$ molecule that antagonizes the binding of the chemokine @GENE$ (SDF-1) to its cognate receptor CXCR4.",
        "relation": "CPR:4"
    },
    {
        "id": "18847313.T3.T11",
        "sentence": "Plerixafor (AMD3100, Genzyme Corporation) is a @CHEMICAL$ molecule that antagonizes the binding of the chemokine stromal cell-derived factor-1 (@GENE$) to its cognate receptor CXCR4.",
        "relation": "CPR:4"
    },
    {
        "id": "18847313.T3.T12",
        "sentence": "Plerixafor (AMD3100, Genzyme Corporation) is a @CHEMICAL$ molecule that antagonizes the binding of the chemokine stromal cell-derived factor-1 (SDF-1) to its cognate receptor @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23183186.T6.T39",
        "sentence": "This stimulation was attenuated by the @CHEMICAL$ inhibitor @GENE$ (IPA3) or dominant-negative Pak1.",
        "relation": "CPR:4"
    },
    {
        "id": "23183186.T7.T39",
        "sentence": "This stimulation was attenuated by the @CHEMICAL$ inhibitor 2,2'-dihydroxy-1,1'-dinaphthyldisulfide (@GENE$) or dominant-negative Pak1.",
        "relation": "CPR:4"
    },
    {
        "id": "17018843.T4.T40",
        "sentence": "Chronic insulin (24 h) activates NHE3 through the classic @CHEMICAL$-serum- and glucocorticoid-dependent kinase 1 (PI3K-SGK1) pathway as insulin stimulates SGK1 phosphorylation and the insulin effect can be blocked by the PI3K inhibitor @GENE$ or a dominant-negative SGK1.",
        "relation": "CPR:4"
    },
    {
        "id": "17018843.T4.T42",
        "sentence": "Chronic insulin (24 h) activates NHE3 through the classic phosphatidylinositol 3-kinase-serum- and glucocorticoid-dependent kinase 1 (@CHEMICAL$-SGK1) pathway as insulin stimulates SGK1 phosphorylation and the insulin effect can be blocked by the PI3K inhibitor @GENE$ or a dominant-negative SGK1.",
        "relation": "CPR:4"
    },
    {
        "id": "17018843.T4.T47",
        "sentence": "Chronic insulin (24 h) activates NHE3 through the classic phosphatidylinositol 3-kinase-serum- and glucocorticoid-dependent kinase 1 (PI3K-SGK1) pathway as insulin stimulates SGK1 phosphorylation and the insulin effect can be blocked by the @CHEMICAL$ inhibitor @GENE$ or a dominant-negative SGK1.",
        "relation": "CPR:4"
    },
    {
        "id": "17067304.T12.T28",
        "sentence": "Results showed that neonatal @CHEMICAL$ treatment induced @GENE$ priming that was eliminated by olanzapine treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "17067304.T13.T28",
        "sentence": "Results showed that neonatal quinpirole treatment induced @CHEMICAL$ priming that was eliminated by @GENE$ treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "17067304.T1.T18",
        "sentence": "Brain tissue analyses revealed that neonatal @CHEMICAL$ treatment produced a significant decrease in hippocampal @GENE$, BDNF and ChAT that was eliminated by olanzapine treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "17067304.T1.T19",
        "sentence": "Brain tissue analyses revealed that neonatal @CHEMICAL$ treatment produced a significant decrease in hippocampal NGF, @GENE$ and ChAT that was eliminated by olanzapine treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "17067304.T1.T20",
        "sentence": "Brain tissue analyses revealed that neonatal @CHEMICAL$ treatment produced a significant decrease in hippocampal NGF, BDNF and @GENE$ that was eliminated by olanzapine treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "17067304.T2.T18",
        "sentence": "Brain tissue analyses revealed that neonatal quinpirole treatment produced a significant decrease in hippocampal @CHEMICAL$, BDNF and ChAT that was eliminated by @GENE$ treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "17067304.T2.T19",
        "sentence": "Brain tissue analyses revealed that neonatal quinpirole treatment produced a significant decrease in hippocampal NGF, @CHEMICAL$ and ChAT that was eliminated by @GENE$ treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "17067304.T2.T20",
        "sentence": "Brain tissue analyses revealed that neonatal quinpirole treatment produced a significant decrease in hippocampal NGF, BDNF and @CHEMICAL$ that was eliminated by @GENE$ treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "17067304.T3.T21",
        "sentence": "Neonatal @CHEMICAL$ treatment produced a significant decrease in @GENE$ and ChAT in the frontal cortex that was unaffected by olanzapine treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "17067304.T3.T22",
        "sentence": "Neonatal @CHEMICAL$ treatment produced a significant decrease in BDNF and @GENE$ in the frontal cortex that was unaffected by olanzapine treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "17067304.T5.T23",
        "sentence": "These results show that @CHEMICAL$ eliminates @GENE$ priming and cognitive impairment and also alleviates decreases in neurotrophins and acetylcholinergic markers produced by D2 priming in the hippocampus.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T9.T45",
        "sentence": "Suppression of Src/@CHEMICAL$ and GSK-3/b-catenin signaling by @GENE$ inhibits the growth of human colorectal cancer cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T9.T46",
        "sentence": "Suppression of Src/ERK and @CHEMICAL$/b-catenin signaling by @GENE$ inhibits the growth of human colorectal cancer cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T9.T44",
        "sentence": "Suppression of @CHEMICAL$/ERK and GSK-3/b-catenin signaling by @GENE$ inhibits the growth of human colorectal cancer cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T9.T47",
        "sentence": "Suppression of Src/ERK and GSK-3/@CHEMICAL$ signaling by @GENE$ inhibits the growth of human colorectal cancer cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T5.T21",
        "sentence": "@CHEMICAL$ inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of @GENE$, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/CIP1) and p53.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T5.T22",
        "sentence": "@CHEMICAL$ inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, @GENE$, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/CIP1) and p53.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T5.T23",
        "sentence": "@CHEMICAL$ inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, @GENE$, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/CIP1) and p53.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T5.T24",
        "sentence": "@CHEMICAL$ inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, @GENE$ (CDK2), CDK4, c-Myc, and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/CIP1) and p53.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T5.T25",
        "sentence": "@CHEMICAL$ inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (@GENE$), CDK4, c-Myc, and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/CIP1) and p53.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T5.T26",
        "sentence": "@CHEMICAL$ inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), @GENE$, c-Myc, and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/CIP1) and p53.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T5.T27",
        "sentence": "@CHEMICAL$ inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, @GENE$, and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/CIP1) and p53.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T5.T28",
        "sentence": "@CHEMICAL$ inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and @GENE$ (pRb), and the upregulation of p21(WAF1/CIP1) and p53.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T5.T29",
        "sentence": "@CHEMICAL$ inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and retinoblastoma protein (@GENE$), and the upregulation of p21(WAF1/CIP1) and p53.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T5.T30",
        "sentence": "@CHEMICAL$ inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and retinoblastoma protein (pRb), and the upregulation of @GENE$(WAF1/CIP1) and p53.",
        "relation": "CPR:3"
    },
    {
        "id": "23333577.T5.T31",
        "sentence": "@CHEMICAL$ inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and retinoblastoma protein (pRb), and the upregulation of p21(@GENE$/CIP1) and p53.",
        "relation": "CPR:3"
    },
    {
        "id": "23333577.T5.T32",
        "sentence": "@CHEMICAL$ inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/@GENE$) and p53.",
        "relation": "CPR:3"
    },
    {
        "id": "23333577.T5.T33",
        "sentence": "@CHEMICAL$ inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/CIP1) and @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23333577.T6.T37",
        "sentence": "@CHEMICAL$ was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/@GENE$ (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3b (GSK-3b) signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T6.T38",
        "sentence": "@CHEMICAL$ was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (@GENE$) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3b (GSK-3b) signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T6.T39",
        "sentence": "@CHEMICAL$ was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and @GENE$ (PI3K)/Akt/ glycogen synthase kinase 3b (GSK-3b) signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T6.T40",
        "sentence": "@CHEMICAL$ was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (@GENE$)/Akt/ glycogen synthase kinase 3b (GSK-3b) signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T6.T41",
        "sentence": "@CHEMICAL$ was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/@GENE$/ glycogen synthase kinase 3b (GSK-3b) signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T6.T34",
        "sentence": "@CHEMICAL$ was also found to attenuate the activation of proteins involved in f@GENE$ (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3b (GSK-3b) signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T6.T35",
        "sentence": "@CHEMICAL$ was also found to attenuate the activation of proteins involved in focal adhesion kinase (@GENE$)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3b (GSK-3b) signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T6.T36",
        "sentence": "@CHEMICAL$ was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/@GENE$/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3b (GSK-3b) signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T6.T42",
        "sentence": "@CHEMICAL$ was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ @GENE$ (GSK-3b) signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T6.T43",
        "sentence": "@CHEMICAL$ was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3b (@GENE$) signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T8.T11",
        "sentence": "Subsequently, @CHEMICAL$ suppressed the nuclear translocation of b-catenin, one of downstream molecules of @GENE$/Akt/GSK-3b signaling, and these events led to the sequential downregulation of b-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T8.T12",
        "sentence": "Subsequently, @CHEMICAL$ suppressed the nuclear translocation of b-catenin, one of downstream molecules of PI3K/@GENE$/GSK-3b signaling, and these events led to the sequential downregulation of b-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T8.T10",
        "sentence": "Subsequently, @CHEMICAL$ suppressed the nuclear translocation of @GENE$, one of downstream molecules of PI3K/Akt/GSK-3b signaling, and these events led to the sequential downregulation of b-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T8.T13",
        "sentence": "Subsequently, @CHEMICAL$ suppressed the nuclear translocation of b-catenin, one of downstream molecules of PI3K/Akt/@GENE$ signaling, and these events led to the sequential downregulation of b-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T8.T14",
        "sentence": "Subsequently, @CHEMICAL$ suppressed the nuclear translocation of b-catenin, one of downstream molecules of PI3K/Akt/GSK-3b signaling, and these events led to the sequential downregulation of @GENE$-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T8.T15",
        "sentence": "Subsequently, @CHEMICAL$ suppressed the nuclear translocation of b-catenin, one of downstream molecules of PI3K/Akt/GSK-3b signaling, and these events led to the sequential downregulation of b-catenin-mediated transcription of target genes including @GENE$, ID2, survivin, cyclin D1, MMP7, and c-Myc.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T8.T16",
        "sentence": "Subsequently, @CHEMICAL$ suppressed the nuclear translocation of b-catenin, one of downstream molecules of PI3K/Akt/GSK-3b signaling, and these events led to the sequential downregulation of b-catenin-mediated transcription of target genes including BMP4, @GENE$, survivin, cyclin D1, MMP7, and c-Myc.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T8.T17",
        "sentence": "Subsequently, @CHEMICAL$ suppressed the nuclear translocation of b-catenin, one of downstream molecules of PI3K/Akt/GSK-3b signaling, and these events led to the sequential downregulation of b-catenin-mediated transcription of target genes including BMP4, ID2, @GENE$, cyclin D1, MMP7, and c-Myc.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T8.T18",
        "sentence": "Subsequently, @CHEMICAL$ suppressed the nuclear translocation of b-catenin, one of downstream molecules of PI3K/Akt/GSK-3b signaling, and these events led to the sequential downregulation of b-catenin-mediated transcription of target genes including BMP4, ID2, survivin, @GENE$, MMP7, and c-Myc.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T8.T19",
        "sentence": "Subsequently, @CHEMICAL$ suppressed the nuclear translocation of b-catenin, one of downstream molecules of PI3K/Akt/GSK-3b signaling, and these events led to the sequential downregulation of b-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, @GENE$, and c-Myc.",
        "relation": "CPR:4"
    },
    {
        "id": "23333577.T8.T20",
        "sentence": "Subsequently, @CHEMICAL$ suppressed the nuclear translocation of b-catenin, one of downstream molecules of PI3K/Akt/GSK-3b signaling, and these events led to the sequential downregulation of b-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23265543.T7.T21",
        "sentence": "Overall, higher alcohol production was reduced by @CHEMICAL$ supplementation, and this can be correlated with a general downregulation of genes encoding @GENE$ and dehydrogenases of the Ehrlich pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23265543.T7.T22",
        "sentence": "Overall, higher alcohol production was reduced by @CHEMICAL$ supplementation, and this can be correlated with a general downregulation of genes encoding decarboxylases and @GENE$ of the Ehrlich pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23534442.T16.T23",
        "sentence": "Novel analgesic/anti-inflammatory agents: 1,5-diarylpyrrole nitrooxyalkyl ethers and related compounds as @CHEMICAL$ inhibiting @GENE$ donors.",
        "relation": "CPR:4"
    },
    {
        "id": "23534442.T17.T23",
        "sentence": "Novel analgesic/anti-inflammatory agents: @CHEMICAL$ and related compounds as @GENE$ inhibiting nitric oxide donors.",
        "relation": "CPR:4"
    },
    {
        "id": "23534442.T3.T19",
        "sentence": "New classes of @CHEMICAL$-derived nitrooxyalkyl inverse esters, carbonates, and ethers (7-10) as @GENE$ selective inhibitors and NO donors were synthesized and are herein reported.",
        "relation": "CPR:4"
    },
    {
        "id": "23534442.T4.T19",
        "sentence": "New classes of pyrrole-derived @CHEMICAL$ inverse esters, carbonates, and ethers (7-10) as @GENE$ selective inhibitors and NO donors were synthesized and are herein reported.",
        "relation": "CPR:4"
    },
    {
        "id": "23534442.T5.T19",
        "sentence": "New classes of pyrrole-derived nitrooxyalkyl inverse @CHEMICAL$, carbonates, and ethers (7-10) as @GENE$ selective inhibitors and NO donors were synthesized and are herein reported.",
        "relation": "CPR:4"
    },
    {
        "id": "23534442.T6.T19",
        "sentence": "New classes of pyrrole-derived nitrooxyalkyl inverse esters, @CHEMICAL$, and ethers (7-10) as @GENE$ selective inhibitors and NO donors were synthesized and are herein reported.",
        "relation": "CPR:4"
    },
    {
        "id": "23534442.T7.T19",
        "sentence": "New classes of pyrrole-derived nitrooxyalkyl inverse esters, carbonates, and @CHEMICAL$ (7-10) as @GENE$ selective inhibitors and NO donors were synthesized and are herein reported.",
        "relation": "CPR:4"
    },
    {
        "id": "23534442.T11.T20",
        "sentence": "@CHEMICAL$ derivatives showed NO-dependent vasorelaxing properties, while most of the compounds proved to be very potent and selective @GENE$ inhibitors in in vitro experimental models.",
        "relation": "CPR:4"
    },
    {
        "id": "12184062.T13.T27",
        "sentence": "The clinical profile of the @CHEMICAL$ blocker @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12184062.T2.T15",
        "sentence": "In clinical trials @CHEMICAL$ has proven to be at least as effective as the @GENE$ inhibitor enalapril in reducing BP, but with a significantly lower incidence of side effects.",
        "relation": "CPR:4"
    },
    {
        "id": "22815248.T22.T32",
        "sentence": "A significant decrease of aspartate aminotransferase, @CHEMICAL$, lactate dehydrogenase (LDH) activities and glutathione (GSH) levels and an increase of malondialdehyde (MDA) quantity was observed after @GENE$ and PC administration alone.",
        "relation": "CPR:4"
    },
    {
        "id": "22815248.T22.T33",
        "sentence": "A significant decrease of aspartate aminotransferase, alanine aminotransferase, @CHEMICAL$ (LDH) activities and glutathione (GSH) levels and an increase of malondialdehyde (MDA) quantity was observed after @GENE$ and PC administration alone.",
        "relation": "CPR:4"
    },
    {
        "id": "22815248.T22.T34",
        "sentence": "A significant decrease of aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase (@CHEMICAL$) activities and glutathione (GSH) levels and an increase of malondialdehyde (MDA) quantity was observed after @GENE$ and PC administration alone.",
        "relation": "CPR:4"
    },
    {
        "id": "22815248.T22.T31",
        "sentence": "A significant decrease of @CHEMICAL$, alanine aminotransferase, lactate dehydrogenase (LDH) activities and glutathione (GSH) levels and an increase of malondialdehyde (MDA) quantity was observed after @GENE$ and PC administration alone.",
        "relation": "CPR:4"
    },
    {
        "id": "22815248.T4.T28",
        "sentence": "In the CCl4 hepatotoxicity model, pre-treatment with PSM or silymarin resulted in significantly increased activities of @CHEMICAL$ and aniline 4-hydroxylase activity and cytochrome P450, compared to the @GENE$ only group.",
        "relation": "CPR:3"
    },
    {
        "id": "22815248.T4.T29",
        "sentence": "In the CCl4 hepatotoxicity model, pre-treatment with PSM or silymarin resulted in significantly increased activities of ethylmorphine-N-demethylase and @CHEMICAL$ activity and cytochrome P450, compared to the @GENE$ only group.",
        "relation": "CPR:3"
    },
    {
        "id": "22815248.T4.T30",
        "sentence": "In the CCl4 hepatotoxicity model, pre-treatment with PSM or silymarin resulted in significantly increased activities of ethylmorphine-N-demethylase and aniline 4-hydroxylase activity and @CHEMICAL$, compared to the @GENE$ only group.",
        "relation": "CPR:3"
    },
    {
        "id": "22815248.T26.T28",
        "sentence": "In the CCl4 hepatotoxicity model, pre-treatment with PSM or @CHEMICAL$ resulted in significantly increased activities of @GENE$ and aniline 4-hydroxylase activity and cytochrome P450, compared to the CCl4 only group.",
        "relation": "CPR:3"
    },
    {
        "id": "22815248.T26.T29",
        "sentence": "In the CCl4 hepatotoxicity model, pre-treatment with PSM or @CHEMICAL$ resulted in significantly increased activities of ethylmorphine-N-demethylase and @GENE$ activity and cytochrome P450, compared to the CCl4 only group.",
        "relation": "CPR:3"
    },
    {
        "id": "22815248.T26.T30",
        "sentence": "In the CCl4 hepatotoxicity model, pre-treatment with PSM or @CHEMICAL$ resulted in significantly increased activities of ethylmorphine-N-demethylase and aniline 4-hydroxylase activity and @GENE$, compared to the CCl4 only group.",
        "relation": "CPR:3"
    },
    {
        "id": "15114505.T23.T28",
        "sentence": "In vitro inhibition of @CHEMICAL$ by @GENE$ from Sophora flavescens.",
        "relation": "CPR:4"
    },
    {
        "id": "15114505.T1.T24",
        "sentence": "Four prenylflavonoids, kurarinone ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and @CHEMICAL$ ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on @GENE$ (DGAT).",
        "relation": "CPR:4"
    },
    {
        "id": "15114505.T1.T25",
        "sentence": "Four prenylflavonoids, kurarinone ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and @CHEMICAL$ ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "15114505.T3.T24",
        "sentence": "Four prenylflavonoids, @CHEMICAL$ ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on @GENE$ (DGAT).",
        "relation": "CPR:4"
    },
    {
        "id": "15114505.T3.T25",
        "sentence": "Four prenylflavonoids, @CHEMICAL$ ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "15114505.T5.T24",
        "sentence": "Four prenylflavonoids, kurarinone ( 1), a @CHEMICAL$ of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on @GENE$ (DGAT).",
        "relation": "CPR:4"
    },
    {
        "id": "15114505.T5.T25",
        "sentence": "Four prenylflavonoids, kurarinone ( 1), a @CHEMICAL$ of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "15114505.T8.T24",
        "sentence": "Four @CHEMICAL$, kurarinone ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on @GENE$ (DGAT).",
        "relation": "CPR:4"
    },
    {
        "id": "15114505.T8.T25",
        "sentence": "Four @CHEMICAL$, kurarinone ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "15114505.T11.T24",
        "sentence": "Four prenylflavonoids, kurarinone ( 1), a chalcone of 1, @CHEMICAL$ ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on @GENE$ (DGAT).",
        "relation": "CPR:4"
    },
    {
        "id": "15114505.T11.T25",
        "sentence": "Four prenylflavonoids, kurarinone ( 1), a chalcone of 1, @CHEMICAL$ ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "15114505.T16.T24",
        "sentence": "Four prenylflavonoids, kurarinone ( 1), a chalcone of 1, kuraridin ( 2), @CHEMICAL$ ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on @GENE$ (DGAT).",
        "relation": "CPR:4"
    },
    {
        "id": "15114505.T16.T25",
        "sentence": "Four prenylflavonoids, kurarinone ( 1), a chalcone of 1, kuraridin ( 2), @CHEMICAL$ ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "15114505.T19.T24",
        "sentence": "Four prenylflavonoids, kurarinone ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), @CHEMICAL$ ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on @GENE$ (DGAT).",
        "relation": "CPR:4"
    },
    {
        "id": "15114505.T19.T25",
        "sentence": "Four prenylflavonoids, kurarinone ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), @CHEMICAL$ ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "15114505.T4.T26",
        "sentence": "The @CHEMICAL$ inhibited @GENE$ activity in a dose-dependent manner with IC50 values of 10.9 microM ( 1), 9.8 microM ( 2), 8.6 microM ( 3), 142.0 microM ( 4) and 250 microM ( 5).",
        "relation": "CPR:4"
    },
    {
        "id": "15114505.T17.T27",
        "sentence": "These data suggest that the @CHEMICAL$ side chain and the position of the hydroxy group are important for high @GENE$ inhibitory activity.",
        "relation": "CPR:4"
    },
    {
        "id": "15114505.T18.T27",
        "sentence": "These data suggest that the lavandulyl side chain and the position of the @CHEMICAL$ group are important for high @GENE$ inhibitory activity.",
        "relation": "CPR:4"
    },
    {
        "id": "17494951.T1.T14",
        "sentence": "Dexamethasone (DXM) decreased the expression of CXCL-8, VEGF, and iNOS induced by reIL-4, while @CHEMICAL$ (1400W), a selective inhibitor of @GENE$, decreased the expression of E-selectin, VEGF, and iNOS.",
        "relation": "CPR:4"
    },
    {
        "id": "17494951.T1.T15",
        "sentence": "Dexamethasone (DXM) decreased the expression of CXCL-8, VEGF, and iNOS induced by reIL-4, while @CHEMICAL$ (1400W), a selective inhibitor of iNOS, decreased the expression of @GENE$, VEGF, and iNOS.",
        "relation": "CPR:4"
    },
    {
        "id": "17494951.T1.T16",
        "sentence": "Dexamethasone (DXM) decreased the expression of CXCL-8, VEGF, and iNOS induced by reIL-4, while @CHEMICAL$ (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, @GENE$, and iNOS.",
        "relation": "CPR:4"
    },
    {
        "id": "17494951.T1.T17",
        "sentence": "Dexamethasone (DXM) decreased the expression of CXCL-8, VEGF, and iNOS induced by reIL-4, while @CHEMICAL$ (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17494951.T2.T14",
        "sentence": "Dexamethasone (DXM) decreased the expression of CXCL-8, VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (@CHEMICAL$), a selective inhibitor of @GENE$, decreased the expression of E-selectin, VEGF, and iNOS.",
        "relation": "CPR:4"
    },
    {
        "id": "17494951.T2.T15",
        "sentence": "Dexamethasone (DXM) decreased the expression of CXCL-8, VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (@CHEMICAL$), a selective inhibitor of iNOS, decreased the expression of @GENE$, VEGF, and iNOS.",
        "relation": "CPR:4"
    },
    {
        "id": "17494951.T2.T16",
        "sentence": "Dexamethasone (DXM) decreased the expression of CXCL-8, VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (@CHEMICAL$), a selective inhibitor of iNOS, decreased the expression of E-selectin, @GENE$, and iNOS.",
        "relation": "CPR:4"
    },
    {
        "id": "17494951.T2.T17",
        "sentence": "Dexamethasone (DXM) decreased the expression of CXCL-8, VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (@CHEMICAL$), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17494951.T7.T10",
        "sentence": "@CHEMICAL$ (DXM) decreased the expression of @GENE$, VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and iNOS.",
        "relation": "CPR:4"
    },
    {
        "id": "17494951.T7.T11",
        "sentence": "@CHEMICAL$ (DXM) decreased the expression of CXCL-8, @GENE$, and iNOS induced by reIL-4, while 1400W dihydrochloride (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and iNOS.",
        "relation": "CPR:4"
    },
    {
        "id": "17494951.T7.T12",
        "sentence": "@CHEMICAL$ (DXM) decreased the expression of CXCL-8, VEGF, and @GENE$ induced by reIL-4, while 1400W dihydrochloride (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and iNOS.",
        "relation": "CPR:4"
    },
    {
        "id": "17494951.T8.T10",
        "sentence": "Dexamethasone (@CHEMICAL$) decreased the expression of @GENE$, VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and iNOS.",
        "relation": "CPR:4"
    },
    {
        "id": "17494951.T8.T11",
        "sentence": "Dexamethasone (@CHEMICAL$) decreased the expression of CXCL-8, @GENE$, and iNOS induced by reIL-4, while 1400W dihydrochloride (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and iNOS.",
        "relation": "CPR:4"
    },
    {
        "id": "17494951.T8.T12",
        "sentence": "Dexamethasone (@CHEMICAL$) decreased the expression of CXCL-8, VEGF, and @GENE$ induced by reIL-4, while 1400W dihydrochloride (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and iNOS.",
        "relation": "CPR:4"
    },
    {
        "id": "17494951.T3.T18",
        "sentence": "@CHEMICAL$ and 1400W attenuated the mRNA expression of @GENE$ and iNOS induced by the costimulation of reIL-4, reTNF-alpha, and LPS.",
        "relation": "CPR:4"
    },
    {
        "id": "17494951.T3.T19",
        "sentence": "@CHEMICAL$ and 1400W attenuated the mRNA expression of E-selectin and @GENE$ induced by the costimulation of reIL-4, reTNF-alpha, and LPS.",
        "relation": "CPR:4"
    },
    {
        "id": "17494951.T4.T18",
        "sentence": "DXM and @CHEMICAL$ attenuated the mRNA expression of @GENE$ and iNOS induced by the costimulation of reIL-4, reTNF-alpha, and LPS.",
        "relation": "CPR:4"
    },
    {
        "id": "17494951.T4.T19",
        "sentence": "DXM and @CHEMICAL$ attenuated the mRNA expression of E-selectin and @GENE$ induced by the costimulation of reIL-4, reTNF-alpha, and LPS.",
        "relation": "CPR:4"
    },
    {
        "id": "17000933.T1.T30",
        "sentence": "The beneficial role of @CHEMICAL$ on blood pressure, cardiac hypertrophy, vascular @GENE$ expression, perivascular fibrosis, and impaired NO-dependent relaxation of isolated aortic rings was completely abrogated by coadministration of medroxyprogesterone acetate.",
        "relation": "CPR:3"
    },
    {
        "id": "17000933.T4.T30",
        "sentence": "The beneficial role of 17beta-estradiol on blood pressure, cardiac hypertrophy, vascular @CHEMICAL$ expression, perivascular fibrosis, and impaired NO-dependent relaxation of isolated aortic rings was completely abrogated by coadministration of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23007555.T5.T19",
        "sentence": "At a low pH (pH 7.4), but not pH 7.9, @CHEMICAL$ reduces the mean open time of @GENE$/GluN2B receptors, which may be responsible for its usefulness as a context-dependent inhibitor in conditions like ischemia and stroke, when the pH of the extracellular milieu becomes acidic.",
        "relation": "CPR:4"
    },
    {
        "id": "23007555.T5.T20",
        "sentence": "At a low pH (pH 7.4), but not pH 7.9, @CHEMICAL$ reduces the mean open time of GluN1/@GENE$ receptors, which may be responsible for its usefulness as a context-dependent inhibitor in conditions like ischemia and stroke, when the pH of the extracellular milieu becomes acidic.",
        "relation": "CPR:4"
    },
    {
        "id": "23557706.T2.T14",
        "sentence": "Pharmacological doses of the @CHEMICAL$ inhibitor @GENE$ reduce albuminura in diabetes.",
        "relation": "CPR:4"
    },
    {
        "id": "23557706.T3.T16",
        "sentence": "High @CHEMICAL$ (HG) induces apoptosis of podocytes, inhibits @GENE$ activation, inactivates tuberin and activates mTOR.",
        "relation": "CPR:4"
    },
    {
        "id": "23557706.T3.T17",
        "sentence": "High @CHEMICAL$ (HG) induces apoptosis of podocytes, inhibits AMPK activation, inactivates @GENE$ and activates mTOR.",
        "relation": "CPR:4"
    },
    {
        "id": "23557706.T3.T18",
        "sentence": "High @CHEMICAL$ (HG) induces apoptosis of podocytes, inhibits AMPK activation, inactivates tuberin and activates @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23557706.T5.T25",
        "sentence": "Inhibition of mTOR by low dose @CHEMICAL$ decreases HG-induced Nox4 and Nox1, @GENE$ activity and podocyte apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23557706.T5.T22",
        "sentence": "Inhibition of @CHEMICAL$ by low dose @GENE$ decreases HG-induced Nox4 and Nox1, NADPH oxidase activity and podocyte apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23557706.T5.T23",
        "sentence": "Inhibition of mTOR by low dose @CHEMICAL$ decreases HG-induced @GENE$ and Nox1, NADPH oxidase activity and podocyte apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23557706.T5.T24",
        "sentence": "Inhibition of mTOR by low dose @CHEMICAL$ decreases HG-induced Nox4 and @GENE$, NADPH oxidase activity and podocyte apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23557706.T8.T36",
        "sentence": "Inhibition of @CHEMICAL$ by small dose of @GENE$ reduces podocyte apoptosis, attenuates glomerular injury and albuminuria.",
        "relation": "CPR:4"
    },
    {
        "id": "16432501.T18.T24",
        "sentence": "Systemic administration of @CHEMICAL$ agonists, @GENE$ and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses. beta(2)-Adrenoceptor agonists provide a potential therapy for muscle wasting and weakness, but their use may be limited by adverse effects on the heart, mediated in part, by beta(1)-adrenoceptor activation.",
        "relation": "CPR:5"
    },
    {
        "id": "16432501.T19.T24",
        "sentence": "Systemic administration of @CHEMICAL$ agonists, formoterol and @GENE$, elicit skeletal muscle hypertrophy in rats at micromolar doses. beta(2)-Adrenoceptor agonists provide a potential therapy for muscle wasting and weakness, but their use may be limited by adverse effects on the heart, mediated in part, by beta(1)-adrenoceptor activation.",
        "relation": "CPR:5"
    },
    {
        "id": "16432501.T10.T23",
        "sentence": "Two beta(2)-agonists, @CHEMICAL$ and salmeterol, are approved for treating asthma and have an extended duration of action and increased safety, associated with greater @GENE$ selectivity.",
        "relation": "CPR:5"
    },
    {
        "id": "16432501.T11.T23",
        "sentence": "Two beta(2)-agonists, formoterol and @CHEMICAL$, are approved for treating asthma and have an extended duration of action and increased safety, associated with greater @GENE$ selectivity.",
        "relation": "CPR:5"
    },
    {
        "id": "16432501.T5.T21",
        "sentence": "A dose of 25 microg kg(-1) day(-1) of @CHEMICAL$ elicited greater EDL and soleus hypertrophy than salmeterol, but resulted in similar @GENE$ downregulation.",
        "relation": "CPR:4"
    },
    {
        "id": "16432501.T6.T21",
        "sentence": "A dose of 25 microg kg(-1) day(-1) of formoterol elicited greater EDL and soleus hypertrophy than @CHEMICAL$, but resulted in similar @GENE$ downregulation.",
        "relation": "CPR:4"
    },
    {
        "id": "19275550.T7.T12",
        "sentence": "Clinical utility of @CHEMICAL$, an @GENE$ inhibitor in cardiometabolic disorders.",
        "relation": "CPR:4"
    },
    {
        "id": "19275550.T3.T10",
        "sentence": "@CHEMICAL$, an @GENE$ inhibitor, delays the absorption of carbohydrate from the small intestine, thereby reducing postprandial hyperglycemia.",
        "relation": "CPR:4"
    },
    {
        "id": "23402841.T1.T17",
        "sentence": "The values of mean corpuscular hemoglobin concentration and mean corpuscular @CHEMICAL$ increased in the @GENE$ group.",
        "relation": "CPR:3"
    },
    {
        "id": "23402841.T1.T29",
        "sentence": "The values of mean corpuscular @CHEMICAL$ concentration and mean corpuscular hemoglobin increased in the @GENE$ group.",
        "relation": "CPR:3"
    },
    {
        "id": "23160530.T8.T25",
        "sentence": "First, we showed that intracerebroventricular administration of @CHEMICAL$ in rats increases @GENE$ expression in hypothalamic glial-like tanycytes.",
        "relation": "CPR:3"
    },
    {
        "id": "10411647.T15.T26",
        "sentence": "On phosphorylation of @CHEMICAL$ by @GENE$, the affinity for H4biopterin increased ([S]0.5 = 11 +/- 2 microM) and the negative cooperativity was amplified (h = 0.27 +/- 0.03).",
        "relation": "CPR:9"
    },
    {
        "id": "12167567.T20.T22",
        "sentence": "Disposition of a specific @CHEMICAL$ inhibitor, @GENE$, in human.",
        "relation": "CPR:4"
    },
    {
        "id": "12167567.T1.T21",
        "sentence": "@CHEMICAL$ is a potent and specific inhibitor of @GENE$, which is used for the treatment of rheumatoid arthritis, osteoarthritis, and the dysmenorrhea pain.",
        "relation": "CPR:4"
    },
    {
        "id": "22619007.T5.T11",
        "sentence": "In mechanistic studies, @CHEMICAL$ decreased the protein level of @GENE$, which might be the possible molecular mechanism of Silibinin efficacy on the growth inhibition in SGC-7901 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "22619007.T7.T12",
        "sentence": "In addition, @CHEMICAL$ caused an increase in @GENE$ and p21 protein level as well as mRNA levels.",
        "relation": "CPR:3"
    },
    {
        "id": "22619007.T7.T13",
        "sentence": "In addition, @CHEMICAL$ caused an increase in p53 and @GENE$ protein level as well as mRNA levels.",
        "relation": "CPR:3"
    },
    {
        "id": "17553661.T1.T35",
        "sentence": "Transfection of HepG2 cells with hGSTA4 provides protection against 4-hydroxynonenal-mediated oxidative injury. @CHEMICAL$ (4-HNE) is a mutagenic alpha,beta-unsaturated aldehyde produced during oxidative injury that is conjugated by several @GENE$ (GST) isoforms.",
        "relation": "CPR:9"
    },
    {
        "id": "17553661.T1.T38",
        "sentence": "Transfection of HepG2 cells with hGSTA4 provides protection against 4-hydroxynonenal-mediated oxidative injury. @CHEMICAL$ (4-HNE) is a mutagenic alpha,beta-unsaturated aldehyde produced during oxidative injury that is conjugated by several glutathione S-transferase (@GENE$) isoforms.",
        "relation": "CPR:9"
    },
    {
        "id": "17553661.T17.T35",
        "sentence": "Transfection of HepG2 cells with hGSTA4 provides protection against 4-hydroxynonenal-mediated oxidative injury. 4-Hydroxynonenal (@CHEMICAL$) is a mutagenic alpha,beta-unsaturated aldehyde produced during oxidative injury that is conjugated by several @GENE$ (GST) isoforms.",
        "relation": "CPR:9"
    },
    {
        "id": "17553661.T17.T38",
        "sentence": "Transfection of HepG2 cells with hGSTA4 provides protection against 4-hydroxynonenal-mediated oxidative injury. 4-Hydroxynonenal (@CHEMICAL$) is a mutagenic alpha,beta-unsaturated aldehyde produced during oxidative injury that is conjugated by several glutathione S-transferase (@GENE$) isoforms.",
        "relation": "CPR:9"
    },
    {
        "id": "17553661.T24.T35",
        "sentence": "Transfection of HepG2 cells with hGSTA4 provides protection against 4-hydroxynonenal-mediated oxidative injury. 4-Hydroxynonenal (4-HNE) is a mutagenic @CHEMICAL$ produced during oxidative injury that is conjugated by several @GENE$ (GST) isoforms.",
        "relation": "CPR:9"
    },
    {
        "id": "17553661.T24.T38",
        "sentence": "Transfection of HepG2 cells with hGSTA4 provides protection against 4-hydroxynonenal-mediated oxidative injury. 4-Hydroxynonenal (4-HNE) is a mutagenic @CHEMICAL$ produced during oxidative injury that is conjugated by several glutathione S-transferase (@GENE$) isoforms.",
        "relation": "CPR:9"
    },
    {
        "id": "17553661.T22.T42",
        "sentence": "The alpha class @CHEMICAL$ enzyme (hGSTA4-4) has a particularly high catalytic efficiency toward @GENE$ conjugation.",
        "relation": "CPR:9"
    },
    {
        "id": "17553661.T22.T43",
        "sentence": "The alpha class human GSTA4-4 enzyme (@CHEMICAL$) has a particularly high catalytic efficiency toward @GENE$ conjugation.",
        "relation": "CPR:9"
    },
    {
        "id": "17553661.T27.T48",
        "sentence": "HepG2 cells transfected with an hGSTA4 vector construct exhibited high steady-state hGSTA4 mRNA, high @CHEM-GENE$ catalytic activities, but lower basal glutathione (GSH) concentrations relative to insert-free vector (control) cells.",
        "relation": "CPR:9"
    },
    {
        "id": "17553661.T3.T50",
        "sentence": "Specifically, @CHEMICAL$ cells had significantly higher GSH concentrations when exposed to 5-15 microM @GENE$, but not at 20 microM 4-HNE, suggesting extensive GSH utilization at high concentrations of 4-HNE.",
        "relation": "CPR:9"
    },
    {
        "id": "17553661.T4.T50",
        "sentence": "Specifically, @CHEMICAL$ cells had significantly higher GSH concentrations when exposed to 5-15 microM 4-HNE, but not at 20 microM @GENE$, suggesting extensive GSH utilization at high concentrations of 4-HNE.",
        "relation": "CPR:9"
    },
    {
        "id": "17553661.T15.T40",
        "sentence": "In summary, our data indicates that over-expression of hGSTA4 at levels conferring high @CHEMICAL$-@GENE$ conjugating activity confers a partial growth advantage to HepG2 cells and protects against 4-HNE oxidative injury.",
        "relation": "CPR:9"
    },
    {
        "id": "17553661.T18.T41",
        "sentence": "However, the loss of proliferative capacity of @CHEMICAL$ cells challenged with levels of @GENE$ associated with severe oxidative stress indicates a role of other aldehyde metabolizing enzymes, and/or GSH-electrophile transporter proteins, in providing full cellular protection against 4-HNE toxicity.",
        "relation": "CPR:9"
    },
    {
        "id": "12582227.T11.T23",
        "sentence": "OBJECTIVE: Preclinical evaluation of @CHEMICAL$, a peroxisome proliferator-activated receptor alpha (PPARalpha) and @GENE$ agonist, as a body-weight lowering, hypolipidemic and euglycemic agent.",
        "relation": "CPR:5"
    },
    {
        "id": "12582227.T11.T31",
        "sentence": "OBJECTIVE: Preclinical evaluation of @CHEMICAL$, a @GENE$ (PPARalpha) and PPARgamma agonist, as a body-weight lowering, hypolipidemic and euglycemic agent.",
        "relation": "CPR:5"
    },
    {
        "id": "12582227.T11.T34",
        "sentence": "OBJECTIVE: Preclinical evaluation of @CHEMICAL$, a peroxisome proliferator-activated receptor alpha (@GENE$) and PPARgamma agonist, as a body-weight lowering, hypolipidemic and euglycemic agent.",
        "relation": "CPR:5"
    },
    {
        "id": "12582227.T19.T32",
        "sentence": "RESULTS: @CHEMICAL$ showed concentration-dependent transactivation of @GENE$ and PPARgamma.",
        "relation": "CPR:5"
    },
    {
        "id": "12582227.T19.T33",
        "sentence": "RESULTS: @CHEMICAL$ showed concentration-dependent transactivation of PPARalpha and @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "12582227.T3.T26",
        "sentence": "DRF 2655 showed body-weight lowering and euglycemic and hypolipidemic effects in various animal models. db/db mice treated with @CHEMICAL$ showed 5- and 3.6-fold inhibition in phosphoenolpyruvate carboxykinase and glucose 6-phosphatase activity and 651% and 77% increases in the beta-oxidation enzymes @GENE$ and carnitine acetyltransferase, respectively.",
        "relation": "CPR:3"
    },
    {
        "id": "12582227.T3.T24",
        "sentence": "DRF 2655 showed body-weight lowering and euglycemic and hypolipidemic effects in various animal models. db/db mice treated with @CHEMICAL$ showed 5- and 3.6-fold inhibition in @GENE$ and glucose 6-phosphatase activity and 651% and 77% increases in the beta-oxidation enzymes carnitine palmitoyltransferase and carnitine acetyltransferase, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "12582227.T3.T25",
        "sentence": "DRF 2655 showed body-weight lowering and euglycemic and hypolipidemic effects in various animal models. db/db mice treated with @CHEMICAL$ showed 5- and 3.6-fold inhibition in phosphoenolpyruvate carboxykinase and @GENE$ activity and 651% and 77% increases in the beta-oxidation enzymes carnitine palmitoyltransferase and carnitine acetyltransferase, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "12582227.T3.T27",
        "sentence": "DRF 2655 showed body-weight lowering and euglycemic and hypolipidemic effects in various animal models. db/db mice treated with @CHEMICAL$ showed 5- and 3.6-fold inhibition in phosphoenolpyruvate carboxykinase and glucose 6-phosphatase activity and 651% and 77% increases in the beta-oxidation enzymes carnitine palmitoyltransferase and @GENE$, respectively.",
        "relation": "CPR:3"
    },
    {
        "id": "7832763.T1.T18",
        "sentence": "The enzyme @CHEMICAL$ catalyses the oxygenation of arachidonic acid, leading to the formation of @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "7832763.T5.T18",
        "sentence": "The enzyme @CHEMICAL$ catalyses the oxygenation of @GENE$, leading to the formation of prostaglandins.",
        "relation": "CPR:9"
    },
    {
        "id": "7832763.T6.T26",
        "sentence": "Constitutive and inducible forms of human cyclo-oxygenase (hCOX-1 and hCOX-2) were cloned and expressed in insect cells, utilizing a baculovirus expression system. @CHEMICAL$ had a specific activity of 18.8 mumol of O2/mg with a Km of 13.8 microM for @GENE$ and Vmax. of 1500 nmol of O2/nmol of enzyme, whereas hCOX-2 had a specific activity of 12.2 mumol of O2/mg with a Km of 8.7 microM for arachidonate and a Vmax. of 1090 nmol of O2/nmol of enzyme.",
        "relation": "CPR:9"
    },
    {
        "id": "7832763.T8.T27",
        "sentence": "Constitutive and inducible forms of human cyclo-oxygenase (hCOX-1 and hCOX-2) were cloned and expressed in insect cells, utilizing a baculovirus expression system. hCOX-1 had a specific activity of 18.8 mumol of O2/mg with a Km of 13.8 microM for arachidonate and Vmax. of 1500 nmol of O2/nmol of enzyme, whereas @CHEMICAL$ had a specific activity of 12.2 mumol of O2/mg with a Km of 8.7 microM for @GENE$ and a Vmax. of 1090 nmol of O2/nmol of enzyme.",
        "relation": "CPR:9"
    },
    {
        "id": "7832763.T10.T28",
        "sentence": "@CHEMICAL$ inhibited both @GENE$ and hCOX-2, whereas NS-398 and Dup-697 selectively inhibited hCOX-2.",
        "relation": "CPR:4"
    },
    {
        "id": "7832763.T10.T29",
        "sentence": "@CHEMICAL$ inhibited both hCOX-1 and @GENE$, whereas NS-398 and Dup-697 selectively inhibited hCOX-2.",
        "relation": "CPR:4"
    },
    {
        "id": "7832763.T11.T30",
        "sentence": "Indomethacin inhibited both hCOX-1 and hCOX-2, whereas @CHEMICAL$ and Dup-697 selectively inhibited @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "7832763.T12.T30",
        "sentence": "Indomethacin inhibited both hCOX-1 and hCOX-2, whereas NS-398 and @CHEMICAL$ selectively inhibited @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "7832763.T13.T31",
        "sentence": "Both @CHEMICAL$ and Dup-697 exhibited time-dependent inactivation of @GENE$, as did indomethacin on both enzymes.",
        "relation": "CPR:4"
    },
    {
        "id": "7832763.T14.T31",
        "sentence": "Both NS-398 and @CHEMICAL$ exhibited time-dependent inactivation of @GENE$, as did indomethacin on both enzymes.",
        "relation": "CPR:4"
    },
    {
        "id": "7832763.T15.T31",
        "sentence": "Both NS-398 and Dup-697 exhibited time-dependent inactivation of @CHEMICAL$, as did @GENE$ on both enzymes.",
        "relation": "CPR:4"
    },
    {
        "id": "7832763.T2.T16",
        "sentence": "The competitive inhibitor of @CHEMICAL$, @GENE$, also displayed competitive inhibition of hCOX-2.",
        "relation": "CPR:4"
    },
    {
        "id": "7832763.T2.T17",
        "sentence": "The competitive inhibitor of hCOX-1, @CHEMICAL$, also displayed competitive inhibition of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "16395286.T6.T22",
        "sentence": "@CHEMICAL$ was shown to decrease cerebral @GENE$ activities and angiogenesis induced by vascular endothelial growth factor (VEGF).",
        "relation": "CPR:4"
    },
    {
        "id": "16395286.T6.T23",
        "sentence": "@CHEMICAL$ was shown to decrease cerebral MMP-9 activities and angiogenesis induced by @GENE$ (VEGF).",
        "relation": "CPR:4"
    },
    {
        "id": "16395286.T6.T24",
        "sentence": "@CHEMICAL$ was shown to decrease cerebral MMP-9 activities and angiogenesis induced by vascular endothelial growth factor (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "16395286.T11.T28",
        "sentence": "Our results have shown that @CHEMICAL$ messenger ribonucleic acid (mRNA) expression was inhibited by @GENE$ starting at 10 mg/kg/day (P<0.02).",
        "relation": "CPR:4"
    },
    {
        "id": "16395286.T12.T29",
        "sentence": "@CHEMICAL$ showed more potent inhibition on @GENE$ mRNA expression, starting at 1 (P<0.005) and further at more than 30 (P<0.001) mg/kg/day.",
        "relation": "CPR:4"
    },
    {
        "id": "16395286.T13.T15",
        "sentence": "At the enzymatic activity level, @CHEMICAL$ started to suppress @GENE$ activity at 5 mg/kg/day (P<0.001), while minocycline had an effect at a lower dose, 1 mg/kg/day (P<0.02).",
        "relation": "CPR:4"
    },
    {
        "id": "16395286.T2.T17",
        "sentence": "We also assessed the potential relevant signaling pathway in vitro to elucidate the mechanisms underlying the @CHEMICAL$ inhibition by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "16395286.T3.T18",
        "sentence": "In vitro, @CHEMICAL$, but not doxycycline, inhibits @GENE$, at least in part, via the extracellular signaling-related kinase 1/2 (ERK1/2)-mediated pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "16395286.T4.T18",
        "sentence": "In vitro, minocycline, but not @CHEMICAL$, inhibits @GENE$, at least in part, via the extracellular signaling-related kinase 1/2 (ERK1/2)-mediated pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "16395286.T5.T21",
        "sentence": "This study provided the evidence that the @CHEMICAL$ inhibit stimulated cerebral @GENE$ at multiple levels and are effective at very low doses, offering great potential for therapeutic use.",
        "relation": "CPR:4"
    },
    {
        "id": "12668769.T36.T59",
        "sentence": "One major route involves the tetrahydrofolate (THF)-dependent activities of the @CHEMICAL$ (GDC, EC 2.1.1.10) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with @GENE$ (Gly) as one-carbon (1-C) source.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T36.T62",
        "sentence": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (@CHEMICAL$, EC 2.1.1.10) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with @GENE$ (Gly) as one-carbon (1-C) source.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T36.T67",
        "sentence": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, EC 2.1.1.10) and @CHEMICAL$ (SHMT, EC 2.1.2.1) with @GENE$ (Gly) as one-carbon (1-C) source.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T36.T74",
        "sentence": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, EC 2.1.1.10) and serine hydroxymethyltransferase (@CHEMICAL$, EC 2.1.2.1) with @GENE$ (Gly) as one-carbon (1-C) source.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T36.T64",
        "sentence": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, @CHEMICAL$) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with @GENE$ (Gly) as one-carbon (1-C) source.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T36.T77",
        "sentence": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, EC 2.1.1.10) and serine hydroxymethyltransferase (SHMT, @CHEMICAL$) with @GENE$ (Gly) as one-carbon (1-C) source.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T37.T59",
        "sentence": "One major route involves the tetrahydrofolate (THF)-dependent activities of the @CHEMICAL$ (GDC, EC 2.1.1.10) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with glycine (@GENE$) as one-carbon (1-C) source.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T37.T62",
        "sentence": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (@CHEMICAL$, EC 2.1.1.10) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with glycine (@GENE$) as one-carbon (1-C) source.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T37.T67",
        "sentence": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, EC 2.1.1.10) and @CHEMICAL$ (SHMT, EC 2.1.2.1) with glycine (@GENE$) as one-carbon (1-C) source.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T37.T74",
        "sentence": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, EC 2.1.1.10) and serine hydroxymethyltransferase (@CHEMICAL$, EC 2.1.2.1) with glycine (@GENE$) as one-carbon (1-C) source.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T37.T64",
        "sentence": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, @CHEMICAL$) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with glycine (@GENE$) as one-carbon (1-C) source.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T37.T77",
        "sentence": "One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, EC 2.1.1.10) and serine hydroxymethyltransferase (SHMT, @CHEMICAL$) with glycine (@GENE$) as one-carbon (1-C) source.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T43.T81",
        "sentence": "An alternative THF-dependent pathway involves the C1-THF synthase/@CHEMICAL$ activities with @GENE$ as 1-C source.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T43.T80",
        "sentence": "An alternative THF-dependent pathway involves the @CHEMICAL$/SHMT activities with @GENE$ as 1-C source.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T46.T82",
        "sentence": "Firstly, transgenic plants overexpressing @CHEMICAL$ (FDH, EC 1.2.1.2) were used to continue our previous studies on the function of FDH in @GENE$ metabolism.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T46.T83",
        "sentence": "Firstly, transgenic plants overexpressing formate dehydrogenase (@CHEMICAL$, EC 1.2.1.2) were used to continue our previous studies on the function of FDH in @GENE$ metabolism.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T46.T84",
        "sentence": "Firstly, transgenic plants overexpressing formate dehydrogenase (FDH, @CHEMICAL$) were used to continue our previous studies on the function of FDH in @GENE$ metabolism.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T46.T85",
        "sentence": "Firstly, transgenic plants overexpressing formate dehydrogenase (FDH, EC 1.2.1.2) were used to continue our previous studies on the function of @CHEMICAL$ in @GENE$ metabolism.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T5.T54",
        "sentence": "We concluded that FDH has no direct role in the regulation of the above two pathways of Ser synthesis; the breakdown of @CHEMICAL$ to CO(2) by the @GENE$ reaction is the primary and preferred fate of the organic acid in Arabidopsis.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T7.T54",
        "sentence": "We concluded that FDH has no direct role in the regulation of the above two pathways of Ser synthesis; the breakdown of formate to @CHEMICAL$ by the @GENE$ reaction is the primary and preferred fate of the organic acid in Arabidopsis.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T10.T56",
        "sentence": "The ratio between the GDC/@CHEMICAL$ and C1-THF synthase/SHMT pathways of @GENE$ synthesis from [alpha-(13)C]Gly and [(13)C]formate, respectively, in Arabidopsis shoots was 21 : 1; in roots, 9 : 1.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T10.T58",
        "sentence": "The ratio between the GDC/SHMT and C1-THF synthase/@CHEMICAL$ pathways of @GENE$ synthesis from [alpha-(13)C]Gly and [(13)C]formate, respectively, in Arabidopsis shoots was 21 : 1; in roots, 9 : 1.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T11.T55",
        "sentence": "The ratio between the @CHEMICAL$/SHMT and C1-THF synthase/SHMT pathways of Ser synthesis from @GENE$ and [(13)C]formate, respectively, in Arabidopsis shoots was 21 : 1; in roots, 9 : 1.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T12.T57",
        "sentence": "The ratio between the GDC/SHMT and @CHEMICAL$/SHMT pathways of Ser synthesis from [alpha-(13)C]Gly and @GENE$, respectively, in Arabidopsis shoots was 21 : 1; in roots, 9 : 1.",
        "relation": "CPR:9"
    },
    {
        "id": "12668769.T27.T69",
        "sentence": "On the other hand, the accumulation of @CHEMICAL$ through the C1-THF synthase/@GENE$ pathway in glyD plants was 2.5-fold greater than that in WT plants.",
        "relation": "CPR:9"
    },
    {
        "id": "14587496.T2.T12",
        "sentence": "BACKGROUND: @CHEMICAL$ is a carbamate drug designed to inhibit both @GENE$ and butyrylcholinesterase by reversibly covalently bonding to these enzymes.",
        "relation": "CPR:4"
    },
    {
        "id": "14587496.T2.T13",
        "sentence": "BACKGROUND: @CHEMICAL$ is a carbamate drug designed to inhibit both acetylcholinesterase and @GENE$ by reversibly covalently bonding to these enzymes.",
        "relation": "CPR:4"
    },
    {
        "id": "14587496.T6.T12",
        "sentence": "BACKGROUND: Rivastigmine is a @CHEMICAL$ drug designed to inhibit both @GENE$ and butyrylcholinesterase by reversibly covalently bonding to these enzymes.",
        "relation": "CPR:4"
    },
    {
        "id": "14587496.T6.T13",
        "sentence": "BACKGROUND: Rivastigmine is a @CHEMICAL$ drug designed to inhibit both acetylcholinesterase and @GENE$ by reversibly covalently bonding to these enzymes.",
        "relation": "CPR:4"
    },
    {
        "id": "11166732.T1.T8",
        "sentence": "@CHEMICAL$ is a @GENE$ inhibitor which is currently evaluated as an adjuvant agent for malignant glioma.",
        "relation": "CPR:4"
    },
    {
        "id": "11166732.T3.T10",
        "sentence": "High @CHEMICAL$ protein levels, but not genetic or functional p53 status, were associated with increased @GENE$-induced DNA/topoisomerase I complex formation.",
        "relation": "CPR:3"
    },
    {
        "id": "11562773.T2.T10",
        "sentence": "@CHEMICAL$ is a specific inhibitor of @GENE$ but does not inhibit tPA.",
        "relation": "CPR:4"
    },
    {
        "id": "10522750.T11.T33",
        "sentence": "The inhibitory effect of endothelin-1 on the contraction induced by 5-HT is abolished by deendothelialization, by the @CHEMICAL$ antagonist @GENE$, by indomethacin, or by glibenclamide.",
        "relation": "CPR:6"
    },
    {
        "id": "10522750.T19.T37",
        "sentence": "The potentiation of the contractile effect induced by 5-HT is only somewhat modified by deendothelialization, but abolished by the @CHEMICAL$ antagonists @GENE$ and ridogrel.",
        "relation": "CPR:6"
    },
    {
        "id": "10522750.T20.T37",
        "sentence": "The potentiation of the contractile effect induced by 5-HT is only somewhat modified by deendothelialization, but abolished by the @CHEMICAL$ antagonists GR32191 and @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "23375228.T1.T5",
        "sentence": "A novel class of @CHEMICAL$ has been discovered as antagonists of the @GENE$:FcRn protein-protein interaction through optimization of a hit derived from a virtual ligand-based screen.",
        "relation": "CPR:6"
    },
    {
        "id": "23375228.T1.T6",
        "sentence": "A novel class of @CHEMICAL$ has been discovered as antagonists of the IgG:@GENE$ protein-protein interaction through optimization of a hit derived from a virtual ligand-based screen.",
        "relation": "CPR:6"
    },
    {
        "id": "7906055.T11.T21",
        "sentence": "@CHEMICAL$, locally synthesized, is an endogenous agonist at @GENE$, a noncatecholamine ligand at alpha 2-adrenergic receptors and may act as a neurotransmitter.",
        "relation": "CPR:5"
    },
    {
        "id": "23439661.T1.T15",
        "sentence": "Disposition and Metabolism of GSK2251052 in Humans: A Novel Boron-Containing Antibiotic. @CHEMICAL$ (GSK2251052) is a novel boron-containing antibiotic that inhibits @GENE$, and that has been in development for the treatment of serious Gram-negative infections.",
        "relation": "CPR:4"
    },
    {
        "id": "23439661.T11.T15",
        "sentence": "Disposition and Metabolism of GSK2251052 in Humans: A Novel Boron-Containing Antibiotic. (S)-3-(Aminomethyl)-7-(3-hydroxypropoxy)-1-hydroxy-1,3-dihydro-2,1-benzoxaborole (@CHEMICAL$) is a novel boron-containing antibiotic that inhibits @GENE$, and that has been in development for the treatment of serious Gram-negative infections.",
        "relation": "CPR:4"
    },
    {
        "id": "23439661.T7.T16",
        "sentence": "A combination of in vitro metabolism experiments and a pharmacokinetic study in monkeys with the inhibitor @CHEMICAL$ provided strong evidence that @GENE$, potentially in association with aldehyde dehydrogenase, is the primary enzyme involved in the formation of the M3 metabolite.",
        "relation": "CPR:4"
    },
    {
        "id": "23632081.T2.T15",
        "sentence": "In functional transport assays, we found that one of the identified molecules, ATM7, increased the reuptake of @CHEMICAL$, possibly by facilitating the interaction of serotonin with transport-ready conformations of @GENE$ when concentrations of serotonin were low and rate limiting.",
        "relation": "CPR:9"
    },
    {
        "id": "23632081.T3.T15",
        "sentence": "In functional transport assays, we found that one of the identified molecules, ATM7, increased the reuptake of serotonin, possibly by facilitating the interaction of @CHEMICAL$ with transport-ready conformations of @GENE$ when concentrations of serotonin were low and rate limiting.",
        "relation": "CPR:9"
    },
    {
        "id": "23632081.T4.T15",
        "sentence": "In functional transport assays, we found that one of the identified molecules, ATM7, increased the reuptake of serotonin, possibly by facilitating the interaction of serotonin with transport-ready conformations of @CHEMICAL$ when concentrations of @GENE$ were low and rate limiting.",
        "relation": "CPR:9"
    },
    {
        "id": "22349823.T7.T28",
        "sentence": "They display sensitivity to @CHEMICAL$ inhibitors, including @GENE$ and erlotinib.",
        "relation": "CPR:4"
    },
    {
        "id": "22349823.T8.T28",
        "sentence": "They display sensitivity to @CHEMICAL$ inhibitors, including gefitinib and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12196163.T11.T17",
        "sentence": "Among the [Fe-S] cluster biosynthetic proteins are included a pyridoxal phosphate-dependent enzyme (@CHEMICAL$) that is involved in the activation of sulphur from @GENE$, and a molecular scaffold protein (NifU) upon which [Fe-S] cluster precursors are formed.",
        "relation": "CPR:9"
    },
    {
        "id": "23074021.T2.T17",
        "sentence": "In addition, the number and area of @CHEMICAL$ (GST-P) positive foci and proliferating cell nuclear antigen (PCNA) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg @GENE$ compared with the control animals.",
        "relation": "CPR:3"
    },
    {
        "id": "23074021.T2.T18",
        "sentence": "In addition, the number and area of glutathione S-transferase placental form (@CHEMICAL$) positive foci and proliferating cell nuclear antigen (PCNA) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg @GENE$ compared with the control animals.",
        "relation": "CPR:3"
    },
    {
        "id": "23074021.T2.T19",
        "sentence": "In addition, the number and area of glutathione S-transferase placental form (GST-P) positive foci and @CHEMICAL$ (PCNA) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg @GENE$ compared with the control animals.",
        "relation": "CPR:3"
    },
    {
        "id": "23074021.T2.T20",
        "sentence": "In addition, the number and area of glutathione S-transferase placental form (GST-P) positive foci and proliferating cell nuclear antigen (@CHEMICAL$) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg @GENE$ compared with the control animals.",
        "relation": "CPR:3"
    },
    {
        "id": "23416143.T10.T23",
        "sentence": "Consumption of @CHEMICAL$ for 8weeks induced severe liver damage with increases in prognostic indicators such as @GENE$, alanine transaminase in serum whereas co-administration of CNF suppressed their increases.",
        "relation": "CPR:3"
    },
    {
        "id": "23416143.T10.T24",
        "sentence": "Consumption of @CHEMICAL$ for 8weeks induced severe liver damage with increases in prognostic indicators such as aspartate transaminase, @GENE$ in serum whereas co-administration of CNF suppressed their increases.",
        "relation": "CPR:3"
    },
    {
        "id": "23416143.T16.T18",
        "sentence": "Chronic consumption of @CHEMICAL$ also stimulated abrupt increases in pro-inflammatory cytokines such as @GENE$, tumor necrosis factor (TNF)-a and interleukin (IL)-1b in liver otherwise co-administration of CNF effectively suppressed production of these cytokines dose-dependently.",
        "relation": "CPR:3"
    },
    {
        "id": "23416143.T16.T19",
        "sentence": "Chronic consumption of @CHEMICAL$ also stimulated abrupt increases in pro-inflammatory cytokines such as nuclear factor (NF)-kB, @GENE$ and interleukin (IL)-1b in liver otherwise co-administration of CNF effectively suppressed production of these cytokines dose-dependently.",
        "relation": "CPR:3"
    },
    {
        "id": "23416143.T16.T20",
        "sentence": "Chronic consumption of @CHEMICAL$ also stimulated abrupt increases in pro-inflammatory cytokines such as nuclear factor (NF)-kB, tumor necrosis factor (TNF)-a and @GENE$ in liver otherwise co-administration of CNF effectively suppressed production of these cytokines dose-dependently.",
        "relation": "CPR:3"
    },
    {
        "id": "23349501.T19.T22",
        "sentence": "Dietary @CHEMICAL$/DHA treatment restored endogenous biosynthesis of n-3 derived lipid mediators in obesity while attenuating adipose tissue inflammation and improving @GENE$ sensitivity.",
        "relation": "CPR:3"
    },
    {
        "id": "23349501.T20.T22",
        "sentence": "Dietary EPA/@CHEMICAL$ treatment restored endogenous biosynthesis of n-3 derived lipid mediators in obesity while attenuating adipose tissue inflammation and improving @GENE$ sensitivity.",
        "relation": "CPR:3"
    },
    {
        "id": "23349501.T1.T23",
        "sentence": "Notably, @CHEMICAL$ treatment reduced adipose tissue expression of inflammatory @GENE$, increased adiponectin expression and improved glucose tolerance parallel to insulin sensitivity in obese mice.",
        "relation": "CPR:4"
    },
    {
        "id": "23349501.T1.T25",
        "sentence": "Notably, @CHEMICAL$ treatment reduced adipose tissue expression of inflammatory cytokines, increased adiponectin expression and improved glucose tolerance parallel to @GENE$ sensitivity in obese mice.",
        "relation": "CPR:3"
    },
    {
        "id": "23349501.T1.T24",
        "sentence": "Notably, @CHEMICAL$ treatment reduced adipose tissue expression of inflammatory cytokines, increased @GENE$ expression and improved glucose tolerance parallel to insulin sensitivity in obese mice.",
        "relation": "CPR:3"
    },
    {
        "id": "23164673.T12.T30",
        "sentence": "Furthermore, we validated the inhibition of GSK-3b/@CHEMICAL$ signaling following @GENE$ treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "23164673.T12.T29",
        "sentence": "Furthermore, we validated the inhibition of @CHEMICAL$/NF-kB signaling following @GENE$ treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "23164673.T13.T15",
        "sentence": "Western blots showed a decrease in nuclear p65 protein expression after exposure to different concentrations of @CHEMICAL$, while the phosphorylation of @GENE$ was simultaneously increased.",
        "relation": "CPR:3"
    },
    {
        "id": "23164673.T13.T31",
        "sentence": "Western blots showed a decrease in nuclear @CHEMICAL$ protein expression after exposure to different concentrations of @GENE$, while the phosphorylation of GSK-3b was simultaneously increased.",
        "relation": "CPR:4"
    },
    {
        "id": "23164673.T2.T18",
        "sentence": "Transduction with constitutively active forms of GSK-3b could protect against the downregulation of p65 and upregulation of cleaved-@CHEMICAL$ that are induced by @GENE$ treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "23164673.T2.T17",
        "sentence": "Transduction with constitutively active forms of GSK-3b could protect against the downregulation of @CHEMICAL$ and upregulation of cleaved-PARP that are induced by @GENE$ treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "23164673.T3.T20",
        "sentence": "However, combined treatment with @CHEMICAL$ and SB216367 resulted in a significant reduction in p65 and an increase in cleaved-@GENE$ in U2OS cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23164673.T3.T19",
        "sentence": "However, combined treatment with @CHEMICAL$ and SB216367 resulted in a significant reduction in @GENE$ and an increase in cleaved-PARP in U2OS cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23164673.T4.T20",
        "sentence": "However, combined treatment with cinobufagin and @CHEMICAL$ resulted in a significant reduction in p65 and an increase in cleaved-@GENE$ in U2OS cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23164673.T4.T19",
        "sentence": "However, combined treatment with cinobufagin and @CHEMICAL$ resulted in a significant reduction in @GENE$ and an increase in cleaved-PARP in U2OS cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23479389.T3.T9",
        "sentence": "@CHEMICAL$: a novel @GENE$ antagonist for the treatment of cardiovascular disease.",
        "relation": "CPR:6"
    },
    {
        "id": "23479389.T1.T5",
        "sentence": "A small library consisting of 89 compounds from 39 Chinese herbs was profiled using a cell-based calcium mobilization assay which was developed and characterized for high-throughput screening. @CHEMICAL$ derived from Zingiber officinale Roscoe (ginger) was identified as a novel @GENE$ antagonist, with an IC50 value of 8.173 mM. The hit was further tested by a specificity assay indicating that it had no antagonistic effects on other evaluated GPCRs, such as endothelin receptors.",
        "relation": "CPR:6"
    },
    {
        "id": "23479389.T2.T8",
        "sentence": "The major ingredient of ginger, @CHEMICAL$, could inhibit @GENE$ activation, which partially clarified the mechanism of ginger regulating blood pressure and strengthening heart in the cardiovascular system.",
        "relation": "CPR:4"
    },
    {
        "id": "23494186.T3.T11",
        "sentence": "In patients who do not reach the LDL-C target, combination therapy with additional @CHEMICAL$-C lowering drugs (e.g. @GENE$, bile acid sequestrants or fibrates) should be considered.",
        "relation": "CPR:4"
    },
    {
        "id": "23494186.T4.T11",
        "sentence": "In patients who do not reach the LDL-C target, combination therapy with additional @CHEMICAL$-C lowering drugs (e.g. ezetimibe, @GENE$ sequestrants or fibrates) should be considered.",
        "relation": "CPR:4"
    },
    {
        "id": "23494186.T5.T11",
        "sentence": "In patients who do not reach the LDL-C target, combination therapy with additional @CHEMICAL$-C lowering drugs (e.g. ezetimibe, bile acid sequestrants or @GENE$) should be considered.",
        "relation": "CPR:4"
    },
    {
        "id": "10839989.T8.T48",
        "sentence": "@CHEMICAL$ derivatives were not oxidized to products serving as substrates for @GENE$ and,depending on the substituent, were competitive inhibitors of phenylalanine hydroxylase: N(5)-methyl- and N(5)-hydroxymethyl H(4)biopterin inhibited phenylalanine hydroxylase, whereas N(5)-formyl- and N(5)-acetyl H(4)biopterin had no effect.",
        "relation": "CPR:9"
    },
    {
        "id": "10839989.T11.T50",
        "sentence": "N(5)-Substituted H(4)biopterin derivatives were not oxidized to products serving as substrates for dihydropteridine reductase and,depending on the substituent, were competitive inhibitors of phenylalanine hydroxylase: @CHEMICAL$- and N(5)-hydroxymethyl H(4)biopterin inhibited @GENE$, whereas N(5)-formyl- and N(5)-acetyl H(4)biopterin had no effect.",
        "relation": "CPR:4"
    },
    {
        "id": "10839989.T12.T50",
        "sentence": "N(5)-Substituted H(4)biopterin derivatives were not oxidized to products serving as substrates for dihydropteridine reductase and,depending on the substituent, were competitive inhibitors of phenylalanine hydroxylase: N(5)-methyl- and @CHEMICAL$ inhibited @GENE$, whereas N(5)-formyl- and N(5)-acetyl H(4)biopterin had no effect.",
        "relation": "CPR:4"
    },
    {
        "id": "10839989.T18.T51",
        "sentence": "Our data demonstrate differences in the mechanism of stimulation of @CHEMICAL$ and nitric oxide synthase by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "21712771.T5.T20",
        "sentence": "Transfection of the brain cDNA into COS-1 cells resulted in transporter activity that was blocked by the @CHEMICAL$ inhibitor @GENE$ and a proton ionophore, but not by tetrabenazine, which has a high affinity for VMAT-2.",
        "relation": "CPR:4"
    },
    {
        "id": "16801455.T27.T50",
        "sentence": "@CHEMICAL$ modulates @GENE$ synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells.",
        "relation": "CPR:9"
    },
    {
        "id": "16801455.T28.T50",
        "sentence": "@CHEMICAL$ modulates nitric-oxide synthesis through nonfreely exchangeable @GENE$ pools in human endothelial cells.",
        "relation": "CPR:9"
    },
    {
        "id": "16801455.T6.T38",
        "sentence": "Reduced synthesis of nitric oxide (NO) contributes to the endothelial dysfunction and may be related to limited availability of @CHEMICAL$, the common substrate of constitutive nitric-oxide synthase (@GENE$) and cytosolic arginase I and mitochondrial arginase II.",
        "relation": "CPR:9"
    },
    {
        "id": "16801455.T6.T36",
        "sentence": "Reduced synthesis of nitric oxide (NO) contributes to the endothelial dysfunction and may be related to limited availability of @CHEMICAL$, the common substrate of @GENE$ (NOS) and cytosolic arginase I and mitochondrial arginase II.",
        "relation": "CPR:9"
    },
    {
        "id": "16801455.T6.T39",
        "sentence": "Reduced synthesis of nitric oxide (NO) contributes to the endothelial dysfunction and may be related to limited availability of @CHEMICAL$, the common substrate of constitutive nitric-oxide synthase (NOS) and cytosolic @GENE$ and mitochondrial arginase II.",
        "relation": "CPR:9"
    },
    {
        "id": "16801455.T6.T40",
        "sentence": "Reduced synthesis of nitric oxide (NO) contributes to the endothelial dysfunction and may be related to limited availability of @CHEMICAL$, the common substrate of constitutive nitric-oxide synthase (NOS) and cytosolic arginase I and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "16801455.T14.T38",
        "sentence": "Reduced synthesis of @CHEMICAL$ (NO) contributes to the endothelial dysfunction and may be related to limited availability of L-arginine, the common substrate of constitutive nitric-oxide synthase (@GENE$) and cytosolic arginase I and mitochondrial arginase II.",
        "relation": "CPR:9"
    },
    {
        "id": "16801455.T14.T36",
        "sentence": "Reduced synthesis of @CHEMICAL$ (NO) contributes to the endothelial dysfunction and may be related to limited availability of L-arginine, the common substrate of @GENE$ (NOS) and cytosolic arginase I and mitochondrial arginase II.",
        "relation": "CPR:9"
    },
    {
        "id": "16801455.T14.T39",
        "sentence": "Reduced synthesis of @CHEMICAL$ (NO) contributes to the endothelial dysfunction and may be related to limited availability of L-arginine, the common substrate of constitutive nitric-oxide synthase (NOS) and cytosolic @GENE$ and mitochondrial arginase II.",
        "relation": "CPR:9"
    },
    {
        "id": "16801455.T14.T40",
        "sentence": "Reduced synthesis of @CHEMICAL$ (NO) contributes to the endothelial dysfunction and may be related to limited availability of L-arginine, the common substrate of constitutive nitric-oxide synthase (NOS) and cytosolic arginase I and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "16801455.T16.T38",
        "sentence": "Reduced synthesis of nitric oxide (@CHEMICAL$) contributes to the endothelial dysfunction and may be related to limited availability of L-arginine, the common substrate of constitutive nitric-oxide synthase (@GENE$) and cytosolic arginase I and mitochondrial arginase II.",
        "relation": "CPR:9"
    },
    {
        "id": "16801455.T16.T36",
        "sentence": "Reduced synthesis of nitric oxide (@CHEMICAL$) contributes to the endothelial dysfunction and may be related to limited availability of L-arginine, the common substrate of @GENE$ (NOS) and cytosolic arginase I and mitochondrial arginase II.",
        "relation": "CPR:9"
    },
    {
        "id": "16801455.T16.T39",
        "sentence": "Reduced synthesis of nitric oxide (@CHEMICAL$) contributes to the endothelial dysfunction and may be related to limited availability of L-arginine, the common substrate of constitutive nitric-oxide synthase (NOS) and cytosolic @GENE$ and mitochondrial arginase II.",
        "relation": "CPR:9"
    },
    {
        "id": "16801455.T16.T40",
        "sentence": "Reduced synthesis of nitric oxide (@CHEMICAL$) contributes to the endothelial dysfunction and may be related to limited availability of L-arginine, the common substrate of constitutive nitric-oxide synthase (NOS) and cytosolic arginase I and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "16801455.T15.T41",
        "sentence": "To determine whether @CHEMICAL$ modulate the endothelial @GENE$ synthesis, we investigated the effects of the competitive arginase inhibitor N(omega)-hydroxy-nor-L-arginine (Nor-NOHA) on the activity of NOS, arginases, and L-arginine transporter and on NO release at surface of human umbilical vein endothelial cells (HUVECs).",
        "relation": "CPR:9"
    },
    {
        "id": "16801455.T17.T42",
        "sentence": "To determine whether arginases modulate the endothelial NO synthesis, we investigated the effects of the competitive @CHEMICAL$ inhibitor @GENE$ (Nor-NOHA) on the activity of NOS, arginases, and L-arginine transporter and on NO release at surface of human umbilical vein endothelial cells (HUVECs).",
        "relation": "CPR:4"
    },
    {
        "id": "16801455.T18.T42",
        "sentence": "To determine whether arginases modulate the endothelial NO synthesis, we investigated the effects of the competitive @CHEMICAL$ inhibitor N(omega)-hydroxy-nor-L-arginine (@GENE$) on the activity of NOS, arginases, and L-arginine transporter and on NO release at surface of human umbilical vein endothelial cells (HUVECs).",
        "relation": "CPR:4"
    },
    {
        "id": "16801455.T21.T46",
        "sentence": "In unstimulated cells, @CHEMICAL$ dose-dependently reduced the @GENE$ activity with maximal inhibition at 20 microM. When HUVECs were stimulated by thrombin without extracellular L-arginine, Nor-NOHA dose-dependently increased the NOS activity and the NO release with maximal effects at 20 microM. Extracellular L-arginine also dose-dependently increased NO release and arginase activity.",
        "relation": "CPR:4"
    },
    {
        "id": "16801455.T23.T48",
        "sentence": "In unstimulated cells, Nor-NOHA dose-dependently reduced the arginase activity with maximal inhibition at 20 microM. When HUVECs were stimulated by thrombin without extracellular L-arginine, @CHEMICAL$ dose-dependently increased the @GENE$ activity and the NO release with maximal effects at 20 microM. Extracellular L-arginine also dose-dependently increased NO release and arginase activity.",
        "relation": "CPR:3"
    },
    {
        "id": "16801455.T25.T49",
        "sentence": "In unstimulated cells, Nor-NOHA dose-dependently reduced the arginase activity with maximal inhibition at 20 microM. When HUVECs were stimulated by thrombin without extracellular L-arginine, Nor-NOHA dose-dependently increased the NOS activity and the NO release with maximal effects at 20 microM. Extracellular @CHEMICAL$ also dose-dependently increased NO release and @GENE$ activity.",
        "relation": "CPR:3"
    },
    {
        "id": "16801455.T5.T31",
        "sentence": "However, despite activation of L-arginine uptake, the inhibition of @CHEMICAL$ activity by @GENE$ was still significant.",
        "relation": "CPR:4"
    },
    {
        "id": "16801455.T11.T37",
        "sentence": "These data suggest that endothelial @CHEMICAL$ synthesis depends on the activity of @GENE$ in mitochondria and l-arginine carriers in cell membrane.",
        "relation": "CPR:9"
    },
    {
        "id": "16686685.T21.T25",
        "sentence": "However, pretreatment with agents that block late I(Na), like lidocaine, mexiletine, and @CHEMICAL$, a novel mixed @GENE$ blocker for the rapid pharmacologic conversion of atrial fibrillation, significantly attenuates the prolonging effects of Class III agents or those induced by ATX-II, a specific toxin that delays Na channel inactivation and amplifies late I(Na) greatly, mimicking LQT3.",
        "relation": "CPR:4"
    },
    {
        "id": "16686685.T4.T23",
        "sentence": "The @CHEMICAL$ block caused by @GENE$ and RSD1235 can be through the open or inactivated states of the channel, but both equivalently inhibit a late component of Na current (I(Na)), recorded at 22 degrees C using whole-cell patch clamp of Nav 1.5 expressed in HEK cells.",
        "relation": "CPR:4"
    },
    {
        "id": "16686685.T5.T23",
        "sentence": "The @CHEMICAL$ block caused by lidocaine and @GENE$ can be through the open or inactivated states of the channel, but both equivalently inhibit a late component of Na current (I(Na)), recorded at 22 degrees C using whole-cell patch clamp of Nav 1.5 expressed in HEK cells.",
        "relation": "CPR:4"
    },
    {
        "id": "10712236.T21.T39",
        "sentence": "Depletion of @CHEMICAL$, spermidine, and spermine by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of @GENE$ (ODC) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.",
        "relation": "CPR:9"
    },
    {
        "id": "10712236.T21.T40",
        "sentence": "Depletion of @CHEMICAL$, spermidine, and spermine by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of ornithine decarboxylase (@GENE$) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.",
        "relation": "CPR:9"
    },
    {
        "id": "10712236.T22.T39",
        "sentence": "Depletion of putrescine, @CHEMICAL$, and spermine by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of @GENE$ (ODC) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.",
        "relation": "CPR:9"
    },
    {
        "id": "10712236.T22.T40",
        "sentence": "Depletion of putrescine, @CHEMICAL$, and spermine by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of ornithine decarboxylase (@GENE$) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.",
        "relation": "CPR:9"
    },
    {
        "id": "10712236.T23.T39",
        "sentence": "Depletion of putrescine, spermidine, and @CHEMICAL$ by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of @GENE$ (ODC) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.",
        "relation": "CPR:9"
    },
    {
        "id": "10712236.T23.T40",
        "sentence": "Depletion of putrescine, spermidine, and @CHEMICAL$ by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of ornithine decarboxylase (@GENE$) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.",
        "relation": "CPR:9"
    },
    {
        "id": "10712236.T24.T39",
        "sentence": "Depletion of putrescine, spermidine, and spermine by @CHEMICAL$ (DFMO), a specific inhibitor of @GENE$ (ODC) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.",
        "relation": "CPR:4"
    },
    {
        "id": "10712236.T24.T40",
        "sentence": "Depletion of putrescine, spermidine, and spermine by @CHEMICAL$ (DFMO), a specific inhibitor of ornithine decarboxylase (@GENE$) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.",
        "relation": "CPR:4"
    },
    {
        "id": "10712236.T25.T39",
        "sentence": "Depletion of putrescine, spermidine, and spermine by DL-alpha-difluoromethylornithine (@CHEMICAL$), a specific inhibitor of @GENE$ (ODC) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.",
        "relation": "CPR:4"
    },
    {
        "id": "10712236.T25.T40",
        "sentence": "Depletion of putrescine, spermidine, and spermine by DL-alpha-difluoromethylornithine (@CHEMICAL$), a specific inhibitor of ornithine decarboxylase (@GENE$) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index.",
        "relation": "CPR:4"
    },
    {
        "id": "10712236.T29.T31",
        "sentence": "Addition of @CHEMICAL$ restored the induction of apoptosis as indicated by an increase in the number of detached cells and @GENE$ activity.",
        "relation": "CPR:3"
    },
    {
        "id": "10712236.T3.T33",
        "sentence": "Inhibition of @CHEMICAL$ by a specific inhibitor [@GENE$; DEGBG] led to depletion of spermidine and spermine with a significant accumulation of putrescine and induction of ODC.",
        "relation": "CPR:4"
    },
    {
        "id": "10712236.T4.T33",
        "sentence": "Inhibition of @CHEMICAL$ by a specific inhibitor [diethylglyoxal bis-(guanylhydrazone); @GENE$] led to depletion of spermidine and spermine with a significant accumulation of putrescine and induction of ODC.",
        "relation": "CPR:4"
    },
    {
        "id": "10712236.T5.T33",
        "sentence": "Inhibition of @CHEMICAL$ by a specific inhibitor [diethylglyoxal bis-(guanylhydrazone); DEGBG] led to depletion of @GENE$ and spermine with a significant accumulation of putrescine and induction of ODC.",
        "relation": "CPR:9"
    },
    {
        "id": "10712236.T6.T33",
        "sentence": "Inhibition of @CHEMICAL$ by a specific inhibitor [diethylglyoxal bis-(guanylhydrazone); DEGBG] led to depletion of spermidine and @GENE$ with a significant accumulation of putrescine and induction of ODC.",
        "relation": "CPR:9"
    },
    {
        "id": "10712236.T14.T36",
        "sentence": "The above results indicate that polyamine depletion delays the onset of apoptosis in IEC-6 cells and confers protection against DNA damaging agents, suggesting that @CHEMICAL$ might be involved in the @GENE$ activating signal cascade.",
        "relation": "CPR:3"
    },
    {
        "id": "14692707.T1.T13",
        "sentence": "On the other hand, in patients with a mean serum @CHEMICAL$ level (Cmin) of less than 2.5 nmol/l up to 2 weeks after the start ofcarvedilol therapy, the degree of reduction in the @GENE$ value after the 3rd month was significantly larger, relative to the patient group with Cmin over 2.5 nmol/l.",
        "relation": "CPR:4"
    },
    {
        "id": "14692707.T2.T13",
        "sentence": "On the other hand, in patients with a mean serum carvedilol level (Cmin) of less than 2.5 nmol/l up to 2 weeks after the start of@CHEMICAL$ therapy, the degree of reduction in the @GENE$ value after the 3rd month was significantly larger, relative to the patient group with Cmin over 2.5 nmol/l.",
        "relation": "CPR:4"
    },
    {
        "id": "9666414.T6.T16",
        "sentence": "Two mechanisms of action have been identified for @CHEMICAL$: inhibition of dihydroorotate dehydrogenase (DHODH) and inhibition of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "9666414.T6.T14",
        "sentence": "Two mechanisms of action have been identified for @CHEMICAL$: inhibition of @GENE$ (DHODH) and inhibition of tyrosine kinases.",
        "relation": "CPR:4"
    },
    {
        "id": "9666414.T6.T15",
        "sentence": "Two mechanisms of action have been identified for @CHEMICAL$: inhibition of dihydroorotate dehydrogenase (@GENE$) and inhibition of tyrosine kinases.",
        "relation": "CPR:4"
    },
    {
        "id": "9666414.T9.T18",
        "sentence": "DHODH inhibition occurs at lower concentrations of @CHEMICAL$ than that of @GENE$ and is currently considered the major mode of action.",
        "relation": "CPR:4"
    },
    {
        "id": "9666414.T9.T17",
        "sentence": "@CHEMICAL$ inhibition occurs at lower concentrations of @GENE$ than that of tyrosine kinases and is currently considered the major mode of action.",
        "relation": "CPR:4"
    },
    {
        "id": "12513997.T18.T32",
        "sentence": "@CHEMICAL$ accumulation and freeze tolerance of Saccharomyces cerevisiae are caused by a mutation in the PRO1 gene encoding @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "12513997.T15.T28",
        "sentence": "Interestingly, the allele of PRO1 was shown to enhance the activities of @CHEMICAL$ and gamma-glutamyl phosphate reductase, both of which catalyze the first two steps of @GENE$ synthesis from L-glutamate and which together may form a complex in vivo.",
        "relation": "CPR:9"
    },
    {
        "id": "12513997.T15.T29",
        "sentence": "Interestingly, the allele of PRO1 was shown to enhance the activities of gamma-glutamyl kinase and @CHEMICAL$, both of which catalyze the first two steps of @GENE$ synthesis from L-glutamate and which together may form a complex in vivo.",
        "relation": "CPR:9"
    },
    {
        "id": "12513997.T16.T28",
        "sentence": "Interestingly, the allele of PRO1 was shown to enhance the activities of @CHEMICAL$ and gamma-glutamyl phosphate reductase, both of which catalyze the first two steps of L-proline synthesis from @GENE$ and which together may form a complex in vivo.",
        "relation": "CPR:9"
    },
    {
        "id": "12513997.T16.T29",
        "sentence": "Interestingly, the allele of PRO1 was shown to enhance the activities of gamma-glutamyl kinase and @CHEMICAL$, both of which catalyze the first two steps of L-proline synthesis from @GENE$ and which together may form a complex in vivo.",
        "relation": "CPR:9"
    },
    {
        "id": "12513997.T1.T30",
        "sentence": "When cultured in liquid minimal medium, yeast cells expressing the mutated @CHEMICAL$ were found to accumulate intracellular @GENE$ and showed a prominent increase in cell viability after freezing at -20 degrees C compared to the viability of cells harboring the wild-type PRO1 gene.",
        "relation": "CPR:9"
    },
    {
        "id": "12513997.T5.T21",
        "sentence": "These results suggest that the altered @CHEMICAL$ results in stabilization of the complex or has an indirect effect on gamma-glutamyl phosphate reductase activity, which leads to an increase in @GENE$ production in Saccharomyces cerevisiae.",
        "relation": "CPR:9"
    },
    {
        "id": "12513997.T5.T22",
        "sentence": "These results suggest that the altered gamma-glutamyl kinase results in stabilization of the complex or has an indirect effect on @CHEMICAL$ activity, which leads to an increase in @GENE$ production in Saccharomyces cerevisiae.",
        "relation": "CPR:9"
    },
    {
        "id": "23145773.T7.T22",
        "sentence": "Structural optimization of @CHEMICAL$ as highly potent and selective @GENE$ inhibitors for the treatment of osteoporosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23145773.T1.T9",
        "sentence": "We report here the optimization of @CHEMICAL$ inhibitors in the @GENE$ class by varying the size of the linker (n equals 0 and 2) between the amide moiety and the phenyl group.",
        "relation": "CPR:4"
    },
    {
        "id": "23145773.T5.T11",
        "sentence": "While none of the phenethylamides (n = 2) were active, most of the @CHEMICAL$ (n = 0) turned out to moderately or strongly inhibit @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "16651698.T2.T8",
        "sentence": "Multiple exposure to @CHEMICAL$, a @GENE$ (PDE) inhibitor, induces acinar hypertrophy in the salivary gland.",
        "relation": "CPR:4"
    },
    {
        "id": "16651698.T2.T12",
        "sentence": "Multiple exposure to @CHEMICAL$, a phosphodiesterase (@GENE$) inhibitor, induces acinar hypertrophy in the salivary gland.",
        "relation": "CPR:4"
    },
    {
        "id": "16651698.T5.T13",
        "sentence": "@CHEMICAL$ exposure resulted in a sustained increase in mRNA expression for @GENE$ and PDE3A, but PDE4D gene expression was unchanged.",
        "relation": "CPR:3"
    },
    {
        "id": "16651698.T5.T14",
        "sentence": "@CHEMICAL$ exposure resulted in a sustained increase in mRNA expression for CysS and @GENE$, but PDE4D gene expression was unchanged.",
        "relation": "CPR:3"
    },
    {
        "id": "20012638.T1.T22",
        "sentence": "@CHEMICAL$ (Bricanyl) and its prodrug Bambuterol (Bambec) are highly potent @GENE$ agonists often used in asthma patients.",
        "relation": "CPR:5"
    },
    {
        "id": "20012638.T6.T22",
        "sentence": "Terbutaline (@CHEMICAL$) and its prodrug Bambuterol (Bambec) are highly potent @GENE$ agonists often used in asthma patients.",
        "relation": "CPR:5"
    },
    {
        "id": "20012638.T11.T22",
        "sentence": "Terbutaline (Bricanyl) and its prodrug @CHEMICAL$ (Bambec) are highly potent @GENE$ agonists often used in asthma patients.",
        "relation": "CPR:5"
    },
    {
        "id": "20012638.T13.T22",
        "sentence": "Terbutaline (Bricanyl) and its prodrug Bambuterol (@CHEMICAL$) are highly potent @GENE$ agonists often used in asthma patients.",
        "relation": "CPR:5"
    },
    {
        "id": "8894610.T26.T35",
        "sentence": "@CHEMICAL$, an @GENE$ antagonist, inhibits the positive inotropic effect but not the accumulation of inositol phosphates in rabbit heart.",
        "relation": "CPR:6"
    },
    {
        "id": "8894610.T13.T34",
        "sentence": "The influence of @CHEMICAL$, a selective @GENE$ antagonist, on the positive inotropic effect and the accumulation of inositol phosphates that are induced via alpha 1-adrenoceptors was studied in comparison with that of another alpha 1A-adrenoceptor ligand oxymetazoline in the rabbit ventricular myocardium.",
        "relation": "CPR:6"
    },
    {
        "id": "8894610.T18.T33",
        "sentence": "@CHEMICAL$ elicited a concentration-dependent positive inotropic effect via @GENE$ in the presence of either (+/-)-bupranolol or S(-)-timolol.",
        "relation": "CPR:5"
    },
    {
        "id": "8894610.T1.T28",
        "sentence": "At 100 nM and higher, it suppressed the maximal response to phenylephrine. (+/-)-Tamsulosin effectively antagonized the positive inotropic effect of @CHEMICAL$ even after inactivation of @GENE$ by treatment with chlorethylclonidine, which is an indication that the (+/-)-tamsulosin-sensitive subtype belongs to a class resistant to chlorethylclonidine. (+/-)-Tamsulosin, over the range of concentrations at which it antagonized the positive inotropic effect mediated by alpha 1-adrenoceptors, did not affect the accumulation of [3H]inositol phosphates that was induced by 10 microM phenylephrine.",
        "relation": "CPR:5"
    },
    {
        "id": "8894610.T2.T28",
        "sentence": "At 100 nM and higher, it suppressed the maximal response to phenylephrine. (+/-)-Tamsulosin effectively antagonized the positive inotropic effect of phenylephrine even after inactivation of @CHEMICAL$ by treatment with @GENE$, which is an indication that the (+/-)-tamsulosin-sensitive subtype belongs to a class resistant to chlorethylclonidine. (+/-)-Tamsulosin, over the range of concentrations at which it antagonized the positive inotropic effect mediated by alpha 1-adrenoceptors, did not affect the accumulation of [3H]inositol phosphates that was induced by 10 microM phenylephrine.",
        "relation": "CPR:4"
    },
    {
        "id": "8894610.T5.T29",
        "sentence": "At 100 nM and higher, it suppressed the maximal response to phenylephrine. (+/-)-Tamsulosin effectively antagonized the positive inotropic effect of phenylephrine even after inactivation of alpha 1B-adrenoceptors by treatment with chlorethylclonidine, which is an indication that the (+/-)-tamsulosin-sensitive subtype belongs to a class resistant to chlorethylclonidine. @CHEMICAL$, over the range of concentrations at which it antagonized the positive inotropic effect mediated by @GENE$, did not affect the accumulation of [3H]inositol phosphates that was induced by 10 microM phenylephrine.",
        "relation": "CPR:6"
    },
    {
        "id": "8894610.T25.T28",
        "sentence": "At 100 nM and higher, it suppressed the maximal response to phenylephrine. @CHEMICAL$ effectively antagonized the positive inotropic effect of phenylephrine even after inactivation of @GENE$ by treatment with chlorethylclonidine, which is an indication that the (+/-)-tamsulosin-sensitive subtype belongs to a class resistant to chlorethylclonidine. (+/-)-Tamsulosin, over the range of concentrations at which it antagonized the positive inotropic effect mediated by alpha 1-adrenoceptors, did not affect the accumulation of [3H]inositol phosphates that was induced by 10 microM phenylephrine.",
        "relation": "CPR:6"
    },
    {
        "id": "8894610.T14.T31",
        "sentence": "These results indicate that the positive inotropic effect, mediated via @CHEMICAL$- and oxymetazoline-sensitive subtype of @GENE$, is exerted by a subcellular mechanism that is independent of the accumulation of inositol phosphates.",
        "relation": "CPR:6"
    },
    {
        "id": "8894610.T15.T31",
        "sentence": "These results indicate that the positive inotropic effect, mediated via (+/-)-tamsulosin- and @CHEMICAL$-sensitive subtype of @GENE$, is exerted by a subcellular mechanism that is independent of the accumulation of inositol phosphates.",
        "relation": "CPR:5"
    },
    {
        "id": "23313376.T18.T43",
        "sentence": "@CHEMICAL$ exerts antitumor activity against human osteosarcoma cells by inhibiting the @GENE$/STAT3 signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23313376.T18.T44",
        "sentence": "@CHEMICAL$ exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/@GENE$ signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23313376.T1.T19",
        "sentence": "Furthermore, @CHEMICAL$ treatment directly inhibited the phosphorylation of @GENE$ at Tyr 1007 and the downstream activation of STAT3.",
        "relation": "CPR:4"
    },
    {
        "id": "23313376.T1.T20",
        "sentence": "Furthermore, @CHEMICAL$ treatment directly inhibited the phosphorylation of JAK2 at Tyr 1007 and the downstream activation of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23313376.T4.T21",
        "sentence": "@CHEMICAL$ also down-regulated the expression of @GENE$ target genes, including the anti-apoptotic proteins Bcl-xL and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, Bak, cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and p27.",
        "relation": "CPR:4"
    },
    {
        "id": "23313376.T4.T22",
        "sentence": "@CHEMICAL$ also down-regulated the expression of STAT3 target genes, including the anti-apoptotic proteins @GENE$ and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, Bak, cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and p27.",
        "relation": "CPR:4"
    },
    {
        "id": "23313376.T4.T23",
        "sentence": "@CHEMICAL$ also down-regulated the expression of STAT3 target genes, including the anti-apoptotic proteins Bcl-xL and @GENE$, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, Bak, cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and p27.",
        "relation": "CPR:4"
    },
    {
        "id": "23313376.T4.T24",
        "sentence": "@CHEMICAL$ also down-regulated the expression of STAT3 target genes, including the anti-apoptotic proteins Bcl-xL and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (@GENE$, Bak, cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and p27.",
        "relation": "CPR:3"
    },
    {
        "id": "23313376.T4.T25",
        "sentence": "@CHEMICAL$ also down-regulated the expression of STAT3 target genes, including the anti-apoptotic proteins Bcl-xL and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, @GENE$, cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and p27.",
        "relation": "CPR:3"
    },
    {
        "id": "23313376.T4.T26",
        "sentence": "@CHEMICAL$ also down-regulated the expression of STAT3 target genes, including the anti-apoptotic proteins Bcl-xL and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, Bak, cytosolic @GENE$, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and p27.",
        "relation": "CPR:3"
    },
    {
        "id": "23313376.T4.T27",
        "sentence": "@CHEMICAL$ also down-regulated the expression of STAT3 target genes, including the anti-apoptotic proteins Bcl-xL and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, Bak, cytosolic Cytochrome c, and cleaved @GENE$) and cyclin-dependent kinase inhibitors such as p21 and p27.",
        "relation": "CPR:3"
    },
    {
        "id": "23313376.T4.T29",
        "sentence": "@CHEMICAL$ also down-regulated the expression of STAT3 target genes, including the anti-apoptotic proteins Bcl-xL and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, Bak, cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as @GENE$ and p27.",
        "relation": "CPR:3"
    },
    {
        "id": "23313376.T4.T30",
        "sentence": "@CHEMICAL$ also down-regulated the expression of STAT3 target genes, including the anti-apoptotic proteins Bcl-xL and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, Bak, cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23313376.T7.T31",
        "sentence": "PTE, used in combination with a known @CHEMICAL$/STAT3 inhibitor, @GENE$, further decreased the viability of osteosarcoma cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23313376.T7.T32",
        "sentence": "PTE, used in combination with a known JAK2/@CHEMICAL$ inhibitor, @GENE$, further decreased the viability of osteosarcoma cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23313376.T8.T33",
        "sentence": "Taken together, @CHEMICAL$ is a potent inhibitor of osteosarcoma cell growth that targets the @GENE$/STAT3 signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23313376.T8.T34",
        "sentence": "Taken together, @CHEMICAL$ is a potent inhibitor of osteosarcoma cell growth that targets the JAK2/@GENE$ signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23313376.T9.T35",
        "sentence": "These data suggest that inhibition of @CHEMICAL$/STAT3 signaling is a novel mechanism of action for @GENE$ during therapeutic intervention in osteosarcoma cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "23313376.T9.T36",
        "sentence": "These data suggest that inhibition of JAK2/@CHEMICAL$ signaling is a novel mechanism of action for @GENE$ during therapeutic intervention in osteosarcoma cancers.",
        "relation": "CPR:4"
    },
    {
        "id": "23435910.T14.T23",
        "sentence": "Furthermore, @CHEMICAL$ reduced hepatic hydroxyproline content, which correlated with a reduction in the expression of @GENE$ mRNA and histological analysis of collagen in liver tissue.",
        "relation": "CPR:4"
    },
    {
        "id": "23435910.T16.T25",
        "sentence": "Additionally, the expression of hepatic fibrosis-related factors such as @CHEMICAL$ and transforming growth factor-b1 (TGF-b1), were reduced in rats treated with @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23435910.T16.T26",
        "sentence": "Additionally, the expression of hepatic fibrosis-related factors such as a-smooth muscle actin and @CHEMICAL$ (TGF-b1), were reduced in rats treated with @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23435910.T16.T27",
        "sentence": "Additionally, the expression of hepatic fibrosis-related factors such as a-smooth muscle actin and transforming growth factor-b1 (@CHEMICAL$), were reduced in rats treated with @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23435910.T2.T20",
        "sentence": "In conclusion, we find that @CHEMICAL$ exhibits hepatoprotective and antifibrotic effects against DMN-induced liver injury, most likely due to its antioxidant activities of scavenging radicals, its capacity to suppress @GENE$ and its ability to attenuate activation of hepatic stellate cells.",
        "relation": "CPR:4"
    },
    {
        "id": "15982930.T12.T33",
        "sentence": "@CHEMICAL$ inhibits growth of tumors through @GENE$ degradation independent of antiangiogenesis.",
        "relation": "CPR:4"
    },
    {
        "id": "15982930.T11.T13",
        "sentence": "@CHEMICAL$ reduced COX-2 expression accompanied by a decrease of bcl-2 protein, TNFalpha, VEGF, GSH and an increased @GENE$, but had no effect on that of COX-1, in MCF-7 and HL-60.",
        "relation": "CPR:3"
    },
    {
        "id": "15982930.T11.T29",
        "sentence": "@CHEMICAL$ reduced @GENE$ expression accompanied by a decrease of bcl-2 protein, TNFalpha, VEGF, GSH and an increased cytochrome c, but had no effect on that of COX-1, in MCF-7 and HL-60.",
        "relation": "CPR:4"
    },
    {
        "id": "15982930.T11.T30",
        "sentence": "@CHEMICAL$ reduced COX-2 expression accompanied by a decrease of @GENE$ protein, TNFalpha, VEGF, GSH and an increased cytochrome c, but had no effect on that of COX-1, in MCF-7 and HL-60.",
        "relation": "CPR:4"
    },
    {
        "id": "15982930.T11.T31",
        "sentence": "@CHEMICAL$ reduced COX-2 expression accompanied by a decrease of bcl-2 protein, @GENE$, VEGF, GSH and an increased cytochrome c, but had no effect on that of COX-1, in MCF-7 and HL-60.",
        "relation": "CPR:4"
    },
    {
        "id": "15982930.T11.T32",
        "sentence": "@CHEMICAL$ reduced COX-2 expression accompanied by a decrease of bcl-2 protein, TNFalpha, @GENE$, GSH and an increased cytochrome c, but had no effect on that of COX-1, in MCF-7 and HL-60.",
        "relation": "CPR:4"
    },
    {
        "id": "15982930.T6.T21",
        "sentence": "These results demonstrated that @CHEMICAL$ might inhibit growth of tumors through @GENE$ degradation independent of antiangiogenesis.",
        "relation": "CPR:4"
    },
    {
        "id": "23614730.T1.T17",
        "sentence": "Results: The administration of @CHEMICAL$ 1.6% w/w created significant increased changes in the levels of total WBC, lymphocytes, RBC, @GENE$, packed cell volume, platelets, mean corpuscular volume, and mean corpuscular hemoglobin in rats after 24, 48, and 72 h of continuous inhalation; however, there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of CK, g-GT, SOD, NO, MDA, AFP, IL-2, and TNFa were recorded.",
        "relation": "CPR:3"
    },
    {
        "id": "23614730.T1.T18",
        "sentence": "Results: The administration of @CHEMICAL$ 1.6% w/w created significant increased changes in the levels of total WBC, lymphocytes, RBC, hemoglobin, packed cell volume, platelets, mean corpuscular volume, and mean corpuscular @GENE$ in rats after 24, 48, and 72 h of continuous inhalation; however, there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48 h to return to normal after 72 h. Significant increases in the levels of CK, g-GT, SOD, NO, MDA, AFP, IL-2, and TNFa were recorded.",
        "relation": "CPR:3"
    },
    {
        "id": "17325667.T11.T29",
        "sentence": "Gene expression profiling (GEP) of GIST-S, GIST-R cells and two @CHEMICAL$ resistant GIST patients demonstrated that @GENE$ is downregulated implying a major role in IM resistance.",
        "relation": "CPR:4"
    },
    {
        "id": "17325667.T12.T29",
        "sentence": "Gene expression profiling (GEP) of GIST-S, GIST-R cells and two IM resistant GIST patients demonstrated that @CHEMICAL$ is downregulated implying a major role in @GENE$ resistance.",
        "relation": "CPR:4"
    },
    {
        "id": "17325667.T2.T28",
        "sentence": "Molecular modeling of the kinase domain of mutant c-Kit (V654A) and AXL showed no binding to IM but efficient binding to @CHEMICAL$, a novel c-Kit/AXL @GENE$ inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "17325667.T2.T26",
        "sentence": "Molecular modeling of the kinase domain of mutant c-Kit (V654A) and AXL showed no binding to IM but efficient binding to @CHEMICAL$, a novel @GENE$/AXL kinase inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "17325667.T2.T27",
        "sentence": "Molecular modeling of the kinase domain of mutant c-Kit (V654A) and AXL showed no binding to IM but efficient binding to @CHEMICAL$, a novel c-Kit/@GENE$ kinase inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "19568704.T1.T29",
        "sentence": "INTRODUCTION: In this study, we examined the effects of the @CHEMICAL$ inhibitors acarbose and @GENE$ on postprandial plasma glucose and serum triglyceride levels in patients with type 2 diabetes mellitus.",
        "relation": "CPR:4"
    },
    {
        "id": "19568704.T7.T29",
        "sentence": "INTRODUCTION: In this study, we examined the effects of the @CHEMICAL$ inhibitors acarbose and voglibose on postprandial plasma @GENE$ and serum triglyceride levels in patients with type 2 diabetes mellitus.",
        "relation": "CPR:4"
    },
    {
        "id": "19568704.T22.T29",
        "sentence": "INTRODUCTION: In this study, we examined the effects of the @CHEMICAL$ inhibitors @GENE$ and voglibose on postprandial plasma glucose and serum triglyceride levels in patients with type 2 diabetes mellitus.",
        "relation": "CPR:4"
    },
    {
        "id": "23535516.T3.T30",
        "sentence": "Blockade of @CHEMICAL$ and ERK pathways with @GENE$ and U0126, respectively, abrogated the myocardial infarct size reduction by NDP-a-MSH.",
        "relation": "CPR:4"
    },
    {
        "id": "23535516.T4.T31",
        "sentence": "Blockade of JAK and @CHEMICAL$ pathways with AG490 and @GENE$, respectively, abrogated the myocardial infarct size reduction by NDP-a-MSH.",
        "relation": "CPR:4"
    },
    {
        "id": "12392782.T1.T16",
        "sentence": "The @CHEMICAL$ pathway generates inflammatory @GENE$, while the 5-LOX pathway generates inflammatory leukotrienes.",
        "relation": "CPR:9"
    },
    {
        "id": "12392782.T2.T17",
        "sentence": "The COX pathway generates inflammatory prostaglandins, while the @CHEMICAL$ pathway generates inflammatory @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "12392782.T3.T19",
        "sentence": "They included the COX-1 inhibitor indomethacin; the @CHEMICAL$ inhibitor @GENE$; the mixed COX-1/COX-2 inhibitor ibuprofen; the nitric oxide (NO) derivatives of indomethacin, ibuprofen and flurbiprofen; the 5-LOX inhibitor REV 5901; and the 5-LOX activating protein (FLAP) inhibitor MK-886.",
        "relation": "CPR:4"
    },
    {
        "id": "12392782.T4.T20",
        "sentence": "They included the COX-1 inhibitor indomethacin; the COX-2 inhibitor NS-398; the mixed @CHEMICAL$/COX-2 inhibitor @GENE$; the nitric oxide (NO) derivatives of indomethacin, ibuprofen and flurbiprofen; the 5-LOX inhibitor REV 5901; and the 5-LOX activating protein (FLAP) inhibitor MK-886.",
        "relation": "CPR:4"
    },
    {
        "id": "12392782.T4.T21",
        "sentence": "They included the COX-1 inhibitor indomethacin; the COX-2 inhibitor NS-398; the mixed COX-1/@CHEMICAL$ inhibitor @GENE$; the nitric oxide (NO) derivatives of indomethacin, ibuprofen and flurbiprofen; the 5-LOX inhibitor REV 5901; and the 5-LOX activating protein (FLAP) inhibitor MK-886.",
        "relation": "CPR:4"
    },
    {
        "id": "12392782.T10.T22",
        "sentence": "They included the COX-1 inhibitor indomethacin; the COX-2 inhibitor NS-398; the mixed COX-1/COX-2 inhibitor ibuprofen; the nitric oxide (NO) derivatives of indomethacin, ibuprofen and flurbiprofen; the @CHEMICAL$ inhibitor @GENE$; and the 5-LOX activating protein (FLAP) inhibitor MK-886.",
        "relation": "CPR:4"
    },
    {
        "id": "12392782.T11.T23",
        "sentence": "They included the COX-1 inhibitor indomethacin; the COX-2 inhibitor NS-398; the mixed COX-1/COX-2 inhibitor ibuprofen; the nitric oxide (NO) derivatives of indomethacin, ibuprofen and flurbiprofen; the 5-LOX inhibitor REV 5901; and the @CHEMICAL$ (FLAP) inhibitor @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12392782.T11.T24",
        "sentence": "They included the COX-1 inhibitor indomethacin; the COX-2 inhibitor NS-398; the mixed COX-1/COX-2 inhibitor ibuprofen; the nitric oxide (NO) derivatives of indomethacin, ibuprofen and flurbiprofen; the 5-LOX inhibitor REV 5901; and the 5-LOX activating protein (@CHEMICAL$) inhibitor @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23639362.T5.T19",
        "sentence": "Additionally, @CHEMICAL$ significantly down-regulated @GENE$ expression in the mitochondria of dopaminergic cells in the SN, followed by an increase in Bax expression, cytochrome C translocation to the cytosol, andcleaved-caspase-3 expression, whereas these were inhibited by CRE or EB treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "23639362.T5.T20",
        "sentence": "Additionally, @CHEMICAL$ significantly down-regulated Bcl-2 expression in the mitochondria of dopaminergic cells in the SN, followed by an increase in @GENE$ expression, cytochrome C translocation to the cytosol, andcleaved-caspase-3 expression, whereas these were inhibited by CRE or EB treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "23639362.T5.T22",
        "sentence": "Additionally, @CHEMICAL$ significantly down-regulated Bcl-2 expression in the mitochondria of dopaminergic cells in the SN, followed by an increase in Bax expression, cytochrome C translocation to the cytosol, andcleaved-@GENE$ expression, whereas these were inhibited by CRE or EB treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "23386390.T9.T25",
        "sentence": "Add-on therapy with the @CHEMICAL$ inhibitor @GENE$ improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus.",
        "relation": "CPR:4"
    },
    {
        "id": "23386390.T8.T21",
        "sentence": "The @CHEMICAL$ (HbA1c) of all patients improved significantly from 8.1+1.2% to 7.6+1.1% after 12 weeks of add-on therapy with @GENE$ (p<0.01), and the insulin dosage was reduced from 27.3+15.8 U/day to 24.5+16.5 U/day (p<0.001).",
        "relation": "CPR:3"
    },
    {
        "id": "23386390.T8.T22",
        "sentence": "The hemoglobin A1c (@CHEMICAL$) of all patients improved significantly from 8.1+1.2% to 7.6+1.1% after 12 weeks of add-on therapy with @GENE$ (p<0.01), and the insulin dosage was reduced from 27.3+15.8 U/day to 24.5+16.5 U/day (p<0.001).",
        "relation": "CPR:3"
    },
    {
        "id": "16766717.T5.T14",
        "sentence": "In the present study, we have evaluated possible participation of @CHEMICAL$ (MCTs) responsible for the bidirectional membrane transport of @GENE$ in the cytoprotective property in osteoblasts.",
        "relation": "CPR:9"
    },
    {
        "id": "16766717.T5.T15",
        "sentence": "In the present study, we have evaluated possible participation of monocarboxylate transporters (@CHEMICAL$) responsible for the bidirectional membrane transport of @GENE$ in the cytoprotective property in osteoblasts.",
        "relation": "CPR:9"
    },
    {
        "id": "23247008.T2.T13",
        "sentence": "@CHEMICAL$, another mitochondrial enzyme sharing 72% identity with ALDH2, is also capable of metabolizing @GENE$ but has a tissue distribution and pattern of activity distinct from that of ALDH2.",
        "relation": "CPR:9"
    },
    {
        "id": "23247008.T2.T21",
        "sentence": "Mammalian ALDH1B1, another mitochondrial enzyme sharing 72% identity with @CHEMICAL$, is also capable of metabolizing @GENE$ but has a tissue distribution and pattern of activity distinct from that of ALDH2.",
        "relation": "CPR:9"
    },
    {
        "id": "2083404.T1.T29",
        "sentence": "@CHEMICAL$ (ASA) and other non-steroidal anti-inflammatory drugs, which are @GENE$ (COX) inhibitors, precipitate asthmatic attacks in ASA-intolerant patients, while sodium salicylate, hardly active on COX by itself, is well tolerated by these patients.",
        "relation": "CPR:4"
    },
    {
        "id": "2083404.T1.T30",
        "sentence": "@CHEMICAL$ (ASA) and other non-steroidal anti-inflammatory drugs, which are cyclooxygenase (@GENE$) inhibitors, precipitate asthmatic attacks in ASA-intolerant patients, while sodium salicylate, hardly active on COX by itself, is well tolerated by these patients.",
        "relation": "CPR:4"
    },
    {
        "id": "2083404.T21.T29",
        "sentence": "Aspirin (@CHEMICAL$) and other non-steroidal anti-inflammatory drugs, which are @GENE$ (COX) inhibitors, precipitate asthmatic attacks in ASA-intolerant patients, while sodium salicylate, hardly active on COX by itself, is well tolerated by these patients.",
        "relation": "CPR:4"
    },
    {
        "id": "2083404.T21.T30",
        "sentence": "Aspirin (@CHEMICAL$) and other non-steroidal anti-inflammatory drugs, which are cyclooxygenase (@GENE$) inhibitors, precipitate asthmatic attacks in ASA-intolerant patients, while sodium salicylate, hardly active on COX by itself, is well tolerated by these patients.",
        "relation": "CPR:4"
    },
    {
        "id": "2083404.T12.T28",
        "sentence": "However, salicylate moiety appears to interfere with @CHEMICAL$ inhibitory action on platelets and vascular @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "2083404.T6.T26",
        "sentence": "Although the precise mechanism of the protective action of trilisate is unknown, our data support the possibility of interaction between @CHEMICAL$ and ASA on @GENE$ locus in the respiratory tract in ASA-intolerant patients.",
        "relation": "CPR:4"
    },
    {
        "id": "2083404.T7.T26",
        "sentence": "Although the precise mechanism of the protective action of trilisate is unknown, our data support the possibility of interaction between salicylate and @CHEMICAL$ on @GENE$ locus in the respiratory tract in ASA-intolerant patients.",
        "relation": "CPR:4"
    },
    {
        "id": "11986668.T11.T21",
        "sentence": "@CHEMICAL$ inhibits @GENE$ release and delays progression of amyotrophic lateral sclerosis in mice.",
        "relation": "CPR:4"
    },
    {
        "id": "11986668.T8.T19",
        "sentence": "We find that @CHEMICAL$ inhibits mitochondrial permeability-transition-mediated @GENE$ release.",
        "relation": "CPR:4"
    },
    {
        "id": "11986668.T9.T20",
        "sentence": "@CHEMICAL$-mediated inhibition of @GENE$ release is demonstrated in vivo, in cells, and in isolated mitochondria.",
        "relation": "CPR:4"
    },
    {
        "id": "23578952.T8.T22",
        "sentence": "Here we studied the effects of the recently developed @CHEMICAL$ inhibitor @GENE$ on basal and stress-induced corticosterone levels in male CD1 mice, and found that this compound dramatically increased basal levels without affecting stress responses.",
        "relation": "CPR:4"
    },
    {
        "id": "23643933.T7.T17",
        "sentence": "Considerable attention has focused on the antitumor effect of @CHEMICAL$ inhibitor (@GENE$, TSA) as well as the coding gene expression-induced apoptosis of cancer cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23643933.T8.T17",
        "sentence": "Considerable attention has focused on the antitumor effect of @CHEMICAL$ inhibitor (Trichostatin A, @GENE$) as well as the coding gene expression-induced apoptosis of cancer cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23643933.T1.T18",
        "sentence": "Among these differentially expressed lncRNAs, the greatest change was noted for @CHEMICAL$, which had more than 300 folds induction upon @GENE$ treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "23643933.T2.T11",
        "sentence": "@CHEMICAL$ selectively induced @GENE$ in four studied HCC cell lines.",
        "relation": "CPR:3"
    },
    {
        "id": "23643933.T3.T13",
        "sentence": "The @CHEMICAL$-induced @GENE$ expression was positively correlated with the apoptotic effect of TSA in HCC cells.",
        "relation": "CPR:3"
    },
    {
        "id": "10730683.T10.T14",
        "sentence": "@CHEMICAL$, a new @GENE$ inhibitor for the management of obesity.",
        "relation": "CPR:4"
    },
    {
        "id": "10730683.T3.T12",
        "sentence": "@CHEMICAL$ treatment also results in modest improvements in total cholesterol, @GENE$, blood pressure, and fasting glucose and insulin concentrations.",
        "relation": "CPR:3"
    },
    {
        "id": "10730683.T3.T13",
        "sentence": "@CHEMICAL$ treatment also results in modest improvements in total cholesterol, low-density lipoprotein, blood pressure, and fasting glucose and @GENE$ concentrations.",
        "relation": "CPR:3"
    },
    {
        "id": "1663395.T4.T6",
        "sentence": "Evidence has accumulated in the last few years that the expression of the microsomal/peroxidase antigen (@CHEMICAL$) in thyroid cells is induced by TSH, through pathways which involve intracellular @GENE$ accumulation and protein synthesis.",
        "relation": "CPR:3"
    },
    {
        "id": "1663395.T4.T24",
        "sentence": "Evidence has accumulated in the last few years that the expression of the @CHEMICAL$ (M/TPO-Ag) in thyroid cells is induced by TSH, through pathways which involve intracellular @GENE$ accumulation and protein synthesis.",
        "relation": "CPR:3"
    },
    {
        "id": "1663395.T5.T21",
        "sentence": "TSH and @CHEMICAL$ also increase the levels of the specific mRNA for @GENE$ in thyroid cells from different species.",
        "relation": "CPR:3"
    },
    {
        "id": "23506741.T11.T27",
        "sentence": "A novel @CHEMICAL$ derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of @GENE$ inflammasome.",
        "relation": "CPR:4"
    },
    {
        "id": "23506741.T8.T20",
        "sentence": "In addition, the disease activity index, histopathologic scores and @CHEMICAL$ activity were also significantly reduced by @GENE$ treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "23506741.T9.T21",
        "sentence": "Moreover, protein and mRNA levels of DSS-induced proinflammatory @CHEMICAL$ in colon, including TNF-a, IL-1b, IL-18, IL-17A and IFN-g, were markedly suppressed by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23506741.T9.T22",
        "sentence": "Moreover, protein and mRNA levels of DSS-induced proinflammatory cytokines in colon, including @CHEMICAL$, IL-1b, IL-18, IL-17A and IFN-g, were markedly suppressed by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23506741.T9.T23",
        "sentence": "Moreover, protein and mRNA levels of DSS-induced proinflammatory cytokines in colon, including TNF-a, @CHEMICAL$, IL-18, IL-17A and IFN-g, were markedly suppressed by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23506741.T9.T24",
        "sentence": "Moreover, protein and mRNA levels of DSS-induced proinflammatory cytokines in colon, including TNF-a, IL-1b, @CHEMICAL$, IL-17A and IFN-g, were markedly suppressed by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23506741.T9.T25",
        "sentence": "Moreover, protein and mRNA levels of DSS-induced proinflammatory cytokines in colon, including TNF-a, IL-1b, IL-18, @CHEMICAL$ and IFN-g, were markedly suppressed by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23506741.T9.T26",
        "sentence": "Moreover, protein and mRNA levels of DSS-induced proinflammatory cytokines in colon, including TNF-a, IL-1b, IL-18, IL-17A and @CHEMICAL$, were markedly suppressed by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23506741.T1.T13",
        "sentence": "Furthermore, a decreased CD11c(+) macrophage infiltration in colons and inactivation of @CHEMICAL$ in peritoneal macrophages were detected in @GENE$-2-treated mice.",
        "relation": "CPR:4"
    },
    {
        "id": "23506741.T2.T14",
        "sentence": "The mechanism of action of @CHEMICAL$ was related to the inhibition of the cleavage of @GENE$, pro-IL-1b and pro-IL-18 which in turn suppressed the activation of NLRP3 inflammasome.",
        "relation": "CPR:4"
    },
    {
        "id": "23506741.T2.T15",
        "sentence": "The mechanism of action of @CHEMICAL$ was related to the inhibition of the cleavage of pro-caspase-1, @GENE$ and pro-IL-18 which in turn suppressed the activation of NLRP3 inflammasome.",
        "relation": "CPR:4"
    },
    {
        "id": "23506741.T2.T16",
        "sentence": "The mechanism of action of @CHEMICAL$ was related to the inhibition of the cleavage of pro-caspase-1, pro-IL-1b and @GENE$ which in turn suppressed the activation of NLRP3 inflammasome.",
        "relation": "CPR:4"
    },
    {
        "id": "23506741.T2.T17",
        "sentence": "The mechanism of action of @CHEMICAL$ was related to the inhibition of the cleavage of pro-caspase-1, pro-IL-1b and pro-IL-18 which in turn suppressed the activation of @GENE$ inflammasome.",
        "relation": "CPR:4"
    },
    {
        "id": "23506741.T3.T18",
        "sentence": "Taken together, our results demonstrate the ability of @CHEMICAL$ to inhibit @GENE$ inflammasome activation and its potential use in the treatment of inflammatory bowel diseases.",
        "relation": "CPR:4"
    },
    {
        "id": "17611273.T12.T22",
        "sentence": "At PND35, the medial prefrontal cortex (mPFC) of rats given @CHEMICAL$ showed 55% greater immunoreactivity (-ir) for the catecholamine marker @GENE$ (TH), 60% more Nissl-stained cells, and 40% less norepinephrine transporter (NET)-ir density.",
        "relation": "CPR:3"
    },
    {
        "id": "17611273.T12.T23",
        "sentence": "At PND35, the medial prefrontal cortex (mPFC) of rats given @CHEMICAL$ showed 55% greater immunoreactivity (-ir) for the catecholamine marker tyrosine hydroxylase (@GENE$), 60% more Nissl-stained cells, and 40% less norepinephrine transporter (NET)-ir density.",
        "relation": "CPR:3"
    },
    {
        "id": "17611273.T12.T24",
        "sentence": "At PND35, the medial prefrontal cortex (mPFC) of rats given @CHEMICAL$ showed 55% greater immunoreactivity (-ir) for the catecholamine marker tyrosine hydroxylase (TH), 60% more Nissl-stained cells, and 40% less @GENE$ (NET)-ir density.",
        "relation": "CPR:4"
    },
    {
        "id": "17611273.T12.T25",
        "sentence": "At PND35, the medial prefrontal cortex (mPFC) of rats given @CHEMICAL$ showed 55% greater immunoreactivity (-ir) for the catecholamine marker tyrosine hydroxylase (TH), 60% more Nissl-stained cells, and 40% less norepinephrine transporter (@GENE$)-ir density.",
        "relation": "CPR:4"
    },
    {
        "id": "17611273.T16.T18",
        "sentence": "In hippocampal dentate gyrus, @CHEMICAL$-receiving rats showed a 51% decrease in NET-ir density and a 61% expanded distribution of the new-cell marker PSA-NCAM (polysialylated form of @GENE$).",
        "relation": "CPR:3"
    },
    {
        "id": "17611273.T16.T26",
        "sentence": "In hippocampal dentate gyrus, @CHEMICAL$-receiving rats showed a 51% decrease in @GENE$-ir density and a 61% expanded distribution of the new-cell marker PSA-NCAM (polysialylated form of neural cell adhesion molecule).",
        "relation": "CPR:4"
    },
    {
        "id": "17611273.T16.T27",
        "sentence": "In hippocampal dentate gyrus, @CHEMICAL$-receiving rats showed a 51% decrease in NET-ir density and a 61% expanded distribution of the new-cell marker PSA-@GENE$ (polysialylated form of neural cell adhesion molecule).",
        "relation": "CPR:3"
    },
    {
        "id": "17611273.T1.T19",
        "sentence": "In medial striatum, @CHEMICAL$-ir decreased by 21%, and in hypothalamus neuropeptide Y-ir increased by 10% in @GENE$-exposed rats.",
        "relation": "CPR:4"
    },
    {
        "id": "17611273.T1.T20",
        "sentence": "In medial striatum, TH-ir decreased by 21%, and in hypothalamus @CHEMICAL$-ir increased by 10% in @GENE$-exposed rats.",
        "relation": "CPR:3"
    },
    {
        "id": "10082498.T19.T32",
        "sentence": "At 4 hours, losartan blocked 43% of the @CHEMICAL$-induced systolic blood pressure increase; @GENE$, 51%; and irbesartan, 88% (P<0.01 between drugs).",
        "relation": "CPR:4"
    },
    {
        "id": "10082498.T20.T32",
        "sentence": "At 4 hours, losartan blocked 43% of the @CHEMICAL$-induced systolic blood pressure increase; valsartan, 51%; and @GENE$, 88% (P<0.01 between drugs).",
        "relation": "CPR:4"
    },
    {
        "id": "10082498.T4.T24",
        "sentence": "This study thus demonstrates that the first administration of the recommended starting dose of @CHEMICAL$ induces a greater and longer lasting @GENE$ blockade than that of valsartan and losartan in normotensive subjects.",
        "relation": "CPR:4"
    },
    {
        "id": "10082498.T6.T24",
        "sentence": "This study thus demonstrates that the first administration of the recommended starting dose of irbesartan induces a greater and longer lasting @CHEMICAL$ blockade than that of @GENE$ and losartan in normotensive subjects.",
        "relation": "CPR:4"
    },
    {
        "id": "10082498.T7.T24",
        "sentence": "This study thus demonstrates that the first administration of the recommended starting dose of irbesartan induces a greater and longer lasting @CHEMICAL$ blockade than that of valsartan and @GENE$ in normotensive subjects.",
        "relation": "CPR:4"
    },
    {
        "id": "10226872.T15.T27",
        "sentence": "In humans, prolonged administration of the @CHEMICAL$ agonist @GENE$ leads to a desensitization of beta 2-adrenoceptor-mediated cardiovascular responses, which can be blunted by concomitant administration of the antianaphylactic drug ketotifen.",
        "relation": "CPR:5"
    },
    {
        "id": "10226872.T16.T29",
        "sentence": "beta 2-Adrenoceptor cardiovascular function was assessed by the increase in heart rate and reduction of diastolic blood pressure induced by an incremental intravenous infusion of the unselective @CHEMICAL$ agonist @GENE$; beta 1-adrenoceptor cardiovascular function was assessed by exercise-induced tachycardia.",
        "relation": "CPR:5"
    },
    {
        "id": "10362188.T12.T22",
        "sentence": "A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study. OBJECTIVES: This study examined the effect of a small-molecule, direct @CHEMICAL$ inhibitor, @GENE$, on reperfusion induced by tissue plasminogen activator (TPA) in patients with acute myocardial infarction (AMI).",
        "relation": "CPR:4"
    },
    {
        "id": "10362188.T7.T19",
        "sentence": "In vitro and in vivo studies have shown that @CHEMICAL$ has advantages over heparin for the inhibition of clot-bound @GENE$ and for the enhancement of thrombolysis with TPA.",
        "relation": "CPR:4"
    },
    {
        "id": "10373224.T1.T31",
        "sentence": "The functional inhibitory characteristics of the @CHEMICAL$ blockers (ARB) candesartan; @GENE$; and losartan and its active metabolite EXP 3174 (EXP) were studied in rabbit aortic strips and rat portal vein preparations in vitro.",
        "relation": "CPR:4"
    },
    {
        "id": "10373224.T24.T31",
        "sentence": "The functional inhibitory characteristics of the @CHEMICAL$ blockers (ARB) @GENE$; irbesartan; and losartan and its active metabolite EXP 3174 (EXP) were studied in rabbit aortic strips and rat portal vein preparations in vitro.",
        "relation": "CPR:4"
    },
    {
        "id": "10373224.T3.T31",
        "sentence": "The functional inhibitory characteristics of the @CHEMICAL$ blockers (ARB) candesartan; irbesartan; and @GENE$ and its active metabolite EXP 3174 (EXP) were studied in rabbit aortic strips and rat portal vein preparations in vitro.",
        "relation": "CPR:4"
    },
    {
        "id": "10373224.T8.T31",
        "sentence": "The functional inhibitory characteristics of the @CHEMICAL$ blockers (ARB) candesartan; irbesartan; and losartan and its active metabolite @GENE$ (EXP) were studied in rabbit aortic strips and rat portal vein preparations in vitro.",
        "relation": "CPR:4"
    },
    {
        "id": "10373224.T9.T31",
        "sentence": "The functional inhibitory characteristics of the @CHEMICAL$ blockers (ARB) candesartan; irbesartan; and losartan and its active metabolite EXP 3174 (@GENE$) were studied in rabbit aortic strips and rat portal vein preparations in vitro.",
        "relation": "CPR:4"
    },
    {
        "id": "10373224.T15.T32",
        "sentence": "In both vascular preparations, @CHEMICAL$ caused a marked decrease in the maximal contractile response of the @GENE$ (Ang II) concentration-response curve.",
        "relation": "CPR:4"
    },
    {
        "id": "10373224.T15.T33",
        "sentence": "In both vascular preparations, @CHEMICAL$ caused a marked decrease in the maximal contractile response of the angiotensin II (@GENE$) concentration-response curve.",
        "relation": "CPR:4"
    },
    {
        "id": "10373224.T6.T29",
        "sentence": "In addition, when @CHEMICAL$ was given to conscious rats, the inhibitory effect on @GENE$-induced blood pressure responses persisted during the 24-hour period despite nondetectable plasma concentrations of candesartan at 24 hours.",
        "relation": "CPR:4"
    },
    {
        "id": "10373224.T12.T30",
        "sentence": "At clinically relevant concentrations, @CHEMICAL$ is an insurmountable and long-lasting antagonist of the vascular contractile responses to @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "10381787.T11.T21",
        "sentence": "Dose-dependent inhibition of platelet @CHEMICAL$ and monocyte cyclooxygenase-2 by @GENE$ in healthy subjects.",
        "relation": "CPR:4"
    },
    {
        "id": "10381787.T11.T22",
        "sentence": "Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte @CHEMICAL$ by @GENE$ in healthy subjects.",
        "relation": "CPR:4"
    },
    {
        "id": "10381787.T5.T17",
        "sentence": "Concentration-response curves for the inhibition of monocyte @CHEMICAL$ and platelet COX-1 were obtained in vitro after the incubation of @GENE$ with whole blood samples.",
        "relation": "CPR:4"
    },
    {
        "id": "10381787.T5.T18",
        "sentence": "Concentration-response curves for the inhibition of monocyte COX-2 and platelet @CHEMICAL$ were obtained in vitro after the incubation of @GENE$ with whole blood samples.",
        "relation": "CPR:4"
    },
    {
        "id": "10381787.T8.T19",
        "sentence": "Before dosing and 24 h after the seventh dose of each regimen, heparinized whole blood samples were incubated with lipopolysaccharide (10 microgram/ml) for 24 h at 37 degrees C, and @CHEMICAL$ was measured in plasma as an index of monocyte @GENE$ activity.",
        "relation": "CPR:9"
    },
    {
        "id": "10381787.T9.T20",
        "sentence": "The production of @CHEMICAL$ in whole blood allowed to clot at 37 degrees C for 60 min was assessed as an index of platelet @GENE$ activity.",
        "relation": "CPR:9"
    },
    {
        "id": "10381787.T2.T13",
        "sentence": "In contrast, the administration of 7.5 and 15 mg of @CHEMICAL$ caused dose-dependent reductions in monocyte @GENE$ activity by 51% and 70%, respectively, and in platelet COX-1 activity by 25% and 35%, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "10381787.T2.T14",
        "sentence": "In contrast, the administration of 7.5 and 15 mg of @CHEMICAL$ caused dose-dependent reductions in monocyte COX-2 activity by 51% and 70%, respectively, and in platelet @GENE$ activity by 25% and 35%, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "10381787.T3.T15",
        "sentence": "Although the IC50 value of @CHEMICAL$ for inhibition of @GENE$ was 10-fold higher than the IC50 value of COX-2 in vitro, this biochemical selectivity was inadequate to clearly separate the effects of meloxicam on the two isozymes after oral dosing as a function of the daily dose and interindividual variation in steady-state plasma levels.",
        "relation": "CPR:4"
    },
    {
        "id": "10381787.T3.T16",
        "sentence": "Although the IC50 value of @CHEMICAL$ for inhibition of COX-1 was 10-fold higher than the IC50 value of @GENE$ in vitro, this biochemical selectivity was inadequate to clearly separate the effects of meloxicam on the two isozymes after oral dosing as a function of the daily dose and interindividual variation in steady-state plasma levels.",
        "relation": "CPR:4"
    },
    {
        "id": "10432475.T27.T52",
        "sentence": "In distinction, the preferential @CHEMICAL$ antagonist, @GENE$, and the preferential beta 2-AR antagonist, ICI118,551, did not increase basal levels of DA, NAD, or 5-HT.",
        "relation": "CPR:6"
    },
    {
        "id": "10432475.T28.T53",
        "sentence": "In distinction, the preferential beta 1-AR antagonist, betaxolol, and the preferential @CHEMICAL$ antagonist, @GENE$, did not increase basal levels of DA, NAD, or 5-HT.",
        "relation": "CPR:6"
    },
    {
        "id": "10432475.T35.T55",
        "sentence": "The selective @CHEMICAL$ receptor antagonist, @GENE$, slightly attenuated the (-)-pindolol-induced increase in DA and NAD levels, while the selective 5-HT1B antagonist, SB224,289, was ineffective.",
        "relation": "CPR:6"
    },
    {
        "id": "10432475.T39.T57",
        "sentence": "The selective 5-HT1A receptor antagonist, WAY100,635, slightly attenuated the (-)-pindolol-induced increase in DA and NAD levels, while the selective @CHEMICAL$ antagonist, @GENE$, was ineffective.",
        "relation": "CPR:6"
    },
    {
        "id": "10439935.T5.T26",
        "sentence": "UNLABELLED: @CHEMICAL$ is a potent and specific peripheral @GENE$ (COMT) inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "10439935.T5.T28",
        "sentence": "UNLABELLED: @CHEMICAL$ is a potent and specific peripheral catechol-O-methyltransferase (@GENE$) inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "10460702.T22.T44",
        "sentence": "@CHEMICAL$ evokes @GENE$ activation in bovine aortic endothelial cell cultures.",
        "relation": "CPR:3"
    },
    {
        "id": "10460702.T19.T32",
        "sentence": "Activation of @CHEMICAL$ (eNOS) results in the production of @GENE$ (NO) that mediates the vasorelaxing properties of endothelial cells.",
        "relation": "CPR:9"
    },
    {
        "id": "10460702.T19.T38",
        "sentence": "Activation of endothelial nitric oxide synthase (@CHEMICAL$) results in the production of @GENE$ (NO) that mediates the vasorelaxing properties of endothelial cells.",
        "relation": "CPR:9"
    },
    {
        "id": "10460702.T20.T32",
        "sentence": "Activation of @CHEMICAL$ (eNOS) results in the production of nitric oxide (@GENE$) that mediates the vasorelaxing properties of endothelial cells.",
        "relation": "CPR:9"
    },
    {
        "id": "10460702.T20.T38",
        "sentence": "Activation of endothelial nitric oxide synthase (@CHEMICAL$) results in the production of nitric oxide (@GENE$) that mediates the vasorelaxing properties of endothelial cells.",
        "relation": "CPR:9"
    },
    {
        "id": "10460702.T11.T37",
        "sentence": "Here, we tested the hypothesis that 5-HT receptors mediate @CHEMICAL$ activation by measuring agonist-stimulated @GENE$ ([3H]L-Cit) formation in BAEC cultures.",
        "relation": "CPR:9"
    },
    {
        "id": "10460702.T12.T37",
        "sentence": "Here, we tested the hypothesis that 5-HT receptors mediate @CHEMICAL$ activation by measuring agonist-stimulated [3H]L-citrulline (@GENE$) formation in BAEC cultures.",
        "relation": "CPR:9"
    },
    {
        "id": "10460702.T13.T39",
        "sentence": "We found that @CHEMICAL$ stimulated the conversion of [3H]L-arginine ([3H]L-Arg) to [3H]L-Cit, indicating @GENE$ activation.",
        "relation": "CPR:3"
    },
    {
        "id": "10460702.T14.T39",
        "sentence": "We found that 5-HT stimulated the conversion of @CHEMICAL$ ([3H]L-Arg) to [3H]L-Cit, indicating @GENE$ activation.",
        "relation": "CPR:9"
    },
    {
        "id": "10460702.T15.T39",
        "sentence": "We found that 5-HT stimulated the conversion of [3H]L-arginine (@CHEMICAL$) to [3H]L-Cit, indicating @GENE$ activation.",
        "relation": "CPR:9"
    },
    {
        "id": "10460702.T16.T39",
        "sentence": "We found that 5-HT stimulated the conversion of [3H]L-arginine ([3H]L-Arg) to @CHEMICAL$, indicating @GENE$ activation.",
        "relation": "CPR:9"
    },
    {
        "id": "10460702.T17.T40",
        "sentence": "The high affinity @CHEMICAL$ receptor agonist, @GENE$ (5-NOT)-stimulated [3H]L-Cit turnover responses were concentration-(0.01 nM to 100 microM) and time-dependent.",
        "relation": "CPR:5"
    },
    {
        "id": "10460702.T1.T24",
        "sentence": "These responses were effectively blocked by the 5-HT1B receptor antagonist, isamoltane, the 5-HT1B/5-HT2 receptor antagonist, methiothepin, and the @CHEMICAL$ selective antagonists (0.01-10 microM): @GENE$ (L-NMMA) and L-N omega-iminoethyl-L-ornithine (L-NIO).",
        "relation": "CPR:6"
    },
    {
        "id": "10460702.T21.T43",
        "sentence": "These responses were effectively blocked by the 5-HT1B receptor antagonist, isamoltane, the 5-HT1B/@CHEMICAL$ antagonist, @GENE$, and the eNOS selective antagonists (0.01-10 microM): L-Nomega -monomethyl-L-arginine (L-NMMA) and L-N omega-iminoethyl-L-ornithine (L-NIO).",
        "relation": "CPR:6"
    },
    {
        "id": "10460702.T21.T42",
        "sentence": "These responses were effectively blocked by the 5-HT1B receptor antagonist, isamoltane, the @CHEMICAL$/5-HT2 receptor antagonist, @GENE$, and the eNOS selective antagonists (0.01-10 microM): L-Nomega -monomethyl-L-arginine (L-NMMA) and L-N omega-iminoethyl-L-ornithine (L-NIO).",
        "relation": "CPR:6"
    },
    {
        "id": "10460702.T2.T24",
        "sentence": "These responses were effectively blocked by the 5-HT1B receptor antagonist, isamoltane, the 5-HT1B/5-HT2 receptor antagonist, methiothepin, and the @CHEMICAL$ selective antagonists (0.01-10 microM): L-Nomega -monomethyl-L-arginine (@GENE$) and L-N omega-iminoethyl-L-ornithine (L-NIO).",
        "relation": "CPR:6"
    },
    {
        "id": "10460702.T3.T24",
        "sentence": "These responses were effectively blocked by the 5-HT1B receptor antagonist, isamoltane, the 5-HT1B/5-HT2 receptor antagonist, methiothepin, and the @CHEMICAL$ selective antagonists (0.01-10 microM): L-Nomega -monomethyl-L-arginine (L-NMMA) and @GENE$ (L-NIO).",
        "relation": "CPR:6"
    },
    {
        "id": "10460702.T4.T24",
        "sentence": "These responses were effectively blocked by the 5-HT1B receptor antagonist, isamoltane, the 5-HT1B/5-HT2 receptor antagonist, methiothepin, and the @CHEMICAL$ selective antagonists (0.01-10 microM): L-Nomega -monomethyl-L-arginine (L-NMMA) and L-N omega-iminoethyl-L-ornithine (@GENE$).",
        "relation": "CPR:6"
    },
    {
        "id": "10460702.T5.T31",
        "sentence": "These findings lend evidence of a 5-HT1B receptor/eNOS pathway, accounting in part for the activation of @CHEMICAL$ by @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "10531013.T6.T13",
        "sentence": "@CHEMICAL$ inhibits the checkpoint @GENE$ ATM.",
        "relation": "CPR:4"
    },
    {
        "id": "10531013.T6.T14",
        "sentence": "@CHEMICAL$ inhibits the checkpoint kinase @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "10531013.T1.T8",
        "sentence": "We report that the radiation-induced activation of the kinase Cds1 [4] (also known as Chk2 [5]) is inhibited by caffeine in vivo and that ATM @CHEMICAL$ activity is directly inhibited by @GENE$ in vitro.",
        "relation": "CPR:4"
    },
    {
        "id": "10531013.T1.T7",
        "sentence": "We report that the radiation-induced activation of the kinase Cds1 [4] (also known as Chk2 [5]) is inhibited by caffeine in vivo and that @CHEMICAL$ kinase activity is directly inhibited by @GENE$ in vitro.",
        "relation": "CPR:4"
    },
    {
        "id": "10531013.T5.T10",
        "sentence": "We report that the radiation-induced activation of the @CHEMICAL$ Cds1 [4] (also known as Chk2 [5]) is inhibited by @GENE$ in vivo and that ATM kinase activity is directly inhibited by caffeine in vitro.",
        "relation": "CPR:4"
    },
    {
        "id": "10531013.T5.T11",
        "sentence": "We report that the radiation-induced activation of the kinase @CHEMICAL$ [4] (also known as Chk2 [5]) is inhibited by @GENE$ in vivo and that ATM kinase activity is directly inhibited by caffeine in vitro.",
        "relation": "CPR:4"
    },
    {
        "id": "10531013.T5.T12",
        "sentence": "We report that the radiation-induced activation of the kinase Cds1 [4] (also known as @CHEMICAL$ [5]) is inhibited by @GENE$ in vivo and that ATM kinase activity is directly inhibited by caffeine in vitro.",
        "relation": "CPR:4"
    },
    {
        "id": "10531013.T2.T9",
        "sentence": "Inhibition of @CHEMICAL$ provides a molecular explanation of the attenuation of DNA-damage checkpoint responses and for the increased radiosensitivity of @GENE$-treated cells [6] [7] [8].",
        "relation": "CPR:4"
    },
    {
        "id": "10546982.T2.T12",
        "sentence": "The turnover of @CHEMICAL$ was determined from the rate of recovery of binding after administration of @GENE$, an irreversible inhibitor of ligand binding.",
        "relation": "CPR:4"
    },
    {
        "id": "10546982.T3.T13",
        "sentence": "In preliminary studies, in vitro incubation of rat cerebral cortex with @CHEMICAL$ produced a wash and temperature resistant inhibition of @GENE$ binding densities (Bmax).",
        "relation": "CPR:4"
    },
    {
        "id": "10546982.T5.T14",
        "sentence": "Citalopram protected against the @CHEMICAL$-induced inhibition of @GENE$ binding.",
        "relation": "CPR:4"
    },
    {
        "id": "10546982.T1.T11",
        "sentence": "The decrease and recovery of @CHEMICAL$ uptake correlated highly (r = 0.93) with the recovery of @GENE$ binding.",
        "relation": "CPR:9"
    },
    {
        "id": "10579749.T20.T42",
        "sentence": "@CHEMICAL$ was the first, but by no means remained the only, @GENE$ receptor antagonist.",
        "relation": "CPR:6"
    },
    {
        "id": "10579749.T1.T44",
        "sentence": "Among the current @CHEMICAL$ receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: candesartan 1, telmisartan 10, E3174 (the active metabolite of @GENE$) 10, tasosartan 20, losartan 50, eprosartan 100 and the prodrug candesartan cilexetil 280.",
        "relation": "CPR:6"
    },
    {
        "id": "10579749.T2.T44",
        "sentence": "Among the current @CHEMICAL$ receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: candesartan 1, telmisartan 10, E3174 (the active metabolite of losartan) 10, @GENE$ 20, losartan 50, eprosartan 100 and the prodrug candesartan cilexetil 280.",
        "relation": "CPR:6"
    },
    {
        "id": "10579749.T30.T44",
        "sentence": "Among the current @CHEMICAL$ receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: @GENE$ 1, telmisartan 10, E3174 (the active metabolite of losartan) 10, tasosartan 20, losartan 50, eprosartan 100 and the prodrug candesartan cilexetil 280.",
        "relation": "CPR:6"
    },
    {
        "id": "10579749.T31.T44",
        "sentence": "Among the current @CHEMICAL$ receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: candesartan 1, @GENE$ 10, E3174 (the active metabolite of losartan) 10, tasosartan 20, losartan 50, eprosartan 100 and the prodrug candesartan cilexetil 280.",
        "relation": "CPR:6"
    },
    {
        "id": "10579749.T32.T44",
        "sentence": "Among the current @CHEMICAL$ receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: candesartan 1, telmisartan 10, @GENE$ (the active metabolite of losartan) 10, tasosartan 20, losartan 50, eprosartan 100 and the prodrug candesartan cilexetil 280.",
        "relation": "CPR:6"
    },
    {
        "id": "10579749.T3.T44",
        "sentence": "Among the current @CHEMICAL$ receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: candesartan 1, telmisartan 10, E3174 (the active metabolite of losartan) 10, tasosartan 20, @GENE$ 50, eprosartan 100 and the prodrug candesartan cilexetil 280.",
        "relation": "CPR:6"
    },
    {
        "id": "10579749.T4.T44",
        "sentence": "Among the current @CHEMICAL$ receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: candesartan 1, telmisartan 10, E3174 (the active metabolite of losartan) 10, tasosartan 20, losartan 50, @GENE$ 100 and the prodrug candesartan cilexetil 280.",
        "relation": "CPR:6"
    },
    {
        "id": "10579749.T5.T44",
        "sentence": "Among the current @CHEMICAL$ receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: candesartan 1, telmisartan 10, E3174 (the active metabolite of losartan) 10, tasosartan 20, losartan 50, eprosartan 100 and the prodrug @GENE$ 280.",
        "relation": "CPR:6"
    },
    {
        "id": "10579749.T10.T34",
        "sentence": "The mode of (functional) @CHEMICAL$ receptor antagonism has been characterized as surmountable/noncompetitive (losartan, tasosartan, eprosartan) or insurmountable/noncompetitive (candesartan, @GENE$, zolasartan, irbesartan, valsartan, telmisartan, E3174).",
        "relation": "CPR:6"
    },
    {
        "id": "10579749.T11.T34",
        "sentence": "The mode of (functional) @CHEMICAL$ receptor antagonism has been characterized as surmountable/noncompetitive (losartan, tasosartan, eprosartan) or insurmountable/noncompetitive (candesartan, saprisartan, @GENE$, irbesartan, valsartan, telmisartan, E3174).",
        "relation": "CPR:6"
    },
    {
        "id": "10579749.T12.T34",
        "sentence": "The mode of (functional) @CHEMICAL$ receptor antagonism has been characterized as surmountable/noncompetitive (losartan, tasosartan, eprosartan) or insurmountable/noncompetitive (candesartan, saprisartan, zolasartan, @GENE$, valsartan, telmisartan, E3174).",
        "relation": "CPR:6"
    },
    {
        "id": "10579749.T13.T34",
        "sentence": "The mode of (functional) @CHEMICAL$ receptor antagonism has been characterized as surmountable/noncompetitive (losartan, tasosartan, eprosartan) or insurmountable/noncompetitive (candesartan, saprisartan, zolasartan, irbesartan, @GENE$, telmisartan, E3174).",
        "relation": "CPR:6"
    },
    {
        "id": "10579749.T14.T34",
        "sentence": "The mode of (functional) @CHEMICAL$ receptor antagonism has been characterized as surmountable/noncompetitive (losartan, tasosartan, eprosartan) or insurmountable/noncompetitive (candesartan, saprisartan, zolasartan, irbesartan, valsartan, @GENE$, E3174).",
        "relation": "CPR:6"
    },
    {
        "id": "10579749.T15.T34",
        "sentence": "The mode of (functional) @CHEMICAL$ receptor antagonism has been characterized as surmountable/noncompetitive (losartan, tasosartan, eprosartan) or insurmountable/noncompetitive (candesartan, saprisartan, zolasartan, irbesartan, valsartan, telmisartan, @GENE$).",
        "relation": "CPR:6"
    },
    {
        "id": "10579749.T6.T34",
        "sentence": "The mode of (functional) @CHEMICAL$ receptor antagonism has been characterized as surmountable/noncompetitive (@GENE$, tasosartan, eprosartan) or insurmountable/noncompetitive (candesartan, saprisartan, zolasartan, irbesartan, valsartan, telmisartan, E3174).",
        "relation": "CPR:6"
    },
    {
        "id": "10579749.T7.T34",
        "sentence": "The mode of (functional) @CHEMICAL$ receptor antagonism has been characterized as surmountable/noncompetitive (losartan, @GENE$, eprosartan) or insurmountable/noncompetitive (candesartan, saprisartan, zolasartan, irbesartan, valsartan, telmisartan, E3174).",
        "relation": "CPR:6"
    },
    {
        "id": "10579749.T8.T34",
        "sentence": "The mode of (functional) @CHEMICAL$ receptor antagonism has been characterized as surmountable/noncompetitive (losartan, tasosartan, @GENE$) or insurmountable/noncompetitive (candesartan, saprisartan, zolasartan, irbesartan, valsartan, telmisartan, E3174).",
        "relation": "CPR:6"
    },
    {
        "id": "10579749.T9.T34",
        "sentence": "The mode of (functional) @CHEMICAL$ receptor antagonism has been characterized as surmountable/noncompetitive (losartan, tasosartan, eprosartan) or insurmountable/noncompetitive (@GENE$, saprisartan, zolasartan, irbesartan, valsartan, telmisartan, E3174).",
        "relation": "CPR:6"
    },
    {
        "id": "10683249.T2.T19",
        "sentence": "@CHEMICAL$ are flavoproteins that catalyze two-electron reduction and detoxification of @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "10683249.T11.T29",
        "sentence": "A role of cytosolic @CHEMICAL$ in protection of cells from oxidative stress, cytotoxicity, and mutagenicity of @GENE$ was established.",
        "relation": "CPR:9"
    },
    {
        "id": "10683249.T14.T33",
        "sentence": "The @CHEMICAL$ activity showed significantly higher affinity for NADH than NADPH as electron donors and catalyzed reduction of @GENE$ and menadione.",
        "relation": "CPR:9"
    },
    {
        "id": "10683249.T15.T33",
        "sentence": "The @CHEMICAL$ activity showed significantly higher affinity for NADH than NADPH as electron donors and catalyzed reduction of 2,6-dichlorophenolindophenol and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "10683249.T16.T35",
        "sentence": "The mNQO activity was insensitive to @CHEMICAL$, a potent inhibitor of cytosolic @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "10688973.T5.T32",
        "sentence": "The @CHEMICAL$-selective agonist @GENE$ potently and competitively displaced [3H]nociceptin at rat brain receptors (IC(50) 62 nM).",
        "relation": "CPR:5"
    },
    {
        "id": "10688973.T6.T33",
        "sentence": "@CHEMICAL$ exhibited full agonism for enhancement of [35S]GTPgammaS binding to human recombinant @GENE$ receptors (EC(50) 50 nM).",
        "relation": "CPR:5"
    },
    {
        "id": "10688973.T10.T36",
        "sentence": "The related piperidines ohmefentanyl and @CHEMICAL$ and the nonselective opioid receptor agonist etorphine were less potent @GENE$ agonists.",
        "relation": "CPR:5"
    },
    {
        "id": "10688973.T11.T35",
        "sentence": "The related piperidines ohmefentanyl and sufentanil and the nonselective @CHEMICAL$ agonist @GENE$ were less potent nociceptin receptor agonists.",
        "relation": "CPR:5"
    },
    {
        "id": "10688973.T11.T36",
        "sentence": "The related piperidines ohmefentanyl and sufentanil and the nonselective opioid receptor agonist @CHEMICAL$ were less potent @GENE$ agonists.",
        "relation": "CPR:5"
    },
    {
        "id": "10688973.T8.T36",
        "sentence": "The related @CHEMICAL$ ohmefentanyl and sufentanil and the nonselective opioid receptor agonist etorphine were less potent @GENE$ agonists.",
        "relation": "CPR:5"
    },
    {
        "id": "10688973.T9.T36",
        "sentence": "The related piperidines @CHEMICAL$ and sufentanil and the nonselective opioid receptor agonist etorphine were less potent @GENE$ agonists.",
        "relation": "CPR:5"
    },
    {
        "id": "10688973.T12.T14",
        "sentence": "The kappa(1)+kappa(3)-opioid receptor agonist/mu-opioid receptor antagonist @CHEMICAL$ was a pure antagonist at both rat brain and human @GENE$ receptors.",
        "relation": "CPR:6"
    },
    {
        "id": "10688973.T12.T37",
        "sentence": "The kappa(1)+kappa(3)-opioid receptor agonist/@CHEMICAL$ antagonist @GENE$ was a pure antagonist at both rat brain and human ORL1 receptors.",
        "relation": "CPR:6"
    },
    {
        "id": "10688973.T1.T15",
        "sentence": "The nonselective @CHEMICAL$ partial agonist @GENE$ and the nonselective opioid receptor antagonist (-)-quadazocine exhibited pure antagonism at rat brain receptors, but displayed partial agonism at human ORL1 receptors.",
        "relation": "CPR:5"
    },
    {
        "id": "10688973.T2.T16",
        "sentence": "The nonselective opioid receptor partial agonist buprenorphine and the nonselective @CHEMICAL$ antagonist @GENE$ exhibited pure antagonism at rat brain receptors, but displayed partial agonism at human ORL1 receptors.",
        "relation": "CPR:6"
    },
    {
        "id": "10688973.T2.T19",
        "sentence": "The nonselective opioid receptor partial agonist buprenorphine and the nonselective opioid receptor antagonist @CHEMICAL$ exhibited pure antagonism at rat brain receptors, but displayed partial agonism at @GENE$ receptors.",
        "relation": "CPR:5"
    },
    {
        "id": "10697523.T2.T20",
        "sentence": "@CHEMICAL$ and thymidine kinase are key enzymes involved in the de novo and salvage pathways for @GENE$ synthesis, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "10697523.T2.T22",
        "sentence": "Thymidylate synthase and @CHEMICAL$ are key enzymes involved in the de novo and salvage pathways for @GENE$ synthesis, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "10697523.T4.T21",
        "sentence": "@CHEMICAL$ is inhibited by @GENE$, forming an inactive ternary complex with intracellular folate.",
        "relation": "CPR:4"
    },
    {
        "id": "10697523.T12.T23",
        "sentence": "Thirty-week administration of @CHEMICAL$ with or without leucovorin markedly suppressed both colorectal carcinogenesis and tumor growth, resulted in the increase of @GENE$ inhibition and the decrease of thymidine kinase activity in the tumor cells.",
        "relation": "CPR:4"
    },
    {
        "id": "10697523.T12.T24",
        "sentence": "Thirty-week administration of @CHEMICAL$ with or without leucovorin markedly suppressed both colorectal carcinogenesis and tumor growth, resulted in the increase of thymidylate synthase inhibition and the decrease of @GENE$ activity in the tumor cells.",
        "relation": "CPR:4"
    },
    {
        "id": "10697523.T13.T23",
        "sentence": "Thirty-week administration of UFT with or without @CHEMICAL$ markedly suppressed both colorectal carcinogenesis and tumor growth, resulted in the increase of @GENE$ inhibition and the decrease of thymidine kinase activity in the tumor cells.",
        "relation": "CPR:4"
    },
    {
        "id": "10697523.T13.T24",
        "sentence": "Thirty-week administration of UFT with or without @CHEMICAL$ markedly suppressed both colorectal carcinogenesis and tumor growth, resulted in the increase of thymidylate synthase inhibition and the decrease of @GENE$ activity in the tumor cells.",
        "relation": "CPR:4"
    },
    {
        "id": "10698696.T2.T13",
        "sentence": "Ornithine decarboxylase (@CHEMICAL$) catalyses the first step in the synthesis of the polyamines putrescine, @GENE$ and spermine.",
        "relation": "CPR:9"
    },
    {
        "id": "10698696.T2.T6",
        "sentence": "@CHEMICAL$ (ODC) catalyses the first step in the synthesis of the polyamines putrescine, @GENE$ and spermine.",
        "relation": "CPR:9"
    },
    {
        "id": "10698696.T3.T13",
        "sentence": "Ornithine decarboxylase (@CHEMICAL$) catalyses the first step in the synthesis of the polyamines putrescine, spermidine and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "10698696.T3.T6",
        "sentence": "@CHEMICAL$ (ODC) catalyses the first step in the synthesis of the polyamines putrescine, spermidine and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "10698696.T4.T13",
        "sentence": "Ornithine decarboxylase (@CHEMICAL$) catalyses the first step in the synthesis of the polyamines @GENE$, spermidine and spermine.",
        "relation": "CPR:9"
    },
    {
        "id": "10698696.T4.T6",
        "sentence": "@CHEMICAL$ (ODC) catalyses the first step in the synthesis of the polyamines @GENE$, spermidine and spermine.",
        "relation": "CPR:9"
    },
    {
        "id": "10742288.T2.T22",
        "sentence": "In untransfected CHL cells, noradrenaline had no effect at concentrations up to 100 microM. In @CHEMICAL$ transfected cells the rank order of agonist potency was @GENE$ (mean pEC(50)=8.96)>dexmedetomidine (8.88)>UK-14304 (8.42)>B-HT 920 (7.05)>noradrenaline (6.92).",
        "relation": "CPR:5"
    },
    {
        "id": "10742288.T3.T22",
        "sentence": "In untransfected CHL cells, noradrenaline had no effect at concentrations up to 100 microM. In @CHEMICAL$ transfected cells the rank order of agonist potency was A-54741 (mean pEC(50)=8.96)>@GENE$ (8.88)>UK-14304 (8.42)>B-HT 920 (7.05)>noradrenaline (6.92).",
        "relation": "CPR:5"
    },
    {
        "id": "10742288.T4.T22",
        "sentence": "In untransfected CHL cells, noradrenaline had no effect at concentrations up to 100 microM. In @CHEMICAL$ transfected cells the rank order of agonist potency was A-54741 (mean pEC(50)=8.96)>dexmedetomidine (8.88)>@GENE$ (8.42)>B-HT 920 (7.05)>noradrenaline (6.92).",
        "relation": "CPR:5"
    },
    {
        "id": "10742288.T5.T22",
        "sentence": "In untransfected CHL cells, noradrenaline had no effect at concentrations up to 100 microM. In @CHEMICAL$ transfected cells the rank order of agonist potency was A-54741 (mean pEC(50)=8.96)>dexmedetomidine (8.88)>UK-14304 (8.42)>@GENE$ (7.05)>noradrenaline (6.92).",
        "relation": "CPR:5"
    },
    {
        "id": "10742288.T6.T22",
        "sentence": "In untransfected CHL cells, noradrenaline had no effect at concentrations up to 100 microM. In @CHEMICAL$ transfected cells the rank order of agonist potency was A-54741 (mean pEC(50)=8.96)>dexmedetomidine (8.88)>UK-14304 (8.42)>B-HT 920 (7.05)>@GENE$ (6.92).",
        "relation": "CPR:5"
    },
    {
        "id": "10796070.T10.T18",
        "sentence": "@CHEMICAL$ were activated by @GENE$ as assessed using a glucocorticoid-responsive reporter plasmid, pTAT3-CAT.",
        "relation": "CPR:3"
    },
    {
        "id": "10796070.T2.T11",
        "sentence": "The @CHEMICAL$ antagonist @GENE$ (mifepristone) significantly counteracted the effect of dexamethasone on glucocorticoid receptor activation, indicating that the dexamethasone effect is specific and is mediated through the glucocorticoid receptor.",
        "relation": "CPR:6"
    },
    {
        "id": "10796070.T3.T11",
        "sentence": "The @CHEMICAL$ antagonist RU-486 (@GENE$) significantly counteracted the effect of dexamethasone on glucocorticoid receptor activation, indicating that the dexamethasone effect is specific and is mediated through the glucocorticoid receptor.",
        "relation": "CPR:6"
    },
    {
        "id": "10839333.T7.T20",
        "sentence": "RESULTS: @CHEMICAL$ was an effective antipsychotic and improved the extrapyramidal symptoms and @GENE$ level elevation noted at baseline.",
        "relation": "CPR:3"
    },
    {
        "id": "10887187.T7.T23",
        "sentence": "In a physiological K(+) gradient, @CHEMICAL$ is half inhibited by 0.1 mm @GENE$, quinine, and quinidine.",
        "relation": "CPR:4"
    },
    {
        "id": "10887187.T8.T23",
        "sentence": "In a physiological K(+) gradient, @CHEMICAL$ is half inhibited by 0.1 mm Ba(2+), @GENE$, and quinidine.",
        "relation": "CPR:4"
    },
    {
        "id": "10887187.T9.T23",
        "sentence": "In a physiological K(+) gradient, @CHEMICAL$ is half inhibited by 0.1 mm Ba(2+), quinine, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "10917903.T21.T32",
        "sentence": "Initial in vitro studies utilizing HEP-G2 liver cells revealed that addition of @CHEMICAL$ (EPA) blocked @GENE$ activity, the terminal enzymatic step in AA synthesis.",
        "relation": "CPR:4"
    },
    {
        "id": "10917903.T22.T32",
        "sentence": "Initial in vitro studies utilizing HEP-G2 liver cells revealed that addition of eicosapentaenoic acid (@CHEMICAL$) blocked @GENE$ activity, the terminal enzymatic step in AA synthesis.",
        "relation": "CPR:4"
    },
    {
        "id": "10931813.T7.T21",
        "sentence": "BACKGROUND: This study examines the effects of @CHEMICAL$, a @GENE$ opener, on transmural dispersion of repolarization (TDR) and induction of torsade de pointes (TdP) under conditions mimicking the LQT1, LQT2, and LQT3 forms of the congenital long-QT syndrome (LQTS).",
        "relation": "CPR:3"
    },
    {
        "id": "10931813.T10.T22",
        "sentence": "Isoproterenol (50 to 100 nmol/L) was used to mimic an increase in beta-adrenergic tone, @CHEMICAL$ (100 micromol/L) to block @GENE$ (LQT2 model), and ATX-II (20 nmol/L) to augment late I(Na) (LQT3 model).",
        "relation": "CPR:4"
    },
    {
        "id": "10931813.T10.T23",
        "sentence": "Isoproterenol (50 to 100 nmol/L) was used to mimic an increase in beta-adrenergic tone, @CHEMICAL$ (100 micromol/L) to block I(Kr) (LQT2 model), and @GENE$ (20 nmol/L) to augment late I(Na) (LQT3 model).",
        "relation": "CPR:4"
    },
    {
        "id": "10931813.T8.T22",
        "sentence": "@CHEMICAL$ (50 to 100 nmol/L) was used to mimic an increase in beta-adrenergic tone, d-sotalol (100 micromol/L) to block @GENE$ (LQT2 model), and ATX-II (20 nmol/L) to augment late I(Na) (LQT3 model).",
        "relation": "CPR:4"
    },
    {
        "id": "10931813.T8.T23",
        "sentence": "@CHEMICAL$ (50 to 100 nmol/L) was used to mimic an increase in beta-adrenergic tone, d-sotalol (100 micromol/L) to block I(Kr) (LQT2 model), and @GENE$ (20 nmol/L) to augment late I(Na) (LQT3 model).",
        "relation": "CPR:4"
    },
    {
        "id": "10933891.T10.T14",
        "sentence": "Peroxisome proliferator-activated receptor alpha (PPARalpha) activators, bezafibrate and Wy-14,643, increase uncoupling protein-3 mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes. @CHEMICAL$ (UCPs) are inner mitochondrial membrane transporters which act as pores for @GENE$ ions, dissipating the electrochemical gradient that develops during mitochondrial respiration at the expense of ATP synthesis.",
        "relation": "CPR:9"
    },
    {
        "id": "10933891.T10.T18",
        "sentence": "Peroxisome proliferator-activated receptor alpha (PPARalpha) activators, bezafibrate and Wy-14,643, increase uncoupling protein-3 mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes. Uncoupling proteins (@CHEMICAL$) are inner mitochondrial membrane transporters which act as pores for @GENE$ ions, dissipating the electrochemical gradient that develops during mitochondrial respiration at the expense of ATP synthesis.",
        "relation": "CPR:9"
    },
    {
        "id": "10933891.T12.T30",
        "sentence": "@CHEMICAL$ (PPARalpha) activators, @GENE$ and Wy-14,643, increase uncoupling protein-3 mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes. Uncoupling proteins (UCPs) are inner mitochondrial membrane transporters which act as pores for H(+) ions, dissipating the electrochemical gradient that develops during mitochondrial respiration at the expense of ATP synthesis.",
        "relation": "CPR:3"
    },
    {
        "id": "10933891.T12.T31",
        "sentence": "Peroxisome proliferator-activated receptor alpha (PPARalpha) activators, @CHEMICAL$ and Wy-14,643, increase @GENE$ mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes. Uncoupling proteins (UCPs) are inner mitochondrial membrane transporters which act as pores for H(+) ions, dissipating the electrochemical gradient that develops during mitochondrial respiration at the expense of ATP synthesis.",
        "relation": "CPR:3"
    },
    {
        "id": "10933891.T12.T32",
        "sentence": "Peroxisome proliferator-activated receptor alpha (@CHEMICAL$) activators, @GENE$ and Wy-14,643, increase uncoupling protein-3 mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes. Uncoupling proteins (UCPs) are inner mitochondrial membrane transporters which act as pores for H(+) ions, dissipating the electrochemical gradient that develops during mitochondrial respiration at the expense of ATP synthesis.",
        "relation": "CPR:3"
    },
    {
        "id": "10933891.T13.T30",
        "sentence": "@CHEMICAL$ (PPARalpha) activators, bezafibrate and @GENE$, increase uncoupling protein-3 mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes. Uncoupling proteins (UCPs) are inner mitochondrial membrane transporters which act as pores for H(+) ions, dissipating the electrochemical gradient that develops during mitochondrial respiration at the expense of ATP synthesis.",
        "relation": "CPR:3"
    },
    {
        "id": "10933891.T13.T31",
        "sentence": "Peroxisome proliferator-activated receptor alpha (PPARalpha) activators, bezafibrate and @CHEMICAL$, increase @GENE$ mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes. Uncoupling proteins (UCPs) are inner mitochondrial membrane transporters which act as pores for H(+) ions, dissipating the electrochemical gradient that develops during mitochondrial respiration at the expense of ATP synthesis.",
        "relation": "CPR:3"
    },
    {
        "id": "10933891.T13.T32",
        "sentence": "Peroxisome proliferator-activated receptor alpha (@CHEMICAL$) activators, bezafibrate and @GENE$, increase uncoupling protein-3 mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes. Uncoupling proteins (UCPs) are inner mitochondrial membrane transporters which act as pores for H(+) ions, dissipating the electrochemical gradient that develops during mitochondrial respiration at the expense of ATP synthesis.",
        "relation": "CPR:3"
    },
    {
        "id": "10933891.T9.T23",
        "sentence": "Thus, @CHEMICAL$ treatment resulted in an 8-fold induction in @GENE$ mRNA levels in preadipocytes compared with the 3.5-fold induction observed in adipocytes.",
        "relation": "CPR:3"
    },
    {
        "id": "10933891.T1.T15",
        "sentence": "The induction in @CHEMICAL$ expression was not accompanied by changes in the mitochondrial membrane potential of rat primary preadipocytes after @GENE$ or Wy-14,643 treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "10933891.T2.T15",
        "sentence": "The induction in @CHEMICAL$ expression was not accompanied by changes in the mitochondrial membrane potential of rat primary preadipocytes after bezafibrate or @GENE$ treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "10933891.T3.T17",
        "sentence": "Since it has been proposed that UCP-3 could be involved in the regulation of the use of fatty acids as fuel substrates, the @CHEMICAL$ induction achieved after @GENE$ and Wy-14, 643 treatment may indicate a higher oxidation of fatty acids, limiting their availability to be stored as triglycerides.",
        "relation": "CPR:3"
    },
    {
        "id": "10933891.T4.T17",
        "sentence": "Since it has been proposed that UCP-3 could be involved in the regulation of the use of fatty acids as fuel substrates, the @CHEMICAL$ induction achieved after bezafibrate and @GENE$ treatment may indicate a higher oxidation of fatty acids, limiting their availability to be stored as triglycerides.",
        "relation": "CPR:3"
    },
    {
        "id": "10939639.T12.T20",
        "sentence": "@CHEMICAL$ protects against menadione-induced hepatotoxicity by enhancing @GENE$ activity. Pretreating mice with schisandrin B (Sch B), a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis, at a daily dose of 1 mmol/kg for 3 days protected against menadione-induced hepatic oxidative damage in mice, as evidenced by decreases in plasma alanine aminotransferase activity (78%) and hepatic malondialdehyde level (70%), when compared with the menadione intoxicated control.",
        "relation": "CPR:3"
    },
    {
        "id": "10939639.T2.T14",
        "sentence": "Schisandrin B protects against menadione-induced hepatotoxicity by enhancing DT-diaphorase activity. Pretreating mice with schisandrin B (Sch B), a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis, at a daily dose of 1 mmol/kg for 3 days protected against @CHEMICAL$-induced hepatic oxidative damage in mice, as evidenced by decreases in plasma @GENE$ activity (78%) and hepatic malondialdehyde level (70%), when compared with the menadione intoxicated control.",
        "relation": "CPR:4"
    },
    {
        "id": "10939639.T9.T17",
        "sentence": "Hepatocytes isolated from @CHEMICAL$ pretreated (a daily dose of 1 mmol/kg for 3 days) rats showed a significant increase (25%) in @GENE$ activity.",
        "relation": "CPR:3"
    },
    {
        "id": "10939639.T11.T19",
        "sentence": "The ensemble of results suggests that the ability of @CHEMICAL$ pretreatment to enhance hepatocellular @GENE$ activity may at least in part be attributed to the protection against menadione hepatotoxicity.",
        "relation": "CPR:3"
    },
    {
        "id": "10942908.T12.T19",
        "sentence": "The group treated with @CHEMICAL$ alone showed decreased plasma @GENE$ (BChE) activity (87% of control), whereas pyridostigmine plus exercise significantly decreased the BChE activity (79% of control), indicating an interactive effect of the combination.",
        "relation": "CPR:4"
    },
    {
        "id": "10942908.T12.T20",
        "sentence": "The group treated with @CHEMICAL$ alone showed decreased plasma butyrylcholinesterase (@GENE$) activity (87% of control), whereas pyridostigmine plus exercise significantly decreased the BChE activity (79% of control), indicating an interactive effect of the combination.",
        "relation": "CPR:4"
    },
    {
        "id": "10942908.T13.T21",
        "sentence": "The group treated with pyridostigmine alone showed decreased plasma butyrylcholinesterase (BChE) activity (87% of control), whereas @CHEMICAL$ plus exercise significantly decreased the @GENE$ activity (79% of control), indicating an interactive effect of the combination.",
        "relation": "CPR:4"
    },
    {
        "id": "10942908.T1.T16",
        "sentence": "However, @CHEMICAL$ activity in triceps muscle decreased significantly (78% of control) in the group treated with @GENE$ plus exercise.",
        "relation": "CPR:4"
    },
    {
        "id": "10942908.T3.T17",
        "sentence": "@CHEMICAL$ activity in plasma increased slightly (compared to control, @GENE$ or exercise group) in mice treated with pyridostigmine plus exercise, which may be indicative of perturbation in the integrity of the skeletal muscle due to combination.",
        "relation": "CPR:3"
    },
    {
        "id": "10942908.T4.T17",
        "sentence": "@CHEMICAL$ activity in plasma increased slightly (compared to control, pyridostigmine or exercise group) in mice treated with @GENE$ plus exercise, which may be indicative of perturbation in the integrity of the skeletal muscle due to combination.",
        "relation": "CPR:3"
    },
    {
        "id": "11056242.T2.T9",
        "sentence": "RESULT(S): Buserelin acetate, a GnRH agonist (0.1-10 ng/mL), had no significant effect on MCP-1 expression, whereas @CHEMICAL$ (10(-7)-10(-5) M), a testosterone analog, and dexamethasone, an anti-inflammatory glucocorticoid hormone (10(-12)-10(-6)M), showed a direct and a dose-dependent inhibitory effect on @GENE$ expression.",
        "relation": "CPR:4"
    },
    {
        "id": "11056242.T3.T9",
        "sentence": "RESULT(S): Buserelin acetate, a GnRH agonist (0.1-10 ng/mL), had no significant effect on MCP-1 expression, whereas danazol (10(-7)-10(-5) M), a @CHEMICAL$ analog, and dexamethasone, an anti-inflammatory glucocorticoid hormone (10(-12)-10(-6)M), showed a direct and a dose-dependent inhibitory effect on @GENE$ expression.",
        "relation": "CPR:4"
    },
    {
        "id": "11056242.T4.T9",
        "sentence": "RESULT(S): Buserelin acetate, a GnRH agonist (0.1-10 ng/mL), had no significant effect on MCP-1 expression, whereas danazol (10(-7)-10(-5) M), a testosterone analog, and @CHEMICAL$, an anti-inflammatory glucocorticoid hormone (10(-12)-10(-6)M), showed a direct and a dose-dependent inhibitory effect on @GENE$ expression.",
        "relation": "CPR:4"
    },
    {
        "id": "11056242.T6.T15",
        "sentence": "RESULT(S): @CHEMICAL$, a @GENE$ agonist (0.1-10 ng/mL), had no significant effect on MCP-1 expression, whereas danazol (10(-7)-10(-5) M), a testosterone analog, and dexamethasone, an anti-inflammatory glucocorticoid hormone (10(-12)-10(-6)M), showed a direct and a dose-dependent inhibitory effect on MCP-1 expression.",
        "relation": "CPR:5"
    },
    {
        "id": "11146120.T5.T26",
        "sentence": "The present studies were undertaken to compare two compounds, a @CHEMICAL$ analogue (CB1093) with minimal calcaemic effects, and clenbuterol, a long-acting beta(2)-adrenoceptor agonist, both of which induce @GENE$ synthesis in vivo.",
        "relation": "CPR:4"
    },
    {
        "id": "11146120.T6.T26",
        "sentence": "The present studies were undertaken to compare two compounds, a vitamin D(3) analogue (@CHEMICAL$) with minimal calcaemic effects, and clenbuterol, a long-acting beta(2)-adrenoceptor agonist, both of which induce @GENE$ synthesis in vivo.",
        "relation": "CPR:3"
    },
    {
        "id": "11146120.T7.T24",
        "sentence": "The present studies were undertaken to compare two compounds, a vitamin D(3) analogue (CB1093) with minimal calcaemic effects, and @CHEMICAL$, a long-acting @GENE$ agonist, both of which induce NGF synthesis in vivo.",
        "relation": "CPR:5"
    },
    {
        "id": "11146120.T7.T26",
        "sentence": "The present studies were undertaken to compare two compounds, a vitamin D(3) analogue (CB1093) with minimal calcaemic effects, and @CHEMICAL$, a long-acting beta(2)-adrenoceptor agonist, both of which induce @GENE$ synthesis in vivo.",
        "relation": "CPR:3"
    },
    {
        "id": "11146120.T8.T27",
        "sentence": "@CHEMICAL$ caused significant increases in both @GENE$ mRNA and protein in 3T3 cells; with maxima at 10 nM and at 8-12 h exposure.",
        "relation": "CPR:3"
    },
    {
        "id": "11146120.T11.T30",
        "sentence": "Mobility shift assays on whole cell extracts showed that @CHEMICAL$ increased AP1 binding in 3T3 cells prior to increasing @GENE$ synthesis.",
        "relation": "CPR:3"
    },
    {
        "id": "11146120.T13.T32",
        "sentence": "Clenbuterol was without effect on NGF mRNA levels in L929 cells, whereas @CHEMICAL$ caused significant increases in both @GENE$ mRNA and protein levels in both 3T3 and L929 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "11146120.T3.T21",
        "sentence": "This study demonstrates that @CHEMICAL$ and clenbuterol stimulate @GENE$ levels in vitro and that AP-1 binding could be a commonality between the mechanism of NGF induction of these two compounds.",
        "relation": "CPR:3"
    },
    {
        "id": "11146120.T3.T23",
        "sentence": "This study demonstrates that @CHEMICAL$ and clenbuterol stimulate NGF levels in vitro and that AP-1 binding could be a commonality between the mechanism of @GENE$ induction of these two compounds.",
        "relation": "CPR:3"
    },
    {
        "id": "11146120.T4.T21",
        "sentence": "This study demonstrates that CB1093 and @CHEMICAL$ stimulate @GENE$ levels in vitro and that AP-1 binding could be a commonality between the mechanism of NGF induction of these two compounds.",
        "relation": "CPR:3"
    },
    {
        "id": "11146120.T4.T23",
        "sentence": "This study demonstrates that CB1093 and @CHEMICAL$ stimulate NGF levels in vitro and that AP-1 binding could be a commonality between the mechanism of @GENE$ induction of these two compounds.",
        "relation": "CPR:3"
    },
    {
        "id": "11157886.T8.T21",
        "sentence": "Protective effect of @CHEMICAL$ anesthesia on retinal light damage: inhibition of metabolic @GENE$ regeneration.",
        "relation": "CPR:4"
    },
    {
        "id": "11157886.T6.T17",
        "sentence": "RESULTS: @CHEMICAL$ anesthesia reversibly inhibited metabolic @GENE$ regeneration and thus prevented rhodopsin from absorbing high numbers of photons during light exposure.",
        "relation": "CPR:4"
    },
    {
        "id": "11157886.T6.T18",
        "sentence": "RESULTS: @CHEMICAL$ anesthesia reversibly inhibited metabolic rhodopsin regeneration and thus prevented @GENE$ from absorbing high numbers of photons during light exposure.",
        "relation": "CPR:4"
    },
    {
        "id": "11157886.T2.T10",
        "sentence": "CONCLUSIONS: After the initial bleach, @CHEMICAL$ impeded photon absorption by rhodopsin by inhibiting metabolic @GENE$ regeneration.",
        "relation": "CPR:4"
    },
    {
        "id": "11243491.T25.T34",
        "sentence": "OBJECTIVES: The present study was aimed at investigating the action of various antidepressant drugs in 4- and 40-week-old male mice using the mouse forced swimming test and determining the involvement of 5-HT1A and 5-HT1B receptors mediating the effects. METHODS: Different classes of antidepressants [imipramine (tricyclic), maprotiline (noradrenline reuptake inhibitor), venlafaxine (mixed serotonin and noradrenaline reuptake inhibitors), fluvoxamine and sertraline (selective serotonin reuptake inhibitor)] were tested in the same randomised experimental session, alone and in combination with 5-HT1A and 5-HT1B receptor agonists [@CHEMICAL$ (partial @GENE$ agonist), anpirtoline (5-HT1B agonist)] in the mouse forced swimming test.",
        "relation": "CPR:5"
    },
    {
        "id": "11243491.T26.T35",
        "sentence": "OBJECTIVES: The present study was aimed at investigating the action of various antidepressant drugs in 4- and 40-week-old male mice using the mouse forced swimming test and determining the involvement of 5-HT1A and 5-HT1B receptors mediating the effects. METHODS: Different classes of antidepressants [imipramine (tricyclic), maprotiline (noradrenline reuptake inhibitor), venlafaxine (mixed serotonin and noradrenaline reuptake inhibitors), fluvoxamine and sertraline (selective serotonin reuptake inhibitor)] were tested in the same randomised experimental session, alone and in combination with 5-HT1A and 5-HT1B receptor agonists [buspirone (partial 5-HT1A agonist), @CHEMICAL$ (@GENE$ agonist)] in the mouse forced swimming test.",
        "relation": "CPR:5"
    },
    {
        "id": "11252887.T1.T12",
        "sentence": "@CHEMICAL$ (Alimta, LY231514) is a novel, multitargeted antifolate that inhibits thymidylate synthase, @GENE$, and glycinamide ribonucleotide formyl transferase.",
        "relation": "CPR:4"
    },
    {
        "id": "11252887.T1.T13",
        "sentence": "@CHEMICAL$ (Alimta, LY231514) is a novel, multitargeted antifolate that inhibits thymidylate synthase, dihydrofolate reductase, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "11252887.T1.T14",
        "sentence": "@CHEMICAL$ (Alimta, LY231514) is a novel, multitargeted antifolate that inhibits @GENE$, dihydrofolate reductase, and glycinamide ribonucleotide formyl transferase.",
        "relation": "CPR:4"
    },
    {
        "id": "11252887.T4.T12",
        "sentence": "Pemetrexed disodium (@CHEMICAL$, LY231514) is a novel, multitargeted antifolate that inhibits thymidylate synthase, @GENE$, and glycinamide ribonucleotide formyl transferase.",
        "relation": "CPR:4"
    },
    {
        "id": "11252887.T4.T13",
        "sentence": "Pemetrexed disodium (@CHEMICAL$, LY231514) is a novel, multitargeted antifolate that inhibits thymidylate synthase, dihydrofolate reductase, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "11252887.T4.T14",
        "sentence": "Pemetrexed disodium (@CHEMICAL$, LY231514) is a novel, multitargeted antifolate that inhibits @GENE$, dihydrofolate reductase, and glycinamide ribonucleotide formyl transferase.",
        "relation": "CPR:4"
    },
    {
        "id": "11252887.T6.T12",
        "sentence": "Pemetrexed disodium (Alimta, @CHEMICAL$) is a novel, multitargeted antifolate that inhibits thymidylate synthase, @GENE$, and glycinamide ribonucleotide formyl transferase.",
        "relation": "CPR:4"
    },
    {
        "id": "11252887.T6.T13",
        "sentence": "Pemetrexed disodium (Alimta, @CHEMICAL$) is a novel, multitargeted antifolate that inhibits thymidylate synthase, dihydrofolate reductase, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "11252887.T6.T14",
        "sentence": "Pemetrexed disodium (Alimta, @CHEMICAL$) is a novel, multitargeted antifolate that inhibits @GENE$, dihydrofolate reductase, and glycinamide ribonucleotide formyl transferase.",
        "relation": "CPR:4"
    },
    {
        "id": "11304699.T1.T17",
        "sentence": "To mechanistically evaluate this regional selectivity, we assessed @CHEMICAL$ (COX-2) expression in the uninvolved mucosa and demonstrated a 3- to 4-fold excess in the distal relative to the proximal bowel in both MIN mice and @GENE$-treated rats.",
        "relation": "CPR:3"
    },
    {
        "id": "11304699.T1.T18",
        "sentence": "To mechanistically evaluate this regional selectivity, we assessed cyclo-oxygenase-2 (@CHEMICAL$) expression in the uninvolved mucosa and demonstrated a 3- to 4-fold excess in the distal relative to the proximal bowel in both MIN mice and @GENE$-treated rats.",
        "relation": "CPR:3"
    },
    {
        "id": "11309392.T7.T26",
        "sentence": "@CHEMICAL$ (DGK) catalyzes the conversion of @GENE$ to phosphatidic acid, making it an attractive candidate for a signal transduction component.",
        "relation": "CPR:9"
    },
    {
        "id": "11309392.T7.T27",
        "sentence": "Diacylglycerol kinase (@CHEMICAL$) catalyzes the conversion of @GENE$ to phosphatidic acid, making it an attractive candidate for a signal transduction component.",
        "relation": "CPR:9"
    },
    {
        "id": "11309392.T8.T26",
        "sentence": "@CHEMICAL$ (DGK) catalyzes the conversion of diacylglycerol to @GENE$, making it an attractive candidate for a signal transduction component.",
        "relation": "CPR:9"
    },
    {
        "id": "11309392.T8.T27",
        "sentence": "Diacylglycerol kinase (@CHEMICAL$) catalyzes the conversion of diacylglycerol to @GENE$, making it an attractive candidate for a signal transduction component.",
        "relation": "CPR:9"
    },
    {
        "id": "11309392.T1.T12",
        "sentence": "We took advantage of the previous observations that @CHEMICAL$ inhibits @GENE$ (reviewed by Sakane, F., Imai, S., Kai, M., Wada, I., and Kanoh, H. (1996) J. Biol.",
        "relation": "CPR:4"
    },
    {
        "id": "11318430.T1.T10",
        "sentence": "@CHEMICAL$ (NDGA) has been shown to inhibit both 5-lipoxygenase and @GENE$ and is active against several cancer cell lines and at least one mouse tumor model.",
        "relation": "CPR:4"
    },
    {
        "id": "11318430.T1.T9",
        "sentence": "@CHEMICAL$ (NDGA) has been shown to inhibit both @GENE$ and ornithine decarboxylase and is active against several cancer cell lines and at least one mouse tumor model.",
        "relation": "CPR:4"
    },
    {
        "id": "11318430.T3.T10",
        "sentence": "Nordihydroguaiaretic acid (@CHEMICAL$) has been shown to inhibit both 5-lipoxygenase and @GENE$ and is active against several cancer cell lines and at least one mouse tumor model.",
        "relation": "CPR:4"
    },
    {
        "id": "11318430.T3.T9",
        "sentence": "Nordihydroguaiaretic acid (@CHEMICAL$) has been shown to inhibit both @GENE$ and ornithine decarboxylase and is active against several cancer cell lines and at least one mouse tumor model.",
        "relation": "CPR:4"
    },
    {
        "id": "11392054.T24.T25",
        "sentence": "@CHEMICAL$ (CA) is a zinc enzyme that catalyses the reversible hydration reaction of @GENE$ and plays a major role in the acid-base balance.",
        "relation": "CPR:9"
    },
    {
        "id": "11392054.T24.T31",
        "sentence": "Carbonic anhydrase (@CHEMICAL$) is a zinc enzyme that catalyses the reversible hydration reaction of @GENE$ and plays a major role in the acid-base balance.",
        "relation": "CPR:9"
    },
    {
        "id": "11393267.T6.T18",
        "sentence": "The temporal profile of butyrylcholinesterase (BuChE) and in vitro @CHEMICAL$-reactivated @GENE$ was studied in a cohort of 25 organophosphate-poisoned patients to examine their relationship to the development of intermediate syndrome and to understand reasons for lack of efficacy of oxime treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "11393267.T7.T17",
        "sentence": "Reactivation potentials of @CHEMICAL$ (the difference between @GENE$-reactivated and -unreactivated enzyme activity) declined significantly with time after organophosphate ingestion.",
        "relation": "CPR:3"
    },
    {
        "id": "11393267.T8.T17",
        "sentence": "Reactivation potentials of @CHEMICAL$ (the difference between oxime-reactivated and -unreactivated enzyme activity) declined significantly with time after @GENE$ ingestion.",
        "relation": "CPR:4"
    },
    {
        "id": "11393267.T1.T11",
        "sentence": "Patients who received @CHEMICAL$ prior to hospitalization had a higher rate of intermediate syndrome and lower levels of @GENE$ at admission than those who had not.",
        "relation": "CPR:4"
    },
    {
        "id": "11481271.T16.T29",
        "sentence": "The segments were contracted with the @CHEMICAL$ agonists @GENE$, apraclonidine, and oxymetazoline.",
        "relation": "CPR:5"
    },
    {
        "id": "11481271.T17.T29",
        "sentence": "The segments were contracted with the @CHEMICAL$ agonists brimonidine, @GENE$, and oxymetazoline.",
        "relation": "CPR:5"
    },
    {
        "id": "11481271.T18.T29",
        "sentence": "The segments were contracted with the @CHEMICAL$ agonists brimonidine, apraclonidine, and @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "11481271.T20.T33",
        "sentence": "The following alpha(2)-adrenoceptor antagonists were applied: @CHEMICAL$ (@GENE$-selective), ARC239 (alpha(2B)- and alpha(2C)-selective), and prazosin (alpha(2B)- and alpha(2C)-selective).",
        "relation": "CPR:6"
    },
    {
        "id": "11481271.T21.T34",
        "sentence": "The following alpha(2)-adrenoceptor antagonists were applied: BRL44408 (alpha(2A)-selective), @CHEMICAL$ (@GENE$- and alpha(2C)-selective), and prazosin (alpha(2B)- and alpha(2C)-selective).",
        "relation": "CPR:6"
    },
    {
        "id": "11481271.T21.T35",
        "sentence": "The following alpha(2)-adrenoceptor antagonists were applied: BRL44408 (alpha(2A)-selective), @CHEMICAL$ (alpha(2B)- and @GENE$-selective), and prazosin (alpha(2B)- and alpha(2C)-selective).",
        "relation": "CPR:6"
    },
    {
        "id": "11481271.T22.T36",
        "sentence": "The following alpha(2)-adrenoceptor antagonists were applied: BRL44408 (alpha(2A)-selective), ARC239 (alpha(2B)- and alpha(2C)-selective), and @CHEMICAL$ (@GENE$- and alpha(2C)-selective).",
        "relation": "CPR:6"
    },
    {
        "id": "11481271.T22.T37",
        "sentence": "The following alpha(2)-adrenoceptor antagonists were applied: BRL44408 (alpha(2A)-selective), ARC239 (alpha(2B)- and alpha(2C)-selective), and @CHEMICAL$ (alpha(2B)- and @GENE$-selective).",
        "relation": "CPR:6"
    },
    {
        "id": "11481271.T1.T38",
        "sentence": "RESULTS: The @CHEMICAL$ agonists induced vasoconstriction in the porcine ciliary artery with the following potency order (EC(50)) expressed in nanomolar: @GENE$ 2.11, oxymetazoline 5.26, and apraclonidine 13.0.",
        "relation": "CPR:5"
    },
    {
        "id": "11481271.T2.T38",
        "sentence": "RESULTS: The @CHEMICAL$ agonists induced vasoconstriction in the porcine ciliary artery with the following potency order (EC(50)) expressed in nanomolar: brimonidine 2.11, @GENE$ 5.26, and apraclonidine 13.0.",
        "relation": "CPR:5"
    },
    {
        "id": "11481271.T3.T38",
        "sentence": "RESULTS: The @CHEMICAL$ agonists induced vasoconstriction in the porcine ciliary artery with the following potency order (EC(50)) expressed in nanomolar: brimonidine 2.11, oxymetazoline 5.26, and @GENE$ 13.0.",
        "relation": "CPR:5"
    },
    {
        "id": "11481271.T10.T24",
        "sentence": "Schild analyses for the antagonists against brimonidine yielded regression lines with slopes of unity and functional antagonist potencies (pK(B)) for @CHEMICAL$ (7.8), ARC 239 (5.8) and for prazosin (6.0) suggesting the presence of functional @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "11481271.T11.T24",
        "sentence": "Schild analyses for the antagonists against brimonidine yielded regression lines with slopes of unity and functional antagonist potencies (pK(B)) for BRL44408 (7.8), @CHEMICAL$ (5.8) and for prazosin (6.0) suggesting the presence of functional @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "11481271.T12.T24",
        "sentence": "Schild analyses for the antagonists against brimonidine yielded regression lines with slopes of unity and functional antagonist potencies (pK(B)) for BRL44408 (7.8), ARC 239 (5.8) and for @CHEMICAL$ (6.0) suggesting the presence of functional @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "11481271.T13.T26",
        "sentence": "CONCLUSIONS: The @CHEMICAL$ agonists @GENE$, apraclonidine, and oxymetazoline are potent vasoconstrictors in the porcine ciliary artery.",
        "relation": "CPR:5"
    },
    {
        "id": "11481271.T14.T26",
        "sentence": "CONCLUSIONS: The @CHEMICAL$ agonists brimonidine, @GENE$, and oxymetazoline are potent vasoconstrictors in the porcine ciliary artery.",
        "relation": "CPR:5"
    },
    {
        "id": "11481271.T15.T26",
        "sentence": "CONCLUSIONS: The @CHEMICAL$ agonists brimonidine, apraclonidine, and @GENE$ are potent vasoconstrictors in the porcine ciliary artery.",
        "relation": "CPR:5"
    },
    {
        "id": "11742712.T1.T14",
        "sentence": "@CHEMICAL$ (ALIMTA) is a novel antimetabolite that inhibits at least three folate-dependent enzymes, @GENE$, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase.",
        "relation": "CPR:4"
    },
    {
        "id": "11742712.T1.T15",
        "sentence": "@CHEMICAL$ (ALIMTA) is a novel antimetabolite that inhibits at least three folate-dependent enzymes, thymidylate synthase, @GENE$, and glycinamide ribonucleotide formyltransferase.",
        "relation": "CPR:4"
    },
    {
        "id": "11742712.T1.T16",
        "sentence": "@CHEMICAL$ (ALIMTA) is a novel antimetabolite that inhibits at least three folate-dependent enzymes, thymidylate synthase, dihydrofolate reductase, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "11742712.T6.T14",
        "sentence": "Pemetrexed disodium (@CHEMICAL$) is a novel antimetabolite that inhibits at least three folate-dependent enzymes, @GENE$, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase.",
        "relation": "CPR:4"
    },
    {
        "id": "11742712.T6.T15",
        "sentence": "Pemetrexed disodium (@CHEMICAL$) is a novel antimetabolite that inhibits at least three folate-dependent enzymes, thymidylate synthase, @GENE$, and glycinamide ribonucleotide formyltransferase.",
        "relation": "CPR:4"
    },
    {
        "id": "11742712.T6.T16",
        "sentence": "Pemetrexed disodium (@CHEMICAL$) is a novel antimetabolite that inhibits at least three folate-dependent enzymes, thymidylate synthase, dihydrofolate reductase, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "11752472.T19.T34",
        "sentence": "@CHEMICAL$ is present exclusively in the mitochondria, making this compartment the sole site of synthesis of @GENE$ in the plant cell.",
        "relation": "CPR:9"
    },
    {
        "id": "11772142.T7.T33",
        "sentence": "UNLABELLED: @CHEMICAL$ is an inhibitor of the @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "11772142.T18.T31",
        "sentence": "CONCLUSION: @CHEMICAL$ is a well tolerated @GENE$ inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "11799102.T29.T47",
        "sentence": "@CHEMICAL$ suppression in humans by the orally active renin inhibitor @GENE$ (SPP100): comparison with enalapril.",
        "relation": "CPR:4"
    },
    {
        "id": "11799102.T29.T48",
        "sentence": "Angiotensin II suppression in humans by the orally active @CHEMICAL$ inhibitor @GENE$ (SPP100): comparison with enalapril.",
        "relation": "CPR:4"
    },
    {
        "id": "11799102.T30.T47",
        "sentence": "@CHEMICAL$ suppression in humans by the orally active renin inhibitor Aliskiren (@GENE$): comparison with enalapril.",
        "relation": "CPR:4"
    },
    {
        "id": "11799102.T30.T48",
        "sentence": "Angiotensin II suppression in humans by the orally active @CHEMICAL$ inhibitor Aliskiren (@GENE$): comparison with enalapril.",
        "relation": "CPR:4"
    },
    {
        "id": "11799102.T16.T42",
        "sentence": "We tested the new orally active nonpeptidic @CHEMICAL$ inhibitor @GENE$ (Aliskiren, an octanamide with a 50% inhibitory concentration [IC50] in the low nanomolar range) in 18 healthy volunteers on a constant 100 mmol/d sodium diet using a double-blind, 3-way crossover protocol.",
        "relation": "CPR:4"
    },
    {
        "id": "11799102.T17.T42",
        "sentence": "We tested the new orally active nonpeptidic @CHEMICAL$ inhibitor SPP100 (@GENE$, an octanamide with a 50% inhibitory concentration [IC50] in the low nanomolar range) in 18 healthy volunteers on a constant 100 mmol/d sodium diet using a double-blind, 3-way crossover protocol.",
        "relation": "CPR:4"
    },
    {
        "id": "11799102.T18.T42",
        "sentence": "We tested the new orally active nonpeptidic @CHEMICAL$ inhibitor SPP100 (Aliskiren, an @GENE$ with a 50% inhibitory concentration [IC50] in the low nanomolar range) in 18 healthy volunteers on a constant 100 mmol/d sodium diet using a double-blind, 3-way crossover protocol.",
        "relation": "CPR:4"
    },
    {
        "id": "11799102.T26.T44",
        "sentence": "There was a dose-dependent decrease in plasma @CHEMICAL$ activity, Ang I, and Ang II following single doses of @GENE$ starting with 40 mg.",
        "relation": "CPR:4"
    },
    {
        "id": "11799102.T26.T45",
        "sentence": "There was a dose-dependent decrease in plasma renin activity, @CHEMICAL$, and Ang II following single doses of @GENE$ starting with 40 mg.",
        "relation": "CPR:4"
    },
    {
        "id": "11799102.T26.T46",
        "sentence": "There was a dose-dependent decrease in plasma renin activity, Ang I, and @CHEMICAL$ following single doses of @GENE$ starting with 40 mg.",
        "relation": "CPR:4"
    },
    {
        "id": "11799102.T3.T32",
        "sentence": "Inhibition was still marked and significant after repeated dosing with maximal decreases in @CHEMICAL$ levels by 89% and 75% on Days 1 and 8, respectively, when the highest dose of @GENE$ was compared with placebo.",
        "relation": "CPR:4"
    },
    {
        "id": "11799102.T4.T34",
        "sentence": "At the same time, mean plasma active @CHEMICAL$ was increased 16- and 34-fold at the highest dose of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "11799102.T11.T37",
        "sentence": "In conclusion, the @CHEMICAL$ inhibitor @GENE$ dose-dependently decreases Ang II levels in humans following oral administration.",
        "relation": "CPR:4"
    },
    {
        "id": "11799102.T11.T38",
        "sentence": "In conclusion, the renin inhibitor @CHEMICAL$ dose-dependently decreases @GENE$ levels in humans following oral administration.",
        "relation": "CPR:4"
    },
    {
        "id": "11799102.T14.T41",
        "sentence": "@CHEMICAL$ has the potential to become the first orally active renin inhibitor that provides a true alternative to ACE-inhibitors and @GENE$ antagonists in therapy for hypertension and other cardiovascular and renal diseases.",
        "relation": "CPR:6"
    },
    {
        "id": "11799102.T14.T39",
        "sentence": "@CHEMICAL$ has the potential to become the first orally active @GENE$ inhibitor that provides a true alternative to ACE-inhibitors and Ang II receptor antagonists in therapy for hypertension and other cardiovascular and renal diseases.",
        "relation": "CPR:4"
    },
    {
        "id": "11799102.T14.T40",
        "sentence": "@CHEMICAL$ has the potential to become the first orally active renin inhibitor that provides a true alternative to @GENE$-inhibitors and Ang II receptor antagonists in therapy for hypertension and other cardiovascular and renal diseases.",
        "relation": "CPR:4"
    },
    {
        "id": "11893059.T1.T7",
        "sentence": "The earliest known @CHEMICAL$ inhibitors, namely, @GENE$ and tacrine, performed poorly in clinical trials (e.g., poor oral activity, brain penetration, and hepatotoxic liability).",
        "relation": "CPR:4"
    },
    {
        "id": "11893059.T2.T7",
        "sentence": "The earliest known @CHEMICAL$ inhibitors, namely, physostigmine and @GENE$, performed poorly in clinical trials (e.g., poor oral activity, brain penetration, and hepatotoxic liability).",
        "relation": "CPR:4"
    },
    {
        "id": "11893059.T3.T8",
        "sentence": "@CHEMICAL$ inaugurates a new class of @GENE$ inhibitors with longer and more selective action and with manageable adverse effects.",
        "relation": "CPR:4"
    },
    {
        "id": "12046682.T1.T4",
        "sentence": "Thalidomide in multiple myeloma. @CHEMICAL$--removed from widespread clinical use by 1962 because of severe teratogenicity--has anti-angiogenic and immunomodulatory effects, including the inhibition of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12063741.T1.T11",
        "sentence": "As a prodrug @CHEMICAL$ is completely converted to its active metabolite A 77 1726 (M1) which blocks the @GENE$, a key enzyme of the pyrimidine de novo synthesis.",
        "relation": "CPR:4"
    },
    {
        "id": "12063741.T2.T11",
        "sentence": "As a prodrug leflunomide is completely converted to its active metabolite @CHEMICAL$ (M1) which blocks the @GENE$, a key enzyme of the pyrimidine de novo synthesis.",
        "relation": "CPR:4"
    },
    {
        "id": "12080538.T14.T23",
        "sentence": "A recent study showed that @CHEMICAL$, an @GENE$ inhibitor, is as effective or even superior to tamoxifen when used as a first-line therapy.",
        "relation": "CPR:4"
    },
    {
        "id": "12080538.T18.T19",
        "sentence": "@CHEMICAL$, the first agent in this new class, not only induces the degradation of the @GENE$ but also is an estrogen antagonist; further, its lack of agonist activity provides a better safety profile.",
        "relation": "CPR:4"
    },
    {
        "id": "12082550.T16.T29",
        "sentence": "@CHEMICAL$, a specific inhibitor of @GENE$, induces a pronounced apoptotic response in a specific subset of tumor types, including HNSCC and CC.",
        "relation": "CPR:4"
    },
    {
        "id": "12137927.T11.T26",
        "sentence": "Chronic treatment with the @CHEMICAL$ inhibitor, @GENE$ (DMI), reduced NET levels in both control and Dbh -/- mice, demonstrating that NE is not required for the regulation of NET by antidepressant drugs.",
        "relation": "CPR:4"
    },
    {
        "id": "12137927.T11.T27",
        "sentence": "Chronic treatment with the NET inhibitor, @CHEMICAL$ (DMI), reduced @GENE$ levels in both control and Dbh -/- mice, demonstrating that NE is not required for the regulation of NET by antidepressant drugs.",
        "relation": "CPR:4"
    },
    {
        "id": "12170059.T15.T33",
        "sentence": "Probes were perfused with artificial cerebrospinal fluid containing nicotine, the specific @CHEMICAL$ agonist @GENE$, or nicotine plus nAChR antagonists and norepinephrine measured in the microdialysates.",
        "relation": "CPR:5"
    },
    {
        "id": "12170059.T16.T33",
        "sentence": "Probes were perfused with artificial cerebrospinal fluid containing nicotine, the specific @CHEMICAL$ agonist metanicotine, or @GENE$ plus nAChR antagonists and norepinephrine measured in the microdialysates.",
        "relation": "CPR:5"
    },
    {
        "id": "12180353.T15.T22",
        "sentence": "@CHEMICAL$ decreases levels of serum triglycerides and causes some increase in @GENE$-cholesterol levels.",
        "relation": "CPR:3"
    },
    {
        "id": "12180353.T3.T18",
        "sentence": "@CHEMICAL$ undergoes intensive and finally complete hepatic metabolism via the @GENE$ systems.",
        "relation": "CPR:9"
    },
    {
        "id": "12181427.T6.T23",
        "sentence": "We changed the residues to alanine using site-directed mutagenesis technique, expressed the mutants in a baculovirus/Sf9 cell system, and analyzed the kinetic characteristics of inhibition of the mutant enzymes by @CHEMICAL$ and cilostazol, specific inhibitors of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12181427.T7.T23",
        "sentence": "We changed the residues to alanine using site-directed mutagenesis technique, expressed the mutants in a baculovirus/Sf9 cell system, and analyzed the kinetic characteristics of inhibition of the mutant enzymes by milrinone and @CHEMICAL$, specific inhibitors of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "12181427.T8.T24",
        "sentence": "Mutants @CHEMICAL$, D950A, and F1004A had reduced sensitivity to @GENE$ (K(i) changed from 0.66 microM for the recombinant PDE3A to 7.5 to 156 microM for the mutants), and diminished sensitivity to cilostazol (K(i) of the mutants were 18- to 371-fold higher than that of the recombinant PDE3A).",
        "relation": "CPR:4"
    },
    {
        "id": "12181427.T8.T25",
        "sentence": "Mutants Y751A, @CHEMICAL$, and F1004A had reduced sensitivity to @GENE$ (K(i) changed from 0.66 microM for the recombinant PDE3A to 7.5 to 156 microM for the mutants), and diminished sensitivity to cilostazol (K(i) of the mutants were 18- to 371-fold higher than that of the recombinant PDE3A).",
        "relation": "CPR:4"
    },
    {
        "id": "12181427.T8.T26",
        "sentence": "Mutants Y751A, D950A, and @CHEMICAL$ had reduced sensitivity to @GENE$ (K(i) changed from 0.66 microM for the recombinant PDE3A to 7.5 to 156 microM for the mutants), and diminished sensitivity to cilostazol (K(i) of the mutants were 18- to 371-fold higher than that of the recombinant PDE3A).",
        "relation": "CPR:4"
    },
    {
        "id": "12181427.T8.T27",
        "sentence": "Mutants Y751A, D950A, and F1004A had reduced sensitivity to @CHEMICAL$ (K(i) changed from 0.66 microM for the recombinant @GENE$ to 7.5 to 156 microM for the mutants), and diminished sensitivity to cilostazol (K(i) of the mutants were 18- to 371-fold higher than that of the recombinant PDE3A).",
        "relation": "CPR:4"
    },
    {
        "id": "12181427.T9.T28",
        "sentence": "Mutants Y751A, D950A, and F1004A had reduced sensitivity to milrinone (K(i) changed from 0.66 microM for the recombinant PDE3A to 7.5 to 156 microM for the mutants), and diminished sensitivity to @CHEMICAL$ (K(i) of the mutants were 18- to 371-fold higher than that of the recombinant @GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "12181427.T10.T29",
        "sentence": "In contrast, the mutants @CHEMICAL$, F972A and Q975A showed increased K(i) for @GENE$ but no difference for milrinone from the recombinant PDE3A. Molecular models show that the PDE3 inhibitors cilostazol and milrinone share some of common residues but interact with distinct residues at the active site, suggesting that selective inhibitors can be designed with flexible size against PDE3 active site.",
        "relation": "CPR:4"
    },
    {
        "id": "12181427.T10.T30",
        "sentence": "In contrast, the mutants T844A, @CHEMICAL$ and Q975A showed increased K(i) for @GENE$ but no difference for milrinone from the recombinant PDE3A. Molecular models show that the PDE3 inhibitors cilostazol and milrinone share some of common residues but interact with distinct residues at the active site, suggesting that selective inhibitors can be designed with flexible size against PDE3 active site.",
        "relation": "CPR:4"
    },
    {
        "id": "12181427.T10.T31",
        "sentence": "In contrast, the mutants T844A, F972A and @CHEMICAL$ showed increased K(i) for @GENE$ but no difference for milrinone from the recombinant PDE3A. Molecular models show that the PDE3 inhibitors cilostazol and milrinone share some of common residues but interact with distinct residues at the active site, suggesting that selective inhibitors can be designed with flexible size against PDE3 active site.",
        "relation": "CPR:4"
    },
    {
        "id": "12181427.T10.T15",
        "sentence": "In contrast, the mutants T844A, F972A and Q975A showed increased K(i) for @CHEMICAL$ but no difference for milrinone from the recombinant @GENE$. Molecular models show that the PDE3 inhibitors cilostazol and milrinone share some of common residues but interact with distinct residues at the active site, suggesting that selective inhibitors can be designed with flexible size against PDE3 active site.",
        "relation": "CPR:4"
    },
    {
        "id": "12181427.T11.T29",
        "sentence": "In contrast, the mutants @CHEMICAL$, F972A and Q975A showed increased K(i) for cilostazol but no difference for @GENE$ from the recombinant PDE3A. Molecular models show that the PDE3 inhibitors cilostazol and milrinone share some of common residues but interact with distinct residues at the active site, suggesting that selective inhibitors can be designed with flexible size against PDE3 active site.",
        "relation": "CPR:4"
    },
    {
        "id": "12181427.T11.T30",
        "sentence": "In contrast, the mutants T844A, @CHEMICAL$ and Q975A showed increased K(i) for cilostazol but no difference for @GENE$ from the recombinant PDE3A. Molecular models show that the PDE3 inhibitors cilostazol and milrinone share some of common residues but interact with distinct residues at the active site, suggesting that selective inhibitors can be designed with flexible size against PDE3 active site.",
        "relation": "CPR:4"
    },
    {
        "id": "12181427.T11.T31",
        "sentence": "In contrast, the mutants T844A, F972A and @CHEMICAL$ showed increased K(i) for cilostazol but no difference for @GENE$ from the recombinant PDE3A. Molecular models show that the PDE3 inhibitors cilostazol and milrinone share some of common residues but interact with distinct residues at the active site, suggesting that selective inhibitors can be designed with flexible size against PDE3 active site.",
        "relation": "CPR:4"
    },
    {
        "id": "12181427.T11.T15",
        "sentence": "In contrast, the mutants T844A, F972A and Q975A showed increased K(i) for cilostazol but no difference for @CHEMICAL$ from the recombinant @GENE$. Molecular models show that the PDE3 inhibitors cilostazol and milrinone share some of common residues but interact with distinct residues at the active site, suggesting that selective inhibitors can be designed with flexible size against PDE3 active site.",
        "relation": "CPR:4"
    },
    {
        "id": "12181427.T1.T16",
        "sentence": "In contrast, the mutants T844A, F972A and Q975A showed increased K(i) for cilostazol but no difference for milrinone from the recombinant PDE3A. Molecular models show that the @CHEMICAL$ inhibitors @GENE$ and milrinone share some of common residues but interact with distinct residues at the active site, suggesting that selective inhibitors can be designed with flexible size against PDE3 active site.",
        "relation": "CPR:4"
    },
    {
        "id": "12181427.T2.T16",
        "sentence": "In contrast, the mutants T844A, F972A and Q975A showed increased K(i) for cilostazol but no difference for milrinone from the recombinant PDE3A. Molecular models show that the @CHEMICAL$ inhibitors cilostazol and @GENE$ share some of common residues but interact with distinct residues at the active site, suggesting that selective inhibitors can be designed with flexible size against PDE3 active site.",
        "relation": "CPR:4"
    },
    {
        "id": "12181427.T4.T18",
        "sentence": "Our study implies that highly conserved residuals Y751, D950 and F1004 in the @CHEMICAL$ families are key residues for binding of both substrate and inhibitors, and nonconserved T844 may be responsible for the @GENE$ selectivity of PDE3A. Detailed knowledge of the structure of inhibitory sites should contribute to development of more potent and specific inhibitory drugs.",
        "relation": "CPR:4"
    },
    {
        "id": "12181427.T4.T19",
        "sentence": "Our study implies that highly conserved residuals Y751, D950 and F1004 in the PDE families are key residues for binding of both substrate and inhibitors, and nonconserved T844 may be responsible for the @CHEMICAL$ selectivity of @GENE$. Detailed knowledge of the structure of inhibitory sites should contribute to development of more potent and specific inhibitory drugs.",
        "relation": "CPR:4"
    },
    {
        "id": "12217700.T13.T27",
        "sentence": "The bacterial enzyme @CHEMICAL$ (MalP) catalyses the phosphorolysis of an alpha-1,4-glycosidic bond in maltodextrins, removing the non-reducing glucosyl residues of linear oligosaccharides as @GENE$ (Glc1P).",
        "relation": "CPR:9"
    },
    {
        "id": "12217700.T13.T33",
        "sentence": "The bacterial enzyme maltodextrin phosphorylase (@CHEMICAL$) catalyses the phosphorolysis of an alpha-1,4-glycosidic bond in maltodextrins, removing the non-reducing glucosyl residues of linear oligosaccharides as @GENE$ (Glc1P).",
        "relation": "CPR:9"
    },
    {
        "id": "12217700.T14.T27",
        "sentence": "The bacterial enzyme @CHEMICAL$ (MalP) catalyses the phosphorolysis of an alpha-1,4-glycosidic bond in maltodextrins, removing the non-reducing glucosyl residues of linear oligosaccharides as glucose-1-phosphate (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "12217700.T14.T33",
        "sentence": "The bacterial enzyme maltodextrin phosphorylase (@CHEMICAL$) catalyses the phosphorolysis of an alpha-1,4-glycosidic bond in maltodextrins, removing the non-reducing glucosyl residues of linear oligosaccharides as glucose-1-phosphate (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "12383039.T2.T8",
        "sentence": "OBJECTIVE: @CHEMICAL$ is the first in a new class of synthetic @GENE$ inhibitors that binds reversibly with high affinity to antithrombin III.",
        "relation": "CPR:4"
    },
    {
        "id": "12409268.T7.T22",
        "sentence": "It is caused by a deficiency of @CHEMICAL$ (PCC, EC 6.4.1.3), a biotin-dependent enzyme that catalyzes the carboxylation of @GENE$ to D-methylmalonyl-CoA. PCC is a heteropolymeric enzyme composed of alpha- and beta-subunits.",
        "relation": "CPR:9"
    },
    {
        "id": "12409268.T7.T23",
        "sentence": "It is caused by a deficiency of propionyl-CoA carboxylase (@CHEMICAL$, EC 6.4.1.3), a biotin-dependent enzyme that catalyzes the carboxylation of @GENE$ to D-methylmalonyl-CoA. PCC is a heteropolymeric enzyme composed of alpha- and beta-subunits.",
        "relation": "CPR:9"
    },
    {
        "id": "12409268.T7.T24",
        "sentence": "It is caused by a deficiency of propionyl-CoA carboxylase (PCC, @CHEMICAL$), a biotin-dependent enzyme that catalyzes the carboxylation of @GENE$ to D-methylmalonyl-CoA. PCC is a heteropolymeric enzyme composed of alpha- and beta-subunits.",
        "relation": "CPR:9"
    },
    {
        "id": "12409268.T8.T22",
        "sentence": "It is caused by a deficiency of @CHEMICAL$ (PCC, EC 6.4.1.3), a biotin-dependent enzyme that catalyzes the carboxylation of propionyl-CoA to @GENE$. PCC is a heteropolymeric enzyme composed of alpha- and beta-subunits.",
        "relation": "CPR:9"
    },
    {
        "id": "12409268.T8.T23",
        "sentence": "It is caused by a deficiency of propionyl-CoA carboxylase (@CHEMICAL$, EC 6.4.1.3), a biotin-dependent enzyme that catalyzes the carboxylation of propionyl-CoA to @GENE$. PCC is a heteropolymeric enzyme composed of alpha- and beta-subunits.",
        "relation": "CPR:9"
    },
    {
        "id": "12409268.T8.T24",
        "sentence": "It is caused by a deficiency of propionyl-CoA carboxylase (PCC, @CHEMICAL$), a biotin-dependent enzyme that catalyzes the carboxylation of propionyl-CoA to @GENE$. PCC is a heteropolymeric enzyme composed of alpha- and beta-subunits.",
        "relation": "CPR:9"
    },
    {
        "id": "12445705.T27.T57",
        "sentence": "Although only @CHEMICAL$ and ziprasidone are directly acting @GENE$ agonists, WAY100635, a selective 5-HT(1A) antagonist, partially attenuates these atypical APD-induced increases in cortical DA release that may be due to combined 5-HT(2A) and D(2) blockade.",
        "relation": "CPR:5"
    },
    {
        "id": "12445705.T27.T59",
        "sentence": "Although only @CHEMICAL$ and ziprasidone are directly acting 5-HT(1A) agonists, WAY100635, a selective 5-HT(1A) antagonist, partially attenuates these atypical APD-induced increases in cortical DA release that may be due to combined @GENE$ and D(2) blockade.",
        "relation": "CPR:4"
    },
    {
        "id": "12445705.T27.T60",
        "sentence": "Although only @CHEMICAL$ and ziprasidone are directly acting 5-HT(1A) agonists, WAY100635, a selective 5-HT(1A) antagonist, partially attenuates these atypical APD-induced increases in cortical DA release that may be due to combined 5-HT(2A) and @GENE$ blockade.",
        "relation": "CPR:4"
    },
    {
        "id": "12445705.T28.T57",
        "sentence": "Although only clozapine and @CHEMICAL$ are directly acting @GENE$ agonists, WAY100635, a selective 5-HT(1A) antagonist, partially attenuates these atypical APD-induced increases in cortical DA release that may be due to combined 5-HT(2A) and D(2) blockade.",
        "relation": "CPR:5"
    },
    {
        "id": "12445705.T28.T59",
        "sentence": "Although only clozapine and @CHEMICAL$ are directly acting 5-HT(1A) agonists, WAY100635, a selective 5-HT(1A) antagonist, partially attenuates these atypical APD-induced increases in cortical DA release that may be due to combined @GENE$ and D(2) blockade.",
        "relation": "CPR:4"
    },
    {
        "id": "12445705.T28.T60",
        "sentence": "Although only clozapine and @CHEMICAL$ are directly acting 5-HT(1A) agonists, WAY100635, a selective 5-HT(1A) antagonist, partially attenuates these atypical APD-induced increases in cortical DA release that may be due to combined 5-HT(2A) and @GENE$ blockade.",
        "relation": "CPR:4"
    },
    {
        "id": "12445705.T29.T58",
        "sentence": "Although only clozapine and ziprasidone are directly acting 5-HT(1A) agonists, @CHEMICAL$, a selective @GENE$ antagonist, partially attenuates these atypical APD-induced increases in cortical DA release that may be due to combined 5-HT(2A) and D(2) blockade.",
        "relation": "CPR:6"
    },
    {
        "id": "12445705.T29.T59",
        "sentence": "Although only clozapine and ziprasidone are directly acting 5-HT(1A) agonists, @CHEMICAL$, a selective 5-HT(1A) antagonist, partially attenuates these atypical APD-induced increases in cortical DA release that may be due to combined @GENE$ and D(2) blockade.",
        "relation": "CPR:4"
    },
    {
        "id": "12445705.T29.T60",
        "sentence": "Although only clozapine and ziprasidone are directly acting 5-HT(1A) agonists, @CHEMICAL$, a selective 5-HT(1A) antagonist, partially attenuates these atypical APD-induced increases in cortical DA release that may be due to combined 5-HT(2A) and @GENE$ blockade.",
        "relation": "CPR:4"
    },
    {
        "id": "12445705.T22.T56",
        "sentence": "However, @CHEMICAL$ agonism may be important only for @GENE$-induced ACh release.",
        "relation": "CPR:5"
    },
    {
        "id": "12545144.T8.T15",
        "sentence": "BACKGROUND: The novel antiepileptic drug @CHEMICAL$ is the first selective M-current potassium channel opener for @GENE$ and KCNQ3/5 channels.",
        "relation": "CPR:3"
    },
    {
        "id": "12545144.T8.T16",
        "sentence": "BACKGROUND: The novel antiepileptic drug @CHEMICAL$ is the first selective M-current potassium channel opener for KCNQ2/3 and @GENE$ channels.",
        "relation": "CPR:3"
    },
    {
        "id": "12545144.T8.T17",
        "sentence": "BACKGROUND: The novel antiepileptic drug @CHEMICAL$ is the first selective @GENE$ opener for KCNQ2/3 and KCNQ3/5 channels.",
        "relation": "CPR:3"
    },
    {
        "id": "12588370.T3.T12",
        "sentence": "OBJECTIVE: Because of these physiological effects and the widespread use of the selective @CHEMICAL$ inhibitor, @GENE$, we wanted to determine if inhibition of COX-2 would affect incisional skin wound healing.",
        "relation": "CPR:4"
    },
    {
        "id": "12588370.T4.T16",
        "sentence": "METHODS: Using a cutaneous full-thickness, sutured, incisional wound model in hairless SKH-1 mice, we evaluated the role of COX-2 in the wound healing process by comparing the effects of a nonselective @CHEMICAL$ inhibitor, @GENE$, with a selective COX-2 inhibitor, SC-791.",
        "relation": "CPR:4"
    },
    {
        "id": "12657913.T26.T31",
        "sentence": "@CHEMICAL$ antagonists, @GENE$ and homochlorcyclizine, increase the steady-state plasma concentrations of haloperidol and reduced haloperidol.",
        "relation": "CPR:6"
    },
    {
        "id": "12657913.T27.T31",
        "sentence": "@CHEMICAL$ antagonists, promethazine and @GENE$, increase the steady-state plasma concentrations of haloperidol and reduced haloperidol.",
        "relation": "CPR:6"
    },
    {
        "id": "12657913.T16.T28",
        "sentence": "The effects of histamine H1-receptor antagonists, @CHEMICAL$ and homochlorcyclizine, both of which are inhibitors of @GENE$, on the steady-state plasma concentrations (Css) of haloperidol and reduced haloperidol were studied in 23 schizophrenic inpatients receiving haloperidol, 12 to 36 mg/d, for 2 to 29 weeks.",
        "relation": "CPR:4"
    },
    {
        "id": "12657913.T16.T29",
        "sentence": "The effects of @CHEMICAL$ antagonists, @GENE$ and homochlorcyclizine, both of which are inhibitors of CYP2D6, on the steady-state plasma concentrations (Css) of haloperidol and reduced haloperidol were studied in 23 schizophrenic inpatients receiving haloperidol, 12 to 36 mg/d, for 2 to 29 weeks.",
        "relation": "CPR:6"
    },
    {
        "id": "12657913.T19.T28",
        "sentence": "The effects of histamine H1-receptor antagonists, promethazine and @CHEMICAL$, both of which are inhibitors of @GENE$, on the steady-state plasma concentrations (Css) of haloperidol and reduced haloperidol were studied in 23 schizophrenic inpatients receiving haloperidol, 12 to 36 mg/d, for 2 to 29 weeks.",
        "relation": "CPR:4"
    },
    {
        "id": "12657913.T19.T29",
        "sentence": "The effects of @CHEMICAL$ antagonists, promethazine and @GENE$, both of which are inhibitors of CYP2D6, on the steady-state plasma concentrations (Css) of haloperidol and reduced haloperidol were studied in 23 schizophrenic inpatients receiving haloperidol, 12 to 36 mg/d, for 2 to 29 weeks.",
        "relation": "CPR:6"
    },
    {
        "id": "12657913.T10.T30",
        "sentence": "Thus, the current study suggests that coadministration of clinical doses of promethazine and homochlorcyclizine increases the Css of haloperidol and reduced haloperidol via the inhibitory effects on the @CHEMICAL$-catalyzed metabolism of haloperidol and reduced @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "12657913.T5.T30",
        "sentence": "Thus, the current study suggests that coadministration of clinical doses of @CHEMICAL$ and homochlorcyclizine increases the Css of haloperidol and reduced haloperidol via the inhibitory effects on the @GENE$-catalyzed metabolism of haloperidol and reduced haloperidol.",
        "relation": "CPR:4"
    },
    {
        "id": "12657913.T6.T30",
        "sentence": "Thus, the current study suggests that coadministration of clinical doses of promethazine and @CHEMICAL$ increases the Css of haloperidol and reduced haloperidol via the inhibitory effects on the @GENE$-catalyzed metabolism of haloperidol and reduced haloperidol.",
        "relation": "CPR:4"
    },
    {
        "id": "12657913.T9.T30",
        "sentence": "Thus, the current study suggests that coadministration of clinical doses of promethazine and homochlorcyclizine increases the Css of haloperidol and reduced haloperidol via the inhibitory effects on the @CHEMICAL$-catalyzed metabolism of @GENE$ and reduced haloperidol.",
        "relation": "CPR:9"
    },
    {
        "id": "12679340.T1.T21",
        "sentence": "The four lysine residues located in the SMG loop, Lys-260, Lys-263, Lys-265, and Lys-268, also play an important role in mediating the sensitivity of @CHEMICAL$ to @GENE$ and to arginase and appear to be involved in transducing and enhancing the signal given by ornithine for the closure of the catalytic domain.",
        "relation": "CPR:4"
    },
    {
        "id": "1280065.T1.T14",
        "sentence": "Inhibition of binding of both @CHEMICAL$ and plasmin to gp330 by @GENE$ was similar, although EACA inhibited the binding of plasmin to gp330 slightly more than the binding of plasminogen to gp330.",
        "relation": "CPR:4"
    },
    {
        "id": "1280065.T1.T15",
        "sentence": "Inhibition of binding of both plasminogen and @CHEMICAL$ to gp330 by @GENE$ was similar, although EACA inhibited the binding of plasmin to gp330 slightly more than the binding of plasminogen to gp330.",
        "relation": "CPR:4"
    },
    {
        "id": "1280065.T2.T17",
        "sentence": "Inhibition of binding of both plasminogen and plasmin to gp330 by benzamidine was similar, although @CHEMICAL$ inhibited the binding of @GENE$ to gp330 slightly more than the binding of plasminogen to gp330.",
        "relation": "CPR:4"
    },
    {
        "id": "1280065.T2.T19",
        "sentence": "Inhibition of binding of both plasminogen and plasmin to gp330 by benzamidine was similar, although @CHEMICAL$ inhibited the binding of plasmin to gp330 slightly more than the binding of @GENE$ to gp330.",
        "relation": "CPR:4"
    },
    {
        "id": "12818701.T14.T28",
        "sentence": "Involvement of alpha(1)-adrenoceptors was established as mydriatic responses were inhibited by systemic administration of nonselective @CHEMICAL$ antagonists, @GENE$ (0.3-3 mg/kg) and phenoxybenzamine (0.03-0.3 mg/kg), as well as by the selective alpha(1)-adrenoceptor antagonist, prazosin (0.3 mg/kg).",
        "relation": "CPR:6"
    },
    {
        "id": "12818701.T15.T28",
        "sentence": "Involvement of alpha(1)-adrenoceptors was established as mydriatic responses were inhibited by systemic administration of nonselective @CHEMICAL$ antagonists, phentolamine (0.3-3 mg/kg) and @GENE$ (0.03-0.3 mg/kg), as well as by the selective alpha(1)-adrenoceptor antagonist, prazosin (0.3 mg/kg).",
        "relation": "CPR:6"
    },
    {
        "id": "12818701.T16.T30",
        "sentence": "Involvement of alpha(1)-adrenoceptors was established as mydriatic responses were inhibited by systemic administration of nonselective alpha-adrenoceptor antagonists, phentolamine (0.3-3 mg/kg) and phenoxybenzamine (0.03-0.3 mg/kg), as well as by the selective @CHEMICAL$ antagonist, @GENE$ (0.3 mg/kg).",
        "relation": "CPR:6"
    },
    {
        "id": "12818701.T17.T31",
        "sentence": "The @CHEMICAL$ antagonist, @GENE$ (0.5 mg/kg), was without antagonistic effects. alpha(1A)-Adrenoceptor selective antagonists, 2-([2,6-dimethoxyphenoxyethyl]aminomethyl)-1,4-benzodioxane (WB-4101; 0.1-1 mg/kg) and 5-methylurapidil (0.1-1 mg/kg), the alpha(1B)-adrenoceptor selective antagonist, 4-amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6,7-dimethoxyquinazoline (L-765314; 0.3-1 mg/kg), as well as the alpha(1D)-adrenoceptor selective antagonist, 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione (BMY-7378; 1 mg/kg), were used to delineate the adrenoceptor subtypes involved.",
        "relation": "CPR:6"
    },
    {
        "id": "12818701.T18.T32",
        "sentence": "The alpha(2)-adrenoceptor antagonist, rauwolscine (0.5 mg/kg), was without antagonistic effects. @CHEMICAL$ selective antagonists, @GENE$ (WB-4101; 0.1-1 mg/kg) and 5-methylurapidil (0.1-1 mg/kg), the alpha(1B)-adrenoceptor selective antagonist, 4-amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6,7-dimethoxyquinazoline (L-765314; 0.3-1 mg/kg), as well as the alpha(1D)-adrenoceptor selective antagonist, 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione (BMY-7378; 1 mg/kg), were used to delineate the adrenoceptor subtypes involved.",
        "relation": "CPR:6"
    },
    {
        "id": "12818701.T19.T32",
        "sentence": "The alpha(2)-adrenoceptor antagonist, rauwolscine (0.5 mg/kg), was without antagonistic effects. @CHEMICAL$ selective antagonists, 2-([2,6-dimethoxyphenoxyethyl]aminomethyl)-1,4-benzodioxane (@GENE$; 0.1-1 mg/kg) and 5-methylurapidil (0.1-1 mg/kg), the alpha(1B)-adrenoceptor selective antagonist, 4-amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6,7-dimethoxyquinazoline (L-765314; 0.3-1 mg/kg), as well as the alpha(1D)-adrenoceptor selective antagonist, 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione (BMY-7378; 1 mg/kg), were used to delineate the adrenoceptor subtypes involved.",
        "relation": "CPR:6"
    },
    {
        "id": "12818701.T1.T32",
        "sentence": "The alpha(2)-adrenoceptor antagonist, rauwolscine (0.5 mg/kg), was without antagonistic effects. @CHEMICAL$ selective antagonists, 2-([2,6-dimethoxyphenoxyethyl]aminomethyl)-1,4-benzodioxane (WB-4101; 0.1-1 mg/kg) and @GENE$ (0.1-1 mg/kg), the alpha(1B)-adrenoceptor selective antagonist, 4-amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6,7-dimethoxyquinazoline (L-765314; 0.3-1 mg/kg), as well as the alpha(1D)-adrenoceptor selective antagonist, 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione (BMY-7378; 1 mg/kg), were used to delineate the adrenoceptor subtypes involved.",
        "relation": "CPR:6"
    },
    {
        "id": "12818701.T2.T20",
        "sentence": "The alpha(2)-adrenoceptor antagonist, rauwolscine (0.5 mg/kg), was without antagonistic effects. alpha(1A)-Adrenoceptor selective antagonists, 2-([2,6-dimethoxyphenoxyethyl]aminomethyl)-1,4-benzodioxane (WB-4101; 0.1-1 mg/kg) and 5-methylurapidil (0.1-1 mg/kg), the @CHEMICAL$ selective antagonist, @GENE$ (L-765314; 0.3-1 mg/kg), as well as the alpha(1D)-adrenoceptor selective antagonist, 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione (BMY-7378; 1 mg/kg), were used to delineate the adrenoceptor subtypes involved.",
        "relation": "CPR:6"
    },
    {
        "id": "12818701.T3.T20",
        "sentence": "The alpha(2)-adrenoceptor antagonist, rauwolscine (0.5 mg/kg), was without antagonistic effects. alpha(1A)-Adrenoceptor selective antagonists, 2-([2,6-dimethoxyphenoxyethyl]aminomethyl)-1,4-benzodioxane (WB-4101; 0.1-1 mg/kg) and 5-methylurapidil (0.1-1 mg/kg), the @CHEMICAL$ selective antagonist, 4-amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6,7-dimethoxyquinazoline (@GENE$; 0.3-1 mg/kg), as well as the alpha(1D)-adrenoceptor selective antagonist, 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione (BMY-7378; 1 mg/kg), were used to delineate the adrenoceptor subtypes involved.",
        "relation": "CPR:6"
    },
    {
        "id": "12818701.T4.T21",
        "sentence": "The alpha(2)-adrenoceptor antagonist, rauwolscine (0.5 mg/kg), was without antagonistic effects. alpha(1A)-Adrenoceptor selective antagonists, 2-([2,6-dimethoxyphenoxyethyl]aminomethyl)-1,4-benzodioxane (WB-4101; 0.1-1 mg/kg) and 5-methylurapidil (0.1-1 mg/kg), the alpha(1B)-adrenoceptor selective antagonist, 4-amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6,7-dimethoxyquinazoline (L-765314; 0.3-1 mg/kg), as well as the @CHEMICAL$ selective antagonist, @GENE$ (BMY-7378; 1 mg/kg), were used to delineate the adrenoceptor subtypes involved.",
        "relation": "CPR:6"
    },
    {
        "id": "12818701.T5.T21",
        "sentence": "The alpha(2)-adrenoceptor antagonist, rauwolscine (0.5 mg/kg), was without antagonistic effects. alpha(1A)-Adrenoceptor selective antagonists, 2-([2,6-dimethoxyphenoxyethyl]aminomethyl)-1,4-benzodioxane (WB-4101; 0.1-1 mg/kg) and 5-methylurapidil (0.1-1 mg/kg), the alpha(1B)-adrenoceptor selective antagonist, 4-amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6,7-dimethoxyquinazoline (L-765314; 0.3-1 mg/kg), as well as the @CHEMICAL$ selective antagonist, 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione (@GENE$; 1 mg/kg), were used to delineate the adrenoceptor subtypes involved.",
        "relation": "CPR:6"
    },
    {
        "id": "12824918.T2.T10",
        "sentence": "To further investigate this positive correlation and its possible therapeutic implications, a selective @CHEMICAL$ inhibitor, @GENE$, was tested on three variants of HT-29 colon cancer cell lines, HT-29/Inv1, HT-29/Inv2 and HT-29/Inv3, with graded increases of in vitro Matrigel invasive potential and COX-2 expression levels.",
        "relation": "CPR:4"
    },
    {
        "id": "12827214.T36.T46",
        "sentence": "However, other @CHEMICAL$ antagonists (@GENE$, WB4101 and corynanthine) did not inhibit the binding at a range of concentrations that generally exhibit alpha(1)-adrenoceptor antagonism, and noradrenaline, rauwolscine and propranolol were without effect on the [(3)H]prazosin binding.",
        "relation": "CPR:6"
    },
    {
        "id": "12827214.T37.T46",
        "sentence": "However, other @CHEMICAL$ antagonists (tamsulosin, @GENE$ and corynanthine) did not inhibit the binding at a range of concentrations that generally exhibit alpha(1)-adrenoceptor antagonism, and noradrenaline, rauwolscine and propranolol were without effect on the [(3)H]prazosin binding.",
        "relation": "CPR:6"
    },
    {
        "id": "12827214.T38.T46",
        "sentence": "However, other @CHEMICAL$ antagonists (tamsulosin, WB4101 and @GENE$) did not inhibit the binding at a range of concentrations that generally exhibit alpha(1)-adrenoceptor antagonism, and noradrenaline, rauwolscine and propranolol were without effect on the [(3)H]prazosin binding.",
        "relation": "CPR:6"
    },
    {
        "id": "12837768.T5.T19",
        "sentence": "The potency of MrIA was greater for inhibition of uptake by @CHEMICAL$ of @GENE$ (Ki 1.89 microM) than [3H]dopamine (Ki 4.33 microM), and the human dopamine transporter and serotonin transporter were not inhibited by MrIA (to 7 microM).",
        "relation": "CPR:9"
    },
    {
        "id": "12837768.T6.T19",
        "sentence": "The potency of MrIA was greater for inhibition of uptake by @CHEMICAL$ of [3H]norepinephrine (Ki 1.89 microM) than @GENE$ (Ki 4.33 microM), and the human dopamine transporter and serotonin transporter were not inhibited by MrIA (to 7 microM).",
        "relation": "CPR:9"
    },
    {
        "id": "12837768.T2.T16",
        "sentence": "A comparison of the results with previous data for desipramine and cocaine inhibition of @CHEMICAL$ uptake by the mutant @GENE$ reveals that MrIA binding to hNET occurs at a site that is distinct from but overlaps with the binding sites for tricyclic antidepressants and cocaine.",
        "relation": "CPR:9"
    },
    {
        "id": "1284246.T3.T21",
        "sentence": "A cDNA encoding the complete amino acid sequence of aminoacylase 1 (N-acylamino acid aminohydrolase, ACY-1) [EC 3.5.1.14], a dimeric @CHEMICAL$ having two Zn2+ in the molecule, which catalyzes the deacylation of @GENE$ except L-aspartic acid, has been isolated from porcine kidney lambda gt10 cDNA library and sequenced.",
        "relation": "CPR:9"
    },
    {
        "id": "1284246.T3.T17",
        "sentence": "A cDNA encoding the complete amino acid sequence of aminoacylase 1 (N-acylamino acid aminohydrolase, @CHEMICAL$) [EC 3.5.1.14], a dimeric metalloprotein having two Zn2+ in the molecule, which catalyzes the deacylation of @GENE$ except L-aspartic acid, has been isolated from porcine kidney lambda gt10 cDNA library and sequenced.",
        "relation": "CPR:9"
    },
    {
        "id": "1284246.T3.T18",
        "sentence": "A cDNA encoding the complete amino acid sequence of aminoacylase 1 (N-acylamino acid aminohydrolase, ACY-1) [@CHEMICAL$], a dimeric metalloprotein having two Zn2+ in the molecule, which catalyzes the deacylation of @GENE$ except L-aspartic acid, has been isolated from porcine kidney lambda gt10 cDNA library and sequenced.",
        "relation": "CPR:9"
    },
    {
        "id": "1284246.T3.T23",
        "sentence": "A cDNA encoding the complete amino acid sequence of @CHEMICAL$ (N-acylamino acid aminohydrolase, ACY-1) [EC 3.5.1.14], a dimeric metalloprotein having two Zn2+ in the molecule, which catalyzes the deacylation of @GENE$ except L-aspartic acid, has been isolated from porcine kidney lambda gt10 cDNA library and sequenced.",
        "relation": "CPR:9"
    },
    {
        "id": "1284246.T3.T25",
        "sentence": "A cDNA encoding the complete amino acid sequence of aminoacylase 1 (@CHEMICAL$, ACY-1) [EC 3.5.1.14], a dimeric metalloprotein having two Zn2+ in the molecule, which catalyzes the deacylation of @GENE$ except L-aspartic acid, has been isolated from porcine kidney lambda gt10 cDNA library and sequenced.",
        "relation": "CPR:9"
    },
    {
        "id": "12901032.T6.T22",
        "sentence": "Patients stable on warfarin therapy and concurrently taking a @CHEMICAL$ (COX-2) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, @GENE$, or acetaminophen) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks.",
        "relation": "CPR:4"
    },
    {
        "id": "12901032.T6.T23",
        "sentence": "Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (@CHEMICAL$) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, @GENE$, or acetaminophen) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks.",
        "relation": "CPR:4"
    },
    {
        "id": "12901032.T7.T22",
        "sentence": "Patients stable on warfarin therapy and concurrently taking a @CHEMICAL$ (COX-2) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, salsalate, or @GENE$) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks.",
        "relation": "CPR:4"
    },
    {
        "id": "12901032.T7.T23",
        "sentence": "Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (@CHEMICAL$) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, salsalate, or @GENE$) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks.",
        "relation": "CPR:4"
    },
    {
        "id": "12901032.T8.T22",
        "sentence": "Patients stable on warfarin therapy and concurrently taking a @CHEMICAL$ (COX-2) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, salsalate, or acetaminophen) randomly received @GENE$ 200 mg/day or rofecoxib 25 mg/day for three weeks.",
        "relation": "CPR:4"
    },
    {
        "id": "12901032.T8.T23",
        "sentence": "Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (@CHEMICAL$) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, salsalate, or acetaminophen) randomly received @GENE$ 200 mg/day or rofecoxib 25 mg/day for three weeks.",
        "relation": "CPR:4"
    },
    {
        "id": "12901032.T9.T22",
        "sentence": "Patients stable on warfarin therapy and concurrently taking a @CHEMICAL$ (COX-2) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, salsalate, or acetaminophen) randomly received celecoxib 200 mg/day or @GENE$ 25 mg/day for three weeks.",
        "relation": "CPR:4"
    },
    {
        "id": "12901032.T9.T23",
        "sentence": "Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (@CHEMICAL$) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, salsalate, or acetaminophen) randomly received celecoxib 200 mg/day or @GENE$ 25 mg/day for three weeks.",
        "relation": "CPR:4"
    },
    {
        "id": "12927226.T12.T24",
        "sentence": "@CHEMICAL$ antagonism by @GENE$ lowers heart rate variability and baroreflex gain.",
        "relation": "CPR:6"
    },
    {
        "id": "12927226.T9.T21",
        "sentence": "We sought to assess the effects of the @CHEMICAL$ blocker @GENE$ on HRV and BRG.",
        "relation": "CPR:4"
    },
    {
        "id": "12927226.T11.T13",
        "sentence": "RESULTS: @CHEMICAL$ tended to lower mean AP, it slightly increased heart rate (HR) (p<0.05), and markedly increased circulating @GENE$ levels (p<0.01).",
        "relation": "CPR:3"
    },
    {
        "id": "12927226.T3.T14",
        "sentence": "CONCLUSIONS: @CHEMICAL$ antagonism by @GENE$ lowers heart rate variability and baroreflex gain.",
        "relation": "CPR:6"
    },
    {
        "id": "1318989.T18.T29",
        "sentence": "The antinociceptive activity of the @CHEMICAL$ agonist @GENE$ was also increased in mice treated with alpha N-acetyl beta-endorphin-(1-31).",
        "relation": "CPR:5"
    },
    {
        "id": "1322429.T1.T20",
        "sentence": "@CHEMICAL$, an opiate agonist of high specificity for mu-receptors, was recently reported to suppress @GENE$ and cortisol levels in normal subjects, but not in patients with proven ACTH-dependent Cushing's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "1322429.T14.T33",
        "sentence": "In seven normal subjects, basal @CHEMICAL$ plasma levels were significantly suppressed 3 h after @GENE$ administration (16 mg, orally) from 5 +/- 1 to 2 +/- 0 pmol/L (P less than 0.0001).",
        "relation": "CPR:4"
    },
    {
        "id": "1322429.T18.T37",
        "sentence": "After the combined pituitary stimulation test (100 micrograms human CRH, 100 micrograms GnRH, 100 micrograms GH-releasing hormone, and 200 micrograms @CHEMICAL$), the ACTH peak (maximum increase at 30 min) was significantly blunted by @GENE$ from 9 +/- 1 to 4 +/- 1 pmol/L (P less than 0.001) and the area under the curve of ACTH from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h (P less than 0.05).",
        "relation": "CPR:4"
    },
    {
        "id": "1322429.T18.T34",
        "sentence": "After the combined pituitary stimulation test (100 micrograms @CHEMICAL$, 100 micrograms GnRH, 100 micrograms GH-releasing hormone, and 200 micrograms TRH), the ACTH peak (maximum increase at 30 min) was significantly blunted by @GENE$ from 9 +/- 1 to 4 +/- 1 pmol/L (P less than 0.001) and the area under the curve of ACTH from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h (P less than 0.05).",
        "relation": "CPR:4"
    },
    {
        "id": "1322429.T18.T35",
        "sentence": "After the combined pituitary stimulation test (100 micrograms human CRH, 100 micrograms @CHEMICAL$, 100 micrograms GH-releasing hormone, and 200 micrograms TRH), the ACTH peak (maximum increase at 30 min) was significantly blunted by @GENE$ from 9 +/- 1 to 4 +/- 1 pmol/L (P less than 0.001) and the area under the curve of ACTH from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h (P less than 0.05).",
        "relation": "CPR:4"
    },
    {
        "id": "1322429.T18.T36",
        "sentence": "After the combined pituitary stimulation test (100 micrograms human CRH, 100 micrograms GnRH, 100 micrograms @CHEMICAL$, and 200 micrograms TRH), the ACTH peak (maximum increase at 30 min) was significantly blunted by @GENE$ from 9 +/- 1 to 4 +/- 1 pmol/L (P less than 0.001) and the area under the curve of ACTH from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h (P less than 0.05).",
        "relation": "CPR:4"
    },
    {
        "id": "1322429.T18.T38",
        "sentence": "After the combined pituitary stimulation test (100 micrograms human CRH, 100 micrograms GnRH, 100 micrograms GH-releasing hormone, and 200 micrograms TRH), the @CHEMICAL$ peak (maximum increase at 30 min) was significantly blunted by @GENE$ from 9 +/- 1 to 4 +/- 1 pmol/L (P less than 0.001) and the area under the curve of ACTH from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h (P less than 0.05).",
        "relation": "CPR:4"
    },
    {
        "id": "1322429.T18.T39",
        "sentence": "After the combined pituitary stimulation test (100 micrograms human CRH, 100 micrograms GnRH, 100 micrograms GH-releasing hormone, and 200 micrograms TRH), the ACTH peak (maximum increase at 30 min) was significantly blunted by @CHEMICAL$ from 9 +/- 1 to 4 +/- 1 pmol/L (P less than 0.001) and the area under the curve of @GENE$ from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h (P less than 0.05).",
        "relation": "CPR:4"
    },
    {
        "id": "1322429.T7.T28",
        "sentence": "In summary, @CHEMICAL$ is able to reduce basal and @GENE$-induced ACTH and cortisol levels in normal subjects, but not in patients with Cushing's disease or secondary adrenal failure of hypothalamic origin.",
        "relation": "CPR:4"
    },
    {
        "id": "1322429.T7.T29",
        "sentence": "In summary, @CHEMICAL$ is able to reduce basal and CRH-induced @GENE$ and cortisol levels in normal subjects, but not in patients with Cushing's disease or secondary adrenal failure of hypothalamic origin.",
        "relation": "CPR:4"
    },
    {
        "id": "1329582.T5.T18",
        "sentence": "We also examined the effects of @CHEMICAL$, a @GENE$ antagonist, in parallel.",
        "relation": "CPR:6"
    },
    {
        "id": "1359745.T17.T25",
        "sentence": "The unique role of the enzyme @CHEMICAL$ (5-LO) in the production of @GENE$ (LTs) makes it a likely target for biochemical manipulation.",
        "relation": "CPR:9"
    },
    {
        "id": "1359745.T17.T26",
        "sentence": "The unique role of the enzyme 5-lipoxygenase (@CHEMICAL$) in the production of @GENE$ (LTs) makes it a likely target for biochemical manipulation.",
        "relation": "CPR:9"
    },
    {
        "id": "1359745.T21.T25",
        "sentence": "The unique role of the enzyme @CHEMICAL$ (5-LO) in the production of leukotrienes (@GENE$) makes it a likely target for biochemical manipulation.",
        "relation": "CPR:9"
    },
    {
        "id": "1359745.T21.T26",
        "sentence": "The unique role of the enzyme 5-lipoxygenase (@CHEMICAL$) in the production of leukotrienes (@GENE$) makes it a likely target for biochemical manipulation.",
        "relation": "CPR:9"
    },
    {
        "id": "1359745.T18.T29",
        "sentence": "The compounds identified as 5-LO inhibitors can be divided into antioxidants, substrate-analogous, and a large miscellaneous group of inhibitors, where @CHEMICAL$ are potent and more selective inhibitors of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "1359745.T19.T30",
        "sentence": "The @CHEMICAL$, zileuton, is the first selective @GENE$ inhibitor evaluated for the treatment of patients with IBD.",
        "relation": "CPR:4"
    },
    {
        "id": "1359745.T20.T30",
        "sentence": "The benzothiophene hydroxyurea, @CHEMICAL$, is the first selective @GENE$ inhibitor evaluated for the treatment of patients with IBD.",
        "relation": "CPR:4"
    },
    {
        "id": "14583450.T2.T40",
        "sentence": "Ribonucleotide reductase (@CHEMICAL$) is responsible for the de novo conversion of the ribonucleoside diphosphates to @GENE$, which are essential for DNA synthesis and repair.",
        "relation": "CPR:9"
    },
    {
        "id": "14583450.T2.T7",
        "sentence": "@CHEMICAL$ (RR) is responsible for the de novo conversion of the ribonucleoside diphosphates to @GENE$, which are essential for DNA synthesis and repair.",
        "relation": "CPR:9"
    },
    {
        "id": "14583450.T5.T40",
        "sentence": "Ribonucleotide reductase (@CHEMICAL$) is responsible for the de novo conversion of the @GENE$ to deoxyribonucleoside diphosphates, which are essential for DNA synthesis and repair.",
        "relation": "CPR:9"
    },
    {
        "id": "14583450.T5.T7",
        "sentence": "@CHEMICAL$ (RR) is responsible for the de novo conversion of the @GENE$ to deoxyribonucleoside diphosphates, which are essential for DNA synthesis and repair.",
        "relation": "CPR:9"
    },
    {
        "id": "14583450.T3.T26",
        "sentence": "In PC3 cells, @CHEMICAL$ inhibited @GENE$ and resulted in increased sensitivity to UV irradiation.",
        "relation": "CPR:4"
    },
    {
        "id": "14588118.T3.T14",
        "sentence": "In addition, @CHEMICAL$ treatment significantly reduced the specific @GENE$ activity after SCI as compared to that of vehicle control.",
        "relation": "CPR:4"
    },
    {
        "id": "14588118.T4.T15",
        "sentence": "Furthermore, RT-PCR analyses revealed that @CHEMICAL$ treatment increased expression of @GENE$ mRNA but decreased tumor necrosis factor-alpha expression.",
        "relation": "CPR:3"
    },
    {
        "id": "14588118.T4.T16",
        "sentence": "Furthermore, RT-PCR analyses revealed that @CHEMICAL$ treatment increased expression of interleukin-10 mRNA but decreased @GENE$ expression.",
        "relation": "CPR:4"
    },
    {
        "id": "14619588.T7.T15",
        "sentence": "RESULTS: The density of @CHEMICAL$ in liver tissue in @GENE$ group was higher than that in control group (P < 0.05).",
        "relation": "CPR:3"
    },
    {
        "id": "14619588.T1.T11",
        "sentence": "CONCLUSION: @CHEMICAL$ up-regulated the density of @GENE$ in liver tissue, whereas it had no significant effects on the density of AR in testis and ovary tissues.",
        "relation": "CPR:3"
    },
    {
        "id": "14757145.T3.T14",
        "sentence": "Rats received a concomitant treatment with the selective @CHEMICAL$ antagonist, @GENE$ (50 mg/kg/day p.o.) or were chronically pretreated with the selective beta(2)-adrenoceptor agonist salbutamol (40 microg/kg/h) for 1 week to induce beta(2)-adrenoceptor desensitization.",
        "relation": "CPR:6"
    },
    {
        "id": "14757145.T4.T15",
        "sentence": "Rats received a concomitant treatment with the selective beta(1)-adrenoceptor antagonist, bisoprolol (50 mg/kg/day p.o.) or were chronically pretreated with the selective @CHEMICAL$ agonist @GENE$ (40 microg/kg/h) for 1 week to induce beta(2)-adrenoceptor desensitization.",
        "relation": "CPR:5"
    },
    {
        "id": "14757145.T5.T18",
        "sentence": "The pretreatment with @CHEMICAL$ induced a 59% down-regulation of left ventricular @GENE$ compared to control.",
        "relation": "CPR:4"
    },
    {
        "id": "14757700.T1.T51",
        "sentence": "TRPM8 (CMR1) is a @CHEMICAL$, which can be activated by low temperatures, menthol, @GENE$ and icilin.",
        "relation": "CPR:3"
    },
    {
        "id": "14757700.T1.T40",
        "sentence": "TRPM8 (@CHEMICAL$) is a Ca(2+)-permeable channel, which can be activated by low temperatures, menthol, @GENE$ and icilin.",
        "relation": "CPR:3"
    },
    {
        "id": "14757700.T1.T55",
        "sentence": "@CHEMICAL$ (CMR1) is a Ca(2+)-permeable channel, which can be activated by low temperatures, menthol, @GENE$ and icilin.",
        "relation": "CPR:3"
    },
    {
        "id": "14757700.T35.T51",
        "sentence": "TRPM8 (CMR1) is a @CHEMICAL$, which can be activated by low temperatures, @GENE$, eucalyptol and icilin.",
        "relation": "CPR:3"
    },
    {
        "id": "14757700.T35.T40",
        "sentence": "TRPM8 (@CHEMICAL$) is a Ca(2+)-permeable channel, which can be activated by low temperatures, @GENE$, eucalyptol and icilin.",
        "relation": "CPR:3"
    },
    {
        "id": "14757700.T35.T55",
        "sentence": "@CHEMICAL$ (CMR1) is a Ca(2+)-permeable channel, which can be activated by low temperatures, @GENE$, eucalyptol and icilin.",
        "relation": "CPR:3"
    },
    {
        "id": "14757700.T7.T51",
        "sentence": "TRPM8 (CMR1) is a @CHEMICAL$, which can be activated by low temperatures, menthol, eucalyptol and @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "14757700.T7.T40",
        "sentence": "TRPM8 (@CHEMICAL$) is a Ca(2+)-permeable channel, which can be activated by low temperatures, menthol, eucalyptol and @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "14757700.T7.T55",
        "sentence": "@CHEMICAL$ (CMR1) is a Ca(2+)-permeable channel, which can be activated by low temperatures, menthol, eucalyptol and @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "14757700.T11.T41",
        "sentence": "Known @CHEMICAL$ antagonists (@GENE$, thio-BCTC and capsazepine) were also able to block the response of TRPM8 to menthol (IC(50): 0.8+/-1.0, 3.5+/-1.1 and 18+/-1.1 microM, respectively).",
        "relation": "CPR:6"
    },
    {
        "id": "14757700.T11.T42",
        "sentence": "Known VR1 antagonists (@CHEMICAL$, thio-BCTC and capsazepine) were also able to block the response of @GENE$ to menthol (IC(50): 0.8+/-1.0, 3.5+/-1.1 and 18+/-1.1 microM, respectively).",
        "relation": "CPR:4"
    },
    {
        "id": "14757700.T12.T41",
        "sentence": "Known @CHEMICAL$ antagonists (BCTC, @GENE$ and capsazepine) were also able to block the response of TRPM8 to menthol (IC(50): 0.8+/-1.0, 3.5+/-1.1 and 18+/-1.1 microM, respectively).",
        "relation": "CPR:6"
    },
    {
        "id": "14757700.T12.T42",
        "sentence": "Known VR1 antagonists (BCTC, @CHEMICAL$ and capsazepine) were also able to block the response of @GENE$ to menthol (IC(50): 0.8+/-1.0, 3.5+/-1.1 and 18+/-1.1 microM, respectively).",
        "relation": "CPR:4"
    },
    {
        "id": "14757700.T13.T41",
        "sentence": "Known @CHEMICAL$ antagonists (BCTC, thio-BCTC and @GENE$) were also able to block the response of TRPM8 to menthol (IC(50): 0.8+/-1.0, 3.5+/-1.1 and 18+/-1.1 microM, respectively).",
        "relation": "CPR:6"
    },
    {
        "id": "14757700.T13.T42",
        "sentence": "Known VR1 antagonists (BCTC, thio-BCTC and @CHEMICAL$) were also able to block the response of @GENE$ to menthol (IC(50): 0.8+/-1.0, 3.5+/-1.1 and 18+/-1.1 microM, respectively).",
        "relation": "CPR:4"
    },
    {
        "id": "14757700.T14.T42",
        "sentence": "Known VR1 antagonists (BCTC, thio-BCTC and capsazepine) were also able to block the response of @CHEMICAL$ to @GENE$ (IC(50): 0.8+/-1.0, 3.5+/-1.1 and 18+/-1.1 microM, respectively).",
        "relation": "CPR:3"
    },
    {
        "id": "14757700.T16.T44",
        "sentence": "The Ca(2+) response of @CHEMICAL$-transfected HEK293 cells to the endogenous VR1 agonist @GENE$ was potentiated by low pH.",
        "relation": "CPR:3"
    },
    {
        "id": "14757700.T16.T45",
        "sentence": "The Ca(2+) response of hVR1-transfected HEK293 cells to the endogenous @CHEMICAL$ agonist @GENE$ was potentiated by low pH.",
        "relation": "CPR:5"
    },
    {
        "id": "14757700.T17.T46",
        "sentence": "In contrast, @CHEMICAL$- and icilin-activated @GENE$ currents were suppressed by low pH. 6.",
        "relation": "CPR:3"
    },
    {
        "id": "14757700.T18.T46",
        "sentence": "In contrast, menthol- and @CHEMICAL$-activated @GENE$ currents were suppressed by low pH. 6.",
        "relation": "CPR:3"
    },
    {
        "id": "15049511.T8.T25",
        "sentence": "Inhibitory effects of the @CHEMICAL$ inhibitor @GENE$ on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6.",
        "relation": "CPR:4"
    },
    {
        "id": "15049511.T2.T20",
        "sentence": "The inhibitory effects of @CHEMICAL$, a nonselective irreversible inhibitor of @GENE$ (MAO), on three cytochrome P450 (CYP) enzymes, namely CYP2C9, CYP2C19, and CYP2D6, have been evaluated in vitro.",
        "relation": "CPR:4"
    },
    {
        "id": "15049511.T2.T9",
        "sentence": "The inhibitory effects of @CHEMICAL$, a nonselective irreversible inhibitor of monoamine oxidase (@GENE$), on three cytochrome P450 (CYP) enzymes, namely CYP2C9, CYP2C19, and CYP2D6, have been evaluated in vitro.",
        "relation": "CPR:4"
    },
    {
        "id": "15049511.T4.T17",
        "sentence": "The results demonstrated that @CHEMICAL$ is a competitive inhibitor of @GENE$ (Ki = 32 microM) and CYP2D6 (Ki = 367 microM) and a noncompetitive inhibitor of CYP2C9 (Ki = 56 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "15049511.T4.T18",
        "sentence": "The results demonstrated that @CHEMICAL$ is a competitive inhibitor of CYP2C19 (Ki = 32 microM) and @GENE$ (Ki = 367 microM) and a noncompetitive inhibitor of CYP2C9 (Ki = 56 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "15049511.T4.T19",
        "sentence": "The results demonstrated that @CHEMICAL$ is a competitive inhibitor of CYP2C19 (Ki = 32 microM) and CYP2D6 (Ki = 367 microM) and a noncompetitive inhibitor of @GENE$ (Ki = 56 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "15109613.T3.T10",
        "sentence": "Studies in rats, mice and monkeys show that GC-1 lowers cholesterol with 600- to 1400-fold more potency and approximately two- to threefold more efficacy than @CHEMICAL$, a compound that blocks @GENE$. GC-1 also decreases plasma levels of triglyceride and lipoprotein (a), and induces loss of fat.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T1.T28",
        "sentence": "Although highly homologous to other class III RTKs, Flt3 is resistant to the @CHEMICAL$ STI571 (Gleevec, Imatinib), a potent inhibitor of other @GENE$ in the family, such as the PDGFbeta-receptor or c-Kit.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T1.T29",
        "sentence": "Although highly homologous to other class III RTKs, Flt3 is resistant to the @CHEMICAL$ STI571 (Gleevec, Imatinib), a potent inhibitor of other RTKs in the family, such as the @GENE$ or c-Kit.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T1.T30",
        "sentence": "Although highly homologous to other class III RTKs, Flt3 is resistant to the @CHEMICAL$ STI571 (Gleevec, Imatinib), a potent inhibitor of other RTKs in the family, such as the PDGFbeta-receptor or @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T2.T28",
        "sentence": "Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine @CHEMICAL$ (Gleevec, Imatinib), a potent inhibitor of other @GENE$ in the family, such as the PDGFbeta-receptor or c-Kit.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T2.T29",
        "sentence": "Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine @CHEMICAL$ (Gleevec, Imatinib), a potent inhibitor of other RTKs in the family, such as the @GENE$ or c-Kit.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T2.T30",
        "sentence": "Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine @CHEMICAL$ (Gleevec, Imatinib), a potent inhibitor of other RTKs in the family, such as the PDGFbeta-receptor or @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T3.T28",
        "sentence": "Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (@CHEMICAL$, Imatinib), a potent inhibitor of other @GENE$ in the family, such as the PDGFbeta-receptor or c-Kit.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T3.T29",
        "sentence": "Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (@CHEMICAL$, Imatinib), a potent inhibitor of other RTKs in the family, such as the @GENE$ or c-Kit.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T3.T30",
        "sentence": "Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (@CHEMICAL$, Imatinib), a potent inhibitor of other RTKs in the family, such as the PDGFbeta-receptor or @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T4.T28",
        "sentence": "Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (Gleevec, @CHEMICAL$), a potent inhibitor of other @GENE$ in the family, such as the PDGFbeta-receptor or c-Kit.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T4.T29",
        "sentence": "Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (Gleevec, @CHEMICAL$), a potent inhibitor of other RTKs in the family, such as the @GENE$ or c-Kit.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T4.T30",
        "sentence": "Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (Gleevec, @CHEMICAL$), a potent inhibitor of other RTKs in the family, such as the PDGFbeta-receptor or @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T9.T32",
        "sentence": "STI571 binding to Flt3 is prevented by the phenylalanine 691 side-chain in the ATP binding center and mutating this site to threonine renders the corresponding @CHEMICAL$ mutant sensitive to @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T10.T35",
        "sentence": "Compounds of several other structural families, including the @CHEMICAL$ AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T10.T34",
        "sentence": "Compounds of several other structural families, including the @CHEMICAL$ AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of @GENE$ kinase.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T11.T35",
        "sentence": "Compounds of several other structural families, including the quinoxaline @CHEMICAL$, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T11.T34",
        "sentence": "Compounds of several other structural families, including the quinoxaline @CHEMICAL$, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of @GENE$ kinase.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T12.T35",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the @CHEMICAL$ D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T12.T34",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the @CHEMICAL$ D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of @GENE$ kinase.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T13.T35",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone @CHEMICAL$, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T13.T34",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone @CHEMICAL$, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of @GENE$ kinase.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T14.T35",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the @CHEMICAL$ SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T14.T34",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the @CHEMICAL$ SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of @GENE$ kinase.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T15.T35",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones @CHEMICAL$ and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T15.T34",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones @CHEMICAL$ and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of @GENE$ kinase.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T16.T35",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and @CHEMICAL$, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T16.T34",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and @CHEMICAL$, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of @GENE$ kinase.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T17.T35",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the @CHEMICAL$ PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T17.T34",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the @CHEMICAL$ PKC412 and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of @GENE$ kinase.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T18.T35",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles @CHEMICAL$ and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T18.T34",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles @CHEMICAL$ and CEP-701, and the piperazonyl quinazoline CT53518, are potent inhibitors of @GENE$ kinase.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T19.T35",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and @CHEMICAL$, and the piperazonyl quinazoline CT53518, are potent inhibitors of Flt3 @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T19.T34",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and @CHEMICAL$, and the piperazonyl quinazoline CT53518, are potent inhibitors of @GENE$ kinase.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T20.T35",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the @CHEMICAL$ CT53518, are potent inhibitors of Flt3 @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T20.T34",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the @CHEMICAL$ CT53518, are potent inhibitors of @GENE$ kinase.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T21.T35",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline @CHEMICAL$, are potent inhibitors of Flt3 @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15180525.T21.T34",
        "sentence": "Compounds of several other structural families, including the quinoxaline AG1296, the bis(1H-2-indolyl)-1-methanone D-65476, the indolinones SU5416 and SU11248, the indolocarbazoles PKC412 and CEP-701, and the piperazonyl quinazoline @CHEMICAL$, are potent inhibitors of @GENE$ kinase.",
        "relation": "CPR:4"
    },
    {
        "id": "15192023.T14.T37",
        "sentence": "Novel mechanism of action for @CHEMICAL$: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15192023.T14.T38",
        "sentence": "Novel mechanism of action for @CHEMICAL$: induction of @GENE$, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.",
        "relation": "CPR:3"
    },
    {
        "id": "15192023.T14.T39",
        "sentence": "Novel mechanism of action for @CHEMICAL$: induction of hypoxia-inducible factor-1alpha, @GENE$, and angiogenesis by inhibition of prolyl hydroxylases.",
        "relation": "CPR:3"
    },
    {
        "id": "15192023.T10.T25",
        "sentence": "@CHEMICAL$ induced rapid and transient expression of HIF-1alpha and downstream targets of @GENE$ (endothelin-1, adrenomedullin, haem oxygenase 1, and vascular endothelial growth factor [VEGF]) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation.",
        "relation": "CPR:3"
    },
    {
        "id": "15192023.T10.T24",
        "sentence": "@CHEMICAL$ induced rapid and transient expression of @GENE$ and downstream targets of HIF (endothelin-1, adrenomedullin, haem oxygenase 1, and vascular endothelial growth factor [VEGF]) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation.",
        "relation": "CPR:3"
    },
    {
        "id": "15192023.T10.T26",
        "sentence": "@CHEMICAL$ induced rapid and transient expression of HIF-1alpha and downstream targets of HIF (@GENE$, adrenomedullin, haem oxygenase 1, and vascular endothelial growth factor [VEGF]) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation.",
        "relation": "CPR:3"
    },
    {
        "id": "15192023.T10.T27",
        "sentence": "@CHEMICAL$ induced rapid and transient expression of HIF-1alpha and downstream targets of HIF (endothelin-1, @GENE$, haem oxygenase 1, and vascular endothelial growth factor [VEGF]) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation.",
        "relation": "CPR:3"
    },
    {
        "id": "15192023.T10.T28",
        "sentence": "@CHEMICAL$ induced rapid and transient expression of HIF-1alpha and downstream targets of HIF (endothelin-1, adrenomedullin, @GENE$, and vascular endothelial growth factor [VEGF]) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation.",
        "relation": "CPR:3"
    },
    {
        "id": "15192023.T10.T29",
        "sentence": "@CHEMICAL$ induced rapid and transient expression of HIF-1alpha and downstream targets of HIF (endothelin-1, adrenomedullin, haem oxygenase 1, and @GENE$ [VEGF]) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation.",
        "relation": "CPR:3"
    },
    {
        "id": "15192023.T10.T30",
        "sentence": "@CHEMICAL$ induced rapid and transient expression of HIF-1alpha and downstream targets of HIF (endothelin-1, adrenomedullin, haem oxygenase 1, and vascular endothelial growth factor [@GENE$]) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation.",
        "relation": "CPR:3"
    },
    {
        "id": "15192023.T11.T31",
        "sentence": "@CHEMICAL$ dose-dependently inhibited @GENE$ activity and induced nonhydroxylated HIF-1alpha, evidence for HIF stabilization specifically by inhibition of PHD enzyme activity.",
        "relation": "CPR:4"
    },
    {
        "id": "15192023.T11.T34",
        "sentence": "@CHEMICAL$ dose-dependently inhibited PHD activity and induced nonhydroxylated HIF-1alpha, evidence for HIF stabilization specifically by inhibition of @GENE$ enzyme activity.",
        "relation": "CPR:4"
    },
    {
        "id": "15192023.T11.T32",
        "sentence": "@CHEMICAL$ dose-dependently inhibited PHD activity and induced nonhydroxylated @GENE$, evidence for HIF stabilization specifically by inhibition of PHD enzyme activity.",
        "relation": "CPR:3"
    },
    {
        "id": "15192023.T12.T15",
        "sentence": "In vivo, @CHEMICAL$ induced HIF-1alpha and VEGF protein in tissue extracts and elevated plasma @GENE$ levels.",
        "relation": "CPR:3"
    },
    {
        "id": "15192023.T12.T35",
        "sentence": "In vivo, @CHEMICAL$ induced @GENE$ and VEGF protein in tissue extracts and elevated plasma VEGF levels.",
        "relation": "CPR:3"
    },
    {
        "id": "15192023.T12.T36",
        "sentence": "In vivo, @CHEMICAL$ induced HIF-1alpha and @GENE$ protein in tissue extracts and elevated plasma VEGF levels.",
        "relation": "CPR:3"
    },
    {
        "id": "15192023.T2.T16",
        "sentence": "Thus, @CHEMICAL$ activates the @GENE$ pathway through inhibition of PHD activity and initiates a pro-angiogenic phenotype.",
        "relation": "CPR:3"
    },
    {
        "id": "15192023.T2.T17",
        "sentence": "Thus, @CHEMICAL$ activates the HIF pathway through inhibition of @GENE$ activity and initiates a pro-angiogenic phenotype.",
        "relation": "CPR:4"
    },
    {
        "id": "15198222.T13.T17",
        "sentence": "RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas @CHEMICAL$, carprofen, tolfenamic acid, nimesulide, and etodolac had more than 5 times greater preference for inhibiting @GENE$ than COX-1.",
        "relation": "CPR:4"
    },
    {
        "id": "15198222.T13.T18",
        "sentence": "RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas @CHEMICAL$, carprofen, tolfenamic acid, nimesulide, and etodolac had more than 5 times greater preference for inhibiting COX-2 than @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15198222.T14.T17",
        "sentence": "RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, @CHEMICAL$, tolfenamic acid, nimesulide, and etodolac had more than 5 times greater preference for inhibiting @GENE$ than COX-1.",
        "relation": "CPR:4"
    },
    {
        "id": "15198222.T14.T18",
        "sentence": "RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, @CHEMICAL$, tolfenamic acid, nimesulide, and etodolac had more than 5 times greater preference for inhibiting COX-2 than @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15198222.T15.T17",
        "sentence": "RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, carprofen, @CHEMICAL$, nimesulide, and etodolac had more than 5 times greater preference for inhibiting @GENE$ than COX-1.",
        "relation": "CPR:4"
    },
    {
        "id": "15198222.T15.T18",
        "sentence": "RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, carprofen, @CHEMICAL$, nimesulide, and etodolac had more than 5 times greater preference for inhibiting COX-2 than @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15198222.T16.T17",
        "sentence": "RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, carprofen, tolfenamic acid, @CHEMICAL$, and etodolac had more than 5 times greater preference for inhibiting @GENE$ than COX-1.",
        "relation": "CPR:4"
    },
    {
        "id": "15198222.T16.T18",
        "sentence": "RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, carprofen, tolfenamic acid, @CHEMICAL$, and etodolac had more than 5 times greater preference for inhibiting COX-2 than @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15198222.T1.T17",
        "sentence": "RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, carprofen, tolfenamic acid, nimesulide, and @CHEMICAL$ had more than 5 times greater preference for inhibiting @GENE$ than COX-1.",
        "relation": "CPR:4"
    },
    {
        "id": "15198222.T1.T18",
        "sentence": "RESULTS: Aspirin, diclofenac, indomethacin, ketoprofen, meclofenamic acid, and piroxicam had little selectivity toward COX isozymes, whereas NS398, carprofen, tolfenamic acid, nimesulide, and @CHEMICAL$ had more than 5 times greater preference for inhibiting COX-2 than @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15198222.T2.T22",
        "sentence": "CONCLUSIONS AND CLINICAL RELEVANCE: @CHEMICAL$ was selectively inhibited by @GENE$, nimesulide, and NS398; tolfenamic acid and carprofen also appeared to be preferential COX-2 inhibitors in dogs.",
        "relation": "CPR:4"
    },
    {
        "id": "15198222.T3.T22",
        "sentence": "CONCLUSIONS AND CLINICAL RELEVANCE: @CHEMICAL$ was selectively inhibited by etodolac, @GENE$, and NS398; tolfenamic acid and carprofen also appeared to be preferential COX-2 inhibitors in dogs.",
        "relation": "CPR:4"
    },
    {
        "id": "15198222.T4.T22",
        "sentence": "CONCLUSIONS AND CLINICAL RELEVANCE: @CHEMICAL$ was selectively inhibited by etodolac, nimesulide, and @GENE$; tolfenamic acid and carprofen also appeared to be preferential COX-2 inhibitors in dogs.",
        "relation": "CPR:4"
    },
    {
        "id": "15198222.T5.T23",
        "sentence": "CONCLUSIONS AND CLINICAL RELEVANCE: Canine COX-2 was selectively inhibited by etodolac, nimesulide, and NS398; @CHEMICAL$ and carprofen also appeared to be preferential @GENE$ inhibitors in dogs.",
        "relation": "CPR:4"
    },
    {
        "id": "15198222.T6.T23",
        "sentence": "CONCLUSIONS AND CLINICAL RELEVANCE: Canine COX-2 was selectively inhibited by etodolac, nimesulide, and NS398; tolfenamic acid and @CHEMICAL$ also appeared to be preferential @GENE$ inhibitors in dogs.",
        "relation": "CPR:4"
    },
    {
        "id": "15292070.T1.T2",
        "sentence": "@CHEMICAL$ served as inhibitor of an interfering @GENE$ present in neutrophils, which allowed the lysosomal enzyme implicated in Pompe disease to be selectively analyzed.",
        "relation": "CPR:4"
    },
    {
        "id": "15325927.T6.T11",
        "sentence": "After 12 months of treatment, @CHEMICAL$ significantly improved all end points (plasma concentration of @GENE$ [BNP] from 175 (35 to 209) to 106 (52 to 160) pg/ml, mean (95% confidence interval) p <0.01; New York Heart Association functional class from 2.37 (2.13 to 2.61) to 1.56 (1.21 to 1.91), p <0.01; exercise capacity estimated with the Specific Activity Scale from 4.75 (4.50 to 5.00) to 5.68 (5.22 to 6.14) METs, p <0.02), whereas conventional therapy did not (plasma BNP concentration from 150 (114 to 186) to 174 (100 to 248) pg/ml; New York Heart Association functional class from 2.29 (2.08 to 2.50) to 2.11 (1.73 to 2.49); exercise capacity from 4.57 (4.34 to 4.80) to 4.72 (4.41 to 5.03) METs).",
        "relation": "CPR:4"
    },
    {
        "id": "15325927.T6.T12",
        "sentence": "After 12 months of treatment, @CHEMICAL$ significantly improved all end points (plasma concentration of B-type natriuretic peptide [@GENE$] from 175 (35 to 209) to 106 (52 to 160) pg/ml, mean (95% confidence interval) p <0.01; New York Heart Association functional class from 2.37 (2.13 to 2.61) to 1.56 (1.21 to 1.91), p <0.01; exercise capacity estimated with the Specific Activity Scale from 4.75 (4.50 to 5.00) to 5.68 (5.22 to 6.14) METs, p <0.02), whereas conventional therapy did not (plasma BNP concentration from 150 (114 to 186) to 174 (100 to 248) pg/ml; New York Heart Association functional class from 2.29 (2.08 to 2.50) to 2.11 (1.73 to 2.49); exercise capacity from 4.57 (4.34 to 4.80) to 4.72 (4.41 to 5.03) METs).",
        "relation": "CPR:4"
    },
    {
        "id": "15325927.T1.T8",
        "sentence": "Univariate regression analyses showed that only the use of @CHEMICAL$ was correlated with the decrease in @GENE$ concentration (p <0.03).",
        "relation": "CPR:4"
    },
    {
        "id": "1543672.T18.T25",
        "sentence": "@CHEMICAL$: mode of action and properties of the @GENE$ inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "1543672.T1.T20",
        "sentence": "@CHEMICAL$ (Lamisil) has primarily fungicidal action against many fungi as a result of its specific mechanism of @GENE$ inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "1543672.T7.T20",
        "sentence": "Terbinafine (@CHEMICAL$) has primarily fungicidal action against many fungi as a result of its specific mechanism of @GENE$ inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "1543672.T15.T23",
        "sentence": "@CHEMICAL$ is a potent non-competitive inhibitor of @GENE$ from Candida (Ki = 30 nM).",
        "relation": "CPR:4"
    },
    {
        "id": "1543672.T2.T24",
        "sentence": "In contrast, inhibition of @CHEMICAL$ only occurs at higher drug concentrations (Ki = 77 microM), and is competitive with @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15474503.T3.T29",
        "sentence": "Each statin induced apoA-I expression (mRNA and protein) dose-dependently: the rank order of the @CHEMICAL$ induction @GENE$ (3 microM)>simvastatin (10 microM)>atorvastatin (30 microM).",
        "relation": "CPR:3"
    },
    {
        "id": "15474503.T4.T29",
        "sentence": "Each statin induced apoA-I expression (mRNA and protein) dose-dependently: the rank order of the @CHEMICAL$ induction pitavastatin (3 microM)>@GENE$ (10 microM)>atorvastatin (30 microM).",
        "relation": "CPR:3"
    },
    {
        "id": "15474503.T5.T29",
        "sentence": "Each statin induced apoA-I expression (mRNA and protein) dose-dependently: the rank order of the @CHEMICAL$ induction pitavastatin (3 microM)>simvastatin (10 microM)>@GENE$ (30 microM).",
        "relation": "CPR:3"
    },
    {
        "id": "15474503.T6.T31",
        "sentence": "The induction of @CHEMICAL$ by statins disappeared with addition of @GENE$, which indicates that the effect is HMG-CoA reductase inhibition-dependent.",
        "relation": "CPR:4"
    },
    {
        "id": "15474503.T11.T34",
        "sentence": "Based on HMG-CoA reductase inhibition, pitavastatin-induced @CHEMICAL$ more efficiently than @GENE$ and atorvastatin.",
        "relation": "CPR:3"
    },
    {
        "id": "15474503.T12.T34",
        "sentence": "Based on HMG-CoA reductase inhibition, pitavastatin-induced @CHEMICAL$ more efficiently than simvastatin and @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "15474503.T9.T34",
        "sentence": "Based on HMG-CoA reductase inhibition, @CHEMICAL$-induced @GENE$ more efficiently than simvastatin and atorvastatin.",
        "relation": "CPR:3"
    },
    {
        "id": "15474503.T13.T36",
        "sentence": "Further study revealed that @CHEMICAL$ increased @GENE$ mRNA in HMG-CoA reductase-dependent manner and that Rho and Rho kinase inhibitor (C3T and Y27632) increased apoA-I production in the HepG2 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "15474503.T15.T38",
        "sentence": "Further study revealed that pitavastatin increased ABCA1 mRNA in HMG-CoA reductase-dependent manner and that @CHEMICAL$ and Rho kinase inhibitor (C3T and @GENE$) increased apoA-I production in the HepG2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "15474503.T15.T39",
        "sentence": "Further study revealed that pitavastatin increased ABCA1 mRNA in HMG-CoA reductase-dependent manner and that Rho and @CHEMICAL$ inhibitor (C3T and @GENE$) increased apoA-I production in the HepG2 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "15474503.T15.T40",
        "sentence": "Further study revealed that pitavastatin increased ABCA1 mRNA in HMG-CoA reductase-dependent manner and that Rho and Rho kinase inhibitor (C3T and @CHEMICAL$) increased @GENE$ production in the HepG2 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "15474503.T1.T20",
        "sentence": "These results suggest that @CHEMICAL$ efficiently increases apoA-I in the culture medium of HepG2 cells by promoting apoA-I production through inhibition of HMG-CoA reductase and suppression of @GENE$ activity and by protecting apoA-I from catabolism through ABCA1 induction and lipidation of apoA-I.",
        "relation": "CPR:4"
    },
    {
        "id": "15474503.T1.T17",
        "sentence": "These results suggest that @CHEMICAL$ efficiently increases @GENE$ in the culture medium of HepG2 cells by promoting apoA-I production through inhibition of HMG-CoA reductase and suppression of Rho activity and by protecting apoA-I from catabolism through ABCA1 induction and lipidation of apoA-I.",
        "relation": "CPR:3"
    },
    {
        "id": "15474503.T1.T18",
        "sentence": "These results suggest that @CHEMICAL$ efficiently increases apoA-I in the culture medium of HepG2 cells by promoting @GENE$ production through inhibition of HMG-CoA reductase and suppression of Rho activity and by protecting apoA-I from catabolism through ABCA1 induction and lipidation of apoA-I.",
        "relation": "CPR:3"
    },
    {
        "id": "15474503.T1.T19",
        "sentence": "These results suggest that @CHEMICAL$ efficiently increases apoA-I in the culture medium of HepG2 cells by promoting apoA-I production through inhibition of @GENE$ and suppression of Rho activity and by protecting apoA-I from catabolism through ABCA1 induction and lipidation of apoA-I.",
        "relation": "CPR:4"
    },
    {
        "id": "15474503.T1.T22",
        "sentence": "These results suggest that @CHEMICAL$ efficiently increases apoA-I in the culture medium of HepG2 cells by promoting apoA-I production through inhibition of HMG-CoA reductase and suppression of Rho activity and by protecting apoA-I from catabolism through @GENE$ induction and lipidation of apoA-I.",
        "relation": "CPR:3"
    },
    {
        "id": "15474503.T1.T23",
        "sentence": "These results suggest that @CHEMICAL$ efficiently increases apoA-I in the culture medium of HepG2 cells by promoting apoA-I production through inhibition of HMG-CoA reductase and suppression of Rho activity and by protecting apoA-I from catabolism through ABCA1 induction and lipidation of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "15557593.T5.T17",
        "sentence": "MATERIALS AND METHODS: Seeking to improve efficacy against otherwise intractable end-stage pancreatic islet tumors, two @CHEMICAL$ inhibitors, @GENE$ and SU11248, were used to disrupt PDGFR-mediated pericyte support of tumor endothelial cells in concert with maximum-tolerated dose (MTD) or metronomic chemotherapy and/or VEGFR inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "15557593.T5.T19",
        "sentence": "MATERIALS AND METHODS: Seeking to improve efficacy against otherwise intractable end-stage pancreatic islet tumors, two receptor tyrosine kinase inhibitors, @CHEMICAL$ and SU11248, were used to disrupt PDGFR-mediated pericyte support of tumor endothelial cells in concert with maximum-tolerated dose (MTD) or metronomic chemotherapy and/or @GENE$ inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "15557593.T5.T18",
        "sentence": "MATERIALS AND METHODS: Seeking to improve efficacy against otherwise intractable end-stage pancreatic islet tumors, two receptor tyrosine kinase inhibitors, @CHEMICAL$ and SU11248, were used to disrupt @GENE$-mediated pericyte support of tumor endothelial cells in concert with maximum-tolerated dose (MTD) or metronomic chemotherapy and/or VEGFR inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "15557593.T6.T17",
        "sentence": "MATERIALS AND METHODS: Seeking to improve efficacy against otherwise intractable end-stage pancreatic islet tumors, two @CHEMICAL$ inhibitors, imatinib and @GENE$, were used to disrupt PDGFR-mediated pericyte support of tumor endothelial cells in concert with maximum-tolerated dose (MTD) or metronomic chemotherapy and/or VEGFR inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "15557593.T6.T19",
        "sentence": "MATERIALS AND METHODS: Seeking to improve efficacy against otherwise intractable end-stage pancreatic islet tumors, two receptor tyrosine kinase inhibitors, imatinib and @CHEMICAL$, were used to disrupt PDGFR-mediated pericyte support of tumor endothelial cells in concert with maximum-tolerated dose (MTD) or metronomic chemotherapy and/or @GENE$ inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "15557593.T6.T18",
        "sentence": "MATERIALS AND METHODS: Seeking to improve efficacy against otherwise intractable end-stage pancreatic islet tumors, two receptor tyrosine kinase inhibitors, imatinib and @CHEMICAL$, were used to disrupt @GENE$-mediated pericyte support of tumor endothelial cells in concert with maximum-tolerated dose (MTD) or metronomic chemotherapy and/or VEGFR inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "15557593.T7.T8",
        "sentence": "RESULTS: @CHEMICAL$, despite equivocal efficacy as monotherapy, reduced pericyte coverage of tumor vessels and enhanced efficacy in combination with metronomic chemotherapy or @GENE$ inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "15563928.T9.T25",
        "sentence": "The objective of the present study was to compare the anti-inflammatory effects of the preferential COX-2 inhibitor etodolac with the non-selective @CHEMICAL$ inhibitor @GENE$ in horses with lipopolysaccharide (LPS)-induced synovitis.",
        "relation": "CPR:4"
    },
    {
        "id": "15563928.T5.T16",
        "sentence": "In addition, both drugs significantly reduced PGE2 levels (P<0.05) 6-h following LPS injection, whereas the probable @CHEMICAL$ prostanoid TXB2 was significantly reduced by @GENE$ (P<0.05), but not etodolac.",
        "relation": "CPR:4"
    },
    {
        "id": "15629255.T10.T23",
        "sentence": "Effect of @CHEMICAL$ (@GENE$/ETB receptor antagonist) on metabolic changes during stress and diabetes.",
        "relation": "CPR:6"
    },
    {
        "id": "15629255.T10.T24",
        "sentence": "Effect of @CHEMICAL$ (ETA/@GENE$ receptor antagonist) on metabolic changes during stress and diabetes.",
        "relation": "CPR:6"
    },
    {
        "id": "15629255.T4.T17",
        "sentence": "To test this, we studied the possible effect of the @CHEMICAL$ antagonist, @GENE$ (50 and 100 mg kg(-1)) on serum glucose and insulin levels as well as on liver glycogen contents in normoglycemic stressed animals.",
        "relation": "CPR:6"
    },
    {
        "id": "15646028.T3.T16",
        "sentence": "Pre-irradiation administration of RP-1 enhanced levels of @CHEMICAL$ induced increase in @GENE$ (upto 16 h), complex I/III (4 h) complex II/III activity (upto 24 h; p < 0.01) and inhibited the radiation-induced decrease in MMP significantly (24 h; p < 0.01).",
        "relation": "CPR:3"
    },
    {
        "id": "15646028.T3.T17",
        "sentence": "Pre-irradiation administration of RP-1 enhanced levels of @CHEMICAL$ induced increase in complex I (upto 16 h), @GENE$ (4 h) complex II/III activity (upto 24 h; p < 0.01) and inhibited the radiation-induced decrease in MMP significantly (24 h; p < 0.01).",
        "relation": "CPR:3"
    },
    {
        "id": "15646028.T3.T18",
        "sentence": "Pre-irradiation administration of RP-1 enhanced levels of @CHEMICAL$ induced increase in complex I (upto 16 h), complex I/III (4 h) @GENE$ activity (upto 24 h; p < 0.01) and inhibited the radiation-induced decrease in MMP significantly (24 h; p < 0.01).",
        "relation": "CPR:3"
    },
    {
        "id": "15665864.T2.T14",
        "sentence": "Moreover, @CHEMICAL$ efficiently suppressed the release of @GENE$ from mitochondria of the liver tissues from Jo2-challenged mice.",
        "relation": "CPR:4"
    },
    {
        "id": "15665864.T4.T19",
        "sentence": "Our results suggest that easing of Fas-triggered fulminant hepatitis by @CHEMICAL$ may involve a mitochondrial apoptotic pathway, probably through preventing cytochrome c release and thereby blocking downstream @GENE$ activation.",
        "relation": "CPR:4"
    },
    {
        "id": "15665864.T4.T18",
        "sentence": "Our results suggest that easing of Fas-triggered fulminant hepatitis by @CHEMICAL$ may involve a mitochondrial apoptotic pathway, probably through preventing @GENE$ release and thereby blocking downstream caspase activation.",
        "relation": "CPR:4"
    },
    {
        "id": "15671155.T10.T26",
        "sentence": "Cystathionine-gamma-lyase (@CHEMICAL$) and cystathionine-beta-synthase (CBS) utilize @GENE$ as substrate to form H2S. Of these two enzymes, cystathionine-gamma-lyase (CSE) is believed to be the key enzyme that forms H2S in the cardiovascular system.",
        "relation": "CPR:9"
    },
    {
        "id": "15671155.T10.T29",
        "sentence": "Cystathionine-gamma-lyase (CSE) and @CHEMICAL$ (CBS) utilize @GENE$ as substrate to form H2S. Of these two enzymes, cystathionine-gamma-lyase (CSE) is believed to be the key enzyme that forms H2S in the cardiovascular system.",
        "relation": "CPR:9"
    },
    {
        "id": "15671155.T10.T30",
        "sentence": "Cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (@CHEMICAL$) utilize @GENE$ as substrate to form H2S. Of these two enzymes, cystathionine-gamma-lyase (CSE) is believed to be the key enzyme that forms H2S in the cardiovascular system.",
        "relation": "CPR:9"
    },
    {
        "id": "15671155.T10.T36",
        "sentence": "@CHEMICAL$ (CSE) and cystathionine-beta-synthase (CBS) utilize @GENE$ as substrate to form H2S. Of these two enzymes, cystathionine-gamma-lyase (CSE) is believed to be the key enzyme that forms H2S in the cardiovascular system.",
        "relation": "CPR:9"
    },
    {
        "id": "15671155.T16.T26",
        "sentence": "Cystathionine-gamma-lyase (@CHEMICAL$) and cystathionine-beta-synthase (CBS) utilize L-cysteine as substrate to form @GENE$. Of these two enzymes, cystathionine-gamma-lyase (CSE) is believed to be the key enzyme that forms H2S in the cardiovascular system.",
        "relation": "CPR:9"
    },
    {
        "id": "15671155.T16.T29",
        "sentence": "Cystathionine-gamma-lyase (CSE) and @CHEMICAL$ (CBS) utilize L-cysteine as substrate to form @GENE$. Of these two enzymes, cystathionine-gamma-lyase (CSE) is believed to be the key enzyme that forms H2S in the cardiovascular system.",
        "relation": "CPR:9"
    },
    {
        "id": "15671155.T16.T30",
        "sentence": "Cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (@CHEMICAL$) utilize L-cysteine as substrate to form @GENE$. Of these two enzymes, cystathionine-gamma-lyase (CSE) is believed to be the key enzyme that forms H2S in the cardiovascular system.",
        "relation": "CPR:9"
    },
    {
        "id": "15671155.T16.T36",
        "sentence": "@CHEMICAL$ (CSE) and cystathionine-beta-synthase (CBS) utilize L-cysteine as substrate to form @GENE$. Of these two enzymes, cystathionine-gamma-lyase (CSE) is believed to be the key enzyme that forms H2S in the cardiovascular system.",
        "relation": "CPR:9"
    },
    {
        "id": "15671155.T18.T32",
        "sentence": "Cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS) utilize L-cysteine as substrate to form H2S. Of these two enzymes, @CHEMICAL$ (CSE) is believed to be the key enzyme that forms @GENE$ in the cardiovascular system.",
        "relation": "CPR:9"
    },
    {
        "id": "15671155.T18.T33",
        "sentence": "Cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS) utilize L-cysteine as substrate to form H2S. Of these two enzymes, cystathionine-gamma-lyase (@CHEMICAL$) is believed to be the key enzyme that forms @GENE$ in the cardiovascular system.",
        "relation": "CPR:9"
    },
    {
        "id": "15671155.T21.T35",
        "sentence": "Also, prophylactic, as well as therapeutic, treatment with the @CHEMICAL$ inhibitor, @GENE$ (PAG), significantly reduced the severity of caerulein-induced pancreatitis and associated lung injury, as determined by 1) hyperamylasemia [plasma amylase (U/L) (control, 1204+/-59); prophylactic treatment: placebo, 10635+/-305; PAG, 7904+/-495; therapeutic treatment: placebo, 10427+/-470; PAG, 7811+/-428; P<0.05 PAG c.f. placebo; n=24 animals in each group]; 2) neutrophil sequestration in the pancreas [pancreatic myeloperoxidase oxidase (MPO) activity (fold increase over control) (prophylactic treatment: placebo, 5.78+/-0.63; PAG, 2.97+/-0.39; therapeutic treatment: placebo, 5.48+/-0.52; PAG, 3.03+/-0.47; P<0.05 PAG c.f. placebo; n=24 animals in each group)]; 3) pancreatic acinar cell injury/necrosis; 4) lung MPO activity (fold increase over control) [prophylactic treatment: placebo, 1.99+/-0.16; PAG, 1.34+/-0.14; therapeutic treatment: placebo, 2.03+/-0.12; PAG, 1.41+/-0.97; P<0.05 PAG c.f. placebo; n=24 animals in each group]; and 5) histological evidence of lung injury.",
        "relation": "CPR:4"
    },
    {
        "id": "15671155.T22.T35",
        "sentence": "Also, prophylactic, as well as therapeutic, treatment with the @CHEMICAL$ inhibitor, DL-propargylglycine (@GENE$), significantly reduced the severity of caerulein-induced pancreatitis and associated lung injury, as determined by 1) hyperamylasemia [plasma amylase (U/L) (control, 1204+/-59); prophylactic treatment: placebo, 10635+/-305; PAG, 7904+/-495; therapeutic treatment: placebo, 10427+/-470; PAG, 7811+/-428; P<0.05 PAG c.f. placebo; n=24 animals in each group]; 2) neutrophil sequestration in the pancreas [pancreatic myeloperoxidase oxidase (MPO) activity (fold increase over control) (prophylactic treatment: placebo, 5.78+/-0.63; PAG, 2.97+/-0.39; therapeutic treatment: placebo, 5.48+/-0.52; PAG, 3.03+/-0.47; P<0.05 PAG c.f. placebo; n=24 animals in each group)]; 3) pancreatic acinar cell injury/necrosis; 4) lung MPO activity (fold increase over control) [prophylactic treatment: placebo, 1.99+/-0.16; PAG, 1.34+/-0.14; therapeutic treatment: placebo, 2.03+/-0.12; PAG, 1.41+/-0.97; P<0.05 PAG c.f. placebo; n=24 animals in each group]; and 5) histological evidence of lung injury.",
        "relation": "CPR:4"
    },
    {
        "id": "15671155.T6.T27",
        "sentence": "Also, prophylactic, as well as therapeutic, treatment with the CSE inhibitor, DL-propargylglycine (PAG), significantly reduced the severity of caerulein-induced pancreatitis and associated lung injury, as determined by 1) hyperamylasemia [plasma amylase (U/L) (control, 1204+/-59); prophylactic treatment: placebo, 10635+/-305; PAG, 7904+/-495; therapeutic treatment: placebo, 10427+/-470; PAG, 7811+/-428; P<0.05 PAG c.f. placebo; n=24 animals in each group]; 2) neutrophil sequestration in the pancreas [pancreatic @CHEMICAL$ (MPO) activity (fold increase over control) (prophylactic treatment: placebo, 5.78+/-0.63; @GENE$, 2.97+/-0.39; therapeutic treatment: placebo, 5.48+/-0.52; PAG, 3.03+/-0.47; P<0.05 PAG c.f. placebo; n=24 animals in each group)]; 3) pancreatic acinar cell injury/necrosis; 4) lung MPO activity (fold increase over control) [prophylactic treatment: placebo, 1.99+/-0.16; PAG, 1.34+/-0.14; therapeutic treatment: placebo, 2.03+/-0.12; PAG, 1.41+/-0.97; P<0.05 PAG c.f. placebo; n=24 animals in each group]; and 5) histological evidence of lung injury.",
        "relation": "CPR:3"
    },
    {
        "id": "15671155.T6.T28",
        "sentence": "Also, prophylactic, as well as therapeutic, treatment with the CSE inhibitor, DL-propargylglycine (PAG), significantly reduced the severity of caerulein-induced pancreatitis and associated lung injury, as determined by 1) hyperamylasemia [plasma amylase (U/L) (control, 1204+/-59); prophylactic treatment: placebo, 10635+/-305; PAG, 7904+/-495; therapeutic treatment: placebo, 10427+/-470; PAG, 7811+/-428; P<0.05 PAG c.f. placebo; n=24 animals in each group]; 2) neutrophil sequestration in the pancreas [pancreatic myeloperoxidase oxidase (@CHEMICAL$) activity (fold increase over control) (prophylactic treatment: placebo, 5.78+/-0.63; @GENE$, 2.97+/-0.39; therapeutic treatment: placebo, 5.48+/-0.52; PAG, 3.03+/-0.47; P<0.05 PAG c.f. placebo; n=24 animals in each group)]; 3) pancreatic acinar cell injury/necrosis; 4) lung MPO activity (fold increase over control) [prophylactic treatment: placebo, 1.99+/-0.16; PAG, 1.34+/-0.14; therapeutic treatment: placebo, 2.03+/-0.12; PAG, 1.41+/-0.97; P<0.05 PAG c.f. placebo; n=24 animals in each group]; and 5) histological evidence of lung injury.",
        "relation": "CPR:3"
    },
    {
        "id": "15737409.T15.T31",
        "sentence": "The identification of defective structures in the ABCG5 or ABCG8 transporters in patients with the rare disease of sitosterolemia elucidated their role as sterol efflux pumps regulating at least in parts the intestinal sterol absorption and the hepatic sterol output. ABCG5 and ABCG8 themselves are regulated by cholesterol via liver X receptors (@CHEMICAL$), which are also activated by oxysterols and some derivatives of plant @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "15737409.T17.T35",
        "sentence": "NPC1L1 could recently be identified as a major @CHEMICAL$ for the intestinal uptake of @GENE$ as well as plant sterols.",
        "relation": "CPR:9"
    },
    {
        "id": "15737409.T17.T33",
        "sentence": "@CHEMICAL$ could recently be identified as a major sterol transporter for the intestinal uptake of @GENE$ as well as plant sterols.",
        "relation": "CPR:9"
    },
    {
        "id": "15737409.T18.T35",
        "sentence": "NPC1L1 could recently be identified as a major @CHEMICAL$ for the intestinal uptake of cholesterol as well as plant @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "15737409.T18.T33",
        "sentence": "@CHEMICAL$ could recently be identified as a major sterol transporter for the intestinal uptake of cholesterol as well as plant @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "15787205.T1.T11",
        "sentence": "@CHEMICAL$ has an antidepressant effect through blocking the @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "15811959.T4.T23",
        "sentence": "In vitro studies demonstrated that the retinoid X receptor (RXR) retinoid, @CHEMICAL$, at biologically relevant concentrations of 10(-6) M to 10(-8) M, upregulated both the p55 and p75 subunits of the @GENE$ and enhanced 5- to 10-fold the susceptibility of T-cell leukemia cells to denileukin diftitox.",
        "relation": "CPR:3"
    },
    {
        "id": "15811959.T4.T21",
        "sentence": "In vitro studies demonstrated that the retinoid X receptor (RXR) retinoid, @CHEMICAL$, at biologically relevant concentrations of 10(-6) M to 10(-8) M, upregulated both the @GENE$ and p75 subunits of the IL-2R and enhanced 5- to 10-fold the susceptibility of T-cell leukemia cells to denileukin diftitox.",
        "relation": "CPR:3"
    },
    {
        "id": "15811959.T4.T22",
        "sentence": "In vitro studies demonstrated that the retinoid X receptor (RXR) retinoid, @CHEMICAL$, at biologically relevant concentrations of 10(-6) M to 10(-8) M, upregulated both the p55 and @GENE$ subunits of the IL-2R and enhanced 5- to 10-fold the susceptibility of T-cell leukemia cells to denileukin diftitox.",
        "relation": "CPR:3"
    },
    {
        "id": "15811959.T3.T8",
        "sentence": "Our results demonstrate that the combination of denileukin diftitox and bexarotene is well tolerated and that even low doses (150 mg/day) of @CHEMICAL$ are capable of in vivo upregulation of @GENE$ expression on circulating leukemia cells.",
        "relation": "CPR:3"
    },
    {
        "id": "15837926.T2.T11",
        "sentence": "PSMA acts as a @CHEMICAL$ (GCPII) on small molecule substrates, including @GENE$, the anticancer drug methotrexate, and the neuropeptide N-acetyl-l-aspartyl-l-glutamate.",
        "relation": "CPR:9"
    },
    {
        "id": "15837926.T2.T10",
        "sentence": "@CHEMICAL$ acts as a glutamate carboxypeptidase (GCPII) on small molecule substrates, including @GENE$, the anticancer drug methotrexate, and the neuropeptide N-acetyl-l-aspartyl-l-glutamate.",
        "relation": "CPR:9"
    },
    {
        "id": "15837926.T2.T12",
        "sentence": "PSMA acts as a glutamate carboxypeptidase (@CHEMICAL$) on small molecule substrates, including @GENE$, the anticancer drug methotrexate, and the neuropeptide N-acetyl-l-aspartyl-l-glutamate.",
        "relation": "CPR:9"
    },
    {
        "id": "15837926.T3.T11",
        "sentence": "PSMA acts as a @CHEMICAL$ (GCPII) on small molecule substrates, including folate, the anticancer drug @GENE$, and the neuropeptide N-acetyl-l-aspartyl-l-glutamate.",
        "relation": "CPR:9"
    },
    {
        "id": "15837926.T3.T10",
        "sentence": "@CHEMICAL$ acts as a glutamate carboxypeptidase (GCPII) on small molecule substrates, including folate, the anticancer drug @GENE$, and the neuropeptide N-acetyl-l-aspartyl-l-glutamate.",
        "relation": "CPR:9"
    },
    {
        "id": "15837926.T3.T12",
        "sentence": "PSMA acts as a glutamate carboxypeptidase (@CHEMICAL$) on small molecule substrates, including folate, the anticancer drug @GENE$, and the neuropeptide N-acetyl-l-aspartyl-l-glutamate.",
        "relation": "CPR:9"
    },
    {
        "id": "15837926.T4.T11",
        "sentence": "PSMA acts as a @CHEMICAL$ (GCPII) on small molecule substrates, including folate, the anticancer drug methotrexate, and the neuropeptide @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "15837926.T4.T10",
        "sentence": "@CHEMICAL$ acts as a glutamate carboxypeptidase (GCPII) on small molecule substrates, including folate, the anticancer drug methotrexate, and the neuropeptide @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "15837926.T8.T21",
        "sentence": "Elucidation of the @CHEMICAL$ structure combined with docking studies and a proposed catalytic mechanism provides insight into the recognition of inhibitors and the natural substrate @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "1600046.T10.T23",
        "sentence": "A number of selective @CHEMICAL$ antagonists have been developed including ondansetron, granisetron, tropisetron renzapride and @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "1600046.T6.T23",
        "sentence": "A number of selective @CHEMICAL$ antagonists have been developed including @GENE$, granisetron, tropisetron renzapride and zacopride.",
        "relation": "CPR:6"
    },
    {
        "id": "1600046.T7.T23",
        "sentence": "A number of selective @CHEMICAL$ antagonists have been developed including ondansetron, @GENE$, tropisetron renzapride and zacopride.",
        "relation": "CPR:6"
    },
    {
        "id": "1600046.T8.T23",
        "sentence": "A number of selective @CHEMICAL$ antagonists have been developed including ondansetron, granisetron, @GENE$ renzapride and zacopride.",
        "relation": "CPR:6"
    },
    {
        "id": "1600046.T9.T23",
        "sentence": "A number of selective @CHEMICAL$ antagonists have been developed including ondansetron, granisetron, tropisetron @GENE$ and zacopride.",
        "relation": "CPR:6"
    },
    {
        "id": "1600046.T11.T24",
        "sentence": "While the substituted @CHEMICAL$ prokinetics (for example, metoclopramide, cisapride) also block @GENE$ receptors in high concentrations, their prokinetic action is believed to be on the basis of their agonist effects on the putative 5-HT4 receptor.",
        "relation": "CPR:4"
    },
    {
        "id": "1600046.T11.T25",
        "sentence": "While the substituted @CHEMICAL$ prokinetics (for example, metoclopramide, cisapride) also block 5-HT3 receptors in high concentrations, their prokinetic action is believed to be on the basis of their agonist effects on the putative @GENE$ receptor.",
        "relation": "CPR:5"
    },
    {
        "id": "1600046.T12.T24",
        "sentence": "While the substituted benzamide prokinetics (for example, @CHEMICAL$, cisapride) also block @GENE$ receptors in high concentrations, their prokinetic action is believed to be on the basis of their agonist effects on the putative 5-HT4 receptor.",
        "relation": "CPR:4"
    },
    {
        "id": "1600046.T12.T25",
        "sentence": "While the substituted benzamide prokinetics (for example, @CHEMICAL$, cisapride) also block 5-HT3 receptors in high concentrations, their prokinetic action is believed to be on the basis of their agonist effects on the putative @GENE$ receptor.",
        "relation": "CPR:5"
    },
    {
        "id": "1600046.T13.T24",
        "sentence": "While the substituted benzamide prokinetics (for example, metoclopramide, @CHEMICAL$) also block @GENE$ receptors in high concentrations, their prokinetic action is believed to be on the basis of their agonist effects on the putative 5-HT4 receptor.",
        "relation": "CPR:4"
    },
    {
        "id": "1600046.T13.T25",
        "sentence": "While the substituted benzamide prokinetics (for example, metoclopramide, @CHEMICAL$) also block 5-HT3 receptors in high concentrations, their prokinetic action is believed to be on the basis of their agonist effects on the putative @GENE$ receptor.",
        "relation": "CPR:5"
    },
    {
        "id": "1600046.T14.T26",
        "sentence": "Some @CHEMICAL$ antagonists have 5-HT4 agonist activity (for example, @GENE$, zacopride) and others do not (for example, ondansetron, granisetron), while tropisetron in high concentrations is a 5-HT4 antagonist.",
        "relation": "CPR:6"
    },
    {
        "id": "1600046.T14.T27",
        "sentence": "Some 5-HT3 antagonists have @CHEMICAL$ agonist activity (for example, @GENE$, zacopride) and others do not (for example, ondansetron, granisetron), while tropisetron in high concentrations is a 5-HT4 antagonist.",
        "relation": "CPR:5"
    },
    {
        "id": "1600046.T15.T26",
        "sentence": "Some @CHEMICAL$ antagonists have 5-HT4 agonist activity (for example, renzapride, @GENE$) and others do not (for example, ondansetron, granisetron), while tropisetron in high concentrations is a 5-HT4 antagonist.",
        "relation": "CPR:6"
    },
    {
        "id": "1600046.T15.T27",
        "sentence": "Some 5-HT3 antagonists have @CHEMICAL$ agonist activity (for example, renzapride, @GENE$) and others do not (for example, ondansetron, granisetron), while tropisetron in high concentrations is a 5-HT4 antagonist.",
        "relation": "CPR:5"
    },
    {
        "id": "1600046.T2.T19",
        "sentence": "Some 5-HT3 antagonists have 5-HT4 agonist activity (for example, renzapride, zacopride) and others do not (for example, ondansetron, granisetron), while @CHEMICAL$ in high concentrations is a @GENE$ antagonist.",
        "relation": "CPR:6"
    },
    {
        "id": "16018973.T1.T10",
        "sentence": "We present our studies to demonstrate that HM74A, but not HM74, binds @CHEMICAL$ at high affinities and effectively mediates @GENE$ signaling events in human embryonic kidney HEK293 cells as well as in 3T3L1 adipocytes expressing HM74A.",
        "relation": "CPR:3"
    },
    {
        "id": "16232421.T17.T33",
        "sentence": "When cultured in YPD medium containing 15% glucose under aerobic conditions, the @CHEMICAL$ (alpha-ketoglutarate dehydrogenase) gene disrupted mutant produced a lower level of @GENE$ than the wild-type strain, while the SDH1 (succinate dehydrogenase) gene-disrupted mutant produced an increased level of succinate.",
        "relation": "CPR:9"
    },
    {
        "id": "16232421.T17.T34",
        "sentence": "When cultured in YPD medium containing 15% glucose under aerobic conditions, the KGD1 (@CHEMICAL$) gene disrupted mutant produced a lower level of @GENE$ than the wild-type strain, while the SDH1 (succinate dehydrogenase) gene-disrupted mutant produced an increased level of succinate.",
        "relation": "CPR:9"
    },
    {
        "id": "16232421.T19.T35",
        "sentence": "When cultured in YPD medium containing 15% glucose under aerobic conditions, the KGD1 (alpha-ketoglutarate dehydrogenase) gene disrupted mutant produced a lower level of succinate than the wild-type strain, while the @CHEMICAL$ (succinate dehydrogenase) gene-disrupted mutant produced an increased level of @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "16232421.T19.T36",
        "sentence": "When cultured in YPD medium containing 15% glucose under aerobic conditions, the KGD1 (alpha-ketoglutarate dehydrogenase) gene disrupted mutant produced a lower level of succinate than the wild-type strain, while the SDH1 (@CHEMICAL$) gene-disrupted mutant produced an increased level of @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "16232421.T20.T37",
        "sentence": "On the other hand, the @CHEMICAL$ (fumarase) gene disrupted mutant produced significantly higher levels of @GENE$ but did not form malate at all.",
        "relation": "CPR:9"
    },
    {
        "id": "16232421.T20.T38",
        "sentence": "On the other hand, the FUM1 (@CHEMICAL$) gene disrupted mutant produced significantly higher levels of @GENE$ but did not form malate at all.",
        "relation": "CPR:9"
    },
    {
        "id": "16232421.T3.T28",
        "sentence": "When the growth condition was shifted from aerobic to anaerobic, the increased level of @CHEMICAL$ in @GENE$ disruptants was no longer observed, whereas the decreased level of succinate in the KGD1 diruptant was still observed.",
        "relation": "CPR:9"
    },
    {
        "id": "16232421.T4.T29",
        "sentence": "When the growth condition was shifted from aerobic to anaerobic, the increased level of succinate in SDH1 disruptants was no longer observed, whereas the decreased level of @CHEMICAL$ in the @GENE$ diruptant was still observed.",
        "relation": "CPR:9"
    },
    {
        "id": "16232421.T6.T30",
        "sentence": "A double mutant of the two @CHEMICAL$ isozyme genes (OSM1 and FRDS) showed a @GENE$ productivity of 50% as compared to the parent when cells were incubated in glucose-buffered solution.",
        "relation": "CPR:9"
    },
    {
        "id": "16232421.T6.T31",
        "sentence": "A double mutant of the two fumarate reductase isozyme genes (@CHEMICAL$ and FRDS) showed a @GENE$ productivity of 50% as compared to the parent when cells were incubated in glucose-buffered solution.",
        "relation": "CPR:9"
    },
    {
        "id": "16232421.T6.T32",
        "sentence": "A double mutant of the two fumarate reductase isozyme genes (OSM1 and @CHEMICAL$) showed a @GENE$ productivity of 50% as compared to the parent when cells were incubated in glucose-buffered solution.",
        "relation": "CPR:9"
    },
    {
        "id": "16292755.T10.T31",
        "sentence": "@CHEMICAL$ and probucol significantly suppressed an increase in plasma total-cholesterol (total-C) and @GENE$ cholesterol compared to HC-control group.",
        "relation": "CPR:4"
    },
    {
        "id": "16292755.T11.T31",
        "sentence": "Vitamin E and @CHEMICAL$ significantly suppressed an increase in plasma total-cholesterol (total-C) and @GENE$ cholesterol compared to HC-control group.",
        "relation": "CPR:4"
    },
    {
        "id": "16292755.T15.T32",
        "sentence": "However, plasma @CHEMICAL$-cholesterol (HDL-C) and HDL-C/total-C ratio levels and plasma paraoxonase activity were only significantly higher in @GENE$ group after 8 weeks.",
        "relation": "CPR:3"
    },
    {
        "id": "16292755.T15.T33",
        "sentence": "However, plasma high-density lipoprotein-cholesterol (@CHEMICAL$-C) and HDL-C/total-C ratio levels and plasma paraoxonase activity were only significantly higher in @GENE$ group after 8 weeks.",
        "relation": "CPR:3"
    },
    {
        "id": "16292755.T15.T34",
        "sentence": "However, plasma high-density lipoprotein-cholesterol (HDL-C) and @CHEMICAL$-C/total-C ratio levels and plasma paraoxonase activity were only significantly higher in @GENE$ group after 8 weeks.",
        "relation": "CPR:3"
    },
    {
        "id": "16292755.T15.T35",
        "sentence": "However, plasma high-density lipoprotein-cholesterol (HDL-C) and HDL-C/total-C ratio levels and plasma @CHEMICAL$ activity were only significantly higher in @GENE$ group after 8 weeks.",
        "relation": "CPR:3"
    },
    {
        "id": "16292755.T16.T36",
        "sentence": "Hepatic @CHEMICAL$ activity was significantly lower in both @GENE$ and probucol groups than in HC-control group, while HMG-CoA reductase activity was the highest only in the probucol group.",
        "relation": "CPR:4"
    },
    {
        "id": "16292755.T17.T36",
        "sentence": "Hepatic @CHEMICAL$ activity was significantly lower in both vitamin E and @GENE$ groups than in HC-control group, while HMG-CoA reductase activity was the highest only in the probucol group.",
        "relation": "CPR:4"
    },
    {
        "id": "16292755.T19.T37",
        "sentence": "Hepatic ACAT activity was significantly lower in both vitamin E and probucol groups than in HC-control group, while @CHEMICAL$ activity was the highest only in the @GENE$ group.",
        "relation": "CPR:3"
    },
    {
        "id": "16292755.T2.T27",
        "sentence": "Hepatic mRNA expressions of @CHEMICAL$ and apo C-III were significantly lower in @GENE$ group than in other groups.",
        "relation": "CPR:4"
    },
    {
        "id": "16292755.T2.T28",
        "sentence": "Hepatic mRNA expressions of apo B-100 and @CHEMICAL$ were significantly lower in @GENE$ group than in other groups.",
        "relation": "CPR:4"
    },
    {
        "id": "16292755.T4.T30",
        "sentence": "Vitamin E supplementation was found to alter the plasma HDL-C-related factors; meanwhile, @CHEMICAL$ supplementation was very effective in enhancing cholesterol metabolism, except for a negative effect that reduced plasma @GENE$-C concentration.",
        "relation": "CPR:4"
    },
    {
        "id": "16298345.T2.T13",
        "sentence": "The aim of this study was to determine if macaque represents a suitable species for the pre-clinical evaluation of novel @CHEMICAL$ antagonists, such as @GENE$ (UK-427,857).",
        "relation": "CPR:6"
    },
    {
        "id": "16298345.T3.T13",
        "sentence": "The aim of this study was to determine if macaque represents a suitable species for the pre-clinical evaluation of novel @CHEMICAL$ antagonists, such as maraviroc (@GENE$).",
        "relation": "CPR:6"
    },
    {
        "id": "16298345.T7.T22",
        "sentence": "@CHEMICAL$ inhibited binding of [125I]-MIP-1beta to CCR5 from macaque and human with similar potency (IC50 = 17.50 +/- 1.24 nM and 7.18 +/- 0.93 nM, respectively) and antagonised MIP-1beta induced intracellular calcium release mediated through @GENE$ from macaque and human with similar potency (IC50 = 17.50 +/- 3.30 nM and 12.07 +/- 1.89, respectively).",
        "relation": "CPR:6"
    },
    {
        "id": "16298345.T1.T14",
        "sentence": "However, as with the human receptor, @CHEMICAL$ was shown to be a high affinity, potent functional antagonist of @GENE$ thereby indicating that the macaque should be a suitable species in which to evaluate the pharmacology, safety and potential mechanism-related toxicology of novel CCR5 antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "16298345.T1.T15",
        "sentence": "However, as with the human receptor, @CHEMICAL$ was shown to be a high affinity, potent functional antagonist of macaque CCR5 thereby indicating that the macaque should be a suitable species in which to evaluate the pharmacology, safety and potential mechanism-related toxicology of novel @GENE$ antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "16316409.T7.T33",
        "sentence": "Hence, re-expression of the p75NTR appears to partially reverse de-differentiation of prostate cancer cells by up-regulating the expression of @CHEMICAL$ for localized sequestration of @GENE$ that are available to newly up-regulated RAR-beta, RXR-alpha, and RXR-beta.",
        "relation": "CPR:3"
    },
    {
        "id": "16322797.T7.T21",
        "sentence": "Its special profile of actions, especially the rise in @CHEMICAL$-cholesterol levels induced by @GENE$, is unique among the currently available pharmacological tools to treat lipid disorders.",
        "relation": "CPR:3"
    },
    {
        "id": "16344985.T25.T36",
        "sentence": "@CHEMICAL$ selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by @GENE$: relevance to bipolar disorder.",
        "relation": "CPR:4"
    },
    {
        "id": "16344985.T27.T36",
        "sentence": "Valproic acid selectively inhibits conversion of @CHEMICAL$ to arachidonoyl-CoA by @GENE$: relevance to bipolar disorder.",
        "relation": "CPR:9"
    },
    {
        "id": "16344985.T28.T36",
        "sentence": "Valproic acid selectively inhibits conversion of arachidonic acid to @CHEMICAL$ by @GENE$: relevance to bipolar disorder.",
        "relation": "CPR:9"
    },
    {
        "id": "16344985.T16.T31",
        "sentence": "RATIONALE: Several drugs used to treat bipolar disorder (@CHEMICAL$ and carbamazepine), when administered chronically to rats, reduce the turnover of arachidonic acid, but not docosahexaenoic acid, in brain phospholipids by decreasing the activity of an arachidonic acid-selective @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "16344985.T19.T31",
        "sentence": "RATIONALE: Several drugs used to treat bipolar disorder (lithium and @CHEMICAL$), when administered chronically to rats, reduce the turnover of arachidonic acid, but not docosahexaenoic acid, in brain phospholipids by decreasing the activity of an arachidonic acid-selective @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "16344985.T18.T35",
        "sentence": "MATERIALS AND METHODS/RESULTS: By isolating rat brain microsomal long-chain fatty acyl-CoA synthetases (Acsl), we show in vitro that @CHEMICAL$ is a non-competitive inhibitor of @GENE$, as it reduces the maximal velocity of the reaction without changing the affinity of the substrate for the enzyme.",
        "relation": "CPR:4"
    },
    {
        "id": "16344985.T6.T30",
        "sentence": "Furthermore, brain microsomal Acsl did not produce valproyl-CoA. CONCLUSIONS: This study shows that @CHEMICAL$ acts as a non-competitive inhibitor of @GENE$, and that inhibition is substrate-selective.",
        "relation": "CPR:4"
    },
    {
        "id": "16359899.T1.T10",
        "sentence": "On the other hand, holocarboxylase synthetase (@CHEMICAL$) mRNA levels were markedly low in the deficient animals, and increased upon @GENE$ injection.",
        "relation": "CPR:3"
    },
    {
        "id": "16359899.T1.T9",
        "sentence": "On the other hand, @CHEMICAL$ (HCS) mRNA levels were markedly low in the deficient animals, and increased upon @GENE$ injection.",
        "relation": "CPR:3"
    },
    {
        "id": "16371234.T16.T48",
        "sentence": "Involvement of @CHEMICAL$ and up-regulated prostaglandin E synthases in phosphatidylserine liposome-induced @GENE$ production by microglia.",
        "relation": "CPR:9"
    },
    {
        "id": "16371234.T16.T49",
        "sentence": "Involvement of COX-1 and up-regulated @CHEMICAL$ in phosphatidylserine liposome-induced @GENE$ production by microglia.",
        "relation": "CPR:9"
    },
    {
        "id": "16371234.T4.T24",
        "sentence": "Furthermore, PS liposome-induced PGE2 production was significantly suppressed by @CHEMICAL$, a preferential @GENE$ inhibitor, but not by NS-398, a selective COX-2 inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "16371234.T5.T25",
        "sentence": "Furthermore, PS liposome-induced PGE2 production was significantly suppressed by indomethacin, a preferential COX-1 inhibitor, but not by @CHEMICAL$, a selective @GENE$ inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "16371234.T6.T33",
        "sentence": "These observations strongly suggest that the up-regulation of terminal @CHEMICAL$ that are preferentially coupled with COX-1, especially mPGES-2, plays the pivotal role in PS liposome-induced @GENE$ production by microglia.",
        "relation": "CPR:9"
    },
    {
        "id": "16371234.T6.T34",
        "sentence": "These observations strongly suggest that the up-regulation of terminal PGESs that are preferentially coupled with @CHEMICAL$, especially mPGES-2, plays the pivotal role in PS liposome-induced @GENE$ production by microglia.",
        "relation": "CPR:9"
    },
    {
        "id": "16371234.T6.T35",
        "sentence": "These observations strongly suggest that the up-regulation of terminal PGESs that are preferentially coupled with COX-1, especially @CHEMICAL$, plays the pivotal role in PS liposome-induced @GENE$ production by microglia.",
        "relation": "CPR:9"
    },
    {
        "id": "16425993.T3.T21",
        "sentence": "Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways, including the multiple-@CHEMICAL$ inhibitors (MKIs) @GENE$, sunitinib, and AG013736, which target multiple VEGFRs as well as PDGFR-beta.",
        "relation": "CPR:4"
    },
    {
        "id": "16425993.T3.T23",
        "sentence": "Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways, including the multiple-kinase inhibitors (MKIs) @CHEMICAL$, sunitinib, and AG013736, which target multiple @GENE$ as well as PDGFR-beta.",
        "relation": "CPR:4"
    },
    {
        "id": "16425993.T3.T24",
        "sentence": "Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways, including the multiple-kinase inhibitors (MKIs) @CHEMICAL$, sunitinib, and AG013736, which target multiple VEGFRs as well as @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "16425993.T4.T21",
        "sentence": "Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways, including the multiple-@CHEMICAL$ inhibitors (MKIs) sorafenib, @GENE$, and AG013736, which target multiple VEGFRs as well as PDGFR-beta.",
        "relation": "CPR:4"
    },
    {
        "id": "16425993.T4.T23",
        "sentence": "Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways, including the multiple-kinase inhibitors (MKIs) sorafenib, @CHEMICAL$, and AG013736, which target multiple @GENE$ as well as PDGFR-beta.",
        "relation": "CPR:4"
    },
    {
        "id": "16425993.T4.T24",
        "sentence": "Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways, including the multiple-kinase inhibitors (MKIs) sorafenib, @CHEMICAL$, and AG013736, which target multiple VEGFRs as well as @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "16425993.T5.T21",
        "sentence": "Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways, including the multiple-@CHEMICAL$ inhibitors (MKIs) sorafenib, sunitinib, and @GENE$, which target multiple VEGFRs as well as PDGFR-beta.",
        "relation": "CPR:4"
    },
    {
        "id": "16425993.T5.T23",
        "sentence": "Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways, including the multiple-kinase inhibitors (MKIs) sorafenib, sunitinib, and @CHEMICAL$, which target multiple @GENE$ as well as PDGFR-beta.",
        "relation": "CPR:4"
    },
    {
        "id": "16425993.T5.T24",
        "sentence": "Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways, including the multiple-kinase inhibitors (MKIs) sorafenib, sunitinib, and @CHEMICAL$, which target multiple VEGFRs as well as @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "16425993.T6.T28",
        "sentence": "@CHEMICAL$ has the added advantage of inhibiting multiple different Raf isoforms, which enables it to target TGF-alpha/EGFR signaling and may also enhance its inhibition of @GENE$ and PDGFR-beta.",
        "relation": "CPR:4"
    },
    {
        "id": "16425993.T6.T25",
        "sentence": "@CHEMICAL$ has the added advantage of inhibiting multiple different @GENE$ isoforms, which enables it to target TGF-alpha/EGFR signaling and may also enhance its inhibition of VEGFR and PDGFR-beta.",
        "relation": "CPR:4"
    },
    {
        "id": "16425993.T6.T26",
        "sentence": "@CHEMICAL$ has the added advantage of inhibiting multiple different Raf isoforms, which enables it to target @GENE$/EGFR signaling and may also enhance its inhibition of VEGFR and PDGFR-beta.",
        "relation": "CPR:4"
    },
    {
        "id": "16425993.T6.T27",
        "sentence": "@CHEMICAL$ has the added advantage of inhibiting multiple different Raf isoforms, which enables it to target TGF-alpha/@GENE$ signaling and may also enhance its inhibition of VEGFR and PDGFR-beta.",
        "relation": "CPR:4"
    },
    {
        "id": "16425993.T6.T29",
        "sentence": "@CHEMICAL$ has the added advantage of inhibiting multiple different Raf isoforms, which enables it to target TGF-alpha/EGFR signaling and may also enhance its inhibition of VEGFR and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "16596248.T2.T9",
        "sentence": "Low @CHEMICAL$ expression levels, cytoplasmic expression pattern and C SNP arose as variables associated to longer progression-free survival (PFS) in patients treated with @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "1665782.T11.T25",
        "sentence": "Therefore, in the present studies, animals were rendered tolerant to the @CHEMICAL$-selective agonist [D-Pen2,D-Pen5]enkephalin (@GENE$), and receptor binding activities were measured.",
        "relation": "CPR:5"
    },
    {
        "id": "1665782.T9.T25",
        "sentence": "Therefore, in the present studies, animals were rendered tolerant to the @CHEMICAL$-selective agonist @GENE$ (DPDPE), and receptor binding activities were measured.",
        "relation": "CPR:5"
    },
    {
        "id": "1665782.T6.T19",
        "sentence": "Our conclusion is that chronic @CHEMICAL$ treatment preferentially reduces @GENE$ binding activity.",
        "relation": "CPR:4"
    },
    {
        "id": "1666997.T14.T28",
        "sentence": "Complementary experiments using the 5-HT3-dependent Bezold-Jarisch reflex confirmed that @CHEMICAL$ really acts in vivo as a @GENE$ antagonist (IC50 = 50 micrograms/kg i.v.), whereas amitriptyline is essentially inactive on 5-HT3 receptors.",
        "relation": "CPR:6"
    },
    {
        "id": "16675639.T18.T36",
        "sentence": "Competitive radioligand binding assays were performed using cells expressing either the @CHEMICAL$ (hSERT) or norepinephrine (NE) transporter (hNET) with K(i) values for @GENE$ of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "16675639.T18.T37",
        "sentence": "Competitive radioligand binding assays were performed using cells expressing either the human serotonin (5-HT) transporter (@CHEMICAL$) or norepinephrine (NE) transporter (hNET) with K(i) values for @GENE$ of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "16675639.T18.T38",
        "sentence": "Competitive radioligand binding assays were performed using cells expressing either the human serotonin (5-HT) transporter (hSERT) or @CHEMICAL$ (hNET) with K(i) values for @GENE$ of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "16675639.T18.T39",
        "sentence": "Competitive radioligand binding assays were performed using cells expressing either the human serotonin (5-HT) transporter (hSERT) or norepinephrine (NE) transporter (@CHEMICAL$) with K(i) values for @GENE$ of 40.2 +/- 1.6 and 558.4 +/- 121.6 nM, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "16675639.T22.T41",
        "sentence": "Inhibition of @CHEMICAL$ or [3H]NE uptake by DVS for the @GENE$ or hNET produced IC50 values of 47.3 +/- 19.4 and 531.3 +/- 113.0 nM, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "16675639.T23.T42",
        "sentence": "Inhibition of [3H]5-HT or @CHEMICAL$ uptake by DVS for the hSERT or @GENE$ produced IC50 values of 47.3 +/- 19.4 and 531.3 +/- 113.0 nM, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "16675639.T4.T35",
        "sentence": "To mimic chronic selective serotonin reuptake inhibitor treatment and to block the inhibitory 5-HT(1A) autoreceptors, a @CHEMICAL$ antagonist, @GENE$ (WAY-100635) (0.3 mg/kg s.c.), was administered with DVS (30 mg/kg orally).",
        "relation": "CPR:6"
    },
    {
        "id": "16675639.T5.T35",
        "sentence": "To mimic chronic selective serotonin reuptake inhibitor treatment and to block the inhibitory 5-HT(1A) autoreceptors, a @CHEMICAL$ antagonist, N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinylcyclo hexanecarboxamide maleate salt (@GENE$) (0.3 mg/kg s.c.), was administered with DVS (30 mg/kg orally).",
        "relation": "CPR:6"
    },
    {
        "id": "16763553.T7.T22",
        "sentence": "The tissue RA level is maintained through a cascade of metabolic reactions where @CHEMICAL$ (RALDHs) catalyze the terminal reaction of @GENE$ biosynthesis from retinal, a rate-limiting step.",
        "relation": "CPR:9"
    },
    {
        "id": "16763553.T7.T23",
        "sentence": "The tissue RA level is maintained through a cascade of metabolic reactions where retinal dehydrogenases (@CHEMICAL$) catalyze the terminal reaction of @GENE$ biosynthesis from retinal, a rate-limiting step.",
        "relation": "CPR:9"
    },
    {
        "id": "16763553.T8.T22",
        "sentence": "The tissue RA level is maintained through a cascade of metabolic reactions where @CHEMICAL$ (RALDHs) catalyze the terminal reaction of RA biosynthesis from @GENE$, a rate-limiting step.",
        "relation": "CPR:9"
    },
    {
        "id": "16763553.T8.T23",
        "sentence": "The tissue RA level is maintained through a cascade of metabolic reactions where retinal dehydrogenases (@CHEMICAL$) catalyze the terminal reaction of RA biosynthesis from @GENE$, a rate-limiting step.",
        "relation": "CPR:9"
    },
    {
        "id": "16763553.T14.T28",
        "sentence": "Further, @CHEMICAL$ metabolites, predominantly the oxysterols, the natural ligands for liver X receptor (LXR), induced these genes via upregulation of @GENE$ (SREBP-1c) that bound to the regulatory regions of these genes.",
        "relation": "CPR:3"
    },
    {
        "id": "16763553.T14.T29",
        "sentence": "Further, @CHEMICAL$ metabolites, predominantly the oxysterols, the natural ligands for liver X receptor (LXR), induced these genes via upregulation of sterol regulatory element binding protein-1c (@GENE$) that bound to the regulatory regions of these genes.",
        "relation": "CPR:3"
    },
    {
        "id": "16763553.T15.T28",
        "sentence": "Further, cholesterol metabolites, predominantly the @CHEMICAL$, the natural ligands for liver X receptor (LXR), induced these genes via upregulation of @GENE$ (SREBP-1c) that bound to the regulatory regions of these genes.",
        "relation": "CPR:3"
    },
    {
        "id": "16763553.T15.T29",
        "sentence": "Further, cholesterol metabolites, predominantly the @CHEMICAL$, the natural ligands for liver X receptor (LXR), induced these genes via upregulation of sterol regulatory element binding protein-1c (@GENE$) that bound to the regulatory regions of these genes.",
        "relation": "CPR:3"
    },
    {
        "id": "16769115.T1.T11",
        "sentence": "Hypermethlyation of @CHEMICAL$ can be induced by treating mice with @GENE$, and these mice display brain and behavioral abnormalities similar to +/rl.",
        "relation": "CPR:3"
    },
    {
        "id": "16775509.T7.T14",
        "sentence": "Functional and bioenergetic consequences of @CHEMICAL$ antagonist @GENE$ in hearts with postinfarction LV remodeling.",
        "relation": "CPR:6"
    },
    {
        "id": "16775509.T5.T11",
        "sentence": "Thus, severe LV dysfunction and accompanying abnormal myocardial bioenergetic phenotype were prevented by the @CHEMICAL$ antagonist @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "16782438.T6.T19",
        "sentence": "We evaluated @CHEMICAL$, a @GENE$ inhibitor currently used to treat chronic myelogenous leukemia and gastrointestinal stromal tumors, as a potential drug for systemic treatment of MTC, in 2 MTC-derived cell lines expressing multiple endocrine neoplasia-associated mutant RET receptors.",
        "relation": "CPR:4"
    },
    {
        "id": "16782438.T12.T26",
        "sentence": "RESULTS: @CHEMICAL$ inhibited RET @GENE$ phosphorylation in a dose-dependent manner after 1.5 hours of exposure.",
        "relation": "CPR:4"
    },
    {
        "id": "16782438.T12.T25",
        "sentence": "RESULTS: @CHEMICAL$ inhibited @GENE$ Y1062 phosphorylation in a dose-dependent manner after 1.5 hours of exposure.",
        "relation": "CPR:4"
    },
    {
        "id": "16782438.T3.T16",
        "sentence": "CONCLUSIONS: @CHEMICAL$ inhibits @GENE$-mediated MTC cell growth affecting RET protein levels in vitro in a dose-dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "16782438.T3.T17",
        "sentence": "CONCLUSIONS: @CHEMICAL$ inhibits RET-mediated MTC cell growth affecting @GENE$ protein levels in vitro in a dose-dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "16782438.T4.T18",
        "sentence": "The concentration of @CHEMICAL$ necessary to inhibit @GENE$ in vitro, however, makes it impossible to conclude that imatinib monotherapy will be a good option for systemic therapy of MTC.",
        "relation": "CPR:4"
    },
    {
        "id": "16784786.T29.T48",
        "sentence": "In eukaryotes, the most prominent Mo-enzymes are (1) @CHEMICAL$, which catalyzes the final step in the degradation of @GENE$-containing amino acids and is involved in detoxifying excess sulfite, (2) xanthine dehydrogenase, which is involved in purine catabolism and reactive oxygen production, (3) aldehyde oxidase, which oxidizes a variety of aldehydes and is essential for the biosynthesis of the phytohormone abscisic acid, and in autotrophic organisms also (4) nitrate reductase, which catalyzes the key step in inorganic nitrogen assimilation.",
        "relation": "CPR:9"
    },
    {
        "id": "16819260.T1.T13",
        "sentence": "@CHEMICAL$ is a collective term for compounds which bind to and activate retinoic acid receptors (RARalpha, beta, gamma and RXRalpha, beta, gamma), members of @GENE$ superfamily.",
        "relation": "CPR:3"
    },
    {
        "id": "16819260.T1.T19",
        "sentence": "@CHEMICAL$ is a collective term for compounds which bind to and activate @GENE$ (RARalpha, beta, gamma and RXRalpha, beta, gamma), members of nuclear hormone receptor superfamily.",
        "relation": "CPR:3"
    },
    {
        "id": "16828882.T6.T20",
        "sentence": "The cholesterol-lowering drug @CHEMICAL$ inhibits @GENE$ signaling by binding to an allosteric site on CD11a (LFA-1 alpha chain), which leads to immunomodulation.",
        "relation": "CPR:4"
    },
    {
        "id": "16828882.T10.T29",
        "sentence": "@CHEMICAL$ abolished these anti-@GENE$ mAb-induced increases in lymphocytic cholinergic activity in a manner independent of its cholesterol-lowering activity.",
        "relation": "CPR:4"
    },
    {
        "id": "16829128.T1.T11",
        "sentence": "@CHEMICAL$, popularly known for its cooling effect, activates TRPM8--a cold-activated @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "16829128.T1.T10",
        "sentence": "@CHEMICAL$, popularly known for its cooling effect, activates @GENE$--a cold-activated thermoTRP ion channel.",
        "relation": "CPR:3"
    },
    {
        "id": "16829128.T3.T12",
        "sentence": "However, human physiological studies demonstrate a paradoxical role of menthol in modulation of warm sensation, and here, we show that @CHEMICAL$ also activates heat-activated @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "16829128.T4.T13",
        "sentence": "We further show that @CHEMICAL$ inhibits @GENE$, potentially explaining the use of menthol as an analgesic.",
        "relation": "CPR:4"
    },
    {
        "id": "16829128.T6.T14",
        "sentence": "Similar to @CHEMICAL$, both camphor and cinnamaldehyde (initially reported to be specific activators of @GENE$ and TRPA1, respectively) also modulate other thermoTRPs.",
        "relation": "CPR:3"
    },
    {
        "id": "16829128.T6.T15",
        "sentence": "Similar to @CHEMICAL$, both camphor and cinnamaldehyde (initially reported to be specific activators of TRPV3 and @GENE$, respectively) also modulate other thermoTRPs.",
        "relation": "CPR:3"
    },
    {
        "id": "16829128.T7.T14",
        "sentence": "Similar to menthol, both @CHEMICAL$ and cinnamaldehyde (initially reported to be specific activators of @GENE$ and TRPA1, respectively) also modulate other thermoTRPs.",
        "relation": "CPR:3"
    },
    {
        "id": "16829128.T7.T15",
        "sentence": "Similar to menthol, both @CHEMICAL$ and cinnamaldehyde (initially reported to be specific activators of TRPV3 and @GENE$, respectively) also modulate other thermoTRPs.",
        "relation": "CPR:3"
    },
    {
        "id": "16829128.T8.T14",
        "sentence": "Similar to menthol, both camphor and @CHEMICAL$ (initially reported to be specific activators of @GENE$ and TRPA1, respectively) also modulate other thermoTRPs.",
        "relation": "CPR:3"
    },
    {
        "id": "16829128.T8.T15",
        "sentence": "Similar to menthol, both camphor and @CHEMICAL$ (initially reported to be specific activators of TRPV3 and @GENE$, respectively) also modulate other thermoTRPs.",
        "relation": "CPR:3"
    },
    {
        "id": "16855093.T16.T27",
        "sentence": "The glutamate-aspartate transporter @CHEMICAL$ mediates @GENE$ uptake at inner hair cell afferent synapses in the mammalian cochlea.",
        "relation": "CPR:9"
    },
    {
        "id": "16855093.T16.T28",
        "sentence": "The @CHEMICAL$ GLAST mediates @GENE$ uptake at inner hair cell afferent synapses in the mammalian cochlea.",
        "relation": "CPR:9"
    },
    {
        "id": "16855093.T9.T20",
        "sentence": "Focal application of the transporter substrate D-aspartate elicited inward currents in IPCs, which were larger in the presence of anions that permeate the transporter-associated @CHEMICAL$ and blocked by the transporter antagonist @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "16855093.T13.T21",
        "sentence": "These currents were produced by @CHEMICAL$ (GLAST) (excitatory amino acid transporter 1) because they were weakly inhibited by @GENE$, an antagonist of glutamate transporter-1 (excitatory amino acid transporter 2) and were absent from IPCs in GLAST-/- cochleas.",
        "relation": "CPR:4"
    },
    {
        "id": "16855093.T13.T22",
        "sentence": "These currents were produced by glutamate-aspartate transporters (@CHEMICAL$) (excitatory amino acid transporter 1) because they were weakly inhibited by @GENE$, an antagonist of glutamate transporter-1 (excitatory amino acid transporter 2) and were absent from IPCs in GLAST-/- cochleas.",
        "relation": "CPR:4"
    },
    {
        "id": "16855093.T13.T23",
        "sentence": "These currents were produced by glutamate-aspartate transporters (GLAST) (@CHEMICAL$) because they were weakly inhibited by @GENE$, an antagonist of glutamate transporter-1 (excitatory amino acid transporter 2) and were absent from IPCs in GLAST-/- cochleas.",
        "relation": "CPR:4"
    },
    {
        "id": "16855093.T13.T24",
        "sentence": "These currents were produced by glutamate-aspartate transporters (GLAST) (excitatory amino acid transporter 1) because they were weakly inhibited by @CHEMICAL$, an antagonist of @GENE$ (excitatory amino acid transporter 2) and were absent from IPCs in GLAST-/- cochleas.",
        "relation": "CPR:6"
    },
    {
        "id": "16855093.T13.T25",
        "sentence": "These currents were produced by glutamate-aspartate transporters (GLAST) (excitatory amino acid transporter 1) because they were weakly inhibited by @CHEMICAL$, an antagonist of glutamate transporter-1 (@GENE$) and were absent from IPCs in GLAST-/- cochleas.",
        "relation": "CPR:6"
    },
    {
        "id": "16855093.T2.T17",
        "sentence": "Furthermore, D-aspartate-induced currents in outside-out patches from IPCs exhibited larger steady-state currents than responses elicited by @CHEMICAL$, a prominent feature of @GENE$, and examination of cochlea from GLAST-Discosoma red (DsRed) promoter reporter mice revealed that DsRed expression was restricted to IPCs and other supporting cells surrounding IHCs.",
        "relation": "CPR:9"
    },
    {
        "id": "16874462.T11.T26",
        "sentence": "Overexpression of @CHEMICAL$ induces @GENE$-dependent and mitochondria-mediated apoptosis.",
        "relation": "CPR:9"
    },
    {
        "id": "16874462.T3.T12",
        "sentence": "@CHEMICAL$ (POX), a mitochondrial inner-membrane protein, catalyzes the rate-limiting oxidation of @GENE$ to pyrroline- 5-carboxylate (P5C).",
        "relation": "CPR:9"
    },
    {
        "id": "16874462.T3.T14",
        "sentence": "Proline oxidase (@CHEMICAL$), a mitochondrial inner-membrane protein, catalyzes the rate-limiting oxidation of @GENE$ to pyrroline- 5-carboxylate (P5C).",
        "relation": "CPR:9"
    },
    {
        "id": "16874462.T4.T12",
        "sentence": "@CHEMICAL$ (POX), a mitochondrial inner-membrane protein, catalyzes the rate-limiting oxidation of proline to @GENE$ (P5C).",
        "relation": "CPR:9"
    },
    {
        "id": "16874462.T4.T14",
        "sentence": "Proline oxidase (@CHEMICAL$), a mitochondrial inner-membrane protein, catalyzes the rate-limiting oxidation of proline to @GENE$ (P5C).",
        "relation": "CPR:9"
    },
    {
        "id": "16874462.T5.T12",
        "sentence": "@CHEMICAL$ (POX), a mitochondrial inner-membrane protein, catalyzes the rate-limiting oxidation of proline to pyrroline- 5-carboxylate (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "16874462.T5.T14",
        "sentence": "Proline oxidase (@CHEMICAL$), a mitochondrial inner-membrane protein, catalyzes the rate-limiting oxidation of proline to pyrroline- 5-carboxylate (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "16874462.T7.T22",
        "sentence": "To further investigate the molecular basis of POX-induced apoptosis, we utilized the DLD-1.POX cells to show that cells overproducing @CHEMICAL$ exhibit an @GENE$-dependent apoptotic response.",
        "relation": "CPR:9"
    },
    {
        "id": "16874462.T9.T23",
        "sentence": "The apoptotic effect is specific for L-proline, detectable at 0.2 mM, maximal at 1 mM, and occurs during 48-72 h following the addition of @CHEMICAL$ to cells with maximally induced @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "16874462.T2.T13",
        "sentence": "We conclude that in the presence of @CHEMICAL$, high @GENE$ activity is sufficient to induce mitochondria-mediated apoptosis.",
        "relation": "CPR:9"
    },
    {
        "id": "16893531.T1.T23",
        "sentence": "The exception was @CHEMICAL$, a dual @GENE$/dopamine transporter blocker, which tended to increase spontaneous locomotor activity.",
        "relation": "CPR:4"
    },
    {
        "id": "16893531.T1.T24",
        "sentence": "The exception was @CHEMICAL$, a dual norepinephrine transporter/@GENE$ blocker, which tended to increase spontaneous locomotor activity.",
        "relation": "CPR:4"
    },
    {
        "id": "16893531.T6.T25",
        "sentence": "Coadministration of reboxetine and the @CHEMICAL$ blocker @GENE$ also increased spontaneous locomotor activity.",
        "relation": "CPR:4"
    },
    {
        "id": "16917142.T11.T31",
        "sentence": "@CHEMICAL$ blocks the action of estrogen by binding to the ER, and possesses both @GENE$-agonist and antagonist properties.",
        "relation": "CPR:6"
    },
    {
        "id": "16917142.T11.T31",
        "sentence": "@CHEMICAL$ blocks the action of estrogen by binding to the ER, and possesses both @GENE$-agonist and antagonist properties.",
        "relation": "CPR:5"
    },
    {
        "id": "16917142.T4.T23",
        "sentence": "@CHEMICAL$ is a novel @GENE$ antagonist that destroys the ER and its signaling pathway and is not associated with tamoxifen-like agonist effects.",
        "relation": "CPR:6"
    },
    {
        "id": "16917142.T4.T24",
        "sentence": "@CHEMICAL$ is a novel ER antagonist that destroys the @GENE$ and its signaling pathway and is not associated with tamoxifen-like agonist effects.",
        "relation": "CPR:4"
    },
    {
        "id": "16926278.T19.T25",
        "sentence": "@CHEMICAL$ (PDE5) contains a catalytic domain (C domain) that hydrolyzes @GENE$ and a regulatory domain (R domain) that contains two mammalian cGMP-binding phosphodiesterase, Anabaena adenylyl cyclases, Escherichia coli FhlAs (GAFs) (A and B) and a phosphorylation site for cyclic nucleotide-dependent protein kinases (cNPKs).",
        "relation": "CPR:9"
    },
    {
        "id": "16926278.T19.T40",
        "sentence": "Phosphodiesterase-5 (@CHEMICAL$) contains a catalytic domain (C domain) that hydrolyzes @GENE$ and a regulatory domain (R domain) that contains two mammalian cGMP-binding phosphodiesterase, Anabaena adenylyl cyclases, Escherichia coli FhlAs (GAFs) (A and B) and a phosphorylation site for cyclic nucleotide-dependent protein kinases (cNPKs).",
        "relation": "CPR:9"
    },
    {
        "id": "16926278.T15.T45",
        "sentence": "Binding of @CHEMICAL$ to GAF-A increases @GENE$ phosphorylation of PDE5 and improves catalytic site affinity for cGMP or inhibitors.",
        "relation": "CPR:3"
    },
    {
        "id": "16926278.T15.T46",
        "sentence": "Binding of @CHEMICAL$ to GAF-A increases cNPK phosphorylation of @GENE$ and improves catalytic site affinity for cGMP or inhibitors.",
        "relation": "CPR:3"
    },
    {
        "id": "16926278.T3.T30",
        "sentence": "K(m) values of the mutants for @CHEMICAL$ were similar to that of full-length @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "16938288.T11.T37",
        "sentence": "@CHEMICAL$ downregulates @GENE$ through activation of peroxisome proliferator-activated receptor gamma.",
        "relation": "CPR:4"
    },
    {
        "id": "16938288.T11.T38",
        "sentence": "@CHEMICAL$ downregulates angiotensin II type 1 receptor through activation of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "16938288.T3.T19",
        "sentence": "OBJECTIVE: @CHEMICAL$, an angiotensin II type 1 receptor (AT1R) antagonist, was found to have a unique property: it is a partial agonist of @GENE$ (PPARgamma).",
        "relation": "CPR:5"
    },
    {
        "id": "16938288.T3.T26",
        "sentence": "OBJECTIVE: @CHEMICAL$, an angiotensin II type 1 receptor (AT1R) antagonist, was found to have a unique property: it is a partial agonist of peroxisome proliferator-activated receptor gamma (@GENE$).",
        "relation": "CPR:5"
    },
    {
        "id": "16938288.T3.T28",
        "sentence": "OBJECTIVE: @CHEMICAL$, an @GENE$ (AT1R) antagonist, was found to have a unique property: it is a partial agonist of peroxisome proliferator-activated receptor gamma (PPARgamma).",
        "relation": "CPR:6"
    },
    {
        "id": "16938288.T3.T32",
        "sentence": "OBJECTIVE: @CHEMICAL$, an angiotensin II type 1 receptor (@GENE$) antagonist, was found to have a unique property: it is a partial agonist of peroxisome proliferator-activated receptor gamma (PPARgamma).",
        "relation": "CPR:6"
    },
    {
        "id": "16938288.T9.T34",
        "sentence": "RESULTS: @CHEMICAL$ decreased the expression of @GENE$ at the mRNA and protein levels in a dose- and time-dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "16938288.T10.T36",
        "sentence": "Decreased AT1R promoter activity with unchanged mRNA stability suggested that @CHEMICAL$ suppressed @GENE$ gene expression at the transcriptional level.",
        "relation": "CPR:4"
    },
    {
        "id": "16938288.T1.T13",
        "sentence": "However, the expression of AT1R was not suppressed by other @CHEMICAL$ antagonists such as @GENE$ or olmesartan.",
        "relation": "CPR:6"
    },
    {
        "id": "16938288.T2.T13",
        "sentence": "However, the expression of AT1R was not suppressed by other @CHEMICAL$ antagonists such as candesartan or @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "16938288.T4.T14",
        "sentence": "Since the suppression of @CHEMICAL$ expression was prevented by pretreatment with @GENE$, a PPARgamma antagonist, PPARgamma should have participated in the process.",
        "relation": "CPR:3"
    },
    {
        "id": "16938288.T4.T15",
        "sentence": "Since the suppression of AT1R expression was prevented by pretreatment with @CHEMICAL$, a @GENE$ antagonist, PPARgamma should have participated in the process.",
        "relation": "CPR:6"
    },
    {
        "id": "16938288.T5.T18",
        "sentence": "The deletion and mutation analysis of the AT1R gene promoter indicated that a @CHEMICAL$ located in the proximal promoter region is responsible for the @GENE$-induced downregulation.",
        "relation": "CPR:4"
    },
    {
        "id": "16938288.T5.T17",
        "sentence": "The deletion and mutation analysis of the @CHEMICAL$ gene promoter indicated that a GC box located in the proximal promoter region is responsible for the @GENE$-induced downregulation.",
        "relation": "CPR:4"
    },
    {
        "id": "16938288.T7.T20",
        "sentence": "CONCLUSION: Our data provides a novel insight into an effect of telmisartan: @CHEMICAL$ inhibits @GENE$ gene expression through PPARgamma activation.",
        "relation": "CPR:4"
    },
    {
        "id": "16938288.T7.T21",
        "sentence": "CONCLUSION: Our data provides a novel insight into an effect of telmisartan: @CHEMICAL$ inhibits AT1R gene expression through @GENE$ activation.",
        "relation": "CPR:3"
    },
    {
        "id": "16957773.T5.T17",
        "sentence": "Upon differentiation, osteoclasts express @CHEMICAL$ (VGLUT1), which is essential for vesicular storage and subsequent exocytosis of @GENE$ in neurons.",
        "relation": "CPR:9"
    },
    {
        "id": "16957773.T5.T18",
        "sentence": "Upon differentiation, osteoclasts express vesicular glutamate transporter 1 (@CHEMICAL$), which is essential for vesicular storage and subsequent exocytosis of @GENE$ in neurons.",
        "relation": "CPR:9"
    },
    {
        "id": "16957773.T6.T19",
        "sentence": "@CHEMICAL$ is localized in transcytotic vesicles and accumulates @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "16971132.T4.T12",
        "sentence": "Synthesis, @CHEMICAL$ inhibition, antitumor testing, and molecular modeling study of some new @GENE$ analogs.",
        "relation": "CPR:4"
    },
    {
        "id": "16971132.T1.T7",
        "sentence": "In order to produce potent new leads for anticancer drugs, a new series of quinazoline analogs was designed to resemble @CHEMICAL$ (MTX, 1) structure features and fitted with functional groups believed to enhance inhibition of @GENE$ activity.",
        "relation": "CPR:4"
    },
    {
        "id": "16971132.T2.T7",
        "sentence": "In order to produce potent new leads for anticancer drugs, a new series of quinazoline analogs was designed to resemble methotrexate (@CHEMICAL$, 1) structure features and fitted with functional groups believed to enhance inhibition of @GENE$ activity.",
        "relation": "CPR:4"
    },
    {
        "id": "16971132.T3.T7",
        "sentence": "In order to produce potent new leads for anticancer drugs, a new series of @CHEMICAL$ analogs was designed to resemble methotrexate (MTX, 1) structure features and fitted with functional groups believed to enhance inhibition of @GENE$ activity.",
        "relation": "CPR:4"
    },
    {
        "id": "16988497.T14.T18",
        "sentence": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of @CHEMICAL$ (LA) and alpha-linolenic acid (LNA) and the expression of PBMC @GENE$ and D5D genes.",
        "relation": "CPR:4"
    },
    {
        "id": "16988497.T14.T19",
        "sentence": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of @CHEMICAL$ (LA) and alpha-linolenic acid (LNA) and the expression of PBMC D6D and @GENE$ genes.",
        "relation": "CPR:4"
    },
    {
        "id": "16988497.T15.T18",
        "sentence": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (@CHEMICAL$) and alpha-linolenic acid (LNA) and the expression of PBMC @GENE$ and D5D genes.",
        "relation": "CPR:4"
    },
    {
        "id": "16988497.T15.T19",
        "sentence": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (@CHEMICAL$) and alpha-linolenic acid (LNA) and the expression of PBMC D6D and @GENE$ genes.",
        "relation": "CPR:4"
    },
    {
        "id": "16988497.T16.T18",
        "sentence": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (LA) and @CHEMICAL$ (LNA) and the expression of PBMC @GENE$ and D5D genes.",
        "relation": "CPR:4"
    },
    {
        "id": "16988497.T16.T19",
        "sentence": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (LA) and @CHEMICAL$ (LNA) and the expression of PBMC D6D and @GENE$ genes.",
        "relation": "CPR:4"
    },
    {
        "id": "16988497.T17.T18",
        "sentence": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (LA) and alpha-linolenic acid (@CHEMICAL$) and the expression of PBMC @GENE$ and D5D genes.",
        "relation": "CPR:4"
    },
    {
        "id": "16988497.T17.T19",
        "sentence": "A significant positive correlation was found between dietary intake of total SFAs and total MUFAs and expression of PBMC D6D and D5D genes, but a significant negative correlation between dietary intake of linoleic acid (LA) and alpha-linolenic acid (@CHEMICAL$) and the expression of PBMC D6D and @GENE$ genes.",
        "relation": "CPR:4"
    },
    {
        "id": "16988497.T1.T21",
        "sentence": "CONCLUSION: Intake of high @CHEMICAL$ and MUFAs appears to increase expression of PBMC @GENE$ and D5D genes, whilst high EFAs intake appears to decrease expression of PBMC D6D and D5D genes.",
        "relation": "CPR:3"
    },
    {
        "id": "16988497.T1.T22",
        "sentence": "CONCLUSION: Intake of high @CHEMICAL$ and MUFAs appears to increase expression of PBMC D6D and @GENE$ genes, whilst high EFAs intake appears to decrease expression of PBMC D6D and D5D genes.",
        "relation": "CPR:3"
    },
    {
        "id": "16988497.T2.T21",
        "sentence": "CONCLUSION: Intake of high SFAs and @CHEMICAL$ appears to increase expression of PBMC @GENE$ and D5D genes, whilst high EFAs intake appears to decrease expression of PBMC D6D and D5D genes.",
        "relation": "CPR:3"
    },
    {
        "id": "16988497.T2.T22",
        "sentence": "CONCLUSION: Intake of high SFAs and @CHEMICAL$ appears to increase expression of PBMC D6D and @GENE$ genes, whilst high EFAs intake appears to decrease expression of PBMC D6D and D5D genes.",
        "relation": "CPR:3"
    },
    {
        "id": "16988497.T3.T24",
        "sentence": "CONCLUSION: Intake of high SFAs and MUFAs appears to increase expression of PBMC D6D and D5D genes, whilst high @CHEMICAL$ intake appears to decrease expression of PBMC @GENE$ and D5D genes.",
        "relation": "CPR:4"
    },
    {
        "id": "16988497.T3.T25",
        "sentence": "CONCLUSION: Intake of high SFAs and MUFAs appears to increase expression of PBMC D6D and D5D genes, whilst high @CHEMICAL$ intake appears to decrease expression of PBMC D6D and @GENE$ genes.",
        "relation": "CPR:4"
    },
    {
        "id": "17023173.T2.T9",
        "sentence": "@CHEMICAL$ inhibits @GENE$ and has shown therapeutic effects in patients with hematologic malignancies.",
        "relation": "CPR:4"
    },
    {
        "id": "17065601.T19.T25",
        "sentence": "Our data suggest that @CHEMICAL$ is taken up by Sertoli cells and peritubular cells, principally via system y(+)L (@GENE$/SLC7A6) and system y(+) (SLC7A1 and SLC7A2), with system B(0+) making a minor contribution.",
        "relation": "CPR:9"
    },
    {
        "id": "17090056.T17.T31",
        "sentence": "KIEs were measured on the arsenolysis of @CHEMICAL$ (MTA) catalyzed by @GENE$ and were corrected for the forward commitment to catalysis.",
        "relation": "CPR:9"
    },
    {
        "id": "17090056.T18.T31",
        "sentence": "KIEs were measured on the arsenolysis of 5'-methylthioadenosine (@CHEMICAL$) catalyzed by @GENE$ and were corrected for the forward commitment to catalysis.",
        "relation": "CPR:9"
    },
    {
        "id": "17098734.T9.T20",
        "sentence": "During embryogenesis, lratb is expressed in mostly non-overlapping domains opposite to @CHEMICAL$ (raldh2), the key enzyme for @GENE$ synthesis.",
        "relation": "CPR:9"
    },
    {
        "id": "17098734.T9.T21",
        "sentence": "During embryogenesis, lratb is expressed in mostly non-overlapping domains opposite to retinal dehydrogenase 2 (@CHEMICAL$), the key enzyme for @GENE$ synthesis.",
        "relation": "CPR:9"
    },
    {
        "id": "17098734.T10.T22",
        "sentence": "Blocking @CHEMICAL$ formation by a targeted knock down of @GENE$ results in significantly increased retinoic acid levels, which lead to severe embryonic patterning defects.",
        "relation": "CPR:9"
    },
    {
        "id": "17110146.T13.T36",
        "sentence": "@CHEMICAL$ initiates platelet aggregation by 'simultaneous activation of two @GENE$, P2Y1 and P2Y12.",
        "relation": "CPR:3"
    },
    {
        "id": "17110146.T13.T37",
        "sentence": "@CHEMICAL$ initiates platelet aggregation by 'simultaneous activation of two G protein-coupled receptors, @GENE$ and P2Y12.",
        "relation": "CPR:3"
    },
    {
        "id": "17110146.T13.T38",
        "sentence": "@CHEMICAL$ initiates platelet aggregation by 'simultaneous activation of two G protein-coupled receptors, P2Y1 and @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "17110146.T10.T33",
        "sentence": "Our results imply that @CHEMICAL$ has the potential to be inhibited by @GENE$/ATP analogs, and it suggests that P2Y12 acts as a target of new drugs that inhibit platelet aggregation.",
        "relation": "CPR:4"
    },
    {
        "id": "17110146.T11.T33",
        "sentence": "Our results imply that @CHEMICAL$ has the potential to be inhibited by ADP/@GENE$ analogs, and it suggests that P2Y12 acts as a target of new drugs that inhibit platelet aggregation.",
        "relation": "CPR:4"
    },
    {
        "id": "17125913.T7.T31",
        "sentence": "@CHEMICAL$ decreased @GENE$ expression, but not ERbeta.",
        "relation": "CPR:4"
    },
    {
        "id": "17125913.T9.T34",
        "sentence": "@CHEMICAL$ also increased ERK1/2, @GENE$ and PDGFRalpha phosphorylation while ICI blocked it.",
        "relation": "CPR:3"
    },
    {
        "id": "17125913.T9.T35",
        "sentence": "@CHEMICAL$ also increased ERK1/2, Akt and @GENE$ phosphorylation while ICI blocked it.",
        "relation": "CPR:3"
    },
    {
        "id": "17125913.T10.T39",
        "sentence": "@CHEMICAL$ rapidly increased @GENE$, c-fos and PDGFA expression.",
        "relation": "CPR:3"
    },
    {
        "id": "17125913.T10.T40",
        "sentence": "@CHEMICAL$ rapidly increased c-jun, @GENE$ and PDGFA expression.",
        "relation": "CPR:3"
    },
    {
        "id": "17125913.T10.T41",
        "sentence": "@CHEMICAL$ rapidly increased c-jun, c-fos and @GENE$ expression.",
        "relation": "CPR:3"
    },
    {
        "id": "17125913.T1.T14",
        "sentence": "In conclusion, our results indicate that @CHEMICAL$ increases BC cell proliferation in vitro by stimulating @GENE$, ERK1/2 and PDGFRalpha kinases activity likely by activating c-fos, c-jun and PDGFA by an ERalpha-dependent mechanism.",
        "relation": "CPR:3"
    },
    {
        "id": "17125913.T1.T17",
        "sentence": "In conclusion, our results indicate that @CHEMICAL$ increases BC cell proliferation in vitro by stimulating Akt, ERK1/2 and PDGFRalpha @GENE$ activity likely by activating c-fos, c-jun and PDGFA by an ERalpha-dependent mechanism.",
        "relation": "CPR:3"
    },
    {
        "id": "17125913.T1.T16",
        "sentence": "In conclusion, our results indicate that @CHEMICAL$ increases BC cell proliferation in vitro by stimulating Akt, ERK1/2 and @GENE$ kinases activity likely by activating c-fos, c-jun and PDGFA by an ERalpha-dependent mechanism.",
        "relation": "CPR:3"
    },
    {
        "id": "17125913.T1.T19",
        "sentence": "In conclusion, our results indicate that @CHEMICAL$ increases BC cell proliferation in vitro by stimulating Akt, ERK1/2 and PDGFRalpha kinases activity likely by activating @GENE$, c-jun and PDGFA by an ERalpha-dependent mechanism.",
        "relation": "CPR:3"
    },
    {
        "id": "17125913.T1.T20",
        "sentence": "In conclusion, our results indicate that @CHEMICAL$ increases BC cell proliferation in vitro by stimulating Akt, ERK1/2 and PDGFRalpha kinases activity likely by activating c-fos, @GENE$ and PDGFA by an ERalpha-dependent mechanism.",
        "relation": "CPR:3"
    },
    {
        "id": "17125913.T1.T21",
        "sentence": "In conclusion, our results indicate that @CHEMICAL$ increases BC cell proliferation in vitro by stimulating Akt, ERK1/2 and PDGFRalpha kinases activity likely by activating c-fos, c-jun and @GENE$ by an ERalpha-dependent mechanism.",
        "relation": "CPR:3"
    },
    {
        "id": "17202804.T25.T69",
        "sentence": "@CHEMICAL$ functionally antagonizes testosterone activation of the @GENE$ in prostate cells through focal adhesion complexes involving Hic-5.",
        "relation": "CPR:6"
    },
    {
        "id": "17202804.T26.T69",
        "sentence": "Gonadotropin-releasing hormone functionally antagonizes @CHEMICAL$ activation of the @GENE$ in prostate cells through focal adhesion complexes involving Hic-5.",
        "relation": "CPR:3"
    },
    {
        "id": "17202804.T3.T34",
        "sentence": "@CHEMICAL$-induced @GENE$ activation opposed the association of Hic-5 with androgen receptor as overexpression of a dominant negative Pyk2 enhanced the GnRH-induced nuclear translocation of a green fluorescent protein-tagged human androgen receptor.",
        "relation": "CPR:3"
    },
    {
        "id": "17202804.T3.T35",
        "sentence": "@CHEMICAL$-induced Pyk2 activation opposed the association of @GENE$ with androgen receptor as overexpression of a dominant negative Pyk2 enhanced the GnRH-induced nuclear translocation of a green fluorescent protein-tagged human androgen receptor.",
        "relation": "CPR:4"
    },
    {
        "id": "17202804.T3.T36",
        "sentence": "@CHEMICAL$-induced Pyk2 activation opposed the association of Hic-5 with @GENE$ as overexpression of a dominant negative Pyk2 enhanced the GnRH-induced nuclear translocation of a green fluorescent protein-tagged human androgen receptor.",
        "relation": "CPR:4"
    },
    {
        "id": "17202804.T5.T41",
        "sentence": "@CHEMICAL$-induced @GENE$ activation resulted in the phosphorylation of expressed Hic-5 and promoted its association with the human androgen receptor.",
        "relation": "CPR:3"
    },
    {
        "id": "17202804.T6.T45",
        "sentence": "In contrast to @CHEMICAL$, GnRH-induced nuclear translocation did not transcriptionally activate the @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "17218486.T22.T49",
        "sentence": "The discovery that @CHEMICAL$ and AMPH activate the @GENE$ motivated us to study the effect of these drugs on the mouse TAAR1 (mTAAR1) and a human-rat chimera (hrChTAAR1).",
        "relation": "CPR:3"
    },
    {
        "id": "17218486.T23.T49",
        "sentence": "The discovery that METH and @CHEMICAL$ activate the @GENE$ motivated us to study the effect of these drugs on the mouse TAAR1 (mTAAR1) and a human-rat chimera (hrChTAAR1).",
        "relation": "CPR:3"
    },
    {
        "id": "17218486.T25.T53",
        "sentence": "Furthermore, because S-(+)-isomers of @CHEMICAL$ and AMPH are reported to be more potent and efficacious in vivo than R-(-), we determined the enantiomeric selectivity of all three species of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "17218486.T26.T53",
        "sentence": "Furthermore, because S-(+)-isomers of METH and @CHEMICAL$ are reported to be more potent and efficacious in vivo than R-(-), we determined the enantiomeric selectivity of all three species of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "17218486.T1.T37",
        "sentence": "EC50 values for @CHEMICAL$ were 0.89, 0.92, and 4.44 microM for @GENE$, mTAAR1, and h-rChTAAR1, respectively.",
        "relation": "CPR:3"
    },
    {
        "id": "17218486.T1.T38",
        "sentence": "EC50 values for @CHEMICAL$ were 0.89, 0.92, and 4.44 microM for rTAAR1, @GENE$, and h-rChTAAR1, respectively.",
        "relation": "CPR:3"
    },
    {
        "id": "17218486.T1.T39",
        "sentence": "EC50 values for @CHEMICAL$ were 0.89, 0.92, and 4.44 microM for rTAAR1, mTAAR1, and @GENE$, respectively.",
        "relation": "CPR:3"
    },
    {
        "id": "17218486.T3.T40",
        "sentence": "@CHEMICAL$ was a potent and full agonist at each species of @GENE$, whereas TYR was a full agonist for the rodent TAAR1s but was a partial agonist at h-rChTAAR1.",
        "relation": "CPR:5"
    },
    {
        "id": "17218486.T4.T41",
        "sentence": "PEA was a potent and full agonist at each species of TAAR1, whereas @CHEMICAL$ was a full agonist for the @GENE$ but was a partial agonist at h-rChTAAR1.",
        "relation": "CPR:5"
    },
    {
        "id": "17218486.T4.T42",
        "sentence": "PEA was a potent and full agonist at each species of TAAR1, whereas @CHEMICAL$ was a full agonist for the rodent TAAR1s but was a partial agonist at @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "17218486.T5.T43",
        "sentence": "Interestingly, both isomers of @CHEMICAL$ were full agonists at @GENE$ and h-rChTAAR1, whereas both were partial agonists at rTAAR1.",
        "relation": "CPR:5"
    },
    {
        "id": "17218486.T5.T44",
        "sentence": "Interestingly, both isomers of @CHEMICAL$ were full agonists at mTAAR1 and @GENE$, whereas both were partial agonists at rTAAR1.",
        "relation": "CPR:5"
    },
    {
        "id": "17218486.T5.T45",
        "sentence": "Interestingly, both isomers of @CHEMICAL$ were full agonists at mTAAR1 and h-rChTAAR1, whereas both were partial agonists at @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "17221210.T8.T23",
        "sentence": "Finally, we showed that @CHEMICAL$ activated endocrine cell development by inducing @GENE$ (Neurog3) expression in early endocrine progenitor cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17221210.T8.T24",
        "sentence": "Finally, we showed that @CHEMICAL$ activated endocrine cell development by inducing neurogenin 3 (@GENE$) expression in early endocrine progenitor cells.",
        "relation": "CPR:3"
    },
    {
        "id": "17228881.T24.T40",
        "sentence": "Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the @CHEMICAL$, a new target for @GENE$ and sulfamate inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "17228881.T25.T40",
        "sentence": "Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the @CHEMICAL$, a new target for sulfonamide and @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "17228881.T13.T30",
        "sentence": "The kinetic parameters for the @CHEMICAL$ hydration reaction proved @GENE$ to possess a kcat of 3.4 x 10(5) s-1 and kcat/KM of 4.9 x 10(7) M-1 s-1 (at pH 7.5 and 20 degrees C).",
        "relation": "CPR:9"
    },
    {
        "id": "17228881.T1.T26",
        "sentence": "Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, @CHEMICAL$, dorzolamide, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective @GENE$ inhibitory activity, with inhibition constants of 0.8-79 nM. The best inhibitors were brinzolamide and sulpiride (KI values of 0.8-0.9 nM), the latter compound being also a CA VI-selective inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "17228881.T21.T26",
        "sentence": "Some clinically used compounds, such as @CHEMICAL$, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective @GENE$ inhibitory activity, with inhibition constants of 0.8-79 nM. The best inhibitors were brinzolamide and sulpiride (KI values of 0.8-0.9 nM), the latter compound being also a CA VI-selective inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "17228881.T22.T26",
        "sentence": "Some clinically used compounds, such as acetazolamide, @CHEMICAL$, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective @GENE$ inhibitory activity, with inhibition constants of 0.8-79 nM. The best inhibitors were brinzolamide and sulpiride (KI values of 0.8-0.9 nM), the latter compound being also a CA VI-selective inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "17228881.T23.T26",
        "sentence": "Some clinically used compounds, such as acetazolamide, methazolamide, @CHEMICAL$, dichlorophenamide, dorzolamide, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective @GENE$ inhibitory activity, with inhibition constants of 0.8-79 nM. The best inhibitors were brinzolamide and sulpiride (KI values of 0.8-0.9 nM), the latter compound being also a CA VI-selective inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "17228881.T2.T26",
        "sentence": "Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, @CHEMICAL$, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective @GENE$ inhibitory activity, with inhibition constants of 0.8-79 nM. The best inhibitors were brinzolamide and sulpiride (KI values of 0.8-0.9 nM), the latter compound being also a CA VI-selective inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "17228881.T3.T26",
        "sentence": "Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, @CHEMICAL$, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective @GENE$ inhibitory activity, with inhibition constants of 0.8-79 nM. The best inhibitors were brinzolamide and sulpiride (KI values of 0.8-0.9 nM), the latter compound being also a CA VI-selective inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "17228881.T4.T26",
        "sentence": "Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, @CHEMICAL$, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective @GENE$ inhibitory activity, with inhibition constants of 0.8-79 nM. The best inhibitors were brinzolamide and sulpiride (KI values of 0.8-0.9 nM), the latter compound being also a CA VI-selective inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "17228881.T5.T26",
        "sentence": "Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, topiramate, @CHEMICAL$, and indisulam, or the orphan drug benzolamide, showed effective @GENE$ inhibitory activity, with inhibition constants of 0.8-79 nM. The best inhibitors were brinzolamide and sulpiride (KI values of 0.8-0.9 nM), the latter compound being also a CA VI-selective inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "17228881.T6.T26",
        "sentence": "Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, topiramate, sulpiride, and @CHEMICAL$, or the orphan drug benzolamide, showed effective @GENE$ inhibitory activity, with inhibition constants of 0.8-79 nM. The best inhibitors were brinzolamide and sulpiride (KI values of 0.8-0.9 nM), the latter compound being also a CA VI-selective inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "17228881.T7.T26",
        "sentence": "Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug @CHEMICAL$, showed effective @GENE$ inhibitory activity, with inhibition constants of 0.8-79 nM. The best inhibitors were brinzolamide and sulpiride (KI values of 0.8-0.9 nM), the latter compound being also a CA VI-selective inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "17228881.T8.T27",
        "sentence": "Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective hCA VI inhibitory activity, with inhibition constants of 0.8-79 nM. The best inhibitors were @CHEMICAL$ and sulpiride (KI values of 0.8-0.9 nM), the latter compound being also a @GENE$-selective inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "17228881.T9.T27",
        "sentence": "Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective hCA VI inhibitory activity, with inhibition constants of 0.8-79 nM. The best inhibitors were brinzolamide and @CHEMICAL$ (KI values of 0.8-0.9 nM), the latter compound being also a @GENE$-selective inhibitor.",
        "relation": "CPR:4"
    },
    {
        "id": "17228881.T10.T28",
        "sentence": "The metallic taste reported as a side effect after the treatment with systemic @CHEMICAL$ may be due to the inhibition of the @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17228881.T11.T29",
        "sentence": "Some of the compounds investigated in this study might be used as additives in toothpastes for reducing the acidification produced by the relevant @CHEMICAL$ hydrase activity of enamel @GENE$, which leads to the formation of protons and bicarbonate and may have a role in cariogenesis.",
        "relation": "CPR:9"
    },
    {
        "id": "17228881.T12.T29",
        "sentence": "Some of the compounds investigated in this study might be used as additives in toothpastes for reducing the acidification produced by the relevant CO2 hydrase activity of enamel @CHEMICAL$, which leads to the formation of protons and @GENE$ and may have a role in cariogenesis.",
        "relation": "CPR:9"
    },
    {
        "id": "17229090.T3.T24",
        "sentence": "Transmembrane isoforms of @CHEMICAL$ (AC) integrate a wide variety of extracellular signals from neurotransmitters to morphogens and can also regulate @GENE$ production in response to calcium entry.",
        "relation": "CPR:9"
    },
    {
        "id": "17229090.T3.T28",
        "sentence": "Transmembrane isoforms of adenylate cyclases (@CHEMICAL$) integrate a wide variety of extracellular signals from neurotransmitters to morphogens and can also regulate @GENE$ production in response to calcium entry.",
        "relation": "CPR:9"
    },
    {
        "id": "17234158.T9.T25",
        "sentence": "@CHEMICAL$ inhibits @GENE$ expression in malignant glioma cells.",
        "relation": "CPR:4"
    },
    {
        "id": "17234158.T1.T11",
        "sentence": "Here, we report that the antifibrotic drug @CHEMICAL$ (pirfenidone, PFD) elicits growth-inhibitory effects and reduces @GENE$ protein levels in human glioma cell lines.",
        "relation": "CPR:4"
    },
    {
        "id": "17234158.T2.T11",
        "sentence": "Here, we report that the antifibrotic drug 5-methyl-1-phenyl-2-(1H)-pyridone (@CHEMICAL$, PFD) elicits growth-inhibitory effects and reduces @GENE$ protein levels in human glioma cell lines.",
        "relation": "CPR:4"
    },
    {
        "id": "17234158.T3.T11",
        "sentence": "Here, we report that the antifibrotic drug 5-methyl-1-phenyl-2-(1H)-pyridone (pirfenidone, @CHEMICAL$) elicits growth-inhibitory effects and reduces @GENE$ protein levels in human glioma cell lines.",
        "relation": "CPR:4"
    },
    {
        "id": "17234158.T4.T12",
        "sentence": "This reduction in @CHEMICAL$ is biologically relevant since @GENE$ treatment reduces the growth inhibition of TGF-beta-sensitive CCL-64 cells mediated by conditioned media of glioma cells.",
        "relation": "CPR:4"
    },
    {
        "id": "17234158.T4.T14",
        "sentence": "This reduction in TGF-beta2 is biologically relevant since @CHEMICAL$ treatment reduces the growth inhibition of @GENE$-sensitive CCL-64 cells mediated by conditioned media of glioma cells.",
        "relation": "CPR:4"
    },
    {
        "id": "17234158.T5.T20",
        "sentence": "@CHEMICAL$ leads to a reduction of TGF-beta2 mRNA levels and of the mature TGF-beta2 protein due to decreased expression and direct inhibition of the TGF-beta @GENE$ furin.",
        "relation": "CPR:4"
    },
    {
        "id": "17234158.T5.T17",
        "sentence": "@CHEMICAL$ leads to a reduction of @GENE$ mRNA levels and of the mature TGF-beta2 protein due to decreased expression and direct inhibition of the TGF-beta pro-protein convertase furin.",
        "relation": "CPR:4"
    },
    {
        "id": "17234158.T5.T18",
        "sentence": "@CHEMICAL$ leads to a reduction of TGF-beta2 mRNA levels and of the mature @GENE$ protein due to decreased expression and direct inhibition of the TGF-beta pro-protein convertase furin.",
        "relation": "CPR:4"
    },
    {
        "id": "17234158.T5.T19",
        "sentence": "@CHEMICAL$ leads to a reduction of TGF-beta2 mRNA levels and of the mature TGF-beta2 protein due to decreased expression and direct inhibition of the @GENE$ pro-protein convertase furin.",
        "relation": "CPR:4"
    },
    {
        "id": "17234158.T5.T21",
        "sentence": "@CHEMICAL$ leads to a reduction of TGF-beta2 mRNA levels and of the mature TGF-beta2 protein due to decreased expression and direct inhibition of the TGF-beta pro-protein convertase @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "17234158.T6.T22",
        "sentence": "In addition, @CHEMICAL$ reduces the protein levels of the @GENE$, a TGF-beta target gene and furin substrate involved in carcinogenesis.",
        "relation": "CPR:4"
    },
    {
        "id": "17234158.T6.T23",
        "sentence": "In addition, @CHEMICAL$ reduces the protein levels of the matrix metalloproteinase (MMP)-11, a @GENE$ target gene and furin substrate involved in carcinogenesis.",
        "relation": "CPR:4"
    },
    {
        "id": "17256745.T2.T21",
        "sentence": "UNLABELLED: @CHEMICAL$ (BAAT) is the sole enzyme responsible for conjugation of primary and secondary @GENE$ to taurine and glycine.",
        "relation": "CPR:9"
    },
    {
        "id": "17256745.T2.T32",
        "sentence": "UNLABELLED: Bile acid-coenzyme A:amino acid N-acyltransferase (@CHEMICAL$) is the sole enzyme responsible for conjugation of primary and secondary @GENE$ to taurine and glycine.",
        "relation": "CPR:9"
    },
    {
        "id": "17256745.T3.T21",
        "sentence": "UNLABELLED: @CHEMICAL$ (BAAT) is the sole enzyme responsible for conjugation of primary and secondary bile acids to @GENE$ and glycine.",
        "relation": "CPR:9"
    },
    {
        "id": "17256745.T3.T32",
        "sentence": "UNLABELLED: Bile acid-coenzyme A:amino acid N-acyltransferase (@CHEMICAL$) is the sole enzyme responsible for conjugation of primary and secondary bile acids to @GENE$ and glycine.",
        "relation": "CPR:9"
    },
    {
        "id": "17256745.T5.T21",
        "sentence": "UNLABELLED: @CHEMICAL$ (BAAT) is the sole enzyme responsible for conjugation of primary and secondary bile acids to taurine and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17256745.T5.T32",
        "sentence": "UNLABELLED: Bile acid-coenzyme A:amino acid N-acyltransferase (@CHEMICAL$) is the sole enzyme responsible for conjugation of primary and secondary bile acids to taurine and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17256745.T9.T30",
        "sentence": "The absence or presence of a cytosolic pool of @CHEMICAL$ has important implications for the intracellular transport of unconjugated/deconjugated @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17290783.T2.T9",
        "sentence": "The recombinant strains of the flavinogenic yeast Candida famata, which contain the DNA fragment consisting of the FMN1 gene (encoding the @CHEMICAL$, enzyme that converts @GENE$ to flavinmononucleotide) driven by the strong promoters (the regulated RIB1 or constitutive TEF1 promoter) were isolated.",
        "relation": "CPR:9"
    },
    {
        "id": "17290783.T3.T9",
        "sentence": "The recombinant strains of the flavinogenic yeast Candida famata, which contain the DNA fragment consisting of the FMN1 gene (encoding the @CHEMICAL$, enzyme that converts riboflavin to @GENE$) driven by the strong promoters (the regulated RIB1 or constitutive TEF1 promoter) were isolated.",
        "relation": "CPR:9"
    },
    {
        "id": "1730582.T30.T44",
        "sentence": "Mechanism of the irreversible inactivation of @CHEMICAL$ by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "1730582.T16.T31",
        "sentence": "@CHEMICAL$ (ODC) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5'-phosphate and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor, @GENE$ (DFMO).",
        "relation": "CPR:4"
    },
    {
        "id": "1730582.T16.T36",
        "sentence": "Mouse ornithine decarboxylase (@CHEMICAL$) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5'-phosphate and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor, @GENE$ (DFMO).",
        "relation": "CPR:4"
    },
    {
        "id": "1730582.T17.T31",
        "sentence": "@CHEMICAL$ (ODC) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5'-phosphate and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor, alpha-difluoromethylornithine (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "1730582.T17.T36",
        "sentence": "Mouse ornithine decarboxylase (@CHEMICAL$) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5'-phosphate and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor, alpha-difluoromethylornithine (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "17311416.T18.T28",
        "sentence": "Na+-Dependent transmembrane transport of small neutral @CHEMICAL$, such as glutamine and alanine, is mediated, among others, by the @GENE$ of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T18.T30",
        "sentence": "Na+-Dependent transmembrane transport of small neutral @CHEMICAL$, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the @GENE$ [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T18.T31",
        "sentence": "Na+-Dependent transmembrane transport of small neutral @CHEMICAL$, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [@GENE$, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T18.T35",
        "sentence": "Na+-Dependent transmembrane transport of small neutral @CHEMICAL$, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and @GENE$ families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T18.T32",
        "sentence": "Na+-Dependent transmembrane transport of small neutral @CHEMICAL$, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, @GENE$ (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T18.T33",
        "sentence": "Na+-Dependent transmembrane transport of small neutral @CHEMICAL$, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (@GENE$), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T18.T34",
        "sentence": "Na+-Dependent transmembrane transport of small neutral @CHEMICAL$, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and @GENE$] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T18.T36",
        "sentence": "Na+-Dependent transmembrane transport of small neutral @CHEMICAL$, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [@GENE$ (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T18.T37",
        "sentence": "Na+-Dependent transmembrane transport of small neutral @CHEMICAL$, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (@GENE$), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T18.T38",
        "sentence": "Na+-Dependent transmembrane transport of small neutral @CHEMICAL$, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), @GENE$, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T18.T39",
        "sentence": "Na+-Dependent transmembrane transport of small neutral @CHEMICAL$, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and @GENE$].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T21.T28",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as @CHEMICAL$ and alanine, is mediated, among others, by the @GENE$ of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T21.T30",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as @CHEMICAL$ and alanine, is mediated, among others, by the neutral amino acid transporters of the @GENE$ [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T21.T31",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as @CHEMICAL$ and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [@GENE$, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T21.T35",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as @CHEMICAL$ and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and @GENE$ families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T21.T32",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as @CHEMICAL$ and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, @GENE$ (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T21.T33",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as @CHEMICAL$ and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (@GENE$), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T21.T34",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as @CHEMICAL$ and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and @GENE$] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T21.T36",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as @CHEMICAL$ and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [@GENE$ (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T21.T37",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as @CHEMICAL$ and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (@GENE$), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T21.T38",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as @CHEMICAL$ and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), @GENE$, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T21.T39",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as @CHEMICAL$ and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and @GENE$].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T23.T28",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and @CHEMICAL$, is mediated, among others, by the @GENE$ of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T23.T30",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and @CHEMICAL$, is mediated, among others, by the neutral amino acid transporters of the @GENE$ [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T23.T31",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and @CHEMICAL$, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [@GENE$, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T23.T32",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and @CHEMICAL$, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, @GENE$ (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T23.T33",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and @CHEMICAL$, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (@GENE$), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T23.T34",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and @CHEMICAL$, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and @GENE$] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T23.T36",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and @CHEMICAL$, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [@GENE$ (SNAT1), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T23.T37",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and @CHEMICAL$, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (@GENE$), SNAT2, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T23.T38",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and @CHEMICAL$, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), @GENE$, and SNAT4].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T23.T39",
        "sentence": "Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and @CHEMICAL$, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and @GENE$].",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T15.T40",
        "sentence": "Here, we describe a new photolabile @CHEMICAL$ derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by @GENE$, SNAT1, and SNAT2.",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T15.T41",
        "sentence": "Here, we describe a new photolabile @CHEMICAL$ derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, @GENE$, and SNAT2.",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T15.T42",
        "sentence": "Here, we describe a new photolabile @CHEMICAL$ derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, SNAT1, and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T16.T40",
        "sentence": "Here, we describe a new photolabile alanine derivative based on protection of @CHEMICAL$ with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by @GENE$, SNAT1, and SNAT2.",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T16.T41",
        "sentence": "Here, we describe a new photolabile alanine derivative based on protection of @CHEMICAL$ with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, @GENE$, and SNAT2.",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T16.T42",
        "sentence": "Here, we describe a new photolabile alanine derivative based on protection of @CHEMICAL$ with the 4-methoxy-7-nitroindolinyl (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, SNAT1, and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T17.T40",
        "sentence": "Here, we describe a new photolabile alanine derivative based on protection of alanine with the @CHEMICAL$ (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by @GENE$, SNAT1, and SNAT2.",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T17.T41",
        "sentence": "Here, we describe a new photolabile alanine derivative based on protection of alanine with the @CHEMICAL$ (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, @GENE$, and SNAT2.",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T17.T42",
        "sentence": "Here, we describe a new photolabile alanine derivative based on protection of alanine with the @CHEMICAL$ (MNI) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, SNAT1, and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T19.T40",
        "sentence": "Here, we describe a new photolabile alanine derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (@CHEMICAL$) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by @GENE$, SNAT1, and SNAT2.",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T19.T41",
        "sentence": "Here, we describe a new photolabile alanine derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (@CHEMICAL$) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, @GENE$, and SNAT2.",
        "relation": "CPR:9"
    },
    {
        "id": "17311416.T19.T42",
        "sentence": "Here, we describe a new photolabile alanine derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (@CHEMICAL$) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, SNAT1, and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17319904.T1.T13",
        "sentence": "Baseline platelet aggregation to 1 microg mL(-1) collagen, and postaspirin aggregations to 5 microm and 20 microm ADP and collagen, were greater in the upper than in the lower tertile of reticulated platelets. Stimulated P-selectin and @CHEMICAL$ expression were also higher in the upper tertile both before and after @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "17319904.T1.T12",
        "sentence": "Baseline platelet aggregation to 1 microg mL(-1) collagen, and postaspirin aggregations to 5 microm and 20 microm ADP and collagen, were greater in the upper than in the lower tertile of reticulated platelets. Stimulated @CHEMICAL$ and integrin alpha(IIb)beta(3) expression were also higher in the upper tertile both before and after @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "17320868.T19.T32",
        "sentence": "At least 4 h of estrogen pre-treatment was required to elicit protection, an effect that was blocked by the @CHEMICAL$ antagonist, @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "17320868.T2.T35",
        "sentence": "Moreover, ERalpha mediated the protection afforded by estrogen since only the ERalpha agonist, HPTE, but not the @CHEMICAL$ agonist, @GENE$, protected against dopamine cell loss.",
        "relation": "CPR:5"
    },
    {
        "id": "17324065.T10.T20",
        "sentence": "Differential activation of @CHEMICAL$ in discrete nucleus accumbens subregions during early and late @GENE$ sensitization.",
        "relation": "CPR:3"
    },
    {
        "id": "17324065.T5.T15",
        "sentence": "The present study examined the differential @CHEMICAL$-induced activation of the cyclic adenosine monophosphate (cAMP) response element binding protein (@GENE$) throughout discrete zones of analysis of the nucleus accumbens (NAc) in rats.",
        "relation": "CPR:3"
    },
    {
        "id": "17324065.T5.T18",
        "sentence": "The present study examined the differential @CHEMICAL$-induced activation of the @GENE$ (CREB) throughout discrete zones of analysis of the nucleus accumbens (NAc) in rats.",
        "relation": "CPR:3"
    },
    {
        "id": "17324065.T6.T17",
        "sentence": "Using immunohistochemistry, the authors analyzed changes in @CHEMICAL$ phosphorylation in the NAc after 5 days of @GENE$, a short or long drug-free period, and a subsequent challenge injection.",
        "relation": "CPR:3"
    },
    {
        "id": "17324065.T7.T19",
        "sentence": "Repeated @CHEMICAL$ resulted in @GENE$ phosphorylation in all analyzed subregions of the NAc excluding the most ventrolateral region of the shell 2 weeks after cessation of repeated cocaine, but rats challenged after 2 drug-free days yielded a more localized activation of CREB in the 3 most dorsomedial zones of the shell.",
        "relation": "CPR:3"
    },
    {
        "id": "17324065.T9.T12",
        "sentence": "Repeated cocaine resulted in CREB phosphorylation in all analyzed subregions of the NAc excluding the most ventrolateral region of the shell 2 weeks after cessation of repeated @CHEMICAL$, but rats challenged after 2 drug-free days yielded a more localized activation of @GENE$ in the 3 most dorsomedial zones of the shell.",
        "relation": "CPR:3"
    },
    {
        "id": "17324065.T2.T13",
        "sentence": "The temporal and anatomical determinants of @CHEMICAL$-induced @GENE$ activity may indicate functional differences among NAc shell subregions and suggest the involvement of CREB in early and late cocaine effects.",
        "relation": "CPR:3"
    },
    {
        "id": "17327402.T2.T16",
        "sentence": "The carboxylation of @CHEMICAL$ residues to gamma-carboxyglutamic acid (Gla) by the @GENE$ (gamma-carboxylase) is an essential posttranslational modification required for the biological activity of a number of proteins, including proteins involved in blood coagulation and its regulation.",
        "relation": "CPR:9"
    },
    {
        "id": "17327402.T2.T9",
        "sentence": "The carboxylation of @CHEMICAL$ residues to gamma-carboxyglutamic acid (Gla) by the vitamin K-dependent gamma-glutamyl carboxylase (@GENE$) is an essential posttranslational modification required for the biological activity of a number of proteins, including proteins involved in blood coagulation and its regulation.",
        "relation": "CPR:9"
    },
    {
        "id": "17327402.T3.T16",
        "sentence": "The carboxylation of glutamic acid residues to @CHEMICAL$ (Gla) by the @GENE$ (gamma-carboxylase) is an essential posttranslational modification required for the biological activity of a number of proteins, including proteins involved in blood coagulation and its regulation.",
        "relation": "CPR:9"
    },
    {
        "id": "17327402.T3.T9",
        "sentence": "The carboxylation of glutamic acid residues to @CHEMICAL$ (Gla) by the vitamin K-dependent gamma-glutamyl carboxylase (@GENE$) is an essential posttranslational modification required for the biological activity of a number of proteins, including proteins involved in blood coagulation and its regulation.",
        "relation": "CPR:9"
    },
    {
        "id": "17327402.T5.T16",
        "sentence": "The carboxylation of glutamic acid residues to gamma-carboxyglutamic acid (@CHEMICAL$) by the @GENE$ (gamma-carboxylase) is an essential posttranslational modification required for the biological activity of a number of proteins, including proteins involved in blood coagulation and its regulation.",
        "relation": "CPR:9"
    },
    {
        "id": "17327402.T5.T9",
        "sentence": "The carboxylation of glutamic acid residues to gamma-carboxyglutamic acid (@CHEMICAL$) by the vitamin K-dependent gamma-glutamyl carboxylase (@GENE$) is an essential posttranslational modification required for the biological activity of a number of proteins, including proteins involved in blood coagulation and its regulation.",
        "relation": "CPR:9"
    },
    {
        "id": "17334413.T20.T48",
        "sentence": "We posed the following questions: (1) Do cholangiocytes express H3R? (2) Does in vivo administration of @CHEMICAL$ (RAMH) (@GENE$ agonist), thioperamide maleate (H3R antagonist) or histamine, in the absence/presence of thioperamide maleate, to bile duct ligated (BDL) rats regulate cholangiocyte proliferation? and (3) Does RAMH inhibit cholangiocyte proliferation by downregulation of cAMP-dependent phosphorylation of protein kinase A (PKA)/extracellular signal-regulated kinase 1/2 (ERK1/2)/ets-like gene-1 (Elk-1)?",
        "relation": "CPR:5"
    },
    {
        "id": "17334413.T21.T48",
        "sentence": "We posed the following questions: (1) Do cholangiocytes express H3R? (2) Does in vivo administration of (R)-(alpha)-(-)-methylhistamine dihydrobromide (@CHEMICAL$) (@GENE$ agonist), thioperamide maleate (H3R antagonist) or histamine, in the absence/presence of thioperamide maleate, to bile duct ligated (BDL) rats regulate cholangiocyte proliferation? and (3) Does RAMH inhibit cholangiocyte proliferation by downregulation of cAMP-dependent phosphorylation of protein kinase A (PKA)/extracellular signal-regulated kinase 1/2 (ERK1/2)/ets-like gene-1 (Elk-1)?",
        "relation": "CPR:5"
    },
    {
        "id": "17334413.T22.T50",
        "sentence": "We posed the following questions: (1) Do cholangiocytes express H3R? (2) Does in vivo administration of (R)-(alpha)-(-)-methylhistamine dihydrobromide (RAMH) (H3R agonist), @CHEMICAL$ (@GENE$ antagonist) or histamine, in the absence/presence of thioperamide maleate, to bile duct ligated (BDL) rats regulate cholangiocyte proliferation? and (3) Does RAMH inhibit cholangiocyte proliferation by downregulation of cAMP-dependent phosphorylation of protein kinase A (PKA)/extracellular signal-regulated kinase 1/2 (ERK1/2)/ets-like gene-1 (Elk-1)?",
        "relation": "CPR:6"
    },
    {
        "id": "17334413.T16.T39",
        "sentence": "@CHEMICAL$ inhibition of cholangiocyte growth was associated with decreased cAMP levels and @GENE$/ERK1/2/Elk-1 phosphorylation.",
        "relation": "CPR:4"
    },
    {
        "id": "17334413.T16.T40",
        "sentence": "@CHEMICAL$ inhibition of cholangiocyte growth was associated with decreased cAMP levels and PKA/@GENE$/Elk-1 phosphorylation.",
        "relation": "CPR:4"
    },
    {
        "id": "17334413.T16.T41",
        "sentence": "@CHEMICAL$ inhibition of cholangiocyte growth was associated with decreased cAMP levels and PKA/ERK1/2/@GENE$ phosphorylation.",
        "relation": "CPR:4"
    },
    {
        "id": "17344208.T2.T12",
        "sentence": "@CHEMICAL$ (PRODH) and Delta(1)-pyrroline-5-carboxylate dehydrogenase (P5CDH) catalyze the two-step oxidation of @GENE$ to glutamate.",
        "relation": "CPR:9"
    },
    {
        "id": "17344208.T2.T19",
        "sentence": "Proline dehydrogenase (@CHEMICAL$) and Delta(1)-pyrroline-5-carboxylate dehydrogenase (P5CDH) catalyze the two-step oxidation of @GENE$ to glutamate.",
        "relation": "CPR:9"
    },
    {
        "id": "17344208.T2.T22",
        "sentence": "Proline dehydrogenase (PRODH) and @CHEMICAL$ (P5CDH) catalyze the two-step oxidation of @GENE$ to glutamate.",
        "relation": "CPR:9"
    },
    {
        "id": "17344208.T2.T29",
        "sentence": "Proline dehydrogenase (PRODH) and Delta(1)-pyrroline-5-carboxylate dehydrogenase (@CHEMICAL$) catalyze the two-step oxidation of @GENE$ to glutamate.",
        "relation": "CPR:9"
    },
    {
        "id": "17344208.T4.T12",
        "sentence": "@CHEMICAL$ (PRODH) and Delta(1)-pyrroline-5-carboxylate dehydrogenase (P5CDH) catalyze the two-step oxidation of proline to @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17344208.T4.T19",
        "sentence": "Proline dehydrogenase (@CHEMICAL$) and Delta(1)-pyrroline-5-carboxylate dehydrogenase (P5CDH) catalyze the two-step oxidation of proline to @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17344208.T4.T22",
        "sentence": "Proline dehydrogenase (PRODH) and @CHEMICAL$ (P5CDH) catalyze the two-step oxidation of proline to @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17344208.T4.T29",
        "sentence": "Proline dehydrogenase (PRODH) and Delta(1)-pyrroline-5-carboxylate dehydrogenase (@CHEMICAL$) catalyze the two-step oxidation of proline to @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17344208.T6.T15",
        "sentence": "Finally, we demonstrate that @CHEMICAL$ reacts with @GENE$ producing superoxide.",
        "relation": "CPR:9"
    },
    {
        "id": "17344208.T7.T15",
        "sentence": "Finally, we demonstrate that @CHEMICAL$ reacts with O(2) producing @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17344208.T8.T16",
        "sentence": "This is significant because @CHEMICAL$ production underlies the role of @GENE$ in p53-mediated apoptosis, implying commonalities between eukaryotic and bacterial monofunctional PRODHs.",
        "relation": "CPR:9"
    },
    {
        "id": "17352685.T5.T15",
        "sentence": "The @CHEMICAL$ is the predominant @GENE$ degrading enzyme in a variety of inflammatory cells including eosinophils, neutrophils, macrophages, T cells and monocytes.",
        "relation": "CPR:9"
    },
    {
        "id": "17352685.T6.T18",
        "sentence": "Consequently, @CHEMICAL$ inhibitors including @GENE$ and AWD 12-281 have been tested in several models of allergic and irritant skin inflammation.",
        "relation": "CPR:4"
    },
    {
        "id": "17352685.T7.T18",
        "sentence": "Consequently, @CHEMICAL$ inhibitors including cilomilast and @GENE$ have been tested in several models of allergic and irritant skin inflammation.",
        "relation": "CPR:4"
    },
    {
        "id": "17352685.T1.T12",
        "sentence": "Results of early clinical trials with both topically (@CHEMICAL$, CP80,633) and systemically (CC-10004) active @GENE$ inhibitors demonstrated efficacy in atopic dermatitis and in the case of CC-10004, also in psoriasis.",
        "relation": "CPR:4"
    },
    {
        "id": "17352685.T2.T12",
        "sentence": "Results of early clinical trials with both topically (cipamfylline, @CHEMICAL$) and systemically (CC-10004) active @GENE$ inhibitors demonstrated efficacy in atopic dermatitis and in the case of CC-10004, also in psoriasis.",
        "relation": "CPR:4"
    },
    {
        "id": "17367165.T8.T23",
        "sentence": "Although considerable functional diversity exists, most @CHEMICAL$ are activated by @GENE$ binding and then dock to a specific cellular membrane.",
        "relation": "CPR:3"
    },
    {
        "id": "17379925.T10.T14",
        "sentence": "@CHEMICAL$ (BAT) is responsible for the amidation of @GENE$ with the amino acids glycine and taurine.",
        "relation": "CPR:9"
    },
    {
        "id": "17379925.T10.T20",
        "sentence": "Bile acid coenzyme A:amino acid N-acyltransferase (@CHEMICAL$) is responsible for the amidation of @GENE$ with the amino acids glycine and taurine.",
        "relation": "CPR:9"
    },
    {
        "id": "17380207.T5.T11",
        "sentence": "Because of their low asparagine synthetase (@CHEMICAL$) expression and @GENE$ biosynthesis, acute lymphoblastic leukemia (ALL) cells are exquisitely sensitive to asparagine depletion.",
        "relation": "CPR:9"
    },
    {
        "id": "17380207.T5.T9",
        "sentence": "Because of their low @CHEMICAL$ (ASNS) expression and @GENE$ biosynthesis, acute lymphoblastic leukemia (ALL) cells are exquisitely sensitive to asparagine depletion.",
        "relation": "CPR:9"
    },
    {
        "id": "17380207.T1.T6",
        "sentence": "@CHEMICAL$ secretion by MSCs was directly related to their @GENE$ expression levels, suggesting a mechanism - increased concentrations of asparagine in the leukemic cell microenvironment - for the protective effects we observed.",
        "relation": "CPR:9"
    },
    {
        "id": "17403555.T16.T56",
        "sentence": "Furthermore, Abeta(1-40) decreased intracellular ATP in cells expressing NR1/NR2A. @CHEMICAL$ ((+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate), a noncompetitive @GENE$ antagonist, partially prevented the decrease in cell viability and the energy impairment.",
        "relation": "CPR:6"
    },
    {
        "id": "17403555.T17.T56",
        "sentence": "Furthermore, Abeta(1-40) decreased intracellular ATP in cells expressing NR1/NR2A. MK-801 (@CHEMICAL$), a noncompetitive @GENE$ antagonist, partially prevented the decrease in cell viability and the energy impairment.",
        "relation": "CPR:6"
    },
    {
        "id": "17409318.T11.T26",
        "sentence": "The use of @CHEMICAL$ (D6D) twice in the conversion of alpha-linolenic acid (ALA; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of @GENE$ from ALA.",
        "relation": "CPR:9"
    },
    {
        "id": "17409318.T11.T28",
        "sentence": "The use of Delta 6 desaturase (@CHEMICAL$) twice in the conversion of alpha-linolenic acid (ALA; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of @GENE$ from ALA.",
        "relation": "CPR:9"
    },
    {
        "id": "17409318.T12.T26",
        "sentence": "The use of @CHEMICAL$ (D6D) twice in the conversion of alpha-linolenic acid (ALA; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17409318.T12.T28",
        "sentence": "The use of Delta 6 desaturase (@CHEMICAL$) twice in the conversion of alpha-linolenic acid (ALA; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17409318.T19.T26",
        "sentence": "The use of @CHEMICAL$ (D6D) twice in the conversion of @GENE$ (ALA; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA.",
        "relation": "CPR:9"
    },
    {
        "id": "17409318.T19.T28",
        "sentence": "The use of Delta 6 desaturase (@CHEMICAL$) twice in the conversion of @GENE$ (ALA; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA.",
        "relation": "CPR:9"
    },
    {
        "id": "17409318.T23.T26",
        "sentence": "The use of @CHEMICAL$ (D6D) twice in the conversion of alpha-linolenic acid (@GENE$; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA.",
        "relation": "CPR:9"
    },
    {
        "id": "17409318.T23.T28",
        "sentence": "The use of Delta 6 desaturase (@CHEMICAL$) twice in the conversion of alpha-linolenic acid (@GENE$; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA.",
        "relation": "CPR:9"
    },
    {
        "id": "17409318.T2.T26",
        "sentence": "The use of @CHEMICAL$ (D6D) twice in the conversion of alpha-linolenic acid (ALA; 18:3n-3) to @GENE$ (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA.",
        "relation": "CPR:9"
    },
    {
        "id": "17409318.T2.T28",
        "sentence": "The use of Delta 6 desaturase (@CHEMICAL$) twice in the conversion of alpha-linolenic acid (ALA; 18:3n-3) to @GENE$ (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA.",
        "relation": "CPR:9"
    },
    {
        "id": "17409318.T8.T26",
        "sentence": "The use of @CHEMICAL$ (D6D) twice in the conversion of alpha-linolenic acid (ALA; 18:3n-3) to docosahexaenoic acid (@GENE$; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA.",
        "relation": "CPR:9"
    },
    {
        "id": "17409318.T8.T28",
        "sentence": "The use of Delta 6 desaturase (@CHEMICAL$) twice in the conversion of alpha-linolenic acid (ALA; 18:3n-3) to docosahexaenoic acid (@GENE$; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA.",
        "relation": "CPR:9"
    },
    {
        "id": "17409318.T20.T29",
        "sentence": "The accumulation of the post-@CHEMICAL$ products of 22:5n-3, 24:6n-3 and @GENE$, in cell phospholipids was saturated at concentrations of >18 microM ALA.",
        "relation": "CPR:9"
    },
    {
        "id": "17409318.T10.T27",
        "sentence": "The parallel pattern of accumulation of 24:6n-3 and DHA in response to increasing concentrations of ALA suggests that the competition between 24:5n-3 and ALA for @CHEMICAL$ may contribute to the limited accumulation of @GENE$ in cell membranes.",
        "relation": "CPR:9"
    },
    {
        "id": "17409318.T9.T27",
        "sentence": "The parallel pattern of accumulation of 24:6n-3 and DHA in response to increasing concentrations of ALA suggests that the competition between 24:5n-3 and @CHEMICAL$ for @GENE$ may contribute to the limited accumulation of DHA in cell membranes.",
        "relation": "CPR:9"
    },
    {
        "id": "17468175.T15.T26",
        "sentence": "@CHEMICAL$ agonist and D2 receptor antagonist effects of the natural product @GENE$: molecular modeling and dynamics simulations.",
        "relation": "CPR:5"
    },
    {
        "id": "17468175.T15.T27",
        "sentence": "Dopamine D1 receptor agonist and @CHEMICAL$ antagonist effects of the natural product @GENE$: molecular modeling and dynamics simulations.",
        "relation": "CPR:6"
    },
    {
        "id": "17468175.T1.T18",
        "sentence": "@CHEMICAL$ (SPD), an active ingredient of the Chinese herb Stephania, is the first compound found to have dual function as a @GENE$ agonist and D2 antagonist.",
        "relation": "CPR:5"
    },
    {
        "id": "17468175.T1.T19",
        "sentence": "@CHEMICAL$ (SPD), an active ingredient of the Chinese herb Stephania, is the first compound found to have dual function as a dopamine receptor D1 agonist and @GENE$ antagonist.",
        "relation": "CPR:6"
    },
    {
        "id": "17468175.T8.T18",
        "sentence": "(-)-Stepholidine (@CHEMICAL$), an active ingredient of the Chinese herb Stephania, is the first compound found to have dual function as a @GENE$ agonist and D2 antagonist.",
        "relation": "CPR:5"
    },
    {
        "id": "17468175.T8.T19",
        "sentence": "(-)-Stepholidine (@CHEMICAL$), an active ingredient of the Chinese herb Stephania, is the first compound found to have dual function as a dopamine receptor D1 agonist and @GENE$ antagonist.",
        "relation": "CPR:6"
    },
    {
        "id": "17496727.T2.T15",
        "sentence": "The Ki for @CHEMICAL$ inhibition of the @GENE$ variant was comparable with the wild-type, and the variant Km for inosine 5'-monophosphate and nicotinamide adenine dinucleotide did not change significantly.",
        "relation": "CPR:4"
    },
    {
        "id": "17512091.T15.T38",
        "sentence": "@CHEMICAL$ causes loss of GSH and inhibition of @GENE$ in lumbosacral cord of male mice through oxidation of thiol groups, while female mice are resistant.",
        "relation": "CPR:4"
    },
    {
        "id": "17512091.T6.T30",
        "sentence": "Female mice express higher levels of glutaredoxin in certain CNS regions and downregulation of glutaredoxin using antisense oligonucleotides sensitizes them to @CHEMICAL$ toxicity seen as @GENE$ loss.",
        "relation": "CPR:4"
    },
    {
        "id": "17512091.T7.T33",
        "sentence": "Ovariectomy downregulates glutaredoxin and renders female mice vulnerable to @CHEMICAL$ toxicity as evidenced by activation of AP1, loss of GSH and @GENE$ activity indicating the important role of glutaredoxin in neuroprotection.",
        "relation": "CPR:3"
    },
    {
        "id": "17512091.T7.T32",
        "sentence": "Ovariectomy downregulates glutaredoxin and renders female mice vulnerable to @CHEMICAL$ toxicity as evidenced by activation of @GENE$, loss of GSH and complex I activity indicating the important role of glutaredoxin in neuroprotection.",
        "relation": "CPR:3"
    },
    {
        "id": "17512091.T9.T35",
        "sentence": "@CHEMICAL$ protects against mitochondrial dysfunction caused by excitotoxicity by maintaining cellular redox status through higher constitutive expression of @GENE$ in the CNS.",
        "relation": "CPR:3"
    },
    {
        "id": "17554001.T6.T19",
        "sentence": "The mechanisms that specify the vesicular phenotype of inhibitory interneurons in vertebrates are poorly understood because the two main inhibitory transmitters, @CHEMICAL$ and GABA, share the same @GENE$ (VIAAT) and are both present in neurons during postnatal development.",
        "relation": "CPR:9"
    },
    {
        "id": "17554001.T6.T20",
        "sentence": "The mechanisms that specify the vesicular phenotype of inhibitory interneurons in vertebrates are poorly understood because the two main inhibitory transmitters, @CHEMICAL$ and GABA, share the same vesicular inhibitory amino acid transporter (@GENE$) and are both present in neurons during postnatal development.",
        "relation": "CPR:9"
    },
    {
        "id": "17554001.T7.T19",
        "sentence": "The mechanisms that specify the vesicular phenotype of inhibitory interneurons in vertebrates are poorly understood because the two main inhibitory transmitters, glycine and @CHEMICAL$, share the same @GENE$ (VIAAT) and are both present in neurons during postnatal development.",
        "relation": "CPR:9"
    },
    {
        "id": "17554001.T7.T20",
        "sentence": "The mechanisms that specify the vesicular phenotype of inhibitory interneurons in vertebrates are poorly understood because the two main inhibitory transmitters, glycine and @CHEMICAL$, share the same vesicular inhibitory amino acid transporter (@GENE$) and are both present in neurons during postnatal development.",
        "relation": "CPR:9"
    },
    {
        "id": "17554001.T10.T22",
        "sentence": "We have expressed VIAAT and the @CHEMICAL$ for glycine and @GENE$ in a neuroendocrine cell line and measured the quantal release of glycine and GABA using a novel double-sniffer patch-clamp technique.",
        "relation": "CPR:9"
    },
    {
        "id": "17554001.T10.T21",
        "sentence": "We have expressed @CHEMICAL$ and the plasmalemmal transporters for glycine and @GENE$ in a neuroendocrine cell line and measured the quantal release of glycine and GABA using a novel double-sniffer patch-clamp technique.",
        "relation": "CPR:9"
    },
    {
        "id": "17554001.T9.T22",
        "sentence": "We have expressed VIAAT and the @CHEMICAL$ for @GENE$ and GABA in a neuroendocrine cell line and measured the quantal release of glycine and GABA using a novel double-sniffer patch-clamp technique.",
        "relation": "CPR:9"
    },
    {
        "id": "17554001.T9.T21",
        "sentence": "We have expressed @CHEMICAL$ and the plasmalemmal transporters for @GENE$ and GABA in a neuroendocrine cell line and measured the quantal release of glycine and GABA using a novel double-sniffer patch-clamp technique.",
        "relation": "CPR:9"
    },
    {
        "id": "17554001.T13.T23",
        "sentence": "We found that @CHEMICAL$ is released from vesicles when @GENE$ is coexpressed with either the neuronal transporter GlyT2 or the glial transporter GlyT1.",
        "relation": "CPR:9"
    },
    {
        "id": "17554001.T14.T31",
        "sentence": "However, GlyT2 was more effective than GlyT1, probably because GlyT2 is unable to operate in the reverse mode, which gives it an advantage in maintaining the high cytosolic @CHEMICAL$ concentration required for efficient vesicular loading by @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17554001.T1.T15",
        "sentence": "The vesicular inhibitory phenotype was gradually altered from glycinergic to GABAergic through mixed events when @CHEMICAL$ is introduced into the secretory cell and competes for uptake by @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "17554001.T3.T17",
        "sentence": "Interestingly, the VIAAT ortholog from Caenorhabditis elegans (UNC-47), a species lacking glycine transmission, also supports @CHEMICAL$ exocytosis in the presence of @GENE$, and a point mutation of UNC-47 that abolishes GABA transmission in the worm confers glycine specificity.",
        "relation": "CPR:9"
    },
    {
        "id": "17554001.T5.T18",
        "sentence": "Together, these results suggest that an increased cytosolic availability of @CHEMICAL$ in @GENE$-containing terminals was crucial for the emergence of glycinergic transmission in vertebrates.",
        "relation": "CPR:9"
    },
    {
        "id": "17581967.T11.T27",
        "sentence": "@CHEMICAL$/Cl- dipole couples agonist binding to @GENE$ activation.",
        "relation": "CPR:3"
    },
    {
        "id": "17581967.T13.T27",
        "sentence": "Na+/@CHEMICAL$ dipole couples agonist binding to @GENE$ activation.",
        "relation": "CPR:3"
    },
    {
        "id": "17581967.T2.T14",
        "sentence": "@CHEMICAL$ (GluRs) require external Na+ and Cl- as well as the neurotransmitter @GENE$ for activation.",
        "relation": "CPR:3"
    },
    {
        "id": "17581967.T2.T19",
        "sentence": "Kainate-selective ionotropic glutamate receptors (@CHEMICAL$) require external Na+ and Cl- as well as the neurotransmitter @GENE$ for activation.",
        "relation": "CPR:3"
    },
    {
        "id": "17581967.T6.T14",
        "sentence": "@CHEMICAL$ (GluRs) require external @GENE$ and Cl- as well as the neurotransmitter L-glutamate for activation.",
        "relation": "CPR:3"
    },
    {
        "id": "17581967.T6.T19",
        "sentence": "Kainate-selective ionotropic glutamate receptors (@CHEMICAL$) require external @GENE$ and Cl- as well as the neurotransmitter L-glutamate for activation.",
        "relation": "CPR:3"
    },
    {
        "id": "17581967.T7.T14",
        "sentence": "@CHEMICAL$ (GluRs) require external Na+ and @GENE$ as well as the neurotransmitter L-glutamate for activation.",
        "relation": "CPR:3"
    },
    {
        "id": "17581967.T7.T19",
        "sentence": "Kainate-selective ionotropic glutamate receptors (@CHEMICAL$) require external Na+ and @GENE$ as well as the neurotransmitter L-glutamate for activation.",
        "relation": "CPR:3"
    },
    {
        "id": "17581967.T8.T25",
        "sentence": "Additionally, @CHEMICAL$ and Cl- ions coactivate @GENE$ receptors by establishing a dipole, accounting for their common effect on KARs.",
        "relation": "CPR:3"
    },
    {
        "id": "17581967.T9.T25",
        "sentence": "Additionally, Na+ and @CHEMICAL$ ions coactivate @GENE$ receptors by establishing a dipole, accounting for their common effect on KARs.",
        "relation": "CPR:3"
    },
    {
        "id": "17594192.T1.T16",
        "sentence": "@CHEMICAL$, a derivative of physostigmine, was first described as an inhibitor of acetylcholinesterase (@GENE$) and was shown to improve cognition in various experimental paradigms in rodents and dogs.",
        "relation": "CPR:4"
    },
    {
        "id": "17594192.T1.T27",
        "sentence": "@CHEMICAL$, a derivative of physostigmine, was first described as an inhibitor of @GENE$ (AChE) and was shown to improve cognition in various experimental paradigms in rodents and dogs.",
        "relation": "CPR:4"
    },
    {
        "id": "17594192.T7.T16",
        "sentence": "Phenserine, a derivative of @CHEMICAL$, was first described as an inhibitor of acetylcholinesterase (@GENE$) and was shown to improve cognition in various experimental paradigms in rodents and dogs.",
        "relation": "CPR:4"
    },
    {
        "id": "17594192.T7.T27",
        "sentence": "Phenserine, a derivative of @CHEMICAL$, was first described as an inhibitor of @GENE$ (AChE) and was shown to improve cognition in various experimental paradigms in rodents and dogs.",
        "relation": "CPR:4"
    },
    {
        "id": "17594192.T8.T20",
        "sentence": "@CHEMICAL$ deserves attention for an additional quality of action: in addition to inhibiting @GENE$, it modulates the amount of beta-amyloid precursor protein (APP) in neuronal cell culture by reducing APP translation.",
        "relation": "CPR:4"
    },
    {
        "id": "17594192.T8.T23",
        "sentence": "@CHEMICAL$ deserves attention for an additional quality of action: in addition to inhibiting AChE, it modulates the amount of beta-amyloid precursor protein (APP) in neuronal cell culture by reducing @GENE$ translation.",
        "relation": "CPR:4"
    },
    {
        "id": "17594192.T10.T26",
        "sentence": "@CHEMICAL$ apparently reduces translational efficiency of @GENE$ mRNA into protein, a process that may involve an interaction with iron and/or an iron-responsive element.",
        "relation": "CPR:4"
    },
    {
        "id": "17594192.T13.T28",
        "sentence": "As a consequence, @CHEMICAL$ reduces @GENE$ peptide (Abeta) formation in vitro and in vivo.",
        "relation": "CPR:4"
    },
    {
        "id": "17594192.T13.T29",
        "sentence": "As a consequence, @CHEMICAL$ reduces beta-amyloid peptide (@GENE$) formation in vitro and in vivo.",
        "relation": "CPR:4"
    },
    {
        "id": "17594192.T2.T17",
        "sentence": "Phenserine is also unique because of differing actions of its enantiomers: @CHEMICAL$ is the active enantiomer for inhibition of @GENE$, whereas (+)-phenserine ('posiphen') has weak activity as an AChE inhibitor and can be dosed much higher.",
        "relation": "CPR:4"
    },
    {
        "id": "17594192.T3.T18",
        "sentence": "Phenserine is also unique because of differing actions of its enantiomers: (-)-phenserine is the active enantiomer for inhibition of AChE, whereas @CHEMICAL$ ('posiphen') has weak activity as an @GENE$ inhibitor and can be dosed much higher.",
        "relation": "CPR:4"
    },
    {
        "id": "17594192.T4.T18",
        "sentence": "Phenserine is also unique because of differing actions of its enantiomers: (-)-phenserine is the active enantiomer for inhibition of AChE, whereas (+)-phenserine ('@CHEMICAL$') has weak activity as an @GENE$ inhibitor and can be dosed much higher.",
        "relation": "CPR:4"
    },
    {
        "id": "17603555.T27.T55",
        "sentence": "BACKGROUND AND PURPOSE: @CHEMICAL$ (AMPK) is activated by metformin, phenformin, and the AMP mimetic, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (@GENE$).",
        "relation": "CPR:3"
    },
    {
        "id": "17603555.T27.T57",
        "sentence": "BACKGROUND AND PURPOSE: AMP-activated protein kinase (@CHEMICAL$) is activated by metformin, phenformin, and the AMP mimetic, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (@GENE$).",
        "relation": "CPR:3"
    },
    {
        "id": "17603555.T40.T55",
        "sentence": "BACKGROUND AND PURPOSE: @CHEMICAL$ (AMPK) is activated by @GENE$, phenformin, and the AMP mimetic, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).",
        "relation": "CPR:3"
    },
    {
        "id": "17603555.T40.T57",
        "sentence": "BACKGROUND AND PURPOSE: AMP-activated protein kinase (@CHEMICAL$) is activated by @GENE$, phenformin, and the AMP mimetic, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).",
        "relation": "CPR:3"
    },
    {
        "id": "17603555.T42.T55",
        "sentence": "BACKGROUND AND PURPOSE: @CHEMICAL$ (AMPK) is activated by metformin, @GENE$, and the AMP mimetic, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).",
        "relation": "CPR:3"
    },
    {
        "id": "17603555.T42.T57",
        "sentence": "BACKGROUND AND PURPOSE: AMP-activated protein kinase (@CHEMICAL$) is activated by metformin, @GENE$, and the AMP mimetic, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).",
        "relation": "CPR:3"
    },
    {
        "id": "17603555.T8.T55",
        "sentence": "BACKGROUND AND PURPOSE: @CHEMICAL$ (AMPK) is activated by metformin, phenformin, and the AMP mimetic, @GENE$ (AICAR).",
        "relation": "CPR:3"
    },
    {
        "id": "17603555.T8.T57",
        "sentence": "BACKGROUND AND PURPOSE: AMP-activated protein kinase (@CHEMICAL$) is activated by metformin, phenformin, and the AMP mimetic, @GENE$ (AICAR).",
        "relation": "CPR:3"
    },
    {
        "id": "17603555.T43.T59",
        "sentence": "KEY RESULTS: @CHEMICAL$, AICAR and metformin increased @GENE$ activity and decreased I(amiloride).",
        "relation": "CPR:3"
    },
    {
        "id": "17603555.T44.T59",
        "sentence": "KEY RESULTS: Phenformin, @CHEMICAL$ and metformin increased @GENE$ activity and decreased I(amiloride).",
        "relation": "CPR:3"
    },
    {
        "id": "17603555.T45.T59",
        "sentence": "KEY RESULTS: Phenformin, AICAR and @CHEMICAL$ increased @GENE$ activity and decreased I(amiloride).",
        "relation": "CPR:3"
    },
    {
        "id": "17603555.T4.T60",
        "sentence": "The @CHEMICAL$ inhibitor Compound C prevented the action of metformin and AICAR but not @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "17603555.T23.T53",
        "sentence": "Additional pharmacological effects evoked by @CHEMICAL$ and phenformin on I(ouabain), with potential secondary effects on apical Na+ conductance, ENaC activity and monolayer resistance, have important consequences for their use as pharmacological activators of @GENE$ in cell systems where Na+K+ATPase is an important component.",
        "relation": "CPR:3"
    },
    {
        "id": "17603555.T24.T53",
        "sentence": "Additional pharmacological effects evoked by AICAR and @CHEMICAL$ on I(ouabain), with potential secondary effects on apical Na+ conductance, ENaC activity and monolayer resistance, have important consequences for their use as pharmacological activators of @GENE$ in cell systems where Na+K+ATPase is an important component.",
        "relation": "CPR:3"
    },
    {
        "id": "17603555.T25.T53",
        "sentence": "Additional pharmacological effects evoked by AICAR and phenformin on I(@CHEMICAL$), with potential secondary effects on apical Na+ conductance, ENaC activity and monolayer resistance, have important consequences for their use as pharmacological activators of @GENE$ in cell systems where Na+K+ATPase is an important component.",
        "relation": "CPR:3"
    },
    {
        "id": "17604186.T20.T30",
        "sentence": "Neuroprotective effect of @CHEMICAL$, a preferential @GENE$ inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice.",
        "relation": "CPR:4"
    },
    {
        "id": "17604186.T15.T25",
        "sentence": "Brain cyclooxygenases (@CHEMICAL$), the rate-limiting enzyme in @GENE$ synthesis, is rapidly and transiently induced by convulsions in hippocampal and cortical neurons.",
        "relation": "CPR:9"
    },
    {
        "id": "17604186.T15.T29",
        "sentence": "Brain @CHEMICAL$ (COX), the rate-limiting enzyme in @GENE$ synthesis, is rapidly and transiently induced by convulsions in hippocampal and cortical neurons.",
        "relation": "CPR:9"
    },
    {
        "id": "17604186.T10.T27",
        "sentence": "Previous studies have explored the protective effect of naproxen (non-selective COX-inhibitor) or @CHEMICAL$ (selective @GENE$ inhibitor) against chemical kindling in mice.",
        "relation": "CPR:4"
    },
    {
        "id": "17604186.T9.T26",
        "sentence": "Previous studies have explored the protective effect of @CHEMICAL$ (non-selective @GENE$-inhibitor) or rofecoxib (selective COX-2 inhibitor) against chemical kindling in mice.",
        "relation": "CPR:4"
    },
    {
        "id": "17604186.T11.T28",
        "sentence": "With this background, the present study was designed to explore the possible effect of @CHEMICAL$ (a preferential @GENE$ inhibitor) against pentylenetetrazol (PTZ)-induced kindling epilepsy in mice.",
        "relation": "CPR:4"
    },
    {
        "id": "17604186.T1.T23",
        "sentence": "Compared with normal control group, @CHEMICAL$-kindled mice had significantly higher levels of malondialdehyde, nitrite, @GENE$ but had lower levels of reduced glutathione in the whole brain homogenate.",
        "relation": "CPR:3"
    },
    {
        "id": "17604186.T7.T24",
        "sentence": "These results suggested that @CHEMICAL$, a preferential @GENE$ inhibitor offered neuroprotection against PTZ-induced kindling in mice.",
        "relation": "CPR:4"
    },
    {
        "id": "17627474.T10.T22",
        "sentence": "While vitamin C is essential for PHD activity in vitro, N-acetyl-L-cysteine had no effect, and @CHEMICAL$ or n-propyl gallate efficiently inhibited the activity of all three @GENE$, demonstrating different functions of these antioxidants.",
        "relation": "CPR:4"
    },
    {
        "id": "17627474.T11.T22",
        "sentence": "While vitamin C is essential for PHD activity in vitro, N-acetyl-L-cysteine had no effect, and gallic acid or @CHEMICAL$ efficiently inhibited the activity of all three @GENE$, demonstrating different functions of these antioxidants.",
        "relation": "CPR:4"
    },
    {
        "id": "17632548.T18.T39",
        "sentence": "The cysteinyl leukotrienes, namely leukotriene (LT)C4 and its metabolites LTD4 and LTE4, the components of slow-reacting substance of anaphylaxis, are lipid mediators of smooth muscle constriction and inflammation, particularly implicated in bronchial asthma. @CHEMICAL$ (LTC4S), the pivotal enzyme for the biosynthesis of @GENE$ (ref.",
        "relation": "CPR:9"
    },
    {
        "id": "17632548.T18.T40",
        "sentence": "The cysteinyl leukotrienes, namely leukotriene (LT)C4 and its metabolites LTD4 and LTE4, the components of slow-reacting substance of anaphylaxis, are lipid mediators of smooth muscle constriction and inflammation, particularly implicated in bronchial asthma. LTC4 synthase (@CHEMICAL$), the pivotal enzyme for the biosynthesis of @GENE$ (ref.",
        "relation": "CPR:9"
    },
    {
        "id": "17632548.T21.T42",
        "sentence": "10), is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in @CHEMICAL$ and glutathione metabolism that includes 5-lipoxygenase-activating protein, @GENE$ (MGSTs), and microsomal prostaglandin E synthase 1 (ref.",
        "relation": "CPR:9"
    },
    {
        "id": "17632548.T21.T43",
        "sentence": "10), is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in @CHEMICAL$ and glutathione metabolism that includes 5-lipoxygenase-activating protein, microsomal glutathione S-transferases (@GENE$), and microsomal prostaglandin E synthase 1 (ref.",
        "relation": "CPR:9"
    },
    {
        "id": "17632548.T21.T44",
        "sentence": "10), is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in @CHEMICAL$ and glutathione metabolism that includes 5-lipoxygenase-activating protein, microsomal glutathione S-transferases (MGSTs), and @GENE$ (ref.",
        "relation": "CPR:9"
    },
    {
        "id": "17632548.T22.T42",
        "sentence": "10), is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in eicosanoid and @CHEMICAL$ metabolism that includes 5-lipoxygenase-activating protein, @GENE$ (MGSTs), and microsomal prostaglandin E synthase 1 (ref.",
        "relation": "CPR:9"
    },
    {
        "id": "17632548.T22.T43",
        "sentence": "10), is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in eicosanoid and @CHEMICAL$ metabolism that includes 5-lipoxygenase-activating protein, microsomal glutathione S-transferases (@GENE$), and microsomal prostaglandin E synthase 1 (ref.",
        "relation": "CPR:9"
    },
    {
        "id": "17632548.T22.T44",
        "sentence": "10), is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in eicosanoid and @CHEMICAL$ metabolism that includes 5-lipoxygenase-activating protein, microsomal glutathione S-transferases (MGSTs), and @GENE$ (ref.",
        "relation": "CPR:9"
    },
    {
        "id": "17768678.T34.T44",
        "sentence": "@CHEMICAL$ causes an increase in brain ornithine that is prevented by prior @GENE$ inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "17768678.T1.T39",
        "sentence": "@CHEMICAL$ (PLZ), a nonselective irreversible inhibitor of @GENE$ (MAO), also inhibits GABA-transaminase (GABA-T), markedly increasing brain GABA levels.",
        "relation": "CPR:4"
    },
    {
        "id": "17768678.T1.T40",
        "sentence": "@CHEMICAL$ (PLZ), a nonselective irreversible inhibitor of monoamine oxidase (@GENE$), also inhibits GABA-transaminase (GABA-T), markedly increasing brain GABA levels.",
        "relation": "CPR:4"
    },
    {
        "id": "17768678.T1.T36",
        "sentence": "@CHEMICAL$ (PLZ), a nonselective irreversible inhibitor of monoamine oxidase (MAO), also inhibits GABA-transaminase (@GENE$), markedly increasing brain GABA levels.",
        "relation": "CPR:4"
    },
    {
        "id": "17768678.T1.T43",
        "sentence": "@CHEMICAL$ (PLZ), a nonselective irreversible inhibitor of monoamine oxidase (MAO), also inhibits @GENE$ (GABA-T), markedly increasing brain GABA levels.",
        "relation": "CPR:4"
    },
    {
        "id": "17768678.T6.T39",
        "sentence": "Phenelzine (@CHEMICAL$), a nonselective irreversible inhibitor of @GENE$ (MAO), also inhibits GABA-transaminase (GABA-T), markedly increasing brain GABA levels.",
        "relation": "CPR:4"
    },
    {
        "id": "17768678.T6.T40",
        "sentence": "Phenelzine (@CHEMICAL$), a nonselective irreversible inhibitor of monoamine oxidase (@GENE$), also inhibits GABA-transaminase (GABA-T), markedly increasing brain GABA levels.",
        "relation": "CPR:4"
    },
    {
        "id": "17768678.T6.T36",
        "sentence": "Phenelzine (@CHEMICAL$), a nonselective irreversible inhibitor of monoamine oxidase (MAO), also inhibits GABA-transaminase (@GENE$), markedly increasing brain GABA levels.",
        "relation": "CPR:4"
    },
    {
        "id": "17768678.T6.T43",
        "sentence": "Phenelzine (@CHEMICAL$), a nonselective irreversible inhibitor of monoamine oxidase (MAO), also inhibits @GENE$ (GABA-T), markedly increasing brain GABA levels.",
        "relation": "CPR:4"
    },
    {
        "id": "17768678.T16.T38",
        "sentence": "@CHEMICAL$ is also a substrate for @GENE$, and studies suggest that a metabolite formed by the action of this enzyme on PLZ may be responsible for the increase in GABA observed.",
        "relation": "CPR:9"
    },
    {
        "id": "17768678.T31.T42",
        "sentence": "To determine whether a metabolite formed by the action of MAO on PLZ may be responsible for the elevation in brain ORN observed, animals were pretreated with vehicle or the @CHEMICAL$ inhibitor @GENE$ (TCP) before vehicle or PLZ (15 mg/kg), and brains collected 3 h later.",
        "relation": "CPR:4"
    },
    {
        "id": "17768678.T32.T42",
        "sentence": "To determine whether a metabolite formed by the action of MAO on PLZ may be responsible for the elevation in brain ORN observed, animals were pretreated with vehicle or the @CHEMICAL$ inhibitor tranylcypromine (@GENE$) before vehicle or PLZ (15 mg/kg), and brains collected 3 h later.",
        "relation": "CPR:4"
    },
    {
        "id": "17768678.T11.T37",
        "sentence": "ORN levels (measured by an HPLC procedure) were dose- and time-dependently increased in PLZ-treated animals, with levels reaching approximately 650% of control at 6 and 12 h. Pretreatment with TCP completely abolished the PLZ-induced increase in brain ORN, suggesting, as with GABA, that a metabolite of @CHEMICAL$ formed by the action of @GENE$ is responsible for the elevation of brain ORN observed.",
        "relation": "CPR:9"
    },
    {
        "id": "17869551.T11.T36",
        "sentence": "Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle. Nitric oxide (@CHEMICAL$) is an important vasorelaxant produced along with L-citrulline from L-arginine in a reaction catalyzed by @GENE$ (eNOS).",
        "relation": "CPR:9"
    },
    {
        "id": "17869551.T11.T37",
        "sentence": "Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle. Nitric oxide (@CHEMICAL$) is an important vasorelaxant produced along with L-citrulline from L-arginine in a reaction catalyzed by endothelial nitric oxide synthase (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "17869551.T1.T36",
        "sentence": "Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle. @CHEMICAL$ (NO) is an important vasorelaxant produced along with L-citrulline from L-arginine in a reaction catalyzed by @GENE$ (eNOS).",
        "relation": "CPR:9"
    },
    {
        "id": "17869551.T1.T37",
        "sentence": "Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle. @CHEMICAL$ (NO) is an important vasorelaxant produced along with L-citrulline from L-arginine in a reaction catalyzed by endothelial nitric oxide synthase (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "17869551.T23.T36",
        "sentence": "Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle. Nitric oxide (NO) is an important vasorelaxant produced along with @CHEMICAL$ from L-arginine in a reaction catalyzed by @GENE$ (eNOS).",
        "relation": "CPR:9"
    },
    {
        "id": "17869551.T23.T37",
        "sentence": "Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle. Nitric oxide (NO) is an important vasorelaxant produced along with @CHEMICAL$ from L-arginine in a reaction catalyzed by endothelial nitric oxide synthase (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "17869551.T29.T36",
        "sentence": "Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle. Nitric oxide (NO) is an important vasorelaxant produced along with L-citrulline from @CHEMICAL$ in a reaction catalyzed by @GENE$ (eNOS).",
        "relation": "CPR:9"
    },
    {
        "id": "17869551.T29.T37",
        "sentence": "Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle. Nitric oxide (NO) is an important vasorelaxant produced along with L-citrulline from @CHEMICAL$ in a reaction catalyzed by endothelial nitric oxide synthase (@GENE$).",
        "relation": "CPR:9"
    },
    {
        "id": "17869551.T31.T34",
        "sentence": "As further support, @CHEMICAL$, an inhibitor of @GENE$ (AS), a component of the citrulline-NO cycle, inhibited NO production in a dose-dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "17869551.T31.T35",
        "sentence": "As further support, @CHEMICAL$, an inhibitor of argininosuccinate synthase (@GENE$), a component of the citrulline-NO cycle, inhibited NO production in a dose-dependent manner.",
        "relation": "CPR:4"
    },
    {
        "id": "17916059.T11.T16",
        "sentence": "Caution is necessary only when it is coadministered with drugs metabolised by @CHEMICAL$, such as @GENE$, or administered to the elderly or patients with severe hepatic or renal impairment.",
        "relation": "CPR:9"
    },
    {
        "id": "17980251.T27.T30",
        "sentence": "Inhibition of platelet aggregation by AZD6140, a reversible oral @CHEMICAL$ receptor antagonist, compared with @GENE$ in patients with acute coronary syndromes.",
        "relation": "CPR:6"
    },
    {
        "id": "17980251.T28.T30",
        "sentence": "Inhibition of platelet aggregation by @CHEMICAL$, a reversible oral @GENE$ receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.",
        "relation": "CPR:6"
    },
    {
        "id": "17980251.T20.T29",
        "sentence": "@CHEMICAL$ is a reversible oral @GENE$ receptor antagonist that has been studied in ACS patients in comparison with clopidogrel (DISPERSE-2 study).",
        "relation": "CPR:6"
    },
    {
        "id": "17980251.T21.T29",
        "sentence": "AZD6140 is a reversible oral @CHEMICAL$ receptor antagonist that has been studied in ACS patients in comparison with @GENE$ (DISPERSE-2 study).",
        "relation": "CPR:6"
    },
    {
        "id": "18045203.T1.T10",
        "sentence": "The preparation and human muscarinic receptor profiling of oxybutynin and N-desethyloxybutynin enantiomers. @CHEMICAL$ (1) is a non-selective @GENE$ antagonist that is used clinically for the treatment of urinary incontinence.",
        "relation": "CPR:6"
    },
    {
        "id": "18450949.T5.T19",
        "sentence": "Degradation of submandibular gland AQP5 by parasympathetic denervation of chorda tympani and its recovery by @CHEMICAL$, an @GENE$ agonist.",
        "relation": "CPR:5"
    },
    {
        "id": "18450949.T5.T20",
        "sentence": "Degradation of submandibular gland @CHEMICAL$ by parasympathetic denervation of chorda tympani and its recovery by @GENE$, an M3 muscarinic receptor agonist.",
        "relation": "CPR:3"
    },
    {
        "id": "18450949.T1.T10",
        "sentence": "Administration of @CHEMICAL$, an @GENE$ agonist (10 mg/kg for 7 days po), but not pilocarpine (0.3 mg/kg for 7 days po), recovered the AQP5 protein level reduced by CTD and increased the AQP1 protein level above the control one.",
        "relation": "CPR:5"
    },
    {
        "id": "18450949.T1.T11",
        "sentence": "Administration of @CHEMICAL$, an M3 muscarinic receptor agonist (10 mg/kg for 7 days po), but not pilocarpine (0.3 mg/kg for 7 days po), recovered the @GENE$ protein level reduced by CTD and increased the AQP1 protein level above the control one.",
        "relation": "CPR:3"
    },
    {
        "id": "18450949.T1.T12",
        "sentence": "Administration of @CHEMICAL$, an M3 muscarinic receptor agonist (10 mg/kg for 7 days po), but not pilocarpine (0.3 mg/kg for 7 days po), recovered the AQP5 protein level reduced by CTD and increased the @GENE$ protein level above the control one.",
        "relation": "CPR:3"
    },
    {
        "id": "18450949.T4.T16",
        "sentence": "Administration of @CHEMICAL$ (50 mg/kg for 7 days po), a denaturant of lysosomes, increased the @GENE$ protein level reduced by CTD.",
        "relation": "CPR:3"
    },
    {
        "id": "18480678.T17.T30",
        "sentence": "threo-methylphenidate inhibits the @CHEMICAL$ and the norepinephrine transporter, resulting in elevations of these @GENE$ after impulse release.",
        "relation": "CPR:9"
    },
    {
        "id": "18480678.T17.T31",
        "sentence": "threo-methylphenidate inhibits the dopamine transporter and the @CHEMICAL$, resulting in elevations of these @GENE$ after impulse release.",
        "relation": "CPR:9"
    },
    {
        "id": "18480678.T8.T30",
        "sentence": "@CHEMICAL$ inhibits the @GENE$ and the norepinephrine transporter, resulting in elevations of these monoamines after impulse release.",
        "relation": "CPR:4"
    },
    {
        "id": "18480678.T8.T31",
        "sentence": "@CHEMICAL$ inhibits the dopamine transporter and the @GENE$, resulting in elevations of these monoamines after impulse release.",
        "relation": "CPR:4"
    },
    {
        "id": "18593927.T3.T9",
        "sentence": "The direct inhibition of @CHEMICAL$ by @GENE$ is likely a contributing factor.",
        "relation": "CPR:4"
    },
    {
        "id": "18604229.T12.T27",
        "sentence": "The principal aim of the study was to find @CHEMICAL$ analogues that retained @GENE$ inhibition but with reduced cytotoxicity.",
        "relation": "CPR:4"
    },
    {
        "id": "18604229.T10.T25",
        "sentence": "CONCLUSIONS AND IMPLICATIONS: @CHEMICAL$ analogues with better @GENE$ channel inhibition and cytotoxicity profiles than the parent compound have been identified, demonstrating that cytotoxicity and hERG channel interaction are mechanistically distinct and separable properties of the compounds.",
        "relation": "CPR:4"
    },
    {
        "id": "18655903.T11.T48",
        "sentence": "In addition to OT and to a lesser extent AVP (pitressin), a number of OT and AVP analogues; such as @CHEMICAL$ (@GENE$ agonist) dDAVP (desmopressin, V(2) agonist), terlipressin (V(1a) agonist), felypressin (V(1a) agonist) and atosiban (Tractocile OT antagonist) are also in clinical use.",
        "relation": "CPR:5"
    },
    {
        "id": "18655903.T13.T50",
        "sentence": "In addition to OT and to a lesser extent AVP (pitressin), a number of OT and AVP analogues; such as carbetocin (OT agonist) dDAVP (@CHEMICAL$, @GENE$ agonist), terlipressin (V(1a) agonist), felypressin (V(1a) agonist) and atosiban (Tractocile OT antagonist) are also in clinical use.",
        "relation": "CPR:5"
    },
    {
        "id": "18655903.T14.T51",
        "sentence": "In addition to OT and to a lesser extent AVP (pitressin), a number of OT and AVP analogues; such as carbetocin (OT agonist) dDAVP (desmopressin, V(2) agonist), @CHEMICAL$ (@GENE$ agonist), felypressin (V(1a) agonist) and atosiban (Tractocile OT antagonist) are also in clinical use.",
        "relation": "CPR:5"
    },
    {
        "id": "18655903.T15.T52",
        "sentence": "In addition to OT and to a lesser extent AVP (pitressin), a number of OT and AVP analogues; such as carbetocin (OT agonist) dDAVP (desmopressin, V(2) agonist), terlipressin (V(1a) agonist), @CHEMICAL$ (@GENE$ agonist) and atosiban (Tractocile OT antagonist) are also in clinical use.",
        "relation": "CPR:5"
    },
    {
        "id": "18655903.T16.T54",
        "sentence": "In addition to OT and to a lesser extent AVP (pitressin), a number of OT and AVP analogues; such as carbetocin (OT agonist) dDAVP (desmopressin, V(2) agonist), terlipressin (V(1a) agonist), felypressin (V(1a) agonist) and @CHEMICAL$ (Tractocile @GENE$ antagonist) are also in clinical use.",
        "relation": "CPR:6"
    },
    {
        "id": "18655903.T17.T54",
        "sentence": "In addition to OT and to a lesser extent AVP (pitressin), a number of OT and AVP analogues; such as carbetocin (OT agonist) dDAVP (desmopressin, V(2) agonist), terlipressin (V(1a) agonist), felypressin (V(1a) agonist) and atosiban (@CHEMICAL$ @GENE$ antagonist) are also in clinical use.",
        "relation": "CPR:6"
    },
    {
        "id": "18655903.T19.T58",
        "sentence": "While a number of orally active non-peptide @CHEMICAL$ antagonists (Vaptans); notably, @GENE$, Lixivaptan and Satavaptan, are currently in Phase III clinical trials; to date, only the mixed V(2)/V(1a), antagonist Conivaptan (Vaprisol), has been approved by the US FDA for clinical use (by i.v. administration), for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients.",
        "relation": "CPR:6"
    },
    {
        "id": "18655903.T20.T58",
        "sentence": "While a number of orally active non-peptide @CHEMICAL$ antagonists (Vaptans); notably, Tolvaptan, @GENE$ and Satavaptan, are currently in Phase III clinical trials; to date, only the mixed V(2)/V(1a), antagonist Conivaptan (Vaprisol), has been approved by the US FDA for clinical use (by i.v. administration), for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients.",
        "relation": "CPR:6"
    },
    {
        "id": "18655903.T21.T58",
        "sentence": "While a number of orally active non-peptide @CHEMICAL$ antagonists (Vaptans); notably, Tolvaptan, Lixivaptan and @GENE$, are currently in Phase III clinical trials; to date, only the mixed V(2)/V(1a), antagonist Conivaptan (Vaprisol), has been approved by the US FDA for clinical use (by i.v. administration), for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients.",
        "relation": "CPR:6"
    },
    {
        "id": "18655903.T23.T60",
        "sentence": "While a number of orally active non-peptide V(2) antagonists (Vaptans); notably, Tolvaptan, Lixivaptan and Satavaptan, are currently in Phase III clinical trials; to date, only the mixed @CHEMICAL$/V(1a), antagonist @GENE$ (Vaprisol), has been approved by the US FDA for clinical use (by i.v. administration), for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients.",
        "relation": "CPR:6"
    },
    {
        "id": "18655903.T23.T61",
        "sentence": "While a number of orally active non-peptide V(2) antagonists (Vaptans); notably, Tolvaptan, Lixivaptan and Satavaptan, are currently in Phase III clinical trials; to date, only the mixed V(2)/@CHEMICAL$, antagonist @GENE$ (Vaprisol), has been approved by the US FDA for clinical use (by i.v. administration), for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients.",
        "relation": "CPR:6"
    },
    {
        "id": "18655903.T24.T60",
        "sentence": "While a number of orally active non-peptide V(2) antagonists (Vaptans); notably, Tolvaptan, Lixivaptan and Satavaptan, are currently in Phase III clinical trials; to date, only the mixed @CHEMICAL$/V(1a), antagonist Conivaptan (@GENE$), has been approved by the US FDA for clinical use (by i.v. administration), for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients.",
        "relation": "CPR:6"
    },
    {
        "id": "18655903.T24.T61",
        "sentence": "While a number of orally active non-peptide V(2) antagonists (Vaptans); notably, Tolvaptan, Lixivaptan and Satavaptan, are currently in Phase III clinical trials; to date, only the mixed V(2)/@CHEMICAL$, antagonist Conivaptan (@GENE$), has been approved by the US FDA for clinical use (by i.v. administration), for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients.",
        "relation": "CPR:6"
    },
    {
        "id": "1868500.T5.T18",
        "sentence": "Absorbable drugs (@CHEMICAL$, nicotinic acid, probucol, HMG-CoA reductase inhibitors) reduce @GENE$ (VLDL) and/or low-density lipoproteins (LDL) by a variety of mechanisms.",
        "relation": "CPR:4"
    },
    {
        "id": "1868500.T5.T19",
        "sentence": "Absorbable drugs (@CHEMICAL$, nicotinic acid, probucol, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (@GENE$) and/or low-density lipoproteins (LDL) by a variety of mechanisms.",
        "relation": "CPR:4"
    },
    {
        "id": "1868500.T5.T20",
        "sentence": "Absorbable drugs (@CHEMICAL$, nicotinic acid, probucol, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (VLDL) and/or @GENE$ (LDL) by a variety of mechanisms.",
        "relation": "CPR:4"
    },
    {
        "id": "1868500.T5.T21",
        "sentence": "Absorbable drugs (@CHEMICAL$, nicotinic acid, probucol, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (VLDL) and/or low-density lipoproteins (@GENE$) by a variety of mechanisms.",
        "relation": "CPR:4"
    },
    {
        "id": "1868500.T6.T18",
        "sentence": "Absorbable drugs (fibric acids, @CHEMICAL$, probucol, HMG-CoA reductase inhibitors) reduce @GENE$ (VLDL) and/or low-density lipoproteins (LDL) by a variety of mechanisms.",
        "relation": "CPR:4"
    },
    {
        "id": "1868500.T6.T19",
        "sentence": "Absorbable drugs (fibric acids, @CHEMICAL$, probucol, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (@GENE$) and/or low-density lipoproteins (LDL) by a variety of mechanisms.",
        "relation": "CPR:4"
    },
    {
        "id": "1868500.T6.T20",
        "sentence": "Absorbable drugs (fibric acids, @CHEMICAL$, probucol, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (VLDL) and/or @GENE$ (LDL) by a variety of mechanisms.",
        "relation": "CPR:4"
    },
    {
        "id": "1868500.T6.T21",
        "sentence": "Absorbable drugs (fibric acids, @CHEMICAL$, probucol, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (VLDL) and/or low-density lipoproteins (@GENE$) by a variety of mechanisms.",
        "relation": "CPR:4"
    },
    {
        "id": "1868500.T7.T18",
        "sentence": "Absorbable drugs (fibric acids, nicotinic acid, @CHEMICAL$, HMG-CoA reductase inhibitors) reduce @GENE$ (VLDL) and/or low-density lipoproteins (LDL) by a variety of mechanisms.",
        "relation": "CPR:4"
    },
    {
        "id": "1868500.T7.T19",
        "sentence": "Absorbable drugs (fibric acids, nicotinic acid, @CHEMICAL$, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (@GENE$) and/or low-density lipoproteins (LDL) by a variety of mechanisms.",
        "relation": "CPR:4"
    },
    {
        "id": "1868500.T7.T20",
        "sentence": "Absorbable drugs (fibric acids, nicotinic acid, @CHEMICAL$, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (VLDL) and/or @GENE$ (LDL) by a variety of mechanisms.",
        "relation": "CPR:4"
    },
    {
        "id": "1868500.T7.T21",
        "sentence": "Absorbable drugs (fibric acids, nicotinic acid, @CHEMICAL$, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (VLDL) and/or low-density lipoproteins (@GENE$) by a variety of mechanisms.",
        "relation": "CPR:4"
    },
    {
        "id": "1868500.T9.T22",
        "sentence": "@CHEMICAL$, in particular, act by stimulating the catabolism of @GENE$ and also, as a consequence, improving LDL delipidation, thus favoring receptor uptake.",
        "relation": "CPR:4"
    },
    {
        "id": "1868500.T12.T27",
        "sentence": "Probucol acts by a newly described mechanism, i.e. accelerating reverse transport of @CHEMICAL$ from @GENE$ to lower-density lipoproteins.",
        "relation": "CPR:9"
    },
    {
        "id": "1868500.T12.T28",
        "sentence": "Probucol acts by a newly described mechanism, i.e. accelerating reverse transport of @CHEMICAL$ from high-density lipoproteins to @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "18803986.T30.T53",
        "sentence": "@CHEMICAL$: a dual inhibitor of human epidermal growth factor receptor @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "18803986.T30.T52",
        "sentence": "@CHEMICAL$: a dual inhibitor of @GENE$ tyrosine kinases.",
        "relation": "CPR:4"
    },
    {
        "id": "18803986.T5.T37",
        "sentence": "BACKGROUND: @CHEMICAL$, the first dual inhibitor of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) @GENE$, was approved by the US Food and Drug Administration (FDA) in 2007.",
        "relation": "CPR:4"
    },
    {
        "id": "18803986.T5.T35",
        "sentence": "BACKGROUND: @CHEMICAL$, the first dual inhibitor of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (@GENE$) tyrosine kinases, was approved by the US Food and Drug Administration (FDA) in 2007.",
        "relation": "CPR:4"
    },
    {
        "id": "18803986.T5.T49",
        "sentence": "BACKGROUND: @CHEMICAL$, the first dual inhibitor of @GENE$ (EGFR) and human epidermal growth factor receptor 2 (HER2) tyrosine kinases, was approved by the US Food and Drug Administration (FDA) in 2007.",
        "relation": "CPR:4"
    },
    {
        "id": "18803986.T5.T50",
        "sentence": "BACKGROUND: @CHEMICAL$, the first dual inhibitor of epidermal growth factor receptor (@GENE$) and human epidermal growth factor receptor 2 (HER2) tyrosine kinases, was approved by the US Food and Drug Administration (FDA) in 2007.",
        "relation": "CPR:4"
    },
    {
        "id": "18803986.T5.T51",
        "sentence": "BACKGROUND: @CHEMICAL$, the first dual inhibitor of epidermal growth factor receptor (EGFR) and @GENE$ (HER2) tyrosine kinases, was approved by the US Food and Drug Administration (FDA) in 2007.",
        "relation": "CPR:4"
    },
    {
        "id": "18803986.T6.T36",
        "sentence": "@CHEMICAL$ is metabolized primarily by the @GENE$ isozyme, with 1 metabolite remaining active against EGFR but not HER2.",
        "relation": "CPR:9"
    },
    {
        "id": "18803986.T24.T43",
        "sentence": "CONCLUSIONS: @CHEMICAL$ is a dual inhibitor of the EGFR and HER2 @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "18803986.T24.T41",
        "sentence": "CONCLUSIONS: @CHEMICAL$ is a dual inhibitor of the @GENE$ and HER2 tyrosine kinases.",
        "relation": "CPR:4"
    },
    {
        "id": "18803986.T24.T42",
        "sentence": "CONCLUSIONS: @CHEMICAL$ is a dual inhibitor of the EGFR and @GENE$ tyrosine kinases.",
        "relation": "CPR:4"
    },
    {
        "id": "1881457.T11.T27",
        "sentence": "Phenelzine is a more potent @CHEMICAL$ inhibitor than is @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "1881457.T9.T27",
        "sentence": "@CHEMICAL$ is a more potent @GENE$ inhibitor than is N2-acetylphenelzine.",
        "relation": "CPR:4"
    },
    {
        "id": "1881457.T17.T28",
        "sentence": "Acetylation of @CHEMICAL$ at the N2 position presumably interferes with the inhibition of the @GENE$ enzymes for gamma-aminobutyric acid and alanine.",
        "relation": "CPR:4"
    },
    {
        "id": "1881457.T18.T28",
        "sentence": "Acetylation of phenelzine at the @CHEMICAL$ position presumably interferes with the inhibition of the @GENE$ enzymes for gamma-aminobutyric acid and alanine.",
        "relation": "CPR:4"
    },
    {
        "id": "1881457.T20.T28",
        "sentence": "Acetylation of phenelzine at the N2 position presumably interferes with the inhibition of the @CHEMICAL$ enzymes for @GENE$ and alanine.",
        "relation": "CPR:4"
    },
    {
        "id": "1881457.T21.T28",
        "sentence": "Acetylation of phenelzine at the N2 position presumably interferes with the inhibition of the @CHEMICAL$ enzymes for gamma-aminobutyric acid and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "18973551.T4.T25",
        "sentence": "All neurotrophic effects were blocked by the unselective D2/D3 receptor antagonist sulpiride (5 microm) and by the selective @CHEMICAL$ antagonist @GENE$ at a low dose (50 nm).",
        "relation": "CPR:6"
    },
    {
        "id": "18973551.T5.T26",
        "sentence": "@CHEMICAL$ and 7-OH-DPAT also increased the phosphorylation of @GENE$ (ERK) within minutes, an effect blocked by pretreatment with SB-277011-A. Inhibition of the D2/D3 receptor signalling pathway to ERK was obtained with PD98059, GF109203 or LY294002, resulting in blockade of neurotrophic effects.",
        "relation": "CPR:3"
    },
    {
        "id": "18973551.T5.T27",
        "sentence": "@CHEMICAL$ and 7-OH-DPAT also increased the phosphorylation of extracellular signal-regulated kinase (@GENE$) within minutes, an effect blocked by pretreatment with SB-277011-A. Inhibition of the D2/D3 receptor signalling pathway to ERK was obtained with PD98059, GF109203 or LY294002, resulting in blockade of neurotrophic effects.",
        "relation": "CPR:3"
    },
    {
        "id": "18973551.T6.T26",
        "sentence": "Quinpirole and @CHEMICAL$ also increased the phosphorylation of @GENE$ (ERK) within minutes, an effect blocked by pretreatment with SB-277011-A. Inhibition of the D2/D3 receptor signalling pathway to ERK was obtained with PD98059, GF109203 or LY294002, resulting in blockade of neurotrophic effects.",
        "relation": "CPR:3"
    },
    {
        "id": "18973551.T6.T27",
        "sentence": "Quinpirole and @CHEMICAL$ also increased the phosphorylation of extracellular signal-regulated kinase (@GENE$) within minutes, an effect blocked by pretreatment with SB-277011-A. Inhibition of the D2/D3 receptor signalling pathway to ERK was obtained with PD98059, GF109203 or LY294002, resulting in blockade of neurotrophic effects.",
        "relation": "CPR:3"
    },
    {
        "id": "18973551.T7.T26",
        "sentence": "Quinpirole and 7-OH-DPAT also increased the phosphorylation of @CHEMICAL$ (ERK) within minutes, an effect blocked by pretreatment with @GENE$. Inhibition of the D2/D3 receptor signalling pathway to ERK was obtained with PD98059, GF109203 or LY294002, resulting in blockade of neurotrophic effects.",
        "relation": "CPR:4"
    },
    {
        "id": "18973551.T7.T27",
        "sentence": "Quinpirole and 7-OH-DPAT also increased the phosphorylation of extracellular signal-regulated kinase (@CHEMICAL$) within minutes, an effect blocked by pretreatment with @GENE$. Inhibition of the D2/D3 receptor signalling pathway to ERK was obtained with PD98059, GF109203 or LY294002, resulting in blockade of neurotrophic effects.",
        "relation": "CPR:4"
    },
    {
        "id": "18974361.T14.T26",
        "sentence": "This study identified four clinically approved antihypertensive drugs (@CHEMICAL$, felodipine, isradipine, and nitrendipine) as potent @GENE$ blockers (IC(50) < 3 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "18974361.T15.T26",
        "sentence": "This study identified four clinically approved antihypertensive drugs (efonidipine, @CHEMICAL$, isradipine, and nitrendipine) as potent @GENE$ blockers (IC(50) < 3 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "18974361.T16.T26",
        "sentence": "This study identified four clinically approved antihypertensive drugs (efonidipine, felodipine, @CHEMICAL$, and nitrendipine) as potent @GENE$ blockers (IC(50) < 3 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "18974361.T17.T26",
        "sentence": "This study identified four clinically approved antihypertensive drugs (efonidipine, felodipine, isradipine, and @CHEMICAL$) as potent @GENE$ blockers (IC(50) < 3 microM).",
        "relation": "CPR:4"
    },
    {
        "id": "19023039.T14.T39",
        "sentence": "We found compounds that inhibited @CHEMICAL$ currents with a rank order of potency: @GENE$ > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = niflumic acid.",
        "relation": "CPR:4"
    },
    {
        "id": "19023039.T15.T39",
        "sentence": "We found compounds that inhibited @CHEMICAL$ currents with a rank order of potency: carbenoxolone > @GENE$ (DIDS) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = niflumic acid.",
        "relation": "CPR:4"
    },
    {
        "id": "19023039.T16.T39",
        "sentence": "We found compounds that inhibited @CHEMICAL$ currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (@GENE$) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = niflumic acid.",
        "relation": "CPR:4"
    },
    {
        "id": "19023039.T1.T39",
        "sentence": "We found compounds that inhibited @CHEMICAL$ currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) approximately @GENE$ approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = niflumic acid.",
        "relation": "CPR:4"
    },
    {
        "id": "19023039.T2.T39",
        "sentence": "We found compounds that inhibited @CHEMICAL$ currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately @GENE$ > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = niflumic acid.",
        "relation": "CPR:4"
    },
    {
        "id": "19023039.T3.T39",
        "sentence": "We found compounds that inhibited @CHEMICAL$ currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > @GENE$ >> probenecid >> flufenamic acid = niflumic acid.",
        "relation": "CPR:4"
    },
    {
        "id": "19023039.T4.T39",
        "sentence": "We found compounds that inhibited @CHEMICAL$ currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> @GENE$ >> flufenamic acid = niflumic acid.",
        "relation": "CPR:4"
    },
    {
        "id": "19023039.T5.T39",
        "sentence": "We found compounds that inhibited @CHEMICAL$ currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> @GENE$ = niflumic acid.",
        "relation": "CPR:4"
    },
    {
        "id": "19023039.T6.T39",
        "sentence": "We found compounds that inhibited @CHEMICAL$ currents with a rank order of potency: carbenoxolone > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "19023039.T10.T18",
        "sentence": "Triphosphate nucleotides (ATP, GTP, and @CHEMICAL$) rapidly and reversibly inhibited @GENE$ currents via mechanism(s) independent of purine receptors.",
        "relation": "CPR:4"
    },
    {
        "id": "19023039.T7.T18",
        "sentence": "@CHEMICAL$ (ATP, GTP, and UTP) rapidly and reversibly inhibited @GENE$ currents via mechanism(s) independent of purine receptors.",
        "relation": "CPR:4"
    },
    {
        "id": "19023039.T8.T18",
        "sentence": "Triphosphate nucleotides (@CHEMICAL$, GTP, and UTP) rapidly and reversibly inhibited @GENE$ currents via mechanism(s) independent of purine receptors.",
        "relation": "CPR:4"
    },
    {
        "id": "19023039.T9.T18",
        "sentence": "Triphosphate nucleotides (ATP, @CHEMICAL$, and UTP) rapidly and reversibly inhibited @GENE$ currents via mechanism(s) independent of purine receptors.",
        "relation": "CPR:4"
    },
    {
        "id": "19023039.T11.T24",
        "sentence": "When Panx1 was coexpressed with purinergic P2X(7) receptor (P2X(7)R), @CHEMICAL$ was found to act as a @GENE$ antagonist to inhibit ATP-evoked currents, but none of the other compounds inhibited P2X(7)R currents.",
        "relation": "CPR:6"
    },
    {
        "id": "19057128.T7.T21",
        "sentence": "We investigated the effect of @CHEMICAL$, an @GENE$ inhibitor, on MMP-2 and MMP-9 in monocrotaline-induced right ventricular hypertrophy.",
        "relation": "CPR:4"
    },
    {
        "id": "19057128.T3.T17",
        "sentence": "However, captopril did not attenuate an increase in pulmonary artery pressure. @CHEMICAL$ and MMP-9 expressions and activities in right ventricles increased significantly in @GENE$-injected rats and captopril inhibited them.",
        "relation": "CPR:3"
    },
    {
        "id": "19057128.T3.T18",
        "sentence": "However, captopril did not attenuate an increase in pulmonary artery pressure. MMP-2 and @CHEMICAL$ expressions and activities in right ventricles increased significantly in @GENE$-injected rats and captopril inhibited them.",
        "relation": "CPR:3"
    },
    {
        "id": "19057128.T4.T17",
        "sentence": "However, captopril did not attenuate an increase in pulmonary artery pressure. @CHEMICAL$ and MMP-9 expressions and activities in right ventricles increased significantly in monocrotaline-injected rats and @GENE$ inhibited them.",
        "relation": "CPR:4"
    },
    {
        "id": "19057128.T4.T18",
        "sentence": "However, captopril did not attenuate an increase in pulmonary artery pressure. MMP-2 and @CHEMICAL$ expressions and activities in right ventricles increased significantly in monocrotaline-injected rats and @GENE$ inhibited them.",
        "relation": "CPR:4"
    },
    {
        "id": "19057128.T5.T19",
        "sentence": "These findings indicate that @CHEMICAL$ attenuates the development of monocrotaline-induced right ventricular hypertrophy in association with inhibition of @GENE$ and MMP-9 in rats.",
        "relation": "CPR:4"
    },
    {
        "id": "19057128.T5.T20",
        "sentence": "These findings indicate that @CHEMICAL$ attenuates the development of monocrotaline-induced right ventricular hypertrophy in association with inhibition of MMP-2 and @GENE$ in rats.",
        "relation": "CPR:4"
    },
    {
        "id": "19057128.T6.T19",
        "sentence": "These findings indicate that captopril attenuates the development of @CHEMICAL$-induced right ventricular hypertrophy in association with inhibition of @GENE$ and MMP-9 in rats.",
        "relation": "CPR:3"
    },
    {
        "id": "19057128.T6.T20",
        "sentence": "These findings indicate that captopril attenuates the development of @CHEMICAL$-induced right ventricular hypertrophy in association with inhibition of MMP-2 and @GENE$ in rats.",
        "relation": "CPR:3"
    },
    {
        "id": "19119014.T1.T24",
        "sentence": "@CHEMICAL$ and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase (@GENE$, EC 4.2.1.1) with a very different profile as compared to classical inhibitors, such as acetazolamide, methazolamide, and ethoxzolamide.",
        "relation": "CPR:4"
    },
    {
        "id": "19119014.T1.T36",
        "sentence": "@CHEMICAL$ and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of @GENE$ (CA, EC 4.2.1.1) with a very different profile as compared to classical inhibitors, such as acetazolamide, methazolamide, and ethoxzolamide.",
        "relation": "CPR:4"
    },
    {
        "id": "19119014.T1.T26",
        "sentence": "@CHEMICAL$ and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase (CA, @GENE$) with a very different profile as compared to classical inhibitors, such as acetazolamide, methazolamide, and ethoxzolamide.",
        "relation": "CPR:4"
    },
    {
        "id": "19119014.T7.T24",
        "sentence": "Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase (@CHEMICAL$, EC 4.2.1.1) with a very different profile as compared to classical inhibitors, such as @GENE$, methazolamide, and ethoxzolamide.",
        "relation": "CPR:4"
    },
    {
        "id": "19119014.T7.T36",
        "sentence": "Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of @CHEMICAL$ (CA, EC 4.2.1.1) with a very different profile as compared to classical inhibitors, such as @GENE$, methazolamide, and ethoxzolamide.",
        "relation": "CPR:4"
    },
    {
        "id": "19119014.T7.T26",
        "sentence": "Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase (CA, @CHEMICAL$) with a very different profile as compared to classical inhibitors, such as @GENE$, methazolamide, and ethoxzolamide.",
        "relation": "CPR:4"
    },
    {
        "id": "19119014.T8.T24",
        "sentence": "Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase (@CHEMICAL$, EC 4.2.1.1) with a very different profile as compared to classical inhibitors, such as acetazolamide, @GENE$, and ethoxzolamide.",
        "relation": "CPR:4"
    },
    {
        "id": "19119014.T8.T36",
        "sentence": "Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of @CHEMICAL$ (CA, EC 4.2.1.1) with a very different profile as compared to classical inhibitors, such as acetazolamide, @GENE$, and ethoxzolamide.",
        "relation": "CPR:4"
    },
    {
        "id": "19119014.T8.T26",
        "sentence": "Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase (CA, @CHEMICAL$) with a very different profile as compared to classical inhibitors, such as acetazolamide, @GENE$, and ethoxzolamide.",
        "relation": "CPR:4"
    },
    {
        "id": "19119014.T9.T24",
        "sentence": "Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase (@CHEMICAL$, EC 4.2.1.1) with a very different profile as compared to classical inhibitors, such as acetazolamide, methazolamide, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "19119014.T9.T36",
        "sentence": "Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of @CHEMICAL$ (CA, EC 4.2.1.1) with a very different profile as compared to classical inhibitors, such as acetazolamide, methazolamide, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "19119014.T9.T26",
        "sentence": "Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase (CA, @CHEMICAL$) with a very different profile as compared to classical inhibitors, such as acetazolamide, methazolamide, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "19119014.T10.T30",
        "sentence": "Some of these structurally related compounds have a very different behavior against the widespread isozyme CA II, with @CHEMICAL$, trichloromethiazide, and furosemide being efficient inhibitors against @GENE$ (K(I)s of 65-138 nM), whereas indapamide is a much weaker one (K(I) of 2520 nM).",
        "relation": "CPR:4"
    },
    {
        "id": "19119014.T11.T30",
        "sentence": "Some of these structurally related compounds have a very different behavior against the widespread isozyme CA II, with chlorthalidone, @CHEMICAL$, and furosemide being efficient inhibitors against @GENE$ (K(I)s of 65-138 nM), whereas indapamide is a much weaker one (K(I) of 2520 nM).",
        "relation": "CPR:4"
    },
    {
        "id": "19119014.T12.T30",
        "sentence": "Some of these structurally related compounds have a very different behavior against the widespread isozyme CA II, with chlorthalidone, trichloromethiazide, and @CHEMICAL$ being efficient inhibitors against @GENE$ (K(I)s of 65-138 nM), whereas indapamide is a much weaker one (K(I) of 2520 nM).",
        "relation": "CPR:4"
    },
    {
        "id": "19119014.T13.T30",
        "sentence": "Some of these structurally related compounds have a very different behavior against the widespread isozyme CA II, with chlorthalidone, trichloromethiazide, and furosemide being efficient inhibitors against @CHEMICAL$ (K(I)s of 65-138 nM), whereas @GENE$ is a much weaker one (K(I) of 2520 nM).",
        "relation": "CPR:4"
    },
    {
        "id": "19281809.T28.T38",
        "sentence": "@CHEMICAL$, a selective @GENE$ inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats.",
        "relation": "CPR:4"
    },
    {
        "id": "19281809.T25.T32",
        "sentence": "The low-affinity @CHEMICAL$ (SGLT2) is responsible for most of the @GENE$ reabsorption in the kidney and has been highlighted as a novel therapeutic target for the treatment of diabetes.",
        "relation": "CPR:9"
    },
    {
        "id": "19281809.T25.T35",
        "sentence": "The low-affinity sodium glucose cotransporter (@CHEMICAL$) is responsible for most of the @GENE$ reabsorption in the kidney and has been highlighted as a novel therapeutic target for the treatment of diabetes.",
        "relation": "CPR:9"
    },
    {
        "id": "19281809.T12.T33",
        "sentence": "We discovered @CHEMICAL$, a novel selective @GENE$ inhibitor, and found that selective inhibition of SGLT2 increased urinary glucose excretion and consequently decreased plasma glucose levels.",
        "relation": "CPR:4"
    },
    {
        "id": "19281809.T12.T34",
        "sentence": "We discovered @CHEMICAL$, a novel selective SGLT2 inhibitor, and found that selective inhibition of @GENE$ increased urinary glucose excretion and consequently decreased plasma glucose levels.",
        "relation": "CPR:4"
    },
    {
        "id": "19281809.T19.T36",
        "sentence": "In this report, we examined the antihyperglycemic effects of sergliflozin etabonate in normal and diabetic rats in comparison with those of a sulfonylurea (gliclazide) and an @CHEMICAL$ inhibitor (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "19281809.T6.T30",
        "sentence": "Chronic treatment with @CHEMICAL$ reduced the levels of @GENE$ and fasting plasma glucose, and improved the glycemic response after glucose loading in Zucker fatty rats.",
        "relation": "CPR:4"
    },
    {
        "id": "19293728.T2.T11",
        "sentence": "Although the D1-like receptor, by itself, had no effect on VSMC proliferation, stimulation with @CHEMICAL$, a @GENE$ agonist, inhibited the stimulatory effect of insulin.",
        "relation": "CPR:5"
    },
    {
        "id": "19293728.T2.T12",
        "sentence": "Although the D1-like receptor, by itself, had no effect on VSMC proliferation, stimulation with @CHEMICAL$, a D1-like receptor agonist, inhibited the stimulatory effect of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "19293728.T3.T13",
        "sentence": "The inhibitory effect of @CHEMICAL$ on @GENE$-mediated VSMC proliferation was receptor specific, because its effect could be blocked by SCH23390, a D1-like receptor antagonist.",
        "relation": "CPR:4"
    },
    {
        "id": "19293728.T4.T14",
        "sentence": "The inhibitory effect of fenoldopam on insulin-mediated VSMC proliferation was receptor specific, because its effect could be blocked by @CHEMICAL$, a @GENE$ antagonist.",
        "relation": "CPR:6"
    },
    {
        "id": "19293728.T5.T15",
        "sentence": "@CHEMICAL$ also inhibited @GENE$ mRNA and protein expression, which was time dependent and concentration dependent.",
        "relation": "CPR:4"
    },
    {
        "id": "19293728.T6.T18",
        "sentence": "A PKC or MAP kinase inhibitor blocked the inhibitory effect of @CHEMICAL$ on @GENE$ expression, indicating that PKC and MAP kinase were involved in the signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "19472276.T4.T11",
        "sentence": "The progress of the enzymatic reaction of the hydrolysis of @CHEMICAL$ at pH 8 in the presence of @GENE$ and the inhibitor studied is determined by measuring at 230 nm the peak area of the reaction product thiocholine (TCh).",
        "relation": "CPR:9"
    },
    {
        "id": "19651196.T17.T27",
        "sentence": "The mechanism of @CHEMICAL$ poisoning involves inhibition of @GENE$ (AChE) leading to inactivation of the enzyme which has an important role in neurotransmission.",
        "relation": "CPR:4"
    },
    {
        "id": "19651196.T17.T28",
        "sentence": "The mechanism of @CHEMICAL$ poisoning involves inhibition of acetylcholinesterase (@GENE$) leading to inactivation of the enzyme which has an important role in neurotransmission.",
        "relation": "CPR:4"
    },
    {
        "id": "19651196.T21.T30",
        "sentence": "They act by reactivation of @CHEMICAL$ inhibited by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "19651196.T10.T26",
        "sentence": "Presently, a combination of an antimuscarinic agent, e.g. atropine, @CHEMICAL$ reactivator such as one of the recommended pyridinium oximes (pralidoxime, @GENE$, obidoxime and HI-6) and diazepam are used for the treatment of OP poisoning in humans.",
        "relation": "CPR:3"
    },
    {
        "id": "19651196.T11.T26",
        "sentence": "Presently, a combination of an antimuscarinic agent, e.g. atropine, @CHEMICAL$ reactivator such as one of the recommended pyridinium oximes (pralidoxime, trimedoxime, @GENE$ and HI-6) and diazepam are used for the treatment of OP poisoning in humans.",
        "relation": "CPR:3"
    },
    {
        "id": "19651196.T12.T26",
        "sentence": "Presently, a combination of an antimuscarinic agent, e.g. atropine, @CHEMICAL$ reactivator such as one of the recommended pyridinium oximes (pralidoxime, trimedoxime, obidoxime and @GENE$) and diazepam are used for the treatment of OP poisoning in humans.",
        "relation": "CPR:3"
    },
    {
        "id": "19651196.T13.T26",
        "sentence": "Presently, a combination of an antimuscarinic agent, e.g. atropine, @CHEMICAL$ reactivator such as one of the recommended pyridinium oximes (pralidoxime, trimedoxime, obidoxime and HI-6) and @GENE$ are used for the treatment of OP poisoning in humans.",
        "relation": "CPR:3"
    },
    {
        "id": "19651196.T14.T26",
        "sentence": "Presently, a combination of an antimuscarinic agent, e.g. atropine, @CHEMICAL$ reactivator such as one of the recommended pyridinium oximes (pralidoxime, trimedoxime, obidoxime and HI-6) and diazepam are used for the treatment of @GENE$ poisoning in humans.",
        "relation": "CPR:4"
    },
    {
        "id": "19651196.T7.T26",
        "sentence": "Presently, a combination of an antimuscarinic agent, e.g. @CHEMICAL$, @GENE$ reactivator such as one of the recommended pyridinium oximes (pralidoxime, trimedoxime, obidoxime and HI-6) and diazepam are used for the treatment of OP poisoning in humans.",
        "relation": "CPR:3"
    },
    {
        "id": "19651196.T8.T26",
        "sentence": "Presently, a combination of an antimuscarinic agent, e.g. atropine, @CHEMICAL$ reactivator such as one of the recommended @GENE$ (pralidoxime, trimedoxime, obidoxime and HI-6) and diazepam are used for the treatment of OP poisoning in humans.",
        "relation": "CPR:3"
    },
    {
        "id": "19651196.T9.T26",
        "sentence": "Presently, a combination of an antimuscarinic agent, e.g. atropine, @CHEMICAL$ reactivator such as one of the recommended pyridinium oximes (@GENE$, trimedoxime, obidoxime and HI-6) and diazepam are used for the treatment of OP poisoning in humans.",
        "relation": "CPR:3"
    },
    {
        "id": "19852528.T1.T23",
        "sentence": "@CHEMICAL$ is a second-generation serotonin 5-HT3 receptor antagonist, with a distinct pharmacological profile that differs from first-generation @GENE$ antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "19852528.T1.T25",
        "sentence": "@CHEMICAL$ is a second-generation @GENE$ antagonist, with a distinct pharmacological profile that differs from first-generation 5-HT3 receptor antagonists.",
        "relation": "CPR:6"
    },
    {
        "id": "19852528.T12.T24",
        "sentence": "Oral @CHEMICAL$ is likely to be a useful addition to oral formulations of other @GENE$r antagonists in preventing CINV in patients receiving MEC.",
        "relation": "CPR:6"
    },
    {
        "id": "20053189.T5.T25",
        "sentence": "Luteinizing hormone-releasing hormone (LHRH) agonists, such as @CHEMICAL$, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of @GENE$ and testosterone levels.",
        "relation": "CPR:4"
    },
    {
        "id": "20053189.T5.T22",
        "sentence": "@CHEMICAL$ (LHRH) agonists, such as @GENE$, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.",
        "relation": "CPR:5"
    },
    {
        "id": "20053189.T5.T23",
        "sentence": "Luteinizing hormone-releasing hormone (@CHEMICAL$) agonists, such as @GENE$, goserelin, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.",
        "relation": "CPR:5"
    },
    {
        "id": "20053189.T5.T24",
        "sentence": "Luteinizing hormone-releasing hormone (LHRH) agonists, such as @CHEMICAL$, goserelin, leuprorelin and triptorelin, stimulate the pituitary's @GENE$, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.",
        "relation": "CPR:3"
    },
    {
        "id": "20053189.T6.T25",
        "sentence": "Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, @CHEMICAL$, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of @GENE$ and testosterone levels.",
        "relation": "CPR:4"
    },
    {
        "id": "20053189.T6.T22",
        "sentence": "@CHEMICAL$ (LHRH) agonists, such as buserelin, @GENE$, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.",
        "relation": "CPR:5"
    },
    {
        "id": "20053189.T6.T23",
        "sentence": "Luteinizing hormone-releasing hormone (@CHEMICAL$) agonists, such as buserelin, @GENE$, leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.",
        "relation": "CPR:5"
    },
    {
        "id": "20053189.T6.T24",
        "sentence": "Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, @CHEMICAL$, leuprorelin and triptorelin, stimulate the pituitary's @GENE$, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.",
        "relation": "CPR:3"
    },
    {
        "id": "20053189.T7.T25",
        "sentence": "Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, @CHEMICAL$ and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of @GENE$ and testosterone levels.",
        "relation": "CPR:4"
    },
    {
        "id": "20053189.T7.T22",
        "sentence": "@CHEMICAL$ (LHRH) agonists, such as buserelin, goserelin, @GENE$ and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.",
        "relation": "CPR:5"
    },
    {
        "id": "20053189.T7.T23",
        "sentence": "Luteinizing hormone-releasing hormone (@CHEMICAL$) agonists, such as buserelin, goserelin, @GENE$ and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.",
        "relation": "CPR:5"
    },
    {
        "id": "20053189.T7.T24",
        "sentence": "Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, @CHEMICAL$ and triptorelin, stimulate the pituitary's @GENE$, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.",
        "relation": "CPR:3"
    },
    {
        "id": "20053189.T8.T25",
        "sentence": "Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and @CHEMICAL$, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of @GENE$ and testosterone levels.",
        "relation": "CPR:4"
    },
    {
        "id": "20053189.T8.T22",
        "sentence": "@CHEMICAL$ (LHRH) agonists, such as buserelin, goserelin, leuprorelin and @GENE$, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.",
        "relation": "CPR:5"
    },
    {
        "id": "20053189.T8.T23",
        "sentence": "Luteinizing hormone-releasing hormone (@CHEMICAL$) agonists, such as buserelin, goserelin, leuprorelin and @GENE$, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.",
        "relation": "CPR:5"
    },
    {
        "id": "20053189.T8.T24",
        "sentence": "Luteinizing hormone-releasing hormone (LHRH) agonists, such as buserelin, goserelin, leuprorelin and @CHEMICAL$, stimulate the pituitary's @GENE$, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.",
        "relation": "CPR:3"
    },
    {
        "id": "20053189.T14.T27",
        "sentence": "Two pure @CHEMICAL$ antagonists have been developed, @GENE$ and degarelix, that are devoid of any agonist effect on the GnRH receptor and consequently do not result in testosterone flare.",
        "relation": "CPR:6"
    },
    {
        "id": "20053189.T15.T27",
        "sentence": "Two pure @CHEMICAL$ antagonists have been developed, abarelix and @GENE$, that are devoid of any agonist effect on the GnRH receptor and consequently do not result in testosterone flare.",
        "relation": "CPR:6"
    },
    {
        "id": "20053189.T18.T29",
        "sentence": "@CHEMICAL$ was the first @GENE$ antagonist to be developed and was approved by the USA Food and Drug Administration in 2004 for the initiation of hormonal castration in advanced or metastasizing hormone-dependent prostate carcinoma, when rapid androgen suppression is necessary.",
        "relation": "CPR:6"
    },
    {
        "id": "20151846.T8.T15",
        "sentence": "@CHEMICAL$, a pure @GENE$ downregulator, is a new addition to the antiestrogen therapeutic armamentarium since its FDA approval in 2002.",
        "relation": "CPR:4"
    },
    {
        "id": "2125244.T1.T8",
        "sentence": "The concentration of @CHEMICAL$ required to inhibit the assembly or to induce the disassembly of chick brain MAP2:@GENE$ microtubules is markedly dependent upon the microtubule protein concentration.",
        "relation": "CPR:4"
    },
    {
        "id": "2125244.T1.T8",
        "sentence": "The concentration of @CHEMICAL$ required to inhibit the assembly or to induce the disassembly of chick brain MAP2:@GENE$ microtubules is markedly dependent upon the microtubule protein concentration.",
        "relation": "CPR:3"
    },
    {
        "id": "2125244.T1.T7",
        "sentence": "The concentration of @CHEMICAL$ required to inhibit the assembly or to induce the disassembly of @GENE$:tubulin microtubules is markedly dependent upon the microtubule protein concentration.",
        "relation": "CPR:4"
    },
    {
        "id": "2125244.T1.T7",
        "sentence": "The concentration of @CHEMICAL$ required to inhibit the assembly or to induce the disassembly of @GENE$:tubulin microtubules is markedly dependent upon the microtubule protein concentration.",
        "relation": "CPR:3"
    },
    {
        "id": "2125244.T5.T14",
        "sentence": "It is proposed that two molecules of @CHEMICAL$ interact with each of the three tubulin-binding sites of MAP2 and inhibit the MAP2:@GENE$ interaction by neutralising two highly conserved basic residues.",
        "relation": "CPR:4"
    },
    {
        "id": "2125244.T5.T13",
        "sentence": "It is proposed that two molecules of @CHEMICAL$ interact with each of the three tubulin-binding sites of MAP2 and inhibit the @GENE$:tubulin interaction by neutralising two highly conserved basic residues.",
        "relation": "CPR:4"
    },
    {
        "id": "21606412.T7.T21",
        "sentence": "Activity of @CHEMICAL$ (Cabozantinib), an oral @GENE$ inhibitor, in patients with medullary thyroid cancer.",
        "relation": "CPR:4"
    },
    {
        "id": "21606412.T8.T21",
        "sentence": "Activity of XL184 (@CHEMICAL$), an oral @GENE$ inhibitor, in patients with medullary thyroid cancer.",
        "relation": "CPR:4"
    },
    {
        "id": "21606412.T3.T13",
        "sentence": "PURPOSE: XL184 (@CHEMICAL$) is a potent inhibitor of MET, vascular endothelial growth factor receptor 2 (@GENE$), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.",
        "relation": "CPR:4"
    },
    {
        "id": "21606412.T3.T14",
        "sentence": "PURPOSE: XL184 (@CHEMICAL$) is a potent inhibitor of MET, vascular endothelial growth factor receptor 2 (VEGFR2), and @GENE$, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.",
        "relation": "CPR:4"
    },
    {
        "id": "21606412.T3.T18",
        "sentence": "PURPOSE: XL184 (@CHEMICAL$) is a potent inhibitor of @GENE$, vascular endothelial growth factor receptor 2 (VEGFR2), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.",
        "relation": "CPR:4"
    },
    {
        "id": "21606412.T3.T19",
        "sentence": "PURPOSE: XL184 (@CHEMICAL$) is a potent inhibitor of MET, @GENE$ (VEGFR2), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.",
        "relation": "CPR:4"
    },
    {
        "id": "21606412.T6.T13",
        "sentence": "PURPOSE: @CHEMICAL$ (cabozantinib) is a potent inhibitor of MET, vascular endothelial growth factor receptor 2 (@GENE$), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.",
        "relation": "CPR:4"
    },
    {
        "id": "21606412.T6.T14",
        "sentence": "PURPOSE: @CHEMICAL$ (cabozantinib) is a potent inhibitor of MET, vascular endothelial growth factor receptor 2 (VEGFR2), and @GENE$, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.",
        "relation": "CPR:4"
    },
    {
        "id": "21606412.T6.T18",
        "sentence": "PURPOSE: @CHEMICAL$ (cabozantinib) is a potent inhibitor of @GENE$, vascular endothelial growth factor receptor 2 (VEGFR2), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.",
        "relation": "CPR:4"
    },
    {
        "id": "21606412.T6.T19",
        "sentence": "PURPOSE: @CHEMICAL$ (cabozantinib) is a potent inhibitor of MET, @GENE$ (VEGFR2), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.",
        "relation": "CPR:4"
    },
    {
        "id": "22370636.T3.T16",
        "sentence": "Further, we used this model to test the efficacy of @CHEMICAL$, a @GENE$ inhibitor, in clinical development, and showed that the tumors respond to PI3K inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "22370636.T3.T17",
        "sentence": "Further, we used this model to test the efficacy of @CHEMICAL$, a PI3K inhibitor, in clinical development, and showed that the tumors respond to @GENE$ inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "2268554.T18.T28",
        "sentence": "Inhibitory effect of synthetic @CHEMICAL$, 4-MA and cyanoketone on @GENE$ activity.",
        "relation": "CPR:4"
    },
    {
        "id": "2268554.T19.T28",
        "sentence": "Inhibitory effect of synthetic progestins, @CHEMICAL$ and cyanoketone on @GENE$ activity.",
        "relation": "CPR:4"
    },
    {
        "id": "2268554.T20.T28",
        "sentence": "Inhibitory effect of synthetic progestins, 4-MA and @CHEMICAL$ on @GENE$ activity.",
        "relation": "CPR:4"
    },
    {
        "id": "2268554.T1.T22",
        "sentence": "@CHEMICAL$ (3 beta-HSD) purified from human placenta transforms C-21 (@GENE$ and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "relation": "CPR:9"
    },
    {
        "id": "2268554.T1.T26",
        "sentence": "Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase (@CHEMICAL$) purified from human placenta transforms C-21 (@GENE$ and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "relation": "CPR:9"
    },
    {
        "id": "2268554.T2.T22",
        "sentence": "@CHEMICAL$ (3 beta-HSD) purified from human placenta transforms C-21 (pregnenolone and @GENE$) as well as C-19 (dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "relation": "CPR:9"
    },
    {
        "id": "2268554.T2.T26",
        "sentence": "Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase (@CHEMICAL$) purified from human placenta transforms C-21 (pregnenolone and @GENE$) as well as C-19 (dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "relation": "CPR:9"
    },
    {
        "id": "2268554.T4.T22",
        "sentence": "@CHEMICAL$ (3 beta-HSD) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 (@GENE$ and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "relation": "CPR:9"
    },
    {
        "id": "2268554.T4.T26",
        "sentence": "Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase (@CHEMICAL$) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 (@GENE$ and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "relation": "CPR:9"
    },
    {
        "id": "2268554.T5.T22",
        "sentence": "@CHEMICAL$ (3 beta-HSD) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and @GENE$) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "relation": "CPR:9"
    },
    {
        "id": "2268554.T5.T26",
        "sentence": "Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase (@CHEMICAL$) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and @GENE$) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "relation": "CPR:9"
    },
    {
        "id": "2268554.T6.T22",
        "sentence": "@CHEMICAL$ (3 beta-HSD) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding @GENE$ and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "relation": "CPR:9"
    },
    {
        "id": "2268554.T6.T26",
        "sentence": "Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase (@CHEMICAL$) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding @GENE$ and is thus involved in the biosynthesis of all classes of hormonal steroids.",
        "relation": "CPR:9"
    },
    {
        "id": "2268554.T10.T24",
        "sentence": "Trilostane, epostane and cyanoketone are potent inhibitors of 3 beta-HSD with Ki values of approximately 50 nM. @CHEMICAL$, a well known @GENE$ inhibitor, is also a potent inhibitor of 3 beta-HSD with a Ki value of 56 nM. Synthetic progestin compounds such as promegestone and RU2323 show relatively strong inhibitory effects with Ki values of 110 and 190 nM, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "2268554.T10.T25",
        "sentence": "Trilostane, epostane and cyanoketone are potent inhibitors of 3 beta-HSD with Ki values of approximately 50 nM. @CHEMICAL$, a well known 5 alpha-reductase inhibitor, is also a potent inhibitor of @GENE$ with a Ki value of 56 nM. Synthetic progestin compounds such as promegestone and RU2323 show relatively strong inhibitory effects with Ki values of 110 and 190 nM, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "2268554.T7.T23",
        "sentence": "@CHEMICAL$, epostane and cyanoketone are potent inhibitors of @GENE$ with Ki values of approximately 50 nM. 4-MA, a well known 5 alpha-reductase inhibitor, is also a potent inhibitor of 3 beta-HSD with a Ki value of 56 nM. Synthetic progestin compounds such as promegestone and RU2323 show relatively strong inhibitory effects with Ki values of 110 and 190 nM, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "2268554.T8.T23",
        "sentence": "Trilostane, @CHEMICAL$ and cyanoketone are potent inhibitors of @GENE$ with Ki values of approximately 50 nM. 4-MA, a well known 5 alpha-reductase inhibitor, is also a potent inhibitor of 3 beta-HSD with a Ki value of 56 nM. Synthetic progestin compounds such as promegestone and RU2323 show relatively strong inhibitory effects with Ki values of 110 and 190 nM, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "2268554.T9.T23",
        "sentence": "Trilostane, epostane and @CHEMICAL$ are potent inhibitors of @GENE$ with Ki values of approximately 50 nM. 4-MA, a well known 5 alpha-reductase inhibitor, is also a potent inhibitor of 3 beta-HSD with a Ki value of 56 nM. Synthetic progestin compounds such as promegestone and RU2323 show relatively strong inhibitory effects with Ki values of 110 and 190 nM, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "2268554.T14.T27",
        "sentence": "@CHEMICAL$, a progestin used in the treatment of hirsutism, acne and prostate cancer as well as norgestrel and norethindrone that are widely used as oral contraceptives also inhibit @GENE$ activity at Ki values of 1.5, 1.7 and 2.5 microM, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "2268554.T15.T27",
        "sentence": "Cyproterone acetate, a @CHEMICAL$ used in the treatment of hirsutism, acne and prostate cancer as well as norgestrel and norethindrone that are widely used as oral contraceptives also inhibit @GENE$ activity at Ki values of 1.5, 1.7 and 2.5 microM, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "2268554.T16.T27",
        "sentence": "Cyproterone acetate, a progestin used in the treatment of hirsutism, acne and prostate cancer as well as @CHEMICAL$ and norethindrone that are widely used as oral contraceptives also inhibit @GENE$ activity at Ki values of 1.5, 1.7 and 2.5 microM, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "2268554.T17.T27",
        "sentence": "Cyproterone acetate, a progestin used in the treatment of hirsutism, acne and prostate cancer as well as norgestrel and @CHEMICAL$ that are widely used as oral contraceptives also inhibit @GENE$ activity at Ki values of 1.5, 1.7 and 2.5 microM, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "22709946.T1.T9",
        "sentence": "However, chronic treatment of cLH rats with @CHEMICAL$ did not reverse learned helplessness, indicating that the enhanced @GENE$ function is not the only player in the behavioral phenotype of this genetic model of depression.",
        "relation": "CPR:3"
    },
    {
        "id": "22722028.T9.T16",
        "sentence": "Rescue of this impaired extinction consolidation/retrieval was achieved with d-cycloserine (N-methly-d-aspartate partial agonist) or @CHEMICAL$ (@GENE$ (HDAC) inhibitor), applied after extinction training.",
        "relation": "CPR:4"
    },
    {
        "id": "22722028.T9.T17",
        "sentence": "Rescue of this impaired extinction consolidation/retrieval was achieved with d-cycloserine (N-methly-d-aspartate partial agonist) or @CHEMICAL$ (histone deacetylase (@GENE$) inhibitor), applied after extinction training.",
        "relation": "CPR:4"
    },
    {
        "id": "22722028.T1.T10",
        "sentence": "Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of @CHEMICAL$ (a GABAergic enhancer and @GENE$ inhibitor) or AMN082 [metabotropic glutamate receptor 7 (mGlu7) agonist], while MS-275 or PEPA (AMPA receptor potentiator) failed to affect extinction acquisition in S1 mice.",
        "relation": "CPR:4"
    },
    {
        "id": "22722028.T2.T11",
        "sentence": "Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of valproic acid (a GABAergic enhancer and HDAC inhibitor) or @CHEMICAL$ [@GENE$ (mGlu7) agonist], while MS-275 or PEPA (AMPA receptor potentiator) failed to affect extinction acquisition in S1 mice.",
        "relation": "CPR:5"
    },
    {
        "id": "22722028.T2.T12",
        "sentence": "Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of valproic acid (a GABAergic enhancer and HDAC inhibitor) or @CHEMICAL$ [metabotropic glutamate receptor 7 (@GENE$) agonist], while MS-275 or PEPA (AMPA receptor potentiator) failed to affect extinction acquisition in S1 mice.",
        "relation": "CPR:5"
    },
    {
        "id": "22722028.T4.T13",
        "sentence": "Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of valproic acid (a GABAergic enhancer and HDAC inhibitor) or AMN082 [metabotropic glutamate receptor 7 (mGlu7) agonist], while @CHEMICAL$ or PEPA (@GENE$ potentiator) failed to affect extinction acquisition in S1 mice.",
        "relation": "CPR:3"
    },
    {
        "id": "22722028.T5.T13",
        "sentence": "Rescue of both impaired extinction acquisition and deficient extinction consolidation/retrieval was achieved with prior extinction training administration of valproic acid (a GABAergic enhancer and HDAC inhibitor) or AMN082 [metabotropic glutamate receptor 7 (mGlu7) agonist], while MS-275 or @CHEMICAL$ (@GENE$ potentiator) failed to affect extinction acquisition in S1 mice.",
        "relation": "CPR:3"
    },
    {
        "id": "22749926.T8.T11",
        "sentence": "Electroencephalographic recordings during substance consumption showed reduced alpha activity and @CHEMICAL$ latencies in the @GENE$ group compared to the control group.",
        "relation": "CPR:4"
    },
    {
        "id": "22749926.T2.T10",
        "sentence": "These findings suggest that oral consumption of @CHEMICAL$ enhances the efficacy of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "22956632.T5.T24",
        "sentence": "Toxicity profile of small-molecule @CHEMICAL$ antagonist @GENE$ is linked to TNF-a pharmacology.",
        "relation": "CPR:6"
    },
    {
        "id": "22956632.T2.T13",
        "sentence": "@CHEMICAL$ is a small-molecule drug that triggers tumor cell apoptosis by selectively antagonizing @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "22956632.T3.T14",
        "sentence": "@CHEMICAL$ induces @GENE$ transcriptional activity leading to expression of several chemokines and cytokines, of which tumor necrosis factor alpha (TNF-a) is the most important for single-agent tumor activity.",
        "relation": "CPR:3"
    },
    {
        "id": "22982218.T7.T23",
        "sentence": "The @CHEMICAL$ inhibitor @GENE$ modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines.",
        "relation": "CPR:4"
    },
    {
        "id": "22982218.T1.T9",
        "sentence": "Since PARP-1 is supposed to be part of a multimeric repressor of sodium iodide symporter (NIS) expression, in this study the effect of the @CHEMICAL$ inhibitor @GENE$ on several properties of thyroid cancer cell lines was investigated.",
        "relation": "CPR:4"
    },
    {
        "id": "22982218.T2.T10",
        "sentence": "In TPC1, BCPAP, FRO, WRO cell lines @CHEMICAL$ induced a strong increase in @GENE$ mRNA levels.",
        "relation": "CPR:3"
    },
    {
        "id": "22982218.T4.T11",
        "sentence": "Accordingly, in transfection experiments performed in TPC1 cells, treatment with @CHEMICAL$ increased @GENE$ activity without affecting PARP-1 binding to the promoter sequence.",
        "relation": "CPR:3"
    },
    {
        "id": "22982218.T5.T16",
        "sentence": "We also investigated the epigenetic status of NIS promoter after @CHEMICAL$ treatment in TPC1 cell line: in addition to an increase of @GENE$ (H3K9K14ac, H3K4me3), surprisingly we observed also an increase of H3K27me3, a classical repressive mark.",
        "relation": "CPR:3"
    },
    {
        "id": "22982218.T5.T17",
        "sentence": "We also investigated the epigenetic status of NIS promoter after @CHEMICAL$ treatment in TPC1 cell line: in addition to an increase of histone modification activation marks (@GENE$, H3K4me3), surprisingly we observed also an increase of H3K27me3, a classical repressive mark.",
        "relation": "CPR:3"
    },
    {
        "id": "22982218.T5.T18",
        "sentence": "We also investigated the epigenetic status of NIS promoter after @CHEMICAL$ treatment in TPC1 cell line: in addition to an increase of histone modification activation marks (H3K9K14ac, @GENE$), surprisingly we observed also an increase of H3K27me3, a classical repressive mark.",
        "relation": "CPR:3"
    },
    {
        "id": "22989703.T15.T24",
        "sentence": "Both @CHEMICAL$ also decreased CSE-induced ROS production, 8-OHdG formation and reduced the increase in @GENE$ and COX-2 expressions caused by CSE.",
        "relation": "CPR:4"
    },
    {
        "id": "22989703.T15.T25",
        "sentence": "Both @CHEMICAL$ also decreased CSE-induced ROS production, 8-OHdG formation and reduced the increase in NOX-4 and @GENE$ expressions caused by CSE.",
        "relation": "CPR:4"
    },
    {
        "id": "23000451.T3.T10",
        "sentence": "Recent studies, however, have demonstrated a promising potential treatment option with the help of the serum enzyme @CHEMICAL$ (BChE), which is capable of breaking down naturally occurring @GENE$ before the drug can influence the reward centers of the brain or affect other areas of the body.",
        "relation": "CPR:9"
    },
    {
        "id": "23000451.T3.T11",
        "sentence": "Recent studies, however, have demonstrated a promising potential treatment option with the help of the serum enzyme butyrylcholinesterase (@CHEMICAL$), which is capable of breaking down naturally occurring @GENE$ before the drug can influence the reward centers of the brain or affect other areas of the body.",
        "relation": "CPR:9"
    },
    {
        "id": "23000451.T4.T13",
        "sentence": "This prompted the design of variants of @CHEMICAL$ which exhibit significantly improved catalytic activity against @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23000451.T2.T8",
        "sentence": "Here, in expressing @CHEMICAL$-hydrolyzing mutants of @GENE$ in Nicotiana benthamiana using the MagnICON virus-assisted transient expression system, and in reporting their initial biochemical analysis, we provide proof-of-principle that plants can express engineered BChE proteins with desired properties.",
        "relation": "CPR:9"
    },
    {
        "id": "23008503.T5.T21",
        "sentence": "We examined in cats the 1) ulcerogenic effects of selective @CHEMICAL$ (@GENE$, ketorolac) and COX-2 (celecoxib, meloxicam) inhibitors on the gastrointestinal mucosa, 2) effect of feeding and cimetidine on the expression of COX isoforms and prostaglandin E(2) (PGE(2)) level in the duodenum, and 3) localization of COX isoforms in the duodenum.",
        "relation": "CPR:4"
    },
    {
        "id": "23008503.T6.T21",
        "sentence": "We examined in cats the 1) ulcerogenic effects of selective @CHEMICAL$ (SC-560, @GENE$) and COX-2 (celecoxib, meloxicam) inhibitors on the gastrointestinal mucosa, 2) effect of feeding and cimetidine on the expression of COX isoforms and prostaglandin E(2) (PGE(2)) level in the duodenum, and 3) localization of COX isoforms in the duodenum.",
        "relation": "CPR:4"
    },
    {
        "id": "23008503.T7.T22",
        "sentence": "We examined in cats the 1) ulcerogenic effects of selective COX-1 (SC-560, ketorolac) and @CHEMICAL$ (@GENE$, meloxicam) inhibitors on the gastrointestinal mucosa, 2) effect of feeding and cimetidine on the expression of COX isoforms and prostaglandin E(2) (PGE(2)) level in the duodenum, and 3) localization of COX isoforms in the duodenum.",
        "relation": "CPR:4"
    },
    {
        "id": "23008503.T8.T22",
        "sentence": "We examined in cats the 1) ulcerogenic effects of selective COX-1 (SC-560, ketorolac) and @CHEMICAL$ (celecoxib, @GENE$) inhibitors on the gastrointestinal mucosa, 2) effect of feeding and cimetidine on the expression of COX isoforms and prostaglandin E(2) (PGE(2)) level in the duodenum, and 3) localization of COX isoforms in the duodenum.",
        "relation": "CPR:4"
    },
    {
        "id": "23008503.T4.T14",
        "sentence": "Second, feeding increased both the expression of @CHEMICAL$ isoforms and PGE(2) level in the duodenum, and the effects were markedly inhibited by pretreatment with @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23019137.T10.T32",
        "sentence": "Reversal of inhibition by @CHEMICAL$ agonist quinpirole was produced by serotonin (50 mM) and by @GENE$ (5-10 nM).",
        "relation": "CPR:3"
    },
    {
        "id": "23019137.T8.T32",
        "sentence": "Reversal of inhibition by @CHEMICAL$ agonist @GENE$ was produced by serotonin (50 mM) and by neurotensin (5-10 nM).",
        "relation": "CPR:5"
    },
    {
        "id": "23019137.T9.T32",
        "sentence": "Reversal of inhibition by @CHEMICAL$ agonist quinpirole was produced by @GENE$ (50 mM) and by neurotensin (5-10 nM).",
        "relation": "CPR:3"
    },
    {
        "id": "23019137.T3.T13",
        "sentence": "Serotonin-induced or neurotensin-induced reversal was blocked by b-ARK1 inhibitor, dynasore, or @CHEMICAL$ antagonist @GENE$ (Go6976).",
        "relation": "CPR:6"
    },
    {
        "id": "23019137.T4.T13",
        "sentence": "Serotonin-induced or neurotensin-induced reversal was blocked by b-ARK1 inhibitor, dynasore, or @CHEMICAL$ antagonist 5,6,7,13-tetrahydro-13-methyl-5-oxo-12H-indolo[2,3-a]pyrrolo[3,4c]carbazole-12-propanenitrile (@GENE$).",
        "relation": "CPR:6"
    },
    {
        "id": "23042952.T8.T40",
        "sentence": "@CHEMICAL$ targets and activates the @GENE$; in turn, SIRT1 induces an intracellular antioxidative mechanism by inducing mitochondrial superoxide dismutase (SOD2).",
        "relation": "CPR:3"
    },
    {
        "id": "23042952.T8.T41",
        "sentence": "@CHEMICAL$ targets and activates the NAD(+)-dependent protein deacetylase SIRT1; in turn, @GENE$ induces an intracellular antioxidative mechanism by inducing mitochondrial superoxide dismutase (SOD2).",
        "relation": "CPR:3"
    },
    {
        "id": "23042952.T8.T42",
        "sentence": "@CHEMICAL$ targets and activates the NAD(+)-dependent protein deacetylase SIRT1; in turn, SIRT1 induces an intracellular antioxidative mechanism by inducing @GENE$ (SOD2).",
        "relation": "CPR:3"
    },
    {
        "id": "23042952.T8.T43",
        "sentence": "@CHEMICAL$ targets and activates the NAD(+)-dependent protein deacetylase SIRT1; in turn, SIRT1 induces an intracellular antioxidative mechanism by inducing mitochondrial superoxide dismutase (@GENE$).",
        "relation": "CPR:3"
    },
    {
        "id": "23042952.T35.T45",
        "sentence": "However, @CHEMICAL$, but not 3G-RSV, induced @GENE$-dependent histone H3 deacetylation and SOD2 expression in mouse C2C12 skeletal myoblasts; as with RSV, SIRT1 knockdown blunted these effects. RSV and 4'G-RSV, but not 3G-RSV, mitigated oxidative stress-induced cell death in C2C12 cells and primary neonatal rat cardiomyocytes. RSV and 4'G-RSV inhibited C2C12 cell proliferation, but 3G-RSV did not.",
        "relation": "CPR:3"
    },
    {
        "id": "23042952.T35.T47",
        "sentence": "However, @CHEMICAL$, but not 3G-RSV, induced SIRT1-dependent histone H3 deacetylation and @GENE$ expression in mouse C2C12 skeletal myoblasts; as with RSV, SIRT1 knockdown blunted these effects. RSV and 4'G-RSV, but not 3G-RSV, mitigated oxidative stress-induced cell death in C2C12 cells and primary neonatal rat cardiomyocytes. RSV and 4'G-RSV inhibited C2C12 cell proliferation, but 3G-RSV did not.",
        "relation": "CPR:3"
    },
    {
        "id": "23042953.T9.T15",
        "sentence": "Hydrophobic amino acids in the hinge region of the 5A apolipoprotein mimetic peptide are essential for promoting @CHEMICAL$ efflux by the @GENE$ transporter.",
        "relation": "CPR:9"
    },
    {
        "id": "23042953.T5.T12",
        "sentence": "The bihelical @CHEMICAL$ effluxes @GENE$ from cells and reduces inflammation and atherosclerosis in animal models.",
        "relation": "CPR:9"
    },
    {
        "id": "23042953.T7.T14",
        "sentence": "Compared with active peptides containing F or W, peptides containing E in either of these two positions were more than 10-fold less effective in effluxing @CHEMICAL$ by the @GENE$ transporter.",
        "relation": "CPR:9"
    },
    {
        "id": "23042953.T3.T13",
        "sentence": "These results provide a rationale for future design of therapeutic apolipoprotein mimetic peptides and provide new insights into the interaction of hydrophobic residues on apolipoproteins with phospholipids in the lipid microdomain created by the @CHEMICAL$ transporter during the @GENE$ efflux process.",
        "relation": "CPR:9"
    },
    {
        "id": "23042954.T13.T18",
        "sentence": "Efficacy of the GluK1/@CHEMICAL$ antagonist @GENE$ against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration.",
        "relation": "CPR:6"
    },
    {
        "id": "23042954.T13.T17",
        "sentence": "Efficacy of the @CHEMICAL$/AMPA receptor antagonist @GENE$ against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration.",
        "relation": "CPR:6"
    },
    {
        "id": "23042954.T10.T16",
        "sentence": "To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention, we studied the anticonvulsant efficacy of the GluK1 (GluR5)/@CHEMICAL$ antagonist @GENE$ (LY293558) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman.",
        "relation": "CPR:6"
    },
    {
        "id": "23042954.T10.T14",
        "sentence": "To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention, we studied the anticonvulsant efficacy of the @CHEMICAL$ (GluR5)/a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist @GENE$ (LY293558) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman.",
        "relation": "CPR:6"
    },
    {
        "id": "23042954.T10.T15",
        "sentence": "To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention, we studied the anticonvulsant efficacy of the GluK1 (@CHEMICAL$)/a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist @GENE$ (LY293558) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman.",
        "relation": "CPR:6"
    },
    {
        "id": "23042954.T11.T16",
        "sentence": "To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention, we studied the anticonvulsant efficacy of the GluK1 (GluR5)/@CHEMICAL$ antagonist (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid (@GENE$) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman.",
        "relation": "CPR:6"
    },
    {
        "id": "23042954.T11.T14",
        "sentence": "To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention, we studied the anticonvulsant efficacy of the @CHEMICAL$ (GluR5)/a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid (@GENE$) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman.",
        "relation": "CPR:6"
    },
    {
        "id": "23042954.T11.T15",
        "sentence": "To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention, we studied the anticonvulsant efficacy of the GluK1 (@CHEMICAL$)/a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid (@GENE$) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman.",
        "relation": "CPR:6"
    },
    {
        "id": "23047022.T1.T24",
        "sentence": "Although acetylcholinesterase (@CHEMICAL$) is primarily a hydrolytic enzyme, metabolising the neurotransmitter @GENE$ in cholinergic synapses, it also has some non-catalytic functions in the brain which are far less well characterised.",
        "relation": "CPR:9"
    },
    {
        "id": "23047022.T1.T36",
        "sentence": "Although @CHEMICAL$ (AChE) is primarily a hydrolytic enzyme, metabolising the neurotransmitter @GENE$ in cholinergic synapses, it also has some non-catalytic functions in the brain which are far less well characterised.",
        "relation": "CPR:9"
    },
    {
        "id": "23047022.T10.T18",
        "sentence": "Cellular release of AChE by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (mAChR) agonists carbachol or muscarine, with the effect of carbachol blocked by the @CHEMICAL$ antagonist @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "23047022.T10.T15",
        "sentence": "Cellular release of @CHEMICAL$ by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (mAChR) agonists carbachol or muscarine, with the effect of carbachol blocked by the mAChR antagonist @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23047022.T7.T16",
        "sentence": "Cellular release of AChE by SH-SY5Y is significantly enhanced by the @CHEMICAL$ (mAChR) agonists @GENE$ or muscarine, with the effect of carbachol blocked by the mAChR antagonist atropine.",
        "relation": "CPR:5"
    },
    {
        "id": "23047022.T7.T17",
        "sentence": "Cellular release of AChE by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (@CHEMICAL$) agonists @GENE$ or muscarine, with the effect of carbachol blocked by the mAChR antagonist atropine.",
        "relation": "CPR:5"
    },
    {
        "id": "23047022.T7.T15",
        "sentence": "Cellular release of @CHEMICAL$ by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (mAChR) agonists @GENE$ or muscarine, with the effect of carbachol blocked by the mAChR antagonist atropine.",
        "relation": "CPR:3"
    },
    {
        "id": "23047022.T8.T16",
        "sentence": "Cellular release of AChE by SH-SY5Y is significantly enhanced by the @CHEMICAL$ (mAChR) agonists carbachol or @GENE$, with the effect of carbachol blocked by the mAChR antagonist atropine.",
        "relation": "CPR:5"
    },
    {
        "id": "23047022.T8.T17",
        "sentence": "Cellular release of AChE by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (@CHEMICAL$) agonists carbachol or @GENE$, with the effect of carbachol blocked by the mAChR antagonist atropine.",
        "relation": "CPR:5"
    },
    {
        "id": "23047022.T8.T15",
        "sentence": "Cellular release of @CHEMICAL$ by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (mAChR) agonists carbachol or @GENE$, with the effect of carbachol blocked by the mAChR antagonist atropine.",
        "relation": "CPR:3"
    },
    {
        "id": "23047022.T9.T15",
        "sentence": "Cellular release of @CHEMICAL$ by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (mAChR) agonists carbachol or muscarine, with the effect of @GENE$ blocked by the mAChR antagonist atropine.",
        "relation": "CPR:3"
    },
    {
        "id": "23047912.T16.T21",
        "sentence": "@CHEMICAL$ induced ER stress and enhanced @GENE$ cleavage in human neuroblastoma SH-SY5Y cells at low nonexcitotoxic concentrations.",
        "relation": "CPR:3"
    },
    {
        "id": "23047912.T15.T17",
        "sentence": "Nevertheless, low @CHEMICAL$ concentrations (> 0.1mM, 48 h) increased protein ubiquitination, @GENE$ and caspase 12 activity, expression of the endoplasmic reticulum (ER) stress marker CHOP, and enhanced phosphorylation of elf2a in SH-SY5Y cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23047912.T15.T18",
        "sentence": "Nevertheless, low @CHEMICAL$ concentrations (> 0.1mM, 48 h) increased protein ubiquitination, 20S proteasomal and @GENE$ activity, expression of the endoplasmic reticulum (ER) stress marker CHOP, and enhanced phosphorylation of elf2a in SH-SY5Y cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23047912.T15.T19",
        "sentence": "Nevertheless, low @CHEMICAL$ concentrations (> 0.1mM, 48 h) increased protein ubiquitination, 20S proteasomal and caspase 12 activity, expression of the endoplasmic reticulum (ER) stress marker @GENE$, and enhanced phosphorylation of elf2a in SH-SY5Y cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23047912.T15.T20",
        "sentence": "Nevertheless, low @CHEMICAL$ concentrations (> 0.1mM, 48 h) increased protein ubiquitination, 20S proteasomal and caspase 12 activity, expression of the endoplasmic reticulum (ER) stress marker CHOP, and enhanced phosphorylation of @GENE$ in SH-SY5Y cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T17.T47",
        "sentence": "@CHEMICAL$-induced intracellular GTP depletion activates transcription elongation in @GENE$ gene expression.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T6.T28",
        "sentence": "It was reported previously that @CHEMICAL$ gene (F7) expression was up-regulated by @GENE$ treatment in hepatitis C virus-infected haemophilia patients; however, its precise mechanism is still unknown.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T6.T34",
        "sentence": "It was reported previously that FVII gene (@CHEMICAL$) expression was up-regulated by @GENE$ treatment in hepatitis C virus-infected haemophilia patients; however, its precise mechanism is still unknown.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T8.T37",
        "sentence": "In the present study, we investigated the molecular mechanism of @CHEMICAL$-induced up-regulation of @GENE$ expression in HepG2 (human hepatoma cell line).",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T12.T40",
        "sentence": "We found that intracellular GTP depletion by ribavirin as well as other IMPDH (inosine-5'-monophosphate dehydrogenase) inhibitors, such as @CHEMICAL$ and 6-mercaptopurine, up-regulated @GENE$ expression.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T13.T40",
        "sentence": "We found that intracellular GTP depletion by ribavirin as well as other IMPDH (inosine-5'-monophosphate dehydrogenase) inhibitors, such as mycophenolic acid and @CHEMICAL$, up-regulated @GENE$ expression.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T14.T44",
        "sentence": "@CHEMICAL$ unregulated @GENE$ (eleven-nineteen lysine-rich leukaemia) 3 mRNA expression before F7 up-regulation.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T14.T45",
        "sentence": "@CHEMICAL$ unregulated ELL (@GENE$ mRNA expression before F7 up-regulation.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T14.T46",
        "sentence": "@CHEMICAL$ unregulated ELL (eleven-nineteen lysine-rich leukaemia) 3 mRNA expression before @GENE$ up-regulation.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T16.T20",
        "sentence": "We observed that @CHEMICAL$ enhanced @GENE$ recruitment to F7, whereas knockdown of ELL3 diminished ribavirin-induced FVII mRNA up-regulation.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T16.T21",
        "sentence": "We observed that @CHEMICAL$ enhanced ELL3 recruitment to @GENE$, whereas knockdown of ELL3 diminished ribavirin-induced FVII mRNA up-regulation.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T1.T23",
        "sentence": "We observed that ribavirin enhanced ELL3 recruitment to F7, whereas knockdown of ELL3 diminished @CHEMICAL$-induced @GENE$ mRNA up-regulation.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T2.T24",
        "sentence": "@CHEMICAL$ also enhanced recruitment of @GENE$ (cyclin-dependent kinase 9) and AFF4 to F7.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T2.T25",
        "sentence": "@CHEMICAL$ also enhanced recruitment of CDK9 (@GENE$) and AFF4 to F7.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T2.T26",
        "sentence": "@CHEMICAL$ also enhanced recruitment of CDK9 (cyclin-dependent kinase 9) and @GENE$ to F7.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T2.T27",
        "sentence": "@CHEMICAL$ also enhanced recruitment of CDK9 (cyclin-dependent kinase 9) and AFF4 to @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T3.T29",
        "sentence": "These data suggest that @CHEMICAL$-induced intracellular GTP depletion recruits a super elongation complex containing @GENE$, AFF4 and ELL3, to F7, and modulates FVII mRNA transcription elongation.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T3.T30",
        "sentence": "These data suggest that @CHEMICAL$-induced intracellular GTP depletion recruits a super elongation complex containing P-TEFb, @GENE$ and ELL3, to F7, and modulates FVII mRNA transcription elongation.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T3.T31",
        "sentence": "These data suggest that @CHEMICAL$-induced intracellular GTP depletion recruits a super elongation complex containing P-TEFb, AFF4 and @GENE$, to F7, and modulates FVII mRNA transcription elongation.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T3.T32",
        "sentence": "These data suggest that @CHEMICAL$-induced intracellular GTP depletion recruits a super elongation complex containing P-TEFb, AFF4 and ELL3, to @GENE$, and modulates FVII mRNA transcription elongation.",
        "relation": "CPR:3"
    },
    {
        "id": "23050902.T5.T35",
        "sentence": "Collectively, we have elucidated a basal mechanism for @CHEMICAL$-induced @GENE$ mRNA up-regulation by acceleration of transcription elongation, which may be crucial in understanding its pleiotropic functions in vivo.",
        "relation": "CPR:3"
    },
    {
        "id": "23066089.T2.T47",
        "sentence": "The potentiation of heteromeric @CHEMICAL$ by mGlu1 activation was attenuated by GDPbS, blocked by an inhibitor of phospholipase C or the calcium chelator @GENE$ (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A. Protein kinase C (PKC) inhibition reduced the potentiation by mGlu1 of GluK2/GluK5, and conversely, direct activation of PKC by phorbol 12-myristate,13-acetate potentiated GluK2/GluK5.",
        "relation": "CPR:4"
    },
    {
        "id": "23066089.T2.T48",
        "sentence": "The potentiation of heteromeric KARs by @CHEMICAL$ activation was attenuated by GDPbS, blocked by an inhibitor of phospholipase C or the calcium chelator @GENE$ (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A. Protein kinase C (PKC) inhibition reduced the potentiation by mGlu1 of GluK2/GluK5, and conversely, direct activation of PKC by phorbol 12-myristate,13-acetate potentiated GluK2/GluK5.",
        "relation": "CPR:4"
    },
    {
        "id": "23066089.T3.T47",
        "sentence": "The potentiation of heteromeric @CHEMICAL$ by mGlu1 activation was attenuated by GDPbS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (@GENE$), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A. Protein kinase C (PKC) inhibition reduced the potentiation by mGlu1 of GluK2/GluK5, and conversely, direct activation of PKC by phorbol 12-myristate,13-acetate potentiated GluK2/GluK5.",
        "relation": "CPR:4"
    },
    {
        "id": "23066089.T3.T48",
        "sentence": "The potentiation of heteromeric KARs by @CHEMICAL$ activation was attenuated by GDPbS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (@GENE$), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A. Protein kinase C (PKC) inhibition reduced the potentiation by mGlu1 of GluK2/GluK5, and conversely, direct activation of PKC by phorbol 12-myristate,13-acetate potentiated GluK2/GluK5.",
        "relation": "CPR:4"
    },
    {
        "id": "23066089.T4.T21",
        "sentence": "The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDPbS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the @CHEMICAL$ inhibitor @GENE$, but unaffected by the tyrosine kinase inhibitor lavendustin A. Protein kinase C (PKC) inhibition reduced the potentiation by mGlu1 of GluK2/GluK5, and conversely, direct activation of PKC by phorbol 12-myristate,13-acetate potentiated GluK2/GluK5.",
        "relation": "CPR:4"
    },
    {
        "id": "23066089.T4.T47",
        "sentence": "The potentiation of heteromeric @CHEMICAL$ by mGlu1 activation was attenuated by GDPbS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor @GENE$, but unaffected by the tyrosine kinase inhibitor lavendustin A. Protein kinase C (PKC) inhibition reduced the potentiation by mGlu1 of GluK2/GluK5, and conversely, direct activation of PKC by phorbol 12-myristate,13-acetate potentiated GluK2/GluK5.",
        "relation": "CPR:4"
    },
    {
        "id": "23066089.T4.T48",
        "sentence": "The potentiation of heteromeric KARs by @CHEMICAL$ activation was attenuated by GDPbS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor @GENE$, but unaffected by the tyrosine kinase inhibitor lavendustin A. Protein kinase C (PKC) inhibition reduced the potentiation by mGlu1 of GluK2/GluK5, and conversely, direct activation of PKC by phorbol 12-myristate,13-acetate potentiated GluK2/GluK5.",
        "relation": "CPR:4"
    },
    {
        "id": "23066089.T6.T22",
        "sentence": "The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDPbS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the @CHEMICAL$ inhibitor @GENE$. Protein kinase C (PKC) inhibition reduced the potentiation by mGlu1 of GluK2/GluK5, and conversely, direct activation of PKC by phorbol 12-myristate,13-acetate potentiated GluK2/GluK5.",
        "relation": "CPR:4"
    },
    {
        "id": "23066089.T6.T47",
        "sentence": "The potentiation of heteromeric @CHEMICAL$ by mGlu1 activation was attenuated by GDPbS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor @GENE$. Protein kinase C (PKC) inhibition reduced the potentiation by mGlu1 of GluK2/GluK5, and conversely, direct activation of PKC by phorbol 12-myristate,13-acetate potentiated GluK2/GluK5.",
        "relation": "CPR:4"
    },
    {
        "id": "23066089.T6.T48",
        "sentence": "The potentiation of heteromeric KARs by @CHEMICAL$ activation was attenuated by GDPbS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor @GENE$. Protein kinase C (PKC) inhibition reduced the potentiation by mGlu1 of GluK2/GluK5, and conversely, direct activation of PKC by phorbol 12-myristate,13-acetate potentiated GluK2/GluK5.",
        "relation": "CPR:4"
    },
    {
        "id": "23066089.T7.T28",
        "sentence": "The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDPbS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A. Protein kinase C (PKC) inhibition reduced the potentiation by mGlu1 of GluK2/GluK5, and conversely, direct activation of @CHEMICAL$ by @GENE$ potentiated GluK2/GluK5.",
        "relation": "CPR:3"
    },
    {
        "id": "23066089.T7.T29",
        "sentence": "The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDPbS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A. Protein kinase C (PKC) inhibition reduced the potentiation by mGlu1 of GluK2/GluK5, and conversely, direct activation of PKC by @CHEMICAL$ potentiated @GENE$/GluK5.",
        "relation": "CPR:3"
    },
    {
        "id": "23066089.T7.T30",
        "sentence": "The potentiation of heteromeric KARs by mGlu1 activation was attenuated by GDPbS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A. Protein kinase C (PKC) inhibition reduced the potentiation by mGlu1 of GluK2/GluK5, and conversely, direct activation of PKC by @CHEMICAL$ potentiated GluK2/@GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23073075.T1.T27",
        "sentence": "@CHEMICAL$ (FTY720), a novel drug approved for the treatment of relapsing-remitting multiple sclerosis, activates different @GENE$ (S1PR) subtypes.",
        "relation": "CPR:3"
    },
    {
        "id": "23073075.T1.T28",
        "sentence": "@CHEMICAL$ (FTY720), a novel drug approved for the treatment of relapsing-remitting multiple sclerosis, activates different sphingosine-1-phosphate receptor (@GENE$) subtypes.",
        "relation": "CPR:3"
    },
    {
        "id": "23073075.T6.T27",
        "sentence": "Fingolimod (@CHEMICAL$), a novel drug approved for the treatment of relapsing-remitting multiple sclerosis, activates different @GENE$ (S1PR) subtypes.",
        "relation": "CPR:3"
    },
    {
        "id": "23073075.T6.T28",
        "sentence": "Fingolimod (@CHEMICAL$), a novel drug approved for the treatment of relapsing-remitting multiple sclerosis, activates different sphingosine-1-phosphate receptor (@GENE$) subtypes.",
        "relation": "CPR:3"
    },
    {
        "id": "23073075.T2.T21",
        "sentence": "Neuroprotection was attenuated by pertussis toxin, and inhibited by the selective @CHEMICAL$ (S1P1R) antagonist, @GENE$, and by inhibitors of the mitogen associated protein kinase (MAPK) and the phosphatidylinositol-3-kinase (PtdIns-3-K) pathways.",
        "relation": "CPR:6"
    },
    {
        "id": "23073075.T2.T22",
        "sentence": "Neuroprotection was attenuated by pertussis toxin, and inhibited by the selective type-1 S1PR (@CHEMICAL$) antagonist, @GENE$, and by inhibitors of the mitogen associated protein kinase (MAPK) and the phosphatidylinositol-3-kinase (PtdIns-3-K) pathways.",
        "relation": "CPR:6"
    },
    {
        "id": "23075005.T9.T19",
        "sentence": "Pharmacokinetics and metabolism of @CHEMICAL$, a novel @GENE$ inhibitor, in humans.",
        "relation": "CPR:4"
    },
    {
        "id": "23075005.T4.T18",
        "sentence": "The disposition of @CHEMICAL$, an orally active, highly selective @GENE$ inhibitor, was investigated after a single oral dose of 100 mg/1.92 MBq [(14)C]anagliptin to six healthy men.",
        "relation": "CPR:4"
    },
    {
        "id": "23075005.T2.T10",
        "sentence": "Renal clearance of unbound anagliptin and unbound M1 far exceeded glomerular filtration rate, indicating active renal elimination: that might reflect the fact that @CHEMICAL$ may be a substrate of @GENE$, OAT3, MDR1 and MRP2, and M1 a substrate of OAT3, BCRP, MRP2 and MRP4.",
        "relation": "CPR:9"
    },
    {
        "id": "23075005.T2.T11",
        "sentence": "Renal clearance of unbound anagliptin and unbound M1 far exceeded glomerular filtration rate, indicating active renal elimination: that might reflect the fact that @CHEMICAL$ may be a substrate of OAT1, @GENE$, MDR1 and MRP2, and M1 a substrate of OAT3, BCRP, MRP2 and MRP4.",
        "relation": "CPR:9"
    },
    {
        "id": "23075005.T2.T12",
        "sentence": "Renal clearance of unbound anagliptin and unbound M1 far exceeded glomerular filtration rate, indicating active renal elimination: that might reflect the fact that @CHEMICAL$ may be a substrate of OAT1, OAT3, @GENE$ and MRP2, and M1 a substrate of OAT3, BCRP, MRP2 and MRP4.",
        "relation": "CPR:9"
    },
    {
        "id": "23075005.T2.T13",
        "sentence": "Renal clearance of unbound anagliptin and unbound M1 far exceeded glomerular filtration rate, indicating active renal elimination: that might reflect the fact that @CHEMICAL$ may be a substrate of OAT1, OAT3, MDR1 and @GENE$, and M1 a substrate of OAT3, BCRP, MRP2 and MRP4.",
        "relation": "CPR:9"
    },
    {
        "id": "23091188.T21.T51",
        "sentence": "Antiretroviral @CHEMICAL$ inhibitors @GENE$ (LPV) and ritonavir (RTV) are reported BSEP inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23091188.T21.T53",
        "sentence": "Antiretroviral protease inhibitors @CHEMICAL$ (LPV) and ritonavir (RTV) are reported @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23091188.T22.T51",
        "sentence": "Antiretroviral @CHEMICAL$ inhibitors lopinavir (@GENE$) and ritonavir (RTV) are reported BSEP inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23091188.T22.T53",
        "sentence": "Antiretroviral protease inhibitors lopinavir (@CHEMICAL$) and ritonavir (RTV) are reported @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23091188.T23.T51",
        "sentence": "Antiretroviral @CHEMICAL$ inhibitors lopinavir (LPV) and @GENE$ (RTV) are reported BSEP inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23091188.T23.T53",
        "sentence": "Antiretroviral protease inhibitors lopinavir (LPV) and @CHEMICAL$ (RTV) are reported @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23091188.T24.T51",
        "sentence": "Antiretroviral @CHEMICAL$ inhibitors lopinavir (LPV) and ritonavir (@GENE$) are reported BSEP inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23091188.T24.T53",
        "sentence": "Antiretroviral protease inhibitors lopinavir (LPV) and ritonavir (@CHEMICAL$) are reported @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23099431.T1.T10",
        "sentence": "@CHEMICAL$ is a @GENE$ secretagogue that also enhances tissue viability in different organs.",
        "relation": "CPR:3"
    },
    {
        "id": "23102509.T13.T29",
        "sentence": "The altered activities of key enzymes such as @CHEMICAL$ and fructose-1,6-bisphosphatase of @GENE$ metabolism significantly (p<0.05) increased whereas hexokinase, pyruvate kinase, glucose-6-phosphate dehydrogenase and glycogen content significantly (p<0.05) decreased in the liver of diabetic rats and also increased activities of aspartate transaminase (AST), alanine transaminase (ALT) and alkaline phosphatase (ALP).",
        "relation": "CPR:9"
    },
    {
        "id": "23102509.T13.T30",
        "sentence": "The altered activities of key enzymes such as glucose-6-phosphatase and @CHEMICAL$ of @GENE$ metabolism significantly (p<0.05) increased whereas hexokinase, pyruvate kinase, glucose-6-phosphate dehydrogenase and glycogen content significantly (p<0.05) decreased in the liver of diabetic rats and also increased activities of aspartate transaminase (AST), alanine transaminase (ALT) and alkaline phosphatase (ALP).",
        "relation": "CPR:9"
    },
    {
        "id": "23103563.T11.T25",
        "sentence": "@CHEMICAL$ increases the expression of the pro-apoptotic gene @GENE$ by epigenetic mechanisms in tumor cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23103563.T8.T24",
        "sentence": "Further we found stimulation of FAS-expression as a result of epigenetic DNA demethylation that was due to down-regulation of @CHEMICAL$, which was rescued by re-isoprenylation by both @GENE$ and farnesylpyrophosphate.",
        "relation": "CPR:3"
    },
    {
        "id": "23103563.T9.T24",
        "sentence": "Further we found stimulation of FAS-expression as a result of epigenetic DNA demethylation that was due to down-regulation of @CHEMICAL$, which was rescued by re-isoprenylation by both geranylgeranyl-pyrophosphate and @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23103563.T1.T16",
        "sentence": "Data suggest that @CHEMICAL$ via modulation of the activity of small-GTPases induce apoptosis in neoplastic cells by DNA-CpG-demethylation and stimulation of @GENE$-expression.",
        "relation": "CPR:3"
    },
    {
        "id": "23117151.T7.T24",
        "sentence": "The AhR target gene @CHEMICAL$ mRNA expression was induced by @GENE$, but was not affected by the AR CAG length.",
        "relation": "CPR:3"
    },
    {
        "id": "23117151.T9.T28",
        "sentence": "TCDD had no effect on AR activity in PC-3 cells, whereas the shortest @CHEMICAL$ variant was induced by @GENE$ in PNT1A cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23123257.T1.T6",
        "sentence": "Systemic injection to mice of siRNA lipoplexes, rather than of cationic liposome, triggered a production of several cytokines in mice and replacement of plasmid by @CHEMICAL$ reduced the elevation of all assayed @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23123298.T6.T17",
        "sentence": "We found that @CHEMICAL$ markedly induced endoplasmic reticulum (ER) stress-related genes, such as @GENE$, activating transcription factor-4 (ATF4) and/or the CCAAT enhancer-binding protein-homologous protein (CHOP).",
        "relation": "CPR:3"
    },
    {
        "id": "23123298.T6.T18",
        "sentence": "We found that @CHEMICAL$ markedly induced endoplasmic reticulum (ER) stress-related genes, such as regulated in development and DNA damage responses (REDD) 1, @GENE$ (ATF4) and/or the CCAAT enhancer-binding protein-homologous protein (CHOP).",
        "relation": "CPR:3"
    },
    {
        "id": "23123298.T6.T19",
        "sentence": "We found that @CHEMICAL$ markedly induced endoplasmic reticulum (ER) stress-related genes, such as regulated in development and DNA damage responses (REDD) 1, activating transcription factor-4 (@GENE$) and/or the CCAAT enhancer-binding protein-homologous protein (CHOP).",
        "relation": "CPR:3"
    },
    {
        "id": "23123298.T6.T20",
        "sentence": "We found that @CHEMICAL$ markedly induced endoplasmic reticulum (ER) stress-related genes, such as regulated in development and DNA damage responses (REDD) 1, activating transcription factor-4 (ATF4) and/or the @GENE$ (CHOP).",
        "relation": "CPR:3"
    },
    {
        "id": "23123298.T6.T21",
        "sentence": "We found that @CHEMICAL$ markedly induced endoplasmic reticulum (ER) stress-related genes, such as regulated in development and DNA damage responses (REDD) 1, activating transcription factor-4 (ATF4) and/or the CCAAT enhancer-binding protein-homologous protein (@GENE$).",
        "relation": "CPR:3"
    },
    {
        "id": "23123662.T28.T43",
        "sentence": "Contributions of @CHEMICAL$ to the uptake and toxicity of @GENE$ and platinum anticancer drugs in dorsal root ganglion neurons.",
        "relation": "CPR:9"
    },
    {
        "id": "23123662.T29.T43",
        "sentence": "Contributions of @CHEMICAL$ to the uptake and toxicity of copper and @GENE$ anticancer drugs in dorsal root ganglion neurons.",
        "relation": "CPR:9"
    },
    {
        "id": "23123662.T20.T39",
        "sentence": "Heterologous expression of @CHEMICAL$ in HEK293 cells (HEK/rCtr1 cells) increased the uptake and cytotoxicity of @GENE$, oxaliplatin, cisplatin and carboplatin, in comparison to isogenic vector-transfected control cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23123662.T20.T40",
        "sentence": "Heterologous expression of rCtr1 in HEK293 cells (HEK/@CHEMICAL$ cells) increased the uptake and cytotoxicity of @GENE$, oxaliplatin, cisplatin and carboplatin, in comparison to isogenic vector-transfected control cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23123662.T21.T39",
        "sentence": "Heterologous expression of @CHEMICAL$ in HEK293 cells (HEK/rCtr1 cells) increased the uptake and cytotoxicity of copper, @GENE$, cisplatin and carboplatin, in comparison to isogenic vector-transfected control cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23123662.T21.T40",
        "sentence": "Heterologous expression of rCtr1 in HEK293 cells (HEK/@CHEMICAL$ cells) increased the uptake and cytotoxicity of copper, @GENE$, cisplatin and carboplatin, in comparison to isogenic vector-transfected control cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23123662.T22.T39",
        "sentence": "Heterologous expression of @CHEMICAL$ in HEK293 cells (HEK/rCtr1 cells) increased the uptake and cytotoxicity of copper, oxaliplatin, @GENE$ and carboplatin, in comparison to isogenic vector-transfected control cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23123662.T22.T40",
        "sentence": "Heterologous expression of rCtr1 in HEK293 cells (HEK/@CHEMICAL$ cells) increased the uptake and cytotoxicity of copper, oxaliplatin, @GENE$ and carboplatin, in comparison to isogenic vector-transfected control cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23123662.T23.T39",
        "sentence": "Heterologous expression of @CHEMICAL$ in HEK293 cells (HEK/rCtr1 cells) increased the uptake and cytotoxicity of copper, oxaliplatin, cisplatin and @GENE$, in comparison to isogenic vector-transfected control cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23123662.T23.T40",
        "sentence": "Heterologous expression of rCtr1 in HEK293 cells (HEK/@CHEMICAL$ cells) increased the uptake and cytotoxicity of copper, oxaliplatin, cisplatin and @GENE$, in comparison to isogenic vector-transfected control cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23123662.T24.T41",
        "sentence": "Cultured rat DRG neurons endogenously expressed @CHEMICAL$ protein on their neuronal cell body plasma membranes and cytoplasm, and displayed substantial capacity for taking up @GENE$, but were resistant to copper toxicity.",
        "relation": "CPR:9"
    },
    {
        "id": "23123662.T26.T42",
        "sentence": "The uptake of @CHEMICAL$ by both cultured rat DRG neurons and HEK/@GENE$ cells was saturable and inhibited by cold temperature, silver and zinc, consistent with it being mediated by rCtr1.",
        "relation": "CPR:9"
    },
    {
        "id": "23123662.T10.T33",
        "sentence": "In conclusion, @CHEMICAL$ can transport copper and @GENE$ drugs, and sensitizes cells to their cytotoxicities.",
        "relation": "CPR:9"
    },
    {
        "id": "23123662.T9.T33",
        "sentence": "In conclusion, @CHEMICAL$ can transport @GENE$ and platinum drugs, and sensitizes cells to their cytotoxicities.",
        "relation": "CPR:9"
    },
    {
        "id": "23123662.T11.T34",
        "sentence": "DRG neurons display substantial capacity for accumulating @CHEMICAL$ via a transport process mediated by @GENE$, but appear able to resist copper toxicity and use alternative mechanisms to take up oxaliplatin.",
        "relation": "CPR:9"
    },
    {
        "id": "23123662.T13.T34",
        "sentence": "DRG neurons display substantial capacity for accumulating copper via a transport process mediated by @CHEMICAL$, but appear able to resist copper toxicity and use alternative mechanisms to take up @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23128353.T8.T19",
        "sentence": "Examination of phosphorylation in @CHEMICAL$, we found an inhibitory effect by @GENE$ at 20 and 50 mM. Glucosamine at 50 mM was demonstrated to elevate both the mRNA and protein expression of p53 and heme oxygenase-1 (HO-1), but also caused a reduction in p21 protein expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23128353.T9.T20",
        "sentence": "Examination of phosphorylation in retinoblastoma (Rb) protein, we found an inhibitory effect by glucosamine at 20 and 50 mM. @CHEMICAL$ at 50 mM was demonstrated to elevate both the mRNA and protein expression of @GENE$ and heme oxygenase-1 (HO-1), but also caused a reduction in p21 protein expression.",
        "relation": "CPR:3"
    },
    {
        "id": "23128353.T9.T21",
        "sentence": "Examination of phosphorylation in retinoblastoma (Rb) protein, we found an inhibitory effect by glucosamine at 20 and 50 mM. @CHEMICAL$ at 50 mM was demonstrated to elevate both the mRNA and protein expression of p53 and @GENE$ (HO-1), but also caused a reduction in p21 protein expression.",
        "relation": "CPR:3"
    },
    {
        "id": "23128353.T9.T23",
        "sentence": "Examination of phosphorylation in retinoblastoma (Rb) protein, we found an inhibitory effect by glucosamine at 20 and 50 mM. @CHEMICAL$ at 50 mM was demonstrated to elevate both the mRNA and protein expression of p53 and heme oxygenase-1 (HO-1), but also caused a reduction in @GENE$ protein expression.",
        "relation": "CPR:4"
    },
    {
        "id": "23128353.T1.T12",
        "sentence": "In addition, @CHEMICAL$ attenuated @GENE$ protein stability via the proteasomal proteolytic pathway, as well as inducing p21 nuclear accumulation.",
        "relation": "CPR:4"
    },
    {
        "id": "23128353.T1.T13",
        "sentence": "In addition, @CHEMICAL$ attenuated p21 protein stability via the proteasomal proteolytic pathway, as well as inducing @GENE$ nuclear accumulation.",
        "relation": "CPR:3"
    },
    {
        "id": "23128353.T2.T14",
        "sentence": "Altogether, our results suggest that a high dose of @CHEMICAL$ may inhibit cell proliferation through apoptosis and disturb cell cycle progression with a halt at G(0)/G(1) phase, and that this occurs, at least in part, by a reduction in @GENE$ phosphorylation together with modulation of p21, p53 and HO-1 expression, and nuclear p21 accumulation.",
        "relation": "CPR:4"
    },
    {
        "id": "23128353.T2.T18",
        "sentence": "Altogether, our results suggest that a high dose of @CHEMICAL$ may inhibit cell proliferation through apoptosis and disturb cell cycle progression with a halt at G(0)/G(1) phase, and that this occurs, at least in part, by a reduction in Rb phosphorylation together with modulation of p21, p53 and HO-1 expression, and nuclear @GENE$ accumulation.",
        "relation": "CPR:3"
    },
    {
        "id": "23131177.T12.T28",
        "sentence": "Characterization of substituted @CHEMICAL$ as highly selective agonists at the @GENE$.",
        "relation": "CPR:5"
    },
    {
        "id": "23142699.T1.T7",
        "sentence": "We show that the expression of @CHEMICAL$ is induced in response to @GENE$ in MCF-7 cells and that the induction is mediated by ERa-regulated enhancers located distally upstream from the gene.",
        "relation": "CPR:3"
    },
    {
        "id": "23142699.T1.T8",
        "sentence": "We show that the expression of PIM-1 is induced in response to @CHEMICAL$ in MCF-7 cells and that the induction is mediated by @GENE$-regulated enhancers located distally upstream from the gene.",
        "relation": "CPR:3"
    },
    {
        "id": "23143891.T14.T24",
        "sentence": "In this work, the metabolism of four frequently prescribed inhaled GCs, @CHEMICAL$, flunisolide, budesonide, and fluticasone propionate, by the @GENE$ family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites.",
        "relation": "CPR:9"
    },
    {
        "id": "23143891.T15.T24",
        "sentence": "In this work, the metabolism of four frequently prescribed inhaled GCs, triamcinolone acetonide, @CHEMICAL$, budesonide, and fluticasone propionate, by the @GENE$ family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites.",
        "relation": "CPR:9"
    },
    {
        "id": "23143891.T16.T24",
        "sentence": "In this work, the metabolism of four frequently prescribed inhaled GCs, triamcinolone acetonide, flunisolide, @CHEMICAL$, and fluticasone propionate, by the @GENE$ family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites.",
        "relation": "CPR:9"
    },
    {
        "id": "23143891.T17.T24",
        "sentence": "In this work, the metabolism of four frequently prescribed inhaled GCs, triamcinolone acetonide, flunisolide, budesonide, and @CHEMICAL$, by the @GENE$ family of enzymes was studied to identify differences in their rates of clearance and to identify their metabolites.",
        "relation": "CPR:9"
    },
    {
        "id": "23143891.T1.T19",
        "sentence": "@CHEMICAL$, which is particularly relevant to GC metabolism in the lungs, was also shown to efficiently metabolize @GENE$, budesonide, and fluticasone propionate.",
        "relation": "CPR:9"
    },
    {
        "id": "23143891.T2.T19",
        "sentence": "@CHEMICAL$, which is particularly relevant to GC metabolism in the lungs, was also shown to efficiently metabolize triamcinolone acetonide, @GENE$, and fluticasone propionate.",
        "relation": "CPR:9"
    },
    {
        "id": "23143891.T3.T19",
        "sentence": "@CHEMICAL$, which is particularly relevant to GC metabolism in the lungs, was also shown to efficiently metabolize triamcinolone acetonide, budesonide, and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23143891.T4.T20",
        "sentence": "In contrast, @CHEMICAL$ was only metabolized via @GENE$, with no significant turnover by CYP3A5 or CYP3A7.",
        "relation": "CPR:9"
    },
    {
        "id": "23159329.T11.T24",
        "sentence": "Distinct roles of @CHEMICAL$ in modulating spatial memory consolidation, retrieval, reconsolidation and the accompanying changes of @GENE$ and CREB activation in hippocampus and prefrontal cortex.",
        "relation": "CPR:3"
    },
    {
        "id": "23159329.T11.T25",
        "sentence": "Distinct roles of @CHEMICAL$ in modulating spatial memory consolidation, retrieval, reconsolidation and the accompanying changes of ERK and @GENE$ activation in hippocampus and prefrontal cortex.",
        "relation": "CPR:3"
    },
    {
        "id": "23159329.T2.T13",
        "sentence": "In contrast, activation of both @CHEMICAL$ and CREB in the PFC was found following memory retrieval but not other processes in @GENE$-treated mouse groups.",
        "relation": "CPR:3"
    },
    {
        "id": "23159329.T2.T14",
        "sentence": "In contrast, activation of both ERK and @CHEMICAL$ in the PFC was found following memory retrieval but not other processes in @GENE$-treated mouse groups.",
        "relation": "CPR:3"
    },
    {
        "id": "23159329.T4.T15",
        "sentence": "Moreover, activation of the @CHEMICAL$ and CREB signaling pathway in the hippocampus might be involved in @GENE$-induced spatial memory changes.",
        "relation": "CPR:3"
    },
    {
        "id": "23159329.T4.T16",
        "sentence": "Moreover, activation of the ERK and @CHEMICAL$ signaling pathway in the hippocampus might be involved in @GENE$-induced spatial memory changes.",
        "relation": "CPR:3"
    },
    {
        "id": "23161868.T1.T4",
        "sentence": "A reporter construct driven by 4 kb of the chicken ras-dva 5'-flanking region, containing six putative @CHEMICAL$ and two potential glucocorticoid receptor (GR) binding sites, was highly activated in embryonic pituitary cells and up-regulated by @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23161868.T1.T5",
        "sentence": "A reporter construct driven by 4 kb of the chicken ras-dva 5'-flanking region, containing six putative pituitary-specific transcription factor-1 (Pit-1) binding sites and two potential @CHEMICAL$, was highly activated in embryonic pituitary cells and up-regulated by @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23161868.T1.T3",
        "sentence": "A reporter construct driven by 4 kb of the @CHEMICAL$ 5'-flanking region, containing six putative pituitary-specific transcription factor-1 (Pit-1) binding sites and two potential glucocorticoid receptor (GR) binding sites, was highly activated in embryonic pituitary cells and up-regulated by @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23161868.T2.T10",
        "sentence": "However, mutating putative @CHEMICAL$ did not substantially reduce induction of ras-dva promoter activity by @GENE$, suggesting additional DNA elements within the 5'-flanking region are responsible for glucocorticoid regulation.",
        "relation": "CPR:3"
    },
    {
        "id": "23161868.T2.T11",
        "sentence": "However, mutating putative GR binding sites did not substantially reduce induction of @CHEMICAL$ activity by @GENE$, suggesting additional DNA elements within the 5'-flanking region are responsible for glucocorticoid regulation.",
        "relation": "CPR:3"
    },
    {
        "id": "23164615.T2.T11",
        "sentence": "To investigate the role of mGluR8 in modulating the synaptic responses of retinal ganglion cells, we used a recently identified positive allosteric modulator of mGluR8, AZ12216052 (AZ) and the @CHEMICAL$-specific orthosteric agonist @GENE$ (DCPG).",
        "relation": "CPR:5"
    },
    {
        "id": "23164615.T3.T11",
        "sentence": "To investigate the role of mGluR8 in modulating the synaptic responses of retinal ganglion cells, we used a recently identified positive allosteric modulator of mGluR8, AZ12216052 (AZ) and the @CHEMICAL$-specific orthosteric agonist (S)-3,4-dicarboxyphenylglycine (@GENE$).",
        "relation": "CPR:5"
    },
    {
        "id": "23178182.T18.T40",
        "sentence": "UCCB01-125, a dimeric inhibitor of PSD-95, reduces inflammatory pain without disrupting cognitive or motor performance: comparison with the @CHEMICAL$ antagonist @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "23178182.T13.T38",
        "sentence": "Here, we compared the effects of a dimeric @CHEMICAL$ inhibitor, @GENE$, and the NMDAR antagonist, MK-801, on mechanical hypersensitivity in the complete Freund's adjuvant (CFA) model of inflammatory pain.",
        "relation": "CPR:4"
    },
    {
        "id": "23178182.T14.T39",
        "sentence": "Here, we compared the effects of a dimeric PSD-95 inhibitor, UCCB01-125, and the @CHEMICAL$ antagonist, @GENE$, on mechanical hypersensitivity in the complete Freund's adjuvant (CFA) model of inflammatory pain.",
        "relation": "CPR:6"
    },
    {
        "id": "23182766.T3.T15",
        "sentence": "The treatment also prevented the high @CHEMICAL$ diet-induced increase in serum @GENE$, total and isoforms, markers of neurological, cardiac and muscular damage.",
        "relation": "CPR:3"
    },
    {
        "id": "23192339.T1.T13",
        "sentence": "GIP potentiates @CHEMICAL$-stimulated @GENE$ secretion and induces energy accumulation into adipose tissue, resulting in obesity.",
        "relation": "CPR:3"
    },
    {
        "id": "23194076.T8.T24",
        "sentence": "Diet, physical exercise and @CHEMICAL$ administration increase serum @GENE$ (AMH) levels in women with polycystic ovary syndrome (PCOS).",
        "relation": "CPR:3"
    },
    {
        "id": "23194076.T8.T25",
        "sentence": "Diet, physical exercise and @CHEMICAL$ administration increase serum Anti-Mullerian Hormone (@GENE$) levels in women with polycystic ovary syndrome (PCOS).",
        "relation": "CPR:3"
    },
    {
        "id": "23194076.T7.T11",
        "sentence": "We concluded that in overweight and obese women with PCOS @CHEMICAL$ administration, combined with diet and physical exercise, for 24 weeks, resulted in significant weight loss, improvement of hyperandrogenism and insulin sensitivity, and increased serum @GENE$ levels.",
        "relation": "CPR:3"
    },
    {
        "id": "23201003.T2.T22",
        "sentence": "Moreover, @CHEMICAL$ decreased expression of @GENE$ and Oat3 in rat kidney.",
        "relation": "CPR:4"
    },
    {
        "id": "23201003.T2.T23",
        "sentence": "Moreover, @CHEMICAL$ decreased expression of Oat1 and @GENE$ in rat kidney.",
        "relation": "CPR:4"
    },
    {
        "id": "23201003.T8.T24",
        "sentence": "The mechanism of interaction between JBP485 and 1,25(OH)(2)D(3) could be explained at least in part by inhibitory effect of @CHEMICAL$ on expression of @GENE$ in rat kidney.",
        "relation": "CPR:4"
    },
    {
        "id": "23220614.T13.T35",
        "sentence": "@CHEMICAL$ is able to induce apoptosis through mitochondrial dysfunction and inhibition of @GENE$/Akt signaling pathway in HepG2 cells, however, the effects of ISO on MAPK signaling pathways remain unknown.",
        "relation": "CPR:4"
    },
    {
        "id": "23220614.T13.T36",
        "sentence": "@CHEMICAL$ is able to induce apoptosis through mitochondrial dysfunction and inhibition of PI3K/@GENE$ signaling pathway in HepG2 cells, however, the effects of ISO on MAPK signaling pathways remain unknown.",
        "relation": "CPR:4"
    },
    {
        "id": "23220614.T20.T41",
        "sentence": "@CHEMICAL$ significantly inhibited the levels of ERK1/2 kinase and increased the expression of @GENE$ and p38 kinases.",
        "relation": "CPR:3"
    },
    {
        "id": "23220614.T20.T42",
        "sentence": "@CHEMICAL$ significantly inhibited the levels of ERK1/2 kinase and increased the expression of JNK and @GENE$ kinases.",
        "relation": "CPR:3"
    },
    {
        "id": "23220614.T20.T43",
        "sentence": "@CHEMICAL$ significantly inhibited the levels of ERK1/2 kinase and increased the expression of JNK and p38 @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23220614.T21.T45",
        "sentence": "Furthermore, @CHEMICAL$ (an ERK1/2 inhibitor) significantly enhanced the ISO-induced the @GENE$/Bcl-2 ratio, the release of cytochrome c to the cytosol fraction, and the levels of cleaved caspase-3.",
        "relation": "CPR:3"
    },
    {
        "id": "23220614.T21.T46",
        "sentence": "Furthermore, @CHEMICAL$ (an ERK1/2 inhibitor) significantly enhanced the ISO-induced the Bax/@GENE$ ratio, the release of cytochrome c to the cytosol fraction, and the levels of cleaved caspase-3.",
        "relation": "CPR:3"
    },
    {
        "id": "23220614.T22.T45",
        "sentence": "Furthermore, U0126 (an ERK1/2 inhibitor) significantly enhanced the @CHEMICAL$-induced the @GENE$/Bcl-2 ratio, the release of cytochrome c to the cytosol fraction, and the levels of cleaved caspase-3.",
        "relation": "CPR:3"
    },
    {
        "id": "23220614.T22.T46",
        "sentence": "Furthermore, U0126 (an ERK1/2 inhibitor) significantly enhanced the @CHEMICAL$-induced the Bax/@GENE$ ratio, the release of cytochrome c to the cytosol fraction, and the levels of cleaved caspase-3.",
        "relation": "CPR:3"
    },
    {
        "id": "23220614.T2.T24",
        "sentence": "While @CHEMICAL$ (a @GENE$ inhibitor) and SB203580 (a p38 inhibitor) markedly prevented the expression of these proteins induced by ISO.",
        "relation": "CPR:4"
    },
    {
        "id": "23220614.T3.T25",
        "sentence": "While SP600125 (a JNK inhibitor) and @CHEMICAL$ (a @GENE$ inhibitor) markedly prevented the expression of these proteins induced by ISO.",
        "relation": "CPR:4"
    },
    {
        "id": "23220614.T4.T24",
        "sentence": "While SP600125 (a @CHEMICAL$ inhibitor) and SB203580 (a p38 inhibitor) markedly prevented the expression of these proteins induced by @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23220614.T4.T25",
        "sentence": "While SP600125 (a JNK inhibitor) and SB203580 (a @CHEMICAL$ inhibitor) markedly prevented the expression of these proteins induced by @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23220614.T7.T27",
        "sentence": "@CHEMICAL$ also suppressed the p-@GENE$ and p-p38, but failed to reverse the effects of ISO.",
        "relation": "CPR:4"
    },
    {
        "id": "23220614.T7.T28",
        "sentence": "@CHEMICAL$ also suppressed the p-JNK and @GENE$, but failed to reverse the effects of ISO.",
        "relation": "CPR:4"
    },
    {
        "id": "23220614.T10.T30",
        "sentence": "These results demonstrated for the first time that @CHEMICAL$ induces apoptosis in HepG2 cells through inactivating ERK1/2 kinase and activating @GENE$ and p38 kinases, and ROS stimulated by ISO is able to activate the MAPK singaling pathway as the upstream signaling molecules.",
        "relation": "CPR:3"
    },
    {
        "id": "23220614.T10.T31",
        "sentence": "These results demonstrated for the first time that @CHEMICAL$ induces apoptosis in HepG2 cells through inactivating ERK1/2 kinase and activating JNK and @GENE$ kinases, and ROS stimulated by ISO is able to activate the MAPK singaling pathway as the upstream signaling molecules.",
        "relation": "CPR:3"
    },
    {
        "id": "23220614.T10.T32",
        "sentence": "These results demonstrated for the first time that @CHEMICAL$ induces apoptosis in HepG2 cells through inactivating ERK1/2 kinase and activating JNK and p38 @GENE$, and ROS stimulated by ISO is able to activate the MAPK singaling pathway as the upstream signaling molecules.",
        "relation": "CPR:3"
    },
    {
        "id": "23220614.T11.T33",
        "sentence": "These results demonstrated for the first time that ISO induces apoptosis in HepG2 cells through inactivating ERK1/2 kinase and activating JNK and p38 kinases, and ROS stimulated by @CHEMICAL$ is able to activate the @GENE$ singaling pathway as the upstream signaling molecules.",
        "relation": "CPR:3"
    },
    {
        "id": "23220618.T10.T33",
        "sentence": "Treatment with @CHEMICAL$ and hyperoside resulted in significantly prolonged aPTT and PT and inhibition of the activities of @GENE$ and FXa, and IMG or hyperoside inhibited production of thrombin and FXa in HUVECs.",
        "relation": "CPR:4"
    },
    {
        "id": "23220618.T10.T34",
        "sentence": "Treatment with @CHEMICAL$ and hyperoside resulted in significantly prolonged aPTT and PT and inhibition of the activities of thrombin and @GENE$, and IMG or hyperoside inhibited production of thrombin and FXa in HUVECs.",
        "relation": "CPR:4"
    },
    {
        "id": "23220618.T11.T33",
        "sentence": "Treatment with IMG and @CHEMICAL$ resulted in significantly prolonged aPTT and PT and inhibition of the activities of @GENE$ and FXa, and IMG or hyperoside inhibited production of thrombin and FXa in HUVECs.",
        "relation": "CPR:4"
    },
    {
        "id": "23220618.T11.T34",
        "sentence": "Treatment with IMG and @CHEMICAL$ resulted in significantly prolonged aPTT and PT and inhibition of the activities of thrombin and @GENE$, and IMG or hyperoside inhibited production of thrombin and FXa in HUVECs.",
        "relation": "CPR:4"
    },
    {
        "id": "23220618.T12.T35",
        "sentence": "Treatment with IMG and hyperoside resulted in significantly prolonged aPTT and PT and inhibition of the activities of thrombin and FXa, and @CHEMICAL$ or hyperoside inhibited production of @GENE$ and FXa in HUVECs.",
        "relation": "CPR:3"
    },
    {
        "id": "23220618.T12.T36",
        "sentence": "Treatment with IMG and hyperoside resulted in significantly prolonged aPTT and PT and inhibition of the activities of thrombin and FXa, and @CHEMICAL$ or hyperoside inhibited production of thrombin and @GENE$ in HUVECs.",
        "relation": "CPR:4"
    },
    {
        "id": "23220618.T13.T35",
        "sentence": "Treatment with IMG and hyperoside resulted in significantly prolonged aPTT and PT and inhibition of the activities of thrombin and FXa, and IMG or @CHEMICAL$ inhibited production of @GENE$ and FXa in HUVECs.",
        "relation": "CPR:4"
    },
    {
        "id": "23220618.T13.T36",
        "sentence": "Treatment with IMG and hyperoside resulted in significantly prolonged aPTT and PT and inhibition of the activities of thrombin and FXa, and IMG or @CHEMICAL$ inhibited production of thrombin and @GENE$ in HUVECs.",
        "relation": "CPR:4"
    },
    {
        "id": "23220618.T15.T19",
        "sentence": "In addition, treatment with @CHEMICAL$ and hyperoside resulted in inhibition of @GENE$-induced production of PAI-1, and treatment with IMG resulted in significant reduction of the PAI-1 to t-PA ratio.",
        "relation": "CPR:4"
    },
    {
        "id": "23220618.T15.T20",
        "sentence": "In addition, treatment with @CHEMICAL$ and hyperoside resulted in inhibition of TNF-a-induced production of @GENE$, and treatment with IMG resulted in significant reduction of the PAI-1 to t-PA ratio.",
        "relation": "CPR:4"
    },
    {
        "id": "23220618.T16.T19",
        "sentence": "In addition, treatment with IMG and @CHEMICAL$ resulted in inhibition of @GENE$-induced production of PAI-1, and treatment with IMG resulted in significant reduction of the PAI-1 to t-PA ratio.",
        "relation": "CPR:4"
    },
    {
        "id": "23220618.T16.T20",
        "sentence": "In addition, treatment with IMG and @CHEMICAL$ resulted in inhibition of TNF-a-induced production of @GENE$, and treatment with IMG resulted in significant reduction of the PAI-1 to t-PA ratio.",
        "relation": "CPR:4"
    },
    {
        "id": "23220618.T2.T21",
        "sentence": "In addition, treatment with IMG and hyperoside resulted in inhibition of TNF-a-induced production of PAI-1, and treatment with @CHEMICAL$ resulted in significant reduction of the @GENE$ to t-PA ratio.",
        "relation": "CPR:4"
    },
    {
        "id": "23220618.T2.T22",
        "sentence": "In addition, treatment with IMG and hyperoside resulted in inhibition of TNF-a-induced production of PAI-1, and treatment with @CHEMICAL$ resulted in significant reduction of the PAI-1 to @GENE$ ratio.",
        "relation": "CPR:4"
    },
    {
        "id": "23220644.T6.T17",
        "sentence": "Optimization of @CHEMICAL$ as dual function inhibitors targeting @GENE$ and leukotriene A4 hydrolase.",
        "relation": "CPR:4"
    },
    {
        "id": "23220644.T6.T18",
        "sentence": "Optimization of @CHEMICAL$ as dual function inhibitors targeting phospholipase A2 and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23220644.T1.T12",
        "sentence": "Dual function inhibitors targeting phospholipase A(2) (@CHEMICAL$) and leukotriene A(4) hydrolase (LTA(4)H) may balance the @GENE$ (AA) metabolic network and be used as new anti-inflammatory drugs.",
        "relation": "CPR:9"
    },
    {
        "id": "23220644.T1.T8",
        "sentence": "Dual function inhibitors targeting @CHEMICAL$ (PLA(2)) and leukotriene A(4) hydrolase (LTA(4)H) may balance the @GENE$ (AA) metabolic network and be used as new anti-inflammatory drugs.",
        "relation": "CPR:9"
    },
    {
        "id": "23220644.T1.T13",
        "sentence": "Dual function inhibitors targeting phospholipase A(2) (PLA(2)) and @CHEMICAL$ (LTA(4)H) may balance the @GENE$ (AA) metabolic network and be used as new anti-inflammatory drugs.",
        "relation": "CPR:9"
    },
    {
        "id": "23220644.T1.T16",
        "sentence": "Dual function inhibitors targeting phospholipase A(2) (PLA(2)) and leukotriene A(4) hydrolase (@CHEMICAL$) may balance the @GENE$ (AA) metabolic network and be used as new anti-inflammatory drugs.",
        "relation": "CPR:9"
    },
    {
        "id": "23220644.T2.T10",
        "sentence": "In previous study, we discovered multi-target drugs towards the AA metabolic network, among which a dual-target inhibitor (@CHEMICAL$) for human nonpancreatic secretory phospholipase A(2) (hnps-PLA(2)) and @GENE$ (LTA(4)H-h) was found.",
        "relation": "CPR:4"
    },
    {
        "id": "23220644.T2.T11",
        "sentence": "In previous study, we discovered multi-target drugs towards the AA metabolic network, among which a dual-target inhibitor (@CHEMICAL$) for human nonpancreatic secretory phospholipase A(2) (hnps-PLA(2)) and human leukotriene A(4) hydrolase (@GENE$) was found.",
        "relation": "CPR:4"
    },
    {
        "id": "23220644.T2.T7",
        "sentence": "In previous study, we discovered multi-target drugs towards the AA metabolic network, among which a dual-target inhibitor (@CHEMICAL$) for @GENE$ (hnps-PLA(2)) and human leukotriene A(4) hydrolase (LTA(4)H-h) was found.",
        "relation": "CPR:4"
    },
    {
        "id": "23220644.T2.T9",
        "sentence": "In previous study, we discovered multi-target drugs towards the AA metabolic network, among which a dual-target inhibitor (@CHEMICAL$) for human nonpancreatic secretory phospholipase A(2) (@GENE$) and human leukotriene A(4) hydrolase (LTA(4)H-h) was found.",
        "relation": "CPR:4"
    },
    {
        "id": "23220749.T12.T27",
        "sentence": "Whereas the addition of @CHEMICAL$ in the low micromolar range produced an irreversible activation of the channel, application of higher concentrations caused a reversible voltage-dependent inhibition of heterologously expressed @GENE$ channels, resulting from a reduction of single-channel open times.",
        "relation": "CPR:4"
    },
    {
        "id": "23220749.T2.T15",
        "sentence": "In addition, we provide evidence that @CHEMICAL$ also acts on endogenous TRPA1 in cultured dorsal root ganglion neurons from rats and in the enterochromaffin model cell line QGP-1, from which serotonin is released upon activation of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23220749.T4.T17",
        "sentence": "Our study shows that human TRPA1 is a target for @CHEMICAL$, suggesting that an activation of @GENE$ might contribute to adverse side effects such as nausea and painful injections, which can occur during treatment with apomorphine.",
        "relation": "CPR:3"
    },
    {
        "id": "23220749.T5.T17",
        "sentence": "Our study shows that human TRPA1 is a target for apomorphine, suggesting that an activation of @CHEMICAL$ might contribute to adverse side effects such as nausea and painful injections, which can occur during treatment with @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23221600.T9.T33",
        "sentence": "@CHEMICAL$ (SCD-1) gene expression is negatively regulated by @GENE$ without direct binding of thyroid hormone receptor to the gene promoter.",
        "relation": "CPR:4"
    },
    {
        "id": "23221600.T9.T35",
        "sentence": "Human stearoyl-CoA desaturase 1 (@CHEMICAL$) gene expression is negatively regulated by @GENE$ without direct binding of thyroid hormone receptor to the gene promoter.",
        "relation": "CPR:4"
    },
    {
        "id": "23221600.T3.T19",
        "sentence": "Dietary @CHEMICAL$ increase @GENE$ gene expression in liver by sterol response element binding protein (SREBP)-1c-dependent and SREBP-1c -independent pathways.",
        "relation": "CPR:3"
    },
    {
        "id": "23221600.T5.T23",
        "sentence": "Previous report demonstrated that @CHEMICAL$ (TH) negatively regulates @GENE$ before SREBP-1c was revealed.",
        "relation": "CPR:4"
    },
    {
        "id": "23223177.T3.T19",
        "sentence": "Exposure of H9c2 cells to high @CHEMICAL$ reduced @GENE$ activity, inhibited Jun NH2-terminal kinase 1 (JNK1)-B-cell lymphoma 2 (Bcl-2) signaling, and promoted Beclin1 binding to Bcl-2.",
        "relation": "CPR:4"
    },
    {
        "id": "23223177.T3.T20",
        "sentence": "Exposure of H9c2 cells to high @CHEMICAL$ reduced AMPK activity, inhibited @GENE$ (JNK1)-B-cell lymphoma 2 (Bcl-2) signaling, and promoted Beclin1 binding to Bcl-2.",
        "relation": "CPR:4"
    },
    {
        "id": "23223177.T3.T21",
        "sentence": "Exposure of H9c2 cells to high @CHEMICAL$ reduced AMPK activity, inhibited Jun NH2-terminal kinase 1 (@GENE$)-B-cell lymphoma 2 (Bcl-2) signaling, and promoted Beclin1 binding to Bcl-2.",
        "relation": "CPR:4"
    },
    {
        "id": "23223177.T3.T22",
        "sentence": "Exposure of H9c2 cells to high @CHEMICAL$ reduced AMPK activity, inhibited Jun NH2-terminal kinase 1 (JNK1)-@GENE$ (Bcl-2) signaling, and promoted Beclin1 binding to Bcl-2.",
        "relation": "CPR:4"
    },
    {
        "id": "23223177.T3.T23",
        "sentence": "Exposure of H9c2 cells to high @CHEMICAL$ reduced AMPK activity, inhibited Jun NH2-terminal kinase 1 (JNK1)-B-cell lymphoma 2 (@GENE$) signaling, and promoted Beclin1 binding to Bcl-2.",
        "relation": "CPR:4"
    },
    {
        "id": "23223177.T1.T7",
        "sentence": "Finally, chronic administration of @CHEMICAL$ in diabetic mice restored cardiac autophagy by activating @GENE$-Bcl-2 pathways and dissociating Beclin1 and Bcl-2.",
        "relation": "CPR:3"
    },
    {
        "id": "23223177.T1.T8",
        "sentence": "Finally, chronic administration of @CHEMICAL$ in diabetic mice restored cardiac autophagy by activating JNK1-@GENE$ pathways and dissociating Beclin1 and Bcl-2.",
        "relation": "CPR:3"
    },
    {
        "id": "23228696.T16.T40",
        "sentence": "@CHEMICAL$-mediated downregulation of @GENE$ mitogen-activated protein kinase-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel.",
        "relation": "CPR:4"
    },
    {
        "id": "23228696.T16.T41",
        "sentence": "@CHEMICAL$-mediated downregulation of p38 @GENE$-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel.",
        "relation": "CPR:4"
    },
    {
        "id": "23228696.T13.T30",
        "sentence": "In this current study, @CHEMICAL$ was found to increase phosphorylation of @GENE$ (MAPK) kinase 3/6 (MKK3/6)-p38 MAPK as well as protein and mRNA levels of ERCC1 in H1650 and H1703 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23228696.T13.T32",
        "sentence": "In this current study, @CHEMICAL$ was found to increase phosphorylation of mitogen-activated protein kinase (MAPK) kinase 3/6 (MKK3/6)-@GENE$ MAPK as well as protein and mRNA levels of ERCC1 in H1650 and H1703 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23228696.T13.T33",
        "sentence": "In this current study, @CHEMICAL$ was found to increase phosphorylation of mitogen-activated protein kinase (MAPK) kinase 3/6 (MKK3/6)-p38 @GENE$ as well as protein and mRNA levels of ERCC1 in H1650 and H1703 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23228696.T13.T34",
        "sentence": "In this current study, @CHEMICAL$ was found to increase phosphorylation of mitogen-activated protein kinase (MAPK) kinase 3/6 (MKK3/6)-p38 MAPK as well as protein and mRNA levels of @GENE$ in H1650 and H1703 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23228696.T14.T35",
        "sentence": "Moreover, @CHEMICAL$-induced @GENE$ protein and mRNA levels significantly decreased via the downregulation of p38 activity by either a p38 MAPK inhibitor SB202190 or p38 knockdown with specific small interfering RNA (siRNA).",
        "relation": "CPR:3"
    },
    {
        "id": "23228696.T15.T36",
        "sentence": "Moreover, paclitaxel-induced ERCC1 protein and mRNA levels significantly decreased via the downregulation of @CHEMICAL$ activity by either a p38 MAPK inhibitor @GENE$ or p38 knockdown with specific small interfering RNA (siRNA).",
        "relation": "CPR:4"
    },
    {
        "id": "23228696.T15.T37",
        "sentence": "Moreover, paclitaxel-induced ERCC1 protein and mRNA levels significantly decreased via the downregulation of p38 activity by either a @CHEMICAL$ MAPK inhibitor @GENE$ or p38 knockdown with specific small interfering RNA (siRNA).",
        "relation": "CPR:4"
    },
    {
        "id": "23228696.T15.T38",
        "sentence": "Moreover, paclitaxel-induced ERCC1 protein and mRNA levels significantly decreased via the downregulation of p38 activity by either a p38 @CHEMICAL$ inhibitor @GENE$ or p38 knockdown with specific small interfering RNA (siRNA).",
        "relation": "CPR:4"
    },
    {
        "id": "23228696.T3.T19",
        "sentence": "Furthermore, @CHEMICAL$ was able to not only decrease the paclitaxel-induced @GENE$ MAPK-mediated ERCC1 expression, but also augment the cytotoxic effect induced by paclitaxel.",
        "relation": "CPR:4"
    },
    {
        "id": "23228696.T3.T20",
        "sentence": "Furthermore, @CHEMICAL$ was able to not only decrease the paclitaxel-induced p38 @GENE$-mediated ERCC1 expression, but also augment the cytotoxic effect induced by paclitaxel.",
        "relation": "CPR:4"
    },
    {
        "id": "23228696.T3.T21",
        "sentence": "Furthermore, @CHEMICAL$ was able to not only decrease the paclitaxel-induced p38 MAPK-mediated @GENE$ expression, but also augment the cytotoxic effect induced by paclitaxel.",
        "relation": "CPR:4"
    },
    {
        "id": "23228696.T4.T19",
        "sentence": "Furthermore, metformin was able to not only decrease the @CHEMICAL$-induced @GENE$ MAPK-mediated ERCC1 expression, but also augment the cytotoxic effect induced by paclitaxel.",
        "relation": "CPR:3"
    },
    {
        "id": "23228696.T4.T20",
        "sentence": "Furthermore, metformin was able to not only decrease the @CHEMICAL$-induced p38 @GENE$-mediated ERCC1 expression, but also augment the cytotoxic effect induced by paclitaxel.",
        "relation": "CPR:3"
    },
    {
        "id": "23228696.T4.T21",
        "sentence": "Furthermore, metformin was able to not only decrease the @CHEMICAL$-induced p38 MAPK-mediated @GENE$ expression, but also augment the cytotoxic effect induced by paclitaxel.",
        "relation": "CPR:3"
    },
    {
        "id": "23228696.T6.T25",
        "sentence": "Finally, expression of constitutive activate MKK6 or HA-p38 MAPK vectors in lung cancer cells was able to abrogate @CHEMICAL$ downregulation by @GENE$ and paclitaxel as well as cell viability and DNA repair capacity.",
        "relation": "CPR:4"
    },
    {
        "id": "23228696.T7.T25",
        "sentence": "Finally, expression of constitutive activate MKK6 or HA-p38 MAPK vectors in lung cancer cells was able to abrogate @CHEMICAL$ downregulation by metformin and @GENE$ as well as cell viability and DNA repair capacity.",
        "relation": "CPR:4"
    },
    {
        "id": "23228696.T8.T26",
        "sentence": "Overall, our results suggest that inhibition of the @CHEMICAL$ MAPK signaling by @GENE$ coupled with paclitaxel therapy in human NSCLC cells may be a clinically useful combination, which however will require further validation.",
        "relation": "CPR:4"
    },
    {
        "id": "23228696.T8.T27",
        "sentence": "Overall, our results suggest that inhibition of the p38 @CHEMICAL$ signaling by @GENE$ coupled with paclitaxel therapy in human NSCLC cells may be a clinically useful combination, which however will require further validation.",
        "relation": "CPR:4"
    },
    {
        "id": "23228697.T1.T17",
        "sentence": "@CHEMICAL$ has been the most used anti-obesity drug and the mechanism of its action is to reduce lipid absorption by inhibiting gastrointestinal @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23228697.T6.T25",
        "sentence": "This study was designed to test the hypothesis that @CHEMICAL$ inhibits @GENE$ with higher potency toward CES1 than CES2, a carboxylesterase with little lipase activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23228697.T6.T28",
        "sentence": "This study was designed to test the hypothesis that @CHEMICAL$ inhibits CESs with higher potency toward CES1 than CES2, a @GENE$ with little lipase activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23228697.T6.T29",
        "sentence": "This study was designed to test the hypothesis that @CHEMICAL$ inhibits CESs with higher potency toward CES1 than CES2, a carboxylesterase with little @GENE$ activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23228697.T6.T26",
        "sentence": "This study was designed to test the hypothesis that @CHEMICAL$ inhibits CESs with higher potency toward @GENE$ than CES2, a carboxylesterase with little lipase activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23228697.T6.T27",
        "sentence": "This study was designed to test the hypothesis that @CHEMICAL$ inhibits CESs with higher potency toward CES1 than @GENE$, a carboxylesterase with little lipase activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23228697.T12.T31",
        "sentence": "Contrary to the hypothesis, orlistat at 1 nM inhibited @CHEMICAL$ activity by 75% but no inhibition on CES1, placing CES2 one of the most sensitive targets of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23228697.T12.T33",
        "sentence": "Contrary to the hypothesis, orlistat at 1 nM inhibited CES2 activity by 75% but no inhibition on CES1, placing @CHEMICAL$ one of the most sensitive targets of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23228697.T4.T16",
        "sentence": "Inhibition of this @CHEMICAL$ probably presents a major source for altered therapeutic activity of these medicines if co-administered with @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23229509.T5.T10",
        "sentence": "Regulation of multiple @CHEMICAL$ (AC) provides unique inputs to mediate the synthesis of @GENE$, a ubiquitous second messenger that controls many aspects of cellular function.",
        "relation": "CPR:9"
    },
    {
        "id": "23229509.T5.T13",
        "sentence": "Regulation of multiple adenylyl cyclases (@CHEMICAL$) provides unique inputs to mediate the synthesis of @GENE$, a ubiquitous second messenger that controls many aspects of cellular function.",
        "relation": "CPR:9"
    },
    {
        "id": "23229509.T2.T9",
        "sentence": "On stimulation by G(s), the activities of @CHEMICAL$ can be further selectively modulated by other pathways to ensure precise control of intracellular @GENE$ responses to specific stimuli.",
        "relation": "CPR:9"
    },
    {
        "id": "23229510.T11.T26",
        "sentence": "We identified one compound, @CHEMICAL$ (N-(1-benzyl-piperidin-4-yl)-2-(4-fluoro-phenyl)-benzo[d]imidazo[2,1-b]thiazole-7-carboxamide), that activated the ISR and dose-dependently increased levels of @GENE$ in transformed cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23229510.T12.T26",
        "sentence": "We identified one compound, E235 @CHEMICAL$, that activated the ISR and dose-dependently increased levels of @GENE$ in transformed cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23229510.T6.T16",
        "sentence": "@CHEMICAL$ also activated DNA damage response signaling, resulting in increased levels of Ser15-@GENE$, g-H2AX, and phosphorylated checkpoint kinase 2 (Chk2), although E235 does not appear to cause physical DNA damage.",
        "relation": "CPR:3"
    },
    {
        "id": "23229510.T6.T17",
        "sentence": "@CHEMICAL$ also activated DNA damage response signaling, resulting in increased levels of Ser15-phosphorylated p53, @GENE$, and phosphorylated checkpoint kinase 2 (Chk2), although E235 does not appear to cause physical DNA damage.",
        "relation": "CPR:3"
    },
    {
        "id": "23229510.T6.T18",
        "sentence": "@CHEMICAL$ also activated DNA damage response signaling, resulting in increased levels of Ser15-phosphorylated p53, g-H2AX, and @GENE$ (Chk2), although E235 does not appear to cause physical DNA damage.",
        "relation": "CPR:3"
    },
    {
        "id": "23229510.T6.T19",
        "sentence": "@CHEMICAL$ also activated DNA damage response signaling, resulting in increased levels of Ser15-phosphorylated p53, g-H2AX, and phosphorylated checkpoint kinase 2 (@GENE$), although E235 does not appear to cause physical DNA damage.",
        "relation": "CPR:3"
    },
    {
        "id": "23240892.T15.T17",
        "sentence": "Cell culture studies demonstrated that @CHEMICAL$ is capable of delivering anti-TNF (tumor necrosis factor)-a siRNA to lipopolysaccharide (LPS)-stimulated macrophages and significantly inhibits the expression of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23240892.T4.T19",
        "sentence": "@CHEMICAL$/anti-TNF-a siRNA nanocomplexes significantly reduced the @GENE$ (alanine transaminase) and the hepatic cellular damages in APAP-intoxicated mice.",
        "relation": "CPR:4"
    },
    {
        "id": "23240892.T4.T20",
        "sentence": "@CHEMICAL$/anti-TNF-a siRNA nanocomplexes significantly reduced the ALT (@GENE$) and the hepatic cellular damages in APAP-intoxicated mice.",
        "relation": "CPR:4"
    },
    {
        "id": "23246481.T14.T25",
        "sentence": "@CHEMICAL$ inhibits H2O2-induced vascular permeability through suppressing the phosphorylation of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23246481.T15.T25",
        "sentence": "Wogonin inhibits @CHEMICAL$-induced vascular permeability through suppressing the phosphorylation of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23246481.T6.T16",
        "sentence": "We found that @CHEMICAL$ can suppress the H2O2-stimulated @GENE$ remodeling and albumin uptake of HUVECs, as well as transendothelial cell migration of the human breast carcinoma cell MDA-MB-231.",
        "relation": "CPR:4"
    },
    {
        "id": "23246481.T6.T17",
        "sentence": "We found that @CHEMICAL$ can suppress the H2O2-stimulated actin remodeling and @GENE$ uptake of HUVECs, as well as transendothelial cell migration of the human breast carcinoma cell MDA-MB-231.",
        "relation": "CPR:4"
    },
    {
        "id": "23246481.T7.T16",
        "sentence": "We found that wogonin can suppress the @CHEMICAL$-stimulated @GENE$ remodeling and albumin uptake of HUVECs, as well as transendothelial cell migration of the human breast carcinoma cell MDA-MB-231.",
        "relation": "CPR:3"
    },
    {
        "id": "23246481.T7.T17",
        "sentence": "We found that wogonin can suppress the @CHEMICAL$-stimulated actin remodeling and @GENE$ uptake of HUVECs, as well as transendothelial cell migration of the human breast carcinoma cell MDA-MB-231.",
        "relation": "CPR:3"
    },
    {
        "id": "23246481.T8.T18",
        "sentence": "The mechanism revealed that @CHEMICAL$ inhibited H2O2-induced phosphorylation of @GENE$ (cav-1) associating with the suppression of stabilization of VE-cadherin and b-catenin.",
        "relation": "CPR:4"
    },
    {
        "id": "23246481.T8.T19",
        "sentence": "The mechanism revealed that @CHEMICAL$ inhibited H2O2-induced phosphorylation of caveolin-1 (@GENE$) associating with the suppression of stabilization of VE-cadherin and b-catenin.",
        "relation": "CPR:4"
    },
    {
        "id": "23246481.T8.T20",
        "sentence": "The mechanism revealed that @CHEMICAL$ inhibited H2O2-induced phosphorylation of caveolin-1 (cav-1) associating with the suppression of stabilization of @GENE$ and b-catenin.",
        "relation": "CPR:4"
    },
    {
        "id": "23246481.T8.T21",
        "sentence": "The mechanism revealed that @CHEMICAL$ inhibited H2O2-induced phosphorylation of caveolin-1 (cav-1) associating with the suppression of stabilization of VE-cadherin and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23246481.T9.T18",
        "sentence": "The mechanism revealed that wogonin inhibited @CHEMICAL$-induced phosphorylation of @GENE$ (cav-1) associating with the suppression of stabilization of VE-cadherin and b-catenin.",
        "relation": "CPR:3"
    },
    {
        "id": "23246481.T9.T19",
        "sentence": "The mechanism revealed that wogonin inhibited @CHEMICAL$-induced phosphorylation of caveolin-1 (@GENE$) associating with the suppression of stabilization of VE-cadherin and b-catenin.",
        "relation": "CPR:3"
    },
    {
        "id": "23246481.T10.T22",
        "sentence": "Moreover, @CHEMICAL$ repressed anisomycin-induced phosphorylation of @GENE$, cav-1 and vascular permeability.",
        "relation": "CPR:4"
    },
    {
        "id": "23246481.T10.T23",
        "sentence": "Moreover, @CHEMICAL$ repressed anisomycin-induced phosphorylation of p38, @GENE$ and vascular permeability.",
        "relation": "CPR:4"
    },
    {
        "id": "23246481.T11.T22",
        "sentence": "Moreover, wogonin repressed @CHEMICAL$-induced phosphorylation of @GENE$, cav-1 and vascular permeability.",
        "relation": "CPR:3"
    },
    {
        "id": "23246481.T11.T23",
        "sentence": "Moreover, wogonin repressed @CHEMICAL$-induced phosphorylation of p38, @GENE$ and vascular permeability.",
        "relation": "CPR:3"
    },
    {
        "id": "23246481.T12.T24",
        "sentence": "These results suggested that @CHEMICAL$ could inhibit H2O2-induced vascular permeability by downregulating the phosphorylation of @GENE$, and that it might have a therapeutic potential for the diseases associated with the development of both oxidant and vascular permeability.",
        "relation": "CPR:4"
    },
    {
        "id": "23246481.T13.T24",
        "sentence": "These results suggested that wogonin could inhibit @CHEMICAL$-induced vascular permeability by downregulating the phosphorylation of @GENE$, and that it might have a therapeutic potential for the diseases associated with the development of both oxidant and vascular permeability.",
        "relation": "CPR:3"
    },
    {
        "id": "23253441.T1.T5",
        "sentence": "In an attempt to further improve overall profiles of the oxadiazine series of GSMs, in particular the hERG activity, conformational modifications of the core structure resulted in the identification of fused @CHEMICAL$ such as 7i which had an improved @GENE$ inhibition profile and was a highly efficacious GSM in vitro and in vivo in rats.",
        "relation": "CPR:4"
    },
    {
        "id": "23254198.T14.T22",
        "sentence": "Both CE and E(2) alone increased DNA synthesis and reduced apoptosis with activation of @CHEMICAL$, Akt, and p70S6K and up-regulation of antiapoptotic factors survivin, Bcl-2, and X-linked inhibitor of apoptosis protein, These effects could be completely blocked by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23254198.T14.T23",
        "sentence": "Both CE and E(2) alone increased DNA synthesis and reduced apoptosis with activation of MAPK, @CHEMICAL$, and p70S6K and up-regulation of antiapoptotic factors survivin, Bcl-2, and X-linked inhibitor of apoptosis protein, These effects could be completely blocked by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23254198.T14.T24",
        "sentence": "Both CE and E(2) alone increased DNA synthesis and reduced apoptosis with activation of MAPK, Akt, and @CHEMICAL$ and up-regulation of antiapoptotic factors survivin, Bcl-2, and X-linked inhibitor of apoptosis protein, These effects could be completely blocked by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23254198.T14.T25",
        "sentence": "Both CE and E(2) alone increased DNA synthesis and reduced apoptosis with activation of MAPK, Akt, and p70S6K and up-regulation of antiapoptotic factors @CHEMICAL$, Bcl-2, and X-linked inhibitor of apoptosis protein, These effects could be completely blocked by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23254198.T14.T26",
        "sentence": "Both CE and E(2) alone increased DNA synthesis and reduced apoptosis with activation of MAPK, Akt, and p70S6K and up-regulation of antiapoptotic factors survivin, @CHEMICAL$, and X-linked inhibitor of apoptosis protein, These effects could be completely blocked by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23254198.T14.T27",
        "sentence": "Both CE and E(2) alone increased DNA synthesis and reduced apoptosis with activation of MAPK, Akt, and p70S6K and up-regulation of antiapoptotic factors survivin, Bcl-2, and @CHEMICAL$, These effects could be completely blocked by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23261524.T2.T21",
        "sentence": "We used @CHEMICAL$, a well-known disruptor of @GENE$-Mdm2 interaction, to validate the specificity of the assay.",
        "relation": "CPR:4"
    },
    {
        "id": "23261524.T2.T22",
        "sentence": "We used @CHEMICAL$, a well-known disruptor of p53-@GENE$ interaction, to validate the specificity of the assay.",
        "relation": "CPR:4"
    },
    {
        "id": "23261524.T1.T5",
        "sentence": "The reduction of BiFC signal mediated by @CHEMICAL$ was correlated with an increase in Puma transactivation, @GENE$ cleavage, and cell death.",
        "relation": "CPR:3"
    },
    {
        "id": "23261524.T1.T4",
        "sentence": "The reduction of BiFC signal mediated by @CHEMICAL$ was correlated with an increase in @GENE$ transactivation, PARP cleavage, and cell death.",
        "relation": "CPR:3"
    },
    {
        "id": "23261589.T5.T19",
        "sentence": "@CHEMICAL$ toxicity coincided with reduced @GENE$ level and its downstream effectors: pCREB, pGSK-3b, Bcl-2 and neurotrophins GDNF, BDNF suggesting repressed PI3K/Akt signaling.",
        "relation": "CPR:4"
    },
    {
        "id": "23261589.T5.T20",
        "sentence": "@CHEMICAL$ toxicity coincided with reduced pAkt level and its downstream effectors: @GENE$, pGSK-3b, Bcl-2 and neurotrophins GDNF, BDNF suggesting repressed PI3K/Akt signaling.",
        "relation": "CPR:4"
    },
    {
        "id": "23261589.T5.T23",
        "sentence": "@CHEMICAL$ toxicity coincided with reduced pAkt level and its downstream effectors: pCREB, pGSK-3b, Bcl-2 and @GENE$ GDNF, BDNF suggesting repressed PI3K/Akt signaling.",
        "relation": "CPR:4"
    },
    {
        "id": "23261589.T5.T26",
        "sentence": "@CHEMICAL$ toxicity coincided with reduced pAkt level and its downstream effectors: pCREB, pGSK-3b, Bcl-2 and neurotrophins GDNF, BDNF suggesting repressed @GENE$/Akt signaling.",
        "relation": "CPR:4"
    },
    {
        "id": "23261589.T5.T27",
        "sentence": "@CHEMICAL$ toxicity coincided with reduced pAkt level and its downstream effectors: pCREB, pGSK-3b, Bcl-2 and neurotrophins GDNF, BDNF suggesting repressed PI3K/@GENE$ signaling.",
        "relation": "CPR:4"
    },
    {
        "id": "23261589.T5.T21",
        "sentence": "@CHEMICAL$ toxicity coincided with reduced pAkt level and its downstream effectors: pCREB, @GENE$, Bcl-2 and neurotrophins GDNF, BDNF suggesting repressed PI3K/Akt signaling.",
        "relation": "CPR:4"
    },
    {
        "id": "23261589.T5.T22",
        "sentence": "@CHEMICAL$ toxicity coincided with reduced pAkt level and its downstream effectors: pCREB, pGSK-3b, @GENE$ and neurotrophins GDNF, BDNF suggesting repressed PI3K/Akt signaling.",
        "relation": "CPR:4"
    },
    {
        "id": "23261589.T5.T24",
        "sentence": "@CHEMICAL$ toxicity coincided with reduced pAkt level and its downstream effectors: pCREB, pGSK-3b, Bcl-2 and neurotrophins @GENE$, BDNF suggesting repressed PI3K/Akt signaling.",
        "relation": "CPR:4"
    },
    {
        "id": "23261589.T5.T25",
        "sentence": "@CHEMICAL$ toxicity coincided with reduced pAkt level and its downstream effectors: pCREB, pGSK-3b, Bcl-2 and neurotrophins GDNF, @GENE$ suggesting repressed PI3K/Akt signaling.",
        "relation": "CPR:4"
    },
    {
        "id": "23261589.T8.T30",
        "sentence": "This was confirmed on adding @CHEMICAL$ the @GENE$ inhibitor which abolished the protection.",
        "relation": "CPR:4"
    },
    {
        "id": "23261676.T15.T31",
        "sentence": "@CHEMICAL$ induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers, heart mitochondrial lipid peroxidation, calcium, and a significant decrease in the activities/levels of heart mitochondrial @GENE$, glutathione reductase, reduced glutathione, isocitrate, succinate, malate, a-ketoglutarate and NADH-dehydrogenases, cytochrome-C-oxidase and adenosine triphosphate.",
        "relation": "CPR:4"
    },
    {
        "id": "23261676.T15.T33",
        "sentence": "@CHEMICAL$ induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers, heart mitochondrial lipid peroxidation, calcium, and a significant decrease in the activities/levels of heart mitochondrial glutathione peroxidase, glutathione reductase, reduced glutathione, isocitrate, succinate, malate, a-ketoglutarate and @GENE$, cytochrome-C-oxidase and adenosine triphosphate.",
        "relation": "CPR:4"
    },
    {
        "id": "23261676.T15.T34",
        "sentence": "@CHEMICAL$ induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers, heart mitochondrial lipid peroxidation, calcium, and a significant decrease in the activities/levels of heart mitochondrial glutathione peroxidase, glutathione reductase, reduced glutathione, isocitrate, succinate, malate, a-ketoglutarate and NADH-dehydrogenases, @GENE$ and adenosine triphosphate.",
        "relation": "CPR:4"
    },
    {
        "id": "23261676.T15.T32",
        "sentence": "@CHEMICAL$ induced myocardial infarcted rats showed a significant increase in the levels of cardiac diagnostic markers, heart mitochondrial lipid peroxidation, calcium, and a significant decrease in the activities/levels of heart mitochondrial glutathione peroxidase, @GENE$, reduced glutathione, isocitrate, succinate, malate, a-ketoglutarate and NADH-dehydrogenases, cytochrome-C-oxidase and adenosine triphosphate.",
        "relation": "CPR:4"
    },
    {
        "id": "23261757.T6.T11",
        "sentence": "Increased urinary excretion of @CHEMICAL$, hemopexin, transferrin and VDBP correlates with chronic sensitization to @GENE$ nephrotoxicity in rats.",
        "relation": "CPR:3"
    },
    {
        "id": "23261757.T6.T12",
        "sentence": "Increased urinary excretion of albumin, @CHEMICAL$, transferrin and VDBP correlates with chronic sensitization to @GENE$ nephrotoxicity in rats.",
        "relation": "CPR:3"
    },
    {
        "id": "23261757.T6.T13",
        "sentence": "Increased urinary excretion of albumin, hemopexin, @CHEMICAL$ and VDBP correlates with chronic sensitization to @GENE$ nephrotoxicity in rats.",
        "relation": "CPR:3"
    },
    {
        "id": "23261757.T6.T14",
        "sentence": "Increased urinary excretion of albumin, hemopexin, transferrin and @CHEMICAL$ correlates with chronic sensitization to @GENE$ nephrotoxicity in rats.",
        "relation": "CPR:3"
    },
    {
        "id": "23265905.T2.T9",
        "sentence": "Design and synthesis of novel @CHEMICAL$ derivatives as @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23266270.T2.T19",
        "sentence": "@CHEMICAL$ induced dose-dependent reduction of the protein levels of @GENE$ (iNOS) and cyclooxygenase-2 (COX-2) and concomitant reduction in the production of NO and prostaglandin E(2) (PGE(2)).",
        "relation": "CPR:4"
    },
    {
        "id": "23266270.T2.T20",
        "sentence": "@CHEMICAL$ induced dose-dependent reduction of the protein levels of inducible nitric oxide synthase (@GENE$) and cyclooxygenase-2 (COX-2) and concomitant reduction in the production of NO and prostaglandin E(2) (PGE(2)).",
        "relation": "CPR:4"
    },
    {
        "id": "23266270.T2.T21",
        "sentence": "@CHEMICAL$ induced dose-dependent reduction of the protein levels of inducible nitric oxide synthase (iNOS) and @GENE$ (COX-2) and concomitant reduction in the production of NO and prostaglandin E(2) (PGE(2)).",
        "relation": "CPR:4"
    },
    {
        "id": "23266270.T2.T22",
        "sentence": "@CHEMICAL$ induced dose-dependent reduction of the protein levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (@GENE$) and concomitant reduction in the production of NO and prostaglandin E(2) (PGE(2)).",
        "relation": "CPR:4"
    },
    {
        "id": "23266270.T7.T23",
        "sentence": "Additionally, @CHEMICAL$ suppressed the production of inflammatory @GENE$, including tumor necrosis factor-a (TNF-a), interleukin (IL)-1b, and IL-6.",
        "relation": "CPR:4"
    },
    {
        "id": "23266270.T7.T24",
        "sentence": "Additionally, @CHEMICAL$ suppressed the production of inflammatory cytokines, including @GENE$ (TNF-a), interleukin (IL)-1b, and IL-6.",
        "relation": "CPR:4"
    },
    {
        "id": "23266270.T7.T25",
        "sentence": "Additionally, @CHEMICAL$ suppressed the production of inflammatory cytokines, including tumor necrosis factor-a (@GENE$), interleukin (IL)-1b, and IL-6.",
        "relation": "CPR:4"
    },
    {
        "id": "23266270.T7.T26",
        "sentence": "Additionally, @CHEMICAL$ suppressed the production of inflammatory cytokines, including tumor necrosis factor-a (TNF-a), @GENE$, and IL-6.",
        "relation": "CPR:4"
    },
    {
        "id": "23266270.T7.T27",
        "sentence": "Additionally, @CHEMICAL$ suppressed the production of inflammatory cytokines, including tumor necrosis factor-a (TNF-a), interleukin (IL)-1b, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23266270.T12.T32",
        "sentence": "@CHEMICAL$ inhibited LPS-induced phosphorylation of @GENE$, JNK, and p38.",
        "relation": "CPR:4"
    },
    {
        "id": "23266270.T12.T33",
        "sentence": "@CHEMICAL$ inhibited LPS-induced phosphorylation of ERK, @GENE$, and p38.",
        "relation": "CPR:4"
    },
    {
        "id": "23266270.T12.T34",
        "sentence": "@CHEMICAL$ inhibited LPS-induced phosphorylation of ERK, JNK, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23266270.T13.T36",
        "sentence": "Furthermore, @CHEMICAL$ inhibited the LPS-induced phosphorylation of inhibitor kB (IkB)-a and @GENE$ p50.",
        "relation": "CPR:4"
    },
    {
        "id": "23266270.T13.T16",
        "sentence": "Furthermore, @CHEMICAL$ inhibited the LPS-induced phosphorylation of inhibitor kB (IkB)-a and NF-kB @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23266270.T13.T35",
        "sentence": "Furthermore, @CHEMICAL$ inhibited the LPS-induced phosphorylation of @GENE$ and NF-kB p50.",
        "relation": "CPR:4"
    },
    {
        "id": "23266270.T1.T17",
        "sentence": "Taken together, the results of this study demonstrate that @CHEMICAL$ inhibits LPS-stimulated inflammation by blocking the @GENE$ and MAPK pathways in macrophages.",
        "relation": "CPR:4"
    },
    {
        "id": "23266270.T1.T18",
        "sentence": "Taken together, the results of this study demonstrate that @CHEMICAL$ inhibits LPS-stimulated inflammation by blocking the NF-kB and @GENE$ pathways in macrophages.",
        "relation": "CPR:4"
    },
    {
        "id": "23267840.T13.T24",
        "sentence": "This leads to decreased expression of @CHEMICAL$, which in turn reduces @GENE$ transport.",
        "relation": "CPR:9"
    },
    {
        "id": "23281812.T6.T20",
        "sentence": "@CHEMICAL$ type dual inhibitors of @GENE$/aldosterone synthase as a novel strategy for breast cancer patients with elevated cardiovascular risks.",
        "relation": "CPR:4"
    },
    {
        "id": "23281812.T6.T21",
        "sentence": "@CHEMICAL$ type dual inhibitors of aromatase/@GENE$ as a novel strategy for breast cancer patients with elevated cardiovascular risks.",
        "relation": "CPR:4"
    },
    {
        "id": "23282066.T1.T14",
        "sentence": "Furthermore, @CHEMICAL$ caused mechanism-based inactivation of @GENE$-dependent TRZ 1'-hydroxylation in mouse, rat and human intestinal microsomes with similar potencies.",
        "relation": "CPR:4"
    },
    {
        "id": "23282066.T2.T14",
        "sentence": "Furthermore, MDZ caused mechanism-based inactivation of @CHEMICAL$-dependent @GENE$ 1'-hydroxylation in mouse, rat and human intestinal microsomes with similar potencies.",
        "relation": "CPR:9"
    },
    {
        "id": "23295740.T15.T31",
        "sentence": "@CHEMICAL$ represses @GENE$ microRNAs and promotes epithelial-to-mesenchymal transition by up-regulating c-Myc in endometrial carcinoma cell lines.",
        "relation": "CPR:4"
    },
    {
        "id": "23295740.T15.T30",
        "sentence": "@CHEMICAL$ represses miR-200 microRNAs and promotes epithelial-to-mesenchymal transition by up-regulating @GENE$ in endometrial carcinoma cell lines.",
        "relation": "CPR:3"
    },
    {
        "id": "23295740.T12.T25",
        "sentence": "@CHEMICAL$, a miRNA family with tumor suppressive functions in a wide range of cancers, was found reduced in response to @GENE$ treatment.",
        "relation": "CPR:4"
    },
    {
        "id": "23295740.T1.T16",
        "sentence": "Consistent with zinc finger E-box binding homeobox 2, which was confirmed as a direct target of miR-200b in endometrial cancer cell lines, some other key factors of EMT such as Snail and N-cadherin increased, whereas @CHEMICAL$ decreased in the @GENE$-treated cells, contributing to TAM-induced EMT in these endometrial cancer cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23295740.T1.T28",
        "sentence": "Consistent with zinc finger E-box binding homeobox 2, which was confirmed as a direct target of miR-200b in endometrial cancer cell lines, some other key factors of EMT such as @CHEMICAL$ and N-cadherin increased, whereas E-cadherin decreased in the @GENE$-treated cells, contributing to TAM-induced EMT in these endometrial cancer cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23295740.T1.T29",
        "sentence": "Consistent with zinc finger E-box binding homeobox 2, which was confirmed as a direct target of miR-200b in endometrial cancer cell lines, some other key factors of EMT such as Snail and @CHEMICAL$ increased, whereas E-cadherin decreased in the @GENE$-treated cells, contributing to TAM-induced EMT in these endometrial cancer cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23295740.T3.T19",
        "sentence": "In addition, we showed that c-Myc directly binds to and represses the promoter of miR-200 miRNAs, and its up-regulation in @CHEMICAL$-treated endometrial cancer cells leads to the down-regulation of @GENE$ and eventually to EMT.",
        "relation": "CPR:4"
    },
    {
        "id": "23295740.T4.T20",
        "sentence": "Collectively, our data suggest that @CHEMICAL$ can repress the @GENE$ family and induce EMT via the up-regulation of c-Myc in endometrial cancer cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23295740.T4.T21",
        "sentence": "Collectively, our data suggest that @CHEMICAL$ can repress the miR-200 family and induce EMT via the up-regulation of @GENE$ in endometrial cancer cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23297412.T1.T10",
        "sentence": "Here, we show that oral administration of @CHEMICAL$, which leads to activation of an @GENE$, suppresses cardiac hypertrophy and fibrosis and restores cardiac diastolic function in dystrophin-deficient mdx mice.",
        "relation": "CPR:3"
    },
    {
        "id": "23297412.T3.T14",
        "sentence": "The pro-hypertrophic co-activator p300 protein but not p300 mRNA was up-regulated in the mdx heart, and @CHEMICAL$ administration down-regulated the @GENE$ protein level.",
        "relation": "CPR:4"
    },
    {
        "id": "23297412.T5.T16",
        "sentence": "In cultured cardiomyocytes, cardiomyocyte hypertrophy induced by the a(1)-agonist phenylephrine was inhibited by the overexpression of SIRT1 as well as @CHEMICAL$, both of which down-regulated @GENE$ protein levels but not p300 mRNA levels.",
        "relation": "CPR:4"
    },
    {
        "id": "23305921.T23.T28",
        "sentence": "Synthesis and dual biological effects of @CHEMICAL$/prolyl hydroxamic acid derivatives as @GENE$ inhibitor and antioxidant.",
        "relation": "CPR:4"
    },
    {
        "id": "23305921.T24.T28",
        "sentence": "Synthesis and dual biological effects of hydroxycinnamoyl phenylalanyl/@CHEMICAL$ derivatives as @GENE$ inhibitor and antioxidant.",
        "relation": "CPR:4"
    },
    {
        "id": "23305921.T15.T25",
        "sentence": "We previously reported that caffeoyl-amino acidyl-hydroxamic acid (@CHEMICAL$) acted as both a good antioxidant and @GENE$ inhibitor, in particular when caffeic acid was conjugated with proline or amino acids having aromatic ring like phenylalanine.",
        "relation": "CPR:4"
    },
    {
        "id": "23305921.T6.T25",
        "sentence": "We previously reported that @CHEMICAL$ (CA-Xaa-NHOH) acted as both a good antioxidant and @GENE$ inhibitor, in particular when caffeic acid was conjugated with proline or amino acids having aromatic ring like phenylalanine.",
        "relation": "CPR:4"
    },
    {
        "id": "23305921.T21.T27",
        "sentence": "In addition, derivatives of @CHEMICAL$ and sinapic acid efficiently inhibited @GENE$ activity and reduced melanin content in melanocytes Mel-Ab cell.",
        "relation": "CPR:4"
    },
    {
        "id": "23305921.T22.T27",
        "sentence": "In addition, derivatives of caffeic acid and @CHEMICAL$ efficiently inhibited @GENE$ activity and reduced melanin content in melanocytes Mel-Ab cell.",
        "relation": "CPR:4"
    },
    {
        "id": "23307549.T1.T13",
        "sentence": "@CHEMICAL$ is a small-molecule inhibitor of @GENE$ and JAK2 and recently became the first drug approved by the United States Food and Drug Administration for the treatment of symptomatic intermediate- or high-risk myelofibrosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23307549.T1.T14",
        "sentence": "@CHEMICAL$ is a small-molecule inhibitor of JAK1 and @GENE$ and recently became the first drug approved by the United States Food and Drug Administration for the treatment of symptomatic intermediate- or high-risk myelofibrosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23318731.T19.T26",
        "sentence": "@CHEMICAL$ and BaP treatments significantly increased active @GENE$ levels in a time-dependent manner.",
        "relation": "CPR:3"
    },
    {
        "id": "23318731.T20.T26",
        "sentence": "Pb and @CHEMICAL$ treatments significantly increased active @GENE$ levels in a time-dependent manner.",
        "relation": "CPR:3"
    },
    {
        "id": "23318833.T8.T26",
        "sentence": "@CHEMICAL$ increased the number and area of @GENE$ (GST-P)(+) liver cell foci and the numbers of proliferating and apoptotic cells in randomly selected areas in liver sections.",
        "relation": "CPR:3"
    },
    {
        "id": "23318833.T8.T27",
        "sentence": "@CHEMICAL$ increased the number and area of glutathione S-transferase placental form (@GENE$)(+) liver cell foci and the numbers of proliferating and apoptotic cells in randomly selected areas in liver sections.",
        "relation": "CPR:3"
    },
    {
        "id": "23318833.T12.T30",
        "sentence": "@CHEMICAL$ also increased the numbers of ED2(+), cyclooxygenase-2(+), and heme oxygenase-1(+) liver cells, as well as the number of @GENE$(+) lymphocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "23318833.T12.T28",
        "sentence": "@CHEMICAL$ also increased the numbers of ED2(+), @GENE$(+), and heme oxygenase-1(+) liver cells, as well as the number of CD3(+) lymphocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "23318833.T12.T29",
        "sentence": "@CHEMICAL$ also increased the numbers of ED2(+), cyclooxygenase-2(+), and @GENE$(+) liver cells, as well as the number of CD3(+) lymphocytes.",
        "relation": "CPR:4"
    },
    {
        "id": "23319419.T18.T41",
        "sentence": "@CHEMICAL$ interacts with a common binding site to elicit opposite effects on inactivation gating of EAG and ERG @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23319419.T18.T39",
        "sentence": "@CHEMICAL$ interacts with a common binding site to elicit opposite effects on inactivation gating of @GENE$ and ERG potassium channels.",
        "relation": "CPR:3"
    },
    {
        "id": "23319419.T18.T40",
        "sentence": "@CHEMICAL$ interacts with a common binding site to elicit opposite effects on inactivation gating of EAG and @GENE$ potassium channels.",
        "relation": "CPR:3"
    },
    {
        "id": "23319419.T12.T34",
        "sentence": "Although @CHEMICAL$ greatly attenuates @GENE$ inactivation by shifting its voltage dependence to more positive potentials, it enhances the rate and extent of EAG inactivation without altering its voltage dependence.",
        "relation": "CPR:3"
    },
    {
        "id": "23319419.T12.T35",
        "sentence": "Although @CHEMICAL$ greatly attenuates ERG inactivation by shifting its voltage dependence to more positive potentials, it enhances the rate and extent of @GENE$ inactivation without altering its voltage dependence.",
        "relation": "CPR:4"
    },
    {
        "id": "23319419.T17.T20",
        "sentence": "@CHEMICAL$ is a mixed agonist of mutant @GENE$ and EAG/ERG chimera channels that inactivate by a combination of slow and fast mechanisms.",
        "relation": "CPR:5"
    },
    {
        "id": "23319419.T17.T21",
        "sentence": "@CHEMICAL$ is a mixed agonist of mutant EAG and @GENE$/ERG chimera channels that inactivate by a combination of slow and fast mechanisms.",
        "relation": "CPR:5"
    },
    {
        "id": "23319419.T17.T22",
        "sentence": "@CHEMICAL$ is a mixed agonist of mutant EAG and EAG/@GENE$ chimera channels that inactivate by a combination of slow and fast mechanisms.",
        "relation": "CPR:5"
    },
    {
        "id": "23321689.T2.T15",
        "sentence": "PNU-282987 on the other hand displayed an increase in anxiety-like behavior at a higher dose (10 mg/kg) that was significantly reduced by the @CHEMICAL$ antagonist @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "23321689.T3.T16",
        "sentence": "However the @CHEMICAL$ antagonist @GENE$ was unable to reverse these anxiety-like effects seen with PNU-282987.",
        "relation": "CPR:6"
    },
    {
        "id": "23322164.T23.T46",
        "sentence": "@CHEMICAL$ and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23322164.T23.T47",
        "sentence": "Carnitine palmitoyltransferase 2 and @CHEMICAL$ are involved in the mitochondrial synthesis and export of @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23322164.T10.T34",
        "sentence": "This shows that CPT2 and CACT are crucial for mitochondrial acylcarnitine formation and export to the extracellular fluids in mFAOD.-Violante, S., IJlst, L., te Brinke, H., Tavares de Almeida, I., Wanders, R. J. A., Ventura, F. V., Houten, S. M. @CHEMICAL$ and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23322164.T10.T35",
        "sentence": "This shows that CPT2 and CACT are crucial for mitochondrial acylcarnitine formation and export to the extracellular fluids in mFAOD.-Violante, S., IJlst, L., te Brinke, H., Tavares de Almeida, I., Wanders, R. J. A., Ventura, F. V., Houten, S. M. Carnitine palmitoyltransferase 2 and @CHEMICAL$ are involved in the mitochondrial synthesis and export of @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23322164.T5.T32",
        "sentence": "This shows that @CHEMICAL$ and CACT are crucial for mitochondrial @GENE$ formation and export to the extracellular fluids in mFAOD.-Violante, S., IJlst, L., te Brinke, H., Tavares de Almeida, I., Wanders, R. J. A., Ventura, F. V., Houten, S. M. Carnitine palmitoyltransferase 2 and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines.",
        "relation": "CPR:9"
    },
    {
        "id": "23322164.T5.T33",
        "sentence": "This shows that CPT2 and @CHEMICAL$ are crucial for mitochondrial @GENE$ formation and export to the extracellular fluids in mFAOD.-Violante, S., IJlst, L., te Brinke, H., Tavares de Almeida, I., Wanders, R. J. A., Ventura, F. V., Houten, S. M. Carnitine palmitoyltransferase 2 and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines.",
        "relation": "CPR:9"
    },
    {
        "id": "23327794.T9.T14",
        "sentence": "As a result of this study, @CHEMICAL$ (1) was found to be a selective cytotoxic agent for colon cancer cells over normal colon cells and to exhibit @GENE$ antagonistic activity for both the ha3b4 and ha4b2 receptor subtypes.",
        "relation": "CPR:6"
    },
    {
        "id": "23334403.T5.T22",
        "sentence": "PURPOSE: To characterise further the previously observed cytochrome P450 3A4 (CYP3A4) interaction of the dual @CHEMICAL$ antagonist @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "23353901.T12.T41",
        "sentence": "Commercially-available @CHEMICAL$ agonists (@GENE$, Ro 60-0175, WAY 161503, mCPP, and 1-methylpsilocin), novel 4-phenyl-2-N,N-dimethyl-aminotetralin (PAT)-type 5-HT2C agonists (with 5-HT2A/2B antagonist activity), and antagonists selective for 5-HT2A (M100907), 5-HT2C (SB-242084), and 5-HT2B/2C (SB-206553) receptors attenuated the DOI-elicited-HTR.",
        "relation": "CPR:5"
    },
    {
        "id": "23353901.T13.T41",
        "sentence": "Commercially-available @CHEMICAL$ agonists (CP 809101, @GENE$, WAY 161503, mCPP, and 1-methylpsilocin), novel 4-phenyl-2-N,N-dimethyl-aminotetralin (PAT)-type 5-HT2C agonists (with 5-HT2A/2B antagonist activity), and antagonists selective for 5-HT2A (M100907), 5-HT2C (SB-242084), and 5-HT2B/2C (SB-206553) receptors attenuated the DOI-elicited-HTR.",
        "relation": "CPR:5"
    },
    {
        "id": "23353901.T14.T41",
        "sentence": "Commercially-available @CHEMICAL$ agonists (CP 809101, Ro 60-0175, @GENE$, mCPP, and 1-methylpsilocin), novel 4-phenyl-2-N,N-dimethyl-aminotetralin (PAT)-type 5-HT2C agonists (with 5-HT2A/2B antagonist activity), and antagonists selective for 5-HT2A (M100907), 5-HT2C (SB-242084), and 5-HT2B/2C (SB-206553) receptors attenuated the DOI-elicited-HTR.",
        "relation": "CPR:5"
    },
    {
        "id": "23353901.T15.T41",
        "sentence": "Commercially-available @CHEMICAL$ agonists (CP 809101, Ro 60-0175, WAY 161503, @GENE$, and 1-methylpsilocin), novel 4-phenyl-2-N,N-dimethyl-aminotetralin (PAT)-type 5-HT2C agonists (with 5-HT2A/2B antagonist activity), and antagonists selective for 5-HT2A (M100907), 5-HT2C (SB-242084), and 5-HT2B/2C (SB-206553) receptors attenuated the DOI-elicited-HTR.",
        "relation": "CPR:5"
    },
    {
        "id": "23353901.T16.T41",
        "sentence": "Commercially-available @CHEMICAL$ agonists (CP 809101, Ro 60-0175, WAY 161503, mCPP, and @GENE$), novel 4-phenyl-2-N,N-dimethyl-aminotetralin (PAT)-type 5-HT2C agonists (with 5-HT2A/2B antagonist activity), and antagonists selective for 5-HT2A (M100907), 5-HT2C (SB-242084), and 5-HT2B/2C (SB-206553) receptors attenuated the DOI-elicited-HTR.",
        "relation": "CPR:5"
    },
    {
        "id": "23353901.T18.T42",
        "sentence": "Commercially-available 5-HT2C agonists (CP 809101, Ro 60-0175, WAY 161503, mCPP, and 1-methylpsilocin), novel @CHEMICAL$ (PAT)-type @GENE$ agonists (with 5-HT2A/2B antagonist activity), and antagonists selective for 5-HT2A (M100907), 5-HT2C (SB-242084), and 5-HT2B/2C (SB-206553) receptors attenuated the DOI-elicited-HTR.",
        "relation": "CPR:5"
    },
    {
        "id": "23353901.T19.T42",
        "sentence": "Commercially-available 5-HT2C agonists (CP 809101, Ro 60-0175, WAY 161503, mCPP, and 1-methylpsilocin), novel 4-phenyl-2-N,N-dimethyl-aminotetralin (@CHEMICAL$)-type @GENE$ agonists (with 5-HT2A/2B antagonist activity), and antagonists selective for 5-HT2A (M100907), 5-HT2C (SB-242084), and 5-HT2B/2C (SB-206553) receptors attenuated the DOI-elicited-HTR.",
        "relation": "CPR:5"
    },
    {
        "id": "23353901.T21.T44",
        "sentence": "Commercially-available 5-HT2C agonists (CP 809101, Ro 60-0175, WAY 161503, mCPP, and 1-methylpsilocin), novel 4-phenyl-2-N,N-dimethyl-aminotetralin (PAT)-type 5-HT2C agonists (with 5-HT2A/2B antagonist activity), and antagonists selective for @CHEMICAL$ (@GENE$), 5-HT2C (SB-242084), and 5-HT2B/2C (SB-206553) receptors attenuated the DOI-elicited-HTR.",
        "relation": "CPR:6"
    },
    {
        "id": "23353901.T22.T45",
        "sentence": "Commercially-available 5-HT2C agonists (CP 809101, Ro 60-0175, WAY 161503, mCPP, and 1-methylpsilocin), novel 4-phenyl-2-N,N-dimethyl-aminotetralin (PAT)-type 5-HT2C agonists (with 5-HT2A/2B antagonist activity), and antagonists selective for 5-HT2A (M100907), @CHEMICAL$ (@GENE$), and 5-HT2B/2C (SB-206553) receptors attenuated the DOI-elicited-HTR.",
        "relation": "CPR:6"
    },
    {
        "id": "23353901.T6.T27",
        "sentence": "In vitro molecular pharmacology studies showed that 5-HT2C agonists potent for attenuating the DOI-elicited-HTR also reduced the efficacy of @CHEMICAL$ to activate @GENE$ receptor-mediated PLC signaling in HEK cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23361846.T1.T24",
        "sentence": "@CHEMICAL$ N-demethylation in vitro is catalyzed by hepatic cytochrome P4502B6 (CYP2B6) and CYP3A4, but clinical disposition is often attributed to @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23361846.T1.T30",
        "sentence": "@CHEMICAL$ N-demethylation in vitro is catalyzed by hepatic @GENE$ (CYP2B6) and CYP3A4, but clinical disposition is often attributed to CYP3A4.",
        "relation": "CPR:9"
    },
    {
        "id": "23361846.T1.T31",
        "sentence": "@CHEMICAL$ N-demethylation in vitro is catalyzed by hepatic cytochrome P4502B6 (@GENE$) and CYP3A4, but clinical disposition is often attributed to CYP3A4.",
        "relation": "CPR:9"
    },
    {
        "id": "23361846.T1.T32",
        "sentence": "@CHEMICAL$ N-demethylation in vitro is catalyzed by hepatic cytochrome P4502B6 (CYP2B6) and @GENE$, but clinical disposition is often attributed to CYP3A4.",
        "relation": "CPR:9"
    },
    {
        "id": "23361846.T2.T24",
        "sentence": "Methadone @CHEMICAL$-demethylation in vitro is catalyzed by hepatic cytochrome P4502B6 (CYP2B6) and CYP3A4, but clinical disposition is often attributed to @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23361846.T2.T30",
        "sentence": "Methadone @CHEMICAL$-demethylation in vitro is catalyzed by hepatic @GENE$ (CYP2B6) and CYP3A4, but clinical disposition is often attributed to CYP3A4.",
        "relation": "CPR:9"
    },
    {
        "id": "23361846.T2.T31",
        "sentence": "Methadone @CHEMICAL$-demethylation in vitro is catalyzed by hepatic cytochrome P4502B6 (@GENE$) and CYP3A4, but clinical disposition is often attributed to CYP3A4.",
        "relation": "CPR:9"
    },
    {
        "id": "23361846.T2.T32",
        "sentence": "Methadone @CHEMICAL$-demethylation in vitro is catalyzed by hepatic cytochrome P4502B6 (CYP2B6) and @GENE$, but clinical disposition is often attributed to CYP3A4.",
        "relation": "CPR:9"
    },
    {
        "id": "23361846.T7.T26",
        "sentence": "This investigation tested the hypothesis that CYP2B6 is a prominent @CHEMICAL$ isoform responsible for clinical @GENE$ N-demethylation and clearance, using the in vivo mechanism-based CYP2B6 inhibitor ticlopidine, given orally for 4 days.",
        "relation": "CPR:9"
    },
    {
        "id": "23361846.T7.T25",
        "sentence": "This investigation tested the hypothesis that @CHEMICAL$ is a prominent CYP isoform responsible for clinical @GENE$ N-demethylation and clearance, using the in vivo mechanism-based CYP2B6 inhibitor ticlopidine, given orally for 4 days.",
        "relation": "CPR:9"
    },
    {
        "id": "23361846.T8.T26",
        "sentence": "This investigation tested the hypothesis that CYP2B6 is a prominent @CHEMICAL$ isoform responsible for clinical methadone @GENE$-demethylation and clearance, using the in vivo mechanism-based CYP2B6 inhibitor ticlopidine, given orally for 4 days.",
        "relation": "CPR:9"
    },
    {
        "id": "23361846.T8.T25",
        "sentence": "This investigation tested the hypothesis that @CHEMICAL$ is a prominent CYP isoform responsible for clinical methadone @GENE$-demethylation and clearance, using the in vivo mechanism-based CYP2B6 inhibitor ticlopidine, given orally for 4 days.",
        "relation": "CPR:9"
    },
    {
        "id": "23361846.T9.T27",
        "sentence": "This investigation tested the hypothesis that CYP2B6 is a prominent CYP isoform responsible for clinical methadone N-demethylation and clearance, using the in vivo mechanism-based @CHEMICAL$ inhibitor @GENE$, given orally for 4 days.",
        "relation": "CPR:4"
    },
    {
        "id": "23361846.T6.T23",
        "sentence": "CYP2B6 inhibition reduces methadone N-demethylation and clearance, and alters methadone concentrations, demonstrating an important role for @CHEMICAL$ in clinical @GENE$ disposition.",
        "relation": "CPR:9"
    },
    {
        "id": "23373701.T2.T23",
        "sentence": "We found that treatment of both differentiated dopaminergic-like SH-SY5Y cells and rat midbrain slices with the @CHEMICAL$ (D2R) agonist, @GENE$, triggered an increase in the expression of GDNF that was temporally preceded by an increase in the levels of zinc-finger protein 268 (Zif268), a DNA-binding transcription factor encoded by an immediate-early gene.",
        "relation": "CPR:5"
    },
    {
        "id": "23373701.T2.T25",
        "sentence": "We found that treatment of both differentiated dopaminergic-like SH-SY5Y cells and rat midbrain slices with the dopamine D2 receptor (@CHEMICAL$) agonist, @GENE$, triggered an increase in the expression of GDNF that was temporally preceded by an increase in the levels of zinc-finger protein 268 (Zif268), a DNA-binding transcription factor encoded by an immediate-early gene.",
        "relation": "CPR:5"
    },
    {
        "id": "23373701.T2.T26",
        "sentence": "We found that treatment of both differentiated dopaminergic-like SH-SY5Y cells and rat midbrain slices with the dopamine D2 receptor (D2R) agonist, @CHEMICAL$, triggered an increase in the expression of @GENE$ that was temporally preceded by an increase in the levels of zinc-finger protein 268 (Zif268), a DNA-binding transcription factor encoded by an immediate-early gene.",
        "relation": "CPR:3"
    },
    {
        "id": "23373701.T2.T27",
        "sentence": "We found that treatment of both differentiated dopaminergic-like SH-SY5Y cells and rat midbrain slices with the dopamine D2 receptor (D2R) agonist, @CHEMICAL$, triggered an increase in the expression of GDNF that was temporally preceded by an increase in the levels of @GENE$ (Zif268), a DNA-binding transcription factor encoded by an immediate-early gene.",
        "relation": "CPR:3"
    },
    {
        "id": "23373701.T2.T28",
        "sentence": "We found that treatment of both differentiated dopaminergic-like SH-SY5Y cells and rat midbrain slices with the dopamine D2 receptor (D2R) agonist, @CHEMICAL$, triggered an increase in the expression of GDNF that was temporally preceded by an increase in the levels of zinc-finger protein 268 (@GENE$), a DNA-binding transcription factor encoded by an immediate-early gene.",
        "relation": "CPR:3"
    },
    {
        "id": "23373701.T4.T29",
        "sentence": "Moreover, the @CHEMICAL$ inhibitor @GENE$ blocked the increase of both GDNF and Zif268 expression following potassium-evoked dopamine release in SH-SY5Y cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23373701.T4.T30",
        "sentence": "Moreover, the D2R inhibitor @CHEMICAL$ blocked the increase of both @GENE$ and Zif268 expression following potassium-evoked dopamine release in SH-SY5Y cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23373701.T4.T31",
        "sentence": "Moreover, the D2R inhibitor @CHEMICAL$ blocked the increase of both GDNF and @GENE$ expression following potassium-evoked dopamine release in SH-SY5Y cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23376249.T3.T13",
        "sentence": "Synthesis and biological evaluation of @CHEMICAL$ analogues as novel @GENE$ and BuChE inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23376249.T3.T14",
        "sentence": "Synthesis and biological evaluation of @CHEMICAL$ analogues as novel AChE and @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23376249.T2.T4",
        "sentence": "In this paper a series of new @CHEMICAL$ derivatives has been designed, synthesized and evaluated as the @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23376356.T1.T15",
        "sentence": "@CHEMICAL$, a specific @GENE$/AKT inhibitor, selectively activated the p38 MAPK kinase pathway and enhanced c-Jun phosphorylation, but did not activate JNK.",
        "relation": "CPR:4"
    },
    {
        "id": "23376356.T1.T16",
        "sentence": "@CHEMICAL$, a specific PI3K/@GENE$ inhibitor, selectively activated the p38 MAPK kinase pathway and enhanced c-Jun phosphorylation, but did not activate JNK.",
        "relation": "CPR:4"
    },
    {
        "id": "23376356.T1.T17",
        "sentence": "@CHEMICAL$, a specific PI3K/AKT inhibitor, selectively activated the @GENE$ MAPK kinase pathway and enhanced c-Jun phosphorylation, but did not activate JNK.",
        "relation": "CPR:3"
    },
    {
        "id": "23376356.T1.T18",
        "sentence": "@CHEMICAL$, a specific PI3K/AKT inhibitor, selectively activated the p38 @GENE$ kinase pathway and enhanced c-Jun phosphorylation, but did not activate JNK.",
        "relation": "CPR:3"
    },
    {
        "id": "23376356.T1.T19",
        "sentence": "@CHEMICAL$, a specific PI3K/AKT inhibitor, selectively activated the p38 MAPK @GENE$ pathway and enhanced c-Jun phosphorylation, but did not activate JNK.",
        "relation": "CPR:3"
    },
    {
        "id": "23376356.T1.T20",
        "sentence": "@CHEMICAL$, a specific PI3K/AKT inhibitor, selectively activated the p38 MAPK kinase pathway and enhanced @GENE$ phosphorylation, but did not activate JNK.",
        "relation": "CPR:3"
    },
    {
        "id": "23376356.T2.T22",
        "sentence": "The pharmacological inhibitors @CHEMICAL$ (@GENE$ inhibitor) and SP600125 (a JNK inhibitor) protected primary cultures of rat CGCs from LY294002-induced apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23376356.T3.T23",
        "sentence": "The pharmacological inhibitors SB203580 (p38 inhibitor) and @CHEMICAL$ (a @GENE$ inhibitor) protected primary cultures of rat CGCs from LY294002-induced apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23380477.T1.T15",
        "sentence": "Today, we used @CHEMICAL$, a hypoxia mimetic that inhibits proteasomal @GENE$ degradation and generates reactive oxygen species (ROS).",
        "relation": "CPR:3"
    },
    {
        "id": "23380477.T4.T20",
        "sentence": "An autophagic signaling was evidenced by an increase of Beclin-1, ATG 5-12, and LC3-II expression whereas the @CHEMICAL$(mut) presence decreased with @GENE$ time exposure.",
        "relation": "CPR:4"
    },
    {
        "id": "23382381.T2.T28",
        "sentence": "Cellular responses to DNA damage induced by @CHEMICAL$ or doxorubicin include down-regulation of endogenous @GENE$ coincident with increases in p53.",
        "relation": "CPR:4"
    },
    {
        "id": "23382381.T2.T29",
        "sentence": "Cellular responses to DNA damage induced by @CHEMICAL$ or doxorubicin include down-regulation of endogenous supervillin coincident with increases in @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23382381.T3.T28",
        "sentence": "Cellular responses to DNA damage induced by etoposide or @CHEMICAL$ include down-regulation of endogenous @GENE$ coincident with increases in p53.",
        "relation": "CPR:4"
    },
    {
        "id": "23382381.T3.T29",
        "sentence": "Cellular responses to DNA damage induced by etoposide or @CHEMICAL$ include down-regulation of endogenous supervillin coincident with increases in @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23384387.T11.T21",
        "sentence": "Novel @CHEMICAL$ derivatives that modulate body weight through enhancement of hypothalamic pro-opiomelanocortin (@GENE$) and/or decreased neuropeptide Y (NPY).",
        "relation": "CPR:3"
    },
    {
        "id": "23384387.T11.T22",
        "sentence": "Novel @CHEMICAL$ derivatives that modulate body weight through enhancement of hypothalamic pro-opiomelanocortin (POMC) and/or decreased @GENE$ (NPY).",
        "relation": "CPR:4"
    },
    {
        "id": "23384387.T11.T23",
        "sentence": "Novel @CHEMICAL$ derivatives that modulate body weight through enhancement of hypothalamic pro-opiomelanocortin (POMC) and/or decreased neuropeptide Y (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "23384387.T11.T24",
        "sentence": "Novel @CHEMICAL$ derivatives that modulate body weight through enhancement of hypothalamic @GENE$ (POMC) and/or decreased neuropeptide Y (NPY).",
        "relation": "CPR:3"
    },
    {
        "id": "23397032.T1.T11",
        "sentence": "@CHEMICAL$ suppressed @GENE$ gene transcription enhanced by PTH(1-34) without affecting DFosB expression or Smad1 phosphorylation, and dexamethasone-GC receptor complex was bound to JunD, which forms heterodimers with DFosB. High doses of PTH(1-34) counteracted the effect of dexamethasone on apoptosis of mPOBs, which was blunted by neutralizing anti-IL-11 antibody or IL-11 small interfering RNA.",
        "relation": "CPR:4"
    },
    {
        "id": "23402856.T18.T28",
        "sentence": "Number and area of preneoplastic foci positive for @CHEMICAL$ (GST-P) were consistently higher in these groups than the sum of individual values in the groups treated with @GENE$ or HCB alone.",
        "relation": "CPR:3"
    },
    {
        "id": "23402856.T18.T29",
        "sentence": "Number and area of preneoplastic foci positive for glutathione S-transferase placental form (@CHEMICAL$) were consistently higher in these groups than the sum of individual values in the groups treated with @GENE$ or HCB alone.",
        "relation": "CPR:3"
    },
    {
        "id": "23402856.T19.T28",
        "sentence": "Number and area of preneoplastic foci positive for @CHEMICAL$ (GST-P) were consistently higher in these groups than the sum of individual values in the groups treated with HEP or @GENE$ alone.",
        "relation": "CPR:3"
    },
    {
        "id": "23402856.T19.T29",
        "sentence": "Number and area of preneoplastic foci positive for glutathione S-transferase placental form (@CHEMICAL$) were consistently higher in these groups than the sum of individual values in the groups treated with HEP or @GENE$ alone.",
        "relation": "CPR:3"
    },
    {
        "id": "23402856.T3.T27",
        "sentence": "On the basis of these findings, we conclude that @CHEMICAL$ and HCB have additive and synergistic effects on the development of @GENE$-positive foci and that higher risks are associated with a combination of residual organochlorine pesticides in foods than with individual residual organochlorine pesticides.",
        "relation": "CPR:3"
    },
    {
        "id": "23402856.T5.T27",
        "sentence": "On the basis of these findings, we conclude that HEP and @CHEMICAL$ have additive and synergistic effects on the development of @GENE$-positive foci and that higher risks are associated with a combination of residual organochlorine pesticides in foods than with individual residual organochlorine pesticides.",
        "relation": "CPR:3"
    },
    {
        "id": "23403092.T9.T20",
        "sentence": "The food contaminant @CHEMICAL$ activates the @GENE$ in the intestine: interest of ex vivo models as an alternative to in vivo experiments.",
        "relation": "CPR:3"
    },
    {
        "id": "23403092.T2.T11",
        "sentence": "Taken together these results indicate that in vivo or ex vivo exposure of intestinal tissue to @CHEMICAL$ lead to similar intestinal lesions and activation of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23403272.T19.T33",
        "sentence": "@CHEMICAL$ protects human EA.hy926 endothelial cells against gamma-radiation induced oxidative injury by activating the @GENE$/heme oxygenase-1 pathway.",
        "relation": "CPR:3"
    },
    {
        "id": "23403272.T19.T34",
        "sentence": "@CHEMICAL$ protects human EA.hy926 endothelial cells against gamma-radiation induced oxidative injury by activating the NF-E2-related factor 2/@GENE$ pathway.",
        "relation": "CPR:3"
    },
    {
        "id": "23403272.T10.T29",
        "sentence": "In particular, we showed that @CHEMICAL$ significantly reduced the formation of intracellular reactive oxygen species (ROS), the level of malondialdehyde (MDA) and @GENE$ (LDH) leakage, and enhanced production of the endogenous antioxidants, glutathione (GSH) and superoxide dismutase (SOD) in EA.hy926 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23403272.T10.T30",
        "sentence": "In particular, we showed that @CHEMICAL$ significantly reduced the formation of intracellular reactive oxygen species (ROS), the level of malondialdehyde (MDA) and lactate dehydrogenase (@GENE$) leakage, and enhanced production of the endogenous antioxidants, glutathione (GSH) and superoxide dismutase (SOD) in EA.hy926 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23403272.T10.T31",
        "sentence": "In particular, we showed that @CHEMICAL$ significantly reduced the formation of intracellular reactive oxygen species (ROS), the level of malondialdehyde (MDA) and lactate dehydrogenase (LDH) leakage, and enhanced production of the endogenous antioxidants, glutathione (GSH) and @GENE$ (SOD) in EA.hy926 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23403272.T10.T32",
        "sentence": "In particular, we showed that @CHEMICAL$ significantly reduced the formation of intracellular reactive oxygen species (ROS), the level of malondialdehyde (MDA) and lactate dehydrogenase (LDH) leakage, and enhanced production of the endogenous antioxidants, glutathione (GSH) and superoxide dismutase (@GENE$) in EA.hy926 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23403272.T18.T21",
        "sentence": "Treatment of these cells with @CHEMICAL$ significantly induced @GENE$ expression.",
        "relation": "CPR:3"
    },
    {
        "id": "23403272.T2.T24",
        "sentence": "The @CHEMICAL$-induced @GENE$ expression was abrogated by Nrf2 siRNA.",
        "relation": "CPR:3"
    },
    {
        "id": "23403272.T3.T26",
        "sentence": "Furthermore, inhibition of @CHEMICAL$ with @GENE$ (ZNPP) significantly reversed the protective effect of Paeoniflorin against radiation-induced damage in EA.hy926 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23403272.T4.T26",
        "sentence": "Furthermore, inhibition of @CHEMICAL$ with zinc protoporphyrin IX (@GENE$) significantly reversed the protective effect of Paeoniflorin against radiation-induced damage in EA.hy926 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23403272.T5.T26",
        "sentence": "Furthermore, inhibition of @CHEMICAL$ with zinc protoporphyrin IX (ZNPP) significantly reversed the protective effect of @GENE$ against radiation-induced damage in EA.hy926 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23403272.T6.T27",
        "sentence": "Our findings confirmed that @CHEMICAL$ protected EA.hy926 cells against radiation-induced injury through the @GENE$/HO-1 pathway.",
        "relation": "CPR:3"
    },
    {
        "id": "23403272.T6.T28",
        "sentence": "Our findings confirmed that @CHEMICAL$ protected EA.hy926 cells against radiation-induced injury through the Nrf2/@GENE$ pathway.",
        "relation": "CPR:3"
    },
    {
        "id": "23404093.T5.T12",
        "sentence": "@CHEMICAL$, a second-generation @GENE$ receptor antagonist with a different half-life, a different binding capacity and a different mechanism of action than the first-generation 5-HT3 receptor antagonists appears to be the most effective agent in its class.",
        "relation": "CPR:6"
    },
    {
        "id": "23404093.T6.T14",
        "sentence": "@CHEMICAL$, the first and only agent clinically available in the @GENE$ antagonist drug class has been used effectively as an additive agent to the 5-HT3 receptor antagonists and dexamethasone to control CINV.",
        "relation": "CPR:6"
    },
    {
        "id": "23404093.T8.T16",
        "sentence": "@CHEMICAL$ and netupitant are other @GENE$ antagonists that are currently in phase III clinical trials.",
        "relation": "CPR:6"
    },
    {
        "id": "23404093.T9.T16",
        "sentence": "Rolapitant and @CHEMICAL$ are other @GENE$ antagonists that are currently in phase III clinical trials.",
        "relation": "CPR:6"
    },
    {
        "id": "23411235.T10.T16",
        "sentence": "Moderate inhibitory effect of @CHEMICAL$-C oxidation by @GENE$ was observed.",
        "relation": "CPR:4"
    },
    {
        "id": "23411279.T8.T13",
        "sentence": "Aqueous @CHEMICAL$ (80%) extract of lentil hulls exhibited high antioxidant and anti-inflammatory activities preferentially inhibiting 15-LOX (IC(50), 55 mg/ml), with moderate COX-1 (IC(50), 66 mg/ml) and COX-2 (IC(50), 119 mg/ml) inhibitory effects on the @GENE$ pathway, whereas faba bean hull extracts exerted relatively mild LOX inhibitory activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23411279.T8.T14",
        "sentence": "Aqueous @CHEMICAL$ (80%) extract of lentil hulls exhibited high antioxidant and anti-inflammatory activities preferentially inhibiting 15-LOX (IC(50), 55 mg/ml), with moderate COX-1 (IC(50), 66 mg/ml) and COX-2 (IC(50), 119 mg/ml) inhibitory effects on the COX pathway, whereas faba bean hull extracts exerted relatively mild @GENE$ inhibitory activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23411279.T8.T10",
        "sentence": "Aqueous @CHEMICAL$ (80%) extract of lentil hulls exhibited high antioxidant and anti-inflammatory activities preferentially inhibiting @GENE$ (IC(50), 55 mg/ml), with moderate COX-1 (IC(50), 66 mg/ml) and COX-2 (IC(50), 119 mg/ml) inhibitory effects on the COX pathway, whereas faba bean hull extracts exerted relatively mild LOX inhibitory activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23411279.T8.T11",
        "sentence": "Aqueous @CHEMICAL$ (80%) extract of lentil hulls exhibited high antioxidant and anti-inflammatory activities preferentially inhibiting 15-LOX (IC(50), 55 mg/ml), with moderate @GENE$ (IC(50), 66 mg/ml) and COX-2 (IC(50), 119 mg/ml) inhibitory effects on the COX pathway, whereas faba bean hull extracts exerted relatively mild LOX inhibitory activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23411279.T8.T12",
        "sentence": "Aqueous @CHEMICAL$ (80%) extract of lentil hulls exhibited high antioxidant and anti-inflammatory activities preferentially inhibiting 15-LOX (IC(50), 55 mg/ml), with moderate COX-1 (IC(50), 66 mg/ml) and @GENE$ (IC(50), 119 mg/ml) inhibitory effects on the COX pathway, whereas faba bean hull extracts exerted relatively mild LOX inhibitory activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23411280.T10.T12",
        "sentence": "@CHEMICAL$ (HDC) catalyses the formation of histamine, a bioactive @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23411280.T10.T15",
        "sentence": "Histidine decarboxylase (@CHEMICAL$) catalyses the formation of histamine, a bioactive @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23411280.T8.T12",
        "sentence": "@CHEMICAL$ (HDC) catalyses the formation of @GENE$, a bioactive amine.",
        "relation": "CPR:9"
    },
    {
        "id": "23411280.T8.T15",
        "sentence": "Histidine decarboxylase (@CHEMICAL$) catalyses the formation of @GENE$, a bioactive amine.",
        "relation": "CPR:9"
    },
    {
        "id": "23411280.T3.T14",
        "sentence": "We searched for inhibitors of @CHEMICAL$ from the @GENE$ extract of the petal of Filipendula ulmaria, also called meadowsweet.",
        "relation": "CPR:4"
    },
    {
        "id": "23414838.T6.T10",
        "sentence": "Discovery of a novel series of @CHEMICAL$ @GENE$ agonists.",
        "relation": "CPR:5"
    },
    {
        "id": "23414838.T4.T8",
        "sentence": "High throughput screening led to the identification of a novel series of @CHEMICAL$ a7 nicotinic acetylcholine receptor (@GENE$) agonists.",
        "relation": "CPR:5"
    },
    {
        "id": "23414838.T4.T9",
        "sentence": "High throughput screening led to the identification of a novel series of @CHEMICAL$ @GENE$ (nAChR) agonists.",
        "relation": "CPR:5"
    },
    {
        "id": "23416002.T7.T17",
        "sentence": "@CHEMICAL$ derived quinazolines as @GENE$/PKA inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23416002.T7.T18",
        "sentence": "@CHEMICAL$ derived quinazolines as Rock/@GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23416002.T8.T17",
        "sentence": "Amino acid derived @CHEMICAL$ as @GENE$/PKA inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23416002.T8.T18",
        "sentence": "Amino acid derived @CHEMICAL$ as Rock/@GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23416002.T5.T13",
        "sentence": "SAR and lead optimization studies for @CHEMICAL$ inhibitors based on @GENE$-derived quinazolines are described.",
        "relation": "CPR:4"
    },
    {
        "id": "23416002.T6.T13",
        "sentence": "SAR and lead optimization studies for @CHEMICAL$ inhibitors based on amino acid-derived @GENE$ are described.",
        "relation": "CPR:4"
    },
    {
        "id": "23416002.T3.T12",
        "sentence": "This is distinct from @CHEMICAL$ inhibitors based on non-@GENE$ derived quinazolinones, where high selectivity against PKA could be obtained.(22) The inhibitors presented here in some cases possessed sub-nanomolar inhibition of Rock, nanomolar potency in ppMLC cell based assays, low to fair cytochrome P-450 inhibition, and good human microsomal stability.",
        "relation": "CPR:4"
    },
    {
        "id": "23416002.T3.T14",
        "sentence": "This is distinct from Rock inhibitors based on non-@CHEMICAL$ derived quinazolinones, where high selectivity against @GENE$ could be obtained.(22) The inhibitors presented here in some cases possessed sub-nanomolar inhibition of Rock, nanomolar potency in ppMLC cell based assays, low to fair cytochrome P-450 inhibition, and good human microsomal stability.",
        "relation": "CPR:4"
    },
    {
        "id": "23416002.T4.T12",
        "sentence": "This is distinct from @CHEMICAL$ inhibitors based on non-amino acid derived @GENE$, where high selectivity against PKA could be obtained.(22) The inhibitors presented here in some cases possessed sub-nanomolar inhibition of Rock, nanomolar potency in ppMLC cell based assays, low to fair cytochrome P-450 inhibition, and good human microsomal stability.",
        "relation": "CPR:4"
    },
    {
        "id": "23416002.T4.T14",
        "sentence": "This is distinct from Rock inhibitors based on non-amino acid derived @CHEMICAL$, where high selectivity against @GENE$ could be obtained.(22) The inhibitors presented here in some cases possessed sub-nanomolar inhibition of Rock, nanomolar potency in ppMLC cell based assays, low to fair cytochrome P-450 inhibition, and good human microsomal stability.",
        "relation": "CPR:4"
    },
    {
        "id": "23416065.T5.T23",
        "sentence": "The @CHEMICAL$ inhibitor, @GENE$, is used in the clinic for its anti-inflammatory activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23424204.T14.T17",
        "sentence": "Although there was no change in the levels of insulin receptor (IR), Akt (protein kinase B) and glucose transporter-4 (GLUT4) messenger RNA, @CHEMICAL$ significantly decreased the IR, @GENE$ and GLUT4 protein levels (both plasma membrane and cytosolic fraction) of the gastrocnemius muscle.",
        "relation": "CPR:4"
    },
    {
        "id": "23424204.T14.T18",
        "sentence": "Although there was no change in the levels of insulin receptor (IR), Akt (protein kinase B) and glucose transporter-4 (GLUT4) messenger RNA, @CHEMICAL$ significantly decreased the IR, Akt and @GENE$ protein levels (both plasma membrane and cytosolic fraction) of the gastrocnemius muscle.",
        "relation": "CPR:4"
    },
    {
        "id": "23424204.T14.T31",
        "sentence": "Although there was no change in the levels of insulin receptor (IR), Akt (protein kinase B) and glucose transporter-4 (GLUT4) messenger RNA, @CHEMICAL$ significantly decreased the @GENE$, Akt and GLUT4 protein levels (both plasma membrane and cytosolic fraction) of the gastrocnemius muscle.",
        "relation": "CPR:4"
    },
    {
        "id": "23424204.T4.T20",
        "sentence": "In conclusion, @CHEMICAL$ has adverse effects on phosphorylation of @GENE$, GLUT4 translocation and (14)C-glucose oxidation.",
        "relation": "CPR:4"
    },
    {
        "id": "23424204.T4.T21",
        "sentence": "In conclusion, @CHEMICAL$ has adverse effects on phosphorylation of Akt, @GENE$ translocation and (14)C-glucose oxidation.",
        "relation": "CPR:4"
    },
    {
        "id": "23424207.T21.T41",
        "sentence": "The obtained results showed that @CHEMICAL$ increased lipid peroxidation and abnormal sperm count and decreased plasma testosterone, @GENE$, acid phosphatase, alkaline phosphatase and testicular steroidogenic enzymes: 3b-hydroxysteroid dehydrogenase (HSD), 17b-HSD activities as well as epididymal sperm counts and motility, while RUT and Se treatment reversed this change to control values.",
        "relation": "CPR:4"
    },
    {
        "id": "23424207.T21.T42",
        "sentence": "The obtained results showed that @CHEMICAL$ increased lipid peroxidation and abnormal sperm count and decreased plasma testosterone, lactate dehydrogenase, @GENE$, alkaline phosphatase and testicular steroidogenic enzymes: 3b-hydroxysteroid dehydrogenase (HSD), 17b-HSD activities as well as epididymal sperm counts and motility, while RUT and Se treatment reversed this change to control values.",
        "relation": "CPR:4"
    },
    {
        "id": "23424207.T21.T43",
        "sentence": "The obtained results showed that @CHEMICAL$ increased lipid peroxidation and abnormal sperm count and decreased plasma testosterone, lactate dehydrogenase, acid phosphatase, @GENE$ and testicular steroidogenic enzymes: 3b-hydroxysteroid dehydrogenase (HSD), 17b-HSD activities as well as epididymal sperm counts and motility, while RUT and Se treatment reversed this change to control values.",
        "relation": "CPR:4"
    },
    {
        "id": "23424207.T21.T44",
        "sentence": "The obtained results showed that @CHEMICAL$ increased lipid peroxidation and abnormal sperm count and decreased plasma testosterone, lactate dehydrogenase, acid phosphatase, alkaline phosphatase and @GENE$: 3b-hydroxysteroid dehydrogenase (HSD), 17b-HSD activities as well as epididymal sperm counts and motility, while RUT and Se treatment reversed this change to control values.",
        "relation": "CPR:4"
    },
    {
        "id": "23424207.T21.T45",
        "sentence": "The obtained results showed that @CHEMICAL$ increased lipid peroxidation and abnormal sperm count and decreased plasma testosterone, lactate dehydrogenase, acid phosphatase, alkaline phosphatase and testicular steroidogenic enzymes: @GENE$ (HSD), 17b-HSD activities as well as epididymal sperm counts and motility, while RUT and Se treatment reversed this change to control values.",
        "relation": "CPR:4"
    },
    {
        "id": "23424207.T21.T46",
        "sentence": "The obtained results showed that @CHEMICAL$ increased lipid peroxidation and abnormal sperm count and decreased plasma testosterone, lactate dehydrogenase, acid phosphatase, alkaline phosphatase and testicular steroidogenic enzymes: 3b-hydroxysteroid dehydrogenase (@GENE$), 17b-HSD activities as well as epididymal sperm counts and motility, while RUT and Se treatment reversed this change to control values.",
        "relation": "CPR:4"
    },
    {
        "id": "23424207.T21.T47",
        "sentence": "The obtained results showed that @CHEMICAL$ increased lipid peroxidation and abnormal sperm count and decreased plasma testosterone, lactate dehydrogenase, acid phosphatase, alkaline phosphatase and testicular steroidogenic enzymes: 3b-hydroxysteroid dehydrogenase (HSD), @GENE$ activities as well as epididymal sperm counts and motility, while RUT and Se treatment reversed this change to control values.",
        "relation": "CPR:4"
    },
    {
        "id": "23424207.T27.T40",
        "sentence": "Acute intoxication with @CHEMICAL$ was also followed by significantly decreased activity of the antioxidant defence system (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase (GR), glutathione (GSH), and glutathione-S-transferase (@GENE$)).",
        "relation": "CPR:4"
    },
    {
        "id": "23424207.T27.T48",
        "sentence": "Acute intoxication with @CHEMICAL$ was also followed by significantly decreased activity of the antioxidant defence system (@GENE$ (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase (GR), glutathione (GSH), and glutathione-S-transferase (GST)).",
        "relation": "CPR:4"
    },
    {
        "id": "23424207.T27.T49",
        "sentence": "Acute intoxication with @CHEMICAL$ was also followed by significantly decreased activity of the antioxidant defence system (superoxide dismutase (@GENE$), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase (GR), glutathione (GSH), and glutathione-S-transferase (GST)).",
        "relation": "CPR:4"
    },
    {
        "id": "23424207.T27.T52",
        "sentence": "Acute intoxication with @CHEMICAL$ was also followed by significantly decreased activity of the antioxidant defence system (superoxide dismutase (SOD), catalase (CAT), @GENE$ (GSH-Px), glutathione reductase (GR), glutathione (GSH), and glutathione-S-transferase (GST)).",
        "relation": "CPR:4"
    },
    {
        "id": "23424207.T27.T53",
        "sentence": "Acute intoxication with @CHEMICAL$ was also followed by significantly decreased activity of the antioxidant defence system (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (@GENE$), glutathione reductase (GR), glutathione (GSH), and glutathione-S-transferase (GST)).",
        "relation": "CPR:4"
    },
    {
        "id": "23424207.T27.T56",
        "sentence": "Acute intoxication with @CHEMICAL$ was also followed by significantly decreased activity of the antioxidant defence system (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase (GR), glutathione (GSH), and @GENE$ (GST)).",
        "relation": "CPR:4"
    },
    {
        "id": "23424207.T27.T50",
        "sentence": "Acute intoxication with @CHEMICAL$ was also followed by significantly decreased activity of the antioxidant defence system (superoxide dismutase (SOD), @GENE$ (CAT), glutathione peroxidase (GSH-Px), glutathione reductase (GR), glutathione (GSH), and glutathione-S-transferase (GST)).",
        "relation": "CPR:4"
    },
    {
        "id": "23424207.T27.T51",
        "sentence": "Acute intoxication with @CHEMICAL$ was also followed by significantly decreased activity of the antioxidant defence system (superoxide dismutase (SOD), catalase (@GENE$), glutathione peroxidase (GSH-Px), glutathione reductase (GR), glutathione (GSH), and glutathione-S-transferase (GST)).",
        "relation": "CPR:4"
    },
    {
        "id": "23424207.T27.T54",
        "sentence": "Acute intoxication with @CHEMICAL$ was also followed by significantly decreased activity of the antioxidant defence system (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), @GENE$ (GR), glutathione (GSH), and glutathione-S-transferase (GST)).",
        "relation": "CPR:4"
    },
    {
        "id": "23424207.T27.T55",
        "sentence": "Acute intoxication with @CHEMICAL$ was also followed by significantly decreased activity of the antioxidant defence system (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase (@GENE$), glutathione (GSH), and glutathione-S-transferase (GST)).",
        "relation": "CPR:4"
    },
    {
        "id": "23425605.T3.T27",
        "sentence": "The @CHEMICAL$ inhibitor @GENE$ (300mM, 24h) completely abolished MeHg-induced DA release.",
        "relation": "CPR:4"
    },
    {
        "id": "23425605.T7.T28",
        "sentence": "MeHg significantly increased DA precursor accumulation in cells treated with 3-hydroxybenzylhydrazine (10mM), revealing that @CHEMICAL$ increases @GENE$ activity.",
        "relation": "CPR:3"
    },
    {
        "id": "23428155.T2.T10",
        "sentence": "The solubility-driven structural modification of (pyridin-3-yl) benzoxazinyl-oxazolidinones is described, which resulted in the development of a new series of @CHEMICAL$ analogues with high antibacterial activity against Gram-positive pathogens, including that against linezolid-resistant strains and low @GENE$ inhibition.",
        "relation": "CPR:4"
    },
    {
        "id": "23430109.T3.T24",
        "sentence": "Secondary point mutations in the Fms-like tyrosine kinase 3 (FLT3) tyrosine kinase domain (KD) are common causes of acquired clinical resistance to the @CHEMICAL$ inhibitors @GENE$ (quizartinib) and sorafenib.",
        "relation": "CPR:4"
    },
    {
        "id": "23430109.T4.T24",
        "sentence": "Secondary point mutations in the Fms-like tyrosine kinase 3 (FLT3) tyrosine kinase domain (KD) are common causes of acquired clinical resistance to the @CHEMICAL$ inhibitors AC220 (@GENE$) and sorafenib.",
        "relation": "CPR:4"
    },
    {
        "id": "23430109.T5.T24",
        "sentence": "Secondary point mutations in the Fms-like tyrosine kinase 3 (FLT3) tyrosine kinase domain (KD) are common causes of acquired clinical resistance to the @CHEMICAL$ inhibitors AC220 (quizartinib) and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23430109.T6.T25",
        "sentence": "@CHEMICAL$ (AP24534) is a @GENE$ inhibitor with in vitro and clinical activity in tyrosine kinase inhibitor (TKI)-resistant chronic myeloid leukemia, irrespective of BCR-ABL KD mutation.",
        "relation": "CPR:4"
    },
    {
        "id": "23430109.T7.T25",
        "sentence": "Ponatinib (@CHEMICAL$) is a @GENE$ inhibitor with in vitro and clinical activity in tyrosine kinase inhibitor (TKI)-resistant chronic myeloid leukemia, irrespective of BCR-ABL KD mutation.",
        "relation": "CPR:4"
    },
    {
        "id": "23432582.T10.T18",
        "sentence": "However, the involvement of the caspase-dependent pathway in the process of cell death induced by either BSC 3g or 3n is discarded since cell death could not be prevented by pretreatment with the pan@CHEMICAL$ inhibitor @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23432582.T2.T19",
        "sentence": "Moreover, since reduced levels of @CHEMICAL$ and Chk2 proteins but no change in p53 levels could be detected in MCF-7 cells after @GENE$ 3g or 3n treatment our results suggest that BSC treated cells die from lethal mitosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23432582.T2.T20",
        "sentence": "Moreover, since reduced levels of p21CIP1 and @CHEMICAL$ proteins but no change in p53 levels could be detected in MCF-7 cells after @GENE$ 3g or 3n treatment our results suggest that BSC treated cells die from lethal mitosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23434223.T7.T11",
        "sentence": "A one-pot domino synthesis and discovery of highly functionalized @CHEMICAL$ as @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23434223.T6.T10",
        "sentence": "These compounds were evaluated for their acetylcholinesterase (AChE) inhibitory activity and @CHEMICAL$ was found to be the most potent against @GENE$ with IC50 4.16 mmol/L.",
        "relation": "CPR:4"
    },
    {
        "id": "23434829.T3.T18",
        "sentence": "Furthermore, knockdown of OPN enhanced cell death caused by other drugs, including @CHEMICAL$, doxorubicin, actinomycin-D, and rapamycin, which are also @GENE$ substrates.",
        "relation": "CPR:9"
    },
    {
        "id": "23434829.T4.T18",
        "sentence": "Furthermore, knockdown of OPN enhanced cell death caused by other drugs, including paclitaxel, @CHEMICAL$, actinomycin-D, and rapamycin, which are also @GENE$ substrates.",
        "relation": "CPR:9"
    },
    {
        "id": "23434829.T5.T18",
        "sentence": "Furthermore, knockdown of OPN enhanced cell death caused by other drugs, including paclitaxel, doxorubicin, @CHEMICAL$, and rapamycin, which are also @GENE$ substrates.",
        "relation": "CPR:9"
    },
    {
        "id": "23434829.T6.T18",
        "sentence": "Furthermore, knockdown of OPN enhanced cell death caused by other drugs, including paclitaxel, doxorubicin, actinomycin-D, and @CHEMICAL$, which are also @GENE$ substrates.",
        "relation": "CPR:9"
    },
    {
        "id": "23454148.T19.T33",
        "sentence": "Compared with normally-fed counterparts, PM-CP rats exhibited higher glutathione S-transferase, aminopeptidase N and cysteine S-conjugate beta-lyase (CCBL) and lower gamma-glutamyltransferase activities, PM-FU rats exhibited decreased dihydropyrimidine dehydrogenase and cytochrome P450 1A1/2 activities and PM-@CHEMICAL$ rats showed higher @GENE$ and depleted xanthine oxidase activities.",
        "relation": "CPR:3"
    },
    {
        "id": "23454148.T19.T34",
        "sentence": "Compared with normally-fed counterparts, PM-CP rats exhibited higher glutathione S-transferase, aminopeptidase N and cysteine S-conjugate beta-lyase (CCBL) and lower gamma-glutamyltransferase activities, PM-FU rats exhibited decreased dihydropyrimidine dehydrogenase and cytochrome P450 1A1/2 activities and PM-@CHEMICAL$ rats showed higher quinone reductase and depleted @GENE$ activities.",
        "relation": "CPR:4"
    },
    {
        "id": "23454148.T5.T25",
        "sentence": "Protein-malnourished drug-treated groups exhibited exacerbated gastrotoxicity, relative to normally-fed counterparts, manifested by lower mucus levels, higher permeability and histopathological deterioration, along with increased oxidative stress in PM-CP rats and exaggerated prostaglandin E2 production in PM-MMC rats. Conclusively, protein malnutrition alters CP, FU and @CHEMICAL$ metabolism in rat stomach by enhancing @GENE$ pathway for CP activation, delaying FU elimination and activating two-electron reduction of MMC, potentiating their gastrotoxicity.",
        "relation": "CPR:9"
    },
    {
        "id": "23454527.T4.T10",
        "sentence": "N-acetylcysteine (NAC, 33 mM) and the c-jun N-terminal kinase (@CHEMICAL$) inhibitor (@GENE$, 33 mM) further decreased the viability in the presence of DEP (200 mg/ml) and 3.3% FCS.",
        "relation": "CPR:4"
    },
    {
        "id": "23454527.T4.T9",
        "sentence": "N-acetylcysteine (NAC, 33 mM) and the @CHEMICAL$ (JNK) inhibitor (@GENE$, 33 mM) further decreased the viability in the presence of DEP (200 mg/ml) and 3.3% FCS.",
        "relation": "CPR:4"
    },
    {
        "id": "23455312.T18.T36",
        "sentence": "@CHEMICAL$ activated the @GENE$ cloned from rat cerebral artery myocytes with a potency (EC50 = 53 mM) similar to and an efficacy (*2.5 potentiation) significantly greater than that of LCA.",
        "relation": "CPR:3"
    },
    {
        "id": "23455312.T19.T36",
        "sentence": "HENA activated the @CHEMICAL$ cloned from rat cerebral artery myocytes with a potency (EC50 = 53 mM) similar to and an efficacy (*2.5 potentiation) significantly greater than that of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23455312.T1.T23",
        "sentence": "@CHEMICAL$ failed to activate the channels made of cbv1 + b2, b3, b4, or b1T169A, indicating that this drug selectively targets @GENE$ via the BK b1 steroid-sensing site.",
        "relation": "CPR:3"
    },
    {
        "id": "23455597.T15.T21",
        "sentence": "Assessment of the abuse liability of @CHEMICAL$, a novel @GENE$ antagonist.",
        "relation": "CPR:6"
    },
    {
        "id": "23455597.T10.T17",
        "sentence": "RATIONALE: @CHEMICAL$ antagonists, such as @GENE$, have been shown to possess cognitive-enhancing and wakefulness-promoting effects.",
        "relation": "CPR:6"
    },
    {
        "id": "23455597.T7.T19",
        "sentence": "CONCLUSIONS: The sum of these preclinical data, the first of their kind applied to H3 antagonists, indicates that @CHEMICAL$ is unlikely to possess a high potential for abuse in the human population and suggests that @GENE$ antagonists, as a class, are similar in this regard.",
        "relation": "CPR:6"
    },
    {
        "id": "23461378.T3.T12",
        "sentence": "Uptake of @CHEMICAL$ (5 nM) by @GENE$ was reduced by 82%-95%.",
        "relation": "CPR:9"
    },
    {
        "id": "23461378.T1.T13",
        "sentence": "This methodology was subsequently used to assess the relative contribution of @CHEMICAL$ uptake in human hepatocytes for olmesartan (42%-62%), valsartan (28%-81%), rosuvastatin (64%-72%), @GENE$ (84%-98%) and lopinavir (64%-89%).",
        "relation": "CPR:9"
    },
    {
        "id": "23461378.T2.T13",
        "sentence": "This methodology was subsequently used to assess the relative contribution of @CHEMICAL$ uptake in human hepatocytes for olmesartan (42%-62%), valsartan (28%-81%), rosuvastatin (64%-72%), pitavastatin (84%-98%) and @GENE$ (64%-89%).",
        "relation": "CPR:9"
    },
    {
        "id": "23461378.T4.T13",
        "sentence": "This methodology was subsequently used to assess the relative contribution of @CHEMICAL$ uptake in human hepatocytes for @GENE$ (42%-62%), valsartan (28%-81%), rosuvastatin (64%-72%), pitavastatin (84%-98%) and lopinavir (64%-89%).",
        "relation": "CPR:9"
    },
    {
        "id": "23461378.T5.T13",
        "sentence": "This methodology was subsequently used to assess the relative contribution of @CHEMICAL$ uptake in human hepatocytes for olmesartan (42%-62%), @GENE$ (28%-81%), rosuvastatin (64%-72%), pitavastatin (84%-98%) and lopinavir (64%-89%).",
        "relation": "CPR:9"
    },
    {
        "id": "23461378.T6.T13",
        "sentence": "This methodology was subsequently used to assess the relative contribution of @CHEMICAL$ uptake in human hepatocytes for olmesartan (42%-62%), valsartan (28%-81%), @GENE$ (64%-72%), pitavastatin (84%-98%) and lopinavir (64%-89%).",
        "relation": "CPR:9"
    },
    {
        "id": "23466488.T40.T58",
        "sentence": "Oral @CHEMICAL$ increases active @GENE$ (7-36) amide secretion and improves glycemic control in stretpozotocin-nicotinamide induced diabetic rats.",
        "relation": "CPR:3"
    },
    {
        "id": "23466488.T18.T54",
        "sentence": "The objective of the present investigation was to evaluate @CHEMICAL$ increases @GENE$ (GLP-1) (7-36) amide secretion in streptozotocin-nicotinamide (STZ-NTM) induced diabetic Sprague Dawley rats.",
        "relation": "CPR:3"
    },
    {
        "id": "23466488.T18.T55",
        "sentence": "The objective of the present investigation was to evaluate @CHEMICAL$ increases glucagon like peptide-1 (@GENE$) (7-36) amide secretion in streptozotocin-nicotinamide (STZ-NTM) induced diabetic Sprague Dawley rats.",
        "relation": "CPR:3"
    },
    {
        "id": "23466488.T16.T52",
        "sentence": "@CHEMICAL$ decreased plasma glucose, increased plasma and pancreatic @GENE$, increased plasma and colonic active GLP-1 (7-36) amide secretion as well as decreased oxidative stress in streptozotocin-nicotinamide induced diabetic rats.",
        "relation": "CPR:3"
    },
    {
        "id": "23466488.T16.T53",
        "sentence": "@CHEMICAL$ decreased plasma glucose, increased plasma and pancreatic insulin, increased plasma and colonic active @GENE$ (7-36) amide secretion as well as decreased oxidative stress in streptozotocin-nicotinamide induced diabetic rats.",
        "relation": "CPR:3"
    },
    {
        "id": "23473801.T12.T26",
        "sentence": "In the present study, @CHEMICAL$ (1 and 2mM) inhibited the @GENE$-induced aggregation of human platelets, but did not inhibit the activation of platelets by other agonists, including thrombin, arachidonic acid, and ADP.",
        "relation": "CPR:4"
    },
    {
        "id": "23473801.T15.T29",
        "sentence": "@CHEMICAL$ inhibited the phosphorylation of phospholipase C (PLC)g2, @GENE$ (PKC), mitogen-activated protein kinases (MAPKs), and Akt in collagen-activated human platelets, and significantly reduced intracellular calcium mobilization and hydroxyl radical (OH) formation.",
        "relation": "CPR:4"
    },
    {
        "id": "23473801.T15.T30",
        "sentence": "@CHEMICAL$ inhibited the phosphorylation of phospholipase C (PLC)g2, protein kinase C (@GENE$), mitogen-activated protein kinases (MAPKs), and Akt in collagen-activated human platelets, and significantly reduced intracellular calcium mobilization and hydroxyl radical (OH) formation.",
        "relation": "CPR:4"
    },
    {
        "id": "23473801.T15.T31",
        "sentence": "@CHEMICAL$ inhibited the phosphorylation of phospholipase C (PLC)g2, protein kinase C (PKC), @GENE$ (MAPKs), and Akt in collagen-activated human platelets, and significantly reduced intracellular calcium mobilization and hydroxyl radical (OH) formation.",
        "relation": "CPR:4"
    },
    {
        "id": "23473801.T15.T32",
        "sentence": "@CHEMICAL$ inhibited the phosphorylation of phospholipase C (PLC)g2, protein kinase C (PKC), mitogen-activated protein kinases (@GENE$), and Akt in collagen-activated human platelets, and significantly reduced intracellular calcium mobilization and hydroxyl radical (OH) formation.",
        "relation": "CPR:4"
    },
    {
        "id": "23473801.T15.T33",
        "sentence": "@CHEMICAL$ inhibited the phosphorylation of phospholipase C (PLC)g2, protein kinase C (PKC), mitogen-activated protein kinases (MAPKs), and @GENE$ in collagen-activated human platelets, and significantly reduced intracellular calcium mobilization and hydroxyl radical (OH) formation.",
        "relation": "CPR:4"
    },
    {
        "id": "23473801.T15.T34",
        "sentence": "@CHEMICAL$ inhibited the phosphorylation of phospholipase C (PLC)g2, protein kinase C (PKC), mitogen-activated protein kinases (MAPKs), and Akt in @GENE$-activated human platelets, and significantly reduced intracellular calcium mobilization and hydroxyl radical (OH) formation.",
        "relation": "CPR:4"
    },
    {
        "id": "23473801.T15.T28",
        "sentence": "@CHEMICAL$ inhibited the phosphorylation of @GENE$, protein kinase C (PKC), mitogen-activated protein kinases (MAPKs), and Akt in collagen-activated human platelets, and significantly reduced intracellular calcium mobilization and hydroxyl radical (OH) formation.",
        "relation": "CPR:4"
    },
    {
        "id": "23473801.T19.T35",
        "sentence": "@CHEMICAL$ also reduced the @GENE$ activation and platelet aggregation stimulated by PDBu.",
        "relation": "CPR:4"
    },
    {
        "id": "23473801.T7.T23",
        "sentence": "In conclusion, @CHEMICAL$ may inhibit platelet activation by inhibiting the PLCg2-@GENE$ cascade and hydroxyl radical formation, followed by suppressing the activation of MAPKs and Akt.",
        "relation": "CPR:4"
    },
    {
        "id": "23473801.T7.T24",
        "sentence": "In conclusion, @CHEMICAL$ may inhibit platelet activation by inhibiting the PLCg2-PKC cascade and hydroxyl radical formation, followed by suppressing the activation of @GENE$ and Akt.",
        "relation": "CPR:4"
    },
    {
        "id": "23473801.T7.T25",
        "sentence": "In conclusion, @CHEMICAL$ may inhibit platelet activation by inhibiting the PLCg2-PKC cascade and hydroxyl radical formation, followed by suppressing the activation of MAPKs and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23473801.T7.T22",
        "sentence": "In conclusion, @CHEMICAL$ may inhibit platelet activation by inhibiting the @GENE$-PKC cascade and hydroxyl radical formation, followed by suppressing the activation of MAPKs and Akt.",
        "relation": "CPR:4"
    },
    {
        "id": "23474386.T4.T11",
        "sentence": "Novel @CHEMICAL$ derivatives as potent @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23477419.T17.T21",
        "sentence": "Design, Synthesis, and Pharmacological Characterization of Novel @CHEMICAL$ Analogues as Extremely Potent @GENE$ Agonists.",
        "relation": "CPR:5"
    },
    {
        "id": "23494106.T1.T24",
        "sentence": "Furthermore, no impact on cytokine release (i.e., on IL-10, IL-6, IL-12/23p40 and TNFa levels) was seen in LPS-stimulated human PBMCs, except with @CHEMICAL$ and JWH-122 which caused a decrease of TNFa and @GENE$/23p40.",
        "relation": "CPR:4"
    },
    {
        "id": "23494106.T1.T23",
        "sentence": "Furthermore, no impact on cytokine release (i.e., on IL-10, IL-6, IL-12/23p40 and TNFa levels) was seen in LPS-stimulated human PBMCs, except with @CHEMICAL$ and JWH-122 which caused a decrease of @GENE$ and IL-12/23p40.",
        "relation": "CPR:4"
    },
    {
        "id": "23494106.T1.T25",
        "sentence": "Furthermore, no impact on cytokine release (i.e., on IL-10, IL-6, IL-12/23p40 and TNFa levels) was seen in LPS-stimulated human PBMCs, except with @CHEMICAL$ and JWH-122 which caused a decrease of TNFa and IL-12/@GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23494106.T2.T24",
        "sentence": "Furthermore, no impact on cytokine release (i.e., on IL-10, IL-6, IL-12/23p40 and TNFa levels) was seen in LPS-stimulated human PBMCs, except with JWH-210 and @CHEMICAL$ which caused a decrease of TNFa and @GENE$/23p40.",
        "relation": "CPR:4"
    },
    {
        "id": "23494106.T2.T23",
        "sentence": "Furthermore, no impact on cytokine release (i.e., on IL-10, IL-6, IL-12/23p40 and TNFa levels) was seen in LPS-stimulated human PBMCs, except with JWH-210 and @CHEMICAL$ which caused a decrease of @GENE$ and IL-12/23p40.",
        "relation": "CPR:4"
    },
    {
        "id": "23494106.T2.T25",
        "sentence": "Furthermore, no impact on cytokine release (i.e., on IL-10, IL-6, IL-12/23p40 and TNFa levels) was seen in LPS-stimulated human PBMCs, except with JWH-210 and @CHEMICAL$ which caused a decrease of TNFa and IL-12/@GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23494944.T9.T18",
        "sentence": "@CHEMICAL$ markedly reduced AA performance and activities of @GENE$ (COX) and acetylcholinesterase (AChE) in all regions.",
        "relation": "CPR:4"
    },
    {
        "id": "23494944.T9.T19",
        "sentence": "@CHEMICAL$ markedly reduced AA performance and activities of cytochrome c oxidase (@GENE$) and acetylcholinesterase (AChE) in all regions.",
        "relation": "CPR:4"
    },
    {
        "id": "23494944.T9.T20",
        "sentence": "@CHEMICAL$ markedly reduced AA performance and activities of cytochrome c oxidase (COX) and @GENE$ (AChE) in all regions.",
        "relation": "CPR:4"
    },
    {
        "id": "23494944.T9.T21",
        "sentence": "@CHEMICAL$ markedly reduced AA performance and activities of cytochrome c oxidase (COX) and acetylcholinesterase (@GENE$) in all regions.",
        "relation": "CPR:4"
    },
    {
        "id": "23494944.T11.T13",
        "sentence": "GTLE pretreatment completely reversed the damaging effects of @CHEMICAL$ on AA and @GENE$ activity, markedly corrected COX and AChE activities, and moderately improved TGC.",
        "relation": "CPR:4"
    },
    {
        "id": "23494944.T11.T14",
        "sentence": "GTLE pretreatment completely reversed the damaging effects of @CHEMICAL$ on AA and superoxide dismutase activity, markedly corrected @GENE$ and AChE activities, and moderately improved TGC.",
        "relation": "CPR:4"
    },
    {
        "id": "23494944.T11.T15",
        "sentence": "GTLE pretreatment completely reversed the damaging effects of @CHEMICAL$ on AA and superoxide dismutase activity, markedly corrected COX and @GENE$ activities, and moderately improved TGC.",
        "relation": "CPR:4"
    },
    {
        "id": "23500387.T9.T18",
        "sentence": "Our study demonstrated that @CHEMICAL$ inhibited @GENE$-induced increases in eosinophil count; interleukin (IL)-17A level were recovered in bronchoalveolar lavage fluid increased IL-10 level in bronchoalveolar lavage fluid.",
        "relation": "CPR:4"
    },
    {
        "id": "23500387.T9.T19",
        "sentence": "Our study demonstrated that @CHEMICAL$ inhibited OVA-induced increases in eosinophil count; @GENE$ level were recovered in bronchoalveolar lavage fluid increased IL-10 level in bronchoalveolar lavage fluid.",
        "relation": "CPR:4"
    },
    {
        "id": "23500387.T9.T20",
        "sentence": "Our study demonstrated that @CHEMICAL$ inhibited OVA-induced increases in eosinophil count; interleukin (IL)-17A level were recovered in bronchoalveolar lavage fluid increased @GENE$ level in bronchoalveolar lavage fluid.",
        "relation": "CPR:3"
    },
    {
        "id": "23500387.T1.T13",
        "sentence": "Histological studies demonstrated that @CHEMICAL$ substantially inhibited @GENE$-induced eosinophilia in lung tissue.",
        "relation": "CPR:4"
    },
    {
        "id": "23500387.T3.T15",
        "sentence": "The results in vivo show @CHEMICAL$-induced significantly broke Treg/Th17 balance; @GENE$ treatments markedly attenuated the inflammatory in asthma model by regulating Treg/Th17 balance.",
        "relation": "CPR:4"
    },
    {
        "id": "23511016.T6.T11",
        "sentence": "Synthesis of a @CHEMICAL$ (Gd(3+))-conjugate of @GENE$ inhibitor pantoprazole for gastric wall imaging studies.",
        "relation": "CPR:4"
    },
    {
        "id": "23511016.T7.T11",
        "sentence": "Synthesis of a DOTA (@CHEMICAL$)-conjugate of @GENE$ inhibitor pantoprazole for gastric wall imaging studies.",
        "relation": "CPR:4"
    },
    {
        "id": "23511016.T8.T11",
        "sentence": "Synthesis of a DOTA (Gd(3+))-conjugate of @CHEMICAL$ inhibitor @GENE$ for gastric wall imaging studies.",
        "relation": "CPR:4"
    },
    {
        "id": "23511016.T1.T9",
        "sentence": "To overcome this limitation, we de novo synthesized a conjugate that covalently combines a @CHEMICAL$-based MRI contrast agent, encaged with a chelating agent (DOTA), with pantoprazole, which is a widely used @GENE$ inhibitor that binds to proton pumps in the stomach and colon.",
        "relation": "CPR:4"
    },
    {
        "id": "23511016.T2.T9",
        "sentence": "To overcome this limitation, we de novo synthesized a conjugate that covalently combines a Gd-based MRI contrast agent, encaged with a chelating agent (@CHEMICAL$), with pantoprazole, which is a widely used @GENE$ inhibitor that binds to proton pumps in the stomach and colon.",
        "relation": "CPR:4"
    },
    {
        "id": "23511016.T3.T9",
        "sentence": "To overcome this limitation, we de novo synthesized a conjugate that covalently combines a Gd-based MRI contrast agent, encaged with a chelating agent (DOTA), with @CHEMICAL$, which is a widely used @GENE$ inhibitor that binds to proton pumps in the stomach and colon.",
        "relation": "CPR:4"
    },
    {
        "id": "23511125.T1.T24",
        "sentence": "Second, EPSCs were recorded from rat hippocampal slices before and after their superfusion with the reversible @CHEMICAL$ inhibitor @GENE$ (100nM).",
        "relation": "CPR:4"
    },
    {
        "id": "23511711.T12.T20",
        "sentence": "A Nanogram Dose of the @CHEMICAL$ Probe Substrate @GENE$ to Evaluate Drug Interactions.",
        "relation": "CPR:9"
    },
    {
        "id": "23511711.T5.T16",
        "sentence": "We then evaluated the interactions with the @CHEMICAL$ inhibitor @GENE$ (400 mg q.d.) after nanogram and regular doses of midazolam.",
        "relation": "CPR:4"
    },
    {
        "id": "23511711.T10.T17",
        "sentence": "@CHEMICAL$ carrier status had no influence on midazolam oral clearance or its inhibition by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23511711.T9.T17",
        "sentence": "@CHEMICAL$ carrier status had no influence on @GENE$ oral clearance or its inhibition by ketoconazole.",
        "relation": "CPR:9"
    },
    {
        "id": "23512537.T9.T23",
        "sentence": "Metabolism of @CHEMICAL$ by @GENE$ Enzymes.",
        "relation": "CPR:9"
    },
    {
        "id": "23512537.T4.T14",
        "sentence": "It is possible that variations in @CHEMICAL$ enzyme-mediated metabolism of @GENE$ may contribute to this phenomenon.",
        "relation": "CPR:9"
    },
    {
        "id": "23512537.T5.T16",
        "sentence": "This hypothesis was explored by evaluating the contributions of CYP3A4, 3A5, 3A7, and @CHEMICAL$ enzymes in the metabolism of @GENE$ in vitro and relating metabolism to changes in CYP3A enzyme mRNA expression via the glucocorticoid receptor in lung and liver cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23512537.T7.T19",
        "sentence": "@CHEMICAL$ and CYP3A5 metabolized @GENE$ via hydroxylation ([M4] and [M6]) and dehydrogenation ([M5]) at similar rates; CYP3A7 did not metabolize BDP.",
        "relation": "CPR:9"
    },
    {
        "id": "23512537.T7.T20",
        "sentence": "CYP3A4 and @CHEMICAL$ metabolized @GENE$ via hydroxylation ([M4] and [M6]) and dehydrogenation ([M5]) at similar rates; CYP3A7 did not metabolize BDP.",
        "relation": "CPR:9"
    },
    {
        "id": "23512537.T1.T11",
        "sentence": "These studies show that @CHEMICAL$ and CYP3A5 metabolize @GENE$ to inactive metabolites and suggest that differences in the expression or function of these enzymes in the lung and/or liver could influence BDP disposition in humans.",
        "relation": "CPR:9"
    },
    {
        "id": "23512537.T1.T12",
        "sentence": "These studies show that CYP3A4 and @CHEMICAL$ metabolize @GENE$ to inactive metabolites and suggest that differences in the expression or function of these enzymes in the lung and/or liver could influence BDP disposition in humans.",
        "relation": "CPR:9"
    },
    {
        "id": "23512754.T11.T17",
        "sentence": "In macrophages, levels of @CHEMICAL$, IFN-g, NO, IL-6 and IL-10 were increased by @GENE$ used alone or in combination with HSV-2.",
        "relation": "CPR:3"
    },
    {
        "id": "23512754.T11.T18",
        "sentence": "In macrophages, levels of TNF-a, @CHEMICAL$, NO, IL-6 and IL-10 were increased by @GENE$ used alone or in combination with HSV-2.",
        "relation": "CPR:3"
    },
    {
        "id": "23512754.T11.T19",
        "sentence": "In macrophages, levels of TNF-a, IFN-g, NO, @CHEMICAL$ and IL-10 were increased by @GENE$ used alone or in combination with HSV-2.",
        "relation": "CPR:3"
    },
    {
        "id": "23512754.T11.T20",
        "sentence": "In macrophages, levels of TNF-a, IFN-g, NO, IL-6 and @CHEMICAL$ were increased by @GENE$ used alone or in combination with HSV-2.",
        "relation": "CPR:3"
    },
    {
        "id": "23512754.T1.T13",
        "sentence": "Besides, @CHEMICAL$ not only synergized @GENE$ production combined with IFN-g, but also prolonged its expression in time.",
        "relation": "CPR:3"
    },
    {
        "id": "23512754.T1.T14",
        "sentence": "Besides, @CHEMICAL$ not only synergized TNF-a production combined with @GENE$, but also prolonged its expression in time.",
        "relation": "CPR:3"
    },
    {
        "id": "23512754.T2.T15",
        "sentence": "Results indicate that @CHEMICAL$ inhibits HSV-2 multiplication in epithelial cells and also increases @GENE$ production in macrophages, both important actions to the clearance of infecting virus in the mouse vagina.",
        "relation": "CPR:3"
    },
    {
        "id": "23517558.T6.T8",
        "sentence": "Intestinal and hepatic first-pass extraction of the @CHEMICAL$ inhibitor @GENE$ in rats with chronic vascular catheters.",
        "relation": "CPR:4"
    },
    {
        "id": "23517558.T2.T7",
        "sentence": "A catheterized rat model was used to define the intestinal and hepatic components of oral bioavailability for an @CHEMICAL$ inhibitor, @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23519149.T2.T19",
        "sentence": "In DU-PM cells with acquired resistance to @CHEMICAL$, @GENE$ expression was decreased, while Bcl2 was increased.",
        "relation": "CPR:4"
    },
    {
        "id": "23519149.T2.T20",
        "sentence": "In DU-PM cells with acquired resistance to @CHEMICAL$, ErbB3 expression was decreased, while @GENE$ was increased.",
        "relation": "CPR:3"
    },
    {
        "id": "23523780.T2.T6",
        "sentence": "Administration of @CHEMICAL$, a @GENE$ inhibitor, isolated a single response to w-agatoxin, which was characterized by a reduction in network activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23523780.T2.T7",
        "sentence": "Administration of @CHEMICAL$, a GABAA inhibitor, isolated a single response to @GENE$, which was characterized by a reduction in network activity.",
        "relation": "CPR:4"
    },
    {
        "id": "23526814.T9.T15",
        "sentence": "@CHEMICAL$-Containing @GENE$ Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23526814.T1.T10",
        "sentence": "Herein we report novel pyrrole- and benzene-based hydroxamates (8, 10) and 2'-aminoanilides (9, 11) bearing the @CHEMICAL$ group at the CAP moiety as @GENE$ (HDAC) inhibitors. Compounds 8 b and 10 c selectively inhibited HDAC6 at the nanomolar level, whereas the other hydroxamates effected an increase in acetyl-a-tubulin levels in human acute myeloid leukemia U937 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23526814.T1.T11",
        "sentence": "Herein we report novel pyrrole- and benzene-based hydroxamates (8, 10) and 2'-aminoanilides (9, 11) bearing the @CHEMICAL$ group at the CAP moiety as histone deacetylase (@GENE$) inhibitors. Compounds 8 b and 10 c selectively inhibited HDAC6 at the nanomolar level, whereas the other hydroxamates effected an increase in acetyl-a-tubulin levels in human acute myeloid leukemia U937 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23526814.T2.T10",
        "sentence": "Herein we report novel @CHEMICAL$- and benzene-based hydroxamates (8, 10) and 2'-aminoanilides (9, 11) bearing the tert-butylcarbamate group at the CAP moiety as @GENE$ (HDAC) inhibitors. Compounds 8 b and 10 c selectively inhibited HDAC6 at the nanomolar level, whereas the other hydroxamates effected an increase in acetyl-a-tubulin levels in human acute myeloid leukemia U937 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23526814.T2.T11",
        "sentence": "Herein we report novel @CHEMICAL$- and benzene-based hydroxamates (8, 10) and 2'-aminoanilides (9, 11) bearing the tert-butylcarbamate group at the CAP moiety as histone deacetylase (@GENE$) inhibitors. Compounds 8 b and 10 c selectively inhibited HDAC6 at the nanomolar level, whereas the other hydroxamates effected an increase in acetyl-a-tubulin levels in human acute myeloid leukemia U937 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23526814.T3.T13",
        "sentence": "Herein we report novel pyrrole- and benzene-based hydroxamates (8, 10) and 2'-aminoanilides (9, 11) bearing the tert-butylcarbamate group at the CAP moiety as histone deacetylase (HDAC) inhibitors. Compounds 8 b and 10 c selectively inhibited HDAC6 at the nanomolar level, whereas the other @CHEMICAL$ effected an increase in @GENE$ levels in human acute myeloid leukemia U937 cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23526814.T4.T10",
        "sentence": "Herein we report novel pyrrole- and @CHEMICAL$-based hydroxamates (8, 10) and 2'-aminoanilides (9, 11) bearing the tert-butylcarbamate group at the CAP moiety as @GENE$ (HDAC) inhibitors. Compounds 8 b and 10 c selectively inhibited HDAC6 at the nanomolar level, whereas the other hydroxamates effected an increase in acetyl-a-tubulin levels in human acute myeloid leukemia U937 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23526814.T4.T11",
        "sentence": "Herein we report novel pyrrole- and @CHEMICAL$-based hydroxamates (8, 10) and 2'-aminoanilides (9, 11) bearing the tert-butylcarbamate group at the CAP moiety as histone deacetylase (@GENE$) inhibitors. Compounds 8 b and 10 c selectively inhibited HDAC6 at the nanomolar level, whereas the other hydroxamates effected an increase in acetyl-a-tubulin levels in human acute myeloid leukemia U937 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23526814.T6.T10",
        "sentence": "Herein we report novel pyrrole- and benzene-based @CHEMICAL$ (8, 10) and 2'-aminoanilides (9, 11) bearing the tert-butylcarbamate group at the CAP moiety as @GENE$ (HDAC) inhibitors. Compounds 8 b and 10 c selectively inhibited HDAC6 at the nanomolar level, whereas the other hydroxamates effected an increase in acetyl-a-tubulin levels in human acute myeloid leukemia U937 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23526814.T6.T11",
        "sentence": "Herein we report novel pyrrole- and benzene-based @CHEMICAL$ (8, 10) and 2'-aminoanilides (9, 11) bearing the tert-butylcarbamate group at the CAP moiety as histone deacetylase (@GENE$) inhibitors. Compounds 8 b and 10 c selectively inhibited HDAC6 at the nanomolar level, whereas the other hydroxamates effected an increase in acetyl-a-tubulin levels in human acute myeloid leukemia U937 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23526814.T8.T10",
        "sentence": "Herein we report novel pyrrole- and benzene-based hydroxamates (8, 10) and @CHEMICAL$ (9, 11) bearing the tert-butylcarbamate group at the CAP moiety as @GENE$ (HDAC) inhibitors. Compounds 8 b and 10 c selectively inhibited HDAC6 at the nanomolar level, whereas the other hydroxamates effected an increase in acetyl-a-tubulin levels in human acute myeloid leukemia U937 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23526814.T8.T11",
        "sentence": "Herein we report novel pyrrole- and benzene-based hydroxamates (8, 10) and @CHEMICAL$ (9, 11) bearing the tert-butylcarbamate group at the CAP moiety as histone deacetylase (@GENE$) inhibitors. Compounds 8 b and 10 c selectively inhibited HDAC6 at the nanomolar level, whereas the other hydroxamates effected an increase in acetyl-a-tubulin levels in human acute myeloid leukemia U937 cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23528299.T6.T10",
        "sentence": "Discovery of a synthetic @CHEMICAL$ inhibitor @GENE$ as a potential anticancer agent.",
        "relation": "CPR:4"
    },
    {
        "id": "23528299.T5.T8",
        "sentence": "@CHEMICAL$ is the first synthetic @GENE$ inhibitor to be evaluated for both of its anti-invasion and anti-angiogenesis effects.",
        "relation": "CPR:4"
    },
    {
        "id": "23528299.T1.T9",
        "sentence": "As a potent synthetic @CHEMICAL$ inhibitor (IC50=850nM, versus @GENE$ of 8.1mM), LB-4b was determined to have more significant block effects to cancer cell invasion and angiogenesis than bestatin.",
        "relation": "CPR:4"
    },
    {
        "id": "23528299.T2.T9",
        "sentence": "As a potent synthetic @CHEMICAL$ inhibitor (IC50=850nM, versus bestatin of 8.1mM), @GENE$ was determined to have more significant block effects to cancer cell invasion and angiogenesis than bestatin.",
        "relation": "CPR:4"
    },
    {
        "id": "23528299.T3.T9",
        "sentence": "As a potent synthetic @CHEMICAL$ inhibitor (IC50=850nM, versus bestatin of 8.1mM), LB-4b was determined to have more significant block effects to cancer cell invasion and angiogenesis than @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23530959.T2.T12",
        "sentence": "Both types of granules contain @CHEMICAL$ that catalyzes oxidative cross-linking of @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23535337.T8.T21",
        "sentence": "Under @CHEMICAL$ and sorbitol stresses, @GENE$ (CAT) activity in wnk8 mutant was 1.92- and 3.7-times of that in Col-0, respectively.",
        "relation": "CPR:3"
    },
    {
        "id": "23535337.T8.T22",
        "sentence": "Under @CHEMICAL$ and sorbitol stresses, catalase (@GENE$) activity in wnk8 mutant was 1.92- and 3.7-times of that in Col-0, respectively.",
        "relation": "CPR:3"
    },
    {
        "id": "23535337.T9.T21",
        "sentence": "Under NaCl and @CHEMICAL$ stresses, @GENE$ (CAT) activity in wnk8 mutant was 1.92- and 3.7-times of that in Col-0, respectively.",
        "relation": "CPR:3"
    },
    {
        "id": "23535337.T9.T22",
        "sentence": "Under NaCl and @CHEMICAL$ stresses, catalase (@GENE$) activity in wnk8 mutant was 1.92- and 3.7-times of that in Col-0, respectively.",
        "relation": "CPR:3"
    },
    {
        "id": "23536314.T7.T10",
        "sentence": "Immunofluorescence staining and western blotting demonstrated that @CHEMICAL$ treatment reduced GFAP and @GENE$ expression in the retinas of OLETF rats.",
        "relation": "CPR:4"
    },
    {
        "id": "23536314.T7.T9",
        "sentence": "Immunofluorescence staining and western blotting demonstrated that @CHEMICAL$ treatment reduced @GENE$ and VEGF expression in the retinas of OLETF rats.",
        "relation": "CPR:4"
    },
    {
        "id": "23537661.T1.T16",
        "sentence": "At birth, some control (C) and M litters were cross-fostered to create four groups with the following in utero/postnatal exposure: C/C, M/C, C/M, M/M. Other dams received 1.8ng/kg/day of a mixture of @CHEMICAL$ (AhR) agonists (non-ortho PCBs, PC-dibenzodioxins and @GENE$) without or with 0.5M (0.5MAhR).",
        "relation": "CPR:5"
    },
    {
        "id": "23537661.T7.T16",
        "sentence": "At birth, some control (C) and M litters were cross-fostered to create four groups with the following in utero/postnatal exposure: C/C, M/C, C/M, M/M. Other dams received 1.8ng/kg/day of a mixture of @CHEMICAL$ (AhR) agonists (@GENE$s, PC-dibenzodioxins and PC-dibenzofurans) without or with 0.5M (0.5MAhR).",
        "relation": "CPR:5"
    },
    {
        "id": "23537661.T8.T16",
        "sentence": "At birth, some control (C) and M litters were cross-fostered to create four groups with the following in utero/postnatal exposure: C/C, M/C, C/M, M/M. Other dams received 1.8ng/kg/day of a mixture of @CHEMICAL$ (AhR) agonists (non-ortho PCBs, @GENE$ and PC-dibenzofurans) without or with 0.5M (0.5MAhR).",
        "relation": "CPR:5"
    },
    {
        "id": "23541670.T3.T11",
        "sentence": "Discovery of a series of novel @CHEMICAL$, as potent JAK3 @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23541670.T3.T10",
        "sentence": "Discovery of a series of novel @CHEMICAL$, as potent @GENE$ kinase inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "23541670.T1.T8",
        "sentence": "We report the discovery of a novel series of ATP-competitive @CHEMICAL$ (JAK3) inhibitors based on the @GENE$ scaffold.",
        "relation": "CPR:4"
    },
    {
        "id": "23541670.T1.T9",
        "sentence": "We report the discovery of a novel series of ATP-competitive Janus kinase 3 (@CHEMICAL$) inhibitors based on the @GENE$ scaffold.",
        "relation": "CPR:4"
    },
    {
        "id": "23542114.T7.T13",
        "sentence": "@CHEMICAL$ depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of @GENE$ pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23542114.T5.T11",
        "sentence": "@CHEMICAL$ inhibited the phosphorylation and activation of AKT and STAT3 through @GENE$ signaling blockade.",
        "relation": "CPR:4"
    },
    {
        "id": "23542114.T5.T9",
        "sentence": "@CHEMICAL$ inhibited the phosphorylation and activation of @GENE$ and STAT3 through Notch signaling blockade.",
        "relation": "CPR:4"
    },
    {
        "id": "23542114.T5.T10",
        "sentence": "@CHEMICAL$ inhibited the phosphorylation and activation of AKT and @GENE$ through Notch signaling blockade.",
        "relation": "CPR:4"
    },
    {
        "id": "23542114.T6.T12",
        "sentence": "These data show that the @CHEMICAL$ is a promising new approach to decrease glioblastoma proliferation and recurrence by downregulation of @GENE$ pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23561166.T6.T13",
        "sentence": "The high fat diet significantly increased hepatic mRNA expressions of @CHEMICAL$, SREBP1C and SCD-1 genes in comparison to the control diet, which was subsequently reversed by supplementation with @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23561166.T6.T14",
        "sentence": "The high fat diet significantly increased hepatic mRNA expressions of PPARg, @CHEMICAL$ and SCD-1 genes in comparison to the control diet, which was subsequently reversed by supplementation with @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23561166.T6.T15",
        "sentence": "The high fat diet significantly increased hepatic mRNA expressions of PPARg, SREBP1C and @CHEMICAL$ genes in comparison to the control diet, which was subsequently reversed by supplementation with @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23561166.T7.T16",
        "sentence": "In addition, @CHEMICAL$ supplementation significantly reduced hepatic mRNA abundance of @GENE$, ATPCL and G6Pase compared to the control group.",
        "relation": "CPR:4"
    },
    {
        "id": "23561166.T7.T17",
        "sentence": "In addition, @CHEMICAL$ supplementation significantly reduced hepatic mRNA abundance of FAS, @GENE$ and G6Pase compared to the control group.",
        "relation": "CPR:4"
    },
    {
        "id": "23561166.T7.T18",
        "sentence": "In addition, @CHEMICAL$ supplementation significantly reduced hepatic mRNA abundance of FAS, ATPCL and @GENE$ compared to the control group.",
        "relation": "CPR:4"
    },
    {
        "id": "23561166.T8.T19",
        "sentence": "Finally, epididymal mRNA abundance of @CHEMICAL$ was significantly increased by @GENE$ supplementation, compared to levels in the control and HF groups.",
        "relation": "CPR:3"
    },
    {
        "id": "23561166.T9.T20",
        "sentence": "Enhancement of @CHEMICAL$ expression by @GENE$ was further confirmed in differentiated 3T3-L1 adipocytes.",
        "relation": "CPR:3"
    },
    {
        "id": "23567243.T6.T12",
        "sentence": "Western blot assay demonstrated that @CHEMICAL$ decreased @GENE$ level and induced Bax translocation to cause cytochrome c release.",
        "relation": "CPR:4"
    },
    {
        "id": "23567243.T6.T13",
        "sentence": "Western blot assay demonstrated that @CHEMICAL$ decreased Bcl-2 level and induced @GENE$ translocation to cause cytochrome c release.",
        "relation": "CPR:3"
    },
    {
        "id": "23567243.T6.T14",
        "sentence": "Western blot assay demonstrated that @CHEMICAL$ decreased Bcl-2 level and induced Bax translocation to cause @GENE$ release.",
        "relation": "CPR:3"
    },
    {
        "id": "23570998.T15.T24",
        "sentence": "@CHEMICAL$ and rutin also increased @GENE$ activity by about 150 and 240% and demonstrated mineralization up to 110 and 200% respectively as compared to control (which was considered as 100%).",
        "relation": "CPR:3"
    },
    {
        "id": "23570998.T16.T24",
        "sentence": "Quercetin and @CHEMICAL$ also increased @GENE$ activity by about 150 and 240% and demonstrated mineralization up to 110 and 200% respectively as compared to control (which was considered as 100%).",
        "relation": "CPR:3"
    },
    {
        "id": "23570998.T17.T19",
        "sentence": "Further, both the @CHEMICAL$ were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like @GENE$, osterix, RunX2, osteoprotegerin and osteocalcin.",
        "relation": "CPR:3"
    },
    {
        "id": "23570998.T17.T20",
        "sentence": "Further, both the @CHEMICAL$ were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like osteopontin, @GENE$, RunX2, osteoprotegerin and osteocalcin.",
        "relation": "CPR:3"
    },
    {
        "id": "23570998.T17.T21",
        "sentence": "Further, both the @CHEMICAL$ were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like osteopontin, osterix, @GENE$, osteoprotegerin and osteocalcin.",
        "relation": "CPR:3"
    },
    {
        "id": "23570998.T17.T22",
        "sentence": "Further, both the @CHEMICAL$ were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like osteopontin, osterix, RunX2, @GENE$ and osteocalcin.",
        "relation": "CPR:3"
    },
    {
        "id": "23570998.T17.T23",
        "sentence": "Further, both the @CHEMICAL$ were also found to increase the expression of some of the prominent markers for differentiation of osteoblast like osteopontin, osterix, RunX2, osteoprotegerin and @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23578993.T34.T53",
        "sentence": "@CHEMICAL$ (CYP 450 2E1), activity was determined as hydroxylation of @GENE$ in liver microsomes.",
        "relation": "CPR:9"
    },
    {
        "id": "23578993.T34.T54",
        "sentence": "Cytochrome P450 2E1 (@CHEMICAL$), activity was determined as hydroxylation of @GENE$ in liver microsomes.",
        "relation": "CPR:9"
    },
    {
        "id": "23578993.T3.T38",
        "sentence": "Serum markers of liver damage (@CHEMICAL$, ALT, ALP and Bilirubin) were increased by @GENE$ and TAA intoxication (p<0.001), whereas co-treatment with NAC reversed such changes (p<0.001).",
        "relation": "CPR:3"
    },
    {
        "id": "23578993.T3.T39",
        "sentence": "Serum markers of liver damage (AST, @CHEMICAL$, ALP and Bilirubin) were increased by @GENE$ and TAA intoxication (p<0.001), whereas co-treatment with NAC reversed such changes (p<0.001).",
        "relation": "CPR:3"
    },
    {
        "id": "23578993.T3.T40",
        "sentence": "Serum markers of liver damage (AST, ALT, @CHEMICAL$ and Bilirubin) were increased by @GENE$ and TAA intoxication (p<0.001), whereas co-treatment with NAC reversed such changes (p<0.001).",
        "relation": "CPR:3"
    },
    {
        "id": "23578993.T4.T38",
        "sentence": "Serum markers of liver damage (@CHEMICAL$, ALT, ALP and Bilirubin) were increased by CCl4 and @GENE$ intoxication (p<0.001), whereas co-treatment with NAC reversed such changes (p<0.001).",
        "relation": "CPR:3"
    },
    {
        "id": "23578993.T4.T39",
        "sentence": "Serum markers of liver damage (AST, @CHEMICAL$, ALP and Bilirubin) were increased by CCl4 and @GENE$ intoxication (p<0.001), whereas co-treatment with NAC reversed such changes (p<0.001).",
        "relation": "CPR:3"
    },
    {
        "id": "23578993.T4.T40",
        "sentence": "Serum markers of liver damage (AST, ALT, @CHEMICAL$ and Bilirubin) were increased by CCl4 and @GENE$ intoxication (p<0.001), whereas co-treatment with NAC reversed such changes (p<0.001).",
        "relation": "CPR:3"
    },
    {
        "id": "23578993.T5.T38",
        "sentence": "Serum markers of liver damage (@CHEMICAL$, ALT, ALP and Bilirubin) were increased by CCl4 and TAA intoxication (p<0.001), whereas co-treatment with @GENE$ reversed such changes (p<0.001).",
        "relation": "CPR:4"
    },
    {
        "id": "23578993.T5.T39",
        "sentence": "Serum markers of liver damage (AST, @CHEMICAL$, ALP and Bilirubin) were increased by CCl4 and TAA intoxication (p<0.001), whereas co-treatment with @GENE$ reversed such changes (p<0.001).",
        "relation": "CPR:4"
    },
    {
        "id": "23578993.T5.T40",
        "sentence": "Serum markers of liver damage (AST, ALT, @CHEMICAL$ and Bilirubin) were increased by CCl4 and TAA intoxication (p<0.001), whereas co-treatment with @GENE$ reversed such changes (p<0.001).",
        "relation": "CPR:4"
    },
    {
        "id": "23578993.T12.T42",
        "sentence": "LPO was increased while as GSH, CAT and @CHEMICAL$ decreased by the administration of CCl4 and TAA (p<0.001); co-administration of @GENE$ restored these liver markers to normal levels (p<0.001).",
        "relation": "CPR:3"
    },
    {
        "id": "23578993.T12.T41",
        "sentence": "LPO was increased while as GSH, @CHEMICAL$ and GPx decreased by the administration of CCl4 and TAA (p<0.001); co-administration of @GENE$ restored these liver markers to normal levels (p<0.001).",
        "relation": "CPR:3"
    },
    {
        "id": "23583258.T11.T23",
        "sentence": "This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory @CHEMICAL$, IL-6 and IL-8, caused by a mixture of @GENE$ representative of a high cholesterol diet.",
        "relation": "CPR:3"
    },
    {
        "id": "23583258.T11.T24",
        "sentence": "This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory interleukins, @CHEMICAL$ and IL-8, caused by a mixture of @GENE$ representative of a high cholesterol diet.",
        "relation": "CPR:3"
    },
    {
        "id": "23583258.T11.T25",
        "sentence": "This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory interleukins, IL-6 and @CHEMICAL$, caused by a mixture of @GENE$ representative of a high cholesterol diet.",
        "relation": "CPR:3"
    },
    {
        "id": "23583258.T12.T23",
        "sentence": "This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory @CHEMICAL$, IL-6 and IL-8, caused by a mixture of oxysterols representative of a high @GENE$ diet.",
        "relation": "CPR:3"
    },
    {
        "id": "23583258.T12.T24",
        "sentence": "This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory interleukins, @CHEMICAL$ and IL-8, caused by a mixture of oxysterols representative of a high @GENE$ diet.",
        "relation": "CPR:3"
    },
    {
        "id": "23583258.T12.T25",
        "sentence": "This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory interleukins, IL-6 and @CHEMICAL$, caused by a mixture of oxysterols representative of a high @GENE$ diet.",
        "relation": "CPR:3"
    },
    {
        "id": "23583258.T17.T30",
        "sentence": "@CHEMICAL$-dependent NOX1 activation, as well as @GENE$ synthesis, were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction, in particular phenolic acids and flavonoids.",
        "relation": "CPR:3"
    },
    {
        "id": "23583258.T17.T29",
        "sentence": "@CHEMICAL$-dependent @GENE$ activation, as well as interleukin synthesis, were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction, in particular phenolic acids and flavonoids.",
        "relation": "CPR:3"
    },
    {
        "id": "23583258.T2.T30",
        "sentence": "Oxysterol-dependent NOX1 activation, as well as @CHEMICAL$ synthesis, were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction, in particular @GENE$ and flavonoids.",
        "relation": "CPR:4"
    },
    {
        "id": "23583258.T2.T29",
        "sentence": "Oxysterol-dependent @CHEMICAL$ activation, as well as interleukin synthesis, were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction, in particular @GENE$ and flavonoids.",
        "relation": "CPR:4"
    },
    {
        "id": "23583258.T3.T30",
        "sentence": "Oxysterol-dependent NOX1 activation, as well as @CHEMICAL$ synthesis, were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction, in particular phenolic acids and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23583258.T3.T29",
        "sentence": "Oxysterol-dependent @CHEMICAL$ activation, as well as interleukin synthesis, were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction, in particular phenolic acids and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23583258.T4.T21",
        "sentence": "Conversely, cell pre-treatment with Vermentino white wine extract with smaller phenolic fraction showed only a partial NOX1 down-regulation and was ineffective in @CHEMICAL$ synthesis induced by dietary @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23583258.T4.T20",
        "sentence": "Conversely, cell pre-treatment with Vermentino white wine extract with smaller phenolic fraction showed only a partial @CHEMICAL$ down-regulation and was ineffective in interleukin synthesis induced by dietary @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23583258.T8.T22",
        "sentence": "Besides this direct activity, an excess of @CHEMICAL$ compounds detectable in red wine, may exert an additional indirect action by blocking oxysterol-related @GENE$ induction, thus totally preventing the pro-oxidant and pro-inflammatory events triggered by dietary oxysterols.",
        "relation": "CPR:4"
    },
    {
        "id": "23583258.T9.T22",
        "sentence": "Besides this direct activity, an excess of phenolic compounds detectable in red wine, may exert an additional indirect action by blocking @CHEMICAL$-related @GENE$ induction, thus totally preventing the pro-oxidant and pro-inflammatory events triggered by dietary oxysterols.",
        "relation": "CPR:3"
    },
    {
        "id": "23589329.T10.T30",
        "sentence": "@CHEMICAL$ inhibits autophagic flux activating the @GENE$-Keap1 pathway in a p62-dependent manner.",
        "relation": "CPR:3"
    },
    {
        "id": "23589329.T10.T31",
        "sentence": "@CHEMICAL$ inhibits autophagic flux activating the Nrf2-@GENE$ pathway in a p62-dependent manner.",
        "relation": "CPR:3"
    },
    {
        "id": "23589329.T5.T22",
        "sentence": "@CHEMICAL$ deregulates the autophagic pathway through blockage of autophagic flux, resulting in accumulation of autophagosomes and sequestration of p62, Keap1, and @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23589329.T5.T20",
        "sentence": "@CHEMICAL$ deregulates the autophagic pathway through blockage of autophagic flux, resulting in accumulation of autophagosomes and sequestration of @GENE$, Keap1, and LC3.",
        "relation": "CPR:4"
    },
    {
        "id": "23589329.T5.T21",
        "sentence": "@CHEMICAL$ deregulates the autophagic pathway through blockage of autophagic flux, resulting in accumulation of autophagosomes and sequestration of p62, @GENE$, and LC3.",
        "relation": "CPR:4"
    },
    {
        "id": "23589329.T6.T23",
        "sentence": "Thus, @CHEMICAL$ activates @GENE$ through a non-canonical mechanism (p62-dependent), leading to a chronic, sustained activation of Nrf2.",
        "relation": "CPR:3"
    },
    {
        "id": "23589329.T6.T25",
        "sentence": "Thus, @CHEMICAL$ activates Nrf2 through a non-canonical mechanism (p62-dependent), leading to a chronic, sustained activation of @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23589329.T7.T26",
        "sentence": "In contrast, activation of @CHEMICAL$ by @GENE$ and tert-butylhydroquinone depend upon Keap1-C151 and not p62 (the canonical mechanism).",
        "relation": "CPR:3"
    },
    {
        "id": "23589329.T8.T26",
        "sentence": "In contrast, activation of @CHEMICAL$ by sulforaphane and @GENE$ depend upon Keap1-C151 and not p62 (the canonical mechanism).",
        "relation": "CPR:3"
    },
    {
        "id": "23589329.T3.T12",
        "sentence": "Collectively, these findings provide evidence that @CHEMICAL$ causes prolonged activation of @GENE$ through autophagy dysfunction, possibly providing a similar scenario to constitutive activation of Nrf2 found in certain human cancers.",
        "relation": "CPR:3"
    },
    {
        "id": "23589329.T3.T13",
        "sentence": "Collectively, these findings provide evidence that @CHEMICAL$ causes prolonged activation of Nrf2 through autophagy dysfunction, possibly providing a similar scenario to constitutive activation of @GENE$ found in certain human cancers.",
        "relation": "CPR:3"
    },
    {
        "id": "23591044.T25.T47",
        "sentence": "Ovarian AR was not influenced by either treatment, and oviduct @CHEMICAL$ was reduced after @GENE$-melatonin combination.",
        "relation": "CPR:4"
    },
    {
        "id": "23591044.T26.T47",
        "sentence": "Ovarian AR was not influenced by either treatment, and oviduct @CHEMICAL$ was reduced after ethanol-@GENE$ combination.",
        "relation": "CPR:4"
    },
    {
        "id": "23591044.T27.T48",
        "sentence": "Oviduct @CHEMICAL$, ER-b and uterine ER-b were down-regulated by either @GENE$ or melatonin.",
        "relation": "CPR:4"
    },
    {
        "id": "23591044.T27.T49",
        "sentence": "Oviduct ER-a, @CHEMICAL$ and uterine ER-b were down-regulated by either @GENE$ or melatonin.",
        "relation": "CPR:4"
    },
    {
        "id": "23591044.T27.T50",
        "sentence": "Oviduct ER-a, ER-b and uterine @CHEMICAL$ were down-regulated by either @GENE$ or melatonin.",
        "relation": "CPR:4"
    },
    {
        "id": "23591044.T28.T48",
        "sentence": "Oviduct @CHEMICAL$, ER-b and uterine ER-b were down-regulated by either ethanol or @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23591044.T28.T49",
        "sentence": "Oviduct ER-a, @CHEMICAL$ and uterine ER-b were down-regulated by either ethanol or @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23591044.T28.T50",
        "sentence": "Oviduct ER-a, ER-b and uterine @CHEMICAL$ were down-regulated by either ethanol or @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23591044.T4.T35",
        "sentence": "Conversely, ovarian PRA and PRB were positively regulated by ethanol and ethanol-melatonin combination, whereas @CHEMICAL$ was down-regulated in the uterus and oviduct after @GENE$ consumption.",
        "relation": "CPR:4"
    },
    {
        "id": "23591044.T5.T36",
        "sentence": "@CHEMICAL$ was increased in ovaries and uteri of @GENE$-treated rats.",
        "relation": "CPR:3"
    },
    {
        "id": "23597507.T12.T21",
        "sentence": "Intraplantar or intrathecal administered Pha1b reduced both nocifensive behavior and mechanical hypersensitivity induced by capsaicin similarly to that observed with @CHEMICAL$, a specific @GENE$ antagonist.",
        "relation": "CPR:6"
    },
    {
        "id": "23598363.T11.T47",
        "sentence": "Recently, the c-Abl @CHEMICAL$ inhibitor @GENE$ (imatinib) has become the focus of research as a fertoprotective drug against cisplatin.",
        "relation": "CPR:4"
    },
    {
        "id": "23598363.T11.T46",
        "sentence": "Recently, the @CHEMICAL$ kinase inhibitor @GENE$ (imatinib) has become the focus of research as a fertoprotective drug against cisplatin.",
        "relation": "CPR:4"
    },
    {
        "id": "23598363.T12.T47",
        "sentence": "Recently, the c-Abl @CHEMICAL$ inhibitor imatinib mesylate (@GENE$) has become the focus of research as a fertoprotective drug against cisplatin.",
        "relation": "CPR:4"
    },
    {
        "id": "23598363.T12.T46",
        "sentence": "Recently, the @CHEMICAL$ kinase inhibitor imatinib mesylate (@GENE$) has become the focus of research as a fertoprotective drug against cisplatin.",
        "relation": "CPR:4"
    },
    {
        "id": "23598363.T17.T48",
        "sentence": "We found that, before apoptosis, @CHEMICAL$ induces @GENE$ and TAp73 expression in the oocyte.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T17.T49",
        "sentence": "We found that, before apoptosis, @CHEMICAL$ induces c-Abl and @GENE$ expression in the oocyte.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T19.T21",
        "sentence": "While imatinib was unable to block @CHEMICAL$-induced DNA damage and damage response, such as the upregulation of @GENE$, imatinib inhibited the cisplatin-induced nuclear accumulation of c-Abl/TAp73 and the subsequent downregulation of TAp63 and upregulation of Bax, thereby abrogating oocyte cell death.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T1.T22",
        "sentence": "While imatinib was unable to block cisplatin-induced DNA damage and damage response, such as the upregulation of p53, @CHEMICAL$ inhibited the cisplatin-induced nuclear accumulation of @GENE$/TAp73 and the subsequent downregulation of TAp63 and upregulation of Bax, thereby abrogating oocyte cell death.",
        "relation": "CPR:4"
    },
    {
        "id": "23598363.T1.T23",
        "sentence": "While imatinib was unable to block cisplatin-induced DNA damage and damage response, such as the upregulation of p53, @CHEMICAL$ inhibited the cisplatin-induced nuclear accumulation of c-Abl/@GENE$ and the subsequent downregulation of TAp63 and upregulation of Bax, thereby abrogating oocyte cell death.",
        "relation": "CPR:4"
    },
    {
        "id": "23598363.T1.T24",
        "sentence": "While imatinib was unable to block cisplatin-induced DNA damage and damage response, such as the upregulation of p53, @CHEMICAL$ inhibited the cisplatin-induced nuclear accumulation of c-Abl/TAp73 and the subsequent downregulation of @GENE$ and upregulation of Bax, thereby abrogating oocyte cell death.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T1.T25",
        "sentence": "While imatinib was unable to block cisplatin-induced DNA damage and damage response, such as the upregulation of p53, @CHEMICAL$ inhibited the cisplatin-induced nuclear accumulation of c-Abl/TAp73 and the subsequent downregulation of TAp63 and upregulation of @GENE$, thereby abrogating oocyte cell death.",
        "relation": "CPR:4"
    },
    {
        "id": "23598363.T2.T22",
        "sentence": "While imatinib was unable to block cisplatin-induced DNA damage and damage response, such as the upregulation of p53, imatinib inhibited the @CHEMICAL$-induced nuclear accumulation of @GENE$/TAp73 and the subsequent downregulation of TAp63 and upregulation of Bax, thereby abrogating oocyte cell death.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T2.T23",
        "sentence": "While imatinib was unable to block cisplatin-induced DNA damage and damage response, such as the upregulation of p53, imatinib inhibited the @CHEMICAL$-induced nuclear accumulation of c-Abl/@GENE$ and the subsequent downregulation of TAp63 and upregulation of Bax, thereby abrogating oocyte cell death.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T2.T24",
        "sentence": "While imatinib was unable to block cisplatin-induced DNA damage and damage response, such as the upregulation of p53, imatinib inhibited the @CHEMICAL$-induced nuclear accumulation of c-Abl/TAp73 and the subsequent downregulation of @GENE$ and upregulation of Bax, thereby abrogating oocyte cell death.",
        "relation": "CPR:4"
    },
    {
        "id": "23598363.T2.T25",
        "sentence": "While imatinib was unable to block cisplatin-induced DNA damage and damage response, such as the upregulation of p53, imatinib inhibited the @CHEMICAL$-induced nuclear accumulation of c-Abl/TAp73 and the subsequent downregulation of TAp63 and upregulation of @GENE$, thereby abrogating oocyte cell death.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T4.T28",
        "sentence": "Surprisingly, the conditional deletion of Trp63, but not DNp63, in oocytes inhibited apoptosis, as well as the accumulation of @CHEMICAL$ and TAp73 caused by @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T4.T29",
        "sentence": "Surprisingly, the conditional deletion of Trp63, but not DNp63, in oocytes inhibited apoptosis, as well as the accumulation of c-Abl and @CHEMICAL$ caused by @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T6.T34",
        "sentence": "The expression kinetics of TAp63, c-Abl and TAp73 suggest that @CHEMICAL$ activates @GENE$-dependent expression of c-Abl and TAp73 and, in turn, the activation of TAp73 by c-Abl-induced BAX expression.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T6.T35",
        "sentence": "The expression kinetics of TAp63, c-Abl and TAp73 suggest that @CHEMICAL$ activates TAp63-dependent expression of @GENE$ and TAp73 and, in turn, the activation of TAp73 by c-Abl-induced BAX expression.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T6.T36",
        "sentence": "The expression kinetics of TAp63, c-Abl and TAp73 suggest that @CHEMICAL$ activates TAp63-dependent expression of c-Abl and @GENE$ and, in turn, the activation of TAp73 by c-Abl-induced BAX expression.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T6.T37",
        "sentence": "The expression kinetics of TAp63, c-Abl and TAp73 suggest that @CHEMICAL$ activates TAp63-dependent expression of c-Abl and TAp73 and, in turn, the activation of @GENE$ by c-Abl-induced BAX expression.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T6.T38",
        "sentence": "The expression kinetics of TAp63, c-Abl and TAp73 suggest that @CHEMICAL$ activates TAp63-dependent expression of c-Abl and TAp73 and, in turn, the activation of TAp73 by @GENE$-induced BAX expression.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T6.T39",
        "sentence": "The expression kinetics of TAp63, c-Abl and TAp73 suggest that @CHEMICAL$ activates TAp63-dependent expression of c-Abl and TAp73 and, in turn, the activation of TAp73 by c-Abl-induced @GENE$ expression.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T7.T41",
        "sentence": "Our findings indicate that @CHEMICAL$ protects oocytes from cisplatin-induced cell death by inhibiting c-Abl @GENE$, which would otherwise activate TAp73-BAX-mediated apoptosis.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T7.T40",
        "sentence": "Our findings indicate that @CHEMICAL$ protects oocytes from cisplatin-induced cell death by inhibiting @GENE$ kinase, which would otherwise activate TAp73-BAX-mediated apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23598363.T7.T42",
        "sentence": "Our findings indicate that @CHEMICAL$ protects oocytes from cisplatin-induced cell death by inhibiting c-Abl kinase, which would otherwise activate @GENE$-BAX-mediated apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23598363.T7.T43",
        "sentence": "Our findings indicate that @CHEMICAL$ protects oocytes from cisplatin-induced cell death by inhibiting c-Abl kinase, which would otherwise activate TAp73-@GENE$-mediated apoptosis.",
        "relation": "CPR:4"
    },
    {
        "id": "23598363.T8.T41",
        "sentence": "Our findings indicate that imatinib protects oocytes from @CHEMICAL$-induced cell death by inhibiting c-Abl @GENE$, which would otherwise activate TAp73-BAX-mediated apoptosis.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T8.T40",
        "sentence": "Our findings indicate that imatinib protects oocytes from @CHEMICAL$-induced cell death by inhibiting @GENE$ kinase, which would otherwise activate TAp73-BAX-mediated apoptosis.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T8.T42",
        "sentence": "Our findings indicate that imatinib protects oocytes from @CHEMICAL$-induced cell death by inhibiting c-Abl kinase, which would otherwise activate @GENE$-BAX-mediated apoptosis.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T8.T43",
        "sentence": "Our findings indicate that imatinib protects oocytes from @CHEMICAL$-induced cell death by inhibiting c-Abl kinase, which would otherwise activate TAp73-@GENE$-mediated apoptosis.",
        "relation": "CPR:3"
    },
    {
        "id": "23598363.T9.T45",
        "sentence": "Thus, @CHEMICAL$ and other c-Abl @GENE$ inhibitors provide an intriguing new way to halt cisplatin-induced oocyte death in early follicles and perhaps conserve the endocrine function of the ovary against chemotherapy.",
        "relation": "CPR:4"
    },
    {
        "id": "23598363.T9.T44",
        "sentence": "Thus, @CHEMICAL$ and other @GENE$ kinase inhibitors provide an intriguing new way to halt cisplatin-induced oocyte death in early follicles and perhaps conserve the endocrine function of the ovary against chemotherapy.",
        "relation": "CPR:4"
    },
    {
        "id": "23598904.T21.T25",
        "sentence": "Among the possible transporters involved in the uptake of @CHEMICAL$ and Mn(2+), the expression of ZIP8 (Zrt-, Irt-related protein 8), encoded by @GENE$, showed a marked suppression in both RBL-Cdr and RBL-Mnr cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23598904.T21.T29",
        "sentence": "Among the possible transporters involved in the uptake of @CHEMICAL$ and Mn(2+), the expression of @GENE$ (Zrt-, Irt-related protein 8), encoded by Slc39a8, showed a marked suppression in both RBL-Cdr and RBL-Mnr cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23598904.T21.T30",
        "sentence": "Among the possible transporters involved in the uptake of @CHEMICAL$ and Mn(2+), the expression of ZIP8 (@GENE$), encoded by Slc39a8, showed a marked suppression in both RBL-Cdr and RBL-Mnr cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23598904.T22.T25",
        "sentence": "Among the possible transporters involved in the uptake of Cd(2+) and @CHEMICAL$, the expression of ZIP8 (Zrt-, Irt-related protein 8), encoded by @GENE$, showed a marked suppression in both RBL-Cdr and RBL-Mnr cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23598904.T22.T29",
        "sentence": "Among the possible transporters involved in the uptake of Cd(2+) and @CHEMICAL$, the expression of @GENE$ (Zrt-, Irt-related protein 8), encoded by Slc39a8, showed a marked suppression in both RBL-Cdr and RBL-Mnr cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23598904.T22.T30",
        "sentence": "Among the possible transporters involved in the uptake of Cd(2+) and @CHEMICAL$, the expression of ZIP8 (@GENE$), encoded by Slc39a8, showed a marked suppression in both RBL-Cdr and RBL-Mnr cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23598904.T1.T26",
        "sentence": "These results suggest that @CHEMICAL$ plays a pivotal role in the transport and toxicity of @GENE$ and Mn(2+) in RBL-2H3 cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23598904.T2.T26",
        "sentence": "These results suggest that @CHEMICAL$ plays a pivotal role in the transport and toxicity of Cd(2+) and @GENE$ in RBL-2H3 cells.",
        "relation": "CPR:9"
    },
    {
        "id": "23601710.T5.T11",
        "sentence": "Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of @CHEMICAL$ assembly inhibitors 2: Structure-activity relationships (SAR) of the C3-@GENE$ moiety.",
        "relation": "CPR:4"
    },
    {
        "id": "23601710.T6.T11",
        "sentence": "Optimization of a @CHEMICAL$ series of @GENE$ assembly inhibitors 2: Structure-activity relationships (SAR) of the C3-phenyl moiety.",
        "relation": "CPR:4"
    },
    {
        "id": "23601710.T1.T7",
        "sentence": "Detailed structure-activity relationships of the C3-phenyl moiety that allow for the optimization of antiviral potency of a series of @CHEMICAL$ inhibitors of @GENE$ (CA) assembly are described.",
        "relation": "CPR:4"
    },
    {
        "id": "23601710.T1.T8",
        "sentence": "Detailed structure-activity relationships of the C3-phenyl moiety that allow for the optimization of antiviral potency of a series of @CHEMICAL$ inhibitors of HIV capsid (@GENE$) assembly are described.",
        "relation": "CPR:4"
    },
    {
        "id": "23603059.T11.T29",
        "sentence": "@CHEMICAL$ upregulates the expression of @GENE$ in mouse aortic endothelial cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23603059.T6.T21",
        "sentence": "To delineate the pathogenesis, we examined changes in the mRNA levels of 2 angiotensin II Type I receptor (AT1R) subtypes, AT1AR and AT1BR, in a mouse aortic endothelial cell line, END-D. Quantitative real-time PCR analysis revealed significant increases in the mRNA levels of 2 @CHEMICAL$ subtypes, AT1AR and AT1BR following @GENE$ (SA) treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "23603059.T6.T22",
        "sentence": "To delineate the pathogenesis, we examined changes in the mRNA levels of 2 angiotensin II Type I receptor (AT1R) subtypes, AT1AR and AT1BR, in a mouse aortic endothelial cell line, END-D. Quantitative real-time PCR analysis revealed significant increases in the mRNA levels of 2 AT1R subtypes, @CHEMICAL$ and AT1BR following @GENE$ (SA) treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "23603059.T6.T23",
        "sentence": "To delineate the pathogenesis, we examined changes in the mRNA levels of 2 angiotensin II Type I receptor (AT1R) subtypes, AT1AR and AT1BR, in a mouse aortic endothelial cell line, END-D. Quantitative real-time PCR analysis revealed significant increases in the mRNA levels of 2 AT1R subtypes, AT1AR and @CHEMICAL$ following @GENE$ (SA) treatment.",
        "relation": "CPR:3"
    },
    {
        "id": "23603059.T1.T12",
        "sentence": "Finally, SA-induced AT1R expression was found to be prevented both by NAC and specific @CHEMICAL$ inhibitor, @GENE$, strongly indicating that AT1R upregulation is a result of the ROS-mediated activation of the JNK signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23603059.T1.T28",
        "sentence": "Finally, SA-induced @CHEMICAL$ expression was found to be prevented both by NAC and specific JNK inhibitor, @GENE$, strongly indicating that AT1R upregulation is a result of the ROS-mediated activation of the JNK signaling pathway.",
        "relation": "CPR:4"
    },
    {
        "id": "23603059.T2.T15",
        "sentence": "Taken together, our results indicate that @CHEMICAL$ indeed upregulates the @GENE$ expression, thus highlighting a role of arsenic-induced aberrant AT1R signaling in the pathogenesis of hypertension.",
        "relation": "CPR:3"
    },
    {
        "id": "23603059.T3.T16",
        "sentence": "Taken together, our results indicate that arsenic indeed upregulates the AT1R expression, thus highlighting a role of @CHEMICAL$-induced aberrant @GENE$ signaling in the pathogenesis of hypertension.",
        "relation": "CPR:3"
    },
    {
        "id": "23603382.T10.T17",
        "sentence": "The mRNA levels of SOD1, CAT, @CHEMICAL$ and Txnrd1 were increased significantly (P<0.05) in the combined Na2SeO3+@GENE$ treatment group.",
        "relation": "CPR:4"
    },
    {
        "id": "23603382.T10.T15",
        "sentence": "The mRNA levels of @CHEMICAL$, CAT, GPx and Txnrd1 were increased significantly (P<0.05) in the combined Na2SeO3+@GENE$ treatment group.",
        "relation": "CPR:4"
    },
    {
        "id": "23603382.T10.T16",
        "sentence": "The mRNA levels of SOD1, @CHEMICAL$, GPx and Txnrd1 were increased significantly (P<0.05) in the combined Na2SeO3+@GENE$ treatment group.",
        "relation": "CPR:4"
    },
    {
        "id": "23603382.T10.T18",
        "sentence": "The mRNA levels of SOD1, CAT, GPx and @CHEMICAL$ were increased significantly (P<0.05) in the combined Na2SeO3+@GENE$ treatment group.",
        "relation": "CPR:4"
    },
    {
        "id": "23603382.T9.T17",
        "sentence": "The mRNA levels of SOD1, CAT, @CHEMICAL$ and Txnrd1 were increased significantly (P<0.05) in the combined @GENE$+NaAsO2 treatment group.",
        "relation": "CPR:3"
    },
    {
        "id": "23603382.T9.T15",
        "sentence": "The mRNA levels of @CHEMICAL$, CAT, GPx and Txnrd1 were increased significantly (P<0.05) in the combined @GENE$+NaAsO2 treatment group.",
        "relation": "CPR:3"
    },
    {
        "id": "23603382.T9.T16",
        "sentence": "The mRNA levels of SOD1, @CHEMICAL$, GPx and Txnrd1 were increased significantly (P<0.05) in the combined @GENE$+NaAsO2 treatment group.",
        "relation": "CPR:3"
    },
    {
        "id": "23603382.T9.T18",
        "sentence": "The mRNA levels of SOD1, CAT, GPx and @CHEMICAL$ were increased significantly (P<0.05) in the combined @GENE$+NaAsO2 treatment group.",
        "relation": "CPR:4"
    },
    {
        "id": "23603382.T12.T19",
        "sentence": "The expressions of @CHEMICAL$ and HO-1 were significantly (P<0.05) increased in the @GENE$ group and reduced in the combined treatment group.",
        "relation": "CPR:3"
    },
    {
        "id": "23603382.T12.T20",
        "sentence": "The expressions of HSP70 and @CHEMICAL$ were significantly (P<0.05) increased in the @GENE$ group and reduced in the combined treatment group.",
        "relation": "CPR:3"
    },
    {
        "id": "23604720.T9.T18",
        "sentence": "From the 10 isolated compounds, @CHEMICAL$ showed the most potent inhibition, with IC50 values of 0.30 and 0.67 mM for @GENE$ and rhAR, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "23604720.T9.T19",
        "sentence": "From the 10 isolated compounds, @CHEMICAL$ showed the most potent inhibition, with IC50 values of 0.30 and 0.67 mM for rAR and @GENE$, respectively.",
        "relation": "CPR:4"
    },
    {
        "id": "23604720.T10.T11",
        "sentence": "In the kinetic analyses using Lineweaver-Burk plots of 1/velocity and 1/substrate, @CHEMICAL$ showed competitive inhibition of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "23611809.T3.T40",
        "sentence": "Recent observations revealed that @CHEMICAL$ catalyzes N-glucuronidation of @GENE$-containing compounds.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T11.T41",
        "sentence": "Using recombinant @CHEMICAL$, we found that it catalyzes the N-glucuronidation of @GENE$, imipramine, ketotifen, pizotifen, olanzapine, diphenhydramine, tamoxifen, ketoconazole and midazolam.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T12.T41",
        "sentence": "Using recombinant @CHEMICAL$, we found that it catalyzes the N-glucuronidation of amitriptyline, @GENE$, ketotifen, pizotifen, olanzapine, diphenhydramine, tamoxifen, ketoconazole and midazolam.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T13.T41",
        "sentence": "Using recombinant @CHEMICAL$, we found that it catalyzes the N-glucuronidation of amitriptyline, imipramine, @GENE$, pizotifen, olanzapine, diphenhydramine, tamoxifen, ketoconazole and midazolam.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T14.T41",
        "sentence": "Using recombinant @CHEMICAL$, we found that it catalyzes the N-glucuronidation of amitriptyline, imipramine, ketotifen, @GENE$, olanzapine, diphenhydramine, tamoxifen, ketoconazole and midazolam.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T15.T41",
        "sentence": "Using recombinant @CHEMICAL$, we found that it catalyzes the N-glucuronidation of amitriptyline, imipramine, ketotifen, pizotifen, @GENE$, diphenhydramine, tamoxifen, ketoconazole and midazolam.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T16.T41",
        "sentence": "Using recombinant @CHEMICAL$, we found that it catalyzes the N-glucuronidation of amitriptyline, imipramine, ketotifen, pizotifen, olanzapine, @GENE$, tamoxifen, ketoconazole and midazolam.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T17.T41",
        "sentence": "Using recombinant @CHEMICAL$, we found that it catalyzes the N-glucuronidation of amitriptyline, imipramine, ketotifen, pizotifen, olanzapine, diphenhydramine, @GENE$, ketoconazole and midazolam.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T18.T41",
        "sentence": "Using recombinant @CHEMICAL$, we found that it catalyzes the N-glucuronidation of amitriptyline, imipramine, ketotifen, pizotifen, olanzapine, diphenhydramine, tamoxifen, @GENE$ and midazolam.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T19.T41",
        "sentence": "Using recombinant @CHEMICAL$, we found that it catalyzes the N-glucuronidation of amitriptyline, imipramine, ketotifen, pizotifen, olanzapine, diphenhydramine, tamoxifen, ketoconazole and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T28.T45",
        "sentence": "This group of drugs contains secondary or primary amines, and these results suggest that @CHEMICAL$ preferably conjugates @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T4.T30",
        "sentence": "Kinetic analyses revealed that the affinity and clearance of @CHEMICAL$ for @GENE$, imipramine, and diphenhydramine are significantly higher than the corresponding values of UGT1A4 and UGT1A3, although the Vmax values of UGT1A4 toward these drugs are considerably higher.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T4.T31",
        "sentence": "Kinetic analyses revealed that the affinity and clearance of UGT2B10 for @CHEMICAL$, imipramine, and diphenhydramine are significantly higher than the corresponding values of @GENE$ and UGT1A3, although the Vmax values of UGT1A4 toward these drugs are considerably higher.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T4.T33",
        "sentence": "Kinetic analyses revealed that the affinity and clearance of UGT2B10 for @CHEMICAL$, imipramine, and diphenhydramine are significantly higher than the corresponding values of UGT1A4 and UGT1A3, although the Vmax values of @GENE$ toward these drugs are considerably higher.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T5.T30",
        "sentence": "Kinetic analyses revealed that the affinity and clearance of @CHEMICAL$ for amitriptyline, @GENE$, and diphenhydramine are significantly higher than the corresponding values of UGT1A4 and UGT1A3, although the Vmax values of UGT1A4 toward these drugs are considerably higher.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T5.T31",
        "sentence": "Kinetic analyses revealed that the affinity and clearance of UGT2B10 for amitriptyline, @CHEMICAL$, and diphenhydramine are significantly higher than the corresponding values of @GENE$ and UGT1A3, although the Vmax values of UGT1A4 toward these drugs are considerably higher.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T5.T32",
        "sentence": "Kinetic analyses revealed that the affinity and clearance of UGT2B10 for amitriptyline, @CHEMICAL$, and diphenhydramine are significantly higher than the corresponding values of UGT1A4 and @GENE$, although the Vmax values of UGT1A4 toward these drugs are considerably higher.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T5.T33",
        "sentence": "Kinetic analyses revealed that the affinity and clearance of UGT2B10 for amitriptyline, @CHEMICAL$, and diphenhydramine are significantly higher than the corresponding values of UGT1A4 and UGT1A3, although the Vmax values of @GENE$ toward these drugs are considerably higher.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T6.T30",
        "sentence": "Kinetic analyses revealed that the affinity and clearance of @CHEMICAL$ for amitriptyline, imipramine, and @GENE$ are significantly higher than the corresponding values of UGT1A4 and UGT1A3, although the Vmax values of UGT1A4 toward these drugs are considerably higher.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T6.T31",
        "sentence": "Kinetic analyses revealed that the affinity and clearance of UGT2B10 for amitriptyline, imipramine, and @CHEMICAL$ are significantly higher than the corresponding values of @GENE$ and UGT1A3, although the Vmax values of UGT1A4 toward these drugs are considerably higher.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T6.T32",
        "sentence": "Kinetic analyses revealed that the affinity and clearance of UGT2B10 for amitriptyline, imipramine, and @CHEMICAL$ are significantly higher than the corresponding values of UGT1A4 and @GENE$, although the Vmax values of UGT1A4 toward these drugs are considerably higher.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T6.T33",
        "sentence": "Kinetic analyses revealed that the affinity and clearance of UGT2B10 for amitriptyline, imipramine, and @CHEMICAL$ are significantly higher than the corresponding values of UGT1A4 and UGT1A3, although the Vmax values of @GENE$ toward these drugs are considerably higher.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T9.T35",
        "sentence": "In conclusion, this study expands the understanding of the substrate specificity of @CHEMICAL$, highlighting its preference for @GENE$ with higher affinities and clearance values than those of UGT1A4 and UGT1A3.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T9.T36",
        "sentence": "In conclusion, this study expands the understanding of the substrate specificity of UGT2B10, highlighting its preference for @CHEMICAL$ with higher affinities and clearance values than those of @GENE$ and UGT1A3.",
        "relation": "CPR:9"
    },
    {
        "id": "23611809.T9.T37",
        "sentence": "In conclusion, this study expands the understanding of the substrate specificity of UGT2B10, highlighting its preference for @CHEMICAL$ with higher affinities and clearance values than those of UGT1A4 and @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23611835.T1.T14",
        "sentence": "@CHEMICAL$ (SB) is an @GENE$ (IL-8RB) antagonist that has previously been shown to inhibit IL-8-based cancer cell invasion, and to possess in vivo anti-inflammatory and anti-nociceptive effects.",
        "relation": "CPR:6"
    },
    {
        "id": "23611835.T1.T16",
        "sentence": "@CHEMICAL$ (SB) is an IL-8 receptor B (@GENE$) antagonist that has previously been shown to inhibit IL-8-based cancer cell invasion, and to possess in vivo anti-inflammatory and anti-nociceptive effects.",
        "relation": "CPR:6"
    },
    {
        "id": "23611835.T1.T22",
        "sentence": "@CHEMICAL$ (SB) is an IL-8 receptor B (IL-8RB) antagonist that has previously been shown to inhibit @GENE$-based cancer cell invasion, and to possess in vivo anti-inflammatory and anti-nociceptive effects.",
        "relation": "CPR:4"
    },
    {
        "id": "23611835.T3.T21",
        "sentence": "Of note, @CHEMICAL$ which is a close structural analogue of SB225002 with a potent @GENE$ antagonistic activity did not exhibit a similar antimitotic activity.",
        "relation": "CPR:6"
    },
    {
        "id": "23611835.T4.T21",
        "sentence": "Of note, SB265610 which is a close structural analogue of @CHEMICAL$ with a potent @GENE$ antagonistic activity did not exhibit a similar antimitotic activity.",
        "relation": "CPR:6"
    },
    {
        "id": "23614643.T1.T9",
        "sentence": "In support of this observation, elongation can be reversed by the @CHEMICAL$ inhibitor @GENE$, mRNA for the FGFR antagonist sprouty4, or FGF8 morpholino.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T18.T39",
        "sentence": "@CHEMICAL$ Suppresses Proliferation and Survival of TW2.6 Human Oral Cancer Cells via Inhibition of @GENE$ Signaling.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T6.T19",
        "sentence": "Treatment with @CHEMICAL$ decreased protein abundance of @GENE$, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3b, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-kB, phospho-NF-kB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T6.T23",
        "sentence": "Treatment with @CHEMICAL$ decreased protein abundance of Akt, Akt1, Akt2, Akt3, @GENE$ Ser473, phospho-Akt Thr 308, GSK3b, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-kB, phospho-NF-kB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T6.T24",
        "sentence": "Treatment with @CHEMICAL$ decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, @GENE$ Thr 308, GSK3b, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-kB, phospho-NF-kB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T6.T30",
        "sentence": "Treatment with @CHEMICAL$ decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3b, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, @GENE$, phospho-NF-kB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T6.T31",
        "sentence": "Treatment with @CHEMICAL$ decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3b, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-kB, @GENE$ Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T6.T20",
        "sentence": "Treatment with @CHEMICAL$ decreased protein abundance of Akt, @GENE$, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3b, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-kB, phospho-NF-kB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T6.T21",
        "sentence": "Treatment with @CHEMICAL$ decreased protein abundance of Akt, Akt1, @GENE$, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3b, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-kB, phospho-NF-kB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T6.T22",
        "sentence": "Treatment with @CHEMICAL$ decreased protein abundance of Akt, Akt1, Akt2, @GENE$, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3b, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-kB, phospho-NF-kB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T6.T25",
        "sentence": "Treatment with @CHEMICAL$ decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, @GENE$, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-kB, phospho-NF-kB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T6.T26",
        "sentence": "Treatment with @CHEMICAL$ decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3b, @GENE$, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-kB, phospho-NF-kB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T6.T27",
        "sentence": "Treatment with @CHEMICAL$ decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3b, FOXO1, @GENE$, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-kB, phospho-NF-kB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T6.T28",
        "sentence": "Treatment with @CHEMICAL$ decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3b, FOXO1, FOXO3a, @GENE$ Thr24, phospho-FoxO3a Thr32, NF-kB, phospho-NF-kB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T6.T29",
        "sentence": "Treatment with @CHEMICAL$ decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3b, FOXO1, FOXO3a, phospho-FOXO1 Thr24, @GENE$ Thr32, NF-kB, phospho-NF-kB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T6.T32",
        "sentence": "Treatment with @CHEMICAL$ decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3b, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-kB, phospho-NF-kB Ser536, @GENE$, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T6.T33",
        "sentence": "Treatment with @CHEMICAL$ decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3b, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-kB, phospho-NF-kB Ser536, Rb, @GENE$ Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T6.T34",
        "sentence": "Treatment with @CHEMICAL$ decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3b, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-kB, phospho-NF-kB Ser536, Rb, phospho-Rb Ser807/811, @GENE$, and cyclin D1, but increased cell cycle inhibitor p27Kip.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T6.T35",
        "sentence": "Treatment with @CHEMICAL$ decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3b, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-kB, phospho-NF-kB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and @GENE$, but increased cell cycle inhibitor p27Kip.",
        "relation": "CPR:4"
    },
    {
        "id": "23615471.T6.T36",
        "sentence": "Treatment with @CHEMICAL$ decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3b, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-kB, phospho-NF-kB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23618921.T19.T35",
        "sentence": "Here we show that @CHEMICAL$ rapidly increases the levels of both @GENE$ and ATF4 as well as Nrf2- and ATF4-dependent gene transcription via distinct mechanisms.",
        "relation": "CPR:3"
    },
    {
        "id": "23618921.T19.T36",
        "sentence": "Here we show that @CHEMICAL$ rapidly increases the levels of both Nrf2 and @GENE$ as well as Nrf2- and ATF4-dependent gene transcription via distinct mechanisms.",
        "relation": "CPR:3"
    },
    {
        "id": "23618921.T19.T37",
        "sentence": "Here we show that @CHEMICAL$ rapidly increases the levels of both Nrf2 and ATF4 as well as @GENE$- and ATF4-dependent gene transcription via distinct mechanisms.",
        "relation": "CPR:3"
    },
    {
        "id": "23618921.T19.T38",
        "sentence": "Here we show that @CHEMICAL$ rapidly increases the levels of both Nrf2 and ATF4 as well as Nrf2- and @GENE$-dependent gene transcription via distinct mechanisms.",
        "relation": "CPR:3"
    },
    {
        "id": "23618921.T2.T23",
        "sentence": "Although @CHEMICAL$ greatly increases the stability of both @GENE$ and ATF4, only the effect on ATF4 is dependent on protein kinase activity.",
        "relation": "CPR:3"
    },
    {
        "id": "23618921.T2.T24",
        "sentence": "Although @CHEMICAL$ greatly increases the stability of both Nrf2 and @GENE$, only the effect on ATF4 is dependent on protein kinase activity.",
        "relation": "CPR:3"
    },
    {
        "id": "23623750.T10.T46",
        "sentence": "@CHEMICAL$, FMO2, FMO3, and FMO5 metabolized @GENE$, and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "23623750.T10.T47",
        "sentence": "Cynomolgus FMO1, @CHEMICAL$, FMO3, and FMO5 metabolized @GENE$, and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "23623750.T10.T48",
        "sentence": "Cynomolgus FMO1, FMO2, @CHEMICAL$, and FMO5 metabolized @GENE$, and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "23623750.T10.T49",
        "sentence": "Cynomolgus FMO1, FMO2, FMO3, and @CHEMICAL$ metabolized @GENE$, and FMO1/FMO3 and FMO3 also metabolized methimazole and trimethylamine, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "23623750.T2.T13",
        "sentence": "Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and @CHEMICAL$/FMO3 and FMO3 also metabolized @GENE$ and trimethylamine, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "23623750.T2.T14",
        "sentence": "Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/@CHEMICAL$ and FMO3 also metabolized @GENE$ and trimethylamine, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "23623750.T2.T15",
        "sentence": "Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/FMO3 and @CHEMICAL$ also metabolized @GENE$ and trimethylamine, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "23623750.T3.T13",
        "sentence": "Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and @CHEMICAL$/FMO3 and FMO3 also metabolized methimazole and @GENE$, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "23623750.T3.T14",
        "sentence": "Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/@CHEMICAL$ and FMO3 also metabolized methimazole and @GENE$, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "23623750.T3.T15",
        "sentence": "Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/FMO3 and @CHEMICAL$ also metabolized methimazole and @GENE$, respectively.",
        "relation": "CPR:9"
    },
    {
        "id": "23623750.T4.T16",
        "sentence": "Rates of @CHEMICAL$ N-oxygenation (catalyzed by @GENE$) varied (approximately 20-fold) among the 28 cynomolgus livers and were significantly correlated with FMO3 protein expression, indicating that the inter-animal variations in benzydamine N-oxygenation might be partly accounted for by the variable FMO3 expression.",
        "relation": "CPR:9"
    },
    {
        "id": "23623750.T5.T16",
        "sentence": "Rates of benzydamine @CHEMICAL$-oxygenation (catalyzed by @GENE$) varied (approximately 20-fold) among the 28 cynomolgus livers and were significantly correlated with FMO3 protein expression, indicating that the inter-animal variations in benzydamine N-oxygenation might be partly accounted for by the variable FMO3 expression.",
        "relation": "CPR:9"
    },
    {
        "id": "23623750.T6.T18",
        "sentence": "Rates of benzydamine N-oxygenation (catalyzed by FMO3) varied (approximately 20-fold) among the 28 cynomolgus livers and were significantly correlated with FMO3 protein expression, indicating that the inter-animal variations in @CHEMICAL$ N-oxygenation might be partly accounted for by the variable @GENE$ expression.",
        "relation": "CPR:9"
    },
    {
        "id": "23623750.T7.T18",
        "sentence": "Rates of benzydamine N-oxygenation (catalyzed by FMO3) varied (approximately 20-fold) among the 28 cynomolgus livers and were significantly correlated with FMO3 protein expression, indicating that the inter-animal variations in benzydamine @CHEMICAL$-oxygenation might be partly accounted for by the variable @GENE$ expression.",
        "relation": "CPR:9"
    },
    {
        "id": "23623750.T8.T19",
        "sentence": "@CHEMICAL$ metabolized @GENE$ only slightly, but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism, unlike cynomolgus FMO1, FMO2, FMO3, and FMO5 which were all functional.",
        "relation": "CPR:9"
    },
    {
        "id": "23623750.T8.T22",
        "sentence": "Cynomolgus FMO6 metabolized @CHEMICAL$ only slightly, but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism, unlike cynomolgus @GENE$, FMO2, FMO3, and FMO5 which were all functional.",
        "relation": "CPR:9"
    },
    {
        "id": "23623750.T8.T23",
        "sentence": "Cynomolgus FMO6 metabolized @CHEMICAL$ only slightly, but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism, unlike cynomolgus FMO1, @GENE$, FMO3, and FMO5 which were all functional.",
        "relation": "CPR:9"
    },
    {
        "id": "23623750.T8.T24",
        "sentence": "Cynomolgus FMO6 metabolized @CHEMICAL$ only slightly, but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism, unlike cynomolgus FMO1, FMO2, @GENE$, and FMO5 which were all functional.",
        "relation": "CPR:9"
    },
    {
        "id": "23623750.T8.T25",
        "sentence": "Cynomolgus FMO6 metabolized @CHEMICAL$ only slightly, but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism, unlike cynomolgus FMO1, FMO2, FMO3, and @GENE$ which were all functional.",
        "relation": "CPR:9"
    },
    {
        "id": "23625915.T4.T38",
        "sentence": "Activation of @CHEMICAL$ using @GENE$ resulted in STIM1 phosphorylation on serine residues and prevented PAR-1-induced Ca2+ entry.",
        "relation": "CPR:3"
    },
    {
        "id": "23625915.T4.T39",
        "sentence": "Activation of AMPK using @CHEMICAL$ resulted in @GENE$ phosphorylation on serine residues and prevented PAR-1-induced Ca2+ entry.",
        "relation": "CPR:3"
    },
    {
        "id": "23625915.T4.T40",
        "sentence": "Activation of AMPK using @CHEMICAL$ resulted in STIM1 phosphorylation on serine residues and prevented @GENE$-induced Ca2+ entry.",
        "relation": "CPR:4"
    },
    {
        "id": "23625915.T7.T41",
        "sentence": "Further, @CHEMICAL$ pretreatment blocked @GENE$-induced increase in permeability of mouse-lung microvessels.",
        "relation": "CPR:4"
    },
    {
        "id": "23625915.T9.T46",
        "sentence": "Interestingly, @CHEMICAL$, a selective inhibitor of @GENE$ MAPK, blocked STIM1 phosphorylation and led to sustained STIM1-puncta formation and Ca2+ entry.",
        "relation": "CPR:4"
    },
    {
        "id": "23625915.T9.T48",
        "sentence": "Interestingly, @CHEMICAL$, a selective inhibitor of p38 @GENE$, blocked STIM1 phosphorylation and led to sustained STIM1-puncta formation and Ca2+ entry.",
        "relation": "CPR:4"
    },
    {
        "id": "23625915.T9.T49",
        "sentence": "Interestingly, @CHEMICAL$, a selective inhibitor of p38 MAPK, blocked @GENE$ phosphorylation and led to sustained STIM1-puncta formation and Ca2+ entry.",
        "relation": "CPR:4"
    },
    {
        "id": "23628605.T4.T24",
        "sentence": "Mitochondria in the steroidogenic cells of the adrenal, gonad, placenta and brain contain the @CHEMICAL$ side-chain cleavage enzyme, @GENE$, and its two electron-transfer partners, ferredoxin reductase and ferredoxin.",
        "relation": "CPR:9"
    },
    {
        "id": "23628605.T1.T22",
        "sentence": "The precise fashion in which these proteins interact and move @CHEMICAL$ from the OMM to @GENE$, and the means by which cholesterol is loaded into the OMM, remain unclear.",
        "relation": "CPR:9"
    },
    {
        "id": "23631440.T9.T21",
        "sentence": "@CHEMICAL$ Inhibitors Based on the @GENE$ Core.",
        "relation": "CPR:4"
    },
    {
        "id": "23631440.T1.T11",
        "sentence": "New series of @CHEMICAL$, 2-mercaptocyclopentane arylsulfonamide, and 3-mercapto-4-arylsulfonamido pyrrolidine @GENE$ inhibitors (MMPIs) were designed, synthesized, and evaluated.",
        "relation": "CPR:4"
    },
    {
        "id": "23631440.T3.T11",
        "sentence": "New series of pyrrolidine mercaptosulfide, @CHEMICAL$, and 3-mercapto-4-arylsulfonamido pyrrolidine @GENE$ inhibitors (MMPIs) were designed, synthesized, and evaluated.",
        "relation": "CPR:4"
    },
    {
        "id": "23631440.T7.T11",
        "sentence": "New series of pyrrolidine mercaptosulfide, 2-mercaptocyclopentane arylsulfonamide, and @CHEMICAL$ @GENE$ inhibitors (MMPIs) were designed, synthesized, and evaluated.",
        "relation": "CPR:4"
    },
    {
        "id": "23631440.T2.T12",
        "sentence": "Exhibiting unique properties over other MMPIs (e.g., @CHEMICAL$), these newly reported compounds are capable of modulating activities of several @GENE$ in the low nanomolar range, including MMP-2 (~2 to 50 nM), MMP-13 (~2 to 50 nM), and MMP-14 (~4 to 60 nM).",
        "relation": "CPR:4"
    },
    {
        "id": "23631440.T2.T13",
        "sentence": "Exhibiting unique properties over other MMPIs (e.g., @CHEMICAL$), these newly reported compounds are capable of modulating activities of several MMPs in the low nanomolar range, including @GENE$ (~2 to 50 nM), MMP-13 (~2 to 50 nM), and MMP-14 (~4 to 60 nM).",
        "relation": "CPR:4"
    },
    {
        "id": "23631440.T2.T14",
        "sentence": "Exhibiting unique properties over other MMPIs (e.g., @CHEMICAL$), these newly reported compounds are capable of modulating activities of several MMPs in the low nanomolar range, including MMP-2 (~2 to 50 nM), @GENE$ (~2 to 50 nM), and MMP-14 (~4 to 60 nM).",
        "relation": "CPR:4"
    },
    {
        "id": "23631440.T2.T15",
        "sentence": "Exhibiting unique properties over other MMPIs (e.g., @CHEMICAL$), these newly reported compounds are capable of modulating activities of several MMPs in the low nanomolar range, including MMP-2 (~2 to 50 nM), MMP-13 (~2 to 50 nM), and @GENE$ (~4 to 60 nM).",
        "relation": "CPR:4"
    },
    {
        "id": "23638842.T3.T14",
        "sentence": "Recent literature shows that Brassica vegetables (Cruciferae) possess therapeutic effects particularly ascribed due to their content in @CHEMICAL$, which upon @GENE$ hydrolysis release the corresponding isothiocyanates.",
        "relation": "CPR:9"
    },
    {
        "id": "23638842.T4.T14",
        "sentence": "Recent literature shows that Brassica vegetables (Cruciferae) possess therapeutic effects particularly ascribed due to their content in glucosinolates, which upon @CHEMICAL$ hydrolysis release the corresponding @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "23638842.T1.T8",
        "sentence": "RESULTS: By Western blot analysis of spinal cord tissues, we have demonstrated that treatment with bioactive @CHEMICAL$ significantly decreased @GENE$ translocation, pro-inflammatory cytokine production such as interleukin-1b (IL-1b), and apoptosis (Bax and caspase 3 expression).",
        "relation": "CPR:4"
    },
    {
        "id": "23638842.T1.T9",
        "sentence": "RESULTS: By Western blot analysis of spinal cord tissues, we have demonstrated that treatment with bioactive @CHEMICAL$ significantly decreased nuclear factor (NF)-kB translocation, pro-inflammatory @GENE$ production such as interleukin-1b (IL-1b), and apoptosis (Bax and caspase 3 expression).",
        "relation": "CPR:4"
    },
    {
        "id": "23638842.T1.T10",
        "sentence": "RESULTS: By Western blot analysis of spinal cord tissues, we have demonstrated that treatment with bioactive @CHEMICAL$ significantly decreased nuclear factor (NF)-kB translocation, pro-inflammatory cytokine production such as @GENE$ (IL-1b), and apoptosis (Bax and caspase 3 expression).",
        "relation": "CPR:4"
    },
    {
        "id": "23638842.T1.T11",
        "sentence": "RESULTS: By Western blot analysis of spinal cord tissues, we have demonstrated that treatment with bioactive @CHEMICAL$ significantly decreased nuclear factor (NF)-kB translocation, pro-inflammatory cytokine production such as interleukin-1b (@GENE$), and apoptosis (Bax and caspase 3 expression).",
        "relation": "CPR:4"
    },
    {
        "id": "23638842.T1.T12",
        "sentence": "RESULTS: By Western blot analysis of spinal cord tissues, we have demonstrated that treatment with bioactive @CHEMICAL$ significantly decreased nuclear factor (NF)-kB translocation, pro-inflammatory cytokine production such as interleukin-1b (IL-1b), and apoptosis (@GENE$ and caspase 3 expression).",
        "relation": "CPR:4"
    },
    {
        "id": "23638842.T1.T13",
        "sentence": "RESULTS: By Western blot analysis of spinal cord tissues, we have demonstrated that treatment with bioactive @CHEMICAL$ significantly decreased nuclear factor (NF)-kB translocation, pro-inflammatory cytokine production such as interleukin-1b (IL-1b), and apoptosis (Bax and @GENE$ expression).",
        "relation": "CPR:4"
    },
    {
        "id": "23639191.T17.T33",
        "sentence": "Herein, we investigated the effect of a natural neuroprotective flavonoid, calycopterin, on @CHEMICAL$-induced disruption of @GENE$ system and cAMP response element binding protein (CREB) phosphorylation. METHODS: PC12 cells were treated with 25, 50 and 100mM of calycopterin for 3h, followed by adding H2O2 (150mM) for 24h.",
        "relation": "CPR:4"
    },
    {
        "id": "23639191.T17.T34",
        "sentence": "Herein, we investigated the effect of a natural neuroprotective flavonoid, calycopterin, on @CHEMICAL$-induced disruption of phase II detoxifying enzyme system and @GENE$ (CREB) phosphorylation. METHODS: PC12 cells were treated with 25, 50 and 100mM of calycopterin for 3h, followed by adding H2O2 (150mM) for 24h.",
        "relation": "CPR:4"
    },
    {
        "id": "23639191.T17.T35",
        "sentence": "Herein, we investigated the effect of a natural neuroprotective flavonoid, calycopterin, on @CHEMICAL$-induced disruption of phase II detoxifying enzyme system and cAMP response element binding protein (@GENE$) phosphorylation. METHODS: PC12 cells were treated with 25, 50 and 100mM of calycopterin for 3h, followed by adding H2O2 (150mM) for 24h.",
        "relation": "CPR:4"
    },
    {
        "id": "23639191.T7.T25",
        "sentence": "In H2O2-treated cells, @CHEMICAL$ also suppressed @GENE$ release to cytosol that is necessary for maintaining mitochondrial homeostasis in survived cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23639191.T8.T26",
        "sentence": "Moreover, @CHEMICAL$, in presence of H2O2 inhibited the decrease caused by oxidative stress in stress-sensing transcription factors, @GENE$ and Nrf2, which play an important role in antioxidant capacity of the cell.",
        "relation": "CPR:3"
    },
    {
        "id": "23639191.T8.T27",
        "sentence": "Moreover, @CHEMICAL$, in presence of H2O2 inhibited the decrease caused by oxidative stress in stress-sensing transcription factors, CREB and @GENE$, which play an important role in antioxidant capacity of the cell.",
        "relation": "CPR:3"
    },
    {
        "id": "23639191.T10.T28",
        "sentence": "There was also an increase in @CHEMICAL$ and HO-1 levels in @GENE$ pretreated cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23639191.T10.T29",
        "sentence": "There was also an increase in g-GCS and @CHEMICAL$ levels in @GENE$ pretreated cells.",
        "relation": "CPR:3"
    },
    {
        "id": "23639191.T12.T30",
        "sentence": "In the presence of H2O2, @CHEMICAL$ inhibited decrease in GSH level and @GENE$ activity. CONCLUSION: We provided documentation of neuroprotective effect of a natural flavone, calycopterin, against H2O2-induced oxidative stress in differentiated PC12 cells by modulating the level of CREB phosphorylation and Nrf2 pathway.",
        "relation": "CPR:3"
    },
    {
        "id": "23639249.T14.T29",
        "sentence": "@CHEMICAL$ stimulates Th17 differentiation enhancing phosphorylation of @GENE$ and STAT3 to worsen experimental autoimmune encephalomyelitis.",
        "relation": "CPR:3"
    },
    {
        "id": "23639249.T14.T30",
        "sentence": "@CHEMICAL$ stimulates Th17 differentiation enhancing phosphorylation of c-Src and @GENE$ to worsen experimental autoimmune encephalomyelitis.",
        "relation": "CPR:3"
    },
    {
        "id": "23639249.T4.T18",
        "sentence": "In the present study, using in vitro Th17 differentiation model, we examined effects of @CHEMICAL$ activation by @GENE$ (I3S), a uremic toxin, on Th17 differentiation and investigated underlying mechanisms. I3S increased expression of RORgt, the master transcription factor for Th17 differentiation, and stimulated Th17 differentiation, in a comparative manner as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a prototypical AhR ligand.",
        "relation": "CPR:3"
    },
    {
        "id": "23639249.T5.T18",
        "sentence": "In the present study, using in vitro Th17 differentiation model, we examined effects of @CHEMICAL$ activation by indoxyl 3-sulfate (@GENE$), a uremic toxin, on Th17 differentiation and investigated underlying mechanisms. I3S increased expression of RORgt, the master transcription factor for Th17 differentiation, and stimulated Th17 differentiation, in a comparative manner as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a prototypical AhR ligand.",
        "relation": "CPR:3"
    },
    {
        "id": "23639249.T6.T19",
        "sentence": "In the present study, using in vitro Th17 differentiation model, we examined effects of AhR activation by indoxyl 3-sulfate (I3S), a uremic toxin, on Th17 differentiation and investigated underlying mechanisms. @CHEMICAL$ increased expression of @GENE$, the master transcription factor for Th17 differentiation, and stimulated Th17 differentiation, in a comparative manner as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a prototypical AhR ligand.",
        "relation": "CPR:3"
    },
    {
        "id": "23639249.T10.T21",
        "sentence": "Activation of @CHEMICAL$, which is phosphorylated by the IL-6 signaling pathways and thus is necessary for Th17 differentiation, was strongly stimulated by I3S and @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23639249.T10.T22",
        "sentence": "Activation of STAT3, which is phosphorylated by the @CHEMICAL$ signaling pathways and thus is necessary for Th17 differentiation, was strongly stimulated by I3S and @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "23639249.T9.T21",
        "sentence": "Activation of @CHEMICAL$, which is phosphorylated by the IL-6 signaling pathways and thus is necessary for Th17 differentiation, was strongly stimulated by @GENE$ and TCDD.",
        "relation": "CPR:3"
    },
    {
        "id": "23639249.T9.T22",
        "sentence": "Activation of STAT3, which is phosphorylated by the @CHEMICAL$ signaling pathways and thus is necessary for Th17 differentiation, was strongly stimulated by @GENE$ and TCDD.",
        "relation": "CPR:3"
    },
    {
        "id": "23639249.T11.T23",
        "sentence": "Phosphorylation of @CHEMICAL$, which was shown to be activated by AhR ligands, was also increased by @GENE$ and TCDD, and blocking of c-Src activity by 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine (PP2) inhibited phosphorylation of both c-Src and STAT3, raising a possibility that stimulatory activities of I3S and TCDD on Th17 differentiation could be exerted via increased phosphorylation of c-Src, which in turn stimulates STAT3 activation.",
        "relation": "CPR:3"
    },
    {
        "id": "23639249.T12.T23",
        "sentence": "Phosphorylation of @CHEMICAL$, which was shown to be activated by AhR ligands, was also increased by I3S and @GENE$, and blocking of c-Src activity by 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine (PP2) inhibited phosphorylation of both c-Src and STAT3, raising a possibility that stimulatory activities of I3S and TCDD on Th17 differentiation could be exerted via increased phosphorylation of c-Src, which in turn stimulates STAT3 activation.",
        "relation": "CPR:3"
    },
    {
        "id": "23639249.T13.T25",
        "sentence": "Phosphorylation of c-Src, which was shown to be activated by AhR ligands, was also increased by I3S and TCDD, and blocking of @CHEMICAL$ activity by @GENE$ (PP2) inhibited phosphorylation of both c-Src and STAT3, raising a possibility that stimulatory activities of I3S and TCDD on Th17 differentiation could be exerted via increased phosphorylation of c-Src, which in turn stimulates STAT3 activation.",
        "relation": "CPR:4"
    },
    {
        "id": "23639249.T13.T27",
        "sentence": "Phosphorylation of c-Src, which was shown to be activated by AhR ligands, was also increased by I3S and TCDD, and blocking of c-Src activity by @CHEMICAL$ (PP2) inhibited phosphorylation of both @GENE$ and STAT3, raising a possibility that stimulatory activities of I3S and TCDD on Th17 differentiation could be exerted via increased phosphorylation of c-Src, which in turn stimulates STAT3 activation.",
        "relation": "CPR:4"
    },
    {
        "id": "23639249.T13.T28",
        "sentence": "Phosphorylation of c-Src, which was shown to be activated by AhR ligands, was also increased by I3S and TCDD, and blocking of c-Src activity by @CHEMICAL$ (PP2) inhibited phosphorylation of both c-Src and @GENE$, raising a possibility that stimulatory activities of I3S and TCDD on Th17 differentiation could be exerted via increased phosphorylation of c-Src, which in turn stimulates STAT3 activation.",
        "relation": "CPR:4"
    },
    {
        "id": "23639249.T1.T15",
        "sentence": "Phosphorylation of c-Src, which was shown to be activated by AhR ligands, was also increased by I3S and TCDD, and blocking of c-Src activity by 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine (PP2) inhibited phosphorylation of both c-Src and STAT3, raising a possibility that stimulatory activities of @CHEMICAL$ and TCDD on Th17 differentiation could be exerted via increased phosphorylation of @GENE$, which in turn stimulates STAT3 activation.",
        "relation": "CPR:3"
    },
    {
        "id": "23639249.T1.T16",
        "sentence": "Phosphorylation of c-Src, which was shown to be activated by AhR ligands, was also increased by I3S and TCDD, and blocking of c-Src activity by 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine (PP2) inhibited phosphorylation of both c-Src and STAT3, raising a possibility that stimulatory activities of @CHEMICAL$ and TCDD on Th17 differentiation could be exerted via increased phosphorylation of c-Src, which in turn stimulates @GENE$ activation.",
        "relation": "CPR:3"
    },
    {
        "id": "23639249.T2.T15",
        "sentence": "Phosphorylation of c-Src, which was shown to be activated by AhR ligands, was also increased by I3S and TCDD, and blocking of c-Src activity by 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine (PP2) inhibited phosphorylation of both c-Src and STAT3, raising a possibility that stimulatory activities of I3S and @CHEMICAL$ on Th17 differentiation could be exerted via increased phosphorylation of @GENE$, which in turn stimulates STAT3 activation.",
        "relation": "CPR:3"
    },
    {
        "id": "23639249.T2.T16",
        "sentence": "Phosphorylation of c-Src, which was shown to be activated by AhR ligands, was also increased by I3S and TCDD, and blocking of c-Src activity by 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine (PP2) inhibited phosphorylation of both c-Src and STAT3, raising a possibility that stimulatory activities of I3S and @CHEMICAL$ on Th17 differentiation could be exerted via increased phosphorylation of c-Src, which in turn stimulates @GENE$ activation.",
        "relation": "CPR:3"
    },
    {
        "id": "23639249.T3.T17",
        "sentence": "Finally, we found that @CHEMICAL$ worsened experimental autoimmune encephalomyelitis (EAE), which is primarily mediated by Th17 cells, enhancing the frequency of @GENE$-producing cells in draining lymph nodes.",
        "relation": "CPR:3"
    },
    {
        "id": "23639626.T16.T36",
        "sentence": "@CHEMICAL$ induces the expression of @GENE$ in 5L rat hepatoma cells: a cautionary tale of the use of this cell line in studies on dioxin toxicity.",
        "relation": "CPR:3"
    },
    {
        "id": "23639626.T12.T31",
        "sentence": "\"By \"\"working upwards\"\" from mTOR, we observed that @CHEMICAL$ inhibited endogenous and IGF-I-induced @GENE$ and ERK activation by interfering with tyrosine phosphorylation of insulin receptor substrate 1.\"",
        "relation": "CPR:4"
    },
    {
        "id": "23639626.T12.T32",
        "sentence": "\"By \"\"working upwards\"\" from mTOR, we observed that @CHEMICAL$ inhibited endogenous and IGF-I-induced AKT and @GENE$ activation by interfering with tyrosine phosphorylation of insulin receptor substrate 1.\"",
        "relation": "CPR:4"
    },
    {
        "id": "23639626.T12.T30",
        "sentence": "\"By \"\"working upwards\"\" from mTOR, we observed that @CHEMICAL$ inhibited endogenous and @GENE$-induced AKT and ERK activation by interfering with tyrosine phosphorylation of insulin receptor substrate 1.\"",
        "relation": "CPR:4"
    },
    {
        "id": "23639626.T14.T34",
        "sentence": "This inhibition was mediated by a @CHEMICAL$-induced secreted factor which was identified as @GENE$ (IGFBP-4).",
        "relation": "CPR:3"
    },
    {
        "id": "23639626.T14.T35",
        "sentence": "This inhibition was mediated by a @CHEMICAL$-induced secreted factor which was identified as insulin-like growth factor binding protein 4 (@GENE$).",
        "relation": "CPR:3"
    },
    {
        "id": "23639626.T2.T20",
        "sentence": "The induction of IGFBP-4 protein was dependent on a functional aryl hydrocarbon receptor and was preceded by a rapid increase in the level of @CHEMICAL$ mRNA indicating that IGFBP-4 is a previously unknown transcriptional target of @GENE$ in 5L cells.",
        "relation": "CPR:4"
    },
    {
        "id": "23639626.T5.T25",
        "sentence": "The observations suggest that in 5L cells the Igfbp-4 gene may have got under the control of a promoter containing dioxin responsive element(s) leading to the induction of @CHEMICAL$ by @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "2386945.T8.T40",
        "sentence": "Although numerous mechanisms of action of @CHEMICAL$ and thioridazine have been identified, both drugs are @GENE$ antagonists at drug concentrations that inhibit breast cancer cell growth in vitro.",
        "relation": "CPR:6"
    },
    {
        "id": "2386945.T9.T40",
        "sentence": "Although numerous mechanisms of action of pimozide and @CHEMICAL$ have been identified, both drugs are @GENE$ antagonists at drug concentrations that inhibit breast cancer cell growth in vitro.",
        "relation": "CPR:6"
    },
    {
        "id": "2386945.T12.T41",
        "sentence": "Inhibition of MCF-7 cell growth by the selective @CHEMICAL$ antagonists @GENE$ and W-12 is consistent with a role for calmodulin antagonism in the broad growth-inhibitory properties of pimozide.",
        "relation": "CPR:6"
    },
    {
        "id": "2386945.T13.T41",
        "sentence": "Inhibition of MCF-7 cell growth by the selective @CHEMICAL$ antagonists W-13 and @GENE$ is consistent with a role for calmodulin antagonism in the broad growth-inhibitory properties of pimozide.",
        "relation": "CPR:6"
    },
    {
        "id": "2386945.T15.T42",
        "sentence": "Inhibition of MCF-7 cell growth by the selective calmodulin antagonists W-13 and W-12 is consistent with a role for @CHEMICAL$ antagonism in the broad growth-inhibitory properties of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "2506486.T10.T39",
        "sentence": "Levels of homovanillic acid (HVA), dihydroxyphenylacetic acid (DOPAC) and dihydroxyphenylglycol (DHPG) in plasma and the striatium were measured after inhibition of monoamine oxidase type A (MAO-A) by clorgyline (4 mg/kg i.p.), @CHEMICAL$ by @GENE$ (1 mg/kg i.p.), both MAO-A and MAO-B by nialamide (75 mg/kg i.p.) or peripheral neuronal MAO by debrisoquin (40 mg/kg i.p.).",
        "relation": "CPR:4"
    },
    {
        "id": "2506486.T11.T40",
        "sentence": "Levels of homovanillic acid (HVA), dihydroxyphenylacetic acid (DOPAC) and dihydroxyphenylglycol (DHPG) in plasma and the striatium were measured after inhibition of monoamine oxidase type A (MAO-A) by clorgyline (4 mg/kg i.p.), MAO-B by (-)deprenyl (1 mg/kg i.p.), both @CHEMICAL$ and MAO-B by @GENE$ (75 mg/kg i.p.) or peripheral neuronal MAO by debrisoquin (40 mg/kg i.p.).",
        "relation": "CPR:4"
    },
    {
        "id": "2506486.T11.T41",
        "sentence": "Levels of homovanillic acid (HVA), dihydroxyphenylacetic acid (DOPAC) and dihydroxyphenylglycol (DHPG) in plasma and the striatium were measured after inhibition of monoamine oxidase type A (MAO-A) by clorgyline (4 mg/kg i.p.), MAO-B by (-)deprenyl (1 mg/kg i.p.), both MAO-A and @CHEMICAL$ by @GENE$ (75 mg/kg i.p.) or peripheral neuronal MAO by debrisoquin (40 mg/kg i.p.).",
        "relation": "CPR:4"
    },
    {
        "id": "2506486.T13.T42",
        "sentence": "Levels of homovanillic acid (HVA), dihydroxyphenylacetic acid (DOPAC) and dihydroxyphenylglycol (DHPG) in plasma and the striatium were measured after inhibition of monoamine oxidase type A (MAO-A) by clorgyline (4 mg/kg i.p.), MAO-B by (-)deprenyl (1 mg/kg i.p.), both MAO-A and MAO-B by nialamide (75 mg/kg i.p.) or peripheral neuronal @CHEMICAL$ by @GENE$ (40 mg/kg i.p.).",
        "relation": "CPR:4"
    },
    {
        "id": "2506486.T9.T37",
        "sentence": "Levels of homovanillic acid (HVA), dihydroxyphenylacetic acid (DOPAC) and dihydroxyphenylglycol (DHPG) in plasma and the striatium were measured after inhibition of @CHEMICAL$ (MAO-A) by @GENE$ (4 mg/kg i.p.), MAO-B by (-)deprenyl (1 mg/kg i.p.), both MAO-A and MAO-B by nialamide (75 mg/kg i.p.) or peripheral neuronal MAO by debrisoquin (40 mg/kg i.p.).",
        "relation": "CPR:4"
    },
    {
        "id": "2506486.T9.T38",
        "sentence": "Levels of homovanillic acid (HVA), dihydroxyphenylacetic acid (DOPAC) and dihydroxyphenylglycol (DHPG) in plasma and the striatium were measured after inhibition of monoamine oxidase type A (@CHEMICAL$) by @GENE$ (4 mg/kg i.p.), MAO-B by (-)deprenyl (1 mg/kg i.p.), both MAO-A and MAO-B by nialamide (75 mg/kg i.p.) or peripheral neuronal MAO by debrisoquin (40 mg/kg i.p.).",
        "relation": "CPR:4"
    },
    {
        "id": "2506486.T1.T36",
        "sentence": "The results suggest that most of the HVA in plasma is derived from deamination of @CHEMICAL$ by @GENE$ in peripheral neurons; that DOPAC in plasma is derived from cells outside the central nervous system; that DHPG in plasma is derived virtually exclusively from the metabolism of norepinephrine in sympathetic nerve endings and that residual levels of HVA after treatment with debrisoquin provide an improved but limited indication of central dopaminergic activity.",
        "relation": "CPR:9"
    },
    {
        "id": "2506486.T31.T36",
        "sentence": "The results suggest that most of the @CHEMICAL$ in plasma is derived from deamination of DA by @GENE$ in peripheral neurons; that DOPAC in plasma is derived from cells outside the central nervous system; that DHPG in plasma is derived virtually exclusively from the metabolism of norepinephrine in sympathetic nerve endings and that residual levels of HVA after treatment with debrisoquin provide an improved but limited indication of central dopaminergic activity.",
        "relation": "CPR:9"
    },
    {
        "id": "2832297.T2.T7",
        "sentence": "After @CHEMICAL$ administration @GENE$ levels fell to a nadir of 135 +/- 76 pg/ml, and then CRH was still able to induce an ACTH increase; the pattern of ACTH response to CRH was slightly delayed.",
        "relation": "CPR:4"
    },
    {
        "id": "2832297.T2.T9",
        "sentence": "After @CHEMICAL$ administration ACTH levels fell to a nadir of 135 +/- 76 pg/ml, and then CRH was still able to induce an @GENE$ increase; the pattern of ACTH response to CRH was slightly delayed.",
        "relation": "CPR:3"
    },
    {
        "id": "2857786.T1.T18",
        "sentence": "@CHEMICAL$ is known to be an inhibitor of acetylcholinesterase, and recent data have shown this drug to antagonize @GENE$ as well.",
        "relation": "CPR:6"
    },
    {
        "id": "2857786.T1.T20",
        "sentence": "@CHEMICAL$ is known to be an inhibitor of @GENE$, and recent data have shown this drug to antagonize muscarinic receptors as well.",
        "relation": "CPR:4"
    },
    {
        "id": "2857786.T14.T21",
        "sentence": "Ambenonium was a less potent antagonist of tissue responses to acetylcholine, and the underestimation in the pKB (as compared to that obtained with bethanechol) could be eliminated by prior treatment of tissues with the @CHEMICAL$ inhibitor @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "2857786.T15.T19",
        "sentence": "These data suggested that @CHEMICAL$ had a dual effect on tissue responses to acetylcholine-producing potentiation by blockade of acetylcholinesterase and concomitant antagonism by blockade of @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "2857786.T15.T19",
        "sentence": "These data suggested that @CHEMICAL$ had a dual effect on tissue responses to acetylcholine-producing potentiation by blockade of acetylcholinesterase and concomitant antagonism by blockade of @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "2857786.T15.T17",
        "sentence": "These data suggested that @CHEMICAL$ had a dual effect on tissue responses to acetylcholine-producing potentiation by blockade of @GENE$ and concomitant antagonism by blockade of muscarinic receptors.",
        "relation": "CPR:4"
    },
    {
        "id": "2857786.T2.T17",
        "sentence": "These data suggested that ambenonium had a dual effect on tissue responses to @CHEMICAL$-producing potentiation by blockade of @GENE$ and concomitant antagonism by blockade of muscarinic receptors.",
        "relation": "CPR:5"
    },
    {
        "id": "2891463.T2.T28",
        "sentence": "However, @CHEMICAL$ produces less systemic beta 2- and possibly @GENE$ blockade than either timolol or levobunolol.",
        "relation": "CPR:4"
    },
    {
        "id": "2891463.T3.T28",
        "sentence": "However, betaxolol produces less systemic beta 2- and possibly @CHEMICAL$ blockade than either @GENE$ or levobunolol.",
        "relation": "CPR:4"
    },
    {
        "id": "2891463.T4.T28",
        "sentence": "However, betaxolol produces less systemic beta 2- and possibly @CHEMICAL$ blockade than either timolol or @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "3094574.T26.T37",
        "sentence": "@CHEMICAL$ catalyzes an unusual oxidative decarboxylation of @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "3094574.T12.T27",
        "sentence": "@CHEMICAL$ usually catalyzes the conversion of @GENE$ to o-diphenols and oxidation of diphenols to the corresponding quinones.",
        "relation": "CPR:9"
    },
    {
        "id": "3094574.T23.T27",
        "sentence": "@CHEMICAL$ usually catalyzes the conversion of monophenols to o-diphenols and oxidation of @GENE$ to the corresponding quinones.",
        "relation": "CPR:9"
    },
    {
        "id": "3094574.T18.T35",
        "sentence": "@CHEMICAL$ inhibitors such as @GENE$, potassium cyanide, and sodium azide inhibited the reaction drastically, suggesting the participation of the active site copper of the enzyme in the catalysis.",
        "relation": "CPR:4"
    },
    {
        "id": "3094574.T19.T35",
        "sentence": "@CHEMICAL$ inhibitors such as phenylthiourea, @GENE$, and sodium azide inhibited the reaction drastically, suggesting the participation of the active site copper of the enzyme in the catalysis.",
        "relation": "CPR:4"
    },
    {
        "id": "3094574.T20.T35",
        "sentence": "@CHEMICAL$ inhibitors such as phenylthiourea, potassium cyanide, and @GENE$ inhibited the reaction drastically, suggesting the participation of the active site copper of the enzyme in the catalysis.",
        "relation": "CPR:4"
    },
    {
        "id": "3094574.T22.T36",
        "sentence": "@CHEMICAL$, a well-known competitive inhibitor of @GENE$, competitively inhibited the new reaction also.",
        "relation": "CPR:4"
    },
    {
        "id": "3094574.T10.T28",
        "sentence": "Present studies demonstrate that @CHEMICAL$ will also catalyze quinone methide production with the same active site copper if a suitable substrate such as @GENE$ is provided.",
        "relation": "CPR:9"
    },
    {
        "id": "3094574.T9.T28",
        "sentence": "Present studies demonstrate that @CHEMICAL$ will also catalyze @GENE$ production with the same active site copper if a suitable substrate such as 3,4-dihydroxymandelic acid is provided.",
        "relation": "CPR:9"
    },
    {
        "id": "3146348.T2.T13",
        "sentence": "The activation of human [Glu1]plasminogen [( Glu1]Pg) by human recombinant (rec) two-chain tissue plasminogen activator (@CHEMICAL$) is inhibited by @GENE$, at physiological concentrations, and stimulated by epsilon-aminocaproic acid (EACA), as well as fibrin(ogen).",
        "relation": "CPR:4"
    },
    {
        "id": "3146348.T2.T15",
        "sentence": "The activation of @CHEMICAL$ [( Glu1]Pg) by human recombinant (rec) two-chain tissue plasminogen activator (t-PA) is inhibited by @GENE$, at physiological concentrations, and stimulated by epsilon-aminocaproic acid (EACA), as well as fibrin(ogen).",
        "relation": "CPR:4"
    },
    {
        "id": "3146348.T2.T19",
        "sentence": "The activation of human [Glu1]plasminogen [@CHEMICAL$) by human recombinant (rec) two-chain tissue plasminogen activator (t-PA) is inhibited by @GENE$, at physiological concentrations, and stimulated by epsilon-aminocaproic acid (EACA), as well as fibrin(ogen).",
        "relation": "CPR:4"
    },
    {
        "id": "3146348.T2.T23",
        "sentence": "The activation of human [Glu1]plasminogen [( Glu1]Pg) by human recombinant (rec) two-chain @CHEMICAL$ (t-PA) is inhibited by @GENE$, at physiological concentrations, and stimulated by epsilon-aminocaproic acid (EACA), as well as fibrin(ogen).",
        "relation": "CPR:4"
    },
    {
        "id": "3146348.T3.T13",
        "sentence": "The activation of human [Glu1]plasminogen [( Glu1]Pg) by human recombinant (rec) two-chain tissue plasminogen activator (@CHEMICAL$) is inhibited by Cl-, at physiological concentrations, and stimulated by @GENE$ (EACA), as well as fibrin(ogen).",
        "relation": "CPR:3"
    },
    {
        "id": "3146348.T3.T15",
        "sentence": "The activation of @CHEMICAL$ [( Glu1]Pg) by human recombinant (rec) two-chain tissue plasminogen activator (t-PA) is inhibited by Cl-, at physiological concentrations, and stimulated by @GENE$ (EACA), as well as fibrin(ogen).",
        "relation": "CPR:3"
    },
    {
        "id": "3146348.T3.T19",
        "sentence": "The activation of human [Glu1]plasminogen [@CHEMICAL$) by human recombinant (rec) two-chain tissue plasminogen activator (t-PA) is inhibited by Cl-, at physiological concentrations, and stimulated by @GENE$ (EACA), as well as fibrin(ogen).",
        "relation": "CPR:3"
    },
    {
        "id": "3146348.T3.T23",
        "sentence": "The activation of human [Glu1]plasminogen [( Glu1]Pg) by human recombinant (rec) two-chain @CHEMICAL$ (t-PA) is inhibited by Cl-, at physiological concentrations, and stimulated by @GENE$ (EACA), as well as fibrin(ogen).",
        "relation": "CPR:3"
    },
    {
        "id": "3146348.T4.T13",
        "sentence": "The activation of human [Glu1]plasminogen [( Glu1]Pg) by human recombinant (rec) two-chain tissue plasminogen activator (@CHEMICAL$) is inhibited by Cl-, at physiological concentrations, and stimulated by epsilon-aminocaproic acid (@GENE$), as well as fibrin(ogen).",
        "relation": "CPR:3"
    },
    {
        "id": "3146348.T4.T15",
        "sentence": "The activation of @CHEMICAL$ [( Glu1]Pg) by human recombinant (rec) two-chain tissue plasminogen activator (t-PA) is inhibited by Cl-, at physiological concentrations, and stimulated by epsilon-aminocaproic acid (@GENE$), as well as fibrin(ogen).",
        "relation": "CPR:3"
    },
    {
        "id": "3146348.T4.T19",
        "sentence": "The activation of human [Glu1]plasminogen [@CHEMICAL$) by human recombinant (rec) two-chain tissue plasminogen activator (t-PA) is inhibited by Cl-, at physiological concentrations, and stimulated by epsilon-aminocaproic acid (@GENE$), as well as fibrin(ogen).",
        "relation": "CPR:3"
    },
    {
        "id": "3146348.T4.T23",
        "sentence": "The activation of human [Glu1]plasminogen [( Glu1]Pg) by human recombinant (rec) two-chain @CHEMICAL$ (t-PA) is inhibited by Cl-, at physiological concentrations, and stimulated by epsilon-aminocaproic acid (@GENE$), as well as fibrin(ogen).",
        "relation": "CPR:3"
    },
    {
        "id": "3146348.T1.T11",
        "sentence": "The presence of @CHEMICAL$ inhibits the stimulation of @GENE$ activation that would normally occur in the presence of fibrinogen, a result of possible importance to the observation that some degree of systemic fibrinogenolysis accompanies therapeutic use of tissue plasminogen activator.",
        "relation": "CPR:4"
    },
    {
        "id": "7500004.T25.T38",
        "sentence": "Sodium-dependent norepinephrine-induced currents in @CHEMICAL$-transfected HEK-293 cells blocked by @GENE$ and antidepressants.",
        "relation": "CPR:4"
    },
    {
        "id": "7500004.T26.T38",
        "sentence": "Sodium-dependent @CHEMICAL$-induced currents in @GENE$-transfected HEK-293 cells blocked by cocaine and antidepressants.",
        "relation": "CPR:3"
    },
    {
        "id": "7500004.T20.T37",
        "sentence": "Whole-cell voltage-clamp of @CHEMICAL$-293 cells reveals @GENE$-induced, Na(+)-dependent currents blocked by antidepressants and cocaine that are absent in parental cells.",
        "relation": "CPR:3"
    },
    {
        "id": "7500004.T22.T37",
        "sentence": "Whole-cell voltage-clamp of @CHEMICAL$-293 cells reveals NE-induced, Na(+)-dependent currents blocked by antidepressants and @GENE$ that are absent in parental cells.",
        "relation": "CPR:4"
    },
    {
        "id": "7500004.T6.T30",
        "sentence": "To explain our observations, we propose that @CHEMICAL$ function as ion-gated ligand channels with an indefinite stoichiometry relating ion flux to @GENE$ transport.",
        "relation": "CPR:9"
    },
    {
        "id": "7554708.T17.T25",
        "sentence": "BACKGROUND: The active metabolite of the anti-inflammatory drug @CHEMICAL$ has been characterized as a selective inhibitor of the inducible @GENE$ (PGHS).",
        "relation": "CPR:4"
    },
    {
        "id": "7554708.T17.T28",
        "sentence": "BACKGROUND: The active metabolite of the anti-inflammatory drug @CHEMICAL$ has been characterized as a selective inhibitor of the inducible prostaglandin H synthase (@GENE$).",
        "relation": "CPR:4"
    },
    {
        "id": "7554708.T16.T31",
        "sentence": "Moreover, the production of @CHEMICAL$ during whole blood clotting was assessed as an index of the @GENE$ activity of platelet PGHS-1 ex vivo.",
        "relation": "CPR:9"
    },
    {
        "id": "7554708.T16.T32",
        "sentence": "Moreover, the production of @CHEMICAL$ during whole blood clotting was assessed as an index of the cyclooxygenase activity of platelet @GENE$ ex vivo.",
        "relation": "CPR:9"
    },
    {
        "id": "7554708.T4.T24",
        "sentence": "The daily administration of low-dose @CHEMICAL$ (40 mg), a selective inhibitor of platelet @GENE$, caused a cumulative inhibition of urinary 11-dehydro-TXB2 and whole blood TXB2 production that recovered with a timecourse consistent with platelet turnover.",
        "relation": "CPR:4"
    },
    {
        "id": "7554708.T5.T24",
        "sentence": "The daily administration of low-dose aspirin (40 mg), a selective inhibitor of platelet @CHEMICAL$, caused a cumulative inhibition of urinary @GENE$ and whole blood TXB2 production that recovered with a timecourse consistent with platelet turnover.",
        "relation": "CPR:9"
    },
    {
        "id": "7554708.T7.T24",
        "sentence": "The daily administration of low-dose aspirin (40 mg), a selective inhibitor of platelet @CHEMICAL$, caused a cumulative inhibition of urinary 11-dehydro-TXB2 and whole blood @GENE$ production that recovered with a timecourse consistent with platelet turnover.",
        "relation": "CPR:9"
    },
    {
        "id": "7554708.T8.T26",
        "sentence": "CONCLUSIONS: @CHEMICAL$ does dose-dependently inhibit the @GENE$ activity of platelet PGHS-1 of healthy subjects both in vivo and ex vivo.",
        "relation": "CPR:4"
    },
    {
        "id": "7554708.T8.T27",
        "sentence": "CONCLUSIONS: @CHEMICAL$ does dose-dependently inhibit the cyclooxygenase activity of platelet @GENE$ of healthy subjects both in vivo and ex vivo.",
        "relation": "CPR:4"
    },
    {
        "id": "7714410.T22.T25",
        "sentence": "Preclinical efficacy of @CHEMICAL$, a potent, selective @GENE$ antagonist for topical ocular use.",
        "relation": "CPR:6"
    },
    {
        "id": "7756657.T1.T2",
        "sentence": "(2) Exposure histories vary in secondary 11q23 leukemia, as the only @CHEMICAL$ inhibitor was @GENE$ in one case, and, in another case, no topoisomerase II inhibitor was administered.",
        "relation": "CPR:4"
    },
    {
        "id": "7825862.T1.T13",
        "sentence": "@CHEMICAL$, piroxicam, and sulindac sulfide were found to preferentially inhibit @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "7825862.T2.T13",
        "sentence": "Indomethacin, @CHEMICAL$, and sulindac sulfide were found to preferentially inhibit @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "7825862.T3.T13",
        "sentence": "Indomethacin, piroxicam, and @CHEMICAL$ were found to preferentially inhibit @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "7825862.T5.T15",
        "sentence": "@CHEMICAL$, the active metabolite of Relafen, inhibits murine @GENE$ preferentially.",
        "relation": "CPR:4"
    },
    {
        "id": "7825862.T6.T15",
        "sentence": "6-Methoxy-2-naphthylacetic acid, the active metabolite of @CHEMICAL$, inhibits murine @GENE$ preferentially.",
        "relation": "CPR:4"
    },
    {
        "id": "7825862.T10.T17",
        "sentence": "Aspirin irreversibly inhibits PGHS-1, preventing this isozyme from forming PGH2 or any other oxygenated product; in contrast, aspirin treatment of @CHEMICAL$ causes this enzyme to form 15-hydroxy-5c,8c,11c,13t-eicosatetraenoic acid (@GENE$) instead of PGH2.",
        "relation": "CPR:9"
    },
    {
        "id": "7825862.T7.T16",
        "sentence": "@CHEMICAL$ irreversibly inhibits @GENE$, preventing this isozyme from forming PGH2 or any other oxygenated product; in contrast, aspirin treatment of PGHS-2 causes this enzyme to form 15-hydroxy-5c,8c,11c,13t-eicosatetraenoic acid (15-HETE) instead of PGH2.",
        "relation": "CPR:4"
    },
    {
        "id": "7825862.T9.T17",
        "sentence": "Aspirin irreversibly inhibits PGHS-1, preventing this isozyme from forming PGH2 or any other oxygenated product; in contrast, aspirin treatment of @CHEMICAL$ causes this enzyme to form @GENE$ (15-HETE) instead of PGH2.",
        "relation": "CPR:9"
    },
    {
        "id": "7902561.T14.T18",
        "sentence": "Anorexia induced by (+)-amphetamine, phentermine, diethylpropion and phenylpropanolamine seems to be the result of their ability to increase the release of noradrenaline and/or dopamine from nerve terminals and inhibit their reuptake or, in the case of @CHEMICAL$, to stimulate directly @GENE$.",
        "relation": "CPR:3"
    },
    {
        "id": "8032658.T50.T69",
        "sentence": "Under these conditions, blockade of @CHEMICAL$ with @GENE$ (100 microM for 15 min) caused a leftward displacement of concentration-effect curves for both 5-methoxytryptamine (5-MeO-T) and tryptamine.",
        "relation": "CPR:4"
    },
    {
        "id": "8032658.T10.T61",
        "sentence": "In addition several ligands known to act as agonists at either @CHEMICAL$ or 5-HT2C receptors including 1-m-chlorophenylpiperazine (m-CPP), @GENE$, MK 212 and SCH 23390 were also agonists in rat fundus whilst sumatriptan, renzapride and 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) were very weak or inactive.",
        "relation": "CPR:5"
    },
    {
        "id": "8032658.T10.T62",
        "sentence": "In addition several ligands known to act as agonists at either 5-HT2A or @CHEMICAL$ receptors including 1-m-chlorophenylpiperazine (m-CPP), @GENE$, MK 212 and SCH 23390 were also agonists in rat fundus whilst sumatriptan, renzapride and 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) were very weak or inactive.",
        "relation": "CPR:5"
    },
    {
        "id": "8032658.T11.T61",
        "sentence": "In addition several ligands known to act as agonists at either @CHEMICAL$ or 5-HT2C receptors including 1-m-chlorophenylpiperazine (m-CPP), Ru 24969, @GENE$ and SCH 23390 were also agonists in rat fundus whilst sumatriptan, renzapride and 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) were very weak or inactive.",
        "relation": "CPR:5"
    },
    {
        "id": "8032658.T11.T62",
        "sentence": "In addition several ligands known to act as agonists at either 5-HT2A or @CHEMICAL$ receptors including 1-m-chlorophenylpiperazine (m-CPP), Ru 24969, @GENE$ and SCH 23390 were also agonists in rat fundus whilst sumatriptan, renzapride and 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) were very weak or inactive.",
        "relation": "CPR:5"
    },
    {
        "id": "8032658.T12.T61",
        "sentence": "In addition several ligands known to act as agonists at either @CHEMICAL$ or 5-HT2C receptors including 1-m-chlorophenylpiperazine (m-CPP), Ru 24969, MK 212 and @GENE$ were also agonists in rat fundus whilst sumatriptan, renzapride and 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) were very weak or inactive.",
        "relation": "CPR:5"
    },
    {
        "id": "8032658.T12.T62",
        "sentence": "In addition several ligands known to act as agonists at either 5-HT2A or @CHEMICAL$ receptors including 1-m-chlorophenylpiperazine (m-CPP), Ru 24969, MK 212 and @GENE$ were also agonists in rat fundus whilst sumatriptan, renzapride and 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) were very weak or inactive.",
        "relation": "CPR:5"
    },
    {
        "id": "8032658.T8.T61",
        "sentence": "In addition several ligands known to act as agonists at either @CHEMICAL$ or 5-HT2C receptors including @GENE$ (m-CPP), Ru 24969, MK 212 and SCH 23390 were also agonists in rat fundus whilst sumatriptan, renzapride and 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) were very weak or inactive.",
        "relation": "CPR:5"
    },
    {
        "id": "8032658.T8.T62",
        "sentence": "In addition several ligands known to act as agonists at either 5-HT2A or @CHEMICAL$ receptors including @GENE$ (m-CPP), Ru 24969, MK 212 and SCH 23390 were also agonists in rat fundus whilst sumatriptan, renzapride and 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) were very weak or inactive.",
        "relation": "CPR:5"
    },
    {
        "id": "8032658.T9.T61",
        "sentence": "In addition several ligands known to act as agonists at either @CHEMICAL$ or 5-HT2C receptors including 1-m-chlorophenylpiperazine (@GENE$), Ru 24969, MK 212 and SCH 23390 were also agonists in rat fundus whilst sumatriptan, renzapride and 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) were very weak or inactive.",
        "relation": "CPR:5"
    },
    {
        "id": "8032658.T9.T62",
        "sentence": "In addition several ligands known to act as agonists at either 5-HT2A or @CHEMICAL$ receptors including 1-m-chlorophenylpiperazine (@GENE$), Ru 24969, MK 212 and SCH 23390 were also agonists in rat fundus whilst sumatriptan, renzapride and 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) were very weak or inactive.",
        "relation": "CPR:5"
    },
    {
        "id": "8294418.T20.T37",
        "sentence": "Phorbol esters and @CHEMICAL$ destabilize @GENE$ mRNA in vascular smooth muscle cells.",
        "relation": "CPR:4"
    },
    {
        "id": "8294418.T3.T35",
        "sentence": "The mechanism by which @CHEMICAL$ (NE) down-regulates alpha 1B-adrenergic receptor (@GENE$) mRNA was studied in rabbit aortic smooth muscle cells.",
        "relation": "CPR:4"
    },
    {
        "id": "8294418.T3.T29",
        "sentence": "The mechanism by which @CHEMICAL$ (NE) down-regulates @GENE$ (alpha-AR) mRNA was studied in rabbit aortic smooth muscle cells.",
        "relation": "CPR:4"
    },
    {
        "id": "8294418.T8.T35",
        "sentence": "The mechanism by which norepinephrine (@CHEMICAL$) down-regulates alpha 1B-adrenergic receptor (@GENE$) mRNA was studied in rabbit aortic smooth muscle cells.",
        "relation": "CPR:4"
    },
    {
        "id": "8294418.T8.T29",
        "sentence": "The mechanism by which norepinephrine (@CHEMICAL$) down-regulates @GENE$ (alpha-AR) mRNA was studied in rabbit aortic smooth muscle cells.",
        "relation": "CPR:4"
    },
    {
        "id": "8294418.T1.T25",
        "sentence": "@CHEMICAL$, phorbol esters, and bradykinin each decreased @GENE$ mRNA levels by 70-80%.",
        "relation": "CPR:4"
    },
    {
        "id": "8294418.T2.T25",
        "sentence": "NE, @CHEMICAL$, and bradykinin each decreased @GENE$ mRNA levels by 70-80%.",
        "relation": "CPR:4"
    },
    {
        "id": "8294418.T4.T26",
        "sentence": "The @CHEMICAL$ inhibitor @GENE$ (H-7) abolished the effects of phorbol esters and NE and decreased basal mRNA levels by 52 +/- 3%.",
        "relation": "CPR:4"
    },
    {
        "id": "8294418.T5.T26",
        "sentence": "The @CHEMICAL$ inhibitor (+)-1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride (@GENE$) abolished the effects of phorbol esters and NE and decreased basal mRNA levels by 52 +/- 3%.",
        "relation": "CPR:4"
    },
    {
        "id": "8294418.T10.T27",
        "sentence": "Neither ryanodine nor @CHEMICAL$ inhibited down-regulation of @GENE$ mRNA by NE.",
        "relation": "CPR:3"
    },
    {
        "id": "8294418.T11.T27",
        "sentence": "Neither ryanodine nor EGTA inhibited down-regulation of @CHEMICAL$ mRNA by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "8294418.T9.T27",
        "sentence": "Neither @CHEMICAL$ nor EGTA inhibited down-regulation of @GENE$ mRNA by NE.",
        "relation": "CPR:3"
    },
    {
        "id": "8294418.T12.T28",
        "sentence": "@CHEMICAL$ caused @GENE$ mRNA level to decrease with a half-life of 3.2 +/- 0.4 h and blocked the effect of H-7 to decrease basal alpha-AR mRNA level.",
        "relation": "CPR:4"
    },
    {
        "id": "8294418.T12.T30",
        "sentence": "@CHEMICAL$ caused alpha-AR mRNA level to decrease with a half-life of 3.2 +/- 0.4 h and blocked the effect of H-7 to decrease basal @GENE$ mRNA level.",
        "relation": "CPR:4"
    },
    {
        "id": "8294418.T14.T31",
        "sentence": "Both @CHEMICAL$ and phorbol esters increased the rate of @GENE$ mRNA degradation.",
        "relation": "CPR:4"
    },
    {
        "id": "8294418.T15.T31",
        "sentence": "Both NE and @CHEMICAL$ increased the rate of @GENE$ mRNA degradation.",
        "relation": "CPR:4"
    },
    {
        "id": "8294418.T16.T33",
        "sentence": "In @CHEMICAL$-desensitized cells, phorbol esters and bradykinin each caused the expected down-regulation of @GENE$ mRNA.",
        "relation": "CPR:4"
    },
    {
        "id": "8294418.T17.T33",
        "sentence": "In NE-desensitized cells, @CHEMICAL$ and bradykinin each caused the expected down-regulation of @GENE$ mRNA.",
        "relation": "CPR:4"
    },
    {
        "id": "8294418.T18.T34",
        "sentence": "The @CHEMICAL$ inhibitor @GENE$ prolonged the normally transient effect of NE for at least 24 h. We conclude that protein kinase C exerts two opposing effects on alpha-AR mRNA levels, 1) a decrease in the stability of the mRNA that requires the sustained phosphorylation of a protein kinase C substrate and 2) a permissive effect on alpha-AR gene transcription.",
        "relation": "CPR:4"
    },
    {
        "id": "8384716.T6.T25",
        "sentence": "The specific binding is displaced by the selective @CHEMICAL$ agonist @GENE$ but not by the mixed 5-HT1A/1D agonist 5-carboxyamidotryptamine.",
        "relation": "CPR:5"
    },
    {
        "id": "8384716.T12.T28",
        "sentence": "HeLa cells transfected with the MR77 gene exhibited inhibition of @CHEMICAL$ in response to @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "8425287.T28.T41",
        "sentence": "The antiarrhythmic effects of exogenous adenosine and Valsalva on this form of VT may be due to receptor-mediated inhibition of adenylate cyclase or to noncardiac receptor-mediated effects, i.e., exogenous @CHEMICAL$ may modulate VT through alterations in autonomic tone by activation of arterial @GENE$, and Valsalva has been shown to decrease venous return, resulting in a reduction in cardiac dimensions and myocardial stretch.",
        "relation": "CPR:3"
    },
    {
        "id": "8425287.T8.T34",
        "sentence": "VT recurred with the addition of @CHEMICAL$, a competitive @GENE$ antagonist.",
        "relation": "CPR:6"
    },
    {
        "id": "8425287.T10.T35",
        "sentence": "@CHEMICAL$ (10 mg i.v.), a @GENE$ inhibitor that potentiates the effects of acetylcholine at the muscarinic cholinergic receptor, terminated VT in four of four patients, an effect that was reversed by atropine.",
        "relation": "CPR:4"
    },
    {
        "id": "8425287.T13.T36",
        "sentence": "Edrophonium (10 mg i.v.), a cholinesterase inhibitor that potentiates the effects of acetylcholine at the @CHEMICAL$, terminated VT in four of four patients, an effect that was reversed by @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "8566141.T17.T31",
        "sentence": "@CHEMICAL$ induces @GENE$ in rat striatum: reversal with dopamine D1 and NMDA receptor antagonists.",
        "relation": "CPR:3"
    },
    {
        "id": "8566141.T1.T24",
        "sentence": "@CHEMICAL$ (1-aminoadamantane) induced @GENE$ expression in the central, dorsal-medial and ventral-medial part of the striatum.",
        "relation": "CPR:3"
    },
    {
        "id": "8566141.T2.T24",
        "sentence": "Amantadine (@CHEMICAL$) induced @GENE$ expression in the central, dorsal-medial and ventral-medial part of the striatum.",
        "relation": "CPR:3"
    },
    {
        "id": "8566141.T3.T20",
        "sentence": "The distribution pattern of @CHEMICAL$ induced by @GENE$ was more similar to those seen with dopaminomimetics than with N-methyl-D-aspartate (NMDA) receptor antagonists.",
        "relation": "CPR:3"
    },
    {
        "id": "8566141.T10.T25",
        "sentence": "Pretreatment with the dopamine D1 receptor antagonist, SCH23390, and the NMDA receptor antagonist, MK-801, blocked @CHEMICAL$ induction of @GENE$ in the striatum.",
        "relation": "CPR:3"
    },
    {
        "id": "8566141.T7.T22",
        "sentence": "Pretreatment with the @CHEMICAL$ antagonist, @GENE$, and the NMDA receptor antagonist, MK-801, blocked amantadine induction of Fos in the striatum.",
        "relation": "CPR:6"
    },
    {
        "id": "8566141.T7.T25",
        "sentence": "Pretreatment with the dopamine D1 receptor antagonist, @CHEMICAL$, and the NMDA receptor antagonist, MK-801, blocked amantadine induction of @GENE$ in the striatum.",
        "relation": "CPR:4"
    },
    {
        "id": "8566141.T9.T23",
        "sentence": "Pretreatment with the dopamine D1 receptor antagonist, SCH23390, and the @CHEMICAL$ antagonist, @GENE$, blocked amantadine induction of Fos in the striatum.",
        "relation": "CPR:6"
    },
    {
        "id": "8566141.T9.T25",
        "sentence": "Pretreatment with the dopamine D1 receptor antagonist, SCH23390, and the NMDA receptor antagonist, @CHEMICAL$, blocked amantadine induction of @GENE$ in the striatum.",
        "relation": "CPR:4"
    },
    {
        "id": "8566141.T11.T26",
        "sentence": "However, @CHEMICAL$ induction of @GENE$ in the striatum was unaffected by the dopamine D2 receptor antagonist, sulpiride.",
        "relation": "CPR:3"
    },
    {
        "id": "8566141.T13.T27",
        "sentence": "However, amantadine induction of Fos in the striatum was unaffected by the @CHEMICAL$ antagonist, @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "8566141.T14.T28",
        "sentence": "These results suggest that @CHEMICAL$ induction of @GENE$ in the rat striatum is related to dopamine D1 and NMDA receptors.",
        "relation": "CPR:3"
    },
    {
        "id": "8697470.T1.T14",
        "sentence": "After CFVs were observed for 30 min, the animals were randomly divided in four groups: 5 animals received via a small catheter (26G) placed proximally to the stenosis, an intra-arterial infusion of human recombinant FVIIai (0.1 mg/kg/min for 10 min); 9 animals received AP-1, a monoclonal antibody against rabbit TF (0.1 mg/kg i.v. bolus); 7 animals received ridogrel, a dual thromboxane A2 synthetase inhibitor and thromboxane A2 receptor antagonist (10 mg/kg i.v. bolus); finally, 8 rabbits received @CHEMICAL$ (ATA), an inhibitor of platelet @GENE$/von Willebrand factor interaction (10 mg/kg i.v. bolus).",
        "relation": "CPR:4"
    },
    {
        "id": "8697470.T1.T15",
        "sentence": "After CFVs were observed for 30 min, the animals were randomly divided in four groups: 5 animals received via a small catheter (26G) placed proximally to the stenosis, an intra-arterial infusion of human recombinant FVIIai (0.1 mg/kg/min for 10 min); 9 animals received AP-1, a monoclonal antibody against rabbit TF (0.1 mg/kg i.v. bolus); 7 animals received ridogrel, a dual thromboxane A2 synthetase inhibitor and thromboxane A2 receptor antagonist (10 mg/kg i.v. bolus); finally, 8 rabbits received @CHEMICAL$ (ATA), an inhibitor of platelet glycoprotein Ib/@GENE$ interaction (10 mg/kg i.v. bolus).",
        "relation": "CPR:4"
    },
    {
        "id": "8697470.T2.T14",
        "sentence": "After CFVs were observed for 30 min, the animals were randomly divided in four groups: 5 animals received via a small catheter (26G) placed proximally to the stenosis, an intra-arterial infusion of human recombinant FVIIai (0.1 mg/kg/min for 10 min); 9 animals received AP-1, a monoclonal antibody against rabbit TF (0.1 mg/kg i.v. bolus); 7 animals received ridogrel, a dual thromboxane A2 synthetase inhibitor and thromboxane A2 receptor antagonist (10 mg/kg i.v. bolus); finally, 8 rabbits received aurintrycarboxilic acid (@CHEMICAL$), an inhibitor of platelet @GENE$/von Willebrand factor interaction (10 mg/kg i.v. bolus).",
        "relation": "CPR:4"
    },
    {
        "id": "8697470.T2.T15",
        "sentence": "After CFVs were observed for 30 min, the animals were randomly divided in four groups: 5 animals received via a small catheter (26G) placed proximally to the stenosis, an intra-arterial infusion of human recombinant FVIIai (0.1 mg/kg/min for 10 min); 9 animals received AP-1, a monoclonal antibody against rabbit TF (0.1 mg/kg i.v. bolus); 7 animals received ridogrel, a dual thromboxane A2 synthetase inhibitor and thromboxane A2 receptor antagonist (10 mg/kg i.v. bolus); finally, 8 rabbits received aurintrycarboxilic acid (@CHEMICAL$), an inhibitor of platelet glycoprotein Ib/@GENE$ interaction (10 mg/kg i.v. bolus).",
        "relation": "CPR:4"
    },
    {
        "id": "8710929.T10.T19",
        "sentence": "These events are stimulated by NE and by guanethidine, an @CHEMICAL$ substrate, and they are blocked by @GENE$ and the antidepressant desipramine.",
        "relation": "CPR:4"
    },
    {
        "id": "8710929.T11.T19",
        "sentence": "These events are stimulated by NE and by guanethidine, an @CHEMICAL$ substrate, and they are blocked by cocaine and the antidepressant @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "8710929.T8.T19",
        "sentence": "These events are stimulated by @CHEMICAL$ and by guanethidine, an @GENE$ substrate, and they are blocked by cocaine and the antidepressant desipramine.",
        "relation": "CPR:9"
    },
    {
        "id": "8710929.T9.T19",
        "sentence": "These events are stimulated by NE and by @CHEMICAL$, an @GENE$ substrate, and they are blocked by cocaine and the antidepressant desipramine.",
        "relation": "CPR:9"
    },
    {
        "id": "8710929.T12.T20",
        "sentence": "Voltage-clamp data combined with @CHEMICAL$ uptake data from these same cells indicate that @GENE$ have two functional modes of conduction: a classical transporter mode (T-mode) and a novel channel mode (C-mode).",
        "relation": "CPR:9"
    },
    {
        "id": "8733007.T12.T20",
        "sentence": "In extending these initial findings, we have shown that cardiac fibrosis (i) is not reversed by correction of mineralocorticoid-induced hypokalemia; (ii) appears not to involve the plasma or tissue renin-angiotensin systems, as fibrosis is largely unaffected by concurrent administration of Losartan or Perindopril; (iii) is independent of cardiac hypertrophy, in that it is equally seen in right and left ventricles, and in rats rendered hypertensive without cardiac hypertrophy by the administration of 9 alpha-fluorocortisol; (iv) is independent of elevated blood pressure, in that it is found in normotensive animals infused peripherally with aldosterone and intracerebroventricularly with the @CHEMICAL$ (MR) antagonist @GENE$; (v) is via classical MR, in that it is blocked by concurrent administration of the MR antagonist potassium canrenoate; and (vi) may or may not be a direct cardiac effect, inasmuch as data for in vivo effects on collagen formation by cardiac fibroblasts are conflicting.",
        "relation": "CPR:6"
    },
    {
        "id": "8733007.T12.T21",
        "sentence": "In extending these initial findings, we have shown that cardiac fibrosis (i) is not reversed by correction of mineralocorticoid-induced hypokalemia; (ii) appears not to involve the plasma or tissue renin-angiotensin systems, as fibrosis is largely unaffected by concurrent administration of Losartan or Perindopril; (iii) is independent of cardiac hypertrophy, in that it is equally seen in right and left ventricles, and in rats rendered hypertensive without cardiac hypertrophy by the administration of 9 alpha-fluorocortisol; (iv) is independent of elevated blood pressure, in that it is found in normotensive animals infused peripherally with aldosterone and intracerebroventricularly with the mineralocorticoid receptor (@CHEMICAL$) antagonist @GENE$; (v) is via classical MR, in that it is blocked by concurrent administration of the MR antagonist potassium canrenoate; and (vi) may or may not be a direct cardiac effect, inasmuch as data for in vivo effects on collagen formation by cardiac fibroblasts are conflicting.",
        "relation": "CPR:6"
    },
    {
        "id": "8733007.T1.T13",
        "sentence": "In extending these initial findings, we have shown that cardiac fibrosis (i) is not reversed by correction of mineralocorticoid-induced hypokalemia; (ii) appears not to involve the plasma or tissue renin-angiotensin systems, as fibrosis is largely unaffected by concurrent administration of Losartan or Perindopril; (iii) is independent of cardiac hypertrophy, in that it is equally seen in right and left ventricles, and in rats rendered hypertensive without cardiac hypertrophy by the administration of 9 alpha-fluorocortisol; (iv) is independent of elevated blood pressure, in that it is found in normotensive animals infused peripherally with aldosterone and intracerebroventricularly with the mineralocorticoid receptor (MR) antagonist RU28318; (v) is via classical @CHEMICAL$, in that it is blocked by concurrent administration of the MR antagonist @GENE$; and (vi) may or may not be a direct cardiac effect, inasmuch as data for in vivo effects on collagen formation by cardiac fibroblasts are conflicting.",
        "relation": "CPR:6"
    },
    {
        "id": "8733007.T1.T14",
        "sentence": "In extending these initial findings, we have shown that cardiac fibrosis (i) is not reversed by correction of mineralocorticoid-induced hypokalemia; (ii) appears not to involve the plasma or tissue renin-angiotensin systems, as fibrosis is largely unaffected by concurrent administration of Losartan or Perindopril; (iii) is independent of cardiac hypertrophy, in that it is equally seen in right and left ventricles, and in rats rendered hypertensive without cardiac hypertrophy by the administration of 9 alpha-fluorocortisol; (iv) is independent of elevated blood pressure, in that it is found in normotensive animals infused peripherally with aldosterone and intracerebroventricularly with the mineralocorticoid receptor (MR) antagonist RU28318; (v) is via classical MR, in that it is blocked by concurrent administration of the @CHEMICAL$ antagonist @GENE$; and (vi) may or may not be a direct cardiac effect, inasmuch as data for in vivo effects on collagen formation by cardiac fibroblasts are conflicting.",
        "relation": "CPR:6"
    },
    {
        "id": "8740147.T32.T57",
        "sentence": "@CHEMICAL$ and debrisoquine are substrates of @GENE$ and potent inhibitors of monoamine oxidase in perfused lungs of rats.",
        "relation": "CPR:9"
    },
    {
        "id": "8740147.T32.T58",
        "sentence": "@CHEMICAL$ and debrisoquine are substrates of uptake1 and potent inhibitors of @GENE$ in perfused lungs of rats.",
        "relation": "CPR:4"
    },
    {
        "id": "8740147.T33.T57",
        "sentence": "Amezinium and @CHEMICAL$ are substrates of @GENE$ and potent inhibitors of monoamine oxidase in perfused lungs of rats.",
        "relation": "CPR:9"
    },
    {
        "id": "8740147.T33.T58",
        "sentence": "Amezinium and @CHEMICAL$ are substrates of uptake1 and potent inhibitors of @GENE$ in perfused lungs of rats.",
        "relation": "CPR:4"
    },
    {
        "id": "8740147.T22.T35",
        "sentence": "Previous studies have resulted in the classification of @CHEMICAL$ as a selective inhibitor of neuronal @GENE$ (MAO), because it is a much more potent MAO inhibitor in intact tissues, in which it is accumulated in noradrenergic neurones by uptake1, than in tissue homogenates.",
        "relation": "CPR:4"
    },
    {
        "id": "8740147.T22.T36",
        "sentence": "Previous studies have resulted in the classification of @CHEMICAL$ as a selective inhibitor of neuronal monoamine oxidase (@GENE$), because it is a much more potent MAO inhibitor in intact tissues, in which it is accumulated in noradrenergic neurones by uptake1, than in tissue homogenates.",
        "relation": "CPR:4"
    },
    {
        "id": "8740147.T22.T40",
        "sentence": "Previous studies have resulted in the classification of @CHEMICAL$ as a selective inhibitor of neuronal monoamine oxidase (MAO), because it is a much more potent @GENE$ inhibitor in intact tissues, in which it is accumulated in noradrenergic neurones by uptake1, than in tissue homogenates.",
        "relation": "CPR:4"
    },
    {
        "id": "8740147.T23.T51",
        "sentence": "In addition, another drug that is both a substrate of @CHEMICAL$ and a MAO inhibitor, @GENE$, was investigated in the study.",
        "relation": "CPR:9"
    },
    {
        "id": "8740147.T23.T52",
        "sentence": "In addition, another drug that is both a substrate of uptake1 and a @CHEMICAL$ inhibitor, @GENE$, was investigated in the study.",
        "relation": "CPR:4"
    },
    {
        "id": "8740147.T9.T41",
        "sentence": "When MAO-B was also inhibited, 10 nmol/l @CHEMICAL$ caused 84% inhibition of the deamination of noradrenaline by @GENE$ in the lungs.",
        "relation": "CPR:4"
    },
    {
        "id": "8740147.T15.T45",
        "sentence": "The results when considered with previous reports in the literature show that @CHEMICAL$ is about 1000 times more potent and debrisoquine is about 20 times more potent for @GENE$ inhibition in rat lungs than in tissue homogenates, and the reason for their high potencies in the intact lungs is transport and accumulation of the drugs in the pulmonary endothelial cells by uptake1.",
        "relation": "CPR:4"
    },
    {
        "id": "8740147.T15.T46",
        "sentence": "The results when considered with previous reports in the literature show that @CHEMICAL$ is about 1000 times more potent and debrisoquine is about 20 times more potent for MAO inhibition in rat lungs than in tissue homogenates, and the reason for their high potencies in the intact lungs is transport and accumulation of the drugs in the pulmonary endothelial cells by @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "8740147.T16.T45",
        "sentence": "The results when considered with previous reports in the literature show that amezinium is about 1000 times more potent and @CHEMICAL$ is about 20 times more potent for @GENE$ inhibition in rat lungs than in tissue homogenates, and the reason for their high potencies in the intact lungs is transport and accumulation of the drugs in the pulmonary endothelial cells by uptake1.",
        "relation": "CPR:4"
    },
    {
        "id": "8740147.T16.T46",
        "sentence": "The results when considered with previous reports in the literature show that amezinium is about 1000 times more potent and @CHEMICAL$ is about 20 times more potent for MAO inhibition in rat lungs than in tissue homogenates, and the reason for their high potencies in the intact lungs is transport and accumulation of the drugs in the pulmonary endothelial cells by @GENE$.",
        "relation": "CPR:9"
    },
    {
        "id": "8740147.T17.T47",
        "sentence": "@CHEMICAL$ is much less potent as a @GENE$ inhibitor in cells with the uptake2 transporter, such as the myocardial cells of the heart.",
        "relation": "CPR:4"
    },
    {
        "id": "8740147.T17.T48",
        "sentence": "@CHEMICAL$ is much less potent as a MAO inhibitor in cells with the @GENE$, such as the myocardial cells of the heart.",
        "relation": "CPR:9"
    },
    {
        "id": "8740147.T18.T49",
        "sentence": "The results also confirmed previous reports that @CHEMICAL$ is highly selective for @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "8836617.T11.T20",
        "sentence": "We have investigated the effects of @CHEMICAL$ [(+)-(2s,3s)-3-(2-methoxybenzylamino)-2-phenylpiperidine], a @GENE$ antagonist, HOE 140 (D-Arg[Hyp3,Thi5,D-Tic7,Oic8]bradykinin), a bradykinin B2 receptor antagonist, and ketotifen (4-(1-methyl-4-piperidylidene)4 H-benzo[4,5]cycloheptal[1,2-b]thiophen-10(9H)-one hydrogen fumarate), a histamine H1 receptor antagonist with mast cell-stabilizing properties, on microvascular leakage induced by gaseous formaldehyde.",
        "relation": "CPR:6"
    },
    {
        "id": "8836617.T12.T20",
        "sentence": "We have investigated the effects of CP-99,994 @CHEMICAL$, a @GENE$ antagonist, HOE 140 (D-Arg[Hyp3,Thi5,D-Tic7,Oic8]bradykinin), a bradykinin B2 receptor antagonist, and ketotifen (4-(1-methyl-4-piperidylidene)4 H-benzo[4,5]cycloheptal[1,2-b]thiophen-10(9H)-one hydrogen fumarate), a histamine H1 receptor antagonist with mast cell-stabilizing properties, on microvascular leakage induced by gaseous formaldehyde.",
        "relation": "CPR:6"
    },
    {
        "id": "8836617.T5.T23",
        "sentence": "We have investigated the effects of CP-99,994 [(+)-(2s,3s)-3-(2-methoxybenzylamino)-2-phenylpiperidine], a tachykinin NK1 receptor antagonist, @CHEMICAL$ (D-Arg[Hyp3,Thi5,D-Tic7,Oic8]bradykinin), a @GENE$ antagonist, and ketotifen (4-(1-methyl-4-piperidylidene)4 H-benzo[4,5]cycloheptal[1,2-b]thiophen-10(9H)-one hydrogen fumarate), a histamine H1 receptor antagonist with mast cell-stabilizing properties, on microvascular leakage induced by gaseous formaldehyde.",
        "relation": "CPR:6"
    },
    {
        "id": "8836617.T6.T23",
        "sentence": "We have investigated the effects of CP-99,994 [(+)-(2s,3s)-3-(2-methoxybenzylamino)-2-phenylpiperidine], a tachykinin NK1 receptor antagonist, HOE 140 @CHEMICAL$, a @GENE$ antagonist, and ketotifen (4-(1-methyl-4-piperidylidene)4 H-benzo[4,5]cycloheptal[1,2-b]thiophen-10(9H)-one hydrogen fumarate), a histamine H1 receptor antagonist with mast cell-stabilizing properties, on microvascular leakage induced by gaseous formaldehyde.",
        "relation": "CPR:6"
    },
    {
        "id": "8836617.T8.T24",
        "sentence": "We have investigated the effects of CP-99,994 [(+)-(2s,3s)-3-(2-methoxybenzylamino)-2-phenylpiperidine], a tachykinin NK1 receptor antagonist, HOE 140 (D-Arg[Hyp3,Thi5,D-Tic7,Oic8]bradykinin), a bradykinin B2 receptor antagonist, and @CHEMICAL$ (4-(1-methyl-4-piperidylidene)4 H-benzo[4,5]cycloheptal[1,2-b]thiophen-10(9H)-one hydrogen fumarate), a @GENE$ antagonist with mast cell-stabilizing properties, on microvascular leakage induced by gaseous formaldehyde.",
        "relation": "CPR:6"
    },
    {
        "id": "8836617.T9.T24",
        "sentence": "We have investigated the effects of CP-99,994 [(+)-(2s,3s)-3-(2-methoxybenzylamino)-2-phenylpiperidine], a tachykinin NK1 receptor antagonist, HOE 140 (D-Arg[Hyp3,Thi5,D-Tic7,Oic8]bradykinin), a bradykinin B2 receptor antagonist, and ketotifen @CHEMICAL$, a @GENE$ antagonist with mast cell-stabilizing properties, on microvascular leakage induced by gaseous formaldehyde.",
        "relation": "CPR:6"
    },
    {
        "id": "9486667.T16.T41",
        "sentence": "Molecular determinants of @CHEMICAL$ block of HERG @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "9486667.T16.T40",
        "sentence": "Molecular determinants of @CHEMICAL$ block of @GENE$ K+ channels.",
        "relation": "CPR:4"
    },
    {
        "id": "9486667.T10.T28",
        "sentence": "HERG/@CHEMICAL$ channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as dofetilide, @GENE$, and MK-499, at submicromolar concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "9486667.T10.T26",
        "sentence": "@CHEMICAL$/IKr channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as dofetilide, @GENE$, and MK-499, at submicromolar concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "9486667.T11.T28",
        "sentence": "HERG/@CHEMICAL$ channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as dofetilide, E4031, and @GENE$, at submicromolar concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "9486667.T11.T26",
        "sentence": "@CHEMICAL$/IKr channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as dofetilide, E4031, and @GENE$, at submicromolar concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "9486667.T8.T28",
        "sentence": "HERG/@CHEMICAL$ channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic @GENE$ drugs, such as dofetilide, E4031, and MK-499, at submicromolar concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "9486667.T8.T26",
        "sentence": "@CHEMICAL$/IKr channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic @GENE$ drugs, such as dofetilide, E4031, and MK-499, at submicromolar concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "9486667.T9.T28",
        "sentence": "HERG/@CHEMICAL$ channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as @GENE$, E4031, and MK-499, at submicromolar concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "9486667.T9.T26",
        "sentence": "@CHEMICAL$/IKr channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as @GENE$, E4031, and MK-499, at submicromolar concentrations.",
        "relation": "CPR:4"
    },
    {
        "id": "9521275.T4.T10",
        "sentence": "Treatment using a combination of testosterone and the @CHEMICAL$ inhibitor @GENE$ may have significantly better effects on sexual function and also seizure frequency than testosterone alone.",
        "relation": "CPR:4"
    },
    {
        "id": "9631585.T5.T12",
        "sentence": "A case of therapy-related acute myeloblastic leukemia with t(16;21)(q24;q22) after chemotherapy with @CHEMICAL$ inhibitors, @GENE$ and mitoxantrone, and the alkylating agent, cyclophosphamide.",
        "relation": "CPR:4"
    },
    {
        "id": "9631585.T6.T12",
        "sentence": "A case of therapy-related acute myeloblastic leukemia with t(16;21)(q24;q22) after chemotherapy with @CHEMICAL$ inhibitors, etoposide and @GENE$, and the alkylating agent, cyclophosphamide.",
        "relation": "CPR:4"
    },
    {
        "id": "9631585.T1.T8",
        "sentence": "A 59-year-old female suffering from malignant lymphoma developed therapy-related acute myeloblastic leukemia (t-AML) after chemotherapy consisting of treatment with @CHEMICAL$ inhibitors, @GENE$ and mitoxantrone, and an alkylating agent, cyclophosphamide.",
        "relation": "CPR:4"
    },
    {
        "id": "9631585.T2.T8",
        "sentence": "A 59-year-old female suffering from malignant lymphoma developed therapy-related acute myeloblastic leukemia (t-AML) after chemotherapy consisting of treatment with @CHEMICAL$ inhibitors, etoposide and @GENE$, and an alkylating agent, cyclophosphamide.",
        "relation": "CPR:4"
    },
    {
        "id": "9673855.T1.T40",
        "sentence": "@CHEMICAL$ (deprenyl), a selective, irreversible inhibitor of @GENE$ (MAO-B) is widely used in the treatment of Parkinson's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "9673855.T1.T41",
        "sentence": "@CHEMICAL$ (deprenyl), a selective, irreversible inhibitor of monoamine oxidase type B (@GENE$) is widely used in the treatment of Parkinson's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "9673855.T2.T40",
        "sentence": "Selegiline (@CHEMICAL$), a selective, irreversible inhibitor of @GENE$ (MAO-B) is widely used in the treatment of Parkinson's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "9673855.T2.T41",
        "sentence": "Selegiline (@CHEMICAL$), a selective, irreversible inhibitor of monoamine oxidase type B (@GENE$) is widely used in the treatment of Parkinson's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "9673855.T25.T39",
        "sentence": "Unlike the nonselective @CHEMICAL$ inhibitors, @GENE$ does not significantly potentiate tyramine-induced hypertension (the 'cheese effect') at the dosages (5 to 10 mg daily) used for the treatment of Parkinson's disease.",
        "relation": "CPR:4"
    },
    {
        "id": "9673855.T12.T36",
        "sentence": "A low tyramine diet is recommended if @CHEMICAL$ is used together with nonselective @GENE$ inhibitors or the selective, reversible MAO-A inhibitor, moclobemide.",
        "relation": "CPR:4"
    },
    {
        "id": "9673855.T13.T37",
        "sentence": "A low tyramine diet is recommended if selegiline is used together with nonselective MAO inhibitors or the selective, reversible @CHEMICAL$ inhibitor, @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "9710435.T25.T35",
        "sentence": "@CHEMICAL$ inhibits @GENE$-mediated Cl- secretion.",
        "relation": "CPR:4"
    },
    {
        "id": "9710435.T3.T29",
        "sentence": "@CHEMICAL$ (300 microM) reduced @GENE$ Cl- current by 60+/-16% and this was explained by a short-lived block (approximately 1.2 ms) which causes an apparent reduction in single channel amplitude from 1.07+/-0.04 pA to 0.59+/-0.04 pA (n = 3).",
        "relation": "CPR:4"
    },
    {
        "id": "9710435.T4.T30",
        "sentence": "Similarly, @CHEMICAL$ (3 mM) reduced @GENE$ Cl- current by 50+/-8% with an apparent reduction in single channel amplitude from 1.08+/-0.03 pA to 0.48+/-0.06 pA (n = 4).",
        "relation": "CPR:4"
    },
    {
        "id": "9710435.T6.T32",
        "sentence": "Based on these results, we conclude that the NSAIDs @CHEMICAL$ and salicylic acid inhibit cAMP-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of CFTR @GENE$ as well as basolateral membrane K+ channels.",
        "relation": "CPR:4"
    },
    {
        "id": "9710435.T6.T33",
        "sentence": "Based on these results, we conclude that the NSAIDs @CHEMICAL$ and salicylic acid inhibit cAMP-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of CFTR Cl- channels as well as basolateral membrane @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "9710435.T6.T31",
        "sentence": "Based on these results, we conclude that the NSAIDs @CHEMICAL$ and salicylic acid inhibit cAMP-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of @GENE$ Cl- channels as well as basolateral membrane K+ channels.",
        "relation": "CPR:4"
    },
    {
        "id": "9710435.T7.T32",
        "sentence": "Based on these results, we conclude that the NSAIDs ibuprofen and @CHEMICAL$ inhibit cAMP-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of CFTR @GENE$ as well as basolateral membrane K+ channels.",
        "relation": "CPR:4"
    },
    {
        "id": "9710435.T7.T33",
        "sentence": "Based on these results, we conclude that the NSAIDs ibuprofen and @CHEMICAL$ inhibit cAMP-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of CFTR Cl- channels as well as basolateral membrane @GENE$.",
        "relation": "CPR:4"
    },
    {
        "id": "9710435.T7.T31",
        "sentence": "Based on these results, we conclude that the NSAIDs ibuprofen and @CHEMICAL$ inhibit cAMP-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of @GENE$ Cl- channels as well as basolateral membrane K+ channels.",
        "relation": "CPR:4"
    },
    {
        "id": "9832994.T17.T27",
        "sentence": "Additional neuroendocrine experiments in a parallel group of rats revealed a dose-related increase in @CHEMICAL$ and ACTH levels after i.v. @GENE$, pointing to a general state of arousal in these mCPP-treated animals.",
        "relation": "CPR:3"
    },
    {
        "id": "9832994.T17.T28",
        "sentence": "Additional neuroendocrine experiments in a parallel group of rats revealed a dose-related increase in plasma prolactin and @CHEMICAL$ levels after i.v. @GENE$, pointing to a general state of arousal in these mCPP-treated animals.",
        "relation": "CPR:3"
    },
    {
        "id": "9832994.T14.T25",
        "sentence": "These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide, and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective @CHEMICAL$/5-HT2C antagonist @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "9832994.T14.T26",
        "sentence": "These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide, and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/@CHEMICAL$ antagonist @GENE$.",
        "relation": "CPR:6"
    },
    {
        "id": "9832994.T6.T23",
        "sentence": "These data indicate that mixed @CHEMICAL$/5-HT2 receptor antagonists such as @GENE$ and methysergide, and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin.",
        "relation": "CPR:6"
    },
    {
        "id": "9832994.T6.T24",
        "sentence": "These data indicate that mixed 5-HT1/@CHEMICAL$ receptor antagonists such as @GENE$ and methysergide, and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin.",
        "relation": "CPR:6"
    },
    {
        "id": "9832994.T7.T23",
        "sentence": "These data indicate that mixed @CHEMICAL$/5-HT2 receptor antagonists such as pizotifen and @GENE$, and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin.",
        "relation": "CPR:6"
    },
    {
        "id": "9832994.T7.T24",
        "sentence": "These data indicate that mixed 5-HT1/@CHEMICAL$ receptor antagonists such as pizotifen and @GENE$, and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin.",
        "relation": "CPR:6"
    },
    {
        "id": "9851542.T19.T32",
        "sentence": "The cardiovascular effects of three different @CHEMICAL$ inhibitors: @GENE$, tacrine and rivastigmine injected by intravenous (i.v.) route were compared in freely moving Wistar rats.",
        "relation": "CPR:4"
    },
    {
        "id": "9851542.T21.T32",
        "sentence": "The cardiovascular effects of three different @CHEMICAL$ inhibitors: physostigmine, @GENE$ and rivastigmine injected by intravenous (i.v.) route were compared in freely moving Wistar rats.",
        "relation": "CPR:4"
    },
    {
        "id": "9851542.T2.T32",
        "sentence": "The cardiovascular effects of three different @CHEMICAL$ inhibitors: physostigmine, tacrine and @GENE$ injected by intravenous (i.v.) route were compared in freely moving Wistar rats.",
        "relation": "CPR:4"
    },
    {
        "id": "9851542.T12.T33",
        "sentence": "@CHEMICAL$ was chosen as a model to study the mechanisms underlying the cardiovascular effects of i.v. @GENE$ inhibitors.",
        "relation": "CPR:4"
    },
    {
        "id": "9851542.T17.T34",
        "sentence": "The @CHEMICAL$ antagonist @GENE$ or the vasopressin V1 receptor antagonist, [beta-mercapto-beta,beta-cyclopenta-methylenepropionyl1, O-Me-Tyr2, Arg8] vasopressin partially but significantly reduced tacrine pressor effect and mostly abolished it when administered concomitantly.",
        "relation": "CPR:6"
    },
    {
        "id": "9851542.T20.T35",
        "sentence": "The alpha1-adrenoceptor antagonist prazosin or the @CHEMICAL$ antagonist, @GENE$ partially but significantly reduced tacrine pressor effect and mostly abolished it when administered concomitantly.",
        "relation": "CPR:6"
    },
    {
        "id": "9851542.T3.T24",
        "sentence": "administration of the non-selective @CHEMICAL$ antagonist @GENE$ (ID50 = 1.45 microg), the muscarinic M1 receptor antagonist pirenzepine (ID50 = 4.33 microg), the muscarinic M2 receptor antagonist methoctramine (ID50 = 1.39 microg) and the muscarinic M3 receptor antagonist para-fluoro-hexahydro-sila-difenidol (ID50 = 31.19 microg).",
        "relation": "CPR:6"
    },
    {
        "id": "9851542.T4.T25",
        "sentence": "administration of the non-selective muscarinic receptor antagonist atropine (ID50 = 1.45 microg), the @CHEMICAL$ antagonist @GENE$ (ID50 = 4.33 microg), the muscarinic M2 receptor antagonist methoctramine (ID50 = 1.39 microg) and the muscarinic M3 receptor antagonist para-fluoro-hexahydro-sila-difenidol (ID50 = 31.19 microg).",
        "relation": "CPR:6"
    },
    {
        "id": "9851542.T5.T26",
        "sentence": "administration of the non-selective muscarinic receptor antagonist atropine (ID50 = 1.45 microg), the muscarinic M1 receptor antagonist pirenzepine (ID50 = 4.33 microg), the @CHEMICAL$ antagonist @GENE$ (ID50 = 1.39 microg) and the muscarinic M3 receptor antagonist para-fluoro-hexahydro-sila-difenidol (ID50 = 31.19 microg).",
        "relation": "CPR:6"
    },
    {
        "id": "9851542.T6.T27",
        "sentence": "administration of the non-selective muscarinic receptor antagonist atropine (ID50 = 1.45 microg), the muscarinic M1 receptor antagonist pirenzepine (ID50 = 4.33 microg), the muscarinic M2 receptor antagonist methoctramine (ID50 = 1.39 microg) and the @CHEMICAL$ antagonist @GENE$ (ID50 = 31.19 microg).",
        "relation": "CPR:6"
    },
    {
        "id": "9876137.T8.T23",
        "sentence": "State-dependent @CHEMICAL$ block of @GENE$ isoforms, chimeras, and channels coexpressed with the beta1 subunit.",
        "relation": "CPR:4"
    },
    {
        "id": "9876137.T1.T10",
        "sentence": "@CHEMICAL$ block of @GENE$ and rat skeletal (mu1) muscle sodium channels was examined under whole-cell voltage clamp in transiently transfected HEK293t cells.",
        "relation": "CPR:4"
    },
    {
        "id": "9876137.T1.T15",
        "sentence": "@CHEMICAL$ block of human cardiac (hH1) and @GENE$ was examined under whole-cell voltage clamp in transiently transfected HEK293t cells.",
        "relation": "CPR:4"
    },
    {
        "id": "9876137.T5.T13",
        "sentence": "@CHEMICAL$ block of @GENE$ was greater than block of mu1 channels at voltages between -120 mV and -90 mV, suggesting that greater steady-state inactivation of hH1 channels in this voltage range makes them more susceptible to cocaine block.",
        "relation": "CPR:4"
    },
    {
        "id": "9876137.T5.T14",
        "sentence": "@CHEMICAL$ block of hH1 channels was greater than block of @GENE$ at voltages between -120 mV and -90 mV, suggesting that greater steady-state inactivation of hH1 channels in this voltage range makes them more susceptible to cocaine block.",
        "relation": "CPR:4"
    },
    {
        "id": "9876137.T5.T16",
        "sentence": "@CHEMICAL$ block of hH1 channels was greater than block of mu1 channels at voltages between -120 mV and -90 mV, suggesting that greater steady-state inactivation of @GENE$ in this voltage range makes them more susceptible to cocaine block.",
        "relation": "CPR:4"
    },
    {
        "id": "9876137.T6.T16",
        "sentence": "Cocaine block of hH1 channels was greater than block of mu1 channels at voltages between -120 mV and -90 mV, suggesting that greater steady-state inactivation of @CHEMICAL$ in this voltage range makes them more susceptible to @GENE$ block.",
        "relation": "CPR:4"
    }
]